data_2m8c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m8c _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.03 164.31 62.27 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.651 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 143.46 99.37 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.47 2.114 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.65 -40.67 88.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -138.78 141.6 38.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 9' ' ' ILE . 82.5 mt -110.02 127.69 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.4 mtp180 -101.65 117.56 35.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.157 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.6 104.71 2.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -127.87 119.52 25.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 18.2 t0 -113.23 91.89 20.62 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.069 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.309 -1.505 0 C-N-CA 122.466 2.111 . . . . 0.0 111.904 179.486 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.6 t0 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.142 0.496 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.66 -40.97 85.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.107 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.81 -37.7 82.89 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.095 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.39 -45.04 89.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.126 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.3 -47.9 80.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -53.22 -54.34 37.54 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.55 -40.25 62.35 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.102 0.477 . . . . 0.0 110.13 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.13 -42.02 80.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.945 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.2 m -54.13 -43.95 70.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.01 -47.12 81.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.225 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -59.86 -41.79 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.474 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.36 -18.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.81 52.59 4.22 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.354 0.409 . . . . 0.0 110.659 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 p -146.63 171.11 15.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -88.63 141.39 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.984 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.95 130.61 56.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.569 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.06 127.23 44.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.277 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.66 135.81 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.438 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.54 128.92 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.939 0.4 . . . . 0.0 110.423 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.46 139.2 58.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 175.37 129.88 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.0 146.43 71.09 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.632 2.221 . . . . 0.0 112.402 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.4 mt -40.44 -56.73 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.07 -27.14 2.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.39 -20.69 19.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.048 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.53 -42.41 95.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.622 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.62 -56.96 24.95 Favored Pre-proline 0 C--O 1.241 0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.667 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.6 Cg_exo -54.46 -43.52 58.04 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.435 2.09 . . . . 0.0 111.521 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.6 m -59.09 -44.32 91.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.777 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.42 -44.14 88.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 65' ' ' LYS . 54.0 mtmt -64.6 -39.95 94.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.46 11.29 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.96 12.12 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.762 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.63 78.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.51 152.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -92.98 -20.59 20.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.23 156.18 26.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.489 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.29 127.11 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.451 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -128.32 105.9 8.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.268 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.659 ' HG ' ' H ' ' A' ' 73' ' ' SER . 47.9 t -159.33 179.87 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.659 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -64.78 -15.14 61.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.427 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.622 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.2 tp -36.4 123.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.583 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.73 154.72 25.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.778 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -104.82 148.35 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.2 p -149.62 152.53 35.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.738 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.37 -46.89 56.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.99 -40.17 72.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.479 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.622 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.8 mtt180 -68.09 -37.9 81.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.15 -37.83 75.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.994 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.03 -27.44 66.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.16 7.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.554 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.7 pt -139.28 -168.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.28 146.92 29.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.83 149.81 51.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.668 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.7 t -164.09 -152.81 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.512 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.668 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.7 m-20 41.86 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.948 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.63 121.07 0.2 Allowed 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.61 0.569 . . . . 0.0 110.522 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.3 mt -75.13 -68.37 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.866 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -150.71 167.27 27.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.705 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.5 123.22 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.306 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.87 67.96 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.642 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.64 -104.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.38 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.9 p -159.76 166.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.635 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.35 145.99 22.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.22 135.9 41.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.49 110.98 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.5 164.14 34.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.732 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.17 148.33 25.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.924 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.68 -27.63 41.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.53 -41.66 90.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.273 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -102.17 122.0 43.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.802 0.334 . . . . 0.0 110.143 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.11 109.55 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 105' ' ' ILE . 96.9 mt -128.33 129.75 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.623 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.83 159.02 34.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.358 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.466 ' C ' ' HG1' ' A' ' 108' ' ' THR . 18.7 Cg_endo -59.76 89.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.74 2.293 . . . . 0.0 111.934 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.466 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 7.0 m -168.5 140.53 2.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.798 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -66.74 -33.05 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.185 0.516 . . . . 0.0 110.218 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.51 -62.37 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.612 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.19 -22.31 28.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 110.859 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -76.32 -25.89 55.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -54.56 132.69 45.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.612 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -16.57 30.25 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -85.85 151.22 23.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.35 135.91 37.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.244 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.38 136.51 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.702 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.43 139.98 14.9 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.3 t -132.01 161.59 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 42.2 tp -92.92 119.04 31.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.488 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.9 157.3 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.79 47.99 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.4 p -149.51 168.14 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.26 -25.71 59.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -61.14 -55.16 35.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.43 -54.08 50.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.38 -51.15 70.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.542 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.594 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.3 t80 -62.23 -43.81 97.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.466 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.49 -44.53 97.88 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.82 -14.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.42 -34.66 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.594 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.7 t60 -74.47 -50.43 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.435 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.37 12.53 36.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.139 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.91 -55.52 0.47 Allowed Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.416 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.466 ' CD ' ' O ' ' A' ' 131' ' ' GLU . 56.6 Cg_endo -72.27 -10.32 25.54 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.727 2.285 . . . . 0.0 111.984 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.53 -9.18 59.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.26 37.88 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.32 137.94 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.59 129.62 35.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.64 138.52 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.54 131.89 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 t -98.16 130.33 44.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.603 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -111.44 156.23 21.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.278 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.03 6.48 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.742 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.62 130.66 6.22 Favored Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.92 -45.87 80.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 110.459 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.55 -23.61 62.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.66 -36.93 85.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.95 -46.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.316 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.511 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.3 m-85 -64.04 -37.85 88.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.02 -42.45 98.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.049 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.442 ' N ' ' HG ' ' A' ' 151' ' ' SER . 54.4 m-20 -63.87 -44.45 93.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.108 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -59.09 -47.86 83.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.147 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.05 -23.15 67.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.176 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.66 25.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.07 71.05 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.26 -18.39 63.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.8 pt -127.7 137.64 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.09 0.471 . . . . 0.0 110.554 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.99 -28.35 62.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.964 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.41 155.71 1.88 Allowed 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.72 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.97 103.18 14.44 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.2 tt0 -132.96 165.27 25.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.509 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.432 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.82 152.13 41.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.658 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.13 -54.23 28.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.647 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.8 -48.63 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.303 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.8 88.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 110.644 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.36 -63.28 1.18 Allowed 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.362 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 73.7 m -59.15 -47.18 86.25 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.92 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.55 -36.8 24.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.72 -64.99 0.52 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.7 t80 -41.34 -71.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.877 0.37 . . . . 0.0 111.009 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.73 -40.03 93.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.7 -3.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.499 ' H ' ' C ' ' A' ' 173' ' ' LEU . 54.5 mt-30 -122.71 149.34 55.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.49 -20.27 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.796 2.331 . . . . 0.0 112.175 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.76 -42.98 94.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.495 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.2 84.2 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.63 -41.73 95.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 0.0 110.333 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.1 m-20 -65.4 -34.09 77.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.514 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.6 m-85 -155.82 142.62 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.58 99.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.471 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.22 167.29 29.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.43 56.24 2.87 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.05 -117.88 0.01 OUTLIER Glycine 0 CA--C 1.543 1.789 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.76 136.28 35.0 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -125.08 -108.64 0.32 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.408 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.0 p -165.84 164.85 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.939 -0.553 . . . . 0.0 109.807 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.19 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.373 1.046 . . . . 0.0 110.675 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -82.15 118.05 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.801 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -72.03 -18.89 61.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.48 -32.54 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.9 -44.26 97.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.712 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.3 m-85 -114.48 9.63 16.76 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.691 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.97 -153.52 51.33 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.74 -25.47 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.324 . . . . 0.0 110.447 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.21 -123.92 1.28 Allowed Glycine 0 N--CA 1.46 0.245 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -129.6 156.23 44.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.69 -169.61 30.52 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -95.0 138.99 31.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.535 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.87 107.56 3.25 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.9 mt -119.76 159.54 24.32 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.1 mtm180 -86.98 149.04 25.05 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.71 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.29 -48.07 65.55 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.712 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -40.51 -23.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.709 0.29 . . . . 0.0 110.666 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.57 52.06 0.2 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.28 -45.74 86.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.87 -47.08 32.06 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.47 -43.94 97.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.14 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.873 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.51 -36.98 72.26 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.772 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.57 -77.37 0.11 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 212' ' ' ALA . 89.7 mt -29.14 -45.49 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.247 0.342 . . . . 0.0 110.692 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.439 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.3 m-20 -64.04 -45.07 90.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.731 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.57 -43.61 98.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.893 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.15 93.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.28 -43.72 98.41 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.086 0.47 . . . . 0.0 110.145 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.21 91.9 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.529 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -42.35 98.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.092 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.525 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.39 -38.47 77.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.44 -39.88 81.35 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.404 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.1 92.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.522 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.525 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.8 p30 -86.33 1.04 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.482 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.2 19.42 61.71 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 73.4 m -58.13 -45.94 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.086 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 77.3 t80 -63.5 -57.14 11.15 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.9 mt-10 -57.38 -41.05 79.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.185 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.01 -48.28 82.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.09 -41.82 98.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.293 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.8 -49.84 76.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.65 -35.56 72.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.393 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -70.59 -50.9 32.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.617 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.507 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.5 m-85 -61.97 -45.62 92.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.484 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -154.82 156.1 35.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.39 99.3 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.022 0.439 . . . . 0.0 110.409 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -156.24 -166.32 2.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.412 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.3 t0 -122.71 110.8 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.44 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 92.8 m-85 -59.22 -42.54 91.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.35 94.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 117.817 -1.546 . . . . 0.0 110.968 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.8 54.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.06 143.62 99.15 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.417 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.15 -40.49 90.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.597 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.9 143.18 36.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.414 HD12 HG21 ' A' ' 9' ' ' ILE . 84.1 mt -110.19 128.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.86 116.51 32.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.27 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.8 mt -111.28 138.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.351 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.43 104.44 2.11 Favored Glycine 0 N--CA 1.462 0.409 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.6 m -127.53 119.1 25.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 110.631 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 21.5 t70 -113.55 92.55 24.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.966 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 C--N 1.31 -1.474 0 C-N-CA 122.531 2.154 . . . . 0.0 111.767 179.592 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.7 t0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 121.102 0.477 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.76 -41.74 85.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.236 0.541 . . . . 0.0 111.282 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 48.9 m-20 -60.95 -37.48 82.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.815 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.05 -43.83 86.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.183 0.516 . . . . 0.0 110.555 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.15 -41.47 92.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.316 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.2 -52.89 63.73 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.535 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.21 -37.2 64.29 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.034 0.445 . . . . 0.0 109.891 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.47 -42.58 78.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.129 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.74 -44.36 73.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.125 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.07 -46.92 82.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.23 0.538 . . . . 0.0 110.399 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -60.28 -40.87 91.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.94 -17.82 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.705 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.74 52.16 4.51 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.706 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.19 170.12 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.2 140.22 29.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.008 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -116.81 131.49 56.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.04 127.5 43.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.436 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -94.06 135.52 35.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.5 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.5 128.92 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.988 0.423 . . . . 0.0 110.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.9 139.48 58.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.483 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.1 p30 175.68 131.43 0.16 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.778 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.8 Cg_endo -68.08 145.41 67.11 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.613 2.209 . . . . 0.0 112.602 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 58' ' ' LEU . 82.3 mt -40.37 -56.51 1.99 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -47.88 -26.66 1.77 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.855 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.1 -20.51 19.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.124 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 55' ' ' LEU . 58.1 mt -64.16 -42.47 96.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.563 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -63.17 -56.23 29.66 Favored Pre-proline 0 C--O 1.242 0.66 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.919 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.1 Cg_exo -55.29 -42.7 65.88 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.486 2.124 . . . . 0.0 111.202 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 68.7 m -58.96 -44.12 91.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.866 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.191 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.36 -40.27 95.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.4 11.1 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.631 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.35 11.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.755 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.18 -34.74 78.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.667 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.72 153.09 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.31 -20.87 19.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.7 156.72 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.493 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.6 127.02 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.5 ttp -128.4 106.66 9.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.247 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.639 ' HG ' ' H ' ' A' ' 73' ' ' SER . 42.3 t -160.35 -178.23 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.585 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.639 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -64.15 -15.32 59.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.48 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.621 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -38.27 123.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.614 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.34 156.88 22.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -105.15 149.05 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -149.83 152.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.27 -47.03 55.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.647 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.33 -40.05 73.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.301 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.621 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -67.92 -37.92 82.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.226 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.26 -37.05 74.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.56 -27.43 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.257 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.31 -51.73 7.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.615 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.4 -168.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.74 146.67 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 110.73 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -129.79 149.88 51.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.709 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.667 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.5 t -164.4 -151.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.667 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.2 m-20 43.23 19.52 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.83 120.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.652 0.595 . . . . 0.0 110.509 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -77.18 -69.29 0.54 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.92 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -149.62 166.17 30.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.517 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.98 122.31 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.387 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.59 69.39 0.98 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.538 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.9 -105.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -158.85 165.63 33.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.59 145.79 21.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.85 136.13 41.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 110.92 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.833 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.37 164.93 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 0.0 110.714 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.7 148.53 23.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.866 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.49 -28.29 59.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.01 -41.85 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.245 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -101.71 122.04 43.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.121 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.16 109.7 19.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -126.63 129.63 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.636 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.01 154.25 41.25 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.553 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.65 91.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -170.74 144.35 2.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.22 -33.72 62.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 110.229 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.65 -62.04 2.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.607 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -56.65 -22.05 31.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.725 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -76.47 -25.62 54.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.18 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.59 47.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -16.09 30.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.73 151.67 23.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.217 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.23 135.21 38.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.2 t -126.74 136.2 61.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.02 138.81 14.38 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.13 161.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.239 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.0 tp -92.53 117.69 30.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.399 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.72 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.585 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.93 50.39 52.93 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.77 168.84 22.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.456 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 71.6 p -73.29 -26.82 61.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.372 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.62 -55.03 38.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.605 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.507 ' CD ' ' HG ' ' A' ' 142' ' ' SER . 80.7 tt0 -57.21 -54.38 47.47 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.497 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -60.41 -51.37 69.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.64 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.01 -44.02 97.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.346 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.59 -44.49 97.89 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.67 -14.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.213 . . . . 0.0 110.705 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.3 tt0 -125.53 -34.53 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.565 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.65 -50.62 17.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.28 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -99.42 12.26 36.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.096 0.474 . . . . 0.0 111.133 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.69 -55.55 0.48 Allowed Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.483 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.471 ' CD ' ' O ' ' A' ' 131' ' ' GLU . 56.8 Cg_endo -72.4 -10.23 25.23 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.751 2.301 . . . . 0.0 112.039 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.38 -8.93 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.58 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.12 33.09 37.23 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.51 137.98 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.76 129.89 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.4 138.13 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.99 133.06 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.507 ' HG ' ' CD ' ' A' ' 126' ' ' GLU . 7.7 t -96.86 127.25 42.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.83 153.33 25.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.32 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.94 6.95 29.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.43 130.44 6.01 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.98 -45.72 80.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.56 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.51 -23.46 62.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.47 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.461 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.7 -36.98 86.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -65.85 -46.86 87.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.366 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.09 -37.85 88.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.218 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.98 -44.52 92.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.181 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.31 -47.64 84.65 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.087 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.06 -23.0 67.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.15 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.59 -18.24 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.48 11.73 71.14 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.87 -18.05 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.86 137.73 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 110.527 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.21 -28.44 62.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.07 155.63 2.0 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.795 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.51 50.51 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -86.08 103.05 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.6 tt0 -132.6 164.68 26.12 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -72.99 152.6 41.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.392 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.6 mt-10 -65.7 -54.04 32.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.406 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.75 -48.7 87.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.428 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.93 87.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.844 0.354 . . . . 0.0 110.429 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.16 -63.68 1.08 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.8 m -58.92 -46.97 86.64 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.812 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 80.8 tt0 -49.95 -37.48 32.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.228 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.2 -65.39 0.54 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.658 ' N ' ' O ' ' A' ' 168' ' ' ALA . 29.7 t80 -40.74 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.831 0.348 . . . . 0.0 111.089 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -61.88 -39.6 92.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.62 -3.96 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.276 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 173' ' ' LEU . 22.8 mt-30 -123.46 142.01 37.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -43.95 -15.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.82 2.347 . . . . 0.0 112.132 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.8 t -62.8 -42.96 98.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.438 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.83 -32.85 80.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.99 -41.55 96.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.2 m-20 -65.78 -34.63 78.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.687 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.08 143.53 18.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.635 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.2 pttt -177.16 99.57 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.117 0.484 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.6 m-85 -159.19 168.21 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.631 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.42 55.96 3.1 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.68 -116.78 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.0 135.43 36.78 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.102 1.868 . . . . 0.0 111.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.8 p -125.25 -108.38 0.32 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.315 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.57 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.97 164.8 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 119.03 -0.51 . . . . 0.0 109.929 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.07 155.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.259 0.975 . . . . 0.0 110.539 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.75 117.97 23.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.808 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.67 -19.02 62.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.24 -32.06 73.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.08 -43.94 98.12 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.735 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.456 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.95 7.33 16.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 0.0 110.689 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.3 -155.09 50.01 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.43 -25.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.863 0.363 . . . . 0.0 110.593 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.05 -126.08 1.54 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -131.91 159.7 37.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.89 25.4 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.501 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.13 141.16 31.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.2 112.02 3.99 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.8 mt -121.18 160.35 23.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.85 149.04 25.11 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.705 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.44 -48.2 65.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -40.9 -22.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.602 0.239 . . . . 0.0 110.587 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.86 52.09 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.431 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.31 -46.3 84.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.42 -46.93 36.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.5 tp -62.44 -43.93 97.65 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.359 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.24 -42.76 99.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.974 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.74 -37.37 73.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.948 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.6 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.1 mt -29.15 -45.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.316 0.385 . . . . 0.0 110.843 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.442 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.4 m-20 -64.16 -45.1 89.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.64 -43.57 98.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.945 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.15 92.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.307 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.05 -43.66 98.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.175 0.512 . . . . 0.0 110.312 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.27 91.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.319 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -64.07 -41.79 97.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.291 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.6 mtp -58.04 -38.19 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.49 -38.9 77.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.418 . . . . 0.0 110.554 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.15 93.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.1 p-10 -88.72 0.42 56.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.33 68.47 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -58.38 -45.85 87.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.4 t80 -63.43 -57.53 9.99 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.1 mt-10 -57.01 -41.06 77.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.402 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.07 -48.12 82.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.338 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.07 -41.59 98.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.333 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.84 76.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.6 -35.86 73.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.43 -50.91 33.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.465 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.513 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.5 -45.46 92.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.35 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.7 m-85 -153.76 155.32 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.416 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.15 98.54 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 110.458 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -155.42 -165.49 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.465 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.56 109.37 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -63.75 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 85.2 m-85 -57.18 -43.64 82.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.0 94.17 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.425 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.899 -1.5 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.5 164.43 59.96 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.689 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.07 143.69 99.11 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.658 2.239 . . . . 0.0 112.244 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.405 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.39 -40.83 89.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.75 139.2 38.23 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.361 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.1 121.1 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.8 118.59 31.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.5 138.23 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.305 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.57 105.39 2.14 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.8 m -128.73 120.84 27.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 122.687 -0.302 . . . . 0.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.8 t70 -114.29 92.61 28.05 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.918 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--N 1.309 -1.544 0 C-N-CA 122.499 2.133 . . . . 0.0 111.851 179.442 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 121.0 0.428 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.76 -40.79 84.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.939 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.97 -37.5 82.66 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.718 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.49 -44.94 89.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.117 0.484 . . . . 0.0 110.164 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.54 -48.16 80.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.901 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.26 -53.87 44.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.437 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.87 -40.32 63.33 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.029 0.442 . . . . 0.0 109.951 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.87 -42.08 81.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.57 -45.1 69.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.169 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.31 -46.34 83.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.277 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -60.55 -42.1 95.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.194 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.36 -17.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.718 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.94 52.75 4.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.78 171.09 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.975 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.81 142.18 27.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.995 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.1 m -117.14 131.06 56.97 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.617 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.15 126.94 43.75 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.4 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -93.73 134.69 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.98 128.14 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.027 0.442 . . . . 0.0 110.344 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.14 137.79 57.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.557 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.53 131.68 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.75 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -67.77 144.51 65.65 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.665 2.244 . . . . 0.0 112.732 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.3 mt -39.87 -55.44 1.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.96 0.41 . . . . 0.0 111.261 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.71 -26.33 2.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.08 -21.11 18.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.13 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.7 -42.64 97.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.748 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 mm -62.22 -56.66 28.97 Favored Pre-proline 0 C--O 1.242 0.67 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.795 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.8 Cg_exo -56.09 -41.69 74.26 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.551 2.167 . . . . 0.0 110.947 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 70.6 m -59.08 -44.48 91.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.968 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.38 -43.91 92.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.269 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.32 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.493 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.17 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.25 11.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.37 -35.53 80.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 pt -122.43 152.78 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.0 -22.53 19.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.19 155.71 27.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.616 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.98 129.08 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.96 0.409 . . . . 0.0 110.384 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -131.28 106.82 8.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 110.231 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.655 ' HG ' ' H ' ' A' ' 73' ' ' SER . 42.1 t -159.05 178.47 10.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.577 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.655 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.2 p -65.24 -15.2 62.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.513 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.613 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.24 124.5 0.61 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.673 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.542 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.8 154.26 26.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.677 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.0 148.65 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 p -149.07 152.3 35.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.738 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -46.92 53.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.004 0.431 . . . . 0.0 110.463 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.06 -39.63 72.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.613 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.81 -37.9 79.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.015 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.85 -38.48 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.23 -27.34 67.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.33 -51.11 7.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.4 pt -138.98 -168.21 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.986 0.422 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.25 147.57 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.135 0.493 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -129.86 149.92 51.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.655 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.36 -153.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.456 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.655 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.7 m-20 41.66 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.944 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.35 0.2 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.594 0.559 . . . . 0.0 110.559 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.428 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.2 mt -75.23 -68.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -150.49 167.17 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.637 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.83 123.38 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.85 68.55 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.663 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.83 -104.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.322 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.3 p -159.37 165.98 32.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.63 146.11 21.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.47 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.95 136.23 41.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.816 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.37 164.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.937 0.399 . . . . 0.0 110.679 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.56 24.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.07 -27.85 47.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.04 -41.66 88.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.344 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.0 t -102.4 122.36 44.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.01 109.36 19.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.89 129.84 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.29 159.06 33.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.444 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.5 Cg_endo -60.11 89.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.777 2.318 . . . . 0.0 112.008 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.9 m -168.82 140.99 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.94 -33.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 110.225 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.22 -22.04 26.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.888 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.3 mt -76.72 -25.83 53.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.16 46.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.507 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.9 -15.85 30.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.54 151.32 23.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 110.308 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.02 135.55 37.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.278 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.3 136.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.53 138.68 14.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.2 t -130.88 161.61 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.255 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.494 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 45.1 tp -92.38 117.57 30.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.578 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -51.87 157.57 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.61 50.23 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -149.96 168.87 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 110.795 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.4 p -73.7 -26.52 60.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.412 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.78 -55.15 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.598 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.02 -54.72 43.57 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.461 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.07 -51.33 70.08 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.504 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -61.8 -44.12 97.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 110.489 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.59 -44.47 97.92 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.76 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.575 0.226 . . . . 0.0 110.647 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.517 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.29 -34.62 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.68 -50.67 16.75 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.331 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.19 12.25 36.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.208 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.69 -55.51 0.48 Allowed Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.429 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.13 -10.28 25.68 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.802 2.334 . . . . 0.0 111.969 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.73 -8.92 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.561 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.77 33.46 37.58 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.52 137.83 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.35 129.74 34.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.254 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.6 pt -126.34 138.09 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.21 133.12 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.33 127.57 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.84 153.67 25.08 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.282 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.0 7.05 29.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.621 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.54 130.5 6.02 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.78 -45.82 81.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.54 -23.67 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.523 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.69 -36.82 85.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 149' ' ' ILE . 96.5 mt -66.19 -47.03 85.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.521 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.64 -37.98 89.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.361 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.8 p -61.06 -42.26 98.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.023 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.16 -44.58 91.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.12 -47.81 83.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.097 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.7 m -63.49 -22.77 67.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.992 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.19 -18.6 25.44 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.579 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.97 11.04 70.85 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.32 -17.92 63.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.623 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -128.23 137.36 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.12 0.486 . . . . 0.0 110.424 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.86 -27.43 61.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.59 155.98 1.84 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.17 136.88 49.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.9 0.381 . . . . 0.0 110.005 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -85.41 103.3 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.0 tt0 -133.04 165.21 25.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.46 152.12 42.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.772 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.05 -54.53 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 72.6 t -60.2 -48.44 88.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.586 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.94 90.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 0.0 110.457 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.64 -62.97 1.26 Allowed 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.2 m -59.61 -47.83 84.04 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.914 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -49.56 -36.7 24.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.179 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.424 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.39 -66.17 0.54 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.1 t80 -40.68 -70.7 0.1 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.655 0.264 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.58 -40.12 93.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -60.69 -3.19 0.66 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.302 0.572 . . . . 0.0 110.254 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.5 mt-30 -122.15 147.6 49.72 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.35 -19.12 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.844 2.362 . . . . 0.0 112.034 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.8 -43.21 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.524 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.99 -32.95 83.98 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.53 -41.09 93.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.758 0.313 . . . . 0.0 110.458 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -66.16 -32.9 74.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.53 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.0 m-85 -156.51 142.53 18.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.545 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -176.82 99.56 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.31 166.99 30.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.7 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.23 -117.71 0.01 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.89 136.01 35.97 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.266 1.977 . . . . 0.0 111.928 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.9 p -125.41 -108.02 0.32 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.78 165.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.039 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 154.04 156.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.379 1.049 . . . . 0.0 110.502 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.26 117.35 22.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.904 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.32 -18.85 62.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.66 -32.53 74.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.1 -44.15 97.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.727 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.5 m-85 -114.46 9.66 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.628 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.08 -154.77 52.29 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.32 -25.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.38 -123.97 1.28 Allowed Glycine 0 N--CA 1.46 0.24 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.56 156.25 44.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.54 -169.76 30.56 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.04 137.7 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.65 108.32 3.3 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.3 mt -123.54 159.2 29.66 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 120.672 0.273 . . . . 0.0 110.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -86.79 149.51 24.8 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.712 0.292 . . . . 0.0 110.757 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.68 -47.79 63.73 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.746 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.72 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.42 52.23 0.19 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.505 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.38 -45.77 86.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.34 -47.26 35.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.52 -43.86 97.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.4 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.79 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.0 -36.19 70.12 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.687 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.15 -77.42 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.2 mt -28.17 -46.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.971 0.415 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.44 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.0 m-20 -64.6 -44.71 89.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.781 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.98 -43.86 97.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.026 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.05 93.12 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.29 -43.55 98.69 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.16 0.505 . . . . 0.0 110.166 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.12 92.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.258 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.531 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.9 -41.92 97.58 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.523 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -59.1 -38.0 78.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.78 -39.84 79.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.066 0.46 . . . . 0.0 110.34 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.07 92.21 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.519 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.3 p30 -86.26 1.09 52.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.504 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.97 19.43 61.22 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 68.3 m -58.41 -45.64 88.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.428 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 81.6 t80 -63.55 -58.25 7.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.936 0.398 . . . . 0.0 110.351 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.2 mt-10 -56.54 -41.37 76.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.486 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.96 -48.4 81.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.98 -41.59 98.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.84 -50.28 74.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.4 -35.41 71.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.478 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.03 -50.84 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.1 m-85 -62.2 -45.57 92.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.5 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.87 155.53 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.373 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.3 p-10 -97.56 95.93 7.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 110.491 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -153.63 -166.01 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.92 110.4 15.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.7 m -63.69 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.584 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 89.9 m-85 -57.8 -43.53 85.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.25 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.47 94.9 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.23 164.61 59.69 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.745 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.09 143.69 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.21 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.31 -40.4 89.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.74 143.2 36.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.37 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -110.36 128.68 66.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.381 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.8 mtp180 -104.38 118.16 35.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.04 139.2 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.03 104.69 2.19 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.8 m -127.72 118.33 23.6 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.659 -0.318 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.2 t70 -113.38 92.59 23.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.912 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.31 -1.451 0 C-N-CA 122.467 2.111 . . . . 0.0 111.965 179.594 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.44 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.0 t0 . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.954 0.407 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.55 -40.79 82.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.987 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.7 m-20 -60.65 -37.79 82.68 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.985 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.19 -43.89 85.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.499 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.1 -41.73 93.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -58.83 -53.13 61.83 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.638 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.93 -37.06 63.44 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.01 -42.4 76.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.121 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.6 -44.62 73.22 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.229 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -64.02 -47.18 81.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.254 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -59.86 -40.72 89.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.092 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.53 -17.78 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.774 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.66 52.4 4.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.24 170.06 17.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.04 140.26 29.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.028 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.0 m -116.91 131.52 56.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.19 127.71 43.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.476 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -94.26 135.97 35.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.406 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.57 128.68 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.77 140.02 58.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 174.97 131.68 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.724 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.21 145.43 66.38 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.678 2.252 . . . . 0.0 112.576 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 58' ' ' LEU . 81.6 mt -40.14 -56.91 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.4 -26.75 1.41 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.986 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.29 -20.76 18.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.123 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 55' ' ' LEU . 59.0 mt -63.97 -42.49 97.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.731 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.568 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.38 -56.64 28.59 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 123.698 0.624 . . . . 0.0 109.67 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.49 -42.24 70.0 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.534 2.156 . . . . 0.0 111.025 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -58.86 -44.18 90.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.787 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.09 -44.29 91.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.83 -40.52 95.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.476 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.51 10.9 1.84 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.31 11.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.31 -34.13 77.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.551 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.96 154.16 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -92.81 -20.83 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.99 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.82 158.88 23.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.583 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 70' ' ' ILE . 96.5 mt -115.82 127.02 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-O 120.945 0.402 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.44 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -127.5 106.05 8.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.268 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 t -161.07 -177.4 6.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.591 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.28 -15.05 59.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.369 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.619 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.8 tp -38.27 123.23 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.552 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.45 156.58 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.685 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.6 pt -105.21 149.39 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -150.25 152.85 35.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.667 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.26 -47.56 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.025 0.44 . . . . 0.0 110.51 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.66 -39.93 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.63 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.619 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.41 -37.67 80.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.004 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -37.39 74.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.111 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.15 -51.94 7.06 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.48 -168.29 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-O 121.04 0.448 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.91 146.73 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.832 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -129.93 149.94 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.607 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.681 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.7 t -164.48 -151.67 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.681 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.2 m-20 43.74 19.26 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.99 119.92 0.11 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.483 0.489 . . . . 0.0 110.631 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.66 -70.14 0.5 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.722 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -148.91 165.72 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.523 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.98 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.374 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.25 68.97 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.51 -104.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.329 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.37 165.86 32.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.599 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.62 146.02 21.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -101.47 136.31 41.53 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.57 111.22 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.73 164.86 32.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.78 148.45 23.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -27.83 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.247 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.89 -41.85 88.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -102.55 122.45 44.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.146 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.85 109.36 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.415 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.28 130.07 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.593 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.03 159.01 34.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.472 ' C ' ' HG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.96 90.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.813 2.342 . . . . 0.0 111.994 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.472 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 7.1 m -168.97 141.56 2.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.69 -33.33 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 110.343 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.59 -62.24 1.93 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.43 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.35 -22.0 28.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.866 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.64 -25.74 54.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.286 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.87 133.28 47.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.472 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.86 -15.79 30.15 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.49 151.33 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.898 0.38 . . . . 0.0 110.378 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.09 135.14 38.28 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.99 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.658 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.65 14.34 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 54.8 t -130.75 161.59 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.2 tp -92.41 117.67 30.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.81 157.51 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.694 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.92 50.58 51.89 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.6 p -149.63 168.68 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.777 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 68.6 p -73.09 -27.3 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.3 -54.84 40.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.467 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.3 -54.38 47.4 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.378 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.62 -51.6 68.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.6 t80 -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.028 0.442 . . . . 0.0 110.457 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.66 -44.31 98.1 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.62 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.603 0.239 . . . . 0.0 110.705 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.66 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.4 -50.83 16.98 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.392 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.2 12.74 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.474 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.11 -55.6 0.46 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.369 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.17 -10.48 25.91 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.963 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.46 -8.73 59.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.53 36.97 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.77 137.88 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.481 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.51 130.03 34.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.51 138.1 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.09 133.22 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.051 0.453 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.94 127.11 42.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -110.74 153.62 25.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.02 6.83 29.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.12 130.34 5.88 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.92 -45.67 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.484 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.84 -24.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.497 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.59 -36.38 84.04 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.14 -46.95 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.062 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.0 m-85 -63.82 -37.66 88.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.343 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.23 -42.78 99.19 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.121 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.429 ' N ' ' HG ' ' A' ' 151' ' ' SER . 53.9 m-20 -63.95 -44.5 92.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -59.0 -48.24 82.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.079 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.7 m -62.88 -22.92 67.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.09 26.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.571 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.35 11.58 71.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -17.82 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 35.6 pt -128.31 137.77 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.113 0.483 . . . . 0.0 110.487 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.8 -28.36 62.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.59 155.7 1.8 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.819 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.53 50.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.064 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.53 103.15 14.13 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.08 0.467 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 46.9 tt0 -132.27 164.74 25.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.437 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -73.02 152.03 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -65.91 -54.2 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.3 -48.98 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.524 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.09 89.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.25 -63.25 1.19 Allowed 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.437 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.5 m -58.85 -47.11 86.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.861 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -50.06 -37.04 31.53 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.02 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.13 -65.85 0.55 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.71 -70.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.802 -0.234 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.65 -39.98 93.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.874 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.455 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.62 -3.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.627 . . . . 0.0 110.367 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.6 mt-30 -124.21 141.62 37.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.807 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.87 -14.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.859 2.372 . . . . 0.0 112.319 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 175' ' ' GLN . 77.9 t -63.47 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.486 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.75 79.59 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.01 -41.35 96.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.773 0.321 . . . . 0.0 110.388 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.4 m-20 -65.9 -34.7 78.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.756 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.3 m-85 -156.98 143.26 18.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.85 99.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.758 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.2 m-85 -159.28 168.01 27.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.33 55.76 3.17 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.91 -116.99 0.01 OUTLIER Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.12 135.92 37.7 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.295 1.997 . . . . 0.0 112.016 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.0 p -124.97 -108.02 0.33 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.513 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.87 165.25 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.98 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.35 155.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.436 1.085 . . . . 0.0 110.476 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.09 118.31 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.911 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.3 mp0 -71.87 -18.74 62.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.76 -31.96 73.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.99 -44.24 97.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.754 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.3 m-85 -113.69 7.2 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.724 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.53 -155.33 49.9 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.43 -25.54 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.834 0.35 . . . . 0.0 110.551 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.09 -125.84 1.5 Allowed Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.3 p -132.15 160.03 37.22 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.862 0.363 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.7 25.27 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -98.17 141.41 31.12 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 110.493 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.38 3.89 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -119.52 160.57 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.37 149.04 24.75 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.574 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.03 -48.73 64.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.809 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -40.83 -22.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.828 0.347 . . . . 0.0 110.657 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.07 51.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.66 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.38 -46.1 84.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.762 0.315 . . . . 0.0 111.108 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.43 -47.14 35.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.42 -43.7 98.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.446 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.38 -42.94 99.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.881 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.67 -37.52 73.55 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.897 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.24 -77.57 0.1 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.5 mt -28.63 -45.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.942 0.401 . . . . 0.0 110.813 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.442 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.4 m-20 -63.76 -45.18 90.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.54 -43.68 98.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.2 92.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.205 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.16 -43.58 98.66 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.144 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.32 92.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.85 -42.52 97.55 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.022 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.499 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.13 -38.22 73.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.65 -38.83 77.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.114 0.483 . . . . 0.0 110.415 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.53 92.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.674 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.34 0.43 56.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.783 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.67 20.2 67.91 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.8 m -57.91 -46.08 85.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.0 t80 -63.54 -57.6 9.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.88 -41.7 78.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.347 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -48.42 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.42 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.84 -41.54 97.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.366 . . . . 0.0 110.446 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.16 -49.78 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.632 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -35.86 73.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.399 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.58 -50.94 31.98 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.449 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.35 -45.23 94.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.502 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.8 m-85 -153.47 154.96 35.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.0 p-10 -98.21 96.95 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 110.509 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -154.09 -165.11 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.518 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.426 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.68 109.24 14.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.79 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.578 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 83.9 m-85 -56.79 -43.63 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.1 -37.16 94.47 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.744 0 CA-C-O 117.907 -1.496 . . . . 0.0 110.938 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.7 164.66 53.36 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.763 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.0 143.83 99.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.654 2.236 . . . . 0.0 112.267 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.26 -40.59 90.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.42 142.73 37.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.05 128.71 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.029 0.442 . . . . 0.0 110.318 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.02 117.45 34.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.311 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.0 140.57 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.278 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.24 105.39 1.96 Allowed Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 77.2 m -127.76 120.8 28.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.722 -0.281 . . . . 0.0 110.617 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.3 t70 -112.73 93.99 26.57 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.31 -1.482 0 C-N-CA 122.518 2.145 . . . . 0.0 111.778 179.503 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 28.7 t0 . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 121.044 0.45 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -66.75 -40.55 86.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.985 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -61.15 -36.97 81.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.723 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.98 -45.07 87.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.426 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.27 -46.86 85.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.974 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.89 -53.82 47.25 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.516 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.21 -39.13 66.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.947 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.98 -43.15 79.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.7 m -54.4 -43.63 71.64 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.26 -47.02 81.2 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 110.328 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mmt-85 -60.35 -41.17 93.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.018 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -75.75 -18.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.755 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.52 51.92 3.9 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.76 170.14 17.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.956 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.45 141.74 28.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.006 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.4 m -117.76 132.11 56.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.573 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -127.16 126.16 42.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.01 135.96 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.48 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.99 129.21 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.076 0.465 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.04 139.97 56.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.512 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.41 135.07 0.17 Allowed Pre-proline 0 N--CA 1.445 -0.683 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.18 143.8 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.631 2.221 . . . . 0.0 112.705 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.5 mt -40.48 -54.45 2.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.036 0.446 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.92 -26.44 2.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.54 -21.01 19.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.2 mt -64.14 -42.77 96.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.787 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.544 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.0 -56.46 31.49 Favored Pre-proline 0 C--O 1.242 0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.743 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.544 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 52.2 Cg_exo -55.64 -42.33 68.68 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.021 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -58.84 -44.27 90.89 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.822 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -59.06 -44.36 91.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.8 -40.86 95.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.582 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 56.06 11.92 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.796 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.25 -33.93 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.04 153.53 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.367 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.08 -21.33 20.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.14 158.52 24.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.495 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.0 128.02 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.395 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -129.52 107.42 9.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 110.222 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.665 ' HG ' ' H ' ' A' ' 73' ' ' SER . 35.2 t -162.06 -178.68 6.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.665 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -64.26 -15.77 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.622 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -35.53 122.46 0.63 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.6 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -80.95 154.23 27.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.694 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.4 pt -105.02 148.17 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.4 p -150.14 152.86 35.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.16 -46.85 54.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.6 -40.18 71.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.469 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.622 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.2 mtt180 -68.32 -37.99 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.023 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 84' ' ' ILE . 87.9 mt-30 -57.88 -38.0 74.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.089 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.07 -27.81 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.213 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.86 -50.79 8.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.725 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -139.78 -166.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.969 0.414 . . . . 0.0 110.496 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.79 147.45 30.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.805 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.27 150.69 51.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.633 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.6 t -164.77 -152.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.427 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.633 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.8 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.847 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -29.95 121.72 0.17 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.664 0.603 . . . . 0.0 110.627 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 66.0 mt -78.3 -70.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.844 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -148.7 165.56 31.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.54 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.68 67.74 0.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.621 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -86.87 -106.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.1 p -159.47 167.81 27.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.05 146.78 23.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -102.04 135.99 42.65 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.773 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.59 112.05 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.88 164.71 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.755 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.05 148.64 24.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.55 -27.96 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.03 -41.58 88.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -102.25 122.34 44.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 110.162 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.18 109.88 19.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.25 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.13 130.04 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.602 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -109.3 154.29 42.25 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.502 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.17 92.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.0 m -170.45 144.4 2.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.75 -33.88 61.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.279 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.94 -62.17 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.474 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.21 -21.85 25.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.97 -25.42 52.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.265 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.08 133.21 48.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.429 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.63 -15.75 29.02 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.07 150.87 24.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 110.284 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.29 134.34 38.19 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.15 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.58 136.33 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.606 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.67 138.77 14.45 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.7 161.5 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.048 0.451 . . . . 0.0 110.238 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.6 tp -92.54 118.1 30.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.499 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.48 156.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.59 50.64 53.44 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.7 p -149.11 167.6 25.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 67.2 p -70.92 -30.45 66.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -58.61 -54.76 43.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.509 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.58 -55.98 27.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.28 -51.53 69.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.654 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -61.71 -44.11 97.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.453 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.38 -44.38 98.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.56 -14.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.496 0.189 . . . . 0.0 110.712 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.48 -34.53 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.74 -50.64 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.335 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.42 12.53 36.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.2 -55.51 0.46 Allowed Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.482 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 131' ' ' GLU . 56.7 Cg_endo -72.36 -10.02 25.02 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.784 2.323 . . . . 0.0 112.036 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.86 -8.79 59.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.58 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.19 33.22 36.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.62 137.62 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.977 0.418 . . . . 0.0 110.487 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.23 130.16 34.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.61 138.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.26 133.5 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -96.58 126.49 41.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.55 25.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.259 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.83 7.27 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.617 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.73 130.1 5.86 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.13 -45.6 80.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.8 0.333 . . . . 0.0 110.556 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.37 -23.49 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 110.493 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.76 -36.8 85.48 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.414 HG22 HD12 ' A' ' 149' ' ' ILE . 96.7 mt -65.9 -46.84 87.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.178 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.0 m-85 -64.05 -37.88 89.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.08 -42.61 98.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.157 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.408 ' H ' ' HG ' ' A' ' 151' ' ' SER . 53.4 m-20 -64.67 -43.86 92.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.046 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.33 -47.85 83.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.029 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.39 -22.95 67.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.124 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -18.71 25.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.516 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.11 71.76 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.58 -18.1 63.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 0.0 110.629 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.5 pt -128.05 137.79 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.165 0.507 . . . . 0.0 110.518 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.75 -29.46 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.93 155.4 2.03 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.792 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 139.15 52.16 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 110.052 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.97 102.85 14.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.4 164.38 26.65 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.472 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.427 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.7 40.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -65.96 -54.33 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.317 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.19 -48.5 87.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.446 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.17 86.09 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.345 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.27 -63.26 1.24 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.364 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 68.9 m -58.22 -45.8 87.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.934 0.397 . . . . 0.0 110.445 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.43 -41.17 13.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.74 -61.93 0.47 Allowed Glycine 0 N--CA 1.466 0.647 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.649 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.5 t80 -40.79 -71.14 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.954 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.58 -40.97 98.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.1 tttt -59.83 -2.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.117 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.5 mt-30 -125.81 141.52 39.56 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.898 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.54 -14.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 86.9 t -63.02 -43.21 98.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.415 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.2 84.37 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.3 -40.92 95.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.832 0.349 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.12 -34.26 77.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.8 143.09 18.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.666 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -175.98 99.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.852 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.3 m-85 -158.94 167.59 28.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.585 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.9 56.18 3.14 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -52.1 -115.9 0.01 OUTLIER Glycine 0 CA--C 1.542 1.719 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.61 135.74 41.24 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.222 1.948 . . . . 0.0 111.86 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.9 p -124.58 -108.78 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.425 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.19 164.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 118.859 -0.591 . . . . 0.0 110.002 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.3 tttt 155.13 155.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.439 1.087 . . . . 0.0 110.505 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -81.06 118.16 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.858 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.6 mp0 -70.93 -19.34 62.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.38 -31.79 73.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.606 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.1 -44.05 97.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.753 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.04 9.26 15.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.673 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.39 51.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.0 p -70.7 -25.5 26.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.0 -124.37 1.34 Allowed Glycine 0 C--N 1.33 0.226 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.0 p -130.07 157.2 43.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.651 0.263 . . . . 0.0 110.297 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.08 -168.57 29.46 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -96.09 138.35 33.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.84 105.66 2.97 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ALA . 79.0 mt -117.88 158.65 24.48 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.3 mtm180 -86.71 148.66 25.34 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.596 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.7 mttm -51.7 -47.56 63.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.92 -22.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 0.0 110.577 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.09 51.64 0.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.07 -46.55 83.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.8 0.333 . . . . 0.0 111.15 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.5 -47.12 35.01 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.27 -43.7 98.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.35 -42.96 99.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.903 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.42 -37.08 72.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 109.896 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.55 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 212' ' ' ALA . 88.2 mt -28.68 -45.17 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.943 0.401 . . . . 0.0 110.878 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.451 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.0 m-20 -64.24 -45.01 90.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.815 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.84 98.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.927 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.11 92.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.293 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.09 -43.78 98.37 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.171 0.51 . . . . 0.0 110.282 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.15 91.54 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -64.13 -42.38 96.86 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.232 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.497 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.5 mtp -57.47 -38.21 74.13 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.43 -39.18 78.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.08 0.467 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.617 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 19.4 p-10 -89.17 0.04 57.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.69 20.59 70.31 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.3 m -58.66 -45.68 88.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 75.2 t80 -62.22 -56.43 18.67 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.198 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.423 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.9 mt-10 -57.32 -40.25 77.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.234 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.7 -47.68 84.68 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.14 -40.95 97.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.875 0.369 . . . . 0.0 110.316 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.69 76.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.72 -35.92 73.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -69.17 -51.9 33.44 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.564 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 10.7 m-85 -62.38 -45.82 91.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.51 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.9 m-85 -154.14 154.61 33.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.3 p-10 -99.09 95.95 7.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.407 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 236' ' ' PHE . 14.6 p90 -151.99 -163.77 1.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.21 108.24 13.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.687 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.33 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.596 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.423 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 90.1 m-85 -58.65 -41.65 86.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.285 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.16 -36.93 94.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.92 -1.489 . . . . 0.0 110.938 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.72 164.45 60.22 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.02 143.72 99.33 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.703 2.269 . . . . 0.0 112.226 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.29 -40.48 90.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.54 143.35 37.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.351 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 9' ' ' ILE . 84.8 mt -110.29 128.1 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.986 0.422 . . . . 0.0 110.367 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.84 118.75 37.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.252 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.427 HG23 HD11 ' A' ' 11' ' ' ILE . 94.0 mt -112.99 138.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.53 100.32 1.6 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 84.8 m -123.69 118.62 27.66 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.71 -0.288 . . . . 0.0 110.854 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t0 -113.25 93.19 25.06 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.31 -1.491 0 C-N-CA 122.486 2.124 . . . . 0.0 111.905 179.549 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.2 t0 . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.945 0.402 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.7 -40.91 82.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.78 -37.87 83.36 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.038 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.66 -43.93 87.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.18 0.514 . . . . 0.0 110.465 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.75 92.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.2 -53.31 58.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.529 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.75 -38.08 64.03 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.66 -42.23 78.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.024 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.7 m -54.47 -43.95 72.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.123 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.12 -47.05 81.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.9 mmt-85 -60.44 -40.93 92.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.13 -18.23 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.792 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.86 52.22 4.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -145.27 170.16 16.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.933 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -87.86 140.21 29.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.081 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -116.32 130.87 57.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.569 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.3 128.25 44.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.9 136.53 35.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -129.49 128.4 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.31 139.07 58.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.55 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 174.32 132.62 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.7 Cg_endo -68.11 145.03 65.62 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 112.75 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.1 mt -40.44 -55.53 2.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.165 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.22 -26.4 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.967 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.62 19.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.022 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.83 -42.78 94.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.909 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.65 -56.35 33.67 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.98 -42.72 63.88 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.967 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -59.08 -44.1 91.87 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.812 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.65 -44.2 90.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.75 -40.06 94.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.15 11.32 1.54 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.503 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.02 11.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.46 -34.12 77.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.48 153.29 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.379 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.11 -20.25 20.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.52 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.545 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.56 127.87 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.33 106.54 9.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.251 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -159.19 -178.85 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.578 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.71 -15.03 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.1 tp -37.77 123.87 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.597 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.73 23.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.746 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.4 pt -105.31 148.98 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.08 152.71 35.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.756 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.25 -47.66 55.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.986 0.422 . . . . 0.0 110.61 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.14 -39.8 72.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.582 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.614 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.9 mtt180 -68.18 -37.79 81.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.3 -36.98 74.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.58 -27.58 67.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.215 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.97 -52.22 6.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -138.09 -168.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.094 0.473 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.59 146.66 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.085 0.469 . . . . 0.0 110.807 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -129.81 149.94 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.637 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.691 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.3 t -164.64 -151.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.691 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.4 m-20 43.25 19.36 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.3 120.11 0.12 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.552 0.533 . . . . 0.0 110.577 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.19 -69.86 0.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.794 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -149.39 166.18 29.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.569 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.02 122.16 27.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.389 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.38 68.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.627 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.99 -104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.414 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.1 p -159.74 165.89 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.621 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.07 146.45 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.069 0.462 . . . . 0.0 110.465 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.96 135.89 42.73 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.798 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.55 110.92 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.38 165.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.755 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 148.41 23.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.017 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.47 -27.43 37.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -59.5 -41.67 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.4 122.08 43.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.154 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.88 109.33 19.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.375 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.63 130.03 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.605 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.28 159.4 34.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.478 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.483 ' C ' ' HG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.24 89.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.874 2.383 . . . . 0.0 112.006 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.483 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.8 m -168.79 140.84 2.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.98 -32.72 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.116 0.484 . . . . 0.0 110.268 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.81 -62.62 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.99 -22.06 24.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.888 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.58 -25.84 54.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.57 132.38 44.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.502 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.93 33.92 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.55 151.46 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.838 0.351 . . . . 0.0 110.447 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -97.01 136.19 37.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.27 136.68 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.672 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.54 139.5 14.74 Favored Glycine 0 CA--C 1.521 0.469 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.2 t -131.64 161.74 40.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.113 0.482 . . . . 0.0 110.281 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.3 tp -92.84 119.07 31.79 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.563 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.87 157.13 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.34 50.83 47.78 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.8 p -149.49 168.12 24.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.824 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.446 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.34 -25.54 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.445 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -61.27 -55.08 35.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.581 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -57.48 -54.06 51.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.408 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.3 -51.17 70.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.522 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.592 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.7 t80 -62.16 -43.83 97.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.429 . . . . 0.0 110.416 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.81 -44.41 97.91 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.9 -14.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.641 0.258 . . . . 0.0 110.642 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.25 -34.65 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.592 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.47 -50.68 17.33 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.329 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -98.94 12.82 34.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.2 -55.66 0.45 Allowed Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.428 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.2 -10.74 26.23 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.754 2.303 . . . . 0.0 112.008 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.14 -8.96 59.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.588 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.78 33.49 37.46 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.61 138.1 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.66 129.69 35.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.275 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.81 138.77 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.61 132.11 71.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.997 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.39 130.48 45.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.635 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.68 156.43 21.88 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.264 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.82 6.64 29.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.4 130.91 6.17 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.98 -45.93 79.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.32 . . . . 0.0 110.429 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.01 -23.84 63.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.456 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.466 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.67 -36.45 84.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.17 -47.28 85.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.4 m-85 -63.68 -37.67 88.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.234 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.26 -42.65 98.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.13 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.43 -45.21 91.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.002 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.06 -48.24 82.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.167 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.75 -23.04 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.161 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -18.22 25.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.549 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.57 69.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.98 -18.2 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.602 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.0 pt -128.52 137.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.165 0.507 . . . . 0.0 110.47 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.13 -28.41 62.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.4 155.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.5 137.89 51.07 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.913 0.387 . . . . 0.0 110.066 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -85.74 103.25 14.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.61 164.93 25.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.491 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.0 151.73 41.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.03 -54.23 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.32 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.29 -48.73 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.57 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.91 90.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.782 0.325 . . . . 0.0 110.57 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.07 -63.06 1.25 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.7 m -58.62 -46.85 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -50.23 -36.9 32.9 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.054 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.33 0.55 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 33.8 t80 -40.28 -70.98 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.765 -0.256 . . . . 0.0 111.101 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.65 -39.95 93.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.9 -3.23 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.274 0.559 . . . . 0.0 110.298 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 173' ' ' LEU . 55.1 mt-30 -123.91 142.23 38.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.02 -14.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.82 2.347 . . . . 0.0 112.227 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.1 t -63.0 -42.86 98.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.434 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.71 -32.96 80.64 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.13 -41.41 96.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.819 0.342 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.1 m-20 -65.96 -34.82 78.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.652 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.8 m-85 -156.72 142.91 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.54 99.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.153 0.502 . . . . 0.0 110.736 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.25 167.06 29.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.628 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.81 56.03 3.02 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.3 0.01 OUTLIER Glycine 0 CA--C 1.539 1.578 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.28 135.49 38.76 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.247 1.965 . . . . 0.0 111.862 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.3 p -124.42 -108.82 0.32 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.582 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.83 165.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.062 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.76 155.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.324 1.015 . . . . 0.0 110.51 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -81.95 118.45 22.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.861 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -72.05 -18.73 61.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.68 -32.17 73.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.64 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.95 -44.3 97.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.446 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.9 m-85 -114.08 8.38 16.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.67 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.2 -154.55 50.79 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.68 -25.65 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.815 0.341 . . . . 0.0 110.59 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.27 -125.48 1.45 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.7 p -132.15 160.19 36.76 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.66 25.05 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.24 141.06 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.908 0.385 . . . . 0.0 110.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.16 111.8 3.96 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -121.2 159.95 24.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.682 0.277 . . . . 0.0 110.287 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -86.5 149.14 25.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.66 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.15 -48.43 64.92 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -40.4 -22.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.631 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.14 52.02 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.592 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.39 -46.33 83.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.25 -47.06 37.58 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.4 -43.78 98.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.405 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.52 -42.76 99.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.897 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.81 -37.5 73.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.88 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.31 -77.42 0.11 Allowed 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.504 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.4 mt -28.66 -45.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.8 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.443 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.1 m-20 -63.9 -44.99 91.3 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.738 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.71 -43.63 98.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.966 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.16 92.92 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.247 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.2 -43.49 98.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.156 0.503 . . . . 0.0 110.22 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.23 92.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.271 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.11 -42.12 97.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.9 mtp -57.52 -38.07 74.04 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.78 -38.76 76.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.49 92.76 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.662 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.4 p-10 -88.19 0.63 55.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.765 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.76 19.85 67.75 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.7 m -57.93 -46.18 85.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.7 t80 -63.6 -57.61 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.925 0.393 . . . . 0.0 110.47 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.6 mt-10 -56.81 -41.73 78.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.352 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -48.21 82.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.96 -41.58 98.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.451 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.1 -49.84 76.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.77 -35.6 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.51 -50.95 32.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.498 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.1 m-85 -62.19 -45.61 92.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.48 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.7 m-85 -154.64 155.62 35.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.6 p-10 -97.56 101.24 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.444 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -157.88 -165.94 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.3 t0 -122.72 110.2 15.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.62 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.0 m -63.3 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 94.4 m-85 -59.22 -42.62 91.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -36.69 93.74 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 117.88 -1.511 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.83 164.38 61.53 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.73 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.24 143.64 98.42 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.738 2.292 . . . . 0.0 112.208 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.35 -40.98 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -137.96 139.68 39.84 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.371 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.405 HD12 HG22 ' A' ' 9' ' ' ILE . 80.9 mt -107.83 121.26 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.472 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.56 118.23 31.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.122 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.24 138.62 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.271 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.54 106.07 2.25 Favored Glycine 0 N--CA 1.463 0.458 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -129.5 120.24 25.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.657 -0.319 . . . . 0.0 110.76 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.5 t70 -114.05 93.02 28.31 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.852 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.127 . . . . 0.0 111.925 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.444 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.3 t0 . . . . . 0 C--O 1.228 -0.069 0 CA-C-O 120.984 0.421 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.23 -40.72 83.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.029 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -60.59 -37.84 82.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.893 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.3 tp -65.19 -44.14 89.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.224 0.535 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.41 -47.34 84.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.907 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -54.25 -54.1 44.73 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.518 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.77 -39.11 61.98 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.035 0.445 . . . . 0.0 110.087 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.19 -41.93 80.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.969 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -53.95 -45.08 71.18 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.061 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.17 -46.28 84.69 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.343 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -60.7 -41.93 96.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.989 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.62 -17.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.712 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.84 52.57 4.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.612 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -146.41 170.94 15.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.913 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.71 142.48 27.64 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.987 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.4 m -117.39 131.86 56.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.3 m -128.33 127.81 43.39 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.474 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -94.44 135.28 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.445 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.35 128.59 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.012 0.434 . . . . 0.0 110.305 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.84 137.32 57.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 177.23 131.86 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.19 144.74 64.03 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.664 2.243 . . . . 0.0 112.678 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.6 mt -40.06 -56.03 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 111.272 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.11 -26.35 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.35 -20.99 18.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.139 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.7 -42.47 97.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.759 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.564 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.39 -56.86 26.58 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 123.81 0.694 . . . . 0.0 109.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.2 Cg_exo -56.21 -41.36 77.47 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.499 2.133 . . . . 0.0 110.992 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 69.1 m -59.26 -44.27 92.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.86 -43.86 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.43 95.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.478 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.13 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.43 11.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.41 -35.43 80.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.598 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.9 pt -122.79 153.27 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.318 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -92.94 -21.87 19.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.131 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.28 156.42 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.628 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.05 128.26 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.397 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.444 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.1 ttp -130.44 107.0 8.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 110.267 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 t -159.38 179.21 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.88 -15.18 61.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.612 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.0 tp -36.27 124.78 0.78 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.606 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.541 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -83.33 155.87 23.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.674 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -105.59 149.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -149.55 152.43 35.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.693 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.84 -47.46 51.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.77 -39.91 71.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.668 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.47 -37.81 80.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.043 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.95 -38.26 75.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.053 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.24 -27.51 67.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.26 -51.47 7.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.9 pt -138.21 -168.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 121.076 0.465 . . . . 0.0 110.442 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.83 147.66 29.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -130.08 150.0 51.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.658 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.711 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.71 -152.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.711 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.4 m-20 42.41 20.09 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -29.17 120.77 0.14 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.66 0.6 . . . . 0.0 110.526 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -76.86 -69.63 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.868 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -149.4 166.3 29.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.617 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.26 122.74 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.58 69.59 0.9 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.65 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.61 -104.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.422 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.29 166.02 32.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.9 145.75 21.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 110.414 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.89 136.2 41.13 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.41 111.11 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.1 164.99 33.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.84 23.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.039 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.28 60.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.142 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.98 -41.73 88.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.251 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.1 t -102.09 122.01 43.29 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.976 0.417 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.11 109.93 19.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.333 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.415 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.0 129.94 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.539 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.93 154.23 42.0 Favored Pre-proline 0 C--N 1.334 -0.099 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.513 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.36 92.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.767 2.311 . . . . 0.0 111.907 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.7 m -171.04 144.47 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.36 -33.73 61.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.164 0.507 . . . . 0.0 110.281 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -58.24 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.425 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.34 -22.13 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.869 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.29 -25.8 55.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.338 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.9 45.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.67 -16.5 30.67 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.94 151.21 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.382 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.91 37.72 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.41 136.61 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 139.53 14.74 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 54.8 t -131.83 161.74 40.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.096 0.474 . . . . 0.0 110.287 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.2 tp -92.73 118.82 31.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.63 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -51.93 157.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.06 50.66 50.54 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.3 p -149.45 168.23 24.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.791 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.433 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.18 -25.64 59.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.431 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -61.25 -55.1 35.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.544 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.64 -53.92 52.74 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -60.55 -51.36 69.76 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.46 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.1 t80 -62.08 -44.01 97.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.426 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.74 -44.42 97.93 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.94 -14.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.627 0.251 . . . . 0.0 110.675 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.19 -34.84 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.43 -50.57 17.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.435 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -99.04 12.56 35.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.207 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.95 -55.7 0.46 Allowed Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.4 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.08 -10.6 26.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.778 2.319 . . . . 0.0 111.961 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.45 -8.76 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.74 33.37 38.01 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.24 137.87 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 110.532 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -87.58 129.73 35.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.233 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.6 pt -127.26 138.99 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.95 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.58 132.08 71.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.975 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.8 t -98.52 130.52 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -111.69 156.68 21.5 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.294 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.06 6.46 28.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.565 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.98 6.36 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.19 -46.15 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.12 62.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.89 -36.54 84.7 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.41 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.29 -47.44 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.093 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.509 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.3 m-85 -63.72 -37.84 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.263 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.01 -42.19 97.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.081 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -64.19 -44.4 92.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.97 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.1 tp -58.88 -48.2 82.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.164 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -63.06 -23.01 67.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.42 -18.36 25.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.493 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.79 11.2 71.16 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.57 -18.25 63.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.659 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.8 pt -127.9 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.456 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 -28.3 62.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.999 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.41 155.62 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.574 0.546 . . . . 0.0 110.873 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.43 138.0 51.21 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.993 0.425 . . . . 0.0 110.045 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.21 103.17 14.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.041 0.448 . . . . 0.0 110.569 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.25 24.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.04 152.55 41.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.04 -54.27 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.347 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.39 -48.66 87.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.437 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.8 88.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 110.44 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.46 -63.63 1.09 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.413 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 73.4 m -59.09 -47.11 86.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.749 0.309 . . . . 0.0 110.981 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -50.17 -37.6 35.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.02 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.7 -66.15 0.56 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.657 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.3 -70.69 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.734 -0.274 . . . . 0.0 111.123 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -61.36 -39.78 91.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -60.67 -3.36 0.69 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.412 0.625 . . . . 0.0 110.354 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 173' ' ' LEU . 54.9 mt-30 -123.27 142.25 38.08 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 122.118 -0.363 . . . . 0.0 110.845 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -44.27 -16.21 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.848 2.365 . . . . 0.0 112.275 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 74.5 t -62.82 -43.04 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.15 -33.06 82.8 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.82 -41.25 95.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 0.0 110.413 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -66.04 -34.27 77.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.509 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.4 m-85 -157.12 143.92 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.725 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.27 99.59 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.0 m-85 -159.09 167.14 29.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.614 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.69 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.44 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.539 1.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.09 135.69 37.41 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.285 1.99 . . . . 0.0 111.99 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.3 p -124.94 -108.13 0.33 Allowed 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.496 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.91 165.33 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 118.815 -0.612 . . . . 0.0 109.955 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.53 156.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.496 1.122 . . . . 0.0 110.468 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.07 118.04 22.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.917 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.1 mp0 -71.62 -18.94 62.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.0 -44.19 97.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.433 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.97 8.97 17.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.56 -155.12 52.04 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.31 -25.26 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 0.0 110.53 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.61 -125.2 1.42 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.5 p -131.76 159.46 38.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 110.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.98 -162.87 24.94 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.7 139.12 34.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.945 0.402 . . . . 0.0 110.468 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.65 112.61 4.04 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.5 mt -124.76 159.5 30.81 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.752 0.311 . . . . 0.0 110.346 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -85.89 149.77 24.99 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.793 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.04 -48.29 64.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.746 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -38.57 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.708 0.289 . . . . 0.0 110.715 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.53 52.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.614 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -64.48 -46.13 84.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.742 0.306 . . . . 0.0 111.136 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.0 -47.07 39.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.57 -43.4 98.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.466 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.6 ttt-85 -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.775 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.41 -36.97 72.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.118 0.485 . . . . 0.0 109.84 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.49 -77.43 0.11 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 212' ' ' ALA . 98.0 mt -28.43 -45.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.988 0.423 . . . . 0.0 110.808 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.426 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.0 m-20 -64.29 -45.14 89.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.78 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.69 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.89 -43.93 97.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.968 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.19 92.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.14 -43.62 98.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.162 0.506 . . . . 0.0 110.163 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.27 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.89 -42.45 97.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -57.47 -38.24 74.19 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.86 -38.95 76.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 0.0 110.421 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.91 93.94 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -88.95 1.3 55.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.803 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.68 19.86 65.5 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 77.0 m -58.11 -45.7 86.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.77 -57.69 9.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.499 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -57.3 -41.43 79.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.59 -48.45 80.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.483 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -41.49 98.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.448 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.48 -49.94 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.724 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.28 -35.37 73.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.379 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.96 -50.99 28.43 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.501 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.15 -45.27 94.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.8 m-85 -153.51 154.86 35.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.416 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.4 p-10 -96.78 95.5 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -153.12 -167.06 2.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.482 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.43 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.48 110.25 15.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.0 m -63.52 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.574 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.6 m-85 -57.06 -43.94 82.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.238 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.75 -37.48 94.76 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.793 -1.559 . . . . 0.0 110.985 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 164.36 57.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.671 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -61.09 143.28 98.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.694 2.263 . . . . 0.0 112.14 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.63 -40.87 88.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.658 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -138.38 141.5 39.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.438 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.8 mt -109.21 127.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.331 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.84 118.8 37.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.315 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.71 141.81 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.83 107.08 2.16 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.7 m -128.81 120.83 27.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.68 0.276 . . . . 0.0 110.489 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 9.7 t70 -113.01 94.25 29.01 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.946 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.64 2.227 . . . . 0.0 111.786 179.457 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.8 t0 . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 120.968 0.413 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.98 -39.96 82.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.2 m-20 -60.69 -37.63 82.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.982 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -65.45 -44.3 87.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.24 0.543 . . . . 0.0 110.608 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.44 -46.4 86.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.122 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.46 -53.77 49.84 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.41 -38.91 63.89 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.884 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.27 -42.64 79.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.054 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 48.9 m -53.68 -44.15 69.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -63.98 -46.95 82.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.04 0.448 . . . . 0.0 110.528 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -60.46 -41.48 94.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.146 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.27 -18.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.51 52.25 3.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -146.87 171.05 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.802 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.45 142.14 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -117.59 131.82 56.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.492 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.62 127.01 43.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.401 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -95.72 137.23 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.47 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.3 129.46 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.549 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -68.43 139.06 55.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 p30 176.21 135.25 0.19 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.2 143.32 58.64 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.671 2.248 . . . . 0.0 112.63 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.8 mt -39.34 -55.25 1.76 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.077 0.465 . . . . 0.0 111.078 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.73 -26.25 2.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.752 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.03 -21.37 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.846 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.2 mt -63.95 -42.96 97.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.379 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.573 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -62.47 -55.86 35.56 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.029 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.1 Cg_exo -55.7 -42.23 69.54 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.559 2.172 . . . . 0.0 111.257 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.4 m -58.82 -44.54 90.9 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.182 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.78 -44.65 90.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.361 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.4 mtmt -64.8 -40.84 95.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.531 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.39 1.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.562 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.2 11.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.646 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.0 mttt -63.5 -33.27 75.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.699 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 67' ' ' ILE . 44.5 pt -124.56 154.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.507 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -91.49 -20.89 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.744 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.06 160.38 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.0 mt -116.08 127.33 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.521 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.77 107.72 9.88 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.315 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.53 ' HG ' ' H ' ' A' ' 73' ' ' SER . 35.7 t -162.42 -177.13 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.53 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.4 p -64.02 -15.68 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.618 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.3 122.99 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -83.09 156.34 23.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.766 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.6 pt -105.53 149.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.7 p -150.87 152.85 34.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.596 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.81 -47.69 51.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.85 -39.85 72.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.35 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.618 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -69.03 -37.36 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.908 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -58.21 -37.29 74.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 110.399 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.84 67.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.71 -51.84 7.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.739 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.58 -167.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.509 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.37 147.14 29.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.087 0.47 . . . . 0.0 110.652 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -130.47 150.6 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.652 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.685 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.0 t -165.51 -151.01 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.495 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.685 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.0 m-20 43.09 20.02 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.777 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.98 120.51 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.582 0.551 . . . . 0.0 110.678 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.5 mt -79.42 -71.31 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.801 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -148.46 165.4 31.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.23 126.25 31.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.455 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.37 67.48 0.73 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.503 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.55 -105.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.41 167.3 29.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.574 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.2 146.77 23.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -102.01 135.99 42.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.691 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.52 111.66 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.074 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.9 164.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.606 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.88 24.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.825 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.07 60.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.82 -42.07 88.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.287 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -101.97 122.04 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.348 . . . . 0.0 110.245 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.85 109.68 19.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.328 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.3 130.41 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.532 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -109.71 154.14 42.62 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.53 92.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.715 2.276 . . . . 0.0 112.064 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.5 m -170.86 144.8 2.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.752 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.98 -33.98 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.333 0.587 . . . . 0.0 110.432 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.74 -62.14 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.676 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.8 t -56.48 -22.21 30.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.667 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.9 -25.65 53.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.47 132.85 45.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.575 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.49 -16.5 29.8 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.79 151.22 23.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.808 0.337 . . . . 0.0 110.358 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.1 135.5 37.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.47 136.27 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.639 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.72 14.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.6 161.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 39.5 tp -92.7 119.27 31.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -51.32 156.78 1.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.637 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.64 50.92 51.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.3 p -148.69 166.74 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.727 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.1 p -71.81 -29.67 64.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.457 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.4 mt-30 -58.77 -54.78 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.588 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.59 -55.77 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.397 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.1 -51.94 67.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.9 t80 -61.64 -44.19 97.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.468 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.49 -44.48 97.95 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.74 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.563 0.221 . . . . 0.0 110.605 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.76 2.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.593 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.37 -50.72 17.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.01 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -99.6 12.77 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.478 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.13 -55.42 0.46 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.51 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.34 -10.06 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.77 2.314 . . . . 0.0 112.093 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.72 -8.45 59.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.639 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.38 37.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.53 138.1 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.57 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.9 130.29 34.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -127.37 138.98 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.778 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.47 132.37 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.3 t -97.81 129.47 44.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.454 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -111.3 156.35 21.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.342 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.85 7.07 27.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.27 6.08 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.08 -45.9 79.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.372 . . . . 0.0 110.578 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.09 62.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.461 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.0 t-20 -64.86 -36.53 84.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.514 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.408 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.3 -47.36 84.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.055 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.0 m-85 -63.85 -37.67 88.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.5 p -61.4 -42.53 98.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.092 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.15 -44.37 92.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.343 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.01 -47.86 83.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.184 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.54 -22.96 67.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.995 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.56 25.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 10.96 71.05 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.68 -18.15 63.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.704 0.288 . . . . 0.0 110.636 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.5 pt -128.18 137.81 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.13 -29.76 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.8 154.92 2.01 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 138.73 52.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.233 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -86.12 102.64 14.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.25 164.4 26.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.27 152.28 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.7 mt-10 -66.0 -54.43 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.077 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.84 -48.83 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.577 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.36 87.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.749 0.309 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -62.92 -62.95 1.37 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 68.1 m -58.29 -45.9 87.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.953 0.406 . . . . 0.0 110.49 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -45.98 -40.78 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.401 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.46 0.46 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.62 -71.59 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.718 0.294 . . . . 0.0 110.747 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -62.67 -41.05 98.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.719 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.0 tttt -59.65 -3.05 0.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.169 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 173' ' ' LEU . 57.2 mt-30 -125.96 142.04 41.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.47 -15.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.803 2.335 . . . . 0.0 112.188 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 175' ' ' GLN . 89.7 t -62.5 -43.12 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.27 84.69 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.28 -40.72 95.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.511 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 49.0 m-20 -67.07 -33.6 75.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.5 m-85 -156.59 142.35 17.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.3 pttt -175.47 99.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.712 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 93.5 m-85 -158.93 167.13 30.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.544 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.69 56.13 3.2 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.95 -115.95 0.01 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.35 135.16 39.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.327 2.018 . . . . 0.0 111.931 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.8 p -124.12 -108.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.068 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.9 164.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.038 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.7 tttt 153.85 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 124.17 0.919 . . . . 0.0 110.51 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.61 119.42 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.239 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.7 mp0 -71.72 -16.34 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.0 -32.21 73.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.683 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.05 -44.33 97.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -114.38 8.81 16.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.15 -153.78 51.34 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.93 -25.53 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.559 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.91 -126.55 1.61 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.9 p -132.29 160.26 36.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.82 -161.94 24.09 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.45 140.13 33.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.542 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.52 3.57 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' ALA . 83.0 mt -118.13 159.64 22.92 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.584 0.23 . . . . 0.0 110.443 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.69 148.84 25.27 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.608 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.21 -48.68 61.97 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -41.02 -22.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.497 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.52 51.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.465 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.46 -46.28 83.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.99 -47.2 38.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.387 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.28 -42.91 99.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.71 -37.46 73.56 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.205 0.526 . . . . 0.0 110.143 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.697 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.12 -77.43 0.1 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.923 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.508 ' C ' ' O ' ' A' ' 212' ' ' ALA . 88.7 mt -27.95 -45.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.913 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.441 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.4 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.741 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.697 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.1 -43.54 98.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.114 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.99 91.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.453 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.23 -43.36 99.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.412 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.23 91.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.368 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.22 -42.15 96.7 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.393 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.31 -38.2 73.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.62 -38.88 77.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.537 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.54 91.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 18.9 p-10 -88.74 0.28 56.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.762 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.01 20.42 68.8 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -57.54 -46.39 83.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.2 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.06 -58.04 8.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.996 0.427 . . . . 0.0 110.485 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.75 -42.53 79.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.545 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.81 -48.8 80.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.442 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.16 -41.48 98.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.49 -50.19 74.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.745 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -34.76 72.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -71.42 -51.83 21.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.176 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.42 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 40.1 m-85 -62.73 -44.61 95.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 230' ' ' ALA . 83.9 m-85 -151.31 153.09 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.513 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 49.0 p-10 -98.21 93.92 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.464 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.89 -165.59 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.444 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -122.39 108.75 13.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.683 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.53 -40.06 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -57.37 -43.57 83.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.71 -37.55 94.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.219 -0.796 0 CA-C-O 117.924 -1.486 . . . . 0.0 111.005 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.3 60.14 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.99 143.47 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 122.737 2.291 . . . . 0.0 112.261 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.42 -40.91 89.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.633 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -138.0 139.0 39.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.34 121.21 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.587 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.1 118.88 32.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.6 138.67 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.369 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.7 105.29 2.11 Favored Glycine 0 N--CA 1.463 0.442 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.9 m -128.75 120.52 26.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.648 -0.325 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.7 t70 -114.35 92.85 29.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.953 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.526 0 C-N-CA 122.544 2.162 . . . . 0.0 111.974 179.404 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.946 0.403 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.15 -40.84 83.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.83 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.3 -37.77 81.58 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.19 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.38 -45.05 89.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 110.163 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.19 -48.77 77.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.915 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.65 -54.69 29.88 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.15 -40.46 61.45 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.17 -41.7 81.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.971 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.8 m -53.43 -45.18 69.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.167 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.33 -46.38 83.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.279 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -60.23 -42.31 94.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.53 -16.99 15.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.41 52.96 4.46 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.706 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.8 p -146.96 171.54 15.08 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.89 142.31 27.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.038 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.14 130.92 56.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.63 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.4 m -127.29 127.1 43.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -94.03 134.89 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.4 t -129.09 127.77 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 137.89 57.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.07 131.04 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.5 Cg_endo -67.84 145.31 68.24 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.684 2.256 . . . . 0.0 112.562 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.8 mt -40.41 -56.07 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.979 0.418 . . . . 0.0 111.035 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.05 -26.69 1.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.008 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -20.96 18.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.7 mt -63.77 -42.53 97.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.641 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.588 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.3 -56.84 26.99 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.821 0.701 . . . . 0.0 109.688 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.1 Cg_exo -55.84 -41.83 73.31 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.556 2.171 . . . . 0.0 111.102 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 70.7 m -59.05 -44.5 91.81 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.055 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.45 -43.89 93.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.185 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.45 95.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.23 10.22 2.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.496 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.21 12.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.56 -35.38 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.549 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.43 153.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.297 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -93.17 -22.27 19.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.5 155.94 27.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.607 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.08 128.63 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.123 0.487 . . . . 0.0 110.362 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.11 107.22 8.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.679 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.8 t -159.48 178.64 9.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.618 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.679 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.4 p -65.01 -15.34 62.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.493 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.613 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.16 124.65 0.6 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.549 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.15 154.38 25.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 pt -105.16 148.86 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.134 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -149.16 152.18 35.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.9 -47.15 52.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.434 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.55 -40.21 71.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.707 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.613 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.4 -37.92 80.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.072 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.78 -38.84 76.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.94 -27.43 66.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.206 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.46 -51.0 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.526 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -139.01 -168.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.072 0.463 . . . . 0.0 110.49 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.31 147.74 29.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.01 150.11 51.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.549 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.643 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.9 t -163.36 -153.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.437 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.643 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.3 m-20 41.55 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.933 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.72 121.38 0.2 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.478 0.486 . . . . 0.0 110.503 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 58.6 mt -75.0 -68.56 0.54 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -150.78 167.61 26.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.6 29.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.368 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.05 68.24 0.81 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.713 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.58 -104.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.9 p -159.26 165.49 33.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.639 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.05 146.45 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.112 0.482 . . . . 0.0 110.432 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.95 135.99 41.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.762 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.06 164.49 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.11 148.25 25.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.01 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.19 -28.39 58.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.05 -41.66 88.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -101.63 121.41 41.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.153 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.06 109.88 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.419 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 105' ' ' ILE . 97.2 mt -126.57 129.54 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.609 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -107.16 154.11 40.64 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.35 91.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.793 2.329 . . . . 0.0 111.946 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.3 m -170.44 143.44 2.29 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.516 0.51 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.59 -33.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.35 -62.07 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.439 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -56.6 -22.48 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.826 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.2 mt -75.89 -26.03 56.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.276 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.6 47.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.454 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.79 -16.99 28.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.01 151.34 23.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.434 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.78 135.2 37.8 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.287 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.58 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.594 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 138.45 14.26 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.6 161.56 40.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.497 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 42.6 tp -92.52 117.51 30.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.648 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.55 157.91 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.71 50.63 52.83 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.1 p -149.9 168.75 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.783 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.451 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.8 p -73.3 -26.88 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.458 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.49 -55.31 35.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.534 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -56.98 -54.9 41.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.8 m -60.26 -51.38 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.524 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.3 t80 -61.99 -44.08 97.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.441 . . . . 0.0 110.502 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.52 -44.55 97.84 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.54 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.657 0.265 . . . . 0.0 110.651 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.5 -34.64 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.611 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.6 -50.65 17.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 111.366 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.3 12.17 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.171 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.483 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.57 -55.29 0.49 Allowed Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.35 -10.1 25.13 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.796 2.331 . . . . 0.0 111.994 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.85 -9.02 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.25 37.09 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.33 137.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.29 129.79 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.343 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.4 138.14 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.0 133.25 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.023 0.44 . . . . 0.0 109.979 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.88 127.08 42.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.31 25.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.33 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.02 7.22 29.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.19 5.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -65.81 -45.77 81.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.463 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.77 -23.47 62.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.73 -36.8 85.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.94 -46.62 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.016 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.682 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.8 m-85 -64.7 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.04 -41.86 97.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.39 -43.2 91.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.998 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.4 tp -58.77 -48.2 82.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.172 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.84 -22.48 66.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.224 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.47 -18.41 25.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.55 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.64 72.38 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.82 -17.82 63.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.645 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.493 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.64 -28.0 62.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.38 155.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.517 0.511 . . . . 0.0 110.809 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.01 137.21 50.15 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.022 0.439 . . . . 0.0 110.074 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -86.03 103.32 14.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.682 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 49.7 tt0 -132.85 165.56 24.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.446 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.442 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -72.89 153.12 41.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.69 -54.68 20.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.29 -48.89 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.506 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.96 89.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.41 -62.92 1.3 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.456 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.5 m -59.56 -47.49 85.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.99 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -48.93 -37.27 19.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.113 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.03 0.55 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 168' ' ' ALA . 23.8 t80 -40.72 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.771 -0.252 . . . . 0.0 111.087 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -61.44 -40.39 94.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.38 -3.35 0.42 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.632 . . . . 0.0 110.321 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.9 mt-30 -122.82 150.09 57.87 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.69 -20.92 7.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.853 2.369 . . . . 0.0 112.231 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.79 -43.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.577 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.13 -33.28 85.31 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.48 -41.14 93.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.738 0.304 . . . . 0.0 110.459 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.6 m-20 -66.12 -32.91 74.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.2 142.64 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.557 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.44 99.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.085 0.469 . . . . 0.0 110.727 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.24 167.53 28.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.647 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.91 56.45 2.74 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.67 -118.61 0.01 OUTLIER Glycine 0 CA--C 1.535 1.337 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.55 135.7 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.395 2.063 . . . . 0.0 111.996 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.3 p -125.2 -108.32 0.32 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.435 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.12 164.56 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.065 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 154.13 155.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.346 1.029 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -81.92 117.4 22.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 195' ' ' GLY . 54.1 mp0 -71.44 -18.94 62.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.81 -32.37 73.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.565 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.93 -44.58 97.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.669 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.451 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.2 m-85 -114.13 9.64 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.646 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.74 -153.86 51.8 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.74 -24.93 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.789 0.328 . . . . 0.0 110.501 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.34 -124.14 1.3 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.49 156.16 44.57 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.646 0.26 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.56 30.37 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.17 137.41 33.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.534 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.32 108.38 3.28 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.44 159.12 29.68 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.293 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -86.42 149.79 24.76 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.803 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.2 -47.76 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.522 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.53 -25.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.791 0.329 . . . . 0.0 110.574 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.4 52.07 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.611 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -64.49 -45.11 88.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.162 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.9 -47.39 30.21 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.46 -43.72 98.14 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.506 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.2 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.798 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.91 -36.35 70.06 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.09 -77.38 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.514 ' C ' ' O ' ' A' ' 212' ' ' ALA . 96.6 mt -28.4 -46.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.956 0.408 . . . . 0.0 110.637 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.444 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.0 m-20 -64.4 -44.84 90.02 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.779 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.02 -43.56 98.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.037 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.87 92.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.199 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.34 -43.71 98.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.126 0.488 . . . . 0.0 110.144 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.53 93.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.383 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.533 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -42.71 97.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.22 -37.85 72.85 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.2 -38.88 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.44 . . . . 0.0 110.437 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.73 94.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.17 2.13 54.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.67 63.09 Favored Glycine 0 C--O 1.225 -0.451 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 83.9 m -58.07 -45.84 86.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.0 t80 -63.7 -57.73 9.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.4 mt-10 -57.11 -41.46 79.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.232 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.64 -48.33 81.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.459 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.21 -41.55 98.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.829 0.347 . . . . 0.0 110.294 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.76 -50.0 75.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.92 -35.43 73.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.428 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.75 -51.21 28.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.544 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.2 m-85 -61.88 -45.83 92.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.97 155.54 35.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.09 97.43 9.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.001 0.429 . . . . 0.0 110.496 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.86 -166.49 2.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.477 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.03 110.99 16.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.0 m -63.22 -40.34 88.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 94.0 m-85 -58.89 -42.48 89.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.274 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.94 94.12 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.957 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.47 164.59 59.93 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.07 143.63 99.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.749 2.299 . . . . 0.0 112.276 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.11 -40.24 90.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.81 142.92 36.63 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 9' ' ' ILE . 84.0 mt -109.97 129.08 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -104.1 117.12 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.337 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -111.89 138.86 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.82 104.86 2.13 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.6 m -127.98 119.3 25.21 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 122.588 -0.36 . . . . 0.0 110.91 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.9 t70 -113.63 92.46 24.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.311 -1.44 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.54 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.472 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.8 t0 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.927 0.394 . . . . 0.0 111.573 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.7 mt -68.55 -40.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.422 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.5 m-20 -61.41 -37.66 84.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.686 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.0 -43.92 86.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.13 -41.88 93.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.909 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.67 -53.3 59.92 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.589 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.92 -37.06 63.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.117 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.86 -42.29 77.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.102 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.75 -44.59 73.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.077 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.81 -47.22 81.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.162 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -59.85 -40.97 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.054 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.37 -17.53 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.5 52.45 4.64 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.21 170.23 16.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.898 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.37 140.59 29.32 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.964 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.5 m -117.13 131.88 56.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.583 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -128.28 127.63 43.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -93.91 135.71 34.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.58 128.82 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.31 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.83 139.4 58.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.606 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.38 131.7 0.15 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.692 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.34 145.28 65.08 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.67 2.247 . . . . 0.0 112.591 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' LEU . 82.1 mt -40.27 -56.67 1.91 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.085 0.469 . . . . 0.0 111.283 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.47 -26.74 1.47 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.57 19.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.194 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' LEU . 58.7 mt -63.98 -42.56 97.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.859 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.559 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.32 -57.02 25.36 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 123.933 0.771 . . . . 0.0 109.527 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.3 Cg_exo -55.46 -42.65 65.95 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.49 2.126 . . . . 0.0 110.939 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -59.19 -43.88 92.2 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.01 -44.05 91.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.109 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.72 -40.02 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.507 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.54 11.23 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.479 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.12 11.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -34.34 77.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.1 pt -124.05 153.52 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.189 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.35 -20.59 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.4 157.32 25.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.545 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.91 127.36 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.472 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.33 106.45 9.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.309 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -160.07 -178.33 6.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.575 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.3 p -64.24 -15.38 59.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.417 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.62 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.1 tp -37.96 123.76 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.557 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.44 156.84 22.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 pt -105.27 149.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.131 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.3 p -149.87 152.9 35.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.751 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.44 -47.5 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.9 -40.05 72.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.691 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.62 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.01 -37.82 81.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.078 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.26 -37.37 74.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.05 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.55 -27.2 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.127 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.5 -51.91 6.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.329 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.27 -168.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.118 0.485 . . . . 0.0 110.407 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.79 29.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.94 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.93 149.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.609 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.678 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.7 t -164.37 -151.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.421 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.678 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.2 m-20 43.37 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -28.27 120.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.581 0.551 . . . . 0.0 110.518 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.5 mt -77.25 -69.9 0.5 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -149.17 166.12 29.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.589 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.88 121.67 27.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.298 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.87 69.29 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.699 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.88 -105.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.424 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.15 165.76 33.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.615 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.47 146.02 22.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.133 0.492 . . . . 0.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.08 136.11 41.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.51 111.06 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.27 165.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.73 148.45 23.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.154 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.13 -28.22 57.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.201 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.0 -41.78 88.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.12 122.22 43.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.114 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.04 110.0 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.33 129.84 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.531 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.85 154.34 41.87 Favored Pre-proline 0 N--CA 1.457 -0.096 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.641 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.511 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.24 92.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.832 2.354 . . . . 0.0 111.82 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -170.86 144.09 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.666 0.604 . . . . 0.0 110.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.3 -33.74 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.306 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -57.85 -62.11 2.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.74 -21.85 31.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.893 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.8 mt -76.19 -25.93 55.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.373 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.44 47.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.459 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.17 -16.25 29.5 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.5 151.56 23.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.29 135.4 38.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.231 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.04 136.49 60.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.615 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 138.62 14.32 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.1 t -130.89 161.76 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.213 0.53 . . . . 0.0 110.205 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.3 tp -92.5 117.54 30.05 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.75 157.79 1.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.76 50.29 54.52 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.46 168.78 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.835 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.453 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 77.0 p -73.1 -27.35 61.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.418 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.45 -54.87 40.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.51 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' CD ' ' HG ' ' A' ' 142' ' ' SER . 80.4 tt0 -57.16 -54.5 46.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.408 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -60.73 -51.14 70.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.446 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.02 -43.95 97.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.986 0.422 . . . . 0.0 110.476 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.68 -44.44 97.91 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.62 -14.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.6 0.238 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.3 -34.73 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.46 -50.66 17.44 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.478 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.13 12.45 36.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.293 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.93 -55.6 0.46 Allowed Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.347 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.19 -10.45 25.83 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.793 2.328 . . . . 0.0 111.951 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.51 -8.66 59.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.72 33.53 37.6 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.79 137.99 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.987 0.423 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.71 130.08 34.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.233 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.56 138.35 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.1 t -123.04 133.19 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.426 ' HG ' ' CD ' ' A' ' 126' ' ' GLU . 7.9 t -97.0 127.26 42.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.85 153.28 25.64 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.67 6.88 30.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.96 130.49 5.95 Favored Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.93 -45.67 81.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.44 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.15 -23.98 63.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.055 0.455 . . . . 0.0 110.513 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.5 t-20 -64.7 -36.53 84.59 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.551 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 149' ' ' ILE . 96.6 mt -65.93 -47.07 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.515 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.7 m-85 -63.8 -37.66 88.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.26 -42.61 98.92 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.137 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.403 ' H ' ' HG ' ' A' ' 151' ' ' SER . 51.8 m-20 -63.86 -44.96 91.53 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.0 tp -58.91 -47.72 84.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.213 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -63.25 -22.47 66.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.072 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.95 -18.33 24.88 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.459 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.48 70.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -17.87 63.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.2 pt -128.24 137.45 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.449 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.8 -27.95 62.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.57 155.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.617 0.573 . . . . 0.0 110.835 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.48 50.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.957 0.408 . . . . 0.0 110.035 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.95 103.0 14.26 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.083 0.468 . . . . 0.0 110.577 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.17 165.02 25.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.441 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.429 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.34 152.4 40.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.606 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -65.99 -54.09 30.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.35 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.5 t -60.45 -48.94 86.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.405 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.8 87.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.787 0.327 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.15 -63.53 1.13 Allowed 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.425 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.0 m -58.77 -46.72 86.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.756 0.313 . . . . 0.0 110.908 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.1 tt0 -50.04 -37.95 35.53 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.896 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.86 -65.76 0.55 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.1 t80 -40.48 -71.08 0.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.777 -0.249 . . . . 0.0 111.213 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.47 -40.06 93.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.005 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.45 -3.28 0.42 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 110.306 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 177' ' ' VAL . 61.1 mt-30 -124.37 141.81 38.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 O-C-N 121.965 -0.459 . . . . 0.0 110.858 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.71 -14.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.823 2.349 . . . . 0.0 112.379 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.0 t -63.29 -42.96 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.445 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.89 80.62 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.72 -42.13 96.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.774 0.321 . . . . 0.0 110.318 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 60.1 m-20 -65.01 -35.23 80.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.7 m-85 -156.8 143.72 18.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.11 99.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.135 0.493 . . . . 0.0 110.798 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.15 168.49 26.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.1 55.85 3.19 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.52 -116.68 0.01 OUTLIER Glycine 0 CA--C 1.538 1.498 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.14 135.63 37.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.367 2.045 . . . . 0.0 111.963 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.0 p -125.34 -108.05 0.32 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.597 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.48 165.38 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-O 118.739 -0.648 . . . . 0.0 109.966 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.54 155.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.625 1.203 . . . . 0.0 110.616 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.19 22.99 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.823 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.4 mp0 -71.93 -18.54 62.01 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.566 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.98 -44.26 97.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.799 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.453 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.3 m-85 -113.79 7.88 17.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.716 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.78 -154.49 50.04 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.87 -25.4 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.0 110.536 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.92 -125.88 1.52 Allowed Glycine 0 CA--C 1.517 0.211 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -132.05 159.86 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.859 0.362 . . . . 0.0 110.372 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.66 -162.59 25.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.21 141.12 31.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.97 0.414 . . . . 0.0 110.611 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.27 111.73 3.95 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.6 mt -120.55 160.3 23.46 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.93 149.28 24.9 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 120.83 0.348 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.5 -48.59 65.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.763 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.49 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -71.76 51.96 0.21 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.708 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -64.37 -46.2 84.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.11 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.48 -47.08 35.48 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.096 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.24 -43.79 98.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.459 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.57 -42.85 99.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.746 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.71 -37.55 73.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.694 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.32 -77.47 0.1 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.9 mt -28.95 -45.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.984 0.421 . . . . 0.0 110.769 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.443 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.1 m-20 -63.69 -45.47 89.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.49 -43.74 98.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.947 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.23 92.61 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.15 -43.67 98.52 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.16 0.505 . . . . 0.0 110.112 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.98 -39.36 91.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.71 -42.67 97.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.895 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.14 -38.32 73.32 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.71 -38.76 77.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 110.447 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.01 -45.48 92.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.24 0.66 55.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.54 20.06 67.5 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 84.5 m -58.09 -46.13 86.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.58 -57.15 11.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.953 0.406 . . . . 0.0 110.451 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.9 mt-10 -57.23 -41.42 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.149 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.458 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.01 -41.53 98.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.413 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.99 -49.67 77.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.713 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.03 -35.82 73.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.318 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.45 -50.84 33.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.536 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.0 m-85 -62.31 -45.76 91.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.534 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.47 155.44 36.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.99 98.19 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.417 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -155.16 -165.74 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.45 109.67 14.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.74 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.75 -40.54 89.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.581 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 85.3 m-85 -57.03 -43.76 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.03 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.18 164.25 54.59 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.731 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.39 99.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.662 2.241 . . . . 0.0 112.335 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.45 -40.52 89.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.0 m-20 -139.14 142.77 38.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.398 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -109.87 127.25 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.899 0.38 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.67 120.49 40.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.87 141.88 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.927 0.394 . . . . 0.0 110.376 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.66 102.36 1.58 Allowed Glycine 0 N--CA 1.463 0.483 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.9 m -125.13 119.83 29.68 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 122.693 -0.298 . . . . 0.0 111.118 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.4 t70 -112.41 94.77 28.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--N 1.309 -1.532 0 C-N-CA 122.459 2.106 . . . . 0.0 112.25 179.109 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.2 t0 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.948 0.404 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.1 mt -67.26 -40.28 84.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.886 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 55.0 m-20 -61.02 -37.3 82.07 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.709 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.0 tp -65.83 -44.68 84.86 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.15 -46.5 85.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -54.3 -54.19 43.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.387 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.06 -38.15 62.23 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.953 0.406 . . . . 0.0 110.419 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.51 -42.46 74.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.608 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -54.28 -44.42 71.89 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.044 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.63 -48.04 78.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.018 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -59.35 -41.28 88.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.096 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.28 -18.21 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.571 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.11 52.35 4.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 170.28 16.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.16 141.64 28.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.06 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -117.23 131.61 56.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.682 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -127.89 127.37 43.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.454 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.24 137.81 34.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.903 0.382 . . . . 0.0 110.399 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.56 129.52 64.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.403 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -67.65 139.97 56.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.78 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 173.65 135.52 0.13 Allowed Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.2 Cg_endo -68.62 144.19 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.592 2.195 . . . . 0.0 112.546 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.5 mt -40.75 -54.1 2.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.043 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -48.67 -26.18 2.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.15 -20.78 18.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.72 -42.47 95.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.001 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.589 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.28 -57.31 26.58 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.744 0.652 . . . . 0.0 109.616 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.0 Cg_exo -54.65 -43.26 60.71 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.658 2.239 . . . . 0.0 111.19 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.3 m -58.27 -44.74 88.55 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.691 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.87 -44.47 91.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.194 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.81 -41.06 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.492 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.08 11.31 1.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.85 12.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -33.58 75.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.529 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 67' ' ' ILE . 45.1 pt -124.29 154.43 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -91.75 -20.81 21.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.146 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.55 159.95 22.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 70' ' ' ILE . 96.3 mt -115.82 127.54 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.067 0.46 . . . . 0.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -129.03 107.2 9.42 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.28 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.565 ' HG ' ' N ' ' A' ' 73' ' ' SER . 46.9 t -162.17 -176.95 5.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.633 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.565 ' N ' ' HG ' ' A' ' 72' ' ' SER . 77.9 p -64.34 -15.94 61.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.59 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.4 tp -36.89 122.63 0.83 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -82.55 155.78 24.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.627 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -105.29 149.17 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.296 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.3 p -150.53 152.92 34.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.812 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.21 -47.84 54.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.967 0.413 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.5 -39.83 70.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.776 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.59 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -68.41 -37.75 80.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.67 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.852 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.88 -27.58 66.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.129 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.11 -51.55 7.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.7 -167.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.36 147.04 29.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 111.044 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -130.28 150.29 51.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.656 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.1 t -165.13 -150.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.431 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.656 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.3 m-20 42.55 19.94 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.93 121.09 0.11 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.38 0.425 . . . . 0.0 110.471 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -79.28 -71.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.782 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -148.19 165.27 31.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.624 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.32 126.05 31.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.19 67.74 0.75 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.752 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.68 -105.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.47 167.3 29.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.634 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.23 146.59 22.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.68 135.88 42.47 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.786 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.55 111.58 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.77 164.69 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.04 148.3 24.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.14 -27.88 48.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -59.29 -41.46 89.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.35 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -102.45 122.48 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.61 109.7 19.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.434 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 105' ' ' ILE . 96.9 mt -128.2 129.97 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.718 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.6 35.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.451 . . . . 0.0 110.507 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.471 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.9 Cg_endo -60.45 91.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.783 2.322 . . . . 0.0 111.9 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -169.57 141.97 2.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 123.584 0.553 . . . . 0.0 110.75 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.07 -33.42 60.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.215 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.19 -62.77 1.53 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.294 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.0 t -56.2 -21.91 25.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.138 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.12 -26.62 56.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.307 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.04 133.22 48.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.387 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -16.25 29.64 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.34 151.18 23.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.421 . . . . 0.0 110.409 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.71 134.88 38.12 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.198 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.65 136.48 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.692 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.7 138.83 14.49 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.09 161.55 40.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.145 0.497 . . . . 0.0 110.313 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.493 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.2 tp -92.42 118.07 30.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.563 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.57 157.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.58 50.66 53.41 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.3 p -149.05 167.96 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.831 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.5 p -71.5 -29.76 65.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.2 mt-30 -58.93 -55.13 39.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.42 -55.46 33.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.38 -51.26 70.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.77 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.598 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.5 t80 -62.06 -43.91 97.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.95 -44.36 97.92 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.12 -14.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.35 2.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.598 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.31 -50.7 17.75 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.38 12.61 35.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.248 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.97 -55.46 0.47 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.37 -9.98 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.78 2.32 . . . . 0.0 111.913 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -83.0 -8.74 59.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.23 33.35 36.05 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.7 137.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.009 0.433 . . . . 0.0 110.472 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -87.58 130.26 34.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.258 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.4 137.96 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.9 t -123.03 133.33 69.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.87 126.87 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -110.67 153.65 24.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.73 7.98 28.68 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.15 130.09 5.79 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.04 -45.91 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.38 -23.51 62.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.495 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.463 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.66 -36.66 84.98 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.535 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 149' ' ' ILE . 96.5 mt -65.98 -47.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.13 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.63 -38.0 89.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.22 -42.58 98.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.182 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -64.06 -45.13 90.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.037 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.47 -47.95 82.38 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.206 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.56 -22.86 67.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.005 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.9 -18.76 25.54 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.548 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.01 11.17 70.51 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.61 -18.12 63.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.593 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.5 pt -128.46 137.57 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 110.444 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.64 -28.72 62.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.53 155.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.24 138.62 51.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.018 0.437 . . . . 0.0 109.96 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.48 102.98 14.58 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.214 0.531 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.93 25.2 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.438 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.83 152.23 40.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 98.0 mt-10 -66.05 -53.97 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.268 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 70.4 t -60.08 -49.22 84.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.42 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.96 85.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.882 0.372 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.26 1.25 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.318 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 68.2 m -57.98 -46.39 85.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.293 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -45.61 -41.56 10.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.389 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.477 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.52 -62.06 0.47 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.721 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.655 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.69 -71.56 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.534 0.207 . . . . 0.0 111.136 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -62.16 -41.23 98.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.5 tttt -59.98 -2.17 0.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.53 0.681 . . . . 0.0 110.318 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 173' ' ' LEU . 52.5 mt-30 -126.45 141.93 41.49 Favored Pre-proline 0 CA--C 1.532 0.272 0 O-C-N 122.079 -0.388 . . . . 0.0 110.733 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.65 -14.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.842 2.361 . . . . 0.0 112.397 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 175' ' ' GLN . 87.6 t -62.94 -42.89 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.17 84.33 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.38 -41.1 96.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.92 -34.9 79.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.476 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.52 142.97 18.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.0 pttt -175.88 99.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.962 0.41 . . . . 0.0 110.796 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.5 m-85 -158.68 167.11 30.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.683 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.19 55.98 3.14 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 134.98 36.06 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 111.949 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.461 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -124.32 -108.35 0.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.547 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -165.42 165.07 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 CA-C-O 119.16 -0.447 . . . . 0.0 110.156 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.8 tttt 154.13 155.24 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.283 0.989 . . . . 0.0 110.669 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.15 118.51 22.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.776 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.4 mp0 -71.17 -19.07 62.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.55 -31.81 73.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.546 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.88 -44.33 97.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -114.16 8.44 16.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.819 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.44 -153.58 50.76 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.1 p -71.01 -25.65 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.71 -125.97 1.53 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.5 p -132.16 160.42 36.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.504 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.54 -162.04 24.02 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.68 139.83 33.8 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.959 0.409 . . . . 0.0 110.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.65 108.75 3.47 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.0 mt -117.72 159.41 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 0.0 110.253 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.82 149.19 25.02 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 120.886 0.374 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.61 64.16 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.645 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -40.64 -22.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.81 51.55 0.28 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -64.47 -46.03 84.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.171 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.28 -47.08 37.15 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.26 -43.65 98.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.474 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.45 -43.05 99.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.823 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.77 -37.51 73.8 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.26 -77.69 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.518 ' C ' ' O ' ' A' ' 212' ' ' ALA . 87.3 mt -28.54 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.448 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.6 m-20 -63.43 -45.57 90.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.02 -43.84 98.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.94 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.26 92.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.077 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -61.11 -43.67 98.53 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.058 0.456 . . . . 0.0 110.015 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.34 92.07 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.058 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.67 -43.52 96.45 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.2 -38.65 71.27 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.73 -38.75 76.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.024 0.44 . . . . 0.0 110.367 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.56 91.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 20.6 p-10 -88.61 -0.02 56.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.78 20.86 68.8 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.5 m -58.05 -46.38 85.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 80.4 t80 -63.26 -57.62 9.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.443 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.423 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.4 mt-10 -57.05 -42.43 80.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.399 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -48.66 80.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.71 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.34 -41.38 98.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.566 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.67 -50.04 75.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.63 -34.65 73.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.719 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -71.16 -51.77 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.706 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.432 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 39.4 m-85 -62.52 -44.94 95.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.67 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 230' ' ' ALA . 84.0 m-85 -151.06 153.21 34.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 49.1 p-10 -98.34 93.6 6.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.495 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.56 -165.64 2.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.511 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.447 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.36 108.8 13.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.4 -40.59 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.423 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.2 m-85 -57.3 -43.49 83.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.16 94.31 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.683 0 CA-C-O 117.876 -1.513 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.73 164.37 56.03 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.78 143.75 99.44 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 122.692 2.261 . . . . 0.0 112.3 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.24 -40.0 89.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -140.1 145.54 37.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.42 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.28 130.04 66.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -105.93 117.88 35.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.448 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -113.27 140.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.44 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.2 100.45 1.46 Allowed Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.5 m -123.66 119.3 29.42 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.66 -0.318 . . . . 0.0 111.151 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 8.1 t70 -112.33 93.98 24.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.309 -1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.16 179.303 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 . . . . . 0 C--O 1.226 -0.143 0 CA-C-O 121.004 0.431 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.85 -40.13 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.892 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.03 -37.02 81.09 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.89 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.48 -44.66 82.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.177 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.8 -41.67 91.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.095 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -57.8 -53.43 58.33 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.596 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.97 -36.16 65.07 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.314 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.93 -43.18 72.17 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -55.04 -43.6 73.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.3 -48.02 77.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.019 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.49 -40.79 88.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.32 -18.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.46 51.75 4.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.123 0.487 . . . . 0.0 110.799 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -144.39 169.26 18.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.75 140.36 29.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.065 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -117.31 132.29 56.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.0 m -128.16 126.88 41.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.386 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.5 136.69 34.52 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.455 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.33 129.34 64.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.346 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.67 141.19 56.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.757 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 172.65 135.86 0.1 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.497 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.56 144.19 59.75 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.644 2.23 . . . . 0.0 112.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.0 mt -41.17 -53.64 3.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.916 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.84 -26.11 2.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.41 19.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.143 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.84 -42.5 94.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.963 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.42 -56.97 28.54 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.772 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.1 Cg_exo -55.18 -43.04 62.8 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.562 2.175 . . . . 0.0 111.137 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -58.32 -44.42 88.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.764 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.95 -44.48 91.45 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.65 -40.92 96.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 0.0 110.431 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.77 11.38 1.38 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 55.92 12.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.53 -33.81 76.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 67' ' ' ILE . 42.4 pt -124.71 153.73 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.323 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -92.83 -20.46 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.29 158.38 24.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.674 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.4 HD13 HG23 ' A' ' 70' ' ' ILE . 96.4 mt -116.41 127.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.502 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.68 106.65 9.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.301 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.501 ' HG ' ' N ' ' A' ' 73' ' ' SER . 40.6 t -161.11 -177.97 6.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.501 ' N ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.33 -15.54 60.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.627 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.13 123.09 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.558 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -82.44 155.84 24.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.704 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -105.03 148.73 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.45 152.81 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.781 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.66 52.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 110.567 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.37 -39.96 70.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.627 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.61 -37.57 79.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.89 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.33 -38.09 76.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.86 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.86 -27.69 66.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.02 -51.36 7.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.957 0.408 . . . . 0.0 110.69 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -139.12 -167.83 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.1 0.476 . . . . 0.0 110.457 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.64 147.06 29.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.044 0.449 . . . . 0.0 110.966 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -130.05 150.21 51.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.629 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.717 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.2 t -165.08 -150.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.717 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.3 m-20 42.52 20.08 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.7 mttt -27.79 121.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.494 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 17.6 mt -79.84 -72.49 0.4 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -147.77 164.74 32.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.2 127.67 32.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.19 67.34 0.69 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.12 -106.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.47 167.65 28.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.58 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.413 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.4 mt -101.03 135.96 41.64 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.786 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.87 111.03 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.72 164.41 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.956 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.64 148.69 24.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.6 -28.16 53.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.13 -41.43 88.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.266 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.31 122.25 43.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 110.218 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.71 109.71 19.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.403 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 105' ' ' ILE . 96.9 mt -128.39 130.01 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.634 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.1 158.84 34.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.568 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.484 ' C ' ' HG1' ' A' ' 108' ' ' THR . 20.5 Cg_endo -60.06 90.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.819 2.346 . . . . 0.0 111.858 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.484 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 7.0 m -169.17 141.43 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.538 0.524 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.76 -33.14 59.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.31 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -57.15 -62.56 1.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.381 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.56 -21.8 29.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.062 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.1 -26.95 56.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.347 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.87 132.82 47.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.373 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -15.93 33.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.72 151.25 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 0.0 110.45 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.06 135.35 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.998 0.427 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.63 136.5 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 137.62 13.84 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.63 161.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.118 0.485 . . . . 0.0 110.31 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.493 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.2 tp -92.75 119.38 32.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.49 156.81 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.65 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.12 50.55 50.84 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.2 p -148.87 167.83 24.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 67.1 p -71.98 -28.68 63.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.458 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -59.7 -55.33 35.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.47 -55.11 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.55 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.55 -51.12 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.69 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.3 t80 -62.03 -43.9 97.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.091 0.472 . . . . 0.0 110.434 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.25 -44.38 97.77 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.03 -14.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 0.0 110.795 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.54 -34.24 2.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.692 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.36 -51.07 16.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.959 0.409 . . . . 0.0 111.539 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.24 12.69 35.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.241 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.49 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.93 -55.48 0.47 Allowed Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.341 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.23 -10.09 25.27 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.781 2.32 . . . . 0.0 111.945 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.99 -8.93 59.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.46 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.55 33.36 34.92 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.58 137.44 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.913 0.387 . . . . 0.0 110.547 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.28 130.28 34.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.59 138.32 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.37 133.33 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 109.979 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.08 127.34 42.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.57 153.85 24.57 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.97 6.68 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.68 130.43 5.82 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.07 -45.92 79.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.56 -24.27 63.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.516 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.473 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -36.69 85.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.456 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.42 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -65.9 -46.71 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.067 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -64.3 -37.87 89.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.269 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.56 -42.29 96.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.122 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.461 ' N ' ' HG ' ' A' ' 151' ' ' SER . 53.1 m-20 -65.77 -42.35 90.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.843 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.5 tp -59.23 -48.59 81.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.185 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.2 m -62.64 -22.39 66.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.002 0.43 . . . . 0.0 110.204 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.36 -17.9 26.47 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.562 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.58 11.56 74.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.6 -17.84 63.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.41 136.65 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 110.502 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.95 -28.84 62.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.201 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.13 155.12 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.792 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.22 138.27 51.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 109.978 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.15 103.21 14.58 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.23 0.538 . . . . 0.0 110.599 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.67 25.78 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.436 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.66 152.76 40.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.54 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.24 -53.97 30.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.06 -49.02 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.365 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.81 84.22 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 110.837 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.78 1.1 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.6 m -57.64 -46.13 84.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.7 tt0 -46.32 -42.31 14.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.338 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.1 -61.87 0.48 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.762 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.0 t80 -40.38 -71.19 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.584 0.23 . . . . 0.0 111.214 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -62.28 -40.81 97.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.8 tttt -59.86 -2.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.579 0.704 . . . . 0.0 110.494 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 177' ' ' VAL . 58.1 mt-30 -126.5 141.78 41.09 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.832 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -43.43 -14.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.861 2.374 . . . . 0.0 112.328 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' GLN . 90.0 t -62.87 -43.03 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.589 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.86 -33.44 85.38 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.38 96.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.731 0.301 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -65.79 -34.95 79.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.503 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.8 m-85 -156.64 143.25 18.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.737 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -176.16 99.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.746 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.5 167.01 30.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.23 55.39 3.09 Favored Glycine 0 C--O 1.225 -0.413 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.11 -116.83 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.05 134.65 36.57 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.46 2.107 . . . . 0.0 111.893 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.3 p -124.03 -108.63 0.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.542 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.603 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.43 165.01 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.4 tttt 154.61 155.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.178 0.924 . . . . 0.0 110.665 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -81.27 118.92 23.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.3 -19.1 62.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.45 -31.41 72.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.494 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.89 -44.4 97.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.736 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.29 8.61 16.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.722 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.22 -153.81 49.97 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.65 -25.72 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.559 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.99 -126.59 1.62 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.6 p -132.21 160.24 36.7 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.26 -162.93 25.27 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.06 140.22 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.419 . . . . 0.0 110.591 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.72 108.8 3.48 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.3 mt -118.22 159.72 22.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.944 0.402 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.73 148.79 25.28 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.38 64.26 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -40.57 -22.51 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.0 110.739 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.77 51.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.748 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -64.32 -46.62 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.23 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.16 -47.09 38.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.05 -43.52 98.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.53 -43.13 99.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.799 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.56 -37.65 73.47 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.696 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.29 -77.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.518 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.3 mt -28.72 -45.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.846 0.355 . . . . 0.0 110.518 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.451 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 87.9 m-20 -63.66 -45.81 88.45 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.02 -44.11 97.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.33 92.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.148 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.95 -43.81 98.16 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.15 91.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.087 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -64.05 -43.59 95.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.859 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.24 -38.52 71.19 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -38.98 77.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.27 -45.55 90.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 19.1 p-10 -88.73 -0.71 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.21 20.44 71.19 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.5 -46.22 87.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.494 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 71.0 t80 -62.35 -56.2 20.65 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.244 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.5 mt-10 -57.48 -40.26 78.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.059 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.32 -47.92 83.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.491 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.08 -40.77 96.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -61.11 -49.14 78.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.01 -35.74 73.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.503 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.49 -51.39 36.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.584 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 8.8 m-85 -62.01 -46.3 89.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.52 154.92 33.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.49 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -98.31 96.89 8.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.45 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.63 -164.67 2.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.555 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -121.96 108.92 13.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.734 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.45 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.409 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 91.3 m-85 -58.82 -42.38 89.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.288 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -62.96 -37.93 95.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.712 0 CA-C-O 117.905 -1.497 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.85 164.26 57.51 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.642 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.08 143.82 99.13 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.625 2.217 . . . . 0.0 112.309 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.09 -40.6 90.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.578 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.21 143.7 38.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.447 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.33 129.03 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.854 0.359 . . . . 0.0 110.466 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.57 117.56 34.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.372 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 141.78 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.973 0.416 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.67 106.74 2.12 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.8 m -128.94 120.06 25.44 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.634 -0.333 . . . . 0.0 111.107 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 26.9 t0 -112.41 94.67 28.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.079 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.309 -1.538 0 C-N-CA 122.463 2.109 . . . . 0.0 112.205 179.12 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 . . . . . 0 C--O 1.227 -0.126 0 CA-C-O 121.005 0.431 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.1 mt -66.85 -39.98 84.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.793 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.0 -37.01 81.02 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.787 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.91 -44.84 84.02 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.33 -45.53 87.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.02 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -54.61 -54.36 42.55 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.51 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.9 -37.53 63.87 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.475 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.31 -43.11 74.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.588 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 52.0 m -54.25 -44.0 71.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.035 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -64.01 -47.93 78.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.006 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.55 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.11 -18.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.24 52.33 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.68 170.23 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.19 141.74 28.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.101 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.57 132.19 56.56 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.78 126.6 42.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.389 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.93 136.69 34.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.31 129.18 64.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.93 139.66 56.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.779 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 p30 175.52 135.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.52 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.1 Cg_endo -68.65 143.71 57.51 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.644 2.229 . . . . 0.0 112.461 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.6 mt -40.62 -54.78 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.032 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.43 1.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.89 -20.97 18.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.92 -42.48 97.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.791 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.604 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.88 -57.1 26.22 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.711 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -54.93 -42.94 64.2 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.615 2.21 . . . . 0.0 111.214 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.52 -44.88 89.7 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.749 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.75 -44.48 90.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.75 -41.02 96.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.484 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.06 11.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 55.97 12.32 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.77 -33.83 76.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 67' ' ' ILE . 45.7 pt -124.06 154.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.261 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -91.85 -20.79 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.02 160.53 21.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.637 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 70' ' ' ILE . 96.1 mt -116.1 127.76 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.052 0.453 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.2 ttp -129.12 107.42 9.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.334 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.628 ' HG ' ' H ' ' A' ' 73' ' ' SER . 38.3 t -162.72 -176.91 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.628 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -63.89 -16.22 60.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.62 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.4 tp -36.99 122.75 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.491 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.94 155.88 23.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.712 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 pt -105.36 149.46 8.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.347 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.7 p -150.49 152.76 34.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.775 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.02 -47.66 53.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 110.589 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.26 -39.93 70.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.807 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.62 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -38.1 75.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.81 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.75 -27.65 66.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.078 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.08 -51.1 7.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.039 0.447 . . . . 0.0 110.73 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.15 -167.57 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.135 0.493 . . . . 0.0 110.498 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.93 147.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -130.35 150.49 51.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.724 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.3 t -165.28 -150.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.455 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.724 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.2 m-20 42.51 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.04 120.99 0.11 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.499 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -79.95 -72.51 0.4 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.932 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -147.81 165.11 31.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.641 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.05 127.56 32.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.387 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.19 66.99 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.591 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.27 -106.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.0 p -159.23 167.44 29.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.616 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.85 146.79 23.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 0.0 110.415 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.47 135.84 42.3 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.773 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.83 110.98 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.75 164.44 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.59 148.43 24.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.06 -28.24 50.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.248 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.09 -41.35 87.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.252 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 t -102.38 122.28 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.262 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.01 109.52 19.89 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.067 0.46 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.05 129.76 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.705 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.37 159.0 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.554 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.479 ' C ' ' HG1' ' A' ' 108' ' ' THR . 20.6 Cg_endo -60.3 90.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.74 2.293 . . . . 0.0 111.884 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.479 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 7.3 m -169.05 141.29 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.543 0.527 . . . . 0.0 110.73 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.83 -33.52 62.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.246 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.15 -62.57 1.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -56.02 -22.0 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.12 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.46 -26.19 55.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.317 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.2 47.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.422 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.77 -15.67 30.27 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.14 150.85 24.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.429 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.55 134.82 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 110.259 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.58 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.663 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.76 137.44 13.78 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.47 161.49 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.127 0.489 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.49 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.4 tp -92.51 119.3 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.528 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.13 156.7 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.717 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.54 53.51 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -148.41 167.3 25.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.294 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 74.8 p -70.59 -31.27 68.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.468 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -58.22 -54.97 40.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.431 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -56.27 -55.74 29.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.74 -51.24 70.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.818 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.4 t80 -62.02 -44.09 97.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.78 -44.24 98.15 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.33 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.843 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.38 2.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.09 -50.98 17.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.025 0.44 . . . . 0.0 111.578 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.23 12.74 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.306 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.93 -55.37 0.47 Allowed Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.432 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.25 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.747 2.298 . . . . 0.0 111.951 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -8.85 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.484 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.39 35.79 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.48 137.52 41.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.969 0.414 . . . . 0.0 110.49 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.42 130.48 34.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.343 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.22 138.57 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.45 133.61 68.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.042 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 126.77 42.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -110.14 153.9 24.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.286 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.22 6.68 28.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.13 130.2 5.83 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.97 -45.9 80.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.2 -23.78 63.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.473 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.64 -36.72 85.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 149' ' ' ILE . 96.7 mt -65.9 -46.88 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.149 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.671 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.51 -37.55 87.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.67 -41.85 95.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 -42.29 89.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.7 tp -59.21 -48.53 81.25 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.134 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.5 -22.33 66.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 0.0 110.198 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.57 -17.77 26.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.603 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.87 74.4 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.86 -18.22 63.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.612 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.71 135.98 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.479 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.32 -29.34 63.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.269 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.17 155.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.801 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.95 138.85 52.22 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.97 0.415 . . . . 0.0 109.924 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -86.75 102.71 14.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.216 0.531 . . . . 0.0 110.783 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.671 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 51.0 tt0 -131.94 164.58 25.82 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.386 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.439 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.55 153.27 40.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.526 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.67 -54.25 25.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.237 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.6 t -59.97 -49.08 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.84 84.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.941 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.72 1.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.455 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 67.0 m -57.82 -46.37 84.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.32 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.6 tt0 -46.1 -41.87 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.411 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.451 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.25 -62.11 0.48 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.707 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.2 t80 -40.3 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.786 -0.244 . . . . 0.0 111.184 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -62.14 -40.71 96.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.55 -2.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.422 0.629 . . . . 0.0 110.394 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 177' ' ' VAL . 53.5 mt-30 -126.21 141.6 40.24 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.799 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.39 -14.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.792 2.328 . . . . 0.0 112.335 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 175' ' ' GLN . 91.0 t -63.04 -43.04 98.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.88 -33.46 85.49 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.06 -41.37 96.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.0 110.444 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -65.74 -34.81 79.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.465 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -156.92 143.53 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.734 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.19 99.38 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.4 m-85 -158.9 167.01 30.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.632 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.9 55.96 3.02 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.17 -116.92 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 134.76 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.502 2.135 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.2 p -124.23 -108.5 0.33 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.24 164.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.213 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.5 tttt 154.68 155.11 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 124.041 0.838 . . . . 0.0 110.706 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -81.04 118.5 22.55 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.777 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -70.5 -18.81 62.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.51 -31.61 72.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.93 -44.4 97.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.702 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.07 8.33 16.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.788 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.66 -153.52 50.42 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.8 -25.76 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.554 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.77 -126.98 1.68 Allowed Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.8 p -132.21 160.37 36.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.418 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.98 -161.65 23.73 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.94 140.06 33.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.925 0.393 . . . . 0.0 110.611 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.73 108.71 3.48 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -117.45 159.36 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.251 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.31 148.84 25.43 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.86 -48.46 64.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.69 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -40.85 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -72.9 51.51 0.29 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.895 0.379 . . . . 0.0 110.794 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.46 -46.3 83.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.06 -47.22 38.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.026 0.441 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.14 -43.46 98.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.464 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.7 -43.02 99.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.825 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -37.44 73.52 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.48 -77.47 0.11 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.3 mt -28.52 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.444 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.3 m-20 -63.5 -45.92 88.47 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.83 -43.94 97.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.929 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.1 91.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.083 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.28 91.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.051 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.73 -43.69 95.77 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.26 -38.48 71.22 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.57 -39.04 77.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.987 0.423 . . . . 0.0 110.271 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.39 91.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.649 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 19.3 p-10 -89.02 -0.5 57.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.87 20.75 70.81 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.48 -46.27 87.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.499 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 73.2 t80 -62.3 -56.46 18.22 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.414 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -57.08 -40.42 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.176 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.53 -47.89 83.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.485 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.11 -40.96 97.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.44 77.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.501 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.93 -35.74 73.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.63 -51.45 34.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.97 -45.97 91.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.6 m-85 -155.05 154.76 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.522 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.2 p-10 -97.99 96.0 7.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.439 . . . . 0.0 110.526 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.0 -164.7 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.545 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.14 108.98 13.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.4 m -63.54 -40.64 89.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.358 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.414 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 90.4 m-85 -58.53 -42.6 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.39 -37.67 95.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.689 0 CA-C-O 117.848 -1.529 . . . . 0.0 111.021 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 164.13 63.33 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.643 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.05 143.6 99.19 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 122.591 2.194 . . . . 0.0 112.313 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.43 -41.13 89.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.562 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -137.93 139.44 39.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.417 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.82 121.36 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.675 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.93 118.82 32.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.178 0.513 . . . . 0.0 110.154 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.56 138.69 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.96 105.75 2.15 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.2 m -129.04 120.61 26.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 122.69 -0.3 . . . . 0.0 111.018 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.6 t70 -114.42 92.9 29.77 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.502 2.135 . . . . 0.0 112.07 179.244 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.469 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.9 t0 . . . . . 0 C--O 1.227 -0.098 0 CA-C-O 120.97 0.414 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.01 -40.86 83.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.873 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -60.91 -37.26 81.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.829 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.88 -45.08 87.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.12 -48.54 78.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.982 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -53.0 -54.66 31.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.33 -39.88 61.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.864 0.364 . . . . 0.0 110.298 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.67 -41.94 78.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 110.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.44 -45.19 69.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.084 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.09 -46.84 82.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.042 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -60.01 -42.28 93.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.16 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.32 -17.23 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.72 53.21 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.489 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.26 171.56 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.11 142.61 27.5 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.018 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.45 131.15 56.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.24 126.94 43.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.411 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -93.73 134.66 35.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.06 127.81 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.262 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.63 137.8 57.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.776 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.05 131.53 0.17 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.555 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.7 Cg_endo -68.01 144.74 65.15 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.729 2.286 . . . . 0.0 112.435 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.4 mt -40.33 -55.55 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.42 1.94 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.04 -20.94 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.249 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 mt -63.8 -42.42 97.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.596 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.623 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.2 -56.99 25.98 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.806 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.48 -42.41 68.26 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.59 2.193 . . . . 0.0 111.179 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 70.7 m -58.7 -44.89 90.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.931 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.05 -44.06 91.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.35 -40.72 96.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.956 0.408 . . . . 0.0 110.452 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.04 2.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.514 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.19 12.08 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.463 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -35.5 80.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.481 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -122.34 152.89 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.264 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.2 -22.18 19.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.61 155.99 27.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.0 129.28 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 110.406 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.34 106.52 8.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.395 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.8 t -158.95 178.43 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.636 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.7 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -65.4 -15.35 62.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.611 ' CD1' HH12 ' A' ' 80' ' ' ARG . 43.9 tp -34.82 124.65 0.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.01 153.86 25.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.645 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 pt -104.84 148.86 8.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.297 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -149.36 152.13 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.854 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.85 -47.28 51.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.507 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.32 -39.83 70.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.735 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.611 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.94 -37.91 79.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.84 -38.95 76.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.816 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.89 -27.42 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.096 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.42 -50.84 7.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.048 0.451 . . . . 0.0 110.655 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.18 -168.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.131 0.491 . . . . 0.0 110.456 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.43 147.66 30.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.007 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -129.88 149.9 51.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.563 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.642 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.7 t -163.09 -153.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.592 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.642 ' H ' ' HG1' ' A' ' 87' ' ' THR . 92.8 m-20 41.34 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.945 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.62 121.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.346 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.429 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.9 mt -75.09 -68.7 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -150.34 167.49 26.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.76 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.5 123.55 29.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.218 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.55 68.32 0.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.47 -104.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.35 165.7 32.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.741 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.34 146.35 22.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 0.0 110.443 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.9 mt -101.08 136.12 41.44 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.988 0.423 . . . . 0.0 110.81 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.8 110.41 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.2 164.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.71 148.48 23.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.988 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.6 -27.66 40.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.226 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.29 -41.83 89.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.316 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.5 122.14 43.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.94 109.35 19.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.424 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.9 129.65 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.772 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.25 159.0 33.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.523 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.468 ' C ' ' HG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.46 89.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.685 2.256 . . . . 0.0 111.904 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.468 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.6 m -169.08 140.31 2.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.31 -32.38 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -57.34 -62.92 1.43 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -55.39 -22.41 19.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.62 -25.8 54.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.67 132.67 46.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.95 -16.13 28.93 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.03 151.1 23.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.84 135.37 37.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.35 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.74 136.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.648 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 137.79 13.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 56.0 t -130.51 161.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.089 0.471 . . . . 0.0 110.336 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.499 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 42.1 tp -92.37 118.16 30.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.535 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.03 157.75 1.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.67 50.98 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.2 p -149.68 168.89 22.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.5 p -73.53 -27.25 61.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.45 -55.45 33.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.48 -55.1 37.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.583 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.05 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.705 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.8 t80 -62.08 -43.91 97.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.04 -44.46 97.75 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.41 -14.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.784 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.23 -34.36 2.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.55 -50.54 17.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.18 12.48 36.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.239 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.79 -55.51 0.47 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.332 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.33 25.66 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 111.952 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.76 -9.0 59.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.32 37.65 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.598 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.51 129.87 34.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.333 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 138.29 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.923 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.25 133.21 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 109.946 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.46 127.63 43.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -110.7 153.89 24.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -106.91 7.13 29.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.72 130.73 6.06 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.95 -45.92 80.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.768 0.318 . . . . 0.0 110.474 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.25 62.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.7 -36.84 85.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.543 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 149' ' ' ILE . 96.7 mt -65.97 -46.79 87.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.138 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.685 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.7 m-85 -64.45 -37.65 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.348 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.86 -42.16 97.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.023 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.99 -43.38 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.96 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.8 tp -58.98 -48.15 82.6 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.096 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.79 -22.32 66.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.955 0.407 . . . . 0.0 110.164 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.78 -18.21 25.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.07 11.92 72.04 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.17 -18.24 63.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.602 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.9 pt -127.02 135.92 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.371 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.54 -28.11 62.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.43 155.71 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.49 50.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 109.947 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.94 103.14 14.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.264 0.555 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.685 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 50.2 tt0 -132.65 165.14 25.15 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.382 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -72.79 153.05 41.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 110.634 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.4 -54.64 22.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.39 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 72.6 t -60.27 -48.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.618 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.08 89.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.862 0.363 . . . . 0.0 110.83 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.47 -63.27 1.18 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.1 m -59.28 -47.75 84.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.916 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.98 -37.44 20.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.195 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.08 -66.36 0.55 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.1 t80 -40.27 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.663 0.268 . . . . 0.0 111.194 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.35 -40.13 93.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.78 -2.84 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.443 0.64 . . . . 0.0 110.475 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.4 mt-30 -123.37 148.79 56.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.828 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.66 -19.97 3.95 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.892 2.395 . . . . 0.0 112.148 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.14 -42.55 93.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.99 -33.21 84.86 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.72 -41.26 94.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.695 0.283 . . . . 0.0 110.399 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.59 -33.93 77.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.327 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.35 142.66 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.732 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.19 99.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.754 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.17 166.76 30.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.713 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.87 56.54 2.72 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.44 -118.27 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.41 135.68 32.48 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.511 2.14 . . . . 0.0 111.918 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.7 p -125.41 -107.79 0.32 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.591 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -166.14 165.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.334 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 156.78 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 123.983 0.802 . . . . 0.0 110.665 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.84 117.24 22.58 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.5 mp0 -71.13 -18.89 62.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.85 -32.59 74.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.568 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.96 -44.54 97.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.71 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.4 m-85 -114.03 9.63 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.769 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.0 -154.76 52.38 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.39 -25.1 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.527 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.22 -124.32 1.32 Allowed Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.8 p -129.32 156.19 44.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.707 0.289 . . . . 0.0 110.33 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.6 -169.61 30.42 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.1 137.44 33.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.46 108.2 3.27 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.52 159.39 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.955 0.407 . . . . 0.0 110.206 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 90.0 mtm180 -86.84 149.64 24.69 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.89 -48.2 64.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.3 tp10 -38.23 -25.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.56 52.26 0.2 Allowed 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.677 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -64.56 -45.15 88.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.8 -47.3 31.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.26 -43.94 97.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.454 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.24 -42.92 99.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.724 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -36.23 70.28 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.45 -77.51 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.525 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.0 mt -28.46 -46.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.356 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.443 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.9 m-20 -64.33 -44.96 89.91 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.636 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.96 -43.66 98.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.962 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.21 93.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -43.57 98.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.28 92.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.63 -42.74 98.13 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.53 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.31 -38.42 77.05 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.86 -39.99 79.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.188 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -45.86 93.03 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.53 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.1 p30 -86.68 1.33 52.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.489 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.42 19.71 60.27 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 69.7 m -58.35 -45.63 87.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.429 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.2 t80 -63.62 -58.01 8.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.438 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.89 -41.44 78.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.349 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.6 -48.53 80.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.565 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.07 -41.49 98.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.327 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.19 74.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.73 -35.16 72.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.18 -50.97 27.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.481 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.09 -45.5 93.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.2 m-85 -153.27 155.16 36.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.7 p-10 -97.26 94.86 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.504 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -152.71 -166.43 2.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.86 110.37 15.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.799 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 m -63.55 -40.64 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.426 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.9 m-85 -56.62 -43.83 80.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.46 94.89 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.414 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.642 0 CA-C-O 117.895 -1.503 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.88 164.27 61.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.718 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.83 143.66 99.41 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.33 -41.02 90.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.622 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.42 139.69 39.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.56 121.43 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.07 118.51 31.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.067 0.46 . . . . 0.0 110.193 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.62 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.362 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.88 105.47 2.12 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -128.77 120.37 26.26 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.676 -0.308 . . . . 0.0 110.909 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.7 t70 -114.13 92.41 26.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.454 2.103 . . . . 0.0 112.187 179.209 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.9 0.381 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.25 -40.06 82.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.98 -37.64 83.17 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.959 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.71 -45.25 87.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.028 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.1 -48.51 78.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.872 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -52.85 -54.81 29.11 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.353 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -51.96 -39.99 60.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.41 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.82 -41.77 78.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.752 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.3 m -53.74 -45.08 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.063 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.13 -47.03 81.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.2 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.6 -42.38 92.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.37 -17.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.62 53.02 4.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -147.03 171.2 15.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.92 142.51 27.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.35 131.22 56.83 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -127.25 126.91 43.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.39 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.4 134.73 35.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.492 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.08 127.53 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.273 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.55 137.87 57.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.74 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.93 131.76 0.16 Allowed Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.593 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' ALA . 44.2 Cg_endo -68.26 145.12 65.04 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.743 2.295 . . . . 0.0 112.382 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.7 mt -40.44 -55.58 2.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 111.074 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.27 -26.43 1.98 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -21.0 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.183 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.3 mt -63.98 -42.42 97.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.619 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -57.47 23.48 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 123.952 0.783 . . . . 0.0 109.555 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 43.4 Cg_exo -55.01 -42.39 69.62 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.628 2.219 . . . . 0.0 111.36 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 68.4 m -58.69 -44.82 90.38 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.959 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.05 -44.02 91.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.255 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.55 -40.49 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.437 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.06 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.567 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.29 12.07 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.66 -35.39 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 pt -122.39 153.0 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.231 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.32 -22.16 19.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.143 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.53 155.82 27.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.656 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.11 129.03 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 110.423 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.15 106.67 8.5 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.329 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.689 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.8 t -159.11 178.67 9.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.689 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -65.43 -15.28 62.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -34.95 124.48 0.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.62 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.2 p -81.91 153.97 26.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.6 pt -104.74 148.66 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.214 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.2 152.15 35.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.73 -47.43 50.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.31 -39.85 70.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.786 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.614 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -69.1 -37.71 78.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.824 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.83 -38.87 76.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.965 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.76 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.199 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.2 -50.9 7.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.716 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.07 -168.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.102 0.477 . . . . 0.0 110.481 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.3 147.73 29.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.568 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.649 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.18 -153.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.503 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.649 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.9 m-20 41.23 20.32 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.027 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.64 0.2 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.468 0.48 . . . . 0.0 110.419 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.425 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.2 mt -75.37 -68.81 0.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -178.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -150.47 167.6 26.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.37 123.7 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.301 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.91 68.49 0.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.71 -104.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.5 p -159.53 165.73 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.582 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.53 145.98 21.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.178 0.513 . . . . 0.0 110.443 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.84 136.27 40.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.56 111.01 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.16 165.09 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.921 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.0 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.01 -28.47 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.237 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.84 -41.98 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.266 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -101.92 121.76 42.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.212 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.87 109.92 19.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.422 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 HG22 ' A' ' 105' ' ' ILE . 97.2 mt -127.0 129.62 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.56 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -108.17 154.32 41.34 Favored Pre-proline 0 C--N 1.333 -0.124 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.648 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.516 ' C ' ' HG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.33 92.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.819 2.346 . . . . 0.0 111.768 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.516 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.7 m -171.19 144.09 2.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 123.637 0.586 . . . . 0.0 110.82 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.3 -33.58 61.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.275 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -58.02 -62.48 1.79 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.291 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.07 -22.33 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.08 -25.68 55.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.54 133.11 46.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.454 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.0 -17.16 28.74 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.89 151.38 23.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 110.524 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -96.27 136.23 37.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.303 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.7 136.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.667 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 139.78 14.86 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.83 161.84 40.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.327 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 42.4 tp -92.72 118.05 30.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.709 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.47 157.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.584 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.68 51.45 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.7 p -149.65 168.58 23.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.6 p -74.33 -25.58 59.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.497 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -61.01 -55.8 28.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.537 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.04 -54.29 48.42 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.498 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.21 -51.31 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.616 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.45 -43.73 98.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.057 0.456 . . . . 0.0 110.458 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.63 -44.54 97.81 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.68 -14.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 0.0 110.745 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.07 -34.77 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.565 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.37 -50.43 18.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 111.516 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.16 12.79 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.187 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.486 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.09 -55.62 0.46 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.08 -10.44 25.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.783 2.322 . . . . 0.0 111.919 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.59 -8.97 59.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.504 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.63 33.41 38.38 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.31 138.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.031 0.443 . . . . 0.0 110.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.88 129.78 35.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.2 138.9 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.58 132.05 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.999 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.9 t -98.51 130.61 45.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.81 156.58 21.76 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.06 6.89 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.642 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.76 130.75 6.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.89 -46.01 79.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 110.429 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.81 -23.25 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.451 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.71 -36.58 84.75 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.61 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.19 -47.32 84.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.054 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.519 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.83 -37.97 89.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.0 -42.13 97.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.03 -45.4 89.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.8 tp -58.06 -48.28 80.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.327 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.2 m -63.12 -22.94 67.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.018 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.53 -18.73 24.75 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.503 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.13 70.34 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.46 -18.16 63.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.593 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.88 136.88 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.069 0.462 . . . . 0.0 110.434 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.74 -27.46 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.72 155.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.851 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.12 136.94 49.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.076 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.47 103.33 14.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 110.76 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.71 23.91 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.409 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.98 152.45 41.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.506 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.27 -54.55 23.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.28 -49.01 85.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.342 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.77 88.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 110.76 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.21 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.6 m -59.24 -47.87 83.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.978 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.13 -37.5 22.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.125 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.405 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.84 -66.23 0.56 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.662 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.9 t80 -40.69 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.561 0.219 . . . . 0.0 111.092 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -61.1 -40.25 93.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.03 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -60.53 -2.73 0.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.448 0.642 . . . . 0.0 110.386 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.0 mt-30 -122.98 147.41 51.31 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 122.099 -0.376 . . . . 0.0 110.781 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.76 -19.7 2.32 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.864 2.376 . . . . 0.0 112.306 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.55 -42.91 95.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.531 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.17 -33.26 85.32 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.41 -41.41 93.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.77 0.319 . . . . 0.0 110.479 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.3 m-20 -65.52 -33.59 76.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.1 m-85 -155.98 142.68 18.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.9 99.52 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.2 m-85 -159.24 167.46 28.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.631 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.34 56.3 2.87 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.02 -118.03 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.3 135.39 31.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.48 2.12 . . . . 0.0 112.051 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.15 -107.93 0.33 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.555 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.609 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.75 165.35 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.053 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.32 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 O-C-N 124.34 1.025 . . . . 0.0 110.607 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.15 117.67 22.48 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.76 -18.86 62.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.89 -32.38 73.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.504 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.79 -44.74 96.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.685 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.467 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.6 m-85 -113.97 9.66 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.722 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.22 -154.92 52.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.51 -24.74 25.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.02 -124.12 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.43 156.33 44.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 110.289 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.53 -169.53 30.26 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.37 137.26 33.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.29 108.21 3.26 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -123.46 159.31 29.31 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.278 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -86.61 149.62 24.8 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.87 -48.34 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.554 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -37.95 -25.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.826 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.45 52.25 0.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.649 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -45.69 86.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.152 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.49 -47.3 34.06 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.114 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.35 -43.74 98.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.747 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.86 -36.66 70.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.84 -77.15 0.11 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.5 mt -28.91 -46.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.443 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.1 m-20 -64.31 -44.99 89.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.802 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.9 -43.73 98.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.36 93.81 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.18 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.32 -43.35 99.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.58 -39.08 92.57 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.531 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.73 -42.96 97.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.87 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.527 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.4 mtp -57.82 -38.21 75.16 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.02 -39.74 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.1 0.476 . . . . 0.0 110.26 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.0 92.43 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.443 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.2 p30 -86.43 1.26 51.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.69 19.57 60.73 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 70.3 m -58.28 -45.92 87.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.425 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 79.7 t80 -63.53 -57.59 9.7 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.397 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.5 mt-10 -56.97 -41.64 78.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.103 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.57 -48.81 79.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.505 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.62 -41.86 98.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.865 0.364 . . . . 0.0 110.566 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.78 -49.98 75.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -35.02 72.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.376 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.14 -50.93 28.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.418 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.24 -45.37 93.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.536 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.5 m-85 -154.26 155.62 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.6 97.17 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.974 0.416 . . . . 0.0 110.468 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -154.52 -166.02 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.417 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.23 110.53 15.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.9 m -63.39 -40.32 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.541 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 92.3 m-85 -58.54 -42.73 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.312 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.5 -37.15 94.35 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.871 -1.516 . . . . 0.0 110.917 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.48 164.26 62.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.82 99.43 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.24 -40.46 90.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.546 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.46 142.37 37.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.419 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 9' ' ' ILE . 82.4 mt -109.36 128.08 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.942 0.401 . . . . 0.0 110.483 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.68 117.55 34.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.348 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.58 139.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.425 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.45 105.44 2.16 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.6 m -128.11 119.33 25.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.75 -0.265 . . . . 0.0 111.077 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.4 t70 -113.53 92.58 24.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.308 -1.591 0 C-N-CA 122.484 2.123 . . . . 0.0 112.12 179.183 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.478 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.8 t0 . . . . . 0 C--O 1.227 -0.09 0 CA-C-O 120.917 0.389 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -69.33 -40.64 80.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.931 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.2 -37.34 82.64 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.744 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.37 -43.93 84.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.151 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.97 -45.14 91.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.13 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.54 -53.95 51.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.491 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.75 -37.72 59.87 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.945 0.403 . . . . 0.0 110.419 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.45 -41.9 75.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.4 m -54.16 -44.69 71.68 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.115 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.77 -47.59 80.34 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.53 -41.27 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.153 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.27 -17.75 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.78 52.72 4.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -145.96 170.51 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.33 141.15 28.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.163 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.13 131.46 56.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.655 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -128.12 127.76 43.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.509 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.51 136.01 35.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.526 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.2 t -129.87 128.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.06 139.08 58.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.3 131.63 0.15 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.47 145.09 63.63 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.688 2.258 . . . . 0.0 112.417 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 58' ' ' LEU . 81.6 mt -40.11 -56.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.46 -26.67 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.146 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.13 -20.78 18.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.184 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 55' ' ' LEU . 58.5 mt -63.99 -42.51 97.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.619 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.611 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.36 -56.96 25.72 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.821 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.2 Cg_exo -54.79 -43.71 56.65 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.608 2.205 . . . . 0.0 111.353 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.59 -44.71 89.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.84 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.09 -44.24 87.52 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.153 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.58 -40.34 95.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.966 0.412 . . . . 0.0 110.517 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.29 11.22 1.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.597 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.14 11.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.51 -34.28 77.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.489 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.87 153.47 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -93.24 -20.81 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.11 157.25 25.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.52 127.29 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.105 0.478 . . . . 0.0 110.457 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.478 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.45 106.3 8.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.383 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.462 ' HG ' ' H ' ' A' ' 73' ' ' SER . 48.3 t -159.9 -178.54 7.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.462 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.35 -15.49 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.615 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.7 tp -37.48 123.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 11.1 p -83.21 156.34 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 pt -105.13 149.41 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.317 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -150.42 152.4 34.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.754 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.04 -47.99 53.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 110.653 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.59 -39.58 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.803 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.615 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.8 -37.56 79.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.35 -37.34 75.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.24 -27.52 67.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.165 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.35 -51.54 7.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.598 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -138.46 -168.82 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 121.062 0.458 . . . . 0.0 110.468 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.72 29.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -129.74 149.89 51.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.686 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.3 t -164.18 -151.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.686 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.5 m-20 42.77 19.32 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.815 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -28.38 120.5 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.04 -69.83 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -149.26 166.29 29.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.57 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.22 121.19 26.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.289 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.44 69.6 1.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.89 -104.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.25 165.72 32.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.5 146.22 22.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.441 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.26 136.2 41.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.786 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.75 110.71 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.63 165.11 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.854 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.46 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.031 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.99 -27.99 48.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.232 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.01 -41.74 88.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -102.35 122.35 44.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.237 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.54 109.56 19.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.43 129.88 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.81 34.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.564 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.64 89.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.773 2.316 . . . . 0.0 111.918 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -169.29 140.76 2.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.744 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.69 -32.61 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.228 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.08 -62.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.273 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.75 -22.17 22.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.925 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.73 -25.8 53.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.271 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 132.86 46.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.456 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.72 -15.56 30.56 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.53 151.39 23.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 110.45 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.21 135.58 37.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.368 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.78 136.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.52 137.72 13.88 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.44 161.71 39.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.08 0.467 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.499 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.9 tp -92.39 117.9 30.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.78 157.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.71 50.73 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.59 168.75 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.436 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 69.3 p -73.15 -27.94 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.401 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.01 -55.37 34.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.442 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -56.21 -55.34 34.38 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.06 -50.99 71.52 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.587 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 67.3 t80 -61.94 -43.98 97.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.043 0.449 . . . . 0.0 110.474 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.97 -44.44 97.8 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.41 -14.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.7 tt0 -124.96 -34.76 2.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.707 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.587 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.38 -50.51 18.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 111.471 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -99.14 12.88 34.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.184 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.1 -55.58 0.46 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.376 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.5 25.75 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.777 2.318 . . . . 0.0 111.957 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.37 -8.97 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.47 37.25 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.74 138.26 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.9 0.381 . . . . 0.0 110.527 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.79 130.18 34.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.329 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.6 138.12 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.841 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.02 133.44 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.08 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.18 127.15 42.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.725 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 153.53 25.0 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.03 7.07 29.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.654 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.17 5.84 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.93 -45.86 80.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.317 . . . . 0.0 110.431 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.58 -23.5 62.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.522 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.78 -36.45 84.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.52 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 149' ' ' ILE . 96.7 mt -66.22 -46.87 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.04 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.685 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.45 -37.44 87.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.393 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.4 p -60.92 -41.94 97.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.177 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.64 -42.93 90.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.795 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.63 -48.58 80.53 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.26 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.51 -22.18 66.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.402 . . . . 0.0 110.239 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.01 -17.75 25.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.21 73.3 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.33 -17.96 63.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.899 0.38 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.92 136.14 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.63 -29.02 63.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.07 155.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.82 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.46 137.58 50.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.025 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -85.74 102.72 13.89 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.207 0.527 . . . . 0.0 110.799 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.685 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 50.1 tt0 -132.0 164.91 25.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.393 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.44 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.49 153.12 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.5 mt-10 -66.21 -54.54 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.05 -49.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.549 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.08 88.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.803 0.335 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.98 -63.73 1.08 Allowed 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.538 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.6 m -58.51 -47.42 84.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.776 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -49.3 -38.17 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.14 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.6 -66.11 0.56 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.35 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.615 0.245 . . . . 0.0 111.151 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.25 -40.03 92.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.71 -2.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.446 0.641 . . . . 0.0 110.521 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 173' ' ' LEU . 60.5 mt-30 -124.44 141.6 38.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.754 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.86 -15.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.825 2.35 . . . . 0.0 112.279 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.0 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.596 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.87 80.91 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.42 96.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.302 . . . . 0.0 110.517 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -66.07 -34.47 78.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.452 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.3 m-85 -156.96 143.27 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.75 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.4 pttt -176.92 99.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.006 0.431 . . . . 0.0 110.725 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.22 167.66 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.98 55.76 3.05 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.62 -117.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.44 135.34 32.74 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.5 2.133 . . . . 0.0 112.008 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.6 p -125.38 -107.7 0.32 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.486 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.45 165.59 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.244 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.39 156.61 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.995 0.81 . . . . 0.0 110.642 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -83.16 117.85 23.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.027 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.88 -16.73 62.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.43 -32.89 74.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.543 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.02 -44.51 97.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.764 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.436 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.5 7.82 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.77 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.16 -154.16 50.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.92 -25.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.862 0.363 . . . . 0.0 110.556 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.57 -126.01 1.55 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.81 159.79 37.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 110.461 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.5 -162.41 24.61 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.503 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.59 141.07 31.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.021 0.439 . . . . 0.0 110.525 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.22 111.39 3.9 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -120.44 160.58 22.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.394 . . . . 0.0 110.235 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 149.05 24.98 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.92 -49.16 63.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.93 -22.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.004 0.43 . . . . 0.0 110.82 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.06 52.13 0.24 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.764 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.52 -46.02 84.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.18 34.71 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.1 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.2 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.513 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.54 -42.86 99.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.875 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.68 -37.41 73.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.848 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.522 ' C ' ' O ' ' A' ' 212' ' ' ALA . 87.2 mt -28.45 -45.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.465 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.441 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.7 m-20 -63.55 -45.63 89.66 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.33 -43.72 98.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.016 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.33 92.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.184 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.2 -43.46 98.85 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.078 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.25 92.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.162 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.75 -43.15 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.862 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.1 mtp -56.49 -38.42 71.72 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -70.04 -38.82 75.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.0 110.352 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.44 92.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.29 0.91 55.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.683 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.11 20.09 66.66 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -57.82 -46.54 84.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.8 t80 -63.34 -57.5 10.15 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.429 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.74 -41.88 78.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.309 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.26 -48.74 79.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.518 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.57 -41.66 97.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.426 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.93 -49.94 75.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.602 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -35.54 72.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.451 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.84 -50.92 30.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.2 -45.53 92.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.58 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.5 m-85 -154.05 155.41 35.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.7 p-10 -98.08 97.66 9.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.396 . . . . 0.0 110.527 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -154.63 -165.51 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.8 t0 -122.72 109.54 14.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 m -63.77 -40.61 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.503 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.429 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 85.9 m-85 -56.55 -43.97 80.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.319 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.54 93.55 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 117.909 -1.495 . . . . 0.0 110.939 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.08 164.44 58.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.683 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.97 143.48 99.35 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.723 2.282 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.25 -40.2 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.557 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.56 36.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.443 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 9' ' ' ILE . 85.0 mt -110.46 128.23 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.423 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.0 mtp180 -103.66 118.7 37.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.34 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.64 138.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.37 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.12 99.9 1.58 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.1 m -123.58 118.76 28.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.759 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.3 t70 -113.67 92.86 25.8 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.547 0 C-N-CA 122.537 2.158 . . . . 0.0 111.913 179.439 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.1 t0 . . . . . 0 C--O 1.23 0.027 0 CA-C-O 120.974 0.416 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.19 -40.59 80.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.979 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 47.8 m-20 -60.43 -37.91 82.41 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.274 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -66.21 -43.71 85.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 110.543 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.35 -44.27 92.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.171 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -56.77 -53.48 57.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.47 -37.79 63.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.051 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.21 -42.24 76.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.994 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.36 -44.37 72.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.215 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.27 -47.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.365 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.77 -40.84 89.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.126 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.61 -17.73 14.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.83 52.36 4.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.653 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.4 170.25 16.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.831 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.26 140.64 29.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m -116.83 131.17 57.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -128.19 128.0 43.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.523 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.31 136.19 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.542 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.54 128.15 65.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.43 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.5 139.07 57.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 173.97 132.92 0.12 Allowed Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.1 Cg_endo -68.35 144.74 63.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.703 2.269 . . . . 0.0 112.574 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' LEU . 76.1 mt -40.09 -55.94 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.986 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.9 -26.48 1.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.862 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.26 -20.62 19.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.918 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 55' ' ' LEU . 84.8 mt -65.07 -42.83 93.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.68 -55.74 39.35 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.077 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.2 Cg_exo -56.12 -42.99 60.75 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.622 2.215 . . . . 0.0 111.161 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -58.98 -44.16 91.54 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.06 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.28 -44.47 88.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.13 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.78 -40.0 94.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.493 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 11.24 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.532 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.25 11.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.76 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.49 -33.86 76.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.643 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.48 153.27 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.58 -20.66 19.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.977 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.92 26.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 97.0 mt -116.73 128.18 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.506 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.3 ttp -128.43 106.22 8.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.411 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.6 t -158.68 -179.73 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.63 -14.62 58.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.503 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.626 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.0 tp -37.55 124.18 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.584 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.557 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.14 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.644 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.4 pt -104.93 148.96 8.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.184 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.4 p -150.63 152.62 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.679 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.08 -48.01 53.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.47 -39.98 71.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.579 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.626 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.77 -37.52 79.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -36.93 74.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.233 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.45 -27.53 67.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.292 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.23 -51.74 7.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.68 -168.55 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.4 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.71 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.599 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.684 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.3 t -164.61 -151.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.49 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.684 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.8 m-20 43.23 19.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.686 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.89 120.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.354 0.409 . . . . 0.0 110.532 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -77.34 -70.07 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.756 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -149.16 165.99 30.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.553 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.79 121.07 26.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.57 69.99 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.663 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -86.54 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.429 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.51 165.78 32.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.54 146.08 22.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.64 136.14 41.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.61 110.88 28.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.011 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.76 164.87 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.712 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.82 148.39 23.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.841 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.62 -27.67 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.309 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.16 -41.82 89.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.329 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.33 122.18 43.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.361 . . . . 0.0 110.254 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.34 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.394 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -128.56 129.88 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.44 159.2 33.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.6 Cg_endo -59.63 89.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.802 2.335 . . . . 0.0 112.02 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.0 m -168.93 140.91 2.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.21 -32.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.38 -62.56 1.68 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.61 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.0 t -56.07 -22.19 26.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.678 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.3 mt -76.99 -25.38 52.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.76 132.73 46.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.474 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.27 -16.03 31.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.48 151.59 23.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -96.52 135.63 38.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.393 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.04 136.66 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.639 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.36 138.8 14.43 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 54.7 t -131.04 161.59 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.965 0.412 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.6 tp -92.42 117.49 29.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.555 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.73 157.87 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.82 50.57 52.47 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.97 169.0 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.4 p -73.79 -26.33 60.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.497 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.69 -55.31 34.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.564 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.89 -54.64 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.421 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.17 -51.38 69.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.571 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.5 t80 -62.08 -43.76 98.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.416 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.8 -44.33 98.02 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.58 -14.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.615 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.32 -34.4 2.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.71 -51.03 15.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.13 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.12 12.98 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.996 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.49 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.61 -55.46 0.44 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.45 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.32 -10.39 25.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.834 2.356 . . . . 0.0 112.051 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.61 -8.73 59.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.623 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.9 33.47 37.0 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.87 138.22 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.6 129.79 34.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.421 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.9 pt -125.96 137.78 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.01 132.92 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.427 . . . . 0.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.75 43.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.617 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -110.89 153.67 25.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.373 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.8 6.95 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.19 130.68 5.97 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.01 -45.76 80.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.91 -24.08 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.69 -36.37 84.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.2 -47.13 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.3 m-85 -63.58 -37.8 88.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.364 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.22 -42.63 98.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.46 -45.42 90.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.227 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -58.62 -48.1 82.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.256 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.0 m -63.18 -22.94 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.013 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.3 25.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.86 11.34 70.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.75 -17.84 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.78 137.98 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.23 -28.02 61.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.61 155.49 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.689 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.85 50.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.153 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -85.71 103.05 14.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.58 165.11 25.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.451 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.446 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.26 151.97 41.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.7 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -65.71 -54.17 30.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.6 t -60.04 -49.12 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.03 89.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.772 0.32 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.42 1.16 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.483 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.4 m -58.67 -47.2 85.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.95 -37.34 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.117 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.458 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.14 -65.8 0.55 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.675 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.0 t80 -40.73 -70.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.646 0.26 . . . . 0.0 110.989 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.778 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -59.47 -3.19 0.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.176 0.512 . . . . 0.0 110.377 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 173' ' ' LEU . 50.6 mt-30 -124.58 141.34 37.56 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -43.43 -14.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.844 2.362 . . . . 0.0 112.165 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.0 t -63.07 -42.8 97.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.445 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.87 -33.02 81.69 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.06 -41.35 96.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.793 0.33 . . . . 0.0 110.446 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.16 -34.46 78.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.555 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.8 m-85 -156.96 142.89 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.645 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.71 100.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.049 0.452 . . . . 0.0 110.72 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.5 m-85 -159.41 167.52 28.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.613 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.18 56.06 3.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.04 -116.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.84 135.03 35.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.436 2.091 . . . . 0.0 111.911 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.7 p -124.6 -108.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -166.39 165.17 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.66 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 O-C-N 123.951 0.782 . . . . 0.0 110.494 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.22 118.3 23.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.066 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.5 mp0 -72.13 -18.68 61.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -64.04 -31.87 73.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.636 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.83 -44.57 96.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.683 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.46 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.7 m-85 -113.88 7.35 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.641 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.2 -155.32 50.37 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.19 -25.54 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.16 -125.57 1.46 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -132.07 160.12 36.87 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.412 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.23 -163.2 25.71 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -97.66 141.01 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.15 4.0 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -122.04 160.75 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.285 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 148.97 25.03 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.654 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.75 -48.83 63.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.714 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -39.88 -23.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.784 0.326 . . . . 0.0 110.544 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.0 m-20 -71.78 52.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.623 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.43 -46.27 83.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.16 34.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.42 -43.74 98.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.53 -42.84 99.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.005 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.44 -37.3 72.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.027 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.46 0.11 Allowed 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.519 ' C ' ' O ' ' A' ' 212' ' ' ALA . 87.9 mt -28.2 -45.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.659 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.446 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.1 m-20 -63.83 -45.46 89.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.661 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.51 98.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.114 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.46 93.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.33 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.12 -43.39 98.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.241 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.36 92.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.98 -42.39 97.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.228 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.13 -38.29 73.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.9 -38.77 76.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.0 110.417 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.46 92.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.6 p-10 -88.57 0.59 56.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.1 67.95 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.7 m -57.6 -46.16 84.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.6 t80 -63.65 -57.93 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 110.53 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.56 -41.68 77.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.7 -48.53 80.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.8 -41.62 97.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.397 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.07 -49.81 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.75 -35.65 73.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -70.78 -50.98 30.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.273 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.16 -45.85 91.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.1 m-85 -153.53 155.48 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.431 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.2 p-10 -98.01 99.23 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -156.4 -165.59 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.493 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.7 t0 -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.6 m -63.76 -40.23 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.572 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.8 m-85 -56.76 -44.11 81.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.304 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.33 -36.54 93.54 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.917 -1.49 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.21 61.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.698 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.79 143.53 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 122.727 2.285 . . . . 0.0 112.308 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.404 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.39 -40.89 89.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.586 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.65 139.48 38.51 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.359 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.41 121.5 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.665 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.18 118.49 31.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.106 0.479 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.09 138.56 40.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.404 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.83 105.94 2.2 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.9 m -129.32 120.41 25.59 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 122.694 -0.298 . . . . 0.0 110.953 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.4 t70 -114.18 92.58 27.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.454 2.103 . . . . 0.0 112.197 179.188 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.2 t0 . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.917 0.389 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.03 -40.35 83.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.971 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.03 -37.58 83.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.909 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.74 -45.25 87.25 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -56.96 -48.63 77.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.881 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.85 -54.71 30.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.356 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -52.21 -39.94 60.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 110.412 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.73 -41.83 78.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.71 -45.29 70.4 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.074 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.93 -47.03 82.13 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.064 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.61 -42.35 92.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.41 -17.1 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.655 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.63 53.11 4.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.548 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.06 171.27 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.876 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -89.02 142.56 27.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.46 131.15 56.79 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.19 126.92 43.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.386 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -93.36 134.67 35.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.523 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.04 127.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.285 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.31 137.99 57.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.89 131.34 0.16 Allowed Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.539 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.2 Cg_endo -68.23 145.22 65.52 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.677 2.251 . . . . 0.0 112.437 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -40.29 -55.79 2.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -48.33 -26.25 1.94 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.9 18.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.96 -42.38 97.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.16 -57.43 23.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 123.872 0.733 . . . . 0.0 109.485 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.595 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -54.93 -42.39 69.5 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.62 2.214 . . . . 0.0 111.267 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 69.9 m -58.76 -44.87 90.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.873 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 tp -59.1 -44.01 91.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.219 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.47 -40.53 95.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.82 9.96 2.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.24 12.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.59 -35.46 80.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.29 153.19 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.58 -21.98 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.178 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.63 155.74 26.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.777 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.06 128.95 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.176 0.513 . . . . 0.0 110.441 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.0 ttp -131.06 106.47 8.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.706 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.4 t -159.1 178.53 9.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.706 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -65.22 -15.41 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.611 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -34.84 124.23 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.606 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.87 153.87 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.613 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -104.58 148.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.241 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -149.12 152.09 35.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.799 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.72 -47.28 50.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.35 -39.7 70.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.611 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -69.31 -37.57 77.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.755 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.89 -39.07 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.819 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.73 -27.63 66.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.24 -50.67 8.19 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.729 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.2 pt -139.39 -168.11 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.088 0.47 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.118 0.485 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -130.0 150.0 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.554 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.67 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.05 -153.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.67 ' H ' ' HG1' ' A' ' 87' ' ' THR . 94.2 m-20 41.17 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.088 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.59 121.79 0.2 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.39 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.9 mt -75.6 -68.94 0.52 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -150.11 167.38 26.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.729 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.3 123.78 29.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.233 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.89 68.55 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.792 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.01 -104.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.45 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.53 165.7 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.41 146.04 22.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.16 0.505 . . . . 0.0 110.444 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -100.96 136.26 41.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.832 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.72 110.41 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.1 165.16 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.72 148.34 24.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.84 -27.38 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.177 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.33 -41.86 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.323 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.58 122.37 44.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.146 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.4 19.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.84 130.1 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.67 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.67 159.06 33.75 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.576 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.459 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.84 89.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.81 2.34 . . . . 0.0 111.939 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.0 m -169.27 140.68 2.39 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.523 0.514 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.8 -32.84 59.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.276 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.14 -62.74 1.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.307 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 t -55.96 -22.2 25.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -76.44 -25.9 54.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.323 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.7 133.11 46.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.388 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.89 -15.93 29.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.56 151.36 23.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.458 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.89 135.48 37.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.014 0.435 . . . . 0.0 110.336 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.54 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.51 138.59 14.33 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.87 161.65 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 121.102 0.477 . . . . 0.0 110.314 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 44.3 tp -92.35 117.53 30.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.682 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.64 157.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.663 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.52 53.56 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.68 168.93 22.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.775 0.321 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.3 p -73.54 -26.85 61.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.54 -55.57 31.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.48 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.53 -54.9 40.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.575 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.21 -50.88 71.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.56 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.0 t80 -62.23 -43.82 97.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.92 -44.54 97.69 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.27 -14.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.825 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.28 -34.57 2.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.598 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.4 -50.59 17.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 111.557 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -99.15 12.47 36.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.83 -55.51 0.47 Allowed Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.24 -10.27 25.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.791 2.327 . . . . 0.0 111.923 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -9.01 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.495 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.42 37.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.51 138.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.986 0.422 . . . . 0.0 110.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.48 129.75 34.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.32 138.14 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.23 133.15 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.077 0.465 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.39 127.67 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.99 153.74 25.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.245 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.09 7.42 29.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.645 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.75 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.97 -45.91 80.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.468 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.58 -23.32 62.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.89 -36.71 85.25 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 149' ' ' ILE . 96.5 mt -66.12 -47.08 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.078 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.518 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.2 m-85 -63.61 -38.06 89.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.271 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.14 -42.27 98.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.4 ' H ' ' HG ' ' A' ' 151' ' ' SER . 52.6 m-20 -64.04 -45.34 89.27 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.6 tp -58.3 -48.17 81.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.3 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -63.25 -22.77 67.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.242 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.74 24.94 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.13 11.46 69.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -18.15 63.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.94 0.4 . . . . 0.0 110.618 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.2 pt -128.29 137.36 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.397 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.89 -27.24 61.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.83 155.87 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.527 0.517 . . . . 0.0 110.838 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.05 136.83 49.8 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 109.967 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -85.2 103.05 13.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.831 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.5 tt0 -132.52 165.5 24.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.409 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.81 152.31 41.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.549 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.2 mt-10 -66.27 -54.46 24.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.33 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 72.1 t -60.29 -48.98 86.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.395 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.93 88.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.821 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.45 -63.1 1.22 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.6 m -59.4 -47.99 83.34 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.003 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.9 tt0 -49.06 -37.33 20.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.434 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.82 -66.32 0.56 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -71.23 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 122.745 -0.268 . . . . 0.0 111.17 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 175' ' ' GLN . 94.9 mt -61.01 -40.31 93.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -60.1 -2.79 0.47 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.538 0.685 . . . . 0.0 110.457 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 173' ' ' LEU . 43.0 mt-30 -123.36 148.95 56.74 Favored Pre-proline 0 N--CA 1.453 -0.306 0 O-C-N 122.011 -0.431 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.48 -20.41 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.933 2.422 . . . . 0.0 112.299 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.01 -43.24 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.588 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.59 -33.05 83.55 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.57 -41.4 94.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.733 0.302 . . . . 0.0 110.412 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.9 m-20 -65.55 -33.81 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.438 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.3 m-85 -156.19 143.0 18.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.1 pttt -177.15 99.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.093 0.473 . . . . 0.0 110.73 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.1 166.82 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.59 56.57 2.77 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -118.05 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.28 135.98 31.44 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.412 2.075 . . . . 0.0 112.015 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.47 -107.9 0.32 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.647 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.611 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.68 165.31 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.144 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.29 156.15 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.25 0.969 . . . . 0.0 110.62 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.15 117.57 22.4 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.863 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.61 -18.78 62.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.99 -32.35 73.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.518 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.94 -44.62 97.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.746 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.9 m-85 -114.0 9.59 17.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.783 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.19 -154.92 52.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.53 -24.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 110.428 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 159.93 -124.16 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.3 p -129.4 156.45 44.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.712 0.292 . . . . 0.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.64 -169.42 30.22 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -94.39 137.3 33.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.922 0.391 . . . . 0.0 110.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.25 107.77 3.21 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.4 mt -123.06 159.22 28.9 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.906 0.384 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 90.0 mtm180 -86.87 149.57 24.72 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.85 -48.34 64.04 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.527 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.5 tp10 -37.98 -25.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.94 0.4 . . . . 0.0 110.842 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.47 52.2 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.622 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -64.39 -45.68 86.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.274 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.54 -47.23 34.06 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.26 -43.91 97.74 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.18 -43.0 99.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.01 -36.39 70.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.1 -77.31 0.11 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 212' ' ' ALA . 98.3 mt -28.86 -46.08 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.958 0.408 . . . . 0.0 110.506 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.441 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.1 m-20 -64.31 -44.94 90.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.782 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.5 tttm -62.08 -43.63 98.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.993 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.06 93.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.15 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.23 -43.39 98.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.994 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.26 92.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.53 -43.26 97.65 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.508 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.79 -38.32 72.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.99 -38.9 76.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 110.378 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.619 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.51 1.09 56.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.676 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.47 20.64 65.9 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.3 m -58.2 -45.97 86.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.8 t80 -63.93 -57.86 8.49 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.441 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.423 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.5 mt-10 -56.83 -41.83 78.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.2 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.44 -48.72 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.532 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.69 -41.88 98.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.87 0.367 . . . . 0.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.13 74.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.84 -34.9 72.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.22 -50.82 29.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.394 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.4 -45.83 91.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.552 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 66.6 m-85 -153.85 155.79 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.05 98.08 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.982 0.42 . . . . 0.0 110.412 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -155.59 -165.59 2.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.33 110.67 15.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.585 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.0 m -63.57 -40.47 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.46 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.423 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 90.8 m-85 -58.5 -42.55 87.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.281 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.26 -37.04 94.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.702 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 164.38 59.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.647 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.89 143.39 99.35 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.05 -40.31 90.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.82 142.81 36.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 9' ' ' ILE . 83.5 mt -109.88 128.73 65.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.468 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -103.6 117.0 33.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.34 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -111.83 139.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.409 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.09 105.08 2.14 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -128.14 118.98 24.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.71 -0.289 . . . . 0.0 111.069 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.1 t70 -113.53 93.15 26.26 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.301 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.2 t0 . . . . . 0 C--O 1.227 -0.13 0 CA-C-O 120.931 0.396 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.88 -40.71 81.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.104 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -61.3 -37.35 82.92 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.754 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.43 -43.99 84.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.985 0.422 . . . . 0.0 110.259 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.91 -41.84 92.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.111 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -58.74 -53.61 56.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -36.73 62.61 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 110.332 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.4 -42.37 75.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.824 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.49 -44.48 72.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.116 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.97 -47.61 79.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.42 -41.03 88.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.4 -17.59 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.6 52.74 4.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.489 . . . . 0.0 110.651 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.08 17.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.885 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.36 140.84 29.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.153 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -117.31 132.01 56.69 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.632 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.43 127.73 43.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.89 135.78 34.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.64 128.44 65.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.368 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 139.41 58.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.06 131.99 0.14 Allowed Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.3 Cg_endo -68.49 145.21 63.9 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.297 . . . . 0.0 112.426 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 58' ' ' LEU . 82.2 mt -40.49 -56.66 2.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.1 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.19 -26.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.64 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.232 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 55' ' ' LEU . 57.1 mt -63.97 -42.43 97.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.68 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.44 -56.89 26.1 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.696 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.5 Cg_exo -55.0 -43.32 60.65 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.595 2.197 . . . . 0.0 111.113 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -58.52 -44.64 89.58 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.763 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.52 -44.37 89.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.095 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.54 -40.5 95.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.11 11.08 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 56.13 11.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.44 -34.33 77.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.94 153.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.43 -20.35 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.128 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.55 157.64 25.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.18 127.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.523 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.42 106.79 9.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.383 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.706 ' HG ' ' H ' ' A' ' 73' ' ' SER . 41.2 t -160.28 -178.06 6.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.706 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.3 -15.52 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.391 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.623 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -37.97 123.88 1.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.62 156.82 22.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.594 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -105.02 149.3 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.0 p -150.3 152.28 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.735 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.94 52.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.021 0.438 . . . . 0.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.47 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.887 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.623 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.73 -37.57 79.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.912 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.34 -27.85 67.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.142 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.92 -51.98 7.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -138.19 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.1 0.476 . . . . 0.0 110.433 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.78 29.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.038 0.447 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.627 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.665 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.8 t -164.39 -151.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.512 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.665 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.1 m-20 43.29 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.11 119.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.6 mt -77.19 -70.07 0.49 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -149.35 166.33 29.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.91 122.51 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.297 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.85 68.86 0.93 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.762 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.69 -104.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.429 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.4 p -159.05 165.74 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.656 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.24 146.22 22.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.117 0.484 . . . . 0.0 110.353 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.06 135.99 41.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.7 110.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.29 165.03 32.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.938 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.84 148.67 23.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.3 -28.48 58.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.247 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -58.93 -41.76 88.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.281 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -101.94 122.03 43.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.75 109.86 19.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.28 129.73 70.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.579 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.5 153.97 41.81 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.672 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.3 Cg_endo -59.05 92.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -171.08 144.11 2.06 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.604 0.565 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.14 -33.55 61.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.287 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.301 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.1 t -56.95 -21.99 34.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.962 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.43 -27.08 58.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.94 133.43 48.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.46 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.19 -17.34 28.7 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.31 151.76 23.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.902 0.382 . . . . 0.0 110.431 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.58 38.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.372 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.15 136.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.622 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.34 139.32 14.65 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.3 161.63 40.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.097 0.475 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.2 tp -92.73 117.61 30.18 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.627 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.56 157.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.15 50.71 49.73 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.8 p -149.71 168.85 22.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.2 p -73.83 -25.78 60.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -61.1 -55.39 33.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.435 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.34 -53.81 53.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.77 -51.32 69.84 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.586 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.1 t80 -62.19 -43.9 97.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.85 -44.58 97.66 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.33 -14.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.782 0.325 . . . . 0.0 110.765 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.19 -34.56 2.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.667 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.39 -50.73 17.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 111.562 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.19 12.46 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.209 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.489 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.7 -55.56 0.48 Allowed Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.375 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.23 25.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.001 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.85 -8.78 59.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.44 37.02 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.31 137.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.81 129.94 35.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.8 138.56 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 63.1 t -123.92 133.65 68.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 109.935 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -95.57 127.56 41.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.55 150.62 27.22 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.251 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.96 6.05 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.13 131.37 5.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.69 -45.7 81.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 110.415 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.85 -24.24 63.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.55 -36.52 84.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.443 HD13 HG22 ' A' ' 149' ' ' ILE . 96.7 mt -66.0 -46.62 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.001 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.8 m-85 -64.37 -37.75 88.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.339 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.79 -42.12 96.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.181 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.405 ' H ' ' HG ' ' A' ' 151' ' ' SER . 49.9 m-20 -65.58 -43.28 90.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.3 tp -58.58 -48.92 79.33 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.18 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -62.15 -22.52 65.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.382 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.91 25.62 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.544 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 12.12 73.1 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.99 -17.42 63.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.563 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.2 pt -127.39 136.48 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 110.42 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.92 -28.1 62.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.38 155.1 1.79 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.853 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.65 137.1 50.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.039 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -85.55 102.5 13.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.144 0.497 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.4 tt0 -131.6 165.0 24.62 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.377 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.44 153.11 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.47 -54.29 25.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.337 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.22 -49.17 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.438 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.82 87.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.13 -63.51 1.13 Allowed 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.572 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.2 m -58.78 -47.27 85.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.889 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -49.25 -38.4 26.74 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.48 -66.02 0.56 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.0 t80 -40.32 -71.04 0.09 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.608 0.242 . . . . 0.0 111.229 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.2 -40.07 92.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.959 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.65 -2.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.8 mt-30 -124.27 141.77 38.3 Favored Pre-proline 0 C--N 1.33 -0.244 0 O-C-N 122.079 -0.388 . . . . 0.0 110.845 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -43.95 -15.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.871 2.381 . . . . 0.0 112.277 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 175' ' ' GLN . 79.4 t -62.97 -42.83 98.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.95 81.37 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.75 -41.58 95.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.726 0.298 . . . . 0.0 110.479 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.8 -34.49 78.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.578 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.6 m-85 -157.25 143.96 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.4 pttt -177.81 100.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.075 0.464 . . . . 0.0 110.782 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.9 m-85 -159.06 168.18 27.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.01 55.57 3.09 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.68 -117.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.83 135.22 35.48 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.487 2.125 . . . . 0.0 112.008 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.0 p -125.08 -108.14 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.54 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.64 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.178 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.53 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 124.17 0.919 . . . . 0.0 110.634 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.2 118.23 22.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.791 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.87 -18.57 62.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.05 73.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.97 -44.36 97.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.743 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.435 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.68 7.58 17.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.697 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.99 -154.84 50.21 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.7 -25.39 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.56 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.05 -126.14 1.55 Allowed Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -131.97 159.92 37.3 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.427 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.65 -162.39 24.7 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -98.5 141.02 31.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.621 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.81 3.96 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.4 mt -120.64 160.54 23.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.307 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.95 148.98 25.1 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.18 -49.04 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.662 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -39.89 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.89 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -71.91 52.13 0.23 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.5 -46.16 84.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.18 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.46 -47.07 35.68 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.27 -43.92 97.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.459 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.55 -42.89 99.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.6 -37.36 73.1 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.64 -77.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 212' ' ' ALA . 87.4 mt -28.72 -45.65 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.858 0.361 . . . . 0.0 110.481 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.444 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.4 m-20 -63.59 -45.64 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.6 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.77 98.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.968 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.26 -43.33 99.05 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.105 0.479 . . . . 0.0 110.071 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.41 93.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.074 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.62 -43.01 98.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.78 -38.37 72.39 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.81 -38.79 76.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.47 . . . . 0.0 110.373 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.41 92.81 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 21.0 p-10 -88.36 0.38 56.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.743 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.56 20.11 67.59 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.6 m -58.04 -46.22 85.7 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.1 t80 -63.42 -57.46 10.21 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.448 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.435 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.6 mt-10 -56.91 -41.78 78.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.245 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.3 -48.67 79.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.48 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.51 -41.73 97.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.39 -49.68 76.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.692 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.87 -35.26 72.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.465 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.72 -51.16 29.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.39 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.17 -45.92 91.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.581 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.0 m-85 -154.11 155.14 34.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.4 p-10 -97.84 101.21 12.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.476 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -157.51 -165.44 1.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.63 109.94 14.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.6 m -63.63 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.435 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 93.2 m-85 -58.27 -43.6 88.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.217 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.65 -36.76 93.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.418 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.657 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.983 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.12 164.47 56.69 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.82 143.34 99.36 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.624 2.216 . . . . 0.0 112.29 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.49 -40.23 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.554 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.69 36.86 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.7 128.58 66.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.5 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -104.83 118.59 36.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 110.362 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.7 138.52 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.89 99.58 1.55 Allowed Glycine 0 N--CA 1.463 0.495 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.6 m -123.41 117.68 25.74 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.696 -0.297 . . . . 0.0 111.255 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 12.8 t0 -112.85 93.04 22.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.424 2.083 . . . . 0.0 112.188 179.373 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.5 t0 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.976 0.417 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.55 -41.37 82.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.119 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.71 -37.57 82.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.094 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.47 -43.96 84.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.188 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.02 -41.75 92.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.133 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.7 -53.32 59.69 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.554 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.08 -36.56 63.29 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.266 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.0 mt -69.53 -42.37 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.772 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.62 -44.02 72.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.3 tttm -64.07 -47.65 79.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -59.82 -40.81 89.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.948 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.36 -18.24 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.616 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.79 52.51 4.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 110.618 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -144.99 169.94 17.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.9 139.93 30.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.056 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -116.52 131.31 56.98 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.9 m -128.47 128.03 43.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.74 136.44 35.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.75 128.72 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.343 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.84 139.37 58.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.781 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 173.89 132.81 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.519 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.4 Cg_endo -68.55 144.92 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.562 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 58' ' ' LEU . 76.9 mt -40.81 -55.81 2.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.41 -26.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.173 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.46 -20.18 19.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 55' ' ' LEU . 86.5 mt -64.93 -42.45 94.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.959 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.599 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.52 -56.91 28.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.685 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.599 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.4 Cg_exo -55.35 -43.24 60.43 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.586 2.191 . . . . 0.0 111.035 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -58.68 -44.41 90.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.2 tp -58.53 -44.31 89.52 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.9 mtmt -64.55 -40.36 95.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.996 0.426 . . . . 0.0 110.434 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 11.22 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.565 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 55.95 11.84 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.17 77.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.494 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.7 pt -124.54 153.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.281 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.284 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.95 156.88 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.755 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.11 128.0 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 110.534 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.477 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.38 106.51 9.05 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.399 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.2 t -159.66 -179.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.3 -15.31 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.391 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.622 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.0 tp -37.78 123.86 1.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.07 156.37 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 pt -104.87 148.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.238 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.9 p -150.04 152.5 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.27 -47.69 55.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.604 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.72 -39.71 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.788 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.622 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.27 -37.83 81.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.928 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.29 75.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.59 67.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.076 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.12 -51.76 7.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.6 pt -138.45 -168.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.88 146.87 29.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -129.87 150.0 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.641 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.667 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.2 t -164.41 -151.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.444 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.667 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.1 m-20 43.07 19.3 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.8 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mttt -28.27 120.22 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -77.26 -69.99 0.5 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.825 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -149.4 166.25 29.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.08 123.39 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.47 67.97 0.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.5 -104.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.436 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.2 p -159.58 165.99 31.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.7 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.52 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.144 0.497 . . . . 0.0 110.456 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.3 135.86 42.1 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.67 110.45 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.28 165.11 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.935 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.19 148.61 23.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.97 -27.84 46.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.191 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -59.1 -41.8 88.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.221 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.45 122.14 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.129 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.54 109.26 19.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.068 0.461 . . . . 0.0 110.398 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.18 129.88 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.73 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.98 159.05 34.01 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.53 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.1 Cg_endo -59.63 89.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.707 2.271 . . . . 0.0 111.943 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.6 m -169.23 140.91 2.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.546 0.529 . . . . 0.0 110.786 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.55 -32.58 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.227 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.19 -62.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.375 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.2 t -56.11 -22.18 26.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.124 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.96 -26.81 57.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.345 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.71 132.84 46.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.436 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.41 -15.92 32.43 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -87.1 151.78 22.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.71 135.89 38.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.075 0.464 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.99 136.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.738 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 138.93 14.5 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.24 161.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.068 0.461 . . . . 0.0 110.386 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.1 tp -92.71 117.95 30.54 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.51 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.58 49.15 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.7 p -149.67 168.98 22.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.94 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.44 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.3 p -74.01 -25.73 60.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.401 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -61.21 -55.44 32.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.468 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.09 -54.06 51.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.57 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.46 -51.01 71.31 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.702 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.25 -43.86 97.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.11 0.481 . . . . 0.0 110.44 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.21 -44.55 97.55 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.27 -14.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.801 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.38 2.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.43 -50.75 17.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 111.653 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -98.98 12.54 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.32 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.489 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.9 -55.58 0.47 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.377 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.16 -10.44 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.825 2.35 . . . . 0.0 111.959 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.61 -8.84 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.496 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.89 33.45 37.09 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.54 138.06 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.65 129.73 35.03 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.307 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.52 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.11 133.56 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.026 0.441 . . . . 0.0 109.959 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 127.97 42.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -108.29 150.45 27.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.165 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.37 5.61 34.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.68 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.44 131.87 6.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.63 -45.76 81.83 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.411 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.61 -24.43 63.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 151' ' ' SER . 56.9 t-20 -64.45 -36.69 85.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.79 -46.56 88.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.43 -37.6 88.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.315 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.88 -42.5 98.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.2 -43.13 92.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.884 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -59.17 -48.37 81.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.5 m -62.69 -22.26 66.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.915 0.388 . . . . 0.0 110.026 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.89 -17.71 26.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.63 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.54 11.95 73.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.78 -17.57 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.609 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.0 pt -127.53 136.62 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.993 0.425 . . . . 0.0 110.479 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.01 -28.28 62.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.36 155.27 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.802 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.61 137.44 50.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 109.95 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.66 102.95 14.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.239 0.542 . . . . 0.0 110.714 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.14 165.14 24.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.377 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.44 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.24 152.35 41.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.601 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.2 -54.13 28.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.343 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.4 -49.17 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.512 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.85 88.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 110.867 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.01 -63.49 1.14 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.589 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.9 m -58.67 -47.01 85.92 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.792 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.66 -38.05 30.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.057 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.445 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.68 -65.59 0.55 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.2 t80 -40.63 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.644 0.259 . . . . 0.0 111.394 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.4 mt -61.38 -39.87 92.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.81 -2.92 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.537 0.684 . . . . 0.0 110.499 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.2 mt-30 -124.43 142.1 39.39 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.09 -0.382 . . . . 0.0 110.891 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -44.06 -15.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.808 2.339 . . . . 0.0 112.299 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.5 t -63.09 -43.03 98.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.632 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.62 -32.86 79.84 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.31 95.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 181' ' ' TYR . 47.7 m-20 -65.8 -34.92 79.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 180' ' ' ASP . 77.5 m-85 -157.04 143.54 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -177.22 100.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 110.728 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -159.31 167.5 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.699 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.31 55.52 3.05 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.45 -117.46 0.01 OUTLIER Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.93 135.5 36.23 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.465 2.11 . . . . 0.0 111.932 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 89.4 p -124.95 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.601 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -165.79 165.37 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.185 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.49 156.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 124.169 0.918 . . . . 0.0 110.649 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.14 118.28 22.94 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.73 -18.63 62.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.9 -32.36 73.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.57 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.86 -44.25 97.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.44 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.8 m-85 -114.05 8.36 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.719 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.12 -154.7 51.04 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.71 -25.51 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.869 0.366 . . . . 0.0 110.551 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.0 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.4 p -131.97 160.06 36.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.827 0.346 . . . . 0.0 110.41 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.42 24.6 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.87 32.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.914 0.387 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.86 3.96 Favored Glycine 0 C--N 1.329 0.179 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.6 mt -121.28 160.27 24.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.94 0.4 . . . . 0.0 110.164 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.81 149.08 25.09 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.881 0.372 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.37 -48.6 65.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.669 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.94 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.015 0.436 . . . . 0.0 110.831 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.1 m-20 -71.89 52.17 0.23 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -64.42 -46.03 84.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.313 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.7 -46.94 34.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.241 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.25 -43.87 97.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.438 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.728 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.73 -37.35 73.41 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.702 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.38 0.11 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 212' ' ' ALA . 85.5 mt -28.91 -45.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.471 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.449 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.6 m-20 -63.61 -45.28 91.03 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.49 -43.79 98.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.095 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.15 -43.52 98.75 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 110.046 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.29 92.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.064 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.9 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.0 -38.32 72.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.84 -38.79 76.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 110.322 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.28 93.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.656 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.33 0.31 56.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.727 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.55 20.25 67.71 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.28 -46.15 86.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 77.2 t80 -63.44 -57.36 10.51 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.372 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.43 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.6 mt-10 -56.99 -41.46 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.236 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.62 -48.36 81.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.598 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.88 -41.61 98.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.402 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.62 -49.79 76.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.639 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.56 -35.35 72.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.529 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.57 -51.07 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.544 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.7 m-85 -62.28 -45.7 92.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.617 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.2 m-85 -154.3 154.82 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.0 p-10 -97.79 100.13 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.409 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -156.25 -165.39 1.9 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.58 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.6 t0 -122.5 109.89 14.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.39 -40.46 89.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.43 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 93.0 m-85 -59.06 -42.53 90.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.304 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.25 -37.08 94.3 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.659 0 CA-C-O 117.872 -1.516 . . . . 0.0 110.975 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.04 164.33 61.94 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.595 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.84 143.53 99.39 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.574 2.182 . . . . 0.0 112.32 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.41 -40.78 89.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.09 141.22 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.442 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 9' ' ' ILE . 82.8 mt -109.27 127.43 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 110.567 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.28 117.71 35.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.12 0.486 . . . . 0.0 110.277 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.16 138.55 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.922 0.391 . . . . 0.0 110.537 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.59 105.25 2.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.4 m -128.3 119.52 25.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.676 -0.308 . . . . 0.0 111.242 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 10.8 t0 -113.44 92.59 23.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.308 -1.597 0 C-N-CA 122.44 2.093 . . . . 0.0 112.12 179.353 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 121.028 0.442 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.9 -41.02 84.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.845 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -60.88 -37.24 81.5 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.945 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -65.1 -45.07 86.7 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.2 -48.01 79.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.993 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.3 -54.27 38.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.352 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.75 -39.59 62.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.85 0.357 . . . . 0.0 110.308 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.0 -42.16 76.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 110.622 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.74 -44.62 70.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.128 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -63.83 -47.38 81.01 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.84 -41.68 91.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.56 -18.09 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.552 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.04 52.76 3.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.505 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -146.6 171.21 15.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.69 141.31 28.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.073 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.4 m -116.8 130.42 56.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.0 m -126.81 126.93 44.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -93.88 135.5 35.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.581 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.53 128.32 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.324 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.04 139.67 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 173.93 129.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.4 Cg_endo -67.5 146.32 73.81 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.753 2.302 . . . . 0.0 112.471 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 58' ' ' LEU . 83.6 mt -40.45 -56.57 2.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.148 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.97 -26.82 1.91 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 111.271 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.75 -20.69 19.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.294 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 55' ' ' LEU . 60.6 mt -64.42 -42.27 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.717 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.62 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.19 -56.76 28.13 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.7 Cg_exo -55.36 -44.06 52.52 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.628 2.219 . . . . 0.0 111.141 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.4 m -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.692 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.94 -44.24 86.82 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.6 -40.17 95.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.5 178.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.26 11.19 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.82 12.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.24 -34.28 77.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 178.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 pt -123.76 152.93 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.218 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.44 -20.65 20.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.302 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.38 156.51 26.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.47 126.99 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.016 0.436 . . . . 0.0 110.475 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.31 106.04 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.309 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.63 ' HG ' ' H ' ' A' ' 73' ' ' SER . 45.6 t -159.67 -179.84 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.589 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.63 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.66 -15.48 61.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.379 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.624 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.8 tp -36.23 123.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.52 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.555 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -81.66 154.6 26.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -104.55 148.01 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -149.57 152.35 35.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.867 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.24 -47.23 55.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.624 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.48 -37.87 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.1 -38.05 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.786 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.05 -27.43 66.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.061 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.58 -50.83 7.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -139.53 -168.31 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.58 147.16 29.79 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.08 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.92 150.03 51.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.574 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.665 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.9 t -164.05 -152.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.534 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.665 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.8 m-20 41.64 19.5 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.889 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.35 121.34 0.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.392 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.433 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.6 mt -75.11 -68.66 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.893 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -150.8 167.72 26.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.27 28.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.264 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.86 68.26 0.91 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.785 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.84 -104.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.405 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.47 165.89 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.709 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.28 145.93 22.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.434 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.74 136.14 41.08 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 110.816 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.5 110.98 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.19 165.01 32.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.046 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.52 24.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.18 -28.31 57.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.179 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.18 -41.69 89.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -101.83 121.74 42.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.246 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.83 109.86 19.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.103 0.477 . . . . 0.0 110.503 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.04 129.79 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -108.76 154.18 41.89 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.519 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.24 92.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.758 2.305 . . . . 0.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -171.08 144.04 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.633 0.583 . . . . 0.0 110.795 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.47 -33.82 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -57.54 -62.7 1.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 t -56.22 -22.44 29.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.014 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.5 -26.52 58.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.246 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.39 133.44 45.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.81 -16.87 29.42 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.21 151.55 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.428 . . . . 0.0 110.491 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.31 136.15 37.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.3 t -127.59 136.99 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.78 139.9 14.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.6 t -132.1 161.71 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.044 0.449 . . . . 0.0 110.388 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.499 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.0 tp -92.91 118.32 31.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.46 157.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.609 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.04 50.84 49.58 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -149.69 168.46 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.9 p -74.49 -25.63 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.482 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -61.0 -55.77 28.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.562 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.14 -54.11 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.588 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.28 -51.28 70.23 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.73 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.28 -43.8 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.128 0.489 . . . . 0.0 110.582 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.64 -44.48 97.89 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.63 -14.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.79 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.19 -34.64 2.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.762 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.12 -50.55 18.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.614 -178.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -99.12 12.39 36.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.287 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.49 -55.41 0.49 Allowed Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.434 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.2 -10.39 25.73 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.786 2.324 . . . . 0.0 111.993 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.63 -9.05 59.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.459 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.75 33.3 38.17 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.98 138.09 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.902 0.382 . . . . 0.0 110.627 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.92 129.8 35.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.195 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.16 138.98 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.2 t -125.59 132.1 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 109.943 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -98.43 130.59 45.05 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.998 0.427 . . . . 0.0 110.879 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -111.82 156.44 21.99 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.353 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.07 6.67 29.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.818 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.65 6.25 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -65.88 -46.03 79.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.439 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.95 -23.15 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.571 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.463 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.51 -36.96 85.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 110.561 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.13 -47.08 85.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.207 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.2 m-85 -63.87 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.08 -42.28 98.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.68 -45.24 90.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.06 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -58.87 -47.81 83.6 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.991 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -63.09 -22.93 67.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.947 0.403 . . . . 0.0 110.123 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.7 24.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.02 11.28 70.28 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.63 -18.17 63.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.627 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.87 136.7 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.382 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.77 -27.83 62.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.3 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.61 155.75 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.8 137.34 50.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.93 0.395 . . . . 0.0 109.955 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.92 103.19 14.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.34 0.59 . . . . 0.0 110.819 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.75 165.3 24.86 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.78 152.7 41.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.73 -54.69 20.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.279 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.08 -48.83 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.623 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.77 88.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.861 0.363 . . . . 0.0 110.856 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.2 -63.13 1.23 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 73.6 m -59.12 -47.63 84.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.851 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.4 tt0 -48.54 -38.02 19.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.17 -65.38 0.54 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.9 t80 -40.68 -71.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 111.286 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.31 -40.04 92.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -59.7 -2.91 0.41 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.451 0.643 . . . . 0.0 110.442 -179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 173' ' ' LEU . 23.4 mt-30 -123.8 148.46 56.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.93 -20.45 2.98 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 112.195 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.74 -42.89 93.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.96 -33.24 84.88 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.44 95.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.677 0.275 . . . . 0.0 110.459 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.41 -33.62 76.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.315 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.1 m-85 -156.56 142.74 18.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.693 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.554 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.94 99.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.779 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.22 167.6 28.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.29 56.17 2.9 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -117.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.52 135.12 33.29 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.514 2.142 . . . . 0.0 111.89 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.4 p -125.08 -108.36 0.32 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.59 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.44 164.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.363 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.86 156.07 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.91 0.756 . . . . 0.0 110.657 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -82.37 117.66 22.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.937 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.97 -17.35 62.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.14 -33.05 74.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.586 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.16 -44.46 97.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.697 -178.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.6 m-85 -113.63 9.36 17.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.768 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.84 -153.51 51.43 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.66 -25.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.846 0.355 . . . . 0.0 110.5 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.13 -123.94 1.28 Allowed Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.9 p -129.36 156.27 44.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.733 0.301 . . . . 0.0 110.324 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.74 -169.44 30.34 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -95.32 138.94 32.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.71 107.26 3.2 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.664 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.1 mt -119.25 160.06 22.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.69 149.06 24.48 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.27 -48.66 65.16 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.543 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.15 -23.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -71.7 52.11 0.21 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.52 -45.23 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.16 -47.17 29.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.327 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.25 -44.17 97.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.448 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.08 -43.13 99.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.846 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.42 -37.21 72.41 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.67 -78.04 0.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.525 ' C ' ' O ' ' A' ' 212' ' ' ALA . 89.9 mt -28.48 -46.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.68 0.276 . . . . 0.0 110.321 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.446 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.6 m-20 -63.85 -45.01 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 178.139 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.78 -43.73 98.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.44 93.85 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.006 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.26 -43.61 98.6 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.994 0.426 . . . . 0.0 109.914 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.26 92.66 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.534 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.94 -42.89 97.21 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -57.05 -38.08 72.72 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.89 -38.96 76.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 110.348 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.86 94.31 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.677 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.1 p-10 -89.15 1.02 56.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.59 20.48 65.97 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.5 m -58.05 -46.33 85.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.433 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 75.1 t80 -63.64 -58.02 8.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.418 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.6 -41.76 77.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.14 -41.61 98.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.311 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.97 -50.34 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -35.33 71.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.648 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.8 -51.0 29.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.627 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 39.2 m-85 -61.95 -46.04 91.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.61 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.6 m-85 -154.35 155.79 35.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.36 99.41 10.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -156.27 -166.21 2.1 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.41 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.87 110.75 15.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.795 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.3 m -63.34 -40.41 88.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.414 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -58.93 -42.9 90.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.251 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.37 -37.37 94.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.866 -1.519 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.54 164.34 58.63 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.87 99.44 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.14 -40.53 90.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.89 144.01 36.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.5 128.4 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.96 118.62 37.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.85 138.7 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.378 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.73 100.36 1.59 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -123.8 118.56 27.43 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.718 -0.283 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.8 t70 -113.32 93.15 25.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.987 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.308 -1.579 0 C-N-CA 122.468 2.112 . . . . 0.0 112.084 179.368 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 . . . . . 0 C--O 1.227 -0.103 0 CA-C-O 120.926 0.394 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.7 mt -68.81 -41.14 82.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -60.72 -37.66 82.47 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.081 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.09 -44.08 85.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.206 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.1 -44.31 91.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.093 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.51 -53.84 52.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.541 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.32 -37.44 62.28 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.57 -42.09 74.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.764 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.5 m -54.45 -44.1 72.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.102 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.15 -47.69 78.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -59.53 -41.21 89.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.069 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.22 -18.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.683 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.9 52.49 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.586 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -145.36 170.1 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.18 140.48 29.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.059 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -116.7 131.23 57.01 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.3 127.99 43.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.436 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -94.69 136.38 35.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.435 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.72 128.57 65.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.311 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.14 139.08 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.748 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 174.09 132.85 0.12 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.7 Cg_endo -68.42 144.75 62.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.647 2.231 . . . . 0.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' LEU . 77.8 mt -40.49 -55.65 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.098 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -47.84 -26.45 1.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.34 19.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.184 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 55' ' ' LEU . 85.1 mt -65.03 -42.33 94.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.826 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.604 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.83 -56.59 30.84 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.739 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.2 Cg_exo -55.47 -43.26 59.94 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.591 2.194 . . . . 0.0 111.108 177.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.7 m -58.83 -44.44 90.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.27 -44.36 88.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.69 -40.08 94.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 0.0 110.469 178.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.07 11.26 1.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.505 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.94 11.86 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.34 -34.19 77.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.546 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.6 pt -124.4 153.15 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.285 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.96 -19.83 20.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.03 156.9 25.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.726 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.61 127.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 110.541 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.18 106.55 9.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -159.84 -179.08 7.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.639 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.29 -15.27 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.414 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.625 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.0 tp -37.56 123.77 1.01 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.533 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.16 156.38 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.627 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 pt -104.98 148.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.264 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.0 p -150.26 152.6 34.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.722 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.11 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.63 -39.62 71.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.708 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.625 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.7 mtt180 -68.73 -37.74 79.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -37.56 75.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.931 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.66 67.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.12 -51.73 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.617 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -138.52 -168.34 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.139 0.495 . . . . 0.0 110.416 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.03 147.04 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -130.07 150.23 51.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.605 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.8 t -164.57 -151.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.479 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.605 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.3 m-20 42.97 19.26 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.21 120.49 0.11 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.4 mt -77.19 -70.01 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.778 -178.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -149.38 166.35 29.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.589 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.29 122.32 27.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.37 68.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.79 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.08 -104.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.57 165.86 31.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.624 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.68 146.7 23.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 0.0 110.473 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.6 135.68 42.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.78 110.36 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.31 164.97 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.5 -27.61 39.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.38 -41.71 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.359 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.1 t -102.38 122.0 43.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.236 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.49 109.19 19.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.411 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.469 ' C ' ' NE2' ' A' ' 106' ' ' GLN . 97.0 mt -128.37 129.61 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.612 ' NE2' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.06 159.15 33.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.555 179.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.456 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.39 89.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 111.908 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -168.88 140.35 2.53 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.511 0.507 . . . . 0.0 110.811 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.47 -32.63 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.324 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -56.74 -62.85 1.45 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.443 -178.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.64 -22.08 31.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.965 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.63 -27.26 58.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.334 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -55.08 132.96 48.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.449 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.14 -16.52 32.96 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.98 151.81 22.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 110.449 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.65 135.59 38.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.997 0.427 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -126.87 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.65 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.54 14.29 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.96 161.62 40.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.065 0.459 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.497 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.0 tp -92.71 118.33 30.95 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.56 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -52.02 157.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.1 50.64 50.43 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.7 p -149.55 168.74 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.889 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.438 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.8 p -73.67 -26.53 60.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.391 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.68 -55.36 34.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.99 -54.36 47.61 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.549 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.52 -51.03 71.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.2 t80 -62.21 -43.82 97.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 0.0 110.398 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.34 97.9 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.32 -14.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 0.0 110.684 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.44 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.703 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.37 -50.93 16.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.008 0.432 . . . . 0.0 111.545 -178.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.26 12.81 35.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.183 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.49 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.07 -55.5 0.46 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.375 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.35 -10.21 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.797 2.331 . . . . 0.0 111.993 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.76 -8.86 59.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.18 33.33 36.3 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.41 137.89 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.963 0.411 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.58 129.71 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.299 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.08 137.97 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.857 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.34 133.23 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 109.998 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.37 127.98 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.02 153.78 25.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -106.84 6.51 29.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.69 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -66.18 -45.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.472 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.04 -23.74 63.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.471 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.479 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.58 -36.63 84.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.523 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -65.97 -46.95 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.117 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.6 m-85 -64.21 -37.69 88.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.297 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.98 -42.49 98.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.71 -43.54 93.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.038 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.84 -48.34 81.69 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.168 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.38 -22.47 66.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.149 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.04 -17.81 25.64 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.577 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 12.11 73.03 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.97 -17.61 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.37 136.5 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.83 -28.36 62.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.35 155.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.52 50.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.91 0.386 . . . . 0.0 110.04 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.83 102.9 14.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.149 0.499 . . . . 0.0 110.656 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.19 165.17 24.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.396 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.39 152.27 40.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.561 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.19 -54.18 28.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.31 -49.18 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.456 -179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.87 88.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.811 0.338 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.18 -63.21 1.21 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.2 m -58.69 -47.26 85.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.924 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.67 -37.58 29.16 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.057 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.402 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.81 -66.47 0.56 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.8 t80 -40.2 -71.04 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.619 0.247 . . . . 0.0 111.21 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.21 -39.94 92.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.87 -2.69 0.42 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.505 0.669 . . . . 0.0 110.477 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.4 mt-30 -124.42 141.7 38.33 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.885 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.89 -15.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.835 2.357 . . . . 0.0 112.275 179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.2 t -63.08 -42.75 97.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.9 80.69 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.93 -41.55 96.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.307 . . . . 0.0 110.404 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 58.9 m-20 -65.27 -35.08 79.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.745 179.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.3 m-85 -156.73 143.2 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.737 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.93 99.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 110.725 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.19 167.55 28.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.631 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.14 55.44 3.1 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.42 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.8 135.05 35.27 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.467 2.111 . . . . 0.0 111.933 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.2 p -124.66 -108.33 0.33 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.505 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.62 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.83 165.17 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.239 -179.367 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.65 155.91 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.146 0.903 . . . . 0.0 110.646 179.197 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.26 118.59 23.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.812 178.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.2 mp0 -72.05 -18.53 61.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.92 -32.1 73.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.524 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.97 -44.38 97.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.767 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.438 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.9 m-85 -114.22 8.55 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.751 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.13 -154.79 51.12 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.72 -25.51 26.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.825 0.345 . . . . 0.0 110.508 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.13 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -132.06 160.05 37.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 110.413 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.39 24.6 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.78 32.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.89 111.62 3.91 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -120.89 160.33 23.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.226 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.71 148.93 25.23 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.612 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.06 -48.87 64.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.637 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.06 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -72.17 51.96 0.24 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -64.42 -45.92 85.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.231 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.72 -47.04 33.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.26 -43.84 97.91 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.461 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.6 -42.87 99.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.88 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.56 -37.5 73.23 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.52 -77.4 0.11 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.519 ' C ' ' O ' ' A' ' 212' ' ' ALA . 85.4 mt -28.85 -45.66 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.815 0.34 . . . . 0.0 110.489 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.447 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.4 m-20 -63.57 -45.33 90.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.689 178.048 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.44 -43.63 98.53 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.45 93.47 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.105 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.2 -43.42 98.91 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.063 0.459 . . . . 0.0 110.064 179.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.38 92.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.089 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.531 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.91 -42.91 97.28 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.825 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.77 -38.41 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.85 -38.83 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.46 92.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.27 0.54 56.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.59 20.09 67.63 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.4 m -58.07 -46.26 85.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.6 t80 -63.53 -57.51 9.95 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.453 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.432 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.6 mt-10 -56.91 -41.73 78.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.258 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -48.53 80.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.75 -41.79 98.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.469 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.2 -49.81 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.68 -35.38 72.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.426 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.64 -51.07 30.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.461 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.7 m-85 -62.19 -45.92 91.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.593 179.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.6 m-85 -154.39 155.52 35.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.443 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.2 p-10 -98.05 101.68 13.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.497 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -158.16 -165.24 1.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.425 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -122.89 110.02 14.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.57 -40.2 88.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 93.7 m-85 -58.86 -42.96 90.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.257 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.24 -36.51 93.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.684 0 CA-C-O 117.872 -1.515 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.22 164.18 62.9 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.46 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.573 2.182 . . . . 0.0 112.279 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.51 -40.94 89.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -138.17 139.12 39.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.406 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.46 121.44 61.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.0 110.649 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.08 118.87 32.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.18 0.514 . . . . 0.0 110.176 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.56 138.44 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.516 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.47 105.71 2.2 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.0 m -129.15 120.44 25.86 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 122.707 -0.29 . . . . 0.0 111.136 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 11.3 t0 -114.26 92.95 29.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.081 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--N 1.308 -1.602 0 C-N-CA 122.396 2.064 . . . . 0.0 112.105 179.253 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.978 0.418 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.71 -40.97 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -60.99 -37.21 81.69 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.766 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.9 -45.29 86.54 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.11 -48.46 78.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.017 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.18 -54.56 34.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.372 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.31 -39.95 61.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.269 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.66 -41.85 78.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.02 0.438 . . . . 0.0 110.64 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.0 m -53.47 -45.18 69.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.11 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.02 -46.93 82.27 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -60.08 -42.08 93.85 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.132 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.26 -17.41 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.81 53.23 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.439 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.29 171.73 14.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.3 142.86 27.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.0 m -117.71 131.37 56.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.785 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.29 126.89 43.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.39 179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -93.72 134.72 35.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.637 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.2 127.78 65.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.45 138.1 57.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.73 130.9 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 57' ' ' ALA . 46.3 Cg_endo -67.74 144.95 67.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.74 2.293 . . . . 0.0 112.521 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.2 mt -40.33 -55.62 2.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.22 -26.63 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.85 -20.95 19.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.269 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 mt -63.87 -42.34 97.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.629 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.17 -56.95 26.44 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.772 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -55.63 -42.46 67.41 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.6 2.2 . . . . 0.0 111.178 177.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 69.8 m -58.71 -44.98 90.53 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.919 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.86 -44.04 90.96 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.35 -40.69 96.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.88 9.91 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.24 12.21 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.43 -35.69 81.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -122.2 152.97 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.297 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -93.21 -22.21 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.406 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.55 156.05 27.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.85 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.82 128.85 71.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.117 0.484 . . . . 0.0 110.488 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.482 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.21 106.74 8.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.389 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.715 ' HG ' ' H ' ' A' ' 73' ' ' SER . 38.0 t -159.55 178.66 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.715 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.2 p -64.93 -15.59 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.362 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.7 tp -34.99 124.28 0.57 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.889 0.376 . . . . 0.0 110.503 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.83 154.04 26.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.703 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 pt -104.74 148.43 9.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.335 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.1 152.06 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.856 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.97 -47.06 52.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.416 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.49 -39.85 70.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.692 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.614 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.77 -38.01 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.75 -38.94 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.45 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.094 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.57 -50.57 8.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.5 pt -139.38 -168.33 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.185 0.517 . . . . 0.0 110.466 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.42 147.79 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.47 . . . . 0.0 111.061 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -130.07 150.05 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.57 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.32 -153.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.558 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.672 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.8 m-20 41.27 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.68 0.2 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.364 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.43 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 59.1 mt -75.11 -68.79 0.52 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -178.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -150.75 167.59 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.67 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.237 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.7 68.25 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.849 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.59 -104.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.1 165.76 33.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.17 146.26 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.453 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.8 mt -100.85 135.95 41.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.66 110.61 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.28 164.4 34.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.47 148.68 24.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.003 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.02 -28.56 57.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.199 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -58.93 -41.66 87.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.319 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -101.84 121.66 42.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.43 110.07 20.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -126.22 129.45 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.702 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -106.52 154.12 40.13 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.666 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.507 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.54 91.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.771 2.314 . . . . 0.0 111.711 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.0 m -170.64 143.39 2.17 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.589 0.556 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.84 -33.27 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.072 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.36 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -55.86 -22.2 24.08 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.094 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 mt -76.2 -25.9 55.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.229 179.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.81 133.69 47.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.407 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.22 -16.58 28.09 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.15 151.27 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.016 0.436 . . . . 0.0 110.373 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -95.53 135.17 37.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.377 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -127.15 136.72 59.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.61 138.47 14.29 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.5 t -130.77 161.68 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.071 0.462 . . . . 0.0 110.338 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.0 tp -92.67 117.7 30.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.496 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.78 157.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.59 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.65 50.68 52.87 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.78 168.76 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 0.0 110.864 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.452 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.0 p -73.17 -27.49 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.458 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.2 -55.58 32.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.55 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -56.57 -55.03 38.94 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.63 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.15 -51.03 71.32 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.735 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.4 t80 -62.11 -43.93 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.123 0.487 . . . . 0.0 110.496 179.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.73 -44.58 97.72 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.24 -14.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.896 0.379 . . . . 0.0 110.787 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.37 -34.39 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.717 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.51 -50.62 17.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 0.0 111.617 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.96 12.17 36.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.46 -55.55 0.49 Allowed Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.37 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 55.9 Cg_endo -72.04 -10.48 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.769 2.312 . . . . 0.0 111.991 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.59 -9.29 59.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.461 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.23 37.14 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.29 137.84 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.41 129.91 34.86 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.63 138.24 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.03 133.54 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.072 0.463 . . . . 0.0 109.991 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.91 127.08 42.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.65 153.19 25.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.051 0.453 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.97 7.23 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.95 130.42 5.93 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -66.06 -45.82 80.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.425 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.77 -23.4 62.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.564 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -37.13 86.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.516 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.82 -46.64 88.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.186 -179.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.685 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 60.9 m-85 -64.58 -37.7 88.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.322 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.88 -42.01 97.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.058 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.24 -43.32 91.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.995 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.9 tp -58.97 -47.93 83.36 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.046 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.6 m -62.9 -22.42 66.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.44 25.13 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.66 72.28 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.75 -17.91 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.9 135.78 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.45 -27.65 62.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.296 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.74 155.9 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.79 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.96 137.03 50.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -85.85 103.4 14.56 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.347 0.594 . . . . 0.0 110.851 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.685 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 49.7 tt0 -132.93 165.31 24.96 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.372 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.446 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -72.62 153.15 41.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 110.563 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -66.64 -54.86 18.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.361 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 75.6 t -60.23 -48.95 86.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.689 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.98 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.774 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.51 -63.01 1.24 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.662 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.0 m -59.55 -48.0 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.99 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.41 -37.71 17.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.07 -65.86 0.55 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.664 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.7 t80 -40.58 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 111.236 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.3 mt -61.43 -40.22 93.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 -179.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.82 -3.04 0.45 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.451 0.643 . . . . 0.0 110.521 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.9 mt-30 -122.86 149.4 56.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.08 -21.1 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.823 2.349 . . . . 0.0 112.182 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.98 -42.75 94.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.643 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.42 -33.27 85.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.4 -41.34 93.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.313 . . . . 0.0 110.464 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.4 m-20 -65.67 -33.23 75.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.299 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.37 142.64 18.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.42 99.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.21 167.22 29.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.716 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.32 56.38 2.69 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.22 -118.89 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.52 135.55 33.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.462 2.108 . . . . 0.0 111.923 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.7 p -125.43 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.566 -179.024 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.643 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.11 164.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.643 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 154.26 155.86 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.918 0.761 . . . . 0.0 110.641 179.216 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.06 117.19 22.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.857 179.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -71.2 -18.85 62.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.79 -32.43 73.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.555 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.05 -44.48 97.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 -178.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -114.01 9.3 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.728 179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.2 -154.3 51.74 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.38 -25.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 110.488 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.22 -124.24 1.32 Allowed Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.9 p -129.42 156.4 44.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.257 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.73 -169.43 30.31 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -94.48 137.51 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.963 0.411 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.47 108.09 3.26 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.2 mt -123.02 159.26 28.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.023 0.44 . . . . 0.0 110.114 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 89.9 mtm180 -86.94 149.75 24.57 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.91 -48.09 64.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.515 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -38.46 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.899 0.381 . . . . 0.0 110.733 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.69 52.11 0.21 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.642 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.57 -44.76 89.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.1 -47.33 29.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.32 -44.07 97.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.421 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.22 -43.06 99.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.16 -36.36 70.67 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.26 -77.65 0.11 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.527 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.2 mt -28.31 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.335 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.438 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.6 m-20 -64.22 -44.91 90.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.616 178.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.1 -43.69 98.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.951 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.01 -38.99 93.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.038 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.35 -43.72 98.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 109.903 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.56 93.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.534 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -43.06 97.83 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.2 mtp -57.04 -37.94 72.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.08 -39.01 75.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 110.337 178.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.69 94.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.6 p-10 -89.2 1.53 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.73 20.42 64.04 Favored Glycine 0 C--O 1.226 -0.382 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.461 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 79.7 m -58.26 -45.99 86.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.43 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.4 t80 -63.84 -58.09 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.396 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.4 mt-10 -56.67 -41.55 77.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.38 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.78 -48.37 81.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.2 -41.59 98.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.312 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.69 -50.35 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.597 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.34 -35.17 71.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -71.11 -50.92 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.598 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.4 m-85 -62.0 -45.56 93.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.47 155.84 35.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.42 97.94 9.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -155.49 -166.24 2.19 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.42 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.0 t0 -123.22 111.06 16.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.59 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.54 -40.59 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 92.9 m-85 -58.61 -42.86 89.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.36 -37.19 94.45 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.628 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.955 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.4 164.38 61.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.744 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.71 143.38 99.39 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 122.655 2.237 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.4 -40.7 89.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.597 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.54 141.9 37.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 9' ' ' ILE . 84.4 mt -109.57 127.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -102.5 119.69 39.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.093 0.473 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -113.69 138.56 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.292 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.78 100.31 1.57 Allowed Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -123.79 119.01 28.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.673 -0.31 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 19.5 t70 -113.16 92.34 21.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.016 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 122.42 2.08 . . . . 0.0 112.13 179.288 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 . . . . . 0 C--O 1.226 -0.159 0 CA-C-O 120.97 0.414 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.0 -40.67 83.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.041 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -60.81 -37.56 82.41 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.88 -178.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.8 -45.0 88.08 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.14 -48.15 79.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.825 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.01 -54.49 34.54 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.323 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.58 -39.59 61.74 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.026 0.441 . . . . 0.0 110.393 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.07 -42.02 76.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.8 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.01 -44.14 70.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.041 -179.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.92 -47.56 80.06 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.973 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.56 -41.78 90.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.111 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.68 -18.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.4 m-20 60.5 52.71 4.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.188 0.518 . . . . 0.0 110.623 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.8 p -146.1 170.75 16.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.25 140.75 29.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -116.3 130.12 56.62 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.69 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.14 127.49 44.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.396 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -94.73 136.36 35.14 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.66 128.58 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 110.304 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.01 139.34 58.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.79 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 173.39 130.07 0.1 Allowed Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.519 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.0 Cg_endo -67.95 146.73 72.43 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.743 2.295 . . . . 0.0 112.514 -179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.7 mt -41.05 -55.92 2.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -48.06 -26.76 1.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.251 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.94 -20.3 19.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.252 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.26 -42.36 93.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.579 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.35 -57.27 26.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 123.801 0.688 . . . . 0.0 109.516 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.9 Cg_exo -55.02 -43.95 54.4 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.571 2.181 . . . . 0.0 111.083 177.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -58.65 -44.55 90.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.575 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.33 -44.24 88.61 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.78 -40.24 94.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.983 0.42 . . . . 0.0 110.488 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.84 11.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.937 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.11 76.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 178.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.18 152.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.18 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.07 -20.23 20.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 155.87 26.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.76 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 97.0 mt -116.43 127.89 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 110.443 179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -128.16 105.64 8.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 110.326 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.548 ' HG ' ' N ' ' A' ' 73' ' ' SER . 47.2 t -158.66 179.24 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -65.19 -14.93 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.394 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.619 ' CD1' HH12 ' A' ' 80' ' ' ARG . 39.4 tp -35.98 124.22 0.73 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.47 154.11 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -104.51 148.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.207 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -149.8 152.63 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.818 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.28 -47.38 55.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.032 0.444 . . . . 0.0 110.548 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.44 -39.93 70.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.619 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.5 -37.83 80.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.21 -37.95 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.798 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.01 -27.73 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.094 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.13 -50.73 8.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.976 0.417 . . . . 0.0 110.774 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.67 -168.6 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.165 0.507 . . . . 0.0 110.383 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.33 147.28 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.119 0.485 . . . . 0.0 111.059 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.93 149.85 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.621 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.81 -152.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.47 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.621 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.3 m-20 41.72 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.019 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.22 121.41 0.18 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.385 0.428 . . . . 0.0 110.433 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.435 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.0 mt -75.44 -68.81 0.53 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.81 -178.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -150.32 167.45 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.66 123.58 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.176 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.23 68.27 0.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.775 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.16 -104.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.442 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -159.64 165.83 31.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.11 146.35 22.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.423 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.1 mt -101.38 136.04 41.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.72 111.0 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.26 165.2 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.959 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.4 23.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.64 -27.77 42.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -59.13 -41.87 89.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.249 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.6 122.18 43.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.019 0.437 . . . . 0.0 110.154 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.81 109.34 19.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.395 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.97 129.78 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.641 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.82 159.07 33.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.575 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.514 ' C ' ' HG1' ' A' ' 108' ' ' THR . 19.9 Cg_endo -59.79 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.789 2.326 . . . . 0.0 111.93 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.514 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.9 m -169.02 141.2 2.6 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.596 0.56 . . . . 0.0 110.858 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.38 -33.24 61.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -57.24 -62.65 1.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.333 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.58 -22.11 31.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.066 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -75.53 -26.88 58.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 178.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.9 133.29 47.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 -179.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.77 -16.92 28.95 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.2 151.46 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.497 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.22 135.56 37.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.273 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.27 136.73 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.47 138.86 14.47 Favored Glycine 0 N--CA 1.462 0.383 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.92 161.68 40.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.497 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.5 tp -92.56 117.72 30.26 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.696 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.76 157.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.17 50.53 50.75 Favored Glycine 0 N--CA 1.463 0.436 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -149.6 168.79 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.457 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.1 p -73.69 -26.29 60.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.435 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.93 -55.45 32.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.431 -179.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -56.94 -54.35 47.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.583 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.3 -51.12 70.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.641 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.8 t80 -62.31 -43.82 97.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.144 0.497 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.78 -44.41 97.92 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.3 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.65 2.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.34 -50.92 16.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.698 -178.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -99.0 12.43 36.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.72 -55.54 0.48 Allowed Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.16 25.29 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.737 2.291 . . . . 0.0 111.933 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.93 -8.85 59.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 -179.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.32 36.87 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.31 137.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.01 0.434 . . . . 0.0 110.565 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.4 129.75 34.92 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.1 pt -126.19 138.05 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.5 t -123.16 133.28 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.082 0.467 . . . . 0.0 109.899 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.36 127.59 43.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.17 153.76 25.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.265 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -107.05 7.01 29.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.67 130.28 5.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -65.74 -45.81 81.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.07 -23.91 63.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.461 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.49 -36.75 85.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.13 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.42 -38.22 90.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.13 -42.5 98.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.164 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.47 -45.95 88.45 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.46 -48.14 81.74 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.161 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.32 -23.31 67.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.935 0.398 . . . . 0.0 110.066 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.89 -18.79 25.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.45 11.09 69.52 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.24 -18.31 63.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.3 pt -128.69 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.083 0.468 . . . . 0.0 110.443 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.0 -27.35 61.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.92 155.88 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.583 0.552 . . . . 0.0 110.91 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.94 137.09 50.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.987 0.422 . . . . 0.0 109.935 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.42 103.27 14.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.238 0.542 . . . . 0.0 110.798 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.3 tt0 -132.47 165.51 24.14 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.341 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.429 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.0 152.03 41.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.565 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.33 -54.33 25.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.4 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.38 -48.83 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.417 -179.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.72 88.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.3 -62.99 1.26 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.507 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.1 m -58.87 -47.38 85.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.88 -179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -49.16 -37.85 23.62 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.067 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.11 -65.93 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.0 t80 -40.27 -71.15 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.824 -0.221 . . . . 0.0 111.245 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.06 -40.03 92.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.948 -179.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.92 -2.28 0.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.613 0.721 . . . . 0.0 110.323 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 173' ' ' LEU . 56.2 mt-30 -124.25 141.4 37.29 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.905 -0.497 . . . . 0.0 110.8 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.75 -16.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.843 2.362 . . . . 0.0 112.409 179.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 72.1 t -62.88 -43.0 98.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.619 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.85 82.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.91 -41.39 96.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.73 0.3 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.8 m-20 -65.58 -34.52 78.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.04 142.74 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.64 99.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.0 110.757 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.7 m-85 -159.07 166.82 30.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.668 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.04 56.36 2.9 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.06 -117.24 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.59 135.68 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.419 2.079 . . . . 0.0 111.984 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.9 p -124.7 -108.33 0.33 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.77 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.21 165.08 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 155.69 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 124.461 1.101 . . . . 0.0 110.69 178.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.75 118.24 22.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.87 -18.71 62.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.47 74.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.92 -44.55 97.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.685 -177.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.457 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -114.24 10.05 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.758 178.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.45 51.47 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.85 -25.09 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.486 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 159.91 -123.97 1.29 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -129.51 156.54 43.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.76 -169.59 30.55 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -94.88 138.73 32.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.945 0.402 . . . . 0.0 110.607 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.39 107.17 3.16 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.62 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.7 mt -119.83 159.98 23.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.923 0.392 . . . . 0.0 110.143 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.76 149.11 24.39 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-O 120.833 0.349 . . . . 0.0 110.654 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.4 -48.5 65.65 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.549 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -39.76 -23.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.55 52.21 0.2 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.799 0.333 . . . . 0.0 110.661 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.33 -45.78 86.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.99 -47.12 30.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.281 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.08 -43.99 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.48 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.52 -36.98 72.27 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.94 -77.22 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.511 ' C ' ' O ' ' A' ' 212' ' ' ALA . 89.0 mt -29.26 -45.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.446 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.6 m-20 -63.81 -44.96 91.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.728 177.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.73 -43.79 98.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.897 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.29 93.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.05 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.18 -43.47 98.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.194 0.521 . . . . 0.0 110.032 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.33 93.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.021 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.532 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.58 -43.19 97.72 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.92 -38.28 72.65 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.95 -38.84 76.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.673 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -89.33 0.98 56.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.99 20.45 66.81 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -58.33 -45.94 87.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -63.99 -57.6 9.21 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.436 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.425 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.7 mt-10 -57.04 -41.44 78.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.169 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.56 -48.54 80.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.518 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.77 -41.83 98.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 110.546 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.71 -50.03 75.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.66 -35.04 71.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.409 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.83 -50.87 30.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.55 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 40.2 m-85 -62.25 -45.93 91.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.76 155.61 34.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.4 p-10 -97.35 99.05 10.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.76 -166.03 2.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.08 110.81 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.9 m -63.65 -40.44 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.473 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.425 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 92.6 m-85 -59.04 -42.59 90.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.305 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.2 94.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.607 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 164.25 56.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.93 143.27 99.31 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.574 2.183 . . . . 0.0 112.297 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.34 -40.71 90.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -139.13 139.95 37.79 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 9' ' ' ILE . 81.0 mt -107.81 120.69 59.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 110.681 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.06 118.78 32.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.145 0.498 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -112.42 138.56 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.01 101.42 1.51 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -124.68 120.71 32.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 122.717 -0.284 . . . . 0.0 111.142 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t70 -114.07 92.73 27.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.194 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.308 -1.599 0 C-N-CA 122.417 2.078 . . . . 0.0 112.105 179.183 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.6 t0 . . . . . 0 C--O 1.227 -0.126 0 CA-C-O 120.983 0.42 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.85 -40.79 84.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -60.81 -37.38 81.77 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.891 -178.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.72 -44.49 85.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.89 -47.91 81.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.035 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.95 -54.4 39.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.347 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.35 -38.85 59.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.943 0.401 . . . . 0.0 110.311 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.29 -41.77 76.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.46 . . . . 0.0 110.556 178.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 51.0 m -53.79 -44.93 70.54 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.033 -179.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.25 -47.31 80.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.037 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.8 -42.15 92.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.201 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.32 -17.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.09 52.84 3.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.492 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.54 170.91 15.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.36 142.43 27.74 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.075 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 m -117.34 131.87 56.71 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.575 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.9 m -128.75 128.12 43.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -95.19 135.57 36.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.478 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.8 129.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.427 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.75 136.65 56.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.777 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 176.41 131.42 0.18 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.49 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.8 Cg_endo -68.28 144.81 63.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.691 2.261 . . . . 0.0 112.536 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -40.29 -55.43 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.21 -26.27 1.87 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.163 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.57 -21.05 18.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.14 -42.44 96.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.88 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.612 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.68 -57.12 26.68 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 123.738 0.648 . . . . 0.0 109.67 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.14 -42.27 70.46 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.612 2.208 . . . . 0.0 111.267 177.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -45.06 90.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.944 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.6 tp -58.94 -44.08 91.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.128 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.5 -40.66 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.955 0.407 . . . . 0.0 110.456 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.86 10.38 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.84 12.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.5 -35.16 79.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.498 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -122.9 153.54 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.212 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.54 -21.53 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.285 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.3 156.72 26.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.67 129.06 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -130.55 106.7 8.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.3 t -158.96 178.69 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.575 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -65.33 -15.16 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.612 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -35.56 124.84 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.573 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.54 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -83.0 155.0 24.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.662 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 pt -105.04 149.2 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.314 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -149.37 152.33 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.829 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.95 -47.48 52.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.544 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.65 -39.53 71.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.88 -37.86 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -57.99 -38.62 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.868 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.81 -27.59 66.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.105 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.26 -51.22 7.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -138.5 -168.23 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 110.501 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.03 147.71 29.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.09 150.08 51.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.653 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.662 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.73 -152.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.498 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.662 ' H ' ' HG1' ' A' ' 87' ' ' THR . 97.2 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.948 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.7 mttt -29.32 121.02 0.15 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.336 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.4 mt -76.64 -69.53 0.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.842 -178.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -149.47 166.43 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.614 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.46 122.75 28.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.38 69.46 0.91 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.813 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.51 -104.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.393 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.17 165.77 32.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.56 145.91 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.125 0.488 . . . . 0.0 110.439 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.89 136.26 41.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.99 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.19 165.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.996 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.48 23.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.96 -28.35 56.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.04 -41.7 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.301 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.13 122.19 43.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.06 109.9 19.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -126.87 129.59 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.656 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -108.28 154.3 41.44 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 110.679 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.24 92.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.756 2.304 . . . . 0.0 111.649 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.02 144.02 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.669 0.606 . . . . 0.0 110.773 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.55 -33.7 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.162 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -57.35 -62.63 1.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.263 -178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.37 -21.93 27.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.037 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.0 -26.2 56.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.309 179.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.77 133.7 47.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.382 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.08 -16.78 26.36 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -85.92 151.44 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.494 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -95.86 135.39 37.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.25 136.66 60.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.658 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.5 138.53 14.3 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.9 161.66 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 44.2 tp -92.43 117.42 29.9 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.599 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.73 158.04 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.47 50.48 55.02 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -149.62 168.95 22.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.928 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.458 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 67.2 p -73.24 -27.58 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.13 -55.36 34.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.67 -54.82 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.695 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.37 -51.04 71.18 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.74 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.2 -43.83 97.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.44 97.81 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.43 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.0 110.778 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.23 -34.46 2.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.35 -50.56 18.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.473 . . . . 0.0 111.649 -178.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.27 12.59 35.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.83 -55.53 0.47 Allowed Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.413 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.29 -10.31 25.49 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.778 2.319 . . . . 0.0 111.934 -179.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.65 -8.88 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.14 37.63 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.28 138.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.85 130.19 34.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.0 138.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.14 133.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 109.99 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.11 127.3 42.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.83 153.7 25.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.33 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.24 7.13 29.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.41 130.47 6.03 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.03 -45.92 79.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.441 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.21 62.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.572 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.87 -36.78 85.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.536 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 149' ' ' ILE . 96.6 mt -66.03 -47.13 86.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.159 -179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.1 m-85 -63.74 -37.91 89.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.253 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.19 -42.4 98.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.096 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.403 ' H ' ' HG ' ' A' ' 151' ' ' SER . 54.9 m-20 -63.73 -45.21 90.96 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.981 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.69 -47.94 82.82 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.31 -22.96 67.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.21 -18.66 25.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.641 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.65 69.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.92 -18.13 63.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -127.87 136.96 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.66 -27.62 62.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.8 155.89 1.74 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.817 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.92 137.12 50.19 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 109.991 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.67 103.05 14.13 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.237 0.541 . . . . 0.0 110.817 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.39 165.2 24.79 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.0 152.6 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.05 -54.37 26.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.332 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.403 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 70.8 t -60.24 -49.13 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.439 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.93 87.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.828 0.347 . . . . 0.0 110.759 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.37 -63.35 1.16 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 72.5 m -59.15 -47.88 83.67 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.927 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.01 -38.19 22.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.46 -65.73 0.56 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.676 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -70.94 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.8 mt -61.06 -39.88 91.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.192 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.65 -2.72 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.462 0.649 . . . . 0.0 110.399 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.4 mt-30 -124.14 142.21 39.26 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.5 -16.47 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.844 2.363 . . . . 0.0 112.32 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 175' ' ' GLN . 73.0 t -62.69 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.586 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.01 82.73 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.75 -41.27 95.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.733 0.302 . . . . 0.0 110.567 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -66.0 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.393 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.6 m-85 -157.07 143.65 18.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.59 100.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 110.757 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.34 167.37 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.72 56.09 2.85 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.53 -117.94 0.01 OUTLIER Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.59 135.29 33.76 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.504 2.136 . . . . 0.0 111.969 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.9 p -125.36 -107.89 0.32 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.574 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.67 165.11 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.628 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.51 156.05 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 124.024 0.828 . . . . 0.0 110.696 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.46 117.61 22.61 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.38 -18.91 62.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.72 -32.28 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.491 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.0 -44.46 97.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.706 -178.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.458 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.2 m-85 -114.07 9.47 17.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.784 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.37 -155.13 52.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.55 -25.14 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 0.0 110.517 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.72 -125.17 1.41 Allowed Glycine 0 CA--C 1.518 0.272 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.6 p -131.52 159.3 38.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.63 -163.37 25.47 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.4 138.93 34.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.453 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.25 112.05 3.92 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -124.73 160.1 29.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 89.7 mtm180 -86.53 149.66 24.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.786 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.95 -48.4 64.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.669 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.4 tp10 -38.15 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.95 52.02 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.604 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -64.76 -44.86 88.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.401 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.16 -47.1 38.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.84 -43.49 98.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.45 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.75 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.43 -36.7 71.71 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.18 -77.31 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.523 ' C ' ' O ' ' A' ' 212' ' ' ALA . 96.7 mt -28.63 -46.21 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.432 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.1 m-20 -64.01 -45.3 89.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.661 178.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.78 -43.79 98.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.955 178.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.21 93.23 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.024 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.24 -43.54 98.71 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.33 92.86 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.095 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.531 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -43.19 96.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -56.68 -38.29 72.02 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.88 76.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.98 94.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 21.4 p-10 -88.65 1.19 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.36 20.32 65.29 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 72.3 m -58.3 -45.81 87.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.9 t80 -63.89 -58.14 7.67 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.482 179.289 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.429 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.89 -41.86 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.412 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.28 -48.63 79.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.0 -41.49 98.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.407 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.43 -50.18 74.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.62 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.89 -35.17 72.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.21 -50.95 27.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.501 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.18 -45.75 92.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.532 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -152.97 154.92 35.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.437 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.6 p-10 -97.06 95.36 7.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.987 0.422 . . . . 0.0 110.567 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.25 -166.67 2.49 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.66 110.33 15.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.5 m -63.64 -40.65 89.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.429 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.6 m-85 -56.35 -43.9 79.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -37.6 95.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.681 0 CA-C-O 117.875 -1.514 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.23 61.08 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.676 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.85 143.45 99.37 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.645 2.23 . . . . 0.0 112.299 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.32 -40.35 89.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.91 143.14 36.49 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.456 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.04 128.09 66.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 110.515 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -103.77 118.56 36.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.6 138.4 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.449 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.2 1.61 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.8 m -123.94 118.32 26.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.713 -0.287 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 24.4 t70 -113.33 92.3 22.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.309 -1.512 0 C-N-CA 122.524 2.149 . . . . 0.0 112.114 179.39 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 . . . . . 0 C--O 1.227 -0.114 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.61 -41.01 82.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.097 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.74 -37.63 82.41 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.18 -178.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.19 -44.0 85.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.299 178.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.525 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.82 92.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.069 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.44 -53.67 54.68 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.504 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.26 -37.58 62.25 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.975 0.417 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.52 -42.03 75.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.8 m -54.54 -44.5 72.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.111 -179.388 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.436 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.81 -47.65 80.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.066 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -59.4 -40.96 88.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.56 -17.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.9 52.44 4.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.151 0.501 . . . . 0.0 110.606 -179.238 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.29 169.99 17.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.12 140.66 29.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -116.87 131.32 56.98 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.638 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.42 128.1 43.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.472 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -94.64 136.34 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.511 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.67 128.38 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.8 139.31 58.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.721 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 173.84 132.3 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.56 145.22 63.48 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.692 2.262 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 58' ' ' LEU . 78.5 mt -40.48 -55.94 2.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.72 -26.55 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.117 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.35 19.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 55' ' ' LEU . 85.3 mt -65.08 -42.56 94.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.854 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 mm -61.51 -56.64 31.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.757 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.595 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -55.44 -43.51 57.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 122.64 2.227 . . . . 0.0 111.128 177.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -44.36 90.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.848 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.28 -44.46 88.45 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.59 -40.21 95.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 110.446 178.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.0 11.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.538 -179.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.01 11.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.47 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 178.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.9 pt -124.48 153.28 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.361 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -94.59 -20.0 19.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.21 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.45 156.29 25.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.83 127.94 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 110.544 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.26 106.31 8.94 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.4 t -159.0 -179.57 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.569 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.56 -15.01 60.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.337 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -37.58 124.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.531 -179.579 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.09 156.25 23.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.667 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.7 pt -104.87 148.9 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.273 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -150.4 152.75 34.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.22 -47.93 54.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.601 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.52 -39.79 70.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.733 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.53 -37.63 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.94 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.3 -27.56 67.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.175 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.16 -51.77 7.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 110.574 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.61 -168.55 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.86 147.02 29.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -129.99 149.96 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.681 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.8 t -164.34 -151.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.478 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.681 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.6 m-20 42.97 19.34 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.26 120.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.409 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.1 mt -77.04 -69.93 0.49 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 -178.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -149.3 166.26 29.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.584 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 121.67 27.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.73 69.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.746 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.94 -105.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.31 165.83 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.69 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.6 145.94 21.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 110.5 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.06 136.11 41.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.768 178.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 111.1 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.41 165.12 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.2 148.63 23.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.14 -28.34 57.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.98 -41.88 88.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.325 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.86 121.76 42.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 110.23 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.64 109.61 19.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.464 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -126.84 129.81 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.636 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.71 154.15 41.87 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.654 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.519 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.26 92.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.824 2.349 . . . . 0.0 111.674 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.14 144.31 2.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.635 0.585 . . . . 0.0 110.787 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.26 -33.57 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.281 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.6 -62.39 1.82 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.335 -178.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.31 -22.24 29.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.936 -179.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -76.07 -26.14 56.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.84 133.35 47.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.402 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.4 -16.51 29.29 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.59 151.91 23.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.949 0.404 . . . . 0.0 110.408 -179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.38 135.64 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.307 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.04 136.61 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.662 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 139.05 14.54 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.502 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.31 161.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 110.35 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.502 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 44.2 tp -92.69 117.24 29.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.62 157.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.635 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.87 50.44 52.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.83 169.26 21.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.316 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.01 -25.9 60.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.9 -55.55 31.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.18 -53.94 52.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.59 -51.16 70.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.578 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.36 -43.71 98.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.384 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.01 -44.66 97.48 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.11 -14.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 0.0 110.75 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.34 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.665 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.63 -50.68 16.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.506 -178.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -99.19 12.72 35.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.17 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.491 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.24 -55.54 0.45 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.34 -10.3 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.821 2.347 . . . . 0.0 111.98 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.69 -8.7 59.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 -179.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.07 33.17 37.17 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.62 138.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.86 130.0 35.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.2 pt -126.43 138.23 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.2 t -123.18 133.16 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 109.992 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.18 127.79 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.804 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.15 153.52 25.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.74 6.55 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.699 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.6 130.43 5.98 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.05 -45.6 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.49 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.09 -23.95 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.7 -36.57 84.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.97 -47.0 86.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.126 -179.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.517 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 58.9 m-85 -63.73 -37.94 89.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.232 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.26 -42.56 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.153 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.405 ' H ' ' HG ' ' A' ' 151' ' ' SER . 53.6 m-20 -63.72 -45.63 89.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.865 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.8 tp -58.46 -48.08 81.92 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.19 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -63.18 -22.79 67.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.91 0.386 . . . . 0.0 110.077 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.6 -18.6 24.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.55 70.01 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.83 -17.92 63.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.588 179.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.1 pt -128.53 137.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.17 -27.83 61.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.53 155.47 1.79 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.791 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.83 137.31 50.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.0 110.029 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.64 102.91 13.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.225 0.536 . . . . 0.0 110.673 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.9 tt0 -132.08 165.1 24.79 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.52 152.45 40.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.0 -54.13 29.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.25 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.7 t -60.5 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.47 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.95 87.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.77 0.319 . . . . 0.0 110.789 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.34 1.18 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.567 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.4 m -58.67 -47.2 85.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.798 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.1 -38.25 24.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.066 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.514 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.88 -65.43 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.1 t80 -40.51 -71.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.594 0.235 . . . . 0.0 111.23 -178.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.47 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.077 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.53 -2.99 0.39 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.46 0.648 . . . . 0.0 110.448 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.514 HE21 ' C ' ' A' ' 171' ' ' GLY . 49.1 mt-30 -124.85 141.2 37.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -43.6 -14.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.858 2.372 . . . . 0.0 112.341 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.2 t -63.23 -42.91 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.553 -179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.75 -32.89 80.63 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.83 -41.6 96.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.725 0.297 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.0 m-20 -65.62 -34.92 79.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.4 m-85 -156.77 143.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.7 pttt -177.03 99.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.733 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.7 m-85 -159.24 167.98 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.37 55.86 3.14 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.13 -117.05 0.01 OUTLIER Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.66 135.04 34.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.483 2.122 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.5 p -125.11 -108.31 0.32 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.506 -179.035 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.57 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.628 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.48 155.61 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 124.077 0.861 . . . . 0.0 110.703 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.33 118.31 23.06 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.026 0.441 . . . . 0.0 109.812 179.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.94 -18.49 62.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.87 -32.24 73.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.539 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.84 -44.44 96.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.725 -178.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -113.84 8.22 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.719 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.3 -154.76 50.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.56 -25.28 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.851 0.358 . . . . 0.0 110.56 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.8 -125.75 1.5 Allowed Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.0 p -132.04 160.08 36.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.43 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.47 -162.59 24.89 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.18 140.92 31.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.615 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.11 111.9 3.97 Favored Glycine 0 CA--C 1.517 0.19 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.7 mt -121.61 160.79 23.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -87.11 148.94 25.01 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.15 -48.82 64.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.629 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -39.82 -23.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.973 0.416 . . . . 0.0 110.719 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.65 52.17 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.759 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.37 -46.29 84.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.182 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.46 -47.07 35.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.2 -43.89 97.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.45 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.56 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.856 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.51 -37.34 72.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.8 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.3 mt -29.01 -45.62 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.447 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.8 m-20 -63.62 -45.48 90.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.7 98.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.945 178.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.36 92.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.152 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -61.19 -43.39 98.95 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.027 0.441 . . . . 0.0 110.063 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.26 92.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.15 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.96 97.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.886 179.283 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.78 -38.47 72.55 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -69.85 -38.81 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.374 178.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.42 92.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.661 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 20.9 p-10 -88.35 0.4 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.698 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.61 20.38 67.96 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.0 m -58.18 -46.17 86.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.46 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.1 t80 -63.65 -57.43 10.08 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.454 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.89 -41.68 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.25 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.51 -48.6 80.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.493 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.83 -41.59 97.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.74 76.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.715 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.94 -35.45 73.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.414 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.59 -51.0 31.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.462 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.35 -45.45 93.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -153.74 155.15 35.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.16 99.47 10.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.527 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -156.41 -165.17 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.526 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.74 109.22 13.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -63.6 -40.35 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.513 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.7 m-85 -56.91 -43.7 81.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.83 93.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.708 0 CA-C-O 117.881 -1.51 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.29 164.25 62.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.587 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.91 143.53 99.37 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.564 2.176 . . . . 0.0 112.324 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.38 -41.02 90.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.081 0.467 . . . . 0.0 110.511 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.4 139.07 38.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.388 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.19 121.47 61.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.706 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.91 118.76 31.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 110.13 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -112.4 138.42 41.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 105.47 2.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -129.09 120.2 25.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.136 179.618 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 5.2 t0 -114.57 92.69 29.69 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.177 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--N 1.309 -1.503 0 C-N-CA 122.404 2.069 . . . . 0.0 112.135 179.462 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.7 t0 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.988 0.423 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -67.79 -40.97 84.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.847 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -61.05 -37.21 81.81 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.824 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.99 -45.26 86.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.02 -48.32 78.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.981 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -53.23 -54.47 35.62 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.31 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.48 -39.81 61.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.872 0.367 . . . . 0.0 110.26 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.79 -42.05 77.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.053 0.454 . . . . 0.0 110.53 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.44 -44.91 69.23 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.146 -179.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.26 -46.94 81.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.992 179.0 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -60.04 -42.14 93.78 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.216 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.28 -17.46 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.429 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.85 53.2 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.424 -179.177 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.12 171.51 15.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -89.16 142.69 27.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.03 0.443 . . . . 0.0 109.956 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.54 131.4 56.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -127.54 127.25 43.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.401 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.86 134.68 35.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.08 127.89 66.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.38 138.0 57.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.829 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.69 130.33 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.6 Cg_endo -67.58 145.07 69.03 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.71 2.273 . . . . 0.0 112.512 -179.186 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.2 mt -40.13 -55.76 2.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.37 -26.37 2.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.857 0.361 . . . . 0.0 111.224 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.19 -20.91 18.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.75 -42.37 97.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.643 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.628 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.21 -57.0 25.79 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.795 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.3 Cg_exo -55.39 -42.46 68.06 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.681 2.254 . . . . 0.0 111.213 177.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 70.1 m -58.69 -45.08 90.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.906 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.88 -44.2 91.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.148 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.26 -40.82 96.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.426 . . . . 0.0 110.424 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.79 9.87 2.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.416 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.21 12.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.991 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.36 -35.52 80.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.503 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.34 153.14 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.287 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -93.28 -22.18 19.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.462 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.62 156.14 27.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.01 129.01 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.493 . . . . 0.0 110.469 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -131.29 106.72 8.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.3 t -159.39 178.5 9.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.519 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.99 -15.52 62.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.8 tp -34.98 124.37 0.57 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.596 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.0 154.03 25.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -104.74 148.46 9.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.348 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.8 p -149.01 152.2 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.09 53.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.43 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.51 -39.74 70.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.671 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.614 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.8 mtt180 -68.98 -37.94 79.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.819 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -57.9 -39.03 76.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.711 -179.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.79 -27.38 66.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.57 -50.77 7.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.046 0.451 . . . . 0.0 110.634 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -139.14 -168.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.1 0.476 . . . . 0.0 110.543 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.92 150.02 51.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.674 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.17 -153.26 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.57 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.674 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.7 m-20 41.19 20.14 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.32 0.2 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.324 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 58.5 mt -74.79 -68.51 0.54 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.931 -178.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -150.52 167.55 26.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.751 -179.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.67 123.62 29.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.184 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.94 68.66 0.83 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.809 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -85.67 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.06 165.63 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.698 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.49 146.09 22.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.79 136.19 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 110.813 178.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.86 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.27 164.91 33.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.81 148.56 23.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.93 -28.42 56.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.241 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -58.76 -41.94 87.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.319 -179.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.93 121.74 42.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.016 0.436 . . . . 0.0 110.147 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -86.88 109.72 19.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -125.97 129.14 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.718 179.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -106.44 154.28 39.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.721 179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.49 90.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.766 2.311 . . . . 0.0 111.628 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -170.87 143.74 2.11 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.587 0.555 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.71 -33.05 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.085 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.3 -62.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.191 -178.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -55.74 -22.14 22.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.43 -25.91 54.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.254 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.71 133.83 47.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.5 -15.56 29.28 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.94 151.52 23.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.6 135.16 37.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.357 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.16 136.59 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.57 138.45 14.27 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.3 t -130.77 161.56 40.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.082 0.468 . . . . 0.0 110.359 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.3 tp -92.41 117.45 29.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.7 158.06 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.608 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.61 50.56 53.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.4 p -149.77 168.9 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.73 0.3 . . . . 0.0 110.9 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.1 p -73.3 -27.54 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.434 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.15 -55.65 31.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.507 -179.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.5 -54.96 39.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.698 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -60.11 -51.16 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.792 -179.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.5 t80 -62.07 -43.96 97.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.591 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.58 -44.39 98.02 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.336 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.33 -14.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.8 tt0 -125.23 -34.28 2.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.53 -50.56 17.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.129 0.49 . . . . 0.0 111.673 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.0 12.29 36.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.252 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.66 -55.38 0.48 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.347 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 55.7 Cg_endo -72.2 -10.61 26.03 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.75 2.3 . . . . 0.0 111.965 -179.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.44 -9.17 59.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.42 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.93 33.16 37.79 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.24 138.07 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 110.628 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.67 129.84 35.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.28 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.21 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.96 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.5 t -123.0 133.35 69.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.026 0.441 . . . . 0.0 109.981 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.4 43.13 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -110.64 153.37 25.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.01 6.68 29.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.759 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.21 130.17 5.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.8 -45.87 80.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.715 0.293 . . . . 0.0 110.383 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.82 -23.32 62.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.608 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.58 -37.07 86.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.11 0.481 . . . . 0.0 110.537 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -65.81 -46.82 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.231 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.684 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.5 m-85 -64.48 -37.72 88.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.345 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.97 -42.23 97.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.1 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.84 -43.52 92.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.122 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.01 -47.76 84.03 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.023 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.85 -22.57 66.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.025 0.44 . . . . 0.0 110.12 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.63 -18.26 25.43 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.592 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.95 72.18 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.98 -18.03 63.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.606 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.6 pt -127.04 135.92 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.399 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -72.55 -27.82 62.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.313 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.52 155.99 1.88 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.838 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.15 136.71 49.58 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.68 103.48 14.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.281 0.562 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.684 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 49.8 tt0 -132.76 165.25 24.97 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.446 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.84 153.09 41.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.34 -54.65 22.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.401 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.422 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 71.4 t -60.07 -49.06 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.705 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.33 -39.06 89.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.797 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.14 1.21 Allowed 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.0 m -59.5 -48.16 82.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.911 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -48.55 -37.74 18.63 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.342 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.75 -66.14 0.56 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.667 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.2 t80 -40.56 -70.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 111.218 -178.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.7 mt -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.23 -3.03 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.443 0.639 . . . . 0.0 110.499 -179.528 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' A' ' 173' ' ' LEU . 55.8 mt-30 -122.71 147.09 49.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.853 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.48 -19.64 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.844 2.362 . . . . 0.0 112.228 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.87 -42.8 96.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.672 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.63 -32.97 83.35 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.044 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.57 -41.26 94.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.7 m-20 -65.83 -33.47 75.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.25 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.0 m-85 -156.79 143.04 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.675 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.8 pttt -177.94 100.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.39 167.12 29.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.696 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.07 56.72 2.66 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.43 -118.37 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.36 135.35 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.477 2.118 . . . . 0.0 111.941 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -125.36 -107.9 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.61 -179.087 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.2 p -165.59 164.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.41 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.4 tttt 153.99 156.28 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.823 0.702 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.55 116.87 22.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.02 -18.94 62.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.81 -32.52 74.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.557 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.04 -44.47 97.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.691 -178.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -113.96 9.23 17.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.743 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.18 -154.83 52.23 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.14 -25.06 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.25 -124.33 1.33 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.22 156.23 44.29 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 110.234 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.56 -169.42 30.15 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -94.52 137.48 33.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.55 108.29 3.29 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.7 mt -123.39 159.37 29.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.441 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 90.0 mtm180 -86.76 149.61 24.74 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.94 -48.04 64.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.518 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.38 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.5 m-20 -71.75 52.27 0.22 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.64 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.53 -45.54 86.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.345 -179.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.44 -47.12 35.48 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.32 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.3 -44.11 97.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.425 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.15 -36.43 70.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.19 -77.73 0.11 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.527 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.0 mt -28.27 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.736 0.303 . . . . 0.0 110.29 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.441 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.2 m-20 -64.23 -44.83 90.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.662 178.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.99 -43.77 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.957 178.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.27 94.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.057 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -61.25 -43.71 98.44 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 109.894 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.15 92.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.529 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.67 -42.89 97.99 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.535 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -58.28 -38.33 76.8 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.0 -40.02 78.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 0.0 110.095 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.68 93.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.0 p30 -86.73 1.54 51.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.451 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.26 19.52 59.69 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 72.6 m -58.31 -45.65 87.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.49 -58.15 7.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.341 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.7 mt-10 -56.89 -41.33 77.86 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.46 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.53 -48.36 81.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.643 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.296 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.74 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.463 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.44 -35.39 72.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.645 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -71.14 -50.86 28.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.4 m-85 -62.27 -45.28 93.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.503 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.9 m-85 -153.3 155.06 35.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.407 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.5 p-10 -97.56 95.22 7.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.954 0.406 . . . . 0.0 110.505 179.513 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -153.16 -166.12 2.35 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.99 109.98 14.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.822 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.4 m -63.43 -40.67 89.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.39 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.2 m-85 -56.38 -43.91 79.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.49 94.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.67 0 CA-C-O 117.934 -1.481 . . . . 0.0 110.95 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.22 59.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.604 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.88 144.0 99.47 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.6 2.2 . . . . 0.0 112.235 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -65.86 -40.62 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.62 144.47 37.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.464 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -110.92 129.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -104.42 116.56 32.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.425 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.8 140.99 29.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.17 106.39 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 m -128.49 120.23 26.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.679 0.276 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.7 t70 -112.54 94.22 26.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.104 179.606 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 C--N 1.308 -1.594 0 C-N-CA 122.467 2.111 . . . . 0.0 112.19 179.334 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.8 t0 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.041 0.448 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.02 -39.99 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.741 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -60.98 -36.66 80.03 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.967 -178.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.21 -44.71 83.07 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.47 -45.08 89.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.214 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.93 -54.24 45.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.505 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.13 -37.32 64.23 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.62 -43.36 72.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 54.4 m -54.13 -44.24 71.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.165 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.9 tttm -63.91 -48.0 78.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.043 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.51 -41.11 89.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.171 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.37 -18.53 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.507 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.51 52.24 3.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.14 169.93 17.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.1 140.85 29.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.155 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.17 132.01 56.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.97 126.79 42.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.441 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.18 136.51 34.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.566 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.35 128.93 64.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.416 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.07 139.88 56.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 p30 175.0 135.16 0.16 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.37 143.34 57.74 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.715 2.277 . . . . 0.0 112.45 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 54' ' ' PRO . 83.6 mt -39.88 -54.56 2.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.119 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.84 -25.97 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.139 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.33 -20.99 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.117 -179.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.04 -42.43 97.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.58 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.63 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -56.57 30.27 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.008 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.3 Cg_exo -55.05 -42.94 64.16 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.293 176.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.4 m -58.48 -44.94 89.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.854 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 tp -58.65 -44.54 90.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.4 mtmt -64.7 -41.18 96.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.397 . . . . 0.0 110.453 178.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.03 11.08 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 56.29 11.95 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.61 -33.69 76.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 67' ' ' ILE . 44.8 pt -124.41 154.55 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.322 -179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -92.6 -20.79 20.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.175 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.19 159.64 23.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 70' ' ' ILE . 96.0 mt -116.29 127.39 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 110.537 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 61.9 ttp -128.68 107.38 9.63 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.323 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.548 ' HG ' ' H ' ' A' ' 73' ' ' SER . 36.7 t -162.27 -176.79 5.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.548 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.22 -15.89 60.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.345 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.62 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.6 tp -37.51 122.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 110.502 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.03 156.21 23.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.69 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -105.21 149.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.383 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.0 p -150.52 152.52 34.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.787 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.08 -47.72 53.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.44 -39.78 70.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.62 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.67 -37.79 79.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.022 0.439 . . . . 0.0 110.875 179.203 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.2 -37.71 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.931 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.86 -27.41 66.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.153 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.58 -51.12 7.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 110.543 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -139.15 -168.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.49 147.29 29.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -130.33 150.47 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.69 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.1 t -165.02 -150.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.474 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.69 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.0 m-20 42.74 19.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.14 120.87 0.09 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.484 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -80.0 -72.79 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.923 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -147.86 164.98 32.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.58 127.49 32.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.11 67.48 0.7 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.692 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.27 -106.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 32.2 p -159.45 167.85 27.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.21 146.68 23.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.055 0.455 . . . . 0.0 110.492 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -101.68 135.94 42.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.743 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 111.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.98 164.67 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 -179.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 148.44 24.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.31 -28.24 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.2 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -59.07 -41.35 87.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -102.38 122.31 44.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.332 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.51 109.39 19.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.062 0.458 . . . . 0.0 110.532 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.4 129.85 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.25 158.79 36.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.481 ' O ' ' OG1' ' A' ' 108' ' ' THR . 21.0 Cg_endo -60.3 91.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.736 2.29 . . . . 0.0 111.883 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.7 m -169.89 142.62 2.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.56 -33.5 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.284 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -56.73 -63.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.343 -178.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -56.86 -21.75 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.059 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.5 -28.28 59.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -55.06 132.55 47.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.53 -16.35 35.83 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.64 151.21 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 -179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -96.38 135.58 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.287 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.44 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.708 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.83 137.81 13.97 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 54.4 t -131.44 161.7 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.047 0.451 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.493 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 39.2 tp -92.99 120.55 33.41 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -52.01 155.49 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.6 50.91 45.62 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -147.85 166.1 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.662 0.267 . . . . 0.0 110.886 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 68.6 p -71.28 -30.62 66.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.3 mt-30 -58.35 -55.16 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.24 -55.43 33.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.799 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 m -60.56 -51.65 68.52 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.872 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.589 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 68.5 t80 -61.83 -44.41 96.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 110.547 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.0 -44.37 97.88 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -45.44 -14.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 0.0 110.731 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.35 -34.43 2.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.589 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.8 t60 -74.04 -50.46 19.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.523 -178.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.92 12.53 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.165 -179.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.51 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.24 -55.14 0.51 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.37 -9.8 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.789 2.326 . . . . 0.0 111.988 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.12 -8.62 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.388 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.09 33.51 36.1 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.79 137.57 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.0 110.594 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.97 130.27 35.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.276 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.6 pt -128.34 139.75 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.974 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.96 132.47 70.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.133 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.3 t -97.82 129.83 44.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.763 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.1 156.93 20.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.0 6.97 27.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.25 130.56 6.08 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.24 -46.58 76.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.712 0.291 . . . . 0.0 110.413 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.02 -23.22 63.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.563 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.61 -36.54 84.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.527 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.26 -47.67 83.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.121 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.4 m-85 -63.59 -37.86 88.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.37 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.84 -42.62 98.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.44 -43.74 93.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.21 -48.53 81.29 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.179 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.72 -22.85 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.962 0.411 . . . . 0.0 110.199 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.29 -18.19 26.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.3 11.03 73.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.48 -18.12 63.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.4 pt -128.37 137.31 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.38 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.88 -29.36 63.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.26 155.13 1.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.821 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.61 139.09 52.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.946 0.403 . . . . 0.0 110.029 179.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.51 103.15 14.77 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.234 0.54 . . . . 0.0 110.714 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.36 164.69 25.92 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -73.53 152.45 40.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.2 -54.11 29.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.59 -49.25 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.91 84.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.844 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.94 1.05 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.533 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 68.0 m -57.82 -46.51 84.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.298 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.05 -41.87 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.26 -62.26 0.48 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.623 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.31 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.618 0.247 . . . . 0.0 111.083 -178.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.35 -40.71 97.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.13 -2.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.383 0.611 . . . . 0.0 110.532 -179.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.5 mt-30 -126.25 141.5 40.01 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.825 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.45 -14.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.828 2.352 . . . . 0.0 112.211 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 92.5 t -63.28 -42.91 98.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.67 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.31 84.61 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.1 -41.21 96.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.727 0.299 . . . . 0.0 110.48 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -65.8 -34.7 78.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.467 179.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.18 143.35 17.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.6 pttt -175.96 99.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.745 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.76 166.78 31.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.698 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.83 55.89 3.05 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.21 -116.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.56 134.02 32.52 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.573 2.182 . . . . 0.0 111.906 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -123.27 -109.4 0.33 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.453 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.64 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 4.4 p -164.84 164.09 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.6 tttt 154.71 154.09 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.791 0.682 . . . . 0.0 110.657 179.276 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -80.06 119.26 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.951 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.36 -19.76 62.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.18 -31.0 72.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.668 -178.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -114.46 8.18 16.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.735 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.7 -154.1 49.68 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.79 -25.74 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 110.606 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.1 -126.9 1.66 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.0 p -132.28 160.56 35.86 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.484 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.96 -161.74 23.87 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.8 140.45 32.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.976 0.417 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.19 3.53 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -117.86 159.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 110.248 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.9 mtm180 -86.76 148.57 25.36 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.511 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.63 -48.48 63.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.663 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -40.94 -22.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 0.0 110.734 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -73.08 51.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.739 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.41 -46.42 83.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.19 -47.12 37.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.14 -43.7 98.26 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.59 -43.1 99.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.39 -37.59 72.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.43 -77.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.255 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.528 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.9 mt -28.03 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.448 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.2 m-20 -63.63 -45.76 88.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.94 -43.96 97.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.945 178.686 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.2 91.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.082 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.2 91.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.181 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.93 -43.44 95.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.887 179.347 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.511 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.36 -38.53 71.53 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -39.11 77.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 0.0 110.288 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.25 -45.63 90.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.653 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 19.3 p-10 -88.58 -0.49 57.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.71 20.49 70.27 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.9 m -58.19 -46.36 85.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.484 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -62.21 -56.68 16.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.419 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.71 -40.76 76.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.317 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -47.92 83.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.535 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.1 -40.75 96.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.251 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.62 -49.7 76.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.557 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.5 -35.74 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -69.77 -51.6 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.499 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.93 -46.27 90.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.579 179.372 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.67 154.64 33.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.517 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.5 p-10 -98.28 95.19 7.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.979 0.419 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -151.5 -164.13 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.12 108.49 13.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.787 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 26.0 m -63.56 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.367 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.419 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 89.7 m-85 -58.53 -42.51 87.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.64 95.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.669 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.28 164.39 61.59 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.86 143.52 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.539 2.159 . . . . 0.0 112.287 179.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.17 -40.33 90.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.79 142.51 36.7 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.485 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 9' ' ' ILE . 83.0 mt -109.62 128.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.915 0.388 . . . . 0.0 110.489 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -103.39 116.86 33.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.128 0.49 . . . . 0.0 110.392 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.59 138.93 38.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.952 0.406 . . . . 0.0 110.575 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.02 104.4 2.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -127.57 119.24 25.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 122.759 -0.26 . . . . 0.0 111.217 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 16.4 t70 -113.63 93.21 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.155 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.308 -1.561 0 C-N-CA 122.502 2.134 . . . . 0.0 112.115 179.253 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.6 t0 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.98 0.419 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.68 -40.77 82.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.055 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 53.0 m-20 -61.16 -37.15 81.86 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.972 -178.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.77 -43.99 82.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.054 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.539 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.78 -41.89 92.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.293 -179.114 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -58.8 -53.52 57.4 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.546 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.65 -36.81 62.48 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.924 0.392 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.69 -42.37 74.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 178.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.25 -44.79 72.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.208 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -63.74 -47.79 79.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.987 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.199 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.46 -17.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.76 52.69 4.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.5 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.62 140.86 29.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.136 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.39 131.79 56.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.636 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.2 127.67 43.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -93.86 135.67 34.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.59 128.27 65.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.345 179.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.11 139.29 58.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.819 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.1 p30 174.95 132.35 0.14 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.42 144.55 61.94 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.728 2.286 . . . . 0.0 112.467 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 58' ' ' LEU . 82.0 mt -40.01 -56.34 1.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -47.55 -26.48 1.45 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.127 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.36 -20.63 18.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.19 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 55' ' ' LEU . 57.4 mt -63.99 -42.35 97.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.629 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.49 -56.69 27.77 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.894 -179.305 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.8 Cg_exo -54.94 -43.59 57.9 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.646 2.23 . . . . 0.0 111.249 177.02 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -58.55 -44.69 89.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.781 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.14 -44.32 87.75 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.149 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.56 -40.39 95.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.021 0.439 . . . . 0.0 110.541 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 11.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.517 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.21 12.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.761 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.44 -34.46 77.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.536 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -123.8 153.25 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.278 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.71 -20.57 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.97 157.05 25.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.739 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.02 127.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.062 0.458 . . . . 0.0 110.495 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -128.64 106.69 9.12 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.543 ' HG ' ' N ' ' A' ' 73' ' ' SER . 47.0 t -159.98 -178.23 6.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.582 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.543 ' N ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -64.26 -15.47 60.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.612 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.0 tp -38.05 123.81 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.45 156.71 22.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 pt -104.88 148.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.365 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -149.92 152.32 34.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.833 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.19 -47.84 54.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.606 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.81 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.74 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.7 mtt180 -68.45 -37.8 80.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.11 74.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.875 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.45 67.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.132 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.45 -51.71 7.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.533 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.33 -168.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.81 146.73 29.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.034 0.445 . . . . 0.0 110.985 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -129.76 149.98 51.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.614 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.676 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.6 t -164.15 -151.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.516 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.676 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.5 m-20 43.11 19.18 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.801 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.92 120.12 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.0 mt -77.0 -69.99 0.49 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -149.34 166.31 29.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.619 -179.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.26 121.65 27.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.438 . . . . 0.0 110.29 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.94 69.82 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.782 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.22 -104.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.465 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.29 165.87 32.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.697 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.73 145.84 21.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.503 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.27 136.05 41.75 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.77 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 110.79 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.65 164.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 -179.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.94 148.42 23.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.57 -27.75 41.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.272 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -59.25 -41.74 89.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.326 -179.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.47 122.59 44.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.299 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.92 109.41 19.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.427 ' C ' ' NE2' ' A' ' 106' ' ' GLN . 97.1 mt -128.15 129.6 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.583 ' NE2' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.89 158.9 34.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.569 179.916 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.497 ' C ' ' HG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.58 89.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.734 2.289 . . . . 0.0 111.913 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.497 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.9 m -169.05 140.89 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.701 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.27 -32.96 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.237 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -56.98 -62.82 1.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 -178.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -55.95 -22.04 24.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.032 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.57 -26.15 54.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.22 46.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.405 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.82 -15.6 30.88 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.98 151.86 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -179.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.48 135.51 38.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.068 0.461 . . . . 0.0 110.298 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.0 136.71 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.45 138.65 14.36 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.02 161.62 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.03 0.443 . . . . 0.0 110.367 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.5 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.2 tp -92.6 117.61 30.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.491 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.75 157.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.01 50.61 51.2 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.6 p -149.84 168.98 22.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.674 0.273 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -73.81 -26.38 60.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.446 179.401 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.66 -55.7 30.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.465 -179.392 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.66 -54.47 45.74 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.63 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.31 -51.25 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.675 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.05 -43.73 98.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.58 179.176 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.47 97.72 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.23 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.34 -34.15 2.74 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.47 -50.88 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.038 0.446 . . . . 0.0 111.533 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -99.07 12.61 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.99 -55.58 0.46 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.23 -10.44 25.76 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.783 2.322 . . . . 0.0 111.979 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.54 -8.88 59.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.425 -179.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.38 36.97 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.67 138.27 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.593 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.92 129.81 35.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.301 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.04 133.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 110.067 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.15 127.67 43.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -110.92 153.59 25.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.413 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.94 6.93 29.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.91 130.43 5.94 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.96 -45.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.714 0.292 . . . . 0.0 110.417 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.11 -23.72 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.72 -36.43 84.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.3 -47.12 85.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.109 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -63.56 -37.86 88.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.396 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.21 -42.72 99.08 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.229 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.444 ' N ' ' HG ' ' A' ' 151' ' ' SER . 55.6 m-20 -63.43 -45.32 91.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 42.8 tp -58.76 -48.19 82.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.189 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.73 -22.9 66.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.947 0.403 . . . . 0.0 110.22 179.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.77 -18.22 25.31 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.622 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.71 11.24 71.34 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.43 -17.87 63.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 110.631 179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.4 pt -128.5 137.36 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.43 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.06 -27.89 62.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.63 155.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.811 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.37 50.71 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.019 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.63 103.12 14.16 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.277 0.56 . . . . 0.0 110.761 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.35 165.06 25.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.375 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.443 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.36 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.987 0.422 . . . . 0.0 110.526 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.426 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.01 -54.28 28.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.212 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.78 -49.3 84.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.67 -179.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.83 -38.8 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.678 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.67 1.09 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.583 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.6 m -58.61 -47.62 83.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.73 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -48.75 -38.68 22.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.268 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.421 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.69 -65.65 0.55 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.678 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.7 t80 -40.23 -71.13 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.704 -0.292 . . . . 0.0 111.235 -178.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.3 mt -61.39 -39.81 92.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.79 -3.11 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.461 0.648 . . . . 0.0 110.535 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.5 mt-30 -124.68 141.79 38.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -43.92 -14.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.797 2.331 . . . . 0.0 112.197 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.9 t -63.17 -42.78 97.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.91 81.5 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.1 -41.28 96.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.622 0.248 . . . . 0.0 110.449 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.6 m-20 -65.98 -34.61 78.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.457 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.9 m-85 -157.44 143.5 17.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.08 100.25 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.1 m-85 -159.49 167.74 27.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.654 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.57 55.65 3.15 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.59 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -179.756 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.57 135.23 33.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.518 2.146 . . . . 0.0 111.953 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.24 -108.0 0.32 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.503 -179.023 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.14 165.22 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.366 -179.408 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.26 155.84 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 123.758 0.661 . . . . 0.0 110.668 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.17 22.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.852 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.6 mp0 -71.87 -18.69 62.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.592 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.98 -44.26 97.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.738 -178.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.0 m-85 -113.71 7.51 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.78 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.35 -155.5 50.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.54 -25.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.0 110.63 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.96 -126.16 1.56 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.5 p -131.99 160.02 37.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.79 0.329 . . . . 0.0 110.483 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.46 24.87 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.17 141.16 31.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.26 111.9 3.98 Favored Glycine 0 C--N 1.329 0.185 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.6 mt -120.98 160.82 22.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -87.38 149.07 24.72 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.09 -48.93 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 -179.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -40.14 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.019 0.438 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.25 52.23 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -46.06 84.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.54 -47.06 35.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.19 -44.07 97.42 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.451 -179.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.4 -43.0 99.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.919 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.6 -37.28 72.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.792 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.527 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.8 mt -28.11 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 110.358 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.447 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.8 m-20 -63.53 -45.51 90.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.582 178.238 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.34 -43.62 98.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.34 93.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.057 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.19 -43.56 98.69 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.5 93.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.221 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.66 -43.08 97.79 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.841 179.317 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.79 -38.26 72.29 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.81 76.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.945 0.403 . . . . 0.0 110.302 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.12 93.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.659 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 20.7 p-10 -88.73 0.41 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.682 179.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.57 20.24 67.74 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.461 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 89.1 m -57.83 -46.38 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.51 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.3 t80 -63.45 -58.01 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.414 179.234 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.9 mt-10 -56.23 -41.74 76.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.53 -48.45 80.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.85 -41.41 97.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.368 179.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.09 -50.21 74.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.508 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.18 -35.77 72.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.669 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.62 -51.09 30.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.42 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.18 -45.77 91.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.57 155.0 35.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.6 p-10 -97.95 98.24 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.24 -165.43 2.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.591 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.67 109.41 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.774 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.5 m -63.86 -40.56 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.478 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.5 m-85 -56.7 -43.75 80.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.95 94.09 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.426 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.908 -1.496 . . . . 0.0 110.955 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.58 164.29 59.17 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.593 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.89 143.55 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.58 2.187 . . . . 0.0 112.295 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.23 -40.23 90.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.76 142.22 36.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.401 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.412 HD12 HG21 ' A' ' 9' ' ' ILE . 83.3 mt -109.41 128.68 65.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 110.511 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.41 117.02 33.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.154 0.502 . . . . 0.0 110.379 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -111.97 139.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.555 -179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.98 105.26 2.18 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -128.12 119.1 24.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.255 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.9 t0 -113.63 93.35 27.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.121 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 122.418 2.079 . . . . 0.0 112.132 179.271 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.471 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 35.0 t0 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.48 -41.23 83.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.403 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.2 m-20 -60.89 -37.06 80.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.029 -178.468 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.81 -43.81 82.86 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.07 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.536 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.92 -41.72 92.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.124 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.89 -53.61 56.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.58 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.86 -36.56 62.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.913 0.387 . . . . 0.0 110.309 179.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.67 -42.42 74.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 178.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.5 m -54.35 -44.71 72.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.158 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -63.91 -47.74 79.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.058 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.46 -40.85 88.22 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.163 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.34 -17.97 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.536 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 60.77 52.79 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.545 -179.258 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.55 170.58 16.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.46 140.77 29.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.8 m -117.3 131.74 56.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.725 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.7 m -128.24 127.63 43.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.481 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.15 135.79 35.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.595 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.64 128.52 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.02 139.56 58.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 174.87 131.81 0.14 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.9 Cg_endo -68.05 144.78 65.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.745 2.297 . . . . 0.0 112.477 -179.388 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 58' ' ' LEU . 83.3 mt -40.23 -56.0 2.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.98 -26.28 1.7 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.16 -179.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.44 -20.65 18.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 55' ' ' LEU . 57.3 mt -63.99 -42.3 97.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.656 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.54 -56.68 27.71 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.93 -179.291 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.3 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.599 2.199 . . . . 0.0 111.12 177.232 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.86 -44.6 91.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.729 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.22 -44.36 88.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.53 -40.48 95.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.972 0.415 . . . . 0.0 110.443 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.21 11.13 1.62 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 56.06 12.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.36 77.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.584 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.87 153.89 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.339 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.4 -20.83 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.329 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.52 157.76 25.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.783 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.8 127.43 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 110.502 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.471 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.82 106.89 9.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.395 179.761 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.6 t -160.74 -177.7 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.583 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.14 -15.86 60.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.624 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.3 tp -37.98 123.52 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 110.455 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.4 156.85 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.703 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 pt -105.22 149.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.356 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.4 p -150.17 152.68 35.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.835 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.42 -47.48 56.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.574 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.73 -39.85 71.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.624 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.3 mtt180 -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 110.962 178.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.25 -37.18 74.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.822 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.48 -27.57 67.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.087 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.73 7.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.0 110.531 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.24 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.122 0.487 . . . . 0.0 110.452 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.94 146.6 29.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.72 149.97 51.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.673 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.7 t -164.26 -151.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.437 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.673 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.4 m-20 42.88 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.767 179.57 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -28.39 120.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.403 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.468 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.02 -69.88 0.5 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.888 -178.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -149.27 166.28 29.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.64 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.41 121.56 27.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.308 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.77 69.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 -179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.92 -104.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.22 165.62 33.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.777 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 79.0 ttt-85 -155.49 146.11 22.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.438 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.4 135.93 42.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.987 0.423 . . . . 0.0 110.818 178.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.56 110.62 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.3 165.02 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.79 23.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.79 -27.95 45.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.12 -41.79 89.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -102.35 122.21 43.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.257 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.7 108.92 19.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.085 0.469 . . . . 0.0 110.425 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.07 129.92 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.751 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.59 159.18 34.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.95 0.405 . . . . 0.0 110.511 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.32 89.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.674 2.249 . . . . 0.0 111.891 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -169.2 140.82 2.45 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.459 0.474 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.09 -32.71 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.145 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.23 -62.95 1.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 t -55.74 -22.17 22.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.015 -179.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.4 -26.21 55.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.21 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.71 44.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.435 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.93 30.99 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -86.15 151.34 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.0 110.441 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.72 136.11 37.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.294 -179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.06 136.65 60.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.731 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 138.26 14.17 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.1 t -131.26 161.75 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.352 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.0 tp -93.05 119.63 32.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -52.04 157.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.97 50.72 50.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.1 p -149.05 167.97 24.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.715 0.293 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.423 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.3 p -74.06 -26.22 60.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.392 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.79 -55.47 32.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.21 -53.78 54.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.1 m -60.58 -51.34 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.1 t80 -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.131 0.491 . . . . 0.0 110.489 179.207 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.19 -44.49 97.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.276 -0.729 . . . . 0.0 111.276 -179.282 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.43 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.24 -34.1 2.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.56 -50.52 17.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.026 0.441 . . . . 0.0 111.586 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -98.94 12.5 35.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.272 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.92 -55.32 0.47 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.38 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.2 -10.71 26.18 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.778 2.319 . . . . 0.0 111.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -8.9 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.82 33.43 37.46 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.29 138.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.644 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.06 130.01 35.12 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.229 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.53 139.31 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.6 132.39 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.962 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.44 130.32 45.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.55 156.55 21.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.375 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.87 6.26 29.19 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.739 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.8 6.24 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.13 -45.9 79.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.63 -23.31 62.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.532 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.2 t-20 -64.54 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.507 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.04 -47.16 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.26 -179.538 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.681 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 62.7 m-85 -64.36 -37.56 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.324 179.777 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.81 -42.17 97.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.055 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.95 -43.02 94.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.92 179.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.48 -47.94 83.58 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.024 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.4 m -62.63 -22.74 66.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -17.52 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.659 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 11.82 74.38 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.72 -18.11 63.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 35.3 pt -127.15 136.23 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.377 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.82 -28.9 62.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.302 -179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.11 155.55 1.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.13 138.04 51.56 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -86.25 102.93 14.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.265 0.555 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.681 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 50.8 tt0 -132.24 164.87 25.42 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.388 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.447 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.14 152.98 40.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.968 0.413 . . . . 0.0 110.549 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.08 -54.38 26.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.295 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.07 -49.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.709 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.06 88.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.788 0.327 . . . . 0.0 110.851 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.78 1.06 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.678 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.6 m -58.64 -47.45 84.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.708 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.13 -38.4 25.0 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.228 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.67 -65.56 0.55 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.683 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.7 t80 -40.34 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.722 0.296 . . . . 0.0 111.312 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.8 mt -61.53 -39.61 91.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.044 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.06 -3.19 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.515 -179.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 173' ' ' LEU . 61.4 mt-30 -124.28 142.28 39.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.1 -15.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.833 2.355 . . . . 0.0 112.22 179.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.3 t -62.98 -42.75 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.01 82.37 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.0 -41.29 96.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.673 0.273 . . . . 0.0 110.509 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.4 m-20 -66.02 -34.58 78.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.388 179.514 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -157.07 143.21 17.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.91 99.91 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.9 0.381 . . . . 0.0 110.782 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.26 166.73 30.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.729 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.45 56.01 2.91 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.29 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.8 135.51 35.33 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.478 2.119 . . . . 0.0 111.9 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.15 -107.87 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.552 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -166.5 165.39 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.351 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.21 156.42 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.748 0.655 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -82.88 117.98 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.27 -18.65 62.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.74 -32.01 73.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.581 -179.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.06 -44.29 97.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.772 -178.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.423 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.4 m-85 -113.7 7.68 17.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.763 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.89 -155.4 50.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.32 -25.52 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.65 -126.36 1.6 Allowed Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.66 159.64 37.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 110.47 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.61 24.96 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.32 141.18 31.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.967 0.413 . . . . 0.0 110.579 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.04 3.84 Favored Glycine 0 C--N 1.329 0.173 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.7 mt -119.71 160.52 22.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 110.202 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -87.28 149.03 24.83 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.847 0.356 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.33 -48.77 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.685 -179.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -40.63 -22.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.123 0.487 . . . . 0.0 110.682 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.08 52.18 0.24 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.769 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.45 -45.88 85.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.301 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.62 -47.14 33.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.055 0.455 . . . . 0.0 111.279 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.18 -44.08 97.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.49 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.864 179.536 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.75 -37.33 73.42 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.526 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.2 mt -28.39 -45.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 0.0 110.322 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.1 m-20 -63.57 -45.54 89.97 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.495 178.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.47 -43.59 98.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.25 92.86 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.045 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.002 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.51 92.95 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.179 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.54 -43.13 98.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.84 -38.27 72.42 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.89 -38.84 76.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 110.364 178.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.35 93.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 20.9 p-10 -88.34 0.44 56.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.681 179.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.34 20.3 67.37 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.01 -46.36 85.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.0 t80 -63.47 -57.88 8.82 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . 0.43 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.7 mt-10 -56.33 -41.72 76.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.514 -179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.66 -48.19 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.686 -179.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.15 -41.48 98.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.17 -50.11 75.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.532 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.21 -35.8 72.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.59 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.44 -50.91 33.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.2 m-85 -62.5 -45.28 93.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.521 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 72.1 m-85 -153.93 155.02 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.526 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.34 98.63 9.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.419 . . . . 0.0 110.511 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -155.59 -165.11 1.89 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.577 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.0 t0 -122.67 109.15 13.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.803 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.1 m -63.72 -40.53 89.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.421 179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.43 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 85.8 m-85 -56.76 -43.71 81.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.42 -36.77 93.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.663 0 CA-C-O 117.853 -1.526 . . . . 0.0 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.03 164.31 62.27 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.651 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 143.46 99.37 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.47 2.114 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.65 -40.67 88.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -138.78 141.6 38.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 9' ' ' ILE . 82.5 mt -110.02 127.69 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.4 mtp180 -101.65 117.56 35.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.157 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.6 104.71 2.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -127.87 119.52 25.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 18.2 t0 -113.23 91.89 20.62 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.069 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.87 134.06 57.43 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.466 2.111 . . . . 0.0 111.904 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.3 p -141.32 -19.65 0.78 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.4 m-85 -123.97 98.43 5.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.319 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.624 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -28.79 -61.09 0.22 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 121.851 0.834 . . . . 0.0 110.969 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.78 -40.52 47.78 Favored 'Trans proline' 0 C--N 1.297 -2.176 0 C-N-CA 121.896 1.73 . . . . 0.0 112.22 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -78.37 -43.1 28.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.134 0.492 . . . . 0.0 110.866 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.624 ' O ' ' O ' ' A' ' 18' ' ' ALA . 97.0 mt-10 -149.28 -154.56 0.56 Allowed 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.147 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.66 177.66 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.837 0.351 . . . . 0.0 110.164 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.28 144.65 46.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.406 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -95.49 134.84 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.489 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -64.82 -18.9 65.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.451 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.24 -6.63 55.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.507 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.75 -7.98 55.91 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.31 158.38 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.411 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -111.87 131.74 55.16 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.337 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.32 151.54 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.89 151.81 6.75 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -58.83 -42.41 89.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.872 0.368 . . . . 0.0 110.838 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.6 t0 -69.25 -28.84 66.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 0.0 111.232 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.66 -40.97 85.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.107 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.81 -37.7 82.89 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.095 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.39 -45.04 89.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.126 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.3 -47.9 80.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -53.22 -54.34 37.54 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.55 -40.25 62.35 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.102 0.477 . . . . 0.0 110.13 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.13 -42.02 80.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.945 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.2 m -54.13 -43.95 70.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.01 -47.12 81.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.225 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -59.86 -41.79 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.474 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.36 -18.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.81 52.59 4.22 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.354 0.409 . . . . 0.0 110.659 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 p -146.63 171.11 15.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -88.63 141.39 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.984 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.95 130.61 56.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.569 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.06 127.23 44.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.277 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.66 135.81 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.438 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.54 128.92 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.939 0.4 . . . . 0.0 110.423 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.46 139.2 58.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 175.37 129.88 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.0 146.43 71.09 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.632 2.221 . . . . 0.0 112.402 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.4 mt -40.44 -56.73 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.07 -27.14 2.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.39 -20.69 19.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.048 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.53 -42.41 95.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.622 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.62 -56.96 24.95 Favored Pre-proline 0 C--O 1.241 0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.667 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.6 Cg_exo -54.46 -43.52 58.04 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.435 2.09 . . . . 0.0 111.521 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.6 m -59.09 -44.32 91.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.777 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.42 -44.14 88.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 65' ' ' LYS . 54.0 mtmt -64.6 -39.95 94.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.46 11.29 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.96 12.12 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.762 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.63 78.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.51 152.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -92.98 -20.59 20.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.23 156.18 26.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.489 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.29 127.11 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.451 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -128.32 105.9 8.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.268 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.659 ' HG ' ' H ' ' A' ' 73' ' ' SER . 47.9 t -159.33 179.87 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.659 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -64.78 -15.14 61.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.427 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.622 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.2 tp -36.4 123.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.583 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.73 154.72 25.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.778 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -104.82 148.35 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.2 p -149.62 152.53 35.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.738 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.37 -46.89 56.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.99 -40.17 72.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.479 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.622 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.8 mtt180 -68.09 -37.9 81.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.15 -37.83 75.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.994 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.03 -27.44 66.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.16 7.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.554 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.7 pt -139.28 -168.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.28 146.92 29.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.83 149.81 51.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.668 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.7 t -164.09 -152.81 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.512 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.668 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.7 m-20 41.86 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.948 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.63 121.07 0.2 Allowed 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.61 0.569 . . . . 0.0 110.522 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.3 mt -75.13 -68.37 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.866 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -150.71 167.27 27.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.705 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.5 123.22 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.306 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.87 67.96 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.642 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.64 -104.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.38 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.9 p -159.76 166.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.635 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.35 145.99 22.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.22 135.9 41.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.49 110.98 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.5 164.14 34.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.732 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.17 148.33 25.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.924 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.68 -27.63 41.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.53 -41.66 90.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.273 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -102.17 122.0 43.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.802 0.334 . . . . 0.0 110.143 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.11 109.55 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 105' ' ' ILE . 96.9 mt -128.33 129.75 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.623 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.83 159.02 34.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.358 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.466 ' C ' ' HG1' ' A' ' 108' ' ' THR . 18.7 Cg_endo -59.76 89.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.74 2.293 . . . . 0.0 111.934 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.466 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 7.0 m -168.5 140.53 2.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.798 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -66.74 -33.05 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.185 0.516 . . . . 0.0 110.218 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.51 -62.37 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.612 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.19 -22.31 28.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 110.859 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -76.32 -25.89 55.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -54.56 132.69 45.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.612 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -16.57 30.25 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -85.85 151.22 23.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.35 135.91 37.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.244 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.38 136.51 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.702 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.43 139.98 14.9 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.3 t -132.01 161.59 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 42.2 tp -92.92 119.04 31.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.488 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.9 157.3 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.79 47.99 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.4 p -149.51 168.14 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.26 -25.71 59.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -61.14 -55.16 35.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.43 -54.08 50.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.38 -51.15 70.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.542 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.594 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.3 t80 -62.23 -43.81 97.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.466 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.49 -44.53 97.88 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.82 -14.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.42 -34.66 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.594 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.7 t60 -74.47 -50.43 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.435 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.37 12.53 36.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.139 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.91 -55.52 0.47 Allowed Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.416 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' CD ' ' O ' ' A' ' 131' ' ' GLU . 56.6 Cg_endo -72.27 -10.32 25.54 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.727 2.285 . . . . 0.0 111.984 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.53 -9.18 59.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.26 37.88 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.32 137.94 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.59 129.62 35.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.64 138.52 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.54 131.89 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 t -98.16 130.33 44.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.603 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -111.44 156.23 21.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.278 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.03 6.48 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.742 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.62 130.66 6.22 Favored Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.92 -45.87 80.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 110.459 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.55 -23.61 62.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.66 -36.93 85.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.95 -46.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.316 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.511 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.3 m-85 -64.04 -37.85 88.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.02 -42.45 98.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.049 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.442 ' N ' ' HG ' ' A' ' 151' ' ' SER . 54.4 m-20 -63.87 -44.45 93.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.108 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -59.09 -47.86 83.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.147 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.05 -23.15 67.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.176 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.66 25.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.07 71.05 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.26 -18.39 63.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.8 pt -127.7 137.64 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.09 0.471 . . . . 0.0 110.554 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.99 -28.35 62.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.964 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.41 155.71 1.88 Allowed 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.72 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.97 103.18 14.44 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.2 tt0 -132.96 165.27 25.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.509 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.432 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.82 152.13 41.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.658 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.13 -54.23 28.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.647 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.8 -48.63 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.303 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.8 88.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 110.644 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.36 -63.28 1.18 Allowed 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.362 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 73.7 m -59.15 -47.18 86.25 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.92 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.55 -36.8 24.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.72 -64.99 0.52 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.7 t80 -41.34 -71.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.877 0.37 . . . . 0.0 111.009 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.73 -40.03 93.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.7 -3.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.499 ' H ' ' C ' ' A' ' 173' ' ' LEU . 54.5 mt-30 -122.71 149.34 55.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.49 -20.27 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.796 2.331 . . . . 0.0 112.175 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.76 -42.98 94.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.495 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.2 84.2 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.63 -41.73 95.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 0.0 110.333 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.1 m-20 -65.4 -34.09 77.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.514 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.6 m-85 -155.82 142.62 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.58 99.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.471 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.22 167.29 29.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.43 56.24 2.87 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.05 -117.88 0.01 OUTLIER Glycine 0 CA--C 1.543 1.789 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.76 136.28 35.0 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -125.08 -108.64 0.32 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.408 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.0 p -165.84 164.85 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.939 -0.553 . . . . 0.0 109.807 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.19 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.373 1.046 . . . . 0.0 110.675 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -82.15 118.05 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.801 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -72.03 -18.89 61.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.48 -32.54 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.9 -44.26 97.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.712 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.3 m-85 -114.48 9.63 16.76 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.691 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.97 -153.52 51.33 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.74 -25.47 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.324 . . . . 0.0 110.447 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.21 -123.92 1.28 Allowed Glycine 0 N--CA 1.46 0.245 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -129.6 156.23 44.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.69 -169.61 30.52 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -95.0 138.99 31.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.535 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.87 107.56 3.25 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.9 mt -119.76 159.54 24.32 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.1 mtm180 -86.98 149.04 25.05 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.71 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.29 -48.07 65.55 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.712 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -40.51 -23.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.709 0.29 . . . . 0.0 110.666 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.57 52.06 0.2 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.28 -45.74 86.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.87 -47.08 32.06 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.47 -43.94 97.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.14 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.873 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.51 -36.98 72.26 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.772 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.57 -77.37 0.11 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 212' ' ' ALA . 89.7 mt -29.14 -45.49 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.247 0.342 . . . . 0.0 110.692 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.439 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.3 m-20 -64.04 -45.07 90.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.731 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.57 -43.61 98.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.893 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.15 93.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.28 -43.72 98.41 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.086 0.47 . . . . 0.0 110.145 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.21 91.9 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.529 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -42.35 98.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.092 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.525 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.39 -38.47 77.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.44 -39.88 81.35 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.404 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.1 92.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.522 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.525 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.8 p30 -86.33 1.04 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.482 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.2 19.42 61.71 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 73.4 m -58.13 -45.94 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.086 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 77.3 t80 -63.5 -57.14 11.15 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.9 mt-10 -57.38 -41.05 79.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.185 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.01 -48.28 82.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.09 -41.82 98.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.293 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.8 -49.84 76.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.65 -35.56 72.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.393 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -70.59 -50.9 32.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.617 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.507 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.5 m-85 -61.97 -45.62 92.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.484 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -154.82 156.1 35.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.39 99.3 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.022 0.439 . . . . 0.0 110.409 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -156.24 -166.32 2.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.412 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.3 t0 -122.71 110.8 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.44 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 92.8 m-85 -59.22 -42.54 91.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.35 94.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 117.817 -1.546 . . . . 0.0 110.968 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.8 54.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.06 143.62 99.15 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.417 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.15 -40.49 90.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.597 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.9 143.18 36.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.414 HD12 HG21 ' A' ' 9' ' ' ILE . 84.1 mt -110.19 128.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.86 116.51 32.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.27 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.8 mt -111.28 138.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.351 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.43 104.44 2.11 Favored Glycine 0 N--CA 1.462 0.409 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.6 m -127.53 119.1 25.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 110.631 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 21.5 t70 -113.55 92.55 24.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.966 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.44 134.31 60.8 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.531 2.154 . . . . 0.0 111.767 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 p -141.67 -19.53 0.75 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.766 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 20' ' ' PHE . 97.0 m-85 -124.76 98.86 5.89 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.345 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -28.64 -61.28 0.21 Allowed Pre-proline 0 N--CA 1.467 0.417 0 CA-C-O 121.974 0.892 . . . . 0.0 111.004 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 6.0 Cg_endo -50.07 -39.44 50.86 Favored 'Trans proline' 0 C--N 1.295 -2.238 0 C-N-CA 122.105 1.87 . . . . 0.0 112.07 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.3 t80 -78.82 -43.15 25.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.279 0.562 . . . . 0.0 110.885 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.635 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.5 mt-10 -149.34 -155.28 0.62 Allowed 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.231 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.05 177.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.781 0.324 . . . . 0.0 110.246 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.94 143.23 44.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.45 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.2 t-20 -95.91 141.84 28.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.394 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.47 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.2 p -66.15 -19.01 65.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.578 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -77.87 -6.87 55.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.439 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.69 -7.0 59.16 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.38 158.0 27.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 0.0 110.406 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.8 mt -111.77 133.8 53.76 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.22 150.81 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.287 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.79 6.76 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -58.81 -42.13 88.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.741 0.305 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.7 t0 -70.17 -28.53 65.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.102 0.477 . . . . 0.0 111.205 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.76 -41.74 85.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.236 0.541 . . . . 0.0 111.282 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 48.9 m-20 -60.95 -37.48 82.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.815 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.05 -43.83 86.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.183 0.516 . . . . 0.0 110.555 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.15 -41.47 92.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.316 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.2 -52.89 63.73 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.535 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.21 -37.2 64.29 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.034 0.445 . . . . 0.0 109.891 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.47 -42.58 78.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.129 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.74 -44.36 73.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.125 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.07 -46.92 82.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.23 0.538 . . . . 0.0 110.399 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -60.28 -40.87 91.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.94 -17.82 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.705 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.74 52.16 4.51 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.706 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.19 170.12 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.2 140.22 29.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.008 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -116.81 131.49 56.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.04 127.5 43.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.436 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -94.06 135.52 35.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.5 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.5 128.92 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.988 0.423 . . . . 0.0 110.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.9 139.48 58.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.483 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.1 p30 175.68 131.43 0.16 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.778 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.8 Cg_endo -68.08 145.41 67.11 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.613 2.209 . . . . 0.0 112.602 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 58' ' ' LEU . 82.3 mt -40.37 -56.51 1.99 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -47.88 -26.66 1.77 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.855 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.1 -20.51 19.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.124 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 55' ' ' LEU . 58.1 mt -64.16 -42.47 96.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.563 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -63.17 -56.23 29.66 Favored Pre-proline 0 C--O 1.242 0.66 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.919 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.1 Cg_exo -55.29 -42.7 65.88 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.486 2.124 . . . . 0.0 111.202 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 68.7 m -58.96 -44.12 91.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.866 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.191 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.36 -40.27 95.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.4 11.1 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.631 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.35 11.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.755 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.18 -34.74 78.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.667 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.72 153.09 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.31 -20.87 19.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.7 156.72 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.493 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.6 127.02 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.5 ttp -128.4 106.66 9.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.247 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.639 ' HG ' ' H ' ' A' ' 73' ' ' SER . 42.3 t -160.35 -178.23 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.585 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.639 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -64.15 -15.32 59.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.48 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.621 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -38.27 123.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.614 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.34 156.88 22.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -105.15 149.05 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -149.83 152.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.27 -47.03 55.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.647 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.33 -40.05 73.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.301 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.621 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -67.92 -37.92 82.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.226 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.26 -37.05 74.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.56 -27.43 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.257 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.31 -51.73 7.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.615 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.4 -168.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.74 146.67 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 110.73 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -129.79 149.88 51.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.709 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.667 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.5 t -164.4 -151.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.667 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.2 m-20 43.23 19.52 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.83 120.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.652 0.595 . . . . 0.0 110.509 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -77.18 -69.29 0.54 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.92 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -149.62 166.17 30.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.517 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.98 122.31 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.387 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.59 69.39 0.98 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.538 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.9 -105.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -158.85 165.63 33.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.59 145.79 21.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.85 136.13 41.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 110.92 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.833 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.37 164.93 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 0.0 110.714 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.7 148.53 23.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.866 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.49 -28.29 59.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.01 -41.85 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.245 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -101.71 122.04 43.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.121 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.16 109.7 19.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -126.63 129.63 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.636 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.01 154.25 41.25 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.553 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.65 91.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -170.74 144.35 2.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.22 -33.72 62.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 110.229 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.65 -62.04 2.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.607 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -56.65 -22.05 31.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.725 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -76.47 -25.62 54.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.18 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.59 47.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -16.09 30.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.73 151.67 23.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.217 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.23 135.21 38.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.2 t -126.74 136.2 61.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.02 138.81 14.38 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.13 161.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.239 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.0 tp -92.53 117.69 30.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.399 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.72 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.585 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.93 50.39 52.93 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.77 168.84 22.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.456 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 71.6 p -73.29 -26.82 61.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.372 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.62 -55.03 38.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.605 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.507 ' CD ' ' HG ' ' A' ' 142' ' ' SER . 80.7 tt0 -57.21 -54.38 47.47 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.497 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -60.41 -51.37 69.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.64 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.01 -44.02 97.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.346 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.59 -44.49 97.89 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.67 -14.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.213 . . . . 0.0 110.705 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.3 tt0 -125.53 -34.53 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.565 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.65 -50.62 17.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.28 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -99.42 12.26 36.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.096 0.474 . . . . 0.0 111.133 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.69 -55.55 0.48 Allowed Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.483 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.471 ' CD ' ' O ' ' A' ' 131' ' ' GLU . 56.8 Cg_endo -72.4 -10.23 25.23 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.751 2.301 . . . . 0.0 112.039 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.38 -8.93 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.58 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.12 33.09 37.23 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.51 137.98 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.76 129.89 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.4 138.13 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.99 133.06 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.507 ' HG ' ' CD ' ' A' ' 126' ' ' GLU . 7.7 t -96.86 127.25 42.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.83 153.33 25.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.32 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.94 6.95 29.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.43 130.44 6.01 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.98 -45.72 80.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.56 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.51 -23.46 62.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.47 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.461 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.7 -36.98 86.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -65.85 -46.86 87.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.366 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.09 -37.85 88.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.218 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.98 -44.52 92.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.181 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.31 -47.64 84.65 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.087 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.06 -23.0 67.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.15 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.59 -18.24 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.48 11.73 71.14 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.87 -18.05 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.86 137.73 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 110.527 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.21 -28.44 62.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.07 155.63 2.0 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.795 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.51 50.51 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -86.08 103.05 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.6 tt0 -132.6 164.68 26.12 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -72.99 152.6 41.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.392 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.6 mt-10 -65.7 -54.04 32.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.406 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.75 -48.7 87.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.428 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.93 87.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.844 0.354 . . . . 0.0 110.429 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.16 -63.68 1.08 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.8 m -58.92 -46.97 86.64 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.812 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 80.8 tt0 -49.95 -37.48 32.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.228 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.2 -65.39 0.54 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.658 ' N ' ' O ' ' A' ' 168' ' ' ALA . 29.7 t80 -40.74 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.831 0.348 . . . . 0.0 111.089 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -61.88 -39.6 92.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.62 -3.96 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.276 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 173' ' ' LEU . 22.8 mt-30 -123.46 142.01 37.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -43.95 -15.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.82 2.347 . . . . 0.0 112.132 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.8 t -62.8 -42.96 98.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.438 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.83 -32.85 80.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.99 -41.55 96.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.2 m-20 -65.78 -34.63 78.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.687 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.08 143.53 18.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.635 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.2 pttt -177.16 99.57 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.117 0.484 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.6 m-85 -159.19 168.21 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.631 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.42 55.96 3.1 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.68 -116.78 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.0 135.43 36.78 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.102 1.868 . . . . 0.0 111.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.8 p -125.25 -108.38 0.32 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.315 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.57 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.97 164.8 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 119.03 -0.51 . . . . 0.0 109.929 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.07 155.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.259 0.975 . . . . 0.0 110.539 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.75 117.97 23.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.808 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.67 -19.02 62.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.24 -32.06 73.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.08 -43.94 98.12 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.735 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.456 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.95 7.33 16.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 0.0 110.689 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.3 -155.09 50.01 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.43 -25.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.863 0.363 . . . . 0.0 110.593 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.05 -126.08 1.54 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -131.91 159.7 37.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.89 25.4 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.501 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.13 141.16 31.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.2 112.02 3.99 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.8 mt -121.18 160.35 23.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.85 149.04 25.11 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.705 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.44 -48.2 65.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -40.9 -22.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.602 0.239 . . . . 0.0 110.587 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.86 52.09 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.431 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.31 -46.3 84.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.42 -46.93 36.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.5 tp -62.44 -43.93 97.65 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.359 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.24 -42.76 99.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.974 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.74 -37.37 73.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.948 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.6 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.1 mt -29.15 -45.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.316 0.385 . . . . 0.0 110.843 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.442 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.4 m-20 -64.16 -45.1 89.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.64 -43.57 98.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.945 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.15 92.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.307 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.05 -43.66 98.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.175 0.512 . . . . 0.0 110.312 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.27 91.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.319 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -64.07 -41.79 97.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.291 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.6 mtp -58.04 -38.19 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.49 -38.9 77.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.418 . . . . 0.0 110.554 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.15 93.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.1 p-10 -88.72 0.42 56.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.33 68.47 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -58.38 -45.85 87.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.4 t80 -63.43 -57.53 9.99 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.1 mt-10 -57.01 -41.06 77.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.402 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.07 -48.12 82.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.338 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.07 -41.59 98.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.333 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.84 76.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.6 -35.86 73.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.43 -50.91 33.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.465 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.513 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.5 -45.46 92.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.35 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.7 m-85 -153.76 155.32 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.416 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.15 98.54 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 110.458 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -155.42 -165.49 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.465 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.56 109.37 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -63.75 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 85.2 m-85 -57.18 -43.64 82.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.0 94.17 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.425 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.899 -1.5 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.5 164.43 59.96 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.689 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.07 143.69 99.11 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.658 2.239 . . . . 0.0 112.244 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.39 -40.83 89.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.75 139.2 38.23 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.361 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.1 121.1 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.8 118.59 31.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.5 138.23 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.305 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.57 105.39 2.14 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.8 m -128.73 120.84 27.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 122.687 -0.302 . . . . 0.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.8 t70 -114.29 92.61 28.05 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.918 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.51 134.73 63.24 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.499 2.133 . . . . 0.0 111.851 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 p -141.92 -20.04 0.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.754 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -123.61 98.93 6.05 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.446 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.643 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -28.81 -61.4 0.22 Allowed Pre-proline 0 C--O 1.218 -0.602 0 CA-C-O 122.017 0.913 . . . . 0.0 111.083 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.78 -40.78 47.69 Favored 'Trans proline' 0 C--N 1.291 -2.487 0 C-N-CA 122.348 2.032 . . . . 0.0 112.197 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -77.96 -43.02 31.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -149.64 -153.8 0.51 Allowed 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.186 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.95 177.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.92 0.39 . . . . 0.0 110.299 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.47 144.59 46.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.425 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.62 134.46 38.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.502 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.66 -19.04 65.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.524 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.21 -6.55 55.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.99 -8.48 55.87 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.78 158.49 26.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.882 0.373 . . . . 0.0 110.409 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -112.35 131.29 55.61 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.371 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.23 151.54 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.307 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.01 151.53 6.64 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -58.93 -41.99 88.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.698 0.285 . . . . 0.0 110.758 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 -69.53 -28.64 66.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.76 -40.79 84.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.939 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.97 -37.5 82.66 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.718 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.49 -44.94 89.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.117 0.484 . . . . 0.0 110.164 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.54 -48.16 80.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.901 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.26 -53.87 44.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.437 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.87 -40.32 63.33 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.029 0.442 . . . . 0.0 109.951 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.87 -42.08 81.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.57 -45.1 69.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.169 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.31 -46.34 83.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.277 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -60.55 -42.1 95.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.194 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.36 -17.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.718 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.94 52.75 4.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.78 171.09 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.975 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.81 142.18 27.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.995 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.1 m -117.14 131.06 56.97 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.617 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.15 126.94 43.75 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.4 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -93.73 134.69 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.98 128.14 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.027 0.442 . . . . 0.0 110.344 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.14 137.79 57.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.557 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.53 131.68 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.75 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -67.77 144.51 65.65 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.665 2.244 . . . . 0.0 112.732 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.3 mt -39.87 -55.44 1.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.96 0.41 . . . . 0.0 111.261 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.71 -26.33 2.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.08 -21.11 18.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.13 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.7 -42.64 97.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.748 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.551 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 mm -62.22 -56.66 28.97 Favored Pre-proline 0 C--O 1.242 0.67 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.795 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.8 Cg_exo -56.09 -41.69 74.26 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.551 2.167 . . . . 0.0 110.947 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 70.6 m -59.08 -44.48 91.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.968 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.38 -43.91 92.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.269 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.32 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.493 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.17 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.25 11.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.37 -35.53 80.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 pt -122.43 152.78 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.0 -22.53 19.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.19 155.71 27.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.616 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.98 129.08 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.96 0.409 . . . . 0.0 110.384 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -131.28 106.82 8.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 110.231 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.655 ' HG ' ' H ' ' A' ' 73' ' ' SER . 42.1 t -159.05 178.47 10.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.577 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.655 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.2 p -65.24 -15.2 62.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.513 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.613 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.24 124.5 0.61 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.673 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.542 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.8 154.26 26.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.677 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.0 148.65 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 p -149.07 152.3 35.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.738 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -46.92 53.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.004 0.431 . . . . 0.0 110.463 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.06 -39.63 72.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.613 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.81 -37.9 79.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.015 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.85 -38.48 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.23 -27.34 67.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.33 -51.11 7.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.4 pt -138.98 -168.21 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.986 0.422 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.25 147.57 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.135 0.493 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -129.86 149.92 51.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.655 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.36 -153.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.456 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.655 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.7 m-20 41.66 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.944 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.35 0.2 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.594 0.559 . . . . 0.0 110.559 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.428 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.2 mt -75.23 -68.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -150.49 167.17 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.637 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.83 123.38 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.85 68.55 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.663 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.83 -104.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.322 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.3 p -159.37 165.98 32.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.63 146.11 21.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.47 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.95 136.23 41.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.816 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.37 164.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.937 0.399 . . . . 0.0 110.679 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.56 24.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.07 -27.85 47.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.04 -41.66 88.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.344 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.0 t -102.4 122.36 44.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.01 109.36 19.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.89 129.84 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.29 159.06 33.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.444 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.5 Cg_endo -60.11 89.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.777 2.318 . . . . 0.0 112.008 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.9 m -168.82 140.99 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.94 -33.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 110.225 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.22 -22.04 26.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.888 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.3 mt -76.72 -25.83 53.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.16 46.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.507 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.9 -15.85 30.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.54 151.32 23.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 110.308 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.02 135.55 37.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.278 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.3 136.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.53 138.68 14.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.2 t -130.88 161.61 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.255 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.494 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 45.1 tp -92.38 117.57 30.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.578 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -51.87 157.57 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.61 50.23 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -149.96 168.87 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 110.795 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.4 p -73.7 -26.52 60.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.412 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.78 -55.15 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.598 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.02 -54.72 43.57 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.461 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.07 -51.33 70.08 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.504 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -61.8 -44.12 97.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 110.489 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.59 -44.47 97.92 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.76 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.575 0.226 . . . . 0.0 110.647 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.517 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.29 -34.62 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.68 -50.67 16.75 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.331 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.19 12.25 36.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.208 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.69 -55.51 0.48 Allowed Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.429 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.13 -10.28 25.68 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.802 2.334 . . . . 0.0 111.969 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.73 -8.92 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.561 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.77 33.46 37.58 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.52 137.83 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.35 129.74 34.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.254 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.6 pt -126.34 138.09 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.21 133.12 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.33 127.57 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.84 153.67 25.08 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.282 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.0 7.05 29.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.621 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.54 130.5 6.02 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.78 -45.82 81.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.54 -23.67 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.523 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.69 -36.82 85.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 149' ' ' ILE . 96.5 mt -66.19 -47.03 85.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.521 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.64 -37.98 89.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.361 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.8 p -61.06 -42.26 98.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.023 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.16 -44.58 91.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.6 tp -59.12 -47.81 83.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.097 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.7 m -63.49 -22.77 67.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.992 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.19 -18.6 25.44 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.579 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.97 11.04 70.85 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.32 -17.92 63.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.623 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -128.23 137.36 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.12 0.486 . . . . 0.0 110.424 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.86 -27.43 61.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.59 155.98 1.84 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.17 136.88 49.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.9 0.381 . . . . 0.0 110.005 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -85.41 103.3 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.0 tt0 -133.04 165.21 25.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.418 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.46 152.12 42.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.772 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.05 -54.53 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 72.6 t -60.2 -48.44 88.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.586 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.94 90.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 0.0 110.457 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.64 -62.97 1.26 Allowed 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.2 m -59.61 -47.83 84.04 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.914 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -49.56 -36.7 24.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.179 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.424 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.39 -66.17 0.54 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.1 t80 -40.68 -70.7 0.1 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.655 0.264 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.58 -40.12 93.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -60.69 -3.19 0.66 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.302 0.572 . . . . 0.0 110.254 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.5 mt-30 -122.15 147.6 49.72 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.35 -19.12 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.844 2.362 . . . . 0.0 112.034 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.8 -43.21 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.524 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.99 -32.95 83.98 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.53 -41.09 93.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.758 0.313 . . . . 0.0 110.458 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -66.16 -32.9 74.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.53 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.0 m-85 -156.51 142.53 18.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.545 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -176.82 99.56 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.31 166.99 30.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.7 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.23 -117.71 0.01 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.89 136.01 35.97 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.266 1.977 . . . . 0.0 111.928 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.9 p -125.41 -108.02 0.32 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.78 165.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.039 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 154.04 156.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.379 1.049 . . . . 0.0 110.502 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.26 117.35 22.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.904 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.32 -18.85 62.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.66 -32.53 74.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.1 -44.15 97.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.727 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.5 m-85 -114.46 9.66 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.628 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.08 -154.77 52.29 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.0 p -70.32 -25.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.38 -123.97 1.28 Allowed Glycine 0 N--CA 1.46 0.24 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.56 156.25 44.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.54 -169.76 30.56 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.04 137.7 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.65 108.32 3.3 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.3 mt -123.54 159.2 29.66 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 120.672 0.273 . . . . 0.0 110.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -86.79 149.51 24.8 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.712 0.292 . . . . 0.0 110.757 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.68 -47.79 63.73 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.746 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.72 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.42 52.23 0.19 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.505 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.38 -45.77 86.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.34 -47.26 35.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.52 -43.86 97.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.4 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.79 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.0 -36.19 70.12 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.687 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.15 -77.42 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.2 mt -28.17 -46.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.971 0.415 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.44 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.0 m-20 -64.6 -44.71 89.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.781 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.98 -43.86 97.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.026 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.05 93.12 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.29 -43.55 98.69 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.16 0.505 . . . . 0.0 110.166 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.12 92.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.258 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.531 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.9 -41.92 97.58 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.523 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -59.1 -38.0 78.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.78 -39.84 79.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.066 0.46 . . . . 0.0 110.34 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.07 92.21 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.519 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.3 p30 -86.26 1.09 52.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.504 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.97 19.43 61.22 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 68.3 m -58.41 -45.64 88.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.428 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 81.6 t80 -63.55 -58.25 7.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.936 0.398 . . . . 0.0 110.351 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.2 mt-10 -56.54 -41.37 76.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.486 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.96 -48.4 81.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.98 -41.59 98.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.84 -50.28 74.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.4 -35.41 71.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.478 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.03 -50.84 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.1 m-85 -62.2 -45.57 92.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.5 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.87 155.53 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.373 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.3 p-10 -97.56 95.93 7.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 110.491 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -153.63 -166.01 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.92 110.4 15.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.7 m -63.69 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.584 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 89.9 m-85 -57.8 -43.53 85.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.25 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.47 94.9 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.23 164.61 59.69 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.745 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.09 143.69 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.21 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.31 -40.4 89.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.74 143.2 36.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.37 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -110.36 128.68 66.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.381 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.8 mtp180 -104.38 118.16 35.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.04 139.2 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.03 104.69 2.19 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.8 m -127.72 118.33 23.6 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.659 -0.318 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.2 t70 -113.38 92.59 23.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.912 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.39 134.32 60.68 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.467 2.111 . . . . 0.0 111.965 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.7 p -141.25 -19.38 0.79 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.765 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.7 m-85 -125.11 98.97 5.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.462 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.617 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -28.82 -61.3 0.22 Allowed Pre-proline 0 C--O 1.219 -0.55 0 CA-C-O 121.97 0.89 . . . . 0.0 111.175 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.6 Cg_endo -49.64 -39.48 46.62 Favored 'Trans proline' 0 C--N 1.291 -2.489 0 C-N-CA 122.57 2.18 . . . . 0.0 112.194 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.4 t80 -79.57 -43.29 23.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.911 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.617 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.19 -155.5 0.64 Allowed 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.145 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.95 177.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.947 0.403 . . . . 0.0 110.308 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.15 140.66 46.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.432 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -92.31 137.83 32.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -65.05 -19.47 66.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.47 -6.0 55.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.97 -8.31 57.63 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.74 157.01 28.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.377 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -111.96 133.56 54.07 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.412 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.17 151.0 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.275 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.16 151.49 6.64 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.87 -42.16 88.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.711 0.291 . . . . 0.0 110.874 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.44 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.0 t0 -69.82 -28.11 65.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.55 -40.79 82.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.987 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.7 m-20 -60.65 -37.79 82.68 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.985 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.19 -43.89 85.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.499 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.1 -41.73 93.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -58.83 -53.13 61.83 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.638 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.93 -37.06 63.44 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.01 -42.4 76.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.121 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.6 -44.62 73.22 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.229 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -64.02 -47.18 81.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.254 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -59.86 -40.72 89.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.092 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.53 -17.78 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.774 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.66 52.4 4.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.24 170.06 17.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.04 140.26 29.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.028 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.0 m -116.91 131.52 56.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.19 127.71 43.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.476 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -94.26 135.97 35.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.406 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.57 128.68 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.77 140.02 58.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 174.97 131.68 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.724 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.21 145.43 66.38 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.678 2.252 . . . . 0.0 112.576 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 58' ' ' LEU . 81.6 mt -40.14 -56.91 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.4 -26.75 1.41 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.986 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.29 -20.76 18.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.123 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 55' ' ' LEU . 59.0 mt -63.97 -42.49 97.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.731 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.568 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.38 -56.64 28.59 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 123.698 0.624 . . . . 0.0 109.67 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.49 -42.24 70.0 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.534 2.156 . . . . 0.0 111.025 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -58.86 -44.18 90.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.787 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.09 -44.29 91.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.83 -40.52 95.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.476 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.51 10.9 1.84 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.31 11.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.31 -34.13 77.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.551 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.96 154.16 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -92.81 -20.83 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.99 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.82 158.88 23.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.583 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 70' ' ' ILE . 96.5 mt -115.82 127.02 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-O 120.945 0.402 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.44 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -127.5 106.05 8.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.268 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.3 t -161.07 -177.4 6.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.591 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.28 -15.05 59.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.369 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.619 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.8 tp -38.27 123.23 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.552 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.45 156.58 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.685 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.6 pt -105.21 149.39 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -150.25 152.85 35.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.667 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.26 -47.56 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.025 0.44 . . . . 0.0 110.51 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.66 -39.93 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.63 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.619 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.41 -37.67 80.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.004 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -37.39 74.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.111 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.15 -51.94 7.06 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.48 -168.29 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-O 121.04 0.448 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.91 146.73 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.832 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -129.93 149.94 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.607 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.681 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.7 t -164.48 -151.67 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.681 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.2 m-20 43.74 19.26 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.99 119.92 0.11 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.483 0.489 . . . . 0.0 110.631 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.66 -70.14 0.5 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.722 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -148.91 165.72 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.523 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.98 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.374 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.25 68.97 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.51 -104.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.329 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.37 165.86 32.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.599 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.62 146.02 21.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -101.47 136.31 41.53 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.57 111.22 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.73 164.86 32.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.78 148.45 23.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -27.83 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.247 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.89 -41.85 88.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -102.55 122.45 44.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.146 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.85 109.36 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.415 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.28 130.07 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.593 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.03 159.01 34.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.472 ' C ' ' HG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.96 90.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.813 2.342 . . . . 0.0 111.994 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.472 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 7.1 m -168.97 141.56 2.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.69 -33.33 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 110.343 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.59 -62.24 1.93 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.43 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.35 -22.0 28.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.866 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.64 -25.74 54.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.286 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.87 133.28 47.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.472 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.86 -15.79 30.15 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.49 151.33 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.898 0.38 . . . . 0.0 110.378 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.09 135.14 38.28 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.99 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.658 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.65 14.34 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 54.8 t -130.75 161.59 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.2 tp -92.41 117.67 30.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.81 157.51 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.694 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.92 50.58 51.89 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.6 p -149.63 168.68 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.777 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 68.6 p -73.09 -27.3 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.3 -54.84 40.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.467 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.3 -54.38 47.4 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.378 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.62 -51.6 68.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.6 t80 -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.028 0.442 . . . . 0.0 110.457 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.66 -44.31 98.1 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.62 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.603 0.239 . . . . 0.0 110.705 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.66 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.4 -50.83 16.98 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.392 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.2 12.74 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.474 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.11 -55.6 0.46 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.369 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.17 -10.48 25.91 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.963 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.46 -8.73 59.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.53 36.97 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.77 137.88 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.481 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.51 130.03 34.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.51 138.1 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.09 133.22 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.051 0.453 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.94 127.11 42.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -110.74 153.62 25.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.02 6.83 29.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.12 130.34 5.88 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.92 -45.67 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.484 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.84 -24.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.497 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.59 -36.38 84.04 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.14 -46.95 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.062 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.0 m-85 -63.82 -37.66 88.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.343 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.23 -42.78 99.19 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.121 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.429 ' N ' ' HG ' ' A' ' 151' ' ' SER . 53.9 m-20 -63.95 -44.5 92.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.3 tp -59.0 -48.24 82.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.079 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.7 m -62.88 -22.92 67.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.09 26.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.571 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.35 11.58 71.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -17.82 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 35.6 pt -128.31 137.77 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.113 0.483 . . . . 0.0 110.487 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.8 -28.36 62.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.59 155.7 1.8 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.819 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.53 50.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.064 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.53 103.15 14.13 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.08 0.467 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 46.9 tt0 -132.27 164.74 25.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.437 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -73.02 152.03 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -65.91 -54.2 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.3 -48.98 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.524 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.09 89.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.25 -63.25 1.19 Allowed 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.437 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.5 m -58.85 -47.11 86.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.861 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -50.06 -37.04 31.53 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.02 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.13 -65.85 0.55 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.71 -70.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.802 -0.234 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.65 -39.98 93.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.874 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.455 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.62 -3.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.627 . . . . 0.0 110.367 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.6 mt-30 -124.21 141.62 37.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.807 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.87 -14.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.859 2.372 . . . . 0.0 112.319 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 175' ' ' GLN . 77.9 t -63.47 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.486 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.75 79.59 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.01 -41.35 96.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.773 0.321 . . . . 0.0 110.388 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.4 m-20 -65.9 -34.7 78.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.756 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.3 m-85 -156.98 143.26 18.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.85 99.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.758 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.2 m-85 -159.28 168.01 27.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.33 55.76 3.17 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.91 -116.99 0.01 OUTLIER Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.12 135.92 37.7 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.295 1.997 . . . . 0.0 112.016 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.0 p -124.97 -108.02 0.33 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.513 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.87 165.25 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.98 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.35 155.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.436 1.085 . . . . 0.0 110.476 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.09 118.31 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.911 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.3 mp0 -71.87 -18.74 62.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.76 -31.96 73.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.6 mt -60.99 -44.24 97.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.754 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.3 m-85 -113.69 7.2 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.724 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.53 -155.33 49.9 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.43 -25.54 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.834 0.35 . . . . 0.0 110.551 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.09 -125.84 1.5 Allowed Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.3 p -132.15 160.03 37.22 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.862 0.363 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.7 25.27 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -98.17 141.41 31.12 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 110.493 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.38 3.89 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -119.52 160.57 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.37 149.04 24.75 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.574 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.03 -48.73 64.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.809 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -40.83 -22.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.828 0.347 . . . . 0.0 110.657 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.07 51.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.66 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.38 -46.1 84.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.762 0.315 . . . . 0.0 111.108 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.43 -47.14 35.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.42 -43.7 98.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.446 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.38 -42.94 99.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.881 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.67 -37.52 73.55 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.897 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.24 -77.57 0.1 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.5 mt -28.63 -45.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.942 0.401 . . . . 0.0 110.813 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.442 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.4 m-20 -63.76 -45.18 90.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.54 -43.68 98.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.2 92.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.205 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.16 -43.58 98.66 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.144 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.32 92.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.85 -42.52 97.55 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.022 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.499 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.13 -38.22 73.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.65 -38.83 77.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.114 0.483 . . . . 0.0 110.415 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.53 92.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.674 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.34 0.43 56.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.783 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.67 20.2 67.91 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.8 m -57.91 -46.08 85.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.0 t80 -63.54 -57.6 9.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.88 -41.7 78.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.347 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -48.42 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.42 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.84 -41.54 97.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.366 . . . . 0.0 110.446 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.16 -49.78 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.632 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -35.86 73.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.399 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.58 -50.94 31.98 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.449 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.35 -45.23 94.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.502 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.8 m-85 -153.47 154.96 35.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.0 p-10 -98.21 96.95 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 110.509 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -154.09 -165.11 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.518 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.426 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.68 109.24 14.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.79 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.578 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 83.9 m-85 -56.79 -43.63 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.1 -37.16 94.47 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.744 0 CA-C-O 117.907 -1.496 . . . . 0.0 110.938 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.7 164.66 53.36 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.763 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.0 143.83 99.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.654 2.236 . . . . 0.0 112.267 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.26 -40.59 90.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.42 142.73 37.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.05 128.71 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.029 0.442 . . . . 0.0 110.318 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.02 117.45 34.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.311 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.0 140.57 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.278 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.24 105.39 1.96 Allowed Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 77.2 m -127.76 120.8 28.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.722 -0.281 . . . . 0.0 110.617 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.3 t70 -112.73 93.99 26.57 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.77 135.03 65.95 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.518 2.145 . . . . 0.0 111.778 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 p -137.32 -18.39 1.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.74 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' ALA . 84.0 m-85 -124.85 98.02 5.52 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.54 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.684 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -30.33 -60.95 0.26 Allowed Pre-proline 0 C--O 1.218 -0.591 0 CA-C-O 122.274 1.035 . . . . 0.0 111.079 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 6.4 Cg_endo -50.29 -41.9 49.22 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 122.323 2.015 . . . . 0.0 112.179 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.5 t80 -77.42 -42.6 35.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.176 0.512 . . . . 0.0 110.785 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.684 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.2 mt-10 -147.13 -160.21 1.13 Allowed 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.403 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 158.91 179.84 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.857 0.361 . . . . 0.0 110.16 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -133.69 141.94 47.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.42 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -90.88 137.68 32.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.509 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -65.32 -19.1 65.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.601 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -79.04 -5.17 53.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.431 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.48 -9.94 57.58 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.11 159.69 26.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.388 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.5 mt -114.42 134.2 55.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.476 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -131.93 150.56 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.197 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.75 153.83 7.35 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -60.46 -41.6 94.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.867 0.365 . . . . 0.0 110.77 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 28.7 t0 -70.52 -32.68 70.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.342 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -66.75 -40.55 86.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.985 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -61.15 -36.97 81.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.723 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.98 -45.07 87.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.426 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.27 -46.86 85.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.974 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.89 -53.82 47.25 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.516 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.21 -39.13 66.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.947 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.98 -43.15 79.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.7 m -54.4 -43.63 71.64 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.26 -47.02 81.2 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 110.328 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mmt-85 -60.35 -41.17 93.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.018 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -75.75 -18.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.755 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.52 51.92 3.9 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.76 170.14 17.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.956 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.45 141.74 28.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.006 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.4 m -117.76 132.11 56.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.573 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -127.16 126.16 42.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.01 135.96 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.48 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.99 129.21 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.076 0.465 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.04 139.97 56.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.512 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.41 135.07 0.17 Allowed Pre-proline 0 N--CA 1.445 -0.683 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.18 143.8 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.631 2.221 . . . . 0.0 112.705 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.5 mt -40.48 -54.45 2.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.036 0.446 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.92 -26.44 2.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.54 -21.01 19.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.2 mt -64.14 -42.77 96.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.787 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.544 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.0 -56.46 31.49 Favored Pre-proline 0 C--O 1.242 0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.743 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.544 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 52.2 Cg_exo -55.64 -42.33 68.68 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.021 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -58.84 -44.27 90.89 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.822 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -59.06 -44.36 91.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.8 -40.86 95.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.582 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 56.06 11.92 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.796 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.25 -33.93 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.04 153.53 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.367 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.08 -21.33 20.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.14 158.52 24.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.495 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.0 128.02 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.395 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -129.52 107.42 9.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 110.222 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.665 ' HG ' ' H ' ' A' ' 73' ' ' SER . 35.2 t -162.06 -178.68 6.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.665 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -64.26 -15.77 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.622 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -35.53 122.46 0.63 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.6 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -80.95 154.23 27.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.694 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.4 pt -105.02 148.17 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.4 p -150.14 152.86 35.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.16 -46.85 54.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.6 -40.18 71.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.469 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.622 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.2 mtt180 -68.32 -37.99 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.023 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 84' ' ' ILE . 87.9 mt-30 -57.88 -38.0 74.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.089 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.07 -27.81 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.213 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.86 -50.79 8.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.725 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -139.78 -166.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.969 0.414 . . . . 0.0 110.496 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.79 147.45 30.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.805 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.27 150.69 51.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.633 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.6 t -164.77 -152.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.427 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.633 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.8 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.847 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -29.95 121.72 0.17 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.664 0.603 . . . . 0.0 110.627 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 66.0 mt -78.3 -70.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.844 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -148.7 165.56 31.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.54 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.68 67.74 0.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.621 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -86.87 -106.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.1 p -159.47 167.81 27.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.05 146.78 23.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -102.04 135.99 42.65 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.773 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.59 112.05 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.88 164.71 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.755 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.05 148.64 24.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.55 -27.96 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.03 -41.58 88.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -102.25 122.34 44.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 110.162 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.18 109.88 19.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.25 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.13 130.04 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.602 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -109.3 154.29 42.25 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.502 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.17 92.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.0 m -170.45 144.4 2.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.75 -33.88 61.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.279 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.94 -62.17 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.474 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.21 -21.85 25.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.97 -25.42 52.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.265 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.08 133.21 48.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.429 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.63 -15.75 29.02 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.07 150.87 24.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 110.284 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.29 134.34 38.19 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.15 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.58 136.33 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.606 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.67 138.77 14.45 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.7 161.5 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.048 0.451 . . . . 0.0 110.238 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.6 tp -92.54 118.1 30.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.499 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.48 156.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.59 50.64 53.44 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.7 p -149.11 167.6 25.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 67.2 p -70.92 -30.45 66.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.45 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -58.61 -54.76 43.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.509 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.58 -55.98 27.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.28 -51.53 69.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.654 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -61.71 -44.11 97.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.453 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.38 -44.38 98.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.56 -14.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.496 0.189 . . . . 0.0 110.712 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.48 -34.53 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.74 -50.64 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.335 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.42 12.53 36.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.2 -55.51 0.46 Allowed Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.482 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 131' ' ' GLU . 56.7 Cg_endo -72.36 -10.02 25.02 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.784 2.323 . . . . 0.0 112.036 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.86 -8.79 59.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.58 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.19 33.22 36.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.62 137.62 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.977 0.418 . . . . 0.0 110.487 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.23 130.16 34.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.61 138.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.26 133.5 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -96.58 126.49 41.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.55 25.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.259 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.83 7.27 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.617 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.73 130.1 5.86 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.13 -45.6 80.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.8 0.333 . . . . 0.0 110.556 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.37 -23.49 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 110.493 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.76 -36.8 85.48 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.414 HG22 HD12 ' A' ' 149' ' ' ILE . 96.7 mt -65.9 -46.84 87.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.178 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.0 m-85 -64.05 -37.88 89.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.08 -42.61 98.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.157 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.408 ' H ' ' HG ' ' A' ' 151' ' ' SER . 53.4 m-20 -64.67 -43.86 92.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.046 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.33 -47.85 83.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.029 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.39 -22.95 67.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.124 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -18.71 25.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.516 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.11 71.76 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.58 -18.1 63.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 0.0 110.629 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.5 pt -128.05 137.79 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.165 0.507 . . . . 0.0 110.518 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.75 -29.46 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.93 155.4 2.03 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.792 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 139.15 52.16 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 110.052 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.97 102.85 14.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.4 164.38 26.65 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.472 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.427 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.7 40.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -65.96 -54.33 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.317 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.19 -48.5 87.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.446 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.17 86.09 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.345 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.27 -63.26 1.24 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.364 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 68.9 m -58.22 -45.8 87.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.934 0.397 . . . . 0.0 110.445 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.43 -41.17 13.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.74 -61.93 0.47 Allowed Glycine 0 N--CA 1.466 0.647 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.649 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.5 t80 -40.79 -71.14 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.954 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.58 -40.97 98.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.1 tttt -59.83 -2.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.117 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.5 mt-30 -125.81 141.52 39.56 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.898 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.54 -14.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 86.9 t -63.02 -43.21 98.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.415 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.2 84.37 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.3 -40.92 95.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.832 0.349 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.12 -34.26 77.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.8 143.09 18.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.666 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -175.98 99.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.852 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.3 m-85 -158.94 167.59 28.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.585 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.9 56.18 3.14 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -52.1 -115.9 0.01 OUTLIER Glycine 0 CA--C 1.542 1.719 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.61 135.74 41.24 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.222 1.948 . . . . 0.0 111.86 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.9 p -124.58 -108.78 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.425 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.19 164.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 118.859 -0.591 . . . . 0.0 110.002 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.3 tttt 155.13 155.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.439 1.087 . . . . 0.0 110.505 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -81.06 118.16 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.858 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.6 mp0 -70.93 -19.34 62.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.38 -31.79 73.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.606 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.1 -44.05 97.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.753 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.04 9.26 15.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.673 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.39 51.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.0 p -70.7 -25.5 26.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.0 -124.37 1.34 Allowed Glycine 0 C--N 1.33 0.226 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.0 p -130.07 157.2 43.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.651 0.263 . . . . 0.0 110.297 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.08 -168.57 29.46 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -96.09 138.35 33.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.84 105.66 2.97 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ALA . 79.0 mt -117.88 158.65 24.48 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.3 mtm180 -86.71 148.66 25.34 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.596 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.7 mttm -51.7 -47.56 63.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.92 -22.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 0.0 110.577 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.09 51.64 0.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.07 -46.55 83.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.8 0.333 . . . . 0.0 111.15 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.5 -47.12 35.01 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.27 -43.7 98.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.35 -42.96 99.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.903 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.42 -37.08 72.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 109.896 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.55 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 212' ' ' ALA . 88.2 mt -28.68 -45.17 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.943 0.401 . . . . 0.0 110.878 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.451 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.0 m-20 -64.24 -45.01 90.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.815 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.84 98.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.927 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.11 92.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.293 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.09 -43.78 98.37 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.171 0.51 . . . . 0.0 110.282 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.15 91.54 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -64.13 -42.38 96.86 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.232 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.497 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.5 mtp -57.47 -38.21 74.13 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.43 -39.18 78.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.08 0.467 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.617 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 19.4 p-10 -89.17 0.04 57.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.69 20.59 70.31 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.3 m -58.66 -45.68 88.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 75.2 t80 -62.22 -56.43 18.67 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.198 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.423 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.9 mt-10 -57.32 -40.25 77.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.234 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.7 -47.68 84.68 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.14 -40.95 97.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.875 0.369 . . . . 0.0 110.316 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.69 76.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.72 -35.92 73.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -69.17 -51.9 33.44 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.564 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 10.7 m-85 -62.38 -45.82 91.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.51 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.9 m-85 -154.14 154.61 33.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.3 p-10 -99.09 95.95 7.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.407 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 236' ' ' PHE . 14.6 p90 -151.99 -163.77 1.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.21 108.24 13.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.687 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.6 m -63.33 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.596 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.423 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 90.1 m-85 -58.65 -41.65 86.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.285 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.16 -36.93 94.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.92 -1.489 . . . . 0.0 110.938 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.72 164.45 60.22 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.02 143.72 99.33 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.703 2.269 . . . . 0.0 112.226 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.29 -40.48 90.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.54 143.35 37.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.351 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 9' ' ' ILE . 84.8 mt -110.29 128.1 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.986 0.422 . . . . 0.0 110.367 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.84 118.75 37.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.252 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.427 HG23 HD11 ' A' ' 11' ' ' ILE . 94.0 mt -112.99 138.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.53 100.32 1.6 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 84.8 m -123.69 118.62 27.66 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.71 -0.288 . . . . 0.0 110.854 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t0 -113.25 93.19 25.06 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.29 133.86 57.97 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.486 2.124 . . . . 0.0 111.905 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.5 p -139.69 -19.93 0.92 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.761 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.1 m-85 -124.94 99.2 6.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.424 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.63 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -28.86 -61.32 0.22 Allowed Pre-proline 0 C--O 1.218 -0.57 0 CA-C-O 121.982 0.896 . . . . 0.0 111.137 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.92 -39.58 49.28 Favored 'Trans proline' 0 C--N 1.292 -2.417 0 C-N-CA 122.412 2.074 . . . . 0.0 112.161 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 17' ' ' TYR . 29.4 t80 -79.04 -43.1 24.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.98 0.419 . . . . 0.0 110.93 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.63 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.7 mt-10 -149.21 -155.86 0.67 Allowed 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.187 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.44 177.7 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.909 0.385 . . . . 0.0 110.325 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.32 139.03 45.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.401 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -90.43 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.576 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.87 -19.26 65.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.11 -6.02 55.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.429 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.45 -8.71 57.0 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.68 157.61 27.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 110.435 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.4 mt -112.9 134.88 54.2 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 110.416 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.59 151.29 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.325 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.76 6.75 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -58.89 -42.09 88.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.709 0.29 . . . . 0.0 110.794 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.2 t0 -69.97 -27.97 65.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.279 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.7 -40.91 82.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.78 -37.87 83.36 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.038 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.66 -43.93 87.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.18 0.514 . . . . 0.0 110.465 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.75 92.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.2 -53.31 58.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.529 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.75 -38.08 64.03 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.66 -42.23 78.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.024 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.7 m -54.47 -43.95 72.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.123 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.12 -47.05 81.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.9 mmt-85 -60.44 -40.93 92.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.13 -18.23 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.792 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.86 52.22 4.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -145.27 170.16 16.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.933 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -87.86 140.21 29.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.081 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -116.32 130.87 57.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.569 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.3 128.25 44.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.9 136.53 35.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -129.49 128.4 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.31 139.07 58.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.55 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 174.32 132.62 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.7 Cg_endo -68.11 145.03 65.62 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 112.75 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 78.1 mt -40.44 -55.53 2.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.165 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.22 -26.4 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.967 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.62 19.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.022 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.83 -42.78 94.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.909 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.65 -56.35 33.67 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.98 -42.72 63.88 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.967 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -59.08 -44.1 91.87 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.812 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.65 -44.2 90.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.75 -40.06 94.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.15 11.32 1.54 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.503 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.02 11.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.46 -34.12 77.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.48 153.29 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.379 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.11 -20.25 20.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.52 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.545 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.56 127.87 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.33 106.54 9.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.251 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -159.19 -178.85 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.578 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.71 -15.03 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.1 tp -37.77 123.87 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.597 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.73 23.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.746 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.4 pt -105.31 148.98 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.08 152.71 35.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.756 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.25 -47.66 55.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.986 0.422 . . . . 0.0 110.61 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.14 -39.8 72.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.582 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.614 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.9 mtt180 -68.18 -37.79 81.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.3 -36.98 74.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.58 -27.58 67.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.215 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.97 -52.22 6.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -138.09 -168.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.094 0.473 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.59 146.66 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.085 0.469 . . . . 0.0 110.807 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -129.81 149.94 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.637 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.691 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.3 t -164.64 -151.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.691 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.4 m-20 43.25 19.36 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.3 120.11 0.12 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.552 0.533 . . . . 0.0 110.577 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.19 -69.86 0.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.794 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -149.39 166.18 29.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.569 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.02 122.16 27.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.389 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.38 68.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.627 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.99 -104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.414 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.1 p -159.74 165.89 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.621 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.07 146.45 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.069 0.462 . . . . 0.0 110.465 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.96 135.89 42.73 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.798 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.55 110.92 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.38 165.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.755 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 148.41 23.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.017 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.47 -27.43 37.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -59.5 -41.67 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.4 122.08 43.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.154 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.88 109.33 19.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.375 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.63 130.03 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.605 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.28 159.4 34.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.478 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' C ' ' HG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.24 89.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.874 2.383 . . . . 0.0 112.006 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.483 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.8 m -168.79 140.84 2.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.98 -32.72 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.116 0.484 . . . . 0.0 110.268 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.81 -62.62 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.99 -22.06 24.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.888 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.58 -25.84 54.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.57 132.38 44.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.502 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.93 33.92 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.55 151.46 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.838 0.351 . . . . 0.0 110.447 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -97.01 136.19 37.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.27 136.68 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.672 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.54 139.5 14.74 Favored Glycine 0 CA--C 1.521 0.469 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.2 t -131.64 161.74 40.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.113 0.482 . . . . 0.0 110.281 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.3 tp -92.84 119.07 31.79 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.563 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.87 157.13 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.34 50.83 47.78 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.8 p -149.49 168.12 24.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.824 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.446 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.34 -25.54 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.445 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -61.27 -55.08 35.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.581 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -57.48 -54.06 51.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.408 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.3 -51.17 70.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.522 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.592 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.7 t80 -62.16 -43.83 97.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.429 . . . . 0.0 110.416 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.81 -44.41 97.91 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.9 -14.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.641 0.258 . . . . 0.0 110.642 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.25 -34.65 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.592 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.47 -50.68 17.33 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.329 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -98.94 12.82 34.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.2 -55.66 0.45 Allowed Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.428 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.2 -10.74 26.23 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.754 2.303 . . . . 0.0 112.008 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.14 -8.96 59.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.588 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.78 33.49 37.46 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.61 138.1 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.66 129.69 35.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.275 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.81 138.77 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.61 132.11 71.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.997 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.39 130.48 45.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.635 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.68 156.43 21.88 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.264 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.82 6.64 29.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.4 130.91 6.17 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.98 -45.93 79.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.32 . . . . 0.0 110.429 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.01 -23.84 63.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.456 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.466 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.67 -36.45 84.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.17 -47.28 85.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.4 m-85 -63.68 -37.67 88.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.234 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.26 -42.65 98.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.13 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.43 -45.21 91.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.002 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.06 -48.24 82.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.167 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.75 -23.04 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.161 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -18.22 25.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.549 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.57 69.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.98 -18.2 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.602 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.0 pt -128.52 137.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.165 0.507 . . . . 0.0 110.47 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.13 -28.41 62.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.4 155.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.5 137.89 51.07 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.913 0.387 . . . . 0.0 110.066 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -85.74 103.25 14.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.61 164.93 25.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.491 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.0 151.73 41.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.03 -54.23 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.32 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 67.1 t -60.29 -48.73 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.57 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.91 90.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.782 0.325 . . . . 0.0 110.57 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.07 -63.06 1.25 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.7 m -58.62 -46.85 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -50.23 -36.9 32.9 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.054 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.33 0.55 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 33.8 t80 -40.28 -70.98 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.765 -0.256 . . . . 0.0 111.101 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.65 -39.95 93.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.9 -3.23 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.274 0.559 . . . . 0.0 110.298 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.506 ' H ' ' C ' ' A' ' 173' ' ' LEU . 55.1 mt-30 -123.91 142.23 38.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.02 -14.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.82 2.347 . . . . 0.0 112.227 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.1 t -63.0 -42.86 98.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.434 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.71 -32.96 80.64 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.13 -41.41 96.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.819 0.342 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.1 m-20 -65.96 -34.82 78.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.652 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.8 m-85 -156.72 142.91 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.54 99.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.153 0.502 . . . . 0.0 110.736 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.25 167.06 29.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.628 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.81 56.03 3.02 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.3 0.01 OUTLIER Glycine 0 CA--C 1.539 1.578 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.28 135.49 38.76 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.247 1.965 . . . . 0.0 111.862 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.3 p -124.42 -108.82 0.32 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.582 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.83 165.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.062 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.76 155.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.324 1.015 . . . . 0.0 110.51 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -81.95 118.45 22.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.861 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -72.05 -18.73 61.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.68 -32.17 73.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.64 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.95 -44.3 97.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.446 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.9 m-85 -114.08 8.38 16.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.67 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.2 -154.55 50.79 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.68 -25.65 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.815 0.341 . . . . 0.0 110.59 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.27 -125.48 1.45 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.7 p -132.15 160.19 36.76 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.66 25.05 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.24 141.06 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.908 0.385 . . . . 0.0 110.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.16 111.8 3.96 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -121.2 159.95 24.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.682 0.277 . . . . 0.0 110.287 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -86.5 149.14 25.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.66 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.15 -48.43 64.92 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -40.4 -22.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.631 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.14 52.02 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.592 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.39 -46.33 83.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.25 -47.06 37.58 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.4 -43.78 98.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.405 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.52 -42.76 99.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.897 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.81 -37.5 73.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.88 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.31 -77.42 0.11 Allowed 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.504 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.4 mt -28.66 -45.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.8 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.443 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.1 m-20 -63.9 -44.99 91.3 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.738 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.71 -43.63 98.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.966 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.16 92.92 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.247 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.2 -43.49 98.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.156 0.503 . . . . 0.0 110.22 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.23 92.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.271 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.11 -42.12 97.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.9 mtp -57.52 -38.07 74.04 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.78 -38.76 76.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.49 92.76 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.662 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.4 p-10 -88.19 0.63 55.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.765 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.76 19.85 67.75 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.7 m -57.93 -46.18 85.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.7 t80 -63.6 -57.61 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.925 0.393 . . . . 0.0 110.47 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.6 mt-10 -56.81 -41.73 78.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.352 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -48.21 82.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.96 -41.58 98.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.451 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.1 -49.84 76.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.77 -35.6 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.51 -50.95 32.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.498 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.1 m-85 -62.19 -45.61 92.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.48 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.7 m-85 -154.64 155.62 35.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.6 p-10 -97.56 101.24 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.444 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -157.88 -165.94 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.3 t0 -122.72 110.2 15.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.62 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.0 m -63.3 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 94.4 m-85 -59.22 -42.62 91.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -36.69 93.74 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 117.88 -1.511 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.83 164.38 61.53 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.73 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.24 143.64 98.42 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.738 2.292 . . . . 0.0 112.208 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.35 -40.98 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -137.96 139.68 39.84 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.371 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.405 HD12 HG22 ' A' ' 9' ' ' ILE . 80.9 mt -107.83 121.26 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.472 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.56 118.23 31.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.122 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.24 138.62 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.271 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.54 106.07 2.25 Favored Glycine 0 N--CA 1.463 0.458 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -129.5 120.24 25.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.657 -0.319 . . . . 0.0 110.76 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.5 t70 -114.05 93.02 28.31 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.852 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.74 134.39 62.44 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.127 . . . . 0.0 111.925 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -141.85 -19.7 0.74 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -124.58 99.46 6.19 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.414 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.654 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.05 -61.27 0.22 Allowed Pre-proline 0 C--O 1.217 -0.631 0 CA-C-O 122.058 0.932 . . . . 0.0 111.127 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.6 Cg_endo -49.68 -40.21 46.89 Favored 'Trans proline' 0 C--N 1.289 -2.576 0 C-N-CA 122.487 2.125 . . . . 0.0 112.165 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -78.37 -42.61 29.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.94 0.4 . . . . 0.0 110.872 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.654 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.4 mt-10 -149.63 -154.83 0.58 Allowed 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.276 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.33 177.93 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.947 0.404 . . . . 0.0 110.282 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -136.52 143.68 43.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.477 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 25' ' ' SER . 61.9 t-20 -96.58 141.28 30.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.392 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.1 p -65.99 -19.32 65.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.573 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -77.37 -7.13 55.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.09 -6.57 58.28 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.93 157.73 26.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.366 . . . . 0.0 110.425 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 82.9 mt -111.66 133.65 53.76 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 110.324 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.84 151.28 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.28 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.12 151.56 6.67 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -58.71 -42.36 88.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.675 0.274 . . . . 0.0 110.843 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.444 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.3 t0 -69.35 -28.44 66.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.404 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.23 -40.72 83.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.029 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -60.59 -37.84 82.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.893 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.3 tp -65.19 -44.14 89.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.224 0.535 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.41 -47.34 84.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.907 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -54.25 -54.1 44.73 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.518 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.77 -39.11 61.98 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.035 0.445 . . . . 0.0 110.087 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.19 -41.93 80.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.969 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -53.95 -45.08 71.18 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.061 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.17 -46.28 84.69 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.343 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -60.7 -41.93 96.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.989 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.62 -17.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.712 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.84 52.57 4.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.612 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -146.41 170.94 15.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.913 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.71 142.48 27.64 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.987 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.4 m -117.39 131.86 56.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.3 m -128.33 127.81 43.39 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.474 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -94.44 135.28 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.445 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.35 128.59 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.012 0.434 . . . . 0.0 110.305 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.84 137.32 57.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 177.23 131.86 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.19 144.74 64.03 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.664 2.243 . . . . 0.0 112.678 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.6 mt -40.06 -56.03 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 111.272 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.11 -26.35 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.35 -20.99 18.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.139 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.7 -42.47 97.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.759 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.564 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.39 -56.86 26.58 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 123.81 0.694 . . . . 0.0 109.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.2 Cg_exo -56.21 -41.36 77.47 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.499 2.133 . . . . 0.0 110.992 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 69.1 m -59.26 -44.27 92.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.86 -43.86 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.43 95.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.478 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.13 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.43 11.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.41 -35.43 80.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.598 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.9 pt -122.79 153.27 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.318 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -92.94 -21.87 19.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.131 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.28 156.42 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.628 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.05 128.26 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.397 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.444 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.1 ttp -130.44 107.0 8.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 110.267 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 t -159.38 179.21 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.88 -15.18 61.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.612 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.0 tp -36.27 124.78 0.78 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.606 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.541 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -83.33 155.87 23.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.674 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -105.59 149.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -149.55 152.43 35.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.693 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.84 -47.46 51.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.77 -39.91 71.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.668 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.47 -37.81 80.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.043 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.95 -38.26 75.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.053 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.24 -27.51 67.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.26 -51.47 7.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.9 pt -138.21 -168.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 121.076 0.465 . . . . 0.0 110.442 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.83 147.66 29.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -130.08 150.0 51.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.658 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.711 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.71 -152.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.711 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.4 m-20 42.41 20.09 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -29.17 120.77 0.14 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.66 0.6 . . . . 0.0 110.526 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -76.86 -69.63 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.868 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -149.4 166.3 29.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.617 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.26 122.74 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.58 69.59 0.9 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.65 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.61 -104.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.422 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.29 166.02 32.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.9 145.75 21.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 110.414 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.89 136.2 41.13 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.41 111.11 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.1 164.99 33.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.84 23.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.039 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.28 60.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.142 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.98 -41.73 88.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.251 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.1 t -102.09 122.01 43.29 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.976 0.417 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.11 109.93 19.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.333 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.415 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.0 129.94 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.539 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.93 154.23 42.0 Favored Pre-proline 0 C--N 1.334 -0.099 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.513 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.36 92.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.767 2.311 . . . . 0.0 111.907 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.7 m -171.04 144.47 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.36 -33.73 61.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.164 0.507 . . . . 0.0 110.281 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -58.24 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.425 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.34 -22.13 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.869 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.29 -25.8 55.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.338 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.9 45.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.67 -16.5 30.67 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.94 151.21 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.382 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.91 37.72 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.41 136.61 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 139.53 14.74 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 54.8 t -131.83 161.74 40.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.096 0.474 . . . . 0.0 110.287 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.2 tp -92.73 118.82 31.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.63 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -51.93 157.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.06 50.66 50.54 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.3 p -149.45 168.23 24.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.791 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.433 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.18 -25.64 59.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.431 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -61.25 -55.1 35.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.544 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.64 -53.92 52.74 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -60.55 -51.36 69.76 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.46 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.1 t80 -62.08 -44.01 97.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.426 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.74 -44.42 97.93 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.94 -14.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.627 0.251 . . . . 0.0 110.675 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.19 -34.84 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.43 -50.57 17.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.435 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -99.04 12.56 35.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.207 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.95 -55.7 0.46 Allowed Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.4 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.08 -10.6 26.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.778 2.319 . . . . 0.0 111.961 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.45 -8.76 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.74 33.37 38.01 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.24 137.87 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 110.532 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -87.58 129.73 35.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.233 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.6 pt -127.26 138.99 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.95 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.58 132.08 71.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.975 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.8 t -98.52 130.52 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -111.69 156.68 21.5 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.294 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.06 6.46 28.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.565 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.98 6.36 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.19 -46.15 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.12 62.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.89 -36.54 84.7 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.41 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.29 -47.44 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.093 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.509 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.3 m-85 -63.72 -37.84 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.263 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.01 -42.19 97.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.081 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -64.19 -44.4 92.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.97 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.1 tp -58.88 -48.2 82.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.164 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -63.06 -23.01 67.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.42 -18.36 25.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.493 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.79 11.2 71.16 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.57 -18.25 63.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.659 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.8 pt -127.9 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.456 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 -28.3 62.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.999 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.41 155.62 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.574 0.546 . . . . 0.0 110.873 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.43 138.0 51.21 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.993 0.425 . . . . 0.0 110.045 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.21 103.17 14.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.041 0.448 . . . . 0.0 110.569 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.25 24.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.04 152.55 41.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.04 -54.27 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.347 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.39 -48.66 87.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.437 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.8 88.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 110.44 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.46 -63.63 1.09 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.413 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 73.4 m -59.09 -47.11 86.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.749 0.309 . . . . 0.0 110.981 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -50.17 -37.6 35.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.02 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.7 -66.15 0.56 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.657 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.3 -70.69 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.734 -0.274 . . . . 0.0 111.123 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -61.36 -39.78 91.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -60.67 -3.36 0.69 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.412 0.625 . . . . 0.0 110.354 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 173' ' ' LEU . 54.9 mt-30 -123.27 142.25 38.08 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 122.118 -0.363 . . . . 0.0 110.845 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -44.27 -16.21 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.848 2.365 . . . . 0.0 112.275 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 74.5 t -62.82 -43.04 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.15 -33.06 82.8 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.82 -41.25 95.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 0.0 110.413 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -66.04 -34.27 77.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.509 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.4 m-85 -157.12 143.92 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.725 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.27 99.59 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.0 m-85 -159.09 167.14 29.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.614 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.69 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.44 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.539 1.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.09 135.69 37.41 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.285 1.99 . . . . 0.0 111.99 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.465 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.3 p -124.94 -108.13 0.33 Allowed 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.496 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.91 165.33 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 118.815 -0.612 . . . . 0.0 109.955 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.53 156.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.496 1.122 . . . . 0.0 110.468 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.07 118.04 22.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.917 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.1 mp0 -71.62 -18.94 62.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.0 -44.19 97.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.433 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.97 8.97 17.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.56 -155.12 52.04 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.31 -25.26 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 0.0 110.53 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.61 -125.2 1.42 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.5 p -131.76 159.46 38.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 110.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.98 -162.87 24.94 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.7 139.12 34.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.945 0.402 . . . . 0.0 110.468 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.65 112.61 4.04 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.5 mt -124.76 159.5 30.81 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.752 0.311 . . . . 0.0 110.346 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -85.89 149.77 24.99 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.793 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.04 -48.29 64.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.746 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -38.57 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.708 0.289 . . . . 0.0 110.715 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.53 52.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.614 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -64.48 -46.13 84.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.742 0.306 . . . . 0.0 111.136 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.0 -47.07 39.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.57 -43.4 98.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.466 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.6 ttt-85 -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.775 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.41 -36.97 72.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.118 0.485 . . . . 0.0 109.84 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.49 -77.43 0.11 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 212' ' ' ALA . 98.0 mt -28.43 -45.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.988 0.423 . . . . 0.0 110.808 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.426 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.0 m-20 -64.29 -45.14 89.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.78 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.69 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.89 -43.93 97.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.968 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.19 92.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.14 -43.62 98.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.162 0.506 . . . . 0.0 110.163 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.27 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.89 -42.45 97.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -57.47 -38.24 74.19 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.86 -38.95 76.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 0.0 110.421 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.91 93.94 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -88.95 1.3 55.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.803 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.68 19.86 65.5 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 77.0 m -58.11 -45.7 86.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.77 -57.69 9.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.499 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -57.3 -41.43 79.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.59 -48.45 80.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.483 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -41.49 98.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.448 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.48 -49.94 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.724 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.28 -35.37 73.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.379 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.96 -50.99 28.43 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.501 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.15 -45.27 94.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.8 m-85 -153.51 154.86 35.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.416 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.4 p-10 -96.78 95.5 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -153.12 -167.06 2.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.482 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.43 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.48 110.25 15.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.0 m -63.52 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.574 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.6 m-85 -57.06 -43.94 82.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.238 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.75 -37.48 94.76 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.793 -1.559 . . . . 0.0 110.985 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 164.36 57.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.671 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -61.09 143.28 98.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.694 2.263 . . . . 0.0 112.14 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.63 -40.87 88.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.658 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -138.38 141.5 39.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.438 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.8 mt -109.21 127.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.331 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.84 118.8 37.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.315 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.71 141.81 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.83 107.08 2.16 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.7 m -128.81 120.83 27.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.68 0.276 . . . . 0.0 110.489 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 9.7 t70 -113.01 94.25 29.01 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.946 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.37 134.96 63.83 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.64 2.227 . . . . 0.0 111.786 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.2 p -136.7 -18.7 1.4 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.647 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' O ' ' C ' ' A' ' 18' ' ' ALA . 81.1 m-85 -125.22 97.93 5.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.422 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.682 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.63 -61.4 0.23 Allowed Pre-proline 0 C--O 1.222 -0.372 0 CA-C-O 122.0 0.905 . . . . 0.0 111.018 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 6.5 Cg_endo -50.13 -41.22 50.04 Favored 'Trans proline' 0 C--N 1.294 -2.336 0 C-N-CA 122.506 2.137 . . . . 0.0 112.153 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.1 t80 -78.51 -43.05 27.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.126 0.488 . . . . 0.0 110.643 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.682 ' O ' ' O ' ' A' ' 18' ' ' ALA . 94.8 mt-10 -146.73 -160.7 1.19 Allowed 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.159 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.4 t 157.36 -178.97 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.771 0.32 . . . . 0.0 110.299 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.73 140.94 46.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.557 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.3 t-20 -90.32 141.83 28.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.421 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.0 p -66.27 -18.79 65.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.577 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.27 -6.08 53.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.504 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.34 -9.83 57.74 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -79.65 163.02 24.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.801 0.334 . . . . 0.0 110.379 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.1 mt -117.62 137.35 52.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.494 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.24 151.27 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.318 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.49 154.05 7.42 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.63 -41.35 94.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.739 0.304 . . . . 0.0 110.686 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.8 t0 -70.5 -32.3 69.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.98 -39.96 82.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.2 m-20 -60.69 -37.63 82.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.982 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -65.45 -44.3 87.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.24 0.543 . . . . 0.0 110.608 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.44 -46.4 86.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.122 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.46 -53.77 49.84 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.41 -38.91 63.89 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.884 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.27 -42.64 79.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.054 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 48.9 m -53.68 -44.15 69.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -63.98 -46.95 82.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.04 0.448 . . . . 0.0 110.528 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -60.46 -41.48 94.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.146 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.27 -18.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.51 52.25 3.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -146.87 171.05 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.802 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.45 142.14 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -117.59 131.82 56.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.492 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.62 127.01 43.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.401 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -95.72 137.23 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.47 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.3 129.46 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.549 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -68.43 139.06 55.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 p30 176.21 135.25 0.19 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.2 143.32 58.64 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.671 2.248 . . . . 0.0 112.63 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.8 mt -39.34 -55.25 1.76 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.077 0.465 . . . . 0.0 111.078 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.73 -26.25 2.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.752 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.03 -21.37 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.846 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.2 mt -63.95 -42.96 97.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.379 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.573 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -62.47 -55.86 35.56 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.029 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.1 Cg_exo -55.7 -42.23 69.54 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.559 2.172 . . . . 0.0 111.257 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.4 m -58.82 -44.54 90.9 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.182 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.78 -44.65 90.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.361 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.4 mtmt -64.8 -40.84 95.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.531 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.39 1.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.562 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.2 11.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.646 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.0 mttt -63.5 -33.27 75.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.699 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 67' ' ' ILE . 44.5 pt -124.56 154.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.507 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -91.49 -20.89 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.744 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.06 160.38 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.0 mt -116.08 127.33 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.521 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.77 107.72 9.88 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.315 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.53 ' HG ' ' H ' ' A' ' 73' ' ' SER . 35.7 t -162.42 -177.13 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.53 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.4 p -64.02 -15.68 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.618 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.3 122.99 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -83.09 156.34 23.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.766 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.6 pt -105.53 149.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.7 p -150.87 152.85 34.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.596 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.81 -47.69 51.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.85 -39.85 72.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.35 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.618 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -69.03 -37.36 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.908 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -58.21 -37.29 74.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 110.399 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.84 67.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.71 -51.84 7.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.739 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.58 -167.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.509 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.37 147.14 29.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.087 0.47 . . . . 0.0 110.652 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -130.47 150.6 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.652 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.685 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.0 t -165.51 -151.01 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.495 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.685 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.0 m-20 43.09 20.02 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.777 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.98 120.51 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.582 0.551 . . . . 0.0 110.678 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.5 mt -79.42 -71.31 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.801 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -148.46 165.4 31.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.23 126.25 31.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.455 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.37 67.48 0.73 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.503 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.55 -105.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.41 167.3 29.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.574 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.2 146.77 23.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -102.01 135.99 42.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.691 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.52 111.66 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.074 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -134.9 164.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.606 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.88 24.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.825 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.07 60.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.82 -42.07 88.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.287 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -101.97 122.04 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.348 . . . . 0.0 110.245 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.85 109.68 19.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.328 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.3 130.41 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.532 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -109.71 154.14 42.62 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.53 92.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.715 2.276 . . . . 0.0 112.064 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.5 m -170.86 144.8 2.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.752 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.98 -33.98 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.333 0.587 . . . . 0.0 110.432 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.74 -62.14 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.676 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.8 t -56.48 -22.21 30.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.667 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.9 -25.65 53.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.47 132.85 45.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.575 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.49 -16.5 29.8 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.79 151.22 23.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.808 0.337 . . . . 0.0 110.358 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.1 135.5 37.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.47 136.27 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.639 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.72 14.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.6 161.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 39.5 tp -92.7 119.27 31.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -51.32 156.78 1.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.637 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.64 50.92 51.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.3 p -148.69 166.74 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.727 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.1 p -71.81 -29.67 64.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.457 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.4 mt-30 -58.77 -54.78 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.588 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.59 -55.77 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.397 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.1 -51.94 67.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.9 t80 -61.64 -44.19 97.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.468 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.49 -44.48 97.95 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.74 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.563 0.221 . . . . 0.0 110.605 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.76 2.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.593 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.37 -50.72 17.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.01 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -99.6 12.77 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.478 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.13 -55.42 0.46 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.51 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.34 -10.06 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.77 2.314 . . . . 0.0 112.093 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.72 -8.45 59.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.639 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.38 37.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.53 138.1 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.57 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.9 130.29 34.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -127.37 138.98 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.778 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.47 132.37 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.3 t -97.81 129.47 44.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.454 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -111.3 156.35 21.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.342 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.85 7.07 27.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.27 6.08 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.08 -45.9 79.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.372 . . . . 0.0 110.578 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.09 62.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.461 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.0 t-20 -64.86 -36.53 84.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.514 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.408 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.3 -47.36 84.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.055 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.0 m-85 -63.85 -37.67 88.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.5 p -61.4 -42.53 98.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.092 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.15 -44.37 92.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.343 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.01 -47.86 83.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.184 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.54 -22.96 67.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.995 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.56 25.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 10.96 71.05 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.68 -18.15 63.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.704 0.288 . . . . 0.0 110.636 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.5 pt -128.18 137.81 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.13 -29.76 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -174.8 154.92 2.01 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 138.73 52.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.233 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -86.12 102.64 14.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.25 164.4 26.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.27 152.28 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.7 mt-10 -66.0 -54.43 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.077 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.84 -48.83 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.577 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.36 87.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.749 0.309 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -62.92 -62.95 1.37 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 68.1 m -58.29 -45.9 87.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.953 0.406 . . . . 0.0 110.49 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -45.98 -40.78 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.401 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.46 0.46 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.62 -71.59 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.718 0.294 . . . . 0.0 110.747 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -62.67 -41.05 98.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.719 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.0 tttt -59.65 -3.05 0.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.169 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 173' ' ' LEU . 57.2 mt-30 -125.96 142.04 41.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.47 -15.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.803 2.335 . . . . 0.0 112.188 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 175' ' ' GLN . 89.7 t -62.5 -43.12 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.27 84.69 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.28 -40.72 95.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.511 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 49.0 m-20 -67.07 -33.6 75.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.5 m-85 -156.59 142.35 17.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.3 pttt -175.47 99.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.712 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 93.5 m-85 -158.93 167.13 30.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.544 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.69 56.13 3.2 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.95 -115.95 0.01 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.35 135.16 39.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.327 2.018 . . . . 0.0 111.931 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.8 p -124.12 -108.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.068 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.9 164.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.038 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.7 tttt 153.85 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 124.17 0.919 . . . . 0.0 110.51 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.61 119.42 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.239 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.7 mp0 -71.72 -16.34 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.0 -32.21 73.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.683 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.05 -44.33 97.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -114.38 8.81 16.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.15 -153.78 51.34 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.93 -25.53 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.559 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.91 -126.55 1.61 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.9 p -132.29 160.26 36.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.82 -161.94 24.09 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.45 140.13 33.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.542 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.52 3.57 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' ALA . 83.0 mt -118.13 159.64 22.92 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.584 0.23 . . . . 0.0 110.443 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.69 148.84 25.27 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.608 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.21 -48.68 61.97 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -41.02 -22.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.497 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.52 51.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.465 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.46 -46.28 83.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.99 -47.2 38.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.387 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.28 -42.91 99.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.71 -37.46 73.56 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.205 0.526 . . . . 0.0 110.143 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.697 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.12 -77.43 0.1 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.923 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.508 ' C ' ' O ' ' A' ' 212' ' ' ALA . 88.7 mt -27.95 -45.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.913 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.441 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.4 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.741 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.697 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.1 -43.54 98.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.114 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.99 91.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.453 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.23 -43.36 99.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.412 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.23 91.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.368 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.22 -42.15 96.7 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.393 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.31 -38.2 73.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.62 -38.88 77.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.537 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.54 91.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 18.9 p-10 -88.74 0.28 56.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.762 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.01 20.42 68.8 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -57.54 -46.39 83.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.2 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.06 -58.04 8.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.996 0.427 . . . . 0.0 110.485 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.75 -42.53 79.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.545 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.81 -48.8 80.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.442 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.16 -41.48 98.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.49 -50.19 74.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.745 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -34.76 72.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -71.42 -51.83 21.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.176 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.42 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 40.1 m-85 -62.73 -44.61 95.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 230' ' ' ALA . 83.9 m-85 -151.31 153.09 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.513 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 49.0 p-10 -98.21 93.92 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.464 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.89 -165.59 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.444 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -122.39 108.75 13.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.683 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.53 -40.06 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -57.37 -43.57 83.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.71 -37.55 94.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.219 -0.796 0 CA-C-O 117.924 -1.486 . . . . 0.0 111.005 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.3 60.14 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.99 143.47 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 122.737 2.291 . . . . 0.0 112.261 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.42 -40.91 89.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.633 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -138.0 139.0 39.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.34 121.21 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.587 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.1 118.88 32.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.6 138.67 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.369 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.7 105.29 2.11 Favored Glycine 0 N--CA 1.463 0.442 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.9 m -128.75 120.52 26.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.648 -0.325 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.7 t70 -114.35 92.85 29.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.953 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.33 134.42 60.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.544 2.162 . . . . 0.0 111.974 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.7 p -141.48 -20.31 0.76 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.716 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.6 m-85 -123.56 99.15 6.17 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.656 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.06 -61.29 0.22 Allowed Pre-proline 0 C--O 1.218 -0.559 0 CA-C-O 121.814 0.816 . . . . 0.0 111.085 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.41 -40.98 44.47 Favored 'Trans proline' 0 C--N 1.291 -2.461 0 C-N-CA 122.495 2.13 . . . . 0.0 112.211 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.3 t80 -78.13 -42.75 30.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.702 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.656 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -149.81 -154.11 0.53 Allowed 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.048 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.75 177.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.034 0.445 . . . . 0.0 110.269 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.47 144.75 46.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.442 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -95.94 134.56 38.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -64.84 -18.88 65.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.522 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.02 -6.06 53.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.29 -8.09 56.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.74 159.12 25.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 110.459 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.3 mt -112.42 131.17 55.7 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.82 151.42 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.368 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.15 151.43 6.61 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -58.67 -42.38 88.33 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.695 -0.297 . . . . 0.0 110.819 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 -69.35 -28.49 66.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.266 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.15 -40.84 83.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.83 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.3 -37.77 81.58 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.19 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.38 -45.05 89.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 110.163 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.19 -48.77 77.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.915 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.65 -54.69 29.88 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.15 -40.46 61.45 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.17 -41.7 81.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.971 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.8 m -53.43 -45.18 69.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.167 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.33 -46.38 83.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.279 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -60.23 -42.31 94.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.53 -16.99 15.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.41 52.96 4.46 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.706 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.8 p -146.96 171.54 15.08 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.89 142.31 27.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.038 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.14 130.92 56.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.63 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.4 m -127.29 127.1 43.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -94.03 134.89 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.4 t -129.09 127.77 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 137.89 57.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.07 131.04 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.5 Cg_endo -67.84 145.31 68.24 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.684 2.256 . . . . 0.0 112.562 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.8 mt -40.41 -56.07 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.979 0.418 . . . . 0.0 111.035 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.05 -26.69 1.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.008 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -20.96 18.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.7 mt -63.77 -42.53 97.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.641 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.588 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.3 -56.84 26.99 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.821 0.701 . . . . 0.0 109.688 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.1 Cg_exo -55.84 -41.83 73.31 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.556 2.171 . . . . 0.0 111.102 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 70.7 m -59.05 -44.5 91.81 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.055 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 tp -59.45 -43.89 93.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.185 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.45 95.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.23 10.22 2.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.496 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.21 12.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.56 -35.38 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.549 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.43 153.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.297 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -93.17 -22.27 19.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.5 155.94 27.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.607 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.08 128.63 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.123 0.487 . . . . 0.0 110.362 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.11 107.22 8.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.679 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.8 t -159.48 178.64 9.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.618 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.679 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.4 p -65.01 -15.34 62.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.493 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.613 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.16 124.65 0.6 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.549 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.15 154.38 25.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 pt -105.16 148.86 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.134 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -149.16 152.18 35.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.9 -47.15 52.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.434 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.55 -40.21 71.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.707 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.613 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.4 -37.92 80.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.072 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.78 -38.84 76.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.94 -27.43 66.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.206 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.46 -51.0 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.526 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -139.01 -168.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.072 0.463 . . . . 0.0 110.49 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.31 147.74 29.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -130.01 150.11 51.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.549 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.643 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.9 t -163.36 -153.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.437 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.643 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.3 m-20 41.55 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.933 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.72 121.38 0.2 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.478 0.486 . . . . 0.0 110.503 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 58.6 mt -75.0 -68.56 0.54 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -150.78 167.61 26.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.6 29.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.368 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.05 68.24 0.81 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.713 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.58 -104.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.9 p -159.26 165.49 33.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.639 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.05 146.45 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.112 0.482 . . . . 0.0 110.432 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.95 135.99 41.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.762 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.06 164.49 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.11 148.25 25.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.01 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.19 -28.39 58.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.05 -41.66 88.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -101.63 121.41 41.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.153 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.06 109.88 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.419 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 105' ' ' ILE . 97.2 mt -126.57 129.54 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.609 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -107.16 154.11 40.64 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.35 91.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.793 2.329 . . . . 0.0 111.946 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.3 m -170.44 143.44 2.29 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.516 0.51 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.59 -33.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.35 -62.07 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.439 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -56.6 -22.48 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.826 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.2 mt -75.89 -26.03 56.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.276 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.6 47.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.454 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.79 -16.99 28.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.01 151.34 23.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.434 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.78 135.2 37.8 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.287 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.58 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.594 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 138.45 14.26 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.6 161.56 40.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.497 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 42.6 tp -92.52 117.51 30.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.648 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.55 157.91 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.71 50.63 52.83 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.1 p -149.9 168.75 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.783 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.451 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.8 p -73.3 -26.88 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.458 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.49 -55.31 35.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.534 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -56.98 -54.9 41.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.8 m -60.26 -51.38 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.524 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.3 t80 -61.99 -44.08 97.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.441 . . . . 0.0 110.502 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.52 -44.55 97.84 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.54 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.657 0.265 . . . . 0.0 110.651 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.5 -34.64 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.611 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.6 -50.65 17.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 111.366 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.3 12.17 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.171 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.483 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.57 -55.29 0.49 Allowed Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.35 -10.1 25.13 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.796 2.331 . . . . 0.0 111.994 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.85 -9.02 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.25 37.09 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.33 137.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.29 129.79 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.343 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.4 138.14 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.0 133.25 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.023 0.44 . . . . 0.0 109.979 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.88 127.08 42.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.31 25.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.33 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.02 7.22 29.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.19 5.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -65.81 -45.77 81.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.463 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.77 -23.47 62.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.73 -36.8 85.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.94 -46.62 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.016 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.682 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.8 m-85 -64.7 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.04 -41.86 97.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.39 -43.2 91.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.998 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.4 tp -58.77 -48.2 82.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.172 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.84 -22.48 66.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.224 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.47 -18.41 25.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.55 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.64 72.38 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.82 -17.82 63.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.645 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.493 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.64 -28.0 62.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.38 155.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.517 0.511 . . . . 0.0 110.809 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.01 137.21 50.15 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.022 0.439 . . . . 0.0 110.074 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -86.03 103.32 14.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.682 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 49.7 tt0 -132.85 165.56 24.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.446 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.442 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -72.89 153.12 41.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.69 -54.68 20.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.29 -48.89 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.506 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.96 89.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.41 -62.92 1.3 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.456 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.5 m -59.56 -47.49 85.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.99 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -48.93 -37.27 19.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.113 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.03 0.55 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 168' ' ' ALA . 23.8 t80 -40.72 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.771 -0.252 . . . . 0.0 111.087 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -61.44 -40.39 94.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.38 -3.35 0.42 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.632 . . . . 0.0 110.321 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.9 mt-30 -122.82 150.09 57.87 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.69 -20.92 7.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.853 2.369 . . . . 0.0 112.231 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.79 -43.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.577 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.13 -33.28 85.31 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.48 -41.14 93.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.738 0.304 . . . . 0.0 110.459 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.6 m-20 -66.12 -32.91 74.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.2 142.64 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.557 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.44 99.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.085 0.469 . . . . 0.0 110.727 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.24 167.53 28.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.647 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.91 56.45 2.74 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.67 -118.61 0.01 OUTLIER Glycine 0 CA--C 1.535 1.337 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.55 135.7 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.395 2.063 . . . . 0.0 111.996 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.3 p -125.2 -108.32 0.32 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.435 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.12 164.56 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.065 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 154.13 155.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.346 1.029 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -81.92 117.4 22.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 195' ' ' GLY . 54.1 mp0 -71.44 -18.94 62.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.81 -32.37 73.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.565 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.93 -44.58 97.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.669 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.451 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.2 m-85 -114.13 9.64 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.646 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.74 -153.86 51.8 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.74 -24.93 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.789 0.328 . . . . 0.0 110.501 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.34 -124.14 1.3 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.49 156.16 44.57 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.646 0.26 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.56 30.37 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.17 137.41 33.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.534 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.32 108.38 3.28 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.44 159.12 29.68 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.293 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -86.42 149.79 24.76 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.803 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.2 -47.76 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.522 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.53 -25.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.791 0.329 . . . . 0.0 110.574 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.4 52.07 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.611 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -64.49 -45.11 88.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.162 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.9 -47.39 30.21 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.46 -43.72 98.14 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.506 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.2 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.798 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.91 -36.35 70.06 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.09 -77.38 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.514 ' C ' ' O ' ' A' ' 212' ' ' ALA . 96.6 mt -28.4 -46.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.956 0.408 . . . . 0.0 110.637 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.444 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.0 m-20 -64.4 -44.84 90.02 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.779 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.02 -43.56 98.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.037 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.87 92.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.199 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.34 -43.71 98.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.126 0.488 . . . . 0.0 110.144 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.53 93.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.383 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.533 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -42.71 97.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.22 -37.85 72.85 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.2 -38.88 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.44 . . . . 0.0 110.437 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.73 94.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.17 2.13 54.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.67 63.09 Favored Glycine 0 C--O 1.225 -0.451 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 83.9 m -58.07 -45.84 86.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.0 t80 -63.7 -57.73 9.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.4 mt-10 -57.11 -41.46 79.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.232 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.64 -48.33 81.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.459 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.21 -41.55 98.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.829 0.347 . . . . 0.0 110.294 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.76 -50.0 75.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.92 -35.43 73.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.428 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.75 -51.21 28.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.544 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.2 m-85 -61.88 -45.83 92.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.97 155.54 35.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.09 97.43 9.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.001 0.429 . . . . 0.0 110.496 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.86 -166.49 2.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.477 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.03 110.99 16.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.0 m -63.22 -40.34 88.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 94.0 m-85 -58.89 -42.48 89.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.274 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.94 94.12 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.957 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.47 164.59 59.93 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.07 143.63 99.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.749 2.299 . . . . 0.0 112.276 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.11 -40.24 90.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.81 142.92 36.63 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 9' ' ' ILE . 84.0 mt -109.97 129.08 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -104.1 117.12 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.337 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -111.89 138.86 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.82 104.86 2.13 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.6 m -127.98 119.3 25.21 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 122.588 -0.36 . . . . 0.0 110.91 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.9 t70 -113.63 92.46 24.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.33 134.3 60.36 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 p -141.36 -19.31 0.78 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.783 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.5 m-85 -124.77 99.14 6.02 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.421 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.644 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.23 -61.04 0.23 Allowed Pre-proline 0 C--O 1.217 -0.656 0 CA-C-O 122.039 0.923 . . . . 0.0 111.201 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.5 Cg_endo -49.76 -39.97 47.76 Favored 'Trans proline' 0 C--N 1.288 -2.658 0 C-N-CA 122.581 2.187 . . . . 0.0 112.225 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.5 t80 -78.78 -42.69 27.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.973 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.644 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.37 -155.51 0.64 Allowed 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.216 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.92 178.21 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.035 0.445 . . . . 0.0 110.312 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -136.09 143.41 44.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.471 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.2 t-20 -95.62 141.43 29.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.486 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.3 p -65.76 -19.14 65.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.551 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.14 -6.97 56.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.15 -7.32 58.54 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.18 157.85 27.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.393 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.0 mt -111.54 133.77 53.58 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.92 0.391 . . . . 0.0 110.395 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.52 151.31 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.328 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.7 151.98 6.81 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -58.75 -42.31 88.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.613 -0.345 . . . . 0.0 110.98 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.472 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.8 t0 -69.83 -28.48 65.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.7 mt -68.55 -40.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.422 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.5 m-20 -61.41 -37.66 84.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.686 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.0 -43.92 86.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.13 -41.88 93.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.909 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.67 -53.3 59.92 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.589 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.92 -37.06 63.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.117 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.86 -42.29 77.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.102 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.75 -44.59 73.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.077 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.81 -47.22 81.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.162 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -59.85 -40.97 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.054 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.37 -17.53 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.5 52.45 4.64 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.21 170.23 16.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.898 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.37 140.59 29.32 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.964 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.5 m -117.13 131.88 56.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.583 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -128.28 127.63 43.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -93.91 135.71 34.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.58 128.82 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.31 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.83 139.4 58.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.606 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.436 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.38 131.7 0.15 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.692 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.34 145.28 65.08 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.67 2.247 . . . . 0.0 112.591 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' LEU . 82.1 mt -40.27 -56.67 1.91 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.085 0.469 . . . . 0.0 111.283 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.47 -26.74 1.47 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.57 19.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.194 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' LEU . 58.7 mt -63.98 -42.56 97.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.859 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.559 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.32 -57.02 25.36 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 123.933 0.771 . . . . 0.0 109.527 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.3 Cg_exo -55.46 -42.65 65.95 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.49 2.126 . . . . 0.0 110.939 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -59.19 -43.88 92.2 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.01 -44.05 91.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.109 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.72 -40.02 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.507 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.54 11.23 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.479 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.12 11.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -34.34 77.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.1 pt -124.05 153.52 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.189 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.35 -20.59 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.4 157.32 25.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.545 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.91 127.36 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.472 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.33 106.45 9.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.309 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 t -160.07 -178.33 6.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.575 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.3 p -64.24 -15.38 59.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.417 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.62 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.1 tp -37.96 123.76 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.557 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.44 156.84 22.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 pt -105.27 149.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.131 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.3 p -149.87 152.9 35.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.751 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.44 -47.5 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.9 -40.05 72.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.691 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.62 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.01 -37.82 81.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.078 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.26 -37.37 74.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.05 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.55 -27.2 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.127 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.5 -51.91 6.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.329 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.27 -168.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.118 0.485 . . . . 0.0 110.407 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.79 29.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.94 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.93 149.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.609 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.678 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.7 t -164.37 -151.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.421 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.678 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.2 m-20 43.37 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -28.27 120.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.581 0.551 . . . . 0.0 110.518 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.5 mt -77.25 -69.9 0.5 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -149.17 166.12 29.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.589 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.88 121.67 27.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.298 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.87 69.29 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.699 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.88 -105.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.424 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.15 165.76 33.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.615 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.47 146.02 22.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.133 0.492 . . . . 0.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.08 136.11 41.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.51 111.06 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.27 165.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.73 148.45 23.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.154 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.13 -28.22 57.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.201 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.0 -41.78 88.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.12 122.22 43.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.114 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.04 110.0 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.33 129.84 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.531 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.85 154.34 41.87 Favored Pre-proline 0 N--CA 1.457 -0.096 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.641 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.511 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.24 92.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.832 2.354 . . . . 0.0 111.82 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -170.86 144.09 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.666 0.604 . . . . 0.0 110.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.3 -33.74 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.306 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -57.85 -62.11 2.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.74 -21.85 31.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.893 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.8 mt -76.19 -25.93 55.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.373 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.44 47.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.459 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.17 -16.25 29.5 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.5 151.56 23.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.29 135.4 38.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.231 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.04 136.49 60.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.615 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 138.62 14.32 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.1 t -130.89 161.76 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.213 0.53 . . . . 0.0 110.205 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.3 tp -92.5 117.54 30.05 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.75 157.79 1.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.76 50.29 54.52 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.46 168.78 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.835 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.453 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 77.0 p -73.1 -27.35 61.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.418 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.45 -54.87 40.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.51 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' CD ' ' HG ' ' A' ' 142' ' ' SER . 80.4 tt0 -57.16 -54.5 46.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.408 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -60.73 -51.14 70.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.446 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.02 -43.95 97.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.986 0.422 . . . . 0.0 110.476 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.68 -44.44 97.91 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.62 -14.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.6 0.238 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.3 -34.73 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.46 -50.66 17.44 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.478 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.13 12.45 36.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.293 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.93 -55.6 0.46 Allowed Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.347 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.19 -10.45 25.83 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.793 2.328 . . . . 0.0 111.951 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.51 -8.66 59.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.72 33.53 37.6 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.79 137.99 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.987 0.423 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.71 130.08 34.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.233 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.56 138.35 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.1 t -123.04 133.19 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.426 ' HG ' ' CD ' ' A' ' 126' ' ' GLU . 7.9 t -97.0 127.26 42.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.85 153.28 25.64 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.67 6.88 30.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.96 130.49 5.95 Favored Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.93 -45.67 81.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.44 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.15 -23.98 63.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.055 0.455 . . . . 0.0 110.513 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.5 t-20 -64.7 -36.53 84.59 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.551 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 149' ' ' ILE . 96.6 mt -65.93 -47.07 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.515 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.7 m-85 -63.8 -37.66 88.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.26 -42.61 98.92 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.137 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.403 ' H ' ' HG ' ' A' ' 151' ' ' SER . 51.8 m-20 -63.86 -44.96 91.53 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.0 tp -58.91 -47.72 84.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.213 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -63.25 -22.47 66.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.072 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.95 -18.33 24.88 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.459 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.48 70.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -17.87 63.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.2 pt -128.24 137.45 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.449 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.8 -27.95 62.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.57 155.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.617 0.573 . . . . 0.0 110.835 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.48 50.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.957 0.408 . . . . 0.0 110.035 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.95 103.0 14.26 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.083 0.468 . . . . 0.0 110.577 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.17 165.02 25.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.441 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.429 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.34 152.4 40.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.606 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -65.99 -54.09 30.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.35 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.5 t -60.45 -48.94 86.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.405 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.8 87.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.787 0.327 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.15 -63.53 1.13 Allowed 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.425 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.0 m -58.77 -46.72 86.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.756 0.313 . . . . 0.0 110.908 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.1 tt0 -50.04 -37.95 35.53 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.896 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.86 -65.76 0.55 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.1 t80 -40.48 -71.08 0.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.777 -0.249 . . . . 0.0 111.213 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.47 -40.06 93.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.005 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.45 -3.28 0.42 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 110.306 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 177' ' ' VAL . 61.1 mt-30 -124.37 141.81 38.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 O-C-N 121.965 -0.459 . . . . 0.0 110.858 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.71 -14.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.823 2.349 . . . . 0.0 112.379 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.0 t -63.29 -42.96 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.445 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.89 80.62 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.72 -42.13 96.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.774 0.321 . . . . 0.0 110.318 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 60.1 m-20 -65.01 -35.23 80.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.7 m-85 -156.8 143.72 18.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.11 99.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.135 0.493 . . . . 0.0 110.798 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.15 168.49 26.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.1 55.85 3.19 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.52 -116.68 0.01 OUTLIER Glycine 0 CA--C 1.538 1.498 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.14 135.63 37.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.367 2.045 . . . . 0.0 111.963 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.0 p -125.34 -108.05 0.32 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.597 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.48 165.38 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-O 118.739 -0.648 . . . . 0.0 109.966 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.54 155.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.625 1.203 . . . . 0.0 110.616 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.19 22.99 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.823 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.4 mp0 -71.93 -18.54 62.01 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.566 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.98 -44.26 97.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.799 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.453 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.3 m-85 -113.79 7.88 17.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.716 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.78 -154.49 50.04 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.87 -25.4 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.0 110.536 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.92 -125.88 1.52 Allowed Glycine 0 CA--C 1.517 0.211 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -132.05 159.86 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.859 0.362 . . . . 0.0 110.372 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.66 -162.59 25.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.21 141.12 31.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.97 0.414 . . . . 0.0 110.611 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.27 111.73 3.95 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.6 mt -120.55 160.3 23.46 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.93 149.28 24.9 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 120.83 0.348 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.5 -48.59 65.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.763 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.49 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -71.76 51.96 0.21 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.708 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -64.37 -46.2 84.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.11 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.48 -47.08 35.48 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.096 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.24 -43.79 98.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.459 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.57 -42.85 99.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.746 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.71 -37.55 73.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.694 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.32 -77.47 0.1 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.503 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.9 mt -28.95 -45.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.984 0.421 . . . . 0.0 110.769 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.443 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.1 m-20 -63.69 -45.47 89.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.49 -43.74 98.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.947 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.23 92.61 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.15 -43.67 98.52 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.16 0.505 . . . . 0.0 110.112 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.98 -39.36 91.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.71 -42.67 97.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.895 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.14 -38.32 73.32 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.71 -38.76 77.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 110.447 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.01 -45.48 92.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.24 0.66 55.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.54 20.06 67.5 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 84.5 m -58.09 -46.13 86.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.58 -57.15 11.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.953 0.406 . . . . 0.0 110.451 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.9 mt-10 -57.23 -41.42 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.149 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.458 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.01 -41.53 98.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.413 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.99 -49.67 77.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.713 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.03 -35.82 73.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.318 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.45 -50.84 33.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.536 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.0 m-85 -62.31 -45.76 91.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.534 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.47 155.44 36.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.99 98.19 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.417 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -155.16 -165.74 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.45 109.67 14.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.74 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.3 m -63.75 -40.54 89.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.581 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 85.3 m-85 -57.03 -43.76 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.03 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.18 164.25 54.59 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.731 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.39 99.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.662 2.241 . . . . 0.0 112.335 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.45 -40.52 89.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.0 m-20 -139.14 142.77 38.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.398 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -109.87 127.25 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.899 0.38 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.67 120.49 40.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.87 141.88 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.927 0.394 . . . . 0.0 110.376 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.66 102.36 1.58 Allowed Glycine 0 N--CA 1.463 0.483 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.9 m -125.13 119.83 29.68 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 122.693 -0.298 . . . . 0.0 111.118 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.4 t70 -112.41 94.77 28.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.01 134.91 61.96 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.459 2.106 . . . . 0.0 112.25 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.1 p -136.49 -19.02 1.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.731 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.7 m-85 -125.63 98.19 5.47 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.715 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.671 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -30.11 -61.21 0.25 Allowed Pre-proline 0 C--O 1.218 -0.585 0 CA-C-O 121.735 0.778 . . . . 0.0 111.064 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 6.4 Cg_endo -50.2 -40.21 51.7 Favored 'Trans proline' 0 C--N 1.293 -2.394 0 C-N-CA 122.4 2.067 . . . . 0.0 112.315 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.5 t80 -79.16 -43.29 24.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.017 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.671 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.0 mt-10 -146.29 -161.59 1.35 Allowed 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.225 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.2 t 158.13 -179.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.429 . . . . 0.0 110.25 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -133.12 141.04 47.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.4 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.28 137.44 32.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.605 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -65.24 -18.86 65.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.512 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.0 -5.11 53.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.441 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.35 -10.89 56.72 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.64 162.47 24.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.976 0.417 . . . . 0.0 110.391 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.07 137.68 52.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.943 0.402 . . . . 0.0 110.471 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.25 151.48 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.312 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.55 153.52 7.2 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.07 -41.38 92.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.42 . . . . 0.0 111.068 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.2 t0 -70.18 -32.5 70.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.227 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.1 mt -67.26 -40.28 84.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.886 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 55.0 m-20 -61.02 -37.3 82.07 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.709 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.0 tp -65.83 -44.68 84.86 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.15 -46.5 85.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -54.3 -54.19 43.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.387 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.06 -38.15 62.23 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.953 0.406 . . . . 0.0 110.419 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.51 -42.46 74.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.608 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -54.28 -44.42 71.89 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.044 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.63 -48.04 78.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.018 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -59.35 -41.28 88.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.096 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.28 -18.21 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.571 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.11 52.35 4.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 170.28 16.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.16 141.64 28.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.06 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -117.23 131.61 56.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.682 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -127.89 127.37 43.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.454 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.24 137.81 34.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.903 0.382 . . . . 0.0 110.399 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.56 129.52 64.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.403 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -67.65 139.97 56.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.78 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 173.65 135.52 0.13 Allowed Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.48 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.2 Cg_endo -68.62 144.19 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.592 2.195 . . . . 0.0 112.546 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.5 mt -40.75 -54.1 2.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.043 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -48.67 -26.18 2.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.15 -20.78 18.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.72 -42.47 95.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.001 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.589 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.28 -57.31 26.58 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.744 0.652 . . . . 0.0 109.616 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.0 Cg_exo -54.65 -43.26 60.71 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.658 2.239 . . . . 0.0 111.19 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.3 m -58.27 -44.74 88.55 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.691 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.87 -44.47 91.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.194 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.81 -41.06 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.492 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.08 11.31 1.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.85 12.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -33.58 75.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.529 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 67' ' ' ILE . 45.1 pt -124.29 154.43 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -91.75 -20.81 21.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.146 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.55 159.95 22.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 70' ' ' ILE . 96.3 mt -115.82 127.54 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.067 0.46 . . . . 0.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -129.03 107.2 9.42 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.28 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.565 ' HG ' ' N ' ' A' ' 73' ' ' SER . 46.9 t -162.17 -176.95 5.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.633 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.565 ' N ' ' HG ' ' A' ' 72' ' ' SER . 77.9 p -64.34 -15.94 61.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.59 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.4 tp -36.89 122.63 0.83 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -82.55 155.78 24.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.627 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -105.29 149.17 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.296 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.3 p -150.53 152.92 34.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.812 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.21 -47.84 54.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.967 0.413 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.5 -39.83 70.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.776 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.59 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -68.41 -37.75 80.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.67 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.852 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.88 -27.58 66.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.129 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.11 -51.55 7.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.7 -167.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.36 147.04 29.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 111.044 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -130.28 150.29 51.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.656 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.1 t -165.13 -150.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.431 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.656 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.3 m-20 42.55 19.94 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.93 121.09 0.11 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.38 0.425 . . . . 0.0 110.471 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -79.28 -71.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.782 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -148.19 165.27 31.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.624 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.32 126.05 31.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -106.19 67.74 0.75 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.752 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.68 -105.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.47 167.3 29.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.634 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.23 146.59 22.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.68 135.88 42.47 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.786 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.55 111.58 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.77 164.69 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.04 148.3 24.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.14 -27.88 48.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -59.29 -41.46 89.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.35 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -102.45 122.48 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.61 109.7 19.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.434 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 105' ' ' ILE . 96.9 mt -128.2 129.97 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.718 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.6 35.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.451 . . . . 0.0 110.507 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.471 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.9 Cg_endo -60.45 91.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.783 2.322 . . . . 0.0 111.9 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -169.57 141.97 2.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 123.584 0.553 . . . . 0.0 110.75 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.07 -33.42 60.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.215 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.19 -62.77 1.53 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.294 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.0 t -56.2 -21.91 25.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.138 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.12 -26.62 56.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.307 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.04 133.22 48.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.387 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -16.25 29.64 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.34 151.18 23.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.421 . . . . 0.0 110.409 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.71 134.88 38.12 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.198 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.65 136.48 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.692 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.7 138.83 14.49 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.09 161.55 40.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.145 0.497 . . . . 0.0 110.313 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.493 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.2 tp -92.42 118.07 30.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.563 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.57 157.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.58 50.66 53.41 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.3 p -149.05 167.96 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.831 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.5 p -71.5 -29.76 65.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.2 mt-30 -58.93 -55.13 39.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.42 -55.46 33.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.38 -51.26 70.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.77 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.598 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.5 t80 -62.06 -43.91 97.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.95 -44.36 97.92 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.12 -14.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.35 2.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.598 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.31 -50.7 17.75 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.38 12.61 35.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.248 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.97 -55.46 0.47 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.37 -9.98 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.78 2.32 . . . . 0.0 111.913 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -83.0 -8.74 59.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.23 33.35 36.05 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.7 137.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.009 0.433 . . . . 0.0 110.472 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -87.58 130.26 34.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.258 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.4 137.96 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.9 t -123.03 133.33 69.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.87 126.87 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -110.67 153.65 24.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.73 7.98 28.68 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.15 130.09 5.79 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.04 -45.91 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.38 -23.51 62.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.495 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.463 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.66 -36.66 84.98 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.535 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 149' ' ' ILE . 96.5 mt -65.98 -47.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.13 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.63 -38.0 89.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.22 -42.58 98.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.182 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -64.06 -45.13 90.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.037 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.47 -47.95 82.38 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.206 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.56 -22.86 67.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.005 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.9 -18.76 25.54 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.548 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.01 11.17 70.51 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.61 -18.12 63.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.593 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.5 pt -128.46 137.57 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 110.444 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.64 -28.72 62.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.53 155.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.24 138.62 51.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.018 0.437 . . . . 0.0 109.96 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.48 102.98 14.58 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.214 0.531 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.93 25.2 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.438 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.83 152.23 40.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 98.0 mt-10 -66.05 -53.97 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.268 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 70.4 t -60.08 -49.22 84.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.42 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.96 85.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.882 0.372 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.26 1.25 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.318 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 68.2 m -57.98 -46.39 85.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.293 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -45.61 -41.56 10.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.389 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.477 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.52 -62.06 0.47 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.721 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.655 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.69 -71.56 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.534 0.207 . . . . 0.0 111.136 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -62.16 -41.23 98.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.5 tttt -59.98 -2.17 0.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.53 0.681 . . . . 0.0 110.318 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.517 ' H ' ' C ' ' A' ' 173' ' ' LEU . 52.5 mt-30 -126.45 141.93 41.49 Favored Pre-proline 0 CA--C 1.532 0.272 0 O-C-N 122.079 -0.388 . . . . 0.0 110.733 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.65 -14.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.842 2.361 . . . . 0.0 112.397 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 175' ' ' GLN . 87.6 t -62.94 -42.89 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.17 84.33 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.38 -41.1 96.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.92 -34.9 79.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.476 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.52 142.97 18.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.0 pttt -175.88 99.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.962 0.41 . . . . 0.0 110.796 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.5 m-85 -158.68 167.11 30.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.683 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.19 55.98 3.14 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 134.98 36.06 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 111.949 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.461 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -124.32 -108.35 0.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.547 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.605 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -165.42 165.07 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 CA-C-O 119.16 -0.447 . . . . 0.0 110.156 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.8 tttt 154.13 155.24 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.283 0.989 . . . . 0.0 110.669 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.15 118.51 22.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.776 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.4 mp0 -71.17 -19.07 62.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.55 -31.81 73.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.546 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.88 -44.33 97.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 -178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -114.16 8.44 16.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.819 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.44 -153.58 50.76 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.1 p -71.01 -25.65 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.71 -125.97 1.53 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.5 p -132.16 160.42 36.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.504 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.54 -162.04 24.02 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.68 139.83 33.8 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.959 0.409 . . . . 0.0 110.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.65 108.75 3.47 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.0 mt -117.72 159.41 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 0.0 110.253 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.82 149.19 25.02 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 120.886 0.374 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.61 64.16 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.645 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -40.64 -22.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.81 51.55 0.28 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -64.47 -46.03 84.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.171 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.28 -47.08 37.15 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.26 -43.65 98.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.474 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.45 -43.05 99.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.823 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.77 -37.51 73.8 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.26 -77.69 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.518 ' C ' ' O ' ' A' ' 212' ' ' ALA . 87.3 mt -28.54 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.448 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.6 m-20 -63.43 -45.57 90.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.02 -43.84 98.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.94 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.26 92.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.077 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -61.11 -43.67 98.53 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.058 0.456 . . . . 0.0 110.015 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.34 92.07 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.058 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.67 -43.52 96.45 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.2 -38.65 71.27 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.73 -38.75 76.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.024 0.44 . . . . 0.0 110.367 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.56 91.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 20.6 p-10 -88.61 -0.02 56.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.78 20.86 68.8 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.5 m -58.05 -46.38 85.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 80.4 t80 -63.26 -57.62 9.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.443 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.423 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.4 mt-10 -57.05 -42.43 80.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.399 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -48.66 80.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.71 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.34 -41.38 98.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.566 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.67 -50.04 75.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.63 -34.65 73.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.719 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -71.16 -51.77 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.706 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.432 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 39.4 m-85 -62.52 -44.94 95.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.67 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 230' ' ' ALA . 84.0 m-85 -151.06 153.21 34.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 49.1 p-10 -98.34 93.6 6.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.495 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.56 -165.64 2.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.511 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.447 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.36 108.8 13.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.4 -40.59 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.423 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.2 m-85 -57.3 -43.49 83.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.16 94.31 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.683 0 CA-C-O 117.876 -1.513 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.73 164.37 56.03 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.78 143.75 99.44 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 122.692 2.261 . . . . 0.0 112.3 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.24 -40.0 89.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -140.1 145.54 37.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.42 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.28 130.04 66.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -105.93 117.88 35.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.448 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -113.27 140.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.44 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.2 100.45 1.46 Allowed Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.5 m -123.66 119.3 29.42 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.66 -0.318 . . . . 0.0 111.151 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 8.1 t70 -112.33 93.98 24.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.22 135.18 63.91 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.16 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.7 p -137.22 -18.16 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.71 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.9 m-85 -124.84 97.59 5.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.711 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.69 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -30.48 -61.26 0.25 Allowed Pre-proline 0 C--O 1.218 -0.577 0 CA-C-O 121.729 0.776 . . . . 0.0 111.071 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 6.5 Cg_endo -49.86 -41.23 47.78 Favored 'Trans proline' 0 C--N 1.292 -2.435 0 C-N-CA 122.419 2.08 . . . . 0.0 112.357 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.2 t80 -78.31 -43.06 28.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.078 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.69 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.0 mt-10 -146.35 -161.5 1.33 Allowed 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.167 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.3 t 157.81 -179.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.03 0.443 . . . . 0.0 110.224 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.2 mttt -133.73 140.71 47.16 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.471 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -88.87 138.68 31.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.606 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -65.26 -19.15 65.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.501 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -79.81 -5.16 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.0 -10.45 57.02 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.59 158.91 27.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.389 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.6 mt -114.21 135.38 54.11 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.536 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -131.62 150.61 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.267 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.99 152.99 7.03 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -60.23 -41.5 93.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.973 0.416 . . . . 0.0 110.851 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 -70.2 -32.75 70.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.354 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.85 -40.13 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.892 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.03 -37.02 81.09 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.89 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.48 -44.66 82.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.177 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.8 -41.67 91.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.095 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -57.8 -53.43 58.33 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.596 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.97 -36.16 65.07 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.314 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.93 -43.18 72.17 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -55.04 -43.6 73.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.3 -48.02 77.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.019 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.49 -40.79 88.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.5 mt -76.32 -18.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.46 51.75 4.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.123 0.487 . . . . 0.0 110.799 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -144.39 169.26 18.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.75 140.36 29.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.065 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -117.31 132.29 56.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.0 m -128.16 126.88 41.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.386 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.5 136.69 34.52 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.455 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.33 129.34 64.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.346 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.67 141.19 56.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.757 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 172.65 135.86 0.1 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.497 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.56 144.19 59.75 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.644 2.23 . . . . 0.0 112.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.0 mt -41.17 -53.64 3.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.916 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.84 -26.11 2.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.41 19.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.143 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.84 -42.5 94.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.963 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.42 -56.97 28.54 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.772 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.1 Cg_exo -55.18 -43.04 62.8 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.562 2.175 . . . . 0.0 111.137 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -58.32 -44.42 88.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.764 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.95 -44.48 91.45 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.65 -40.92 96.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 0.0 110.431 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.77 11.38 1.38 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 55.92 12.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.53 -33.81 76.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 67' ' ' ILE . 42.4 pt -124.71 153.73 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.323 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -92.83 -20.46 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.29 158.38 24.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.674 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.4 HD13 HG23 ' A' ' 70' ' ' ILE . 96.4 mt -116.41 127.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.502 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.68 106.65 9.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.301 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.501 ' HG ' ' N ' ' A' ' 73' ' ' SER . 40.6 t -161.11 -177.97 6.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.501 ' N ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.33 -15.54 60.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.627 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.13 123.09 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.558 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -82.44 155.84 24.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.704 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -105.03 148.73 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.45 152.81 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.781 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.66 52.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 110.567 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.37 -39.96 70.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.627 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.61 -37.57 79.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.89 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.33 -38.09 76.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.86 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.86 -27.69 66.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.02 -51.36 7.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.957 0.408 . . . . 0.0 110.69 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -139.12 -167.83 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.1 0.476 . . . . 0.0 110.457 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.64 147.06 29.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.044 0.449 . . . . 0.0 110.966 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -130.05 150.21 51.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.629 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.717 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.2 t -165.08 -150.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.717 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.3 m-20 42.52 20.08 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.7 mttt -27.79 121.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.494 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 17.6 mt -79.84 -72.49 0.4 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -147.77 164.74 32.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.2 127.67 32.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.19 67.34 0.69 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.12 -106.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.47 167.65 28.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.58 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.413 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.4 mt -101.03 135.96 41.64 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.786 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.87 111.03 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.72 164.41 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.956 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.64 148.69 24.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.6 -28.16 53.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.13 -41.43 88.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.266 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.31 122.25 43.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 110.218 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.71 109.71 19.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.403 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 105' ' ' ILE . 96.9 mt -128.39 130.01 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.634 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.1 158.84 34.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.568 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.484 ' C ' ' HG1' ' A' ' 108' ' ' THR . 20.5 Cg_endo -60.06 90.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.819 2.346 . . . . 0.0 111.858 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.484 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 7.0 m -169.17 141.43 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.538 0.524 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.76 -33.14 59.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.31 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -57.15 -62.56 1.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.381 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.56 -21.8 29.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.062 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.1 -26.95 56.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.347 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.87 132.82 47.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.373 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -15.93 33.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.72 151.25 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 0.0 110.45 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.06 135.35 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.998 0.427 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.63 136.5 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 137.62 13.84 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.63 161.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.118 0.485 . . . . 0.0 110.31 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.493 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.2 tp -92.75 119.38 32.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.49 156.81 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.65 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.12 50.55 50.84 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.2 p -148.87 167.83 24.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 67.1 p -71.98 -28.68 63.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.458 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -59.7 -55.33 35.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.47 -55.11 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.55 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.55 -51.12 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.69 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.3 t80 -62.03 -43.9 97.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.091 0.472 . . . . 0.0 110.434 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.25 -44.38 97.77 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.03 -14.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 0.0 110.795 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.54 -34.24 2.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.692 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.36 -51.07 16.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.959 0.409 . . . . 0.0 111.539 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.24 12.69 35.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.241 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.49 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.93 -55.48 0.47 Allowed Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.341 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.23 -10.09 25.27 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.781 2.32 . . . . 0.0 111.945 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.99 -8.93 59.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.46 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.55 33.36 34.92 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.58 137.44 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.913 0.387 . . . . 0.0 110.547 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.28 130.28 34.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.59 138.32 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.37 133.33 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 109.979 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.08 127.34 42.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.57 153.85 24.57 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.97 6.68 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.68 130.43 5.82 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.07 -45.92 79.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.56 -24.27 63.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.516 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.473 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -36.69 85.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.456 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.42 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -65.9 -46.71 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.067 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -64.3 -37.87 89.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.269 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.56 -42.29 96.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.122 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.461 ' N ' ' HG ' ' A' ' 151' ' ' SER . 53.1 m-20 -65.77 -42.35 90.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.843 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.5 tp -59.23 -48.59 81.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.185 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.2 m -62.64 -22.39 66.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.002 0.43 . . . . 0.0 110.204 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.36 -17.9 26.47 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.562 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.58 11.56 74.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.6 -17.84 63.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.41 136.65 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 110.502 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.95 -28.84 62.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.201 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.13 155.12 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.792 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.22 138.27 51.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 109.978 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.15 103.21 14.58 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.23 0.538 . . . . 0.0 110.599 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.67 25.78 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.436 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.66 152.76 40.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.54 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.24 -53.97 30.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.06 -49.02 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.365 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.81 84.22 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 110.837 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.78 1.1 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.6 m -57.64 -46.13 84.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.7 tt0 -46.32 -42.31 14.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.338 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.1 -61.87 0.48 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.762 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.0 t80 -40.38 -71.19 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.584 0.23 . . . . 0.0 111.214 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -62.28 -40.81 97.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.8 tttt -59.86 -2.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.579 0.704 . . . . 0.0 110.494 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 177' ' ' VAL . 58.1 mt-30 -126.5 141.78 41.09 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.832 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -43.43 -14.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.861 2.374 . . . . 0.0 112.328 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' GLN . 90.0 t -62.87 -43.03 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.589 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.86 -33.44 85.38 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.38 96.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.731 0.301 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -65.79 -34.95 79.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.503 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.8 m-85 -156.64 143.25 18.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.737 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -176.16 99.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.746 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.5 167.01 30.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.23 55.39 3.09 Favored Glycine 0 C--O 1.225 -0.413 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.11 -116.83 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.05 134.65 36.57 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.46 2.107 . . . . 0.0 111.893 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.3 p -124.03 -108.63 0.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.542 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.603 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.43 165.01 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.4 tttt 154.61 155.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.178 0.924 . . . . 0.0 110.665 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -81.27 118.92 23.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.3 -19.1 62.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.45 -31.41 72.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.494 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.89 -44.4 97.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.736 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.29 8.61 16.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.722 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.22 -153.81 49.97 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.8 p -70.65 -25.72 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.559 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.99 -126.59 1.62 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.6 p -132.21 160.24 36.7 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.26 -162.93 25.27 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.06 140.22 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.419 . . . . 0.0 110.591 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.72 108.8 3.48 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.3 mt -118.22 159.72 22.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.944 0.402 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.73 148.79 25.28 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.38 64.26 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -40.57 -22.51 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.0 110.739 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.77 51.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.748 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -64.32 -46.62 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.23 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.16 -47.09 38.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.05 -43.52 98.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.53 -43.13 99.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.799 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.56 -37.65 73.47 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.696 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.29 -77.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.518 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.3 mt -28.72 -45.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.846 0.355 . . . . 0.0 110.518 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.451 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 87.9 m-20 -63.66 -45.81 88.45 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.02 -44.11 97.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.33 92.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.148 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.95 -43.81 98.16 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.15 91.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.087 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -64.05 -43.59 95.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.859 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.24 -38.52 71.19 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -38.98 77.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.27 -45.55 90.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 19.1 p-10 -88.73 -0.71 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.21 20.44 71.19 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.5 -46.22 87.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.494 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 71.0 t80 -62.35 -56.2 20.65 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.244 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.5 mt-10 -57.48 -40.26 78.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.059 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.32 -47.92 83.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.491 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.08 -40.77 96.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -61.11 -49.14 78.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.01 -35.74 73.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.503 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.49 -51.39 36.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.584 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 8.8 m-85 -62.01 -46.3 89.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.52 154.92 33.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.49 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -98.31 96.89 8.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.45 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.63 -164.67 2.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.555 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -121.96 108.92 13.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.734 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.45 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.409 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 91.3 m-85 -58.82 -42.38 89.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.288 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -62.96 -37.93 95.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.712 0 CA-C-O 117.905 -1.497 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.85 164.26 57.51 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.642 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.08 143.82 99.13 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.625 2.217 . . . . 0.0 112.309 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.09 -40.6 90.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.578 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.21 143.7 38.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.447 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.33 129.03 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.854 0.359 . . . . 0.0 110.466 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.57 117.56 34.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.372 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 141.78 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.973 0.416 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.67 106.74 2.12 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.8 m -128.94 120.06 25.44 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.634 -0.333 . . . . 0.0 111.107 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 26.9 t0 -112.41 94.67 28.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.079 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.18 134.74 61.89 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.463 2.109 . . . . 0.0 112.205 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.1 p -136.77 -18.54 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.73 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.9 m-85 -124.66 98.06 5.56 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.817 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.704 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -30.47 -61.21 0.25 Allowed Pre-proline 0 C--O 1.218 -0.596 0 CA-C-O 121.633 0.73 . . . . 0.0 110.991 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 6.3 Cg_endo -49.92 -41.48 47.58 Favored 'Trans proline' 0 C--N 1.294 -2.334 0 C-N-CA 122.364 2.042 . . . . 0.0 112.328 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.3 t80 -77.99 -42.7 31.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.972 0.415 . . . . 0.0 111.011 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.704 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.2 mt-10 -146.77 -160.97 1.23 Allowed 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.131 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.3 t 157.64 -178.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.085 0.469 . . . . 0.0 110.172 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.544 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.76 140.32 45.82 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.439 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.1 t-20 -90.46 141.93 28.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.471 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.2 p -66.14 -19.02 65.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.585 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.11 -6.16 53.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.478 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.85 -9.2 58.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.49 162.34 25.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 110.44 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.01 136.09 53.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.922 0.392 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 p -132.34 151.03 34.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.343 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.49 153.47 7.18 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.47 -41.2 93.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.974 0.416 . . . . 0.0 110.838 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 -70.23 -32.8 70.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.279 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.1 mt -66.85 -39.98 84.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.793 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.0 -37.01 81.02 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.787 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.91 -44.84 84.02 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.33 -45.53 87.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.02 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -54.61 -54.36 42.55 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.51 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.9 -37.53 63.87 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.475 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.31 -43.11 74.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.588 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 52.0 m -54.25 -44.0 71.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.035 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -64.01 -47.93 78.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.006 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.55 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.11 -18.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.24 52.33 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.68 170.23 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.19 141.74 28.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.101 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.57 132.19 56.56 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.78 126.6 42.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.389 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.93 136.69 34.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.31 129.18 64.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.93 139.66 56.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.779 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 p30 175.52 135.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.52 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.1 Cg_endo -68.65 143.71 57.51 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.644 2.229 . . . . 0.0 112.461 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.6 mt -40.62 -54.78 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.032 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.43 1.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.89 -20.97 18.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.92 -42.48 97.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.791 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.604 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.88 -57.1 26.22 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.711 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -54.93 -42.94 64.2 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.615 2.21 . . . . 0.0 111.214 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.52 -44.88 89.7 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.749 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.75 -44.48 90.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.75 -41.02 96.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.484 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.06 11.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 55.97 12.32 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.77 -33.83 76.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 67' ' ' ILE . 45.7 pt -124.06 154.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.261 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -91.85 -20.79 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.02 160.53 21.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.637 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 70' ' ' ILE . 96.1 mt -116.1 127.76 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.052 0.453 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.2 ttp -129.12 107.42 9.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.334 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.628 ' HG ' ' H ' ' A' ' 73' ' ' SER . 38.3 t -162.72 -176.91 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.628 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -63.89 -16.22 60.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.62 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.4 tp -36.99 122.75 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.491 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.94 155.88 23.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.712 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.5 pt -105.36 149.46 8.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.347 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.7 p -150.49 152.76 34.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.775 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.02 -47.66 53.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 110.589 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.26 -39.93 70.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.807 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.62 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -38.1 75.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.81 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.75 -27.65 66.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.078 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.08 -51.1 7.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.039 0.447 . . . . 0.0 110.73 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.15 -167.57 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.135 0.493 . . . . 0.0 110.498 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.93 147.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -130.35 150.49 51.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.724 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.3 t -165.28 -150.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.455 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.724 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.2 m-20 42.51 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.04 120.99 0.11 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.499 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -79.95 -72.51 0.4 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.932 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -147.81 165.11 31.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.641 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.05 127.56 32.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.387 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.19 66.99 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.591 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.27 -106.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.0 p -159.23 167.44 29.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.616 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.85 146.79 23.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 0.0 110.415 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.47 135.84 42.3 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.773 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.83 110.98 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.75 164.44 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.59 148.43 24.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.06 -28.24 50.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.248 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.09 -41.35 87.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.252 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 t -102.38 122.28 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.262 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.01 109.52 19.89 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.067 0.46 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.05 129.76 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.705 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.37 159.0 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.554 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.479 ' C ' ' HG1' ' A' ' 108' ' ' THR . 20.6 Cg_endo -60.3 90.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.74 2.293 . . . . 0.0 111.884 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.479 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 7.3 m -169.05 141.29 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.543 0.527 . . . . 0.0 110.73 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.83 -33.52 62.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.246 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.15 -62.57 1.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -56.02 -22.0 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.12 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.46 -26.19 55.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.317 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.2 47.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.422 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.77 -15.67 30.27 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.14 150.85 24.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.429 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.55 134.82 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 110.259 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.58 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.663 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.76 137.44 13.78 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.47 161.49 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.127 0.489 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.49 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.4 tp -92.51 119.3 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.528 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.13 156.7 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.717 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.54 53.51 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -148.41 167.3 25.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.294 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 74.8 p -70.59 -31.27 68.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.468 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -58.22 -54.97 40.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.431 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -56.27 -55.74 29.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.74 -51.24 70.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.818 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.4 t80 -62.02 -44.09 97.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.78 -44.24 98.15 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.33 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.843 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.38 2.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.09 -50.98 17.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.025 0.44 . . . . 0.0 111.578 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.23 12.74 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.306 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.93 -55.37 0.47 Allowed Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.432 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.25 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.747 2.298 . . . . 0.0 111.951 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -8.85 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.484 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.39 35.79 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.48 137.52 41.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.969 0.414 . . . . 0.0 110.49 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.42 130.48 34.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.343 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.22 138.57 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.45 133.61 68.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.042 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 126.77 42.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -110.14 153.9 24.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.286 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.22 6.68 28.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.13 130.2 5.83 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.97 -45.9 80.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.2 -23.78 63.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.473 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.64 -36.72 85.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 149' ' ' ILE . 96.7 mt -65.9 -46.88 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.149 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.671 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.51 -37.55 87.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.67 -41.85 95.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 -42.29 89.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.7 tp -59.21 -48.53 81.25 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.134 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.5 -22.33 66.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 0.0 110.198 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.57 -17.77 26.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.603 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.87 74.4 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.86 -18.22 63.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.612 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.71 135.98 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.479 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.32 -29.34 63.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.269 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.17 155.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.801 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.95 138.85 52.22 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.97 0.415 . . . . 0.0 109.924 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -86.75 102.71 14.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.216 0.531 . . . . 0.0 110.783 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.671 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 51.0 tt0 -131.94 164.58 25.82 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.386 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.439 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.55 153.27 40.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.526 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.67 -54.25 25.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.237 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.6 t -59.97 -49.08 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.84 84.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.941 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.72 1.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.455 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 67.0 m -57.82 -46.37 84.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.32 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.6 tt0 -46.1 -41.87 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.411 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.451 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.25 -62.11 0.48 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.707 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.2 t80 -40.3 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.786 -0.244 . . . . 0.0 111.184 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -62.14 -40.71 96.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.55 -2.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.422 0.629 . . . . 0.0 110.394 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 177' ' ' VAL . 53.5 mt-30 -126.21 141.6 40.24 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.799 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.39 -14.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.792 2.328 . . . . 0.0 112.335 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 175' ' ' GLN . 91.0 t -63.04 -43.04 98.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.88 -33.46 85.49 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.06 -41.37 96.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.0 110.444 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -65.74 -34.81 79.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.465 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -156.92 143.53 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.734 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.19 99.38 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.4 m-85 -158.9 167.01 30.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.632 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.9 55.96 3.02 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.17 -116.92 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 134.76 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.502 2.135 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.2 p -124.23 -108.5 0.33 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.24 164.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.213 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.614 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.5 tttt 154.68 155.11 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 124.041 0.838 . . . . 0.0 110.706 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -81.04 118.5 22.55 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.777 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -70.5 -18.81 62.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.51 -31.61 72.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.93 -44.4 97.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.702 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.07 8.33 16.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.788 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.66 -153.52 50.42 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.8 -25.76 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.554 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.77 -126.98 1.68 Allowed Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.8 p -132.21 160.37 36.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.418 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.98 -161.65 23.73 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.94 140.06 33.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.925 0.393 . . . . 0.0 110.611 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.73 108.71 3.48 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -117.45 159.36 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.251 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.31 148.84 25.43 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.86 -48.46 64.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.69 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -40.85 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -72.9 51.51 0.29 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.895 0.379 . . . . 0.0 110.794 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.46 -46.3 83.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.06 -47.22 38.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.026 0.441 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.14 -43.46 98.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.464 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.7 -43.02 99.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.825 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -37.44 73.52 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.48 -77.47 0.11 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.3 mt -28.52 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.444 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.3 m-20 -63.5 -45.92 88.47 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.83 -43.94 97.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.929 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.1 91.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.083 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.28 91.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.051 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.73 -43.69 95.77 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.26 -38.48 71.22 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.57 -39.04 77.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.987 0.423 . . . . 0.0 110.271 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.39 91.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.649 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 19.3 p-10 -89.02 -0.5 57.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.87 20.75 70.81 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.48 -46.27 87.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.499 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 73.2 t80 -62.3 -56.46 18.22 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.414 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -57.08 -40.42 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.176 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.53 -47.89 83.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.485 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.11 -40.96 97.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.44 77.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.501 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.93 -35.74 73.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.63 -51.45 34.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.97 -45.97 91.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.6 m-85 -155.05 154.76 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.522 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.2 p-10 -97.99 96.0 7.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.439 . . . . 0.0 110.526 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.0 -164.7 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.545 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.14 108.98 13.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.4 m -63.54 -40.64 89.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.358 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.414 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 90.4 m-85 -58.53 -42.6 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.39 -37.67 95.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.689 0 CA-C-O 117.848 -1.529 . . . . 0.0 111.021 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 164.13 63.33 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.643 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.05 143.6 99.19 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 122.591 2.194 . . . . 0.0 112.313 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.43 -41.13 89.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.562 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -137.93 139.44 39.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.417 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.82 121.36 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.675 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.93 118.82 32.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.178 0.513 . . . . 0.0 110.154 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.56 138.69 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.96 105.75 2.15 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.2 m -129.04 120.61 26.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 122.69 -0.3 . . . . 0.0 111.018 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.6 t70 -114.42 92.9 29.77 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.19 134.58 61.12 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.502 2.135 . . . . 0.0 112.07 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 p -141.84 -20.31 0.73 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.775 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.5 m-85 -123.54 99.09 6.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.614 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.672 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.12 -61.46 0.22 Allowed Pre-proline 0 C--O 1.218 -0.575 0 CA-C-O 121.433 0.635 . . . . 0.0 111.015 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.5 Cg_endo -49.35 -40.63 43.91 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 122.272 1.981 . . . . 0.0 112.284 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -78.21 -42.75 30.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.036 0.446 . . . . 0.0 110.942 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.9 mt-10 -149.73 -153.9 0.52 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.912 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.86 177.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.023 0.439 . . . . 0.0 110.389 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.42 144.71 46.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.452 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -95.9 134.37 38.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.637 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.76 -19.0 65.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.11 -6.17 53.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.41 -7.9 56.54 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.65 159.14 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 110.442 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.5 mt -112.57 131.18 55.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.999 0.428 . . . . 0.0 110.449 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.95 151.32 32.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.325 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.02 151.27 6.52 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -58.55 -42.03 86.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.855 0.36 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.469 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.9 t0 -69.7 -28.55 65.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.157 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.01 -40.86 83.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.873 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -60.91 -37.26 81.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.829 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.88 -45.08 87.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.12 -48.54 78.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.982 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -53.0 -54.66 31.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.33 -39.88 61.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.864 0.364 . . . . 0.0 110.298 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.67 -41.94 78.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 110.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.44 -45.19 69.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.084 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.09 -46.84 82.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.042 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -60.01 -42.28 93.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.16 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.32 -17.23 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.72 53.21 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.489 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.26 171.56 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.11 142.61 27.5 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.018 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.45 131.15 56.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.24 126.94 43.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.411 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -93.73 134.66 35.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.06 127.81 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.262 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.63 137.8 57.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.776 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.05 131.53 0.17 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.555 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.7 Cg_endo -68.01 144.74 65.15 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.729 2.286 . . . . 0.0 112.435 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.4 mt -40.33 -55.55 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.42 1.94 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.04 -20.94 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.249 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 mt -63.8 -42.42 97.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.596 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.623 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.2 -56.99 25.98 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.806 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.48 -42.41 68.26 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.59 2.193 . . . . 0.0 111.179 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 70.7 m -58.7 -44.89 90.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.931 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.05 -44.06 91.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.35 -40.72 96.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.956 0.408 . . . . 0.0 110.452 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.04 2.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.514 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.19 12.08 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.463 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -35.5 80.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.481 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -122.34 152.89 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.264 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.2 -22.18 19.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.61 155.99 27.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.0 129.28 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 110.406 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.34 106.52 8.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.395 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.8 t -158.95 178.43 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.636 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.7 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -65.4 -15.35 62.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.611 ' CD1' HH12 ' A' ' 80' ' ' ARG . 43.9 tp -34.82 124.65 0.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.01 153.86 25.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.645 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 pt -104.84 148.86 8.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.297 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -149.36 152.13 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.854 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.85 -47.28 51.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.507 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.32 -39.83 70.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.735 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.611 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.94 -37.91 79.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.84 -38.95 76.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.816 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.89 -27.42 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.096 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.42 -50.84 7.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.048 0.451 . . . . 0.0 110.655 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.18 -168.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.131 0.491 . . . . 0.0 110.456 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.43 147.66 30.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.007 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -129.88 149.9 51.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.563 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.642 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.7 t -163.09 -153.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.592 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.642 ' H ' ' HG1' ' A' ' 87' ' ' THR . 92.8 m-20 41.34 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.945 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.62 121.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.346 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.429 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.9 mt -75.09 -68.7 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -150.34 167.49 26.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.76 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.5 123.55 29.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.218 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.55 68.32 0.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.47 -104.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.35 165.7 32.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.741 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.34 146.35 22.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 0.0 110.443 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.9 mt -101.08 136.12 41.44 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.988 0.423 . . . . 0.0 110.81 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.8 110.41 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.2 164.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.71 148.48 23.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.988 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.6 -27.66 40.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.226 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.29 -41.83 89.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.316 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.5 122.14 43.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.94 109.35 19.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.424 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.9 129.65 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.772 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.25 159.0 33.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.523 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.468 ' C ' ' HG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.46 89.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.685 2.256 . . . . 0.0 111.904 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.468 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.6 m -169.08 140.31 2.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.31 -32.38 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -57.34 -62.92 1.43 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -55.39 -22.41 19.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.62 -25.8 54.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.67 132.67 46.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.95 -16.13 28.93 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.03 151.1 23.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.84 135.37 37.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.35 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.74 136.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.648 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 137.79 13.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 56.0 t -130.51 161.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.089 0.471 . . . . 0.0 110.336 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 42.1 tp -92.37 118.16 30.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.535 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.03 157.75 1.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.67 50.98 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.2 p -149.68 168.89 22.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.5 p -73.53 -27.25 61.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.45 -55.45 33.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.48 -55.1 37.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.583 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.05 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.705 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.8 t80 -62.08 -43.91 97.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.04 -44.46 97.75 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.41 -14.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.784 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.23 -34.36 2.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.55 -50.54 17.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.18 12.48 36.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.239 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.79 -55.51 0.47 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.332 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.33 25.66 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 111.952 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.76 -9.0 59.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.32 37.65 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.598 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.51 129.87 34.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.333 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 138.29 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.923 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.25 133.21 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 109.946 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.46 127.63 43.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -110.7 153.89 24.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -106.91 7.13 29.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.72 130.73 6.06 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.95 -45.92 80.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.768 0.318 . . . . 0.0 110.474 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.25 62.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.7 -36.84 85.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.543 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 149' ' ' ILE . 96.7 mt -65.97 -46.79 87.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.138 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.685 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.7 m-85 -64.45 -37.65 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.348 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.86 -42.16 97.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.023 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.99 -43.38 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.96 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.8 tp -58.98 -48.15 82.6 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.096 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.79 -22.32 66.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.955 0.407 . . . . 0.0 110.164 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.78 -18.21 25.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.07 11.92 72.04 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.17 -18.24 63.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.602 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.9 pt -127.02 135.92 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.371 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.54 -28.11 62.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.43 155.71 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.49 50.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 109.947 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.94 103.14 14.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.264 0.555 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.685 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 50.2 tt0 -132.65 165.14 25.15 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.382 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -72.79 153.05 41.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 110.634 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.4 -54.64 22.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.39 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 72.6 t -60.27 -48.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.618 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.08 89.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.862 0.363 . . . . 0.0 110.83 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.47 -63.27 1.18 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.1 m -59.28 -47.75 84.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.916 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.98 -37.44 20.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.195 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.08 -66.36 0.55 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.1 t80 -40.27 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.663 0.268 . . . . 0.0 111.194 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.35 -40.13 93.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.78 -2.84 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.443 0.64 . . . . 0.0 110.475 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.503 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.4 mt-30 -123.37 148.79 56.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.828 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.66 -19.97 3.95 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.892 2.395 . . . . 0.0 112.148 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.14 -42.55 93.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.99 -33.21 84.86 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.72 -41.26 94.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.695 0.283 . . . . 0.0 110.399 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.59 -33.93 77.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.327 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.35 142.66 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.732 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.19 99.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.754 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.17 166.76 30.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.713 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.87 56.54 2.72 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.44 -118.27 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.41 135.68 32.48 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.511 2.14 . . . . 0.0 111.918 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.7 p -125.41 -107.79 0.32 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.591 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -166.14 165.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.334 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 156.78 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 123.983 0.802 . . . . 0.0 110.665 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.84 117.24 22.58 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.5 mp0 -71.13 -18.89 62.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.85 -32.59 74.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.568 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.96 -44.54 97.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.71 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.4 m-85 -114.03 9.63 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.769 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.0 -154.76 52.38 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.39 -25.1 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.527 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.22 -124.32 1.32 Allowed Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.8 p -129.32 156.19 44.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.707 0.289 . . . . 0.0 110.33 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.6 -169.61 30.42 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.1 137.44 33.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.46 108.2 3.27 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.52 159.39 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.955 0.407 . . . . 0.0 110.206 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 90.0 mtm180 -86.84 149.64 24.69 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.89 -48.2 64.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.3 tp10 -38.23 -25.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.56 52.26 0.2 Allowed 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.677 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -64.56 -45.15 88.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.8 -47.3 31.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.26 -43.94 97.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.454 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.24 -42.92 99.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.724 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -36.23 70.28 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.45 -77.51 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.525 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.0 mt -28.46 -46.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.356 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.443 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.9 m-20 -64.33 -44.96 89.91 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.636 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.96 -43.66 98.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.962 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.21 93.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -43.57 98.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.28 92.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.63 -42.74 98.13 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.53 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.31 -38.42 77.05 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.86 -39.99 79.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.188 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -45.86 93.03 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.53 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.1 p30 -86.68 1.33 52.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.489 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.42 19.71 60.27 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 69.7 m -58.35 -45.63 87.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.429 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.2 t80 -63.62 -58.01 8.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.438 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.89 -41.44 78.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.349 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.6 -48.53 80.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.565 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.07 -41.49 98.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.327 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.19 74.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.73 -35.16 72.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.18 -50.97 27.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.481 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.09 -45.5 93.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.2 m-85 -153.27 155.16 36.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.7 p-10 -97.26 94.86 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.504 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -152.71 -166.43 2.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.86 110.37 15.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.799 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 m -63.55 -40.64 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.426 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.9 m-85 -56.62 -43.83 80.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.46 94.89 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.414 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.642 0 CA-C-O 117.895 -1.503 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.88 164.27 61.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.718 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.83 143.66 99.41 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.33 -41.02 90.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.622 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.42 139.69 39.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.56 121.43 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.07 118.51 31.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.067 0.46 . . . . 0.0 110.193 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.62 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.362 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.88 105.47 2.12 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -128.77 120.37 26.26 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.676 -0.308 . . . . 0.0 110.909 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.7 t70 -114.13 92.41 26.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.91 134.45 59.43 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.454 2.103 . . . . 0.0 112.187 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 p -141.79 -20.24 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.764 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.6 m-85 -123.42 99.04 6.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.464 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.651 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.09 -61.32 0.22 Allowed Pre-proline 0 C--O 1.218 -0.585 0 CA-C-O 121.737 0.779 . . . . 0.0 111.09 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.29 -40.85 43.43 Favored 'Trans proline' 0 C--N 1.29 -2.53 0 C-N-CA 122.567 2.178 . . . . 0.0 112.214 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.9 t80 -78.44 -42.72 29.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -149.78 -154.13 0.53 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.019 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 162.07 177.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.066 0.46 . . . . 0.0 110.294 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.45 144.45 46.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.448 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.37 134.26 38.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.587 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.73 -18.81 65.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.569 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.47 -6.53 55.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.421 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.06 -8.47 55.74 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.04 158.86 26.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.986 0.422 . . . . 0.0 110.434 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -112.46 131.31 55.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.936 0.398 . . . . 0.0 110.426 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.21 151.59 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.333 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.11 151.41 6.6 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -58.74 -42.14 88.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 122.515 -0.403 . . . . 0.0 110.979 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 -69.24 -28.4 66.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.229 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.25 -40.06 82.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.98 -37.64 83.17 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.959 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.71 -45.25 87.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.028 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.1 -48.51 78.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.872 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -52.85 -54.81 29.11 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.353 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -51.96 -39.99 60.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.41 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.82 -41.77 78.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.752 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.3 m -53.74 -45.08 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.063 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.13 -47.03 81.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.2 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.6 -42.38 92.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.37 -17.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.62 53.02 4.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -147.03 171.2 15.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.92 142.51 27.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.35 131.22 56.83 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -127.25 126.91 43.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.39 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.4 134.73 35.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.492 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.08 127.53 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.273 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.55 137.87 57.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.74 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.93 131.76 0.16 Allowed Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.593 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' ALA . 44.2 Cg_endo -68.26 145.12 65.04 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.743 2.295 . . . . 0.0 112.382 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.7 mt -40.44 -55.58 2.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 111.074 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.27 -26.43 1.98 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -21.0 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.183 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.3 mt -63.98 -42.42 97.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.619 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -57.47 23.48 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 123.952 0.783 . . . . 0.0 109.555 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 43.4 Cg_exo -55.01 -42.39 69.62 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.628 2.219 . . . . 0.0 111.36 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 68.4 m -58.69 -44.82 90.38 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.959 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.05 -44.02 91.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.255 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.55 -40.49 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.437 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.06 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.567 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.29 12.07 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.66 -35.39 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 pt -122.39 153.0 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.231 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.32 -22.16 19.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.143 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.53 155.82 27.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.656 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.11 129.03 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 110.423 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.15 106.67 8.5 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.329 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.689 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.8 t -159.11 178.67 9.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.689 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -65.43 -15.28 62.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -34.95 124.48 0.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.62 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.2 p -81.91 153.97 26.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.6 pt -104.74 148.66 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.214 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.2 152.15 35.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.73 -47.43 50.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.31 -39.85 70.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.786 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.614 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -69.1 -37.71 78.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.824 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.83 -38.87 76.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.965 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.76 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.199 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.2 -50.9 7.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.716 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.07 -168.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.102 0.477 . . . . 0.0 110.481 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.3 147.73 29.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.568 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.649 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.18 -153.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.503 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.649 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.9 m-20 41.23 20.32 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.027 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.64 0.2 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.468 0.48 . . . . 0.0 110.419 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.425 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.2 mt -75.37 -68.81 0.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -178.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -150.47 167.6 26.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.37 123.7 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.301 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.91 68.49 0.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.71 -104.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.5 p -159.53 165.73 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.582 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.53 145.98 21.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.178 0.513 . . . . 0.0 110.443 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.84 136.27 40.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.56 111.01 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.16 165.09 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.921 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.0 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.01 -28.47 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.237 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.84 -41.98 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.266 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -101.92 121.76 42.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.212 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.87 109.92 19.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.422 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 HG22 ' A' ' 105' ' ' ILE . 97.2 mt -127.0 129.62 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.56 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -108.17 154.32 41.34 Favored Pre-proline 0 C--N 1.333 -0.124 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.648 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.516 ' C ' ' HG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.33 92.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.819 2.346 . . . . 0.0 111.768 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.516 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.7 m -171.19 144.09 2.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 123.637 0.586 . . . . 0.0 110.82 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.3 -33.58 61.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.275 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -58.02 -62.48 1.79 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.291 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.07 -22.33 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.08 -25.68 55.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.54 133.11 46.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.454 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.0 -17.16 28.74 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.89 151.38 23.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 110.524 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -96.27 136.23 37.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.303 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.7 136.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.667 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 139.78 14.86 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.83 161.84 40.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.327 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 42.4 tp -92.72 118.05 30.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.709 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.47 157.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.584 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.68 51.45 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.7 p -149.65 168.58 23.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.6 p -74.33 -25.58 59.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.497 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -61.01 -55.8 28.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.537 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.04 -54.29 48.42 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.498 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.21 -51.31 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.616 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.45 -43.73 98.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.057 0.456 . . . . 0.0 110.458 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.63 -44.54 97.81 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.68 -14.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 0.0 110.745 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.07 -34.77 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.565 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.37 -50.43 18.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 111.516 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.16 12.79 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.187 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.486 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.09 -55.62 0.46 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.08 -10.44 25.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.783 2.322 . . . . 0.0 111.919 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.59 -8.97 59.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.504 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.63 33.41 38.38 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.31 138.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.031 0.443 . . . . 0.0 110.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.88 129.78 35.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.2 138.9 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.58 132.05 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.999 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.9 t -98.51 130.61 45.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.81 156.58 21.76 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.06 6.89 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.642 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.76 130.75 6.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.89 -46.01 79.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 110.429 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.81 -23.25 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.451 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.71 -36.58 84.75 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.61 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.19 -47.32 84.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.054 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.519 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.83 -37.97 89.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.0 -42.13 97.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.03 -45.4 89.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.8 tp -58.06 -48.28 80.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.327 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.2 m -63.12 -22.94 67.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.018 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.53 -18.73 24.75 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.503 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.13 70.34 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.46 -18.16 63.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.593 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.6 pt -127.88 136.88 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.069 0.462 . . . . 0.0 110.434 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.74 -27.46 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.72 155.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.851 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.12 136.94 49.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.076 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.47 103.33 14.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 110.76 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.71 23.91 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.409 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.98 152.45 41.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.506 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.27 -54.55 23.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.28 -49.01 85.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.342 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.77 88.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 110.76 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.21 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.6 m -59.24 -47.87 83.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.978 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.13 -37.5 22.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.125 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.405 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.84 -66.23 0.56 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.662 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.9 t80 -40.69 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.561 0.219 . . . . 0.0 111.092 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -61.1 -40.25 93.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.03 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -60.53 -2.73 0.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.448 0.642 . . . . 0.0 110.386 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.486 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.0 mt-30 -122.98 147.41 51.31 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 122.099 -0.376 . . . . 0.0 110.781 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.76 -19.7 2.32 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.864 2.376 . . . . 0.0 112.306 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.55 -42.91 95.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.531 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.17 -33.26 85.32 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.41 -41.41 93.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.77 0.319 . . . . 0.0 110.479 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.3 m-20 -65.52 -33.59 76.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.1 m-85 -155.98 142.68 18.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.9 99.52 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.2 m-85 -159.24 167.46 28.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.631 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.34 56.3 2.87 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.02 -118.03 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.3 135.39 31.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.48 2.12 . . . . 0.0 112.051 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.15 -107.93 0.33 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.555 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.609 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.75 165.35 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.053 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.32 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 O-C-N 124.34 1.025 . . . . 0.0 110.607 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.15 117.67 22.48 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.76 -18.86 62.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.89 -32.38 73.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.504 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.8 mt -60.79 -44.74 96.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.685 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.467 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.6 m-85 -113.97 9.66 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.722 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.22 -154.92 52.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.51 -24.74 25.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.02 -124.12 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.43 156.33 44.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 110.289 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.53 -169.53 30.26 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.37 137.26 33.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.29 108.21 3.26 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -123.46 159.31 29.31 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.278 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -86.61 149.62 24.8 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.87 -48.34 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.554 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -37.95 -25.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.826 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.45 52.25 0.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.649 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -45.69 86.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.152 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.49 -47.3 34.06 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.114 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.35 -43.74 98.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.747 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.86 -36.66 70.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.84 -77.15 0.11 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.5 mt -28.91 -46.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.443 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.1 m-20 -64.31 -44.99 89.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.802 178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.9 -43.73 98.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.36 93.81 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.18 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.32 -43.35 99.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.58 -39.08 92.57 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.531 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.73 -42.96 97.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.87 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.527 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.4 mtp -57.82 -38.21 75.16 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.02 -39.74 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.1 0.476 . . . . 0.0 110.26 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.0 92.43 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.443 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.2 p30 -86.43 1.26 51.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.69 19.57 60.73 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 70.3 m -58.28 -45.92 87.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.425 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 79.7 t80 -63.53 -57.59 9.7 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.397 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.5 mt-10 -56.97 -41.64 78.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.103 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.57 -48.81 79.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.505 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.62 -41.86 98.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.865 0.364 . . . . 0.0 110.566 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.78 -49.98 75.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -35.02 72.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.376 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.14 -50.93 28.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.418 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.24 -45.37 93.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.536 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.5 m-85 -154.26 155.62 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.6 97.17 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.974 0.416 . . . . 0.0 110.468 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -154.52 -166.02 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.417 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.23 110.53 15.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.9 m -63.39 -40.32 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.541 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 92.3 m-85 -58.54 -42.73 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.312 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.5 -37.15 94.35 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.871 -1.516 . . . . 0.0 110.917 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.48 164.26 62.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.82 99.43 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.24 -40.46 90.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.546 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.46 142.37 37.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.419 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 9' ' ' ILE . 82.4 mt -109.36 128.08 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.942 0.401 . . . . 0.0 110.483 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.68 117.55 34.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.348 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.58 139.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.425 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.45 105.44 2.16 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.6 m -128.11 119.33 25.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.75 -0.265 . . . . 0.0 111.077 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.4 t70 -113.53 92.58 24.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.05 134.25 58.98 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.484 2.123 . . . . 0.0 112.12 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.0 p -141.09 -19.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.713 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.8 m-85 -124.88 98.91 5.9 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.547 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.651 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -28.91 -61.47 0.22 Allowed Pre-proline 0 C--O 1.22 -0.48 0 CA-C-O 121.519 0.676 . . . . 0.0 111.053 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.31 -39.69 43.53 Favored 'Trans proline' 0 C--N 1.294 -2.326 0 C-N-CA 122.484 2.123 . . . . 0.0 112.279 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.1 t80 -79.34 -42.77 24.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.906 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.9 mt-10 -149.49 -155.75 0.66 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.03 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.41 177.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 0.0 110.377 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.56 140.6 46.24 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -92.23 136.96 32.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.619 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -65.07 -19.1 65.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.479 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.82 -5.82 54.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.454 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.96 -8.71 57.83 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.64 157.79 27.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.474 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.1 mt -112.48 133.59 54.46 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.935 0.398 . . . . 0.0 110.451 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -132.93 150.82 33.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.353 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.22 6.5 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.39 -41.95 86.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 110.926 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.478 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.8 t0 -70.58 -27.55 64.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.322 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -69.33 -40.64 80.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.931 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.2 -37.34 82.64 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.744 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.37 -43.93 84.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.151 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.97 -45.14 91.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.13 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.54 -53.95 51.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.491 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.75 -37.72 59.87 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.945 0.403 . . . . 0.0 110.419 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.45 -41.9 75.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.4 m -54.16 -44.69 71.68 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.115 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.77 -47.59 80.34 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.53 -41.27 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.153 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.27 -17.75 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.78 52.72 4.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -145.96 170.51 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.33 141.15 28.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.163 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.13 131.46 56.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.655 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -128.12 127.76 43.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.509 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.51 136.01 35.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.526 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.2 t -129.87 128.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.06 139.08 58.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.3 131.63 0.15 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.47 145.09 63.63 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.688 2.258 . . . . 0.0 112.417 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 58' ' ' LEU . 81.6 mt -40.11 -56.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.46 -26.67 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.146 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.13 -20.78 18.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.184 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 55' ' ' LEU . 58.5 mt -63.99 -42.51 97.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.619 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.611 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.36 -56.96 25.72 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.821 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.2 Cg_exo -54.79 -43.71 56.65 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.608 2.205 . . . . 0.0 111.353 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.59 -44.71 89.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.84 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.09 -44.24 87.52 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.153 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.58 -40.34 95.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.966 0.412 . . . . 0.0 110.517 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.29 11.22 1.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.597 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.14 11.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.51 -34.28 77.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.489 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.87 153.47 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -93.24 -20.81 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.11 157.25 25.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.52 127.29 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.105 0.478 . . . . 0.0 110.457 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.478 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.45 106.3 8.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.383 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.462 ' HG ' ' H ' ' A' ' 73' ' ' SER . 48.3 t -159.9 -178.54 7.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.462 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.35 -15.49 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.615 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.7 tp -37.48 123.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 11.1 p -83.21 156.34 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 pt -105.13 149.41 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.317 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -150.42 152.4 34.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.754 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.04 -47.99 53.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 110.653 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.59 -39.58 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.803 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.615 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.8 -37.56 79.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.35 -37.34 75.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.24 -27.52 67.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.165 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.35 -51.54 7.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.598 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -138.46 -168.82 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 121.062 0.458 . . . . 0.0 110.468 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.72 29.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -129.74 149.89 51.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.686 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.3 t -164.18 -151.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.686 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.5 m-20 42.77 19.32 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.815 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -28.38 120.5 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.04 -69.83 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -149.26 166.29 29.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.57 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.22 121.19 26.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.289 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.44 69.6 1.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.89 -104.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.25 165.72 32.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.5 146.22 22.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.441 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.26 136.2 41.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.786 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.75 110.71 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.63 165.11 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.854 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.46 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.031 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.99 -27.99 48.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.232 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.01 -41.74 88.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -102.35 122.35 44.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.237 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.54 109.56 19.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.43 129.88 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.81 34.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.564 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.64 89.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.773 2.316 . . . . 0.0 111.918 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -169.29 140.76 2.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.744 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.69 -32.61 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.228 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.08 -62.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.273 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.75 -22.17 22.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.925 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.73 -25.8 53.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.271 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 132.86 46.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.456 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.72 -15.56 30.56 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.53 151.39 23.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 110.45 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.21 135.58 37.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.368 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.78 136.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.52 137.72 13.88 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.44 161.71 39.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.08 0.467 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.9 tp -92.39 117.9 30.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.78 157.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.71 50.73 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.59 168.75 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.436 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 69.3 p -73.15 -27.94 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.401 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.01 -55.37 34.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.442 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -56.21 -55.34 34.38 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.06 -50.99 71.52 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.587 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 67.3 t80 -61.94 -43.98 97.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.043 0.449 . . . . 0.0 110.474 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.97 -44.44 97.8 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.41 -14.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.7 tt0 -124.96 -34.76 2.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.707 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.587 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.38 -50.51 18.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 111.471 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -99.14 12.88 34.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.184 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.1 -55.58 0.46 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.376 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.5 25.75 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.777 2.318 . . . . 0.0 111.957 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.37 -8.97 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.47 37.25 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.74 138.26 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.9 0.381 . . . . 0.0 110.527 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.79 130.18 34.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.329 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.6 138.12 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.841 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.02 133.44 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.08 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.18 127.15 42.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.725 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 153.53 25.0 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.03 7.07 29.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.654 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.17 5.84 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.93 -45.86 80.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.317 . . . . 0.0 110.431 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.58 -23.5 62.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.522 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.78 -36.45 84.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.52 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 149' ' ' ILE . 96.7 mt -66.22 -46.87 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.04 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.685 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.45 -37.44 87.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.393 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.4 p -60.92 -41.94 97.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.177 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.64 -42.93 90.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.795 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 44.7 tp -58.63 -48.58 80.53 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.26 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.51 -22.18 66.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.402 . . . . 0.0 110.239 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.01 -17.75 25.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.21 73.3 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.33 -17.96 63.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.899 0.38 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.92 136.14 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.63 -29.02 63.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.07 155.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.82 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.46 137.58 50.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.025 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -85.74 102.72 13.89 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.207 0.527 . . . . 0.0 110.799 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.685 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 50.1 tt0 -132.0 164.91 25.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.393 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.44 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.49 153.12 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.5 mt-10 -66.21 -54.54 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.05 -49.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.549 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.08 88.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.803 0.335 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.98 -63.73 1.08 Allowed 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.538 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.6 m -58.51 -47.42 84.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.776 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -49.3 -38.17 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.14 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.6 -66.11 0.56 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.35 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.615 0.245 . . . . 0.0 111.151 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.25 -40.03 92.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.71 -2.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.446 0.641 . . . . 0.0 110.521 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 173' ' ' LEU . 60.5 mt-30 -124.44 141.6 38.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.754 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.86 -15.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.825 2.35 . . . . 0.0 112.279 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.0 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.596 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.87 80.91 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.42 96.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.302 . . . . 0.0 110.517 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -66.07 -34.47 78.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.452 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.3 m-85 -156.96 143.27 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.75 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.4 pttt -176.92 99.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.006 0.431 . . . . 0.0 110.725 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.22 167.66 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.98 55.76 3.05 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.62 -117.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.44 135.34 32.74 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.5 2.133 . . . . 0.0 112.008 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.6 p -125.38 -107.7 0.32 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.486 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.45 165.59 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.244 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.39 156.61 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.995 0.81 . . . . 0.0 110.642 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -83.16 117.85 23.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.027 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.88 -16.73 62.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.43 -32.89 74.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.543 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.02 -44.51 97.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.764 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.436 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.5 7.82 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.77 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.16 -154.16 50.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.92 -25.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.862 0.363 . . . . 0.0 110.556 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.57 -126.01 1.55 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.81 159.79 37.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 110.461 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.5 -162.41 24.61 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.503 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.59 141.07 31.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.021 0.439 . . . . 0.0 110.525 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.22 111.39 3.9 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -120.44 160.58 22.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.394 . . . . 0.0 110.235 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 149.05 24.98 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.92 -49.16 63.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.93 -22.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.004 0.43 . . . . 0.0 110.82 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.06 52.13 0.24 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.764 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.52 -46.02 84.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.18 34.71 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.1 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.2 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.513 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.54 -42.86 99.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.875 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.68 -37.41 73.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.848 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.522 ' C ' ' O ' ' A' ' 212' ' ' ALA . 87.2 mt -28.45 -45.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.465 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.441 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.7 m-20 -63.55 -45.63 89.66 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.33 -43.72 98.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.016 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.33 92.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.184 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.2 -43.46 98.85 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.078 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.25 92.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.162 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.75 -43.15 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.862 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.1 mtp -56.49 -38.42 71.72 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -70.04 -38.82 75.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.0 110.352 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.44 92.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.29 0.91 55.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.683 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.11 20.09 66.66 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -57.82 -46.54 84.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.8 t80 -63.34 -57.5 10.15 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.429 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.74 -41.88 78.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.309 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.26 -48.74 79.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.518 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.57 -41.66 97.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.426 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.93 -49.94 75.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.602 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -35.54 72.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.451 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.84 -50.92 30.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.2 -45.53 92.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.58 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.5 m-85 -154.05 155.41 35.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.7 p-10 -98.08 97.66 9.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.396 . . . . 0.0 110.527 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -154.63 -165.51 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.8 t0 -122.72 109.54 14.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 24.1 m -63.77 -40.61 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.503 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.429 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 85.9 m-85 -56.55 -43.97 80.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.319 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.54 93.55 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 117.909 -1.495 . . . . 0.0 110.939 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.08 164.44 58.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.683 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.97 143.48 99.35 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.723 2.282 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.25 -40.2 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.557 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.56 36.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.443 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 9' ' ' ILE . 85.0 mt -110.46 128.23 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.423 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.0 mtp180 -103.66 118.7 37.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.34 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.64 138.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.37 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.12 99.9 1.58 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.1 m -123.58 118.76 28.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.759 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.3 t70 -113.67 92.86 25.8 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.09 133.92 57.58 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.537 2.158 . . . . 0.0 111.913 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 p -140.63 -19.76 0.84 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.662 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.4 m-85 -124.72 99.06 5.99 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.494 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.645 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -28.8 -61.67 0.21 Allowed Pre-proline 0 C--O 1.222 -0.392 0 CA-C-O 121.638 0.732 . . . . 0.0 110.914 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.9 Cg_endo -49.58 -39.34 46.09 Favored 'Trans proline' 0 C--N 1.296 -2.235 0 C-N-CA 122.523 2.149 . . . . 0.0 112.161 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.3 t80 -79.52 -43.06 23.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.972 0.415 . . . . 0.0 110.791 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.9 mt-10 -149.4 -155.41 0.63 Allowed 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.0 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.75 177.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.876 0.37 . . . . 0.0 110.402 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.5 140.01 45.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.465 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -91.71 136.47 33.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.555 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.8 p -64.91 -19.01 65.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.488 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -79.13 -5.48 54.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.486 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.91 -8.48 57.81 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.02 157.63 26.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.812 0.339 . . . . 0.0 110.469 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -112.68 134.29 54.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.481 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.44 151.0 32.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.408 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.27 151.32 6.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -58.69 -41.98 87.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.793 0.33 . . . . 0.0 110.738 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.1 t0 -70.06 -27.69 64.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.212 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.19 -40.59 80.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.979 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 47.8 m-20 -60.43 -37.91 82.41 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.274 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -66.21 -43.71 85.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 110.543 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.35 -44.27 92.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.171 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -56.77 -53.48 57.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.47 -37.79 63.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.051 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.21 -42.24 76.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.994 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.36 -44.37 72.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.215 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.27 -47.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.365 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.77 -40.84 89.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.126 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -76.61 -17.73 14.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.83 52.36 4.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.653 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.4 170.25 16.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.831 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.26 140.64 29.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m -116.83 131.17 57.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -128.19 128.0 43.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.523 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.31 136.19 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.542 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.54 128.15 65.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.43 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.5 139.07 57.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 173.97 132.92 0.12 Allowed Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.1 Cg_endo -68.35 144.74 63.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.703 2.269 . . . . 0.0 112.574 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' LEU . 76.1 mt -40.09 -55.94 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.986 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.9 -26.48 1.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.862 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.26 -20.62 19.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.918 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 55' ' ' LEU . 84.8 mt -65.07 -42.83 93.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.68 -55.74 39.35 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.077 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.2 Cg_exo -56.12 -42.99 60.75 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.622 2.215 . . . . 0.0 111.161 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -58.98 -44.16 91.54 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.06 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.28 -44.47 88.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.13 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.78 -40.0 94.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.493 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 11.24 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.532 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.25 11.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.76 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.49 -33.86 76.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.643 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.48 153.27 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -94.58 -20.66 19.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.977 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.92 26.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 97.0 mt -116.73 128.18 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.506 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.3 ttp -128.43 106.22 8.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.411 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.6 t -158.68 -179.73 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.63 -14.62 58.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.503 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.626 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.0 tp -37.55 124.18 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.584 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.557 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.14 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.644 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.4 pt -104.93 148.96 8.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.184 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.4 p -150.63 152.62 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.679 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.08 -48.01 53.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.47 -39.98 71.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.579 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.626 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.77 -37.52 79.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -36.93 74.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.233 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.45 -27.53 67.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.292 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.23 -51.74 7.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.68 -168.55 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.4 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.71 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.599 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.684 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.3 t -164.61 -151.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.49 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.684 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.8 m-20 43.23 19.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.686 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.89 120.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.354 0.409 . . . . 0.0 110.532 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -77.34 -70.07 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.756 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -149.16 165.99 30.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.553 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.79 121.07 26.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.57 69.99 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.663 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -86.54 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.429 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.51 165.78 32.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.54 146.08 22.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.64 136.14 41.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.61 110.88 28.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.011 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.76 164.87 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.712 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.82 148.39 23.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.841 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.62 -27.67 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.309 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.16 -41.82 89.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.329 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.33 122.18 43.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.361 . . . . 0.0 110.254 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.34 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.394 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -128.56 129.88 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.44 159.2 33.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.6 Cg_endo -59.63 89.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.802 2.335 . . . . 0.0 112.02 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.0 m -168.93 140.91 2.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.21 -32.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.38 -62.56 1.68 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.61 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.0 t -56.07 -22.19 26.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.678 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.3 mt -76.99 -25.38 52.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.76 132.73 46.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.474 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.27 -16.03 31.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.48 151.59 23.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -96.52 135.63 38.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.393 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.04 136.66 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.639 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.36 138.8 14.43 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 54.7 t -131.04 161.59 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.965 0.412 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.6 tp -92.42 117.49 29.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.555 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.73 157.87 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.82 50.57 52.47 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.97 169.0 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.4 p -73.79 -26.33 60.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.497 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.69 -55.31 34.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.564 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.89 -54.64 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.421 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.17 -51.38 69.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.571 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.5 t80 -62.08 -43.76 98.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.416 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.8 -44.33 98.02 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.58 -14.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.615 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.32 -34.4 2.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.71 -51.03 15.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.13 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.12 12.98 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.996 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.49 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.61 -55.46 0.44 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.45 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.32 -10.39 25.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.834 2.356 . . . . 0.0 112.051 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.61 -8.73 59.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.623 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.9 33.47 37.0 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.87 138.22 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.6 129.79 34.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.421 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.9 pt -125.96 137.78 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.01 132.92 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.427 . . . . 0.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.75 43.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.617 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -110.89 153.67 25.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.373 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.8 6.95 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.19 130.68 5.97 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.01 -45.76 80.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.91 -24.08 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.69 -36.37 84.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.2 -47.13 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.3 m-85 -63.58 -37.8 88.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.364 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.22 -42.63 98.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.46 -45.42 90.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.227 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -58.62 -48.1 82.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.256 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.0 m -63.18 -22.94 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.013 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.3 25.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.86 11.34 70.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.75 -17.84 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.8 pt -128.78 137.98 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.23 -28.02 61.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.61 155.49 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.689 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.85 50.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.153 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -85.71 103.05 14.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.58 165.11 25.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.451 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.446 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.26 151.97 41.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.7 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -65.71 -54.17 30.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.6 t -60.04 -49.12 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.03 89.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.772 0.32 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.42 1.16 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.483 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.4 m -58.67 -47.2 85.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.95 -37.34 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.117 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.458 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.14 -65.8 0.55 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.675 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.0 t80 -40.73 -70.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.646 0.26 . . . . 0.0 110.989 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.778 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -59.47 -3.19 0.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.176 0.512 . . . . 0.0 110.377 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.513 ' H ' ' C ' ' A' ' 173' ' ' LEU . 50.6 mt-30 -124.58 141.34 37.56 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -43.43 -14.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.844 2.362 . . . . 0.0 112.165 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.0 t -63.07 -42.8 97.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.445 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.87 -33.02 81.69 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.06 -41.35 96.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.793 0.33 . . . . 0.0 110.446 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.16 -34.46 78.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.555 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.8 m-85 -156.96 142.89 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.645 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.71 100.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.049 0.452 . . . . 0.0 110.72 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.5 m-85 -159.41 167.52 28.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.613 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.18 56.06 3.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.04 -116.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.84 135.03 35.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.436 2.091 . . . . 0.0 111.911 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.7 p -124.6 -108.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.625 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -166.39 165.17 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.66 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 O-C-N 123.951 0.782 . . . . 0.0 110.494 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.22 118.3 23.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.066 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.5 mp0 -72.13 -18.68 61.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -64.04 -31.87 73.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.636 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.7 mt -60.83 -44.57 96.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.683 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.46 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.7 m-85 -113.88 7.35 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.641 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.2 -155.32 50.37 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.19 -25.54 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.16 -125.57 1.46 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -132.07 160.12 36.87 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.412 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.23 -163.2 25.71 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -97.66 141.01 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.15 4.0 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -122.04 160.75 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.285 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 148.97 25.03 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.654 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.75 -48.83 63.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.714 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -39.88 -23.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.784 0.326 . . . . 0.0 110.544 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.0 m-20 -71.78 52.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.623 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.43 -46.27 83.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.16 34.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.42 -43.74 98.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.53 -42.84 99.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.005 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.44 -37.3 72.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.027 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.46 0.11 Allowed 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.519 ' C ' ' O ' ' A' ' 212' ' ' ALA . 87.9 mt -28.2 -45.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.659 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.446 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.1 m-20 -63.83 -45.46 89.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.661 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.51 98.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.114 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.46 93.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.33 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.12 -43.39 98.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.241 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.36 92.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.98 -42.39 97.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.228 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.13 -38.29 73.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.9 -38.77 76.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.0 110.417 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.46 92.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.6 p-10 -88.57 0.59 56.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.1 67.95 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.7 m -57.6 -46.16 84.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.6 t80 -63.65 -57.93 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 110.53 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.56 -41.68 77.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.7 -48.53 80.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.8 -41.62 97.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.397 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.07 -49.81 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.75 -35.65 73.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -70.78 -50.98 30.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.273 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.16 -45.85 91.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.1 m-85 -153.53 155.48 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.431 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.2 p-10 -98.01 99.23 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -156.4 -165.59 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.493 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.7 t0 -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.6 m -63.76 -40.23 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.572 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.8 m-85 -56.76 -44.11 81.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.304 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.33 -36.54 93.54 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.917 -1.49 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.21 61.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.698 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.79 143.53 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 122.727 2.285 . . . . 0.0 112.308 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.39 -40.89 89.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.586 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.65 139.48 38.51 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.359 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.41 121.5 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.665 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.18 118.49 31.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.106 0.479 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.09 138.56 40.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.404 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.83 105.94 2.2 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.9 m -129.32 120.41 25.59 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 122.694 -0.298 . . . . 0.0 110.953 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.4 t70 -114.18 92.58 27.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.97 134.36 59.2 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.454 2.103 . . . . 0.0 112.197 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 p -141.75 -20.21 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.781 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.8 m-85 -123.42 99.16 6.19 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.555 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.658 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.19 -61.37 0.22 Allowed Pre-proline 0 C--O 1.217 -0.618 0 CA-C-O 121.688 0.756 . . . . 0.0 111.099 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.9 Cg_endo -49.36 -40.64 43.98 Favored 'Trans proline' 0 C--N 1.29 -2.502 0 C-N-CA 122.449 2.1 . . . . 0.0 112.259 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.1 t80 -78.36 -42.55 30.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.795 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.658 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -150.04 -153.89 0.52 Allowed 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.049 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.96 177.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.023 0.44 . . . . 0.0 110.376 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.58 144.47 46.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.412 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -95.31 134.31 38.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.585 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.68 -18.92 65.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.516 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.44 -6.71 56.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.052 0.453 . . . . 0.0 110.453 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.18 -8.21 55.27 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -80.08 158.5 26.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.978 0.418 . . . . 0.0 110.426 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.13 130.93 55.73 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.12 151.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.318 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.02 151.25 6.51 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -58.5 -42.12 86.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 122.555 -0.38 . . . . 0.0 111.007 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.2 t0 -69.2 -28.59 66.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.243 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.03 -40.35 83.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.971 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.03 -37.58 83.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.909 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.74 -45.25 87.25 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -56.96 -48.63 77.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.881 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.85 -54.71 30.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.356 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -52.21 -39.94 60.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 110.412 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.73 -41.83 78.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.71 -45.29 70.4 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.074 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.93 -47.03 82.13 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.064 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.61 -42.35 92.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.41 -17.1 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.655 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.63 53.11 4.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.548 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.06 171.27 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.876 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -89.02 142.56 27.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.46 131.15 56.79 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.19 126.92 43.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.386 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -93.36 134.67 35.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.523 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.04 127.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.285 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.31 137.99 57.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.89 131.34 0.16 Allowed Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.539 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.2 Cg_endo -68.23 145.22 65.52 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.677 2.251 . . . . 0.0 112.437 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -40.29 -55.79 2.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -48.33 -26.25 1.94 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.9 18.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.96 -42.38 97.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.16 -57.43 23.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 123.872 0.733 . . . . 0.0 109.485 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.595 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -54.93 -42.39 69.5 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.62 2.214 . . . . 0.0 111.267 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 69.9 m -58.76 -44.87 90.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.873 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 tp -59.1 -44.01 91.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.219 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.47 -40.53 95.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.82 9.96 2.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.24 12.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.59 -35.46 80.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.29 153.19 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -93.58 -21.98 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.178 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.63 155.74 26.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.777 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.06 128.95 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.176 0.513 . . . . 0.0 110.441 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.0 ttp -131.06 106.47 8.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.706 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.4 t -159.1 178.53 9.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.706 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -65.22 -15.41 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.611 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -34.84 124.23 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.606 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.87 153.87 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.613 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -104.58 148.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.241 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -149.12 152.09 35.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.799 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.72 -47.28 50.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.35 -39.7 70.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.611 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -69.31 -37.57 77.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.755 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.89 -39.07 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.819 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.73 -27.63 66.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.24 -50.67 8.19 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.729 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.2 pt -139.39 -168.11 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.088 0.47 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.118 0.485 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -130.0 150.0 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.554 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.67 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.05 -153.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.67 ' H ' ' HG1' ' A' ' 87' ' ' THR . 94.2 m-20 41.17 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.088 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.59 121.79 0.2 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.39 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.9 mt -75.6 -68.94 0.52 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -150.11 167.38 26.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.729 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.3 123.78 29.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.233 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.89 68.55 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.792 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.01 -104.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.45 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.53 165.7 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.41 146.04 22.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.16 0.505 . . . . 0.0 110.444 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -100.96 136.26 41.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.832 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.72 110.41 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.1 165.16 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.72 148.34 24.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.84 -27.38 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.177 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.33 -41.86 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.323 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.58 122.37 44.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.146 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.4 19.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.84 130.1 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.67 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.67 159.06 33.75 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.576 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.459 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.84 89.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.81 2.34 . . . . 0.0 111.939 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.0 m -169.27 140.68 2.39 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.523 0.514 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.8 -32.84 59.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.276 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -57.14 -62.74 1.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.307 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 t -55.96 -22.2 25.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -76.44 -25.9 54.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.323 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.7 133.11 46.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.388 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.89 -15.93 29.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.56 151.36 23.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.458 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.89 135.48 37.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.014 0.435 . . . . 0.0 110.336 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.54 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.51 138.59 14.33 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.87 161.65 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 121.102 0.477 . . . . 0.0 110.314 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 44.3 tp -92.35 117.53 30.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.682 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.64 157.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.663 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.52 53.56 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.68 168.93 22.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.775 0.321 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.3 p -73.54 -26.85 61.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.54 -55.57 31.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.48 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.53 -54.9 40.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.575 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.21 -50.88 71.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.56 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.0 t80 -62.23 -43.82 97.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.92 -44.54 97.69 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.27 -14.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.825 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.28 -34.57 2.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.598 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.4 -50.59 17.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 111.557 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -99.15 12.47 36.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.487 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.83 -55.51 0.47 Allowed Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.24 -10.27 25.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.791 2.327 . . . . 0.0 111.923 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -9.01 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.495 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.42 37.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.51 138.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.986 0.422 . . . . 0.0 110.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.48 129.75 34.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.32 138.14 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.23 133.15 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.077 0.465 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.39 127.67 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.99 153.74 25.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.245 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.09 7.42 29.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.645 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.75 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.97 -45.91 80.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.468 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.58 -23.32 62.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.459 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.89 -36.71 85.25 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 149' ' ' ILE . 96.5 mt -66.12 -47.08 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.078 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.518 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.2 m-85 -63.61 -38.06 89.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.271 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.14 -42.27 98.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.4 ' H ' ' HG ' ' A' ' 151' ' ' SER . 52.6 m-20 -64.04 -45.34 89.27 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.6 tp -58.3 -48.17 81.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.3 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -63.25 -22.77 67.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.242 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.74 24.94 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.13 11.46 69.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -18.15 63.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.94 0.4 . . . . 0.0 110.618 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.2 pt -128.29 137.36 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.397 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.89 -27.24 61.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.83 155.87 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.527 0.517 . . . . 0.0 110.838 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.05 136.83 49.8 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 109.967 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -85.2 103.05 13.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.831 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.5 tt0 -132.52 165.5 24.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.409 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.81 152.31 41.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.549 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.2 mt-10 -66.27 -54.46 24.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.33 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 72.1 t -60.29 -48.98 86.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.395 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.93 88.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.821 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.45 -63.1 1.22 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.6 m -59.4 -47.99 83.34 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.003 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.9 tt0 -49.06 -37.33 20.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.434 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.82 -66.32 0.56 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -71.23 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 122.745 -0.268 . . . . 0.0 111.17 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 175' ' ' GLN . 94.9 mt -61.01 -40.31 93.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -60.1 -2.79 0.47 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.538 0.685 . . . . 0.0 110.457 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.492 ' H ' ' C ' ' A' ' 173' ' ' LEU . 43.0 mt-30 -123.36 148.95 56.74 Favored Pre-proline 0 N--CA 1.453 -0.306 0 O-C-N 122.011 -0.431 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.48 -20.41 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.933 2.422 . . . . 0.0 112.299 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.01 -43.24 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.588 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.59 -33.05 83.55 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.57 -41.4 94.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.733 0.302 . . . . 0.0 110.412 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.9 m-20 -65.55 -33.81 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.438 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.3 m-85 -156.19 143.0 18.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.1 pttt -177.15 99.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.093 0.473 . . . . 0.0 110.73 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.1 166.82 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.59 56.57 2.77 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -118.05 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.28 135.98 31.44 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.412 2.075 . . . . 0.0 112.015 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.47 -107.9 0.32 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.647 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.611 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.68 165.31 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.144 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.29 156.15 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.25 0.969 . . . . 0.0 110.62 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.15 117.57 22.4 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.863 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.61 -18.78 62.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.99 -32.35 73.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.518 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.94 -44.62 97.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.746 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.9 m-85 -114.0 9.59 17.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.783 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.19 -154.92 52.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.53 -24.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 110.428 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 159.93 -124.16 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.3 p -129.4 156.45 44.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.712 0.292 . . . . 0.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.64 -169.42 30.22 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -94.39 137.3 33.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.922 0.391 . . . . 0.0 110.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.25 107.77 3.21 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.4 mt -123.06 159.22 28.9 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.906 0.384 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 90.0 mtm180 -86.87 149.57 24.72 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.85 -48.34 64.04 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.527 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.5 tp10 -37.98 -25.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.94 0.4 . . . . 0.0 110.842 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.47 52.2 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.622 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -64.39 -45.68 86.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.274 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.54 -47.23 34.06 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.26 -43.91 97.74 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.18 -43.0 99.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.01 -36.39 70.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.1 -77.31 0.11 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 212' ' ' ALA . 98.3 mt -28.86 -46.08 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.958 0.408 . . . . 0.0 110.506 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.441 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.1 m-20 -64.31 -44.94 90.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.782 178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.5 tttm -62.08 -43.63 98.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.993 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.06 93.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.15 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.23 -43.39 98.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.994 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.26 92.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.53 -43.26 97.65 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.508 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.79 -38.32 72.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.99 -38.9 76.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 110.378 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.619 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.51 1.09 56.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.676 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.47 20.64 65.9 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.3 m -58.2 -45.97 86.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.8 t80 -63.93 -57.86 8.49 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.441 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.423 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.5 mt-10 -56.83 -41.83 78.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.2 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.44 -48.72 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.532 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.69 -41.88 98.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.87 0.367 . . . . 0.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.13 74.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.84 -34.9 72.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.22 -50.82 29.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.394 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.4 -45.83 91.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.552 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 66.6 m-85 -153.85 155.79 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.05 98.08 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.982 0.42 . . . . 0.0 110.412 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -155.59 -165.59 2.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.33 110.67 15.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.585 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.0 m -63.57 -40.47 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.46 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.423 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 90.8 m-85 -58.5 -42.55 87.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.281 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.26 -37.04 94.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.702 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 164.38 59.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.647 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.89 143.39 99.35 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.05 -40.31 90.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.82 142.81 36.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 9' ' ' ILE . 83.5 mt -109.88 128.73 65.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.468 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -103.6 117.0 33.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.34 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -111.83 139.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.409 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.09 105.08 2.14 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -128.14 118.98 24.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.71 -0.289 . . . . 0.0 111.069 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.1 t70 -113.53 93.15 26.26 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.16 133.89 57.7 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.2 p -140.79 -19.71 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.749 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.498 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.6 m-85 -124.87 99.27 6.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.594 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.657 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.18 -61.23 0.23 Allowed Pre-proline 0 C--O 1.218 -0.592 0 CA-C-O 121.672 0.749 . . . . 0.0 111.083 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.64 -39.5 46.62 Favored 'Trans proline' 0 C--N 1.293 -2.359 0 C-N-CA 122.449 2.1 . . . . 0.0 112.215 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.7 t80 -79.13 -42.6 25.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.054 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.657 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.6 mt-10 -149.38 -156.02 0.68 Allowed 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.116 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.93 178.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.067 0.46 . . . . 0.0 110.269 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -135.86 143.0 44.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.462 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.1 t-20 -95.5 141.61 28.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.528 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.0 p -65.92 -19.22 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.511 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.98 -6.71 55.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.424 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.77 -6.93 58.98 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.76 158.26 26.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 110.431 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.9 mt -111.89 134.09 53.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.381 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.33 151.11 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.96 0.41 . . . . 0.0 110.31 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.76 151.65 6.66 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -58.63 -42.04 87.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.812 0.339 . . . . 0.0 110.964 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.2 t0 -70.24 -28.32 65.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.364 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.88 -40.71 81.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.104 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -61.3 -37.35 82.92 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.754 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.43 -43.99 84.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.985 0.422 . . . . 0.0 110.259 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.91 -41.84 92.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.111 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -58.74 -53.61 56.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -36.73 62.61 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 110.332 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.4 -42.37 75.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.824 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.49 -44.48 72.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.116 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.97 -47.61 79.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.42 -41.03 88.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.4 -17.59 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.6 52.74 4.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.489 . . . . 0.0 110.651 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.08 17.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.885 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.36 140.84 29.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.153 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -117.31 132.01 56.69 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.632 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.43 127.73 43.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.89 135.78 34.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.64 128.44 65.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.368 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 139.41 58.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.06 131.99 0.14 Allowed Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.3 Cg_endo -68.49 145.21 63.9 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.297 . . . . 0.0 112.426 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 58' ' ' LEU . 82.2 mt -40.49 -56.66 2.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.1 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.19 -26.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.64 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.232 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 55' ' ' LEU . 57.1 mt -63.97 -42.43 97.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.68 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.596 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.44 -56.89 26.1 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.696 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.5 Cg_exo -55.0 -43.32 60.65 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.595 2.197 . . . . 0.0 111.113 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -58.52 -44.64 89.58 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.763 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.52 -44.37 89.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.095 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.54 -40.5 95.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.11 11.08 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 56.13 11.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.44 -34.33 77.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.94 153.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.43 -20.35 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.128 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.55 157.64 25.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.18 127.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.523 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.42 106.79 9.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.383 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.706 ' HG ' ' H ' ' A' ' 73' ' ' SER . 41.2 t -160.28 -178.06 6.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.706 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.3 -15.52 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.391 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.623 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -37.97 123.88 1.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.62 156.82 22.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.594 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -105.02 149.3 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.301 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.0 p -150.3 152.28 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.735 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.94 52.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.021 0.438 . . . . 0.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.47 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.887 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.623 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.73 -37.57 79.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.912 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.34 -27.85 67.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.142 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.92 -51.98 7.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -138.19 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.1 0.476 . . . . 0.0 110.433 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.78 29.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.038 0.447 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.627 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.665 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.8 t -164.39 -151.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.512 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.665 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.1 m-20 43.29 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.11 119.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.6 mt -77.19 -70.07 0.49 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -149.35 166.33 29.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.91 122.51 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.297 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.85 68.86 0.93 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.762 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.69 -104.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.429 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.4 p -159.05 165.74 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.656 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.24 146.22 22.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.117 0.484 . . . . 0.0 110.353 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.06 135.99 41.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.7 110.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.29 165.03 32.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.938 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.84 148.67 23.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.3 -28.48 58.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.247 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -58.93 -41.76 88.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.281 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -101.94 122.03 43.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.75 109.86 19.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.28 129.73 70.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.579 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.5 153.97 41.81 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.672 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.3 Cg_endo -59.05 92.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -171.08 144.11 2.06 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.604 0.565 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.14 -33.55 61.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.287 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.301 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.1 t -56.95 -21.99 34.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.962 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.43 -27.08 58.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.94 133.43 48.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.46 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.19 -17.34 28.7 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.31 151.76 23.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.902 0.382 . . . . 0.0 110.431 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.58 38.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.372 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.15 136.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.622 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.34 139.32 14.65 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.3 161.63 40.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.097 0.475 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.2 tp -92.73 117.61 30.18 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.627 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.56 157.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.15 50.71 49.73 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.8 p -149.71 168.85 22.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.2 p -73.83 -25.78 60.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -61.1 -55.39 33.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.435 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.34 -53.81 53.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.77 -51.32 69.84 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.586 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.1 t80 -62.19 -43.9 97.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.85 -44.58 97.66 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.33 -14.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.782 0.325 . . . . 0.0 110.765 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.19 -34.56 2.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.667 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.39 -50.73 17.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 111.562 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.19 12.46 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.209 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.489 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.7 -55.56 0.48 Allowed Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.375 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.23 25.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.001 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.85 -8.78 59.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.44 37.02 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.31 137.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.81 129.94 35.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.8 138.56 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 63.1 t -123.92 133.65 68.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 109.935 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -95.57 127.56 41.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.55 150.62 27.22 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.251 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.96 6.05 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.13 131.37 5.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.69 -45.7 81.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 110.415 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.85 -24.24 63.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.55 -36.52 84.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.443 HD13 HG22 ' A' ' 149' ' ' ILE . 96.7 mt -66.0 -46.62 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.001 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.8 m-85 -64.37 -37.75 88.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.339 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.79 -42.12 96.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.181 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.405 ' H ' ' HG ' ' A' ' 151' ' ' SER . 49.9 m-20 -65.58 -43.28 90.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.3 tp -58.58 -48.92 79.33 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.18 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -62.15 -22.52 65.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.382 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.91 25.62 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.544 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 12.12 73.1 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.99 -17.42 63.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.563 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.2 pt -127.39 136.48 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 110.42 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.92 -28.1 62.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.38 155.1 1.79 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.853 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.65 137.1 50.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.039 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -85.55 102.5 13.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.144 0.497 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.4 tt0 -131.6 165.0 24.62 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.377 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.44 153.11 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.47 -54.29 25.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.337 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.22 -49.17 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.438 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.82 87.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.13 -63.51 1.13 Allowed 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.572 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.2 m -58.78 -47.27 85.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.889 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -49.25 -38.4 26.74 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.48 -66.02 0.56 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.0 t80 -40.32 -71.04 0.09 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.608 0.242 . . . . 0.0 111.229 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.2 -40.07 92.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.959 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.65 -2.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.51 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.8 mt-30 -124.27 141.77 38.3 Favored Pre-proline 0 C--N 1.33 -0.244 0 O-C-N 122.079 -0.388 . . . . 0.0 110.845 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -43.95 -15.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.871 2.381 . . . . 0.0 112.277 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 175' ' ' GLN . 79.4 t -62.97 -42.83 98.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.95 81.37 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.75 -41.58 95.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.726 0.298 . . . . 0.0 110.479 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.8 -34.49 78.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.578 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.6 m-85 -157.25 143.96 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.4 pttt -177.81 100.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.075 0.464 . . . . 0.0 110.782 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.9 m-85 -159.06 168.18 27.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.01 55.57 3.09 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.68 -117.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.83 135.22 35.48 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.487 2.125 . . . . 0.0 112.008 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.0 p -125.08 -108.14 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.54 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.64 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.178 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.53 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 124.17 0.919 . . . . 0.0 110.634 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.2 118.23 22.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.791 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.87 -18.57 62.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.05 73.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.97 -44.36 97.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.743 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.435 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.68 7.58 17.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.697 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.99 -154.84 50.21 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.7 -25.39 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.56 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.05 -126.14 1.55 Allowed Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -131.97 159.92 37.3 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.427 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.65 -162.39 24.7 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -98.5 141.02 31.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.621 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.81 3.96 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.4 mt -120.64 160.54 23.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.307 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.95 148.98 25.1 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.18 -49.04 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.662 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -39.89 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.89 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -71.91 52.13 0.23 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.5 -46.16 84.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.18 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.46 -47.07 35.68 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.27 -43.92 97.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.459 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.55 -42.89 99.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.6 -37.36 73.1 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.64 -77.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 212' ' ' ALA . 87.4 mt -28.72 -45.65 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.858 0.361 . . . . 0.0 110.481 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.444 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.4 m-20 -63.59 -45.64 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.6 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.77 98.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.968 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.26 -43.33 99.05 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.105 0.479 . . . . 0.0 110.071 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.41 93.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.074 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.62 -43.01 98.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.78 -38.37 72.39 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.81 -38.79 76.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.47 . . . . 0.0 110.373 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.41 92.81 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 21.0 p-10 -88.36 0.38 56.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.743 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.56 20.11 67.59 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.6 m -58.04 -46.22 85.7 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.1 t80 -63.42 -57.46 10.21 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.448 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.435 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.6 mt-10 -56.91 -41.78 78.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.245 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.3 -48.67 79.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.48 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.51 -41.73 97.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.39 -49.68 76.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.692 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.87 -35.26 72.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.465 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.72 -51.16 29.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.39 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.17 -45.92 91.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.581 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.0 m-85 -154.11 155.14 34.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.4 p-10 -97.84 101.21 12.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.476 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -157.51 -165.44 1.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.63 109.94 14.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.6 m -63.63 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.435 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 93.2 m-85 -58.27 -43.6 88.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.217 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.65 -36.76 93.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.418 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.657 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.983 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.12 164.47 56.69 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.82 143.34 99.36 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.624 2.216 . . . . 0.0 112.29 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.49 -40.23 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.554 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.69 36.86 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.7 128.58 66.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.5 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -104.83 118.59 36.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 110.362 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.7 138.52 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.89 99.58 1.55 Allowed Glycine 0 N--CA 1.463 0.495 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.6 m -123.41 117.68 25.74 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.696 -0.297 . . . . 0.0 111.255 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 12.8 t0 -112.85 93.04 22.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.18 133.84 57.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.424 2.083 . . . . 0.0 112.188 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.5 p -141.05 -19.5 0.8 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.742 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.6 m-85 -124.78 99.05 5.97 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.649 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.649 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.08 -61.33 0.22 Allowed Pre-proline 0 C--O 1.218 -0.577 0 CA-C-O 121.563 0.697 . . . . 0.0 111.125 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.73 -39.05 47.57 Favored 'Trans proline' 0 C--N 1.293 -2.384 0 C-N-CA 122.36 2.04 . . . . 0.0 112.254 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.9 t80 -79.38 -42.9 24.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.952 0.406 . . . . 0.0 111.132 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.8 mt-10 -149.25 -155.97 0.68 Allowed 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.114 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.24 177.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.0 110.317 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -135.84 142.06 44.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.44 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.3 t-20 -94.81 141.71 28.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.467 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.1 p -65.88 -19.21 65.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.542 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.28 -6.96 56.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.433 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.33 -7.47 58.31 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -78.92 158.02 28.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.97 0.414 . . . . 0.0 110.403 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.62 134.54 54.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.929 0.395 . . . . 0.0 110.401 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.42 151.2 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.361 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.83 151.64 6.67 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -58.59 -42.09 87.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.903 0.383 . . . . 0.0 111.012 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.5 t0 -70.17 -28.01 64.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.433 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.55 -41.37 82.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.119 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.71 -37.57 82.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.094 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.47 -43.96 84.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.188 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.02 -41.75 92.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.133 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.7 -53.32 59.69 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.554 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.08 -36.56 63.29 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.266 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.0 mt -69.53 -42.37 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.772 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.62 -44.02 72.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.3 tttm -64.07 -47.65 79.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -59.82 -40.81 89.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.948 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.36 -18.24 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.616 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.79 52.51 4.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 110.618 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -144.99 169.94 17.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.9 139.93 30.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.056 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -116.52 131.31 56.98 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.9 m -128.47 128.03 43.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.74 136.44 35.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.75 128.72 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.343 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.84 139.37 58.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.781 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 173.89 132.81 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.519 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.4 Cg_endo -68.55 144.92 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.562 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 58' ' ' LEU . 76.9 mt -40.81 -55.81 2.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.41 -26.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.173 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.46 -20.18 19.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 55' ' ' LEU . 86.5 mt -64.93 -42.45 94.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.959 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.599 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.52 -56.91 28.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.685 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.599 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.4 Cg_exo -55.35 -43.24 60.43 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.586 2.191 . . . . 0.0 111.035 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -58.68 -44.41 90.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.2 tp -58.53 -44.31 89.52 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.9 mtmt -64.55 -40.36 95.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.996 0.426 . . . . 0.0 110.434 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 11.22 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.565 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 55.95 11.84 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.17 77.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.494 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.7 pt -124.54 153.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.281 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.284 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.95 156.88 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.755 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.11 128.0 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 110.534 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.477 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.38 106.51 9.05 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.399 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.2 t -159.66 -179.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.3 -15.31 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.391 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.622 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.0 tp -37.78 123.86 1.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.07 156.37 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 pt -104.87 148.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.238 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.9 p -150.04 152.5 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.27 -47.69 55.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.604 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.72 -39.71 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.788 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.622 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.27 -37.83 81.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.928 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.29 75.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.59 67.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.076 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.12 -51.76 7.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.6 pt -138.45 -168.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.88 146.87 29.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -129.87 150.0 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.641 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.667 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.2 t -164.41 -151.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.444 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.667 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.1 m-20 43.07 19.3 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.8 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mttt -28.27 120.22 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -77.26 -69.99 0.5 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.825 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -149.4 166.25 29.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.08 123.39 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.47 67.97 0.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.5 -104.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.436 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.2 p -159.58 165.99 31.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.7 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.52 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.144 0.497 . . . . 0.0 110.456 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.3 135.86 42.1 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.67 110.45 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.28 165.11 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.935 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.19 148.61 23.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.97 -27.84 46.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.191 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -59.1 -41.8 88.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.221 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.45 122.14 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.129 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.54 109.26 19.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.068 0.461 . . . . 0.0 110.398 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.18 129.88 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.73 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.98 159.05 34.01 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.53 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.1 Cg_endo -59.63 89.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.707 2.271 . . . . 0.0 111.943 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.6 m -169.23 140.91 2.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.546 0.529 . . . . 0.0 110.786 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.55 -32.58 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.227 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.19 -62.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.375 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.2 t -56.11 -22.18 26.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.124 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.96 -26.81 57.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.345 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.71 132.84 46.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.436 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.41 -15.92 32.43 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -87.1 151.78 22.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.71 135.89 38.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.075 0.464 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.99 136.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.738 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 138.93 14.5 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.24 161.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.068 0.461 . . . . 0.0 110.386 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.1 tp -92.71 117.95 30.54 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.51 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.58 49.15 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.7 p -149.67 168.98 22.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.94 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.44 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.3 p -74.01 -25.73 60.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.401 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -61.21 -55.44 32.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.468 -179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.09 -54.06 51.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.57 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.46 -51.01 71.31 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.702 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.25 -43.86 97.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.11 0.481 . . . . 0.0 110.44 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.21 -44.55 97.55 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.27 -14.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.801 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.38 2.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.43 -50.75 17.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 111.653 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -98.98 12.54 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.32 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.489 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.9 -55.58 0.47 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.377 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.16 -10.44 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.825 2.35 . . . . 0.0 111.959 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.61 -8.84 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.496 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.89 33.45 37.09 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.54 138.06 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.65 129.73 35.03 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.307 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.52 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.11 133.56 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.026 0.441 . . . . 0.0 109.959 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 127.97 42.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -108.29 150.45 27.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.165 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.37 5.61 34.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.68 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.44 131.87 6.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.63 -45.76 81.83 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.411 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.61 -24.43 63.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 151' ' ' SER . 56.9 t-20 -64.45 -36.69 85.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.417 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.79 -46.56 88.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.43 -37.6 88.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.315 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.88 -42.5 98.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.2 -43.13 92.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.884 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.0 tp -59.17 -48.37 81.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.5 m -62.69 -22.26 66.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.915 0.388 . . . . 0.0 110.026 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.89 -17.71 26.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.63 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.54 11.95 73.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.78 -17.57 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.609 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.0 pt -127.53 136.62 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.993 0.425 . . . . 0.0 110.479 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.01 -28.28 62.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.36 155.27 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.802 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.61 137.44 50.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 109.95 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.66 102.95 14.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.239 0.542 . . . . 0.0 110.714 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.14 165.14 24.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.377 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.44 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.24 152.35 41.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.601 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.2 -54.13 28.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.343 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.4 -49.17 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.512 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.85 88.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 110.867 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.01 -63.49 1.14 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.589 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.9 m -58.67 -47.01 85.92 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.792 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.66 -38.05 30.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.057 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.445 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.68 -65.59 0.55 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.2 t80 -40.63 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.644 0.259 . . . . 0.0 111.394 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.4 mt -61.38 -39.87 92.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.81 -2.92 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.537 0.684 . . . . 0.0 110.499 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.2 mt-30 -124.43 142.1 39.39 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.09 -0.382 . . . . 0.0 110.891 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -44.06 -15.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.808 2.339 . . . . 0.0 112.299 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.5 t -63.09 -43.03 98.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.632 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.62 -32.86 79.84 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.31 95.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 181' ' ' TYR . 47.7 m-20 -65.8 -34.92 79.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 180' ' ' ASP . 77.5 m-85 -157.04 143.54 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -177.22 100.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 110.728 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -159.31 167.5 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.699 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.31 55.52 3.05 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.45 -117.46 0.01 OUTLIER Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.93 135.5 36.23 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.465 2.11 . . . . 0.0 111.932 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 89.4 p -124.95 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.601 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -165.79 165.37 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.185 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.49 156.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 124.169 0.918 . . . . 0.0 110.649 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.14 118.28 22.94 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.73 -18.63 62.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.9 -32.36 73.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.57 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.86 -44.25 97.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.44 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.8 m-85 -114.05 8.36 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.719 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.12 -154.7 51.04 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.71 -25.51 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.869 0.366 . . . . 0.0 110.551 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.0 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.4 p -131.97 160.06 36.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.827 0.346 . . . . 0.0 110.41 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.42 24.6 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.87 32.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.914 0.387 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.86 3.96 Favored Glycine 0 C--N 1.329 0.179 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.6 mt -121.28 160.27 24.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.94 0.4 . . . . 0.0 110.164 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.81 149.08 25.09 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.881 0.372 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.37 -48.6 65.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.669 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.94 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.015 0.436 . . . . 0.0 110.831 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.1 m-20 -71.89 52.17 0.23 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -64.42 -46.03 84.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.313 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.7 -46.94 34.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.241 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.25 -43.87 97.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.438 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.728 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.73 -37.35 73.41 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.702 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.38 0.11 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.517 ' C ' ' O ' ' A' ' 212' ' ' ALA . 85.5 mt -28.91 -45.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.471 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.449 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.6 m-20 -63.61 -45.28 91.03 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.49 -43.79 98.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.095 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.15 -43.52 98.75 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 110.046 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.29 92.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.064 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.9 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.0 -38.32 72.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.84 -38.79 76.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 110.322 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.28 93.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.656 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.33 0.31 56.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.727 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.55 20.25 67.71 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.28 -46.15 86.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 77.2 t80 -63.44 -57.36 10.51 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.372 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.43 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.6 mt-10 -56.99 -41.46 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.236 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.62 -48.36 81.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.598 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.88 -41.61 98.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.402 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.62 -49.79 76.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.639 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.56 -35.35 72.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.529 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.57 -51.07 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.544 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.7 m-85 -62.28 -45.7 92.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.617 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.2 m-85 -154.3 154.82 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.0 p-10 -97.79 100.13 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.409 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -156.25 -165.39 1.9 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.58 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.6 t0 -122.5 109.89 14.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 21.2 m -63.39 -40.46 89.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.43 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 93.0 m-85 -59.06 -42.53 90.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.304 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.25 -37.08 94.3 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.659 0 CA-C-O 117.872 -1.516 . . . . 0.0 110.975 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.04 164.33 61.94 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.595 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.84 143.53 99.39 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.574 2.182 . . . . 0.0 112.32 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.41 -40.78 89.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.09 141.22 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.442 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 9' ' ' ILE . 82.8 mt -109.27 127.43 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 110.567 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.28 117.71 35.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.12 0.486 . . . . 0.0 110.277 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.16 138.55 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.922 0.391 . . . . 0.0 110.537 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.59 105.25 2.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.4 m -128.3 119.52 25.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.676 -0.308 . . . . 0.0 111.242 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 10.8 t0 -113.44 92.59 23.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.33 134.13 59.49 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.44 2.093 . . . . 0.0 112.12 179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -141.39 -19.87 0.77 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.728 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -123.28 98.62 5.95 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.706 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.662 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.12 -61.4 0.22 Allowed Pre-proline 0 C--O 1.218 -0.564 0 CA-C-O 121.441 0.639 . . . . 0.0 111.055 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.38 -40.5 44.19 Favored 'Trans proline' 0 C--N 1.295 -2.25 0 C-N-CA 122.26 1.974 . . . . 0.0 112.241 -179.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.9 t80 -78.37 -43.12 28.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.107 0.48 . . . . 0.0 111.002 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.662 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.8 mt-10 -149.23 -154.38 0.55 Allowed 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.938 -178.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.71 177.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.049 0.452 . . . . 0.0 110.407 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.43 144.76 46.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.38 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -95.81 134.44 38.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.613 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -64.61 -18.95 65.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.537 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.28 -6.36 54.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.453 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.81 -8.52 56.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -80.14 158.73 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 110.471 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.45 131.76 55.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.952 0.406 . . . . 0.0 110.428 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.15 151.59 32.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.296 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.87 151.67 6.69 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.93 -41.93 88.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.856 0.36 . . . . 0.0 110.941 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 -69.66 -28.6 66.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.152 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.9 -41.02 84.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.845 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -60.88 -37.24 81.5 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.945 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -65.1 -45.07 86.7 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.2 -48.01 79.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.993 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.3 -54.27 38.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.352 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.75 -39.59 62.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.85 0.357 . . . . 0.0 110.308 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.0 -42.16 76.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 110.622 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.74 -44.62 70.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.128 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -63.83 -47.38 81.01 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.84 -41.68 91.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.56 -18.09 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.552 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.04 52.76 3.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.505 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -146.6 171.21 15.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.69 141.31 28.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.073 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.4 m -116.8 130.42 56.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.0 m -126.81 126.93 44.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -93.88 135.5 35.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.581 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.53 128.32 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.324 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.04 139.67 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 173.93 129.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.4 Cg_endo -67.5 146.32 73.81 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.753 2.302 . . . . 0.0 112.471 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' A' ' 58' ' ' LEU . 83.6 mt -40.45 -56.57 2.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.148 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.97 -26.82 1.91 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 111.271 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.75 -20.69 19.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.294 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 55' ' ' LEU . 60.6 mt -64.42 -42.27 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.717 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.62 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.19 -56.76 28.13 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.62 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.7 Cg_exo -55.36 -44.06 52.52 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.628 2.219 . . . . 0.0 111.141 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.4 m -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.692 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.94 -44.24 86.82 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.6 -40.17 95.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.5 178.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.26 11.19 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.82 12.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.24 -34.28 77.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 178.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 pt -123.76 152.93 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.218 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.44 -20.65 20.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.302 -179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.38 156.51 26.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.8 mt -115.47 126.99 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.016 0.436 . . . . 0.0 110.475 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.31 106.04 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.309 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.63 ' HG ' ' H ' ' A' ' 73' ' ' SER . 45.6 t -159.67 -179.84 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.589 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.63 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.66 -15.48 61.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.379 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.624 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.8 tp -36.23 123.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.52 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.555 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -81.66 154.6 26.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -104.55 148.01 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -149.57 152.35 35.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.867 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.24 -47.23 55.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.624 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.48 -37.87 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.1 -38.05 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.786 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.05 -27.43 66.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.061 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.58 -50.83 7.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -139.53 -168.31 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.58 147.16 29.79 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.08 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.92 150.03 51.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.574 179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.665 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.9 t -164.05 -152.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.534 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.665 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.8 m-20 41.64 19.5 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.889 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.35 121.34 0.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.392 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.433 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.6 mt -75.11 -68.66 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.893 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -150.8 167.72 26.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.27 28.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.264 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.86 68.26 0.91 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.785 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.84 -104.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.405 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.47 165.89 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.709 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.28 145.93 22.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.434 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.74 136.14 41.08 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 110.816 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.5 110.98 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.19 165.01 32.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.046 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.52 24.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.18 -28.31 57.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.179 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.18 -41.69 89.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -101.83 121.74 42.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.246 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.83 109.86 19.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.103 0.477 . . . . 0.0 110.503 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -127.04 129.79 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -108.76 154.18 41.89 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.24 92.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.758 2.305 . . . . 0.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -171.08 144.04 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.633 0.583 . . . . 0.0 110.795 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.47 -33.82 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -57.54 -62.7 1.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 t -56.22 -22.44 29.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.014 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.5 -26.52 58.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.246 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.39 133.44 45.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.81 -16.87 29.42 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.21 151.55 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.428 . . . . 0.0 110.491 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.31 136.15 37.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.3 t -127.59 136.99 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.78 139.9 14.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.6 t -132.1 161.71 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.044 0.449 . . . . 0.0 110.388 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.499 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.0 tp -92.91 118.32 31.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.46 157.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.609 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.04 50.84 49.58 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -149.69 168.46 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.9 p -74.49 -25.63 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.482 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -61.0 -55.77 28.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.562 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.14 -54.11 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.588 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.28 -51.28 70.23 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.73 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.28 -43.8 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.128 0.489 . . . . 0.0 110.582 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.64 -44.48 97.89 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.63 -14.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.79 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.19 -34.64 2.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.762 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.12 -50.55 18.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.614 -178.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -99.12 12.39 36.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.287 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.49 -55.41 0.49 Allowed Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.434 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.2 -10.39 25.73 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.786 2.324 . . . . 0.0 111.993 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.63 -9.05 59.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.459 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.75 33.3 38.17 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.98 138.09 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.902 0.382 . . . . 0.0 110.627 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.92 129.8 35.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.195 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.16 138.98 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.2 t -125.59 132.1 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 109.943 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -98.43 130.59 45.05 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.998 0.427 . . . . 0.0 110.879 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -111.82 156.44 21.99 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.353 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.07 6.67 29.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.818 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.65 6.25 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -65.88 -46.03 79.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.439 179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.95 -23.15 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.571 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.463 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.51 -36.96 85.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 110.561 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.13 -47.08 85.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.207 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.2 m-85 -63.87 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.08 -42.28 98.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.68 -45.24 90.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.06 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.9 tp -58.87 -47.81 83.6 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.991 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -63.09 -22.93 67.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.947 0.403 . . . . 0.0 110.123 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.7 24.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.02 11.28 70.28 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.63 -18.17 63.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.627 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.87 136.7 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.382 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.77 -27.83 62.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.3 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.61 155.75 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.8 137.34 50.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.93 0.395 . . . . 0.0 109.955 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.92 103.19 14.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.34 0.59 . . . . 0.0 110.819 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.75 165.3 24.86 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.435 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.78 152.7 41.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.73 -54.69 20.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.279 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.08 -48.83 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.623 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.77 88.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.861 0.363 . . . . 0.0 110.856 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.2 -63.13 1.23 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 73.6 m -59.12 -47.63 84.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.851 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.4 tt0 -48.54 -38.02 19.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.17 -65.38 0.54 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.9 t80 -40.68 -71.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 111.286 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.514 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.31 -40.04 92.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -59.7 -2.91 0.41 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.451 0.643 . . . . 0.0 110.442 -179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 173' ' ' LEU . 23.4 mt-30 -123.8 148.46 56.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.93 -20.45 2.98 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 112.195 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.74 -42.89 93.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.96 -33.24 84.88 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.44 95.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.677 0.275 . . . . 0.0 110.459 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.41 -33.62 76.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.315 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.1 m-85 -156.56 142.74 18.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.693 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.554 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.94 99.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.779 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.22 167.6 28.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.29 56.17 2.9 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -117.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.52 135.12 33.29 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.514 2.142 . . . . 0.0 111.89 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.4 p -125.08 -108.36 0.32 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.59 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.44 164.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.363 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.86 156.07 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.91 0.756 . . . . 0.0 110.657 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -82.37 117.66 22.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.937 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.97 -17.35 62.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.14 -33.05 74.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.586 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.16 -44.46 97.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.697 -178.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.6 m-85 -113.63 9.36 17.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.768 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.84 -153.51 51.43 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.66 -25.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.846 0.355 . . . . 0.0 110.5 179.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.13 -123.94 1.28 Allowed Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.9 p -129.36 156.27 44.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.733 0.301 . . . . 0.0 110.324 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.74 -169.44 30.34 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -95.32 138.94 32.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.71 107.26 3.2 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.664 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.1 mt -119.25 160.06 22.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.69 149.06 24.48 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.27 -48.66 65.16 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.543 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.15 -23.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -71.7 52.11 0.21 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.52 -45.23 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.16 -47.17 29.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.327 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.25 -44.17 97.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.448 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.08 -43.13 99.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.846 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.42 -37.21 72.41 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.67 -78.04 0.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.525 ' C ' ' O ' ' A' ' 212' ' ' ALA . 89.9 mt -28.48 -46.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.68 0.276 . . . . 0.0 110.321 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.446 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.6 m-20 -63.85 -45.01 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 178.139 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.78 -43.73 98.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.44 93.85 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.006 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.26 -43.61 98.6 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.994 0.426 . . . . 0.0 109.914 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.26 92.66 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.534 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.94 -42.89 97.21 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -57.05 -38.08 72.72 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.89 -38.96 76.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 110.348 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.86 94.31 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.677 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.1 p-10 -89.15 1.02 56.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.59 20.48 65.97 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.5 m -58.05 -46.33 85.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.433 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 75.1 t80 -63.64 -58.02 8.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.418 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.6 -41.76 77.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.14 -41.61 98.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.311 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.97 -50.34 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -35.33 71.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.648 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.8 -51.0 29.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.627 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 39.2 m-85 -61.95 -46.04 91.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.61 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.6 m-85 -154.35 155.79 35.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.36 99.41 10.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -156.27 -166.21 2.1 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.41 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.87 110.75 15.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.795 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.3 m -63.34 -40.41 88.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.414 179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -58.93 -42.9 90.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.251 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.37 -37.37 94.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.866 -1.519 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.54 164.34 58.63 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.87 99.44 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.14 -40.53 90.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.89 144.01 36.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.5 128.4 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.96 118.62 37.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.85 138.7 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.378 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.73 100.36 1.59 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -123.8 118.56 27.43 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.718 -0.283 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.8 t70 -113.32 93.15 25.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.987 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.16 133.8 57.29 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.468 2.112 . . . . 0.0 112.084 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.2 p -140.18 -19.9 0.88 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.745 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.4 m-85 -124.73 99.08 5.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.601 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.647 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.04 -61.44 0.22 Allowed Pre-proline 0 C--O 1.219 -0.542 0 CA-C-O 121.626 0.727 . . . . 0.0 111.085 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.6 -39.37 46.33 Favored 'Trans proline' 0 C--N 1.294 -2.298 0 C-N-CA 122.439 2.093 . . . . 0.0 112.236 -179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.9 t80 -79.28 -42.96 24.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.928 0.394 . . . . 0.0 111.02 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.27 -155.86 0.67 Allowed 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.01 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.72 177.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.43 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.36 139.46 45.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.39 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -91.01 136.79 32.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.662 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -64.83 -19.22 65.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.539 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -79.13 -5.92 55.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.512 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 -8.24 57.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.1 157.62 26.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.95 0.405 . . . . 0.0 110.438 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.9 mt -112.83 134.56 54.28 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.942 0.401 . . . . 0.0 110.375 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.47 151.31 33.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.407 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.95 151.48 6.61 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.56 -42.12 87.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 -69.99 -27.92 65.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.396 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.7 mt -68.81 -41.14 82.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -60.72 -37.66 82.47 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.081 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.09 -44.08 85.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.206 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.1 -44.31 91.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.093 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.51 -53.84 52.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.541 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.32 -37.44 62.28 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.57 -42.09 74.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.764 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.5 m -54.45 -44.1 72.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.102 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.15 -47.69 78.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -59.53 -41.21 89.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.069 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.22 -18.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.683 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.9 52.49 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.586 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -145.36 170.1 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.18 140.48 29.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.059 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -116.7 131.23 57.01 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.3 127.99 43.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.436 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -94.69 136.38 35.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.435 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.72 128.57 65.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.311 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.14 139.08 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.748 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 174.09 132.85 0.12 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.7 Cg_endo -68.42 144.75 62.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.647 2.231 . . . . 0.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' LEU . 77.8 mt -40.49 -55.65 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.098 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -47.84 -26.45 1.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.34 19.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.184 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 55' ' ' LEU . 85.1 mt -65.03 -42.33 94.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.826 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.604 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.83 -56.59 30.84 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.739 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.604 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.2 Cg_exo -55.47 -43.26 59.94 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.591 2.194 . . . . 0.0 111.108 177.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.7 m -58.83 -44.44 90.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.27 -44.36 88.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.69 -40.08 94.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 0.0 110.469 178.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.07 11.26 1.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.505 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.94 11.86 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.34 -34.19 77.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.546 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.6 pt -124.4 153.15 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.285 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.96 -19.83 20.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.03 156.9 25.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.726 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.61 127.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 110.541 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.18 106.55 9.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -159.84 -179.08 7.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.639 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.29 -15.27 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.414 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.625 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.0 tp -37.56 123.77 1.01 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.533 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.16 156.38 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.627 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 pt -104.98 148.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.264 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.0 p -150.26 152.6 34.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.722 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.11 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.63 -39.62 71.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.708 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.625 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.7 mtt180 -68.73 -37.74 79.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -37.56 75.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.931 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.66 67.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.12 -51.73 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.617 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -138.52 -168.34 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.139 0.495 . . . . 0.0 110.416 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.03 147.04 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -130.07 150.23 51.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.605 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.8 t -164.57 -151.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.479 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.605 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.3 m-20 42.97 19.26 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.21 120.49 0.11 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.4 mt -77.19 -70.01 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.778 -178.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -149.38 166.35 29.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.589 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.29 122.32 27.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.37 68.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.79 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.08 -104.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.57 165.86 31.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.624 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.68 146.7 23.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 0.0 110.473 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.6 135.68 42.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.78 110.36 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.31 164.97 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.5 -27.61 39.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.38 -41.71 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.359 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.1 t -102.38 122.0 43.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.236 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.49 109.19 19.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.411 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.469 ' C ' ' NE2' ' A' ' 106' ' ' GLN . 97.0 mt -128.37 129.61 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.612 ' NE2' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.06 159.15 33.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.555 179.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.39 89.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 111.908 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -168.88 140.35 2.53 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.511 0.507 . . . . 0.0 110.811 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.47 -32.63 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.324 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -56.74 -62.85 1.45 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.443 -178.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.64 -22.08 31.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.965 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.63 -27.26 58.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.334 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -55.08 132.96 48.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.449 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.14 -16.52 32.96 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.98 151.81 22.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 110.449 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.65 135.59 38.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.997 0.427 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -126.87 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.65 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.54 14.29 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.96 161.62 40.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.065 0.459 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.497 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 41.0 tp -92.71 118.33 30.95 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.56 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -52.02 157.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.1 50.64 50.43 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.7 p -149.55 168.74 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.889 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.438 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.8 p -73.67 -26.53 60.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.391 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.68 -55.36 34.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.99 -54.36 47.61 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.549 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.52 -51.03 71.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.2 t80 -62.21 -43.82 97.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 0.0 110.398 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.34 97.9 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -45.32 -14.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 0.0 110.684 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.44 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.703 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.37 -50.93 16.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.008 0.432 . . . . 0.0 111.545 -178.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.26 12.81 35.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.183 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.49 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.07 -55.5 0.46 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.375 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.35 -10.21 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.797 2.331 . . . . 0.0 111.993 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.76 -8.86 59.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.18 33.33 36.3 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.41 137.89 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.963 0.411 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.58 129.71 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.299 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.08 137.97 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.857 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.34 133.23 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 109.998 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.37 127.98 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.02 153.78 25.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -106.84 6.51 29.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.69 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -66.18 -45.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.472 179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.04 -23.74 63.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.471 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.479 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.58 -36.63 84.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.523 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -65.97 -46.95 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.117 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.6 m-85 -64.21 -37.69 88.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.297 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.98 -42.49 98.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.71 -43.54 93.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.038 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.7 tp -58.84 -48.34 81.69 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.168 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.38 -22.47 66.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.149 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.04 -17.81 25.64 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.577 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 12.11 73.03 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.97 -17.61 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.37 136.5 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.83 -28.36 62.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.35 155.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 -179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.52 50.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.91 0.386 . . . . 0.0 110.04 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.83 102.9 14.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.149 0.499 . . . . 0.0 110.656 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.19 165.17 24.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.396 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.39 152.27 40.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.561 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.19 -54.18 28.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.31 -49.18 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.456 -179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.87 88.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.811 0.338 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.18 -63.21 1.21 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.2 m -58.69 -47.26 85.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.924 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.67 -37.58 29.16 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.057 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.402 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.81 -66.47 0.56 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.8 t80 -40.2 -71.04 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.619 0.247 . . . . 0.0 111.21 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.21 -39.94 92.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.87 -2.69 0.42 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.505 0.669 . . . . 0.0 110.477 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.512 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.4 mt-30 -124.42 141.7 38.33 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.885 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.89 -15.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.835 2.357 . . . . 0.0 112.275 179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.2 t -63.08 -42.75 97.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.9 80.69 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.93 -41.55 96.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.307 . . . . 0.0 110.404 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 58.9 m-20 -65.27 -35.08 79.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.745 179.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.3 m-85 -156.73 143.2 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.737 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.93 99.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 110.725 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.19 167.55 28.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.631 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.14 55.44 3.1 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.42 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.8 135.05 35.27 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.467 2.111 . . . . 0.0 111.933 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.2 p -124.66 -108.33 0.33 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.505 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.62 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.83 165.17 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.239 -179.367 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.65 155.91 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.146 0.903 . . . . 0.0 110.646 179.197 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.26 118.59 23.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.812 178.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.2 mp0 -72.05 -18.53 61.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.92 -32.1 73.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.524 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.97 -44.38 97.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.767 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.438 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.9 m-85 -114.22 8.55 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.751 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.13 -154.79 51.12 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.72 -25.51 26.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.825 0.345 . . . . 0.0 110.508 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.13 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -132.06 160.05 37.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 110.413 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.39 24.6 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.78 32.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.89 111.62 3.91 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -120.89 160.33 23.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.226 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.71 148.93 25.23 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.612 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.06 -48.87 64.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.637 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.06 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -72.17 51.96 0.24 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -64.42 -45.92 85.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.231 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.72 -47.04 33.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.26 -43.84 97.91 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.461 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.6 -42.87 99.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.88 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.56 -37.5 73.23 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.52 -77.4 0.11 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.519 ' C ' ' O ' ' A' ' 212' ' ' ALA . 85.4 mt -28.85 -45.66 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.815 0.34 . . . . 0.0 110.489 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.447 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.4 m-20 -63.57 -45.33 90.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.689 178.048 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.44 -43.63 98.53 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.45 93.47 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.105 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.2 -43.42 98.91 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.063 0.459 . . . . 0.0 110.064 179.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.38 92.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.089 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.531 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.91 -42.91 97.28 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.825 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.77 -38.41 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.85 -38.83 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.46 92.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.27 0.54 56.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.59 20.09 67.63 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.4 m -58.07 -46.26 85.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.6 t80 -63.53 -57.51 9.95 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.453 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.432 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.6 mt-10 -56.91 -41.73 78.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.258 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -48.53 80.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.75 -41.79 98.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.469 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.2 -49.81 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.68 -35.38 72.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.426 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.64 -51.07 30.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.461 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.7 m-85 -62.19 -45.92 91.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.593 179.524 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.6 m-85 -154.39 155.52 35.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.443 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.2 p-10 -98.05 101.68 13.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.497 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -158.16 -165.24 1.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.425 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -122.89 110.02 14.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 20.5 m -63.57 -40.2 88.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 93.7 m-85 -58.86 -42.96 90.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.257 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.24 -36.51 93.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.684 0 CA-C-O 117.872 -1.515 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.22 164.18 62.9 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.46 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.573 2.182 . . . . 0.0 112.279 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.51 -40.94 89.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -138.17 139.12 39.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.406 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.46 121.44 61.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.0 110.649 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.08 118.87 32.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.18 0.514 . . . . 0.0 110.176 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.56 138.44 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.516 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.47 105.71 2.2 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.0 m -129.15 120.44 25.86 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 122.707 -0.29 . . . . 0.0 111.136 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 11.3 t0 -114.26 92.95 29.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.081 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.22 134.33 60.04 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.396 2.064 . . . . 0.0 112.105 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.3 p -141.73 -20.19 0.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.6 m-85 -123.46 98.95 6.08 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.701 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.671 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.09 -61.45 0.22 Allowed Pre-proline 0 C--O 1.218 -0.553 0 CA-C-O 121.38 0.61 . . . . 0.0 110.983 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.3 Cg_endo -49.31 -40.56 43.54 Favored 'Trans proline' 0 C--N 1.296 -2.206 0 C-N-CA 122.217 1.945 . . . . 0.0 112.244 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.0 t80 -78.24 -43.1 29.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.053 0.454 . . . . 0.0 110.987 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.671 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.2 mt-10 -149.31 -153.98 0.53 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.989 -178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.84 177.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.042 0.449 . . . . 0.0 110.415 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.51 144.62 46.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.436 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.91 134.33 39.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.669 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -64.6 -19.16 65.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.534 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.87 -6.23 53.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.42 -8.25 56.75 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.38 158.9 25.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.979 0.418 . . . . 0.0 110.469 179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.3 mt -112.32 131.33 55.58 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.961 0.41 . . . . 0.0 110.462 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.0 151.37 32.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.296 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.08 151.28 6.53 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.65 -42.04 87.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.808 0.337 . . . . 0.0 110.912 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 -69.68 -28.56 65.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.128 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.71 -40.97 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -60.99 -37.21 81.69 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.766 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.9 -45.29 86.54 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.11 -48.46 78.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.017 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.18 -54.56 34.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.372 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.31 -39.95 61.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.269 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.66 -41.85 78.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.02 0.438 . . . . 0.0 110.64 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.0 m -53.47 -45.18 69.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.11 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.02 -46.93 82.27 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -60.08 -42.08 93.85 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.132 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.26 -17.41 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.81 53.23 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.439 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.29 171.73 14.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.3 142.86 27.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.0 m -117.71 131.37 56.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.785 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.29 126.89 43.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.39 179.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -93.72 134.72 35.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.637 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.2 127.78 65.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.45 138.1 57.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.73 130.9 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 57' ' ' ALA . 46.3 Cg_endo -67.74 144.95 67.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.74 2.293 . . . . 0.0 112.521 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.2 mt -40.33 -55.62 2.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.22 -26.63 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.85 -20.95 19.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.269 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.1 mt -63.87 -42.34 97.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.629 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.17 -56.95 26.44 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.772 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -55.63 -42.46 67.41 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.6 2.2 . . . . 0.0 111.178 177.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 69.8 m -58.71 -44.98 90.53 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.919 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.86 -44.04 90.96 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.35 -40.69 96.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.88 9.91 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.24 12.21 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.43 -35.69 81.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -122.2 152.97 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.297 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -93.21 -22.21 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.406 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.55 156.05 27.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.85 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -114.82 128.85 71.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.117 0.484 . . . . 0.0 110.488 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.482 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.21 106.74 8.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.389 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.715 ' HG ' ' H ' ' A' ' 73' ' ' SER . 38.0 t -159.55 178.66 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.715 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.2 p -64.93 -15.59 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.362 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.7 tp -34.99 124.28 0.57 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.889 0.376 . . . . 0.0 110.503 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.83 154.04 26.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.703 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 pt -104.74 148.43 9.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.335 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.1 152.06 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.856 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.97 -47.06 52.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.416 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.49 -39.85 70.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.692 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.614 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.77 -38.01 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.75 -38.94 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.45 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.094 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.57 -50.57 8.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.5 pt -139.38 -168.33 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.185 0.517 . . . . 0.0 110.466 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.42 147.79 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.47 . . . . 0.0 111.061 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -130.07 150.05 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.57 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.32 -153.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.558 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.672 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.8 m-20 41.27 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.68 0.2 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.364 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.43 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 59.1 mt -75.11 -68.79 0.52 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -178.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -150.75 167.59 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.67 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.237 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.7 68.25 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.849 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.59 -104.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.1 165.76 33.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.17 146.26 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.453 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.8 mt -100.85 135.95 41.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.66 110.61 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.28 164.4 34.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.47 148.68 24.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.003 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.02 -28.56 57.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.199 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -58.93 -41.66 87.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.319 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -101.84 121.66 42.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.43 110.07 20.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -126.22 129.45 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.702 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -106.52 154.12 40.13 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.666 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.507 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.54 91.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.771 2.314 . . . . 0.0 111.711 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.0 m -170.64 143.39 2.17 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.589 0.556 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.84 -33.27 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.072 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.36 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -55.86 -22.2 24.08 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.094 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 mt -76.2 -25.9 55.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.229 179.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.81 133.69 47.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.407 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.22 -16.58 28.09 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.15 151.27 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.016 0.436 . . . . 0.0 110.373 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -95.53 135.17 37.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.377 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -127.15 136.72 59.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.61 138.47 14.29 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.5 t -130.77 161.68 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.071 0.462 . . . . 0.0 110.338 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.0 tp -92.67 117.7 30.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.496 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.78 157.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.59 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.65 50.68 52.87 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.78 168.76 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 0.0 110.864 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.452 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.0 p -73.17 -27.49 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.458 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.2 -55.58 32.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.55 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -56.57 -55.03 38.94 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.63 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.15 -51.03 71.32 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.735 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.4 t80 -62.11 -43.93 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.123 0.487 . . . . 0.0 110.496 179.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.73 -44.58 97.72 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.24 -14.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.896 0.379 . . . . 0.0 110.787 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.37 -34.39 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.717 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.51 -50.62 17.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 0.0 111.617 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.96 12.17 36.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.46 -55.55 0.49 Allowed Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.37 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 55.9 Cg_endo -72.04 -10.48 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.769 2.312 . . . . 0.0 111.991 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.59 -9.29 59.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.461 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.23 37.14 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.29 137.84 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.41 129.91 34.86 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.63 138.24 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.03 133.54 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.072 0.463 . . . . 0.0 109.991 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.91 127.08 42.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.65 153.19 25.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.051 0.453 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.97 7.23 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.95 130.42 5.93 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -66.06 -45.82 80.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.425 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.77 -23.4 62.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.564 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -37.13 86.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.516 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.82 -46.64 88.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.186 -179.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.685 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 60.9 m-85 -64.58 -37.7 88.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.322 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.88 -42.01 97.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.058 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.24 -43.32 91.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.995 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.9 tp -58.97 -47.93 83.36 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.046 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.6 m -62.9 -22.42 66.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.44 25.13 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.66 72.28 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.75 -17.91 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.9 135.78 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.45 -27.65 62.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.296 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.74 155.9 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.79 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.96 137.03 50.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -85.85 103.4 14.56 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.347 0.594 . . . . 0.0 110.851 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.685 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 49.7 tt0 -132.93 165.31 24.96 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.372 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.446 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -72.62 153.15 41.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 110.563 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -66.64 -54.86 18.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.361 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 75.6 t -60.23 -48.95 86.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.689 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.98 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.774 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.51 -63.01 1.24 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.662 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.0 m -59.55 -48.0 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.99 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.41 -37.71 17.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.07 -65.86 0.55 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.664 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.7 t80 -40.58 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 111.236 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.3 mt -61.43 -40.22 93.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 -179.146 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.82 -3.04 0.45 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.451 0.643 . . . . 0.0 110.521 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.9 mt-30 -122.86 149.4 56.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.08 -21.1 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.823 2.349 . . . . 0.0 112.182 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.98 -42.75 94.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.643 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.42 -33.27 85.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.4 -41.34 93.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.313 . . . . 0.0 110.464 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.4 m-20 -65.67 -33.23 75.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.299 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.37 142.64 18.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.42 99.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.21 167.22 29.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.716 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.32 56.38 2.69 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.22 -118.89 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.52 135.55 33.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.462 2.108 . . . . 0.0 111.923 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.7 p -125.43 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.566 -179.024 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.643 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.11 164.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.643 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 154.26 155.86 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.918 0.761 . . . . 0.0 110.641 179.216 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.06 117.19 22.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.857 179.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -71.2 -18.85 62.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.79 -32.43 73.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.555 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.8 mt -61.05 -44.48 97.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 -178.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -114.01 9.3 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.728 179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.2 -154.3 51.74 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.38 -25.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 110.488 179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.22 -124.24 1.32 Allowed Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.9 p -129.42 156.4 44.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.257 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.73 -169.43 30.31 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -94.48 137.51 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.963 0.411 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.47 108.09 3.26 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.2 mt -123.02 159.26 28.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.023 0.44 . . . . 0.0 110.114 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 89.9 mtm180 -86.94 149.75 24.57 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.91 -48.09 64.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.515 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -38.46 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.899 0.381 . . . . 0.0 110.733 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.69 52.11 0.21 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.642 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.57 -44.76 89.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.1 -47.33 29.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.32 -44.07 97.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.421 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.22 -43.06 99.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.16 -36.36 70.67 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.26 -77.65 0.11 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.527 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.2 mt -28.31 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.335 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.438 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.6 m-20 -64.22 -44.91 90.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.616 178.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.1 -43.69 98.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.951 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.01 -38.99 93.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.038 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.35 -43.72 98.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 109.903 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.56 93.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.534 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -43.06 97.83 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.2 mtp -57.04 -37.94 72.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.08 -39.01 75.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 110.337 178.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.69 94.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.6 p-10 -89.2 1.53 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.73 20.42 64.04 Favored Glycine 0 C--O 1.226 -0.382 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.461 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 79.7 m -58.26 -45.99 86.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.43 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.4 t80 -63.84 -58.09 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.396 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.427 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.4 mt-10 -56.67 -41.55 77.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.38 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.78 -48.37 81.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.2 -41.59 98.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.312 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.69 -50.35 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.597 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.34 -35.17 71.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -71.11 -50.92 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.598 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.4 m-85 -62.0 -45.56 93.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.47 155.84 35.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.42 97.94 9.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -155.49 -166.24 2.19 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.42 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.0 t0 -123.22 111.06 16.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.59 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.54 -40.59 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.427 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 92.9 m-85 -58.61 -42.86 89.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.36 -37.19 94.45 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.628 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.955 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.4 164.38 61.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.744 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.71 143.38 99.39 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 122.655 2.237 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.4 -40.7 89.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.597 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.54 141.9 37.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 9' ' ' ILE . 84.4 mt -109.57 127.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -102.5 119.69 39.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.093 0.473 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -113.69 138.56 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.292 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.78 100.31 1.57 Allowed Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -123.79 119.01 28.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.673 -0.31 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 19.5 t70 -113.16 92.34 21.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.016 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.86 133.66 55.59 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.42 2.08 . . . . 0.0 112.13 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -140.79 -20.11 0.82 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.774 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.1 m-85 -123.36 98.84 6.04 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.537 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.643 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.14 -61.34 0.22 Allowed Pre-proline 0 C--O 1.216 -0.685 0 CA-C-O 121.771 0.796 . . . . 0.0 111.138 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.54 -40.36 45.66 Favored 'Trans proline' 0 C--N 1.288 -2.606 0 C-N-CA 122.469 2.112 . . . . 0.0 112.256 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -78.39 -42.95 28.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.0 0.428 . . . . 0.0 110.91 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.7 mt-10 -149.54 -154.63 0.57 Allowed 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.116 -178.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 162.24 177.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.087 0.47 . . . . 0.0 110.237 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.41 144.05 46.31 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.388 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -95.04 134.6 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.632 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -64.71 -18.89 65.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.527 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.48 -6.47 55.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.93 -8.32 55.84 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.16 158.49 26.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.981 0.42 . . . . 0.0 110.476 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.9 mt -112.44 131.91 55.32 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.941 0.4 . . . . 0.0 110.385 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -134.15 151.61 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.97 0.414 . . . . 0.0 110.323 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.74 6.73 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -58.85 -42.13 88.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.582 -0.364 . . . . 0.0 111.055 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 -69.1 -28.39 66.45 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.353 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.0 -40.67 83.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.041 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -60.81 -37.56 82.41 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.88 -178.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.8 -45.0 88.08 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.14 -48.15 79.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.825 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.01 -54.49 34.54 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.323 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.58 -39.59 61.74 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.026 0.441 . . . . 0.0 110.393 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.07 -42.02 76.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.8 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.01 -44.14 70.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.041 -179.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.92 -47.56 80.06 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.973 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.56 -41.78 90.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.111 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.68 -18.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.4 m-20 60.5 52.71 4.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.188 0.518 . . . . 0.0 110.623 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.8 p -146.1 170.75 16.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.25 140.75 29.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -116.3 130.12 56.62 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.69 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.14 127.49 44.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.396 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -94.73 136.36 35.14 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.66 128.58 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 110.304 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.01 139.34 58.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.79 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 173.39 130.07 0.1 Allowed Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.519 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.0 Cg_endo -67.95 146.73 72.43 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.743 2.295 . . . . 0.0 112.514 -179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.7 mt -41.05 -55.92 2.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -48.06 -26.76 1.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.251 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.94 -20.3 19.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.252 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.26 -42.36 93.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.579 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.35 -57.27 26.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 123.801 0.688 . . . . 0.0 109.516 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.9 Cg_exo -55.02 -43.95 54.4 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.571 2.181 . . . . 0.0 111.083 177.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -58.65 -44.55 90.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.575 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.33 -44.24 88.61 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.8 mtmt -64.78 -40.24 94.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.983 0.42 . . . . 0.0 110.488 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 55.84 11.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.937 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.11 76.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 178.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.18 152.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.18 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -94.07 -20.23 20.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 155.87 26.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.76 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 97.0 mt -116.43 127.89 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 110.443 179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -128.16 105.64 8.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 110.326 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.548 ' HG ' ' N ' ' A' ' 73' ' ' SER . 47.2 t -158.66 179.24 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -65.19 -14.93 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.394 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.619 ' CD1' HH12 ' A' ' 80' ' ' ARG . 39.4 tp -35.98 124.22 0.73 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.47 154.11 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.9 pt -104.51 148.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.207 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -149.8 152.63 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.818 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.28 -47.38 55.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.032 0.444 . . . . 0.0 110.548 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.44 -39.93 70.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.619 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.5 -37.83 80.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.21 -37.95 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.798 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.01 -27.73 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.094 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.13 -50.73 8.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.976 0.417 . . . . 0.0 110.774 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.67 -168.6 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.165 0.507 . . . . 0.0 110.383 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.33 147.28 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.119 0.485 . . . . 0.0 111.059 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -129.93 149.85 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.621 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.81 -152.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.47 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.621 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.3 m-20 41.72 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.019 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.22 121.41 0.18 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.385 0.428 . . . . 0.0 110.433 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.435 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.0 mt -75.44 -68.81 0.53 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.81 -178.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -150.32 167.45 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.66 123.58 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.176 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.23 68.27 0.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.775 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.16 -104.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.442 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -159.64 165.83 31.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.11 146.35 22.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.423 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.1 mt -101.38 136.04 41.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.72 111.0 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.26 165.2 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.959 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.4 23.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.64 -27.77 42.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -59.13 -41.87 89.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.249 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.6 122.18 43.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.019 0.437 . . . . 0.0 110.154 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.81 109.34 19.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.395 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -127.97 129.78 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.641 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.82 159.07 33.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.575 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.514 ' C ' ' HG1' ' A' ' 108' ' ' THR . 19.9 Cg_endo -59.79 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.789 2.326 . . . . 0.0 111.93 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.514 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.9 m -169.02 141.2 2.6 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.596 0.56 . . . . 0.0 110.858 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.38 -33.24 61.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -57.24 -62.65 1.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.333 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.58 -22.11 31.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.066 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -75.53 -26.88 58.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 178.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.9 133.29 47.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 -179.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.77 -16.92 28.95 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.2 151.46 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.497 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.22 135.56 37.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.273 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.27 136.73 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.47 138.86 14.47 Favored Glycine 0 N--CA 1.462 0.383 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.92 161.68 40.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.497 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.5 tp -92.56 117.72 30.26 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.696 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.76 157.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.17 50.53 50.75 Favored Glycine 0 N--CA 1.463 0.436 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -149.6 168.79 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.457 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.1 p -73.69 -26.29 60.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.435 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.93 -55.45 32.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.431 -179.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -56.94 -54.35 47.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.583 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.3 -51.12 70.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.641 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.8 t80 -62.31 -43.82 97.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.144 0.497 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 131' ' ' GLU . . . -61.78 -44.41 97.92 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.3 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.65 2.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.34 -50.92 16.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.698 -178.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -99.0 12.43 36.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.72 -55.54 0.48 Allowed Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.16 25.29 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.737 2.291 . . . . 0.0 111.933 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.93 -8.85 59.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 -179.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.32 36.87 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.31 137.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.01 0.434 . . . . 0.0 110.565 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.4 129.75 34.92 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.1 pt -126.19 138.05 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.5 t -123.16 133.28 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.082 0.467 . . . . 0.0 109.899 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.36 127.59 43.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.17 153.76 25.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.265 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -107.05 7.01 29.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.67 130.28 5.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -65.74 -45.81 81.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.07 -23.91 63.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.461 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.49 -36.75 85.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.413 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.13 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.42 -38.22 90.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.13 -42.5 98.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.164 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.47 -45.95 88.45 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.46 -48.14 81.74 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.161 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.32 -23.31 67.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.935 0.398 . . . . 0.0 110.066 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.89 -18.79 25.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.45 11.09 69.52 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.24 -18.31 63.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.3 pt -128.69 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.083 0.468 . . . . 0.0 110.443 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.0 -27.35 61.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.92 155.88 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.583 0.552 . . . . 0.0 110.91 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.94 137.09 50.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.987 0.422 . . . . 0.0 109.935 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.42 103.27 14.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.238 0.542 . . . . 0.0 110.798 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.3 tt0 -132.47 165.51 24.14 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.341 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.429 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.0 152.03 41.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.565 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.33 -54.33 25.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.4 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.6 t -60.38 -48.83 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.417 -179.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.72 88.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.3 -62.99 1.26 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.507 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.1 m -58.87 -47.38 85.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.88 -179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -49.16 -37.85 23.62 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.067 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.11 -65.93 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.0 t80 -40.27 -71.15 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.824 -0.221 . . . . 0.0 111.245 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.06 -40.03 92.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.948 -179.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.92 -2.28 0.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.613 0.721 . . . . 0.0 110.323 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 173' ' ' LEU . 56.2 mt-30 -124.25 141.4 37.29 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.905 -0.497 . . . . 0.0 110.8 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.75 -16.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.843 2.362 . . . . 0.0 112.409 179.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 72.1 t -62.88 -43.0 98.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.619 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.85 82.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.91 -41.39 96.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.73 0.3 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.8 m-20 -65.58 -34.52 78.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.04 142.74 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.64 99.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.0 110.757 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.7 m-85 -159.07 166.82 30.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.668 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.04 56.36 2.9 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.06 -117.24 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.59 135.68 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.419 2.079 . . . . 0.0 111.984 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.9 p -124.7 -108.33 0.33 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.77 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.21 165.08 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 155.69 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 124.461 1.101 . . . . 0.0 110.69 178.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.75 118.24 22.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.87 -18.71 62.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.47 74.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.92 -44.55 97.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.685 -177.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.457 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -114.24 10.05 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.758 178.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.45 51.47 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.85 -25.09 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.486 179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 159.91 -123.97 1.29 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -129.51 156.54 43.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.76 -169.59 30.55 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -94.88 138.73 32.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.945 0.402 . . . . 0.0 110.607 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.39 107.17 3.16 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.62 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.7 mt -119.83 159.98 23.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.923 0.392 . . . . 0.0 110.143 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.76 149.11 24.39 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-O 120.833 0.349 . . . . 0.0 110.654 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.4 -48.5 65.65 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.549 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -39.76 -23.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.55 52.21 0.2 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.799 0.333 . . . . 0.0 110.661 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.33 -45.78 86.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.99 -47.12 30.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.281 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.08 -43.99 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.48 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.52 -36.98 72.27 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.94 -77.22 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.511 ' C ' ' O ' ' A' ' 212' ' ' ALA . 89.0 mt -29.26 -45.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.446 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.6 m-20 -63.81 -44.96 91.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.728 177.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.73 -43.79 98.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.897 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.29 93.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.05 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.18 -43.47 98.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.194 0.521 . . . . 0.0 110.032 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.33 93.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.021 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.532 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.58 -43.19 97.72 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.92 -38.28 72.65 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.95 -38.84 76.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.673 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -89.33 0.98 56.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.99 20.45 66.81 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -58.33 -45.94 87.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -63.99 -57.6 9.21 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.436 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.425 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.7 mt-10 -57.04 -41.44 78.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.169 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.56 -48.54 80.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.518 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.77 -41.83 98.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 110.546 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.71 -50.03 75.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.66 -35.04 71.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.409 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.83 -50.87 30.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.55 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 40.2 m-85 -62.25 -45.93 91.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.76 155.61 34.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.4 p-10 -97.35 99.05 10.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.76 -166.03 2.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.08 110.81 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.9 m -63.65 -40.44 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.473 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.425 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 92.6 m-85 -59.04 -42.59 90.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.305 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.2 94.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.607 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 164.25 56.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.93 143.27 99.31 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.574 2.183 . . . . 0.0 112.297 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.34 -40.71 90.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -139.13 139.95 37.79 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 9' ' ' ILE . 81.0 mt -107.81 120.69 59.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 110.681 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.06 118.78 32.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.145 0.498 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -112.42 138.56 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.01 101.42 1.51 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -124.68 120.71 32.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 122.717 -0.284 . . . . 0.0 111.142 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t70 -114.07 92.73 27.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.194 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.35 134.59 61.87 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.417 2.078 . . . . 0.0 112.105 179.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 p -142.37 -19.78 0.7 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.771 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.3 m-85 -124.02 99.05 6.06 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.629 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.66 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.11 -61.43 0.22 Allowed Pre-proline 0 C--O 1.217 -0.614 0 CA-C-O 121.528 0.68 . . . . 0.0 111.067 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.53 -39.85 45.62 Favored 'Trans proline' 0 C--N 1.294 -2.303 0 C-N-CA 122.297 1.998 . . . . 0.0 112.293 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -78.88 -42.72 26.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.977 0.418 . . . . 0.0 110.992 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.66 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.69 -154.61 0.56 Allowed 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.043 -178.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 162.14 177.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.041 0.448 . . . . 0.0 110.336 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.56 140.87 45.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.382 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -92.64 137.11 32.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.661 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.4 p -64.98 -19.28 65.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.564 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.75 -6.58 56.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.451 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.71 -8.73 56.58 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -78.98 156.93 28.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 110.485 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.5 mt -111.92 133.57 54.03 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.967 0.413 . . . . 0.0 110.385 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.15 151.45 32.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.37 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.19 151.15 6.49 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -58.58 -41.86 86.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.838 0.352 . . . . 0.0 110.989 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.6 t0 -69.58 -28.34 65.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.245 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.85 -40.79 84.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -60.81 -37.38 81.77 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.891 -178.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.72 -44.49 85.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.89 -47.91 81.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.035 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.95 -54.4 39.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.347 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.35 -38.85 59.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.943 0.401 . . . . 0.0 110.311 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.29 -41.77 76.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.46 . . . . 0.0 110.556 178.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 51.0 m -53.79 -44.93 70.54 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.033 -179.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.25 -47.31 80.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.037 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.8 -42.15 92.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.201 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.32 -17.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.09 52.84 3.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.492 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.54 170.91 15.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.36 142.43 27.74 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.075 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 m -117.34 131.87 56.71 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.575 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.9 m -128.75 128.12 43.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -95.19 135.57 36.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.478 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.8 129.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.427 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.75 136.65 56.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.777 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 176.41 131.42 0.18 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.49 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.8 Cg_endo -68.28 144.81 63.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.691 2.261 . . . . 0.0 112.536 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -40.29 -55.43 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.21 -26.27 1.87 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.163 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.57 -21.05 18.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.14 -42.44 96.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.88 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.612 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.68 -57.12 26.68 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 123.738 0.648 . . . . 0.0 109.67 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.14 -42.27 70.46 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.612 2.208 . . . . 0.0 111.267 177.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -45.06 90.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.944 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.6 tp -58.94 -44.08 91.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.128 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.5 -40.66 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.955 0.407 . . . . 0.0 110.456 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.86 10.38 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.84 12.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.5 -35.16 79.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.498 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -122.9 153.54 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.212 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -93.54 -21.53 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.285 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.3 156.72 26.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.67 129.06 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -130.55 106.7 8.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.3 t -158.96 178.69 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.575 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -65.33 -15.16 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.612 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -35.56 124.84 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.573 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.54 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -83.0 155.0 24.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.662 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.0 pt -105.04 149.2 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.314 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -149.37 152.33 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.829 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.95 -47.48 52.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.544 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.65 -39.53 71.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.88 -37.86 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -57.99 -38.62 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.868 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.81 -27.59 66.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.105 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.26 -51.22 7.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -138.5 -168.23 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 110.501 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.03 147.71 29.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.09 150.08 51.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.653 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.662 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.73 -152.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.498 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.662 ' H ' ' HG1' ' A' ' 87' ' ' THR . 97.2 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.948 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.7 mttt -29.32 121.02 0.15 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.336 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.4 mt -76.64 -69.53 0.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.842 -178.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -149.47 166.43 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.614 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.46 122.75 28.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.38 69.46 0.91 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.813 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.51 -104.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.393 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.17 165.77 32.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.56 145.91 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.125 0.488 . . . . 0.0 110.439 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.89 136.26 41.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.99 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.19 165.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.996 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.48 23.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.96 -28.35 56.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.04 -41.7 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.301 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.13 122.19 43.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.06 109.9 19.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -126.87 129.59 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.656 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -108.28 154.3 41.44 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 110.679 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.24 92.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.756 2.304 . . . . 0.0 111.649 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.02 144.02 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.669 0.606 . . . . 0.0 110.773 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.55 -33.7 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.162 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -57.35 -62.63 1.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.263 -178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.37 -21.93 27.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.037 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.0 -26.2 56.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.309 179.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.77 133.7 47.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.382 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.08 -16.78 26.36 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -85.92 151.44 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.494 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -95.86 135.39 37.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.25 136.66 60.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.658 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.5 138.53 14.3 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.496 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.9 161.66 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.496 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 44.2 tp -92.43 117.42 29.9 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.599 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.73 158.04 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.47 50.48 55.02 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -149.62 168.95 22.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.928 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.458 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 67.2 p -73.24 -27.58 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.13 -55.36 34.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.67 -54.82 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.695 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.37 -51.04 71.18 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.74 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.2 -43.83 97.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.44 97.81 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.43 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.0 110.778 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.23 -34.46 2.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.35 -50.56 18.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.473 . . . . 0.0 111.649 -178.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.27 12.59 35.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.83 -55.53 0.47 Allowed Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.413 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.29 -10.31 25.49 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.778 2.319 . . . . 0.0 111.934 -179.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.65 -8.88 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.14 37.63 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.28 138.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.85 130.19 34.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.0 138.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.14 133.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 109.99 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.11 127.3 42.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.83 153.7 25.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.33 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.24 7.13 29.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.41 130.47 6.03 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.03 -45.92 79.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.441 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.21 62.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.572 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.87 -36.78 85.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.536 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 149' ' ' ILE . 96.6 mt -66.03 -47.13 86.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.159 -179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.1 m-85 -63.74 -37.91 89.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.253 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.19 -42.4 98.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.096 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.403 ' H ' ' HG ' ' A' ' 151' ' ' SER . 54.9 m-20 -63.73 -45.21 90.96 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.981 179.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.69 -47.94 82.82 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.31 -22.96 67.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.21 -18.66 25.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.641 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.65 69.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.92 -18.13 63.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 36.7 pt -127.87 136.96 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.66 -27.62 62.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.8 155.89 1.74 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.817 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.92 137.12 50.19 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 109.991 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.67 103.05 14.13 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.237 0.541 . . . . 0.0 110.817 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.39 165.2 24.79 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.0 152.6 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.05 -54.37 26.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.332 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.403 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 70.8 t -60.24 -49.13 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.439 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.93 87.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.828 0.347 . . . . 0.0 110.759 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.37 -63.35 1.16 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 72.5 m -59.15 -47.88 83.67 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.927 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.01 -38.19 22.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.46 -65.73 0.56 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.676 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -70.94 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.8 mt -61.06 -39.88 91.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.192 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.65 -2.72 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.462 0.649 . . . . 0.0 110.399 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.4 mt-30 -124.14 142.21 39.26 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.5 -16.47 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.844 2.363 . . . . 0.0 112.32 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 175' ' ' GLN . 73.0 t -62.69 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.586 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.01 82.73 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.75 -41.27 95.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.733 0.302 . . . . 0.0 110.567 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -66.0 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.393 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.6 m-85 -157.07 143.65 18.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.59 100.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 110.757 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.34 167.37 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.72 56.09 2.85 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.53 -117.94 0.01 OUTLIER Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.59 135.29 33.76 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.504 2.136 . . . . 0.0 111.969 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.9 p -125.36 -107.89 0.32 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.574 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.67 165.11 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.628 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.51 156.05 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 124.024 0.828 . . . . 0.0 110.696 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.46 117.61 22.61 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.38 -18.91 62.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.72 -32.28 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.491 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 91.3 mt -61.0 -44.46 97.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.706 -178.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.458 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.2 m-85 -114.07 9.47 17.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.784 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.37 -155.13 52.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.55 -25.14 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 0.0 110.517 179.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.72 -125.17 1.41 Allowed Glycine 0 CA--C 1.518 0.272 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.6 p -131.52 159.3 38.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.63 -163.37 25.47 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.4 138.93 34.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.453 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.25 112.05 3.92 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -124.73 160.1 29.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 89.7 mtm180 -86.53 149.66 24.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.786 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.95 -48.4 64.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.669 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.4 tp10 -38.15 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.95 52.02 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.604 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -64.76 -44.86 88.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.401 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.16 -47.1 38.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.84 -43.49 98.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.45 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.75 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.43 -36.7 71.71 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.18 -77.31 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.523 ' C ' ' O ' ' A' ' 212' ' ' ALA . 96.7 mt -28.63 -46.21 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.432 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.1 m-20 -64.01 -45.3 89.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.661 178.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.78 -43.79 98.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.955 178.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.21 93.23 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.024 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.24 -43.54 98.71 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.33 92.86 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.095 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.531 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -43.19 96.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -56.68 -38.29 72.02 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.88 76.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.98 94.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 21.4 p-10 -88.65 1.19 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.36 20.32 65.29 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 72.3 m -58.3 -45.81 87.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.9 t80 -63.89 -58.14 7.67 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.482 179.289 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.429 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.89 -41.86 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.412 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.28 -48.63 79.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.0 -41.49 98.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.407 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.43 -50.18 74.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.62 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.89 -35.17 72.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.21 -50.95 27.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.501 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.18 -45.75 92.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.532 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -152.97 154.92 35.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.437 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.6 p-10 -97.06 95.36 7.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.987 0.422 . . . . 0.0 110.567 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.25 -166.67 2.49 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.66 110.33 15.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.5 m -63.64 -40.65 89.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.429 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.6 m-85 -56.35 -43.9 79.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -37.6 95.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.681 0 CA-C-O 117.875 -1.514 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.23 61.08 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.676 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.85 143.45 99.37 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.645 2.23 . . . . 0.0 112.299 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.32 -40.35 89.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.91 143.14 36.49 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.456 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.04 128.09 66.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 110.515 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -103.77 118.56 36.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.6 138.4 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.449 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.2 1.61 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.8 m -123.94 118.32 26.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.713 -0.287 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 24.4 t70 -113.33 92.3 22.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.98 133.99 57.53 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.524 2.149 . . . . 0.0 112.114 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.7 p -141.26 -19.2 0.79 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.768 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.5 m-85 -124.65 99.0 5.96 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.603 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.647 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.23 -61.36 0.23 Allowed Pre-proline 0 C--O 1.219 -0.538 0 CA-C-O 121.541 0.686 . . . . 0.0 111.058 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.49 -39.69 45.24 Favored 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 122.46 2.107 . . . . 0.0 112.228 -179.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.9 t80 -79.29 -42.84 24.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.984 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.3 mt-10 -149.58 -155.31 0.62 Allowed 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.96 -178.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.93 177.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.047 0.451 . . . . 0.0 110.355 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.64 140.16 45.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.403 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.78 137.14 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.619 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -65.04 -19.08 65.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.507 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.51 -5.47 54.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.455 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.92 -9.32 58.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.45 156.81 29.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 110.424 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -112.08 133.9 53.96 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.96 0.409 . . . . 0.0 110.452 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.56 151.22 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.314 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.96 151.53 6.63 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.58 -42.13 87.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.818 0.342 . . . . 0.0 110.935 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 -70.01 -28.09 65.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.351 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.61 -41.01 82.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.097 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.74 -37.63 82.41 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.18 -178.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.19 -44.0 85.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.299 178.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.525 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.82 92.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.069 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.44 -53.67 54.68 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.504 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.26 -37.58 62.25 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.975 0.417 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.52 -42.03 75.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.8 m -54.54 -44.5 72.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.111 -179.388 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.436 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.81 -47.65 80.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.066 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -59.4 -40.96 88.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.56 -17.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.9 52.44 4.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.151 0.501 . . . . 0.0 110.606 -179.238 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.29 169.99 17.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.12 140.66 29.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -116.87 131.32 56.98 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.638 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.42 128.1 43.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.472 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -94.64 136.34 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.511 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.67 128.38 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.8 139.31 58.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.721 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 173.84 132.3 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.56 145.22 63.48 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.692 2.262 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 58' ' ' LEU . 78.5 mt -40.48 -55.94 2.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.72 -26.55 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.117 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.35 19.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 55' ' ' LEU . 85.3 mt -65.08 -42.56 94.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.854 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 mm -61.51 -56.64 31.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.757 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.595 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -55.44 -43.51 57.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 122.64 2.227 . . . . 0.0 111.128 177.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -44.36 90.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.848 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.28 -44.46 88.45 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.59 -40.21 95.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 110.446 178.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.0 11.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.538 -179.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.01 11.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 179.718 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.47 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 178.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.9 pt -124.48 153.28 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.361 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -94.59 -20.0 19.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.21 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.45 156.29 25.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.83 127.94 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 110.544 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.26 106.31 8.94 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.4 t -159.0 -179.57 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.569 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.56 -15.01 60.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.337 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -37.58 124.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.531 -179.579 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.09 156.25 23.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.667 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.7 pt -104.87 148.9 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.273 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -150.4 152.75 34.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.22 -47.93 54.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.601 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.52 -39.79 70.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.733 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.53 -37.63 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.94 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.3 -27.56 67.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.175 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.16 -51.77 7.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 110.574 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.61 -168.55 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.86 147.02 29.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -129.99 149.96 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.681 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.8 t -164.34 -151.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.478 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.681 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.6 m-20 42.97 19.34 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.26 120.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.409 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.1 mt -77.04 -69.93 0.49 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 -178.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -149.3 166.26 29.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.584 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 121.67 27.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.73 69.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.746 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.94 -105.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.31 165.83 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.69 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.6 145.94 21.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 110.5 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.06 136.11 41.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.768 178.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 111.1 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.41 165.12 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.2 148.63 23.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.14 -28.34 57.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.98 -41.88 88.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.325 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.86 121.76 42.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 110.23 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.64 109.61 19.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.464 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -126.84 129.81 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.636 179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.71 154.15 41.87 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.654 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.26 92.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.824 2.349 . . . . 0.0 111.674 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.14 144.31 2.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.635 0.585 . . . . 0.0 110.787 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.26 -33.57 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.281 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -57.6 -62.39 1.82 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.335 -178.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.31 -22.24 29.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.936 -179.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -76.07 -26.14 56.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.84 133.35 47.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.402 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.4 -16.51 29.29 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.59 151.91 23.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.949 0.404 . . . . 0.0 110.408 -179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.38 135.64 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.307 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.04 136.61 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.662 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 139.05 14.54 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.502 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.31 161.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 110.35 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.502 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 44.2 tp -92.69 117.24 29.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.62 157.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.635 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.87 50.44 52.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.83 169.26 21.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.316 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.01 -25.9 60.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.9 -55.55 31.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.18 -53.94 52.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.59 -51.16 70.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.578 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.36 -43.71 98.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.384 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.01 -44.66 97.48 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -45.11 -14.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 0.0 110.75 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.34 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.665 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.63 -50.68 16.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.506 -178.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -99.19 12.72 35.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.17 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.491 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -84.24 -55.54 0.45 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.34 -10.3 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.821 2.347 . . . . 0.0 111.98 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.69 -8.7 59.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 -179.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.07 33.17 37.17 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.62 138.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.86 130.0 35.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.2 pt -126.43 138.23 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.2 t -123.18 133.16 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 109.992 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.18 127.79 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.804 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.15 153.52 25.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.74 6.55 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.699 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.6 130.43 5.98 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.05 -45.6 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.49 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.09 -23.95 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.7 -36.57 84.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -65.97 -47.0 86.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.126 -179.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.517 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 58.9 m-85 -63.73 -37.94 89.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.232 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.26 -42.56 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.153 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.405 ' H ' ' HG ' ' A' ' 151' ' ' SER . 53.6 m-20 -63.72 -45.63 89.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.865 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.8 tp -58.46 -48.08 81.92 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.19 -179.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -63.18 -22.79 67.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.91 0.386 . . . . 0.0 110.077 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.6 -18.6 24.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.55 70.01 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.83 -17.92 63.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.588 179.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.1 pt -128.53 137.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.17 -27.83 61.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.53 155.47 1.79 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.791 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.83 137.31 50.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.0 110.029 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.64 102.91 13.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.225 0.536 . . . . 0.0 110.673 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.9 tt0 -132.08 165.1 24.79 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.52 152.45 40.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.0 -54.13 29.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.25 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.7 t -60.5 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.47 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.95 87.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.77 0.319 . . . . 0.0 110.789 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.34 1.18 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.567 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.4 m -58.67 -47.2 85.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.798 -179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.1 -38.25 24.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.066 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.514 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.88 -65.43 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.1 t80 -40.51 -71.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.594 0.235 . . . . 0.0 111.23 -178.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.47 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.077 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.53 -2.99 0.39 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.46 0.648 . . . . 0.0 110.448 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.514 HE21 ' C ' ' A' ' 171' ' ' GLY . 49.1 mt-30 -124.85 141.2 37.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -43.6 -14.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.858 2.372 . . . . 0.0 112.341 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.2 t -63.23 -42.91 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.553 -179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.75 -32.89 80.63 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.83 -41.6 96.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.725 0.297 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.0 m-20 -65.62 -34.92 79.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.4 m-85 -156.77 143.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.7 pttt -177.03 99.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.733 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.7 m-85 -159.24 167.98 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.37 55.86 3.14 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.13 -117.05 0.01 OUTLIER Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.66 135.04 34.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.483 2.122 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.5 p -125.11 -108.31 0.32 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.506 -179.035 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.57 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.628 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.48 155.61 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 124.077 0.861 . . . . 0.0 110.703 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.33 118.31 23.06 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.026 0.441 . . . . 0.0 109.812 179.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.94 -18.49 62.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.87 -32.24 73.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.539 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.1 mt -60.84 -44.44 96.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.725 -178.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -113.84 8.22 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.719 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.3 -154.76 50.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 p -70.56 -25.28 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.851 0.358 . . . . 0.0 110.56 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.8 -125.75 1.5 Allowed Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.0 p -132.04 160.08 36.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.43 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.47 -162.59 24.89 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.18 140.92 31.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.615 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.11 111.9 3.97 Favored Glycine 0 CA--C 1.517 0.19 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.7 mt -121.61 160.79 23.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -87.11 148.94 25.01 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.15 -48.82 64.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.629 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -39.82 -23.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.973 0.416 . . . . 0.0 110.719 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.65 52.17 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.759 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.37 -46.29 84.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.182 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.46 -47.07 35.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.2 -43.89 97.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.45 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.56 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.856 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.51 -37.34 72.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.8 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.3 mt -29.01 -45.62 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.447 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.8 m-20 -63.62 -45.48 90.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.7 98.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.945 178.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.36 92.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.152 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -61.19 -43.39 98.95 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.027 0.441 . . . . 0.0 110.063 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.26 92.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.15 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.96 97.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.886 179.283 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.78 -38.47 72.55 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -69.85 -38.81 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.374 178.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.42 92.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.661 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 20.9 p-10 -88.35 0.4 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.698 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.61 20.38 67.96 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.0 m -58.18 -46.17 86.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.46 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.1 t80 -63.65 -57.43 10.08 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.454 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.89 -41.68 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.25 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.51 -48.6 80.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.493 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.83 -41.59 97.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.74 76.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.715 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.94 -35.45 73.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.414 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.59 -51.0 31.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.462 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.35 -45.45 93.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -153.74 155.15 35.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.16 99.47 10.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.527 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -156.41 -165.17 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.526 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.74 109.22 13.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.9 m -63.6 -40.35 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.513 179.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.7 m-85 -56.91 -43.7 81.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.83 93.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.708 0 CA-C-O 117.881 -1.51 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.29 164.25 62.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.587 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.91 143.53 99.37 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.564 2.176 . . . . 0.0 112.324 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.38 -41.02 90.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.081 0.467 . . . . 0.0 110.511 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.4 139.07 38.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.388 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.19 121.47 61.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.706 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.91 118.76 31.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 110.13 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -112.4 138.42 41.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 105.47 2.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -129.09 120.2 25.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.136 179.618 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 5.2 t0 -114.57 92.69 29.69 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.177 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.96 134.73 60.89 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.404 2.069 . . . . 0.0 112.135 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.2 p -142.0 -20.2 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.745 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -123.53 99.14 6.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.697 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.672 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -29.0 -61.63 0.22 Allowed Pre-proline 0 C--O 1.218 -0.577 0 CA-C-O 121.378 0.609 . . . . 0.0 111.029 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.25 -40.62 43.06 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 C-N-CA 122.206 1.937 . . . . 0.0 112.256 -179.227 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -78.19 -42.9 30.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.148 0.499 . . . . 0.0 111.025 179.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.3 mt-10 -149.74 -153.68 0.51 Allowed 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.966 -178.823 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.74 177.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.078 0.466 . . . . 0.0 110.402 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.57 144.76 46.38 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.4 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -95.8 134.47 38.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.652 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -64.66 -19.02 65.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.529 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.23 -6.11 53.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 -7.76 56.77 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.67 158.77 25.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.447 . . . . 0.0 110.441 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -112.07 131.21 55.56 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.988 0.423 . . . . 0.0 110.469 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -134.15 151.4 32.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.304 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.0 151.43 6.59 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -58.74 -41.8 87.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.909 0.385 . . . . 0.0 110.951 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.7 t0 -69.79 -28.47 65.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 -179.701 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -67.79 -40.97 84.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.847 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -61.05 -37.21 81.81 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.824 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.99 -45.26 86.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.02 -48.32 78.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.981 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -53.23 -54.47 35.62 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.31 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.48 -39.81 61.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.872 0.367 . . . . 0.0 110.26 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.79 -42.05 77.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.053 0.454 . . . . 0.0 110.53 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.44 -44.91 69.23 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.146 -179.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.26 -46.94 81.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.992 179.0 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -60.04 -42.14 93.78 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.216 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.1 mt -75.28 -17.46 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.429 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.85 53.2 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.424 -179.177 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.12 171.51 15.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -89.16 142.69 27.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.03 0.443 . . . . 0.0 109.956 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.54 131.4 56.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -127.54 127.25 43.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.401 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.86 134.68 35.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.08 127.89 66.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.38 138.0 57.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.829 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.69 130.33 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.6 Cg_endo -67.58 145.07 69.03 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.71 2.273 . . . . 0.0 112.512 -179.186 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.2 mt -40.13 -55.76 2.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.37 -26.37 2.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.857 0.361 . . . . 0.0 111.224 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.19 -20.91 18.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.75 -42.37 97.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.643 179.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.628 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.21 -57.0 25.79 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.795 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.3 Cg_exo -55.39 -42.46 68.06 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.681 2.254 . . . . 0.0 111.213 177.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 57' ' ' ALA . 70.1 m -58.69 -45.08 90.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.906 -179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.88 -44.2 91.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.148 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.26 -40.82 96.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.426 . . . . 0.0 110.424 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.79 9.87 2.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.416 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.21 12.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.991 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.36 -35.52 80.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.503 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.34 153.14 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.287 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -93.28 -22.18 19.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.462 -179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.62 156.14 27.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.5 mt -115.01 129.01 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.493 . . . . 0.0 110.469 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -131.29 106.72 8.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.519 ' HG ' ' H ' ' A' ' 73' ' ' SER . 40.3 t -159.39 178.5 9.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.519 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.99 -15.52 62.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.8 tp -34.98 124.37 0.57 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.596 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.0 154.03 25.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -104.74 148.46 9.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.348 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.8 p -149.01 152.2 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.09 53.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.43 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.51 -39.74 70.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.671 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.614 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.8 mtt180 -68.98 -37.94 79.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.819 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -57.9 -39.03 76.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.711 -179.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.79 -27.38 66.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.57 -50.77 7.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.046 0.451 . . . . 0.0 110.634 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -139.14 -168.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.1 0.476 . . . . 0.0 110.543 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.92 150.02 51.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.674 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 8.8 t -163.17 -153.26 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.57 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.674 ' H ' ' HG1' ' A' ' 87' ' ' THR . 93.7 m-20 41.19 20.14 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.32 0.2 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.324 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 58.5 mt -74.79 -68.51 0.54 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.931 -178.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -150.52 167.55 26.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.751 -179.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.67 123.62 29.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.184 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.94 68.66 0.83 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.809 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -85.67 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.06 165.63 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.698 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.49 146.09 22.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.79 136.19 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 110.813 178.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.86 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.27 164.91 33.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.81 148.56 23.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.93 -28.42 56.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.241 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -58.76 -41.94 87.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.319 -179.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.93 121.74 42.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.016 0.436 . . . . 0.0 110.147 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -86.88 109.72 19.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 105' ' ' ILE . 97.1 mt -125.97 129.14 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.718 179.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -106.44 154.28 39.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.721 179.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.49 90.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.766 2.311 . . . . 0.0 111.628 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -170.87 143.74 2.11 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.587 0.555 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.71 -33.05 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.085 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.3 -62.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.191 -178.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -55.74 -22.14 22.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.43 -25.91 54.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.254 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.71 133.83 47.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.5 -15.56 29.28 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.94 151.52 23.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.6 135.16 37.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.357 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.16 136.59 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.57 138.45 14.27 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.3 t -130.77 161.56 40.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.082 0.468 . . . . 0.0 110.359 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.495 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.3 tp -92.41 117.45 29.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.7 158.06 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.608 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.61 50.56 53.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.4 p -149.77 168.9 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.73 0.3 . . . . 0.0 110.9 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.1 p -73.3 -27.54 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.434 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.15 -55.65 31.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.507 -179.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.5 -54.96 39.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.698 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -60.11 -51.16 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.792 -179.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.5 t80 -62.07 -43.96 97.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.591 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.58 -44.39 98.02 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.336 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.33 -14.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.8 tt0 -125.23 -34.28 2.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.53 -50.56 17.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.129 0.49 . . . . 0.0 111.673 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.0 12.29 36.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.252 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.66 -55.38 0.48 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.347 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 55.7 Cg_endo -72.2 -10.61 26.03 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.75 2.3 . . . . 0.0 111.965 -179.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.44 -9.17 59.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.42 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.93 33.16 37.79 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.24 138.07 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 110.628 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.67 129.84 35.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.28 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.21 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.96 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.5 t -123.0 133.35 69.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.026 0.441 . . . . 0.0 109.981 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.4 43.13 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -110.64 153.37 25.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.01 6.68 29.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.759 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.21 130.17 5.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -65.8 -45.87 80.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.715 0.293 . . . . 0.0 110.383 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.82 -23.32 62.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.608 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.58 -37.07 86.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.11 0.481 . . . . 0.0 110.537 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.401 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -65.81 -46.82 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.231 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.684 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 61.5 m-85 -64.48 -37.72 88.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.345 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.97 -42.23 97.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.1 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.84 -43.52 92.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.122 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.0 tp -59.01 -47.76 84.03 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.023 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.85 -22.57 66.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.025 0.44 . . . . 0.0 110.12 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.63 -18.26 25.43 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.592 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.95 72.18 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.98 -18.03 63.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.606 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 34.6 pt -127.04 135.92 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.399 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -72.55 -27.82 62.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.313 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.52 155.99 1.88 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.838 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.15 136.71 49.58 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.68 103.48 14.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.281 0.562 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.684 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 49.8 tt0 -132.76 165.25 24.97 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.446 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.84 153.09 41.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.34 -54.65 22.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.401 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.422 ' O ' ' CB ' ' A' ' 170' ' ' GLU . 71.4 t -60.07 -49.06 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.705 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.33 -39.06 89.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.797 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.14 1.21 Allowed 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.0 m -59.5 -48.16 82.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.911 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -48.55 -37.74 18.63 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.342 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.75 -66.14 0.56 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.667 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.2 t80 -40.56 -70.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 111.218 -178.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.7 mt -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.23 -3.03 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.443 0.639 . . . . 0.0 110.499 -179.528 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' A' ' 173' ' ' LEU . 55.8 mt-30 -122.71 147.09 49.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.853 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.48 -19.64 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.844 2.362 . . . . 0.0 112.228 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.87 -42.8 96.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.672 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.63 -32.97 83.35 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.044 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.57 -41.26 94.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.7 m-20 -65.83 -33.47 75.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.25 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.0 m-85 -156.79 143.04 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.675 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.8 pttt -177.94 100.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.39 167.12 29.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.696 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.07 56.72 2.66 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.43 -118.37 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.36 135.35 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.477 2.118 . . . . 0.0 111.941 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -125.36 -107.9 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.61 -179.087 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.2 p -165.59 164.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.41 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.644 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.4 tttt 153.99 156.28 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.823 0.702 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.55 116.87 22.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.02 -18.94 62.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.81 -32.52 74.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.557 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.9 mt -61.04 -44.47 97.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.691 -178.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -113.96 9.23 17.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.743 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.18 -154.83 52.23 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.14 -25.06 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.25 -124.33 1.33 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.22 156.23 44.29 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 110.234 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.56 -169.42 30.15 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -94.52 137.48 33.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.55 108.29 3.29 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.7 mt -123.39 159.37 29.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.441 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 90.0 mtm180 -86.76 149.61 24.74 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.94 -48.04 64.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.518 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.38 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.5 m-20 -71.75 52.27 0.22 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.64 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.53 -45.54 86.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.345 -179.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.44 -47.12 35.48 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.32 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.3 -44.11 97.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.425 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.15 -36.43 70.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.19 -77.73 0.11 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.527 ' C ' ' O ' ' A' ' 212' ' ' ALA . 97.0 mt -28.27 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.736 0.303 . . . . 0.0 110.29 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.441 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 90.2 m-20 -64.23 -44.83 90.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.662 178.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.99 -43.77 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.957 178.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.27 94.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.057 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -61.25 -43.71 98.44 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 109.894 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.15 92.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.529 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.67 -42.89 97.99 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.535 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -58.28 -38.33 76.8 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.0 -40.02 78.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 0.0 110.095 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.68 93.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.0 p30 -86.73 1.54 51.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.451 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.26 19.52 59.69 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 72.6 m -58.31 -45.65 87.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.49 -58.15 7.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.341 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.428 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.7 mt-10 -56.89 -41.33 77.86 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.46 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.53 -48.36 81.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.643 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.296 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.74 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.463 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.44 -35.39 72.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.645 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -71.14 -50.86 28.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.4 m-85 -62.27 -45.28 93.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.503 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.9 m-85 -153.3 155.06 35.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.407 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.5 p-10 -97.56 95.22 7.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.954 0.406 . . . . 0.0 110.505 179.513 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -153.16 -166.12 2.35 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.99 109.98 14.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.822 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.4 m -63.43 -40.67 89.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.39 179.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.428 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.2 m-85 -56.38 -43.91 79.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.49 94.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.67 0 CA-C-O 117.934 -1.481 . . . . 0.0 110.95 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.22 59.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.604 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.88 144.0 99.47 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.6 2.2 . . . . 0.0 112.235 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -65.86 -40.62 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.62 144.47 37.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.464 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -110.92 129.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -104.42 116.56 32.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.425 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.8 140.99 29.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.17 106.39 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 m -128.49 120.23 26.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.679 0.276 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.7 t70 -112.54 94.22 26.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.104 179.606 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.21 134.87 62.68 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.467 2.111 . . . . 0.0 112.19 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 p -136.76 -18.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.705 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.6 m-85 -124.78 97.73 5.41 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.799 -179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.718 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -30.46 -61.34 0.25 Allowed Pre-proline 0 C--O 1.22 -0.494 0 CA-C-O 121.373 0.606 . . . . 0.0 110.965 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 6.7 Cg_endo -49.81 -41.37 46.97 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.263 1.975 . . . . 0.0 112.281 -178.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' TYR . 26.4 t80 -78.25 -42.74 30.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.017 0.437 . . . . 0.0 111.012 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.718 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.0 mt-10 -146.42 -161.12 1.25 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.044 -178.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.3 t 157.59 -179.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.014 0.435 . . . . 0.0 110.345 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -133.69 140.71 47.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.356 179.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.57 138.03 31.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.59 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -64.86 -19.16 65.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.555 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.23 -4.92 52.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.473 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.59 -10.17 57.52 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -80.35 158.97 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.974 0.416 . . . . 0.0 110.46 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.42 136.18 53.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.549 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -131.82 150.8 34.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.362 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.9 152.92 6.99 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -60.3 -41.17 92.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.024 0.44 . . . . 0.0 110.741 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.8 t0 -70.56 -32.41 69.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.106 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.02 -39.99 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.741 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -60.98 -36.66 80.03 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.967 -178.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.21 -44.71 83.07 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.47 -45.08 89.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.214 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.93 -54.24 45.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.505 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.13 -37.32 64.23 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.62 -43.36 72.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 54.4 m -54.13 -44.24 71.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.165 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.9 tttm -63.91 -48.0 78.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.043 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.51 -41.11 89.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.171 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.37 -18.53 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.507 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.51 52.24 3.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.14 169.93 17.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.1 140.85 29.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.155 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.17 132.01 56.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.97 126.79 42.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.441 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.18 136.51 34.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.566 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.35 128.93 64.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.416 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.07 139.88 56.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 p30 175.0 135.16 0.16 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.37 143.34 57.74 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.715 2.277 . . . . 0.0 112.45 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 54' ' ' PRO . 83.6 mt -39.88 -54.56 2.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.119 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.84 -25.97 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.139 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.33 -20.99 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.117 -179.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.04 -42.43 97.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.58 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.63 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -56.57 30.27 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.008 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.63 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.3 Cg_exo -55.05 -42.94 64.16 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.293 176.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.4 m -58.48 -44.94 89.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.854 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 tp -58.65 -44.54 90.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.4 mtmt -64.7 -41.18 96.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.397 . . . . 0.0 110.453 178.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.03 11.08 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 56.29 11.95 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.61 -33.69 76.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 67' ' ' ILE . 44.8 pt -124.41 154.55 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.322 -179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -92.6 -20.79 20.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.175 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.19 159.64 23.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 70' ' ' ILE . 96.0 mt -116.29 127.39 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 110.537 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 61.9 ttp -128.68 107.38 9.63 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.323 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.548 ' HG ' ' H ' ' A' ' 73' ' ' SER . 36.7 t -162.27 -176.79 5.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.548 ' H ' ' HG ' ' A' ' 72' ' ' SER . 78.0 p -64.22 -15.89 60.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.345 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.62 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.6 tp -37.51 122.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 110.502 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.03 156.21 23.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.69 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 pt -105.21 149.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.383 179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.0 p -150.52 152.52 34.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.787 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.08 -47.72 53.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.44 -39.78 70.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.62 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.67 -37.79 79.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.022 0.439 . . . . 0.0 110.875 179.203 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.2 -37.71 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.931 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.86 -27.41 66.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.153 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.58 -51.12 7.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 110.543 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -139.15 -168.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.49 147.29 29.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -130.33 150.47 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.69 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 10.1 t -165.02 -150.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.474 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.69 ' H ' ' HG1' ' A' ' 87' ' ' THR . 99.0 m-20 42.74 19.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.14 120.87 0.09 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.484 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -80.0 -72.79 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.923 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -147.86 164.98 32.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.58 127.49 32.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.11 67.48 0.7 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.692 179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.27 -106.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 32.2 p -159.45 167.85 27.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.21 146.68 23.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.055 0.455 . . . . 0.0 110.492 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -101.68 135.94 42.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.743 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 111.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.98 164.67 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 -179.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 148.44 24.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.31 -28.24 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.2 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -59.07 -41.35 87.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -102.38 122.31 44.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.332 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.51 109.39 19.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.062 0.458 . . . . 0.0 110.532 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.4 129.85 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.25 158.79 36.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.481 ' O ' ' OG1' ' A' ' 108' ' ' THR . 21.0 Cg_endo -60.3 91.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.736 2.29 . . . . 0.0 111.883 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.7 m -169.89 142.62 2.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.56 -33.5 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.284 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -56.73 -63.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.343 -178.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -56.86 -21.75 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.059 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.5 -28.28 59.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -55.06 132.55 47.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.53 -16.35 35.83 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.64 151.21 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 -179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -96.38 135.58 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.287 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.44 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.708 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.83 137.81 13.97 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 54.4 t -131.44 161.7 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.047 0.451 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.493 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 39.2 tp -92.99 120.55 33.41 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -52.01 155.49 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.6 50.91 45.62 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -147.85 166.1 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.662 0.267 . . . . 0.0 110.886 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 68.6 p -71.28 -30.62 66.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.3 mt-30 -58.35 -55.16 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.24 -55.43 33.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.799 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 m -60.56 -51.65 68.52 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.872 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.589 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 68.5 t80 -61.83 -44.41 96.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 110.547 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.0 -44.37 97.88 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -45.44 -14.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 0.0 110.731 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.35 -34.43 2.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.589 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.8 t60 -74.04 -50.46 19.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.523 -178.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.92 12.53 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.165 -179.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.51 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.24 -55.14 0.51 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.37 -9.8 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.789 2.326 . . . . 0.0 111.988 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.12 -8.62 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.388 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.09 33.51 36.1 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.79 137.57 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.0 110.594 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.97 130.27 35.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.276 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.6 pt -128.34 139.75 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.974 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.96 132.47 70.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.133 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.3 t -97.82 129.83 44.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.763 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.1 156.93 20.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.0 6.97 27.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.25 130.56 6.08 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.24 -46.58 76.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.712 0.291 . . . . 0.0 110.413 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.02 -23.22 63.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.563 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.61 -36.54 84.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.527 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.26 -47.67 83.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.121 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.4 m-85 -63.59 -37.86 88.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.37 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.84 -42.62 98.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.44 -43.74 93.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.21 -48.53 81.29 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.179 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.72 -22.85 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.962 0.411 . . . . 0.0 110.199 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.29 -18.19 26.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.3 11.03 73.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.48 -18.12 63.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.4 pt -128.37 137.31 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.38 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.88 -29.36 63.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.26 155.13 1.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.821 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.61 139.09 52.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.946 0.403 . . . . 0.0 110.029 179.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.51 103.15 14.77 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.234 0.54 . . . . 0.0 110.714 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.36 164.69 25.92 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -73.53 152.45 40.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.2 -54.11 29.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.59 -49.25 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.91 84.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.844 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.94 1.05 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.533 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 68.0 m -57.82 -46.51 84.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.298 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.05 -41.87 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.26 -62.26 0.48 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.623 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.31 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.618 0.247 . . . . 0.0 111.083 -178.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.35 -40.71 97.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.13 -2.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.383 0.611 . . . . 0.0 110.532 -179.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.5 mt-30 -126.25 141.5 40.01 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.825 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.45 -14.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.828 2.352 . . . . 0.0 112.211 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 92.5 t -63.28 -42.91 98.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.67 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.31 84.61 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.1 -41.21 96.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.727 0.299 . . . . 0.0 110.48 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -65.8 -34.7 78.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.467 179.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.18 143.35 17.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.6 pttt -175.96 99.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.745 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.76 166.78 31.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.698 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.83 55.89 3.05 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.21 -116.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.56 134.02 32.52 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.573 2.182 . . . . 0.0 111.906 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -123.27 -109.4 0.33 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.453 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.64 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 4.4 p -164.84 164.09 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.6 tttt 154.71 154.09 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.791 0.682 . . . . 0.0 110.657 179.276 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -80.06 119.26 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.951 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.36 -19.76 62.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.18 -31.0 72.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.668 -178.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -114.46 8.18 16.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.735 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.7 -154.1 49.68 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.79 -25.74 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 110.606 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 161.1 -126.9 1.66 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.0 p -132.28 160.56 35.86 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.484 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.96 -161.74 23.87 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.8 140.45 32.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.976 0.417 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.19 3.53 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -117.86 159.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 110.248 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.9 mtm180 -86.76 148.57 25.36 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.511 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.63 -48.48 63.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.663 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -40.94 -22.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 0.0 110.734 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -73.08 51.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.739 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.41 -46.42 83.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.19 -47.12 37.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.14 -43.7 98.26 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.59 -43.1 99.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.39 -37.59 72.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.43 -77.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.255 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.528 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.9 mt -28.03 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.448 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 89.2 m-20 -63.63 -45.76 88.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.94 -43.96 97.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.945 178.686 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.2 91.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.082 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.2 91.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.181 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.93 -43.44 95.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.887 179.347 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.511 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.36 -38.53 71.53 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -39.11 77.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 0.0 110.288 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.25 -45.63 90.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.653 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 19.3 p-10 -88.58 -0.49 57.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.71 20.49 70.27 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.9 m -58.19 -46.36 85.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.484 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -62.21 -56.68 16.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.419 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 97.0 mt-10 -56.71 -40.76 76.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.317 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -47.92 83.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.535 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.1 -40.75 96.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.251 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.62 -49.7 76.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.557 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.5 -35.74 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -69.77 -51.6 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.499 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.93 -46.27 90.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.579 179.372 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.67 154.64 33.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.517 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.5 p-10 -98.28 95.19 7.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.979 0.419 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -151.5 -164.13 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.12 108.49 13.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.787 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 26.0 m -63.56 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.367 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.419 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 89.7 m-85 -58.53 -42.51 87.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.64 95.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.669 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.28 164.39 61.59 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.86 143.52 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.539 2.159 . . . . 0.0 112.287 179.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.17 -40.33 90.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.79 142.51 36.7 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.485 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 9' ' ' ILE . 83.0 mt -109.62 128.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.915 0.388 . . . . 0.0 110.489 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -103.39 116.86 33.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.128 0.49 . . . . 0.0 110.392 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.59 138.93 38.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.952 0.406 . . . . 0.0 110.575 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.02 104.4 2.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -127.57 119.24 25.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 122.759 -0.26 . . . . 0.0 111.217 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 16.4 t70 -113.63 93.21 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.155 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.18 134.08 58.68 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.502 2.134 . . . . 0.0 112.115 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.3 p -141.4 -19.67 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.745 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.7 m-85 -124.53 98.9 5.94 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.721 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.679 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -28.97 -61.53 0.22 Allowed Pre-proline 0 C--O 1.22 -0.495 0 CA-C-O 121.362 0.601 . . . . 0.0 110.965 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.31 -39.71 43.48 Favored 'Trans proline' 0 C--N 1.296 -2.199 0 C-N-CA 122.287 1.991 . . . . 0.0 112.181 -179.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -79.0 -42.61 26.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.024 0.44 . . . . 0.0 110.996 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.679 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.6 mt-10 -149.39 -155.41 0.63 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.988 -178.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.77 178.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.021 0.439 . . . . 0.0 110.402 -179.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.2 mttt -136.17 143.78 44.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.451 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.2 t-20 -96.09 141.38 29.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.558 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.525 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.2 p -66.02 -18.91 65.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.523 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.2 -6.66 55.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.414 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.78 -6.88 58.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.87 158.38 26.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.429 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -112.01 133.93 53.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.474 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.7 151.33 32.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.307 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.63 151.5 6.59 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.62 -41.67 86.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.6 t0 -70.57 -28.24 64.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.201 -179.585 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.68 -40.77 82.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.055 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 53.0 m-20 -61.16 -37.15 81.86 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.972 -178.464 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.77 -43.99 82.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.054 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.539 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.78 -41.89 92.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.293 -179.114 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -58.8 -53.52 57.4 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.546 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.65 -36.81 62.48 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.924 0.392 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.69 -42.37 74.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 178.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.25 -44.79 72.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.208 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -63.74 -47.79 79.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.987 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.199 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.46 -17.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.76 52.69 4.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.5 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.62 140.86 29.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.136 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.39 131.79 56.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.636 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.2 127.67 43.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -93.86 135.67 34.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.59 128.27 65.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.345 179.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.11 139.29 58.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.819 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.1 p30 174.95 132.35 0.14 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.42 144.55 61.94 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.728 2.286 . . . . 0.0 112.467 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 58' ' ' LEU . 82.0 mt -40.01 -56.34 1.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -47.55 -26.48 1.45 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.127 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.36 -20.63 18.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.19 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 55' ' ' LEU . 57.4 mt -63.99 -42.35 97.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.629 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.49 -56.69 27.77 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.894 -179.305 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.8 Cg_exo -54.94 -43.59 57.9 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.646 2.23 . . . . 0.0 111.249 177.02 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -58.55 -44.69 89.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.781 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.14 -44.32 87.75 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.149 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.6 mtmt -64.56 -40.39 95.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.021 0.439 . . . . 0.0 110.541 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 11.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.517 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.7 mttt 56.21 12.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.761 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.44 -34.46 77.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.536 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -123.8 153.25 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.278 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.71 -20.57 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.97 157.05 25.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.739 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.02 127.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.062 0.458 . . . . 0.0 110.495 179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -128.64 106.69 9.12 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.543 ' HG ' ' N ' ' A' ' 73' ' ' SER . 47.0 t -159.98 -178.23 6.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.582 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.543 ' N ' ' HG ' ' A' ' 72' ' ' SER . 78.1 p -64.26 -15.47 60.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.612 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.0 tp -38.05 123.81 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.45 156.71 22.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 pt -104.88 148.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.365 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -149.92 152.32 34.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.833 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.19 -47.84 54.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.606 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.81 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.74 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.612 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.7 mtt180 -68.45 -37.8 80.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.11 74.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.875 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.45 67.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.132 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.45 -51.71 7.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.533 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.33 -168.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.81 146.73 29.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.034 0.445 . . . . 0.0 110.985 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -129.76 149.98 51.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.614 179.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.676 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.6 t -164.15 -151.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.516 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.676 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.5 m-20 43.11 19.18 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.801 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.92 120.12 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.0 mt -77.0 -69.99 0.49 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -149.34 166.31 29.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.619 -179.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.26 121.65 27.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.438 . . . . 0.0 110.29 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.94 69.82 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.782 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.22 -104.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.465 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.29 165.87 32.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.697 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.73 145.84 21.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.503 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.27 136.05 41.75 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.77 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 110.79 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.65 164.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 -179.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.94 148.42 23.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.57 -27.75 41.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.272 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -59.25 -41.74 89.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.326 -179.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.47 122.59 44.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.299 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.92 109.41 19.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.427 ' C ' ' NE2' ' A' ' 106' ' ' GLN . 97.1 mt -128.15 129.6 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.583 ' NE2' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.89 158.9 34.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.569 179.916 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.497 ' C ' ' HG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.58 89.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.734 2.289 . . . . 0.0 111.913 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.497 ' HG1' ' C ' ' A' ' 107' ' ' PRO . 6.9 m -169.05 140.89 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.701 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.27 -32.96 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.237 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -56.98 -62.82 1.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 -178.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -55.95 -22.04 24.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.032 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.57 -26.15 54.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.22 46.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.405 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.82 -15.6 30.88 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.98 151.86 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -179.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.48 135.51 38.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.068 0.461 . . . . 0.0 110.298 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.0 136.71 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.45 138.65 14.36 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.02 161.62 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.03 0.443 . . . . 0.0 110.367 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.5 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 43.2 tp -92.6 117.61 30.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.491 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.75 157.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.01 50.61 51.2 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.6 p -149.84 168.98 22.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.674 0.273 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -73.81 -26.38 60.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.446 179.401 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.66 -55.7 30.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.465 -179.392 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.66 -54.47 45.74 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.63 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.31 -51.25 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.675 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.05 -43.73 98.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.58 179.176 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.47 97.72 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.23 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.34 -34.15 2.74 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.47 -50.88 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.038 0.446 . . . . 0.0 111.533 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -99.07 12.61 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.501 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.99 -55.58 0.46 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.23 -10.44 25.76 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.783 2.322 . . . . 0.0 111.979 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.54 -8.88 59.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.425 -179.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.38 36.97 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.67 138.27 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.593 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.92 129.81 35.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.301 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.04 133.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 110.067 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.15 127.67 43.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -110.92 153.59 25.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.413 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.94 6.93 29.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.91 130.43 5.94 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.96 -45.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.714 0.292 . . . . 0.0 110.417 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.11 -23.72 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.72 -36.43 84.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.419 HG22 HD13 ' A' ' 149' ' ' ILE . 96.6 mt -66.3 -47.12 85.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.109 -179.459 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -63.56 -37.86 88.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.396 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.21 -42.72 99.08 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.229 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.444 ' N ' ' HG ' ' A' ' 151' ' ' SER . 55.6 m-20 -63.43 -45.32 91.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 42.8 tp -58.76 -48.19 82.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.189 -179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.73 -22.9 66.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.947 0.403 . . . . 0.0 110.22 179.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.77 -18.22 25.31 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.622 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.71 11.24 71.34 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.43 -17.87 63.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 110.631 179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 37.4 pt -128.5 137.36 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.43 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.06 -27.89 62.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.63 155.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.811 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.37 50.71 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.019 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.63 103.12 14.16 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.277 0.56 . . . . 0.0 110.761 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.35 165.06 25.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.375 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.443 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.36 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.987 0.422 . . . . 0.0 110.526 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.426 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.01 -54.28 28.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.212 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.78 -49.3 84.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.67 -179.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.83 -38.8 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.678 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.67 1.09 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.583 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 75.6 m -58.61 -47.62 83.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.73 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -48.75 -38.68 22.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.268 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.421 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.69 -65.65 0.55 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.678 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.7 t80 -40.23 -71.13 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.704 -0.292 . . . . 0.0 111.235 -178.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.3 mt -61.39 -39.81 92.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.79 -3.11 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.461 0.648 . . . . 0.0 110.535 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.505 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.5 mt-30 -124.68 141.79 38.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -43.92 -14.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.797 2.331 . . . . 0.0 112.197 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.9 t -63.17 -42.78 97.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.91 81.5 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.1 -41.28 96.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.622 0.248 . . . . 0.0 110.449 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.6 m-20 -65.98 -34.61 78.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.457 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.9 m-85 -157.44 143.5 17.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.08 100.25 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.1 m-85 -159.49 167.74 27.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.654 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.57 55.65 3.15 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.59 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -179.756 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.57 135.23 33.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.518 2.146 . . . . 0.0 111.953 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.24 -108.0 0.32 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.503 -179.023 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.14 165.22 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.366 -179.408 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.26 155.84 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 123.758 0.661 . . . . 0.0 110.668 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.17 22.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.852 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.6 mp0 -71.87 -18.69 62.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.592 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.98 -44.26 97.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.738 -178.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.0 m-85 -113.71 7.51 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.78 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.35 -155.5 50.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.54 -25.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.0 110.63 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.96 -126.16 1.56 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.5 p -131.99 160.02 37.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.79 0.329 . . . . 0.0 110.483 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.46 24.87 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.17 141.16 31.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.26 111.9 3.98 Favored Glycine 0 C--N 1.329 0.185 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.6 mt -120.98 160.82 22.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -87.38 149.07 24.72 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.09 -48.93 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 -179.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -40.14 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.019 0.438 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.25 52.23 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -46.06 84.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.54 -47.06 35.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.19 -44.07 97.42 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.451 -179.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.4 -43.0 99.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.919 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.6 -37.28 72.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.792 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.527 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.8 mt -28.11 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 110.358 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.447 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.8 m-20 -63.53 -45.51 90.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.582 178.238 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.34 -43.62 98.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.34 93.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.057 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.19 -43.56 98.69 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.5 93.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.221 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.66 -43.08 97.79 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.841 179.317 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.79 -38.26 72.29 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.81 76.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.945 0.403 . . . . 0.0 110.302 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.12 93.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.659 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 20.7 p-10 -88.73 0.41 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.682 179.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.57 20.24 67.74 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.461 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 89.1 m -57.83 -46.38 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.51 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.3 t80 -63.45 -58.01 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.414 179.234 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.426 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.9 mt-10 -56.23 -41.74 76.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.53 -48.45 80.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.85 -41.41 97.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.368 179.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.09 -50.21 74.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.508 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.18 -35.77 72.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.669 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.62 -51.09 30.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.42 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.18 -45.77 91.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.57 155.0 35.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.6 p-10 -97.95 98.24 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.24 -165.43 2.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.591 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.67 109.41 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.774 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 23.5 m -63.86 -40.56 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.478 179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 84.5 m-85 -56.7 -43.75 80.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.95 94.09 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.426 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.908 -1.496 . . . . 0.0 110.955 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.58 164.29 59.17 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.593 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.89 143.55 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.58 2.187 . . . . 0.0 112.295 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.23 -40.23 90.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.76 142.22 36.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.401 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.412 HD12 HG21 ' A' ' 9' ' ' ILE . 83.3 mt -109.41 128.68 65.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 110.511 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.41 117.02 33.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.154 0.502 . . . . 0.0 110.379 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -111.97 139.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.555 -179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.98 105.26 2.18 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -128.12 119.1 24.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.255 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.453 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.9 t0 -113.63 93.35 27.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.121 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.48 134.27 60.75 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.418 2.079 . . . . 0.0 112.132 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -141.48 -19.6 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.674 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -124.52 98.9 5.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.721 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.678 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -28.98 -61.66 0.22 Allowed Pre-proline 0 C--O 1.219 -0.531 0 CA-C-O 121.363 0.601 . . . . 0.0 110.987 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.4 -39.45 44.38 Favored 'Trans proline' 0 C--N 1.296 -2.222 0 C-N-CA 122.26 1.973 . . . . 0.0 112.248 -179.232 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.7 t80 -79.06 -42.53 26.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.978 0.418 . . . . 0.0 111.174 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.678 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.8 mt-10 -149.45 -155.64 0.65 Allowed 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.032 -178.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.53 178.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.092 0.472 . . . . 0.0 110.4 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -136.04 143.77 44.89 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.436 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.0 t-20 -96.22 141.38 29.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.452 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.3 p -65.83 -19.09 65.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.573 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.08 -6.89 56.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.13 -7.05 58.44 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.73 158.51 26.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.17 133.92 54.02 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.967 0.413 . . . . 0.0 110.43 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.26 150.93 32.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.307 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.76 151.38 6.55 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -58.48 -41.69 85.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.905 0.383 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.471 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 35.0 t0 -70.71 -28.33 64.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.231 -179.661 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.48 -41.23 83.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.403 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.2 m-20 -60.89 -37.06 80.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.029 -178.468 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.81 -43.81 82.86 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.07 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.536 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.92 -41.72 92.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.124 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.89 -53.61 56.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.58 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.86 -36.56 62.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.913 0.387 . . . . 0.0 110.309 179.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.67 -42.42 74.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 178.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.5 m -54.35 -44.71 72.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.158 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -63.91 -47.74 79.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.058 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.46 -40.85 88.22 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.163 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.34 -17.97 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.536 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 60.77 52.79 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.545 -179.258 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.55 170.58 16.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.46 140.77 29.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.8 m -117.3 131.74 56.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.725 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.7 m -128.24 127.63 43.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.481 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.15 135.79 35.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.595 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.64 128.52 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.02 139.56 58.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 174.87 131.81 0.14 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.9 Cg_endo -68.05 144.78 65.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.745 2.297 . . . . 0.0 112.477 -179.388 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 58' ' ' LEU . 83.3 mt -40.23 -56.0 2.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.98 -26.28 1.7 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.16 -179.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.44 -20.65 18.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 55' ' ' LEU . 57.3 mt -63.99 -42.3 97.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.656 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.54 -56.68 27.71 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.93 -179.291 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.3 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.599 2.199 . . . . 0.0 111.12 177.232 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.86 -44.6 91.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.729 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.22 -44.36 88.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 65' ' ' LYS . 53.7 mtmt -64.53 -40.48 95.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.972 0.415 . . . . 0.0 110.443 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.21 11.13 1.62 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 63' ' ' LYS . 98.8 mttt 56.06 12.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.36 77.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.584 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.87 153.89 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.339 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -93.4 -20.83 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.329 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.52 157.76 25.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.783 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.8 127.43 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 110.502 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.471 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.82 106.89 9.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.395 179.761 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.6 t -160.74 -177.7 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.583 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.14 -15.86 60.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.624 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.3 tp -37.98 123.52 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 110.455 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.4 156.85 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.703 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 pt -105.22 149.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.356 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.4 p -150.17 152.68 35.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.835 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.42 -47.48 56.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.574 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.73 -39.85 71.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.624 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.3 mtt180 -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 110.962 178.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.25 -37.18 74.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.822 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.48 -27.57 67.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.087 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.73 7.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.0 110.531 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.24 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.122 0.487 . . . . 0.0 110.452 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.94 146.6 29.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.72 149.97 51.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.673 ' HG1' ' H ' ' A' ' 88' ' ' ASP . 9.7 t -164.26 -151.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.437 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.673 ' H ' ' HG1' ' A' ' 87' ' ' THR . 98.4 m-20 42.88 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.767 179.57 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -28.39 120.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.403 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.468 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.02 -69.88 0.5 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.888 -178.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -149.27 166.28 29.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.64 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.41 121.56 27.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.308 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -102.77 69.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 -179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.92 -104.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.22 165.62 33.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.777 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 79.0 ttt-85 -155.49 146.11 22.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.438 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.4 135.93 42.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.987 0.423 . . . . 0.0 110.818 178.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.56 110.62 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.3 165.02 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 -179.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.79 23.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.79 -27.95 45.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.12 -41.79 89.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -102.35 122.21 43.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.257 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.7 108.92 19.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.085 0.469 . . . . 0.0 110.425 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -128.07 129.92 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.751 179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.59 159.18 34.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.95 0.405 . . . . 0.0 110.511 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.32 89.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.674 2.249 . . . . 0.0 111.891 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -169.2 140.82 2.45 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.459 0.474 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.09 -32.71 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.145 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -57.23 -62.95 1.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 t -55.74 -22.17 22.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.015 -179.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.4 -26.21 55.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.21 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.71 44.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.435 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.93 30.99 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -86.15 151.34 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.0 110.441 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.72 136.11 37.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.294 -179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.06 136.65 60.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.731 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 138.26 14.17 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 55.1 t -131.26 161.75 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.352 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.498 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 40.0 tp -93.05 119.63 32.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -52.04 157.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.97 50.72 50.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.1 p -149.05 167.97 24.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.715 0.293 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.423 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.3 p -74.06 -26.22 60.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.392 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.79 -55.47 32.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.21 -53.78 54.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.1 m -60.58 -51.34 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.1 t80 -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.131 0.491 . . . . 0.0 110.489 179.207 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.19 -44.49 97.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.276 -0.729 . . . . 0.0 111.276 -179.282 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -45.43 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.24 -34.1 2.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.56 -50.52 17.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.026 0.441 . . . . 0.0 111.586 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -98.94 12.5 35.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.272 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 135' ' ' PRO . . . -83.92 -55.32 0.47 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.38 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.2 -10.71 26.18 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.778 2.319 . . . . 0.0 111.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -8.9 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.82 33.43 37.46 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.29 138.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.644 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.06 130.01 35.12 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.229 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.53 139.31 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.6 132.39 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.962 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.44 130.32 45.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.55 156.55 21.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.375 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.87 6.26 29.19 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.739 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.8 6.24 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.13 -45.9 79.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.4 179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.63 -23.31 62.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.532 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.2 t-20 -64.54 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.507 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 149' ' ' ILE . 96.7 mt -66.04 -47.16 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.26 -179.538 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.681 ' HH ' ' NE2' ' A' ' 163' ' ' GLN . 62.7 m-85 -64.36 -37.56 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.324 179.777 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.81 -42.17 97.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.055 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.95 -43.02 94.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.92 179.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.48 -47.94 83.58 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.024 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.4 m -62.63 -22.74 66.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -17.52 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.659 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 11.82 74.38 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.72 -18.11 63.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 35.3 pt -127.15 136.23 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.377 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.82 -28.9 62.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.302 -179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -175.11 155.55 1.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.13 138.04 51.56 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -86.25 102.93 14.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.265 0.555 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.681 ' NE2' ' HH ' ' A' ' 150' ' ' TYR . 50.8 tt0 -132.24 164.87 25.42 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.388 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.447 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.14 152.98 40.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.968 0.413 . . . . 0.0 110.549 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.08 -54.38 26.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.295 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 72.6 t -60.07 -49.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.709 -179.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.06 88.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.788 0.327 . . . . 0.0 110.851 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.78 1.06 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.678 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.6 m -58.64 -47.45 84.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.708 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.13 -38.4 25.0 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.228 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.67 -65.56 0.55 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.683 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.7 t80 -40.34 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.722 0.296 . . . . 0.0 111.312 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.8 mt -61.53 -39.61 91.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.044 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.06 -3.19 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.515 -179.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 173' ' ' LEU . 61.4 mt-30 -124.28 142.28 39.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.1 -15.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.833 2.355 . . . . 0.0 112.22 179.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.3 t -62.98 -42.75 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.01 82.37 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.0 -41.29 96.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.673 0.273 . . . . 0.0 110.509 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.4 m-20 -66.02 -34.58 78.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.388 179.514 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -157.07 143.21 17.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.91 99.91 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.9 0.381 . . . . 0.0 110.782 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.26 166.73 30.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.729 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.45 56.01 2.91 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.29 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.8 135.51 35.33 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.478 2.119 . . . . 0.0 111.9 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.15 -107.87 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.552 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -166.5 165.39 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.351 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.21 156.42 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.748 0.655 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -82.88 117.98 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.27 -18.65 62.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.74 -32.01 73.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.581 -179.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.06 -44.29 97.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.772 -178.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.423 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.4 m-85 -113.7 7.68 17.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.763 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.89 -155.4 50.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.32 -25.52 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 179.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.65 -126.36 1.6 Allowed Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.66 159.64 37.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 110.47 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.61 24.96 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.32 141.18 31.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.967 0.413 . . . . 0.0 110.579 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.04 3.84 Favored Glycine 0 C--N 1.329 0.173 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.7 mt -119.71 160.52 22.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 110.202 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -87.28 149.03 24.83 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.847 0.356 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.33 -48.77 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.685 -179.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -40.63 -22.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.123 0.487 . . . . 0.0 110.682 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.08 52.18 0.24 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.769 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.45 -45.88 85.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.301 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.62 -47.14 33.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.055 0.455 . . . . 0.0 111.279 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.18 -44.08 97.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.49 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.864 179.536 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.75 -37.33 73.42 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.526 ' C ' ' O ' ' A' ' 212' ' ' ALA . 86.2 mt -28.39 -45.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 0.0 110.322 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' OG1' ' A' ' 87' ' ' THR . 88.1 m-20 -63.57 -45.54 89.97 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.495 178.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.47 -43.59 98.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.25 92.86 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.045 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.002 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.51 92.95 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.179 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.526 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.54 -43.13 98.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.84 -38.27 72.42 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.89 -38.84 76.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 110.364 178.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.35 93.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 223' ' ' ASP . 20.9 p-10 -88.34 0.44 56.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.681 179.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.34 20.3 67.37 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.01 -46.36 85.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.0 t80 -63.47 -57.88 8.82 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.43 ' OE2' ' OH ' ' A' ' 239' ' ' TYR . 96.7 mt-10 -56.33 -41.72 76.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.514 -179.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.66 -48.19 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.686 -179.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.15 -41.48 98.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.17 -50.11 75.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.532 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.21 -35.8 72.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.59 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.44 -50.91 33.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.2 m-85 -62.5 -45.28 93.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.521 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 72.1 m-85 -153.93 155.02 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.526 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.34 98.63 9.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.419 . . . . 0.0 110.511 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -155.59 -165.11 1.89 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.577 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.0 t0 -122.67 109.15 13.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.803 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.1 m -63.72 -40.53 89.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.421 179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.43 ' OH ' ' OE2' ' A' ' 227' ' ' GLU . 85.8 m-85 -56.76 -43.71 81.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.42 -36.77 93.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.663 0 CA-C-O 117.853 -1.526 . . . . 0.0 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.03 164.31 62.27 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.651 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 143.46 99.37 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.47 2.114 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.65 -40.67 88.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -138.78 141.6 38.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.02 127.69 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.4 mtp180 -101.65 117.56 35.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.157 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.6 104.71 2.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -127.87 119.52 25.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 18.2 t0 -113.23 91.89 20.62 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.069 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.309 -1.505 0 C-N-CA 122.466 2.111 . . . . 0.0 111.904 179.486 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.6 t0 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.142 0.496 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.66 -40.97 85.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.107 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.81 -37.7 82.89 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.095 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.39 -45.04 89.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.126 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.3 -47.9 80.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -53.22 -54.34 37.54 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.55 -40.25 62.35 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.102 0.477 . . . . 0.0 110.13 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.13 -42.02 80.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.945 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.2 m -54.13 -43.95 70.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.01 -47.12 81.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.225 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -59.86 -41.79 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.474 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.929 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.36 -18.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.81 52.59 4.22 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.354 0.409 . . . . 0.0 110.659 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 p -146.63 171.11 15.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -88.63 141.39 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.984 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.95 130.61 56.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.569 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.06 127.23 44.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.277 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.66 135.81 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.438 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.54 128.92 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.939 0.4 . . . . 0.0 110.423 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.46 139.2 58.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 175.37 129.88 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.0 146.43 71.09 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.632 2.221 . . . . 0.0 112.402 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.876 HD23 HD12 ' A' ' 58' ' ' LEU . 83.4 mt -40.44 -56.73 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.07 -27.14 2.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.39 -20.69 19.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.048 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.876 HD12 HD23 ' A' ' 55' ' ' LEU . 60.7 mt -64.53 -42.41 95.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.622 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.664 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.62 -56.96 24.95 Favored Pre-proline 0 C--O 1.241 0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.667 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.6 Cg_exo -54.46 -43.52 58.04 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.435 2.09 . . . . 0.0 111.521 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.6 m -59.09 -44.32 91.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.777 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.42 -44.14 88.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -64.6 -39.95 94.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.46 11.29 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.96 12.12 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.762 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.63 78.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.51 152.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -92.98 -20.59 20.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.23 156.18 26.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.489 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 58' ' ' LEU . 96.8 mt -115.29 127.11 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.451 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -128.32 105.9 8.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.268 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.663 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.9 t -159.33 179.87 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.78 -15.14 61.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.427 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.642 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.2 tp -36.4 123.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.583 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.73 154.72 25.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.778 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.82 148.35 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.2 p -149.62 152.53 35.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.738 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.37 -46.89 56.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.99 -40.17 72.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.479 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.642 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.8 mtt180 -68.09 -37.9 81.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.15 -37.83 75.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.994 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.03 -27.44 66.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.16 7.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.554 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.7 pt -139.28 -168.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.28 146.92 29.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.83 149.81 51.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.7 t -164.09 -152.81 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.512 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.507 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.7 m-20 41.86 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.948 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.63 121.07 0.2 Allowed 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.61 0.569 . . . . 0.0 110.522 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.3 mt -75.13 -68.37 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.866 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.9 p90 -150.71 167.27 27.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.705 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.5 123.22 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.306 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.87 67.96 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.642 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.64 -104.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.38 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.9 p -159.76 166.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.635 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.35 145.99 22.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.22 135.9 41.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.49 110.98 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.0 m -134.5 164.14 34.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.732 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.17 148.33 25.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.924 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.68 -27.63 41.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.53 -41.66 90.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.273 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -102.17 122.0 43.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.802 0.334 . . . . 0.0 110.143 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.11 109.55 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.33 129.75 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.623 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.83 159.02 34.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.358 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.449 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.7 Cg_endo -59.76 89.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.74 2.293 . . . . 0.0 111.934 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -168.5 140.53 2.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.798 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -66.74 -33.05 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.185 0.516 . . . . 0.0 110.218 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.51 -62.37 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.612 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.19 -22.31 28.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 110.859 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -76.32 -25.89 55.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -54.56 132.69 45.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.612 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -16.57 30.25 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -85.85 151.22 23.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.35 135.91 37.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.244 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.38 136.51 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.702 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.43 139.98 14.9 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.3 t -132.01 161.59 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.2 tp -92.92 119.04 31.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.488 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.9 157.3 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.79 47.99 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.4 p -149.51 168.14 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.26 -25.71 59.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.14 -55.16 35.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.43 -54.08 50.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.38 -51.15 70.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.542 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.594 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.3 t80 -62.23 -43.81 97.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.466 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.49 -44.53 97.88 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.82 -14.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.42 -34.66 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.594 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.7 t60 -74.47 -50.43 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.435 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.37 12.53 36.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.139 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.741 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.91 -55.52 0.47 Allowed Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.416 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.6 Cg_endo -72.27 -10.32 25.54 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.727 2.285 . . . . 0.0 111.984 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.53 -9.18 59.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.26 37.88 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.32 137.94 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.59 129.62 35.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.64 138.52 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.54 131.89 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 t -98.16 130.33 44.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.603 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -111.44 156.23 21.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.278 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.03 6.48 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.742 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.62 130.66 6.22 Favored Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.404 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.7 tp60 -65.92 -45.87 80.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 110.459 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.55 -23.61 62.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.66 -36.93 85.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.95 -46.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.316 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.511 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.3 m-85 -64.04 -37.85 88.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.02 -42.45 98.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.049 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.87 -44.45 93.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.108 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.4 tp -59.09 -47.86 83.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.147 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.05 -23.15 67.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.176 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.66 25.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.07 71.05 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.26 -18.39 63.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.8 pt -127.7 137.64 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.09 0.471 . . . . 0.0 110.554 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.99 -28.35 62.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.964 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.41 155.71 1.88 Allowed 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.72 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.97 103.18 14.44 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.2 tt0 -132.96 165.27 25.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.509 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.82 152.13 41.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.658 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.13 -54.23 28.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.647 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 91' ' ' TYR . 78.1 t -60.8 -48.63 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.303 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.8 88.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 110.644 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.36 -63.28 1.18 Allowed 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.362 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.436 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.7 m -59.15 -47.18 86.25 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.92 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.55 -36.8 24.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.72 -64.99 0.52 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.7 t80 -41.34 -71.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.877 0.37 . . . . 0.0 111.009 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.73 -40.03 93.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.7 -3.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 173' ' ' LEU . 54.5 mt-30 -122.71 149.34 55.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.49 -20.27 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.796 2.331 . . . . 0.0 112.175 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.76 -42.98 94.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.495 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.2 84.2 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.63 -41.73 95.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 0.0 110.333 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.1 m-20 -65.4 -34.09 77.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.514 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.6 m-85 -155.82 142.62 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.58 99.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.471 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.22 167.29 29.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.43 56.24 2.87 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.05 -117.88 0.01 OUTLIER Glycine 0 CA--C 1.543 1.789 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.76 136.28 35.0 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -125.08 -108.64 0.32 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.408 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.0 p -165.84 164.85 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.939 -0.553 . . . . 0.0 109.807 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.19 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.373 1.046 . . . . 0.0 110.675 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -82.15 118.05 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.801 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -72.03 -18.89 61.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.48 -32.54 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.0 mt -60.9 -44.26 97.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.712 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.3 m-85 -114.48 9.63 16.76 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.691 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.97 -153.52 51.33 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.74 -25.47 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.324 . . . . 0.0 110.447 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.21 -123.92 1.28 Allowed Glycine 0 N--CA 1.46 0.245 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -129.6 156.23 44.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.69 -169.61 30.52 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -95.0 138.99 31.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.535 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.87 107.56 3.25 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.9 mt -119.76 159.54 24.32 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.1 mtm180 -86.98 149.04 25.05 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.71 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.29 -48.07 65.55 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.712 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -40.51 -23.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.709 0.29 . . . . 0.0 110.666 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.57 52.06 0.2 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.28 -45.74 86.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.87 -47.08 32.06 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.47 -43.94 97.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.14 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.873 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.51 -36.98 72.26 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.772 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.57 -77.37 0.11 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 44' ' ' ILE . 89.7 mt -29.14 -45.49 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.247 0.342 . . . . 0.0 110.692 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.04 -45.07 90.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.731 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.57 -43.61 98.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.893 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.15 93.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.28 -43.72 98.41 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.086 0.47 . . . . 0.0 110.145 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.21 91.9 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -42.35 98.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.092 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.525 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.39 -38.47 77.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.44 -39.88 81.35 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.404 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.1 92.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.522 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.525 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.8 p30 -86.33 1.04 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.482 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.2 19.42 61.71 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 73.4 m -58.13 -45.94 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.086 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 77.3 t80 -63.5 -57.14 11.15 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.38 -41.05 79.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.01 -48.28 82.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.09 -41.82 98.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.293 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.8 -49.84 76.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.65 -35.56 72.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.393 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -70.59 -50.9 32.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.617 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.507 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.5 m-85 -61.97 -45.62 92.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.484 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -154.82 156.1 35.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.39 99.3 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.022 0.439 . . . . 0.0 110.409 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -156.24 -166.32 2.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.412 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.3 t0 -122.71 110.8 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.0 m -63.44 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.404 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.8 m-85 -59.22 -42.54 91.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.35 94.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 117.817 -1.546 . . . . 0.0 110.968 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.8 54.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.06 143.62 99.15 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.417 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.15 -40.49 90.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.597 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.9 143.18 36.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.1 mt -110.19 128.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.86 116.51 32.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.27 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.8 mt -111.28 138.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.351 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.43 104.44 2.11 Favored Glycine 0 N--CA 1.462 0.409 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.6 m -127.53 119.1 25.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 110.631 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 21.5 t70 -113.55 92.55 24.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.966 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 C--N 1.31 -1.474 0 C-N-CA 122.531 2.154 . . . . 0.0 111.767 179.592 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.7 t0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 121.102 0.477 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.76 -41.74 85.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.236 0.541 . . . . 0.0 111.282 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 48.9 m-20 -60.95 -37.48 82.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.815 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.05 -43.83 86.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.183 0.516 . . . . 0.0 110.555 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.15 -41.47 92.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.316 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.2 -52.89 63.73 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.535 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.21 -37.2 64.29 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.034 0.445 . . . . 0.0 109.891 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.47 -42.58 78.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.129 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.74 -44.36 73.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.125 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.07 -46.92 82.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.23 0.538 . . . . 0.0 110.399 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -60.28 -40.87 91.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -75.94 -17.82 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.705 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.74 52.16 4.51 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.706 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.19 170.12 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.2 140.22 29.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.008 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -116.81 131.49 56.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.04 127.5 43.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.436 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -94.06 135.52 35.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.5 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.5 128.92 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.988 0.423 . . . . 0.0 110.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.9 139.48 58.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.483 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.1 p30 175.68 131.43 0.16 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.778 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.8 Cg_endo -68.08 145.41 67.11 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.613 2.209 . . . . 0.0 112.602 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 82.3 mt -40.37 -56.51 1.99 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -47.88 -26.66 1.77 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.855 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.1 -20.51 19.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.124 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -64.16 -42.47 96.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.563 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.667 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -63.17 -56.23 29.66 Favored Pre-proline 0 C--O 1.242 0.66 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.919 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.1 Cg_exo -55.29 -42.7 65.88 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.486 2.124 . . . . 0.0 111.202 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -58.96 -44.12 91.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.866 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.191 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.36 -40.27 95.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.4 11.1 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.631 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.35 11.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.755 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.18 -34.74 78.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.667 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.72 153.09 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.31 -20.87 19.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.7 156.72 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.493 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.6 127.02 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.5 ttp -128.4 106.66 9.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.247 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.595 ' OG ' HD21 ' A' ' 55' ' ' LEU . 42.3 t -160.35 -178.23 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.585 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.15 -15.32 59.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.48 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -38.27 123.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.614 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.34 156.88 22.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.644 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.15 149.05 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -149.83 152.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.27 -47.03 55.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.647 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.33 -40.05 73.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.301 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -67.92 -37.92 82.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.226 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.26 -37.05 74.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.56 -27.43 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.257 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.31 -51.73 7.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.615 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.4 -168.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.74 146.67 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 110.73 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.79 149.88 51.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.709 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.5 t -164.4 -151.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.501 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.23 19.52 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.83 120.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.652 0.595 . . . . 0.0 110.509 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -77.18 -69.29 0.54 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.92 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.3 p90 -149.62 166.17 30.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.517 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.98 122.31 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.387 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.449 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.59 69.39 0.98 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.538 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.9 -105.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -158.85 165.63 33.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.59 145.79 21.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.85 136.13 41.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 110.92 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.833 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.37 164.93 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 0.0 110.714 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.7 148.53 23.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.866 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.49 -28.29 59.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.01 -41.85 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.245 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -101.71 122.04 43.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.121 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.16 109.7 19.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.63 129.63 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.636 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.01 154.25 41.25 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.553 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.65 91.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -170.74 144.35 2.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.22 -33.72 62.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 110.229 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.65 -62.04 2.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.607 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -56.65 -22.05 31.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.725 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -76.47 -25.62 54.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.18 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.59 47.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -16.09 30.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.73 151.67 23.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.217 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.23 135.21 38.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.2 t -126.74 136.2 61.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.02 138.81 14.38 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.13 161.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.239 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.538 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.53 117.69 30.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.399 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.72 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.585 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.93 50.39 52.93 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.77 168.84 22.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.456 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 71.6 p -73.29 -26.82 61.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.372 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.62 -55.03 38.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.605 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.21 -54.38 47.47 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -60.41 -51.37 69.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.64 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.01 -44.02 97.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.346 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.59 -44.49 97.89 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.67 -14.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.213 . . . . 0.0 110.705 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.3 tt0 -125.53 -34.53 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.565 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.65 -50.62 17.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.28 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -99.42 12.26 36.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.096 0.474 . . . . 0.0 111.133 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.69 -55.55 0.48 Allowed Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.483 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.4 -10.23 25.23 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.751 2.301 . . . . 0.0 112.039 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.38 -8.93 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.58 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.12 33.09 37.23 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.51 137.98 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.76 129.89 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.4 138.13 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.99 133.06 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.86 127.25 42.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.83 153.33 25.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.32 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.94 6.95 29.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.43 130.44 6.01 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.98 -45.72 80.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.56 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.51 -23.46 62.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.47 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.452 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.7 -36.98 86.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.85 -46.86 87.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.366 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.09 -37.85 88.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.218 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.98 -44.52 92.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.181 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 42.1 tp -59.31 -47.64 84.65 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.087 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.06 -23.0 67.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.15 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.59 -18.24 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.48 11.73 71.14 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.87 -18.05 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.6 pt -127.86 137.73 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 110.527 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.21 -28.44 62.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.07 155.63 2.0 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.795 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.51 50.51 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -86.08 103.05 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.6 tt0 -132.6 164.68 26.12 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -72.99 152.6 41.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.392 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.6 mt-10 -65.7 -54.04 32.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.406 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.1 t -60.75 -48.7 87.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.428 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.93 87.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.844 0.354 . . . . 0.0 110.429 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.16 -63.68 1.08 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.446 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.8 m -58.92 -46.97 86.64 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.812 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 80.8 tt0 -49.95 -37.48 32.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.228 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.2 -65.39 0.54 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.658 ' N ' ' O ' ' A' ' 168' ' ' ALA . 29.7 t80 -40.74 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.831 0.348 . . . . 0.0 111.089 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -61.88 -39.6 92.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.62 -3.96 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.276 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 177' ' ' VAL . 85.4 mt-30 -123.46 142.01 37.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -43.95 -15.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.82 2.347 . . . . 0.0 112.132 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.8 t -62.8 -42.96 98.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.438 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.83 -32.85 80.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.99 -41.55 96.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.2 m-20 -65.78 -34.63 78.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.687 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.08 143.53 18.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.635 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.2 pttt -177.16 99.57 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.117 0.484 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.6 m-85 -159.19 168.21 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.631 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.42 55.96 3.1 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.68 -116.78 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.0 135.43 36.78 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.102 1.868 . . . . 0.0 111.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.8 p -125.25 -108.38 0.32 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.315 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.62 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.97 164.8 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 119.03 -0.51 . . . . 0.0 109.929 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.07 155.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.259 0.975 . . . . 0.0 110.539 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.75 117.97 23.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.808 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.67 -19.02 62.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.24 -32.06 73.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.473 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.4 mt -61.08 -43.94 98.12 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.735 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.456 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.95 7.33 16.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 0.0 110.689 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.3 -155.09 50.01 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.644 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.43 -25.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.863 0.363 . . . . 0.0 110.593 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.449 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.05 -126.08 1.54 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -131.91 159.7 37.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.89 25.4 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.501 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.13 141.16 31.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.2 112.02 3.99 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.8 mt -121.18 160.35 23.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.85 149.04 25.11 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.705 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.44 -48.2 65.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -40.9 -22.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.602 0.239 . . . . 0.0 110.587 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.86 52.09 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.431 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.31 -46.3 84.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.42 -46.93 36.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.5 tp -62.44 -43.93 97.65 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.359 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.24 -42.76 99.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.974 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.74 -37.37 73.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.948 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.6 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 44' ' ' ILE . 86.1 mt -29.15 -45.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.316 0.385 . . . . 0.0 110.843 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -64.16 -45.1 89.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.64 -43.57 98.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.945 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.15 92.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.307 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.05 -43.66 98.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.175 0.512 . . . . 0.0 110.312 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.27 91.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.319 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -64.07 -41.79 97.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.291 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.6 mtp -58.04 -38.19 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.49 -38.9 77.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.418 . . . . 0.0 110.554 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.15 93.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.1 p-10 -88.72 0.42 56.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.33 68.47 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -58.38 -45.85 87.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.4 t80 -63.43 -57.53 9.99 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.01 -41.06 77.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.402 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.07 -48.12 82.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.338 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.07 -41.59 98.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.333 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.84 76.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.6 -35.86 73.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.43 -50.91 33.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.465 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.513 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.5 -45.46 92.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.35 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.7 m-85 -153.76 155.32 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.416 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.15 98.54 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 110.458 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -155.42 -165.49 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.465 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.56 109.37 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.9 m -63.75 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.421 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.2 m-85 -57.18 -43.64 82.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.0 94.17 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.425 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.899 -1.5 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.5 164.43 59.96 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.689 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.07 143.69 99.11 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.658 2.239 . . . . 0.0 112.244 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.405 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.39 -40.83 89.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.75 139.2 38.23 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.361 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.1 121.1 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.8 118.59 31.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.5 138.23 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.305 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.57 105.39 2.14 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.8 m -128.73 120.84 27.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 122.687 -0.302 . . . . 0.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.497 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.8 t70 -114.29 92.61 28.05 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.918 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--N 1.309 -1.544 0 C-N-CA 122.499 2.133 . . . . 0.0 111.851 179.442 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 121.0 0.428 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.76 -40.79 84.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.939 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.97 -37.5 82.66 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.718 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.49 -44.94 89.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.117 0.484 . . . . 0.0 110.164 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.54 -48.16 80.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.901 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.26 -53.87 44.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.437 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.87 -40.32 63.33 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.029 0.442 . . . . 0.0 109.951 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.87 -42.08 81.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.57 -45.1 69.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.169 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.31 -46.34 83.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.277 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -60.55 -42.1 95.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.194 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.895 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.36 -17.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.718 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.94 52.75 4.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.78 171.09 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.975 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.81 142.18 27.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.995 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.1 m -117.14 131.06 56.97 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.617 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.15 126.94 43.75 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.4 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -93.73 134.69 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.98 128.14 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.027 0.442 . . . . 0.0 110.344 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.14 137.79 57.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.557 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.53 131.68 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.75 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -67.77 144.51 65.65 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.665 2.244 . . . . 0.0 112.732 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.89 HD23 HD12 ' A' ' 58' ' ' LEU . 81.3 mt -39.87 -55.44 1.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.96 0.41 . . . . 0.0 111.261 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.71 -26.33 2.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.08 -21.11 18.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.13 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.89 HD12 HD23 ' A' ' 55' ' ' LEU . 60.1 mt -63.7 -42.64 97.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.748 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.68 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 mm -62.22 -56.66 28.97 Favored Pre-proline 0 C--O 1.242 0.67 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.795 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.8 Cg_exo -56.09 -41.69 74.26 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.551 2.167 . . . . 0.0 110.947 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -59.08 -44.48 91.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.968 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.648 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.6 tp -59.38 -43.91 92.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.269 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.32 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.493 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.17 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.25 11.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.37 -35.53 80.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 pt -122.43 152.78 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.0 -22.53 19.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.19 155.71 27.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.616 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -114.98 129.08 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.96 0.409 . . . . 0.0 110.384 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -131.28 106.82 8.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 110.231 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.699 ' OG ' HD21 ' A' ' 55' ' ' LEU . 42.1 t -159.05 178.47 10.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.577 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -65.24 -15.2 62.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.513 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.24 124.5 0.61 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.673 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.542 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.8 154.26 26.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.677 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.627 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.4 pt -105.0 148.65 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 p -149.07 152.3 35.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.738 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -46.92 53.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.004 0.431 . . . . 0.0 110.463 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.06 -39.63 72.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.81 -37.9 79.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.015 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.85 -38.48 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.23 -27.34 67.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.33 -51.11 7.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.4 pt -138.98 -168.21 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.986 0.422 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.25 147.57 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.135 0.493 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.1 m-85 -129.86 149.92 51.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.36 -153.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.456 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.7 m-20 41.66 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.944 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.35 0.2 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.594 0.559 . . . . 0.0 110.559 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.421 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.2 mt -75.23 -68.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.49 167.17 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.637 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.83 123.38 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.85 68.55 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.663 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.83 -104.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.322 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.3 p -159.37 165.98 32.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.63 146.11 21.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.47 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.95 136.23 41.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.816 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.37 164.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.937 0.399 . . . . 0.0 110.679 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.56 24.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.07 -27.85 47.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.04 -41.66 88.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.344 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.0 t -102.4 122.36 44.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.01 109.36 19.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.89 129.84 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.29 159.06 33.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.444 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.5 Cg_endo -60.11 89.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.777 2.318 . . . . 0.0 112.008 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -168.82 140.99 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.94 -33.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 110.225 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.22 -22.04 26.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.888 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.3 mt -76.72 -25.83 53.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.16 46.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.507 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.9 -15.85 30.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.54 151.32 23.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 110.308 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.02 135.55 37.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.278 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.3 136.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.53 138.68 14.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.2 t -130.88 161.61 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.255 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 45.1 tp -92.38 117.57 30.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.578 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -51.87 157.57 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.61 50.23 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -149.96 168.87 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 110.795 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.4 p -73.7 -26.52 60.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.412 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.78 -55.15 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.598 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.02 -54.72 43.57 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.461 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.07 -51.33 70.08 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.504 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -61.8 -44.12 97.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 110.489 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.59 -44.47 97.92 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.76 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.575 0.226 . . . . 0.0 110.647 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.29 -34.62 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.68 -50.67 16.75 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.331 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.19 12.25 36.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.208 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.69 -55.51 0.48 Allowed Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.429 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.13 -10.28 25.68 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.802 2.334 . . . . 0.0 111.969 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.73 -8.92 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.561 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.77 33.46 37.58 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.52 137.83 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.35 129.74 34.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.254 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.6 pt -126.34 138.09 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.21 133.12 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.33 127.57 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.84 153.67 25.08 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.282 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.0 7.05 29.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.621 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.54 130.5 6.02 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.78 -45.82 81.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.54 -23.67 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.523 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.69 -36.82 85.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.19 -47.03 85.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.521 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.64 -37.98 89.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.361 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.8 p -61.06 -42.26 98.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.023 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.16 -44.58 91.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.6 tp -59.12 -47.81 83.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.097 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.7 m -63.49 -22.77 67.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.992 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.19 -18.6 25.44 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.579 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.97 11.04 70.85 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.32 -17.92 63.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.623 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.7 pt -128.23 137.36 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.12 0.486 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.86 -27.43 61.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.59 155.98 1.84 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.17 136.88 49.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.9 0.381 . . . . 0.0 110.005 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -85.41 103.3 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.0 tt0 -133.04 165.21 25.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.46 152.12 42.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.772 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.05 -54.53 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.2 -48.44 88.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.586 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.94 90.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 0.0 110.457 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.64 -62.97 1.26 Allowed 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.436 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -59.61 -47.83 84.04 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.914 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -49.56 -36.7 24.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.179 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.39 -66.17 0.54 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.1 t80 -40.68 -70.7 0.1 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.655 0.264 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.58 -40.12 93.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -60.69 -3.19 0.66 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.302 0.572 . . . . 0.0 110.254 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 173' ' ' LEU . 37.1 mt-30 -122.15 147.6 49.72 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.35 -19.12 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.844 2.362 . . . . 0.0 112.034 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.8 -43.21 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.524 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.99 -32.95 83.98 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.53 -41.09 93.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.758 0.313 . . . . 0.0 110.458 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -66.16 -32.9 74.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.53 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.0 m-85 -156.51 142.53 18.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.545 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -176.82 99.56 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.31 166.99 30.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.7 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.23 -117.71 0.01 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.89 136.01 35.97 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.266 1.977 . . . . 0.0 111.928 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.9 p -125.41 -108.02 0.32 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.78 165.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.039 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 154.04 156.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.379 1.049 . . . . 0.0 110.502 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.26 117.35 22.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.904 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.32 -18.85 62.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.66 -32.53 74.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.2 mt -61.1 -44.15 97.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.727 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.5 m-85 -114.46 9.66 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.628 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.08 -154.77 52.29 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.627 ' CG1' HD11 ' A' ' 76' ' ' ILE . 15.0 p -70.32 -25.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.38 -123.97 1.28 Allowed Glycine 0 N--CA 1.46 0.24 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.56 156.25 44.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.54 -169.76 30.56 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.04 137.7 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.65 108.32 3.3 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.3 mt -123.54 159.2 29.66 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 120.672 0.273 . . . . 0.0 110.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.648 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.8 mtm180 -86.79 149.51 24.8 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.712 0.292 . . . . 0.0 110.757 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.68 -47.79 63.73 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.746 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.72 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.42 52.23 0.19 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.505 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.38 -45.77 86.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.34 -47.26 35.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.52 -43.86 97.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.4 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.79 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.0 -36.19 70.12 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.687 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.15 -77.42 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.895 HD21 HD11 ' A' ' 44' ' ' ILE . 97.2 mt -28.17 -46.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.971 0.415 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.6 -44.71 89.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.781 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.98 -43.86 97.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.026 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.05 93.12 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.29 -43.55 98.69 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.16 0.505 . . . . 0.0 110.166 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.12 92.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.258 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.9 -41.92 97.58 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.523 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -59.1 -38.0 78.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.78 -39.84 79.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.066 0.46 . . . . 0.0 110.34 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.07 92.21 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.519 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.3 p30 -86.26 1.09 52.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.504 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.97 19.43 61.22 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 68.3 m -58.41 -45.64 88.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.6 t80 -63.55 -58.25 7.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.936 0.398 . . . . 0.0 110.351 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.54 -41.37 76.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.486 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.96 -48.4 81.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.98 -41.59 98.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.84 -50.28 74.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.4 -35.41 71.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.478 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.03 -50.84 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.1 m-85 -62.2 -45.57 92.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.5 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.87 155.53 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.373 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.3 p-10 -97.56 95.93 7.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 110.491 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -153.63 -166.01 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.92 110.4 15.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.7 m -63.69 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.584 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.422 ' N ' HG23 ' A' ' 238' ' ' VAL . 89.9 m-85 -57.8 -43.53 85.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.25 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.47 94.9 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.23 164.61 59.69 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.745 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.09 143.69 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.21 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.31 -40.4 89.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.74 143.2 36.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.37 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -110.36 128.68 66.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.381 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.8 mtp180 -104.38 118.16 35.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.04 139.2 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.03 104.69 2.19 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.8 m -127.72 118.33 23.6 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.659 -0.318 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.2 t70 -113.38 92.59 23.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.912 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.31 -1.451 0 C-N-CA 122.467 2.111 . . . . 0.0 111.965 179.594 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.44 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.0 t0 . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.954 0.407 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.55 -40.79 82.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.987 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.7 m-20 -60.65 -37.79 82.68 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.985 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.19 -43.89 85.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.499 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.1 -41.73 93.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -58.83 -53.13 61.83 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.638 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.93 -37.06 63.44 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.01 -42.4 76.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.121 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.6 -44.62 73.22 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.229 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -64.02 -47.18 81.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.254 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -59.86 -40.72 89.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.092 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.989 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.53 -17.78 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.774 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.66 52.4 4.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.24 170.06 17.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.04 140.26 29.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.028 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.0 m -116.91 131.52 56.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.19 127.71 43.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.476 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -94.26 135.97 35.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.406 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.57 128.68 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.77 140.02 58.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 174.97 131.68 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.724 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.21 145.43 66.38 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.678 2.252 . . . . 0.0 112.576 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.875 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.14 -56.91 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.4 -26.75 1.41 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.986 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.29 -20.76 18.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.123 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.875 HD12 HD23 ' A' ' 55' ' ' LEU . 59.0 mt -63.97 -42.49 97.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.731 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.69 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.38 -56.64 28.59 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 123.698 0.624 . . . . 0.0 109.67 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.49 -42.24 70.0 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.534 2.156 . . . . 0.0 111.025 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -58.86 -44.18 90.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.787 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.09 -44.29 91.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.83 -40.52 95.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.476 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.51 10.9 1.84 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.31 11.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.31 -34.13 77.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.551 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.96 154.16 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.81 -20.83 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.99 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.82 158.88 23.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.583 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.604 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.82 127.02 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-O 120.945 0.402 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.44 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -127.5 106.05 8.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.268 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.495 ' OG ' HD21 ' A' ' 55' ' ' LEU . 36.3 t -161.07 -177.4 6.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.28 -15.05 59.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.369 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.637 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.8 tp -38.27 123.23 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.552 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.45 156.58 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.685 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.648 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -105.21 149.39 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -150.25 152.85 35.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.667 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.26 -47.56 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.025 0.44 . . . . 0.0 110.51 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.66 -39.93 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.63 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.637 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.41 -37.67 80.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.004 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -37.39 74.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.111 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.15 -51.94 7.06 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.48 -168.29 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-O 121.04 0.448 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.91 146.73 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.832 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.544 ' CD1' HG22 ' A' ' 76' ' ' ILE . 75.4 m-85 -129.93 149.94 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.607 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.48 -151.67 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.505 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.74 19.26 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.99 119.92 0.11 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.483 0.489 . . . . 0.0 110.631 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.66 -70.14 0.5 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.722 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 42.8 p90 -148.91 165.72 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.523 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.98 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.374 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.454 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.25 68.97 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.51 -104.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.329 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.37 165.86 32.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.599 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.62 146.02 21.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -101.47 136.31 41.53 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.57 111.22 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.73 164.86 32.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.78 148.45 23.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -27.83 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.247 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.89 -41.85 88.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -102.55 122.45 44.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.146 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.85 109.36 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.28 130.07 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.593 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.03 159.01 34.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.96 90.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.813 2.342 . . . . 0.0 111.994 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.1 m -168.97 141.56 2.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.69 -33.33 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 110.343 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.59 -62.24 1.93 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.43 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.35 -22.0 28.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.866 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.64 -25.74 54.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.286 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.87 133.28 47.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.472 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.86 -15.79 30.15 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.49 151.33 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.898 0.38 . . . . 0.0 110.378 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.09 135.14 38.28 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.99 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.658 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.65 14.34 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.8 t -130.75 161.59 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.2 tp -92.41 117.67 30.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.81 157.51 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.694 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.92 50.58 51.89 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.6 p -149.63 168.68 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.777 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 68.6 p -73.09 -27.3 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.3 -54.84 40.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.467 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.3 -54.38 47.4 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.378 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.62 -51.6 68.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.6 t80 -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.028 0.442 . . . . 0.0 110.457 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.66 -44.31 98.1 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.62 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.603 0.239 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.66 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.4 -50.83 16.98 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.392 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.2 12.74 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.11 -55.6 0.46 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.369 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.17 -10.48 25.91 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.963 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.46 -8.73 59.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.53 36.97 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.77 137.88 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.481 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.51 130.03 34.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.51 138.1 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.09 133.22 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.051 0.453 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.94 127.11 42.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -110.74 153.62 25.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.02 6.83 29.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.12 130.34 5.88 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.92 -45.67 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.484 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.84 -24.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.497 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.59 -36.38 84.04 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.14 -46.95 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.062 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.0 m-85 -63.82 -37.66 88.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.343 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.23 -42.78 99.19 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.121 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.95 -44.5 92.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.3 tp -59.0 -48.24 82.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.079 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.7 m -62.88 -22.92 67.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.09 26.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.571 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.35 11.58 71.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -17.82 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 153' ' ' LEU . 35.6 pt -128.31 137.77 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.113 0.483 . . . . 0.0 110.487 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.8 -28.36 62.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.59 155.7 1.8 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.819 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.53 50.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.064 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.53 103.15 14.13 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.08 0.467 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 46.9 tt0 -132.27 164.74 25.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.437 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -73.02 152.03 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -65.91 -54.2 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.3 -48.98 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.524 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.09 89.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.25 -63.25 1.19 Allowed 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.437 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.5 m -58.85 -47.11 86.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -50.06 -37.04 31.53 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.02 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.13 -65.85 0.55 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.71 -70.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.802 -0.234 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.65 -39.98 93.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.874 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.455 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.62 -3.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.627 . . . . 0.0 110.367 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.5 mt-30 -124.21 141.62 37.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.807 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.87 -14.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.859 2.372 . . . . 0.0 112.319 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 175' ' ' GLN . 77.9 t -63.47 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.486 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.75 79.59 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.01 -41.35 96.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.773 0.321 . . . . 0.0 110.388 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.4 m-20 -65.9 -34.7 78.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.756 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.3 m-85 -156.98 143.26 18.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.85 99.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.758 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.2 m-85 -159.28 168.01 27.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.33 55.76 3.17 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.91 -116.99 0.01 OUTLIER Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.12 135.92 37.7 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.295 1.997 . . . . 0.0 112.016 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.0 p -124.97 -108.02 0.33 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.513 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.87 165.25 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.98 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.634 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.35 155.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.436 1.085 . . . . 0.0 110.476 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.09 118.31 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.911 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.3 mp0 -71.87 -18.74 62.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.76 -31.96 73.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.6 mt -60.99 -44.24 97.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.754 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.3 m-85 -113.69 7.2 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.724 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.53 -155.33 49.9 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.648 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.43 -25.54 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.834 0.35 . . . . 0.0 110.551 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.09 -125.84 1.5 Allowed Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.3 p -132.15 160.03 37.22 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.862 0.363 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.7 25.27 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -98.17 141.41 31.12 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 110.493 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.38 3.89 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -119.52 160.57 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.37 149.04 24.75 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.574 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.03 -48.73 64.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.809 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -40.83 -22.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.828 0.347 . . . . 0.0 110.657 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.07 51.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.66 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.38 -46.1 84.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.762 0.315 . . . . 0.0 111.108 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.43 -47.14 35.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.42 -43.7 98.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.446 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.38 -42.94 99.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.881 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.67 -37.52 73.55 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.897 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.24 -77.57 0.1 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.989 HD21 HD11 ' A' ' 44' ' ' ILE . 86.5 mt -28.63 -45.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.942 0.401 . . . . 0.0 110.813 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.4 m-20 -63.76 -45.18 90.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.54 -43.68 98.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.2 92.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.205 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.16 -43.58 98.66 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.144 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.32 92.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.85 -42.52 97.55 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.022 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.499 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.13 -38.22 73.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.65 -38.83 77.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.114 0.483 . . . . 0.0 110.415 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.53 92.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.674 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.34 0.43 56.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.783 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.67 20.2 67.91 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.8 m -57.91 -46.08 85.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.0 t80 -63.54 -57.6 9.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.88 -41.7 78.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.347 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -48.42 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.42 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.84 -41.54 97.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.366 . . . . 0.0 110.446 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.16 -49.78 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.632 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -35.86 73.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.399 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.58 -50.94 31.98 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.449 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.35 -45.23 94.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.502 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.8 m-85 -153.47 154.96 35.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.0 p-10 -98.21 96.95 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 110.509 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -154.09 -165.11 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.518 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.426 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.68 109.24 14.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.5 m -63.79 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.578 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.425 ' N ' HG23 ' A' ' 238' ' ' VAL . 83.9 m-85 -56.79 -43.63 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.1 -37.16 94.47 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.744 0 CA-C-O 117.907 -1.496 . . . . 0.0 110.938 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.7 164.66 53.36 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.763 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.0 143.83 99.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.654 2.236 . . . . 0.0 112.267 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.26 -40.59 90.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.42 142.73 37.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.05 128.71 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.029 0.442 . . . . 0.0 110.318 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.02 117.45 34.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.311 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.0 140.57 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.278 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.24 105.39 1.96 Allowed Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 77.2 m -127.76 120.8 28.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.722 -0.281 . . . . 0.0 110.617 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.3 t70 -112.73 93.99 26.57 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.31 -1.482 0 C-N-CA 122.518 2.145 . . . . 0.0 111.778 179.503 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 28.7 t0 . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 121.044 0.45 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -66.75 -40.55 86.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.985 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -61.15 -36.97 81.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.723 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.98 -45.07 87.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.426 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.27 -46.86 85.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.974 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.89 -53.82 47.25 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.516 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.21 -39.13 66.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.947 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.98 -43.15 79.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.7 m -54.4 -43.63 71.64 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.26 -47.02 81.2 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 110.328 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mmt-85 -60.35 -41.17 93.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.018 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -75.75 -18.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.755 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.52 51.92 3.9 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.76 170.14 17.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.956 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.45 141.74 28.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.006 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.4 m -117.76 132.11 56.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.573 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -127.16 126.16 42.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.01 135.96 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.48 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.99 129.21 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.076 0.465 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.04 139.97 56.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.512 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.41 135.07 0.17 Allowed Pre-proline 0 N--CA 1.445 -0.683 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.18 143.8 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.631 2.221 . . . . 0.0 112.705 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.903 HD23 HD12 ' A' ' 58' ' ' LEU . 82.5 mt -40.48 -54.45 2.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.036 0.446 . . . . 0.0 111.152 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.92 -26.44 2.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.54 -21.01 19.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.903 HD12 HD23 ' A' ' 55' ' ' LEU . 58.2 mt -64.14 -42.77 96.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.787 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.0 -56.46 31.49 Favored Pre-proline 0 C--O 1.242 0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.743 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 52.2 Cg_exo -55.64 -42.33 68.68 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.021 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -58.84 -44.27 90.89 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.822 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -59.06 -44.36 91.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.8 -40.86 95.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.582 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.06 11.92 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.796 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.25 -33.93 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.04 153.53 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.367 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.08 -21.33 20.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.14 158.52 24.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.495 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.562 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -116.0 128.02 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.395 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -129.52 107.42 9.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 110.222 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.538 ' OG ' HD21 ' A' ' 55' ' ' LEU . 35.2 t -162.06 -178.68 6.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.26 -15.77 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.642 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -35.53 122.46 0.63 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.6 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -80.95 154.23 27.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.694 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' CG1' ' A' ' 196' ' ' VAL . 47.4 pt -105.02 148.17 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.4 p -150.14 152.86 35.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.16 -46.85 54.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.6 -40.18 71.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.469 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.642 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.2 mtt180 -68.32 -37.99 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.023 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 84' ' ' ILE . 87.9 mt-30 -57.88 -38.0 74.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.089 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.07 -27.81 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.213 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.86 -50.79 8.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.725 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -139.78 -166.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.969 0.414 . . . . 0.0 110.496 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.79 147.45 30.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.805 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.5 m-85 -130.27 150.69 51.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.6 t -164.77 -152.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.427 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.8 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.847 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -29.95 121.72 0.17 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.664 0.603 . . . . 0.0 110.627 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 66.0 mt -78.3 -70.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.844 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CG ' HG21 ' A' ' 166' ' ' VAL . 51.4 p90 -148.7 165.56 31.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.54 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.448 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.68 67.74 0.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.621 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -86.87 -106.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.1 p -159.47 167.81 27.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.05 146.78 23.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -102.04 135.99 42.65 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.773 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.59 112.05 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.88 164.71 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.05 148.64 24.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.55 -27.96 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.03 -41.58 88.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -102.25 122.34 44.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 110.162 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.18 109.88 19.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.25 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.13 130.04 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.602 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -109.3 154.29 42.25 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.17 92.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -170.45 144.4 2.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.75 -33.88 61.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.279 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.486 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.94 -62.17 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.474 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.21 -21.85 25.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.97 -25.42 52.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.265 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.08 133.21 48.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.429 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.63 -15.75 29.02 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.07 150.87 24.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 110.284 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.29 134.34 38.19 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.15 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.58 136.33 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.606 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.67 138.77 14.45 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.7 161.5 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.048 0.451 . . . . 0.0 110.238 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.6 tp -92.54 118.1 30.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.499 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.48 156.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.59 50.64 53.44 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.7 p -149.11 167.6 25.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 67.2 p -70.92 -30.45 66.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -58.61 -54.76 43.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.509 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.58 -55.98 27.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.28 -51.53 69.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.654 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -61.71 -44.11 97.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.453 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.38 -44.38 98.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.56 -14.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.496 0.189 . . . . 0.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.48 -34.53 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.74 -50.64 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.335 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.42 12.53 36.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.747 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.2 -55.51 0.46 Allowed Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.482 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.7 Cg_endo -72.36 -10.02 25.02 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.784 2.323 . . . . 0.0 112.036 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.86 -8.79 59.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.58 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.19 33.22 36.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.62 137.62 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.977 0.418 . . . . 0.0 110.487 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.23 130.16 34.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.61 138.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.26 133.5 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -96.58 126.49 41.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.55 25.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.259 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.83 7.27 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.617 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.73 130.1 5.86 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.13 -45.6 80.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.8 0.333 . . . . 0.0 110.556 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.37 -23.49 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 110.493 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.76 -36.8 85.48 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.84 87.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.178 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.0 m-85 -64.05 -37.88 89.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.08 -42.61 98.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.157 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.67 -43.86 92.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.046 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.536 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.0 tp -59.33 -47.85 83.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.029 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.39 -22.95 67.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.124 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -18.71 25.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.516 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.11 71.76 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.58 -18.1 63.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 0.0 110.629 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -128.05 137.79 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.165 0.507 . . . . 0.0 110.518 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.75 -29.46 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -174.93 155.4 2.03 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.792 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 139.15 52.16 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 110.052 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.97 102.85 14.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.4 164.38 26.65 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.472 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.46 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.7 40.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -65.96 -54.33 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.317 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.403 HG21 ' CG ' ' A' ' 91' ' ' TYR . 71.1 t -60.19 -48.5 87.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.446 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.17 86.09 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.345 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.27 -63.26 1.24 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.364 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.456 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.9 m -58.22 -45.8 87.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.934 0.397 . . . . 0.0 110.445 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.43 -41.17 13.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.74 -61.93 0.47 Allowed Glycine 0 N--CA 1.466 0.647 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.649 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.5 t80 -40.79 -71.14 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.954 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.58 -40.97 98.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.1 tttt -59.83 -2.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.117 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 32.5 mt-30 -125.81 141.52 39.56 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.898 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.54 -14.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 86.9 t -63.02 -43.21 98.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.415 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.2 84.37 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.3 -40.92 95.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.832 0.349 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.12 -34.26 77.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.8 143.09 18.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.666 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -175.98 99.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.852 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.3 m-85 -158.94 167.59 28.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.585 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.9 56.18 3.14 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -52.1 -115.9 0.01 OUTLIER Glycine 0 CA--C 1.542 1.719 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.61 135.74 41.24 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.222 1.948 . . . . 0.0 111.86 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.9 p -124.58 -108.78 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.425 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.19 164.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 118.859 -0.591 . . . . 0.0 110.002 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.3 tttt 155.13 155.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.439 1.087 . . . . 0.0 110.505 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -81.06 118.16 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.858 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.6 mp0 -70.93 -19.34 62.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.38 -31.79 73.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.606 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 88.0 mt -61.1 -44.05 97.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.753 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.04 9.26 15.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.673 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.39 51.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.0 p -70.7 -25.5 26.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.448 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.0 -124.37 1.34 Allowed Glycine 0 C--N 1.33 0.226 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.0 p -130.07 157.2 43.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.651 0.263 . . . . 0.0 110.297 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.08 -168.57 29.46 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -96.09 138.35 33.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.84 105.66 2.97 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ALA . 79.0 mt -117.88 158.65 24.48 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.3 mtm180 -86.71 148.66 25.34 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.596 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.7 mttm -51.7 -47.56 63.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.92 -22.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 0.0 110.577 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.09 51.64 0.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.07 -46.55 83.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.8 0.333 . . . . 0.0 111.15 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.5 -47.12 35.01 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.27 -43.7 98.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.35 -42.96 99.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.903 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.42 -37.08 72.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 109.896 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.55 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 44' ' ' ILE . 88.2 mt -28.68 -45.17 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.943 0.401 . . . . 0.0 110.878 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.0 m-20 -64.24 -45.01 90.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.815 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.84 98.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.927 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.11 92.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.293 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.09 -43.78 98.37 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.171 0.51 . . . . 0.0 110.282 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.15 91.54 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -64.13 -42.38 96.86 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.232 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.497 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.5 mtp -57.47 -38.21 74.13 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.43 -39.18 78.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.08 0.467 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.617 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.4 p-10 -89.17 0.04 57.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.69 20.59 70.31 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.3 m -58.66 -45.68 88.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 75.2 t80 -62.22 -56.43 18.67 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.198 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.32 -40.25 77.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.234 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.7 -47.68 84.68 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.14 -40.95 97.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.875 0.369 . . . . 0.0 110.316 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.69 76.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.72 -35.92 73.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -69.17 -51.9 33.44 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.564 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 10.7 m-85 -62.38 -45.82 91.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.51 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.9 m-85 -154.14 154.61 33.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.3 p-10 -99.09 95.95 7.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.407 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 236' ' ' PHE . 14.6 p90 -151.99 -163.77 1.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.21 108.24 13.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.687 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 239' ' ' TYR . 25.6 m -63.33 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.596 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.425 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.1 m-85 -58.65 -41.65 86.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.285 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.16 -36.93 94.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.92 -1.489 . . . . 0.0 110.938 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.72 164.45 60.22 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.02 143.72 99.33 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.703 2.269 . . . . 0.0 112.226 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.29 -40.48 90.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.54 143.35 37.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.351 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.29 128.1 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.986 0.422 . . . . 0.0 110.367 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.84 118.75 37.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.252 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.99 138.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.53 100.32 1.6 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 84.8 m -123.69 118.62 27.66 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.71 -0.288 . . . . 0.0 110.854 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t0 -113.25 93.19 25.06 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.31 -1.491 0 C-N-CA 122.486 2.124 . . . . 0.0 111.905 179.549 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.2 t0 . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.945 0.402 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.7 -40.91 82.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.78 -37.87 83.36 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.038 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.66 -43.93 87.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.18 0.514 . . . . 0.0 110.465 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.75 92.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.2 -53.31 58.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.529 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.75 -38.08 64.03 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.66 -42.23 78.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.024 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.7 m -54.47 -43.95 72.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.123 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.12 -47.05 81.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.9 mmt-85 -60.44 -40.93 92.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.025 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.13 -18.23 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.792 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.86 52.22 4.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -145.27 170.16 16.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.933 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -87.86 140.21 29.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.081 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -116.32 130.87 57.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.569 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.3 128.25 44.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.9 136.53 35.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -129.49 128.4 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.31 139.07 58.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.55 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.512 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 174.32 132.62 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.7 Cg_endo -68.11 145.03 65.62 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 112.75 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.938 HD23 HD12 ' A' ' 58' ' ' LEU . 78.1 mt -40.44 -55.53 2.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.22 -26.4 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.967 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.62 19.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.022 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.938 HD12 HD23 ' A' ' 55' ' ' LEU . 85.7 mt -64.83 -42.78 94.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.909 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.678 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.65 -56.35 33.67 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.678 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.98 -42.72 63.88 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.967 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -59.08 -44.1 91.87 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.812 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.65 -44.2 90.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.75 -40.06 94.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.15 11.32 1.54 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.503 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.02 11.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.46 -34.12 77.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.48 153.29 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.379 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -94.11 -20.25 20.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.52 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.545 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.593 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -116.56 127.87 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.33 106.54 9.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.251 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.601 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.1 t -159.19 -178.85 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.578 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.71 -15.03 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.1 tp -37.77 123.87 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.597 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.73 23.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.746 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.4 pt -105.31 148.98 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.08 152.71 35.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.756 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.25 -47.66 55.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.986 0.422 . . . . 0.0 110.61 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.14 -39.8 72.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.582 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.9 mtt180 -68.18 -37.79 81.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.3 -36.98 74.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.58 -27.58 67.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.215 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.97 -52.22 6.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -138.09 -168.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.094 0.473 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.59 146.66 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.085 0.469 . . . . 0.0 110.807 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.554 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.81 149.94 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.637 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -164.64 -151.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.4 m-20 43.25 19.36 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.3 120.11 0.12 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.552 0.533 . . . . 0.0 110.577 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.19 -69.86 0.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.794 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.415 ' CG ' HG21 ' A' ' 166' ' ' VAL . 42.9 p90 -149.39 166.18 29.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.569 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.02 122.16 27.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.389 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.468 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.38 68.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.627 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.99 -104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.414 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.1 p -159.74 165.89 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.621 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.07 146.45 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.069 0.462 . . . . 0.0 110.465 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.96 135.89 42.73 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.798 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.413 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.7 t -122.55 110.92 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.38 165.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.755 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 148.41 23.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.017 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.47 -27.43 37.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -59.5 -41.67 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.4 122.08 43.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.154 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.88 109.33 19.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.375 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.63 130.03 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.605 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.28 159.4 34.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.478 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.24 89.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.874 2.383 . . . . 0.0 112.006 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -168.79 140.84 2.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.98 -32.72 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.116 0.484 . . . . 0.0 110.268 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.502 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -57.81 -62.62 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.99 -22.06 24.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.888 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.58 -25.84 54.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.57 132.38 44.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.502 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.93 33.92 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.55 151.46 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.838 0.351 . . . . 0.0 110.447 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -97.01 136.19 37.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.27 136.68 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.672 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.54 139.5 14.74 Favored Glycine 0 CA--C 1.521 0.469 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.2 t -131.64 161.74 40.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.113 0.482 . . . . 0.0 110.281 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.3 tp -92.84 119.07 31.79 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.563 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.87 157.13 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.34 50.83 47.78 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.8 p -149.49 168.12 24.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.824 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.446 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.34 -25.54 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.445 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.27 -55.08 35.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.581 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -57.48 -54.06 51.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.408 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.3 -51.17 70.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.522 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.592 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.7 t80 -62.16 -43.83 97.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.429 . . . . 0.0 110.416 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.81 -44.41 97.91 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.9 -14.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.641 0.258 . . . . 0.0 110.642 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.25 -34.65 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.592 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.47 -50.68 17.33 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.329 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -98.94 12.82 34.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.2 -55.66 0.45 Allowed Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.428 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.2 -10.74 26.23 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.754 2.303 . . . . 0.0 112.008 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.14 -8.96 59.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.588 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.78 33.49 37.46 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.61 138.1 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.66 129.69 35.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.275 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.81 138.77 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.61 132.11 71.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.997 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.39 130.48 45.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.635 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.68 156.43 21.88 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.264 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.82 6.64 29.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.4 130.91 6.17 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.98 -45.93 79.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.32 . . . . 0.0 110.429 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.01 -23.84 63.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.456 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.455 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.67 -36.45 84.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.17 -47.28 85.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.4 m-85 -63.68 -37.67 88.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.234 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.26 -42.65 98.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.13 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.43 -45.21 91.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.002 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.54 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.7 tp -59.06 -48.24 82.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.167 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.75 -23.04 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.161 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -18.22 25.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.549 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.57 69.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.98 -18.2 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.602 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 153' ' ' LEU . 38.0 pt -128.52 137.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.165 0.507 . . . . 0.0 110.47 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.13 -28.41 62.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.49 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.4 155.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.5 137.89 51.07 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.913 0.387 . . . . 0.0 110.066 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -85.74 103.25 14.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.61 164.93 25.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.491 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.0 151.73 41.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.03 -54.23 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.32 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.1 t -60.29 -48.73 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.57 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.91 90.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.782 0.325 . . . . 0.0 110.57 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.07 -63.06 1.25 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.441 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.7 m -58.62 -46.85 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -50.23 -36.9 32.9 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.054 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.33 0.55 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 33.8 t80 -40.28 -70.98 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.765 -0.256 . . . . 0.0 111.101 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.65 -39.95 93.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.9 -3.23 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.274 0.559 . . . . 0.0 110.298 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.6 mt-30 -123.91 142.23 38.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.02 -14.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.82 2.347 . . . . 0.0 112.227 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.1 t -63.0 -42.86 98.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.434 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.71 -32.96 80.64 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.13 -41.41 96.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.819 0.342 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.1 m-20 -65.96 -34.82 78.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.652 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.8 m-85 -156.72 142.91 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.54 99.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.153 0.502 . . . . 0.0 110.736 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.25 167.06 29.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.628 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.81 56.03 3.02 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.3 0.01 OUTLIER Glycine 0 CA--C 1.539 1.578 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.28 135.49 38.76 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.247 1.965 . . . . 0.0 111.862 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.3 p -124.42 -108.82 0.32 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.83 165.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.062 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.76 155.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.324 1.015 . . . . 0.0 110.51 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -81.95 118.45 22.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.861 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -72.05 -18.73 61.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.68 -32.17 73.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.64 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 128' ' ' PHE . 93.0 mt -60.95 -44.3 97.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.446 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.9 m-85 -114.08 8.38 16.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.67 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.2 -154.55 50.79 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.654 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.68 -25.65 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.815 0.341 . . . . 0.0 110.59 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.27 -125.48 1.45 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.7 p -132.15 160.19 36.76 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.66 25.05 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.24 141.06 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.908 0.385 . . . . 0.0 110.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.16 111.8 3.96 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -121.2 159.95 24.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.682 0.277 . . . . 0.0 110.287 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -86.5 149.14 25.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.66 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.15 -48.43 64.92 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -40.4 -22.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.631 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.14 52.02 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.592 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.39 -46.33 83.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.25 -47.06 37.58 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.4 -43.78 98.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.405 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.52 -42.76 99.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.897 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.81 -37.5 73.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.88 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.31 -77.42 0.11 Allowed 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.025 HD21 HD11 ' A' ' 44' ' ' ILE . 86.4 mt -28.66 -45.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.8 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.1 m-20 -63.9 -44.99 91.3 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.738 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.71 -43.63 98.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.966 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.16 92.92 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.247 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.2 -43.49 98.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.156 0.503 . . . . 0.0 110.22 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.23 92.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.271 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.11 -42.12 97.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.9 mtp -57.52 -38.07 74.04 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.78 -38.76 76.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.49 92.76 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.662 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.4 p-10 -88.19 0.63 55.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.765 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.76 19.85 67.75 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.7 m -57.93 -46.18 85.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.7 t80 -63.6 -57.61 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.925 0.393 . . . . 0.0 110.47 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.81 -41.73 78.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.352 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -48.21 82.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.96 -41.58 98.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.451 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.1 -49.84 76.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.77 -35.6 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.51 -50.95 32.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.498 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.1 m-85 -62.19 -45.61 92.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.48 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.7 m-85 -154.64 155.62 35.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.6 p-10 -97.56 101.24 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.444 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -157.88 -165.94 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.3 t0 -122.72 110.2 15.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.62 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.0 m -63.3 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.412 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.4 m-85 -59.22 -42.62 91.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -36.69 93.74 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 117.88 -1.511 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.83 164.38 61.53 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.73 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.24 143.64 98.42 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.738 2.292 . . . . 0.0 112.208 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.35 -40.98 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -137.96 139.68 39.84 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.371 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.83 121.26 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.472 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.56 118.23 31.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.122 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.24 138.62 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.271 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.54 106.07 2.25 Favored Glycine 0 N--CA 1.463 0.458 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -129.5 120.24 25.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.657 -0.319 . . . . 0.0 110.76 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.522 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.5 t70 -114.05 93.02 28.31 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.852 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.127 . . . . 0.0 111.925 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.444 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.3 t0 . . . . . 0 C--O 1.228 -0.069 0 CA-C-O 120.984 0.421 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.23 -40.72 83.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.029 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -60.59 -37.84 82.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.893 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.3 tp -65.19 -44.14 89.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.224 0.535 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.41 -47.34 84.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.907 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -54.25 -54.1 44.73 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.518 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.77 -39.11 61.98 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.035 0.445 . . . . 0.0 110.087 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.19 -41.93 80.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.969 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -53.95 -45.08 71.18 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.061 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.17 -46.28 84.69 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.343 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -60.7 -41.93 96.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.989 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.933 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -75.62 -17.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.712 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.84 52.57 4.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.612 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -146.41 170.94 15.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.913 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.71 142.48 27.64 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.987 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.4 m -117.39 131.86 56.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.3 m -128.33 127.81 43.39 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.474 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -94.44 135.28 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.445 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.35 128.59 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.012 0.434 . . . . 0.0 110.305 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.84 137.32 57.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.522 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.3 p30 177.23 131.86 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.19 144.74 64.03 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.664 2.243 . . . . 0.0 112.678 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.06 -56.03 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 111.272 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.11 -26.35 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.35 -20.99 18.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.139 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.7 -42.47 97.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.759 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.691 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.39 -56.86 26.58 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 123.81 0.694 . . . . 0.0 109.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.2 Cg_exo -56.21 -41.36 77.47 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.499 2.133 . . . . 0.0 110.992 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -59.26 -44.27 92.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.8 tp -59.86 -43.86 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.43 95.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.478 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.13 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.43 11.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.41 -35.43 80.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.598 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.9 pt -122.79 153.27 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.318 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.4 m-20 -92.94 -21.87 19.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.131 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.28 156.42 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.628 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.05 128.26 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.397 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.444 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.1 ttp -130.44 107.0 8.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 110.267 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.66 ' OG ' HD21 ' A' ' 55' ' ' LEU . 44.5 t -159.38 179.21 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.88 -15.18 61.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.0 tp -36.27 124.78 0.78 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.606 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.541 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -83.33 155.87 23.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.674 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.59 149.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -149.55 152.43 35.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.693 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.84 -47.46 51.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.77 -39.91 71.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.668 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.47 -37.81 80.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.043 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.95 -38.26 75.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.053 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.24 -27.51 67.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.26 -51.47 7.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.9 pt -138.21 -168.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 121.076 0.465 . . . . 0.0 110.442 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.83 147.66 29.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.4 m-85 -130.08 150.0 51.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.71 -152.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.4 m-20 42.41 20.09 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -29.17 120.77 0.14 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.66 0.6 . . . . 0.0 110.526 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -76.86 -69.63 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.868 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.44 ' CG ' HG21 ' A' ' 166' ' ' VAL . 41.4 p90 -149.4 166.3 29.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.617 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.26 122.74 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.58 69.59 0.9 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.65 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.61 -104.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.422 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.29 166.02 32.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.9 145.75 21.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 110.414 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.89 136.2 41.13 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.41 111.11 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.1 164.99 33.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.84 23.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.039 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.28 60.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.142 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.98 -41.73 88.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.251 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.1 t -102.09 122.01 43.29 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.976 0.417 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.11 109.93 19.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.333 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.0 129.94 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.539 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.93 154.23 42.0 Favored Pre-proline 0 C--N 1.334 -0.099 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.36 92.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.767 2.311 . . . . 0.0 111.907 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.7 m -171.04 144.47 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.36 -33.73 61.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.164 0.507 . . . . 0.0 110.281 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.483 ' H ' HG22 ' A' ' 108' ' ' THR . 47.8 tp10 -58.24 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.425 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.34 -22.13 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.869 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.29 -25.8 55.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.338 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.9 45.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.67 -16.5 30.67 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.94 151.21 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.382 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.91 37.72 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.41 136.61 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 139.53 14.74 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.8 t -131.83 161.74 40.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.096 0.474 . . . . 0.0 110.287 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.73 118.82 31.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.63 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -51.93 157.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.06 50.66 50.54 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.3 p -149.45 168.23 24.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.791 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.433 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.18 -25.64 59.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.431 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.25 -55.1 35.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.544 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.64 -53.92 52.74 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -60.55 -51.36 69.76 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.46 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.1 t80 -62.08 -44.01 97.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.426 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.74 -44.42 97.93 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.94 -14.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.627 0.251 . . . . 0.0 110.675 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.19 -34.84 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.43 -50.57 17.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.435 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -99.04 12.56 35.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.207 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.95 -55.7 0.46 Allowed Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.4 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.08 -10.6 26.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.778 2.319 . . . . 0.0 111.961 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.45 -8.76 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.74 33.37 38.01 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.24 137.87 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 110.532 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -87.58 129.73 35.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.233 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.6 pt -127.26 138.99 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.95 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.58 132.08 71.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.975 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.8 t -98.52 130.52 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -111.69 156.68 21.5 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.294 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.06 6.46 28.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.565 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.98 6.36 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.415 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.6 tp60 -66.19 -46.15 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.12 62.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.89 -36.54 84.7 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.29 -47.44 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.093 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.509 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.3 m-85 -63.72 -37.84 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.263 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.01 -42.19 97.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.081 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -64.19 -44.4 92.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.97 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.1 tp -58.88 -48.2 82.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -63.06 -23.01 67.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.42 -18.36 25.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.493 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.79 11.2 71.16 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.57 -18.25 63.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.659 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.8 pt -127.9 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.456 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 -28.3 62.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.999 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.41 155.62 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.574 0.546 . . . . 0.0 110.873 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.43 138.0 51.21 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.993 0.425 . . . . 0.0 110.045 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.21 103.17 14.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.041 0.448 . . . . 0.0 110.569 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.25 24.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.04 152.55 41.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.04 -54.27 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.347 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.9 t -60.39 -48.66 87.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.437 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.8 88.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 110.44 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.46 -63.63 1.09 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.413 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.4 m -59.09 -47.11 86.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.749 0.309 . . . . 0.0 110.981 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -50.17 -37.6 35.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.02 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.7 -66.15 0.56 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.657 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.3 -70.69 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.734 -0.274 . . . . 0.0 111.123 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.448 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.7 mt -61.36 -39.78 91.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -60.67 -3.36 0.69 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.412 0.625 . . . . 0.0 110.354 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.1 mt-30 -123.27 142.25 38.08 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 122.118 -0.363 . . . . 0.0 110.845 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -44.27 -16.21 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.848 2.365 . . . . 0.0 112.275 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 74.5 t -62.82 -43.04 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.15 -33.06 82.8 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.82 -41.25 95.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 0.0 110.413 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -66.04 -34.27 77.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.509 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.4 m-85 -157.12 143.92 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.725 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.27 99.59 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.0 m-85 -159.09 167.14 29.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.614 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.69 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.44 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.539 1.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.09 135.69 37.41 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.285 1.99 . . . . 0.0 111.99 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.3 p -124.94 -108.13 0.33 Allowed 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.496 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.91 165.33 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 118.815 -0.612 . . . . 0.0 109.955 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.53 156.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.496 1.122 . . . . 0.0 110.468 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.07 118.04 22.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.917 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.1 mp0 -71.62 -18.94 62.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.3 mt -61.0 -44.19 97.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.433 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.97 8.97 17.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.56 -155.12 52.04 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.9 p -70.31 -25.26 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.61 -125.2 1.42 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.5 p -131.76 159.46 38.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 110.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.98 -162.87 24.94 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.7 139.12 34.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.945 0.402 . . . . 0.0 110.468 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.65 112.61 4.04 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.5 mt -124.76 159.5 30.81 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.752 0.311 . . . . 0.0 110.346 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.649 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.8 mtm180 -85.89 149.77 24.99 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.04 -48.29 64.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.746 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -38.57 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.708 0.289 . . . . 0.0 110.715 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.53 52.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.614 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -64.48 -46.13 84.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.742 0.306 . . . . 0.0 111.136 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.0 -47.07 39.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.57 -43.4 98.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.466 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.6 ttt-85 -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.775 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.41 -36.97 72.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.118 0.485 . . . . 0.0 109.84 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.49 -77.43 0.11 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 44' ' ' ILE . 98.0 mt -28.43 -45.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.988 0.423 . . . . 0.0 110.808 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 212' ' ' ALA . 90.0 m-20 -64.29 -45.14 89.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.78 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.69 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.89 -43.93 97.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.968 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.19 92.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.14 -43.62 98.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.162 0.506 . . . . 0.0 110.163 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.27 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.89 -42.45 97.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -57.47 -38.24 74.19 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.86 -38.95 76.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 0.0 110.421 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.91 93.94 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -88.95 1.3 55.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.803 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.68 19.86 65.5 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 77.0 m -58.11 -45.7 86.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.77 -57.69 9.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.499 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.3 -41.43 79.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.59 -48.45 80.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.483 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -41.49 98.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.448 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.48 -49.94 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.724 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.28 -35.37 73.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.379 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.96 -50.99 28.43 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.501 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.15 -45.27 94.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.8 m-85 -153.51 154.86 35.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.416 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.4 p-10 -96.78 95.5 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -153.12 -167.06 2.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.482 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.43 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.48 110.25 15.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 239' ' ' TYR . 22.0 m -63.52 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.574 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.418 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.6 m-85 -57.06 -43.94 82.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.238 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.75 -37.48 94.76 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.793 -1.559 . . . . 0.0 110.985 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 164.36 57.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.671 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -61.09 143.28 98.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.694 2.263 . . . . 0.0 112.14 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.63 -40.87 88.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.658 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -138.38 141.5 39.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.438 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.8 mt -109.21 127.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.331 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.84 118.8 37.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.315 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.71 141.81 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.83 107.08 2.16 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.7 m -128.81 120.83 27.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.68 0.276 . . . . 0.0 110.489 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 9.7 t70 -113.01 94.25 29.01 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.946 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.64 2.227 . . . . 0.0 111.786 179.457 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.8 t0 . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 120.968 0.413 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.98 -39.96 82.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.2 m-20 -60.69 -37.63 82.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.982 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -65.45 -44.3 87.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.24 0.543 . . . . 0.0 110.608 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.44 -46.4 86.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.122 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.46 -53.77 49.84 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.41 -38.91 63.89 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.884 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.27 -42.64 79.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.054 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 48.9 m -53.68 -44.15 69.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -63.98 -46.95 82.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.04 0.448 . . . . 0.0 110.528 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -60.46 -41.48 94.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.146 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.023 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -75.27 -18.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.51 52.25 3.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -146.87 171.05 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.802 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.45 142.14 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -117.59 131.82 56.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.492 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.62 127.01 43.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.401 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -95.72 137.23 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.47 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.3 129.46 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.549 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -68.43 139.06 55.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 p30 176.21 135.25 0.19 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.2 143.32 58.64 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.671 2.248 . . . . 0.0 112.63 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 80.8 mt -39.34 -55.25 1.76 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.077 0.465 . . . . 0.0 111.078 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.73 -26.25 2.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.752 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.03 -21.37 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.846 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 55.2 mt -63.95 -42.96 97.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.379 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.688 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -62.47 -55.86 35.56 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.029 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.1 Cg_exo -55.7 -42.23 69.54 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.559 2.172 . . . . 0.0 111.257 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.4 m -58.82 -44.54 90.9 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.182 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.78 -44.65 90.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.361 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.8 -40.84 95.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.531 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.39 1.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.562 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.2 11.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.646 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.0 mttt -63.5 -33.27 75.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.699 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.56 154.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.507 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -91.49 -20.89 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.744 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.06 160.38 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 58' ' ' LEU . 96.0 mt -116.08 127.33 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.77 107.72 9.88 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.315 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.517 ' OG ' HD21 ' A' ' 55' ' ' LEU . 35.7 t -162.42 -177.13 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.4 p -64.02 -15.68 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.636 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.3 122.99 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -83.09 156.34 23.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.766 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -105.53 149.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.7 p -150.87 152.85 34.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.596 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.81 -47.69 51.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.85 -39.85 72.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.35 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.636 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -69.03 -37.36 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.908 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -58.21 -37.29 74.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 110.399 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.84 67.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.71 -51.84 7.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.739 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.58 -167.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.509 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.37 147.14 29.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.087 0.47 . . . . 0.0 110.652 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 76' ' ' ILE . 72.4 m-85 -130.47 150.6 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.652 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.0 t -165.51 -151.01 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.495 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.505 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.0 m-20 43.09 20.02 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.777 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.98 120.51 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.582 0.551 . . . . 0.0 110.678 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.5 mt -79.42 -71.31 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.801 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -148.46 165.4 31.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.23 126.25 31.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.455 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.416 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.37 67.48 0.73 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.55 -105.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.41 167.3 29.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.574 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.2 146.77 23.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -102.01 135.99 42.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.691 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.52 111.66 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.074 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.4 m -134.9 164.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.606 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.88 24.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.825 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.07 60.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.82 -42.07 88.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.287 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -101.97 122.04 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.348 . . . . 0.0 110.245 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.85 109.68 19.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.328 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.3 130.41 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.532 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -109.71 154.14 42.62 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.53 92.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.715 2.276 . . . . 0.0 112.064 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.5 m -170.86 144.8 2.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.752 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.98 -33.98 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.333 0.587 . . . . 0.0 110.432 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.74 -62.14 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.676 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.8 t -56.48 -22.21 30.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.667 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.9 -25.65 53.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.47 132.85 45.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.575 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.49 -16.5 29.8 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.79 151.22 23.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.808 0.337 . . . . 0.0 110.358 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.1 135.5 37.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.47 136.27 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.639 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.72 14.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.6 161.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.548 ' N ' HG12 ' A' ' 119' ' ' VAL . 39.5 tp -92.7 119.27 31.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -51.32 156.78 1.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.637 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.64 50.92 51.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.3 p -148.69 166.74 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.727 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.1 p -71.81 -29.67 64.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.457 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.4 mt-30 -58.77 -54.78 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.588 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.59 -55.77 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.397 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.1 -51.94 67.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.9 t80 -61.64 -44.19 97.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.468 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.49 -44.48 97.95 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.74 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.563 0.221 . . . . 0.0 110.605 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.76 2.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.593 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.37 -50.72 17.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.01 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -99.6 12.77 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.756 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.13 -55.42 0.46 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.51 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.34 -10.06 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.77 2.314 . . . . 0.0 112.093 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.72 -8.45 59.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.639 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.38 37.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.53 138.1 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.57 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.9 130.29 34.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -127.37 138.98 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.778 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.47 132.37 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.3 t -97.81 129.47 44.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.454 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -111.3 156.35 21.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.342 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.85 7.07 27.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.27 6.08 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.08 -45.9 79.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.372 . . . . 0.0 110.578 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.09 62.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.0 t-20 -64.86 -36.53 84.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.514 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.3 -47.36 84.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.0 m-85 -63.85 -37.67 88.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.5 p -61.4 -42.53 98.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.092 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.15 -44.37 92.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.343 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.0 tp -59.01 -47.86 83.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.184 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.54 -22.96 67.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.995 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.56 25.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 10.96 71.05 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.68 -18.15 63.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.704 0.288 . . . . 0.0 110.636 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.5 pt -128.18 137.81 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.13 -29.76 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -174.8 154.92 2.01 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 138.73 52.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.233 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -86.12 102.64 14.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.25 164.4 26.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.27 152.28 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.7 mt-10 -66.0 -54.43 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.077 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.84 -48.83 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.577 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.36 87.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.749 0.309 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -62.92 -62.95 1.37 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.447 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.1 m -58.29 -45.9 87.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.953 0.406 . . . . 0.0 110.49 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -45.98 -40.78 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.401 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.46 0.46 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.62 -71.59 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.718 0.294 . . . . 0.0 110.747 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -62.67 -41.05 98.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.719 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.0 tttt -59.65 -3.05 0.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.169 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.5 mt-30 -125.96 142.04 41.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.47 -15.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.803 2.335 . . . . 0.0 112.188 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 175' ' ' GLN . 89.7 t -62.5 -43.12 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.27 84.69 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.28 -40.72 95.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.511 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 49.0 m-20 -67.07 -33.6 75.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.5 m-85 -156.59 142.35 17.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.3 pttt -175.47 99.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.712 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 93.5 m-85 -158.93 167.13 30.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.544 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.69 56.13 3.2 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.95 -115.95 0.01 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.35 135.16 39.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.327 2.018 . . . . 0.0 111.931 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.8 p -124.12 -108.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.068 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.9 164.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.038 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.634 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.7 tttt 153.85 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 124.17 0.919 . . . . 0.0 110.51 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.61 119.42 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.239 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.7 mp0 -71.72 -16.34 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.0 -32.21 73.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.683 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -61.05 -44.33 97.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -114.38 8.81 16.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.15 -153.78 51.34 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.659 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.8 p -70.93 -25.53 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.559 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.91 -126.55 1.61 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.9 p -132.29 160.26 36.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.82 -161.94 24.09 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.45 140.13 33.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.542 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.52 3.57 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' ALA . 83.0 mt -118.13 159.64 22.92 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.584 0.23 . . . . 0.0 110.443 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.69 148.84 25.27 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.608 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.21 -48.68 61.97 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -41.02 -22.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.497 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.52 51.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.465 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.46 -46.28 83.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.99 -47.2 38.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.387 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.28 -42.91 99.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.71 -37.46 73.56 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.205 0.526 . . . . 0.0 110.143 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.697 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.12 -77.43 0.1 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.923 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.023 HD21 HD11 ' A' ' 44' ' ' ILE . 88.7 mt -27.95 -45.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.913 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.4 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.741 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.697 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.1 -43.54 98.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.114 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.99 91.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.453 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.23 -43.36 99.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.412 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.23 91.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.368 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.22 -42.15 96.7 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.393 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.31 -38.2 73.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.62 -38.88 77.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.537 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.54 91.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 18.9 p-10 -88.74 0.28 56.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.762 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.01 20.42 68.8 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -57.54 -46.39 83.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.2 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.06 -58.04 8.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.996 0.427 . . . . 0.0 110.485 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.75 -42.53 79.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.545 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.81 -48.8 80.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.442 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.16 -41.48 98.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.49 -50.19 74.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.745 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -34.76 72.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -71.42 -51.83 21.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.176 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.42 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 40.1 m-85 -62.73 -44.61 95.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 230' ' ' ALA . 83.9 m-85 -151.31 153.09 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.513 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 49.0 p-10 -98.21 93.92 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.464 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.89 -165.59 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.444 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -122.39 108.75 13.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.683 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 239' ' ' TYR . 28.2 m -63.53 -40.06 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.428 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.1 m-85 -57.37 -43.57 83.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.71 -37.55 94.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.219 -0.796 0 CA-C-O 117.924 -1.486 . . . . 0.0 111.005 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.3 60.14 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.99 143.47 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 122.737 2.291 . . . . 0.0 112.261 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.42 -40.91 89.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.633 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -138.0 139.0 39.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.34 121.21 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.587 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.1 118.88 32.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.6 138.67 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.369 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.7 105.29 2.11 Favored Glycine 0 N--CA 1.463 0.442 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.9 m -128.75 120.52 26.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.648 -0.325 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.509 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.7 t70 -114.35 92.85 29.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.953 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.526 0 C-N-CA 122.544 2.162 . . . . 0.0 111.974 179.404 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.946 0.403 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.15 -40.84 83.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.83 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.3 -37.77 81.58 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.19 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.38 -45.05 89.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 110.163 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.19 -48.77 77.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.915 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.65 -54.69 29.88 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.15 -40.46 61.45 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.17 -41.7 81.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.971 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.8 m -53.43 -45.18 69.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.167 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.33 -46.38 83.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.279 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -60.23 -42.31 94.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 213' ' ' LEU . 97.3 mt -75.53 -16.99 15.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.41 52.96 4.46 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.706 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.8 p -146.96 171.54 15.08 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.89 142.31 27.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.038 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.14 130.92 56.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.63 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.4 m -127.29 127.1 43.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -94.03 134.89 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.4 t -129.09 127.77 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 137.89 57.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.07 131.04 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.5 Cg_endo -67.84 145.31 68.24 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.684 2.256 . . . . 0.0 112.562 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 58' ' ' LEU . 81.8 mt -40.41 -56.07 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.979 0.418 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.05 -26.69 1.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.008 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -20.96 18.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 55' ' ' LEU . 58.7 mt -63.77 -42.53 97.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.641 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.3 -56.84 26.99 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.821 0.701 . . . . 0.0 109.688 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.1 Cg_exo -55.84 -41.83 73.31 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.556 2.171 . . . . 0.0 111.102 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m -59.05 -44.5 91.81 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.055 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.657 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.3 tp -59.45 -43.89 93.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.185 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.45 95.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.23 10.22 2.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.496 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.21 12.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.56 -35.38 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.549 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.43 153.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.297 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.4 m-20 -93.17 -22.27 19.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.5 155.94 27.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.607 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.08 128.63 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.123 0.487 . . . . 0.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.11 107.22 8.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.701 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -159.48 178.64 9.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.618 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.4 p -65.01 -15.34 62.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.493 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.16 124.65 0.6 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.549 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.15 154.38 25.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.63 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.5 pt -105.16 148.86 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.134 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -149.16 152.18 35.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.9 -47.15 52.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.434 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.55 -40.21 71.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.707 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.4 -37.92 80.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.072 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.78 -38.84 76.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.94 -27.43 66.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.206 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.46 -51.0 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.526 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -139.01 -168.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.072 0.463 . . . . 0.0 110.49 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.31 147.74 29.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 76' ' ' ILE . 79.5 m-85 -130.01 150.11 51.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.549 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.9 t -163.36 -153.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.437 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.3 m-20 41.55 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.933 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.72 121.38 0.2 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.478 0.486 . . . . 0.0 110.503 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 58.6 mt -75.0 -68.56 0.54 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.444 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.78 167.61 26.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.6 29.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.368 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -105.05 68.24 0.81 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.713 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.58 -104.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.9 p -159.26 165.49 33.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.639 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.05 146.45 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.112 0.482 . . . . 0.0 110.432 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.95 135.99 41.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.762 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.06 164.49 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.11 148.25 25.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.01 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.19 -28.39 58.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.05 -41.66 88.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -101.63 121.41 41.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.153 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.06 109.88 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.419 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.57 129.54 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -107.16 154.11 40.64 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.35 91.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.793 2.329 . . . . 0.0 111.946 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.3 m -170.44 143.44 2.29 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.516 0.51 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.59 -33.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.35 -62.07 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.439 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -56.6 -22.48 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.826 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.2 mt -75.89 -26.03 56.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.276 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.6 47.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.454 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.79 -16.99 28.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.01 151.34 23.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.434 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.78 135.2 37.8 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.287 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.58 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.594 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 138.45 14.26 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.6 161.56 40.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.6 tp -92.52 117.51 30.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.648 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.55 157.91 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.71 50.63 52.83 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.1 p -149.9 168.75 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.783 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.451 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.8 p -73.3 -26.88 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.458 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.49 -55.31 35.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.534 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -56.98 -54.9 41.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.8 m -60.26 -51.38 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.524 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.3 t80 -61.99 -44.08 97.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.441 . . . . 0.0 110.502 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.52 -44.55 97.84 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.54 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.657 0.265 . . . . 0.0 110.651 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.5 -34.64 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.611 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.6 -50.65 17.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 111.366 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.3 12.17 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.171 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.57 -55.29 0.49 Allowed Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.35 -10.1 25.13 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.796 2.331 . . . . 0.0 111.994 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.85 -9.02 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.25 37.09 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.33 137.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.29 129.79 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.343 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.4 138.14 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.0 133.25 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.023 0.44 . . . . 0.0 109.979 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.88 127.08 42.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.31 25.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.33 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.02 7.22 29.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.19 5.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.409 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.0 tp60 -65.81 -45.77 81.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.463 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.77 -23.47 62.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.73 -36.8 85.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.94 -46.62 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.016 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.494 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.8 m-85 -64.7 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.04 -41.86 97.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.39 -43.2 91.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.998 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.4 tp -58.77 -48.2 82.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.172 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.84 -22.48 66.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.224 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.47 -18.41 25.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.55 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.64 72.38 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.82 -17.82 63.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.645 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.5 pt -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.493 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.64 -28.0 62.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.38 155.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.517 0.511 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.01 137.21 50.15 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.022 0.439 . . . . 0.0 110.074 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -86.03 103.32 14.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.7 tt0 -132.85 165.56 24.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.446 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.474 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -72.89 153.12 41.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.69 -54.68 20.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 91' ' ' TYR . 69.3 t -60.29 -48.89 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.506 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.96 89.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.41 -62.92 1.3 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.456 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.5 m -59.56 -47.49 85.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.99 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -48.93 -37.27 19.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.113 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.03 0.55 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 168' ' ' ALA . 23.8 t80 -40.72 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.771 -0.252 . . . . 0.0 111.087 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -61.44 -40.39 94.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.38 -3.35 0.42 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.632 . . . . 0.0 110.321 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 173' ' ' LEU . 36.9 mt-30 -122.82 150.09 57.87 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.69 -20.92 7.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.853 2.369 . . . . 0.0 112.231 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.79 -43.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.577 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.13 -33.28 85.31 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.48 -41.14 93.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.738 0.304 . . . . 0.0 110.459 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.6 m-20 -66.12 -32.91 74.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.2 142.64 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.557 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.44 99.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.085 0.469 . . . . 0.0 110.727 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.24 167.53 28.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.647 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.91 56.45 2.74 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.67 -118.61 0.01 OUTLIER Glycine 0 CA--C 1.535 1.337 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.55 135.7 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.395 2.063 . . . . 0.0 111.996 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.3 p -125.2 -108.32 0.32 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.435 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.12 164.56 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.065 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.65 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 154.13 155.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.346 1.029 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -81.92 117.4 22.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 195' ' ' GLY . 54.1 mp0 -71.44 -18.94 62.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.81 -32.37 73.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.565 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.8 mt -60.93 -44.58 97.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.669 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.451 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.2 m-85 -114.13 9.64 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.646 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.74 -153.86 51.8 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.63 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.74 -24.93 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.789 0.328 . . . . 0.0 110.501 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.34 -124.14 1.3 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.49 156.16 44.57 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.646 0.26 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.56 30.37 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.17 137.41 33.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.534 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.32 108.38 3.28 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.44 159.12 29.68 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.293 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.657 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.42 149.79 24.76 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.803 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.2 -47.76 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.522 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.53 -25.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.791 0.329 . . . . 0.0 110.574 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.4 52.07 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.611 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -64.49 -45.11 88.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.162 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.9 -47.39 30.21 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.46 -43.72 98.14 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.506 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.2 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.798 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.91 -36.35 70.06 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.09 -77.38 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 44' ' ' ILE . 96.6 mt -28.4 -46.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.956 0.408 . . . . 0.0 110.637 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.4 -44.84 90.02 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.779 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.02 -43.56 98.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.037 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.87 92.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.199 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.34 -43.71 98.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.126 0.488 . . . . 0.0 110.144 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.53 93.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.383 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -42.71 97.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.22 -37.85 72.85 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.2 -38.88 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.44 . . . . 0.0 110.437 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.73 94.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.17 2.13 54.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.67 63.09 Favored Glycine 0 C--O 1.225 -0.451 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.441 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 83.9 m -58.07 -45.84 86.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.0 t80 -63.7 -57.73 9.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.11 -41.46 79.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.232 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.64 -48.33 81.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.459 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.21 -41.55 98.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.829 0.347 . . . . 0.0 110.294 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.76 -50.0 75.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.92 -35.43 73.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.428 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.75 -51.21 28.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.544 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.2 m-85 -61.88 -45.83 92.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.97 155.54 35.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.09 97.43 9.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.001 0.429 . . . . 0.0 110.496 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.86 -166.49 2.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.477 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.03 110.99 16.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.0 m -63.22 -40.34 88.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.417 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.0 m-85 -58.89 -42.48 89.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.274 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.94 94.12 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.957 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.47 164.59 59.93 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.07 143.63 99.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.749 2.299 . . . . 0.0 112.276 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.11 -40.24 90.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.81 142.92 36.63 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.97 129.08 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -104.1 117.12 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.337 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -111.89 138.86 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.82 104.86 2.13 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.6 m -127.98 119.3 25.21 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 122.588 -0.36 . . . . 0.0 110.91 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.9 t70 -113.63 92.46 24.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.311 -1.44 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.54 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.472 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.8 t0 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.927 0.394 . . . . 0.0 111.573 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.7 mt -68.55 -40.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.422 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.5 m-20 -61.41 -37.66 84.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.686 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.0 -43.92 86.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.13 -41.88 93.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.909 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.67 -53.3 59.92 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.589 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.92 -37.06 63.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.117 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.86 -42.29 77.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.102 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.75 -44.59 73.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.077 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.81 -47.22 81.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.162 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -59.85 -40.97 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.054 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.985 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -76.37 -17.53 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.5 52.45 4.64 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.21 170.23 16.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.898 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.37 140.59 29.32 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.964 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.5 m -117.13 131.88 56.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.583 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -128.28 127.63 43.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -93.91 135.71 34.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.58 128.82 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.31 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.83 139.4 58.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.606 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.513 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.38 131.7 0.15 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.692 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.34 145.28 65.08 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.67 2.247 . . . . 0.0 112.591 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.886 HD23 HD12 ' A' ' 58' ' ' LEU . 82.1 mt -40.27 -56.67 1.91 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.085 0.469 . . . . 0.0 111.283 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.47 -26.74 1.47 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.57 19.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.194 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.886 HD12 HD23 ' A' ' 55' ' ' LEU . 58.7 mt -63.98 -42.56 97.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.859 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.687 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.32 -57.02 25.36 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 123.933 0.771 . . . . 0.0 109.527 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.3 Cg_exo -55.46 -42.65 65.95 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.49 2.126 . . . . 0.0 110.939 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -59.19 -43.88 92.2 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.01 -44.05 91.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.109 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.72 -40.02 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.507 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.54 11.23 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.479 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.12 11.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -34.34 77.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.1 pt -124.05 153.52 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.189 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.35 -20.59 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.4 157.32 25.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.545 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.91 127.36 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.472 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.33 106.45 9.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.309 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.585 ' OG ' HD21 ' A' ' 55' ' ' LEU . 41.4 t -160.07 -178.33 6.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.575 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.3 p -64.24 -15.38 59.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.417 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.1 tp -37.96 123.76 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.557 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.44 156.84 22.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.647 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.0 pt -105.27 149.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.131 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.3 p -149.87 152.9 35.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.751 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.44 -47.5 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.9 -40.05 72.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.691 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.01 -37.82 81.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.078 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.26 -37.37 74.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.05 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.55 -27.2 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.127 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.5 -51.91 6.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.329 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.27 -168.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.118 0.485 . . . . 0.0 110.407 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.79 29.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.94 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.0 m-85 -129.93 149.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.37 -151.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.421 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.506 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.37 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -28.27 120.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.581 0.551 . . . . 0.0 110.518 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.5 mt -77.25 -69.9 0.5 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.2 p90 -149.17 166.12 29.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.589 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.88 121.67 27.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.298 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.87 69.29 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.88 -105.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.424 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.15 165.76 33.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.615 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.47 146.02 22.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.133 0.492 . . . . 0.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.08 136.11 41.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.51 111.06 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.27 165.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.73 148.45 23.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.154 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.13 -28.22 57.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.201 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.0 -41.78 88.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.12 122.22 43.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.114 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.04 110.0 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.33 129.84 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.85 154.34 41.87 Favored Pre-proline 0 N--CA 1.457 -0.096 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.641 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.24 92.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.832 2.354 . . . . 0.0 111.82 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -170.86 144.09 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.666 0.604 . . . . 0.0 110.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.3 -33.74 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.306 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.493 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.85 -62.11 2.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.74 -21.85 31.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.893 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.8 mt -76.19 -25.93 55.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.373 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.44 47.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.459 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.17 -16.25 29.5 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.5 151.56 23.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.29 135.4 38.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.231 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.04 136.49 60.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.615 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 138.62 14.32 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.1 t -130.89 161.76 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.213 0.53 . . . . 0.0 110.205 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.3 tp -92.5 117.54 30.05 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.75 157.79 1.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.76 50.29 54.52 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.46 168.78 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.835 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.453 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 77.0 p -73.1 -27.35 61.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.418 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.45 -54.87 40.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.51 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -57.16 -54.5 46.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.408 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -60.73 -51.14 70.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.446 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.02 -43.95 97.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.986 0.422 . . . . 0.0 110.476 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.68 -44.44 97.91 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.62 -14.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.6 0.238 . . . . 0.0 110.746 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.3 -34.73 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.46 -50.66 17.44 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.478 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.13 12.45 36.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.293 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.6 0.46 Allowed Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.347 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.19 -10.45 25.83 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.793 2.328 . . . . 0.0 111.951 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.51 -8.66 59.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.72 33.53 37.6 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.79 137.99 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.987 0.423 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.71 130.08 34.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.233 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.56 138.35 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.1 t -123.04 133.19 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.0 127.26 42.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.85 153.28 25.64 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.67 6.88 30.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.96 130.49 5.95 Favored Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.93 -45.67 81.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.44 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.15 -23.98 63.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.055 0.455 . . . . 0.0 110.513 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.5 t-20 -64.7 -36.53 84.59 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.551 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.93 -47.07 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.515 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.7 m-85 -63.8 -37.66 88.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.26 -42.61 98.92 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.137 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.86 -44.96 91.53 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.0 tp -58.91 -47.72 84.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.213 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -63.25 -22.47 66.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.072 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.95 -18.33 24.88 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.459 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.48 70.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -17.87 63.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.2 pt -128.24 137.45 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.449 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.8 -27.95 62.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.57 155.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.617 0.573 . . . . 0.0 110.835 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.48 50.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.957 0.408 . . . . 0.0 110.035 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.95 103.0 14.26 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.083 0.468 . . . . 0.0 110.577 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.17 165.02 25.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.441 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.463 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.34 152.4 40.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.606 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -65.99 -54.09 30.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.35 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 68.5 t -60.45 -48.94 86.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.405 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.8 87.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.787 0.327 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.15 -63.53 1.13 Allowed 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.425 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.437 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.0 m -58.77 -46.72 86.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.756 0.313 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.1 tt0 -50.04 -37.95 35.53 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.896 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.86 -65.76 0.55 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.1 t80 -40.48 -71.08 0.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.777 -0.249 . . . . 0.0 111.213 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.47 -40.06 93.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.005 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.45 -3.28 0.42 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 110.306 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 177' ' ' VAL . 61.1 mt-30 -124.37 141.81 38.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 O-C-N 121.965 -0.459 . . . . 0.0 110.858 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.71 -14.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.823 2.349 . . . . 0.0 112.379 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.0 t -63.29 -42.96 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.445 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.89 80.62 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.72 -42.13 96.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.774 0.321 . . . . 0.0 110.318 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 60.1 m-20 -65.01 -35.23 80.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.7 m-85 -156.8 143.72 18.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.11 99.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.135 0.493 . . . . 0.0 110.798 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.15 168.49 26.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.1 55.85 3.19 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.52 -116.68 0.01 OUTLIER Glycine 0 CA--C 1.538 1.498 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.14 135.63 37.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.367 2.045 . . . . 0.0 111.963 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.0 p -125.34 -108.05 0.32 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.597 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.48 165.38 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-O 118.739 -0.648 . . . . 0.0 109.966 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.54 155.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.625 1.203 . . . . 0.0 110.616 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.19 22.99 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.823 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.4 mp0 -71.93 -18.54 62.01 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.566 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.1 mt -60.98 -44.26 97.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.799 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.453 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.3 m-85 -113.79 7.88 17.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.716 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.78 -154.49 50.04 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.7 p -70.87 -25.4 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.0 110.536 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.92 -125.88 1.52 Allowed Glycine 0 CA--C 1.517 0.211 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -132.05 159.86 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.859 0.362 . . . . 0.0 110.372 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.66 -162.59 25.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.21 141.12 31.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.97 0.414 . . . . 0.0 110.611 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.27 111.73 3.95 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.6 mt -120.55 160.3 23.46 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.93 149.28 24.9 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 120.83 0.348 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.5 -48.59 65.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.763 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.49 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -71.76 51.96 0.21 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.708 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -64.37 -46.2 84.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.11 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.48 -47.08 35.48 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.096 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.24 -43.79 98.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.459 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.57 -42.85 99.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.746 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.71 -37.55 73.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.694 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.32 -77.47 0.1 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 44' ' ' ILE . 86.9 mt -28.95 -45.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.984 0.421 . . . . 0.0 110.769 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.1 m-20 -63.69 -45.47 89.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.49 -43.74 98.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.947 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.23 92.61 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.15 -43.67 98.52 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.16 0.505 . . . . 0.0 110.112 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.98 -39.36 91.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.71 -42.67 97.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.895 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.14 -38.32 73.32 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.71 -38.76 77.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 110.447 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.01 -45.48 92.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.24 0.66 55.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.54 20.06 67.5 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 84.5 m -58.09 -46.13 86.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.58 -57.15 11.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.953 0.406 . . . . 0.0 110.451 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.23 -41.42 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.149 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.458 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.01 -41.53 98.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.413 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.99 -49.67 77.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.713 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.03 -35.82 73.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.318 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.45 -50.84 33.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.536 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.0 m-85 -62.31 -45.76 91.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.534 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.47 155.44 36.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.99 98.19 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.417 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -155.16 -165.74 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.45 109.67 14.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.74 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.3 m -63.75 -40.54 89.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.581 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.3 m-85 -57.03 -43.76 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.03 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.18 164.25 54.59 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.731 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.39 99.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.662 2.241 . . . . 0.0 112.335 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.45 -40.52 89.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.0 m-20 -139.14 142.77 38.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.398 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -109.87 127.25 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.899 0.38 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.67 120.49 40.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.87 141.88 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.927 0.394 . . . . 0.0 110.376 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.66 102.36 1.58 Allowed Glycine 0 N--CA 1.463 0.483 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.9 m -125.13 119.83 29.68 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 122.693 -0.298 . . . . 0.0 111.118 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.4 t70 -112.41 94.77 28.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--N 1.309 -1.532 0 C-N-CA 122.459 2.106 . . . . 0.0 112.25 179.109 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.2 t0 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.948 0.404 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.1 mt -67.26 -40.28 84.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.886 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 55.0 m-20 -61.02 -37.3 82.07 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.709 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.0 tp -65.83 -44.68 84.86 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.15 -46.5 85.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -54.3 -54.19 43.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.387 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.06 -38.15 62.23 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.953 0.406 . . . . 0.0 110.419 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.51 -42.46 74.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.608 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -54.28 -44.42 71.89 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.044 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.63 -48.04 78.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.018 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -59.35 -41.28 88.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.096 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 213' ' ' LEU . 96.8 mt -76.28 -18.21 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.571 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.11 52.35 4.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 170.28 16.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.16 141.64 28.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.06 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -117.23 131.61 56.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.682 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -127.89 127.37 43.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.454 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.24 137.81 34.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.903 0.382 . . . . 0.0 110.399 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.56 129.52 64.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.403 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -67.65 139.97 56.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.78 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.487 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.65 135.52 0.13 Allowed Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.2 Cg_endo -68.62 144.19 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.592 2.195 . . . . 0.0 112.546 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.946 HD23 HD12 ' A' ' 58' ' ' LEU . 79.5 mt -40.75 -54.1 2.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.043 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -48.67 -26.18 2.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.15 -20.78 18.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.946 HD12 HD23 ' A' ' 55' ' ' LEU . 84.4 mt -64.72 -42.47 95.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.001 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.699 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.28 -57.31 26.58 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.744 0.652 . . . . 0.0 109.616 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.0 Cg_exo -54.65 -43.26 60.71 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.658 2.239 . . . . 0.0 111.19 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.3 m -58.27 -44.74 88.55 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.691 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.87 -44.47 91.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.194 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.81 -41.06 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.492 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.08 11.31 1.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.85 12.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -33.58 75.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.529 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 pt -124.29 154.43 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -91.75 -20.81 21.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.146 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.55 159.95 22.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 58' ' ' LEU . 96.3 mt -115.82 127.54 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.067 0.46 . . . . 0.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -129.03 107.2 9.42 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.28 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.597 ' OG ' HD21 ' A' ' 55' ' ' LEU . 46.9 t -162.17 -176.95 5.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.633 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.34 -15.94 61.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.606 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.4 tp -36.89 122.63 0.83 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -82.55 155.78 24.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.627 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.663 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.29 149.17 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.296 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.3 p -150.53 152.92 34.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.812 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.21 -47.84 54.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.967 0.413 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.5 -39.83 70.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.776 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.606 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -68.41 -37.75 80.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.67 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.852 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.88 -27.58 66.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.129 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.11 -51.55 7.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.7 -167.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.36 147.04 29.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 111.044 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 76' ' ' ILE . 72.3 m-85 -130.28 150.29 51.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.1 t -165.13 -150.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.431 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.3 m-20 42.55 19.94 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.93 121.09 0.11 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.38 0.425 . . . . 0.0 110.471 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -79.28 -71.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.782 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CG ' HG21 ' A' ' 166' ' ' VAL . 35.4 p90 -148.19 165.27 31.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.624 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.32 126.05 31.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.425 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.19 67.74 0.75 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.752 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.68 -105.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.47 167.3 29.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.634 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.23 146.59 22.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.68 135.88 42.47 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.786 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.55 111.58 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.77 164.69 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.04 148.3 24.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.14 -27.88 48.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -59.29 -41.46 89.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.35 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -102.45 122.48 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.61 109.7 19.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.434 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.2 129.97 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.6 35.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.451 . . . . 0.0 110.507 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.9 Cg_endo -60.45 91.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.783 2.322 . . . . 0.0 111.9 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.1 m -169.57 141.97 2.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 123.584 0.553 . . . . 0.0 110.75 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.07 -33.42 60.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.215 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.19 -62.77 1.53 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.294 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.0 t -56.2 -21.91 25.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.138 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.12 -26.62 56.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.307 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.04 133.22 48.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.387 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -16.25 29.64 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.34 151.18 23.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.421 . . . . 0.0 110.409 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.71 134.88 38.12 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.198 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.65 136.48 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.692 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.7 138.83 14.49 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.09 161.55 40.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.145 0.497 . . . . 0.0 110.313 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.42 118.07 30.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.563 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.57 157.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.58 50.66 53.41 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.3 p -149.05 167.96 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.831 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.5 p -71.5 -29.76 65.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.2 mt-30 -58.93 -55.13 39.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.42 -55.46 33.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.38 -51.26 70.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.77 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.598 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.5 t80 -62.06 -43.91 97.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.36 97.92 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.12 -14.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.35 2.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.598 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.31 -50.7 17.75 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.38 12.61 35.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.248 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.97 -55.46 0.47 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.37 -9.98 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.78 2.32 . . . . 0.0 111.913 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -83.0 -8.74 59.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.23 33.35 36.05 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.7 137.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.009 0.433 . . . . 0.0 110.472 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -87.58 130.26 34.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.258 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.4 137.96 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.9 t -123.03 133.33 69.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.87 126.87 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -110.67 153.65 24.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.73 7.98 28.68 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.15 130.09 5.79 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.04 -45.91 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.38 -23.51 62.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.495 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.66 -36.66 84.98 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.535 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.98 -47.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.63 -38.0 89.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.22 -42.58 98.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.182 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -64.06 -45.13 90.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.037 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.529 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.7 tp -58.47 -47.95 82.38 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.206 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.56 -22.86 67.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.005 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.9 -18.76 25.54 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.548 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.01 11.17 70.51 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.61 -18.12 63.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.593 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -128.46 137.57 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 110.444 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.64 -28.72 62.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.53 155.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.24 138.62 51.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.018 0.437 . . . . 0.0 109.96 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.48 102.98 14.58 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.214 0.531 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.93 25.2 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.468 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.83 152.23 40.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 98.0 mt-10 -66.05 -53.97 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.268 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.402 HG21 ' CG ' ' A' ' 91' ' ' TYR . 70.4 t -60.08 -49.22 84.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.42 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.96 85.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.882 0.372 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.26 1.25 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.318 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.2 m -57.98 -46.39 85.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -45.61 -41.56 10.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.389 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.52 -62.06 0.47 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.721 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.655 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.69 -71.56 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.534 0.207 . . . . 0.0 111.136 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -62.16 -41.23 98.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.5 tttt -59.98 -2.17 0.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.53 0.681 . . . . 0.0 110.318 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.5 mt-30 -126.45 141.93 41.49 Favored Pre-proline 0 CA--C 1.532 0.272 0 O-C-N 122.079 -0.388 . . . . 0.0 110.733 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.65 -14.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.842 2.361 . . . . 0.0 112.397 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 175' ' ' GLN . 87.6 t -62.94 -42.89 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.17 84.33 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.38 -41.1 96.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.92 -34.9 79.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.476 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.52 142.97 18.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.0 pttt -175.88 99.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.962 0.41 . . . . 0.0 110.796 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.5 m-85 -158.68 167.11 30.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.683 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.19 55.98 3.14 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 134.98 36.06 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 111.949 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -124.32 -108.35 0.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.547 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -165.42 165.07 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 CA-C-O 119.16 -0.447 . . . . 0.0 110.156 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.8 tttt 154.13 155.24 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.283 0.989 . . . . 0.0 110.669 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.15 118.51 22.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.776 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.4 mp0 -71.17 -19.07 62.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.55 -31.81 73.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.546 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.458 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.9 mt -60.88 -44.33 97.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -114.16 8.44 16.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.819 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.44 -153.58 50.76 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.663 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.1 p -71.01 -25.65 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.71 -125.97 1.53 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.5 p -132.16 160.42 36.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.504 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.54 -162.04 24.02 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.68 139.83 33.8 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.959 0.409 . . . . 0.0 110.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.65 108.75 3.47 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.0 mt -117.72 159.41 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 0.0 110.253 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.82 149.19 25.02 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 120.886 0.374 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.61 64.16 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.645 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -40.64 -22.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.81 51.55 0.28 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -64.47 -46.03 84.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.171 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.28 -47.08 37.15 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.26 -43.65 98.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.474 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.45 -43.05 99.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.823 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.77 -37.51 73.8 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.26 -77.69 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 44' ' ' ILE . 87.3 mt -28.54 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.6 m-20 -63.43 -45.57 90.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.02 -43.84 98.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.94 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.26 92.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.077 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -61.11 -43.67 98.53 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.058 0.456 . . . . 0.0 110.015 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.34 92.07 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.058 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.67 -43.52 96.45 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.2 -38.65 71.27 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.73 -38.75 76.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.024 0.44 . . . . 0.0 110.367 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.56 91.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 20.6 p-10 -88.61 -0.02 56.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.78 20.86 68.8 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.5 m -58.05 -46.38 85.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 80.4 t80 -63.26 -57.62 9.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.443 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.05 -42.43 80.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.399 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -48.66 80.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.71 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.34 -41.38 98.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.566 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.67 -50.04 75.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.63 -34.65 73.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.719 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -71.16 -51.77 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.706 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.432 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 39.4 m-85 -62.52 -44.94 95.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.67 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 230' ' ' ALA . 84.0 m-85 -151.06 153.21 34.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 49.1 p-10 -98.34 93.6 6.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.495 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.56 -165.64 2.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.511 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.447 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.36 108.8 13.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 239' ' ' TYR . 28.9 m -63.4 -40.59 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.433 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.2 m-85 -57.3 -43.49 83.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.16 94.31 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.683 0 CA-C-O 117.876 -1.513 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.73 164.37 56.03 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.78 143.75 99.44 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 122.692 2.261 . . . . 0.0 112.3 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.24 -40.0 89.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -140.1 145.54 37.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.42 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.28 130.04 66.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -105.93 117.88 35.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.448 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -113.27 140.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.44 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.2 100.45 1.46 Allowed Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.5 m -123.66 119.3 29.42 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.66 -0.318 . . . . 0.0 111.151 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 8.1 t70 -112.33 93.98 24.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.309 -1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.16 179.303 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 . . . . . 0 C--O 1.226 -0.143 0 CA-C-O 121.004 0.431 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.85 -40.13 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.892 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.03 -37.02 81.09 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.89 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.48 -44.66 82.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.177 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.8 -41.67 91.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.095 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -57.8 -53.43 58.33 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.596 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.97 -36.16 65.07 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.314 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.93 -43.18 72.17 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -55.04 -43.6 73.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.3 -48.02 77.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.019 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.49 -40.79 88.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -76.32 -18.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.46 51.75 4.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.123 0.487 . . . . 0.0 110.799 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -144.39 169.26 18.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.75 140.36 29.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.065 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -117.31 132.29 56.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.0 m -128.16 126.88 41.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.386 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.5 136.69 34.52 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.455 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.33 129.34 64.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.346 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.67 141.19 56.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.757 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.484 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 172.65 135.86 0.1 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.497 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.56 144.19 59.75 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.644 2.23 . . . . 0.0 112.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.95 HD23 HD12 ' A' ' 58' ' ' LEU . 81.0 mt -41.17 -53.64 3.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.916 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.84 -26.11 2.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.41 19.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.143 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.95 HD12 HD23 ' A' ' 55' ' ' LEU . 84.4 mt -64.84 -42.5 94.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.963 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.705 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.42 -56.97 28.54 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.772 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.705 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.1 Cg_exo -55.18 -43.04 62.8 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.562 2.175 . . . . 0.0 111.137 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -58.32 -44.42 88.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.764 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.95 -44.48 91.45 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.65 -40.92 96.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 0.0 110.431 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.77 11.38 1.38 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.92 12.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.53 -33.81 76.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -124.71 153.73 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.323 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -92.83 -20.46 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.29 158.38 24.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.674 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.566 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.41 127.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.502 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.68 106.65 9.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.301 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.593 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.6 t -161.11 -177.97 6.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.33 -15.54 60.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.646 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.13 123.09 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.558 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -82.44 155.84 24.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.704 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.655 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.03 148.73 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.232 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.45 152.81 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.781 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.66 52.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 110.567 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.37 -39.96 70.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.646 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.61 -37.57 79.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.89 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.33 -38.09 76.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.86 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.86 -27.69 66.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.02 -51.36 7.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.957 0.408 . . . . 0.0 110.69 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -139.12 -167.83 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.1 0.476 . . . . 0.0 110.457 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.64 147.06 29.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.044 0.449 . . . . 0.0 110.966 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.1 m-85 -130.05 150.21 51.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.2 t -165.08 -150.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.3 m-20 42.52 20.08 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.7 mttt -27.79 121.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.494 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 17.6 mt -79.84 -72.49 0.4 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -147.77 164.74 32.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.2 127.67 32.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.404 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -107.19 67.34 0.69 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.12 -106.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.47 167.65 28.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.58 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.413 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.4 mt -101.03 135.96 41.64 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.786 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.87 111.03 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.72 164.41 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.956 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.64 148.69 24.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.6 -28.16 53.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.13 -41.43 88.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.266 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.31 122.25 43.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 110.218 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.71 109.71 19.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.403 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.39 130.01 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.634 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.1 158.84 34.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.568 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.5 Cg_endo -60.06 90.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.819 2.346 . . . . 0.0 111.858 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -169.17 141.43 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.538 0.524 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.76 -33.14 59.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.31 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.15 -62.56 1.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.381 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.56 -21.8 29.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.062 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.1 -26.95 56.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.347 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.87 132.82 47.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.373 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -15.93 33.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.72 151.25 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 0.0 110.45 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.06 135.35 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.998 0.427 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.63 136.5 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 137.62 13.84 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.63 161.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.118 0.485 . . . . 0.0 110.31 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.2 tp -92.75 119.38 32.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.49 156.81 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.65 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.12 50.55 50.84 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.2 p -148.87 167.83 24.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 67.1 p -71.98 -28.68 63.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.458 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -59.7 -55.33 35.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.47 -55.11 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.55 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.55 -51.12 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.69 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.3 t80 -62.03 -43.9 97.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.091 0.472 . . . . 0.0 110.434 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.25 -44.38 97.77 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.03 -14.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 0.0 110.795 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.54 -34.24 2.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.692 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.36 -51.07 16.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.959 0.409 . . . . 0.0 111.539 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.24 12.69 35.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.241 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.48 0.47 Allowed Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.341 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.23 -10.09 25.27 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.781 2.32 . . . . 0.0 111.945 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.99 -8.93 59.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.46 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.55 33.36 34.92 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.58 137.44 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.913 0.387 . . . . 0.0 110.547 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.28 130.28 34.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.59 138.32 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.37 133.33 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 109.979 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.08 127.34 42.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.57 153.85 24.57 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.97 6.68 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.68 130.43 5.82 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.07 -45.92 79.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.56 -24.27 63.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.516 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -36.69 85.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.456 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.71 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.067 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -64.3 -37.87 89.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.269 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.56 -42.29 96.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.122 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -65.77 -42.35 90.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.843 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.5 tp -59.23 -48.59 81.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.185 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.2 m -62.64 -22.39 66.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.002 0.43 . . . . 0.0 110.204 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.36 -17.9 26.47 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.562 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.58 11.56 74.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.6 -17.84 63.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.5 pt -127.41 136.65 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 110.502 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.95 -28.84 62.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.201 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.13 155.12 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.792 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.22 138.27 51.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 109.978 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.15 103.21 14.58 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.23 0.538 . . . . 0.0 110.599 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.67 25.78 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.66 152.76 40.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.54 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.24 -53.97 30.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.06 -49.02 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.365 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.81 84.22 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 110.837 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.78 1.1 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 66.6 m -57.64 -46.13 84.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.7 tt0 -46.32 -42.31 14.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.338 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.1 -61.87 0.48 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.762 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.0 t80 -40.38 -71.19 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.584 0.23 . . . . 0.0 111.214 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -62.28 -40.81 97.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 86.8 tttt -59.86 -2.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.579 0.704 . . . . 0.0 110.494 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.7 mt-30 -126.5 141.78 41.09 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.832 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -43.43 -14.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.861 2.374 . . . . 0.0 112.328 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' GLN . 90.0 t -62.87 -43.03 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.589 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.86 -33.44 85.38 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.38 96.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.731 0.301 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -65.79 -34.95 79.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.503 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.8 m-85 -156.64 143.25 18.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.737 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -176.16 99.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.746 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.5 167.01 30.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.23 55.39 3.09 Favored Glycine 0 C--O 1.225 -0.413 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.11 -116.83 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.05 134.65 36.57 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.46 2.107 . . . . 0.0 111.893 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.3 p -124.03 -108.63 0.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.542 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.43 165.01 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.637 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.4 tttt 154.61 155.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.178 0.924 . . . . 0.0 110.665 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -81.27 118.92 23.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.3 -19.1 62.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.45 -31.41 72.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.494 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -60.89 -44.4 97.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.736 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.29 8.61 16.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.722 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.22 -153.81 49.97 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 76' ' ' ILE . 12.8 p -70.65 -25.72 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.99 -126.59 1.62 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.6 p -132.21 160.24 36.7 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.26 -162.93 25.27 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.06 140.22 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.419 . . . . 0.0 110.591 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.72 108.8 3.48 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.3 mt -118.22 159.72 22.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.944 0.402 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.73 148.79 25.28 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.38 64.26 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -40.57 -22.51 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.0 110.739 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.77 51.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.748 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -64.32 -46.62 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.23 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.16 -47.09 38.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 44' ' ' ILE . 63.6 tp -62.05 -43.52 98.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.53 -43.13 99.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.799 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.56 -37.65 73.47 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.696 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.29 -77.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -28.72 -45.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.846 0.355 . . . . 0.0 110.518 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 212' ' ' ALA . 87.9 m-20 -63.66 -45.81 88.45 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.02 -44.11 97.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.33 92.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.148 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.95 -43.81 98.16 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.15 91.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.087 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -64.05 -43.59 95.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.859 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.24 -38.52 71.19 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -38.98 77.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.27 -45.55 90.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.1 p-10 -88.73 -0.71 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.21 20.44 71.19 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.5 -46.22 87.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.494 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 71.0 t80 -62.35 -56.2 20.65 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.244 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.48 -40.26 78.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.059 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.32 -47.92 83.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.491 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.08 -40.77 96.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -61.11 -49.14 78.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.01 -35.74 73.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.503 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.49 -51.39 36.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.584 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 8.8 m-85 -62.01 -46.3 89.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.52 154.92 33.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.49 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -98.31 96.89 8.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.45 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.63 -164.67 2.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.555 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -121.96 108.92 13.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.734 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.5 m -63.45 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.418 ' N ' HG23 ' A' ' 238' ' ' VAL . 91.3 m-85 -58.82 -42.38 89.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.288 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -62.96 -37.93 95.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.712 0 CA-C-O 117.905 -1.497 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.85 164.26 57.51 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.642 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.08 143.82 99.13 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.625 2.217 . . . . 0.0 112.309 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.09 -40.6 90.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.578 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.21 143.7 38.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.447 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.33 129.03 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.854 0.359 . . . . 0.0 110.466 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.57 117.56 34.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.372 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 141.78 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.973 0.416 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.67 106.74 2.12 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.8 m -128.94 120.06 25.44 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.634 -0.333 . . . . 0.0 111.107 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 26.9 t0 -112.41 94.67 28.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.079 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.309 -1.538 0 C-N-CA 122.463 2.109 . . . . 0.0 112.205 179.12 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 . . . . . 0 C--O 1.227 -0.126 0 CA-C-O 121.005 0.431 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.1 mt -66.85 -39.98 84.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.793 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.0 -37.01 81.02 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.787 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.91 -44.84 84.02 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.33 -45.53 87.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.02 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -54.61 -54.36 42.55 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.51 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.9 -37.53 63.87 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.475 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.31 -43.11 74.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.588 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 52.0 m -54.25 -44.0 71.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.035 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -64.01 -47.93 78.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.006 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.55 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.979 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.11 -18.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.24 52.33 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.68 170.23 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.19 141.74 28.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.101 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.57 132.19 56.56 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.78 126.6 42.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.389 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.93 136.69 34.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.31 129.18 64.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.93 139.66 56.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.779 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.4 p30 175.52 135.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.52 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.1 Cg_endo -68.65 143.71 57.51 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.644 2.229 . . . . 0.0 112.461 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.893 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -40.62 -54.78 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.032 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.43 1.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.89 -20.97 18.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.893 HD12 HD23 ' A' ' 55' ' ' LEU . 54.6 mt -63.92 -42.48 97.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.791 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.706 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.88 -57.1 26.22 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.711 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -54.93 -42.94 64.2 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.615 2.21 . . . . 0.0 111.214 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.52 -44.88 89.7 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.749 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.75 -44.48 90.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.75 -41.02 96.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.484 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.06 11.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.97 12.32 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.77 -33.83 76.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.06 154.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.261 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -91.85 -20.79 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.02 160.53 21.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.637 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 58' ' ' LEU . 96.1 mt -116.1 127.76 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.052 0.453 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.2 ttp -129.12 107.42 9.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.334 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.501 ' OG ' HD21 ' A' ' 55' ' ' LEU . 38.3 t -162.72 -176.91 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -63.89 -16.22 60.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.639 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.4 tp -36.99 122.75 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.491 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.94 155.88 23.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.712 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.5 pt -105.36 149.46 8.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.347 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.7 p -150.49 152.76 34.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.775 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.02 -47.66 53.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 110.589 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.26 -39.93 70.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.807 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.639 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -38.1 75.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.81 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.75 -27.65 66.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.078 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.08 -51.1 7.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.039 0.447 . . . . 0.0 110.73 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.15 -167.57 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.135 0.493 . . . . 0.0 110.498 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.93 147.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HG22 ' A' ' 76' ' ' ILE . 74.3 m-85 -130.35 150.49 51.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -165.28 -150.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.455 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.2 m-20 42.51 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.04 120.99 0.11 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.499 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -79.95 -72.51 0.4 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.932 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -147.81 165.11 31.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.641 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.05 127.56 32.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.387 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.19 66.99 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.591 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.27 -106.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.0 p -159.23 167.44 29.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.616 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.85 146.79 23.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 0.0 110.415 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.47 135.84 42.3 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.773 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.83 110.98 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.75 164.44 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.59 148.43 24.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.06 -28.24 50.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.248 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.09 -41.35 87.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.252 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 t -102.38 122.28 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.262 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.01 109.52 19.89 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.067 0.46 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.05 129.76 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.705 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.37 159.0 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.554 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.6 Cg_endo -60.3 90.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.74 2.293 . . . . 0.0 111.884 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.3 m -169.05 141.29 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.543 0.527 . . . . 0.0 110.73 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.83 -33.52 62.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.246 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.493 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.15 -62.57 1.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -56.02 -22.0 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.12 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.46 -26.19 55.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.317 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.2 47.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.422 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.77 -15.67 30.27 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.14 150.85 24.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.429 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.55 134.82 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 110.259 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.58 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.663 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.76 137.44 13.78 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.47 161.49 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.127 0.489 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.4 tp -92.51 119.3 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.528 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.13 156.7 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.717 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.54 53.51 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -148.41 167.3 25.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.294 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 74.8 p -70.59 -31.27 68.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.468 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -58.22 -54.97 40.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.431 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -56.27 -55.74 29.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.74 -51.24 70.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.818 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.4 t80 -62.02 -44.09 97.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.78 -44.24 98.15 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.843 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.38 2.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.09 -50.98 17.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.025 0.44 . . . . 0.0 111.578 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.23 12.74 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.306 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.768 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.37 0.47 Allowed Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.432 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.25 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.747 2.298 . . . . 0.0 111.951 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -8.85 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.484 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.39 35.79 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.48 137.52 41.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.969 0.414 . . . . 0.0 110.49 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.42 130.48 34.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.343 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.22 138.57 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.45 133.61 68.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.042 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 126.77 42.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -110.14 153.9 24.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.286 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.22 6.68 28.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.13 130.2 5.83 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.97 -45.9 80.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.2 -23.78 63.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.64 -36.72 85.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.88 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.51 -37.55 87.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.67 -41.85 95.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 -42.29 89.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.572 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.7 tp -59.21 -48.53 81.25 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.134 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.5 -22.33 66.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 0.0 110.198 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.57 -17.77 26.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.603 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.87 74.4 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.86 -18.22 63.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.612 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.5 pt -126.71 135.98 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.479 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.32 -29.34 63.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.269 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.17 155.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.95 138.85 52.22 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.97 0.415 . . . . 0.0 109.924 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -86.75 102.71 14.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.216 0.531 . . . . 0.0 110.783 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 96' ' ' ARG . 51.0 tt0 -131.94 164.58 25.82 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.386 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.471 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.55 153.27 40.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.526 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.67 -54.25 25.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.237 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.6 t -59.97 -49.08 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.84 84.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.941 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.72 1.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.455 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.444 ' OG ' HD12 ' A' ' 173' ' ' LEU . 67.0 m -57.82 -46.37 84.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.32 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.6 tt0 -46.1 -41.87 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.411 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.25 -62.11 0.48 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.707 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.2 t80 -40.3 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.786 -0.244 . . . . 0.0 111.184 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -62.14 -40.71 96.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.55 -2.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.422 0.629 . . . . 0.0 110.394 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.0 mt-30 -126.21 141.6 40.24 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.799 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.39 -14.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.792 2.328 . . . . 0.0 112.335 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 175' ' ' GLN . 91.0 t -63.04 -43.04 98.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.88 -33.46 85.49 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.06 -41.37 96.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.0 110.444 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -65.74 -34.81 79.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.465 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -156.92 143.53 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.734 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.19 99.38 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.4 m-85 -158.9 167.01 30.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.632 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.9 55.96 3.02 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.17 -116.92 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 134.76 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.502 2.135 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.2 p -124.23 -108.5 0.33 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.24 164.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.213 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.5 tttt 154.68 155.11 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 124.041 0.838 . . . . 0.0 110.706 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -81.04 118.5 22.55 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.777 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -70.5 -18.81 62.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.51 -31.61 72.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.4 mt -60.93 -44.4 97.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.702 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.07 8.33 16.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.788 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.66 -153.52 50.42 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.659 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.5 p -70.8 -25.76 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.554 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.77 -126.98 1.68 Allowed Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.8 p -132.21 160.37 36.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.418 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.98 -161.65 23.73 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.94 140.06 33.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.925 0.393 . . . . 0.0 110.611 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.73 108.71 3.48 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -117.45 159.36 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.251 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.31 148.84 25.43 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.86 -48.46 64.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.69 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -40.85 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -72.9 51.51 0.29 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.895 0.379 . . . . 0.0 110.794 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.46 -46.3 83.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.06 -47.22 38.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.026 0.441 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.14 -43.46 98.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.464 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.7 -43.02 99.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.825 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -37.44 73.52 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.48 -77.47 0.11 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.979 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -28.52 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.3 m-20 -63.5 -45.92 88.47 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.83 -43.94 97.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.929 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.1 91.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.083 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.28 91.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.051 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.73 -43.69 95.77 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.26 -38.48 71.22 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.57 -39.04 77.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.987 0.423 . . . . 0.0 110.271 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.39 91.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.649 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.3 p-10 -89.02 -0.5 57.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.87 20.75 70.81 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.48 -46.27 87.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.499 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 73.2 t80 -62.3 -56.46 18.22 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.08 -40.42 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.176 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.53 -47.89 83.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.485 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.11 -40.96 97.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.44 77.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.501 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.93 -35.74 73.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.63 -51.45 34.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.97 -45.97 91.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.6 m-85 -155.05 154.76 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.522 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.2 p-10 -97.99 96.0 7.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.439 . . . . 0.0 110.526 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.0 -164.7 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.545 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.14 108.98 13.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.4 m -63.54 -40.64 89.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.358 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.428 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.4 m-85 -58.53 -42.6 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.39 -37.67 95.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.689 0 CA-C-O 117.848 -1.529 . . . . 0.0 111.021 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 164.13 63.33 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.643 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.05 143.6 99.19 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 122.591 2.194 . . . . 0.0 112.313 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.43 -41.13 89.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.562 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -137.93 139.44 39.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.417 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.82 121.36 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.675 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.93 118.82 32.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.178 0.513 . . . . 0.0 110.154 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.56 138.69 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.96 105.75 2.15 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.2 m -129.04 120.61 26.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 122.69 -0.3 . . . . 0.0 111.018 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.6 t70 -114.42 92.9 29.77 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.502 2.135 . . . . 0.0 112.07 179.244 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.469 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.9 t0 . . . . . 0 C--O 1.227 -0.098 0 CA-C-O 120.97 0.414 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.01 -40.86 83.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.873 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -60.91 -37.26 81.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.829 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.88 -45.08 87.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.12 -48.54 78.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.982 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -53.0 -54.66 31.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.33 -39.88 61.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.864 0.364 . . . . 0.0 110.298 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.67 -41.94 78.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 110.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.44 -45.19 69.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.084 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.09 -46.84 82.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.042 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -60.01 -42.28 93.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.16 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.32 -17.23 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.72 53.21 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.489 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.26 171.56 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.11 142.61 27.5 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.018 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.45 131.15 56.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.24 126.94 43.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.411 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -93.73 134.66 35.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.06 127.81 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.262 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.63 137.8 57.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.776 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.05 131.53 0.17 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.555 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.7 Cg_endo -68.01 144.74 65.15 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.729 2.286 . . . . 0.0 112.435 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 58' ' ' LEU . 82.4 mt -40.33 -55.55 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.42 1.94 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.04 -20.94 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.249 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -63.8 -42.42 97.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.596 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.721 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.2 -56.99 25.98 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.806 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.48 -42.41 68.26 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.59 2.193 . . . . 0.0 111.179 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m -58.7 -44.89 90.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.931 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.7 tp -59.05 -44.06 91.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.35 -40.72 96.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.956 0.408 . . . . 0.0 110.452 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.04 2.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.514 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.19 12.08 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.463 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -35.5 80.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.481 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -122.34 152.89 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.264 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.2 -22.18 19.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.61 155.99 27.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.0 129.28 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.34 106.52 8.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.395 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.706 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -158.95 178.43 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.636 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -65.4 -15.35 62.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 43.9 tp -34.82 124.65 0.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.01 153.86 25.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.645 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.637 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.8 pt -104.84 148.86 8.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.297 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -149.36 152.13 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.854 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.85 -47.28 51.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.507 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.32 -39.83 70.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.735 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.94 -37.91 79.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.84 -38.95 76.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.816 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.89 -27.42 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.096 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.42 -50.84 7.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.048 0.451 . . . . 0.0 110.655 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.18 -168.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.131 0.491 . . . . 0.0 110.456 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.43 147.66 30.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.007 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.3 m-85 -129.88 149.9 51.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.563 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.7 t -163.09 -153.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.592 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 92.8 m-20 41.34 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.945 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.62 121.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.346 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.429 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.9 mt -75.09 -68.7 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.34 167.49 26.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.76 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.5 123.55 29.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.218 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.55 68.32 0.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.47 -104.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.35 165.7 32.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.741 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.34 146.35 22.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 0.0 110.443 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.9 mt -101.08 136.12 41.44 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.988 0.423 . . . . 0.0 110.81 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.8 110.41 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.2 164.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.71 148.48 23.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.988 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.6 -27.66 40.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.226 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.29 -41.83 89.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.316 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.5 122.14 43.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.94 109.35 19.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.424 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.9 129.65 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.772 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.25 159.0 33.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.523 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.46 89.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.685 2.256 . . . . 0.0 111.904 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.6 m -169.08 140.31 2.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.31 -32.38 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.0 tp10 -57.34 -62.92 1.43 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -55.39 -22.41 19.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.62 -25.8 54.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.67 132.67 46.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.95 -16.13 28.93 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.03 151.1 23.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.84 135.37 37.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.35 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.74 136.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.648 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 137.79 13.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 56.0 t -130.51 161.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.089 0.471 . . . . 0.0 110.336 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.1 tp -92.37 118.16 30.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.535 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.03 157.75 1.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.67 50.98 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.2 p -149.68 168.89 22.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.5 p -73.53 -27.25 61.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -60.45 -55.45 33.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.48 -55.1 37.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.583 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.05 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.705 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.8 t80 -62.08 -43.91 97.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.04 -44.46 97.75 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.41 -14.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.784 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.23 -34.36 2.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.55 -50.54 17.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.18 12.48 36.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.239 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.79 -55.51 0.47 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.332 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.33 25.66 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 111.952 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.76 -9.0 59.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.32 37.65 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.598 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.51 129.87 34.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.333 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 138.29 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.923 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.25 133.21 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 109.946 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.46 127.63 43.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -110.7 153.89 24.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -106.91 7.13 29.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.72 130.73 6.06 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.405 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.95 -45.92 80.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.768 0.318 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.25 62.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.7 -36.84 85.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.543 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.97 -46.79 87.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.138 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.507 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.7 m-85 -64.45 -37.65 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.348 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.86 -42.16 97.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.023 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.99 -43.38 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.96 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.578 ' HB2' HD11 ' A' ' 158' ' ' ILE . 40.8 tp -58.98 -48.15 82.6 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.79 -22.32 66.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.955 0.407 . . . . 0.0 110.164 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.78 -18.21 25.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.07 11.92 72.04 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.17 -18.24 63.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.602 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.578 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.9 pt -127.02 135.92 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.54 -28.11 62.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.43 155.71 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.49 50.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 109.947 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.94 103.14 14.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.264 0.555 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.65 165.14 25.15 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.382 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.475 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -72.79 153.05 41.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 110.634 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.4 -54.64 22.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.39 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.27 -48.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.618 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.08 89.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.862 0.363 . . . . 0.0 110.83 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.47 -63.27 1.18 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.445 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.1 m -59.28 -47.75 84.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.916 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.98 -37.44 20.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.195 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.08 -66.36 0.55 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.1 t80 -40.27 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.663 0.268 . . . . 0.0 111.194 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.35 -40.13 93.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.78 -2.84 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.443 0.64 . . . . 0.0 110.475 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 173' ' ' LEU . 36.3 mt-30 -123.37 148.79 56.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.828 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.66 -19.97 3.95 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.892 2.395 . . . . 0.0 112.148 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.14 -42.55 93.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.99 -33.21 84.86 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.72 -41.26 94.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.695 0.283 . . . . 0.0 110.399 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.59 -33.93 77.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.327 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.35 142.66 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.732 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.19 99.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.754 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.17 166.76 30.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.713 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.87 56.54 2.72 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.44 -118.27 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.41 135.68 32.48 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.511 2.14 . . . . 0.0 111.918 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.7 p -125.41 -107.79 0.32 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.591 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -166.14 165.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.334 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.671 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 156.78 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 123.983 0.802 . . . . 0.0 110.665 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.84 117.24 22.58 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.5 mp0 -71.13 -18.89 62.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.85 -32.59 74.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.568 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -60.96 -44.54 97.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.71 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.4 m-85 -114.03 9.63 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.769 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.0 -154.76 52.38 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.39 -25.1 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.527 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.22 -124.32 1.32 Allowed Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.8 p -129.32 156.19 44.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.707 0.289 . . . . 0.0 110.33 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.6 -169.61 30.42 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.1 137.44 33.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.46 108.2 3.27 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.52 159.39 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.955 0.407 . . . . 0.0 110.206 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.66 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.84 149.64 24.69 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.89 -48.2 64.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.3 tp10 -38.23 -25.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.56 52.26 0.2 Allowed 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.677 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -64.56 -45.15 88.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.8 -47.3 31.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.26 -43.94 97.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.454 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.24 -42.92 99.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.724 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -36.23 70.28 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.45 -77.51 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 44' ' ' ILE . 97.0 mt -28.46 -46.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.356 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.33 -44.96 89.91 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.636 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.96 -43.66 98.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.962 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.21 93.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -43.57 98.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.28 92.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.63 -42.74 98.13 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.53 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.31 -38.42 77.05 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.86 -39.99 79.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.188 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -45.86 93.03 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.53 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.1 p30 -86.68 1.33 52.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.489 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.42 19.71 60.27 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 69.7 m -58.35 -45.63 87.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.429 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.2 t80 -63.62 -58.01 8.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.438 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.44 78.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.349 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.6 -48.53 80.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.565 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.07 -41.49 98.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.327 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.19 74.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.73 -35.16 72.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.18 -50.97 27.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.481 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.09 -45.5 93.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.2 m-85 -153.27 155.16 36.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.7 p-10 -97.26 94.86 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.504 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -152.71 -166.43 2.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.86 110.37 15.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.799 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.1 m -63.55 -40.64 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.426 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.43 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.9 m-85 -56.62 -43.83 80.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.46 94.89 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.414 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.642 0 CA-C-O 117.895 -1.503 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.88 164.27 61.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.718 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.83 143.66 99.41 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.33 -41.02 90.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.622 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.42 139.69 39.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.56 121.43 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.07 118.51 31.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.067 0.46 . . . . 0.0 110.193 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.62 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.362 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.88 105.47 2.12 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -128.77 120.37 26.26 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.676 -0.308 . . . . 0.0 110.909 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.7 t70 -114.13 92.41 26.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.454 2.103 . . . . 0.0 112.187 179.209 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.9 0.381 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.25 -40.06 82.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.98 -37.64 83.17 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.959 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.71 -45.25 87.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.028 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.1 -48.51 78.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.872 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -52.85 -54.81 29.11 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.353 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -51.96 -39.99 60.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.41 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.82 -41.77 78.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.752 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.3 m -53.74 -45.08 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.063 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.13 -47.03 81.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.2 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.6 -42.38 92.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.89 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.37 -17.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.62 53.02 4.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -147.03 171.2 15.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.92 142.51 27.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.35 131.22 56.83 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -127.25 126.91 43.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.39 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.4 134.73 35.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.492 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.08 127.53 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.273 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.55 137.87 57.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.74 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.93 131.76 0.16 Allowed Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.593 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 57' ' ' ALA . 44.2 Cg_endo -68.26 145.12 65.04 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.743 2.295 . . . . 0.0 112.382 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 81.7 mt -40.44 -55.58 2.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 111.074 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.27 -26.43 1.98 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -21.0 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.183 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 59.3 mt -63.98 -42.42 97.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.619 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -57.47 23.48 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 123.952 0.783 . . . . 0.0 109.555 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 43.4 Cg_exo -55.01 -42.39 69.62 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.628 2.219 . . . . 0.0 111.36 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.69 -44.82 90.38 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.959 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.651 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.4 tp -59.05 -44.02 91.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.255 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.55 -40.49 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.437 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.06 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.567 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.29 12.07 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.66 -35.39 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 pt -122.39 153.0 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.231 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.32 -22.16 19.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.143 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.53 155.82 27.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.656 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.11 129.03 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.15 106.67 8.5 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.329 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.707 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -159.11 178.67 9.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.43 -15.28 62.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -34.95 124.48 0.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.62 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.2 p -81.91 153.97 26.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.634 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -104.74 148.66 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.214 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.2 152.15 35.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.73 -47.43 50.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.31 -39.85 70.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.786 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -69.1 -37.71 78.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.824 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.83 -38.87 76.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.965 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.76 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.199 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.2 -50.9 7.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.716 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.07 -168.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.102 0.477 . . . . 0.0 110.481 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.3 147.73 29.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.549 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.0 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.568 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.18 -153.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.503 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.511 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.9 m-20 41.23 20.32 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.027 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.64 0.2 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.468 0.48 . . . . 0.0 110.419 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.425 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.2 mt -75.37 -68.81 0.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -178.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.9 p90 -150.47 167.6 26.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.37 123.7 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.301 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.465 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.91 68.49 0.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.729 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.71 -104.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.5 p -159.53 165.73 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.582 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.53 145.98 21.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.178 0.513 . . . . 0.0 110.443 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.84 136.27 40.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.56 111.01 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.16 165.09 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.921 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.0 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.01 -28.47 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.237 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.84 -41.98 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.266 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -101.92 121.76 42.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.212 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.87 109.92 19.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.422 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.2 mt -127.0 129.62 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.56 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -108.17 154.32 41.34 Favored Pre-proline 0 C--N 1.333 -0.124 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.648 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.33 92.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.819 2.346 . . . . 0.0 111.768 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.7 m -171.19 144.09 2.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 123.637 0.586 . . . . 0.0 110.82 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.3 -33.58 61.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.275 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 108' ' ' THR . 47.7 tp10 -58.02 -62.48 1.79 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.07 -22.33 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.08 -25.68 55.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.54 133.11 46.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.454 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.0 -17.16 28.74 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.89 151.38 23.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 110.524 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -96.27 136.23 37.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.303 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.7 136.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.667 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 139.78 14.86 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.83 161.84 40.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.327 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.4 tp -92.72 118.05 30.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.709 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.47 157.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.584 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.68 51.45 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.7 p -149.65 168.58 23.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.6 p -74.33 -25.58 59.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.497 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.01 -55.8 28.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.537 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.04 -54.29 48.42 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.498 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.21 -51.31 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.616 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.45 -43.73 98.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.057 0.456 . . . . 0.0 110.458 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.63 -44.54 97.81 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.68 -14.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 0.0 110.745 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.07 -34.77 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.565 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.37 -50.43 18.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 111.516 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.16 12.79 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.187 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.09 -55.62 0.46 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.08 -10.44 25.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.783 2.322 . . . . 0.0 111.919 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.59 -8.97 59.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.504 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.63 33.41 38.38 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.31 138.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.031 0.443 . . . . 0.0 110.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.88 129.78 35.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.2 138.9 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.58 132.05 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.999 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.9 t -98.51 130.61 45.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.81 156.58 21.76 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.06 6.89 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.642 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.76 130.75 6.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.42 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.89 -46.01 79.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 110.429 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.81 -23.25 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.451 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.71 -36.58 84.75 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.61 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.19 -47.32 84.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.054 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.519 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.83 -37.97 89.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.0 -42.13 97.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.03 -45.4 89.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.56 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.8 tp -58.06 -48.28 80.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.327 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.2 m -63.12 -22.94 67.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.018 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.53 -18.73 24.75 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.503 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.13 70.34 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.46 -18.16 63.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.593 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.6 pt -127.88 136.88 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.069 0.462 . . . . 0.0 110.434 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.74 -27.46 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.456 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.72 155.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.851 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.12 136.94 49.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.076 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.47 103.33 14.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 110.76 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.71 23.91 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.409 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.466 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.98 152.45 41.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.506 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.27 -54.55 23.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' CG ' ' A' ' 91' ' ' TYR . 74.3 t -60.28 -49.01 85.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.342 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.77 88.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 110.76 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.21 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -59.24 -47.87 83.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.978 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.13 -37.5 22.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.125 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.84 -66.23 0.56 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.662 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.9 t80 -40.69 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.561 0.219 . . . . 0.0 111.092 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -61.1 -40.25 93.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.03 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -60.53 -2.73 0.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.448 0.642 . . . . 0.0 110.386 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' A' ' 173' ' ' LEU . 36.0 mt-30 -122.98 147.41 51.31 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 122.099 -0.376 . . . . 0.0 110.781 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.76 -19.7 2.32 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.864 2.376 . . . . 0.0 112.306 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.55 -42.91 95.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.531 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.17 -33.26 85.32 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.41 -41.41 93.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.77 0.319 . . . . 0.0 110.479 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.3 m-20 -65.52 -33.59 76.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.1 m-85 -155.98 142.68 18.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.9 99.52 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.2 m-85 -159.24 167.46 28.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.631 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.34 56.3 2.87 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.02 -118.03 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.3 135.39 31.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.48 2.12 . . . . 0.0 112.051 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.15 -107.93 0.33 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.555 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.75 165.35 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.053 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.652 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.32 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 O-C-N 124.34 1.025 . . . . 0.0 110.607 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.15 117.67 22.48 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.76 -18.86 62.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.89 -32.38 73.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.504 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -60.79 -44.74 96.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.685 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.467 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.6 m-85 -113.97 9.66 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.722 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.22 -154.92 52.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.634 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.51 -24.74 25.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.02 -124.12 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.43 156.33 44.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 110.289 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.53 -169.53 30.26 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.37 137.26 33.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.29 108.21 3.26 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -123.46 159.31 29.31 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.278 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.651 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.9 mtm180 -86.61 149.62 24.8 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.87 -48.34 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.554 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -37.95 -25.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.826 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.45 52.25 0.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.649 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -45.69 86.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.152 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.49 -47.3 34.06 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.114 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.35 -43.74 98.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.747 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.86 -36.66 70.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.84 -77.15 0.11 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.89 HD21 HD11 ' A' ' 44' ' ' ILE . 97.5 mt -28.91 -46.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.31 -44.99 89.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.802 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.9 -43.73 98.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.36 93.81 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.18 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.32 -43.35 99.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.58 -39.08 92.57 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.73 -42.96 97.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.87 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.527 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.4 mtp -57.82 -38.21 75.16 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.02 -39.74 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.1 0.476 . . . . 0.0 110.26 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.0 92.43 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.443 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.2 p30 -86.43 1.26 51.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.69 19.57 60.73 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 70.3 m -58.28 -45.92 87.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.425 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 79.7 t80 -63.53 -57.59 9.7 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.397 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.97 -41.64 78.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.103 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.57 -48.81 79.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.505 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.62 -41.86 98.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.865 0.364 . . . . 0.0 110.566 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.78 -49.98 75.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -35.02 72.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.376 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.14 -50.93 28.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.418 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.24 -45.37 93.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.536 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.5 m-85 -154.26 155.62 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.6 97.17 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.974 0.416 . . . . 0.0 110.468 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -154.52 -166.02 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.417 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.23 110.53 15.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.9 m -63.39 -40.32 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.541 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.417 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.3 m-85 -58.54 -42.73 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.312 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.5 -37.15 94.35 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.871 -1.516 . . . . 0.0 110.917 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.48 164.26 62.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.82 99.43 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.24 -40.46 90.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.546 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.46 142.37 37.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.419 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -109.36 128.08 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.942 0.401 . . . . 0.0 110.483 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.68 117.55 34.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.348 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.58 139.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.425 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.45 105.44 2.16 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.6 m -128.11 119.33 25.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.75 -0.265 . . . . 0.0 111.077 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.4 t70 -113.53 92.58 24.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.308 -1.591 0 C-N-CA 122.484 2.123 . . . . 0.0 112.12 179.183 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.478 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.8 t0 . . . . . 0 C--O 1.227 -0.09 0 CA-C-O 120.917 0.389 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -69.33 -40.64 80.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.931 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.2 -37.34 82.64 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.744 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.37 -43.93 84.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.151 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.97 -45.14 91.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.13 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.54 -53.95 51.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.491 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.75 -37.72 59.87 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.945 0.403 . . . . 0.0 110.419 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.45 -41.9 75.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.4 m -54.16 -44.69 71.68 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.115 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.77 -47.59 80.34 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.53 -41.27 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.153 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.0 HD11 HD21 ' A' ' 213' ' ' LEU . 96.8 mt -76.27 -17.75 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.78 52.72 4.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -145.96 170.51 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.33 141.15 28.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.163 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.13 131.46 56.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.655 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -128.12 127.76 43.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.509 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.51 136.01 35.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.526 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.2 t -129.87 128.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.06 139.08 58.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.3 131.63 0.15 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.47 145.09 63.63 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.688 2.258 . . . . 0.0 112.417 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.882 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.11 -56.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.46 -26.67 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.146 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.13 -20.78 18.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.184 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.882 HD12 HD23 ' A' ' 55' ' ' LEU . 58.5 mt -63.99 -42.51 97.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.619 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.712 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.36 -56.96 25.72 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.821 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.2 Cg_exo -54.79 -43.71 56.65 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.608 2.205 . . . . 0.0 111.353 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.59 -44.71 89.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.84 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.09 -44.24 87.52 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.153 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.58 -40.34 95.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.966 0.412 . . . . 0.0 110.517 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.29 11.22 1.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.597 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.14 11.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.51 -34.28 77.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.489 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.87 153.47 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.24 -20.81 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.11 157.25 25.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.595 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.52 127.29 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.105 0.478 . . . . 0.0 110.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.478 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.45 106.3 8.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.383 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.624 ' OG ' HD21 ' A' ' 55' ' ' LEU . 48.3 t -159.9 -178.54 7.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.35 -15.49 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.7 tp -37.48 123.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 11.1 p -83.21 156.34 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.5 pt -105.13 149.41 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.317 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -150.42 152.4 34.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.754 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.04 -47.99 53.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 110.653 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.59 -39.58 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.803 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.8 -37.56 79.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.35 -37.34 75.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.24 -27.52 67.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.165 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.35 -51.54 7.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.598 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -138.46 -168.82 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 121.062 0.458 . . . . 0.0 110.468 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.72 29.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD1' HG22 ' A' ' 76' ' ' ILE . 71.0 m-85 -129.74 149.89 51.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.3 t -164.18 -151.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.5 m-20 42.77 19.32 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.815 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -28.38 120.5 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.04 -69.83 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 46.5 p90 -149.26 166.29 29.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.57 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.22 121.19 26.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.289 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.459 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.44 69.6 1.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.89 -104.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.25 165.72 32.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.5 146.22 22.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.441 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.26 136.2 41.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.786 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.403 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.75 110.71 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.63 165.11 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.854 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.46 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.031 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.99 -27.99 48.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.232 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.01 -41.74 88.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -102.35 122.35 44.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.237 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.54 109.56 19.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.43 129.88 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.81 34.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.564 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.64 89.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.773 2.316 . . . . 0.0 111.918 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -169.29 140.76 2.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.744 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.69 -32.61 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.228 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.5 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.08 -62.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.273 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.75 -22.17 22.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.925 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.73 -25.8 53.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.271 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 132.86 46.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.456 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.72 -15.56 30.56 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.53 151.39 23.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 110.45 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.21 135.58 37.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.368 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.78 136.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.52 137.72 13.88 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.44 161.71 39.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.08 0.467 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.548 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.9 tp -92.39 117.9 30.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.78 157.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.71 50.73 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.59 168.75 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.431 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 69.3 p -73.15 -27.94 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.401 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.01 -55.37 34.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -56.21 -55.34 34.38 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.06 -50.99 71.52 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.587 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 67.3 t80 -61.94 -43.98 97.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.043 0.449 . . . . 0.0 110.474 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.97 -44.44 97.8 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.41 -14.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.7 tt0 -124.96 -34.76 2.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.707 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.587 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.38 -50.51 18.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 111.471 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -99.14 12.88 34.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.184 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.1 -55.58 0.46 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.376 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.5 25.75 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.777 2.318 . . . . 0.0 111.957 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.37 -8.97 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.47 37.25 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.74 138.26 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.9 0.381 . . . . 0.0 110.527 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.79 130.18 34.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.329 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.6 138.12 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.841 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.02 133.44 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.08 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.18 127.15 42.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.725 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 153.53 25.0 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.03 7.07 29.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.654 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.17 5.84 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.93 -45.86 80.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.317 . . . . 0.0 110.431 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.58 -23.5 62.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.522 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.78 -36.45 84.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.52 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.22 -46.87 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.04 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.45 -37.44 87.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.393 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.4 p -60.92 -41.94 97.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.177 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.64 -42.93 90.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.795 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.582 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.7 tp -58.63 -48.58 80.53 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.51 -22.18 66.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.402 . . . . 0.0 110.239 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.01 -17.75 25.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.21 73.3 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.33 -17.96 63.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.899 0.38 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 153' ' ' LEU . 32.9 pt -126.92 136.14 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.63 -29.02 63.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.07 155.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.82 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.46 137.58 50.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.025 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -85.74 102.72 13.89 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.207 0.527 . . . . 0.0 110.799 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.0 164.91 25.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.393 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.49 153.12 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.5 mt-10 -66.21 -54.54 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.05 -49.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.549 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.08 88.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.803 0.335 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.98 -63.73 1.08 Allowed 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.538 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.442 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -58.51 -47.42 84.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.776 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -49.3 -38.17 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.14 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.6 -66.11 0.56 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.35 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.615 0.245 . . . . 0.0 111.151 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.25 -40.03 92.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.71 -2.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.446 0.641 . . . . 0.0 110.521 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 177' ' ' VAL . 60.5 mt-30 -124.44 141.6 38.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.754 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.86 -15.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.825 2.35 . . . . 0.0 112.279 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.0 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.596 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.87 80.91 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.42 96.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.302 . . . . 0.0 110.517 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -66.07 -34.47 78.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.452 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.3 m-85 -156.96 143.27 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.75 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.4 pttt -176.92 99.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.006 0.431 . . . . 0.0 110.725 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.22 167.66 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.98 55.76 3.05 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.62 -117.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.44 135.34 32.74 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.5 2.133 . . . . 0.0 112.008 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.6 p -125.38 -107.7 0.32 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.486 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.666 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.45 165.59 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.244 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.39 156.61 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.995 0.81 . . . . 0.0 110.642 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -83.16 117.85 23.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.027 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.88 -16.73 62.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.43 -32.89 74.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.543 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.7 mt -61.02 -44.51 97.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.764 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.5 7.82 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.77 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.16 -154.16 50.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.654 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.92 -25.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.862 0.363 . . . . 0.0 110.556 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.459 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.57 -126.01 1.55 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.81 159.79 37.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 110.461 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.5 -162.41 24.61 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.503 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.59 141.07 31.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.021 0.439 . . . . 0.0 110.525 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.22 111.39 3.9 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -120.44 160.58 22.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.394 . . . . 0.0 110.235 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 149.05 24.98 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.92 -49.16 63.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.93 -22.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.004 0.43 . . . . 0.0 110.82 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.06 52.13 0.24 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.764 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.52 -46.02 84.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.18 34.71 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.1 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.2 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.513 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.54 -42.86 99.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.875 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.68 -37.41 73.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.848 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.0 HD21 HD11 ' A' ' 44' ' ' ILE . 87.2 mt -28.45 -45.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.465 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.7 m-20 -63.55 -45.63 89.66 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.33 -43.72 98.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.016 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.33 92.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.184 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.2 -43.46 98.85 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.078 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.25 92.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.162 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.75 -43.15 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.862 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.1 mtp -56.49 -38.42 71.72 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -70.04 -38.82 75.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.0 110.352 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.44 92.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.29 0.91 55.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.683 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.11 20.09 66.66 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -57.82 -46.54 84.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.8 t80 -63.34 -57.5 10.15 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -41.88 78.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.309 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.26 -48.74 79.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.518 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.57 -41.66 97.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.426 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.93 -49.94 75.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.602 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -35.54 72.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.451 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.84 -50.92 30.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.2 -45.53 92.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.58 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.5 m-85 -154.05 155.41 35.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.7 p-10 -98.08 97.66 9.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.396 . . . . 0.0 110.527 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -154.63 -165.51 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.8 t0 -122.72 109.54 14.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.1 m -63.77 -40.61 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.503 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.9 m-85 -56.55 -43.97 80.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.319 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.54 93.55 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 117.909 -1.495 . . . . 0.0 110.939 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.08 164.44 58.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.683 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.97 143.48 99.35 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.723 2.282 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.25 -40.2 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.557 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.56 36.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.443 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.46 128.23 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.423 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.0 mtp180 -103.66 118.7 37.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.34 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.64 138.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.37 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.12 99.9 1.58 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.1 m -123.58 118.76 28.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.759 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.3 t70 -113.67 92.86 25.8 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.547 0 C-N-CA 122.537 2.158 . . . . 0.0 111.913 179.439 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.1 t0 . . . . . 0 C--O 1.23 0.027 0 CA-C-O 120.974 0.416 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.19 -40.59 80.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.979 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 47.8 m-20 -60.43 -37.91 82.41 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.274 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -66.21 -43.71 85.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 110.543 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.35 -44.27 92.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.171 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -56.77 -53.48 57.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.47 -37.79 63.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.051 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.21 -42.24 76.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.994 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.36 -44.37 72.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.215 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.27 -47.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.365 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.77 -40.84 89.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.126 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.002 HD11 HD21 ' A' ' 213' ' ' LEU . 97.0 mt -76.61 -17.73 14.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.83 52.36 4.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.653 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.4 170.25 16.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.831 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.26 140.64 29.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m -116.83 131.17 57.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -128.19 128.0 43.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.523 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.31 136.19 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.542 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.54 128.15 65.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.43 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.5 139.07 57.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.513 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 173.97 132.92 0.12 Allowed Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.1 Cg_endo -68.35 144.74 63.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.703 2.269 . . . . 0.0 112.574 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.94 HD23 HD12 ' A' ' 58' ' ' LEU . 76.1 mt -40.09 -55.94 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.986 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.9 -26.48 1.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.862 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.26 -20.62 19.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.918 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.94 HD12 HD23 ' A' ' 55' ' ' LEU . 84.8 mt -65.07 -42.83 93.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.699 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.68 -55.74 39.35 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.077 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.2 Cg_exo -56.12 -42.99 60.75 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.622 2.215 . . . . 0.0 111.161 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -58.98 -44.16 91.54 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.06 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.28 -44.47 88.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.13 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.78 -40.0 94.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.493 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 11.24 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.532 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.25 11.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.76 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.49 -33.86 76.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.643 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.48 153.27 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -94.58 -20.66 19.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.977 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.92 26.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 97.0 mt -116.73 128.18 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.506 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.3 ttp -128.43 106.22 8.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.411 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.624 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.6 t -158.68 -179.73 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.63 -14.62 58.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.503 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.0 tp -37.55 124.18 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.584 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.557 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.14 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.644 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.66 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.4 pt -104.93 148.96 8.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.184 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.4 p -150.63 152.62 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.679 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.08 -48.01 53.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.47 -39.98 71.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.579 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.77 -37.52 79.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -36.93 74.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.233 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.45 -27.53 67.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.292 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.23 -51.74 7.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.68 -168.55 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.4 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.71 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.599 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -164.61 -151.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.49 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.8 m-20 43.23 19.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.686 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.89 120.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.354 0.409 . . . . 0.0 110.532 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -77.34 -70.07 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.756 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.5 p90 -149.16 165.99 30.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.553 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.79 121.07 26.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.57 69.99 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.663 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -86.54 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.429 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.51 165.78 32.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.54 146.08 22.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.64 136.14 41.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.61 110.88 28.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.011 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.76 164.87 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.712 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.82 148.39 23.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.841 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.62 -27.67 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.309 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.16 -41.82 89.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.329 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.33 122.18 43.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.361 . . . . 0.0 110.254 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.34 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.394 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 129.88 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.44 159.2 33.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.6 Cg_endo -59.63 89.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.802 2.335 . . . . 0.0 112.02 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -168.93 140.91 2.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.21 -32.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.38 -62.56 1.68 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.61 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.0 t -56.07 -22.19 26.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.678 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.3 mt -76.99 -25.38 52.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.76 132.73 46.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.474 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.27 -16.03 31.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.48 151.59 23.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -96.52 135.63 38.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.393 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.04 136.66 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.639 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.36 138.8 14.43 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.7 t -131.04 161.59 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.965 0.412 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.6 tp -92.42 117.49 29.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.555 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.73 157.87 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.82 50.57 52.47 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.97 169.0 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.4 p -73.79 -26.33 60.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.497 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -60.69 -55.31 34.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.564 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.89 -54.64 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.421 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.17 -51.38 69.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.571 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.5 t80 -62.08 -43.76 98.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.416 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.8 -44.33 98.02 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.58 -14.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.615 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.32 -34.4 2.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.71 -51.03 15.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.13 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.12 12.98 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.996 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.61 -55.46 0.44 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.45 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.32 -10.39 25.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.834 2.356 . . . . 0.0 112.051 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.61 -8.73 59.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.623 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.9 33.47 37.0 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.87 138.22 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.6 129.79 34.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.421 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.9 pt -125.96 137.78 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.01 132.92 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.427 . . . . 0.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.75 43.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.617 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -110.89 153.67 25.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.373 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.8 6.95 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.19 130.68 5.97 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.01 -45.76 80.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.91 -24.08 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.69 -36.37 84.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.2 -47.13 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.3 m-85 -63.58 -37.8 88.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.364 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.22 -42.63 98.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.46 -45.42 90.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.227 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.544 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.9 tp -58.62 -48.1 82.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.256 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.0 m -63.18 -22.94 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.013 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.3 25.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.86 11.34 70.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.75 -17.84 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.8 pt -128.78 137.98 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.23 -28.02 61.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.481 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.61 155.49 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.689 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.85 50.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.153 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -85.71 103.05 14.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.58 165.11 25.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.451 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.471 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.26 151.97 41.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.7 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -65.71 -54.17 30.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 91' ' ' TYR . 68.6 t -60.04 -49.12 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.03 89.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.772 0.32 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.42 1.16 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.483 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.416 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.4 m -58.67 -47.2 85.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.95 -37.34 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.117 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.14 -65.8 0.55 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.675 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.0 t80 -40.73 -70.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.646 0.26 . . . . 0.0 110.989 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.778 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -59.47 -3.19 0.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.176 0.512 . . . . 0.0 110.377 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 177' ' ' VAL . 33.3 mt-30 -124.58 141.34 37.56 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -43.43 -14.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.844 2.362 . . . . 0.0 112.165 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.0 t -63.07 -42.8 97.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.445 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.87 -33.02 81.69 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.06 -41.35 96.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.793 0.33 . . . . 0.0 110.446 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.16 -34.46 78.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.555 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.8 m-85 -156.96 142.89 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.645 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.71 100.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.049 0.452 . . . . 0.0 110.72 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.5 m-85 -159.41 167.52 28.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.613 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.18 56.06 3.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.04 -116.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.84 135.03 35.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.436 2.091 . . . . 0.0 111.911 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.7 p -124.6 -108.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -166.39 165.17 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.662 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.66 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 O-C-N 123.951 0.782 . . . . 0.0 110.494 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.22 118.3 23.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.066 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.5 mp0 -72.13 -18.68 61.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -64.04 -31.87 73.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.636 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.7 mt -60.83 -44.57 96.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.683 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.46 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.7 m-85 -113.88 7.35 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.641 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.2 -155.32 50.37 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.66 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.19 -25.54 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.16 -125.57 1.46 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -132.07 160.12 36.87 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.412 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.23 -163.2 25.71 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -97.66 141.01 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.15 4.0 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -122.04 160.75 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.285 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 148.97 25.03 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.654 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.75 -48.83 63.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.714 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -39.88 -23.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.784 0.326 . . . . 0.0 110.544 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.0 m-20 -71.78 52.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.623 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.43 -46.27 83.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.16 34.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.42 -43.74 98.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.53 -42.84 99.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.005 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.44 -37.3 72.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.027 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.46 0.11 Allowed 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 44' ' ' ILE . 87.9 mt -28.2 -45.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.659 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.1 m-20 -63.83 -45.46 89.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.661 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.51 98.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.114 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.46 93.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.33 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.12 -43.39 98.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.241 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.36 92.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.98 -42.39 97.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.228 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.13 -38.29 73.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.9 -38.77 76.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.0 110.417 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.46 92.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.6 p-10 -88.57 0.59 56.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.1 67.95 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.7 m -57.6 -46.16 84.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.6 t80 -63.65 -57.93 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 110.53 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.56 -41.68 77.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.7 -48.53 80.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.8 -41.62 97.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.397 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.07 -49.81 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.75 -35.65 73.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -70.78 -50.98 30.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.273 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.16 -45.85 91.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.1 m-85 -153.53 155.48 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.431 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.2 p-10 -98.01 99.23 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -156.4 -165.59 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.493 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.7 t0 -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.6 m -63.76 -40.23 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.572 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.8 m-85 -56.76 -44.11 81.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.304 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.33 -36.54 93.54 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.917 -1.49 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.21 61.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.698 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.79 143.53 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 122.727 2.285 . . . . 0.0 112.308 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.404 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.39 -40.89 89.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.586 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.65 139.48 38.51 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.359 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.41 121.5 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.665 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.18 118.49 31.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.106 0.479 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.09 138.56 40.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.404 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.83 105.94 2.2 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.9 m -129.32 120.41 25.59 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 122.694 -0.298 . . . . 0.0 110.953 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.501 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.4 t70 -114.18 92.58 27.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.454 2.103 . . . . 0.0 112.197 179.188 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.2 t0 . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.917 0.389 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.03 -40.35 83.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.971 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.03 -37.58 83.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.909 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.74 -45.25 87.25 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -56.96 -48.63 77.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.881 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.85 -54.71 30.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.356 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -52.21 -39.94 60.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 110.412 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.73 -41.83 78.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.71 -45.29 70.4 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.074 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.93 -47.03 82.13 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.064 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.61 -42.35 92.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.89 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.41 -17.1 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.655 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.63 53.11 4.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.548 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.06 171.27 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.876 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -89.02 142.56 27.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.46 131.15 56.79 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.19 126.92 43.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.386 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -93.36 134.67 35.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.523 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.04 127.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.285 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.31 137.99 57.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.89 131.34 0.16 Allowed Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.539 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.2 Cg_endo -68.23 145.22 65.52 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.677 2.251 . . . . 0.0 112.437 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.877 HD23 HD12 ' A' ' 58' ' ' LEU . 82.8 mt -40.29 -55.79 2.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -48.33 -26.25 1.94 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.9 18.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.877 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.96 -42.38 97.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.16 -57.43 23.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 123.872 0.733 . . . . 0.0 109.485 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -54.93 -42.39 69.5 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.62 2.214 . . . . 0.0 111.267 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.9 m -58.76 -44.87 90.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.873 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.656 HD21 ' HG3' ' A' ' 203' ' ' ARG . 62.4 tp -59.1 -44.01 91.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.219 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.47 -40.53 95.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.82 9.96 2.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.24 12.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.59 -35.46 80.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.29 153.19 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.58 -21.98 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.178 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.63 155.74 26.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.777 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.06 128.95 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.176 0.513 . . . . 0.0 110.441 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.0 ttp -131.06 106.47 8.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.716 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.4 t -159.1 178.53 9.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.22 -15.41 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -34.84 124.23 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.606 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.87 153.87 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.613 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.58 148.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -149.12 152.09 35.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.799 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.72 -47.28 50.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.35 -39.7 70.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -69.31 -37.57 77.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.755 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.89 -39.07 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.819 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.73 -27.63 66.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.24 -50.67 8.19 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.729 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.2 pt -139.39 -168.11 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.088 0.47 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.118 0.485 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.9 m-85 -130.0 150.0 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.554 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.05 -153.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 94.2 m-20 41.17 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.088 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.59 121.79 0.2 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.39 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.9 mt -75.6 -68.94 0.52 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.11 167.38 26.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.729 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.3 123.78 29.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.233 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.89 68.55 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.792 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.01 -104.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.45 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.53 165.7 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.41 146.04 22.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.16 0.505 . . . . 0.0 110.444 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -100.96 136.26 41.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.832 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.416 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.72 110.41 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.1 165.16 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.72 148.34 24.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.84 -27.38 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.177 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.33 -41.86 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.323 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.58 122.37 44.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.146 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.4 19.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.84 130.1 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.67 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.67 159.06 33.75 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.576 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.84 89.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.81 2.34 . . . . 0.0 111.939 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -169.27 140.68 2.39 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.523 0.514 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.8 -32.84 59.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.276 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.14 -62.74 1.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.307 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 t -55.96 -22.2 25.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -76.44 -25.9 54.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.323 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.7 133.11 46.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.388 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.89 -15.93 29.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.56 151.36 23.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.458 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.89 135.48 37.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.014 0.435 . . . . 0.0 110.336 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.54 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.51 138.59 14.33 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.87 161.65 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 121.102 0.477 . . . . 0.0 110.314 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.3 tp -92.35 117.53 30.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.682 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.64 157.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.663 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.52 53.56 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.68 168.93 22.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.775 0.321 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.3 p -73.54 -26.85 61.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.54 -55.57 31.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.53 -54.9 40.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.575 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.21 -50.88 71.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.56 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.0 t80 -62.23 -43.82 97.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.92 -44.54 97.69 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.27 -14.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.825 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.28 -34.57 2.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.598 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.4 -50.59 17.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 111.557 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -99.15 12.47 36.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.83 -55.51 0.47 Allowed Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.24 -10.27 25.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.791 2.327 . . . . 0.0 111.923 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -9.01 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.495 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.42 37.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.51 138.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.986 0.422 . . . . 0.0 110.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.48 129.75 34.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.32 138.14 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.23 133.15 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.077 0.465 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.39 127.67 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.99 153.74 25.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.245 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.09 7.42 29.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.645 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.75 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.6 tp60 -65.97 -45.91 80.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.468 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.58 -23.32 62.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.89 -36.71 85.25 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.12 -47.08 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.078 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.518 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.2 m-85 -63.61 -38.06 89.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.271 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.14 -42.27 98.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.04 -45.34 89.27 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.6 tp -58.3 -48.17 81.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -63.25 -22.77 67.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.242 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.74 24.94 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.13 11.46 69.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -18.15 63.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.94 0.4 . . . . 0.0 110.618 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.2 pt -128.29 137.36 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.397 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.89 -27.24 61.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.83 155.87 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.527 0.517 . . . . 0.0 110.838 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.05 136.83 49.8 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 109.967 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -85.2 103.05 13.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.831 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.5 tt0 -132.52 165.5 24.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.409 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.81 152.31 41.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.549 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.2 mt-10 -66.27 -54.46 24.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.33 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.1 t -60.29 -48.98 86.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.395 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.93 88.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.821 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.45 -63.1 1.22 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -59.4 -47.99 83.34 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.003 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.9 tt0 -49.06 -37.33 20.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.82 -66.32 0.56 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -71.23 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 122.745 -0.268 . . . . 0.0 111.17 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 175' ' ' GLN . 94.9 mt -61.01 -40.31 93.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -60.1 -2.79 0.47 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.538 0.685 . . . . 0.0 110.457 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 173' ' ' LEU . 39.8 mt-30 -123.36 148.95 56.74 Favored Pre-proline 0 N--CA 1.453 -0.306 0 O-C-N 122.011 -0.431 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.48 -20.41 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.933 2.422 . . . . 0.0 112.299 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.01 -43.24 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.588 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.59 -33.05 83.55 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.57 -41.4 94.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.733 0.302 . . . . 0.0 110.412 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.9 m-20 -65.55 -33.81 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.438 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.3 m-85 -156.19 143.0 18.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.1 pttt -177.15 99.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.093 0.473 . . . . 0.0 110.73 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.1 166.82 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.59 56.57 2.77 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -118.05 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.28 135.98 31.44 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.412 2.075 . . . . 0.0 112.015 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.47 -107.9 0.32 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.647 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.68 165.31 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.144 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.29 156.15 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.25 0.969 . . . . 0.0 110.62 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.15 117.57 22.4 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.863 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.61 -18.78 62.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.99 -32.35 73.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.518 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.4 mt -60.94 -44.62 97.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.746 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.9 m-85 -114.0 9.59 17.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.783 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.19 -154.92 52.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.53 -24.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 110.428 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 159.93 -124.16 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.3 p -129.4 156.45 44.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.712 0.292 . . . . 0.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.64 -169.42 30.22 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -94.39 137.3 33.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.922 0.391 . . . . 0.0 110.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.25 107.77 3.21 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.4 mt -123.06 159.22 28.9 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.906 0.384 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.656 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.87 149.57 24.72 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.85 -48.34 64.04 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.527 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.5 tp10 -37.98 -25.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.94 0.4 . . . . 0.0 110.842 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.47 52.2 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.622 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -64.39 -45.68 86.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.274 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.54 -47.23 34.06 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.26 -43.91 97.74 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.18 -43.0 99.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.01 -36.39 70.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.1 -77.31 0.11 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.89 HD21 HD11 ' A' ' 44' ' ' ILE . 98.3 mt -28.86 -46.08 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.958 0.408 . . . . 0.0 110.506 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.31 -44.94 90.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.782 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.5 tttm -62.08 -43.63 98.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.993 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.06 93.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.15 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.23 -43.39 98.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.994 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.26 92.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.53 -43.26 97.65 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.508 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.79 -38.32 72.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.99 -38.9 76.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 110.378 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.619 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.51 1.09 56.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.676 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.47 20.64 65.9 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.3 m -58.2 -45.97 86.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.8 t80 -63.93 -57.86 8.49 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.441 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.83 -41.83 78.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.2 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.44 -48.72 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.532 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.69 -41.88 98.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.87 0.367 . . . . 0.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.13 74.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.84 -34.9 72.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.22 -50.82 29.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.394 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.4 -45.83 91.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.552 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 66.6 m-85 -153.85 155.79 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.05 98.08 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.982 0.42 . . . . 0.0 110.412 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -155.59 -165.59 2.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.33 110.67 15.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.585 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.0 m -63.57 -40.47 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.46 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.8 m-85 -58.5 -42.55 87.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.281 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.26 -37.04 94.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.702 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 164.38 59.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.647 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.89 143.39 99.35 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.05 -40.31 90.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.82 142.81 36.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.5 mt -109.88 128.73 65.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.468 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -103.6 117.0 33.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.34 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -111.83 139.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.409 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.09 105.08 2.14 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -128.14 118.98 24.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.71 -0.289 . . . . 0.0 111.069 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.521 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.1 t70 -113.53 93.15 26.26 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.301 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.2 t0 . . . . . 0 C--O 1.227 -0.13 0 CA-C-O 120.931 0.396 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.88 -40.71 81.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.104 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -61.3 -37.35 82.92 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.754 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.43 -43.99 84.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.985 0.422 . . . . 0.0 110.259 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.91 -41.84 92.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.111 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -58.74 -53.61 56.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -36.73 62.61 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 110.332 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.4 -42.37 75.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.824 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.49 -44.48 72.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.116 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.97 -47.61 79.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.42 -41.03 88.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.984 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.4 -17.59 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.6 52.74 4.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.489 . . . . 0.0 110.651 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.08 17.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.885 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.36 140.84 29.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.153 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -117.31 132.01 56.69 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.632 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.43 127.73 43.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.89 135.78 34.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.64 128.44 65.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.368 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 139.41 58.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.521 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.06 131.99 0.14 Allowed Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.3 Cg_endo -68.49 145.21 63.9 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.297 . . . . 0.0 112.426 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.886 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.49 -56.66 2.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.1 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.19 -26.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.64 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.232 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.886 HD12 HD23 ' A' ' 55' ' ' LEU . 57.1 mt -63.97 -42.43 97.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.68 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.703 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.44 -56.89 26.1 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.696 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.5 Cg_exo -55.0 -43.32 60.65 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.595 2.197 . . . . 0.0 111.113 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -58.52 -44.64 89.58 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.763 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.52 -44.37 89.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.095 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.54 -40.5 95.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.11 11.08 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.13 11.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.44 -34.33 77.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.94 153.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.43 -20.35 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.128 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.55 157.64 25.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.18 127.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.523 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.42 106.79 9.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.383 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.58 ' OG ' HD21 ' A' ' 55' ' ' LEU . 41.2 t -160.28 -178.06 6.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.3 -15.52 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.391 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -37.97 123.88 1.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.62 156.82 22.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.594 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.645 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.02 149.3 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.301 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.0 p -150.3 152.28 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.735 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.94 52.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.021 0.438 . . . . 0.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.47 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.887 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.73 -37.57 79.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.912 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.34 -27.85 67.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.142 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.92 -51.98 7.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -138.19 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.1 0.476 . . . . 0.0 110.433 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.78 29.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.038 0.447 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.5 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.627 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.39 -151.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.512 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.1 m-20 43.29 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.11 119.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.6 mt -77.19 -70.07 0.49 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.9 p90 -149.35 166.33 29.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.91 122.51 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.297 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.85 68.86 0.93 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.762 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.69 -104.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.429 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.4 p -159.05 165.74 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.656 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.24 146.22 22.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.117 0.484 . . . . 0.0 110.353 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.06 135.99 41.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.7 110.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.5 m -134.29 165.03 32.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.938 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.84 148.67 23.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.3 -28.48 58.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.247 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -58.93 -41.76 88.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.281 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -101.94 122.03 43.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.75 109.86 19.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.28 129.73 70.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.579 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.5 153.97 41.81 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.672 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.3 Cg_endo -59.05 92.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -171.08 144.11 2.06 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.604 0.565 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.14 -33.55 61.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.287 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.301 -178.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.1 t -56.95 -21.99 34.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.962 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.43 -27.08 58.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.94 133.43 48.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.46 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.19 -17.34 28.7 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.31 151.76 23.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.902 0.382 . . . . 0.0 110.431 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.58 38.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.372 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.15 136.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.622 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.34 139.32 14.65 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.3 161.63 40.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.097 0.475 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.73 117.61 30.18 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.627 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.56 157.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.15 50.71 49.73 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.8 p -149.71 168.85 22.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.2 p -73.83 -25.78 60.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -61.1 -55.39 33.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.435 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.34 -53.81 53.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.77 -51.32 69.84 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.586 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.1 t80 -62.19 -43.9 97.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.85 -44.58 97.66 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.782 0.325 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.19 -34.56 2.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.667 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.39 -50.73 17.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 111.562 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.19 12.46 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.209 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.7 -55.56 0.48 Allowed Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.375 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.23 25.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.001 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.85 -8.78 59.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.44 37.02 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.31 137.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.81 129.94 35.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.8 138.56 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 63.1 t -123.92 133.65 68.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 109.935 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -95.57 127.56 41.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.55 150.62 27.22 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.251 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.96 6.05 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.13 131.37 5.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.401 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.5 tp60 -65.69 -45.7 81.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 110.415 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.85 -24.24 63.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.55 -36.52 84.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.0 -46.62 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.001 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.8 m-85 -64.37 -37.75 88.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.339 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.79 -42.12 96.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.181 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -65.58 -43.28 90.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.3 tp -58.58 -48.92 79.33 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.18 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -62.15 -22.52 65.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.382 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.91 25.62 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.544 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 12.12 73.1 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.99 -17.42 63.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.563 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.2 pt -127.39 136.48 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 110.42 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.92 -28.1 62.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.38 155.1 1.79 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.853 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.65 137.1 50.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.039 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -85.55 102.5 13.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.144 0.497 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.4 tt0 -131.6 165.0 24.62 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.377 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.44 153.11 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.47 -54.29 25.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.337 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.0 t -60.22 -49.17 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.438 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.82 87.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.13 -63.51 1.13 Allowed 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.572 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -58.78 -47.27 85.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -49.25 -38.4 26.74 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.48 -66.02 0.56 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.0 t80 -40.32 -71.04 0.09 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.608 0.242 . . . . 0.0 111.229 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.2 -40.07 92.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.959 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.65 -2.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.7 mt-30 -124.27 141.77 38.3 Favored Pre-proline 0 C--N 1.33 -0.244 0 O-C-N 122.079 -0.388 . . . . 0.0 110.845 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -43.95 -15.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.871 2.381 . . . . 0.0 112.277 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 175' ' ' GLN . 79.4 t -62.97 -42.83 98.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.95 81.37 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.75 -41.58 95.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.726 0.298 . . . . 0.0 110.479 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.8 -34.49 78.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.578 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.6 m-85 -157.25 143.96 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.4 pttt -177.81 100.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.075 0.464 . . . . 0.0 110.782 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.9 m-85 -159.06 168.18 27.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.01 55.57 3.09 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.68 -117.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.83 135.22 35.48 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.487 2.125 . . . . 0.0 112.008 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.0 p -125.08 -108.14 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.54 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.64 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.178 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.53 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 124.17 0.919 . . . . 0.0 110.634 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.2 118.23 22.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.791 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.87 -18.57 62.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.05 73.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.464 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.4 mt -60.97 -44.36 97.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.743 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.435 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.68 7.58 17.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.697 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.99 -154.84 50.21 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.645 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.7 -25.39 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.56 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.456 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.05 -126.14 1.55 Allowed Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -131.97 159.92 37.3 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.427 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.65 -162.39 24.7 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -98.5 141.02 31.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.621 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.81 3.96 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.4 mt -120.64 160.54 23.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.307 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.95 148.98 25.1 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.18 -49.04 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.662 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -39.89 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.89 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -71.91 52.13 0.23 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.5 -46.16 84.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.18 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.46 -47.07 35.68 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.27 -43.92 97.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.459 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.55 -42.89 99.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.6 -37.36 73.1 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.64 -77.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.984 HD21 HD11 ' A' ' 44' ' ' ILE . 87.4 mt -28.72 -45.65 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.858 0.361 . . . . 0.0 110.481 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.4 m-20 -63.59 -45.64 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.6 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.77 98.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.968 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.26 -43.33 99.05 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.105 0.479 . . . . 0.0 110.071 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.41 93.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.074 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.62 -43.01 98.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.78 -38.37 72.39 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.81 -38.79 76.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.47 . . . . 0.0 110.373 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.41 92.81 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 21.0 p-10 -88.36 0.38 56.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.743 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.56 20.11 67.59 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.6 m -58.04 -46.22 85.7 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.1 t80 -63.42 -57.46 10.21 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.448 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.91 -41.78 78.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.245 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.3 -48.67 79.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.48 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.51 -41.73 97.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.39 -49.68 76.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.692 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.87 -35.26 72.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.465 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.72 -51.16 29.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.39 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.17 -45.92 91.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.581 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.0 m-85 -154.11 155.14 34.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.4 p-10 -97.84 101.21 12.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.476 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -157.51 -165.44 1.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.63 109.94 14.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.6 m -63.63 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.412 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.2 m-85 -58.27 -43.6 88.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.217 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.65 -36.76 93.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.418 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.657 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.983 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.12 164.47 56.69 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.82 143.34 99.36 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.624 2.216 . . . . 0.0 112.29 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.49 -40.23 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.554 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.69 36.86 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.7 128.58 66.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.5 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -104.83 118.59 36.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 110.362 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.7 138.52 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.89 99.58 1.55 Allowed Glycine 0 N--CA 1.463 0.495 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.6 m -123.41 117.68 25.74 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.696 -0.297 . . . . 0.0 111.255 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.516 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 12.8 t0 -112.85 93.04 22.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.424 2.083 . . . . 0.0 112.188 179.373 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.5 t0 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.976 0.417 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.55 -41.37 82.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.119 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.71 -37.57 82.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.094 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.47 -43.96 84.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.188 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.02 -41.75 92.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.133 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.7 -53.32 59.69 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.554 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.08 -36.56 63.29 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.266 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.0 mt -69.53 -42.37 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.772 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.62 -44.02 72.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.3 tttm -64.07 -47.65 79.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -59.82 -40.81 89.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.948 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.36 -18.24 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.616 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.79 52.51 4.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 110.618 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -144.99 169.94 17.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.9 139.93 30.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.056 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -116.52 131.31 56.98 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.9 m -128.47 128.03 43.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.74 136.44 35.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.75 128.72 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.343 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.84 139.37 58.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.781 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.89 132.81 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.519 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.4 Cg_endo -68.55 144.92 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.562 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.939 HD23 HD12 ' A' ' 58' ' ' LEU . 76.9 mt -40.81 -55.81 2.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.41 -26.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.173 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.46 -20.18 19.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.939 HD12 HD23 ' A' ' 55' ' ' LEU . 86.5 mt -64.93 -42.45 94.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.959 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.52 -56.91 28.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.685 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.4 Cg_exo -55.35 -43.24 60.43 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.586 2.191 . . . . 0.0 111.035 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -58.68 -44.41 90.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.2 tp -58.53 -44.31 89.52 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -64.55 -40.36 95.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.996 0.426 . . . . 0.0 110.434 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 11.22 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.565 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.95 11.84 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.17 77.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.494 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.7 pt -124.54 153.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.281 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.284 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.95 156.88 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.755 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -117.11 128.0 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 110.534 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.477 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.38 106.51 9.05 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.399 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.608 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.2 t -159.66 -179.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.3 -15.31 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.391 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.0 tp -37.78 123.86 1.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.07 156.37 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.3 pt -104.87 148.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.9 p -150.04 152.5 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.27 -47.69 55.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.604 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.72 -39.71 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.788 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.27 -37.83 81.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.928 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.29 75.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.59 67.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.076 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.12 -51.76 7.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.6 pt -138.45 -168.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.88 146.87 29.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.87 150.0 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.641 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.2 t -164.41 -151.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.444 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.1 m-20 43.07 19.3 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.8 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mttt -28.27 120.22 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -77.26 -69.99 0.5 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.825 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 40.3 p90 -149.4 166.25 29.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.08 123.39 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.466 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.47 67.97 0.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.5 -104.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.436 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.2 p -159.58 165.99 31.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.7 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.52 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.144 0.497 . . . . 0.0 110.456 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.3 135.86 42.1 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.409 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.9 t -122.67 110.45 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.28 165.11 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.935 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.19 148.61 23.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.97 -27.84 46.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.191 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -59.1 -41.8 88.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.221 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.45 122.14 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.129 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.54 109.26 19.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.068 0.461 . . . . 0.0 110.398 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.18 129.88 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.73 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.98 159.05 34.01 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.53 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.1 Cg_endo -59.63 89.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.707 2.271 . . . . 0.0 111.943 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.6 m -169.23 140.91 2.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.546 0.529 . . . . 0.0 110.786 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.55 -32.58 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.227 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.19 -62.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.375 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.2 t -56.11 -22.18 26.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.124 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.96 -26.81 57.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.345 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.71 132.84 46.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.436 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.41 -15.92 32.43 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -87.1 151.78 22.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.71 135.89 38.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.075 0.464 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.99 136.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.738 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 138.93 14.5 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.24 161.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.068 0.461 . . . . 0.0 110.386 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.1 tp -92.71 117.95 30.54 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.51 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.58 49.15 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.7 p -149.67 168.98 22.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.94 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.44 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.3 p -74.01 -25.73 60.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.401 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.21 -55.44 32.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.468 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.09 -54.06 51.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.57 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.46 -51.01 71.31 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.702 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.25 -43.86 97.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.11 0.481 . . . . 0.0 110.44 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.21 -44.55 97.55 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.27 -14.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.801 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.38 2.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.43 -50.75 17.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 111.653 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -98.98 12.54 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.32 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.9 -55.58 0.47 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.377 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.16 -10.44 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.825 2.35 . . . . 0.0 111.959 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.61 -8.84 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.496 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.89 33.45 37.09 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.54 138.06 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.65 129.73 35.03 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.307 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.52 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.11 133.56 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.026 0.441 . . . . 0.0 109.959 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 127.97 42.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -108.29 150.45 27.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.165 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.37 5.61 34.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.68 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.44 131.87 6.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.63 -45.76 81.83 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.411 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.61 -24.43 63.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 56.9 t-20 -64.45 -36.69 85.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.79 -46.56 88.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.43 -37.6 88.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.315 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.88 -42.5 98.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.2 -43.13 92.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.884 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.0 tp -59.17 -48.37 81.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.5 m -62.69 -22.26 66.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.915 0.388 . . . . 0.0 110.026 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.89 -17.71 26.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.63 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.54 11.95 73.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.78 -17.57 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.609 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.0 pt -127.53 136.62 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.993 0.425 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.01 -28.28 62.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.36 155.27 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.802 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.61 137.44 50.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 109.95 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.66 102.95 14.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.239 0.542 . . . . 0.0 110.714 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.14 165.14 24.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.377 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.24 152.35 41.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.601 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.2 -54.13 28.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.343 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.4 -49.17 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.512 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.85 88.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 110.867 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.01 -63.49 1.14 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.589 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.9 m -58.67 -47.01 85.92 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.792 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.66 -38.05 30.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.057 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.68 -65.59 0.55 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.2 t80 -40.63 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.644 0.259 . . . . 0.0 111.394 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.4 mt -61.38 -39.87 92.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.81 -2.92 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.537 0.684 . . . . 0.0 110.499 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.8 mt-30 -124.43 142.1 39.39 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.09 -0.382 . . . . 0.0 110.891 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -44.06 -15.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.808 2.339 . . . . 0.0 112.299 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.5 t -63.09 -43.03 98.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.632 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.62 -32.86 79.84 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.31 95.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 181' ' ' TYR . 47.7 m-20 -65.8 -34.92 79.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 180' ' ' ASP . 77.5 m-85 -157.04 143.54 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -177.22 100.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 110.728 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -159.31 167.5 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.699 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.31 55.52 3.05 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.45 -117.46 0.01 OUTLIER Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.93 135.5 36.23 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.465 2.11 . . . . 0.0 111.932 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 89.4 p -124.95 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.601 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.657 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -165.79 165.37 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.185 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.49 156.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 124.169 0.918 . . . . 0.0 110.649 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.14 118.28 22.94 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.73 -18.63 62.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.9 -32.36 73.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.57 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.452 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.6 mt -60.86 -44.25 97.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.44 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.8 m-85 -114.05 8.36 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.719 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.12 -154.7 51.04 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.651 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.71 -25.51 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.869 0.366 . . . . 0.0 110.551 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.0 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.4 p -131.97 160.06 36.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.827 0.346 . . . . 0.0 110.41 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.42 24.6 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.87 32.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.914 0.387 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.86 3.96 Favored Glycine 0 C--N 1.329 0.179 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.6 mt -121.28 160.27 24.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.94 0.4 . . . . 0.0 110.164 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.81 149.08 25.09 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.881 0.372 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.37 -48.6 65.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.669 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.94 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.015 0.436 . . . . 0.0 110.831 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.1 m-20 -71.89 52.17 0.23 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -64.42 -46.03 84.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.313 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.7 -46.94 34.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.241 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.25 -43.87 97.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.438 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.728 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.73 -37.35 73.41 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.702 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.38 0.11 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 44' ' ' ILE . 85.5 mt -28.91 -45.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.471 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.6 m-20 -63.61 -45.28 91.03 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.49 -43.79 98.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.095 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.15 -43.52 98.75 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 110.046 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.29 92.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.064 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.9 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.0 -38.32 72.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.84 -38.79 76.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 110.322 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.28 93.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.656 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.33 0.31 56.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.727 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.55 20.25 67.71 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.28 -46.15 86.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 77.2 t80 -63.44 -57.36 10.51 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.372 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.99 -41.46 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.236 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.62 -48.36 81.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.598 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.88 -41.61 98.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.402 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.62 -49.79 76.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.639 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.56 -35.35 72.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.529 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.57 -51.07 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.544 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.7 m-85 -62.28 -45.7 92.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.617 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.2 m-85 -154.3 154.82 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.0 p-10 -97.79 100.13 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.409 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -156.25 -165.39 1.9 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.58 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.6 t0 -122.5 109.89 14.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.2 m -63.39 -40.46 89.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.416 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.0 m-85 -59.06 -42.53 90.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.304 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.25 -37.08 94.3 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.659 0 CA-C-O 117.872 -1.516 . . . . 0.0 110.975 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.04 164.33 61.94 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.595 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.84 143.53 99.39 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.574 2.182 . . . . 0.0 112.32 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.41 -40.78 89.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.09 141.22 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.442 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.8 mt -109.27 127.43 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 110.567 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.28 117.71 35.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.12 0.486 . . . . 0.0 110.277 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.16 138.55 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.922 0.391 . . . . 0.0 110.537 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.59 105.25 2.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.4 m -128.3 119.52 25.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.676 -0.308 . . . . 0.0 111.242 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 10.8 t0 -113.44 92.59 23.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.308 -1.597 0 C-N-CA 122.44 2.093 . . . . 0.0 112.12 179.353 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 121.028 0.442 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.9 -41.02 84.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.845 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -60.88 -37.24 81.5 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.945 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -65.1 -45.07 86.7 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.2 -48.01 79.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.993 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.3 -54.27 38.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.352 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.75 -39.59 62.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.85 0.357 . . . . 0.0 110.308 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.0 -42.16 76.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 110.622 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.74 -44.62 70.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.128 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -63.83 -47.38 81.01 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.84 -41.68 91.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.914 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -75.56 -18.09 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.552 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.04 52.76 3.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.505 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -146.6 171.21 15.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.69 141.31 28.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.073 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.4 m -116.8 130.42 56.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.0 m -126.81 126.93 44.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -93.88 135.5 35.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.581 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.53 128.32 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.324 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.04 139.67 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.525 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.0 OUTLIER 173.93 129.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.4 Cg_endo -67.5 146.32 73.81 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.753 2.302 . . . . 0.0 112.471 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.862 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -40.45 -56.57 2.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.148 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.97 -26.82 1.91 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 111.271 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.75 -20.69 19.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.294 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.862 HD12 HD23 ' A' ' 55' ' ' LEU . 60.6 mt -64.42 -42.27 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.717 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.715 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.19 -56.76 28.13 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.7 Cg_exo -55.36 -44.06 52.52 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.628 2.219 . . . . 0.0 111.141 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.4 m -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.692 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.94 -44.24 86.82 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.6 -40.17 95.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.5 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.26 11.19 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.82 12.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.24 -34.28 77.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 178.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 pt -123.76 152.93 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.218 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.44 -20.65 20.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.302 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.38 156.51 26.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.59 HG23 HD13 ' A' ' 58' ' ' LEU . 96.8 mt -115.47 126.99 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.016 0.436 . . . . 0.0 110.475 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.31 106.04 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.309 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.681 ' OG ' HD21 ' A' ' 55' ' ' LEU . 45.6 t -159.67 -179.84 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.589 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.66 -15.48 61.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.379 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.8 tp -36.23 123.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.52 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.555 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -81.66 154.6 26.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -104.55 148.01 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -149.57 152.35 35.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.867 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.24 -47.23 55.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.48 -37.87 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.1 -38.05 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.786 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.05 -27.43 66.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.061 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.58 -50.83 7.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -139.53 -168.31 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.58 147.16 29.79 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.08 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.92 150.03 51.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.574 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.9 t -164.05 -152.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.534 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.511 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.8 m-20 41.64 19.5 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.889 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.35 121.34 0.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.392 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.433 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.6 mt -75.11 -68.66 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.893 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.45 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.8 167.72 26.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.27 28.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.264 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.86 68.26 0.91 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.785 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.84 -104.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.405 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.47 165.89 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.709 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.28 145.93 22.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.434 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.74 136.14 41.08 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 110.816 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.5 110.98 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.19 165.01 32.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.046 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.52 24.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.18 -28.31 57.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.179 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.18 -41.69 89.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -101.83 121.74 42.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.246 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.83 109.86 19.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.103 0.477 . . . . 0.0 110.503 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.04 129.79 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -108.76 154.18 41.89 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.518 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.24 92.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.758 2.305 . . . . 0.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -171.08 144.04 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.633 0.583 . . . . 0.0 110.795 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.47 -33.82 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.486 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.54 -62.7 1.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 t -56.22 -22.44 29.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.014 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.5 -26.52 58.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.246 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.39 133.44 45.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.81 -16.87 29.42 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.21 151.55 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.428 . . . . 0.0 110.491 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.31 136.15 37.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.3 t -127.59 136.99 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.78 139.9 14.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -132.1 161.71 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.044 0.449 . . . . 0.0 110.388 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.91 118.32 31.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.46 157.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.609 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.04 50.84 49.58 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -149.69 168.46 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.9 p -74.49 -25.63 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.482 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -61.0 -55.77 28.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.562 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.14 -54.11 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.588 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.28 -51.28 70.23 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.73 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.28 -43.8 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.128 0.489 . . . . 0.0 110.582 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.64 -44.48 97.89 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.233 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.63 -14.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.79 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.19 -34.64 2.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.762 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.12 -50.55 18.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.614 -178.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -99.12 12.39 36.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.287 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.49 -55.41 0.49 Allowed Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.434 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.2 -10.39 25.73 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.786 2.324 . . . . 0.0 111.993 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.63 -9.05 59.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.459 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.75 33.3 38.17 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.98 138.09 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.902 0.382 . . . . 0.0 110.627 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.92 129.8 35.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.195 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.16 138.98 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.2 t -125.59 132.1 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 109.943 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -98.43 130.59 45.05 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.998 0.427 . . . . 0.0 110.879 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -111.82 156.44 21.99 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.353 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.07 6.67 29.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.818 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.65 6.25 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.421 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.1 tp60 -65.88 -46.03 79.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.439 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.95 -23.15 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.571 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.51 -36.96 85.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 110.561 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.13 -47.08 85.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.207 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.2 m-85 -63.87 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.08 -42.28 98.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.68 -45.24 90.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.06 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.9 tp -58.87 -47.81 83.6 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.991 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -63.09 -22.93 67.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.947 0.403 . . . . 0.0 110.123 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.7 24.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.02 11.28 70.28 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.63 -18.17 63.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.627 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -127.87 136.7 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.77 -27.83 62.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.3 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.457 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.61 155.75 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.8 137.34 50.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.93 0.395 . . . . 0.0 109.955 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.92 103.19 14.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.34 0.59 . . . . 0.0 110.819 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.75 165.3 24.86 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.78 152.7 41.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.73 -54.69 20.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.279 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.45 HG21 ' CG ' ' A' ' 91' ' ' TYR . 77.0 t -60.08 -48.83 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.623 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.77 88.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.861 0.363 . . . . 0.0 110.856 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.2 -63.13 1.23 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.429 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.6 m -59.12 -47.63 84.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.851 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.4 tt0 -48.54 -38.02 19.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.17 -65.38 0.54 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.9 t80 -40.68 -71.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 111.286 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.31 -40.04 92.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -59.7 -2.91 0.41 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.451 0.643 . . . . 0.0 110.442 -179.473 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 173' ' ' LEU . 80.3 mt-30 -123.8 148.46 56.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.93 -20.45 2.98 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 112.195 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.74 -42.89 93.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.96 -33.24 84.88 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.44 95.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.677 0.275 . . . . 0.0 110.459 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.41 -33.62 76.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.315 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.1 m-85 -156.56 142.74 18.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.693 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.554 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.94 99.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.779 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.22 167.6 28.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.29 56.17 2.9 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -117.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.52 135.12 33.29 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.514 2.142 . . . . 0.0 111.89 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.4 p -125.08 -108.36 0.32 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.59 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.44 164.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.363 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.86 156.07 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.91 0.756 . . . . 0.0 110.657 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -82.37 117.66 22.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.937 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.97 -17.35 62.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.14 -33.05 74.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.586 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.5 mt -61.16 -44.46 97.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.697 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.6 m-85 -113.63 9.36 17.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.768 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.84 -153.51 51.43 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.66 -25.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.846 0.355 . . . . 0.0 110.5 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.13 -123.94 1.28 Allowed Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.9 p -129.36 156.27 44.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.733 0.301 . . . . 0.0 110.324 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.74 -169.44 30.34 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -95.32 138.94 32.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.71 107.26 3.2 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.664 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.1 mt -119.25 160.06 22.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.69 149.06 24.48 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.27 -48.66 65.16 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.543 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.15 -23.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -71.7 52.11 0.21 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.52 -45.23 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.16 -47.17 29.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.327 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.25 -44.17 97.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.448 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.08 -43.13 99.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.846 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.42 -37.21 72.41 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.67 -78.04 0.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.914 HD21 HD11 ' A' ' 44' ' ' ILE . 89.9 mt -28.48 -46.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.68 0.276 . . . . 0.0 110.321 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.6 m-20 -63.85 -45.01 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 178.139 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.78 -43.73 98.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.44 93.85 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.006 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.26 -43.61 98.6 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.994 0.426 . . . . 0.0 109.914 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.26 92.66 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.94 -42.89 97.21 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -57.05 -38.08 72.72 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.89 -38.96 76.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 110.348 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.86 94.31 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.677 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.1 p-10 -89.15 1.02 56.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.59 20.48 65.97 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.5 m -58.05 -46.33 85.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.433 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 75.1 t80 -63.64 -58.02 8.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.418 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.6 -41.76 77.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.14 -41.61 98.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.311 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.97 -50.34 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -35.33 71.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.648 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.8 -51.0 29.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.627 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 39.2 m-85 -61.95 -46.04 91.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.61 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.6 m-85 -154.35 155.79 35.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.36 99.41 10.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -156.27 -166.21 2.1 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.41 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.87 110.75 15.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.795 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.3 m -63.34 -40.41 88.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.414 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.1 m-85 -58.93 -42.9 90.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.251 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.37 -37.37 94.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.866 -1.519 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.54 164.34 58.63 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.87 99.44 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.14 -40.53 90.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.89 144.01 36.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.5 128.4 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.96 118.62 37.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.85 138.7 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.378 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.73 100.36 1.59 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -123.8 118.56 27.43 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.718 -0.283 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.518 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.8 t70 -113.32 93.15 25.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.987 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.308 -1.579 0 C-N-CA 122.468 2.112 . . . . 0.0 112.084 179.368 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 . . . . . 0 C--O 1.227 -0.103 0 CA-C-O 120.926 0.394 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.7 mt -68.81 -41.14 82.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -60.72 -37.66 82.47 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.081 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.09 -44.08 85.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.206 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.1 -44.31 91.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.093 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.51 -53.84 52.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.541 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.32 -37.44 62.28 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.57 -42.09 74.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.764 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.5 m -54.45 -44.1 72.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.102 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.15 -47.69 78.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -59.53 -41.21 89.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.069 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.006 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -76.22 -18.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.683 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.9 52.49 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.586 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -145.36 170.1 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.18 140.48 29.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.059 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -116.7 131.23 57.01 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.3 127.99 43.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.436 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -94.69 136.38 35.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.435 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.72 128.57 65.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.311 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.14 139.08 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.748 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.518 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 174.09 132.85 0.12 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.7 Cg_endo -68.42 144.75 62.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.647 2.231 . . . . 0.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.936 HD23 HD12 ' A' ' 58' ' ' LEU . 77.8 mt -40.49 -55.65 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.098 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -47.84 -26.45 1.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.34 19.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.184 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.936 HD12 HD23 ' A' ' 55' ' ' LEU . 85.1 mt -65.03 -42.33 94.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.826 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.83 -56.59 30.84 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.739 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.2 Cg_exo -55.47 -43.26 59.94 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.591 2.194 . . . . 0.0 111.108 177.308 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.7 m -58.83 -44.44 90.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.27 -44.36 88.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.69 -40.08 94.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 0.0 110.469 178.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.07 11.26 1.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.505 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.94 11.86 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.34 -34.19 77.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.546 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.6 pt -124.4 153.15 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.285 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.9 m-20 -93.96 -19.83 20.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.03 156.9 25.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.726 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -116.61 127.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 110.541 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.18 106.55 9.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.623 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.1 t -159.84 -179.08 7.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.639 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.29 -15.27 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.414 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.0 tp -37.56 123.77 1.01 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.533 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.16 156.38 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.627 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.652 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.2 pt -104.98 148.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.264 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.0 p -150.26 152.6 34.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.722 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.11 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.63 -39.62 71.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.708 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.7 mtt180 -68.73 -37.74 79.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -37.56 75.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.931 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.66 67.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.12 -51.73 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.617 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -138.52 -168.34 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.139 0.495 . . . . 0.0 110.416 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.03 147.04 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.558 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.4 m-85 -130.07 150.23 51.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.57 -151.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.479 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.3 m-20 42.97 19.26 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.21 120.49 0.11 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.4 mt -77.19 -70.01 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.778 -178.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.0 p90 -149.38 166.35 29.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.589 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.29 122.32 27.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.37 68.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.79 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.08 -104.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.57 165.86 31.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.624 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.68 146.7 23.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 0.0 110.473 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.6 135.68 42.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.411 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.78 110.36 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.31 164.97 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.5 -27.61 39.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.38 -41.71 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.359 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.1 t -102.38 122.0 43.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.236 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.49 109.19 19.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.411 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.37 129.61 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.06 159.15 33.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.555 179.93 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.453 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.39 89.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 111.908 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -168.88 140.35 2.53 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.511 0.507 . . . . 0.0 110.811 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.47 -32.63 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.324 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.3 tp10 -56.74 -62.85 1.45 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.443 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.64 -22.08 31.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.965 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.63 -27.26 58.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.334 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -55.08 132.96 48.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.449 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.14 -16.52 32.96 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.98 151.81 22.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 110.449 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.65 135.59 38.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.997 0.427 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -126.87 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.65 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.54 14.29 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.96 161.62 40.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.065 0.459 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.0 tp -92.71 118.33 30.95 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.56 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -52.02 157.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.1 50.64 50.43 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.7 p -149.55 168.74 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.889 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 81.8 p -73.67 -26.53 60.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.391 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.68 -55.36 34.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.99 -54.36 47.61 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.549 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.52 -51.03 71.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.2 t80 -62.21 -43.82 97.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 0.0 110.398 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.34 97.9 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.32 -14.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.44 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.703 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.37 -50.93 16.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.008 0.432 . . . . 0.0 111.545 -178.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.26 12.81 35.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.183 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.07 -55.5 0.46 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.375 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.35 -10.21 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.797 2.331 . . . . 0.0 111.993 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.76 -8.86 59.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.18 33.33 36.3 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.41 137.89 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.963 0.411 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.58 129.71 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.299 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.08 137.97 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.857 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.34 133.23 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 109.998 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.37 127.98 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.02 153.78 25.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -106.84 6.51 29.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.69 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.5 tp60 -66.18 -45.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.472 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.04 -23.74 63.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.471 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.58 -36.63 84.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.523 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.97 -46.95 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.117 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.6 m-85 -64.21 -37.69 88.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.297 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.98 -42.49 98.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.71 -43.54 93.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.038 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.7 tp -58.84 -48.34 81.69 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.38 -22.47 66.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.149 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.04 -17.81 25.64 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.577 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 12.11 73.03 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.97 -17.61 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.7 pt -127.37 136.5 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.83 -28.36 62.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.35 155.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.52 50.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.91 0.386 . . . . 0.0 110.04 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.83 102.9 14.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.149 0.499 . . . . 0.0 110.656 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.19 165.17 24.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.396 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.466 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.39 152.27 40.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.561 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.19 -54.18 28.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.9 t -60.31 -49.18 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.456 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.87 88.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.811 0.338 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.18 -63.21 1.21 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.427 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -58.69 -47.26 85.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.67 -37.58 29.16 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.057 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.81 -66.47 0.56 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.8 t80 -40.2 -71.04 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.619 0.247 . . . . 0.0 111.21 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.21 -39.94 92.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.87 -2.69 0.42 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.505 0.669 . . . . 0.0 110.477 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 177' ' ' VAL . 32.9 mt-30 -124.42 141.7 38.33 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.885 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.89 -15.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.835 2.357 . . . . 0.0 112.275 179.139 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.2 t -63.08 -42.75 97.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.9 80.69 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.93 -41.55 96.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.307 . . . . 0.0 110.404 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 58.9 m-20 -65.27 -35.08 79.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.745 179.184 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.3 m-85 -156.73 143.2 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.737 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.93 99.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 110.725 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.19 167.55 28.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.631 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.14 55.44 3.1 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.42 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.8 135.05 35.27 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.467 2.111 . . . . 0.0 111.933 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.2 p -124.66 -108.33 0.33 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.505 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.83 165.17 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.239 -179.367 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.65 155.91 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.146 0.903 . . . . 0.0 110.646 179.197 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.26 118.59 23.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.812 178.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.2 mp0 -72.05 -18.53 61.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.92 -32.1 73.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.524 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.8 mt -60.97 -44.38 97.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.767 -178.135 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -114.22 8.55 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.751 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.13 -154.79 51.12 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.652 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.7 p -70.72 -25.51 26.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.825 0.345 . . . . 0.0 110.508 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.13 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -132.06 160.05 37.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 110.413 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.39 24.6 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.78 32.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.89 111.62 3.91 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -120.89 160.33 23.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.226 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.71 148.93 25.23 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.612 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.06 -48.87 64.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.637 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.06 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -72.17 51.96 0.24 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -64.42 -45.92 85.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.231 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.72 -47.04 33.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.26 -43.84 97.91 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.461 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.6 -42.87 99.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.88 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.56 -37.5 73.23 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.52 -77.4 0.11 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.006 HD21 HD11 ' A' ' 44' ' ' ILE . 85.4 mt -28.85 -45.66 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.815 0.34 . . . . 0.0 110.489 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.4 m-20 -63.57 -45.33 90.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.689 178.048 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.44 -43.63 98.53 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.45 93.47 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.105 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.2 -43.42 98.91 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.063 0.459 . . . . 0.0 110.064 179.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.38 92.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.089 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.91 -42.91 97.28 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.825 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.77 -38.41 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.85 -38.83 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.46 92.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.27 0.54 56.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.59 20.09 67.63 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.4 m -58.07 -46.26 85.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.6 t80 -63.53 -57.51 9.95 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.453 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.91 -41.73 78.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -48.53 80.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -179.471 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.75 -41.79 98.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.469 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.2 -49.81 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.68 -35.38 72.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.426 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.64 -51.07 30.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.461 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.7 m-85 -62.19 -45.92 91.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.593 179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.6 m-85 -154.39 155.52 35.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.443 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.2 p-10 -98.05 101.68 13.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.497 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -158.16 -165.24 1.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.425 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -122.89 110.02 14.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.5 m -63.57 -40.2 88.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.415 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.7 m-85 -58.86 -42.96 90.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.257 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.24 -36.51 93.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.684 0 CA-C-O 117.872 -1.515 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.22 164.18 62.9 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.46 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.573 2.182 . . . . 0.0 112.279 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.51 -40.94 89.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -138.17 139.12 39.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.406 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.46 121.44 61.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.0 110.649 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.08 118.87 32.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.18 0.514 . . . . 0.0 110.176 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.56 138.44 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.516 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.47 105.71 2.2 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.0 m -129.15 120.44 25.86 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 122.707 -0.29 . . . . 0.0 111.136 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 11.3 t0 -114.26 92.95 29.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.081 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--N 1.308 -1.602 0 C-N-CA 122.396 2.064 . . . . 0.0 112.105 179.253 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.978 0.418 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.71 -40.97 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -60.99 -37.21 81.69 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.766 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.9 -45.29 86.54 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.11 -48.46 78.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.017 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.18 -54.56 34.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.372 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.31 -39.95 61.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.269 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.66 -41.85 78.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.02 0.438 . . . . 0.0 110.64 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.0 m -53.47 -45.18 69.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.11 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.02 -46.93 82.27 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -60.08 -42.08 93.85 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.132 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.908 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -75.26 -17.41 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.81 53.23 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.439 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.29 171.73 14.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.3 142.86 27.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.0 m -117.71 131.37 56.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.785 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.29 126.89 43.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.39 179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -93.72 134.72 35.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.637 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.2 127.78 65.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.45 138.1 57.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.3 p30 175.73 130.9 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 57' ' ' ALA . 46.3 Cg_endo -67.74 144.95 67.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.74 2.293 . . . . 0.0 112.521 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.877 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.33 -55.62 2.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.22 -26.63 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.85 -20.95 19.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.269 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.877 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -63.87 -42.34 97.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.17 -56.95 26.44 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.772 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -55.63 -42.46 67.41 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.6 2.2 . . . . 0.0 111.178 177.281 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -58.71 -44.98 90.53 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.919 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.652 HD21 ' HG3' ' A' ' 203' ' ' ARG . 59.5 tp -58.86 -44.04 90.96 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.35 -40.69 96.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.88 9.91 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.24 12.21 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.43 -35.69 81.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -122.2 152.97 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.297 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.21 -22.21 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.406 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.55 156.05 27.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.85 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -114.82 128.85 71.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.117 0.484 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.482 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.21 106.74 8.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.389 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.717 ' OG ' HD21 ' A' ' 55' ' ' LEU . 38.0 t -159.55 178.66 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.93 -15.59 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.362 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.631 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.7 tp -34.99 124.28 0.57 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.889 0.376 . . . . 0.0 110.503 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.83 154.04 26.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.703 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.634 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.8 pt -104.74 148.43 9.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.335 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.1 152.06 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.856 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.97 -47.06 52.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.416 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.49 -39.85 70.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.692 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.631 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.77 -38.01 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.75 -38.94 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.45 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.094 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.57 -50.57 8.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.5 pt -139.38 -168.33 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.185 0.517 . . . . 0.0 110.466 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.42 147.79 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.47 . . . . 0.0 111.061 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.0 m-85 -130.07 150.05 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.57 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.32 -153.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.558 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.8 m-20 41.27 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.68 0.2 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.364 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.428 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 59.1 mt -75.11 -68.79 0.52 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -178.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.75 167.59 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.67 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.237 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.465 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.7 68.25 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.59 -104.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.1 165.76 33.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.17 146.26 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.453 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.8 mt -100.85 135.95 41.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.408 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.9 t -122.66 110.61 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.28 164.4 34.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.47 148.68 24.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.003 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.02 -28.56 57.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.199 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -58.93 -41.66 87.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.319 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -101.84 121.66 42.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.43 110.07 20.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.22 129.45 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.702 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -106.52 154.12 40.13 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.666 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.54 91.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.771 2.314 . . . . 0.0 111.711 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -170.64 143.39 2.17 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.589 0.556 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.84 -33.27 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.072 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.36 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -55.86 -22.2 24.08 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.094 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 mt -76.2 -25.9 55.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.229 179.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.81 133.69 47.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.407 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.22 -16.58 28.09 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.15 151.27 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.016 0.436 . . . . 0.0 110.373 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -95.53 135.17 37.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.377 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -127.15 136.72 59.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.61 138.47 14.29 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -130.77 161.68 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.071 0.462 . . . . 0.0 110.338 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.67 117.7 30.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.496 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.78 157.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.59 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.65 50.68 52.87 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.78 168.76 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 0.0 110.864 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.452 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.0 p -73.17 -27.49 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.2 -55.58 32.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.55 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -56.57 -55.03 38.94 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.63 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.15 -51.03 71.32 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.735 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.4 t80 -62.11 -43.93 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.123 0.487 . . . . 0.0 110.496 179.227 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.73 -44.58 97.72 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.24 -14.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.896 0.379 . . . . 0.0 110.787 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.37 -34.39 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.717 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.51 -50.62 17.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 0.0 111.617 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.96 12.17 36.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.46 -55.55 0.49 Allowed Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.37 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 55.9 Cg_endo -72.04 -10.48 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.769 2.312 . . . . 0.0 111.991 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.59 -9.29 59.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.461 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.23 37.14 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.29 137.84 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.41 129.91 34.86 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.63 138.24 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.03 133.54 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.072 0.463 . . . . 0.0 109.991 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.91 127.08 42.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.65 153.19 25.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.051 0.453 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.97 7.23 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.95 130.42 5.93 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.411 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.1 tp60 -66.06 -45.82 80.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.425 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.77 -23.4 62.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.564 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.463 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -37.13 86.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.516 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.82 -46.64 88.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.186 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.507 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.9 m-85 -64.58 -37.7 88.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.322 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.88 -42.01 97.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.058 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.24 -43.32 91.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.995 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.585 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.9 tp -58.97 -47.93 83.36 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.046 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.6 m -62.9 -22.42 66.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.44 25.13 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.66 72.28 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.75 -17.91 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.0 pt -126.9 135.78 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.45 -27.65 62.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.296 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.74 155.9 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.79 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.96 137.03 50.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -85.85 103.4 14.56 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.347 0.594 . . . . 0.0 110.851 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.7 tt0 -132.93 165.31 24.96 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.372 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.477 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -72.62 153.15 41.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 110.563 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -66.64 -54.86 18.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.361 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' CG ' ' A' ' 91' ' ' TYR . 75.6 t -60.23 -48.95 86.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.689 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.98 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.774 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.51 -63.01 1.24 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.662 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.0 m -59.55 -48.0 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.41 -37.71 17.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.07 -65.86 0.55 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.664 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.7 t80 -40.58 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 111.236 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.3 mt -61.43 -40.22 93.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 -179.146 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.82 -3.04 0.45 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.451 0.643 . . . . 0.0 110.521 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 173' ' ' LEU . 36.0 mt-30 -122.86 149.4 56.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.08 -21.1 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.823 2.349 . . . . 0.0 112.182 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.98 -42.75 94.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.643 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.42 -33.27 85.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.4 -41.34 93.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.313 . . . . 0.0 110.464 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.4 m-20 -65.67 -33.23 75.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.299 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.37 142.64 18.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.42 99.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.21 167.22 29.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.716 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.32 56.38 2.69 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.22 -118.89 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.52 135.55 33.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.462 2.108 . . . . 0.0 111.923 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.7 p -125.43 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.566 -179.024 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.11 164.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 154.26 155.86 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.918 0.761 . . . . 0.0 110.641 179.216 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.06 117.19 22.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.857 179.113 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -71.2 -18.85 62.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.79 -32.43 73.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.555 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.485 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -61.05 -44.48 97.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 -178.056 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -114.01 9.3 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.728 179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.2 -154.3 51.74 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.634 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.38 -25.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 110.488 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.22 -124.24 1.32 Allowed Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.9 p -129.42 156.4 44.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.257 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.73 -169.43 30.31 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -94.48 137.51 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.963 0.411 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.47 108.09 3.26 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.2 mt -123.02 159.26 28.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.023 0.44 . . . . 0.0 110.114 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.652 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.9 mtm180 -86.94 149.75 24.57 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.91 -48.09 64.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.515 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -38.46 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.899 0.381 . . . . 0.0 110.733 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.69 52.11 0.21 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.642 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.57 -44.76 89.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.1 -47.33 29.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.32 -44.07 97.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.421 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.22 -43.06 99.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.16 -36.36 70.67 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.26 -77.65 0.11 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 44' ' ' ILE . 97.2 mt -28.31 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.335 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -64.22 -44.91 90.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.616 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.1 -43.69 98.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.951 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.01 -38.99 93.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.038 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.35 -43.72 98.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 109.903 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.56 93.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -43.06 97.83 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.2 mtp -57.04 -37.94 72.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.08 -39.01 75.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 110.337 178.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.69 94.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.6 p-10 -89.2 1.53 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.73 20.42 64.04 Favored Glycine 0 C--O 1.226 -0.382 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 79.7 m -58.26 -45.99 86.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.428 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.4 t80 -63.84 -58.09 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.396 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.67 -41.55 77.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.78 -48.37 81.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.2 -41.59 98.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.312 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.69 -50.35 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.597 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.34 -35.17 71.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -71.11 -50.92 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.598 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.4 m-85 -62.0 -45.56 93.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.47 155.84 35.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.42 97.94 9.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -155.49 -166.24 2.19 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.42 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.0 t0 -123.22 111.06 16.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.59 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 239' ' ' TYR . 22.4 m -63.54 -40.59 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.9 m-85 -58.61 -42.86 89.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.36 -37.19 94.45 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.628 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.955 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.4 164.38 61.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.744 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.71 143.38 99.39 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 122.655 2.237 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.4 -40.7 89.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.597 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.54 141.9 37.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -109.57 127.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -102.5 119.69 39.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.093 0.473 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -113.69 138.56 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.292 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.78 100.31 1.57 Allowed Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -123.79 119.01 28.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.673 -0.31 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 19.5 t70 -113.16 92.34 21.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.016 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 122.42 2.08 . . . . 0.0 112.13 179.288 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 . . . . . 0 C--O 1.226 -0.159 0 CA-C-O 120.97 0.414 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.0 -40.67 83.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.041 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -60.81 -37.56 82.41 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.88 -178.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.8 -45.0 88.08 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.14 -48.15 79.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.825 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.01 -54.49 34.54 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.323 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.58 -39.59 61.74 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.026 0.441 . . . . 0.0 110.393 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.07 -42.02 76.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.8 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.01 -44.14 70.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.041 -179.182 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.92 -47.56 80.06 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.973 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.56 -41.78 90.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.111 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.926 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.68 -18.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.4 m-20 60.5 52.71 4.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.188 0.518 . . . . 0.0 110.623 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.8 p -146.1 170.75 16.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.25 140.75 29.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -116.3 130.12 56.62 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.69 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.14 127.49 44.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.396 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -94.73 136.36 35.14 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.66 128.58 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 110.304 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.01 139.34 58.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.79 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.39 130.07 0.1 Allowed Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.519 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.0 Cg_endo -67.95 146.73 72.43 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.743 2.295 . . . . 0.0 112.514 -179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.909 HD23 HD12 ' A' ' 58' ' ' LEU . 81.7 mt -41.05 -55.92 2.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -48.06 -26.76 1.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.251 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.94 -20.3 19.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.252 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.909 HD12 HD23 ' A' ' 55' ' ' LEU . 86.5 mt -65.26 -42.36 93.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.694 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.35 -57.27 26.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 123.801 0.688 . . . . 0.0 109.516 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.694 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.9 Cg_exo -55.02 -43.95 54.4 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.571 2.181 . . . . 0.0 111.083 177.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -58.65 -44.55 90.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.575 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.33 -44.24 88.61 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.78 -40.24 94.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.983 0.42 . . . . 0.0 110.488 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.84 11.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.937 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.11 76.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 178.872 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.18 152.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.18 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -94.07 -20.23 20.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 155.87 26.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.76 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 58' ' ' LEU . 97.0 mt -116.43 127.89 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 110.443 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -128.16 105.64 8.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 110.326 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.666 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.2 t -158.66 179.24 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.19 -14.93 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.394 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 39.4 tp -35.98 124.22 0.73 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.47 154.11 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.643 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -104.51 148.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.207 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -149.8 152.63 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.818 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.28 -47.38 55.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.032 0.444 . . . . 0.0 110.548 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.44 -39.93 70.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.5 -37.83 80.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.21 -37.95 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.798 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.01 -27.73 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.094 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.13 -50.73 8.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.976 0.417 . . . . 0.0 110.774 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.67 -168.6 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.165 0.507 . . . . 0.0 110.383 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.33 147.28 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.119 0.485 . . . . 0.0 111.059 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.544 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.93 149.85 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.81 -152.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.47 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.3 m-20 41.72 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.019 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.22 121.41 0.18 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.385 0.428 . . . . 0.0 110.433 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.42 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.0 mt -75.44 -68.81 0.53 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.81 -178.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.443 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.4 p90 -150.32 167.45 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.66 123.58 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.176 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.23 68.27 0.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.775 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.16 -104.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.442 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -159.64 165.83 31.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.11 146.35 22.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.423 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.1 mt -101.38 136.04 41.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.418 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.72 111.0 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.26 165.2 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.4 23.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.64 -27.77 42.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -59.13 -41.87 89.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.249 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.6 122.18 43.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.019 0.437 . . . . 0.0 110.154 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.81 109.34 19.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.395 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.97 129.78 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.641 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.82 159.07 33.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.575 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.9 Cg_endo -59.79 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.789 2.326 . . . . 0.0 111.93 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -169.02 141.2 2.6 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.596 0.56 . . . . 0.0 110.858 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.38 -33.24 61.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.24 -62.65 1.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.333 -178.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.58 -22.11 31.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.066 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -75.53 -26.88 58.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 178.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.9 133.29 47.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 -179.093 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.77 -16.92 28.95 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.2 151.46 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.497 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.22 135.56 37.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.273 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.27 136.73 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.47 138.86 14.47 Favored Glycine 0 N--CA 1.462 0.383 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.92 161.68 40.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.536 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.5 tp -92.56 117.72 30.26 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.696 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.76 157.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.17 50.53 50.75 Favored Glycine 0 N--CA 1.463 0.436 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -149.6 168.79 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.457 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.1 p -73.69 -26.29 60.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.435 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.93 -55.45 32.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.431 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -56.94 -54.35 47.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.583 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.3 -51.12 70.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.641 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.8 t80 -62.31 -43.82 97.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.144 0.497 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.78 -44.41 97.92 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.3 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.835 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.65 2.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.34 -50.92 16.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.698 -178.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -99.0 12.43 36.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.72 -55.54 0.48 Allowed Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.16 25.29 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.737 2.291 . . . . 0.0 111.933 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.93 -8.85 59.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 -179.123 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.32 36.87 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.31 137.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.01 0.434 . . . . 0.0 110.565 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.4 129.75 34.92 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.1 pt -126.19 138.05 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.5 t -123.16 133.28 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.082 0.467 . . . . 0.0 109.899 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.36 127.59 43.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.17 153.76 25.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.265 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -107.05 7.01 29.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.67 130.28 5.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -65.74 -45.81 81.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.07 -23.91 63.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.49 -36.75 85.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.13 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.42 -38.22 90.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.13 -42.5 98.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.164 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.47 -45.95 88.45 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.4 tp -58.46 -48.14 81.74 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.161 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.32 -23.31 67.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.935 0.398 . . . . 0.0 110.066 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.89 -18.79 25.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.45 11.09 69.52 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.24 -18.31 63.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 153' ' ' LEU . 38.3 pt -128.69 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.083 0.468 . . . . 0.0 110.443 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.0 -27.35 61.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.485 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.92 155.88 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.583 0.552 . . . . 0.0 110.91 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.94 137.09 50.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.987 0.422 . . . . 0.0 109.935 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.42 103.27 14.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.238 0.542 . . . . 0.0 110.798 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.3 tt0 -132.47 165.51 24.14 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.341 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.0 152.03 41.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.565 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.33 -54.33 25.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.4 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.443 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.6 t -60.38 -48.83 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.417 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.72 88.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.3 -62.99 1.26 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.507 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.1 m -58.87 -47.38 85.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.88 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -49.16 -37.85 23.62 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.067 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.11 -65.93 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.0 t80 -40.27 -71.15 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.824 -0.221 . . . . 0.0 111.245 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.06 -40.03 92.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.948 -179.452 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.92 -2.28 0.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.613 0.721 . . . . 0.0 110.323 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 177' ' ' VAL . 36.6 mt-30 -124.25 141.4 37.29 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.905 -0.497 . . . . 0.0 110.8 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.75 -16.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.843 2.362 . . . . 0.0 112.409 179.049 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 72.1 t -62.88 -43.0 98.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.619 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.85 82.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.112 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.91 -41.39 96.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.73 0.3 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.8 m-20 -65.58 -34.52 78.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.04 142.74 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.64 99.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.0 110.757 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.7 m-85 -159.07 166.82 30.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.668 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.04 56.36 2.9 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.06 -117.24 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.59 135.68 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.419 2.079 . . . . 0.0 111.984 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.9 p -124.7 -108.33 0.33 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.77 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.21 165.08 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 155.69 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 124.461 1.101 . . . . 0.0 110.69 178.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.75 118.24 22.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.87 -18.71 62.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.47 74.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.8 mt -60.92 -44.55 97.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.685 -177.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.457 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -114.24 10.05 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.758 178.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.45 51.47 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.643 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.5 p -70.85 -25.09 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.486 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 159.91 -123.97 1.29 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -129.51 156.54 43.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.76 -169.59 30.55 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -94.88 138.73 32.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.945 0.402 . . . . 0.0 110.607 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.39 107.17 3.16 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.62 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.7 mt -119.83 159.98 23.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.923 0.392 . . . . 0.0 110.143 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.76 149.11 24.39 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-O 120.833 0.349 . . . . 0.0 110.654 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.4 -48.5 65.65 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.549 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -39.76 -23.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.55 52.21 0.2 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.799 0.333 . . . . 0.0 110.661 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.33 -45.78 86.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.99 -47.12 30.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.281 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.08 -43.99 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.48 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.52 -36.98 72.27 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.94 -77.22 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.926 HD21 HD11 ' A' ' 44' ' ' ILE . 89.0 mt -29.26 -45.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -44.96 91.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.728 177.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.73 -43.79 98.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.897 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.29 93.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.05 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.18 -43.47 98.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.194 0.521 . . . . 0.0 110.032 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.33 93.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.021 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.58 -43.19 97.72 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.92 -38.28 72.65 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.95 -38.84 76.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.673 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -89.33 0.98 56.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.99 20.45 66.81 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -58.33 -45.94 87.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -63.99 -57.6 9.21 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.436 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.04 -41.44 78.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.169 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.56 -48.54 80.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.518 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.77 -41.83 98.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 110.546 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.71 -50.03 75.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.66 -35.04 71.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.409 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.83 -50.87 30.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.55 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 40.2 m-85 -62.25 -45.93 91.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.76 155.61 34.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.4 p-10 -97.35 99.05 10.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.76 -166.03 2.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.08 110.81 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.9 m -63.65 -40.44 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.415 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.6 m-85 -59.04 -42.59 90.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.305 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.2 94.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.607 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 164.25 56.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.93 143.27 99.31 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.574 2.183 . . . . 0.0 112.297 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.34 -40.71 90.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -139.13 139.95 37.79 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.0 mt -107.81 120.69 59.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 110.681 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.06 118.78 32.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.145 0.498 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -112.42 138.56 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.01 101.42 1.51 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -124.68 120.71 32.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 122.717 -0.284 . . . . 0.0 111.142 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t70 -114.07 92.73 27.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.194 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.308 -1.599 0 C-N-CA 122.417 2.078 . . . . 0.0 112.105 179.183 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.6 t0 . . . . . 0 C--O 1.227 -0.126 0 CA-C-O 120.983 0.42 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.85 -40.79 84.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -60.81 -37.38 81.77 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.891 -178.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.72 -44.49 85.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.89 -47.91 81.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.035 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.95 -54.4 39.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.347 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.35 -38.85 59.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.943 0.401 . . . . 0.0 110.311 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.29 -41.77 76.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.46 . . . . 0.0 110.556 178.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 51.0 m -53.79 -44.93 70.54 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.033 -179.364 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.25 -47.31 80.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.037 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.8 -42.15 92.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.201 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.945 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.32 -17.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.09 52.84 3.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.492 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.54 170.91 15.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.36 142.43 27.74 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.075 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 m -117.34 131.87 56.71 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.575 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.9 m -128.75 128.12 43.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -95.19 135.57 36.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.478 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.8 129.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.427 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.75 136.65 56.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.777 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 176.41 131.42 0.18 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.49 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.8 Cg_endo -68.28 144.81 63.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.691 2.261 . . . . 0.0 112.536 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.92 HD23 HD12 ' A' ' 58' ' ' LEU . 79.1 mt -40.29 -55.43 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.21 -26.27 1.87 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.163 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.57 -21.05 18.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.92 HD12 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -64.14 -42.44 96.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.88 179.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.716 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.68 -57.12 26.68 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 123.738 0.648 . . . . 0.0 109.67 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.716 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.14 -42.27 70.46 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.612 2.208 . . . . 0.0 111.267 177.237 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -45.06 90.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.944 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.6 tp -58.94 -44.08 91.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.5 -40.66 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.955 0.407 . . . . 0.0 110.456 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.86 10.38 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.84 12.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.5 -35.16 79.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.498 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -122.9 153.54 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.212 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.54 -21.53 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.285 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.3 156.72 26.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.67 129.06 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -130.55 106.7 8.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.703 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.3 t -158.96 178.69 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -65.33 -15.16 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -35.56 124.84 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.573 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.54 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -83.0 155.0 24.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.662 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.638 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.0 pt -105.04 149.2 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -149.37 152.33 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.829 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.95 -47.48 52.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.544 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.65 -39.53 71.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.88 -37.86 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -57.99 -38.62 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.868 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.81 -27.59 66.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.105 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.26 -51.22 7.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -138.5 -168.23 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 110.501 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.03 147.71 29.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 76' ' ' ILE . 75.4 m-85 -130.09 150.08 51.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.653 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.73 -152.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.498 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 97.2 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.948 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.7 mttt -29.32 121.02 0.15 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.336 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.4 mt -76.64 -69.53 0.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.842 -178.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.448 ' CG ' HG21 ' A' ' 166' ' ' VAL . 40.9 p90 -149.47 166.43 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.614 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.46 122.75 28.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.38 69.46 0.91 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.813 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.51 -104.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.393 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.17 165.77 32.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.56 145.91 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.125 0.488 . . . . 0.0 110.439 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.89 136.26 41.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.99 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.19 165.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.996 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.48 23.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.96 -28.35 56.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.04 -41.7 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.301 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.13 122.19 43.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.06 109.9 19.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.87 129.59 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.656 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -108.28 154.3 41.44 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 110.679 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.24 92.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.756 2.304 . . . . 0.0 111.649 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.02 144.02 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.669 0.606 . . . . 0.0 110.773 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.55 -33.7 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.162 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 108' ' ' THR . 47.7 tp10 -57.35 -62.63 1.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.263 -178.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.37 -21.93 27.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.037 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.0 -26.2 56.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.309 179.162 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.77 133.7 47.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.382 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.08 -16.78 26.36 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -85.92 151.44 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.494 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -95.86 135.39 37.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.25 136.66 60.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.658 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.5 138.53 14.3 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.9 161.66 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.2 tp -92.43 117.42 29.9 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.599 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.73 158.04 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.47 50.48 55.02 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -149.62 168.95 22.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.928 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.458 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 67.2 p -73.24 -27.58 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.13 -55.36 34.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.67 -54.82 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.695 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.37 -51.04 71.18 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.74 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.2 -43.83 97.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.44 97.81 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.43 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.0 110.778 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.23 -34.46 2.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.35 -50.56 18.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.473 . . . . 0.0 111.649 -178.837 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.27 12.59 35.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.83 -55.53 0.47 Allowed Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.413 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.29 -10.31 25.49 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.778 2.319 . . . . 0.0 111.934 -179.494 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.65 -8.88 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.14 37.63 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.28 138.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.85 130.19 34.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.0 138.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.14 133.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 109.99 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.11 127.3 42.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.83 153.7 25.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.33 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.24 7.13 29.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.41 130.47 6.03 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.03 -45.92 79.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.441 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.21 62.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.572 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.87 -36.78 85.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.536 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.03 -47.13 86.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.159 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.1 m-85 -63.74 -37.91 89.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.253 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.19 -42.4 98.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.096 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.73 -45.21 90.96 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.981 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.8 tp -58.69 -47.94 82.82 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.114 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.31 -22.96 67.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.21 -18.66 25.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.641 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.65 69.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.92 -18.13 63.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.7 pt -127.87 136.96 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.66 -27.62 62.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.457 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.8 155.89 1.74 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.817 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.92 137.12 50.19 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 109.991 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.67 103.05 14.13 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.237 0.541 . . . . 0.0 110.817 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.39 165.2 24.79 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.458 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.0 152.6 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.05 -54.37 26.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.332 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.448 HG21 ' CG ' ' A' ' 91' ' ' TYR . 70.8 t -60.24 -49.13 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.439 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.93 87.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.828 0.347 . . . . 0.0 110.759 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.37 -63.35 1.16 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.456 ' OG ' HD12 ' A' ' 173' ' ' LEU . 72.5 m -59.15 -47.88 83.67 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.927 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.01 -38.19 22.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.46 -65.73 0.56 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.676 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -70.94 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.456 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.8 mt -61.06 -39.88 91.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.192 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.65 -2.72 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.462 0.649 . . . . 0.0 110.399 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 173' ' ' LEU . 34.8 mt-30 -124.14 142.21 39.26 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.5 -16.47 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.844 2.363 . . . . 0.0 112.32 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 175' ' ' GLN . 73.0 t -62.69 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.586 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.01 82.73 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.75 -41.27 95.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.733 0.302 . . . . 0.0 110.567 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -66.0 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.393 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.6 m-85 -157.07 143.65 18.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.59 100.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 110.757 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.34 167.37 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.72 56.09 2.85 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.53 -117.94 0.01 OUTLIER Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.59 135.29 33.76 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.504 2.136 . . . . 0.0 111.969 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.9 p -125.36 -107.89 0.32 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.574 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.67 165.11 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.51 156.05 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 124.024 0.828 . . . . 0.0 110.696 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.46 117.61 22.61 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.017 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.38 -18.91 62.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.72 -32.28 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.491 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.3 mt -61.0 -44.46 97.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.706 -178.099 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.458 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.2 m-85 -114.07 9.47 17.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.784 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.37 -155.13 52.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.638 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.9 p -70.55 -25.14 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 0.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.72 -125.17 1.41 Allowed Glycine 0 CA--C 1.518 0.272 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.6 p -131.52 159.3 38.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.63 -163.37 25.47 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.4 138.93 34.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.453 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.25 112.05 3.92 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -124.73 160.1 29.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.65 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.7 mtm180 -86.53 149.66 24.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.786 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.95 -48.4 64.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.669 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.4 tp10 -38.15 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.95 52.02 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.604 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -64.76 -44.86 88.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.401 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.16 -47.1 38.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.84 -43.49 98.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.45 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.75 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.43 -36.7 71.71 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.18 -77.31 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.945 HD21 HD11 ' A' ' 44' ' ' ILE . 96.7 mt -28.63 -46.21 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.01 -45.3 89.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.661 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.78 -43.79 98.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.955 178.731 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.21 93.23 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.024 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.24 -43.54 98.71 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.33 92.86 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.095 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -43.19 96.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -56.68 -38.29 72.02 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.88 76.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.98 94.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 21.4 p-10 -88.65 1.19 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.36 20.32 65.29 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.435 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 72.3 m -58.3 -45.81 87.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.9 t80 -63.89 -58.14 7.67 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.482 179.289 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.86 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.28 -48.63 79.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.0 -41.49 98.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.407 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.43 -50.18 74.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.62 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.89 -35.17 72.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.21 -50.95 27.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.501 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.18 -45.75 92.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.532 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -152.97 154.92 35.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.437 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.6 p-10 -97.06 95.36 7.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.987 0.422 . . . . 0.0 110.567 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.25 -166.67 2.49 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.66 110.33 15.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.5 m -63.64 -40.65 89.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.6 m-85 -56.35 -43.9 79.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -37.6 95.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.681 0 CA-C-O 117.875 -1.514 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.23 61.08 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.676 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.85 143.45 99.37 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.645 2.23 . . . . 0.0 112.299 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.32 -40.35 89.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.91 143.14 36.49 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.456 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.04 128.09 66.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 110.515 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -103.77 118.56 36.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.6 138.4 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.449 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.2 1.61 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.75 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.8 m -123.94 118.32 26.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.713 -0.287 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 24.4 t70 -113.33 92.3 22.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.309 -1.512 0 C-N-CA 122.524 2.149 . . . . 0.0 112.114 179.39 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 . . . . . 0 C--O 1.227 -0.114 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.61 -41.01 82.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.097 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.74 -37.63 82.41 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.18 -178.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.19 -44.0 85.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.299 178.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.525 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.82 92.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.069 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.44 -53.67 54.68 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.504 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.26 -37.58 62.25 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.975 0.417 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.52 -42.03 75.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.8 m -54.54 -44.5 72.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.111 -179.388 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.436 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.81 -47.65 80.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.066 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -59.4 -40.96 88.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.98 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -76.56 -17.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.9 52.44 4.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.151 0.501 . . . . 0.0 110.606 -179.238 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.29 169.99 17.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.12 140.66 29.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -116.87 131.32 56.98 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.638 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.42 128.1 43.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.472 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -94.64 136.34 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.511 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.67 128.38 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.8 139.31 58.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.721 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.84 132.3 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.56 145.22 63.48 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.692 2.262 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.929 HD23 HD12 ' A' ' 58' ' ' LEU . 78.5 mt -40.48 -55.94 2.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.72 -26.55 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.117 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.35 19.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.929 HD12 HD23 ' A' ' 55' ' ' LEU . 85.3 mt -65.08 -42.56 94.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.854 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.703 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 mm -61.51 -56.64 31.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.757 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -55.44 -43.51 57.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 122.64 2.227 . . . . 0.0 111.128 177.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -44.36 90.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.848 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.28 -44.46 88.45 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.59 -40.21 95.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 110.446 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.0 11.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.538 -179.549 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.01 11.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.47 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 178.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.9 pt -124.48 153.28 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.361 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -94.59 -20.0 19.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.21 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.45 156.29 25.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 58' ' ' LEU . 96.9 mt -116.83 127.94 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 110.544 179.589 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.26 106.31 8.94 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.626 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.4 t -159.0 -179.57 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.569 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.56 -15.01 60.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.337 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.645 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -37.58 124.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.531 -179.579 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.09 156.25 23.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.667 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.655 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.7 pt -104.87 148.9 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -150.4 152.75 34.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.22 -47.93 54.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.601 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.52 -39.79 70.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.733 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.645 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.53 -37.63 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.94 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.3 -27.56 67.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.175 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.16 -51.77 7.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 110.574 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.61 -168.55 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.86 147.02 29.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.5 m-85 -129.99 149.96 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.34 -151.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.478 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.6 m-20 42.97 19.34 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.26 120.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.409 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.1 mt -77.04 -69.93 0.49 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 -178.629 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.44 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.4 p90 -149.3 166.26 29.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.584 -179.692 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 121.67 27.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.73 69.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.746 -179.679 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.94 -105.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.31 165.83 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.69 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.6 145.94 21.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 110.5 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.06 136.11 41.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.768 178.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 111.1 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.41 165.12 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.2 148.63 23.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.14 -28.34 57.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.98 -41.88 88.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.325 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.86 121.76 42.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 110.23 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.64 109.61 19.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.464 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.84 129.81 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.636 179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.71 154.15 41.87 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.654 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.519 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.26 92.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.824 2.349 . . . . 0.0 111.674 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.14 144.31 2.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.635 0.585 . . . . 0.0 110.787 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.26 -33.57 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.281 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.6 -62.39 1.82 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.335 -178.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.31 -22.24 29.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.936 -179.222 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -76.07 -26.14 56.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.84 133.35 47.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.402 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.4 -16.51 29.29 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.59 151.91 23.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.949 0.404 . . . . 0.0 110.408 -179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.38 135.64 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.307 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.04 136.61 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.662 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 139.05 14.54 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.31 161.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 110.35 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.2 tp -92.69 117.24 29.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.62 157.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.635 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.87 50.44 52.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.83 169.26 21.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.316 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.01 -25.9 60.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.9 -55.55 31.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.18 -53.94 52.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.59 -51.16 70.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.578 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.36 -43.71 98.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.384 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.01 -44.66 97.48 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.11 -14.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 0.0 110.75 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.34 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.665 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.63 -50.68 16.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.506 -178.741 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -99.19 12.72 35.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.17 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.24 -55.54 0.45 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.34 -10.3 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.821 2.347 . . . . 0.0 111.98 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.69 -8.7 59.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 -179.095 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.07 33.17 37.17 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.62 138.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.86 130.0 35.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.2 pt -126.43 138.23 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.2 t -123.18 133.16 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 109.992 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.18 127.79 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.804 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.15 153.52 25.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.74 6.55 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.699 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.6 130.43 5.98 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.05 -45.6 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.49 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.09 -23.95 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.7 -36.57 84.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.97 -47.0 86.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.126 -179.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.517 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 58.9 m-85 -63.73 -37.94 89.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.232 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.26 -42.56 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.153 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -63.72 -45.63 89.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.865 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.8 tp -58.46 -48.08 81.92 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.19 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -63.18 -22.79 67.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.91 0.386 . . . . 0.0 110.077 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.6 -18.6 24.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.55 70.01 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.83 -17.92 63.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.588 179.678 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.1 pt -128.53 137.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.599 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.17 -27.83 61.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.53 155.47 1.79 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.83 137.31 50.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.0 110.029 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.64 102.91 13.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.225 0.536 . . . . 0.0 110.673 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.9 tt0 -132.08 165.1 24.79 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.52 152.45 40.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.0 -54.13 29.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.25 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 91' ' ' TYR . 69.7 t -60.5 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.47 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.95 87.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.77 0.319 . . . . 0.0 110.789 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.34 1.18 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.567 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.445 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.4 m -58.67 -47.2 85.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.798 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.1 -38.25 24.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.066 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.88 -65.43 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.1 t80 -40.51 -71.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.594 0.235 . . . . 0.0 111.23 -178.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.47 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.077 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.53 -2.99 0.39 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.46 0.648 . . . . 0.0 110.448 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.5 mt-30 -124.85 141.2 37.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -43.6 -14.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.858 2.372 . . . . 0.0 112.341 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.2 t -63.23 -42.91 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.553 -179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.75 -32.89 80.63 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.83 -41.6 96.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.725 0.297 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.0 m-20 -65.62 -34.92 79.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.4 m-85 -156.77 143.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.7 pttt -177.03 99.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.733 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.7 m-85 -159.24 167.98 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.37 55.86 3.14 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.13 -117.05 0.01 OUTLIER Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.66 135.04 34.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.483 2.122 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.5 p -125.11 -108.31 0.32 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.506 -179.035 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.57 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.48 155.61 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 124.077 0.861 . . . . 0.0 110.703 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.33 118.31 23.06 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.026 0.441 . . . . 0.0 109.812 179.016 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.94 -18.49 62.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.87 -32.24 73.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.539 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.1 mt -60.84 -44.44 96.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.725 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -113.84 8.22 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.719 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.3 -154.76 50.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.294 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.56 -25.28 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.851 0.358 . . . . 0.0 110.56 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.8 -125.75 1.5 Allowed Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.0 p -132.04 160.08 36.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.43 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.47 -162.59 24.89 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.18 140.92 31.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.615 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.11 111.9 3.97 Favored Glycine 0 CA--C 1.517 0.19 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.7 mt -121.61 160.79 23.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -87.11 148.94 25.01 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.15 -48.82 64.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.629 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -39.82 -23.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.973 0.416 . . . . 0.0 110.719 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.65 52.17 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.759 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.37 -46.29 84.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.182 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.46 -47.07 35.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.2 -43.89 97.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.45 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.56 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.856 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.51 -37.34 72.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.8 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.98 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -29.01 -45.62 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.8 m-20 -63.62 -45.48 90.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.7 98.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.945 178.654 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.36 92.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.152 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -61.19 -43.39 98.95 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.027 0.441 . . . . 0.0 110.063 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.26 92.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.15 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.96 97.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.886 179.283 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.78 -38.47 72.55 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -69.85 -38.81 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.374 178.875 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.42 92.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.661 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.9 p-10 -88.35 0.4 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.698 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.61 20.38 67.96 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.0 m -58.18 -46.17 86.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.46 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.1 t80 -63.65 -57.43 10.08 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.454 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.68 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.25 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.51 -48.6 80.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.493 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.83 -41.59 97.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.74 76.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.715 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.94 -35.45 73.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.414 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.59 -51.0 31.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.462 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.35 -45.45 93.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -153.74 155.15 35.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.16 99.47 10.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.527 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -156.41 -165.17 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.526 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.74 109.22 13.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.9 m -63.6 -40.35 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.7 m-85 -56.91 -43.7 81.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.83 93.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.708 0 CA-C-O 117.881 -1.51 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.29 164.25 62.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.587 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.91 143.53 99.37 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.564 2.176 . . . . 0.0 112.324 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.38 -41.02 90.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.081 0.467 . . . . 0.0 110.511 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.4 139.07 38.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.388 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.19 121.47 61.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.706 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.91 118.76 31.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 110.13 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -112.4 138.42 41.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 105.47 2.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -129.09 120.2 25.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.136 179.618 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.51 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 5.2 t0 -114.57 92.69 29.69 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.177 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--N 1.309 -1.503 0 C-N-CA 122.404 2.069 . . . . 0.0 112.135 179.462 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.7 t0 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.988 0.423 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -67.79 -40.97 84.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.847 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -61.05 -37.21 81.81 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.824 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.99 -45.26 86.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.02 -48.32 78.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.981 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -53.23 -54.47 35.62 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.31 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.48 -39.81 61.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.872 0.367 . . . . 0.0 110.26 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.79 -42.05 77.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.053 0.454 . . . . 0.0 110.53 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.44 -44.91 69.23 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.146 -179.425 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.26 -46.94 81.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.992 179.0 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -60.04 -42.14 93.78 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.216 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.893 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.28 -17.46 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.429 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.85 53.2 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.424 -179.177 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.12 171.51 15.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -89.16 142.69 27.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.03 0.443 . . . . 0.0 109.956 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.54 131.4 56.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -127.54 127.25 43.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.401 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.86 134.68 35.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.08 127.89 66.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.38 138.0 57.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.829 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.51 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.69 130.33 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.6 Cg_endo -67.58 145.07 69.03 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.71 2.273 . . . . 0.0 112.512 -179.186 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.873 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.13 -55.76 2.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.37 -26.37 2.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.857 0.361 . . . . 0.0 111.224 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.19 -20.91 18.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.873 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.75 -42.37 97.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.643 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.721 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.21 -57.0 25.79 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.795 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.3 Cg_exo -55.39 -42.46 68.06 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.681 2.254 . . . . 0.0 111.213 177.274 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.1 m -58.69 -45.08 90.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.906 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 203' ' ' ARG . 62.9 tp -58.88 -44.2 91.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.148 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.26 -40.82 96.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.426 . . . . 0.0 110.424 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.79 9.87 2.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.416 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.21 12.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.991 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.36 -35.52 80.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.503 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.34 153.14 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.287 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.28 -22.18 19.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.462 -179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.62 156.14 27.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.01 129.01 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.493 . . . . 0.0 110.469 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -131.29 106.72 8.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.714 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.3 t -159.39 178.5 9.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.99 -15.52 62.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.633 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.8 tp -34.98 124.37 0.57 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.596 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.0 154.03 25.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.631 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.74 148.46 9.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.348 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.8 p -149.01 152.2 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.09 53.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.43 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.51 -39.74 70.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.671 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.633 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.8 mtt180 -68.98 -37.94 79.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.819 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -57.9 -39.03 76.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.711 -179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.79 -27.38 66.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.57 -50.77 7.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.046 0.451 . . . . 0.0 110.634 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -139.14 -168.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.1 0.476 . . . . 0.0 110.543 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 76' ' ' ILE . 80.0 m-85 -129.92 150.02 51.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.17 -153.26 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.57 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.7 m-20 41.19 20.14 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.32 0.2 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.324 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 58.5 mt -74.79 -68.51 0.54 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.931 -178.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.52 167.55 26.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.751 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.67 123.62 29.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.184 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.94 68.66 0.83 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.809 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -85.67 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.06 165.63 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.698 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.49 146.09 22.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.79 136.19 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 110.813 178.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.86 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.27 164.91 33.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.81 148.56 23.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.93 -28.42 56.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.241 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -58.76 -41.94 87.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.319 -179.374 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.93 121.74 42.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.016 0.436 . . . . 0.0 110.147 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -86.88 109.72 19.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -125.97 129.14 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.718 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -106.44 154.28 39.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.721 179.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.49 90.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.766 2.311 . . . . 0.0 111.628 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -170.87 143.74 2.11 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.587 0.555 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.71 -33.05 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.085 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.3 -62.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.191 -178.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -55.74 -22.14 22.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.43 -25.91 54.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.254 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.71 133.83 47.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.5 -15.56 29.28 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.94 151.52 23.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.6 135.16 37.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.357 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.16 136.59 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.57 138.45 14.27 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.3 t -130.77 161.56 40.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.082 0.468 . . . . 0.0 110.359 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.3 tp -92.41 117.45 29.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.7 158.06 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.608 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.61 50.56 53.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.4 p -149.77 168.9 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.73 0.3 . . . . 0.0 110.9 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.1 p -73.3 -27.54 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.434 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.15 -55.65 31.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.507 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.5 -54.96 39.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.698 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -60.11 -51.16 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.792 -179.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.5 t80 -62.07 -43.96 97.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.591 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.58 -44.39 98.02 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.336 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.8 tt0 -125.23 -34.28 2.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.53 -50.56 17.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.129 0.49 . . . . 0.0 111.673 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.0 12.29 36.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.252 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.66 -55.38 0.48 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.347 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 55.7 Cg_endo -72.2 -10.61 26.03 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.75 2.3 . . . . 0.0 111.965 -179.626 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.44 -9.17 59.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.42 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.93 33.16 37.79 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.24 138.07 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 110.628 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.67 129.84 35.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.28 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.21 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.96 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.5 t -123.0 133.35 69.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.026 0.441 . . . . 0.0 109.981 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.4 43.13 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -110.64 153.37 25.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.01 6.68 29.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.759 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.21 130.17 5.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.418 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.8 -45.87 80.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.715 0.293 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.82 -23.32 62.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.608 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.58 -37.07 86.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.11 0.481 . . . . 0.0 110.537 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.81 -46.82 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.231 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.508 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.5 m-85 -64.48 -37.72 88.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.345 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.97 -42.23 97.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.1 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.84 -43.52 92.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.122 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.583 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.0 tp -59.01 -47.76 84.03 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.023 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.85 -22.57 66.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.025 0.44 . . . . 0.0 110.12 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.63 -18.26 25.43 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.592 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.95 72.18 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.98 -18.03 63.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.606 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.6 pt -127.04 135.92 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.399 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -72.55 -27.82 62.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.313 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.52 155.99 1.88 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.838 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.15 136.71 49.58 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.68 103.48 14.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.281 0.562 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.76 165.25 24.97 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.476 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.84 153.09 41.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.34 -54.65 22.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.401 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.447 HG21 ' CG ' ' A' ' 91' ' ' TYR . 71.4 t -60.07 -49.06 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.705 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.33 -39.06 89.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.797 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.14 1.21 Allowed 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.0 m -59.5 -48.16 82.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.911 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -48.55 -37.74 18.63 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.342 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.75 -66.14 0.56 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.667 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.2 t80 -40.56 -70.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 111.218 -178.898 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.457 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.7 mt -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.23 -3.03 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.443 0.639 . . . . 0.0 110.499 -179.528 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 173' ' ' LEU . 37.4 mt-30 -122.71 147.09 49.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.853 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.48 -19.64 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.844 2.362 . . . . 0.0 112.228 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.87 -42.8 96.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.672 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.63 -32.97 83.35 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.044 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.57 -41.26 94.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.7 m-20 -65.83 -33.47 75.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.25 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.0 m-85 -156.79 143.04 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.675 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.8 pttt -177.94 100.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.39 167.12 29.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.696 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.07 56.72 2.66 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.43 -118.37 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.635 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.36 135.35 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.477 2.118 . . . . 0.0 111.941 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -125.36 -107.9 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.61 -179.087 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.2 p -165.59 164.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.41 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.4 tttt 153.99 156.28 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.823 0.702 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.55 116.87 22.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.02 -18.94 62.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.81 -32.52 74.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.557 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -61.04 -44.47 97.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.691 -178.08 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -113.96 9.23 17.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.743 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.18 -154.83 52.23 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.631 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.14 -25.06 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.47 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.25 -124.33 1.33 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.22 156.23 44.29 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 110.234 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.56 -169.42 30.15 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -94.52 137.48 33.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.55 108.29 3.29 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.7 mt -123.39 159.37 29.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.441 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.659 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.76 149.61 24.74 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.94 -48.04 64.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.518 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.38 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.5 m-20 -71.75 52.27 0.22 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.64 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.53 -45.54 86.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.345 -179.705 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.44 -47.12 35.48 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.32 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.3 -44.11 97.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.425 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.15 -36.43 70.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.19 -77.73 0.11 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.893 HD21 HD11 ' A' ' 44' ' ' ILE . 97.0 mt -28.27 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.736 0.303 . . . . 0.0 110.29 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.23 -44.83 90.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.662 178.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.99 -43.77 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.957 178.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.27 94.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.057 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -61.25 -43.71 98.44 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 109.894 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.15 92.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.67 -42.89 97.99 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.535 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -58.28 -38.33 76.8 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.0 -40.02 78.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 0.0 110.095 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.68 93.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.0 p30 -86.73 1.54 51.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.451 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.26 19.52 59.69 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 72.6 m -58.31 -45.65 87.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.49 -58.15 7.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.341 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.89 -41.33 77.86 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.46 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.53 -48.36 81.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.643 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.296 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.74 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.463 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.44 -35.39 72.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.645 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -71.14 -50.86 28.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.4 m-85 -62.27 -45.28 93.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.503 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.9 m-85 -153.3 155.06 35.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.407 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.5 p-10 -97.56 95.22 7.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.954 0.406 . . . . 0.0 110.505 179.513 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -153.16 -166.12 2.35 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.99 109.98 14.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.822 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.4 m -63.43 -40.67 89.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.39 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.2 m-85 -56.38 -43.91 79.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.49 94.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.67 0 CA-C-O 117.934 -1.481 . . . . 0.0 110.95 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.22 59.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.604 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.88 144.0 99.47 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.6 2.2 . . . . 0.0 112.235 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -65.86 -40.62 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.62 144.47 37.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.464 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -110.92 129.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -104.42 116.56 32.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.425 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.8 140.99 29.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.17 106.39 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 m -128.49 120.23 26.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.679 0.276 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.7 t70 -112.54 94.22 26.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.104 179.606 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 C--N 1.308 -1.594 0 C-N-CA 122.467 2.111 . . . . 0.0 112.19 179.334 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.8 t0 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.041 0.448 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.02 -39.99 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.741 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -60.98 -36.66 80.03 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.967 -178.836 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.21 -44.71 83.07 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.47 -45.08 89.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.214 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.93 -54.24 45.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.505 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.13 -37.32 64.23 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.62 -43.36 72.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 54.4 m -54.13 -44.24 71.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.165 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.9 tttm -63.91 -48.0 78.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.043 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.51 -41.11 89.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.171 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.967 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.37 -18.53 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.507 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.51 52.24 3.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.14 169.93 17.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.1 140.85 29.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.155 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.17 132.01 56.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.97 126.79 42.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.441 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.18 136.51 34.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.566 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.35 128.93 64.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.416 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.07 139.88 56.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.4 p30 175.0 135.16 0.16 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.37 143.34 57.74 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.715 2.277 . . . . 0.0 112.45 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.879 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -39.88 -54.56 2.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.119 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.84 -25.97 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.139 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.33 -20.99 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.117 -179.605 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.879 HD12 HD23 ' A' ' 55' ' ' LEU . 55.1 mt -64.04 -42.43 97.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.58 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -56.57 30.27 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.008 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.3 Cg_exo -55.05 -42.94 64.16 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.293 176.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.4 m -58.48 -44.94 89.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.854 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 tp -58.65 -44.54 90.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.7 -41.18 96.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.397 . . . . 0.0 110.453 178.829 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.03 11.08 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.29 11.95 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.665 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.61 -33.69 76.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -124.41 154.55 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.322 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -92.6 -20.79 20.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.175 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.19 159.64 23.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.582 HG23 HD13 ' A' ' 58' ' ' LEU . 96.0 mt -116.29 127.39 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 110.537 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 61.9 ttp -128.68 107.38 9.63 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.323 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.514 ' OG ' HD21 ' A' ' 55' ' ' LEU . 36.7 t -162.27 -176.79 5.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.22 -15.89 60.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.345 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.637 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.6 tp -37.51 122.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 110.502 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.03 156.21 23.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.69 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.657 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.21 149.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.0 p -150.52 152.52 34.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.787 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.08 -47.72 53.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.44 -39.78 70.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.637 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.67 -37.79 79.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.022 0.439 . . . . 0.0 110.875 179.203 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.2 -37.71 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.931 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.86 -27.41 66.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.153 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.58 -51.12 7.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 110.543 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -139.15 -168.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.49 147.29 29.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.566 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.1 m-85 -130.33 150.47 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.1 t -165.02 -150.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.474 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.0 m-20 42.74 19.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.14 120.87 0.09 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.484 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -80.0 -72.79 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.923 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -147.86 164.98 32.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.58 127.49 32.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.405 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -107.11 67.48 0.7 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.692 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.27 -106.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 32.2 p -159.45 167.85 27.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.21 146.68 23.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.055 0.455 . . . . 0.0 110.492 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -101.68 135.94 42.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.743 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 111.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.98 164.67 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 -179.165 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 148.44 24.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.31 -28.24 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.2 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -59.07 -41.35 87.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -102.38 122.31 44.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.332 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.51 109.39 19.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.062 0.458 . . . . 0.0 110.532 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.4 129.85 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.25 158.79 36.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.473 ' O ' ' OG1' ' A' ' 108' ' ' THR . 21.0 Cg_endo -60.3 91.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.736 2.29 . . . . 0.0 111.883 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.7 m -169.89 142.62 2.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.56 -33.5 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.284 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -56.73 -63.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.343 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -56.86 -21.75 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.059 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.5 -28.28 59.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -55.06 132.55 47.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.53 -16.35 35.83 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.64 151.21 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 -179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -96.38 135.58 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.287 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.44 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.708 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.83 137.81 13.97 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.4 t -131.44 161.7 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.047 0.451 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.552 ' N ' HG12 ' A' ' 119' ' ' VAL . 39.2 tp -92.99 120.55 33.41 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -52.01 155.49 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.6 50.91 45.62 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -147.85 166.1 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.662 0.267 . . . . 0.0 110.886 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 68.6 p -71.28 -30.62 66.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.3 mt-30 -58.35 -55.16 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.24 -55.43 33.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.799 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 m -60.56 -51.65 68.52 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.872 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.589 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 68.5 t80 -61.83 -44.41 96.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 110.547 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.0 -44.37 97.88 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.8 m-20 -45.44 -14.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 0.0 110.731 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.35 -34.43 2.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.589 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.8 t60 -74.04 -50.46 19.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.523 -178.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.92 12.53 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.165 -179.245 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.24 -55.14 0.51 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.37 -9.8 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.789 2.326 . . . . 0.0 111.988 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.12 -8.62 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.388 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.09 33.51 36.1 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.79 137.57 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.0 110.594 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.97 130.27 35.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.276 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.6 pt -128.34 139.75 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.974 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.96 132.47 70.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.133 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.3 t -97.82 129.83 44.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.763 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.1 156.93 20.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.0 6.97 27.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.25 130.56 6.08 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.24 -46.58 76.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.712 0.291 . . . . 0.0 110.413 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.02 -23.22 63.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.563 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.447 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.61 -36.54 84.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.527 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.26 -47.67 83.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.4 m-85 -63.59 -37.86 88.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.37 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.84 -42.62 98.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.44 -43.74 93.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.3 tp -59.21 -48.53 81.29 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.179 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.72 -22.85 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.962 0.411 . . . . 0.0 110.199 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.29 -18.19 26.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.3 11.03 73.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.48 -18.12 63.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.4 pt -128.37 137.31 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.38 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.409 ' O ' HG12 ' A' ' 99' ' ' VAL . 97.6 m-20 -72.88 -29.36 63.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.26 155.13 1.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.821 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.61 139.09 52.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.946 0.403 . . . . 0.0 110.029 179.262 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.51 103.15 14.77 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.234 0.54 . . . . 0.0 110.714 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.36 164.69 25.92 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -73.53 152.45 40.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.2 -54.11 29.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.59 -49.25 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.91 84.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.844 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.94 1.05 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.533 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.446 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.0 m -57.82 -46.51 84.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.298 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.05 -41.87 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.26 -62.26 0.48 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.623 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.31 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.618 0.247 . . . . 0.0 111.083 -178.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.35 -40.71 97.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.13 -2.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.383 0.611 . . . . 0.0 110.532 -179.333 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.5 mt-30 -126.25 141.5 40.01 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.825 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.45 -14.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.828 2.352 . . . . 0.0 112.211 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 92.5 t -63.28 -42.91 98.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.67 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.31 84.61 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.1 -41.21 96.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.727 0.299 . . . . 0.0 110.48 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -65.8 -34.7 78.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.467 179.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.18 143.35 17.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.6 pttt -175.96 99.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.745 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.76 166.78 31.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.698 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.83 55.89 3.05 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.21 -116.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.56 134.02 32.52 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.573 2.182 . . . . 0.0 111.906 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -123.27 -109.4 0.33 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.453 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 4.4 p -164.84 164.09 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.369 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.6 tttt 154.71 154.09 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.791 0.682 . . . . 0.0 110.657 179.276 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -80.06 119.26 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.951 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.36 -19.76 62.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.18 -31.0 72.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 128' ' ' PHE . 87.9 mt -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.668 -178.322 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -114.46 8.18 16.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.735 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.7 -154.1 49.68 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.657 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.2 p -70.79 -25.74 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 110.606 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.1 -126.9 1.66 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.0 p -132.28 160.56 35.86 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.484 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.96 -161.74 23.87 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.77 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.8 140.45 32.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.976 0.417 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.19 3.53 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -117.86 159.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 110.248 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.9 mtm180 -86.76 148.57 25.36 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.511 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.63 -48.48 63.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.663 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -40.94 -22.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 0.0 110.734 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -73.08 51.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.739 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.41 -46.42 83.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.19 -47.12 37.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.413 HD11 HD13 ' A' ' 44' ' ' ILE . 63.4 tp -62.14 -43.7 98.26 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.59 -43.1 99.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.39 -37.59 72.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.43 -77.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.255 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.967 HD21 HD11 ' A' ' 44' ' ' ILE . 86.9 mt -28.03 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.41 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.2 m-20 -63.63 -45.76 88.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.94 -43.96 97.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.945 178.686 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.2 91.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.082 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.2 91.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.181 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.93 -43.44 95.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.887 179.347 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.511 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.36 -38.53 71.53 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -39.11 77.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 0.0 110.288 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.25 -45.63 90.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.653 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.3 p-10 -88.58 -0.49 57.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.71 20.49 70.27 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.9 m -58.19 -46.36 85.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.484 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -62.21 -56.68 16.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.71 -40.76 76.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.317 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -47.92 83.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.535 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.1 -40.75 96.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.251 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.62 -49.7 76.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.557 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.5 -35.74 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -69.77 -51.6 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.499 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.93 -46.27 90.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.579 179.372 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.67 154.64 33.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.517 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.5 p-10 -98.28 95.19 7.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.979 0.419 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -151.5 -164.13 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.12 108.49 13.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.787 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 239' ' ' TYR . 26.0 m -63.56 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.367 179.671 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.432 ' N ' HG23 ' A' ' 238' ' ' VAL . 89.7 m-85 -58.53 -42.51 87.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.64 95.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.669 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.28 164.39 61.59 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.86 143.52 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.539 2.159 . . . . 0.0 112.287 179.372 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.17 -40.33 90.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.79 142.51 36.7 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.485 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.0 mt -109.62 128.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.915 0.388 . . . . 0.0 110.489 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -103.39 116.86 33.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.128 0.49 . . . . 0.0 110.392 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.59 138.93 38.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.952 0.406 . . . . 0.0 110.575 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.02 104.4 2.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -127.57 119.24 25.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 122.759 -0.26 . . . . 0.0 111.217 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 16.4 t70 -113.63 93.21 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.155 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.308 -1.561 0 C-N-CA 122.502 2.134 . . . . 0.0 112.115 179.253 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.6 t0 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.98 0.419 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.68 -40.77 82.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.055 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 53.0 m-20 -61.16 -37.15 81.86 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.972 -178.464 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.77 -43.99 82.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.054 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.539 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.78 -41.89 92.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.293 -179.114 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -58.8 -53.52 57.4 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.546 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.65 -36.81 62.48 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.924 0.392 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.69 -42.37 74.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 178.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.25 -44.79 72.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.208 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -63.74 -47.79 79.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.987 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.199 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.981 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.46 -17.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.76 52.69 4.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.5 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.62 140.86 29.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.136 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.39 131.79 56.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.636 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.2 127.67 43.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -93.86 135.67 34.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.59 128.27 65.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.345 179.447 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.11 139.29 58.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.819 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.1 p30 174.95 132.35 0.14 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.42 144.55 61.94 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.728 2.286 . . . . 0.0 112.467 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.882 HD23 HD12 ' A' ' 58' ' ' LEU . 82.0 mt -40.01 -56.34 1.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -47.55 -26.48 1.45 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.127 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.36 -20.63 18.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.19 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.882 HD12 HD23 ' A' ' 55' ' ' LEU . 57.4 mt -63.99 -42.35 97.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.49 -56.69 27.77 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.894 -179.305 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.8 Cg_exo -54.94 -43.59 57.9 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.646 2.23 . . . . 0.0 111.249 177.02 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -58.55 -44.69 89.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.781 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.14 -44.32 87.75 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.149 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.56 -40.39 95.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.021 0.439 . . . . 0.0 110.541 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 11.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.517 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.21 12.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.44 -34.46 77.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.536 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -123.8 153.25 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.278 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.71 -20.57 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.97 157.05 25.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.739 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.603 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.02 127.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.062 0.458 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -128.64 106.69 9.12 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.583 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.0 t -159.98 -178.23 6.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.582 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.26 -15.47 60.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.0 tp -38.05 123.81 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.45 156.71 22.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.649 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.3 pt -104.88 148.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.365 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -149.92 152.32 34.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.833 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.19 -47.84 54.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.606 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.81 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.74 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.7 mtt180 -68.45 -37.8 80.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.123 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.11 74.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.875 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.45 67.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.132 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.45 -51.71 7.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.533 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.33 -168.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.81 146.73 29.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.034 0.445 . . . . 0.0 110.985 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 76' ' ' ILE . 71.7 m-85 -129.76 149.98 51.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.614 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.6 t -164.15 -151.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.516 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.5 m-20 43.11 19.18 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.801 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.92 120.12 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.0 mt -77.0 -69.99 0.49 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 166' ' ' VAL . 45.0 p90 -149.34 166.31 29.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.619 -179.648 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.26 121.65 27.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.438 . . . . 0.0 110.29 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.94 69.82 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.782 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.22 -104.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.465 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.29 165.87 32.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.697 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.73 145.84 21.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.503 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.27 136.05 41.75 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.77 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 110.79 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.65 164.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.94 148.42 23.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.57 -27.75 41.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.272 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -59.25 -41.74 89.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.326 -179.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.47 122.59 44.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.299 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.92 109.41 19.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.15 129.6 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.89 158.9 34.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.569 179.916 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.58 89.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.734 2.289 . . . . 0.0 111.913 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -169.05 140.89 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.701 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.27 -32.96 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.237 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -56.98 -62.82 1.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 -178.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -55.95 -22.04 24.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.032 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.57 -26.15 54.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.22 46.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.405 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.82 -15.6 30.88 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.98 151.86 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -179.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.48 135.51 38.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.068 0.461 . . . . 0.0 110.298 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.0 136.71 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.45 138.65 14.36 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.02 161.62 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.03 0.443 . . . . 0.0 110.367 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.2 tp -92.6 117.61 30.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.491 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.75 157.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.01 50.61 51.2 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.6 p -149.84 168.98 22.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.674 0.273 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -73.81 -26.38 60.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.446 179.401 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.66 -55.7 30.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.465 -179.392 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.66 -54.47 45.74 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.63 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.31 -51.25 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.675 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.05 -43.73 98.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.58 179.176 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.47 97.72 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.23 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.34 -34.15 2.74 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.47 -50.88 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.038 0.446 . . . . 0.0 111.533 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -99.07 12.61 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.99 -55.58 0.46 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.23 -10.44 25.76 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.783 2.322 . . . . 0.0 111.979 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.54 -8.88 59.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.425 -179.081 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.38 36.97 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.67 138.27 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.593 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.92 129.81 35.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.301 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.04 133.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 110.067 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.15 127.67 43.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -110.92 153.59 25.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.413 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.94 6.93 29.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.91 130.43 5.94 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.96 -45.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.714 0.292 . . . . 0.0 110.417 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.11 -23.72 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.453 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.72 -36.43 84.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.3 -47.12 85.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.109 -179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -63.56 -37.86 88.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.396 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.21 -42.72 99.08 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.229 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.43 -45.32 91.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 42.8 tp -58.76 -48.19 82.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.73 -22.9 66.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.947 0.403 . . . . 0.0 110.22 179.409 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.77 -18.22 25.31 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.622 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.71 11.24 71.34 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.43 -17.87 63.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 110.631 179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.4 pt -128.5 137.36 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.43 179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.06 -27.89 62.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.63 155.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.811 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.37 50.71 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.019 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.63 103.12 14.16 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.277 0.56 . . . . 0.0 110.761 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.35 165.06 25.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.375 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.36 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.987 0.422 . . . . 0.0 110.526 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.426 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.01 -54.28 28.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.212 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.3 t -59.78 -49.3 84.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.67 -179.295 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.83 -38.8 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.678 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.67 1.09 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.583 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -58.61 -47.62 83.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.73 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -48.75 -38.68 22.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.268 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.69 -65.65 0.55 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.678 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.7 t80 -40.23 -71.13 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.704 -0.292 . . . . 0.0 111.235 -178.82 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.3 mt -61.39 -39.81 92.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.79 -3.11 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.461 0.648 . . . . 0.0 110.535 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.0 mt-30 -124.68 141.79 38.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -43.92 -14.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.797 2.331 . . . . 0.0 112.197 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.9 t -63.17 -42.78 97.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.91 81.5 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.1 -41.28 96.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.622 0.248 . . . . 0.0 110.449 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.6 m-20 -65.98 -34.61 78.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.457 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.9 m-85 -157.44 143.5 17.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.08 100.25 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.1 m-85 -159.49 167.74 27.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.654 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.57 55.65 3.15 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.59 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -179.756 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.57 135.23 33.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.518 2.146 . . . . 0.0 111.953 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.24 -108.0 0.32 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.503 -179.023 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.14 165.22 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.366 -179.408 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.26 155.84 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 123.758 0.661 . . . . 0.0 110.668 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.17 22.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.852 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.6 mp0 -71.87 -18.69 62.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.592 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.6 mt -60.98 -44.26 97.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.0 m-85 -113.71 7.51 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.78 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.35 -155.5 50.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.649 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.5 p -70.54 -25.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.0 110.63 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.96 -126.16 1.56 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.5 p -131.99 160.02 37.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.79 0.329 . . . . 0.0 110.483 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.46 24.87 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.17 141.16 31.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.26 111.9 3.98 Favored Glycine 0 C--N 1.329 0.185 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.6 mt -120.98 160.82 22.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -87.38 149.07 24.72 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.09 -48.93 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 -179.425 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -40.14 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.019 0.438 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.25 52.23 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -46.06 84.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.54 -47.06 35.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.19 -44.07 97.42 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.451 -179.542 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.4 -43.0 99.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.919 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.6 -37.28 72.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.792 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.981 HD21 HD11 ' A' ' 44' ' ' ILE . 86.8 mt -28.11 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 110.358 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.8 m-20 -63.53 -45.51 90.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.582 178.238 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.34 -43.62 98.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.34 93.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.057 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.19 -43.56 98.69 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.5 93.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.221 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.66 -43.08 97.79 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.841 179.317 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.79 -38.26 72.29 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.81 76.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.945 0.403 . . . . 0.0 110.302 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.12 93.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.659 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.73 0.41 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.682 179.499 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.57 20.24 67.74 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.461 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 89.1 m -57.83 -46.38 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.51 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.3 t80 -63.45 -58.01 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.414 179.234 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.74 76.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.565 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.53 -48.45 80.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.85 -41.41 97.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.368 179.366 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.09 -50.21 74.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.508 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.18 -35.77 72.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.669 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.62 -51.09 30.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.42 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.18 -45.77 91.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.57 155.0 35.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.6 p-10 -97.95 98.24 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.24 -165.43 2.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.591 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.67 109.41 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.774 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.5 m -63.86 -40.56 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.478 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.5 m-85 -56.7 -43.75 80.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.95 94.09 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.426 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.908 -1.496 . . . . 0.0 110.955 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.58 164.29 59.17 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.593 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.89 143.55 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.58 2.187 . . . . 0.0 112.295 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.23 -40.23 90.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.76 142.22 36.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.401 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.3 mt -109.41 128.68 65.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 110.511 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.41 117.02 33.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.154 0.502 . . . . 0.0 110.379 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -111.97 139.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.555 -179.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.98 105.26 2.18 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -128.12 119.1 24.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.255 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.534 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.9 t0 -113.63 93.35 27.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.121 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 122.418 2.079 . . . . 0.0 112.132 179.271 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.471 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 35.0 t0 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.48 -41.23 83.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.403 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.2 m-20 -60.89 -37.06 80.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.029 -178.468 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.81 -43.81 82.86 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.07 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.536 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.92 -41.72 92.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.124 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.89 -53.61 56.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.58 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.86 -36.56 62.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.913 0.387 . . . . 0.0 110.309 179.332 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.67 -42.42 74.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 178.801 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.5 m -54.35 -44.71 72.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.158 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -63.91 -47.74 79.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.058 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.46 -40.85 88.22 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.163 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.974 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.34 -17.97 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.536 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 60.77 52.79 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.545 -179.258 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.55 170.58 16.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.46 140.77 29.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.8 m -117.3 131.74 56.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.725 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.7 m -128.24 127.63 43.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.481 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.15 135.79 35.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.595 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.64 128.52 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.02 139.56 58.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.534 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 174.87 131.81 0.14 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.9 Cg_endo -68.05 144.78 65.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.745 2.297 . . . . 0.0 112.477 -179.388 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.878 HD23 HD12 ' A' ' 58' ' ' LEU . 83.3 mt -40.23 -56.0 2.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.98 -26.28 1.7 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.16 -179.552 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.44 -20.65 18.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.878 HD12 HD23 ' A' ' 55' ' ' LEU . 57.3 mt -63.99 -42.3 97.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.656 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.717 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.54 -56.68 27.71 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.93 -179.291 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.717 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.3 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.599 2.199 . . . . 0.0 111.12 177.232 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.86 -44.6 91.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.729 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.22 -44.36 88.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.53 -40.48 95.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.972 0.415 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.21 11.13 1.62 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.06 12.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.36 77.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.584 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.87 153.89 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.339 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.4 -20.83 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.329 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.52 157.76 25.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.783 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 HD13 ' A' ' 58' ' ' LEU . 96.2 mt -115.8 127.43 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 110.502 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.471 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.82 106.89 9.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.395 179.761 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.583 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.6 t -160.74 -177.7 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.583 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.14 -15.86 60.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.3 tp -37.98 123.52 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 110.455 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.4 156.85 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.703 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.2 pt -105.22 149.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.356 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.4 p -150.17 152.68 35.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.835 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.42 -47.48 56.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.574 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.73 -39.85 71.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.3 mtt180 -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 110.962 178.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.25 -37.18 74.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.822 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.48 -27.57 67.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.087 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.73 7.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.0 110.531 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.24 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.122 0.487 . . . . 0.0 110.452 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.94 146.6 29.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 76' ' ' ILE . 73.0 m-85 -129.72 149.97 51.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.26 -151.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.437 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.4 m-20 42.88 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.767 179.57 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -28.39 120.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.403 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.468 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.02 -69.88 0.5 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.888 -178.816 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.441 ' CG ' HG21 ' A' ' 166' ' ' VAL . 45.9 p90 -149.27 166.28 29.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.64 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.41 121.56 27.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.308 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.46 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.77 69.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 -179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.92 -104.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.22 165.62 33.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.777 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 79.0 ttt-85 -155.49 146.11 22.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.438 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.4 135.93 42.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.987 0.423 . . . . 0.0 110.818 178.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.56 110.62 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.3 165.02 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 -179.39 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.79 23.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.79 -27.95 45.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.12 -41.79 89.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -102.35 122.21 43.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.257 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.7 108.92 19.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.085 0.469 . . . . 0.0 110.425 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.07 129.92 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.59 159.18 34.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.95 0.405 . . . . 0.0 110.511 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.32 89.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.674 2.249 . . . . 0.0 111.891 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -169.2 140.82 2.45 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.459 0.474 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.09 -32.71 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.145 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.507 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.23 -62.95 1.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 t -55.74 -22.17 22.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.015 -179.154 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.4 -26.21 55.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.21 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.71 44.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.435 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.93 30.99 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -86.15 151.34 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.0 110.441 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.72 136.11 37.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.294 -179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.06 136.65 60.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.731 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 138.26 14.17 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.1 t -131.26 161.75 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.352 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.549 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.0 tp -93.05 119.63 32.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -52.04 157.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.97 50.72 50.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.1 p -149.05 167.97 24.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.715 0.293 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 81.3 p -74.06 -26.22 60.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.392 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.79 -55.47 32.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.21 -53.78 54.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.1 m -60.58 -51.34 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.1 t80 -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.131 0.491 . . . . 0.0 110.489 179.207 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.19 -44.49 97.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.276 -0.729 . . . . 0.0 111.276 -179.282 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.43 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.24 -34.1 2.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.56 -50.52 17.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.026 0.441 . . . . 0.0 111.586 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -98.94 12.5 35.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.272 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.774 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.92 -55.32 0.47 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.38 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.2 -10.71 26.18 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.778 2.319 . . . . 0.0 111.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -8.9 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.82 33.43 37.46 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.29 138.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.644 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.06 130.01 35.12 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.229 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.53 139.31 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.6 132.39 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.962 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.44 130.32 45.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.55 156.55 21.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.375 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.87 6.26 29.19 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.739 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.8 6.24 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.405 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.8 tp60 -66.13 -45.9 79.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.4 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.63 -23.31 62.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.532 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.2 t-20 -64.54 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.507 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.04 -47.16 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.26 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.7 m-85 -64.36 -37.56 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.324 179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.81 -42.17 97.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.055 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.95 -43.02 94.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.92 179.227 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.3 tp -59.48 -47.94 83.58 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.024 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.4 m -62.63 -22.74 66.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.716 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -17.52 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.659 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 11.82 74.38 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.72 -18.11 63.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 153' ' ' LEU . 35.3 pt -127.15 136.23 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.377 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 99' ' ' VAL . 97.6 m-20 -72.82 -28.9 62.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.302 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.484 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.11 155.55 1.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.13 138.04 51.56 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -86.25 102.93 14.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.265 0.555 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.8 tt0 -132.24 164.87 25.42 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.388 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.475 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.14 152.98 40.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.968 0.413 . . . . 0.0 110.549 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.08 -54.38 26.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.295 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.441 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.07 -49.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.709 -179.31 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.06 88.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.788 0.327 . . . . 0.0 110.851 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.78 1.06 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.678 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.6 m -58.64 -47.45 84.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.708 -179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.13 -38.4 25.0 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.228 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.67 -65.56 0.55 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.683 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.7 t80 -40.34 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.722 0.296 . . . . 0.0 111.312 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.8 mt -61.53 -39.61 91.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.044 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.06 -3.19 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.515 -179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.5 mt-30 -124.28 142.28 39.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.1 -15.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.833 2.355 . . . . 0.0 112.22 179.275 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.3 t -62.98 -42.75 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.01 82.37 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.0 -41.29 96.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.673 0.273 . . . . 0.0 110.509 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.4 m-20 -66.02 -34.58 78.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.388 179.514 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -157.07 143.21 17.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.91 99.91 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.9 0.381 . . . . 0.0 110.782 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.26 166.73 30.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.729 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.45 56.01 2.91 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.29 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.8 135.51 35.33 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.478 2.119 . . . . 0.0 111.9 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.15 -107.87 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.552 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.677 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -166.5 165.39 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.351 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.677 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.21 156.42 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.748 0.655 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -82.88 117.98 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.27 -18.65 62.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.74 -32.01 73.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.581 -179.557 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.455 HD11 ' CG ' ' A' ' 128' ' ' PHE . 93.0 mt -61.06 -44.29 97.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.772 -178.183 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.7 7.68 17.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.763 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.89 -155.4 50.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.651 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.1 p -70.32 -25.52 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.65 -126.36 1.6 Allowed Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.355 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.66 159.64 37.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 110.47 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.61 24.96 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.32 141.18 31.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.967 0.413 . . . . 0.0 110.579 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.04 3.84 Favored Glycine 0 C--N 1.329 0.173 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.7 mt -119.71 160.52 22.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 110.202 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -87.28 149.03 24.83 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.847 0.356 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.33 -48.77 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.685 -179.345 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -40.63 -22.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.123 0.487 . . . . 0.0 110.682 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.08 52.18 0.24 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.769 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.45 -45.88 85.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.301 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.62 -47.14 33.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.055 0.455 . . . . 0.0 111.279 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.18 -44.08 97.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.49 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.864 179.536 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.75 -37.33 73.42 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.974 HD21 HD11 ' A' ' 44' ' ' ILE . 86.2 mt -28.39 -45.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 0.0 110.322 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.1 m-20 -63.57 -45.54 89.97 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.495 178.288 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.47 -43.59 98.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.753 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.25 92.86 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.045 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.002 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.51 92.95 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.179 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.54 -43.13 98.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.84 -38.27 72.42 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.89 -38.84 76.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 110.364 178.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.35 93.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 20.9 p-10 -88.34 0.44 56.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.681 179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.34 20.3 67.37 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.01 -46.36 85.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 226' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.0 t80 -63.47 -57.88 8.82 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.33 -41.72 76.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.66 -48.19 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.686 -179.539 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.15 -41.48 98.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.17 -50.11 75.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.532 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.21 -35.8 72.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.59 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.44 -50.91 33.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.2 m-85 -62.5 -45.28 93.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.521 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 72.1 m-85 -153.93 155.02 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.526 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.34 98.63 9.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.419 . . . . 0.0 110.511 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -155.59 -165.11 1.89 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.577 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.0 t0 -122.67 109.15 13.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.803 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 25.1 m -63.72 -40.53 89.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.421 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.8 m-85 -56.76 -43.71 81.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.42 -36.77 93.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.663 0 CA-C-O 117.853 -1.526 . . . . 0.0 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.03 164.31 62.27 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.651 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 143.46 99.37 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.47 2.114 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.65 -40.67 88.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -138.78 141.6 38.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.02 127.69 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.4 mtp180 -101.65 117.56 35.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.157 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.6 104.71 2.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -127.87 119.52 25.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 18.2 t0 -113.23 91.89 20.62 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.069 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.87 134.06 57.43 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.466 2.111 . . . . 0.0 111.904 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.3 p -141.32 -19.65 0.78 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.4 m-85 -123.97 98.43 5.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.319 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.702 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.79 -61.09 0.22 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 121.851 0.834 . . . . 0.0 110.969 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.702 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.78 -40.52 47.78 Favored 'Trans proline' 0 C--N 1.297 -2.176 0 C-N-CA 121.896 1.73 . . . . 0.0 112.22 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -78.37 -43.1 28.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.134 0.492 . . . . 0.0 110.866 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.624 ' O ' ' O ' ' A' ' 18' ' ' ALA . 97.0 mt-10 -149.28 -154.56 0.56 Allowed 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.147 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.66 177.66 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.837 0.351 . . . . 0.0 110.164 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.28 144.65 46.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.406 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -95.49 134.84 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.489 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -64.82 -18.9 65.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.451 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.24 -6.63 55.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.507 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.75 -7.98 55.91 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.31 158.38 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.411 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -111.87 131.74 55.16 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.337 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.688 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.32 151.54 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.89 151.81 6.75 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -58.83 -42.41 89.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.872 0.368 . . . . 0.0 110.838 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.6 t0 -69.25 -28.84 66.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 0.0 111.232 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.688 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -67.66 -40.97 85.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.107 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.81 -37.7 82.89 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.095 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.39 -45.04 89.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.126 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.3 -47.9 80.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -53.22 -54.34 37.54 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.55 -40.25 62.35 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.102 0.477 . . . . 0.0 110.13 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.13 -42.02 80.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.945 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.2 m -54.13 -43.95 70.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.01 -47.12 81.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.225 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -59.86 -41.79 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.474 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.929 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.36 -18.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.81 52.59 4.22 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.354 0.409 . . . . 0.0 110.659 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 p -146.63 171.11 15.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -88.63 141.39 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.984 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.95 130.61 56.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.569 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.06 127.23 44.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.277 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.66 135.81 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.438 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.54 128.92 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.939 0.4 . . . . 0.0 110.423 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.46 139.2 58.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 175.37 129.88 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.0 146.43 71.09 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.632 2.221 . . . . 0.0 112.402 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.876 HD23 HD12 ' A' ' 58' ' ' LEU . 83.4 mt -40.44 -56.73 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.07 -27.14 2.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.39 -20.69 19.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.048 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.876 HD12 HD23 ' A' ' 55' ' ' LEU . 60.7 mt -64.53 -42.41 95.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.622 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.664 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.62 -56.96 24.95 Favored Pre-proline 0 C--O 1.241 0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.667 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.6 Cg_exo -54.46 -43.52 58.04 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.435 2.09 . . . . 0.0 111.521 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.6 m -59.09 -44.32 91.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.777 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.42 -44.14 88.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -64.6 -39.95 94.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.46 11.29 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.96 12.12 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.762 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.63 78.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.51 152.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -92.98 -20.59 20.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.23 156.18 26.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.489 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 58' ' ' LEU . 96.8 mt -115.29 127.11 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.451 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -128.32 105.9 8.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.268 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.663 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.9 t -159.33 179.87 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.78 -15.14 61.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.427 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.642 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.2 tp -36.4 123.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.583 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.73 154.72 25.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.778 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.82 148.35 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.2 p -149.62 152.53 35.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.738 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.37 -46.89 56.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.99 -40.17 72.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.479 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.642 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.8 mtt180 -68.09 -37.9 81.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.15 -37.83 75.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.994 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.03 -27.44 66.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.16 7.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.554 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.7 pt -139.28 -168.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.28 146.92 29.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.83 149.81 51.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.7 t -164.09 -152.81 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.512 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.507 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.7 m-20 41.86 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.948 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.63 121.07 0.2 Allowed 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.61 0.569 . . . . 0.0 110.522 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.3 mt -75.13 -68.37 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.866 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.9 p90 -150.71 167.27 27.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.705 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.5 123.22 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.306 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.87 67.96 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.642 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.64 -104.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.38 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.9 p -159.76 166.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.635 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.35 145.99 22.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.22 135.9 41.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.49 110.98 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.0 m -134.5 164.14 34.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.732 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.17 148.33 25.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.924 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.68 -27.63 41.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.53 -41.66 90.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.273 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -102.17 122.0 43.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.802 0.334 . . . . 0.0 110.143 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.11 109.55 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.33 129.75 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.623 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.83 159.02 34.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.358 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.449 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.7 Cg_endo -59.76 89.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.74 2.293 . . . . 0.0 111.934 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -168.5 140.53 2.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.798 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -66.74 -33.05 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.185 0.516 . . . . 0.0 110.218 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.51 -62.37 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.612 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.19 -22.31 28.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 110.859 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -76.32 -25.89 55.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -54.56 132.69 45.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.612 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -16.57 30.25 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -85.85 151.22 23.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.35 135.91 37.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.244 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.38 136.51 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.702 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.43 139.98 14.9 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.3 t -132.01 161.59 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.2 tp -92.92 119.04 31.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.488 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.9 157.3 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.79 47.99 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.4 p -149.51 168.14 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.26 -25.71 59.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.14 -55.16 35.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.43 -54.08 50.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.38 -51.15 70.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.542 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.594 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.3 t80 -62.23 -43.81 97.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.466 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.49 -44.53 97.88 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.82 -14.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.42 -34.66 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.594 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.7 t60 -74.47 -50.43 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.435 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.37 12.53 36.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.139 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.741 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.91 -55.52 0.47 Allowed Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.416 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.6 Cg_endo -72.27 -10.32 25.54 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.727 2.285 . . . . 0.0 111.984 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.53 -9.18 59.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.26 37.88 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.32 137.94 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.59 129.62 35.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.64 138.52 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.54 131.89 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 t -98.16 130.33 44.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.603 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -111.44 156.23 21.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.278 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.03 6.48 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.742 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.62 130.66 6.22 Favored Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.404 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.7 tp60 -65.92 -45.87 80.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 110.459 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.55 -23.61 62.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.66 -36.93 85.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.95 -46.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.316 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.511 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.3 m-85 -64.04 -37.85 88.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.02 -42.45 98.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.049 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.87 -44.45 93.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.108 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.4 tp -59.09 -47.86 83.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.147 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.05 -23.15 67.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.176 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.66 25.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.07 71.05 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.26 -18.39 63.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.8 pt -127.7 137.64 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.09 0.471 . . . . 0.0 110.554 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.99 -28.35 62.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.964 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.41 155.71 1.88 Allowed 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.72 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.97 103.18 14.44 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.2 tt0 -132.96 165.27 25.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.509 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.82 152.13 41.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.658 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.13 -54.23 28.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.647 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 91' ' ' TYR . 78.1 t -60.8 -48.63 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.303 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.8 88.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 110.644 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.36 -63.28 1.18 Allowed 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.362 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.436 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.7 m -59.15 -47.18 86.25 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.92 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.55 -36.8 24.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.72 -64.99 0.52 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.7 t80 -41.34 -71.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.877 0.37 . . . . 0.0 111.009 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.73 -40.03 93.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.7 -3.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 173' ' ' LEU . 54.5 mt-30 -122.71 149.34 55.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.49 -20.27 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.796 2.331 . . . . 0.0 112.175 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.76 -42.98 94.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.495 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.2 84.2 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.63 -41.73 95.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 0.0 110.333 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.1 m-20 -65.4 -34.09 77.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.514 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.6 m-85 -155.82 142.62 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.58 99.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.471 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.22 167.29 29.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.43 56.24 2.87 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.05 -117.88 0.01 OUTLIER Glycine 0 CA--C 1.543 1.789 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.76 136.28 35.0 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -125.08 -108.64 0.32 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.408 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.0 p -165.84 164.85 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.939 -0.553 . . . . 0.0 109.807 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.19 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.373 1.046 . . . . 0.0 110.675 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -82.15 118.05 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.801 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -72.03 -18.89 61.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.48 -32.54 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.0 mt -60.9 -44.26 97.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.712 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.3 m-85 -114.48 9.63 16.76 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.691 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.97 -153.52 51.33 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.74 -25.47 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.324 . . . . 0.0 110.447 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.21 -123.92 1.28 Allowed Glycine 0 N--CA 1.46 0.245 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -129.6 156.23 44.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.69 -169.61 30.52 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -95.0 138.99 31.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.535 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.87 107.56 3.25 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.9 mt -119.76 159.54 24.32 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.1 mtm180 -86.98 149.04 25.05 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.71 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.29 -48.07 65.55 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.712 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -40.51 -23.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.709 0.29 . . . . 0.0 110.666 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.57 52.06 0.2 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.28 -45.74 86.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.87 -47.08 32.06 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.47 -43.94 97.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.14 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.873 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.51 -36.98 72.26 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.772 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.57 -77.37 0.11 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 44' ' ' ILE . 89.7 mt -29.14 -45.49 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.247 0.342 . . . . 0.0 110.692 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.04 -45.07 90.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.731 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.57 -43.61 98.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.893 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.15 93.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.28 -43.72 98.41 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.086 0.47 . . . . 0.0 110.145 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.21 91.9 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -42.35 98.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.092 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.525 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.39 -38.47 77.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.44 -39.88 81.35 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.404 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.1 92.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.522 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.525 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.8 p30 -86.33 1.04 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.482 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.2 19.42 61.71 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 73.4 m -58.13 -45.94 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.086 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 77.3 t80 -63.5 -57.14 11.15 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.38 -41.05 79.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.01 -48.28 82.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.09 -41.82 98.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.293 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.8 -49.84 76.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.65 -35.56 72.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.393 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -70.59 -50.9 32.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.617 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.507 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.5 m-85 -61.97 -45.62 92.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.484 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -154.82 156.1 35.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.39 99.3 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.022 0.439 . . . . 0.0 110.409 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -156.24 -166.32 2.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.412 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.3 t0 -122.71 110.8 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.0 m -63.44 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.404 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.8 m-85 -59.22 -42.54 91.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.35 94.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 117.817 -1.546 . . . . 0.0 110.968 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.8 54.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.06 143.62 99.15 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.417 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.15 -40.49 90.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.597 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.9 143.18 36.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.1 mt -110.19 128.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.86 116.51 32.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.27 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.8 mt -111.28 138.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.351 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.43 104.44 2.11 Favored Glycine 0 N--CA 1.462 0.409 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.6 m -127.53 119.1 25.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 110.631 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 21.5 t70 -113.55 92.55 24.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.966 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.44 134.31 60.8 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.531 2.154 . . . . 0.0 111.767 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 p -141.67 -19.53 0.75 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.766 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 20' ' ' PHE . 97.0 m-85 -124.76 98.86 5.89 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.345 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.706 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.64 -61.28 0.21 Allowed Pre-proline 0 N--CA 1.467 0.417 0 CA-C-O 121.974 0.892 . . . . 0.0 111.004 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.706 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.0 Cg_endo -50.07 -39.44 50.86 Favored 'Trans proline' 0 C--N 1.295 -2.238 0 C-N-CA 122.105 1.87 . . . . 0.0 112.07 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.3 t80 -78.82 -43.15 25.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.279 0.562 . . . . 0.0 110.885 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.635 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.5 mt-10 -149.34 -155.28 0.62 Allowed 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.231 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.05 177.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.781 0.324 . . . . 0.0 110.246 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.94 143.23 44.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.45 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.2 t-20 -95.91 141.84 28.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.394 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.47 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.2 p -66.15 -19.01 65.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.578 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -77.87 -6.87 55.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.439 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.69 -7.0 59.16 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.38 158.0 27.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 0.0 110.406 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.8 mt -111.77 133.8 53.76 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.671 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.22 150.81 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.79 6.76 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -58.81 -42.13 88.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.741 0.305 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.7 t0 -70.17 -28.53 65.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.102 0.477 . . . . 0.0 111.205 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.671 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -67.76 -41.74 85.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.236 0.541 . . . . 0.0 111.282 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 48.9 m-20 -60.95 -37.48 82.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.815 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.05 -43.83 86.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.183 0.516 . . . . 0.0 110.555 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.15 -41.47 92.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.316 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.2 -52.89 63.73 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.535 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.21 -37.2 64.29 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.034 0.445 . . . . 0.0 109.891 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.47 -42.58 78.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.129 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.74 -44.36 73.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.125 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.07 -46.92 82.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.23 0.538 . . . . 0.0 110.399 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -60.28 -40.87 91.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -75.94 -17.82 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.705 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.74 52.16 4.51 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.706 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.19 170.12 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.2 140.22 29.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.008 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -116.81 131.49 56.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.04 127.5 43.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.436 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -94.06 135.52 35.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.5 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.5 128.92 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.988 0.423 . . . . 0.0 110.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.9 139.48 58.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.483 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.1 p30 175.68 131.43 0.16 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.778 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.8 Cg_endo -68.08 145.41 67.11 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.613 2.209 . . . . 0.0 112.602 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 82.3 mt -40.37 -56.51 1.99 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -47.88 -26.66 1.77 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.855 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.1 -20.51 19.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.124 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -64.16 -42.47 96.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.563 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.667 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -63.17 -56.23 29.66 Favored Pre-proline 0 C--O 1.242 0.66 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.919 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.1 Cg_exo -55.29 -42.7 65.88 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.486 2.124 . . . . 0.0 111.202 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -58.96 -44.12 91.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.866 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.191 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.36 -40.27 95.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.4 11.1 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.631 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.35 11.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.755 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.18 -34.74 78.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.667 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.72 153.09 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.31 -20.87 19.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.7 156.72 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.493 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.6 127.02 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.5 ttp -128.4 106.66 9.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.247 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.595 ' OG ' HD21 ' A' ' 55' ' ' LEU . 42.3 t -160.35 -178.23 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.585 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.15 -15.32 59.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.48 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -38.27 123.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.614 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.34 156.88 22.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.644 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.15 149.05 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -149.83 152.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.27 -47.03 55.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.647 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.33 -40.05 73.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.301 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -67.92 -37.92 82.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.226 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.26 -37.05 74.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.56 -27.43 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.257 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.31 -51.73 7.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.615 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.4 -168.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.74 146.67 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 110.73 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.79 149.88 51.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.709 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.5 t -164.4 -151.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.501 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.23 19.52 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.83 120.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.652 0.595 . . . . 0.0 110.509 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -77.18 -69.29 0.54 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.92 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.3 p90 -149.62 166.17 30.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.517 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.98 122.31 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.387 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.449 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.59 69.39 0.98 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.538 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.9 -105.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -158.85 165.63 33.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.59 145.79 21.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.85 136.13 41.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 110.92 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.833 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.37 164.93 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 0.0 110.714 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.7 148.53 23.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.866 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.49 -28.29 59.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.01 -41.85 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.245 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -101.71 122.04 43.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.121 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.16 109.7 19.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.63 129.63 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.636 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.01 154.25 41.25 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.553 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.65 91.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -170.74 144.35 2.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.22 -33.72 62.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 110.229 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.65 -62.04 2.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.607 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -56.65 -22.05 31.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.725 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -76.47 -25.62 54.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.18 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.59 47.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -16.09 30.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.73 151.67 23.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.217 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.23 135.21 38.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.2 t -126.74 136.2 61.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.02 138.81 14.38 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.13 161.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.239 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.538 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.53 117.69 30.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.399 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.72 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.585 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.93 50.39 52.93 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.77 168.84 22.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.456 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 71.6 p -73.29 -26.82 61.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.372 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.62 -55.03 38.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.605 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.21 -54.38 47.47 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -60.41 -51.37 69.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.64 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.01 -44.02 97.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.346 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.59 -44.49 97.89 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.67 -14.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.213 . . . . 0.0 110.705 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.3 tt0 -125.53 -34.53 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.565 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.65 -50.62 17.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.28 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -99.42 12.26 36.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.096 0.474 . . . . 0.0 111.133 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.69 -55.55 0.48 Allowed Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.483 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.4 -10.23 25.23 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.751 2.301 . . . . 0.0 112.039 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.38 -8.93 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.58 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.12 33.09 37.23 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.51 137.98 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.76 129.89 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.4 138.13 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.99 133.06 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.86 127.25 42.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.83 153.33 25.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.32 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.94 6.95 29.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.43 130.44 6.01 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.98 -45.72 80.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.56 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.51 -23.46 62.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.47 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.452 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.7 -36.98 86.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.85 -46.86 87.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.366 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.09 -37.85 88.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.218 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.98 -44.52 92.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.181 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 42.1 tp -59.31 -47.64 84.65 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.087 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.06 -23.0 67.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.15 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.59 -18.24 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.48 11.73 71.14 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.87 -18.05 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.6 pt -127.86 137.73 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 110.527 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.21 -28.44 62.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.07 155.63 2.0 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.795 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.51 50.51 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -86.08 103.05 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.6 tt0 -132.6 164.68 26.12 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -72.99 152.6 41.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.392 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.6 mt-10 -65.7 -54.04 32.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.406 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.1 t -60.75 -48.7 87.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.428 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.93 87.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.844 0.354 . . . . 0.0 110.429 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.16 -63.68 1.08 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.446 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.8 m -58.92 -46.97 86.64 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.812 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 80.8 tt0 -49.95 -37.48 32.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.228 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.2 -65.39 0.54 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.658 ' N ' ' O ' ' A' ' 168' ' ' ALA . 29.7 t80 -40.74 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.831 0.348 . . . . 0.0 111.089 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -61.88 -39.6 92.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.62 -3.96 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.276 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 177' ' ' VAL . 85.4 mt-30 -123.46 142.01 37.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -43.95 -15.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.82 2.347 . . . . 0.0 112.132 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.8 t -62.8 -42.96 98.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.438 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.83 -32.85 80.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.99 -41.55 96.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.2 m-20 -65.78 -34.63 78.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.687 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.08 143.53 18.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.635 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.2 pttt -177.16 99.57 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.117 0.484 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.6 m-85 -159.19 168.21 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.631 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.42 55.96 3.1 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.68 -116.78 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.0 135.43 36.78 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.102 1.868 . . . . 0.0 111.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.8 p -125.25 -108.38 0.32 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.315 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.62 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.97 164.8 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 119.03 -0.51 . . . . 0.0 109.929 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.07 155.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.259 0.975 . . . . 0.0 110.539 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.75 117.97 23.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.808 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.67 -19.02 62.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.24 -32.06 73.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.473 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.4 mt -61.08 -43.94 98.12 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.735 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.456 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.95 7.33 16.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 0.0 110.689 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.3 -155.09 50.01 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.644 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.43 -25.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.863 0.363 . . . . 0.0 110.593 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.449 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.05 -126.08 1.54 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -131.91 159.7 37.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.89 25.4 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.501 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.13 141.16 31.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.2 112.02 3.99 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.8 mt -121.18 160.35 23.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.85 149.04 25.11 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.705 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.44 -48.2 65.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -40.9 -22.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.602 0.239 . . . . 0.0 110.587 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.86 52.09 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.431 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.31 -46.3 84.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.42 -46.93 36.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.5 tp -62.44 -43.93 97.65 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.359 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.24 -42.76 99.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.974 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.74 -37.37 73.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.948 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.6 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 44' ' ' ILE . 86.1 mt -29.15 -45.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.316 0.385 . . . . 0.0 110.843 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -64.16 -45.1 89.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.64 -43.57 98.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.945 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.15 92.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.307 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.05 -43.66 98.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.175 0.512 . . . . 0.0 110.312 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.27 91.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.319 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -64.07 -41.79 97.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.291 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.6 mtp -58.04 -38.19 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.49 -38.9 77.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.418 . . . . 0.0 110.554 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.15 93.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.1 p-10 -88.72 0.42 56.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.33 68.47 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -58.38 -45.85 87.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.4 t80 -63.43 -57.53 9.99 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.01 -41.06 77.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.402 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.07 -48.12 82.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.338 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.07 -41.59 98.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.333 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.84 76.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.6 -35.86 73.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.43 -50.91 33.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.465 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.513 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.5 -45.46 92.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.35 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.7 m-85 -153.76 155.32 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.416 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.15 98.54 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 110.458 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -155.42 -165.49 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.465 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.56 109.37 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.9 m -63.75 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.421 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.2 m-85 -57.18 -43.64 82.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.0 94.17 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.425 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.899 -1.5 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.5 164.43 59.96 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.689 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.07 143.69 99.11 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.658 2.239 . . . . 0.0 112.244 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.39 -40.83 89.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.75 139.2 38.23 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.361 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.1 121.1 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.8 118.59 31.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.5 138.23 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.305 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.57 105.39 2.14 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.8 m -128.73 120.84 27.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 122.687 -0.302 . . . . 0.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.497 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.8 t70 -114.29 92.61 28.05 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.918 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.51 134.73 63.24 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.499 2.133 . . . . 0.0 111.851 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 p -141.92 -20.04 0.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.754 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -123.61 98.93 6.05 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.446 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.81 -61.4 0.22 Allowed Pre-proline 0 C--O 1.218 -0.602 0 CA-C-O 122.017 0.913 . . . . 0.0 111.083 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.712 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.78 -40.78 47.69 Favored 'Trans proline' 0 C--N 1.291 -2.487 0 C-N-CA 122.348 2.032 . . . . 0.0 112.197 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -77.96 -43.02 31.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -149.64 -153.8 0.51 Allowed 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.186 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.95 177.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.92 0.39 . . . . 0.0 110.299 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.47 144.59 46.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.425 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.62 134.46 38.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.502 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.66 -19.04 65.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.524 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.21 -6.55 55.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.99 -8.48 55.87 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.78 158.49 26.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.882 0.373 . . . . 0.0 110.409 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -112.35 131.29 55.61 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.371 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.691 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.23 151.54 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.403 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.01 151.53 6.64 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -58.93 -41.99 88.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.698 0.285 . . . . 0.0 110.758 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 -69.53 -28.64 66.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.691 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -67.76 -40.79 84.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.939 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.97 -37.5 82.66 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.718 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.49 -44.94 89.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.117 0.484 . . . . 0.0 110.164 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.54 -48.16 80.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.901 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.26 -53.87 44.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.437 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.87 -40.32 63.33 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.029 0.442 . . . . 0.0 109.951 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.87 -42.08 81.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.57 -45.1 69.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.169 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.31 -46.34 83.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.277 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -60.55 -42.1 95.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.194 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.895 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.36 -17.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.718 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.94 52.75 4.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.78 171.09 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.975 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.81 142.18 27.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.995 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.1 m -117.14 131.06 56.97 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.617 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.15 126.94 43.75 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.4 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -93.73 134.69 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.98 128.14 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.027 0.442 . . . . 0.0 110.344 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.14 137.79 57.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.557 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.53 131.68 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.75 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -67.77 144.51 65.65 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.665 2.244 . . . . 0.0 112.732 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.89 HD23 HD12 ' A' ' 58' ' ' LEU . 81.3 mt -39.87 -55.44 1.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.96 0.41 . . . . 0.0 111.261 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.71 -26.33 2.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.08 -21.11 18.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.13 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.89 HD12 HD23 ' A' ' 55' ' ' LEU . 60.1 mt -63.7 -42.64 97.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.748 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.68 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 mm -62.22 -56.66 28.97 Favored Pre-proline 0 C--O 1.242 0.67 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.795 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.8 Cg_exo -56.09 -41.69 74.26 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.551 2.167 . . . . 0.0 110.947 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -59.08 -44.48 91.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.968 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.648 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.6 tp -59.38 -43.91 92.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.269 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.32 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.493 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.17 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.25 11.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.37 -35.53 80.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 pt -122.43 152.78 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.0 -22.53 19.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.19 155.71 27.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.616 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -114.98 129.08 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.96 0.409 . . . . 0.0 110.384 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -131.28 106.82 8.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 110.231 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.699 ' OG ' HD21 ' A' ' 55' ' ' LEU . 42.1 t -159.05 178.47 10.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.577 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -65.24 -15.2 62.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.513 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.24 124.5 0.61 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.673 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.542 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.8 154.26 26.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.677 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.627 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.4 pt -105.0 148.65 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 p -149.07 152.3 35.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.738 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -46.92 53.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.004 0.431 . . . . 0.0 110.463 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.06 -39.63 72.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.81 -37.9 79.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.015 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.85 -38.48 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.23 -27.34 67.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.33 -51.11 7.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.4 pt -138.98 -168.21 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.986 0.422 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.25 147.57 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.135 0.493 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.1 m-85 -129.86 149.92 51.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.36 -153.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.456 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.7 m-20 41.66 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.944 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.35 0.2 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.594 0.559 . . . . 0.0 110.559 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.421 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.2 mt -75.23 -68.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.49 167.17 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.637 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.83 123.38 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.85 68.55 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.663 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.83 -104.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.322 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.3 p -159.37 165.98 32.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.63 146.11 21.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.47 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.95 136.23 41.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.816 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.37 164.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.937 0.399 . . . . 0.0 110.679 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.56 24.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.07 -27.85 47.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.04 -41.66 88.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.344 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.0 t -102.4 122.36 44.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.01 109.36 19.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.89 129.84 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.29 159.06 33.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.444 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.5 Cg_endo -60.11 89.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.777 2.318 . . . . 0.0 112.008 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -168.82 140.99 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.94 -33.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 110.225 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.22 -22.04 26.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.888 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.3 mt -76.72 -25.83 53.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.16 46.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.507 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.9 -15.85 30.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.54 151.32 23.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 110.308 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.02 135.55 37.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.278 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.3 136.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.53 138.68 14.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.2 t -130.88 161.61 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.255 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 45.1 tp -92.38 117.57 30.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.578 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -51.87 157.57 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.61 50.23 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -149.96 168.87 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 110.795 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.4 p -73.7 -26.52 60.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.412 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.78 -55.15 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.598 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.02 -54.72 43.57 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.461 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.07 -51.33 70.08 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.504 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -61.8 -44.12 97.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 110.489 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.59 -44.47 97.92 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.76 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.575 0.226 . . . . 0.0 110.647 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.29 -34.62 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.68 -50.67 16.75 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.331 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.19 12.25 36.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.208 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.69 -55.51 0.48 Allowed Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.429 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.13 -10.28 25.68 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.802 2.334 . . . . 0.0 111.969 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.73 -8.92 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.561 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.77 33.46 37.58 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.52 137.83 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.35 129.74 34.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.254 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.6 pt -126.34 138.09 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.21 133.12 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.33 127.57 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.84 153.67 25.08 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.282 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.0 7.05 29.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.621 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.54 130.5 6.02 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.78 -45.82 81.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.54 -23.67 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.523 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.69 -36.82 85.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.19 -47.03 85.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.521 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.64 -37.98 89.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.361 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.8 p -61.06 -42.26 98.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.023 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.16 -44.58 91.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.6 tp -59.12 -47.81 83.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.097 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.7 m -63.49 -22.77 67.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.992 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.19 -18.6 25.44 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.579 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.97 11.04 70.85 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.32 -17.92 63.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.623 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.7 pt -128.23 137.36 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.12 0.486 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.86 -27.43 61.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.59 155.98 1.84 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.17 136.88 49.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.9 0.381 . . . . 0.0 110.005 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -85.41 103.3 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.0 tt0 -133.04 165.21 25.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.46 152.12 42.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.772 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.05 -54.53 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.2 -48.44 88.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.586 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.94 90.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 0.0 110.457 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.64 -62.97 1.26 Allowed 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.436 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -59.61 -47.83 84.04 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.914 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -49.56 -36.7 24.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.179 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.39 -66.17 0.54 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.1 t80 -40.68 -70.7 0.1 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.655 0.264 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.58 -40.12 93.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -60.69 -3.19 0.66 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.302 0.572 . . . . 0.0 110.254 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 173' ' ' LEU . 37.1 mt-30 -122.15 147.6 49.72 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.35 -19.12 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.844 2.362 . . . . 0.0 112.034 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.8 -43.21 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.524 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.99 -32.95 83.98 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.53 -41.09 93.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.758 0.313 . . . . 0.0 110.458 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -66.16 -32.9 74.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.53 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.0 m-85 -156.51 142.53 18.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.545 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -176.82 99.56 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.31 166.99 30.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.7 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.23 -117.71 0.01 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.89 136.01 35.97 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.266 1.977 . . . . 0.0 111.928 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.9 p -125.41 -108.02 0.32 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.78 165.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.039 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 154.04 156.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.379 1.049 . . . . 0.0 110.502 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.26 117.35 22.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.904 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.32 -18.85 62.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.66 -32.53 74.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.2 mt -61.1 -44.15 97.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.727 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.5 m-85 -114.46 9.66 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.628 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.08 -154.77 52.29 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.627 ' CG1' HD11 ' A' ' 76' ' ' ILE . 15.0 p -70.32 -25.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.38 -123.97 1.28 Allowed Glycine 0 N--CA 1.46 0.24 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.56 156.25 44.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.54 -169.76 30.56 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.04 137.7 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.65 108.32 3.3 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.3 mt -123.54 159.2 29.66 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 120.672 0.273 . . . . 0.0 110.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.648 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.8 mtm180 -86.79 149.51 24.8 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.712 0.292 . . . . 0.0 110.757 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.68 -47.79 63.73 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.746 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.72 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.42 52.23 0.19 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.505 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.38 -45.77 86.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.34 -47.26 35.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.52 -43.86 97.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.4 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.79 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.0 -36.19 70.12 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.687 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.15 -77.42 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.895 HD21 HD11 ' A' ' 44' ' ' ILE . 97.2 mt -28.17 -46.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.971 0.415 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.6 -44.71 89.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.781 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.98 -43.86 97.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.026 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.05 93.12 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.29 -43.55 98.69 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.16 0.505 . . . . 0.0 110.166 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.12 92.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.258 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.9 -41.92 97.58 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.523 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -59.1 -38.0 78.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.78 -39.84 79.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.066 0.46 . . . . 0.0 110.34 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.07 92.21 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.519 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.3 p30 -86.26 1.09 52.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.504 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.97 19.43 61.22 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 68.3 m -58.41 -45.64 88.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.6 t80 -63.55 -58.25 7.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.936 0.398 . . . . 0.0 110.351 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.54 -41.37 76.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.486 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.96 -48.4 81.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.98 -41.59 98.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.84 -50.28 74.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.4 -35.41 71.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.478 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.03 -50.84 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.1 m-85 -62.2 -45.57 92.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.5 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.87 155.53 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.373 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.3 p-10 -97.56 95.93 7.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 110.491 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -153.63 -166.01 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.92 110.4 15.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.7 m -63.69 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.584 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.422 ' N ' HG23 ' A' ' 238' ' ' VAL . 89.9 m-85 -57.8 -43.53 85.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.25 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.47 94.9 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.23 164.61 59.69 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.745 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.09 143.69 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.21 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.31 -40.4 89.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.74 143.2 36.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.37 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -110.36 128.68 66.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.381 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.8 mtp180 -104.38 118.16 35.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.04 139.2 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.03 104.69 2.19 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.8 m -127.72 118.33 23.6 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.659 -0.318 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.2 t70 -113.38 92.59 23.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.912 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.39 134.32 60.68 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.467 2.111 . . . . 0.0 111.965 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.7 p -141.25 -19.38 0.79 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.765 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.7 m-85 -125.11 98.97 5.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.462 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.82 -61.3 0.22 Allowed Pre-proline 0 C--O 1.219 -0.55 0 CA-C-O 121.97 0.89 . . . . 0.0 111.175 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.715 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.6 Cg_endo -49.64 -39.48 46.62 Favored 'Trans proline' 0 C--N 1.291 -2.489 0 C-N-CA 122.57 2.18 . . . . 0.0 112.194 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.4 t80 -79.57 -43.29 23.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.911 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.617 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.19 -155.5 0.64 Allowed 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.145 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.95 177.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.947 0.403 . . . . 0.0 110.308 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.15 140.66 46.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.432 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -92.31 137.83 32.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -65.05 -19.47 66.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.47 -6.0 55.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.97 -8.31 57.63 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.74 157.01 28.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.377 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -111.96 133.56 54.07 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.412 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.678 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.17 151.0 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.275 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.403 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.16 151.49 6.64 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.87 -42.16 88.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.711 0.291 . . . . 0.0 110.874 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.44 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.0 t0 -69.82 -28.11 65.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -68.55 -40.79 82.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.987 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.7 m-20 -60.65 -37.79 82.68 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.985 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.19 -43.89 85.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.499 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.1 -41.73 93.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -58.83 -53.13 61.83 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.638 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.93 -37.06 63.44 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.01 -42.4 76.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.121 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.6 -44.62 73.22 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.229 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -64.02 -47.18 81.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.254 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -59.86 -40.72 89.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.092 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.989 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.53 -17.78 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.774 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.66 52.4 4.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.24 170.06 17.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.04 140.26 29.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.028 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.0 m -116.91 131.52 56.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.19 127.71 43.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.476 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -94.26 135.97 35.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.406 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.57 128.68 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.77 140.02 58.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 174.97 131.68 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.724 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.21 145.43 66.38 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.678 2.252 . . . . 0.0 112.576 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.875 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.14 -56.91 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.4 -26.75 1.41 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.986 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.29 -20.76 18.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.123 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.875 HD12 HD23 ' A' ' 55' ' ' LEU . 59.0 mt -63.97 -42.49 97.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.731 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.69 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.38 -56.64 28.59 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 123.698 0.624 . . . . 0.0 109.67 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.49 -42.24 70.0 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.534 2.156 . . . . 0.0 111.025 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -58.86 -44.18 90.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.787 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.09 -44.29 91.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.83 -40.52 95.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.476 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.51 10.9 1.84 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.31 11.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.31 -34.13 77.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.551 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.96 154.16 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.81 -20.83 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.99 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.82 158.88 23.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.583 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.604 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.82 127.02 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-O 120.945 0.402 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.44 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -127.5 106.05 8.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.268 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.495 ' OG ' HD21 ' A' ' 55' ' ' LEU . 36.3 t -161.07 -177.4 6.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.28 -15.05 59.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.369 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.637 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.8 tp -38.27 123.23 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.552 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.45 156.58 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.685 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.648 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -105.21 149.39 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -150.25 152.85 35.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.667 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.26 -47.56 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.025 0.44 . . . . 0.0 110.51 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.66 -39.93 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.63 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.637 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.41 -37.67 80.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.004 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -37.39 74.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.111 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.15 -51.94 7.06 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.48 -168.29 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-O 121.04 0.448 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.91 146.73 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.832 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.544 ' CD1' HG22 ' A' ' 76' ' ' ILE . 75.4 m-85 -129.93 149.94 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.607 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.48 -151.67 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.505 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.74 19.26 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.99 119.92 0.11 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.483 0.489 . . . . 0.0 110.631 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.66 -70.14 0.5 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.722 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 42.8 p90 -148.91 165.72 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.523 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.98 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.374 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.25 68.97 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.51 -104.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.329 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.37 165.86 32.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.599 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.62 146.02 21.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -101.47 136.31 41.53 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.57 111.22 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.73 164.86 32.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.78 148.45 23.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -27.83 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.247 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.89 -41.85 88.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -102.55 122.45 44.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.146 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.85 109.36 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.28 130.07 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.593 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.03 159.01 34.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.96 90.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.813 2.342 . . . . 0.0 111.994 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.1 m -168.97 141.56 2.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.69 -33.33 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 110.343 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.59 -62.24 1.93 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.43 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.35 -22.0 28.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.866 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.64 -25.74 54.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.286 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.87 133.28 47.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.472 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.86 -15.79 30.15 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.49 151.33 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.898 0.38 . . . . 0.0 110.378 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.09 135.14 38.28 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.99 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.658 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.65 14.34 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.8 t -130.75 161.59 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.2 tp -92.41 117.67 30.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.81 157.51 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.694 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.92 50.58 51.89 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.6 p -149.63 168.68 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.777 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 68.6 p -73.09 -27.3 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.3 -54.84 40.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.467 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.3 -54.38 47.4 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.378 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.62 -51.6 68.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.6 t80 -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.028 0.442 . . . . 0.0 110.457 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.66 -44.31 98.1 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.62 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.603 0.239 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.66 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.4 -50.83 16.98 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.392 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.2 12.74 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.11 -55.6 0.46 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.369 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.17 -10.48 25.91 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.963 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.46 -8.73 59.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.53 36.97 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.77 137.88 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.481 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.51 130.03 34.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.51 138.1 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.09 133.22 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.051 0.453 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.94 127.11 42.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -110.74 153.62 25.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.02 6.83 29.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.12 130.34 5.88 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.92 -45.67 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.484 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.84 -24.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.497 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.59 -36.38 84.04 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.14 -46.95 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.062 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.0 m-85 -63.82 -37.66 88.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.343 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.23 -42.78 99.19 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.121 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.95 -44.5 92.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.3 tp -59.0 -48.24 82.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.079 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.7 m -62.88 -22.92 67.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.09 26.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.571 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.35 11.58 71.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -17.82 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 153' ' ' LEU . 35.6 pt -128.31 137.77 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.113 0.483 . . . . 0.0 110.487 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.8 -28.36 62.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.59 155.7 1.8 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.819 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.53 50.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.064 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.53 103.15 14.13 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.08 0.467 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 46.9 tt0 -132.27 164.74 25.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.437 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -73.02 152.03 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -65.91 -54.2 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.3 -48.98 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.524 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.09 89.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.25 -63.25 1.19 Allowed 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.437 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.5 m -58.85 -47.11 86.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -50.06 -37.04 31.53 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.02 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.13 -65.85 0.55 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.71 -70.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.802 -0.234 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.65 -39.98 93.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.874 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.455 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.62 -3.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.627 . . . . 0.0 110.367 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.5 mt-30 -124.21 141.62 37.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.807 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.87 -14.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.859 2.372 . . . . 0.0 112.319 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 175' ' ' GLN . 77.9 t -63.47 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.486 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.75 79.59 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.01 -41.35 96.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.773 0.321 . . . . 0.0 110.388 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.4 m-20 -65.9 -34.7 78.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.756 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.3 m-85 -156.98 143.26 18.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.85 99.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.758 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.2 m-85 -159.28 168.01 27.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.33 55.76 3.17 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.91 -116.99 0.01 OUTLIER Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.12 135.92 37.7 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.295 1.997 . . . . 0.0 112.016 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.0 p -124.97 -108.02 0.33 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.513 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.87 165.25 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.98 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.634 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.35 155.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.436 1.085 . . . . 0.0 110.476 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.09 118.31 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.911 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.3 mp0 -71.87 -18.74 62.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.76 -31.96 73.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.6 mt -60.99 -44.24 97.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.754 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.3 m-85 -113.69 7.2 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.724 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.53 -155.33 49.9 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.648 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.43 -25.54 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.834 0.35 . . . . 0.0 110.551 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.09 -125.84 1.5 Allowed Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.3 p -132.15 160.03 37.22 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.862 0.363 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.7 25.27 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -98.17 141.41 31.12 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 110.493 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.38 3.89 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -119.52 160.57 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.37 149.04 24.75 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.574 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.03 -48.73 64.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.809 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -40.83 -22.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.828 0.347 . . . . 0.0 110.657 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.07 51.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.66 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.38 -46.1 84.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.762 0.315 . . . . 0.0 111.108 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.43 -47.14 35.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.42 -43.7 98.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.446 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.38 -42.94 99.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.881 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.67 -37.52 73.55 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.897 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.24 -77.57 0.1 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.989 HD21 HD11 ' A' ' 44' ' ' ILE . 86.5 mt -28.63 -45.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.942 0.401 . . . . 0.0 110.813 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.4 m-20 -63.76 -45.18 90.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.54 -43.68 98.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.2 92.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.205 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.16 -43.58 98.66 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.144 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.32 92.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.85 -42.52 97.55 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.022 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.499 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.13 -38.22 73.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.65 -38.83 77.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.114 0.483 . . . . 0.0 110.415 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.53 92.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.674 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.34 0.43 56.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.783 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.67 20.2 67.91 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.8 m -57.91 -46.08 85.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.0 t80 -63.54 -57.6 9.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.88 -41.7 78.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.347 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -48.42 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.42 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.84 -41.54 97.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.366 . . . . 0.0 110.446 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.16 -49.78 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.632 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -35.86 73.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.399 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.58 -50.94 31.98 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.449 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.35 -45.23 94.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.502 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.8 m-85 -153.47 154.96 35.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.0 p-10 -98.21 96.95 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 110.509 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -154.09 -165.11 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.518 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.426 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.68 109.24 14.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.5 m -63.79 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.578 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.425 ' N ' HG23 ' A' ' 238' ' ' VAL . 83.9 m-85 -56.79 -43.63 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.1 -37.16 94.47 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.744 0 CA-C-O 117.907 -1.496 . . . . 0.0 110.938 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.7 164.66 53.36 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.763 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.0 143.83 99.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.654 2.236 . . . . 0.0 112.267 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.26 -40.59 90.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.42 142.73 37.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.05 128.71 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.029 0.442 . . . . 0.0 110.318 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.02 117.45 34.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.311 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.0 140.57 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.278 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.24 105.39 1.96 Allowed Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 77.2 m -127.76 120.8 28.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.722 -0.281 . . . . 0.0 110.617 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.3 t70 -112.73 93.99 26.57 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.77 135.03 65.95 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.518 2.145 . . . . 0.0 111.778 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 p -137.32 -18.39 1.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.74 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' ALA . 84.0 m-85 -124.85 98.02 5.52 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.54 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.691 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -30.33 -60.95 0.26 Allowed Pre-proline 0 C--O 1.218 -0.591 0 CA-C-O 122.274 1.035 . . . . 0.0 111.079 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.691 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.4 Cg_endo -50.29 -41.9 49.22 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 122.323 2.015 . . . . 0.0 112.179 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.5 t80 -77.42 -42.6 35.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.176 0.512 . . . . 0.0 110.785 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.684 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.2 mt-10 -147.13 -160.21 1.13 Allowed 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.403 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 158.91 179.84 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.857 0.361 . . . . 0.0 110.16 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -133.69 141.94 47.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.42 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -90.88 137.68 32.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.509 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -65.32 -19.1 65.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.601 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -79.04 -5.17 53.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.431 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.48 -9.94 57.58 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.11 159.69 26.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.388 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.5 mt -114.42 134.2 55.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.476 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.509 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.3 p -131.93 150.56 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.197 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.75 153.83 7.35 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -60.46 -41.6 94.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.867 0.365 . . . . 0.0 110.77 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 28.7 t0 -70.52 -32.68 70.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.342 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.8 mt -66.75 -40.55 86.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.985 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -61.15 -36.97 81.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.723 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.98 -45.07 87.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.426 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.27 -46.86 85.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.974 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.89 -53.82 47.25 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.516 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.21 -39.13 66.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.947 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.98 -43.15 79.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.7 m -54.4 -43.63 71.64 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.26 -47.02 81.2 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 110.328 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mmt-85 -60.35 -41.17 93.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.018 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -75.75 -18.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.755 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.52 51.92 3.9 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.76 170.14 17.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.956 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.45 141.74 28.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.006 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.4 m -117.76 132.11 56.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.573 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -127.16 126.16 42.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.01 135.96 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.48 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.99 129.21 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.076 0.465 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.04 139.97 56.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.512 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.41 135.07 0.17 Allowed Pre-proline 0 N--CA 1.445 -0.683 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.18 143.8 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.631 2.221 . . . . 0.0 112.705 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.903 HD23 HD12 ' A' ' 58' ' ' LEU . 82.5 mt -40.48 -54.45 2.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.036 0.446 . . . . 0.0 111.152 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.92 -26.44 2.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.54 -21.01 19.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.903 HD12 HD23 ' A' ' 55' ' ' LEU . 58.2 mt -64.14 -42.77 96.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.787 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.0 -56.46 31.49 Favored Pre-proline 0 C--O 1.242 0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.743 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 52.2 Cg_exo -55.64 -42.33 68.68 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.021 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -58.84 -44.27 90.89 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.822 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -59.06 -44.36 91.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.8 -40.86 95.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.582 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.06 11.92 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.796 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.25 -33.93 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.04 153.53 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.367 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.08 -21.33 20.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.14 158.52 24.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.495 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.562 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -116.0 128.02 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.395 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -129.52 107.42 9.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 110.222 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.538 ' OG ' HD21 ' A' ' 55' ' ' LEU . 35.2 t -162.06 -178.68 6.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.26 -15.77 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.642 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -35.53 122.46 0.63 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.6 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -80.95 154.23 27.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.694 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' CG1' ' A' ' 196' ' ' VAL . 47.4 pt -105.02 148.17 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.4 p -150.14 152.86 35.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.16 -46.85 54.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.6 -40.18 71.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.469 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.642 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.2 mtt180 -68.32 -37.99 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.023 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 84' ' ' ILE . 87.9 mt-30 -57.88 -38.0 74.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.089 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.07 -27.81 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.213 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.86 -50.79 8.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.725 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -139.78 -166.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.969 0.414 . . . . 0.0 110.496 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.79 147.45 30.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.805 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.5 m-85 -130.27 150.69 51.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.6 t -164.77 -152.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.427 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.8 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.847 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -29.95 121.72 0.17 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.664 0.603 . . . . 0.0 110.627 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 66.0 mt -78.3 -70.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.844 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CG ' HG21 ' A' ' 166' ' ' VAL . 51.4 p90 -148.7 165.56 31.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.54 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.448 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.68 67.74 0.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.621 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -86.87 -106.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.1 p -159.47 167.81 27.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.05 146.78 23.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -102.04 135.99 42.65 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.773 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.59 112.05 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.88 164.71 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.05 148.64 24.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.55 -27.96 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.03 -41.58 88.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -102.25 122.34 44.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 110.162 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.18 109.88 19.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.25 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.13 130.04 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.602 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -109.3 154.29 42.25 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.17 92.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -170.45 144.4 2.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.75 -33.88 61.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.279 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.486 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.94 -62.17 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.474 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.21 -21.85 25.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.97 -25.42 52.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.265 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.08 133.21 48.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.429 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.63 -15.75 29.02 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.07 150.87 24.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 110.284 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.29 134.34 38.19 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.15 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.58 136.33 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.606 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.67 138.77 14.45 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.7 161.5 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.048 0.451 . . . . 0.0 110.238 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.6 tp -92.54 118.1 30.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.499 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.48 156.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.59 50.64 53.44 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.7 p -149.11 167.6 25.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 67.2 p -70.92 -30.45 66.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -58.61 -54.76 43.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.509 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.58 -55.98 27.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.28 -51.53 69.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.654 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -61.71 -44.11 97.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.453 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.38 -44.38 98.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.56 -14.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.496 0.189 . . . . 0.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.48 -34.53 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.74 -50.64 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.335 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.42 12.53 36.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.747 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.2 -55.51 0.46 Allowed Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.482 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.7 Cg_endo -72.36 -10.02 25.02 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.784 2.323 . . . . 0.0 112.036 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.86 -8.79 59.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.58 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.19 33.22 36.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.62 137.62 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.977 0.418 . . . . 0.0 110.487 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.23 130.16 34.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.61 138.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.26 133.5 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -96.58 126.49 41.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.55 25.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.259 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.83 7.27 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.617 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.73 130.1 5.86 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.13 -45.6 80.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.8 0.333 . . . . 0.0 110.556 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.37 -23.49 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 110.493 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.76 -36.8 85.48 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.84 87.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.178 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.0 m-85 -64.05 -37.88 89.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.08 -42.61 98.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.157 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.67 -43.86 92.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.046 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.536 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.0 tp -59.33 -47.85 83.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.029 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.39 -22.95 67.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.124 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -18.71 25.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.516 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.11 71.76 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.58 -18.1 63.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 0.0 110.629 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -128.05 137.79 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.165 0.507 . . . . 0.0 110.518 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.75 -29.46 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -174.93 155.4 2.03 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.792 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 139.15 52.16 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 110.052 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.97 102.85 14.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.4 164.38 26.65 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.472 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.46 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.7 40.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -65.96 -54.33 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.317 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.403 HG21 ' CG ' ' A' ' 91' ' ' TYR . 71.1 t -60.19 -48.5 87.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.446 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.17 86.09 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.345 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.27 -63.26 1.24 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.364 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.456 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.9 m -58.22 -45.8 87.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.934 0.397 . . . . 0.0 110.445 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.43 -41.17 13.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.74 -61.93 0.47 Allowed Glycine 0 N--CA 1.466 0.647 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.649 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.5 t80 -40.79 -71.14 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.954 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.58 -40.97 98.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.1 tttt -59.83 -2.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.117 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 32.5 mt-30 -125.81 141.52 39.56 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.898 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.54 -14.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 86.9 t -63.02 -43.21 98.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.415 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.2 84.37 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.3 -40.92 95.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.832 0.349 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.12 -34.26 77.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.8 143.09 18.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.666 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -175.98 99.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.852 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.3 m-85 -158.94 167.59 28.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.585 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.9 56.18 3.14 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -52.1 -115.9 0.01 OUTLIER Glycine 0 CA--C 1.542 1.719 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.61 135.74 41.24 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.222 1.948 . . . . 0.0 111.86 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.9 p -124.58 -108.78 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.425 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.19 164.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 118.859 -0.591 . . . . 0.0 110.002 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.3 tttt 155.13 155.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.439 1.087 . . . . 0.0 110.505 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -81.06 118.16 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.858 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.6 mp0 -70.93 -19.34 62.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.38 -31.79 73.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.606 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 88.0 mt -61.1 -44.05 97.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.753 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.04 9.26 15.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.673 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.39 51.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.0 p -70.7 -25.5 26.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.448 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.0 -124.37 1.34 Allowed Glycine 0 C--N 1.33 0.226 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.0 p -130.07 157.2 43.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.651 0.263 . . . . 0.0 110.297 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.08 -168.57 29.46 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -96.09 138.35 33.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.84 105.66 2.97 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ALA . 79.0 mt -117.88 158.65 24.48 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.3 mtm180 -86.71 148.66 25.34 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.596 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.7 mttm -51.7 -47.56 63.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.92 -22.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 0.0 110.577 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.09 51.64 0.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.07 -46.55 83.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.8 0.333 . . . . 0.0 111.15 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.5 -47.12 35.01 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.27 -43.7 98.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.35 -42.96 99.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.903 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.42 -37.08 72.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 109.896 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.55 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 44' ' ' ILE . 88.2 mt -28.68 -45.17 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.943 0.401 . . . . 0.0 110.878 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.0 m-20 -64.24 -45.01 90.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.815 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.84 98.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.927 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.11 92.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.293 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.09 -43.78 98.37 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.171 0.51 . . . . 0.0 110.282 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.15 91.54 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -64.13 -42.38 96.86 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.232 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.497 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.5 mtp -57.47 -38.21 74.13 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.43 -39.18 78.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.08 0.467 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.617 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.4 p-10 -89.17 0.04 57.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.69 20.59 70.31 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.3 m -58.66 -45.68 88.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 75.2 t80 -62.22 -56.43 18.67 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.198 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.32 -40.25 77.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.234 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.7 -47.68 84.68 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.14 -40.95 97.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.875 0.369 . . . . 0.0 110.316 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.69 76.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.72 -35.92 73.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -69.17 -51.9 33.44 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.564 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 10.7 m-85 -62.38 -45.82 91.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.51 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.9 m-85 -154.14 154.61 33.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.3 p-10 -99.09 95.95 7.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.407 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 236' ' ' PHE . 14.6 p90 -151.99 -163.77 1.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.21 108.24 13.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.687 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 239' ' ' TYR . 25.6 m -63.33 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.596 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.425 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.1 m-85 -58.65 -41.65 86.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.285 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.16 -36.93 94.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.92 -1.489 . . . . 0.0 110.938 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.72 164.45 60.22 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.02 143.72 99.33 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.703 2.269 . . . . 0.0 112.226 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.29 -40.48 90.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.54 143.35 37.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.351 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.29 128.1 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.986 0.422 . . . . 0.0 110.367 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.84 118.75 37.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.252 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.99 138.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.53 100.32 1.6 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 84.8 m -123.69 118.62 27.66 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.71 -0.288 . . . . 0.0 110.854 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t0 -113.25 93.19 25.06 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.29 133.86 57.97 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.486 2.124 . . . . 0.0 111.905 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.5 p -139.69 -19.93 0.92 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.761 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.1 m-85 -124.94 99.2 6.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.424 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.86 -61.32 0.22 Allowed Pre-proline 0 C--O 1.218 -0.57 0 CA-C-O 121.982 0.896 . . . . 0.0 111.137 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.714 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.92 -39.58 49.28 Favored 'Trans proline' 0 C--N 1.292 -2.417 0 C-N-CA 122.412 2.074 . . . . 0.0 112.161 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 17' ' ' TYR . 29.4 t80 -79.04 -43.1 24.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.98 0.419 . . . . 0.0 110.93 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.63 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.7 mt-10 -149.21 -155.86 0.67 Allowed 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.187 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.44 177.7 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.909 0.385 . . . . 0.0 110.325 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.32 139.03 45.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.401 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -90.43 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.576 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.87 -19.26 65.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.11 -6.02 55.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.429 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.45 -8.71 57.0 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.68 157.61 27.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 110.435 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.4 mt -112.9 134.88 54.2 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 110.416 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.59 151.29 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.325 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.76 6.75 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -58.89 -42.09 88.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.709 0.29 . . . . 0.0 110.794 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.2 t0 -69.97 -27.97 65.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.279 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.674 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -68.7 -40.91 82.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.098 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.78 -37.87 83.36 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.038 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.66 -43.93 87.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.18 0.514 . . . . 0.0 110.465 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.75 92.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.2 -53.31 58.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.529 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.75 -38.08 64.03 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.66 -42.23 78.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.024 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.7 m -54.47 -43.95 72.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.123 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.12 -47.05 81.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.9 mmt-85 -60.44 -40.93 92.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.025 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.13 -18.23 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.792 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.86 52.22 4.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -145.27 170.16 16.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.933 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -87.86 140.21 29.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.081 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -116.32 130.87 57.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.569 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.3 128.25 44.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.9 136.53 35.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -129.49 128.4 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.31 139.07 58.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.55 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.512 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 174.32 132.62 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.7 Cg_endo -68.11 145.03 65.62 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 112.75 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.938 HD23 HD12 ' A' ' 58' ' ' LEU . 78.1 mt -40.44 -55.53 2.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.22 -26.4 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.967 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.62 19.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.022 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.938 HD12 HD23 ' A' ' 55' ' ' LEU . 85.7 mt -64.83 -42.78 94.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.909 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.678 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.65 -56.35 33.67 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.678 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.98 -42.72 63.88 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.967 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -59.08 -44.1 91.87 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.812 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.65 -44.2 90.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.75 -40.06 94.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.15 11.32 1.54 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.503 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.02 11.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.46 -34.12 77.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.48 153.29 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.379 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -94.11 -20.25 20.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.52 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.545 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.593 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -116.56 127.87 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.33 106.54 9.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.251 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.601 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.1 t -159.19 -178.85 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.578 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.71 -15.03 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.1 tp -37.77 123.87 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.597 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.73 23.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.746 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.4 pt -105.31 148.98 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.08 152.71 35.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.756 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.25 -47.66 55.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.986 0.422 . . . . 0.0 110.61 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.14 -39.8 72.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.582 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.9 mtt180 -68.18 -37.79 81.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.3 -36.98 74.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.58 -27.58 67.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.215 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.97 -52.22 6.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -138.09 -168.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.094 0.473 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.59 146.66 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.085 0.469 . . . . 0.0 110.807 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.554 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.81 149.94 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.637 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -164.64 -151.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.4 m-20 43.25 19.36 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.3 120.11 0.12 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.552 0.533 . . . . 0.0 110.577 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.19 -69.86 0.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.794 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.415 ' CG ' HG21 ' A' ' 166' ' ' VAL . 42.9 p90 -149.39 166.18 29.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.569 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.02 122.16 27.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.389 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.468 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.38 68.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.627 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.99 -104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.414 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.1 p -159.74 165.89 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.621 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.07 146.45 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.069 0.462 . . . . 0.0 110.465 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.96 135.89 42.73 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.798 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.413 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.7 t -122.55 110.92 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.38 165.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.755 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 148.41 23.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.017 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.47 -27.43 37.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -59.5 -41.67 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.4 122.08 43.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.154 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.88 109.33 19.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.375 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.63 130.03 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.605 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.28 159.4 34.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.478 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.24 89.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.874 2.383 . . . . 0.0 112.006 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -168.79 140.84 2.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.98 -32.72 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.116 0.484 . . . . 0.0 110.268 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.502 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -57.81 -62.62 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.99 -22.06 24.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.888 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.58 -25.84 54.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.57 132.38 44.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.502 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.93 33.92 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.55 151.46 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.838 0.351 . . . . 0.0 110.447 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -97.01 136.19 37.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.27 136.68 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.672 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.54 139.5 14.74 Favored Glycine 0 CA--C 1.521 0.469 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.2 t -131.64 161.74 40.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.113 0.482 . . . . 0.0 110.281 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.3 tp -92.84 119.07 31.79 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.563 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.87 157.13 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.34 50.83 47.78 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.8 p -149.49 168.12 24.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.824 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.446 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.34 -25.54 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.445 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.27 -55.08 35.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.581 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -57.48 -54.06 51.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.408 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.3 -51.17 70.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.522 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.592 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.7 t80 -62.16 -43.83 97.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.429 . . . . 0.0 110.416 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.81 -44.41 97.91 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.9 -14.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.641 0.258 . . . . 0.0 110.642 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.25 -34.65 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.592 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.47 -50.68 17.33 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.329 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -98.94 12.82 34.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.2 -55.66 0.45 Allowed Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.428 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.2 -10.74 26.23 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.754 2.303 . . . . 0.0 112.008 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.14 -8.96 59.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.588 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.78 33.49 37.46 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.61 138.1 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.66 129.69 35.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.275 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.81 138.77 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.61 132.11 71.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.997 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.39 130.48 45.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.635 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.68 156.43 21.88 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.264 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.82 6.64 29.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.4 130.91 6.17 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.98 -45.93 79.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.32 . . . . 0.0 110.429 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.01 -23.84 63.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.456 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.455 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.67 -36.45 84.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.17 -47.28 85.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.4 m-85 -63.68 -37.67 88.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.234 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.26 -42.65 98.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.13 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.43 -45.21 91.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.002 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.54 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.7 tp -59.06 -48.24 82.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.167 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.75 -23.04 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.161 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -18.22 25.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.549 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.57 69.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.98 -18.2 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.602 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 153' ' ' LEU . 38.0 pt -128.52 137.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.165 0.507 . . . . 0.0 110.47 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.13 -28.41 62.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.49 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.4 155.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.5 137.89 51.07 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.913 0.387 . . . . 0.0 110.066 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -85.74 103.25 14.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.61 164.93 25.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.491 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.0 151.73 41.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.03 -54.23 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.32 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.1 t -60.29 -48.73 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.57 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.91 90.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.782 0.325 . . . . 0.0 110.57 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.07 -63.06 1.25 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.441 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.7 m -58.62 -46.85 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -50.23 -36.9 32.9 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.054 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.33 0.55 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 33.8 t80 -40.28 -70.98 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.765 -0.256 . . . . 0.0 111.101 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.65 -39.95 93.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.9 -3.23 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.274 0.559 . . . . 0.0 110.298 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.6 mt-30 -123.91 142.23 38.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.02 -14.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.82 2.347 . . . . 0.0 112.227 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.1 t -63.0 -42.86 98.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.434 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.71 -32.96 80.64 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.13 -41.41 96.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.819 0.342 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.1 m-20 -65.96 -34.82 78.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.652 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.8 m-85 -156.72 142.91 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.54 99.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.153 0.502 . . . . 0.0 110.736 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.25 167.06 29.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.628 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.81 56.03 3.02 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.3 0.01 OUTLIER Glycine 0 CA--C 1.539 1.578 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.28 135.49 38.76 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.247 1.965 . . . . 0.0 111.862 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.3 p -124.42 -108.82 0.32 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.83 165.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.062 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.76 155.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.324 1.015 . . . . 0.0 110.51 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -81.95 118.45 22.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.861 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -72.05 -18.73 61.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.68 -32.17 73.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.64 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 128' ' ' PHE . 93.0 mt -60.95 -44.3 97.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.446 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.9 m-85 -114.08 8.38 16.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.67 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.2 -154.55 50.79 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.654 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.68 -25.65 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.815 0.341 . . . . 0.0 110.59 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.27 -125.48 1.45 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.7 p -132.15 160.19 36.76 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.66 25.05 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.24 141.06 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.908 0.385 . . . . 0.0 110.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.16 111.8 3.96 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -121.2 159.95 24.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.682 0.277 . . . . 0.0 110.287 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -86.5 149.14 25.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.66 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.15 -48.43 64.92 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -40.4 -22.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.631 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.14 52.02 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.592 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.39 -46.33 83.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.25 -47.06 37.58 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.4 -43.78 98.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.405 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.52 -42.76 99.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.897 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.81 -37.5 73.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.88 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.31 -77.42 0.11 Allowed 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.025 HD21 HD11 ' A' ' 44' ' ' ILE . 86.4 mt -28.66 -45.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.8 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.1 m-20 -63.9 -44.99 91.3 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.738 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.71 -43.63 98.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.966 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.16 92.92 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.247 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.2 -43.49 98.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.156 0.503 . . . . 0.0 110.22 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.23 92.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.271 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.11 -42.12 97.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.9 mtp -57.52 -38.07 74.04 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.78 -38.76 76.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.49 92.76 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.662 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.4 p-10 -88.19 0.63 55.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.765 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.76 19.85 67.75 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.7 m -57.93 -46.18 85.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.7 t80 -63.6 -57.61 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.925 0.393 . . . . 0.0 110.47 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.81 -41.73 78.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.352 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -48.21 82.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.96 -41.58 98.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.451 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.1 -49.84 76.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.77 -35.6 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.51 -50.95 32.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.498 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.1 m-85 -62.19 -45.61 92.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.48 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.7 m-85 -154.64 155.62 35.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.6 p-10 -97.56 101.24 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.444 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -157.88 -165.94 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.3 t0 -122.72 110.2 15.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.62 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.0 m -63.3 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.412 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.4 m-85 -59.22 -42.62 91.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -36.69 93.74 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 117.88 -1.511 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.83 164.38 61.53 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.73 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.24 143.64 98.42 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.738 2.292 . . . . 0.0 112.208 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.35 -40.98 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -137.96 139.68 39.84 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.371 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.83 121.26 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.472 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.56 118.23 31.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.122 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.24 138.62 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.271 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.54 106.07 2.25 Favored Glycine 0 N--CA 1.463 0.458 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -129.5 120.24 25.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.657 -0.319 . . . . 0.0 110.76 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.522 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.5 t70 -114.05 93.02 28.31 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.852 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.74 134.39 62.44 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.127 . . . . 0.0 111.925 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -141.85 -19.7 0.74 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -124.58 99.46 6.19 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.414 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.711 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.05 -61.27 0.22 Allowed Pre-proline 0 C--O 1.217 -0.631 0 CA-C-O 122.058 0.932 . . . . 0.0 111.127 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.711 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.6 Cg_endo -49.68 -40.21 46.89 Favored 'Trans proline' 0 C--N 1.289 -2.576 0 C-N-CA 122.487 2.125 . . . . 0.0 112.165 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -78.37 -42.61 29.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.94 0.4 . . . . 0.0 110.872 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.654 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.4 mt-10 -149.63 -154.83 0.58 Allowed 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.276 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.33 177.93 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.947 0.404 . . . . 0.0 110.282 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -136.52 143.68 43.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.477 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 25' ' ' SER . 61.9 t-20 -96.58 141.28 30.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.392 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.1 p -65.99 -19.32 65.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.573 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -77.37 -7.13 55.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.09 -6.57 58.28 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.93 157.73 26.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.366 . . . . 0.0 110.425 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 82.9 mt -111.66 133.65 53.76 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 110.324 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.84 151.28 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.12 151.56 6.67 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -58.71 -42.36 88.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.675 0.274 . . . . 0.0 110.843 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.444 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.3 t0 -69.35 -28.44 66.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.404 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -68.23 -40.72 83.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.029 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -60.59 -37.84 82.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.893 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.3 tp -65.19 -44.14 89.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.224 0.535 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.41 -47.34 84.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.907 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -54.25 -54.1 44.73 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.518 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.77 -39.11 61.98 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.035 0.445 . . . . 0.0 110.087 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.19 -41.93 80.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.969 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -53.95 -45.08 71.18 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.061 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.17 -46.28 84.69 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.343 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -60.7 -41.93 96.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.989 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.933 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -75.62 -17.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.712 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.84 52.57 4.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.612 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -146.41 170.94 15.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.913 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.71 142.48 27.64 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.987 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.4 m -117.39 131.86 56.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.3 m -128.33 127.81 43.39 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.474 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -94.44 135.28 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.445 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.35 128.59 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.012 0.434 . . . . 0.0 110.305 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.84 137.32 57.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.522 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.3 p30 177.23 131.86 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.19 144.74 64.03 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.664 2.243 . . . . 0.0 112.678 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.06 -56.03 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 111.272 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.11 -26.35 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.35 -20.99 18.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.139 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.7 -42.47 97.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.759 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.691 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.39 -56.86 26.58 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 123.81 0.694 . . . . 0.0 109.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.2 Cg_exo -56.21 -41.36 77.47 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.499 2.133 . . . . 0.0 110.992 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -59.26 -44.27 92.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.8 tp -59.86 -43.86 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.43 95.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.478 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.13 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.43 11.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.41 -35.43 80.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.598 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.9 pt -122.79 153.27 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.318 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.4 m-20 -92.94 -21.87 19.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.131 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.28 156.42 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.628 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.05 128.26 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.397 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.444 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.1 ttp -130.44 107.0 8.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 110.267 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.66 ' OG ' HD21 ' A' ' 55' ' ' LEU . 44.5 t -159.38 179.21 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.88 -15.18 61.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.0 tp -36.27 124.78 0.78 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.606 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.541 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -83.33 155.87 23.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.674 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.59 149.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -149.55 152.43 35.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.693 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.84 -47.46 51.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.77 -39.91 71.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.668 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.47 -37.81 80.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.043 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.95 -38.26 75.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.053 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.24 -27.51 67.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.26 -51.47 7.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.9 pt -138.21 -168.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 121.076 0.465 . . . . 0.0 110.442 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.83 147.66 29.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.4 m-85 -130.08 150.0 51.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.71 -152.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.4 m-20 42.41 20.09 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -29.17 120.77 0.14 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.66 0.6 . . . . 0.0 110.526 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -76.86 -69.63 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.868 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.44 ' CG ' HG21 ' A' ' 166' ' ' VAL . 41.4 p90 -149.4 166.3 29.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.617 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.26 122.74 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.58 69.59 0.9 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.65 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.61 -104.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.422 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.29 166.02 32.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.9 145.75 21.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 110.414 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.89 136.2 41.13 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.41 111.11 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.1 164.99 33.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.84 23.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.039 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.28 60.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.142 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.98 -41.73 88.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.251 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.1 t -102.09 122.01 43.29 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.976 0.417 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.11 109.93 19.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.333 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.0 129.94 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.539 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.93 154.23 42.0 Favored Pre-proline 0 C--N 1.334 -0.099 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.36 92.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.767 2.311 . . . . 0.0 111.907 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.7 m -171.04 144.47 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.36 -33.73 61.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.164 0.507 . . . . 0.0 110.281 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.483 ' H ' HG22 ' A' ' 108' ' ' THR . 47.8 tp10 -58.24 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.425 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.34 -22.13 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.869 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.29 -25.8 55.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.338 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.9 45.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.67 -16.5 30.67 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.94 151.21 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.382 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.91 37.72 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.41 136.61 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 139.53 14.74 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.8 t -131.83 161.74 40.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.096 0.474 . . . . 0.0 110.287 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.73 118.82 31.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.63 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -51.93 157.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.06 50.66 50.54 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.3 p -149.45 168.23 24.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.791 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.433 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.18 -25.64 59.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.431 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.25 -55.1 35.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.544 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.64 -53.92 52.74 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -60.55 -51.36 69.76 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.46 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.1 t80 -62.08 -44.01 97.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.426 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.74 -44.42 97.93 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.94 -14.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.627 0.251 . . . . 0.0 110.675 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.19 -34.84 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.43 -50.57 17.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.435 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -99.04 12.56 35.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.207 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.95 -55.7 0.46 Allowed Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.4 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.08 -10.6 26.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.778 2.319 . . . . 0.0 111.961 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.45 -8.76 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.74 33.37 38.01 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.24 137.87 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 110.532 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -87.58 129.73 35.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.233 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.6 pt -127.26 138.99 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.95 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.58 132.08 71.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.975 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.8 t -98.52 130.52 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -111.69 156.68 21.5 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.294 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.06 6.46 28.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.565 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.98 6.36 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.415 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.6 tp60 -66.19 -46.15 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.12 62.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.89 -36.54 84.7 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.29 -47.44 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.093 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.509 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.3 m-85 -63.72 -37.84 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.263 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.01 -42.19 97.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.081 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -64.19 -44.4 92.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.97 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.1 tp -58.88 -48.2 82.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -63.06 -23.01 67.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.42 -18.36 25.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.493 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.79 11.2 71.16 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.57 -18.25 63.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.659 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.8 pt -127.9 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.456 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 -28.3 62.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.999 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.41 155.62 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.574 0.546 . . . . 0.0 110.873 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.43 138.0 51.21 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.993 0.425 . . . . 0.0 110.045 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.21 103.17 14.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.041 0.448 . . . . 0.0 110.569 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.25 24.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.04 152.55 41.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.04 -54.27 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.347 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.9 t -60.39 -48.66 87.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.437 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.8 88.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 110.44 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.46 -63.63 1.09 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.413 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.4 m -59.09 -47.11 86.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.749 0.309 . . . . 0.0 110.981 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -50.17 -37.6 35.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.02 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.7 -66.15 0.56 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.657 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.3 -70.69 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.734 -0.274 . . . . 0.0 111.123 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.448 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.7 mt -61.36 -39.78 91.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -60.67 -3.36 0.69 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.412 0.625 . . . . 0.0 110.354 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.1 mt-30 -123.27 142.25 38.08 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 122.118 -0.363 . . . . 0.0 110.845 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -44.27 -16.21 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.848 2.365 . . . . 0.0 112.275 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 74.5 t -62.82 -43.04 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.15 -33.06 82.8 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.82 -41.25 95.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 0.0 110.413 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -66.04 -34.27 77.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.509 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.4 m-85 -157.12 143.92 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.725 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.27 99.59 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.0 m-85 -159.09 167.14 29.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.614 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.69 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.44 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.539 1.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.09 135.69 37.41 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.285 1.99 . . . . 0.0 111.99 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.3 p -124.94 -108.13 0.33 Allowed 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.496 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.91 165.33 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 118.815 -0.612 . . . . 0.0 109.955 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.53 156.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.496 1.122 . . . . 0.0 110.468 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.07 118.04 22.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.917 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.1 mp0 -71.62 -18.94 62.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.3 mt -61.0 -44.19 97.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.433 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.97 8.97 17.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.56 -155.12 52.04 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.9 p -70.31 -25.26 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.61 -125.2 1.42 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.5 p -131.76 159.46 38.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 110.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.98 -162.87 24.94 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.7 139.12 34.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.945 0.402 . . . . 0.0 110.468 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.65 112.61 4.04 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.5 mt -124.76 159.5 30.81 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.752 0.311 . . . . 0.0 110.346 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.649 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.8 mtm180 -85.89 149.77 24.99 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.04 -48.29 64.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.746 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -38.57 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.708 0.289 . . . . 0.0 110.715 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.53 52.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.614 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -64.48 -46.13 84.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.742 0.306 . . . . 0.0 111.136 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.0 -47.07 39.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.57 -43.4 98.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.466 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.6 ttt-85 -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.775 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.41 -36.97 72.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.118 0.485 . . . . 0.0 109.84 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.49 -77.43 0.11 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 44' ' ' ILE . 98.0 mt -28.43 -45.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.988 0.423 . . . . 0.0 110.808 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 212' ' ' ALA . 90.0 m-20 -64.29 -45.14 89.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.78 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.69 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.89 -43.93 97.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.968 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.19 92.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.14 -43.62 98.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.162 0.506 . . . . 0.0 110.163 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.27 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.89 -42.45 97.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -57.47 -38.24 74.19 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.86 -38.95 76.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 0.0 110.421 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.91 93.94 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -88.95 1.3 55.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.803 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.68 19.86 65.5 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 77.0 m -58.11 -45.7 86.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.77 -57.69 9.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.499 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.3 -41.43 79.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.59 -48.45 80.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.483 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -41.49 98.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.448 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.48 -49.94 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.724 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.28 -35.37 73.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.379 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.96 -50.99 28.43 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.501 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.15 -45.27 94.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.8 m-85 -153.51 154.86 35.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.416 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.4 p-10 -96.78 95.5 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -153.12 -167.06 2.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.482 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.43 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.48 110.25 15.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 239' ' ' TYR . 22.0 m -63.52 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.574 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.418 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.6 m-85 -57.06 -43.94 82.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.238 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.75 -37.48 94.76 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.793 -1.559 . . . . 0.0 110.985 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 164.36 57.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.671 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -61.09 143.28 98.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.694 2.263 . . . . 0.0 112.14 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.63 -40.87 88.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.658 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -138.38 141.5 39.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.438 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.8 mt -109.21 127.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.331 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.84 118.8 37.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.315 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.71 141.81 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.83 107.08 2.16 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.7 m -128.81 120.83 27.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.68 0.276 . . . . 0.0 110.489 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 9.7 t70 -113.01 94.25 29.01 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.946 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.37 134.96 63.83 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.64 2.227 . . . . 0.0 111.786 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.2 p -136.7 -18.7 1.4 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.647 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' O ' ' C ' ' A' ' 18' ' ' ALA . 81.1 m-85 -125.22 97.93 5.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.422 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.696 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.63 -61.4 0.23 Allowed Pre-proline 0 C--O 1.222 -0.372 0 CA-C-O 122.0 0.905 . . . . 0.0 111.018 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.696 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.5 Cg_endo -50.13 -41.22 50.04 Favored 'Trans proline' 0 C--N 1.294 -2.336 0 C-N-CA 122.506 2.137 . . . . 0.0 112.153 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.1 t80 -78.51 -43.05 27.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.126 0.488 . . . . 0.0 110.643 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.682 ' O ' ' O ' ' A' ' 18' ' ' ALA . 94.8 mt-10 -146.73 -160.7 1.19 Allowed 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.159 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.4 t 157.36 -178.97 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.771 0.32 . . . . 0.0 110.299 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.73 140.94 46.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.557 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.3 t-20 -90.32 141.83 28.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.421 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.0 p -66.27 -18.79 65.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.577 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.27 -6.08 53.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.504 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.34 -9.83 57.74 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -79.65 163.02 24.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.801 0.334 . . . . 0.0 110.379 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.1 mt -117.62 137.35 52.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.494 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.495 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.1 p -133.24 151.27 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.318 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.49 154.05 7.42 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.63 -41.35 94.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.739 0.304 . . . . 0.0 110.686 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.8 t0 -70.5 -32.3 69.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.495 HD12 ' C ' ' A' ' 30' ' ' VAL . 96.7 mt -67.98 -39.96 82.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.2 m-20 -60.69 -37.63 82.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.982 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -65.45 -44.3 87.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.24 0.543 . . . . 0.0 110.608 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.44 -46.4 86.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.122 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.46 -53.77 49.84 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.41 -38.91 63.89 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.884 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.27 -42.64 79.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.054 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 48.9 m -53.68 -44.15 69.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -63.98 -46.95 82.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.04 0.448 . . . . 0.0 110.528 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -60.46 -41.48 94.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.146 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.023 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -75.27 -18.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.51 52.25 3.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -146.87 171.05 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.802 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.45 142.14 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -117.59 131.82 56.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.492 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.62 127.01 43.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.401 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -95.72 137.23 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.47 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.3 129.46 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.549 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -68.43 139.06 55.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.4 p30 176.21 135.25 0.19 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.2 143.32 58.64 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.671 2.248 . . . . 0.0 112.63 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 80.8 mt -39.34 -55.25 1.76 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.077 0.465 . . . . 0.0 111.078 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.73 -26.25 2.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.752 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.03 -21.37 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.846 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 55.2 mt -63.95 -42.96 97.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.379 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.688 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -62.47 -55.86 35.56 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.029 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.1 Cg_exo -55.7 -42.23 69.54 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.559 2.172 . . . . 0.0 111.257 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.4 m -58.82 -44.54 90.9 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.182 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.78 -44.65 90.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.361 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.8 -40.84 95.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.531 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.39 1.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.562 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.2 11.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.646 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.0 mttt -63.5 -33.27 75.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.699 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.56 154.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.507 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -91.49 -20.89 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.744 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.06 160.38 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 58' ' ' LEU . 96.0 mt -116.08 127.33 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.77 107.72 9.88 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.315 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.517 ' OG ' HD21 ' A' ' 55' ' ' LEU . 35.7 t -162.42 -177.13 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.4 p -64.02 -15.68 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.636 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.3 122.99 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -83.09 156.34 23.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.766 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -105.53 149.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.7 p -150.87 152.85 34.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.596 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.81 -47.69 51.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.85 -39.85 72.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.35 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.636 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -69.03 -37.36 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.908 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -58.21 -37.29 74.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 110.399 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.84 67.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.71 -51.84 7.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.739 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.58 -167.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.509 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.37 147.14 29.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.087 0.47 . . . . 0.0 110.652 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 76' ' ' ILE . 72.4 m-85 -130.47 150.6 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.652 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.0 t -165.51 -151.01 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.495 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.505 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.0 m-20 43.09 20.02 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.777 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.98 120.51 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.582 0.551 . . . . 0.0 110.678 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.5 mt -79.42 -71.31 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.801 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -148.46 165.4 31.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.23 126.25 31.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.455 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.416 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.37 67.48 0.73 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.55 -105.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.41 167.3 29.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.574 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.2 146.77 23.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -102.01 135.99 42.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.691 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.52 111.66 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.074 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.4 m -134.9 164.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.606 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.88 24.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.825 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.07 60.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.82 -42.07 88.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.287 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -101.97 122.04 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.348 . . . . 0.0 110.245 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.85 109.68 19.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.328 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.3 130.41 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.532 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -109.71 154.14 42.62 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.53 92.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.715 2.276 . . . . 0.0 112.064 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.5 m -170.86 144.8 2.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.752 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.98 -33.98 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.333 0.587 . . . . 0.0 110.432 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.74 -62.14 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.676 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.8 t -56.48 -22.21 30.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.667 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.9 -25.65 53.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.47 132.85 45.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.575 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.49 -16.5 29.8 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.79 151.22 23.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.808 0.337 . . . . 0.0 110.358 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.1 135.5 37.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.47 136.27 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.639 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.72 14.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.6 161.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.548 ' N ' HG12 ' A' ' 119' ' ' VAL . 39.5 tp -92.7 119.27 31.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -51.32 156.78 1.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.637 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.64 50.92 51.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.3 p -148.69 166.74 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.727 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.1 p -71.81 -29.67 64.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.457 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.4 mt-30 -58.77 -54.78 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.588 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.59 -55.77 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.397 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.1 -51.94 67.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.9 t80 -61.64 -44.19 97.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.468 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.49 -44.48 97.95 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.74 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.563 0.221 . . . . 0.0 110.605 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.76 2.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.593 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.37 -50.72 17.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.01 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -99.6 12.77 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.756 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.13 -55.42 0.46 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.51 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.34 -10.06 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.77 2.314 . . . . 0.0 112.093 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.72 -8.45 59.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.639 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.38 37.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.53 138.1 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.57 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.9 130.29 34.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -127.37 138.98 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.778 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.47 132.37 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.3 t -97.81 129.47 44.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.454 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -111.3 156.35 21.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.342 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.85 7.07 27.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.27 6.08 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.08 -45.9 79.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.372 . . . . 0.0 110.578 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.09 62.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.0 t-20 -64.86 -36.53 84.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.514 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.3 -47.36 84.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.0 m-85 -63.85 -37.67 88.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.5 p -61.4 -42.53 98.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.092 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.15 -44.37 92.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.343 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.0 tp -59.01 -47.86 83.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.184 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.54 -22.96 67.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.995 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.56 25.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 10.96 71.05 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.68 -18.15 63.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.704 0.288 . . . . 0.0 110.636 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.5 pt -128.18 137.81 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.13 -29.76 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -174.8 154.92 2.01 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 138.73 52.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.233 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -86.12 102.64 14.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.25 164.4 26.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.27 152.28 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.7 mt-10 -66.0 -54.43 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.077 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.84 -48.83 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.577 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.36 87.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.749 0.309 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -62.92 -62.95 1.37 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.447 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.1 m -58.29 -45.9 87.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.953 0.406 . . . . 0.0 110.49 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -45.98 -40.78 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.401 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -112.13 -62.46 0.46 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.62 -71.59 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.718 0.294 . . . . 0.0 110.747 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -62.67 -41.05 98.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.719 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.0 tttt -59.65 -3.05 0.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.169 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.5 mt-30 -125.96 142.04 41.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.47 -15.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.803 2.335 . . . . 0.0 112.188 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 175' ' ' GLN . 89.7 t -62.5 -43.12 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.27 84.69 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.28 -40.72 95.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.511 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 49.0 m-20 -67.07 -33.6 75.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.5 m-85 -156.59 142.35 17.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.3 pttt -175.47 99.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.712 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 93.5 m-85 -158.93 167.13 30.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.544 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.69 56.13 3.2 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.95 -115.95 0.01 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.35 135.16 39.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.327 2.018 . . . . 0.0 111.931 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.8 p -124.12 -108.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.068 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.9 164.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.038 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.634 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.7 tttt 153.85 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 124.17 0.919 . . . . 0.0 110.51 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.61 119.42 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.239 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.7 mp0 -71.72 -16.34 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.0 -32.21 73.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.683 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -61.05 -44.33 97.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -114.38 8.81 16.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.15 -153.78 51.34 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.659 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.8 p -70.93 -25.53 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.559 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.91 -126.55 1.61 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.9 p -132.29 160.26 36.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.82 -161.94 24.09 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.45 140.13 33.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.542 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.52 3.57 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' ALA . 83.0 mt -118.13 159.64 22.92 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.584 0.23 . . . . 0.0 110.443 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.69 148.84 25.27 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.608 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.21 -48.68 61.97 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -41.02 -22.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.497 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.52 51.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.465 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.46 -46.28 83.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.99 -47.2 38.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.387 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.28 -42.91 99.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.71 -37.46 73.56 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.205 0.526 . . . . 0.0 110.143 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.697 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.12 -77.43 0.1 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.923 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.023 HD21 HD11 ' A' ' 44' ' ' ILE . 88.7 mt -27.95 -45.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.913 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.4 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.741 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.697 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.1 -43.54 98.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.114 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.99 91.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.453 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.23 -43.36 99.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.412 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.23 91.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.368 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.22 -42.15 96.7 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.393 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.31 -38.2 73.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.62 -38.88 77.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.537 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.54 91.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 18.9 p-10 -88.74 0.28 56.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.762 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.01 20.42 68.8 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -57.54 -46.39 83.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.2 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.06 -58.04 8.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.996 0.427 . . . . 0.0 110.485 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.75 -42.53 79.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.545 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.81 -48.8 80.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.442 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.16 -41.48 98.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.49 -50.19 74.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.745 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -34.76 72.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -71.42 -51.83 21.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.176 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.42 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 40.1 m-85 -62.73 -44.61 95.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 230' ' ' ALA . 83.9 m-85 -151.31 153.09 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.513 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 49.0 p-10 -98.21 93.92 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.464 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.89 -165.59 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.444 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -122.39 108.75 13.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.683 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 239' ' ' TYR . 28.2 m -63.53 -40.06 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.428 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.1 m-85 -57.37 -43.57 83.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.71 -37.55 94.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.219 -0.796 0 CA-C-O 117.924 -1.486 . . . . 0.0 111.005 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.3 60.14 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.99 143.47 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 122.737 2.291 . . . . 0.0 112.261 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.42 -40.91 89.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.633 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -138.0 139.0 39.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.34 121.21 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.587 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.1 118.88 32.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.6 138.67 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.369 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.7 105.29 2.11 Favored Glycine 0 N--CA 1.463 0.442 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.9 m -128.75 120.52 26.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.648 -0.325 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.509 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.7 t70 -114.35 92.85 29.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.953 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.33 134.42 60.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.544 2.162 . . . . 0.0 111.974 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.7 p -141.48 -20.31 0.76 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.716 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.6 m-85 -123.56 99.15 6.17 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.717 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.06 -61.29 0.22 Allowed Pre-proline 0 C--O 1.218 -0.559 0 CA-C-O 121.814 0.816 . . . . 0.0 111.085 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.717 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.41 -40.98 44.47 Favored 'Trans proline' 0 C--N 1.291 -2.461 0 C-N-CA 122.495 2.13 . . . . 0.0 112.211 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.3 t80 -78.13 -42.75 30.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.702 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.656 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -149.81 -154.11 0.53 Allowed 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.048 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.75 177.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.034 0.445 . . . . 0.0 110.269 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.47 144.75 46.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.442 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -95.94 134.56 38.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -64.84 -18.88 65.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.522 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.02 -6.06 53.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.29 -8.09 56.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.74 159.12 25.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 110.459 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.3 mt -112.42 131.17 55.7 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.69 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.82 151.42 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.368 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.15 151.43 6.61 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -58.67 -42.38 88.33 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.695 -0.297 . . . . 0.0 110.819 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 -69.35 -28.49 66.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.266 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.69 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -68.15 -40.84 83.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.83 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.3 -37.77 81.58 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.19 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.38 -45.05 89.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 110.163 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.19 -48.77 77.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.915 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.65 -54.69 29.88 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.15 -40.46 61.45 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.17 -41.7 81.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.971 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.8 m -53.43 -45.18 69.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.167 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.33 -46.38 83.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.279 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -60.23 -42.31 94.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 213' ' ' LEU . 97.3 mt -75.53 -16.99 15.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.41 52.96 4.46 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.706 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.8 p -146.96 171.54 15.08 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.89 142.31 27.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.038 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.14 130.92 56.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.63 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.4 m -127.29 127.1 43.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -94.03 134.89 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.4 t -129.09 127.77 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 137.89 57.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.07 131.04 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.5 Cg_endo -67.84 145.31 68.24 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.684 2.256 . . . . 0.0 112.562 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 58' ' ' LEU . 81.8 mt -40.41 -56.07 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.979 0.418 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.05 -26.69 1.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.008 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -20.96 18.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 55' ' ' LEU . 58.7 mt -63.77 -42.53 97.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.641 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.3 -56.84 26.99 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.821 0.701 . . . . 0.0 109.688 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.1 Cg_exo -55.84 -41.83 73.31 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.556 2.171 . . . . 0.0 111.102 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m -59.05 -44.5 91.81 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.055 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.657 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.3 tp -59.45 -43.89 93.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.185 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.45 95.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.23 10.22 2.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.496 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.21 12.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.56 -35.38 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.549 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.43 153.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.297 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.4 m-20 -93.17 -22.27 19.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.5 155.94 27.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.607 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.08 128.63 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.123 0.487 . . . . 0.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.11 107.22 8.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.701 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -159.48 178.64 9.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.618 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.4 p -65.01 -15.34 62.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.493 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.16 124.65 0.6 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.549 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.15 154.38 25.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.63 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.5 pt -105.16 148.86 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.134 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -149.16 152.18 35.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.9 -47.15 52.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.434 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.55 -40.21 71.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.707 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.4 -37.92 80.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.072 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.78 -38.84 76.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.94 -27.43 66.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.206 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.46 -51.0 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.526 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -139.01 -168.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.072 0.463 . . . . 0.0 110.49 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.31 147.74 29.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 76' ' ' ILE . 79.5 m-85 -130.01 150.11 51.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.549 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.9 t -163.36 -153.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.437 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.3 m-20 41.55 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.933 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.72 121.38 0.2 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.478 0.486 . . . . 0.0 110.503 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 58.6 mt -75.0 -68.56 0.54 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.444 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.78 167.61 26.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.6 29.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.368 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -105.05 68.24 0.81 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.713 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.58 -104.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.9 p -159.26 165.49 33.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.639 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.05 146.45 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.112 0.482 . . . . 0.0 110.432 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.95 135.99 41.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.762 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.06 164.49 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.11 148.25 25.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.01 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.19 -28.39 58.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.05 -41.66 88.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -101.63 121.41 41.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.153 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.06 109.88 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.419 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.57 129.54 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -107.16 154.11 40.64 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.35 91.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.793 2.329 . . . . 0.0 111.946 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.3 m -170.44 143.44 2.29 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.516 0.51 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.59 -33.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.35 -62.07 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.439 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -56.6 -22.48 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.826 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.2 mt -75.89 -26.03 56.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.276 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.6 47.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.454 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.79 -16.99 28.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.01 151.34 23.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.434 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.78 135.2 37.8 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.287 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.58 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.594 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 138.45 14.26 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.6 161.56 40.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.6 tp -92.52 117.51 30.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.648 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.55 157.91 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.71 50.63 52.83 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.1 p -149.9 168.75 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.783 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.451 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.8 p -73.3 -26.88 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.458 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.49 -55.31 35.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.534 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -56.98 -54.9 41.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.8 m -60.26 -51.38 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.524 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.3 t80 -61.99 -44.08 97.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.441 . . . . 0.0 110.502 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.52 -44.55 97.84 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.54 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.657 0.265 . . . . 0.0 110.651 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.5 -34.64 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.611 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.6 -50.65 17.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 111.366 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.3 12.17 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.171 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.57 -55.29 0.49 Allowed Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.35 -10.1 25.13 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.796 2.331 . . . . 0.0 111.994 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.85 -9.02 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.25 37.09 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.33 137.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.29 129.79 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.343 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.4 138.14 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.0 133.25 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.023 0.44 . . . . 0.0 109.979 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.88 127.08 42.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.31 25.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.33 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.02 7.22 29.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.19 5.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.409 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.0 tp60 -65.81 -45.77 81.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.463 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.77 -23.47 62.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.73 -36.8 85.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.94 -46.62 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.016 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.494 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.8 m-85 -64.7 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.04 -41.86 97.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.39 -43.2 91.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.998 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.4 tp -58.77 -48.2 82.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.172 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.84 -22.48 66.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.224 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.47 -18.41 25.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.55 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.64 72.38 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.82 -17.82 63.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.645 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.5 pt -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.493 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.64 -28.0 62.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.38 155.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.517 0.511 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.01 137.21 50.15 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.022 0.439 . . . . 0.0 110.074 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -86.03 103.32 14.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.7 tt0 -132.85 165.56 24.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.446 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.474 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -72.89 153.12 41.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.69 -54.68 20.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 91' ' ' TYR . 69.3 t -60.29 -48.89 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.506 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.96 89.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.41 -62.92 1.3 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.456 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.5 m -59.56 -47.49 85.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.99 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -48.93 -37.27 19.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.113 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.03 0.55 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 168' ' ' ALA . 23.8 t80 -40.72 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.771 -0.252 . . . . 0.0 111.087 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -61.44 -40.39 94.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.38 -3.35 0.42 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.632 . . . . 0.0 110.321 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 173' ' ' LEU . 36.9 mt-30 -122.82 150.09 57.87 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.69 -20.92 7.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.853 2.369 . . . . 0.0 112.231 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.79 -43.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.577 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.13 -33.28 85.31 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.48 -41.14 93.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.738 0.304 . . . . 0.0 110.459 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.6 m-20 -66.12 -32.91 74.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.2 142.64 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.557 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.44 99.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.085 0.469 . . . . 0.0 110.727 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.24 167.53 28.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.647 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.91 56.45 2.74 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.67 -118.61 0.01 OUTLIER Glycine 0 CA--C 1.535 1.337 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.55 135.7 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.395 2.063 . . . . 0.0 111.996 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.3 p -125.2 -108.32 0.32 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.435 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.12 164.56 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.065 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.65 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 154.13 155.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.346 1.029 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -81.92 117.4 22.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 195' ' ' GLY . 54.1 mp0 -71.44 -18.94 62.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.81 -32.37 73.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.565 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.8 mt -60.93 -44.58 97.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.669 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.451 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.2 m-85 -114.13 9.64 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.646 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.74 -153.86 51.8 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.63 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.74 -24.93 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.789 0.328 . . . . 0.0 110.501 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.34 -124.14 1.3 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.49 156.16 44.57 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.646 0.26 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.56 30.37 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.17 137.41 33.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.534 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.32 108.38 3.28 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.44 159.12 29.68 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.293 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.657 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.42 149.79 24.76 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.803 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.2 -47.76 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.522 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.53 -25.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.791 0.329 . . . . 0.0 110.574 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.4 52.07 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.611 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -64.49 -45.11 88.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.162 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.9 -47.39 30.21 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.46 -43.72 98.14 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.506 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.2 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.798 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.91 -36.35 70.06 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.09 -77.38 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 44' ' ' ILE . 96.6 mt -28.4 -46.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.956 0.408 . . . . 0.0 110.637 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.4 -44.84 90.02 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.779 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.02 -43.56 98.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.037 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.87 92.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.199 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.34 -43.71 98.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.126 0.488 . . . . 0.0 110.144 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.53 93.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.383 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -42.71 97.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.22 -37.85 72.85 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.2 -38.88 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.44 . . . . 0.0 110.437 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.73 94.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.17 2.13 54.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.67 63.09 Favored Glycine 0 C--O 1.225 -0.451 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.441 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 83.9 m -58.07 -45.84 86.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.0 t80 -63.7 -57.73 9.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.11 -41.46 79.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.232 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.64 -48.33 81.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.459 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.21 -41.55 98.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.829 0.347 . . . . 0.0 110.294 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.76 -50.0 75.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.92 -35.43 73.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.428 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.75 -51.21 28.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.544 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.2 m-85 -61.88 -45.83 92.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.97 155.54 35.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.09 97.43 9.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.001 0.429 . . . . 0.0 110.496 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.86 -166.49 2.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.477 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.03 110.99 16.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.0 m -63.22 -40.34 88.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.417 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.0 m-85 -58.89 -42.48 89.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.274 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.94 94.12 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.957 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.47 164.59 59.93 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.07 143.63 99.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.749 2.299 . . . . 0.0 112.276 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.11 -40.24 90.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.81 142.92 36.63 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.97 129.08 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -104.1 117.12 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.337 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -111.89 138.86 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.82 104.86 2.13 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.6 m -127.98 119.3 25.21 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 122.588 -0.36 . . . . 0.0 110.91 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.9 t70 -113.63 92.46 24.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.33 134.3 60.36 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 p -141.36 -19.31 0.78 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.783 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.5 m-85 -124.77 99.14 6.02 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.421 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.717 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.23 -61.04 0.23 Allowed Pre-proline 0 C--O 1.217 -0.656 0 CA-C-O 122.039 0.923 . . . . 0.0 111.201 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.717 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.5 Cg_endo -49.76 -39.97 47.76 Favored 'Trans proline' 0 C--N 1.288 -2.658 0 C-N-CA 122.581 2.187 . . . . 0.0 112.225 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.5 t80 -78.78 -42.69 27.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.973 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.644 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.37 -155.51 0.64 Allowed 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.216 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.92 178.21 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.035 0.445 . . . . 0.0 110.312 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -136.09 143.41 44.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.471 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.2 t-20 -95.62 141.43 29.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.486 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.3 p -65.76 -19.14 65.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.551 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.14 -6.97 56.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.15 -7.32 58.54 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.18 157.85 27.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.393 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.0 mt -111.54 133.77 53.58 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.92 0.391 . . . . 0.0 110.395 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.668 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.52 151.31 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.328 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.7 151.98 6.81 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -58.75 -42.31 88.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.613 -0.345 . . . . 0.0 110.98 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.472 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.8 t0 -69.83 -28.48 65.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.668 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.7 mt -68.55 -40.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.422 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.5 m-20 -61.41 -37.66 84.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.686 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.0 -43.92 86.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.13 -41.88 93.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.909 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.67 -53.3 59.92 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.589 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.92 -37.06 63.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.117 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.86 -42.29 77.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.102 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.75 -44.59 73.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.077 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.81 -47.22 81.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.162 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -59.85 -40.97 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.054 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.985 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -76.37 -17.53 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.5 52.45 4.64 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.21 170.23 16.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.898 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.37 140.59 29.32 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.964 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.5 m -117.13 131.88 56.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.583 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -128.28 127.63 43.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -93.91 135.71 34.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.58 128.82 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.31 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.83 139.4 58.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.606 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.513 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.38 131.7 0.15 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.692 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.34 145.28 65.08 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.67 2.247 . . . . 0.0 112.591 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.886 HD23 HD12 ' A' ' 58' ' ' LEU . 82.1 mt -40.27 -56.67 1.91 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.085 0.469 . . . . 0.0 111.283 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.47 -26.74 1.47 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.57 19.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.194 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.886 HD12 HD23 ' A' ' 55' ' ' LEU . 58.7 mt -63.98 -42.56 97.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.859 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.687 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.32 -57.02 25.36 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 123.933 0.771 . . . . 0.0 109.527 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.3 Cg_exo -55.46 -42.65 65.95 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.49 2.126 . . . . 0.0 110.939 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -59.19 -43.88 92.2 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.01 -44.05 91.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.109 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.72 -40.02 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.507 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.54 11.23 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.479 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.12 11.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -34.34 77.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.1 pt -124.05 153.52 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.189 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.35 -20.59 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.4 157.32 25.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.545 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.91 127.36 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.472 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.33 106.45 9.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.309 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.585 ' OG ' HD21 ' A' ' 55' ' ' LEU . 41.4 t -160.07 -178.33 6.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.575 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.3 p -64.24 -15.38 59.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.417 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.1 tp -37.96 123.76 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.557 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.44 156.84 22.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.647 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.0 pt -105.27 149.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.131 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.3 p -149.87 152.9 35.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.751 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.44 -47.5 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.9 -40.05 72.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.691 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.01 -37.82 81.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.078 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.26 -37.37 74.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.05 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.55 -27.2 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.127 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.5 -51.91 6.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.329 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.27 -168.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.118 0.485 . . . . 0.0 110.407 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.79 29.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.94 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.0 m-85 -129.93 149.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.37 -151.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.421 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.506 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.37 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -28.27 120.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.581 0.551 . . . . 0.0 110.518 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.5 mt -77.25 -69.9 0.5 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.2 p90 -149.17 166.12 29.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.589 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.88 121.67 27.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.298 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.87 69.29 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.88 -105.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.424 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.15 165.76 33.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.615 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.47 146.02 22.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.133 0.492 . . . . 0.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.08 136.11 41.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.51 111.06 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.27 165.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.73 148.45 23.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.154 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.13 -28.22 57.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.201 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.0 -41.78 88.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.12 122.22 43.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.114 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.04 110.0 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.33 129.84 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.85 154.34 41.87 Favored Pre-proline 0 N--CA 1.457 -0.096 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.641 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.24 92.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.832 2.354 . . . . 0.0 111.82 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -170.86 144.09 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.666 0.604 . . . . 0.0 110.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.3 -33.74 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.306 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.493 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.85 -62.11 2.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.74 -21.85 31.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.893 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.8 mt -76.19 -25.93 55.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.373 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.44 47.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.459 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.17 -16.25 29.5 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.5 151.56 23.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.29 135.4 38.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.231 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.04 136.49 60.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.615 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 138.62 14.32 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.1 t -130.89 161.76 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.213 0.53 . . . . 0.0 110.205 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.3 tp -92.5 117.54 30.05 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.75 157.79 1.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.76 50.29 54.52 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.46 168.78 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.835 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.453 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 77.0 p -73.1 -27.35 61.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.418 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.45 -54.87 40.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.51 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -57.16 -54.5 46.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.408 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -60.73 -51.14 70.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.446 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.02 -43.95 97.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.986 0.422 . . . . 0.0 110.476 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.68 -44.44 97.91 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.62 -14.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.6 0.238 . . . . 0.0 110.746 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.3 -34.73 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.46 -50.66 17.44 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.478 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.13 12.45 36.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.293 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.6 0.46 Allowed Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.347 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.19 -10.45 25.83 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.793 2.328 . . . . 0.0 111.951 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.51 -8.66 59.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.72 33.53 37.6 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.79 137.99 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.987 0.423 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.71 130.08 34.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.233 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.56 138.35 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.1 t -123.04 133.19 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.0 127.26 42.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.85 153.28 25.64 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.67 6.88 30.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.96 130.49 5.95 Favored Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.93 -45.67 81.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.44 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.15 -23.98 63.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.055 0.455 . . . . 0.0 110.513 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.5 t-20 -64.7 -36.53 84.59 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.551 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.93 -47.07 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.515 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.7 m-85 -63.8 -37.66 88.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.26 -42.61 98.92 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.137 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.86 -44.96 91.53 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.0 tp -58.91 -47.72 84.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.213 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -63.25 -22.47 66.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.072 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.95 -18.33 24.88 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.459 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.48 70.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -17.87 63.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.2 pt -128.24 137.45 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.449 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.8 -27.95 62.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.57 155.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.617 0.573 . . . . 0.0 110.835 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.48 50.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.957 0.408 . . . . 0.0 110.035 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.95 103.0 14.26 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.083 0.468 . . . . 0.0 110.577 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.17 165.02 25.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.441 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.463 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.34 152.4 40.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.606 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -65.99 -54.09 30.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.35 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 68.5 t -60.45 -48.94 86.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.405 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.8 87.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.787 0.327 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.15 -63.53 1.13 Allowed 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.425 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.437 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.0 m -58.77 -46.72 86.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.756 0.313 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.1 tt0 -50.04 -37.95 35.53 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.896 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.86 -65.76 0.55 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.1 t80 -40.48 -71.08 0.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.777 -0.249 . . . . 0.0 111.213 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.47 -40.06 93.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.005 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.45 -3.28 0.42 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 110.306 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 177' ' ' VAL . 61.1 mt-30 -124.37 141.81 38.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 O-C-N 121.965 -0.459 . . . . 0.0 110.858 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.71 -14.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.823 2.349 . . . . 0.0 112.379 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.0 t -63.29 -42.96 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.445 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.89 80.62 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.72 -42.13 96.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.774 0.321 . . . . 0.0 110.318 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 60.1 m-20 -65.01 -35.23 80.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.7 m-85 -156.8 143.72 18.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.11 99.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.135 0.493 . . . . 0.0 110.798 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.15 168.49 26.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.1 55.85 3.19 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.52 -116.68 0.01 OUTLIER Glycine 0 CA--C 1.538 1.498 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.14 135.63 37.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.367 2.045 . . . . 0.0 111.963 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.0 p -125.34 -108.05 0.32 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.597 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.48 165.38 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-O 118.739 -0.648 . . . . 0.0 109.966 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.54 155.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.625 1.203 . . . . 0.0 110.616 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.19 22.99 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.823 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.4 mp0 -71.93 -18.54 62.01 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.566 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.1 mt -60.98 -44.26 97.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.799 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.453 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.3 m-85 -113.79 7.88 17.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.716 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.78 -154.49 50.04 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.7 p -70.87 -25.4 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.0 110.536 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.92 -125.88 1.52 Allowed Glycine 0 CA--C 1.517 0.211 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -132.05 159.86 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.859 0.362 . . . . 0.0 110.372 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.66 -162.59 25.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.21 141.12 31.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.97 0.414 . . . . 0.0 110.611 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.27 111.73 3.95 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.6 mt -120.55 160.3 23.46 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.93 149.28 24.9 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 120.83 0.348 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.5 -48.59 65.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.763 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.49 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -71.76 51.96 0.21 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.708 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -64.37 -46.2 84.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.11 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.48 -47.08 35.48 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.096 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.24 -43.79 98.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.459 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.57 -42.85 99.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.746 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.71 -37.55 73.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.694 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.32 -77.47 0.1 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 44' ' ' ILE . 86.9 mt -28.95 -45.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.984 0.421 . . . . 0.0 110.769 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.1 m-20 -63.69 -45.47 89.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.49 -43.74 98.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.947 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.23 92.61 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.15 -43.67 98.52 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.16 0.505 . . . . 0.0 110.112 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.98 -39.36 91.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.71 -42.67 97.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.895 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.14 -38.32 73.32 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.71 -38.76 77.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 110.447 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.01 -45.48 92.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.24 0.66 55.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.54 20.06 67.5 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 84.5 m -58.09 -46.13 86.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.58 -57.15 11.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.953 0.406 . . . . 0.0 110.451 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.23 -41.42 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.149 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.458 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.01 -41.53 98.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.413 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.99 -49.67 77.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.713 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.03 -35.82 73.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.318 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.45 -50.84 33.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.536 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.0 m-85 -62.31 -45.76 91.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.534 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.47 155.44 36.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.99 98.19 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.417 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -155.16 -165.74 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.45 109.67 14.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.74 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.3 m -63.75 -40.54 89.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.581 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.3 m-85 -57.03 -43.76 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.03 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.18 164.25 54.59 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.731 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.39 99.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.662 2.241 . . . . 0.0 112.335 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.45 -40.52 89.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.0 m-20 -139.14 142.77 38.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.398 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -109.87 127.25 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.899 0.38 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.67 120.49 40.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.87 141.88 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.927 0.394 . . . . 0.0 110.376 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.66 102.36 1.58 Allowed Glycine 0 N--CA 1.463 0.483 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.9 m -125.13 119.83 29.68 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 122.693 -0.298 . . . . 0.0 111.118 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.4 t70 -112.41 94.77 28.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.01 134.91 61.96 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.459 2.106 . . . . 0.0 112.25 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.1 p -136.49 -19.02 1.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.731 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.7 m-85 -125.63 98.19 5.47 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.715 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -30.11 -61.21 0.25 Allowed Pre-proline 0 C--O 1.218 -0.585 0 CA-C-O 121.735 0.778 . . . . 0.0 111.064 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.712 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.4 Cg_endo -50.2 -40.21 51.7 Favored 'Trans proline' 0 C--N 1.293 -2.394 0 C-N-CA 122.4 2.067 . . . . 0.0 112.315 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.5 t80 -79.16 -43.29 24.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.017 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.671 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.0 mt-10 -146.29 -161.59 1.35 Allowed 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.225 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.2 t 158.13 -179.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.429 . . . . 0.0 110.25 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -133.12 141.04 47.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.4 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.28 137.44 32.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.605 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -65.24 -18.86 65.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.512 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.0 -5.11 53.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.441 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.35 -10.89 56.72 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.64 162.47 24.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.976 0.417 . . . . 0.0 110.391 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.07 137.68 52.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.943 0.402 . . . . 0.0 110.471 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.508 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.1 p -133.25 151.48 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.55 153.52 7.2 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.07 -41.38 92.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.42 . . . . 0.0 111.068 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.2 t0 -70.18 -32.5 70.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.227 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.508 HD12 ' C ' ' A' ' 30' ' ' VAL . 98.1 mt -67.26 -40.28 84.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.886 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 55.0 m-20 -61.02 -37.3 82.07 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.709 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.0 tp -65.83 -44.68 84.86 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.15 -46.5 85.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -54.3 -54.19 43.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.387 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.06 -38.15 62.23 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.953 0.406 . . . . 0.0 110.419 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.51 -42.46 74.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.608 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -54.28 -44.42 71.89 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.044 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.63 -48.04 78.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.018 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -59.35 -41.28 88.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.096 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 213' ' ' LEU . 96.8 mt -76.28 -18.21 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.571 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.11 52.35 4.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 170.28 16.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.16 141.64 28.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.06 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -117.23 131.61 56.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.682 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -127.89 127.37 43.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.454 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.24 137.81 34.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.903 0.382 . . . . 0.0 110.399 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.56 129.52 64.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.403 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -67.65 139.97 56.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.78 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.487 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.65 135.52 0.13 Allowed Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.2 Cg_endo -68.62 144.19 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.592 2.195 . . . . 0.0 112.546 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.946 HD23 HD12 ' A' ' 58' ' ' LEU . 79.5 mt -40.75 -54.1 2.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.043 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -48.67 -26.18 2.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.15 -20.78 18.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.946 HD12 HD23 ' A' ' 55' ' ' LEU . 84.4 mt -64.72 -42.47 95.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.001 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.699 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.28 -57.31 26.58 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.744 0.652 . . . . 0.0 109.616 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.0 Cg_exo -54.65 -43.26 60.71 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.658 2.239 . . . . 0.0 111.19 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.3 m -58.27 -44.74 88.55 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.691 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.87 -44.47 91.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.194 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.81 -41.06 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.492 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.08 11.31 1.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.85 12.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -33.58 75.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.529 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 pt -124.29 154.43 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -91.75 -20.81 21.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.146 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.55 159.95 22.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 58' ' ' LEU . 96.3 mt -115.82 127.54 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.067 0.46 . . . . 0.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -129.03 107.2 9.42 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.28 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.597 ' OG ' HD21 ' A' ' 55' ' ' LEU . 46.9 t -162.17 -176.95 5.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.633 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.34 -15.94 61.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.606 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.4 tp -36.89 122.63 0.83 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -82.55 155.78 24.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.627 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.663 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.29 149.17 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.296 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.3 p -150.53 152.92 34.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.812 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.21 -47.84 54.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.967 0.413 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.5 -39.83 70.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.776 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.606 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -68.41 -37.75 80.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.67 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.852 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.88 -27.58 66.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.129 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.11 -51.55 7.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.7 -167.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.36 147.04 29.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 111.044 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 76' ' ' ILE . 72.3 m-85 -130.28 150.29 51.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.1 t -165.13 -150.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.431 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.3 m-20 42.55 19.94 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.93 121.09 0.11 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.38 0.425 . . . . 0.0 110.471 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -79.28 -71.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.782 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CG ' HG21 ' A' ' 166' ' ' VAL . 35.4 p90 -148.19 165.27 31.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.624 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.32 126.05 31.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.425 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.19 67.74 0.75 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.752 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.68 -105.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.47 167.3 29.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.634 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.23 146.59 22.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.68 135.88 42.47 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.786 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.55 111.58 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.77 164.69 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.04 148.3 24.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.14 -27.88 48.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -59.29 -41.46 89.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.35 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -102.45 122.48 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.61 109.7 19.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.434 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.2 129.97 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.6 35.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.451 . . . . 0.0 110.507 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.9 Cg_endo -60.45 91.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.783 2.322 . . . . 0.0 111.9 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.1 m -169.57 141.97 2.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 123.584 0.553 . . . . 0.0 110.75 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.07 -33.42 60.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.215 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.19 -62.77 1.53 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.294 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.0 t -56.2 -21.91 25.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.138 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.12 -26.62 56.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.307 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.04 133.22 48.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.387 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -16.25 29.64 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.34 151.18 23.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.421 . . . . 0.0 110.409 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.71 134.88 38.12 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.198 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.65 136.48 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.692 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.7 138.83 14.49 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.09 161.55 40.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.145 0.497 . . . . 0.0 110.313 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.42 118.07 30.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.563 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.57 157.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.58 50.66 53.41 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.3 p -149.05 167.96 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.831 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.5 p -71.5 -29.76 65.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.2 mt-30 -58.93 -55.13 39.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.42 -55.46 33.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.38 -51.26 70.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.77 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.598 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.5 t80 -62.06 -43.91 97.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.36 97.92 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.12 -14.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.35 2.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.598 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.31 -50.7 17.75 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.38 12.61 35.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.248 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.97 -55.46 0.47 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.37 -9.98 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.78 2.32 . . . . 0.0 111.913 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -83.0 -8.74 59.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.23 33.35 36.05 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.7 137.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.009 0.433 . . . . 0.0 110.472 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -87.58 130.26 34.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.258 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.4 137.96 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.9 t -123.03 133.33 69.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.87 126.87 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -110.67 153.65 24.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.73 7.98 28.68 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.15 130.09 5.79 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.04 -45.91 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.38 -23.51 62.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.495 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.66 -36.66 84.98 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.535 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.98 -47.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.63 -38.0 89.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.22 -42.58 98.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.182 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -64.06 -45.13 90.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.037 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.529 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.7 tp -58.47 -47.95 82.38 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.206 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.56 -22.86 67.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.005 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.9 -18.76 25.54 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.548 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.01 11.17 70.51 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.61 -18.12 63.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.593 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -128.46 137.57 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 110.444 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.64 -28.72 62.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.53 155.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.24 138.62 51.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.018 0.437 . . . . 0.0 109.96 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.48 102.98 14.58 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.214 0.531 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.93 25.2 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.468 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.83 152.23 40.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 98.0 mt-10 -66.05 -53.97 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.268 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.402 HG21 ' CG ' ' A' ' 91' ' ' TYR . 70.4 t -60.08 -49.22 84.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.42 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.96 85.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.882 0.372 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.26 1.25 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.318 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.2 m -57.98 -46.39 85.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -45.61 -41.56 10.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.389 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.52 -62.06 0.47 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.721 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.655 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.69 -71.56 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.534 0.207 . . . . 0.0 111.136 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -62.16 -41.23 98.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.5 tttt -59.98 -2.17 0.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.53 0.681 . . . . 0.0 110.318 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.5 mt-30 -126.45 141.93 41.49 Favored Pre-proline 0 CA--C 1.532 0.272 0 O-C-N 122.079 -0.388 . . . . 0.0 110.733 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.65 -14.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.842 2.361 . . . . 0.0 112.397 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 175' ' ' GLN . 87.6 t -62.94 -42.89 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.17 84.33 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.38 -41.1 96.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.92 -34.9 79.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.476 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.52 142.97 18.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.0 pttt -175.88 99.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.962 0.41 . . . . 0.0 110.796 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.5 m-85 -158.68 167.11 30.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.683 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.19 55.98 3.14 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 134.98 36.06 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 111.949 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -124.32 -108.35 0.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.547 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -165.42 165.07 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 CA-C-O 119.16 -0.447 . . . . 0.0 110.156 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.8 tttt 154.13 155.24 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.283 0.989 . . . . 0.0 110.669 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.15 118.51 22.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.776 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.4 mp0 -71.17 -19.07 62.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.55 -31.81 73.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.546 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.458 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.9 mt -60.88 -44.33 97.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -114.16 8.44 16.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.819 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.44 -153.58 50.76 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.663 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.1 p -71.01 -25.65 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.71 -125.97 1.53 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.5 p -132.16 160.42 36.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.504 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.54 -162.04 24.02 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.68 139.83 33.8 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.959 0.409 . . . . 0.0 110.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.65 108.75 3.47 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.0 mt -117.72 159.41 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 0.0 110.253 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.82 149.19 25.02 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 120.886 0.374 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.61 64.16 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.645 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -40.64 -22.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.81 51.55 0.28 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -64.47 -46.03 84.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.171 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.28 -47.08 37.15 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.26 -43.65 98.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.474 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.45 -43.05 99.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.823 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.77 -37.51 73.8 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.26 -77.69 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 44' ' ' ILE . 87.3 mt -28.54 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.6 m-20 -63.43 -45.57 90.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.02 -43.84 98.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.94 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.26 92.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.077 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -61.11 -43.67 98.53 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.058 0.456 . . . . 0.0 110.015 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.34 92.07 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.058 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.67 -43.52 96.45 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.2 -38.65 71.27 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.73 -38.75 76.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.024 0.44 . . . . 0.0 110.367 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.56 91.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 20.6 p-10 -88.61 -0.02 56.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.78 20.86 68.8 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.5 m -58.05 -46.38 85.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 80.4 t80 -63.26 -57.62 9.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.443 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.05 -42.43 80.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.399 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -48.66 80.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.71 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.34 -41.38 98.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.566 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.67 -50.04 75.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.63 -34.65 73.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.719 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -71.16 -51.77 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.706 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.432 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 39.4 m-85 -62.52 -44.94 95.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.67 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 230' ' ' ALA . 84.0 m-85 -151.06 153.21 34.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 49.1 p-10 -98.34 93.6 6.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.495 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.56 -165.64 2.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.511 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.447 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.36 108.8 13.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 239' ' ' TYR . 28.9 m -63.4 -40.59 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.433 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.2 m-85 -57.3 -43.49 83.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.16 94.31 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.683 0 CA-C-O 117.876 -1.513 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.73 164.37 56.03 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.78 143.75 99.44 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 122.692 2.261 . . . . 0.0 112.3 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.24 -40.0 89.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -140.1 145.54 37.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.42 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.28 130.04 66.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -105.93 117.88 35.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.448 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -113.27 140.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.44 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.2 100.45 1.46 Allowed Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.5 m -123.66 119.3 29.42 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.66 -0.318 . . . . 0.0 111.151 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 8.1 t70 -112.33 93.98 24.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.22 135.18 63.91 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.16 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.7 p -137.22 -18.16 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.71 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.9 m-85 -124.84 97.59 5.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.711 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.716 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -30.48 -61.26 0.25 Allowed Pre-proline 0 C--O 1.218 -0.577 0 CA-C-O 121.729 0.776 . . . . 0.0 111.071 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.716 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.5 Cg_endo -49.86 -41.23 47.78 Favored 'Trans proline' 0 C--N 1.292 -2.435 0 C-N-CA 122.419 2.08 . . . . 0.0 112.357 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.2 t80 -78.31 -43.06 28.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.078 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.69 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.0 mt-10 -146.35 -161.5 1.33 Allowed 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.167 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.3 t 157.81 -179.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.03 0.443 . . . . 0.0 110.224 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.2 mttt -133.73 140.71 47.16 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.471 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -88.87 138.68 31.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.606 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -65.26 -19.15 65.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.501 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -79.81 -5.16 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.0 -10.45 57.02 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.59 158.91 27.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.389 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.6 mt -114.21 135.38 54.11 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.536 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.508 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.1 p -131.62 150.61 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.267 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.99 152.99 7.03 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -60.23 -41.5 93.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.973 0.416 . . . . 0.0 110.851 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 -70.2 -32.75 70.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.354 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.508 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.9 mt -66.85 -40.13 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.892 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.03 -37.02 81.09 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.89 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.48 -44.66 82.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.177 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.8 -41.67 91.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.095 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -57.8 -53.43 58.33 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.596 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.97 -36.16 65.07 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.314 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.93 -43.18 72.17 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -55.04 -43.6 73.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.3 -48.02 77.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.019 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.49 -40.79 88.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -76.32 -18.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.46 51.75 4.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.123 0.487 . . . . 0.0 110.799 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -144.39 169.26 18.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.75 140.36 29.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.065 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -117.31 132.29 56.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.0 m -128.16 126.88 41.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.386 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.5 136.69 34.52 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.455 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.33 129.34 64.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.346 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.67 141.19 56.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.757 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.484 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 172.65 135.86 0.1 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.497 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.56 144.19 59.75 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.644 2.23 . . . . 0.0 112.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.95 HD23 HD12 ' A' ' 58' ' ' LEU . 81.0 mt -41.17 -53.64 3.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.916 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.84 -26.11 2.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.41 19.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.143 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.95 HD12 HD23 ' A' ' 55' ' ' LEU . 84.4 mt -64.84 -42.5 94.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.963 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.705 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.42 -56.97 28.54 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.772 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.705 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.1 Cg_exo -55.18 -43.04 62.8 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.562 2.175 . . . . 0.0 111.137 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -58.32 -44.42 88.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.764 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.95 -44.48 91.45 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.65 -40.92 96.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 0.0 110.431 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.77 11.38 1.38 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.92 12.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.53 -33.81 76.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -124.71 153.73 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.323 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -92.83 -20.46 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.29 158.38 24.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.674 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.566 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.41 127.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.502 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.68 106.65 9.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.301 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.593 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.6 t -161.11 -177.97 6.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.33 -15.54 60.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.646 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.13 123.09 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.558 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -82.44 155.84 24.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.704 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.655 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.03 148.73 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.232 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.45 152.81 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.781 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.66 52.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 110.567 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.37 -39.96 70.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.646 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.61 -37.57 79.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.89 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.33 -38.09 76.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.86 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.86 -27.69 66.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.02 -51.36 7.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.957 0.408 . . . . 0.0 110.69 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -139.12 -167.83 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.1 0.476 . . . . 0.0 110.457 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.64 147.06 29.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.044 0.449 . . . . 0.0 110.966 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.1 m-85 -130.05 150.21 51.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.2 t -165.08 -150.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.3 m-20 42.52 20.08 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.7 mttt -27.79 121.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.494 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 17.6 mt -79.84 -72.49 0.4 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -147.77 164.74 32.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.2 127.67 32.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.404 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -107.19 67.34 0.69 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.12 -106.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.47 167.65 28.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.58 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.413 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.4 mt -101.03 135.96 41.64 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.786 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.87 111.03 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.72 164.41 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.956 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.64 148.69 24.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.6 -28.16 53.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.13 -41.43 88.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.266 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.31 122.25 43.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 110.218 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.71 109.71 19.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.403 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.39 130.01 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.634 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.1 158.84 34.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.568 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.5 Cg_endo -60.06 90.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.819 2.346 . . . . 0.0 111.858 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -169.17 141.43 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.538 0.524 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.76 -33.14 59.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.31 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.15 -62.56 1.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.381 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.56 -21.8 29.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.062 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.1 -26.95 56.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.347 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.87 132.82 47.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.373 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -15.93 33.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.72 151.25 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 0.0 110.45 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.06 135.35 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.998 0.427 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.63 136.5 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 137.62 13.84 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.63 161.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.118 0.485 . . . . 0.0 110.31 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.2 tp -92.75 119.38 32.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.49 156.81 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.65 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.12 50.55 50.84 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.2 p -148.87 167.83 24.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 67.1 p -71.98 -28.68 63.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.458 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -59.7 -55.33 35.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.47 -55.11 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.55 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.55 -51.12 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.69 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.3 t80 -62.03 -43.9 97.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.091 0.472 . . . . 0.0 110.434 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.25 -44.38 97.77 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.03 -14.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 0.0 110.795 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.54 -34.24 2.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.692 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.36 -51.07 16.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.959 0.409 . . . . 0.0 111.539 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.24 12.69 35.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.241 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.48 0.47 Allowed Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.341 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.23 -10.09 25.27 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.781 2.32 . . . . 0.0 111.945 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.99 -8.93 59.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.46 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.55 33.36 34.92 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.58 137.44 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.913 0.387 . . . . 0.0 110.547 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.28 130.28 34.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.59 138.32 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.37 133.33 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 109.979 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.08 127.34 42.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.57 153.85 24.57 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.97 6.68 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.68 130.43 5.82 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.07 -45.92 79.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.56 -24.27 63.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.516 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -36.69 85.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.456 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.71 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.067 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -64.3 -37.87 89.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.269 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.56 -42.29 96.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.122 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -65.77 -42.35 90.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.843 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.5 tp -59.23 -48.59 81.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.185 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.2 m -62.64 -22.39 66.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.002 0.43 . . . . 0.0 110.204 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.36 -17.9 26.47 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.562 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.58 11.56 74.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.6 -17.84 63.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.5 pt -127.41 136.65 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 110.502 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.95 -28.84 62.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.201 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.13 155.12 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.792 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.22 138.27 51.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 109.978 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.15 103.21 14.58 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.23 0.538 . . . . 0.0 110.599 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.67 25.78 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.66 152.76 40.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.54 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.24 -53.97 30.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.06 -49.02 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.365 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.81 84.22 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 110.837 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.78 1.1 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 66.6 m -57.64 -46.13 84.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.7 tt0 -46.32 -42.31 14.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.338 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.1 -61.87 0.48 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.762 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.0 t80 -40.38 -71.19 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.584 0.23 . . . . 0.0 111.214 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -62.28 -40.81 97.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 86.8 tttt -59.86 -2.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.579 0.704 . . . . 0.0 110.494 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.7 mt-30 -126.5 141.78 41.09 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.832 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -43.43 -14.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.861 2.374 . . . . 0.0 112.328 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' GLN . 90.0 t -62.87 -43.03 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.589 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.86 -33.44 85.38 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.38 96.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.731 0.301 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -65.79 -34.95 79.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.503 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.8 m-85 -156.64 143.25 18.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.737 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -176.16 99.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.746 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.5 167.01 30.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.23 55.39 3.09 Favored Glycine 0 C--O 1.225 -0.413 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.11 -116.83 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.05 134.65 36.57 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.46 2.107 . . . . 0.0 111.893 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.3 p -124.03 -108.63 0.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.542 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.43 165.01 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.637 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.4 tttt 154.61 155.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.178 0.924 . . . . 0.0 110.665 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -81.27 118.92 23.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.3 -19.1 62.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.45 -31.41 72.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.494 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -60.89 -44.4 97.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.736 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.29 8.61 16.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.722 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.22 -153.81 49.97 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 76' ' ' ILE . 12.8 p -70.65 -25.72 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.99 -126.59 1.62 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.6 p -132.21 160.24 36.7 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.26 -162.93 25.27 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.06 140.22 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.419 . . . . 0.0 110.591 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.72 108.8 3.48 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.3 mt -118.22 159.72 22.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.944 0.402 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.73 148.79 25.28 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.38 64.26 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -40.57 -22.51 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.0 110.739 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.77 51.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.748 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -64.32 -46.62 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.23 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.16 -47.09 38.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 44' ' ' ILE . 63.6 tp -62.05 -43.52 98.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.53 -43.13 99.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.799 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.56 -37.65 73.47 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.696 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.29 -77.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -28.72 -45.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.846 0.355 . . . . 0.0 110.518 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 212' ' ' ALA . 87.9 m-20 -63.66 -45.81 88.45 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.02 -44.11 97.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.33 92.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.148 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.95 -43.81 98.16 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.15 91.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.087 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -64.05 -43.59 95.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.859 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.24 -38.52 71.19 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -38.98 77.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.27 -45.55 90.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.1 p-10 -88.73 -0.71 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.21 20.44 71.19 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.5 -46.22 87.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.494 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 71.0 t80 -62.35 -56.2 20.65 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.244 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.48 -40.26 78.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.059 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.32 -47.92 83.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.491 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.08 -40.77 96.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -61.11 -49.14 78.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.01 -35.74 73.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.503 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.49 -51.39 36.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.584 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 8.8 m-85 -62.01 -46.3 89.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.52 154.92 33.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.49 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -98.31 96.89 8.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.45 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.63 -164.67 2.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.555 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -121.96 108.92 13.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.734 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.5 m -63.45 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.418 ' N ' HG23 ' A' ' 238' ' ' VAL . 91.3 m-85 -58.82 -42.38 89.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.288 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -62.96 -37.93 95.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.712 0 CA-C-O 117.905 -1.497 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.85 164.26 57.51 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.642 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.08 143.82 99.13 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.625 2.217 . . . . 0.0 112.309 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.09 -40.6 90.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.578 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.21 143.7 38.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.447 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.33 129.03 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.854 0.359 . . . . 0.0 110.466 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.57 117.56 34.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.372 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 141.78 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.973 0.416 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.67 106.74 2.12 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.8 m -128.94 120.06 25.44 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.634 -0.333 . . . . 0.0 111.107 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 26.9 t0 -112.41 94.67 28.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.079 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.18 134.74 61.89 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.463 2.109 . . . . 0.0 112.205 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.1 p -136.77 -18.54 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.73 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.9 m-85 -124.66 98.06 5.56 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.817 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -30.47 -61.21 0.25 Allowed Pre-proline 0 C--O 1.218 -0.596 0 CA-C-O 121.633 0.73 . . . . 0.0 110.991 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.715 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.3 Cg_endo -49.92 -41.48 47.58 Favored 'Trans proline' 0 C--N 1.294 -2.334 0 C-N-CA 122.364 2.042 . . . . 0.0 112.328 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.3 t80 -77.99 -42.7 31.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.972 0.415 . . . . 0.0 111.011 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.704 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.2 mt-10 -146.77 -160.97 1.23 Allowed 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.131 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.3 t 157.64 -178.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.085 0.469 . . . . 0.0 110.172 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.544 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.76 140.32 45.82 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.439 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.1 t-20 -90.46 141.93 28.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.471 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.2 p -66.14 -19.02 65.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.585 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.11 -6.16 53.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.478 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.85 -9.2 58.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.49 162.34 25.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 110.44 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.01 136.09 53.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.922 0.392 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.505 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.0 p -132.34 151.03 34.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.343 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.49 153.47 7.18 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.47 -41.2 93.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.974 0.416 . . . . 0.0 110.838 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 -70.23 -32.8 70.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.279 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.505 HD12 ' C ' ' A' ' 30' ' ' VAL . 98.1 mt -66.85 -39.98 84.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.793 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.0 -37.01 81.02 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.787 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.91 -44.84 84.02 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.33 -45.53 87.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.02 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -54.61 -54.36 42.55 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.51 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.9 -37.53 63.87 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.475 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.31 -43.11 74.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.588 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 52.0 m -54.25 -44.0 71.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.035 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -64.01 -47.93 78.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.006 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.55 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.979 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.11 -18.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.24 52.33 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.68 170.23 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.19 141.74 28.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.101 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.57 132.19 56.56 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.78 126.6 42.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.389 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.93 136.69 34.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.31 129.18 64.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.93 139.66 56.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.779 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.4 p30 175.52 135.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.52 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.1 Cg_endo -68.65 143.71 57.51 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.644 2.229 . . . . 0.0 112.461 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.893 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -40.62 -54.78 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.032 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.43 1.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.89 -20.97 18.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.893 HD12 HD23 ' A' ' 55' ' ' LEU . 54.6 mt -63.92 -42.48 97.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.791 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.706 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.88 -57.1 26.22 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.711 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -54.93 -42.94 64.2 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.615 2.21 . . . . 0.0 111.214 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.52 -44.88 89.7 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.749 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.75 -44.48 90.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.75 -41.02 96.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.484 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.06 11.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.97 12.32 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.77 -33.83 76.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.06 154.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.261 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -91.85 -20.79 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.02 160.53 21.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.637 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 58' ' ' LEU . 96.1 mt -116.1 127.76 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.052 0.453 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.2 ttp -129.12 107.42 9.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.334 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.501 ' OG ' HD21 ' A' ' 55' ' ' LEU . 38.3 t -162.72 -176.91 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -63.89 -16.22 60.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.639 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.4 tp -36.99 122.75 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.491 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.94 155.88 23.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.712 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.5 pt -105.36 149.46 8.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.347 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.7 p -150.49 152.76 34.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.775 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.02 -47.66 53.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 110.589 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.26 -39.93 70.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.807 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.639 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -38.1 75.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.81 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.75 -27.65 66.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.078 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.08 -51.1 7.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.039 0.447 . . . . 0.0 110.73 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.15 -167.57 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.135 0.493 . . . . 0.0 110.498 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.93 147.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HG22 ' A' ' 76' ' ' ILE . 74.3 m-85 -130.35 150.49 51.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -165.28 -150.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.455 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.2 m-20 42.51 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.04 120.99 0.11 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.499 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -79.95 -72.51 0.4 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.932 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -147.81 165.11 31.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.641 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.05 127.56 32.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.387 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.19 66.99 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.591 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.27 -106.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.0 p -159.23 167.44 29.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.616 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.85 146.79 23.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 0.0 110.415 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.47 135.84 42.3 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.773 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.83 110.98 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.75 164.44 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.59 148.43 24.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.06 -28.24 50.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.248 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.09 -41.35 87.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.252 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 t -102.38 122.28 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.262 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.01 109.52 19.89 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.067 0.46 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.05 129.76 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.705 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.37 159.0 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.554 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.6 Cg_endo -60.3 90.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.74 2.293 . . . . 0.0 111.884 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.3 m -169.05 141.29 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.543 0.527 . . . . 0.0 110.73 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.83 -33.52 62.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.246 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.493 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.15 -62.57 1.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -56.02 -22.0 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.12 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.46 -26.19 55.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.317 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.2 47.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.422 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.77 -15.67 30.27 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.14 150.85 24.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.429 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.55 134.82 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 110.259 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.58 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.663 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.76 137.44 13.78 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.47 161.49 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.127 0.489 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.4 tp -92.51 119.3 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.528 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.13 156.7 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.717 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.54 53.51 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -148.41 167.3 25.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.294 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 74.8 p -70.59 -31.27 68.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.468 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -58.22 -54.97 40.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.431 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -56.27 -55.74 29.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.74 -51.24 70.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.818 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.4 t80 -62.02 -44.09 97.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.78 -44.24 98.15 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.843 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.38 2.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.09 -50.98 17.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.025 0.44 . . . . 0.0 111.578 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.23 12.74 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.306 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.768 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.37 0.47 Allowed Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.432 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.25 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.747 2.298 . . . . 0.0 111.951 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -8.85 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.484 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.39 35.79 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.48 137.52 41.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.969 0.414 . . . . 0.0 110.49 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.42 130.48 34.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.343 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.22 138.57 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.45 133.61 68.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.042 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 126.77 42.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -110.14 153.9 24.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.286 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.22 6.68 28.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.13 130.2 5.83 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.97 -45.9 80.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.2 -23.78 63.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.64 -36.72 85.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.88 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.51 -37.55 87.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.67 -41.85 95.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 -42.29 89.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.572 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.7 tp -59.21 -48.53 81.25 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.134 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.5 -22.33 66.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 0.0 110.198 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.57 -17.77 26.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.603 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.87 74.4 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.86 -18.22 63.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.612 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.5 pt -126.71 135.98 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.479 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.32 -29.34 63.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.269 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.17 155.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.95 138.85 52.22 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.97 0.415 . . . . 0.0 109.924 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -86.75 102.71 14.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.216 0.531 . . . . 0.0 110.783 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 96' ' ' ARG . 51.0 tt0 -131.94 164.58 25.82 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.386 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.471 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.55 153.27 40.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.526 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.67 -54.25 25.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.237 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.6 t -59.97 -49.08 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.84 84.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.941 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.72 1.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.455 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.444 ' OG ' HD12 ' A' ' 173' ' ' LEU . 67.0 m -57.82 -46.37 84.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.32 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.6 tt0 -46.1 -41.87 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.411 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.25 -62.11 0.48 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.707 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.2 t80 -40.3 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.786 -0.244 . . . . 0.0 111.184 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -62.14 -40.71 96.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.55 -2.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.422 0.629 . . . . 0.0 110.394 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.0 mt-30 -126.21 141.6 40.24 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.799 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.39 -14.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.792 2.328 . . . . 0.0 112.335 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 175' ' ' GLN . 91.0 t -63.04 -43.04 98.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.88 -33.46 85.49 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.06 -41.37 96.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.0 110.444 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -65.74 -34.81 79.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.465 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -156.92 143.53 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.734 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.19 99.38 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.4 m-85 -158.9 167.01 30.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.632 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.9 55.96 3.02 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.17 -116.92 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 134.76 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.502 2.135 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.2 p -124.23 -108.5 0.33 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.24 164.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.213 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.5 tttt 154.68 155.11 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 124.041 0.838 . . . . 0.0 110.706 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -81.04 118.5 22.55 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.777 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -70.5 -18.81 62.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.51 -31.61 72.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.4 mt -60.93 -44.4 97.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.702 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.07 8.33 16.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.788 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.66 -153.52 50.42 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.659 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.5 p -70.8 -25.76 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.554 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.77 -126.98 1.68 Allowed Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.8 p -132.21 160.37 36.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.418 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.98 -161.65 23.73 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.94 140.06 33.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.925 0.393 . . . . 0.0 110.611 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.73 108.71 3.48 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -117.45 159.36 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.251 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.31 148.84 25.43 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.86 -48.46 64.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.69 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -40.85 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -72.9 51.51 0.29 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.895 0.379 . . . . 0.0 110.794 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.46 -46.3 83.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.06 -47.22 38.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.026 0.441 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.14 -43.46 98.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.464 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.7 -43.02 99.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.825 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -37.44 73.52 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.48 -77.47 0.11 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.979 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -28.52 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.3 m-20 -63.5 -45.92 88.47 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.83 -43.94 97.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.929 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.1 91.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.083 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.28 91.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.051 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.73 -43.69 95.77 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.26 -38.48 71.22 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.57 -39.04 77.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.987 0.423 . . . . 0.0 110.271 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.39 91.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.649 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.3 p-10 -89.02 -0.5 57.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.87 20.75 70.81 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.48 -46.27 87.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.499 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 73.2 t80 -62.3 -56.46 18.22 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.08 -40.42 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.176 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.53 -47.89 83.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.485 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.11 -40.96 97.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.44 77.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.501 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.93 -35.74 73.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.63 -51.45 34.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.97 -45.97 91.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.6 m-85 -155.05 154.76 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.522 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.2 p-10 -97.99 96.0 7.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.439 . . . . 0.0 110.526 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.0 -164.7 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.545 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.14 108.98 13.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.4 m -63.54 -40.64 89.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.358 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.428 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.4 m-85 -58.53 -42.6 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.39 -37.67 95.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.689 0 CA-C-O 117.848 -1.529 . . . . 0.0 111.021 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 164.13 63.33 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.643 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.05 143.6 99.19 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 122.591 2.194 . . . . 0.0 112.313 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.43 -41.13 89.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.562 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -137.93 139.44 39.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.417 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.82 121.36 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.675 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.93 118.82 32.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.178 0.513 . . . . 0.0 110.154 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.56 138.69 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.96 105.75 2.15 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.2 m -129.04 120.61 26.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 122.69 -0.3 . . . . 0.0 111.018 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.6 t70 -114.42 92.9 29.77 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.19 134.58 61.12 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.502 2.135 . . . . 0.0 112.07 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 p -141.84 -20.31 0.73 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.775 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.5 m-85 -123.54 99.09 6.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.614 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.12 -61.46 0.22 Allowed Pre-proline 0 C--O 1.218 -0.575 0 CA-C-O 121.433 0.635 . . . . 0.0 111.015 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.729 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.5 Cg_endo -49.35 -40.63 43.91 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 122.272 1.981 . . . . 0.0 112.284 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -78.21 -42.75 30.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.036 0.446 . . . . 0.0 110.942 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.9 mt-10 -149.73 -153.9 0.52 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.912 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.86 177.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.023 0.439 . . . . 0.0 110.389 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.42 144.71 46.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.452 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -95.9 134.37 38.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.637 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.76 -19.0 65.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.11 -6.17 53.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.41 -7.9 56.54 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.65 159.14 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 110.442 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.5 mt -112.57 131.18 55.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.999 0.428 . . . . 0.0 110.449 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.685 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.95 151.32 32.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.401 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.02 151.27 6.52 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -58.55 -42.03 86.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.855 0.36 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.469 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.9 t0 -69.7 -28.55 65.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.157 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -68.01 -40.86 83.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.873 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -60.91 -37.26 81.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.829 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.88 -45.08 87.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.12 -48.54 78.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.982 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -53.0 -54.66 31.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.33 -39.88 61.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.864 0.364 . . . . 0.0 110.298 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.67 -41.94 78.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 110.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.44 -45.19 69.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.084 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.09 -46.84 82.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.042 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -60.01 -42.28 93.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.16 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.32 -17.23 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.72 53.21 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.489 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.26 171.56 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.11 142.61 27.5 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.018 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.45 131.15 56.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.24 126.94 43.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.411 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -93.73 134.66 35.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.06 127.81 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.262 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.63 137.8 57.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.776 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 176.05 131.53 0.17 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.555 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.7 Cg_endo -68.01 144.74 65.15 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.729 2.286 . . . . 0.0 112.435 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 58' ' ' LEU . 82.4 mt -40.33 -55.55 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.42 1.94 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.04 -20.94 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.249 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -63.8 -42.42 97.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.596 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.721 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.2 -56.99 25.98 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.806 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.48 -42.41 68.26 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.59 2.193 . . . . 0.0 111.179 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m -58.7 -44.89 90.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.931 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.7 tp -59.05 -44.06 91.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.35 -40.72 96.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.956 0.408 . . . . 0.0 110.452 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.04 2.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.514 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.19 12.08 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.463 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -35.5 80.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.481 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -122.34 152.89 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.264 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.2 -22.18 19.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.61 155.99 27.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.0 129.28 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.34 106.52 8.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.395 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.706 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -158.95 178.43 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.636 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -65.4 -15.35 62.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 43.9 tp -34.82 124.65 0.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.01 153.86 25.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.645 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.637 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.8 pt -104.84 148.86 8.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.297 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -149.36 152.13 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.854 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.85 -47.28 51.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.507 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.32 -39.83 70.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.735 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.94 -37.91 79.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.84 -38.95 76.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.816 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.89 -27.42 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.096 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.42 -50.84 7.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.048 0.451 . . . . 0.0 110.655 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.18 -168.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.131 0.491 . . . . 0.0 110.456 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.43 147.66 30.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.007 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.3 m-85 -129.88 149.9 51.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.563 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.7 t -163.09 -153.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.592 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 92.8 m-20 41.34 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.945 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.62 121.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.346 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.429 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.9 mt -75.09 -68.7 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.34 167.49 26.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.76 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.5 123.55 29.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.218 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.55 68.32 0.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.47 -104.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.35 165.7 32.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.741 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.34 146.35 22.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 0.0 110.443 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.9 mt -101.08 136.12 41.44 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.988 0.423 . . . . 0.0 110.81 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.8 110.41 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.2 164.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.71 148.48 23.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.988 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.6 -27.66 40.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.226 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.29 -41.83 89.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.316 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.5 122.14 43.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.94 109.35 19.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.424 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.9 129.65 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.772 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.25 159.0 33.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.523 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.46 89.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.685 2.256 . . . . 0.0 111.904 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.6 m -169.08 140.31 2.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.31 -32.38 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.0 tp10 -57.34 -62.92 1.43 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -55.39 -22.41 19.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.62 -25.8 54.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.67 132.67 46.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.95 -16.13 28.93 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.03 151.1 23.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.84 135.37 37.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.35 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.74 136.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.648 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 137.79 13.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 56.0 t -130.51 161.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.089 0.471 . . . . 0.0 110.336 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.1 tp -92.37 118.16 30.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.535 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.03 157.75 1.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.67 50.98 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.2 p -149.68 168.89 22.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.5 p -73.53 -27.25 61.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -60.45 -55.45 33.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.48 -55.1 37.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.583 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.05 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.705 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.8 t80 -62.08 -43.91 97.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.04 -44.46 97.75 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.41 -14.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.784 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.23 -34.36 2.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.55 -50.54 17.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.18 12.48 36.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.239 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.79 -55.51 0.47 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.332 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.33 25.66 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 111.952 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.76 -9.0 59.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.32 37.65 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.598 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.51 129.87 34.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.333 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 138.29 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.923 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.25 133.21 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 109.946 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.46 127.63 43.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -110.7 153.89 24.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -106.91 7.13 29.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.72 130.73 6.06 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.405 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.95 -45.92 80.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.768 0.318 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.25 62.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.7 -36.84 85.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.543 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.97 -46.79 87.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.138 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.507 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.7 m-85 -64.45 -37.65 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.348 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.86 -42.16 97.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.023 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.99 -43.38 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.96 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.578 ' HB2' HD11 ' A' ' 158' ' ' ILE . 40.8 tp -58.98 -48.15 82.6 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.79 -22.32 66.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.955 0.407 . . . . 0.0 110.164 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.78 -18.21 25.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.07 11.92 72.04 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.17 -18.24 63.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.602 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.578 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.9 pt -127.02 135.92 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.54 -28.11 62.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.43 155.71 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.49 50.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 109.947 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.94 103.14 14.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.264 0.555 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.65 165.14 25.15 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.382 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.475 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -72.79 153.05 41.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 110.634 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.4 -54.64 22.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.39 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.27 -48.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.618 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.08 89.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.862 0.363 . . . . 0.0 110.83 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.47 -63.27 1.18 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.445 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.1 m -59.28 -47.75 84.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.916 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.98 -37.44 20.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.195 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.08 -66.36 0.55 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.1 t80 -40.27 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.663 0.268 . . . . 0.0 111.194 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.35 -40.13 93.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.78 -2.84 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.443 0.64 . . . . 0.0 110.475 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 173' ' ' LEU . 36.3 mt-30 -123.37 148.79 56.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.828 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.66 -19.97 3.95 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.892 2.395 . . . . 0.0 112.148 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.14 -42.55 93.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.99 -33.21 84.86 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.72 -41.26 94.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.695 0.283 . . . . 0.0 110.399 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.59 -33.93 77.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.327 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.35 142.66 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.732 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.19 99.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.754 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.17 166.76 30.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.713 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.87 56.54 2.72 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.44 -118.27 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.41 135.68 32.48 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.511 2.14 . . . . 0.0 111.918 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.7 p -125.41 -107.79 0.32 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.591 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -166.14 165.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.334 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.671 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 156.78 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 123.983 0.802 . . . . 0.0 110.665 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.84 117.24 22.58 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.5 mp0 -71.13 -18.89 62.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.85 -32.59 74.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.568 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -60.96 -44.54 97.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.71 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.4 m-85 -114.03 9.63 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.769 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.0 -154.76 52.38 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.39 -25.1 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.527 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.22 -124.32 1.32 Allowed Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.8 p -129.32 156.19 44.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.707 0.289 . . . . 0.0 110.33 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.6 -169.61 30.42 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.1 137.44 33.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.46 108.2 3.27 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.52 159.39 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.955 0.407 . . . . 0.0 110.206 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.66 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.84 149.64 24.69 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.89 -48.2 64.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.3 tp10 -38.23 -25.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.56 52.26 0.2 Allowed 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.677 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -64.56 -45.15 88.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.8 -47.3 31.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.26 -43.94 97.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.454 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.24 -42.92 99.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.724 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -36.23 70.28 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.45 -77.51 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 44' ' ' ILE . 97.0 mt -28.46 -46.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.356 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.33 -44.96 89.91 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.636 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.96 -43.66 98.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.962 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.21 93.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -43.57 98.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.28 92.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.63 -42.74 98.13 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.53 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.31 -38.42 77.05 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.86 -39.99 79.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.188 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -45.86 93.03 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.53 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.1 p30 -86.68 1.33 52.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.489 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.42 19.71 60.27 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 69.7 m -58.35 -45.63 87.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.429 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.2 t80 -63.62 -58.01 8.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.438 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.44 78.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.349 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.6 -48.53 80.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.565 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.07 -41.49 98.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.327 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.19 74.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.73 -35.16 72.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.18 -50.97 27.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.481 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.09 -45.5 93.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.2 m-85 -153.27 155.16 36.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.7 p-10 -97.26 94.86 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.504 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -152.71 -166.43 2.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.86 110.37 15.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.799 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.1 m -63.55 -40.64 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.426 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.43 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.9 m-85 -56.62 -43.83 80.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.46 94.89 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.414 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.642 0 CA-C-O 117.895 -1.503 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.88 164.27 61.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.718 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.83 143.66 99.41 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.33 -41.02 90.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.622 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.42 139.69 39.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.56 121.43 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.07 118.51 31.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.067 0.46 . . . . 0.0 110.193 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.62 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.362 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.88 105.47 2.12 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -128.77 120.37 26.26 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.676 -0.308 . . . . 0.0 110.909 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.7 t70 -114.13 92.41 26.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.91 134.45 59.43 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.454 2.103 . . . . 0.0 112.187 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 p -141.79 -20.24 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.764 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.6 m-85 -123.42 99.04 6.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.464 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.09 -61.32 0.22 Allowed Pre-proline 0 C--O 1.218 -0.585 0 CA-C-O 121.737 0.779 . . . . 0.0 111.09 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.72 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.29 -40.85 43.43 Favored 'Trans proline' 0 C--N 1.29 -2.53 0 C-N-CA 122.567 2.178 . . . . 0.0 112.214 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.9 t80 -78.44 -42.72 29.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -149.78 -154.13 0.53 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.019 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 162.07 177.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.066 0.46 . . . . 0.0 110.294 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.45 144.45 46.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.448 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.37 134.26 38.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.587 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.73 -18.81 65.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.569 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.47 -6.53 55.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.421 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.06 -8.47 55.74 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.04 158.86 26.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.986 0.422 . . . . 0.0 110.434 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -112.46 131.31 55.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.936 0.398 . . . . 0.0 110.426 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.697 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.21 151.59 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.333 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.414 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.11 151.41 6.6 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -58.74 -42.14 88.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 122.515 -0.403 . . . . 0.0 110.979 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 -69.24 -28.4 66.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.229 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.697 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.1 mt -68.25 -40.06 82.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.929 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.98 -37.64 83.17 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.959 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.71 -45.25 87.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.028 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.1 -48.51 78.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.872 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -52.85 -54.81 29.11 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.353 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -51.96 -39.99 60.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.41 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.82 -41.77 78.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.752 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.3 m -53.74 -45.08 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.063 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.13 -47.03 81.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.2 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.6 -42.38 92.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.89 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.37 -17.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.62 53.02 4.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -147.03 171.2 15.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.92 142.51 27.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.35 131.22 56.83 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -127.25 126.91 43.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.39 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.4 134.73 35.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.492 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.08 127.53 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.273 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.55 137.87 57.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.74 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.3 p30 175.93 131.76 0.16 Allowed Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.593 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 57' ' ' ALA . 44.2 Cg_endo -68.26 145.12 65.04 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.743 2.295 . . . . 0.0 112.382 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 81.7 mt -40.44 -55.58 2.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 111.074 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.27 -26.43 1.98 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -21.0 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.183 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 59.3 mt -63.98 -42.42 97.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.619 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -57.47 23.48 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 123.952 0.783 . . . . 0.0 109.555 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 43.4 Cg_exo -55.01 -42.39 69.62 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.628 2.219 . . . . 0.0 111.36 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.69 -44.82 90.38 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.959 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.651 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.4 tp -59.05 -44.02 91.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.255 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.55 -40.49 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.437 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.06 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.567 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.29 12.07 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.66 -35.39 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 pt -122.39 153.0 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.231 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.32 -22.16 19.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.143 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.53 155.82 27.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.656 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.11 129.03 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.15 106.67 8.5 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.329 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.707 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -159.11 178.67 9.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.43 -15.28 62.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -34.95 124.48 0.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.62 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.2 p -81.91 153.97 26.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.634 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -104.74 148.66 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.214 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.2 152.15 35.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.73 -47.43 50.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.31 -39.85 70.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.786 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -69.1 -37.71 78.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.824 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.83 -38.87 76.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.965 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.76 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.199 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.2 -50.9 7.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.716 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.07 -168.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.102 0.477 . . . . 0.0 110.481 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.3 147.73 29.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.549 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.0 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.568 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.18 -153.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.503 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.511 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.9 m-20 41.23 20.32 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.027 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.64 0.2 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.468 0.48 . . . . 0.0 110.419 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.425 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.2 mt -75.37 -68.81 0.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -178.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.9 p90 -150.47 167.6 26.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.37 123.7 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.301 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.465 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.91 68.49 0.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.729 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.71 -104.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.5 p -159.53 165.73 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.582 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.53 145.98 21.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.178 0.513 . . . . 0.0 110.443 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.84 136.27 40.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.56 111.01 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.16 165.09 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.921 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.0 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.01 -28.47 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.237 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.84 -41.98 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.266 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -101.92 121.76 42.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.212 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.87 109.92 19.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.422 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.2 mt -127.0 129.62 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.56 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -108.17 154.32 41.34 Favored Pre-proline 0 C--N 1.333 -0.124 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.648 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.33 92.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.819 2.346 . . . . 0.0 111.768 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.7 m -171.19 144.09 2.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 123.637 0.586 . . . . 0.0 110.82 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.3 -33.58 61.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.275 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 108' ' ' THR . 47.7 tp10 -58.02 -62.48 1.79 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.07 -22.33 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.08 -25.68 55.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.54 133.11 46.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.454 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.0 -17.16 28.74 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.89 151.38 23.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 110.524 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -96.27 136.23 37.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.303 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.7 136.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.667 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 139.78 14.86 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.83 161.84 40.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.327 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.4 tp -92.72 118.05 30.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.709 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.47 157.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.584 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.68 51.45 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.7 p -149.65 168.58 23.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.6 p -74.33 -25.58 59.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.497 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.01 -55.8 28.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.537 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.04 -54.29 48.42 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.498 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.21 -51.31 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.616 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.45 -43.73 98.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.057 0.456 . . . . 0.0 110.458 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.63 -44.54 97.81 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.68 -14.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 0.0 110.745 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.07 -34.77 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.565 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.37 -50.43 18.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 111.516 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.16 12.79 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.187 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.09 -55.62 0.46 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.08 -10.44 25.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.783 2.322 . . . . 0.0 111.919 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.59 -8.97 59.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.504 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.63 33.41 38.38 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.31 138.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.031 0.443 . . . . 0.0 110.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.88 129.78 35.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.2 138.9 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.58 132.05 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.999 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.9 t -98.51 130.61 45.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.81 156.58 21.76 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.06 6.89 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.642 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.76 130.75 6.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.42 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.89 -46.01 79.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 110.429 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.81 -23.25 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.451 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.71 -36.58 84.75 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.61 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.19 -47.32 84.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.054 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.519 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.83 -37.97 89.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.0 -42.13 97.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.03 -45.4 89.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.56 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.8 tp -58.06 -48.28 80.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.327 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.2 m -63.12 -22.94 67.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.018 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.53 -18.73 24.75 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.503 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.13 70.34 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.46 -18.16 63.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.593 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.6 pt -127.88 136.88 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.069 0.462 . . . . 0.0 110.434 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.74 -27.46 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.456 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.72 155.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.851 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.12 136.94 49.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.076 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.47 103.33 14.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 110.76 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.71 23.91 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.409 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.466 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.98 152.45 41.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.506 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.27 -54.55 23.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' CG ' ' A' ' 91' ' ' TYR . 74.3 t -60.28 -49.01 85.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.342 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.77 88.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 110.76 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.21 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -59.24 -47.87 83.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.978 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.13 -37.5 22.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.125 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.84 -66.23 0.56 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.662 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.9 t80 -40.69 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.561 0.219 . . . . 0.0 111.092 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -61.1 -40.25 93.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.03 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -60.53 -2.73 0.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.448 0.642 . . . . 0.0 110.386 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' A' ' 173' ' ' LEU . 36.0 mt-30 -122.98 147.41 51.31 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 122.099 -0.376 . . . . 0.0 110.781 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.76 -19.7 2.32 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.864 2.376 . . . . 0.0 112.306 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.55 -42.91 95.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.531 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.17 -33.26 85.32 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.41 -41.41 93.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.77 0.319 . . . . 0.0 110.479 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.3 m-20 -65.52 -33.59 76.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.1 m-85 -155.98 142.68 18.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.9 99.52 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.2 m-85 -159.24 167.46 28.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.631 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.34 56.3 2.87 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.02 -118.03 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.3 135.39 31.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.48 2.12 . . . . 0.0 112.051 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.15 -107.93 0.33 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.555 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.75 165.35 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.053 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.652 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.32 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 O-C-N 124.34 1.025 . . . . 0.0 110.607 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.15 117.67 22.48 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.76 -18.86 62.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.89 -32.38 73.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.504 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -60.79 -44.74 96.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.685 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.467 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.6 m-85 -113.97 9.66 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.722 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.22 -154.92 52.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.634 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.51 -24.74 25.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.02 -124.12 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.43 156.33 44.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 110.289 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.53 -169.53 30.26 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.37 137.26 33.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.29 108.21 3.26 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -123.46 159.31 29.31 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.278 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.651 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.9 mtm180 -86.61 149.62 24.8 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.87 -48.34 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.554 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -37.95 -25.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.826 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.45 52.25 0.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.649 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -45.69 86.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.152 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.49 -47.3 34.06 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.114 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.35 -43.74 98.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.747 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.86 -36.66 70.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.84 -77.15 0.11 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.89 HD21 HD11 ' A' ' 44' ' ' ILE . 97.5 mt -28.91 -46.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.31 -44.99 89.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.802 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.9 -43.73 98.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.36 93.81 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.18 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.32 -43.35 99.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.58 -39.08 92.57 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.73 -42.96 97.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.87 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.527 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.4 mtp -57.82 -38.21 75.16 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.02 -39.74 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.1 0.476 . . . . 0.0 110.26 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.0 92.43 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.443 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.2 p30 -86.43 1.26 51.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.69 19.57 60.73 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 70.3 m -58.28 -45.92 87.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.425 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 79.7 t80 -63.53 -57.59 9.7 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.397 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.97 -41.64 78.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.103 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.57 -48.81 79.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.505 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.62 -41.86 98.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.865 0.364 . . . . 0.0 110.566 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.78 -49.98 75.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -35.02 72.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.376 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.14 -50.93 28.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.418 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.24 -45.37 93.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.536 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.5 m-85 -154.26 155.62 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.6 97.17 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.974 0.416 . . . . 0.0 110.468 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -154.52 -166.02 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.417 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.23 110.53 15.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.9 m -63.39 -40.32 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.541 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.417 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.3 m-85 -58.54 -42.73 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.312 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.5 -37.15 94.35 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.871 -1.516 . . . . 0.0 110.917 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.48 164.26 62.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.82 99.43 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.24 -40.46 90.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.546 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.46 142.37 37.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.419 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -109.36 128.08 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.942 0.401 . . . . 0.0 110.483 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.68 117.55 34.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.348 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.58 139.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.425 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.45 105.44 2.16 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.6 m -128.11 119.33 25.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.75 -0.265 . . . . 0.0 111.077 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.4 t70 -113.53 92.58 24.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.05 134.25 58.98 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.484 2.123 . . . . 0.0 112.12 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.0 p -141.09 -19.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.713 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.8 m-85 -124.88 98.91 5.9 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.547 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.724 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.91 -61.47 0.22 Allowed Pre-proline 0 C--O 1.22 -0.48 0 CA-C-O 121.519 0.676 . . . . 0.0 111.053 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.724 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.31 -39.69 43.53 Favored 'Trans proline' 0 C--N 1.294 -2.326 0 C-N-CA 122.484 2.123 . . . . 0.0 112.279 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.1 t80 -79.34 -42.77 24.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.906 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.9 mt-10 -149.49 -155.75 0.66 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.03 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.41 177.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 0.0 110.377 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.56 140.6 46.24 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -92.23 136.96 32.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.619 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -65.07 -19.1 65.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.479 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.82 -5.82 54.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.454 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.96 -8.71 57.83 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.64 157.79 27.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.474 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.1 mt -112.48 133.59 54.46 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.935 0.398 . . . . 0.0 110.451 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.666 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -132.93 150.82 33.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.353 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.22 6.5 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.39 -41.95 86.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 110.926 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.478 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.8 t0 -70.58 -27.55 64.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.322 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.666 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.8 mt -69.33 -40.64 80.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.931 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.2 -37.34 82.64 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.744 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.37 -43.93 84.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.151 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.97 -45.14 91.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.13 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.54 -53.95 51.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.491 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.75 -37.72 59.87 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.945 0.403 . . . . 0.0 110.419 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.45 -41.9 75.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.4 m -54.16 -44.69 71.68 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.115 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.77 -47.59 80.34 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.53 -41.27 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.153 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.0 HD11 HD21 ' A' ' 213' ' ' LEU . 96.8 mt -76.27 -17.75 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.78 52.72 4.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -145.96 170.51 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.33 141.15 28.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.163 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.13 131.46 56.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.655 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -128.12 127.76 43.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.509 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.51 136.01 35.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.526 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.2 t -129.87 128.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.06 139.08 58.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.3 131.63 0.15 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.47 145.09 63.63 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.688 2.258 . . . . 0.0 112.417 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.882 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.11 -56.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.46 -26.67 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.146 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.13 -20.78 18.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.184 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.882 HD12 HD23 ' A' ' 55' ' ' LEU . 58.5 mt -63.99 -42.51 97.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.619 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.712 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.36 -56.96 25.72 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.821 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.2 Cg_exo -54.79 -43.71 56.65 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.608 2.205 . . . . 0.0 111.353 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.59 -44.71 89.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.84 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.09 -44.24 87.52 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.153 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.58 -40.34 95.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.966 0.412 . . . . 0.0 110.517 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.29 11.22 1.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.597 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.14 11.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.51 -34.28 77.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.489 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.87 153.47 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.24 -20.81 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.11 157.25 25.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.595 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.52 127.29 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.105 0.478 . . . . 0.0 110.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.478 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.45 106.3 8.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.383 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.624 ' OG ' HD21 ' A' ' 55' ' ' LEU . 48.3 t -159.9 -178.54 7.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.35 -15.49 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.7 tp -37.48 123.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 11.1 p -83.21 156.34 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.5 pt -105.13 149.41 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.317 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -150.42 152.4 34.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.754 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.04 -47.99 53.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 110.653 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.59 -39.58 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.803 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.8 -37.56 79.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.35 -37.34 75.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.24 -27.52 67.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.165 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.35 -51.54 7.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.598 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -138.46 -168.82 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 121.062 0.458 . . . . 0.0 110.468 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.72 29.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD1' HG22 ' A' ' 76' ' ' ILE . 71.0 m-85 -129.74 149.89 51.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.3 t -164.18 -151.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.5 m-20 42.77 19.32 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.815 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -28.38 120.5 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.04 -69.83 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 46.5 p90 -149.26 166.29 29.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.57 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.22 121.19 26.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.289 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.459 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.44 69.6 1.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.89 -104.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.25 165.72 32.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.5 146.22 22.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.441 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.26 136.2 41.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.786 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.403 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.75 110.71 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.63 165.11 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.854 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.46 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.031 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.99 -27.99 48.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.232 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.01 -41.74 88.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -102.35 122.35 44.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.237 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.54 109.56 19.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.43 129.88 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.81 34.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.564 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.64 89.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.773 2.316 . . . . 0.0 111.918 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -169.29 140.76 2.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.744 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.69 -32.61 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.228 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.5 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.08 -62.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.273 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.75 -22.17 22.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.925 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.73 -25.8 53.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.271 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 132.86 46.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.456 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.72 -15.56 30.56 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.53 151.39 23.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 110.45 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.21 135.58 37.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.368 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.78 136.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.52 137.72 13.88 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.44 161.71 39.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.08 0.467 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.548 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.9 tp -92.39 117.9 30.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.78 157.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.71 50.73 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.59 168.75 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.431 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 69.3 p -73.15 -27.94 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.401 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.01 -55.37 34.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -56.21 -55.34 34.38 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.06 -50.99 71.52 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.587 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 67.3 t80 -61.94 -43.98 97.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.043 0.449 . . . . 0.0 110.474 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.97 -44.44 97.8 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.41 -14.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.7 tt0 -124.96 -34.76 2.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.707 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.587 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.38 -50.51 18.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 111.471 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -99.14 12.88 34.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.184 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.1 -55.58 0.46 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.376 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.5 25.75 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.777 2.318 . . . . 0.0 111.957 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.37 -8.97 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.47 37.25 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.74 138.26 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.9 0.381 . . . . 0.0 110.527 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.79 130.18 34.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.329 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.6 138.12 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.841 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.02 133.44 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.08 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.18 127.15 42.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.725 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 153.53 25.0 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.03 7.07 29.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.654 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.17 5.84 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.93 -45.86 80.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.317 . . . . 0.0 110.431 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.58 -23.5 62.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.522 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.78 -36.45 84.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.52 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.22 -46.87 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.04 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.45 -37.44 87.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.393 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.4 p -60.92 -41.94 97.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.177 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.64 -42.93 90.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.795 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.582 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.7 tp -58.63 -48.58 80.53 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.51 -22.18 66.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.402 . . . . 0.0 110.239 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.01 -17.75 25.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.21 73.3 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.33 -17.96 63.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.899 0.38 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 153' ' ' LEU . 32.9 pt -126.92 136.14 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.63 -29.02 63.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.07 155.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.82 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.46 137.58 50.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.025 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -85.74 102.72 13.89 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.207 0.527 . . . . 0.0 110.799 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.0 164.91 25.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.393 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.49 153.12 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.5 mt-10 -66.21 -54.54 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.05 -49.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.549 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.08 88.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.803 0.335 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.98 -63.73 1.08 Allowed 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.538 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.442 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -58.51 -47.42 84.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.776 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -49.3 -38.17 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.14 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.6 -66.11 0.56 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.35 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.615 0.245 . . . . 0.0 111.151 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.25 -40.03 92.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.71 -2.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.446 0.641 . . . . 0.0 110.521 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 177' ' ' VAL . 60.5 mt-30 -124.44 141.6 38.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.754 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.86 -15.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.825 2.35 . . . . 0.0 112.279 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.0 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.596 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.87 80.91 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.42 96.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.302 . . . . 0.0 110.517 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -66.07 -34.47 78.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.452 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.3 m-85 -156.96 143.27 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.75 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.4 pttt -176.92 99.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.006 0.431 . . . . 0.0 110.725 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.22 167.66 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.98 55.76 3.05 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.62 -117.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.44 135.34 32.74 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.5 2.133 . . . . 0.0 112.008 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.6 p -125.38 -107.7 0.32 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.486 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.666 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.45 165.59 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.244 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.39 156.61 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.995 0.81 . . . . 0.0 110.642 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -83.16 117.85 23.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.027 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.88 -16.73 62.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.43 -32.89 74.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.543 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.7 mt -61.02 -44.51 97.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.764 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.5 7.82 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.77 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.16 -154.16 50.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.654 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.92 -25.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.862 0.363 . . . . 0.0 110.556 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.459 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.57 -126.01 1.55 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.81 159.79 37.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 110.461 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.5 -162.41 24.61 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.503 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.59 141.07 31.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.021 0.439 . . . . 0.0 110.525 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.22 111.39 3.9 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -120.44 160.58 22.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.394 . . . . 0.0 110.235 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 149.05 24.98 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.92 -49.16 63.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.93 -22.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.004 0.43 . . . . 0.0 110.82 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.06 52.13 0.24 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.764 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.52 -46.02 84.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.18 34.71 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.1 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.2 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.513 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.54 -42.86 99.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.875 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.68 -37.41 73.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.848 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.0 HD21 HD11 ' A' ' 44' ' ' ILE . 87.2 mt -28.45 -45.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.465 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.7 m-20 -63.55 -45.63 89.66 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.33 -43.72 98.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.016 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.33 92.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.184 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.2 -43.46 98.85 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.078 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.25 92.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.162 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.75 -43.15 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.862 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.1 mtp -56.49 -38.42 71.72 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -70.04 -38.82 75.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.0 110.352 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.44 92.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.29 0.91 55.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.683 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.11 20.09 66.66 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -57.82 -46.54 84.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.8 t80 -63.34 -57.5 10.15 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -41.88 78.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.309 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.26 -48.74 79.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.518 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.57 -41.66 97.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.426 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.93 -49.94 75.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.602 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -35.54 72.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.451 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.84 -50.92 30.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.2 -45.53 92.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.58 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.5 m-85 -154.05 155.41 35.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.7 p-10 -98.08 97.66 9.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.396 . . . . 0.0 110.527 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -154.63 -165.51 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.8 t0 -122.72 109.54 14.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.1 m -63.77 -40.61 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.503 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.9 m-85 -56.55 -43.97 80.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.319 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.54 93.55 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 117.909 -1.495 . . . . 0.0 110.939 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.08 164.44 58.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.683 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.97 143.48 99.35 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.723 2.282 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.25 -40.2 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.557 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.56 36.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.443 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.46 128.23 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.423 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.0 mtp180 -103.66 118.7 37.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.34 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.64 138.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.37 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.12 99.9 1.58 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.1 m -123.58 118.76 28.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.759 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.3 t70 -113.67 92.86 25.8 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.09 133.92 57.58 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.537 2.158 . . . . 0.0 111.913 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 p -140.63 -19.76 0.84 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.662 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.4 m-85 -124.72 99.06 5.99 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.494 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.721 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.8 -61.67 0.21 Allowed Pre-proline 0 C--O 1.222 -0.392 0 CA-C-O 121.638 0.732 . . . . 0.0 110.914 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.721 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.9 Cg_endo -49.58 -39.34 46.09 Favored 'Trans proline' 0 C--N 1.296 -2.235 0 C-N-CA 122.523 2.149 . . . . 0.0 112.161 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.3 t80 -79.52 -43.06 23.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.972 0.415 . . . . 0.0 110.791 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.9 mt-10 -149.4 -155.41 0.63 Allowed 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.0 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.75 177.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.876 0.37 . . . . 0.0 110.402 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.5 140.01 45.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.465 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -91.71 136.47 33.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.555 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.8 p -64.91 -19.01 65.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.488 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -79.13 -5.48 54.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.486 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.91 -8.48 57.81 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.02 157.63 26.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.812 0.339 . . . . 0.0 110.469 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -112.68 134.29 54.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.481 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.676 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.44 151.0 32.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.408 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.27 151.32 6.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -58.69 -41.98 87.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.793 0.33 . . . . 0.0 110.738 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.1 t0 -70.06 -27.69 64.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.212 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -69.19 -40.59 80.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.979 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 47.8 m-20 -60.43 -37.91 82.41 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.274 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -66.21 -43.71 85.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 110.543 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.35 -44.27 92.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.171 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -56.77 -53.48 57.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.47 -37.79 63.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.051 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.21 -42.24 76.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.994 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.36 -44.37 72.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.215 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.27 -47.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.365 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.77 -40.84 89.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.126 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.002 HD11 HD21 ' A' ' 213' ' ' LEU . 97.0 mt -76.61 -17.73 14.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.83 52.36 4.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.653 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.4 170.25 16.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.831 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.26 140.64 29.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m -116.83 131.17 57.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -128.19 128.0 43.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.523 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.31 136.19 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.542 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.54 128.15 65.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.43 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.5 139.07 57.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.513 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 173.97 132.92 0.12 Allowed Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.1 Cg_endo -68.35 144.74 63.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.703 2.269 . . . . 0.0 112.574 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.94 HD23 HD12 ' A' ' 58' ' ' LEU . 76.1 mt -40.09 -55.94 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.986 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.9 -26.48 1.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.862 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.26 -20.62 19.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.918 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.94 HD12 HD23 ' A' ' 55' ' ' LEU . 84.8 mt -65.07 -42.83 93.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.699 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.68 -55.74 39.35 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.077 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.2 Cg_exo -56.12 -42.99 60.75 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.622 2.215 . . . . 0.0 111.161 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -58.98 -44.16 91.54 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.06 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.28 -44.47 88.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.13 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.78 -40.0 94.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.493 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 11.24 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.532 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.25 11.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.76 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.49 -33.86 76.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.643 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.48 153.27 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -94.58 -20.66 19.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.977 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.92 26.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 97.0 mt -116.73 128.18 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.506 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.3 ttp -128.43 106.22 8.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.411 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.624 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.6 t -158.68 -179.73 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.63 -14.62 58.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.503 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.0 tp -37.55 124.18 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.584 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.557 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.14 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.644 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.66 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.4 pt -104.93 148.96 8.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.184 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.4 p -150.63 152.62 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.679 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.08 -48.01 53.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.47 -39.98 71.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.579 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.77 -37.52 79.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -36.93 74.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.233 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.45 -27.53 67.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.292 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.23 -51.74 7.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.68 -168.55 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.4 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.71 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.599 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -164.61 -151.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.49 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.8 m-20 43.23 19.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.686 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.89 120.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.354 0.409 . . . . 0.0 110.532 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -77.34 -70.07 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.756 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.5 p90 -149.16 165.99 30.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.553 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.79 121.07 26.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.57 69.99 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.663 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -86.54 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.429 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.51 165.78 32.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.54 146.08 22.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.64 136.14 41.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.61 110.88 28.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.011 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.76 164.87 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.712 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.82 148.39 23.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.841 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.62 -27.67 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.309 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.16 -41.82 89.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.329 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.33 122.18 43.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.361 . . . . 0.0 110.254 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.34 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.394 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 129.88 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.44 159.2 33.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.6 Cg_endo -59.63 89.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.802 2.335 . . . . 0.0 112.02 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -168.93 140.91 2.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.21 -32.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.38 -62.56 1.68 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.61 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.0 t -56.07 -22.19 26.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.678 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.3 mt -76.99 -25.38 52.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.76 132.73 46.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.474 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.27 -16.03 31.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.48 151.59 23.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -96.52 135.63 38.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.393 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.04 136.66 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.639 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.36 138.8 14.43 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.7 t -131.04 161.59 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.965 0.412 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.6 tp -92.42 117.49 29.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.555 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.73 157.87 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.82 50.57 52.47 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.97 169.0 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.4 p -73.79 -26.33 60.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.497 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -60.69 -55.31 34.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.564 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.89 -54.64 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.421 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.17 -51.38 69.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.571 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.5 t80 -62.08 -43.76 98.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.416 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.8 -44.33 98.02 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.58 -14.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.615 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.32 -34.4 2.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.71 -51.03 15.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.13 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.12 12.98 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.996 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.61 -55.46 0.44 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.45 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.32 -10.39 25.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.834 2.356 . . . . 0.0 112.051 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.61 -8.73 59.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.623 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.9 33.47 37.0 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.87 138.22 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.6 129.79 34.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.421 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.9 pt -125.96 137.78 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.01 132.92 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.427 . . . . 0.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.75 43.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.617 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -110.89 153.67 25.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.373 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.8 6.95 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.19 130.68 5.97 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.01 -45.76 80.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.91 -24.08 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.69 -36.37 84.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.2 -47.13 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.3 m-85 -63.58 -37.8 88.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.364 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.22 -42.63 98.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.46 -45.42 90.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.227 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.544 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.9 tp -58.62 -48.1 82.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.256 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.0 m -63.18 -22.94 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.013 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.3 25.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.86 11.34 70.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.75 -17.84 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.8 pt -128.78 137.98 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.23 -28.02 61.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.481 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.61 155.49 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.689 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.85 50.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.153 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -85.71 103.05 14.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.58 165.11 25.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.451 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.471 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.26 151.97 41.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.7 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -65.71 -54.17 30.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 91' ' ' TYR . 68.6 t -60.04 -49.12 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.03 89.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.772 0.32 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.42 1.16 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.483 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.416 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.4 m -58.67 -47.2 85.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.95 -37.34 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.117 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.14 -65.8 0.55 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.675 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.0 t80 -40.73 -70.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.646 0.26 . . . . 0.0 110.989 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.778 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -59.47 -3.19 0.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.176 0.512 . . . . 0.0 110.377 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 177' ' ' VAL . 33.3 mt-30 -124.58 141.34 37.56 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -43.43 -14.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.844 2.362 . . . . 0.0 112.165 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.0 t -63.07 -42.8 97.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.445 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.87 -33.02 81.69 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.06 -41.35 96.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.793 0.33 . . . . 0.0 110.446 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.16 -34.46 78.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.555 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.8 m-85 -156.96 142.89 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.645 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.71 100.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.049 0.452 . . . . 0.0 110.72 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.5 m-85 -159.41 167.52 28.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.613 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.18 56.06 3.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.04 -116.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.84 135.03 35.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.436 2.091 . . . . 0.0 111.911 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.7 p -124.6 -108.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -166.39 165.17 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.662 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.66 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 O-C-N 123.951 0.782 . . . . 0.0 110.494 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.22 118.3 23.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.066 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.5 mp0 -72.13 -18.68 61.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -64.04 -31.87 73.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.636 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.7 mt -60.83 -44.57 96.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.683 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.46 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.7 m-85 -113.88 7.35 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.641 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.2 -155.32 50.37 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.66 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.19 -25.54 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.16 -125.57 1.46 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -132.07 160.12 36.87 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.412 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.23 -163.2 25.71 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -97.66 141.01 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.15 4.0 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -122.04 160.75 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.285 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 148.97 25.03 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.654 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.75 -48.83 63.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.714 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -39.88 -23.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.784 0.326 . . . . 0.0 110.544 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.0 m-20 -71.78 52.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.623 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.43 -46.27 83.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.16 34.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.42 -43.74 98.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.53 -42.84 99.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.005 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.44 -37.3 72.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.027 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.46 0.11 Allowed 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 44' ' ' ILE . 87.9 mt -28.2 -45.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.659 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.1 m-20 -63.83 -45.46 89.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.661 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.51 98.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.114 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.46 93.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.33 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.12 -43.39 98.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.241 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.36 92.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.98 -42.39 97.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.228 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.13 -38.29 73.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.9 -38.77 76.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.0 110.417 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.46 92.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.6 p-10 -88.57 0.59 56.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.1 67.95 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.7 m -57.6 -46.16 84.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.6 t80 -63.65 -57.93 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 110.53 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.56 -41.68 77.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.7 -48.53 80.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.8 -41.62 97.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.397 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.07 -49.81 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.75 -35.65 73.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -70.78 -50.98 30.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.273 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.16 -45.85 91.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.1 m-85 -153.53 155.48 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.431 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.2 p-10 -98.01 99.23 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -156.4 -165.59 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.493 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.7 t0 -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.6 m -63.76 -40.23 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.572 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.8 m-85 -56.76 -44.11 81.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.304 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.33 -36.54 93.54 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.917 -1.49 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.21 61.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.698 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.79 143.53 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 122.727 2.285 . . . . 0.0 112.308 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.39 -40.89 89.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.586 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.65 139.48 38.51 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.359 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.41 121.5 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.665 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.18 118.49 31.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.106 0.479 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.09 138.56 40.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.404 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.83 105.94 2.2 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.9 m -129.32 120.41 25.59 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 122.694 -0.298 . . . . 0.0 110.953 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.501 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.4 t70 -114.18 92.58 27.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.97 134.36 59.2 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.454 2.103 . . . . 0.0 112.197 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 p -141.75 -20.21 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.781 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.8 m-85 -123.42 99.16 6.19 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.555 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.724 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.19 -61.37 0.22 Allowed Pre-proline 0 C--O 1.217 -0.618 0 CA-C-O 121.688 0.756 . . . . 0.0 111.099 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.724 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.9 Cg_endo -49.36 -40.64 43.98 Favored 'Trans proline' 0 C--N 1.29 -2.502 0 C-N-CA 122.449 2.1 . . . . 0.0 112.259 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.1 t80 -78.36 -42.55 30.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.795 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.658 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -150.04 -153.89 0.52 Allowed 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.049 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.96 177.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.023 0.44 . . . . 0.0 110.376 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.58 144.47 46.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.412 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -95.31 134.31 38.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.585 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.68 -18.92 65.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.516 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.44 -6.71 56.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.052 0.453 . . . . 0.0 110.453 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.18 -8.21 55.27 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -80.08 158.5 26.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.978 0.418 . . . . 0.0 110.426 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.13 130.93 55.73 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.692 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.12 151.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.318 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.02 151.25 6.51 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -58.5 -42.12 86.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 122.555 -0.38 . . . . 0.0 111.007 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.2 t0 -69.2 -28.59 66.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.243 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.692 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -68.03 -40.35 83.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.971 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.03 -37.58 83.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.909 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.74 -45.25 87.25 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -56.96 -48.63 77.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.881 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.85 -54.71 30.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.356 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -52.21 -39.94 60.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 110.412 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.73 -41.83 78.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.71 -45.29 70.4 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.074 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.93 -47.03 82.13 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.064 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.61 -42.35 92.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.89 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.41 -17.1 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.655 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.63 53.11 4.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.548 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.06 171.27 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.876 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -89.02 142.56 27.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.46 131.15 56.79 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.19 126.92 43.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.386 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -93.36 134.67 35.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.523 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.04 127.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.285 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.31 137.99 57.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 1.2 p30 175.89 131.34 0.16 Allowed Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.539 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.2 Cg_endo -68.23 145.22 65.52 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.677 2.251 . . . . 0.0 112.437 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.877 HD23 HD12 ' A' ' 58' ' ' LEU . 82.8 mt -40.29 -55.79 2.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -48.33 -26.25 1.94 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.9 18.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.877 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.96 -42.38 97.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.16 -57.43 23.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 123.872 0.733 . . . . 0.0 109.485 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -54.93 -42.39 69.5 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.62 2.214 . . . . 0.0 111.267 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.9 m -58.76 -44.87 90.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.873 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.656 HD21 ' HG3' ' A' ' 203' ' ' ARG . 62.4 tp -59.1 -44.01 91.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.219 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.47 -40.53 95.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.82 9.96 2.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.24 12.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.59 -35.46 80.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.29 153.19 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.58 -21.98 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.178 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.63 155.74 26.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.777 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.06 128.95 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.176 0.513 . . . . 0.0 110.441 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.0 ttp -131.06 106.47 8.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.716 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.4 t -159.1 178.53 9.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.22 -15.41 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -34.84 124.23 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.606 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.87 153.87 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.613 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.58 148.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -149.12 152.09 35.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.799 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.72 -47.28 50.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.35 -39.7 70.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -69.31 -37.57 77.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.755 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.89 -39.07 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.819 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.73 -27.63 66.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.24 -50.67 8.19 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.729 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.2 pt -139.39 -168.11 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.088 0.47 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.118 0.485 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.9 m-85 -130.0 150.0 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.554 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.05 -153.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 94.2 m-20 41.17 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.088 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.59 121.79 0.2 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.39 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.9 mt -75.6 -68.94 0.52 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.11 167.38 26.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.729 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.3 123.78 29.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.233 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.89 68.55 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.792 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.01 -104.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.45 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.53 165.7 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.41 146.04 22.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.16 0.505 . . . . 0.0 110.444 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -100.96 136.26 41.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.832 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.416 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.72 110.41 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.1 165.16 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.72 148.34 24.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.84 -27.38 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.177 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.33 -41.86 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.323 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.58 122.37 44.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.146 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.4 19.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.84 130.1 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.67 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.67 159.06 33.75 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.576 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.84 89.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.81 2.34 . . . . 0.0 111.939 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -169.27 140.68 2.39 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.523 0.514 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.8 -32.84 59.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.276 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.14 -62.74 1.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.307 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 t -55.96 -22.2 25.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -76.44 -25.9 54.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.323 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.7 133.11 46.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.388 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.89 -15.93 29.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.56 151.36 23.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.458 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.89 135.48 37.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.014 0.435 . . . . 0.0 110.336 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.54 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.51 138.59 14.33 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.87 161.65 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 121.102 0.477 . . . . 0.0 110.314 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.3 tp -92.35 117.53 30.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.682 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.64 157.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.663 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.52 53.56 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.68 168.93 22.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.775 0.321 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.3 p -73.54 -26.85 61.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.54 -55.57 31.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.53 -54.9 40.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.575 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.21 -50.88 71.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.56 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.0 t80 -62.23 -43.82 97.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.92 -44.54 97.69 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.27 -14.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.825 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.28 -34.57 2.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.598 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.4 -50.59 17.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 111.557 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -99.15 12.47 36.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.83 -55.51 0.47 Allowed Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.24 -10.27 25.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.791 2.327 . . . . 0.0 111.923 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -9.01 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.495 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.42 37.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.51 138.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.986 0.422 . . . . 0.0 110.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.48 129.75 34.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.32 138.14 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.23 133.15 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.077 0.465 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.39 127.67 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.99 153.74 25.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.245 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.09 7.42 29.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.645 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.75 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.6 tp60 -65.97 -45.91 80.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.468 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.58 -23.32 62.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.89 -36.71 85.25 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.12 -47.08 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.078 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.518 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.2 m-85 -63.61 -38.06 89.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.271 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.14 -42.27 98.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.04 -45.34 89.27 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.6 tp -58.3 -48.17 81.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -63.25 -22.77 67.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.242 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.74 24.94 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.13 11.46 69.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -18.15 63.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.94 0.4 . . . . 0.0 110.618 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.2 pt -128.29 137.36 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.397 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.89 -27.24 61.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.83 155.87 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.527 0.517 . . . . 0.0 110.838 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.05 136.83 49.8 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 109.967 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -85.2 103.05 13.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.831 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.5 tt0 -132.52 165.5 24.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.409 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.81 152.31 41.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.549 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.2 mt-10 -66.27 -54.46 24.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.33 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.1 t -60.29 -48.98 86.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.395 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.93 88.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.821 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.45 -63.1 1.22 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -59.4 -47.99 83.34 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.003 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.9 tt0 -49.06 -37.33 20.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.82 -66.32 0.56 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -71.23 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 122.745 -0.268 . . . . 0.0 111.17 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 175' ' ' GLN . 94.9 mt -61.01 -40.31 93.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -60.1 -2.79 0.47 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.538 0.685 . . . . 0.0 110.457 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 173' ' ' LEU . 39.8 mt-30 -123.36 148.95 56.74 Favored Pre-proline 0 N--CA 1.453 -0.306 0 O-C-N 122.011 -0.431 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.48 -20.41 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.933 2.422 . . . . 0.0 112.299 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.01 -43.24 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.588 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.59 -33.05 83.55 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.57 -41.4 94.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.733 0.302 . . . . 0.0 110.412 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.9 m-20 -65.55 -33.81 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.438 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.3 m-85 -156.19 143.0 18.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.1 pttt -177.15 99.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.093 0.473 . . . . 0.0 110.73 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.1 166.82 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.59 56.57 2.77 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -118.05 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.28 135.98 31.44 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.412 2.075 . . . . 0.0 112.015 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.47 -107.9 0.32 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.647 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.68 165.31 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.144 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.29 156.15 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.25 0.969 . . . . 0.0 110.62 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.15 117.57 22.4 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.863 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.61 -18.78 62.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.99 -32.35 73.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.518 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.4 mt -60.94 -44.62 97.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.746 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.9 m-85 -114.0 9.59 17.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.783 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.19 -154.92 52.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.53 -24.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 110.428 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 159.93 -124.16 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.3 p -129.4 156.45 44.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.712 0.292 . . . . 0.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.64 -169.42 30.22 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -94.39 137.3 33.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.922 0.391 . . . . 0.0 110.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.25 107.77 3.21 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.4 mt -123.06 159.22 28.9 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.906 0.384 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.656 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.87 149.57 24.72 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.85 -48.34 64.04 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.527 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.5 tp10 -37.98 -25.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.94 0.4 . . . . 0.0 110.842 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.47 52.2 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.622 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -64.39 -45.68 86.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.274 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.54 -47.23 34.06 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.26 -43.91 97.74 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.18 -43.0 99.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.01 -36.39 70.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.1 -77.31 0.11 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.89 HD21 HD11 ' A' ' 44' ' ' ILE . 98.3 mt -28.86 -46.08 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.958 0.408 . . . . 0.0 110.506 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.31 -44.94 90.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.782 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.5 tttm -62.08 -43.63 98.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.993 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.06 93.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.15 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.23 -43.39 98.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.994 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.26 92.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.53 -43.26 97.65 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.508 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.79 -38.32 72.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.99 -38.9 76.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 110.378 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.619 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.51 1.09 56.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.676 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.47 20.64 65.9 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.3 m -58.2 -45.97 86.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.8 t80 -63.93 -57.86 8.49 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.441 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.83 -41.83 78.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.2 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.44 -48.72 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.532 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.69 -41.88 98.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.87 0.367 . . . . 0.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.13 74.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.84 -34.9 72.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.22 -50.82 29.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.394 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.4 -45.83 91.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.552 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 66.6 m-85 -153.85 155.79 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.05 98.08 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.982 0.42 . . . . 0.0 110.412 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -155.59 -165.59 2.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.33 110.67 15.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.585 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.0 m -63.57 -40.47 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.46 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.8 m-85 -58.5 -42.55 87.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.281 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.26 -37.04 94.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.702 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 164.38 59.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.647 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.89 143.39 99.35 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.05 -40.31 90.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.82 142.81 36.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.5 mt -109.88 128.73 65.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.468 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -103.6 117.0 33.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.34 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -111.83 139.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.409 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.09 105.08 2.14 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -128.14 118.98 24.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.71 -0.289 . . . . 0.0 111.069 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.521 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.1 t70 -113.53 93.15 26.26 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.16 133.89 57.7 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.2 p -140.79 -19.71 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.749 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.498 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.6 m-85 -124.87 99.27 6.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.594 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.723 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.18 -61.23 0.23 Allowed Pre-proline 0 C--O 1.218 -0.592 0 CA-C-O 121.672 0.749 . . . . 0.0 111.083 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.723 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.64 -39.5 46.62 Favored 'Trans proline' 0 C--N 1.293 -2.359 0 C-N-CA 122.449 2.1 . . . . 0.0 112.215 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.7 t80 -79.13 -42.6 25.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.054 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.657 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.6 mt-10 -149.38 -156.02 0.68 Allowed 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.116 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.93 178.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.067 0.46 . . . . 0.0 110.269 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -135.86 143.0 44.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.462 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.1 t-20 -95.5 141.61 28.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.528 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.0 p -65.92 -19.22 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.511 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.98 -6.71 55.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.424 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.77 -6.93 58.98 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.76 158.26 26.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 110.431 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.9 mt -111.89 134.09 53.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.381 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.665 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.33 151.11 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.96 0.41 . . . . 0.0 110.31 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.76 151.65 6.66 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -58.63 -42.04 87.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.812 0.339 . . . . 0.0 110.964 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.2 t0 -70.24 -28.32 65.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.364 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 30' ' ' VAL . 96.7 mt -68.88 -40.71 81.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.104 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -61.3 -37.35 82.92 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.754 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.43 -43.99 84.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.985 0.422 . . . . 0.0 110.259 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.91 -41.84 92.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.111 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -58.74 -53.61 56.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -36.73 62.61 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 110.332 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.4 -42.37 75.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.824 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.49 -44.48 72.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.116 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.97 -47.61 79.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.42 -41.03 88.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.984 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.4 -17.59 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.6 52.74 4.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.489 . . . . 0.0 110.651 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.08 17.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.885 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.36 140.84 29.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.153 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -117.31 132.01 56.69 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.632 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.43 127.73 43.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.89 135.78 34.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.64 128.44 65.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.368 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 139.41 58.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.521 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.06 131.99 0.14 Allowed Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.3 Cg_endo -68.49 145.21 63.9 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.297 . . . . 0.0 112.426 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.886 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.49 -56.66 2.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.1 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.19 -26.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.64 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.232 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.886 HD12 HD23 ' A' ' 55' ' ' LEU . 57.1 mt -63.97 -42.43 97.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.68 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.703 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.44 -56.89 26.1 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.696 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.5 Cg_exo -55.0 -43.32 60.65 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.595 2.197 . . . . 0.0 111.113 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -58.52 -44.64 89.58 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.763 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.52 -44.37 89.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.095 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.54 -40.5 95.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.11 11.08 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.13 11.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.44 -34.33 77.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.94 153.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.43 -20.35 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.128 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.55 157.64 25.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.18 127.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.523 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.42 106.79 9.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.383 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.58 ' OG ' HD21 ' A' ' 55' ' ' LEU . 41.2 t -160.28 -178.06 6.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.3 -15.52 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.391 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -37.97 123.88 1.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.62 156.82 22.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.594 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.645 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.02 149.3 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.301 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.0 p -150.3 152.28 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.735 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.94 52.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.021 0.438 . . . . 0.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.47 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.887 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.73 -37.57 79.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.912 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.34 -27.85 67.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.142 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.92 -51.98 7.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -138.19 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.1 0.476 . . . . 0.0 110.433 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.78 29.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.038 0.447 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.5 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.627 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.39 -151.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.512 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.1 m-20 43.29 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.11 119.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.6 mt -77.19 -70.07 0.49 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.9 p90 -149.35 166.33 29.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.91 122.51 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.297 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.85 68.86 0.93 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.762 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.69 -104.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.429 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.4 p -159.05 165.74 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.656 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.24 146.22 22.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.117 0.484 . . . . 0.0 110.353 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.06 135.99 41.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.7 110.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.5 m -134.29 165.03 32.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.938 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.84 148.67 23.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.3 -28.48 58.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.247 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -58.93 -41.76 88.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.281 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -101.94 122.03 43.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.75 109.86 19.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.28 129.73 70.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.579 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.5 153.97 41.81 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.672 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.3 Cg_endo -59.05 92.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -171.08 144.11 2.06 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.604 0.565 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.14 -33.55 61.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.287 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.301 -178.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.1 t -56.95 -21.99 34.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.962 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.43 -27.08 58.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.94 133.43 48.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.46 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.19 -17.34 28.7 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.31 151.76 23.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.902 0.382 . . . . 0.0 110.431 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.58 38.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.372 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.15 136.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.622 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.34 139.32 14.65 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.3 161.63 40.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.097 0.475 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.73 117.61 30.18 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.627 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.56 157.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.15 50.71 49.73 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.8 p -149.71 168.85 22.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.2 p -73.83 -25.78 60.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -61.1 -55.39 33.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.435 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.34 -53.81 53.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.77 -51.32 69.84 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.586 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.1 t80 -62.19 -43.9 97.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.85 -44.58 97.66 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.782 0.325 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.19 -34.56 2.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.667 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.39 -50.73 17.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 111.562 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.19 12.46 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.209 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.7 -55.56 0.48 Allowed Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.375 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.23 25.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.001 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.85 -8.78 59.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.44 37.02 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.31 137.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.81 129.94 35.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.8 138.56 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 63.1 t -123.92 133.65 68.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 109.935 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -95.57 127.56 41.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.55 150.62 27.22 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.251 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.96 6.05 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.13 131.37 5.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.401 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.5 tp60 -65.69 -45.7 81.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 110.415 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.85 -24.24 63.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.55 -36.52 84.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.0 -46.62 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.001 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.8 m-85 -64.37 -37.75 88.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.339 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.79 -42.12 96.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.181 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -65.58 -43.28 90.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.3 tp -58.58 -48.92 79.33 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.18 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -62.15 -22.52 65.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.382 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.91 25.62 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.544 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 12.12 73.1 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.99 -17.42 63.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.563 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.2 pt -127.39 136.48 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 110.42 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.92 -28.1 62.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.38 155.1 1.79 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.853 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.65 137.1 50.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.039 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -85.55 102.5 13.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.144 0.497 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.4 tt0 -131.6 165.0 24.62 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.377 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.44 153.11 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.47 -54.29 25.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.337 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.0 t -60.22 -49.17 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.438 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.82 87.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.13 -63.51 1.13 Allowed 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.572 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -58.78 -47.27 85.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -49.25 -38.4 26.74 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.48 -66.02 0.56 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.0 t80 -40.32 -71.04 0.09 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.608 0.242 . . . . 0.0 111.229 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.2 -40.07 92.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.959 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.65 -2.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.7 mt-30 -124.27 141.77 38.3 Favored Pre-proline 0 C--N 1.33 -0.244 0 O-C-N 122.079 -0.388 . . . . 0.0 110.845 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -43.95 -15.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.871 2.381 . . . . 0.0 112.277 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 175' ' ' GLN . 79.4 t -62.97 -42.83 98.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.95 81.37 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.75 -41.58 95.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.726 0.298 . . . . 0.0 110.479 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.8 -34.49 78.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.578 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.6 m-85 -157.25 143.96 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.4 pttt -177.81 100.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.075 0.464 . . . . 0.0 110.782 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.9 m-85 -159.06 168.18 27.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.01 55.57 3.09 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.68 -117.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.83 135.22 35.48 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.487 2.125 . . . . 0.0 112.008 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.0 p -125.08 -108.14 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.54 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.64 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.178 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.53 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 124.17 0.919 . . . . 0.0 110.634 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.2 118.23 22.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.791 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.87 -18.57 62.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.05 73.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.464 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.4 mt -60.97 -44.36 97.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.743 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.435 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.68 7.58 17.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.697 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.99 -154.84 50.21 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.645 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.7 -25.39 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.56 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.456 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.05 -126.14 1.55 Allowed Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -131.97 159.92 37.3 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.427 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.65 -162.39 24.7 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -98.5 141.02 31.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.621 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.81 3.96 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.4 mt -120.64 160.54 23.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.307 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.95 148.98 25.1 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.18 -49.04 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.662 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -39.89 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.89 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -71.91 52.13 0.23 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.5 -46.16 84.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.18 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.46 -47.07 35.68 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.27 -43.92 97.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.459 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.55 -42.89 99.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.6 -37.36 73.1 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.64 -77.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.984 HD21 HD11 ' A' ' 44' ' ' ILE . 87.4 mt -28.72 -45.65 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.858 0.361 . . . . 0.0 110.481 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.4 m-20 -63.59 -45.64 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.6 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.77 98.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.968 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.26 -43.33 99.05 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.105 0.479 . . . . 0.0 110.071 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.41 93.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.074 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.62 -43.01 98.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.78 -38.37 72.39 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.81 -38.79 76.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.47 . . . . 0.0 110.373 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.41 92.81 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 21.0 p-10 -88.36 0.38 56.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.743 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.56 20.11 67.59 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.6 m -58.04 -46.22 85.7 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.1 t80 -63.42 -57.46 10.21 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.448 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.91 -41.78 78.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.245 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.3 -48.67 79.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.48 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.51 -41.73 97.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.39 -49.68 76.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.692 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.87 -35.26 72.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.465 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.72 -51.16 29.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.39 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.17 -45.92 91.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.581 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.0 m-85 -154.11 155.14 34.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.4 p-10 -97.84 101.21 12.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.476 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -157.51 -165.44 1.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.63 109.94 14.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.6 m -63.63 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.412 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.2 m-85 -58.27 -43.6 88.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.217 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.65 -36.76 93.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.418 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.657 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.983 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.12 164.47 56.69 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.82 143.34 99.36 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.624 2.216 . . . . 0.0 112.29 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.49 -40.23 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.554 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.69 36.86 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.7 128.58 66.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.5 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -104.83 118.59 36.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 110.362 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.7 138.52 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.89 99.58 1.55 Allowed Glycine 0 N--CA 1.463 0.495 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.6 m -123.41 117.68 25.74 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.696 -0.297 . . . . 0.0 111.255 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.516 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 12.8 t0 -112.85 93.04 22.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.18 133.84 57.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.424 2.083 . . . . 0.0 112.188 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.5 p -141.05 -19.5 0.8 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.742 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.6 m-85 -124.78 99.05 5.97 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.649 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.728 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.08 -61.33 0.22 Allowed Pre-proline 0 C--O 1.218 -0.577 0 CA-C-O 121.563 0.697 . . . . 0.0 111.125 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.728 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.73 -39.05 47.57 Favored 'Trans proline' 0 C--N 1.293 -2.384 0 C-N-CA 122.36 2.04 . . . . 0.0 112.254 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.9 t80 -79.38 -42.9 24.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.952 0.406 . . . . 0.0 111.132 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.8 mt-10 -149.25 -155.97 0.68 Allowed 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.114 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.24 177.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.0 110.317 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -135.84 142.06 44.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.44 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.3 t-20 -94.81 141.71 28.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.467 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.1 p -65.88 -19.21 65.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.542 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.28 -6.96 56.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.433 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.33 -7.47 58.31 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -78.92 158.02 28.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.97 0.414 . . . . 0.0 110.403 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.62 134.54 54.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.929 0.395 . . . . 0.0 110.401 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.675 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.3 p -133.42 151.2 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.361 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.83 151.64 6.67 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -58.59 -42.09 87.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.903 0.383 . . . . 0.0 111.012 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.5 t0 -70.17 -28.01 64.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.433 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.675 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -68.55 -41.37 82.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.119 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.71 -37.57 82.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.094 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.47 -43.96 84.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.188 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.02 -41.75 92.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.133 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.7 -53.32 59.69 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.554 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.08 -36.56 63.29 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.266 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.0 mt -69.53 -42.37 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.772 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.62 -44.02 72.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.3 tttm -64.07 -47.65 79.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -59.82 -40.81 89.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.948 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.36 -18.24 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.616 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.79 52.51 4.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 110.618 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -144.99 169.94 17.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.9 139.93 30.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.056 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -116.52 131.31 56.98 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.9 m -128.47 128.03 43.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.74 136.44 35.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.75 128.72 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.343 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.84 139.37 58.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.781 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.89 132.81 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.519 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.4 Cg_endo -68.55 144.92 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.562 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.939 HD23 HD12 ' A' ' 58' ' ' LEU . 76.9 mt -40.81 -55.81 2.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.41 -26.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.173 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.46 -20.18 19.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.939 HD12 HD23 ' A' ' 55' ' ' LEU . 86.5 mt -64.93 -42.45 94.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.959 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.52 -56.91 28.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.685 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.4 Cg_exo -55.35 -43.24 60.43 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.586 2.191 . . . . 0.0 111.035 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -58.68 -44.41 90.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.2 tp -58.53 -44.31 89.52 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -64.55 -40.36 95.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.996 0.426 . . . . 0.0 110.434 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 11.22 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.565 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.95 11.84 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.17 77.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.494 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.7 pt -124.54 153.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.281 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.284 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.95 156.88 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.755 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -117.11 128.0 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 110.534 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.477 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.38 106.51 9.05 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.399 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.608 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.2 t -159.66 -179.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.3 -15.31 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.391 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.0 tp -37.78 123.86 1.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.07 156.37 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.3 pt -104.87 148.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.9 p -150.04 152.5 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.27 -47.69 55.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.604 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.72 -39.71 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.788 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.27 -37.83 81.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.928 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.29 75.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.59 67.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.076 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.12 -51.76 7.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.6 pt -138.45 -168.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.88 146.87 29.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.87 150.0 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.641 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.2 t -164.41 -151.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.444 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.1 m-20 43.07 19.3 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.8 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mttt -28.27 120.22 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -77.26 -69.99 0.5 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.825 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 40.3 p90 -149.4 166.25 29.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.08 123.39 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.466 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.47 67.97 0.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.5 -104.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.436 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.2 p -159.58 165.99 31.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.7 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.52 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.144 0.497 . . . . 0.0 110.456 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.3 135.86 42.1 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.409 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.9 t -122.67 110.45 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.28 165.11 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.935 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.19 148.61 23.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.97 -27.84 46.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.191 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -59.1 -41.8 88.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.221 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.45 122.14 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.129 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.54 109.26 19.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.068 0.461 . . . . 0.0 110.398 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.18 129.88 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.73 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.98 159.05 34.01 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.53 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.1 Cg_endo -59.63 89.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.707 2.271 . . . . 0.0 111.943 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.6 m -169.23 140.91 2.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.546 0.529 . . . . 0.0 110.786 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.55 -32.58 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.227 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.19 -62.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.375 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.2 t -56.11 -22.18 26.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.124 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.96 -26.81 57.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.345 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.71 132.84 46.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.436 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.41 -15.92 32.43 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -87.1 151.78 22.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.71 135.89 38.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.075 0.464 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.99 136.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.738 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 138.93 14.5 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.24 161.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.068 0.461 . . . . 0.0 110.386 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.1 tp -92.71 117.95 30.54 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.51 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.58 49.15 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.7 p -149.67 168.98 22.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.94 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.44 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.3 p -74.01 -25.73 60.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.401 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.21 -55.44 32.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.468 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.09 -54.06 51.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.57 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.46 -51.01 71.31 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.702 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.25 -43.86 97.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.11 0.481 . . . . 0.0 110.44 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.21 -44.55 97.55 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.27 -14.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.801 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.38 2.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.43 -50.75 17.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 111.653 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -98.98 12.54 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.32 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.9 -55.58 0.47 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.377 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.16 -10.44 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.825 2.35 . . . . 0.0 111.959 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.61 -8.84 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.496 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.89 33.45 37.09 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.54 138.06 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.65 129.73 35.03 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.307 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.52 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.11 133.56 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.026 0.441 . . . . 0.0 109.959 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 127.97 42.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -108.29 150.45 27.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.165 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.37 5.61 34.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.68 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.44 131.87 6.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.63 -45.76 81.83 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.411 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.61 -24.43 63.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 56.9 t-20 -64.45 -36.69 85.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.79 -46.56 88.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.43 -37.6 88.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.315 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.88 -42.5 98.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.2 -43.13 92.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.884 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.0 tp -59.17 -48.37 81.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.5 m -62.69 -22.26 66.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.915 0.388 . . . . 0.0 110.026 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.89 -17.71 26.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.63 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.54 11.95 73.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.78 -17.57 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.609 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.0 pt -127.53 136.62 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.993 0.425 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.01 -28.28 62.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.36 155.27 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.802 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.61 137.44 50.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 109.95 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.66 102.95 14.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.239 0.542 . . . . 0.0 110.714 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.14 165.14 24.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.377 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.24 152.35 41.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.601 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.2 -54.13 28.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.343 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.4 -49.17 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.512 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.85 88.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 110.867 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.01 -63.49 1.14 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.589 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.9 m -58.67 -47.01 85.92 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.792 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.66 -38.05 30.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.057 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.68 -65.59 0.55 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.2 t80 -40.63 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.644 0.259 . . . . 0.0 111.394 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.4 mt -61.38 -39.87 92.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.81 -2.92 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.537 0.684 . . . . 0.0 110.499 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.8 mt-30 -124.43 142.1 39.39 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.09 -0.382 . . . . 0.0 110.891 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -44.06 -15.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.808 2.339 . . . . 0.0 112.299 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.5 t -63.09 -43.03 98.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.632 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.62 -32.86 79.84 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.31 95.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' A' ' 181' ' ' TYR . 47.7 m-20 -65.8 -34.92 79.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 180' ' ' ASP . 77.5 m-85 -157.04 143.54 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -177.22 100.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 110.728 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -159.31 167.5 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.699 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.31 55.52 3.05 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.45 -117.46 0.01 OUTLIER Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.93 135.5 36.23 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.465 2.11 . . . . 0.0 111.932 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 89.4 p -124.95 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.601 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.657 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -165.79 165.37 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.185 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.49 156.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 124.169 0.918 . . . . 0.0 110.649 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.14 118.28 22.94 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.73 -18.63 62.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.9 -32.36 73.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.57 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.452 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.6 mt -60.86 -44.25 97.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.44 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.8 m-85 -114.05 8.36 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.719 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.12 -154.7 51.04 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.651 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.71 -25.51 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.869 0.366 . . . . 0.0 110.551 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.0 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.4 p -131.97 160.06 36.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.827 0.346 . . . . 0.0 110.41 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.42 24.6 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.87 32.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.914 0.387 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.86 3.96 Favored Glycine 0 C--N 1.329 0.179 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.6 mt -121.28 160.27 24.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.94 0.4 . . . . 0.0 110.164 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.81 149.08 25.09 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.881 0.372 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.37 -48.6 65.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.669 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.94 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.015 0.436 . . . . 0.0 110.831 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.1 m-20 -71.89 52.17 0.23 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -64.42 -46.03 84.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.313 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.7 -46.94 34.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.241 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.25 -43.87 97.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.438 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.728 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.73 -37.35 73.41 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.702 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.38 0.11 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 44' ' ' ILE . 85.5 mt -28.91 -45.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.471 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.6 m-20 -63.61 -45.28 91.03 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.49 -43.79 98.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.095 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.15 -43.52 98.75 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 110.046 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.29 92.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.064 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.9 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.0 -38.32 72.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.84 -38.79 76.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 110.322 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.28 93.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.656 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.33 0.31 56.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.727 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.55 20.25 67.71 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.28 -46.15 86.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 77.2 t80 -63.44 -57.36 10.51 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.372 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.99 -41.46 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.236 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.62 -48.36 81.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.598 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.88 -41.61 98.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.402 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.62 -49.79 76.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.639 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.56 -35.35 72.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.529 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.57 -51.07 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.544 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.7 m-85 -62.28 -45.7 92.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.617 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.2 m-85 -154.3 154.82 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.0 p-10 -97.79 100.13 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.409 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -156.25 -165.39 1.9 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.58 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.6 t0 -122.5 109.89 14.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.2 m -63.39 -40.46 89.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.416 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.0 m-85 -59.06 -42.53 90.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.304 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.25 -37.08 94.3 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.659 0 CA-C-O 117.872 -1.516 . . . . 0.0 110.975 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.04 164.33 61.94 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.595 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.84 143.53 99.39 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.574 2.182 . . . . 0.0 112.32 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.41 -40.78 89.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.09 141.22 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.442 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.8 mt -109.27 127.43 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 110.567 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.28 117.71 35.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.12 0.486 . . . . 0.0 110.277 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.16 138.55 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.922 0.391 . . . . 0.0 110.537 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.59 105.25 2.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.4 m -128.3 119.52 25.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.676 -0.308 . . . . 0.0 111.242 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 10.8 t0 -113.44 92.59 23.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.33 134.13 59.49 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.44 2.093 . . . . 0.0 112.12 179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -141.39 -19.87 0.77 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.728 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -123.28 98.62 5.95 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.706 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.12 -61.4 0.22 Allowed Pre-proline 0 C--O 1.218 -0.564 0 CA-C-O 121.441 0.639 . . . . 0.0 111.055 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.729 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.38 -40.5 44.19 Favored 'Trans proline' 0 C--N 1.295 -2.25 0 C-N-CA 122.26 1.974 . . . . 0.0 112.241 -179.286 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.9 t80 -78.37 -43.12 28.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.107 0.48 . . . . 0.0 111.002 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.662 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.8 mt-10 -149.23 -154.38 0.55 Allowed 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.938 -178.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.71 177.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.049 0.452 . . . . 0.0 110.407 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.43 144.76 46.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.38 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -95.81 134.44 38.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.613 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -64.61 -18.95 65.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.537 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.28 -6.36 54.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.453 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.81 -8.52 56.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -80.14 158.73 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 110.471 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.45 131.76 55.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.952 0.406 . . . . 0.0 110.428 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.685 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.15 151.59 32.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.296 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.87 151.67 6.69 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.93 -41.93 88.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.856 0.36 . . . . 0.0 110.941 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 -69.66 -28.6 66.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.152 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -67.9 -41.02 84.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.845 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -60.88 -37.24 81.5 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.945 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -65.1 -45.07 86.7 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.2 -48.01 79.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.993 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.3 -54.27 38.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.352 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.75 -39.59 62.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.85 0.357 . . . . 0.0 110.308 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.0 -42.16 76.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 110.622 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.74 -44.62 70.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.128 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -63.83 -47.38 81.01 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.84 -41.68 91.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.914 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -75.56 -18.09 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.552 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.04 52.76 3.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.505 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -146.6 171.21 15.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.69 141.31 28.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.073 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.4 m -116.8 130.42 56.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.0 m -126.81 126.93 44.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -93.88 135.5 35.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.581 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.53 128.32 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.324 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.04 139.67 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.525 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.0 OUTLIER 173.93 129.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.4 Cg_endo -67.5 146.32 73.81 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.753 2.302 . . . . 0.0 112.471 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.862 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -40.45 -56.57 2.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.148 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.97 -26.82 1.91 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 111.271 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.75 -20.69 19.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.294 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.862 HD12 HD23 ' A' ' 55' ' ' LEU . 60.6 mt -64.42 -42.27 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.717 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.715 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.19 -56.76 28.13 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.7 Cg_exo -55.36 -44.06 52.52 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.628 2.219 . . . . 0.0 111.141 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.4 m -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.692 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.94 -44.24 86.82 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.6 -40.17 95.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.5 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.26 11.19 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.82 12.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.24 -34.28 77.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 178.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 pt -123.76 152.93 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.218 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.44 -20.65 20.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.302 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.38 156.51 26.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.59 HG23 HD13 ' A' ' 58' ' ' LEU . 96.8 mt -115.47 126.99 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.016 0.436 . . . . 0.0 110.475 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.31 106.04 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.309 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.681 ' OG ' HD21 ' A' ' 55' ' ' LEU . 45.6 t -159.67 -179.84 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.589 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.66 -15.48 61.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.379 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.8 tp -36.23 123.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.52 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.555 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -81.66 154.6 26.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -104.55 148.01 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -149.57 152.35 35.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.867 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.24 -47.23 55.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.48 -37.87 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.1 -38.05 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.786 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.05 -27.43 66.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.061 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.58 -50.83 7.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -139.53 -168.31 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.58 147.16 29.79 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.08 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.92 150.03 51.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.574 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.9 t -164.05 -152.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.534 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.511 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.8 m-20 41.64 19.5 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.889 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.35 121.34 0.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.392 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.433 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.6 mt -75.11 -68.66 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.893 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.45 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.8 167.72 26.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.27 28.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.264 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.86 68.26 0.91 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.785 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.84 -104.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.405 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.47 165.89 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.709 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.28 145.93 22.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.434 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.74 136.14 41.08 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 110.816 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.5 110.98 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.19 165.01 32.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.046 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.52 24.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.18 -28.31 57.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.179 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.18 -41.69 89.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -101.83 121.74 42.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.246 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.83 109.86 19.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.103 0.477 . . . . 0.0 110.503 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.04 129.79 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -108.76 154.18 41.89 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.518 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.24 92.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.758 2.305 . . . . 0.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -171.08 144.04 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.633 0.583 . . . . 0.0 110.795 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.47 -33.82 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.486 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.54 -62.7 1.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 t -56.22 -22.44 29.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.014 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.5 -26.52 58.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.246 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.39 133.44 45.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.81 -16.87 29.42 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.21 151.55 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.428 . . . . 0.0 110.491 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.31 136.15 37.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.3 t -127.59 136.99 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.78 139.9 14.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -132.1 161.71 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.044 0.449 . . . . 0.0 110.388 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.91 118.32 31.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.46 157.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.609 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.04 50.84 49.58 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -149.69 168.46 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.9 p -74.49 -25.63 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.482 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -61.0 -55.77 28.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.562 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.14 -54.11 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.588 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.28 -51.28 70.23 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.73 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.28 -43.8 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.128 0.489 . . . . 0.0 110.582 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.64 -44.48 97.89 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.233 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.63 -14.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.79 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.19 -34.64 2.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.762 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.12 -50.55 18.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.614 -178.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -99.12 12.39 36.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.287 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.49 -55.41 0.49 Allowed Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.434 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.2 -10.39 25.73 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.786 2.324 . . . . 0.0 111.993 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.63 -9.05 59.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.459 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.75 33.3 38.17 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.98 138.09 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.902 0.382 . . . . 0.0 110.627 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.92 129.8 35.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.195 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.16 138.98 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.2 t -125.59 132.1 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 109.943 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -98.43 130.59 45.05 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.998 0.427 . . . . 0.0 110.879 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -111.82 156.44 21.99 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.353 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.07 6.67 29.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.818 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.65 6.25 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.421 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.1 tp60 -65.88 -46.03 79.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.439 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.95 -23.15 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.571 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.51 -36.96 85.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 110.561 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.13 -47.08 85.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.207 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.2 m-85 -63.87 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.08 -42.28 98.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.68 -45.24 90.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.06 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.9 tp -58.87 -47.81 83.6 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.991 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -63.09 -22.93 67.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.947 0.403 . . . . 0.0 110.123 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.7 24.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.02 11.28 70.28 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.63 -18.17 63.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.627 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -127.87 136.7 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.77 -27.83 62.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.3 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.457 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.61 155.75 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.8 137.34 50.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.93 0.395 . . . . 0.0 109.955 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.92 103.19 14.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.34 0.59 . . . . 0.0 110.819 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.75 165.3 24.86 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.78 152.7 41.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.73 -54.69 20.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.279 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.45 HG21 ' CG ' ' A' ' 91' ' ' TYR . 77.0 t -60.08 -48.83 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.623 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.77 88.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.861 0.363 . . . . 0.0 110.856 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.2 -63.13 1.23 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.429 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.6 m -59.12 -47.63 84.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.851 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.4 tt0 -48.54 -38.02 19.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.17 -65.38 0.54 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.9 t80 -40.68 -71.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 111.286 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.31 -40.04 92.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -59.7 -2.91 0.41 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.451 0.643 . . . . 0.0 110.442 -179.473 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 173' ' ' LEU . 80.3 mt-30 -123.8 148.46 56.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.93 -20.45 2.98 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 112.195 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.74 -42.89 93.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.96 -33.24 84.88 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.44 95.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.677 0.275 . . . . 0.0 110.459 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.41 -33.62 76.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.315 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.1 m-85 -156.56 142.74 18.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.693 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.554 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.94 99.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.779 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.22 167.6 28.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.29 56.17 2.9 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -117.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.52 135.12 33.29 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.514 2.142 . . . . 0.0 111.89 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.4 p -125.08 -108.36 0.32 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.59 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.44 164.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.363 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.86 156.07 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.91 0.756 . . . . 0.0 110.657 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -82.37 117.66 22.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.937 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.97 -17.35 62.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.14 -33.05 74.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.586 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.5 mt -61.16 -44.46 97.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.697 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.6 m-85 -113.63 9.36 17.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.768 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.84 -153.51 51.43 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.66 -25.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.846 0.355 . . . . 0.0 110.5 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.13 -123.94 1.28 Allowed Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.9 p -129.36 156.27 44.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.733 0.301 . . . . 0.0 110.324 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.74 -169.44 30.34 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -95.32 138.94 32.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.71 107.26 3.2 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.664 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.1 mt -119.25 160.06 22.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.69 149.06 24.48 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.27 -48.66 65.16 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.543 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.15 -23.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -71.7 52.11 0.21 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.52 -45.23 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.16 -47.17 29.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.327 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.25 -44.17 97.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.448 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.08 -43.13 99.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.846 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.42 -37.21 72.41 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.67 -78.04 0.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.914 HD21 HD11 ' A' ' 44' ' ' ILE . 89.9 mt -28.48 -46.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.68 0.276 . . . . 0.0 110.321 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.6 m-20 -63.85 -45.01 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 178.139 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.78 -43.73 98.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.44 93.85 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.006 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.26 -43.61 98.6 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.994 0.426 . . . . 0.0 109.914 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.26 92.66 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.94 -42.89 97.21 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -57.05 -38.08 72.72 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.89 -38.96 76.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 110.348 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.86 94.31 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.677 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.1 p-10 -89.15 1.02 56.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.59 20.48 65.97 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.5 m -58.05 -46.33 85.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.433 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 75.1 t80 -63.64 -58.02 8.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.418 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.6 -41.76 77.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.14 -41.61 98.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.311 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.97 -50.34 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -35.33 71.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.648 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.8 -51.0 29.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.627 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 39.2 m-85 -61.95 -46.04 91.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.61 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.6 m-85 -154.35 155.79 35.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.36 99.41 10.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -156.27 -166.21 2.1 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.41 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.87 110.75 15.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.795 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.3 m -63.34 -40.41 88.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.414 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.1 m-85 -58.93 -42.9 90.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.251 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.37 -37.37 94.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.866 -1.519 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.54 164.34 58.63 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.87 99.44 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.14 -40.53 90.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.89 144.01 36.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.5 128.4 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.96 118.62 37.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.85 138.7 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.378 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.73 100.36 1.59 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -123.8 118.56 27.43 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.718 -0.283 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.518 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.8 t70 -113.32 93.15 25.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.987 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.16 133.8 57.29 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.468 2.112 . . . . 0.0 112.084 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.2 p -140.18 -19.9 0.88 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.745 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.4 m-85 -124.73 99.08 5.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.601 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.04 -61.44 0.22 Allowed Pre-proline 0 C--O 1.219 -0.542 0 CA-C-O 121.626 0.727 . . . . 0.0 111.085 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.726 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.6 -39.37 46.33 Favored 'Trans proline' 0 C--N 1.294 -2.298 0 C-N-CA 122.439 2.093 . . . . 0.0 112.236 -179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.9 t80 -79.28 -42.96 24.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.928 0.394 . . . . 0.0 111.02 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.27 -155.86 0.67 Allowed 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.01 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.72 177.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.43 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.36 139.46 45.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.39 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -91.01 136.79 32.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.662 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -64.83 -19.22 65.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.539 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -79.13 -5.92 55.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.512 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 -8.24 57.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.1 157.62 26.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.95 0.405 . . . . 0.0 110.438 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.9 mt -112.83 134.56 54.28 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.942 0.401 . . . . 0.0 110.375 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.673 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.47 151.31 33.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.407 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.95 151.48 6.61 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.56 -42.12 87.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 -69.99 -27.92 65.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.396 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.673 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.7 mt -68.81 -41.14 82.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.017 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -60.72 -37.66 82.47 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.081 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.09 -44.08 85.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.206 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.1 -44.31 91.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.093 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.51 -53.84 52.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.541 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.32 -37.44 62.28 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.57 -42.09 74.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.764 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.5 m -54.45 -44.1 72.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.102 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.15 -47.69 78.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -59.53 -41.21 89.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.069 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.006 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -76.22 -18.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.683 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.9 52.49 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.586 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -145.36 170.1 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.18 140.48 29.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.059 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -116.7 131.23 57.01 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.3 127.99 43.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.436 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -94.69 136.38 35.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.435 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.72 128.57 65.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.311 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.14 139.08 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.748 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.518 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 174.09 132.85 0.12 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.7 Cg_endo -68.42 144.75 62.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.647 2.231 . . . . 0.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.936 HD23 HD12 ' A' ' 58' ' ' LEU . 77.8 mt -40.49 -55.65 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.098 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -47.84 -26.45 1.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.34 19.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.184 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.936 HD12 HD23 ' A' ' 55' ' ' LEU . 85.1 mt -65.03 -42.33 94.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.826 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.83 -56.59 30.84 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.739 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.2 Cg_exo -55.47 -43.26 59.94 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.591 2.194 . . . . 0.0 111.108 177.308 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.7 m -58.83 -44.44 90.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.27 -44.36 88.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.69 -40.08 94.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 0.0 110.469 178.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.07 11.26 1.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.505 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.94 11.86 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.34 -34.19 77.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.546 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.6 pt -124.4 153.15 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.285 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.9 m-20 -93.96 -19.83 20.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.03 156.9 25.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.726 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -116.61 127.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 110.541 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.18 106.55 9.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.623 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.1 t -159.84 -179.08 7.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.639 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.29 -15.27 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.414 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.0 tp -37.56 123.77 1.01 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.533 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.16 156.38 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.627 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.652 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.2 pt -104.98 148.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.264 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.0 p -150.26 152.6 34.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.722 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.11 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.63 -39.62 71.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.708 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.7 mtt180 -68.73 -37.74 79.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -37.56 75.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.931 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.66 67.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.12 -51.73 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.617 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -138.52 -168.34 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.139 0.495 . . . . 0.0 110.416 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.03 147.04 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.558 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.4 m-85 -130.07 150.23 51.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.57 -151.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.479 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.3 m-20 42.97 19.26 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.21 120.49 0.11 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.4 mt -77.19 -70.01 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.778 -178.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.0 p90 -149.38 166.35 29.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.589 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.29 122.32 27.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.37 68.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.79 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.08 -104.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.57 165.86 31.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.624 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.68 146.7 23.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 0.0 110.473 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.6 135.68 42.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.411 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.78 110.36 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.31 164.97 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.5 -27.61 39.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.38 -41.71 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.359 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.1 t -102.38 122.0 43.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.236 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.49 109.19 19.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.411 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.37 129.61 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.06 159.15 33.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.555 179.93 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.453 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.39 89.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 111.908 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -168.88 140.35 2.53 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.511 0.507 . . . . 0.0 110.811 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.47 -32.63 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.324 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.3 tp10 -56.74 -62.85 1.45 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.443 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.64 -22.08 31.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.965 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.63 -27.26 58.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.334 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -55.08 132.96 48.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.449 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.14 -16.52 32.96 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.98 151.81 22.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 110.449 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.65 135.59 38.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.997 0.427 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -126.87 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.65 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.54 14.29 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.96 161.62 40.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.065 0.459 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.0 tp -92.71 118.33 30.95 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.56 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -52.02 157.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.1 50.64 50.43 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.7 p -149.55 168.74 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.889 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 81.8 p -73.67 -26.53 60.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.391 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.68 -55.36 34.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.99 -54.36 47.61 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.549 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.52 -51.03 71.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.2 t80 -62.21 -43.82 97.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 0.0 110.398 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.34 97.9 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.32 -14.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.44 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.703 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.37 -50.93 16.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.008 0.432 . . . . 0.0 111.545 -178.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.26 12.81 35.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.183 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.07 -55.5 0.46 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.375 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.35 -10.21 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.797 2.331 . . . . 0.0 111.993 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.76 -8.86 59.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.18 33.33 36.3 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.41 137.89 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.963 0.411 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.58 129.71 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.299 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.08 137.97 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.857 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.34 133.23 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 109.998 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.37 127.98 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.02 153.78 25.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -106.84 6.51 29.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.69 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.5 tp60 -66.18 -45.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.472 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.04 -23.74 63.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.471 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.58 -36.63 84.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.523 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.97 -46.95 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.117 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.6 m-85 -64.21 -37.69 88.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.297 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.98 -42.49 98.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.71 -43.54 93.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.038 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.7 tp -58.84 -48.34 81.69 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.38 -22.47 66.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.149 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.04 -17.81 25.64 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.577 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 12.11 73.03 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.97 -17.61 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.7 pt -127.37 136.5 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.83 -28.36 62.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.35 155.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.52 50.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.91 0.386 . . . . 0.0 110.04 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.83 102.9 14.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.149 0.499 . . . . 0.0 110.656 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.19 165.17 24.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.396 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.466 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.39 152.27 40.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.561 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.19 -54.18 28.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.9 t -60.31 -49.18 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.456 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.87 88.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.811 0.338 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.18 -63.21 1.21 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.427 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -58.69 -47.26 85.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.67 -37.58 29.16 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.057 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.81 -66.47 0.56 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.8 t80 -40.2 -71.04 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.619 0.247 . . . . 0.0 111.21 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.21 -39.94 92.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.87 -2.69 0.42 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.505 0.669 . . . . 0.0 110.477 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 177' ' ' VAL . 32.9 mt-30 -124.42 141.7 38.33 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.885 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.89 -15.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.835 2.357 . . . . 0.0 112.275 179.139 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.2 t -63.08 -42.75 97.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.9 80.69 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.93 -41.55 96.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.307 . . . . 0.0 110.404 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 58.9 m-20 -65.27 -35.08 79.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.745 179.184 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.3 m-85 -156.73 143.2 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.737 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.93 99.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 110.725 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.19 167.55 28.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.631 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.14 55.44 3.1 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.42 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.8 135.05 35.27 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.467 2.111 . . . . 0.0 111.933 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.2 p -124.66 -108.33 0.33 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.505 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.83 165.17 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.239 -179.367 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.65 155.91 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.146 0.903 . . . . 0.0 110.646 179.197 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.26 118.59 23.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.812 178.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.2 mp0 -72.05 -18.53 61.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.92 -32.1 73.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.524 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.8 mt -60.97 -44.38 97.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.767 -178.135 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -114.22 8.55 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.751 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.13 -154.79 51.12 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.652 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.7 p -70.72 -25.51 26.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.825 0.345 . . . . 0.0 110.508 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.13 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -132.06 160.05 37.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 110.413 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.39 24.6 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.78 32.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.89 111.62 3.91 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -120.89 160.33 23.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.226 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.71 148.93 25.23 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.612 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.06 -48.87 64.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.637 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.06 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -72.17 51.96 0.24 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -64.42 -45.92 85.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.231 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.72 -47.04 33.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.26 -43.84 97.91 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.461 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.6 -42.87 99.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.88 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.56 -37.5 73.23 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.52 -77.4 0.11 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.006 HD21 HD11 ' A' ' 44' ' ' ILE . 85.4 mt -28.85 -45.66 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.815 0.34 . . . . 0.0 110.489 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.4 m-20 -63.57 -45.33 90.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.689 178.048 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.44 -43.63 98.53 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.45 93.47 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.105 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.2 -43.42 98.91 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.063 0.459 . . . . 0.0 110.064 179.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.38 92.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.089 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.91 -42.91 97.28 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.825 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.77 -38.41 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.85 -38.83 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.46 92.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.27 0.54 56.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.59 20.09 67.63 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.4 m -58.07 -46.26 85.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.6 t80 -63.53 -57.51 9.95 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.453 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.91 -41.73 78.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -48.53 80.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -179.471 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.75 -41.79 98.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.469 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.2 -49.81 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.68 -35.38 72.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.426 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.64 -51.07 30.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.461 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.7 m-85 -62.19 -45.92 91.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.593 179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.6 m-85 -154.39 155.52 35.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.443 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 46.2 p-10 -98.05 101.68 13.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.497 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -158.16 -165.24 1.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.425 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -122.89 110.02 14.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.5 m -63.57 -40.2 88.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.415 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.7 m-85 -58.86 -42.96 90.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.257 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.24 -36.51 93.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.684 0 CA-C-O 117.872 -1.515 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.22 164.18 62.9 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.46 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.573 2.182 . . . . 0.0 112.279 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.51 -40.94 89.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -138.17 139.12 39.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.406 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.46 121.44 61.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.0 110.649 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.08 118.87 32.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.18 0.514 . . . . 0.0 110.176 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.56 138.44 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.516 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.47 105.71 2.2 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.0 m -129.15 120.44 25.86 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 122.707 -0.29 . . . . 0.0 111.136 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 11.3 t0 -114.26 92.95 29.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.081 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.22 134.33 60.04 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.396 2.064 . . . . 0.0 112.105 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.3 p -141.73 -20.19 0.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.6 m-85 -123.46 98.95 6.08 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.701 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.09 -61.45 0.22 Allowed Pre-proline 0 C--O 1.218 -0.553 0 CA-C-O 121.38 0.61 . . . . 0.0 110.983 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.729 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.3 Cg_endo -49.31 -40.56 43.54 Favored 'Trans proline' 0 C--N 1.296 -2.206 0 C-N-CA 122.217 1.945 . . . . 0.0 112.244 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.0 t80 -78.24 -43.1 29.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.053 0.454 . . . . 0.0 110.987 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.671 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.2 mt-10 -149.31 -153.98 0.53 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.989 -178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.84 177.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.042 0.449 . . . . 0.0 110.415 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.51 144.62 46.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.436 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.91 134.33 39.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.669 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -64.6 -19.16 65.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.534 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.87 -6.23 53.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.42 -8.25 56.75 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.38 158.9 25.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.979 0.418 . . . . 0.0 110.469 179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.3 mt -112.32 131.33 55.58 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.961 0.41 . . . . 0.0 110.462 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.686 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.0 151.37 32.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.296 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.08 151.28 6.53 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.65 -42.04 87.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.808 0.337 . . . . 0.0 110.912 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 -69.68 -28.56 65.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.128 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -67.71 -40.97 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.875 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -60.99 -37.21 81.69 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.766 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.9 -45.29 86.54 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.11 -48.46 78.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.017 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.18 -54.56 34.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.372 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.31 -39.95 61.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.269 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.66 -41.85 78.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.02 0.438 . . . . 0.0 110.64 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.0 m -53.47 -45.18 69.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.11 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.02 -46.93 82.27 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -60.08 -42.08 93.85 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.132 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.908 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -75.26 -17.41 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.81 53.23 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.439 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.29 171.73 14.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.3 142.86 27.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.0 m -117.71 131.37 56.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.785 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.29 126.89 43.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.39 179.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -93.72 134.72 35.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.637 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.2 127.78 65.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.45 138.1 57.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.3 p30 175.73 130.9 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 57' ' ' ALA . 46.3 Cg_endo -67.74 144.95 67.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.74 2.293 . . . . 0.0 112.521 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.877 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.33 -55.62 2.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.22 -26.63 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.85 -20.95 19.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.269 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.877 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -63.87 -42.34 97.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.17 -56.95 26.44 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.772 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -55.63 -42.46 67.41 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.6 2.2 . . . . 0.0 111.178 177.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -58.71 -44.98 90.53 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.919 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.652 HD21 ' HG3' ' A' ' 203' ' ' ARG . 59.5 tp -58.86 -44.04 90.96 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.35 -40.69 96.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.88 9.91 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.24 12.21 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.43 -35.69 81.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -122.2 152.97 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.297 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.21 -22.21 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.406 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.55 156.05 27.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.85 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -114.82 128.85 71.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.117 0.484 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.482 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.21 106.74 8.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.389 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.717 ' OG ' HD21 ' A' ' 55' ' ' LEU . 38.0 t -159.55 178.66 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.93 -15.59 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.362 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.631 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.7 tp -34.99 124.28 0.57 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.889 0.376 . . . . 0.0 110.503 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.83 154.04 26.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.703 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.634 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.8 pt -104.74 148.43 9.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.335 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.1 152.06 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.856 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.97 -47.06 52.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.416 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.49 -39.85 70.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.692 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.631 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.77 -38.01 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.75 -38.94 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.45 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.094 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.57 -50.57 8.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.5 pt -139.38 -168.33 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.185 0.517 . . . . 0.0 110.466 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.42 147.79 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.47 . . . . 0.0 111.061 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.0 m-85 -130.07 150.05 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.57 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.32 -153.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.558 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.8 m-20 41.27 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.68 0.2 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.364 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.428 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 59.1 mt -75.11 -68.79 0.52 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -178.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.75 167.59 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.67 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.237 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.465 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.7 68.25 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.59 -104.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.1 165.76 33.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.17 146.26 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.453 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.8 mt -100.85 135.95 41.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.408 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.9 t -122.66 110.61 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.28 164.4 34.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.47 148.68 24.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.003 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.02 -28.56 57.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.199 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -58.93 -41.66 87.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.319 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -101.84 121.66 42.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.43 110.07 20.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.22 129.45 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.702 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -106.52 154.12 40.13 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.666 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.54 91.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.771 2.314 . . . . 0.0 111.711 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -170.64 143.39 2.17 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.589 0.556 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.84 -33.27 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.072 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.36 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -55.86 -22.2 24.08 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.094 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 mt -76.2 -25.9 55.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.229 179.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.81 133.69 47.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.407 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.22 -16.58 28.09 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.15 151.27 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.016 0.436 . . . . 0.0 110.373 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -95.53 135.17 37.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.377 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -127.15 136.72 59.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.61 138.47 14.29 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -130.77 161.68 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.071 0.462 . . . . 0.0 110.338 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.67 117.7 30.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.496 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.78 157.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.59 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.65 50.68 52.87 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.78 168.76 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 0.0 110.864 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.452 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.0 p -73.17 -27.49 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.2 -55.58 32.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.55 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -56.57 -55.03 38.94 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.63 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.15 -51.03 71.32 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.735 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.4 t80 -62.11 -43.93 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.123 0.487 . . . . 0.0 110.496 179.227 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.73 -44.58 97.72 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.24 -14.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.896 0.379 . . . . 0.0 110.787 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.37 -34.39 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.717 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.51 -50.62 17.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 0.0 111.617 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.96 12.17 36.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.46 -55.55 0.49 Allowed Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.37 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 55.9 Cg_endo -72.04 -10.48 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.769 2.312 . . . . 0.0 111.991 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.59 -9.29 59.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.461 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.23 37.14 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.29 137.84 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.41 129.91 34.86 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.63 138.24 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.03 133.54 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.072 0.463 . . . . 0.0 109.991 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.91 127.08 42.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.65 153.19 25.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.051 0.453 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.97 7.23 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.95 130.42 5.93 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.411 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.1 tp60 -66.06 -45.82 80.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.425 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.77 -23.4 62.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.564 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.463 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -37.13 86.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.516 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.82 -46.64 88.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.186 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.507 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.9 m-85 -64.58 -37.7 88.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.322 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.88 -42.01 97.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.058 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.24 -43.32 91.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.995 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.585 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.9 tp -58.97 -47.93 83.36 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.046 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.6 m -62.9 -22.42 66.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.44 25.13 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.66 72.28 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.75 -17.91 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.0 pt -126.9 135.78 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.45 -27.65 62.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.296 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.74 155.9 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.79 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.96 137.03 50.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -85.85 103.4 14.56 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.347 0.594 . . . . 0.0 110.851 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.7 tt0 -132.93 165.31 24.96 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.372 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.477 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -72.62 153.15 41.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 110.563 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -66.64 -54.86 18.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.361 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' CG ' ' A' ' 91' ' ' TYR . 75.6 t -60.23 -48.95 86.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.689 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.98 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.774 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.51 -63.01 1.24 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.662 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.0 m -59.55 -48.0 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.41 -37.71 17.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.07 -65.86 0.55 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.664 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.7 t80 -40.58 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 111.236 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.3 mt -61.43 -40.22 93.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 -179.146 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.82 -3.04 0.45 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.451 0.643 . . . . 0.0 110.521 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 173' ' ' LEU . 36.0 mt-30 -122.86 149.4 56.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.08 -21.1 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.823 2.349 . . . . 0.0 112.182 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.98 -42.75 94.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.643 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.42 -33.27 85.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.4 -41.34 93.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.313 . . . . 0.0 110.464 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.4 m-20 -65.67 -33.23 75.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.299 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.37 142.64 18.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.42 99.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.21 167.22 29.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.716 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.32 56.38 2.69 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.22 -118.89 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.52 135.55 33.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.462 2.108 . . . . 0.0 111.923 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.7 p -125.43 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.566 -179.024 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.11 164.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 154.26 155.86 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.918 0.761 . . . . 0.0 110.641 179.216 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.06 117.19 22.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.857 179.113 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -71.2 -18.85 62.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.79 -32.43 73.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.555 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.485 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -61.05 -44.48 97.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 -178.056 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -114.01 9.3 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.728 179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.2 -154.3 51.74 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.634 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.38 -25.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 110.488 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.22 -124.24 1.32 Allowed Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.9 p -129.42 156.4 44.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.257 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.73 -169.43 30.31 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -94.48 137.51 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.963 0.411 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.47 108.09 3.26 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.2 mt -123.02 159.26 28.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.023 0.44 . . . . 0.0 110.114 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.652 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.9 mtm180 -86.94 149.75 24.57 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.91 -48.09 64.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.515 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -38.46 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.899 0.381 . . . . 0.0 110.733 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.69 52.11 0.21 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.642 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.57 -44.76 89.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.1 -47.33 29.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.32 -44.07 97.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.421 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.22 -43.06 99.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.16 -36.36 70.67 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.26 -77.65 0.11 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 44' ' ' ILE . 97.2 mt -28.31 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.335 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -64.22 -44.91 90.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.616 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.1 -43.69 98.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.951 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.01 -38.99 93.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.038 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.35 -43.72 98.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 109.903 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.56 93.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -43.06 97.83 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.2 mtp -57.04 -37.94 72.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.08 -39.01 75.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 110.337 178.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.69 94.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.6 p-10 -89.2 1.53 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.73 20.42 64.04 Favored Glycine 0 C--O 1.226 -0.382 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 79.7 m -58.26 -45.99 86.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.428 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.4 t80 -63.84 -58.09 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.396 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.67 -41.55 77.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.78 -48.37 81.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.2 -41.59 98.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.312 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.69 -50.35 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.597 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.34 -35.17 71.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -71.11 -50.92 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.598 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.4 m-85 -62.0 -45.56 93.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.47 155.84 35.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.42 97.94 9.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -155.49 -166.24 2.19 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.42 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.0 t0 -123.22 111.06 16.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.59 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 239' ' ' TYR . 22.4 m -63.54 -40.59 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.9 m-85 -58.61 -42.86 89.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.36 -37.19 94.45 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.628 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.955 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.4 164.38 61.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.744 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.71 143.38 99.39 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 122.655 2.237 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.4 -40.7 89.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.597 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.54 141.9 37.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -109.57 127.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -102.5 119.69 39.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.093 0.473 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -113.69 138.56 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.292 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.78 100.31 1.57 Allowed Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -123.79 119.01 28.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.673 -0.31 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 19.5 t70 -113.16 92.34 21.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.016 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.86 133.66 55.59 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.42 2.08 . . . . 0.0 112.13 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -140.79 -20.11 0.82 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.774 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.1 m-85 -123.36 98.84 6.04 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.537 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.727 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.14 -61.34 0.22 Allowed Pre-proline 0 C--O 1.216 -0.685 0 CA-C-O 121.771 0.796 . . . . 0.0 111.138 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.727 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.54 -40.36 45.66 Favored 'Trans proline' 0 C--N 1.288 -2.606 0 C-N-CA 122.469 2.112 . . . . 0.0 112.256 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -78.39 -42.95 28.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.0 0.428 . . . . 0.0 110.91 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.7 mt-10 -149.54 -154.63 0.57 Allowed 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.116 -178.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 162.24 177.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.087 0.47 . . . . 0.0 110.237 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.41 144.05 46.31 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.388 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -95.04 134.6 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.632 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -64.71 -18.89 65.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.527 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.48 -6.47 55.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.93 -8.32 55.84 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.16 158.49 26.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.981 0.42 . . . . 0.0 110.476 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.9 mt -112.44 131.91 55.32 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.941 0.4 . . . . 0.0 110.385 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -134.15 151.61 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.97 0.414 . . . . 0.0 110.323 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.04 151.74 6.73 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -58.85 -42.13 88.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.582 -0.364 . . . . 0.0 111.055 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 -69.1 -28.39 66.45 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.353 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.2 mt -68.0 -40.67 83.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.041 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -60.81 -37.56 82.41 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.88 -178.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.8 -45.0 88.08 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.14 -48.15 79.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.825 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.01 -54.49 34.54 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.323 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.58 -39.59 61.74 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.026 0.441 . . . . 0.0 110.393 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.07 -42.02 76.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.8 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.01 -44.14 70.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.041 -179.182 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.92 -47.56 80.06 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.973 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.56 -41.78 90.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.111 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.926 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.68 -18.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.4 m-20 60.5 52.71 4.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.188 0.518 . . . . 0.0 110.623 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.8 p -146.1 170.75 16.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.25 140.75 29.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -116.3 130.12 56.62 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.69 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.14 127.49 44.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.396 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -94.73 136.36 35.14 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.66 128.58 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 110.304 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.01 139.34 58.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.79 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.39 130.07 0.1 Allowed Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.519 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.0 Cg_endo -67.95 146.73 72.43 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.743 2.295 . . . . 0.0 112.514 -179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.909 HD23 HD12 ' A' ' 58' ' ' LEU . 81.7 mt -41.05 -55.92 2.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -48.06 -26.76 1.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.251 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.94 -20.3 19.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.252 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.909 HD12 HD23 ' A' ' 55' ' ' LEU . 86.5 mt -65.26 -42.36 93.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.694 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.35 -57.27 26.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 123.801 0.688 . . . . 0.0 109.516 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.694 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.9 Cg_exo -55.02 -43.95 54.4 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.571 2.181 . . . . 0.0 111.083 177.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -58.65 -44.55 90.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.575 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.33 -44.24 88.61 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.78 -40.24 94.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.983 0.42 . . . . 0.0 110.488 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.84 11.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.937 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.11 76.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 178.872 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.18 152.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.18 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -94.07 -20.23 20.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 155.87 26.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.76 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 58' ' ' LEU . 97.0 mt -116.43 127.89 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 110.443 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -128.16 105.64 8.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 110.326 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.666 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.2 t -158.66 179.24 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.19 -14.93 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.394 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 39.4 tp -35.98 124.22 0.73 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.47 154.11 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.643 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -104.51 148.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.207 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -149.8 152.63 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.818 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.28 -47.38 55.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.032 0.444 . . . . 0.0 110.548 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.44 -39.93 70.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.5 -37.83 80.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.21 -37.95 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.798 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.01 -27.73 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.094 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.13 -50.73 8.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.976 0.417 . . . . 0.0 110.774 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.67 -168.6 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.165 0.507 . . . . 0.0 110.383 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.33 147.28 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.119 0.485 . . . . 0.0 111.059 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.544 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.93 149.85 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.81 -152.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.47 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.3 m-20 41.72 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.019 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.22 121.41 0.18 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.385 0.428 . . . . 0.0 110.433 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.42 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.0 mt -75.44 -68.81 0.53 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.81 -178.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.443 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.4 p90 -150.32 167.45 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.66 123.58 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.176 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.23 68.27 0.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.775 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.16 -104.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.442 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -159.64 165.83 31.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.11 146.35 22.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.423 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.1 mt -101.38 136.04 41.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.418 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.72 111.0 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.26 165.2 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.4 23.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.64 -27.77 42.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -59.13 -41.87 89.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.249 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.6 122.18 43.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.019 0.437 . . . . 0.0 110.154 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.81 109.34 19.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.395 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.97 129.78 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.641 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.82 159.07 33.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.575 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.9 Cg_endo -59.79 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.789 2.326 . . . . 0.0 111.93 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -169.02 141.2 2.6 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.596 0.56 . . . . 0.0 110.858 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.38 -33.24 61.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.24 -62.65 1.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.333 -178.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.58 -22.11 31.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.066 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -75.53 -26.88 58.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 178.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.9 133.29 47.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 -179.093 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.77 -16.92 28.95 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.2 151.46 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.497 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.22 135.56 37.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.273 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.27 136.73 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.47 138.86 14.47 Favored Glycine 0 N--CA 1.462 0.383 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.92 161.68 40.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.536 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.5 tp -92.56 117.72 30.26 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.696 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.76 157.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.17 50.53 50.75 Favored Glycine 0 N--CA 1.463 0.436 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -149.6 168.79 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.457 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.1 p -73.69 -26.29 60.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.435 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.93 -55.45 32.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.431 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -56.94 -54.35 47.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.583 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.3 -51.12 70.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.641 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.8 t80 -62.31 -43.82 97.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.144 0.497 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.78 -44.41 97.92 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.3 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.835 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.65 2.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.34 -50.92 16.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.698 -178.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -99.0 12.43 36.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.72 -55.54 0.48 Allowed Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.16 25.29 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.737 2.291 . . . . 0.0 111.933 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.93 -8.85 59.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 -179.123 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.32 36.87 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.31 137.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.01 0.434 . . . . 0.0 110.565 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.4 129.75 34.92 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.1 pt -126.19 138.05 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.5 t -123.16 133.28 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.082 0.467 . . . . 0.0 109.899 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.36 127.59 43.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.17 153.76 25.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.265 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -107.05 7.01 29.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.67 130.28 5.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -65.74 -45.81 81.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.07 -23.91 63.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.49 -36.75 85.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.13 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.42 -38.22 90.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.13 -42.5 98.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.164 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.47 -45.95 88.45 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.4 tp -58.46 -48.14 81.74 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.161 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.32 -23.31 67.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.935 0.398 . . . . 0.0 110.066 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.89 -18.79 25.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.45 11.09 69.52 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.24 -18.31 63.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 153' ' ' LEU . 38.3 pt -128.69 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.083 0.468 . . . . 0.0 110.443 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.0 -27.35 61.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.485 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.92 155.88 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.583 0.552 . . . . 0.0 110.91 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.94 137.09 50.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.987 0.422 . . . . 0.0 109.935 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.42 103.27 14.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.238 0.542 . . . . 0.0 110.798 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.3 tt0 -132.47 165.51 24.14 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.341 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.0 152.03 41.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.565 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.33 -54.33 25.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.4 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.443 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.6 t -60.38 -48.83 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.417 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.72 88.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.3 -62.99 1.26 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.507 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.1 m -58.87 -47.38 85.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.88 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -49.16 -37.85 23.62 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.067 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.11 -65.93 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.0 t80 -40.27 -71.15 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.824 -0.221 . . . . 0.0 111.245 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.06 -40.03 92.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.948 -179.452 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.92 -2.28 0.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.613 0.721 . . . . 0.0 110.323 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 177' ' ' VAL . 36.6 mt-30 -124.25 141.4 37.29 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.905 -0.497 . . . . 0.0 110.8 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.75 -16.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.843 2.362 . . . . 0.0 112.409 179.049 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 72.1 t -62.88 -43.0 98.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.619 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.85 82.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.112 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.91 -41.39 96.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.73 0.3 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.8 m-20 -65.58 -34.52 78.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.04 142.74 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.64 99.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.0 110.757 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.7 m-85 -159.07 166.82 30.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.668 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.04 56.36 2.9 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.06 -117.24 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.59 135.68 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.419 2.079 . . . . 0.0 111.984 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.9 p -124.7 -108.33 0.33 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.77 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.21 165.08 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 155.69 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 124.461 1.101 . . . . 0.0 110.69 178.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.75 118.24 22.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.87 -18.71 62.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.47 74.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.8 mt -60.92 -44.55 97.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.685 -177.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.457 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -114.24 10.05 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.758 178.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.45 51.47 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.643 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.5 p -70.85 -25.09 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.486 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 159.91 -123.97 1.29 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -129.51 156.54 43.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.76 -169.59 30.55 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -94.88 138.73 32.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.945 0.402 . . . . 0.0 110.607 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.39 107.17 3.16 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.62 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.7 mt -119.83 159.98 23.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.923 0.392 . . . . 0.0 110.143 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.76 149.11 24.39 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-O 120.833 0.349 . . . . 0.0 110.654 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.4 -48.5 65.65 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.549 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -39.76 -23.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.55 52.21 0.2 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.799 0.333 . . . . 0.0 110.661 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.33 -45.78 86.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.99 -47.12 30.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.281 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.08 -43.99 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.48 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.52 -36.98 72.27 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.94 -77.22 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.926 HD21 HD11 ' A' ' 44' ' ' ILE . 89.0 mt -29.26 -45.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -44.96 91.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.728 177.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.73 -43.79 98.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.897 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.29 93.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.05 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.18 -43.47 98.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.194 0.521 . . . . 0.0 110.032 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.33 93.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.021 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.58 -43.19 97.72 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.92 -38.28 72.65 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.95 -38.84 76.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.673 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -89.33 0.98 56.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.99 20.45 66.81 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -58.33 -45.94 87.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -63.99 -57.6 9.21 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.436 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.04 -41.44 78.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.169 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.56 -48.54 80.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.518 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.77 -41.83 98.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 110.546 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.71 -50.03 75.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.66 -35.04 71.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.409 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.83 -50.87 30.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.55 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 40.2 m-85 -62.25 -45.93 91.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.76 155.61 34.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.4 p-10 -97.35 99.05 10.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.76 -166.03 2.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.08 110.81 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.9 m -63.65 -40.44 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.415 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.6 m-85 -59.04 -42.59 90.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.305 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.2 94.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.607 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 164.25 56.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.93 143.27 99.31 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.574 2.183 . . . . 0.0 112.297 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.34 -40.71 90.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -139.13 139.95 37.79 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.0 mt -107.81 120.69 59.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 110.681 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.06 118.78 32.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.145 0.498 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -112.42 138.56 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.01 101.42 1.51 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -124.68 120.71 32.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 122.717 -0.284 . . . . 0.0 111.142 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t70 -114.07 92.73 27.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.194 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.35 134.59 61.87 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.417 2.078 . . . . 0.0 112.105 179.183 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 p -142.37 -19.78 0.7 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.771 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.3 m-85 -124.02 99.05 6.06 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.629 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.11 -61.43 0.22 Allowed Pre-proline 0 C--O 1.217 -0.614 0 CA-C-O 121.528 0.68 . . . . 0.0 111.067 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.729 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.53 -39.85 45.62 Favored 'Trans proline' 0 C--N 1.294 -2.303 0 C-N-CA 122.297 1.998 . . . . 0.0 112.293 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -78.88 -42.72 26.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.977 0.418 . . . . 0.0 110.992 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.66 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.69 -154.61 0.56 Allowed 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.043 -178.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 162.14 177.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.041 0.448 . . . . 0.0 110.336 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.56 140.87 45.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.382 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -92.64 137.11 32.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.661 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.4 p -64.98 -19.28 65.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.564 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.75 -6.58 56.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.451 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.71 -8.73 56.58 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -78.98 156.93 28.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 110.485 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.5 mt -111.92 133.57 54.03 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.967 0.413 . . . . 0.0 110.385 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.698 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.3 p -134.15 151.45 32.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.37 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.417 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.19 151.15 6.49 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -58.58 -41.86 86.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.838 0.352 . . . . 0.0 110.989 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.6 t0 -69.58 -28.34 65.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.245 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.2 mt -67.85 -40.79 84.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.983 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -60.81 -37.38 81.77 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.891 -178.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.72 -44.49 85.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.89 -47.91 81.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.035 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.95 -54.4 39.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.347 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.35 -38.85 59.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.943 0.401 . . . . 0.0 110.311 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.29 -41.77 76.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.46 . . . . 0.0 110.556 178.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 51.0 m -53.79 -44.93 70.54 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.033 -179.364 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.25 -47.31 80.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.037 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.8 -42.15 92.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.201 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.945 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.32 -17.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.09 52.84 3.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.492 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.54 170.91 15.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.36 142.43 27.74 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.075 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 m -117.34 131.87 56.71 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.575 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.9 m -128.75 128.12 43.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -95.19 135.57 36.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.478 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.8 129.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.427 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.75 136.65 56.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.777 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 176.41 131.42 0.18 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.49 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.8 Cg_endo -68.28 144.81 63.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.691 2.261 . . . . 0.0 112.536 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.92 HD23 HD12 ' A' ' 58' ' ' LEU . 79.1 mt -40.29 -55.43 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.21 -26.27 1.87 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.163 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.57 -21.05 18.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.92 HD12 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -64.14 -42.44 96.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.88 179.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.716 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.68 -57.12 26.68 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 123.738 0.648 . . . . 0.0 109.67 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.716 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.14 -42.27 70.46 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.612 2.208 . . . . 0.0 111.267 177.237 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -45.06 90.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.944 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.6 tp -58.94 -44.08 91.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.5 -40.66 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.955 0.407 . . . . 0.0 110.456 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.86 10.38 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.84 12.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.5 -35.16 79.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.498 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -122.9 153.54 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.212 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.54 -21.53 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.285 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.3 156.72 26.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.67 129.06 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -130.55 106.7 8.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.703 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.3 t -158.96 178.69 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -65.33 -15.16 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -35.56 124.84 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.573 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.54 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -83.0 155.0 24.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.662 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.638 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.0 pt -105.04 149.2 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -149.37 152.33 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.829 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.95 -47.48 52.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.544 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.65 -39.53 71.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.88 -37.86 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -57.99 -38.62 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.868 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.81 -27.59 66.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.105 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.26 -51.22 7.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -138.5 -168.23 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 110.501 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.03 147.71 29.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 76' ' ' ILE . 75.4 m-85 -130.09 150.08 51.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.653 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.73 -152.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.498 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 97.2 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.948 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.7 mttt -29.32 121.02 0.15 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.336 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.4 mt -76.64 -69.53 0.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.842 -178.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.448 ' CG ' HG21 ' A' ' 166' ' ' VAL . 40.9 p90 -149.47 166.43 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.614 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.46 122.75 28.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.38 69.46 0.91 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.813 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.51 -104.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.393 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.17 165.77 32.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.56 145.91 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.125 0.488 . . . . 0.0 110.439 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.89 136.26 41.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.99 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.19 165.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.996 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.48 23.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.96 -28.35 56.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.04 -41.7 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.301 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.13 122.19 43.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.06 109.9 19.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.87 129.59 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.656 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -108.28 154.3 41.44 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 110.679 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.24 92.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.756 2.304 . . . . 0.0 111.649 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.02 144.02 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.669 0.606 . . . . 0.0 110.773 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.55 -33.7 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.162 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 108' ' ' THR . 47.7 tp10 -57.35 -62.63 1.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.263 -178.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.37 -21.93 27.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.037 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.0 -26.2 56.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.309 179.162 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.77 133.7 47.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.382 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.08 -16.78 26.36 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -85.92 151.44 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.494 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -95.86 135.39 37.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.25 136.66 60.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.658 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.5 138.53 14.3 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.9 161.66 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.2 tp -92.43 117.42 29.9 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.599 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.73 158.04 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.47 50.48 55.02 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -149.62 168.95 22.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.928 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.458 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 67.2 p -73.24 -27.58 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.13 -55.36 34.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.67 -54.82 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.695 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.37 -51.04 71.18 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.74 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.2 -43.83 97.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.44 97.81 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.43 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.0 110.778 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.23 -34.46 2.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.35 -50.56 18.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.473 . . . . 0.0 111.649 -178.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.27 12.59 35.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.83 -55.53 0.47 Allowed Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.413 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.29 -10.31 25.49 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.778 2.319 . . . . 0.0 111.934 -179.494 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.65 -8.88 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.14 37.63 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.28 138.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.85 130.19 34.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.0 138.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.14 133.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 109.99 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.11 127.3 42.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.83 153.7 25.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.33 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.24 7.13 29.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.41 130.47 6.03 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.03 -45.92 79.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.441 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.21 62.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.572 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.87 -36.78 85.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.536 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.03 -47.13 86.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.159 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.1 m-85 -63.74 -37.91 89.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.253 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.19 -42.4 98.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.096 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.73 -45.21 90.96 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.981 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.8 tp -58.69 -47.94 82.82 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.114 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.31 -22.96 67.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.21 -18.66 25.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.641 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.65 69.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.92 -18.13 63.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.7 pt -127.87 136.96 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.66 -27.62 62.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.457 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.8 155.89 1.74 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.817 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.92 137.12 50.19 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 109.991 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.67 103.05 14.13 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.237 0.541 . . . . 0.0 110.817 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.39 165.2 24.79 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.458 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.0 152.6 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.05 -54.37 26.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.332 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.448 HG21 ' CG ' ' A' ' 91' ' ' TYR . 70.8 t -60.24 -49.13 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.439 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.93 87.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.828 0.347 . . . . 0.0 110.759 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.37 -63.35 1.16 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.456 ' OG ' HD12 ' A' ' 173' ' ' LEU . 72.5 m -59.15 -47.88 83.67 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.927 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.01 -38.19 22.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.46 -65.73 0.56 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.676 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -70.94 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.456 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.8 mt -61.06 -39.88 91.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.192 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.65 -2.72 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.462 0.649 . . . . 0.0 110.399 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 173' ' ' LEU . 34.8 mt-30 -124.14 142.21 39.26 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.5 -16.47 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.844 2.363 . . . . 0.0 112.32 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 175' ' ' GLN . 73.0 t -62.69 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.586 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.01 82.73 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.75 -41.27 95.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.733 0.302 . . . . 0.0 110.567 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -66.0 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.393 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.6 m-85 -157.07 143.65 18.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.59 100.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 110.757 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.34 167.37 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.72 56.09 2.85 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.53 -117.94 0.01 OUTLIER Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.59 135.29 33.76 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.504 2.136 . . . . 0.0 111.969 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.9 p -125.36 -107.89 0.32 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.574 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.67 165.11 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.51 156.05 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 124.024 0.828 . . . . 0.0 110.696 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.46 117.61 22.61 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.017 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.38 -18.91 62.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.72 -32.28 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.491 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.3 mt -61.0 -44.46 97.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.706 -178.099 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.458 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.2 m-85 -114.07 9.47 17.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.784 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.37 -155.13 52.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.638 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.9 p -70.55 -25.14 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 0.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.72 -125.17 1.41 Allowed Glycine 0 CA--C 1.518 0.272 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.6 p -131.52 159.3 38.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.63 -163.37 25.47 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.4 138.93 34.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.453 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.25 112.05 3.92 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -124.73 160.1 29.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.65 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.7 mtm180 -86.53 149.66 24.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.786 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.95 -48.4 64.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.669 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.4 tp10 -38.15 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.95 52.02 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.604 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -64.76 -44.86 88.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.401 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.16 -47.1 38.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.84 -43.49 98.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.45 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.75 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.43 -36.7 71.71 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.18 -77.31 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.945 HD21 HD11 ' A' ' 44' ' ' ILE . 96.7 mt -28.63 -46.21 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.01 -45.3 89.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.661 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.78 -43.79 98.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.955 178.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.21 93.23 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.024 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.24 -43.54 98.71 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.33 92.86 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.095 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -43.19 96.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -56.68 -38.29 72.02 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.88 76.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.98 94.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 21.4 p-10 -88.65 1.19 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.36 20.32 65.29 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.435 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 72.3 m -58.3 -45.81 87.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.9 t80 -63.89 -58.14 7.67 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.482 179.289 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.86 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.28 -48.63 79.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.0 -41.49 98.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.407 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.43 -50.18 74.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.62 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.89 -35.17 72.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.21 -50.95 27.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.501 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.18 -45.75 92.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.532 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -152.97 154.92 35.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.437 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.6 p-10 -97.06 95.36 7.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.987 0.422 . . . . 0.0 110.567 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.25 -166.67 2.49 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.66 110.33 15.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.5 m -63.64 -40.65 89.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.6 m-85 -56.35 -43.9 79.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -37.6 95.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.681 0 CA-C-O 117.875 -1.514 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.23 61.08 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.676 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.85 143.45 99.37 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.645 2.23 . . . . 0.0 112.299 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.32 -40.35 89.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.91 143.14 36.49 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.456 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.04 128.09 66.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 110.515 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -103.77 118.56 36.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.6 138.4 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.449 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.2 1.61 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.75 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.8 m -123.94 118.32 26.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.713 -0.287 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 24.4 t70 -113.33 92.3 22.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.98 133.99 57.53 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.524 2.149 . . . . 0.0 112.114 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.7 p -141.26 -19.2 0.79 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.768 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.5 m-85 -124.65 99.0 5.96 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.603 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.728 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.23 -61.36 0.23 Allowed Pre-proline 0 C--O 1.219 -0.538 0 CA-C-O 121.541 0.686 . . . . 0.0 111.058 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.728 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.49 -39.69 45.24 Favored 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 122.46 2.107 . . . . 0.0 112.228 -179.305 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.9 t80 -79.29 -42.84 24.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.984 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.3 mt-10 -149.58 -155.31 0.62 Allowed 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.96 -178.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.93 177.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.047 0.451 . . . . 0.0 110.355 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.64 140.16 45.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.403 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.78 137.14 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.619 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -65.04 -19.08 65.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.507 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.51 -5.47 54.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.455 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.92 -9.32 58.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.45 156.81 29.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 110.424 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -112.08 133.9 53.96 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.96 0.409 . . . . 0.0 110.452 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.676 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.56 151.22 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.314 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.96 151.53 6.63 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.58 -42.13 87.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.818 0.342 . . . . 0.0 110.935 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 -70.01 -28.09 65.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.351 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -68.61 -41.01 82.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.097 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.74 -37.63 82.41 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.18 -178.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.19 -44.0 85.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.299 178.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.525 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.82 92.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.069 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.44 -53.67 54.68 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.504 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.26 -37.58 62.25 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.975 0.417 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.52 -42.03 75.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.8 m -54.54 -44.5 72.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.111 -179.388 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.436 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.81 -47.65 80.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.066 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -59.4 -40.96 88.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.98 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -76.56 -17.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.9 52.44 4.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.151 0.501 . . . . 0.0 110.606 -179.238 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.29 169.99 17.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.12 140.66 29.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -116.87 131.32 56.98 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.638 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.42 128.1 43.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.472 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -94.64 136.34 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.511 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.67 128.38 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.8 139.31 58.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.721 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.84 132.3 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.56 145.22 63.48 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.692 2.262 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.929 HD23 HD12 ' A' ' 58' ' ' LEU . 78.5 mt -40.48 -55.94 2.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.72 -26.55 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.117 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.35 19.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.929 HD12 HD23 ' A' ' 55' ' ' LEU . 85.3 mt -65.08 -42.56 94.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.854 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.703 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 mm -61.51 -56.64 31.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.757 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -55.44 -43.51 57.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 122.64 2.227 . . . . 0.0 111.128 177.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -44.36 90.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.848 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.28 -44.46 88.45 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.59 -40.21 95.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 110.446 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.0 11.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.538 -179.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.01 11.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.47 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 178.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.9 pt -124.48 153.28 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.361 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -94.59 -20.0 19.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.21 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.45 156.29 25.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 58' ' ' LEU . 96.9 mt -116.83 127.94 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 110.544 179.589 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.26 106.31 8.94 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.626 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.4 t -159.0 -179.57 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.569 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.56 -15.01 60.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.337 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.645 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -37.58 124.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.531 -179.579 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.09 156.25 23.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.667 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.655 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.7 pt -104.87 148.9 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -150.4 152.75 34.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.22 -47.93 54.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.601 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.52 -39.79 70.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.733 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.645 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.53 -37.63 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.94 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.3 -27.56 67.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.175 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.16 -51.77 7.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 110.574 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.61 -168.55 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.86 147.02 29.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.5 m-85 -129.99 149.96 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.34 -151.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.478 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.6 m-20 42.97 19.34 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.26 120.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.409 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.1 mt -77.04 -69.93 0.49 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 -178.629 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.44 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.4 p90 -149.3 166.26 29.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.584 -179.692 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 121.67 27.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.73 69.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.746 -179.679 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.94 -105.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.31 165.83 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.69 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.6 145.94 21.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 110.5 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.06 136.11 41.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.768 178.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 111.1 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.41 165.12 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.2 148.63 23.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.14 -28.34 57.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.98 -41.88 88.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.325 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.86 121.76 42.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 110.23 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.64 109.61 19.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.464 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.84 129.81 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.636 179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.71 154.15 41.87 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.654 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.26 92.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.824 2.349 . . . . 0.0 111.674 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.14 144.31 2.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.635 0.585 . . . . 0.0 110.787 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.26 -33.57 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.281 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.6 -62.39 1.82 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.335 -178.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.31 -22.24 29.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.936 -179.222 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -76.07 -26.14 56.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.84 133.35 47.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.402 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.4 -16.51 29.29 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.59 151.91 23.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.949 0.404 . . . . 0.0 110.408 -179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.38 135.64 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.307 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.04 136.61 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.662 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 139.05 14.54 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.31 161.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 110.35 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.2 tp -92.69 117.24 29.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.62 157.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.635 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.87 50.44 52.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.83 169.26 21.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.316 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.01 -25.9 60.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.9 -55.55 31.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.18 -53.94 52.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.59 -51.16 70.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.578 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.36 -43.71 98.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.384 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.01 -44.66 97.48 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.11 -14.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 0.0 110.75 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.34 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.665 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.63 -50.68 16.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.506 -178.741 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -99.19 12.72 35.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.17 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.24 -55.54 0.45 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.34 -10.3 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.821 2.347 . . . . 0.0 111.98 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.69 -8.7 59.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 -179.095 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.07 33.17 37.17 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.62 138.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.86 130.0 35.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.2 pt -126.43 138.23 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.2 t -123.18 133.16 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 109.992 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.18 127.79 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.804 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.15 153.52 25.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.74 6.55 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.699 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.6 130.43 5.98 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.05 -45.6 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.49 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.09 -23.95 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.7 -36.57 84.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.97 -47.0 86.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.126 -179.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.517 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 58.9 m-85 -63.73 -37.94 89.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.232 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.26 -42.56 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.153 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -63.72 -45.63 89.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.865 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.8 tp -58.46 -48.08 81.92 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.19 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -63.18 -22.79 67.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.91 0.386 . . . . 0.0 110.077 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.6 -18.6 24.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.55 70.01 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.83 -17.92 63.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.588 179.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.1 pt -128.53 137.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.599 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.17 -27.83 61.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.53 155.47 1.79 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.83 137.31 50.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.0 110.029 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.64 102.91 13.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.225 0.536 . . . . 0.0 110.673 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.9 tt0 -132.08 165.1 24.79 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.52 152.45 40.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.0 -54.13 29.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.25 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 91' ' ' TYR . 69.7 t -60.5 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.47 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.95 87.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.77 0.319 . . . . 0.0 110.789 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.34 1.18 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.567 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.445 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.4 m -58.67 -47.2 85.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.798 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.1 -38.25 24.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.066 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.88 -65.43 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.1 t80 -40.51 -71.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.594 0.235 . . . . 0.0 111.23 -178.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.47 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.077 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.53 -2.99 0.39 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.46 0.648 . . . . 0.0 110.448 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.5 mt-30 -124.85 141.2 37.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -43.6 -14.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.858 2.372 . . . . 0.0 112.341 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.2 t -63.23 -42.91 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.553 -179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.75 -32.89 80.63 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.83 -41.6 96.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.725 0.297 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.0 m-20 -65.62 -34.92 79.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.4 m-85 -156.77 143.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.7 pttt -177.03 99.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.733 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.7 m-85 -159.24 167.98 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.37 55.86 3.14 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.13 -117.05 0.01 OUTLIER Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.66 135.04 34.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.483 2.122 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.5 p -125.11 -108.31 0.32 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.506 -179.035 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.57 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.48 155.61 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 124.077 0.861 . . . . 0.0 110.703 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.33 118.31 23.06 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.026 0.441 . . . . 0.0 109.812 179.016 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.94 -18.49 62.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.87 -32.24 73.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.539 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.1 mt -60.84 -44.44 96.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.725 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -113.84 8.22 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.719 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.3 -154.76 50.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.294 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.56 -25.28 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.851 0.358 . . . . 0.0 110.56 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.8 -125.75 1.5 Allowed Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.0 p -132.04 160.08 36.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.43 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.47 -162.59 24.89 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.18 140.92 31.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.615 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.11 111.9 3.97 Favored Glycine 0 CA--C 1.517 0.19 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.7 mt -121.61 160.79 23.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -87.11 148.94 25.01 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.15 -48.82 64.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.629 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -39.82 -23.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.973 0.416 . . . . 0.0 110.719 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.65 52.17 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.759 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.37 -46.29 84.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.182 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.46 -47.07 35.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.2 -43.89 97.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.45 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.56 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.856 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.51 -37.34 72.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.8 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.98 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -29.01 -45.62 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.8 m-20 -63.62 -45.48 90.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.7 98.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.945 178.654 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.36 92.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.152 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -61.19 -43.39 98.95 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.027 0.441 . . . . 0.0 110.063 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.26 92.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.15 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.96 97.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.886 179.283 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.78 -38.47 72.55 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -69.85 -38.81 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.374 178.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.42 92.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.661 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.9 p-10 -88.35 0.4 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.698 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.61 20.38 67.96 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.0 m -58.18 -46.17 86.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.46 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.1 t80 -63.65 -57.43 10.08 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.454 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.68 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.25 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.51 -48.6 80.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.493 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.83 -41.59 97.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.74 76.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.715 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.94 -35.45 73.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.414 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.59 -51.0 31.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.462 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.35 -45.45 93.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -153.74 155.15 35.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.16 99.47 10.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.527 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -156.41 -165.17 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.526 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.74 109.22 13.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.9 m -63.6 -40.35 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.7 m-85 -56.91 -43.7 81.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.83 93.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.708 0 CA-C-O 117.881 -1.51 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.29 164.25 62.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.587 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.91 143.53 99.37 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.564 2.176 . . . . 0.0 112.324 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.38 -41.02 90.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.081 0.467 . . . . 0.0 110.511 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.4 139.07 38.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.388 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.19 121.47 61.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.706 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.91 118.76 31.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 110.13 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -112.4 138.42 41.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 105.47 2.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -129.09 120.2 25.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.136 179.618 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.51 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 5.2 t0 -114.57 92.69 29.69 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.177 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.96 134.73 60.89 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.404 2.069 . . . . 0.0 112.135 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.2 p -142.0 -20.2 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.745 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -123.53 99.14 6.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.697 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.733 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.0 -61.63 0.22 Allowed Pre-proline 0 C--O 1.218 -0.577 0 CA-C-O 121.378 0.609 . . . . 0.0 111.029 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.733 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.25 -40.62 43.06 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 C-N-CA 122.206 1.937 . . . . 0.0 112.256 -179.227 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -78.19 -42.9 30.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.148 0.499 . . . . 0.0 111.025 179.608 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.3 mt-10 -149.74 -153.68 0.51 Allowed 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.966 -178.823 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.74 177.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.078 0.466 . . . . 0.0 110.402 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.57 144.76 46.38 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.4 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -95.8 134.47 38.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.652 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -64.66 -19.02 65.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.529 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.23 -6.11 53.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 -7.76 56.77 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.67 158.77 25.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.447 . . . . 0.0 110.441 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -112.07 131.21 55.56 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.988 0.423 . . . . 0.0 110.469 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.69 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.15 151.4 32.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.304 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.409 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.0 151.43 6.59 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -58.74 -41.8 87.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.909 0.385 . . . . 0.0 110.951 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.7 t0 -69.79 -28.47 65.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 -179.701 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.69 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -67.79 -40.97 84.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.847 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -61.05 -37.21 81.81 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.824 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.99 -45.26 86.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.02 -48.32 78.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.981 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -53.23 -54.47 35.62 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.31 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.48 -39.81 61.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.872 0.367 . . . . 0.0 110.26 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.79 -42.05 77.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.053 0.454 . . . . 0.0 110.53 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.44 -44.91 69.23 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.146 -179.425 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.26 -46.94 81.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.992 179.0 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -60.04 -42.14 93.78 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.216 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.893 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.28 -17.46 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.429 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.85 53.2 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.424 -179.177 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.12 171.51 15.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -89.16 142.69 27.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.03 0.443 . . . . 0.0 109.956 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.54 131.4 56.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -127.54 127.25 43.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.401 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.86 134.68 35.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.08 127.89 66.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.38 138.0 57.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.829 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.51 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.69 130.33 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.6 Cg_endo -67.58 145.07 69.03 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.71 2.273 . . . . 0.0 112.512 -179.186 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.873 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.13 -55.76 2.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.37 -26.37 2.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.857 0.361 . . . . 0.0 111.224 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.19 -20.91 18.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.873 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.75 -42.37 97.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.643 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.721 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.21 -57.0 25.79 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.795 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.3 Cg_exo -55.39 -42.46 68.06 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.681 2.254 . . . . 0.0 111.213 177.274 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.1 m -58.69 -45.08 90.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.906 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 203' ' ' ARG . 62.9 tp -58.88 -44.2 91.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.148 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.26 -40.82 96.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.426 . . . . 0.0 110.424 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.79 9.87 2.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.416 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.21 12.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.991 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.36 -35.52 80.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.503 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.34 153.14 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.287 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.28 -22.18 19.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.462 -179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.62 156.14 27.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.01 129.01 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.493 . . . . 0.0 110.469 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -131.29 106.72 8.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.714 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.3 t -159.39 178.5 9.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.99 -15.52 62.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.633 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.8 tp -34.98 124.37 0.57 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.596 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.0 154.03 25.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.631 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.74 148.46 9.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.348 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.8 p -149.01 152.2 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.09 53.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.43 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.51 -39.74 70.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.671 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.633 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.8 mtt180 -68.98 -37.94 79.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.819 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -57.9 -39.03 76.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.711 -179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.79 -27.38 66.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.57 -50.77 7.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.046 0.451 . . . . 0.0 110.634 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -139.14 -168.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.1 0.476 . . . . 0.0 110.543 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 76' ' ' ILE . 80.0 m-85 -129.92 150.02 51.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.17 -153.26 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.57 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.7 m-20 41.19 20.14 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.32 0.2 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.324 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 58.5 mt -74.79 -68.51 0.54 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.931 -178.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.52 167.55 26.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.751 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.67 123.62 29.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.184 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.94 68.66 0.83 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.809 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -85.67 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.06 165.63 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.698 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.49 146.09 22.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.79 136.19 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 110.813 178.721 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.86 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.27 164.91 33.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.81 148.56 23.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.93 -28.42 56.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.241 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -58.76 -41.94 87.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.319 -179.374 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.93 121.74 42.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.016 0.436 . . . . 0.0 110.147 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -86.88 109.72 19.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -125.97 129.14 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.718 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -106.44 154.28 39.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.721 179.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.49 90.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.766 2.311 . . . . 0.0 111.628 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -170.87 143.74 2.11 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.587 0.555 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.71 -33.05 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.085 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.3 -62.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.191 -178.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -55.74 -22.14 22.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.43 -25.91 54.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.254 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.71 133.83 47.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.5 -15.56 29.28 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.94 151.52 23.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.6 135.16 37.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.357 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.16 136.59 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.57 138.45 14.27 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.3 t -130.77 161.56 40.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.082 0.468 . . . . 0.0 110.359 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.3 tp -92.41 117.45 29.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.7 158.06 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.608 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.61 50.56 53.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.4 p -149.77 168.9 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.73 0.3 . . . . 0.0 110.9 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.1 p -73.3 -27.54 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.434 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.15 -55.65 31.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.507 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.5 -54.96 39.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.698 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -60.11 -51.16 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.792 -179.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.5 t80 -62.07 -43.96 97.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.591 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.58 -44.39 98.02 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.336 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.8 tt0 -125.23 -34.28 2.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.53 -50.56 17.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.129 0.49 . . . . 0.0 111.673 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.0 12.29 36.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.252 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.66 -55.38 0.48 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.347 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 55.7 Cg_endo -72.2 -10.61 26.03 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.75 2.3 . . . . 0.0 111.965 -179.626 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.44 -9.17 59.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.42 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.93 33.16 37.79 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.24 138.07 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 110.628 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.67 129.84 35.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.28 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.21 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.96 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.5 t -123.0 133.35 69.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.026 0.441 . . . . 0.0 109.981 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.4 43.13 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -110.64 153.37 25.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.01 6.68 29.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.759 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.21 130.17 5.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.418 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.8 -45.87 80.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.715 0.293 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.82 -23.32 62.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.608 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.58 -37.07 86.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.11 0.481 . . . . 0.0 110.537 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.81 -46.82 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.231 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.508 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.5 m-85 -64.48 -37.72 88.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.345 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.97 -42.23 97.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.1 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.84 -43.52 92.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.122 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.583 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.0 tp -59.01 -47.76 84.03 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.023 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.85 -22.57 66.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.025 0.44 . . . . 0.0 110.12 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.63 -18.26 25.43 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.592 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.95 72.18 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.98 -18.03 63.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.606 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.6 pt -127.04 135.92 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.399 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -72.55 -27.82 62.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.313 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.52 155.99 1.88 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.838 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.15 136.71 49.58 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.68 103.48 14.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.281 0.562 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.76 165.25 24.97 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.476 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.84 153.09 41.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.34 -54.65 22.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.401 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.447 HG21 ' CG ' ' A' ' 91' ' ' TYR . 71.4 t -60.07 -49.06 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.705 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.33 -39.06 89.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.797 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.14 1.21 Allowed 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.0 m -59.5 -48.16 82.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.911 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -48.55 -37.74 18.63 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.342 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.75 -66.14 0.56 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.667 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.2 t80 -40.56 -70.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 111.218 -178.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.457 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.7 mt -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.23 -3.03 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.443 0.639 . . . . 0.0 110.499 -179.528 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 173' ' ' LEU . 37.4 mt-30 -122.71 147.09 49.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.853 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.48 -19.64 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.844 2.362 . . . . 0.0 112.228 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.87 -42.8 96.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.672 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.63 -32.97 83.35 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.044 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.57 -41.26 94.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.7 m-20 -65.83 -33.47 75.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.25 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.0 m-85 -156.79 143.04 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.675 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.8 pttt -177.94 100.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.39 167.12 29.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.696 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.07 56.72 2.66 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.43 -118.37 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.635 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.36 135.35 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.477 2.118 . . . . 0.0 111.941 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -125.36 -107.9 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.61 -179.087 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.2 p -165.59 164.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.41 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.4 tttt 153.99 156.28 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.823 0.702 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.55 116.87 22.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.02 -18.94 62.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.81 -32.52 74.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.557 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -61.04 -44.47 97.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.691 -178.08 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -113.96 9.23 17.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.743 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.18 -154.83 52.23 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.631 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.14 -25.06 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.47 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.25 -124.33 1.33 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.22 156.23 44.29 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 110.234 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.56 -169.42 30.15 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -94.52 137.48 33.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.55 108.29 3.29 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.7 mt -123.39 159.37 29.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.441 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.659 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.76 149.61 24.74 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.94 -48.04 64.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.518 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.38 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.5 m-20 -71.75 52.27 0.22 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.64 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.53 -45.54 86.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.345 -179.705 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.44 -47.12 35.48 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.32 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.3 -44.11 97.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.425 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.15 -36.43 70.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.19 -77.73 0.11 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.893 HD21 HD11 ' A' ' 44' ' ' ILE . 97.0 mt -28.27 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.736 0.303 . . . . 0.0 110.29 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.23 -44.83 90.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.662 178.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.99 -43.77 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.957 178.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.27 94.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.057 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -61.25 -43.71 98.44 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 109.894 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.15 92.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.67 -42.89 97.99 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.535 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -58.28 -38.33 76.8 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.0 -40.02 78.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 0.0 110.095 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.68 93.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.0 p30 -86.73 1.54 51.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.451 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.26 19.52 59.69 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 72.6 m -58.31 -45.65 87.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.49 -58.15 7.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.341 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.89 -41.33 77.86 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.46 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.53 -48.36 81.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.643 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.296 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.74 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.463 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.44 -35.39 72.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.645 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -71.14 -50.86 28.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.4 m-85 -62.27 -45.28 93.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.503 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.9 m-85 -153.3 155.06 35.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.407 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.5 p-10 -97.56 95.22 7.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.954 0.406 . . . . 0.0 110.505 179.513 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -153.16 -166.12 2.35 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.99 109.98 14.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.822 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.4 m -63.43 -40.67 89.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.39 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.2 m-85 -56.38 -43.91 79.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.49 94.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.67 0 CA-C-O 117.934 -1.481 . . . . 0.0 110.95 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.22 59.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.604 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.88 144.0 99.47 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.6 2.2 . . . . 0.0 112.235 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -65.86 -40.62 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.62 144.47 37.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.464 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -110.92 129.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -104.42 116.56 32.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.425 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.8 140.99 29.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.17 106.39 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 m -128.49 120.23 26.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.679 0.276 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.7 t70 -112.54 94.22 26.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.104 179.606 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.21 134.87 62.68 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.467 2.111 . . . . 0.0 112.19 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 p -136.76 -18.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.705 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.6 m-85 -124.78 97.73 5.41 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.799 -179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.718 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -30.46 -61.34 0.25 Allowed Pre-proline 0 C--O 1.22 -0.494 0 CA-C-O 121.373 0.606 . . . . 0.0 110.965 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.714 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.7 Cg_endo -49.81 -41.37 46.97 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.263 1.975 . . . . 0.0 112.281 -178.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' TYR . 26.4 t80 -78.25 -42.74 30.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.017 0.437 . . . . 0.0 111.012 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.718 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.0 mt-10 -146.42 -161.12 1.25 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.044 -178.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.3 t 157.59 -179.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.014 0.435 . . . . 0.0 110.345 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -133.69 140.71 47.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.356 179.647 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.57 138.03 31.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.59 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -64.86 -19.16 65.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.555 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.23 -4.92 52.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.473 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.59 -10.17 57.52 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -80.35 158.97 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.974 0.416 . . . . 0.0 110.46 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.42 136.18 53.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.549 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.511 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.1 p -131.82 150.8 34.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.362 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.9 152.92 6.99 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -60.3 -41.17 92.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.024 0.44 . . . . 0.0 110.741 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.8 t0 -70.56 -32.41 69.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.106 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.511 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.8 mt -67.02 -39.99 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.741 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -60.98 -36.66 80.03 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.967 -178.836 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.21 -44.71 83.07 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.47 -45.08 89.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.214 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.93 -54.24 45.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.505 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.13 -37.32 64.23 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.62 -43.36 72.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 54.4 m -54.13 -44.24 71.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.165 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.9 tttm -63.91 -48.0 78.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.043 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.51 -41.11 89.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.171 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.967 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.37 -18.53 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.507 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.51 52.24 3.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.14 169.93 17.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.1 140.85 29.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.155 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.17 132.01 56.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.97 126.79 42.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.441 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.18 136.51 34.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.566 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.35 128.93 64.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.416 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.07 139.88 56.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.4 p30 175.0 135.16 0.16 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.37 143.34 57.74 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.715 2.277 . . . . 0.0 112.45 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.879 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -39.88 -54.56 2.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.119 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.84 -25.97 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.139 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.33 -20.99 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.117 -179.605 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.879 HD12 HD23 ' A' ' 55' ' ' LEU . 55.1 mt -64.04 -42.43 97.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.58 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -56.57 30.27 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.008 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.3 Cg_exo -55.05 -42.94 64.16 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.293 176.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.4 m -58.48 -44.94 89.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.854 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 tp -58.65 -44.54 90.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.7 -41.18 96.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.397 . . . . 0.0 110.453 178.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.03 11.08 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.29 11.95 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.665 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.61 -33.69 76.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -124.41 154.55 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.322 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -92.6 -20.79 20.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.175 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.19 159.64 23.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.582 HG23 HD13 ' A' ' 58' ' ' LEU . 96.0 mt -116.29 127.39 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 110.537 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 61.9 ttp -128.68 107.38 9.63 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.323 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.514 ' OG ' HD21 ' A' ' 55' ' ' LEU . 36.7 t -162.27 -176.79 5.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.22 -15.89 60.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.345 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.637 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.6 tp -37.51 122.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 110.502 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.03 156.21 23.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.69 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.657 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.21 149.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.0 p -150.52 152.52 34.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.787 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.08 -47.72 53.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.44 -39.78 70.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.637 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.67 -37.79 79.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.022 0.439 . . . . 0.0 110.875 179.203 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.2 -37.71 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.931 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.86 -27.41 66.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.153 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.58 -51.12 7.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 110.543 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -139.15 -168.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.49 147.29 29.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.566 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.1 m-85 -130.33 150.47 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.1 t -165.02 -150.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.474 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.0 m-20 42.74 19.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.14 120.87 0.09 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.484 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -80.0 -72.79 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.923 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -147.86 164.98 32.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.58 127.49 32.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.405 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -107.11 67.48 0.7 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.692 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.27 -106.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 32.2 p -159.45 167.85 27.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.21 146.68 23.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.055 0.455 . . . . 0.0 110.492 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -101.68 135.94 42.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.743 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 111.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.98 164.67 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 -179.165 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 148.44 24.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.31 -28.24 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.2 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -59.07 -41.35 87.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -102.38 122.31 44.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.332 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.51 109.39 19.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.062 0.458 . . . . 0.0 110.532 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.4 129.85 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.25 158.79 36.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' O ' ' OG1' ' A' ' 108' ' ' THR . 21.0 Cg_endo -60.3 91.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.736 2.29 . . . . 0.0 111.883 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.7 m -169.89 142.62 2.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.56 -33.5 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.284 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -56.73 -63.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.343 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -56.86 -21.75 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.059 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.5 -28.28 59.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -55.06 132.55 47.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.53 -16.35 35.83 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.64 151.21 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 -179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -96.38 135.58 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.287 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.44 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.708 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.83 137.81 13.97 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.4 t -131.44 161.7 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.047 0.451 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.552 ' N ' HG12 ' A' ' 119' ' ' VAL . 39.2 tp -92.99 120.55 33.41 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -52.01 155.49 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.6 50.91 45.62 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -147.85 166.1 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.662 0.267 . . . . 0.0 110.886 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 68.6 p -71.28 -30.62 66.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.3 mt-30 -58.35 -55.16 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.24 -55.43 33.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.799 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 m -60.56 -51.65 68.52 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.872 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.589 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 68.5 t80 -61.83 -44.41 96.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 110.547 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.0 -44.37 97.88 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.8 m-20 -45.44 -14.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 0.0 110.731 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.35 -34.43 2.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.589 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.8 t60 -74.04 -50.46 19.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.523 -178.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.92 12.53 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.165 -179.245 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.24 -55.14 0.51 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.37 -9.8 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.789 2.326 . . . . 0.0 111.988 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.12 -8.62 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.388 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.09 33.51 36.1 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.79 137.57 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.0 110.594 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.97 130.27 35.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.276 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.6 pt -128.34 139.75 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.974 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.96 132.47 70.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.133 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.3 t -97.82 129.83 44.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.763 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.1 156.93 20.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.0 6.97 27.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.25 130.56 6.08 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.24 -46.58 76.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.712 0.291 . . . . 0.0 110.413 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.02 -23.22 63.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.563 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.447 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.61 -36.54 84.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.527 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.26 -47.67 83.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.4 m-85 -63.59 -37.86 88.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.37 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.84 -42.62 98.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.44 -43.74 93.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.3 tp -59.21 -48.53 81.29 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.179 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.72 -22.85 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.962 0.411 . . . . 0.0 110.199 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.29 -18.19 26.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.3 11.03 73.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.48 -18.12 63.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.4 pt -128.37 137.31 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.38 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.409 ' O ' HG12 ' A' ' 99' ' ' VAL . 97.6 m-20 -72.88 -29.36 63.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.26 155.13 1.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.821 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.61 139.09 52.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.946 0.403 . . . . 0.0 110.029 179.262 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.51 103.15 14.77 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.234 0.54 . . . . 0.0 110.714 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.36 164.69 25.92 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -73.53 152.45 40.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.2 -54.11 29.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.59 -49.25 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.91 84.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.844 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.94 1.05 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.533 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.446 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.0 m -57.82 -46.51 84.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.298 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.05 -41.87 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.26 -62.26 0.48 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.623 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.31 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.618 0.247 . . . . 0.0 111.083 -178.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.35 -40.71 97.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.13 -2.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.383 0.611 . . . . 0.0 110.532 -179.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.5 mt-30 -126.25 141.5 40.01 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.825 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.45 -14.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.828 2.352 . . . . 0.0 112.211 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 92.5 t -63.28 -42.91 98.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.67 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.31 84.61 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.1 -41.21 96.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.727 0.299 . . . . 0.0 110.48 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -65.8 -34.7 78.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.467 179.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.18 143.35 17.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.6 pttt -175.96 99.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.745 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.76 166.78 31.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.698 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.83 55.89 3.05 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.21 -116.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.56 134.02 32.52 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.573 2.182 . . . . 0.0 111.906 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -123.27 -109.4 0.33 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.453 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 4.4 p -164.84 164.09 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.369 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.6 tttt 154.71 154.09 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.791 0.682 . . . . 0.0 110.657 179.276 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -80.06 119.26 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.951 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.36 -19.76 62.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.18 -31.0 72.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 128' ' ' PHE . 87.9 mt -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.668 -178.322 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -114.46 8.18 16.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.735 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.7 -154.1 49.68 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.657 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.2 p -70.79 -25.74 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 110.606 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.1 -126.9 1.66 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.0 p -132.28 160.56 35.86 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.484 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.96 -161.74 23.87 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.77 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.8 140.45 32.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.976 0.417 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.19 3.53 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -117.86 159.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 110.248 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.9 mtm180 -86.76 148.57 25.36 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.511 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.63 -48.48 63.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.663 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -40.94 -22.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 0.0 110.734 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -73.08 51.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.739 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.41 -46.42 83.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.19 -47.12 37.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.413 HD11 HD13 ' A' ' 44' ' ' ILE . 63.4 tp -62.14 -43.7 98.26 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.59 -43.1 99.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.39 -37.59 72.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.43 -77.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.255 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.967 HD21 HD11 ' A' ' 44' ' ' ILE . 86.9 mt -28.03 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.41 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.2 m-20 -63.63 -45.76 88.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.94 -43.96 97.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.945 178.686 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.2 91.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.082 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.2 91.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.181 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.93 -43.44 95.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.887 179.347 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.511 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.36 -38.53 71.53 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -39.11 77.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 0.0 110.288 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.25 -45.63 90.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.653 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.3 p-10 -88.58 -0.49 57.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.71 20.49 70.27 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.9 m -58.19 -46.36 85.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.484 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -62.21 -56.68 16.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.71 -40.76 76.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.317 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -47.92 83.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.535 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.1 -40.75 96.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.251 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.62 -49.7 76.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.557 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.5 -35.74 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -69.77 -51.6 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.499 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.93 -46.27 90.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.579 179.372 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.67 154.64 33.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.517 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 48.5 p-10 -98.28 95.19 7.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.979 0.419 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -151.5 -164.13 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.12 108.49 13.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.787 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 239' ' ' TYR . 26.0 m -63.56 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.367 179.671 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.432 ' N ' HG23 ' A' ' 238' ' ' VAL . 89.7 m-85 -58.53 -42.51 87.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.64 95.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.669 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.28 164.39 61.59 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.86 143.52 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.539 2.159 . . . . 0.0 112.287 179.372 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.17 -40.33 90.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.79 142.51 36.7 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.485 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.0 mt -109.62 128.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.915 0.388 . . . . 0.0 110.489 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -103.39 116.86 33.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.128 0.49 . . . . 0.0 110.392 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.59 138.93 38.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.952 0.406 . . . . 0.0 110.575 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.02 104.4 2.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -127.57 119.24 25.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 122.759 -0.26 . . . . 0.0 111.217 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 16.4 t70 -113.63 93.21 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.155 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.18 134.08 58.68 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.502 2.134 . . . . 0.0 112.115 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.3 p -141.4 -19.67 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.745 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.7 m-85 -124.53 98.9 5.94 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.721 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.73 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.97 -61.53 0.22 Allowed Pre-proline 0 C--O 1.22 -0.495 0 CA-C-O 121.362 0.601 . . . . 0.0 110.965 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.73 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.31 -39.71 43.48 Favored 'Trans proline' 0 C--N 1.296 -2.199 0 C-N-CA 122.287 1.991 . . . . 0.0 112.181 -179.282 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -79.0 -42.61 26.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.024 0.44 . . . . 0.0 110.996 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.679 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.6 mt-10 -149.39 -155.41 0.63 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.988 -178.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.77 178.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.021 0.439 . . . . 0.0 110.402 -179.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.2 mttt -136.17 143.78 44.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.451 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.2 t-20 -96.09 141.38 29.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.558 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.525 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.2 p -66.02 -18.91 65.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.523 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.2 -6.66 55.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.414 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.78 -6.88 58.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.87 158.38 26.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.429 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -112.01 133.93 53.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.474 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.7 151.33 32.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.307 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.63 151.5 6.59 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.62 -41.67 86.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.6 t0 -70.57 -28.24 64.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.201 -179.585 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.663 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -68.68 -40.77 82.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.055 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 53.0 m-20 -61.16 -37.15 81.86 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.972 -178.464 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.77 -43.99 82.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.054 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.539 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.78 -41.89 92.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.293 -179.114 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -58.8 -53.52 57.4 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.546 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.65 -36.81 62.48 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.924 0.392 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.69 -42.37 74.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 178.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.25 -44.79 72.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.208 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -63.74 -47.79 79.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.987 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.199 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.981 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.46 -17.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.76 52.69 4.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.5 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.62 140.86 29.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.136 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.39 131.79 56.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.636 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.2 127.67 43.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -93.86 135.67 34.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.59 128.27 65.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.345 179.447 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.11 139.29 58.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.819 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.1 p30 174.95 132.35 0.14 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.42 144.55 61.94 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.728 2.286 . . . . 0.0 112.467 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.882 HD23 HD12 ' A' ' 58' ' ' LEU . 82.0 mt -40.01 -56.34 1.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -47.55 -26.48 1.45 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.127 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.36 -20.63 18.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.19 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.882 HD12 HD23 ' A' ' 55' ' ' LEU . 57.4 mt -63.99 -42.35 97.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.49 -56.69 27.77 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.894 -179.305 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.8 Cg_exo -54.94 -43.59 57.9 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.646 2.23 . . . . 0.0 111.249 177.02 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -58.55 -44.69 89.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.781 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.14 -44.32 87.75 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.149 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.56 -40.39 95.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.021 0.439 . . . . 0.0 110.541 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 11.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.517 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.21 12.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.44 -34.46 77.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.536 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -123.8 153.25 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.278 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.71 -20.57 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.97 157.05 25.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.739 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.603 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.02 127.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.062 0.458 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -128.64 106.69 9.12 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.583 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.0 t -159.98 -178.23 6.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.582 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.26 -15.47 60.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.0 tp -38.05 123.81 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.45 156.71 22.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.649 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.3 pt -104.88 148.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.365 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -149.92 152.32 34.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.833 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.19 -47.84 54.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.606 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.81 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.74 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.7 mtt180 -68.45 -37.8 80.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.123 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.11 74.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.875 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.45 67.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.132 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.45 -51.71 7.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.533 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.33 -168.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.81 146.73 29.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.034 0.445 . . . . 0.0 110.985 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 76' ' ' ILE . 71.7 m-85 -129.76 149.98 51.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.614 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.6 t -164.15 -151.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.516 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.5 m-20 43.11 19.18 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.801 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.92 120.12 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.0 mt -77.0 -69.99 0.49 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 166' ' ' VAL . 45.0 p90 -149.34 166.31 29.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.619 -179.648 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.26 121.65 27.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.438 . . . . 0.0 110.29 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.94 69.82 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.782 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.22 -104.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.465 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.29 165.87 32.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.697 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.73 145.84 21.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.503 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.27 136.05 41.75 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.77 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 110.79 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.65 164.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.94 148.42 23.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.57 -27.75 41.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.272 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -59.25 -41.74 89.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.326 -179.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.47 122.59 44.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.299 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.92 109.41 19.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.15 129.6 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.89 158.9 34.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.569 179.916 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.58 89.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.734 2.289 . . . . 0.0 111.913 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -169.05 140.89 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.701 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.27 -32.96 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.237 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -56.98 -62.82 1.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 -178.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -55.95 -22.04 24.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.032 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.57 -26.15 54.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.22 46.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.405 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.82 -15.6 30.88 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.98 151.86 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -179.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.48 135.51 38.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.068 0.461 . . . . 0.0 110.298 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.0 136.71 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.45 138.65 14.36 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.02 161.62 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.03 0.443 . . . . 0.0 110.367 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.2 tp -92.6 117.61 30.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.491 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.75 157.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.01 50.61 51.2 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.6 p -149.84 168.98 22.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.674 0.273 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -73.81 -26.38 60.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.446 179.401 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.66 -55.7 30.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.465 -179.392 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.66 -54.47 45.74 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.63 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.31 -51.25 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.675 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.05 -43.73 98.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.58 179.176 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.47 97.72 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.23 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.34 -34.15 2.74 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.47 -50.88 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.038 0.446 . . . . 0.0 111.533 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -99.07 12.61 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.99 -55.58 0.46 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.23 -10.44 25.76 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.783 2.322 . . . . 0.0 111.979 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.54 -8.88 59.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.425 -179.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.38 36.97 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.67 138.27 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.593 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.92 129.81 35.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.301 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.04 133.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 110.067 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.15 127.67 43.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -110.92 153.59 25.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.413 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.94 6.93 29.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.91 130.43 5.94 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.96 -45.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.714 0.292 . . . . 0.0 110.417 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.11 -23.72 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.453 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.72 -36.43 84.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.3 -47.12 85.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.109 -179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -63.56 -37.86 88.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.396 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.21 -42.72 99.08 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.229 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.43 -45.32 91.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 42.8 tp -58.76 -48.19 82.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.73 -22.9 66.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.947 0.403 . . . . 0.0 110.22 179.409 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.77 -18.22 25.31 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.622 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.71 11.24 71.34 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.43 -17.87 63.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 110.631 179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.4 pt -128.5 137.36 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.43 179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.06 -27.89 62.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.63 155.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.811 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.37 50.71 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.019 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.63 103.12 14.16 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.277 0.56 . . . . 0.0 110.761 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.35 165.06 25.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.375 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.36 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.987 0.422 . . . . 0.0 110.526 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.426 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.01 -54.28 28.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.212 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.3 t -59.78 -49.3 84.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.67 -179.295 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.83 -38.8 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.678 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.67 1.09 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.583 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -58.61 -47.62 83.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.73 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -48.75 -38.68 22.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.268 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.69 -65.65 0.55 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.678 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.7 t80 -40.23 -71.13 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.704 -0.292 . . . . 0.0 111.235 -178.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.3 mt -61.39 -39.81 92.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.79 -3.11 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.461 0.648 . . . . 0.0 110.535 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 177' ' ' VAL . 35.0 mt-30 -124.68 141.79 38.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -43.92 -14.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.797 2.331 . . . . 0.0 112.197 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.9 t -63.17 -42.78 97.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.91 81.5 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.1 -41.28 96.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.622 0.248 . . . . 0.0 110.449 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.6 m-20 -65.98 -34.61 78.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.457 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.9 m-85 -157.44 143.5 17.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.08 100.25 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.1 m-85 -159.49 167.74 27.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.654 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.57 55.65 3.15 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.59 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -179.756 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.57 135.23 33.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.518 2.146 . . . . 0.0 111.953 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.24 -108.0 0.32 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.503 -179.023 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.14 165.22 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.366 -179.408 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.26 155.84 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 123.758 0.661 . . . . 0.0 110.668 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.17 22.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.852 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.6 mp0 -71.87 -18.69 62.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.592 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.6 mt -60.98 -44.26 97.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.0 m-85 -113.71 7.51 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.78 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.35 -155.5 50.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.649 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.5 p -70.54 -25.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.0 110.63 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.96 -126.16 1.56 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.5 p -131.99 160.02 37.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.79 0.329 . . . . 0.0 110.483 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.46 24.87 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.17 141.16 31.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.26 111.9 3.98 Favored Glycine 0 C--N 1.329 0.185 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.6 mt -120.98 160.82 22.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -87.38 149.07 24.72 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.09 -48.93 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 -179.425 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -40.14 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.019 0.438 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.25 52.23 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -46.06 84.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.54 -47.06 35.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.19 -44.07 97.42 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.451 -179.542 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.4 -43.0 99.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.919 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.6 -37.28 72.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.792 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.981 HD21 HD11 ' A' ' 44' ' ' ILE . 86.8 mt -28.11 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 110.358 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.8 m-20 -63.53 -45.51 90.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.582 178.238 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.34 -43.62 98.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.34 93.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.057 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.19 -43.56 98.69 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.5 93.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.221 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.66 -43.08 97.79 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.841 179.317 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.79 -38.26 72.29 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.81 76.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.945 0.403 . . . . 0.0 110.302 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.12 93.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.659 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.73 0.41 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.682 179.499 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.57 20.24 67.74 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.461 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 89.1 m -57.83 -46.38 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.51 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.3 t80 -63.45 -58.01 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.414 179.234 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.74 76.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.565 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.53 -48.45 80.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.85 -41.41 97.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.368 179.366 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.09 -50.21 74.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.508 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.18 -35.77 72.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.669 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.62 -51.09 30.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.42 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.18 -45.77 91.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.57 155.0 35.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.6 p-10 -97.95 98.24 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.24 -165.43 2.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.591 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.67 109.41 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.774 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.5 m -63.86 -40.56 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.478 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.5 m-85 -56.7 -43.75 80.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.95 94.09 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.426 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.908 -1.496 . . . . 0.0 110.955 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.58 164.29 59.17 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.593 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.89 143.55 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.58 2.187 . . . . 0.0 112.295 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.23 -40.23 90.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.76 142.22 36.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.401 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.3 mt -109.41 128.68 65.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 110.511 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.41 117.02 33.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.154 0.502 . . . . 0.0 110.379 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -111.97 139.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.555 -179.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.98 105.26 2.18 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -128.12 119.1 24.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.255 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.534 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.9 t0 -113.63 93.35 27.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.121 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.48 134.27 60.75 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.418 2.079 . . . . 0.0 112.132 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -141.48 -19.6 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.674 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -124.52 98.9 5.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.721 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.736 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.98 -61.66 0.22 Allowed Pre-proline 0 C--O 1.219 -0.531 0 CA-C-O 121.363 0.601 . . . . 0.0 110.987 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.736 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.4 -39.45 44.38 Favored 'Trans proline' 0 C--N 1.296 -2.222 0 C-N-CA 122.26 1.973 . . . . 0.0 112.248 -179.232 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.7 t80 -79.06 -42.53 26.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.978 0.418 . . . . 0.0 111.174 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.678 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.8 mt-10 -149.45 -155.64 0.65 Allowed 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.032 -178.848 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.53 178.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.092 0.472 . . . . 0.0 110.4 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -136.04 143.77 44.89 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.436 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.0 t-20 -96.22 141.38 29.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.452 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.3 p -65.83 -19.09 65.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.573 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.08 -6.89 56.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.13 -7.05 58.44 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.73 158.51 26.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.17 133.92 54.02 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.967 0.413 . . . . 0.0 110.43 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.666 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.26 150.93 32.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.307 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.76 151.38 6.55 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -58.48 -41.69 85.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.905 0.383 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.471 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 35.0 t0 -70.71 -28.33 64.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.231 -179.661 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.666 HD12 ' C ' ' A' ' 30' ' ' VAL . 96.6 mt -68.48 -41.23 83.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.403 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.2 m-20 -60.89 -37.06 80.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.029 -178.468 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.81 -43.81 82.86 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.07 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.536 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.92 -41.72 92.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.124 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.89 -53.61 56.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.58 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.86 -36.56 62.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.913 0.387 . . . . 0.0 110.309 179.332 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.67 -42.42 74.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 178.801 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.5 m -54.35 -44.71 72.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.158 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -63.91 -47.74 79.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.058 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.46 -40.85 88.22 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.163 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.974 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.34 -17.97 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.536 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 60.77 52.79 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.545 -179.258 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.55 170.58 16.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.46 140.77 29.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.8 m -117.3 131.74 56.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.725 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.7 m -128.24 127.63 43.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.481 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.15 135.79 35.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.595 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.64 128.52 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.02 139.56 58.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.534 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 174.87 131.81 0.14 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.9 Cg_endo -68.05 144.78 65.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.745 2.297 . . . . 0.0 112.477 -179.388 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.878 HD23 HD12 ' A' ' 58' ' ' LEU . 83.3 mt -40.23 -56.0 2.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.98 -26.28 1.7 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.16 -179.552 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.44 -20.65 18.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.878 HD12 HD23 ' A' ' 55' ' ' LEU . 57.3 mt -63.99 -42.3 97.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.656 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.717 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.54 -56.68 27.71 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.93 -179.291 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.717 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.3 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.599 2.199 . . . . 0.0 111.12 177.232 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.86 -44.6 91.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.729 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.22 -44.36 88.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.53 -40.48 95.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.972 0.415 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.21 11.13 1.62 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.06 12.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.36 77.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.584 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.87 153.89 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.339 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.4 -20.83 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.329 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.52 157.76 25.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.783 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 HD13 ' A' ' 58' ' ' LEU . 96.2 mt -115.8 127.43 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 110.502 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.471 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.82 106.89 9.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.395 179.761 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.583 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.6 t -160.74 -177.7 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.583 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.14 -15.86 60.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.3 tp -37.98 123.52 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 110.455 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.4 156.85 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.703 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.2 pt -105.22 149.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.356 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.4 p -150.17 152.68 35.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.835 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.42 -47.48 56.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.574 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.73 -39.85 71.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.3 mtt180 -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 110.962 178.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.25 -37.18 74.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.822 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.48 -27.57 67.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.087 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.73 7.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.0 110.531 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.24 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.122 0.487 . . . . 0.0 110.452 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.94 146.6 29.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 76' ' ' ILE . 73.0 m-85 -129.72 149.97 51.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.26 -151.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.437 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.4 m-20 42.88 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.767 179.57 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -28.39 120.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.403 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.468 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.02 -69.88 0.5 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.888 -178.816 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.441 ' CG ' HG21 ' A' ' 166' ' ' VAL . 45.9 p90 -149.27 166.28 29.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.64 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.41 121.56 27.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.308 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.46 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.77 69.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 -179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.92 -104.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.22 165.62 33.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.777 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 79.0 ttt-85 -155.49 146.11 22.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.438 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.4 135.93 42.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.987 0.423 . . . . 0.0 110.818 178.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.56 110.62 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.3 165.02 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 -179.39 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.79 23.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.79 -27.95 45.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.12 -41.79 89.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -102.35 122.21 43.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.257 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.7 108.92 19.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.085 0.469 . . . . 0.0 110.425 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.07 129.92 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.59 159.18 34.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.95 0.405 . . . . 0.0 110.511 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.32 89.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.674 2.249 . . . . 0.0 111.891 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -169.2 140.82 2.45 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.459 0.474 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.09 -32.71 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.145 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.507 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.23 -62.95 1.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 t -55.74 -22.17 22.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.015 -179.154 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.4 -26.21 55.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.21 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.71 44.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.435 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.93 30.99 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -86.15 151.34 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.0 110.441 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.72 136.11 37.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.294 -179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.06 136.65 60.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.731 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 138.26 14.17 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.1 t -131.26 161.75 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.352 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.549 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.0 tp -93.05 119.63 32.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -52.04 157.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.97 50.72 50.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.1 p -149.05 167.97 24.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.715 0.293 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 81.3 p -74.06 -26.22 60.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.392 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.79 -55.47 32.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.21 -53.78 54.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.1 m -60.58 -51.34 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.1 t80 -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.131 0.491 . . . . 0.0 110.489 179.207 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.19 -44.49 97.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.276 -0.729 . . . . 0.0 111.276 -179.282 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.43 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.24 -34.1 2.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.56 -50.52 17.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.026 0.441 . . . . 0.0 111.586 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -98.94 12.5 35.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.272 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.774 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.92 -55.32 0.47 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.38 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.2 -10.71 26.18 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.778 2.319 . . . . 0.0 111.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -8.9 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.82 33.43 37.46 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.29 138.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.644 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.06 130.01 35.12 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.229 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.53 139.31 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.6 132.39 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.962 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.44 130.32 45.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.55 156.55 21.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.375 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.87 6.26 29.19 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.739 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.8 6.24 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.405 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.8 tp60 -66.13 -45.9 79.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.4 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.63 -23.31 62.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.532 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.2 t-20 -64.54 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.507 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.04 -47.16 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.26 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.7 m-85 -64.36 -37.56 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.324 179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.81 -42.17 97.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.055 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.95 -43.02 94.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.92 179.227 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.3 tp -59.48 -47.94 83.58 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.024 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.4 m -62.63 -22.74 66.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.716 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -17.52 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.659 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 11.82 74.38 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.72 -18.11 63.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 153' ' ' LEU . 35.3 pt -127.15 136.23 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.377 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 99' ' ' VAL . 97.6 m-20 -72.82 -28.9 62.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.302 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.484 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.11 155.55 1.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.13 138.04 51.56 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -86.25 102.93 14.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.265 0.555 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.8 tt0 -132.24 164.87 25.42 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.388 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.475 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.14 152.98 40.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.968 0.413 . . . . 0.0 110.549 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.08 -54.38 26.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.295 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.441 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.07 -49.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.709 -179.31 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.06 88.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.788 0.327 . . . . 0.0 110.851 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.78 1.06 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.678 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.6 m -58.64 -47.45 84.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.708 -179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.13 -38.4 25.0 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.228 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.67 -65.56 0.55 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.683 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.7 t80 -40.34 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.722 0.296 . . . . 0.0 111.312 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.8 mt -61.53 -39.61 91.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.044 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.06 -3.19 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.515 -179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 177' ' ' VAL . 34.5 mt-30 -124.28 142.28 39.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.1 -15.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.833 2.355 . . . . 0.0 112.22 179.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.3 t -62.98 -42.75 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.01 82.37 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.0 -41.29 96.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.673 0.273 . . . . 0.0 110.509 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.4 m-20 -66.02 -34.58 78.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.388 179.514 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -157.07 143.21 17.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.91 99.91 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.9 0.381 . . . . 0.0 110.782 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.26 166.73 30.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.729 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.45 56.01 2.91 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.29 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.8 135.51 35.33 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.478 2.119 . . . . 0.0 111.9 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.15 -107.87 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.552 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.677 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -166.5 165.39 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.351 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.677 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.21 156.42 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.748 0.655 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -82.88 117.98 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.27 -18.65 62.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.74 -32.01 73.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.581 -179.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.455 HD11 ' CG ' ' A' ' 128' ' ' PHE . 93.0 mt -61.06 -44.29 97.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.772 -178.183 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.7 7.68 17.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.763 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.89 -155.4 50.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.651 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.1 p -70.32 -25.52 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.65 -126.36 1.6 Allowed Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.355 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.66 159.64 37.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 110.47 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.61 24.96 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.32 141.18 31.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.967 0.413 . . . . 0.0 110.579 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.04 3.84 Favored Glycine 0 C--N 1.329 0.173 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.7 mt -119.71 160.52 22.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 110.202 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -87.28 149.03 24.83 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.847 0.356 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.33 -48.77 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.685 -179.345 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -40.63 -22.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.123 0.487 . . . . 0.0 110.682 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.08 52.18 0.24 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.769 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.45 -45.88 85.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.301 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.62 -47.14 33.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.055 0.455 . . . . 0.0 111.279 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.18 -44.08 97.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.49 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.864 179.536 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.75 -37.33 73.42 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.974 HD21 HD11 ' A' ' 44' ' ' ILE . 86.2 mt -28.39 -45.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 0.0 110.322 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.1 m-20 -63.57 -45.54 89.97 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.495 178.288 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.47 -43.59 98.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.753 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.25 92.86 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.045 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.002 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.51 92.95 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.179 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.54 -43.13 98.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.84 -38.27 72.42 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.89 -38.84 76.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 110.364 178.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.35 93.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 20.9 p-10 -88.34 0.44 56.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.681 179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.34 20.3 67.37 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.01 -46.36 85.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 226' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.0 t80 -63.47 -57.88 8.82 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.33 -41.72 76.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.66 -48.19 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.686 -179.539 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.15 -41.48 98.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.17 -50.11 75.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.532 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.21 -35.8 72.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.59 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.44 -50.91 33.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.2 m-85 -62.5 -45.28 93.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.521 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 72.1 m-85 -153.93 155.02 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.526 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.34 98.63 9.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.419 . . . . 0.0 110.511 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -155.59 -165.11 1.89 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.577 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.0 t0 -122.67 109.15 13.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.803 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 25.1 m -63.72 -40.53 89.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.421 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.8 m-85 -56.76 -43.71 81.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.42 -36.77 93.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.663 0 CA-C-O 117.853 -1.526 . . . . 0.0 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.03 164.31 62.27 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.651 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 143.46 99.37 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.47 2.114 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.65 -40.67 88.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -138.78 141.6 38.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.02 127.69 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.4 mtp180 -101.65 117.56 35.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.157 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.6 104.71 2.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -127.87 119.52 25.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 18.2 t0 -113.23 91.89 20.62 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.069 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.309 -1.505 0 C-N-CA 122.466 2.111 . . . . 0.0 111.904 179.486 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.6 t0 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.142 0.496 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.66 -40.97 85.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.107 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.81 -37.7 82.89 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.095 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.39 -45.04 89.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.126 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.3 -47.9 80.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -53.22 -54.34 37.54 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.55 -40.25 62.35 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.102 0.477 . . . . 0.0 110.13 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.13 -42.02 80.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.945 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.2 m -54.13 -43.95 70.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.01 -47.12 81.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.225 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -59.86 -41.79 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.474 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.929 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.36 -18.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.81 52.59 4.22 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.354 0.409 . . . . 0.0 110.659 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 p -146.63 171.11 15.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -88.63 141.39 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.984 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.95 130.61 56.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.569 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.06 127.23 44.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.277 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.66 135.81 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.438 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.54 128.92 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.939 0.4 . . . . 0.0 110.423 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.46 139.2 58.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 175.37 129.88 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.0 146.43 71.09 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.632 2.221 . . . . 0.0 112.402 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.876 HD23 HD12 ' A' ' 58' ' ' LEU . 83.4 mt -40.44 -56.73 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.07 -27.14 2.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.39 -20.69 19.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.048 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.876 HD12 HD23 ' A' ' 55' ' ' LEU . 60.7 mt -64.53 -42.41 95.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.622 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.664 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.62 -56.96 24.95 Favored Pre-proline 0 C--O 1.241 0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.667 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.6 Cg_exo -54.46 -43.52 58.04 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.435 2.09 . . . . 0.0 111.521 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.6 m -59.09 -44.32 91.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.777 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.42 -44.14 88.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -64.6 -39.95 94.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.46 11.29 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.96 12.12 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.762 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.63 78.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.51 152.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -92.98 -20.59 20.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.23 156.18 26.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.489 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 58' ' ' LEU . 96.8 mt -115.29 127.11 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.451 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -128.32 105.9 8.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.268 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.663 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.9 t -159.33 179.87 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.78 -15.14 61.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.427 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.642 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.2 tp -36.4 123.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.583 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.73 154.72 25.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.778 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.82 148.35 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.2 p -149.62 152.53 35.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.738 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.37 -46.89 56.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.99 -40.17 72.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.479 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.642 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.8 mtt180 -68.09 -37.9 81.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.15 -37.83 75.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.994 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.03 -27.44 66.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.16 7.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.554 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.7 pt -139.28 -168.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.28 146.92 29.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.83 149.81 51.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.7 t -164.09 -152.81 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.512 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.507 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.7 m-20 41.86 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.948 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.63 121.07 0.2 Allowed 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.61 0.569 . . . . 0.0 110.522 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.3 mt -75.13 -68.37 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.866 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.9 p90 -150.71 167.27 27.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.705 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.5 123.22 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.306 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.87 67.96 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.642 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.64 -104.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.38 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.9 p -159.76 166.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.635 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.35 145.99 22.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.22 135.9 41.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.49 110.98 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.0 m -134.5 164.14 34.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.732 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.17 148.33 25.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.924 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.68 -27.63 41.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.53 -41.66 90.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.273 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -102.17 122.0 43.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.802 0.334 . . . . 0.0 110.143 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.11 109.55 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.33 129.75 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.623 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.83 159.02 34.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.358 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.449 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.7 Cg_endo -59.76 89.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.74 2.293 . . . . 0.0 111.934 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -168.5 140.53 2.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.798 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -66.74 -33.05 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.185 0.516 . . . . 0.0 110.218 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.51 -62.37 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.612 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.19 -22.31 28.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 110.859 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -76.32 -25.89 55.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -54.56 132.69 45.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.612 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -16.57 30.25 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -85.85 151.22 23.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.35 135.91 37.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.244 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.38 136.51 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.702 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.43 139.98 14.9 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.3 t -132.01 161.59 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.2 tp -92.92 119.04 31.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.488 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.9 157.3 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.79 47.99 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.4 p -149.51 168.14 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.26 -25.71 59.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.14 -55.16 35.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.43 -54.08 50.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.38 -51.15 70.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.542 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.594 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.3 t80 -62.23 -43.81 97.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.466 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.49 -44.53 97.88 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.82 -14.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.42 -34.66 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.594 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.7 t60 -74.47 -50.43 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.435 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.37 12.53 36.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.139 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.741 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.91 -55.52 0.47 Allowed Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.416 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.6 Cg_endo -72.27 -10.32 25.54 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.727 2.285 . . . . 0.0 111.984 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.53 -9.18 59.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.26 37.88 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.32 137.94 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.59 129.62 35.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.64 138.52 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.54 131.89 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 t -98.16 130.33 44.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.603 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -111.44 156.23 21.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.278 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.03 6.48 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.742 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.62 130.66 6.22 Favored Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.404 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.7 tp60 -65.92 -45.87 80.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 110.459 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.55 -23.61 62.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.66 -36.93 85.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.95 -46.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.316 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.511 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.3 m-85 -64.04 -37.85 88.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.02 -42.45 98.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.049 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.87 -44.45 93.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.108 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.4 tp -59.09 -47.86 83.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.147 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.05 -23.15 67.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.176 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.66 25.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.07 71.05 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.26 -18.39 63.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.8 pt -127.7 137.64 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.09 0.471 . . . . 0.0 110.554 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.99 -28.35 62.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.964 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.41 155.71 1.88 Allowed 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.72 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.97 103.18 14.44 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.2 tt0 -132.96 165.27 25.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.509 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.82 152.13 41.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.658 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.13 -54.23 28.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.647 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 91' ' ' TYR . 78.1 t -60.8 -48.63 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.303 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.8 88.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 110.644 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.36 -63.28 1.18 Allowed 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.362 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.436 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.7 m -59.15 -47.18 86.25 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.92 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.55 -36.8 24.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.72 -64.99 0.52 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.7 t80 -41.34 -71.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.877 0.37 . . . . 0.0 111.009 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.73 -40.03 93.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.7 -3.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 173' ' ' LEU . 54.5 mt-30 -122.71 149.34 55.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.49 -20.27 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.796 2.331 . . . . 0.0 112.175 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.76 -42.98 94.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.495 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.2 84.2 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.63 -41.73 95.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 0.0 110.333 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.1 m-20 -65.4 -34.09 77.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.514 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.6 m-85 -155.82 142.62 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.58 99.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.471 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.22 167.29 29.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.43 56.24 2.87 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.05 -117.88 0.01 OUTLIER Glycine 0 CA--C 1.543 1.789 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.76 136.28 35.0 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -125.08 -108.64 0.32 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.408 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.0 p -165.84 164.85 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.939 -0.553 . . . . 0.0 109.807 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.19 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.373 1.046 . . . . 0.0 110.675 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -82.15 118.05 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.801 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -72.03 -18.89 61.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.48 -32.54 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.0 mt -60.9 -44.26 97.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.712 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.3 m-85 -114.48 9.63 16.76 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.691 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.97 -153.52 51.33 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.74 -25.47 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.324 . . . . 0.0 110.447 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.21 -123.92 1.28 Allowed Glycine 0 N--CA 1.46 0.245 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -129.6 156.23 44.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.69 -169.61 30.52 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -95.0 138.99 31.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.535 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.87 107.56 3.25 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.9 mt -119.76 159.54 24.32 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.1 mtm180 -86.98 149.04 25.05 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.71 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.29 -48.07 65.55 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.712 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -40.51 -23.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.709 0.29 . . . . 0.0 110.666 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.57 52.06 0.2 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.28 -45.74 86.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.87 -47.08 32.06 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.47 -43.94 97.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.14 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.873 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.51 -36.98 72.26 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.772 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.57 -77.37 0.11 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 44' ' ' ILE . 89.7 mt -29.14 -45.49 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.247 0.342 . . . . 0.0 110.692 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.04 -45.07 90.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.731 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.57 -43.61 98.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.893 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.15 93.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.28 -43.72 98.41 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.086 0.47 . . . . 0.0 110.145 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.21 91.9 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -42.35 98.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.092 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.525 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.39 -38.47 77.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.44 -39.88 81.35 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.404 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.1 92.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.522 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.525 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.8 p30 -86.33 1.04 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.482 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.2 19.42 61.71 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 73.4 m -58.13 -45.94 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.086 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 77.3 t80 -63.5 -57.14 11.15 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.38 -41.05 79.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.01 -48.28 82.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.09 -41.82 98.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.293 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.8 -49.84 76.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.65 -35.56 72.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.393 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -70.59 -50.9 32.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.617 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.507 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.5 m-85 -61.97 -45.62 92.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.484 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -154.82 156.1 35.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.39 99.3 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.022 0.439 . . . . 0.0 110.409 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -156.24 -166.32 2.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.412 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.3 t0 -122.71 110.8 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.0 m -63.44 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.404 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.8 m-85 -59.22 -42.54 91.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.35 94.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 117.817 -1.546 . . . . 0.0 110.968 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.8 54.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.06 143.62 99.15 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.417 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.15 -40.49 90.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.597 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.9 143.18 36.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.1 mt -110.19 128.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.86 116.51 32.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.27 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.8 mt -111.28 138.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.351 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.43 104.44 2.11 Favored Glycine 0 N--CA 1.462 0.409 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.6 m -127.53 119.1 25.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 110.631 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 21.5 t70 -113.55 92.55 24.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.966 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 C--N 1.31 -1.474 0 C-N-CA 122.531 2.154 . . . . 0.0 111.767 179.592 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.7 t0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 121.102 0.477 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.76 -41.74 85.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.236 0.541 . . . . 0.0 111.282 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 48.9 m-20 -60.95 -37.48 82.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.815 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.05 -43.83 86.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.183 0.516 . . . . 0.0 110.555 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.15 -41.47 92.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.316 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.2 -52.89 63.73 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.535 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.21 -37.2 64.29 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.034 0.445 . . . . 0.0 109.891 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.47 -42.58 78.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.129 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.74 -44.36 73.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.125 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.07 -46.92 82.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.23 0.538 . . . . 0.0 110.399 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -60.28 -40.87 91.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -75.94 -17.82 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.705 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.74 52.16 4.51 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.706 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.19 170.12 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.2 140.22 29.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.008 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -116.81 131.49 56.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.04 127.5 43.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.436 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -94.06 135.52 35.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.5 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.5 128.92 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.988 0.423 . . . . 0.0 110.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.9 139.48 58.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.483 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.1 p30 175.68 131.43 0.16 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.778 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.8 Cg_endo -68.08 145.41 67.11 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.613 2.209 . . . . 0.0 112.602 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 82.3 mt -40.37 -56.51 1.99 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -47.88 -26.66 1.77 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.855 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.1 -20.51 19.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.124 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -64.16 -42.47 96.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.563 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.667 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -63.17 -56.23 29.66 Favored Pre-proline 0 C--O 1.242 0.66 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.919 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.1 Cg_exo -55.29 -42.7 65.88 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.486 2.124 . . . . 0.0 111.202 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -58.96 -44.12 91.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.866 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.191 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.36 -40.27 95.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.4 11.1 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.631 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.35 11.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.755 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.18 -34.74 78.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.667 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.72 153.09 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.31 -20.87 19.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.7 156.72 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.493 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.6 127.02 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.5 ttp -128.4 106.66 9.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.247 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.595 ' OG ' HD21 ' A' ' 55' ' ' LEU . 42.3 t -160.35 -178.23 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.585 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.15 -15.32 59.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.48 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -38.27 123.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.614 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.34 156.88 22.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.644 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.15 149.05 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -149.83 152.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.27 -47.03 55.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.647 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.33 -40.05 73.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.301 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -67.92 -37.92 82.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.226 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.26 -37.05 74.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.56 -27.43 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.257 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.31 -51.73 7.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.615 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.4 -168.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.74 146.67 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 110.73 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.79 149.88 51.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.709 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.5 t -164.4 -151.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.501 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.23 19.52 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.83 120.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.652 0.595 . . . . 0.0 110.509 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -77.18 -69.29 0.54 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.92 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.3 p90 -149.62 166.17 30.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.517 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.98 122.31 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.387 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.449 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.59 69.39 0.98 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.538 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.9 -105.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -158.85 165.63 33.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.59 145.79 21.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.85 136.13 41.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 110.92 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.833 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.37 164.93 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 0.0 110.714 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.7 148.53 23.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.866 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.49 -28.29 59.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.01 -41.85 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.245 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -101.71 122.04 43.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.121 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.16 109.7 19.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.63 129.63 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.636 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.01 154.25 41.25 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.553 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.65 91.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -170.74 144.35 2.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.22 -33.72 62.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 110.229 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.65 -62.04 2.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.607 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -56.65 -22.05 31.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.725 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -76.47 -25.62 54.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.18 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.59 47.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -16.09 30.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.73 151.67 23.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.217 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.23 135.21 38.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.2 t -126.74 136.2 61.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.02 138.81 14.38 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.13 161.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.239 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.538 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.53 117.69 30.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.399 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.72 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.585 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.93 50.39 52.93 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.77 168.84 22.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.456 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 71.6 p -73.29 -26.82 61.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.372 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.62 -55.03 38.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.605 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.21 -54.38 47.47 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -60.41 -51.37 69.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.64 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.01 -44.02 97.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.346 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.59 -44.49 97.89 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.67 -14.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.213 . . . . 0.0 110.705 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.3 tt0 -125.53 -34.53 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.565 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.65 -50.62 17.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.28 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -99.42 12.26 36.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.096 0.474 . . . . 0.0 111.133 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.69 -55.55 0.48 Allowed Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.483 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.4 -10.23 25.23 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.751 2.301 . . . . 0.0 112.039 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.38 -8.93 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.58 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.12 33.09 37.23 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.51 137.98 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.76 129.89 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.4 138.13 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.99 133.06 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.86 127.25 42.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.83 153.33 25.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.32 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.94 6.95 29.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.43 130.44 6.01 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.98 -45.72 80.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.56 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.51 -23.46 62.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.47 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.452 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.7 -36.98 86.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.85 -46.86 87.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.366 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.09 -37.85 88.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.218 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.98 -44.52 92.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.181 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 42.1 tp -59.31 -47.64 84.65 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.087 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.06 -23.0 67.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.15 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.59 -18.24 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.48 11.73 71.14 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.87 -18.05 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.6 pt -127.86 137.73 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 110.527 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.21 -28.44 62.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.07 155.63 2.0 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.795 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.51 50.51 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -86.08 103.05 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.6 tt0 -132.6 164.68 26.12 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -72.99 152.6 41.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.392 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.6 mt-10 -65.7 -54.04 32.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.406 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.1 t -60.75 -48.7 87.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.428 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.93 87.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.844 0.354 . . . . 0.0 110.429 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.16 -63.68 1.08 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.446 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.8 m -58.92 -46.97 86.64 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.812 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 80.8 tt0 -49.95 -37.48 32.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.228 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.2 -65.39 0.54 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.658 ' N ' ' O ' ' A' ' 168' ' ' ALA . 29.7 t80 -40.74 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.831 0.348 . . . . 0.0 111.089 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.446 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.5 mt -61.88 -39.6 92.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.62 -3.96 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.276 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 177' ' ' VAL . 22.8 mt-30 -123.46 142.01 37.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -43.95 -15.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.82 2.347 . . . . 0.0 112.132 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.8 t -62.8 -42.96 98.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.438 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.83 -32.85 80.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.99 -41.55 96.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.2 m-20 -65.78 -34.63 78.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.687 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.08 143.53 18.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.635 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.2 pttt -177.16 99.57 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.117 0.484 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.6 m-85 -159.19 168.21 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.631 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.42 55.96 3.1 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.68 -116.78 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.0 135.43 36.78 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.102 1.868 . . . . 0.0 111.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.8 p -125.25 -108.38 0.32 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.315 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.62 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.97 164.8 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 119.03 -0.51 . . . . 0.0 109.929 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.07 155.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.259 0.975 . . . . 0.0 110.539 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.75 117.97 23.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.808 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.67 -19.02 62.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.24 -32.06 73.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.473 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.4 mt -61.08 -43.94 98.12 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.735 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.456 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.95 7.33 16.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 0.0 110.689 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.3 -155.09 50.01 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.644 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.43 -25.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.863 0.363 . . . . 0.0 110.593 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.449 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.05 -126.08 1.54 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -131.91 159.7 37.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.89 25.4 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.501 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.13 141.16 31.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.2 112.02 3.99 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.8 mt -121.18 160.35 23.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.85 149.04 25.11 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.705 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.44 -48.2 65.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -40.9 -22.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.602 0.239 . . . . 0.0 110.587 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.86 52.09 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.431 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.31 -46.3 84.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.42 -46.93 36.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.5 tp -62.44 -43.93 97.65 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.359 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.24 -42.76 99.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.974 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.74 -37.37 73.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.948 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.6 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 44' ' ' ILE . 86.1 mt -29.15 -45.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.316 0.385 . . . . 0.0 110.843 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -64.16 -45.1 89.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.64 -43.57 98.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.945 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.15 92.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.307 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.05 -43.66 98.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.175 0.512 . . . . 0.0 110.312 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.27 91.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.319 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -64.07 -41.79 97.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.291 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.6 mtp -58.04 -38.19 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.49 -38.9 77.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.418 . . . . 0.0 110.554 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.15 93.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.1 p-10 -88.72 0.42 56.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.33 68.47 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -58.38 -45.85 87.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.4 t80 -63.43 -57.53 9.99 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.01 -41.06 77.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.402 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.07 -48.12 82.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.338 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.07 -41.59 98.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.333 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.84 76.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.6 -35.86 73.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.43 -50.91 33.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.465 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.513 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.5 -45.46 92.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.35 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.7 m-85 -153.76 155.32 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.416 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.15 98.54 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 110.458 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -155.42 -165.49 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.465 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.56 109.37 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.9 m -63.75 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.421 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.2 m-85 -57.18 -43.64 82.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.0 94.17 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.425 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.899 -1.5 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.5 164.43 59.96 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.689 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.07 143.69 99.11 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.658 2.239 . . . . 0.0 112.244 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.405 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.39 -40.83 89.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.75 139.2 38.23 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.361 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.1 121.1 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.8 118.59 31.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.5 138.23 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.305 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.57 105.39 2.14 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.8 m -128.73 120.84 27.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 122.687 -0.302 . . . . 0.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.497 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.8 t70 -114.29 92.61 28.05 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.918 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--N 1.309 -1.544 0 C-N-CA 122.499 2.133 . . . . 0.0 111.851 179.442 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 121.0 0.428 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -67.76 -40.79 84.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.939 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.97 -37.5 82.66 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.718 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.49 -44.94 89.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.117 0.484 . . . . 0.0 110.164 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.54 -48.16 80.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.901 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.26 -53.87 44.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.437 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.87 -40.32 63.33 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.029 0.442 . . . . 0.0 109.951 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.87 -42.08 81.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.57 -45.1 69.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.169 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.31 -46.34 83.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.277 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -60.55 -42.1 95.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.194 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.895 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.36 -17.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.718 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.94 52.75 4.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.78 171.09 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.975 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.81 142.18 27.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.995 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.1 m -117.14 131.06 56.97 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.617 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.15 126.94 43.75 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.4 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -93.73 134.69 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.98 128.14 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.027 0.442 . . . . 0.0 110.344 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.14 137.79 57.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.557 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 176.53 131.68 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.75 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -67.77 144.51 65.65 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.665 2.244 . . . . 0.0 112.732 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.89 HD23 HD12 ' A' ' 58' ' ' LEU . 81.3 mt -39.87 -55.44 1.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.96 0.41 . . . . 0.0 111.261 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.71 -26.33 2.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.08 -21.11 18.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.13 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.89 HD12 HD23 ' A' ' 55' ' ' LEU . 60.1 mt -63.7 -42.64 97.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.748 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.68 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 mm -62.22 -56.66 28.97 Favored Pre-proline 0 C--O 1.242 0.67 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.795 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.8 Cg_exo -56.09 -41.69 74.26 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.551 2.167 . . . . 0.0 110.947 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -59.08 -44.48 91.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.968 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.648 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.6 tp -59.38 -43.91 92.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.269 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.32 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.493 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.17 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.25 11.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.37 -35.53 80.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 pt -122.43 152.78 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.0 -22.53 19.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.19 155.71 27.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.616 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -114.98 129.08 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.96 0.409 . . . . 0.0 110.384 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -131.28 106.82 8.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 110.231 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.699 ' OG ' HD21 ' A' ' 55' ' ' LEU . 42.1 t -159.05 178.47 10.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.577 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -65.24 -15.2 62.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.513 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.24 124.5 0.61 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.673 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.542 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.8 154.26 26.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.677 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.627 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.4 pt -105.0 148.65 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 p -149.07 152.3 35.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.738 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -46.92 53.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.004 0.431 . . . . 0.0 110.463 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.06 -39.63 72.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.81 -37.9 79.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.015 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.85 -38.48 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.23 -27.34 67.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.33 -51.11 7.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.4 pt -138.98 -168.21 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.986 0.422 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.25 147.57 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.135 0.493 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.1 m-85 -129.86 149.92 51.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.36 -153.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.456 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.7 m-20 41.66 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.944 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.35 0.2 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.594 0.559 . . . . 0.0 110.559 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.421 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.2 mt -75.23 -68.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.49 167.17 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.637 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.83 123.38 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.85 68.55 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.663 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.83 -104.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.322 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.3 p -159.37 165.98 32.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.63 146.11 21.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.47 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.95 136.23 41.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.816 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.37 164.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.937 0.399 . . . . 0.0 110.679 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.56 24.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.07 -27.85 47.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.04 -41.66 88.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.344 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.0 t -102.4 122.36 44.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.01 109.36 19.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.89 129.84 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.29 159.06 33.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.444 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.5 Cg_endo -60.11 89.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.777 2.318 . . . . 0.0 112.008 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -168.82 140.99 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.94 -33.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 110.225 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.22 -22.04 26.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.888 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.3 mt -76.72 -25.83 53.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.16 46.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.507 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.9 -15.85 30.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.54 151.32 23.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 110.308 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.02 135.55 37.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.278 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.3 136.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.53 138.68 14.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.2 t -130.88 161.61 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.255 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 45.1 tp -92.38 117.57 30.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.578 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -51.87 157.57 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.61 50.23 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -149.96 168.87 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 110.795 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.4 p -73.7 -26.52 60.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.412 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.78 -55.15 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.598 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.02 -54.72 43.57 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.461 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.07 -51.33 70.08 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.504 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -61.8 -44.12 97.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 110.489 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.59 -44.47 97.92 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.76 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.575 0.226 . . . . 0.0 110.647 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.29 -34.62 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.68 -50.67 16.75 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.331 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.19 12.25 36.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.208 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.69 -55.51 0.48 Allowed Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.429 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.13 -10.28 25.68 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.802 2.334 . . . . 0.0 111.969 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.73 -8.92 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.561 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.77 33.46 37.58 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.52 137.83 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.35 129.74 34.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.254 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.6 pt -126.34 138.09 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.21 133.12 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.33 127.57 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.84 153.67 25.08 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.282 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.0 7.05 29.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.621 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.54 130.5 6.02 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.78 -45.82 81.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.54 -23.67 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.523 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.69 -36.82 85.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.19 -47.03 85.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.521 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.64 -37.98 89.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.361 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.8 p -61.06 -42.26 98.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.023 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.16 -44.58 91.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.6 tp -59.12 -47.81 83.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.097 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.7 m -63.49 -22.77 67.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.992 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.19 -18.6 25.44 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.579 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.97 11.04 70.85 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.32 -17.92 63.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.623 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.7 pt -128.23 137.36 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.12 0.486 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.86 -27.43 61.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.59 155.98 1.84 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.17 136.88 49.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.9 0.381 . . . . 0.0 110.005 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -85.41 103.3 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.0 tt0 -133.04 165.21 25.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.46 152.12 42.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.772 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.05 -54.53 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.2 -48.44 88.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.586 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.94 90.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 0.0 110.457 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.64 -62.97 1.26 Allowed 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.436 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -59.61 -47.83 84.04 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.914 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -49.56 -36.7 24.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.179 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.456 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.39 -66.17 0.54 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.1 t80 -40.68 -70.7 0.1 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.655 0.264 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.58 -40.12 93.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -60.69 -3.19 0.66 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.302 0.572 . . . . 0.0 110.254 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.456 HE21 ' C ' ' A' ' 171' ' ' GLY . 51.5 mt-30 -122.15 147.6 49.72 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.35 -19.12 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.844 2.362 . . . . 0.0 112.034 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.8 -43.21 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.524 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.99 -32.95 83.98 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.53 -41.09 93.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.758 0.313 . . . . 0.0 110.458 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -66.16 -32.9 74.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.53 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.0 m-85 -156.51 142.53 18.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.545 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -176.82 99.56 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.31 166.99 30.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.7 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.23 -117.71 0.01 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.89 136.01 35.97 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.266 1.977 . . . . 0.0 111.928 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.9 p -125.41 -108.02 0.32 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.78 165.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.039 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 154.04 156.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.379 1.049 . . . . 0.0 110.502 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.26 117.35 22.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.904 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.32 -18.85 62.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.66 -32.53 74.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.2 mt -61.1 -44.15 97.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.727 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.5 m-85 -114.46 9.66 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.628 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.08 -154.77 52.29 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.627 ' CG1' HD11 ' A' ' 76' ' ' ILE . 15.0 p -70.32 -25.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.38 -123.97 1.28 Allowed Glycine 0 N--CA 1.46 0.24 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.56 156.25 44.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.54 -169.76 30.56 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.04 137.7 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.65 108.32 3.3 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.3 mt -123.54 159.2 29.66 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 120.672 0.273 . . . . 0.0 110.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.648 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.8 mtm180 -86.79 149.51 24.8 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.712 0.292 . . . . 0.0 110.757 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.68 -47.79 63.73 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.746 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.72 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.42 52.23 0.19 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.505 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.38 -45.77 86.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.34 -47.26 35.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.52 -43.86 97.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.4 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.79 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.0 -36.19 70.12 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.687 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.15 -77.42 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.895 HD21 HD11 ' A' ' 44' ' ' ILE . 97.2 mt -28.17 -46.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.971 0.415 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.6 -44.71 89.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.781 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.98 -43.86 97.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.026 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.05 93.12 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.29 -43.55 98.69 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.16 0.505 . . . . 0.0 110.166 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.12 92.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.258 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.9 -41.92 97.58 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.523 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -59.1 -38.0 78.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.78 -39.84 79.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.066 0.46 . . . . 0.0 110.34 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.07 92.21 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.519 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.3 p30 -86.26 1.09 52.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.504 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.97 19.43 61.22 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 68.3 m -58.41 -45.64 88.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.6 t80 -63.55 -58.25 7.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.936 0.398 . . . . 0.0 110.351 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.54 -41.37 76.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.486 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.96 -48.4 81.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.98 -41.59 98.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.84 -50.28 74.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.4 -35.41 71.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.478 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.03 -50.84 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.1 m-85 -62.2 -45.57 92.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.5 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.87 155.53 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.373 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.3 p-10 -97.56 95.93 7.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 110.491 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -153.63 -166.01 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.92 110.4 15.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.7 m -63.69 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.584 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.422 ' N ' HG23 ' A' ' 238' ' ' VAL . 89.9 m-85 -57.8 -43.53 85.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.25 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.47 94.9 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.23 164.61 59.69 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.745 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.09 143.69 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.21 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.31 -40.4 89.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.74 143.2 36.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.37 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -110.36 128.68 66.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.381 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.8 mtp180 -104.38 118.16 35.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.04 139.2 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.03 104.69 2.19 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.8 m -127.72 118.33 23.6 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.659 -0.318 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.2 t70 -113.38 92.59 23.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.912 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.31 -1.451 0 C-N-CA 122.467 2.111 . . . . 0.0 111.965 179.594 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.44 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.0 t0 . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.954 0.407 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.55 -40.79 82.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.987 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.7 m-20 -60.65 -37.79 82.68 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.985 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.19 -43.89 85.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.499 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.1 -41.73 93.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -58.83 -53.13 61.83 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.638 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.93 -37.06 63.44 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.01 -42.4 76.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.121 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.6 -44.62 73.22 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.229 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -64.02 -47.18 81.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.254 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -59.86 -40.72 89.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.092 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.989 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.53 -17.78 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.774 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.66 52.4 4.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.24 170.06 17.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.04 140.26 29.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.028 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.0 m -116.91 131.52 56.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.19 127.71 43.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.476 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -94.26 135.97 35.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.406 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.57 128.68 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.77 140.02 58.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 174.97 131.68 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.724 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.21 145.43 66.38 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.678 2.252 . . . . 0.0 112.576 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.875 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.14 -56.91 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.4 -26.75 1.41 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.986 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.29 -20.76 18.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.123 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.875 HD12 HD23 ' A' ' 55' ' ' LEU . 59.0 mt -63.97 -42.49 97.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.731 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.69 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.38 -56.64 28.59 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 123.698 0.624 . . . . 0.0 109.67 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.49 -42.24 70.0 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.534 2.156 . . . . 0.0 111.025 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -58.86 -44.18 90.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.787 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.09 -44.29 91.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.83 -40.52 95.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.476 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.51 10.9 1.84 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.31 11.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.31 -34.13 77.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.551 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.96 154.16 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.81 -20.83 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.99 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.82 158.88 23.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.583 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.604 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.82 127.02 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-O 120.945 0.402 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.44 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -127.5 106.05 8.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.268 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.495 ' OG ' HD21 ' A' ' 55' ' ' LEU . 36.3 t -161.07 -177.4 6.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.28 -15.05 59.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.369 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.637 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.8 tp -38.27 123.23 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.552 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.45 156.58 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.685 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.648 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -105.21 149.39 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -150.25 152.85 35.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.667 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.26 -47.56 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.025 0.44 . . . . 0.0 110.51 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.66 -39.93 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.63 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.637 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.41 -37.67 80.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.004 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -37.39 74.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.111 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.15 -51.94 7.06 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.48 -168.29 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-O 121.04 0.448 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.91 146.73 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.832 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.544 ' CD1' HG22 ' A' ' 76' ' ' ILE . 75.4 m-85 -129.93 149.94 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.607 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.48 -151.67 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.505 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.74 19.26 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.99 119.92 0.11 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.483 0.489 . . . . 0.0 110.631 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.66 -70.14 0.5 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.722 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 42.8 p90 -148.91 165.72 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.523 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.98 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.374 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.454 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.25 68.97 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.51 -104.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.329 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.37 165.86 32.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.599 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.62 146.02 21.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -101.47 136.31 41.53 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.57 111.22 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.73 164.86 32.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.78 148.45 23.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -27.83 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.247 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.89 -41.85 88.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -102.55 122.45 44.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.146 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.85 109.36 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.28 130.07 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.593 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.03 159.01 34.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.96 90.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.813 2.342 . . . . 0.0 111.994 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.1 m -168.97 141.56 2.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.69 -33.33 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 110.343 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.59 -62.24 1.93 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.43 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.35 -22.0 28.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.866 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.64 -25.74 54.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.286 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.87 133.28 47.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.472 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.86 -15.79 30.15 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.49 151.33 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.898 0.38 . . . . 0.0 110.378 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.09 135.14 38.28 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.99 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.658 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.65 14.34 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.8 t -130.75 161.59 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.2 tp -92.41 117.67 30.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.81 157.51 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.694 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.92 50.58 51.89 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.6 p -149.63 168.68 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.777 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 68.6 p -73.09 -27.3 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.3 -54.84 40.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.467 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.3 -54.38 47.4 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.378 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.62 -51.6 68.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.6 t80 -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.028 0.442 . . . . 0.0 110.457 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.66 -44.31 98.1 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.62 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.603 0.239 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.66 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.4 -50.83 16.98 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.392 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.2 12.74 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.11 -55.6 0.46 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.369 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.17 -10.48 25.91 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.963 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.46 -8.73 59.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.53 36.97 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.77 137.88 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.481 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.51 130.03 34.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.51 138.1 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.09 133.22 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.051 0.453 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.94 127.11 42.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -110.74 153.62 25.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.02 6.83 29.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.12 130.34 5.88 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.92 -45.67 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.484 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.84 -24.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.497 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.59 -36.38 84.04 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.14 -46.95 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.062 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.0 m-85 -63.82 -37.66 88.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.343 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.23 -42.78 99.19 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.121 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.95 -44.5 92.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.3 tp -59.0 -48.24 82.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.079 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.7 m -62.88 -22.92 67.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.09 26.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.571 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.35 11.58 71.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -17.82 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 153' ' ' LEU . 35.6 pt -128.31 137.77 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.113 0.483 . . . . 0.0 110.487 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.8 -28.36 62.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.59 155.7 1.8 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.819 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.53 50.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.064 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.53 103.15 14.13 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.08 0.467 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 46.9 tt0 -132.27 164.74 25.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.437 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -73.02 152.03 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -65.91 -54.2 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.3 -48.98 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.524 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.09 89.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.25 -63.25 1.19 Allowed 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.437 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.5 m -58.85 -47.11 86.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -50.06 -37.04 31.53 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.02 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.13 -65.85 0.55 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.71 -70.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.802 -0.234 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.65 -39.98 93.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.874 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.455 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.62 -3.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.627 . . . . 0.0 110.367 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 177' ' ' VAL . 58.6 mt-30 -124.21 141.62 37.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.807 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.87 -14.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.859 2.372 . . . . 0.0 112.319 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 175' ' ' GLN . 77.9 t -63.47 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.486 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.75 79.59 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.01 -41.35 96.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.773 0.321 . . . . 0.0 110.388 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.4 m-20 -65.9 -34.7 78.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.756 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.3 m-85 -156.98 143.26 18.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.85 99.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.758 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.2 m-85 -159.28 168.01 27.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.33 55.76 3.17 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.91 -116.99 0.01 OUTLIER Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.12 135.92 37.7 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.295 1.997 . . . . 0.0 112.016 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.0 p -124.97 -108.02 0.33 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.513 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.87 165.25 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.98 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.634 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.35 155.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.436 1.085 . . . . 0.0 110.476 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.09 118.31 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.911 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.3 mp0 -71.87 -18.74 62.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.76 -31.96 73.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.6 mt -60.99 -44.24 97.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.754 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.3 m-85 -113.69 7.2 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.724 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.53 -155.33 49.9 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.648 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.43 -25.54 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.834 0.35 . . . . 0.0 110.551 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.09 -125.84 1.5 Allowed Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.3 p -132.15 160.03 37.22 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.862 0.363 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.7 25.27 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -98.17 141.41 31.12 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 110.493 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.38 3.89 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -119.52 160.57 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.37 149.04 24.75 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.574 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.03 -48.73 64.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.809 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -40.83 -22.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.828 0.347 . . . . 0.0 110.657 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.07 51.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.66 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.38 -46.1 84.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.762 0.315 . . . . 0.0 111.108 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.43 -47.14 35.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.42 -43.7 98.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.446 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.38 -42.94 99.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.881 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.67 -37.52 73.55 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.897 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.24 -77.57 0.1 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.989 HD21 HD11 ' A' ' 44' ' ' ILE . 86.5 mt -28.63 -45.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.942 0.401 . . . . 0.0 110.813 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.4 m-20 -63.76 -45.18 90.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.54 -43.68 98.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.2 92.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.205 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.16 -43.58 98.66 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.144 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.32 92.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.85 -42.52 97.55 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.022 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.499 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.13 -38.22 73.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.65 -38.83 77.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.114 0.483 . . . . 0.0 110.415 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.53 92.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.674 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.34 0.43 56.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.783 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.67 20.2 67.91 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.8 m -57.91 -46.08 85.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.0 t80 -63.54 -57.6 9.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.88 -41.7 78.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.347 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -48.42 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.42 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.84 -41.54 97.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.366 . . . . 0.0 110.446 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.16 -49.78 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.632 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -35.86 73.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.399 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.58 -50.94 31.98 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.449 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.35 -45.23 94.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.502 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.8 m-85 -153.47 154.96 35.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.0 p-10 -98.21 96.95 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 110.509 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -154.09 -165.11 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.518 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.426 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.68 109.24 14.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.5 m -63.79 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.578 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.425 ' N ' HG23 ' A' ' 238' ' ' VAL . 83.9 m-85 -56.79 -43.63 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.1 -37.16 94.47 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.744 0 CA-C-O 117.907 -1.496 . . . . 0.0 110.938 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.7 164.66 53.36 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.763 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.0 143.83 99.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.654 2.236 . . . . 0.0 112.267 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.26 -40.59 90.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.42 142.73 37.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.05 128.71 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.029 0.442 . . . . 0.0 110.318 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.02 117.45 34.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.311 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.0 140.57 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.278 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.24 105.39 1.96 Allowed Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 77.2 m -127.76 120.8 28.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.722 -0.281 . . . . 0.0 110.617 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.3 t70 -112.73 93.99 26.57 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.31 -1.482 0 C-N-CA 122.518 2.145 . . . . 0.0 111.778 179.503 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 28.7 t0 . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 121.044 0.45 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -66.75 -40.55 86.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.985 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -61.15 -36.97 81.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.723 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.98 -45.07 87.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.426 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.27 -46.86 85.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.974 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.89 -53.82 47.25 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.516 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.21 -39.13 66.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.947 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.98 -43.15 79.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.7 m -54.4 -43.63 71.64 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.26 -47.02 81.2 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 110.328 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mmt-85 -60.35 -41.17 93.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.018 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -75.75 -18.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.755 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.52 51.92 3.9 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.76 170.14 17.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.956 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.45 141.74 28.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.006 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.4 m -117.76 132.11 56.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.573 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -127.16 126.16 42.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.01 135.96 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.48 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.99 129.21 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.076 0.465 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.04 139.97 56.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.512 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 175.41 135.07 0.17 Allowed Pre-proline 0 N--CA 1.445 -0.683 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.18 143.8 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.631 2.221 . . . . 0.0 112.705 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.903 HD23 HD12 ' A' ' 58' ' ' LEU . 82.5 mt -40.48 -54.45 2.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.036 0.446 . . . . 0.0 111.152 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.92 -26.44 2.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.54 -21.01 19.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.903 HD12 HD23 ' A' ' 55' ' ' LEU . 58.2 mt -64.14 -42.77 96.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.787 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.0 -56.46 31.49 Favored Pre-proline 0 C--O 1.242 0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.743 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 52.2 Cg_exo -55.64 -42.33 68.68 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.021 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -58.84 -44.27 90.89 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.822 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -59.06 -44.36 91.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.8 -40.86 95.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.582 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.06 11.92 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.796 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.25 -33.93 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.04 153.53 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.367 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.08 -21.33 20.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.14 158.52 24.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.495 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.562 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -116.0 128.02 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.395 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -129.52 107.42 9.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 110.222 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.538 ' OG ' HD21 ' A' ' 55' ' ' LEU . 35.2 t -162.06 -178.68 6.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.26 -15.77 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.642 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -35.53 122.46 0.63 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.6 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -80.95 154.23 27.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.694 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' CG1' ' A' ' 196' ' ' VAL . 47.4 pt -105.02 148.17 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.4 p -150.14 152.86 35.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.16 -46.85 54.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.6 -40.18 71.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.469 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.642 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.2 mtt180 -68.32 -37.99 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.023 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 84' ' ' ILE . 87.9 mt-30 -57.88 -38.0 74.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.089 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.07 -27.81 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.213 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.86 -50.79 8.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.725 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -139.78 -166.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.969 0.414 . . . . 0.0 110.496 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.79 147.45 30.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.805 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.5 m-85 -130.27 150.69 51.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.6 t -164.77 -152.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.427 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.8 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.847 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -29.95 121.72 0.17 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.664 0.603 . . . . 0.0 110.627 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 66.0 mt -78.3 -70.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.844 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CG ' HG21 ' A' ' 166' ' ' VAL . 51.4 p90 -148.7 165.56 31.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.54 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.448 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.68 67.74 0.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.621 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -86.87 -106.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.1 p -159.47 167.81 27.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.05 146.78 23.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -102.04 135.99 42.65 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.773 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.59 112.05 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.88 164.71 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.05 148.64 24.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.55 -27.96 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.03 -41.58 88.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -102.25 122.34 44.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 110.162 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.18 109.88 19.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.25 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.13 130.04 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.602 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -109.3 154.29 42.25 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.17 92.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -170.45 144.4 2.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.75 -33.88 61.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.279 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.486 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.94 -62.17 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.474 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.21 -21.85 25.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.97 -25.42 52.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.265 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.08 133.21 48.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.429 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.63 -15.75 29.02 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.07 150.87 24.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 110.284 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.29 134.34 38.19 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.15 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.58 136.33 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.606 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.67 138.77 14.45 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.7 161.5 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.048 0.451 . . . . 0.0 110.238 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.6 tp -92.54 118.1 30.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.499 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.48 156.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.59 50.64 53.44 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.7 p -149.11 167.6 25.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 67.2 p -70.92 -30.45 66.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -58.61 -54.76 43.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.509 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.58 -55.98 27.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.28 -51.53 69.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.654 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -61.71 -44.11 97.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.453 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.38 -44.38 98.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.56 -14.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.496 0.189 . . . . 0.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.48 -34.53 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.74 -50.64 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.335 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.42 12.53 36.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.747 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.2 -55.51 0.46 Allowed Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.482 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.7 Cg_endo -72.36 -10.02 25.02 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.784 2.323 . . . . 0.0 112.036 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.86 -8.79 59.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.58 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.19 33.22 36.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.62 137.62 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.977 0.418 . . . . 0.0 110.487 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.23 130.16 34.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.61 138.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.26 133.5 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -96.58 126.49 41.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.55 25.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.259 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.83 7.27 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.617 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.73 130.1 5.86 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.13 -45.6 80.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.8 0.333 . . . . 0.0 110.556 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.37 -23.49 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 110.493 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.76 -36.8 85.48 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.84 87.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.178 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.0 m-85 -64.05 -37.88 89.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.08 -42.61 98.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.157 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.67 -43.86 92.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.046 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.536 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.0 tp -59.33 -47.85 83.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.029 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.39 -22.95 67.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.124 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -18.71 25.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.516 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.11 71.76 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.58 -18.1 63.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 0.0 110.629 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -128.05 137.79 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.165 0.507 . . . . 0.0 110.518 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.75 -29.46 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -174.93 155.4 2.03 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.792 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 139.15 52.16 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 110.052 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.97 102.85 14.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.4 164.38 26.65 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.472 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.46 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.7 40.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -65.96 -54.33 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.317 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.403 HG21 ' CG ' ' A' ' 91' ' ' TYR . 71.1 t -60.19 -48.5 87.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.446 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.17 86.09 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.345 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.27 -63.26 1.24 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.364 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.456 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.9 m -58.22 -45.8 87.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.934 0.397 . . . . 0.0 110.445 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.43 -41.17 13.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.74 -61.93 0.47 Allowed Glycine 0 N--CA 1.466 0.647 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.649 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.5 t80 -40.79 -71.14 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.954 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.58 -40.97 98.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.1 tttt -59.83 -2.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.117 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.5 mt-30 -125.81 141.52 39.56 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.898 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.54 -14.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 86.9 t -63.02 -43.21 98.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.415 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.2 84.37 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.3 -40.92 95.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.832 0.349 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.12 -34.26 77.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.8 143.09 18.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.666 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -175.98 99.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.852 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.3 m-85 -158.94 167.59 28.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.585 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.9 56.18 3.14 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -52.1 -115.9 0.01 OUTLIER Glycine 0 CA--C 1.542 1.719 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.61 135.74 41.24 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.222 1.948 . . . . 0.0 111.86 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.9 p -124.58 -108.78 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.425 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.19 164.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 118.859 -0.591 . . . . 0.0 110.002 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.3 tttt 155.13 155.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.439 1.087 . . . . 0.0 110.505 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -81.06 118.16 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.858 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.6 mp0 -70.93 -19.34 62.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.38 -31.79 73.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.606 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 88.0 mt -61.1 -44.05 97.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.753 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.04 9.26 15.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.673 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.39 51.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.0 p -70.7 -25.5 26.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.448 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.0 -124.37 1.34 Allowed Glycine 0 C--N 1.33 0.226 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.0 p -130.07 157.2 43.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.651 0.263 . . . . 0.0 110.297 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.08 -168.57 29.46 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -96.09 138.35 33.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.84 105.66 2.97 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ALA . 79.0 mt -117.88 158.65 24.48 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.3 mtm180 -86.71 148.66 25.34 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.596 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.7 mttm -51.7 -47.56 63.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.92 -22.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 0.0 110.577 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.09 51.64 0.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.07 -46.55 83.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.8 0.333 . . . . 0.0 111.15 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.5 -47.12 35.01 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.27 -43.7 98.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.35 -42.96 99.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.903 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.42 -37.08 72.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 109.896 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.55 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 44' ' ' ILE . 88.2 mt -28.68 -45.17 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.943 0.401 . . . . 0.0 110.878 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.0 m-20 -64.24 -45.01 90.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.815 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.84 98.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.927 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.11 92.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.293 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.09 -43.78 98.37 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.171 0.51 . . . . 0.0 110.282 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.15 91.54 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -64.13 -42.38 96.86 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.232 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.497 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.5 mtp -57.47 -38.21 74.13 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.43 -39.18 78.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.08 0.467 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.617 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.4 p-10 -89.17 0.04 57.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.69 20.59 70.31 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.3 m -58.66 -45.68 88.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 75.2 t80 -62.22 -56.43 18.67 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.198 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.32 -40.25 77.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.234 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.7 -47.68 84.68 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.14 -40.95 97.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.875 0.369 . . . . 0.0 110.316 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.69 76.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.72 -35.92 73.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -69.17 -51.9 33.44 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.564 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 10.7 m-85 -62.38 -45.82 91.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.51 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.9 m-85 -154.14 154.61 33.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.3 p-10 -99.09 95.95 7.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.407 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 236' ' ' PHE . 14.6 p90 -151.99 -163.77 1.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.21 108.24 13.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.687 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 239' ' ' TYR . 25.6 m -63.33 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.596 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.425 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.1 m-85 -58.65 -41.65 86.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.285 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.16 -36.93 94.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.92 -1.489 . . . . 0.0 110.938 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.72 164.45 60.22 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.02 143.72 99.33 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.703 2.269 . . . . 0.0 112.226 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.29 -40.48 90.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.54 143.35 37.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.351 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.29 128.1 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.986 0.422 . . . . 0.0 110.367 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.84 118.75 37.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.252 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.99 138.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.53 100.32 1.6 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 84.8 m -123.69 118.62 27.66 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.71 -0.288 . . . . 0.0 110.854 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t0 -113.25 93.19 25.06 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.31 -1.491 0 C-N-CA 122.486 2.124 . . . . 0.0 111.905 179.549 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.2 t0 . . . . . 0 CA--C 1.526 0.047 0 CA-C-O 120.945 0.402 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.7 -40.91 82.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.098 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.78 -37.87 83.36 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.038 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.66 -43.93 87.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.18 0.514 . . . . 0.0 110.465 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.75 92.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.2 -53.31 58.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.529 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.75 -38.08 64.03 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.66 -42.23 78.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.024 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.7 m -54.47 -43.95 72.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.123 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.12 -47.05 81.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.9 mmt-85 -60.44 -40.93 92.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.025 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.13 -18.23 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.792 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.86 52.22 4.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -145.27 170.16 16.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.933 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -87.86 140.21 29.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.081 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -116.32 130.87 57.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.569 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.3 128.25 44.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.9 136.53 35.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -129.49 128.4 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.31 139.07 58.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.55 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.512 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 174.32 132.62 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.7 Cg_endo -68.11 145.03 65.62 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 112.75 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.938 HD23 HD12 ' A' ' 58' ' ' LEU . 78.1 mt -40.44 -55.53 2.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.22 -26.4 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.967 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.62 19.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.022 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.938 HD12 HD23 ' A' ' 55' ' ' LEU . 85.7 mt -64.83 -42.78 94.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.909 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.678 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.65 -56.35 33.67 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.678 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.98 -42.72 63.88 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.967 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -59.08 -44.1 91.87 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.812 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.65 -44.2 90.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.75 -40.06 94.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.15 11.32 1.54 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.503 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.02 11.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.46 -34.12 77.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.48 153.29 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.379 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -94.11 -20.25 20.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.52 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.545 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.593 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -116.56 127.87 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.33 106.54 9.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.251 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.601 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.1 t -159.19 -178.85 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.578 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.71 -15.03 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.1 tp -37.77 123.87 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.597 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.73 23.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.746 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.4 pt -105.31 148.98 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.08 152.71 35.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.756 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.25 -47.66 55.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.986 0.422 . . . . 0.0 110.61 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.14 -39.8 72.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.582 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.9 mtt180 -68.18 -37.79 81.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.3 -36.98 74.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.58 -27.58 67.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.215 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.97 -52.22 6.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -138.09 -168.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.094 0.473 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.59 146.66 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.085 0.469 . . . . 0.0 110.807 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.554 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.81 149.94 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.637 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -164.64 -151.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.4 m-20 43.25 19.36 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.3 120.11 0.12 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.552 0.533 . . . . 0.0 110.577 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.19 -69.86 0.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.794 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.415 ' CG ' HG21 ' A' ' 166' ' ' VAL . 42.9 p90 -149.39 166.18 29.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.569 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.02 122.16 27.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.389 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.468 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.38 68.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.627 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.99 -104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.414 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.1 p -159.74 165.89 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.621 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.07 146.45 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.069 0.462 . . . . 0.0 110.465 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.96 135.89 42.73 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.798 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.413 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.7 t -122.55 110.92 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.38 165.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.755 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 148.41 23.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.017 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.47 -27.43 37.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -59.5 -41.67 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.4 122.08 43.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.154 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.88 109.33 19.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.375 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.63 130.03 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.605 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.28 159.4 34.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.478 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.24 89.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.874 2.383 . . . . 0.0 112.006 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -168.79 140.84 2.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.98 -32.72 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.116 0.484 . . . . 0.0 110.268 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.502 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -57.81 -62.62 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.99 -22.06 24.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.888 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.58 -25.84 54.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.57 132.38 44.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.502 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.93 33.92 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.55 151.46 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.838 0.351 . . . . 0.0 110.447 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -97.01 136.19 37.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.27 136.68 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.672 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.54 139.5 14.74 Favored Glycine 0 CA--C 1.521 0.469 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.2 t -131.64 161.74 40.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.113 0.482 . . . . 0.0 110.281 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.3 tp -92.84 119.07 31.79 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.563 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.87 157.13 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.34 50.83 47.78 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.8 p -149.49 168.12 24.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.824 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.446 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.34 -25.54 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.445 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.27 -55.08 35.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.581 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -57.48 -54.06 51.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.408 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.3 -51.17 70.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.522 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.592 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.7 t80 -62.16 -43.83 97.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.429 . . . . 0.0 110.416 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.81 -44.41 97.91 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.9 -14.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.641 0.258 . . . . 0.0 110.642 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.25 -34.65 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.592 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.47 -50.68 17.33 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.329 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -98.94 12.82 34.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.2 -55.66 0.45 Allowed Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.428 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.2 -10.74 26.23 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.754 2.303 . . . . 0.0 112.008 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.14 -8.96 59.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.588 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.78 33.49 37.46 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.61 138.1 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.66 129.69 35.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.275 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.81 138.77 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.61 132.11 71.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.997 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.39 130.48 45.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.635 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.68 156.43 21.88 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.264 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.82 6.64 29.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.4 130.91 6.17 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.98 -45.93 79.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.32 . . . . 0.0 110.429 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.01 -23.84 63.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.456 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.455 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.67 -36.45 84.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.17 -47.28 85.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.4 m-85 -63.68 -37.67 88.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.234 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.26 -42.65 98.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.13 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.43 -45.21 91.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.002 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.54 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.7 tp -59.06 -48.24 82.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.167 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.75 -23.04 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.161 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -18.22 25.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.549 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.57 69.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.98 -18.2 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.602 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 153' ' ' LEU . 38.0 pt -128.52 137.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.165 0.507 . . . . 0.0 110.47 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.13 -28.41 62.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.49 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.4 155.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.5 137.89 51.07 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.913 0.387 . . . . 0.0 110.066 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -85.74 103.25 14.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.61 164.93 25.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.491 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.0 151.73 41.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.03 -54.23 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.32 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.1 t -60.29 -48.73 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.57 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.91 90.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.782 0.325 . . . . 0.0 110.57 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.07 -63.06 1.25 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.441 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.7 m -58.62 -46.85 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -50.23 -36.9 32.9 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.054 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.33 0.55 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 33.8 t80 -40.28 -70.98 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.765 -0.256 . . . . 0.0 111.101 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.65 -39.95 93.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.9 -3.23 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.274 0.559 . . . . 0.0 110.298 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' VAL . 55.1 mt-30 -123.91 142.23 38.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.02 -14.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.82 2.347 . . . . 0.0 112.227 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.1 t -63.0 -42.86 98.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.434 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.71 -32.96 80.64 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.13 -41.41 96.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.819 0.342 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.1 m-20 -65.96 -34.82 78.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.652 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.8 m-85 -156.72 142.91 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.54 99.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.153 0.502 . . . . 0.0 110.736 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.25 167.06 29.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.628 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.81 56.03 3.02 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.3 0.01 OUTLIER Glycine 0 CA--C 1.539 1.578 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.28 135.49 38.76 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.247 1.965 . . . . 0.0 111.862 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.3 p -124.42 -108.82 0.32 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.83 165.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.062 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.76 155.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.324 1.015 . . . . 0.0 110.51 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -81.95 118.45 22.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.861 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -72.05 -18.73 61.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.68 -32.17 73.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.64 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 128' ' ' PHE . 93.0 mt -60.95 -44.3 97.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.446 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.9 m-85 -114.08 8.38 16.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.67 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.2 -154.55 50.79 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.654 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.68 -25.65 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.815 0.341 . . . . 0.0 110.59 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.27 -125.48 1.45 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.7 p -132.15 160.19 36.76 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.66 25.05 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.24 141.06 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.908 0.385 . . . . 0.0 110.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.16 111.8 3.96 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -121.2 159.95 24.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.682 0.277 . . . . 0.0 110.287 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -86.5 149.14 25.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.66 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.15 -48.43 64.92 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -40.4 -22.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.631 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.14 52.02 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.592 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.39 -46.33 83.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.25 -47.06 37.58 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.4 -43.78 98.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.405 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.52 -42.76 99.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.897 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.81 -37.5 73.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.88 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.31 -77.42 0.11 Allowed 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.025 HD21 HD11 ' A' ' 44' ' ' ILE . 86.4 mt -28.66 -45.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.8 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.1 m-20 -63.9 -44.99 91.3 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.738 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.71 -43.63 98.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.966 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.16 92.92 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.247 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.2 -43.49 98.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.156 0.503 . . . . 0.0 110.22 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.23 92.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.271 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.11 -42.12 97.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.9 mtp -57.52 -38.07 74.04 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.78 -38.76 76.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.49 92.76 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.662 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.4 p-10 -88.19 0.63 55.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.765 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.76 19.85 67.75 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.7 m -57.93 -46.18 85.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.7 t80 -63.6 -57.61 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.925 0.393 . . . . 0.0 110.47 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.81 -41.73 78.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.352 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -48.21 82.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.96 -41.58 98.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.451 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.1 -49.84 76.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.77 -35.6 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.51 -50.95 32.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.498 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.1 m-85 -62.19 -45.61 92.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.48 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.7 m-85 -154.64 155.62 35.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 46.6 p-10 -97.56 101.24 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.444 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -157.88 -165.94 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.3 t0 -122.72 110.2 15.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.62 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.0 m -63.3 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.412 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.4 m-85 -59.22 -42.62 91.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -36.69 93.74 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 117.88 -1.511 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.83 164.38 61.53 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.73 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.24 143.64 98.42 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.738 2.292 . . . . 0.0 112.208 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.35 -40.98 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -137.96 139.68 39.84 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.371 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.83 121.26 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.472 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.56 118.23 31.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.122 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.24 138.62 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.271 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.54 106.07 2.25 Favored Glycine 0 N--CA 1.463 0.458 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -129.5 120.24 25.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.657 -0.319 . . . . 0.0 110.76 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.522 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.5 t70 -114.05 93.02 28.31 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.852 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.127 . . . . 0.0 111.925 179.342 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.444 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.3 t0 . . . . . 0 C--O 1.228 -0.069 0 CA-C-O 120.984 0.421 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.23 -40.72 83.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.029 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -60.59 -37.84 82.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.893 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.3 tp -65.19 -44.14 89.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.224 0.535 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.41 -47.34 84.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.907 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -54.25 -54.1 44.73 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.518 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.77 -39.11 61.98 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.035 0.445 . . . . 0.0 110.087 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.19 -41.93 80.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.969 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -53.95 -45.08 71.18 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.061 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.17 -46.28 84.69 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.343 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -60.7 -41.93 96.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.989 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.933 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -75.62 -17.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.712 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.84 52.57 4.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.612 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -146.41 170.94 15.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.913 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.71 142.48 27.64 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.987 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.4 m -117.39 131.86 56.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.3 m -128.33 127.81 43.39 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.474 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -94.44 135.28 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.445 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.35 128.59 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.012 0.434 . . . . 0.0 110.305 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.84 137.32 57.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.522 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.3 p30 177.23 131.86 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.19 144.74 64.03 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.664 2.243 . . . . 0.0 112.678 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.06 -56.03 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 111.272 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.11 -26.35 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.35 -20.99 18.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.139 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.7 -42.47 97.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.759 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.691 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.39 -56.86 26.58 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 123.81 0.694 . . . . 0.0 109.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.2 Cg_exo -56.21 -41.36 77.47 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.499 2.133 . . . . 0.0 110.992 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -59.26 -44.27 92.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.8 tp -59.86 -43.86 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.43 95.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.478 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.13 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.43 11.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.41 -35.43 80.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.598 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.9 pt -122.79 153.27 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.318 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.4 m-20 -92.94 -21.87 19.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.131 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.28 156.42 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.628 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.05 128.26 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.397 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.444 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.1 ttp -130.44 107.0 8.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 110.267 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.66 ' OG ' HD21 ' A' ' 55' ' ' LEU . 44.5 t -159.38 179.21 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.88 -15.18 61.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.0 tp -36.27 124.78 0.78 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.606 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.541 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -83.33 155.87 23.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.674 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.59 149.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -149.55 152.43 35.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.693 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.84 -47.46 51.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.77 -39.91 71.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.668 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.47 -37.81 80.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.043 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.95 -38.26 75.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.053 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.24 -27.51 67.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.26 -51.47 7.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.9 pt -138.21 -168.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 121.076 0.465 . . . . 0.0 110.442 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.83 147.66 29.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.4 m-85 -130.08 150.0 51.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.71 -152.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.4 m-20 42.41 20.09 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -29.17 120.77 0.14 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.66 0.6 . . . . 0.0 110.526 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -76.86 -69.63 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.868 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.44 ' CG ' HG21 ' A' ' 166' ' ' VAL . 41.4 p90 -149.4 166.3 29.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.617 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.26 122.74 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.58 69.59 0.9 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.65 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.61 -104.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.422 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.29 166.02 32.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.9 145.75 21.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 110.414 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.89 136.2 41.13 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.41 111.11 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.1 164.99 33.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.84 23.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.039 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.28 60.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.142 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.98 -41.73 88.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.251 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.1 t -102.09 122.01 43.29 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.976 0.417 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.11 109.93 19.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.333 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.0 129.94 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.539 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.93 154.23 42.0 Favored Pre-proline 0 C--N 1.334 -0.099 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.36 92.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.767 2.311 . . . . 0.0 111.907 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.7 m -171.04 144.47 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.36 -33.73 61.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.164 0.507 . . . . 0.0 110.281 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.483 ' H ' HG22 ' A' ' 108' ' ' THR . 47.8 tp10 -58.24 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.425 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.34 -22.13 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.869 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.29 -25.8 55.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.338 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.9 45.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.67 -16.5 30.67 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.94 151.21 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.382 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.91 37.72 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.41 136.61 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 139.53 14.74 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.8 t -131.83 161.74 40.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.096 0.474 . . . . 0.0 110.287 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.73 118.82 31.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.63 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -51.93 157.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.06 50.66 50.54 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.3 p -149.45 168.23 24.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.791 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.433 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.18 -25.64 59.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.431 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.25 -55.1 35.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.544 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.64 -53.92 52.74 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -60.55 -51.36 69.76 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.46 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.1 t80 -62.08 -44.01 97.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.426 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.74 -44.42 97.93 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.94 -14.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.627 0.251 . . . . 0.0 110.675 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.19 -34.84 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.43 -50.57 17.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.435 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -99.04 12.56 35.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.207 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.95 -55.7 0.46 Allowed Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.4 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.08 -10.6 26.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.778 2.319 . . . . 0.0 111.961 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.45 -8.76 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.74 33.37 38.01 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.24 137.87 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 110.532 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -87.58 129.73 35.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.233 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.6 pt -127.26 138.99 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.95 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.58 132.08 71.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.975 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.8 t -98.52 130.52 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -111.69 156.68 21.5 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.294 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.06 6.46 28.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.565 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.98 6.36 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.415 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.6 tp60 -66.19 -46.15 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.12 62.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.89 -36.54 84.7 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.29 -47.44 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.093 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.509 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.3 m-85 -63.72 -37.84 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.263 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.01 -42.19 97.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.081 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -64.19 -44.4 92.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.97 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.1 tp -58.88 -48.2 82.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -63.06 -23.01 67.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.42 -18.36 25.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.493 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.79 11.2 71.16 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.57 -18.25 63.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.659 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.8 pt -127.9 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.456 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 -28.3 62.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.999 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.41 155.62 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.574 0.546 . . . . 0.0 110.873 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.43 138.0 51.21 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.993 0.425 . . . . 0.0 110.045 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.21 103.17 14.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.041 0.448 . . . . 0.0 110.569 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.25 24.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.04 152.55 41.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.04 -54.27 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.347 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.9 t -60.39 -48.66 87.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.437 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.8 88.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 110.44 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.46 -63.63 1.09 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.413 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.4 m -59.09 -47.11 86.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.749 0.309 . . . . 0.0 110.981 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -50.17 -37.6 35.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.02 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.419 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.7 -66.15 0.56 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.657 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.3 -70.69 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.734 -0.274 . . . . 0.0 111.123 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.448 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.7 mt -61.36 -39.78 91.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -60.67 -3.36 0.69 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.412 0.625 . . . . 0.0 110.354 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 177' ' ' VAL . 54.9 mt-30 -123.27 142.25 38.08 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 122.118 -0.363 . . . . 0.0 110.845 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -44.27 -16.21 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.848 2.365 . . . . 0.0 112.275 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 74.5 t -62.82 -43.04 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.15 -33.06 82.8 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.82 -41.25 95.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 0.0 110.413 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -66.04 -34.27 77.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.509 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.4 m-85 -157.12 143.92 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.725 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.27 99.59 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.0 m-85 -159.09 167.14 29.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.614 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.69 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.44 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.539 1.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.09 135.69 37.41 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.285 1.99 . . . . 0.0 111.99 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.3 p -124.94 -108.13 0.33 Allowed 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.496 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.91 165.33 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 118.815 -0.612 . . . . 0.0 109.955 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.53 156.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.496 1.122 . . . . 0.0 110.468 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.07 118.04 22.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.917 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.1 mp0 -71.62 -18.94 62.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.3 mt -61.0 -44.19 97.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.433 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.97 8.97 17.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.56 -155.12 52.04 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.9 p -70.31 -25.26 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.61 -125.2 1.42 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.5 p -131.76 159.46 38.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 110.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.98 -162.87 24.94 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.7 139.12 34.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.945 0.402 . . . . 0.0 110.468 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.65 112.61 4.04 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.5 mt -124.76 159.5 30.81 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.752 0.311 . . . . 0.0 110.346 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.649 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.8 mtm180 -85.89 149.77 24.99 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.04 -48.29 64.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.746 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -38.57 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.708 0.289 . . . . 0.0 110.715 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.53 52.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.614 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -64.48 -46.13 84.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.742 0.306 . . . . 0.0 111.136 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.0 -47.07 39.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.57 -43.4 98.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.466 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.6 ttt-85 -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.775 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.41 -36.97 72.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.118 0.485 . . . . 0.0 109.84 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.49 -77.43 0.11 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 44' ' ' ILE . 98.0 mt -28.43 -45.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.988 0.423 . . . . 0.0 110.808 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 212' ' ' ALA . 90.0 m-20 -64.29 -45.14 89.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.78 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.69 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.89 -43.93 97.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.968 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.19 92.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.14 -43.62 98.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.162 0.506 . . . . 0.0 110.163 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.27 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.89 -42.45 97.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -57.47 -38.24 74.19 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.86 -38.95 76.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 0.0 110.421 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.91 93.94 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -88.95 1.3 55.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.803 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.68 19.86 65.5 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 77.0 m -58.11 -45.7 86.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.77 -57.69 9.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.499 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.3 -41.43 79.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.59 -48.45 80.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.483 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -41.49 98.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.448 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.48 -49.94 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.724 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.28 -35.37 73.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.379 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.96 -50.99 28.43 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.501 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.15 -45.27 94.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.8 m-85 -153.51 154.86 35.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.416 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.4 p-10 -96.78 95.5 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -153.12 -167.06 2.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.482 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.43 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.48 110.25 15.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 239' ' ' TYR . 22.0 m -63.52 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.574 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.418 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.6 m-85 -57.06 -43.94 82.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.238 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.75 -37.48 94.76 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.793 -1.559 . . . . 0.0 110.985 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 164.36 57.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.671 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -61.09 143.28 98.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.694 2.263 . . . . 0.0 112.14 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.63 -40.87 88.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.658 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -138.38 141.5 39.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.438 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.8 mt -109.21 127.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.331 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.84 118.8 37.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.315 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.71 141.81 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.83 107.08 2.16 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.7 m -128.81 120.83 27.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.68 0.276 . . . . 0.0 110.489 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 9.7 t70 -113.01 94.25 29.01 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.946 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 C--N 1.309 -1.517 0 C-N-CA 122.64 2.227 . . . . 0.0 111.786 179.457 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.8 t0 . . . . . 0 N--CA 1.461 0.09 0 CA-C-O 120.968 0.413 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.98 -39.96 82.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.2 m-20 -60.69 -37.63 82.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.982 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -65.45 -44.3 87.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.24 0.543 . . . . 0.0 110.608 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.44 -46.4 86.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.122 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.46 -53.77 49.84 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.41 -38.91 63.89 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.884 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.27 -42.64 79.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.054 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 48.9 m -53.68 -44.15 69.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -63.98 -46.95 82.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.04 0.448 . . . . 0.0 110.528 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -60.46 -41.48 94.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.146 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.023 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -75.27 -18.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.51 52.25 3.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -146.87 171.05 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.802 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.45 142.14 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -117.59 131.82 56.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.492 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.62 127.01 43.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.401 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -95.72 137.23 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.47 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.3 129.46 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.549 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -68.43 139.06 55.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.4 p30 176.21 135.25 0.19 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.2 143.32 58.64 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.671 2.248 . . . . 0.0 112.63 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 80.8 mt -39.34 -55.25 1.76 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.077 0.465 . . . . 0.0 111.078 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.73 -26.25 2.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.752 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.03 -21.37 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.846 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 55.2 mt -63.95 -42.96 97.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.379 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.688 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -62.47 -55.86 35.56 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.029 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.1 Cg_exo -55.7 -42.23 69.54 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.559 2.172 . . . . 0.0 111.257 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.4 m -58.82 -44.54 90.9 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.182 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.78 -44.65 90.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.361 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.8 -40.84 95.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.531 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.39 1.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.562 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.2 11.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.646 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.0 mttt -63.5 -33.27 75.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.699 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.56 154.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.507 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -91.49 -20.89 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.744 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.06 160.38 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 58' ' ' LEU . 96.0 mt -116.08 127.33 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.77 107.72 9.88 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.315 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.517 ' OG ' HD21 ' A' ' 55' ' ' LEU . 35.7 t -162.42 -177.13 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.4 p -64.02 -15.68 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.636 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.3 122.99 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -83.09 156.34 23.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.766 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -105.53 149.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.7 p -150.87 152.85 34.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.596 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.81 -47.69 51.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.85 -39.85 72.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.35 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.636 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -69.03 -37.36 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.908 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -58.21 -37.29 74.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 110.399 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.84 67.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.71 -51.84 7.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.739 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.58 -167.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.509 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.37 147.14 29.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.087 0.47 . . . . 0.0 110.652 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 76' ' ' ILE . 72.4 m-85 -130.47 150.6 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.652 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.0 t -165.51 -151.01 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.495 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.505 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.0 m-20 43.09 20.02 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.777 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.98 120.51 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.582 0.551 . . . . 0.0 110.678 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.5 mt -79.42 -71.31 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.801 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -148.46 165.4 31.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.23 126.25 31.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.455 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.416 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.37 67.48 0.73 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.55 -105.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.41 167.3 29.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.574 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.2 146.77 23.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -102.01 135.99 42.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.691 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.52 111.66 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.074 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.4 m -134.9 164.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.606 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.88 24.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.825 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.07 60.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.82 -42.07 88.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.287 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -101.97 122.04 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.348 . . . . 0.0 110.245 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.85 109.68 19.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.328 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.3 130.41 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.532 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -109.71 154.14 42.62 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.53 92.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.715 2.276 . . . . 0.0 112.064 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.5 m -170.86 144.8 2.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.752 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.98 -33.98 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.333 0.587 . . . . 0.0 110.432 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.74 -62.14 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.676 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.8 t -56.48 -22.21 30.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.667 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.9 -25.65 53.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.47 132.85 45.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.575 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.49 -16.5 29.8 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.79 151.22 23.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.808 0.337 . . . . 0.0 110.358 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.1 135.5 37.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.47 136.27 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.639 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.72 14.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.6 161.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.548 ' N ' HG12 ' A' ' 119' ' ' VAL . 39.5 tp -92.7 119.27 31.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -51.32 156.78 1.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.637 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.64 50.92 51.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.3 p -148.69 166.74 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.727 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.1 p -71.81 -29.67 64.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.457 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.4 mt-30 -58.77 -54.78 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.588 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.59 -55.77 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.397 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.1 -51.94 67.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.9 t80 -61.64 -44.19 97.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.468 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.49 -44.48 97.95 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.74 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.563 0.221 . . . . 0.0 110.605 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.76 2.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.593 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.37 -50.72 17.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.01 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -99.6 12.77 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.756 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.13 -55.42 0.46 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.51 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.34 -10.06 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.77 2.314 . . . . 0.0 112.093 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.72 -8.45 59.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.639 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.38 37.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.53 138.1 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.57 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.9 130.29 34.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -127.37 138.98 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.778 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.47 132.37 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.3 t -97.81 129.47 44.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.454 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -111.3 156.35 21.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.342 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.85 7.07 27.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.27 6.08 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.08 -45.9 79.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.372 . . . . 0.0 110.578 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.09 62.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.0 t-20 -64.86 -36.53 84.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.514 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.3 -47.36 84.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.0 m-85 -63.85 -37.67 88.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.5 p -61.4 -42.53 98.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.092 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.15 -44.37 92.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.343 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.0 tp -59.01 -47.86 83.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.184 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.54 -22.96 67.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.995 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.56 25.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 10.96 71.05 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.68 -18.15 63.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.704 0.288 . . . . 0.0 110.636 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.5 pt -128.18 137.81 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.13 -29.76 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -174.8 154.92 2.01 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 138.73 52.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.233 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -86.12 102.64 14.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.25 164.4 26.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.27 152.28 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.7 mt-10 -66.0 -54.43 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.077 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.84 -48.83 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.577 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.36 87.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.749 0.309 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -62.92 -62.95 1.37 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.447 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.1 m -58.29 -45.9 87.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.953 0.406 . . . . 0.0 110.49 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -45.98 -40.78 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.401 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.434 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -112.13 -62.46 0.46 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.62 -71.59 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.718 0.294 . . . . 0.0 110.747 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -62.67 -41.05 98.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.719 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.0 tttt -59.65 -3.05 0.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.169 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 177' ' ' VAL . 57.2 mt-30 -125.96 142.04 41.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.47 -15.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.803 2.335 . . . . 0.0 112.188 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 175' ' ' GLN . 89.7 t -62.5 -43.12 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.27 84.69 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.28 -40.72 95.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.511 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 49.0 m-20 -67.07 -33.6 75.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.5 m-85 -156.59 142.35 17.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.3 pttt -175.47 99.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.712 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 93.5 m-85 -158.93 167.13 30.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.544 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.69 56.13 3.2 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.95 -115.95 0.01 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.35 135.16 39.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.327 2.018 . . . . 0.0 111.931 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.8 p -124.12 -108.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.068 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.9 164.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.038 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.634 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.7 tttt 153.85 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 124.17 0.919 . . . . 0.0 110.51 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.61 119.42 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.239 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.7 mp0 -71.72 -16.34 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.0 -32.21 73.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.683 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -61.05 -44.33 97.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -114.38 8.81 16.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.15 -153.78 51.34 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.659 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.8 p -70.93 -25.53 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.559 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.91 -126.55 1.61 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.9 p -132.29 160.26 36.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.82 -161.94 24.09 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.45 140.13 33.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.542 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.52 3.57 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' ALA . 83.0 mt -118.13 159.64 22.92 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.584 0.23 . . . . 0.0 110.443 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.69 148.84 25.27 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.608 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.21 -48.68 61.97 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -41.02 -22.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.497 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.52 51.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.465 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.46 -46.28 83.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.99 -47.2 38.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.387 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.28 -42.91 99.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.71 -37.46 73.56 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.205 0.526 . . . . 0.0 110.143 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.697 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.12 -77.43 0.1 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.923 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.023 HD21 HD11 ' A' ' 44' ' ' ILE . 88.7 mt -27.95 -45.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.913 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.4 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.741 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.697 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.1 -43.54 98.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.114 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.99 91.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.453 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.23 -43.36 99.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.412 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.23 91.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.368 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.22 -42.15 96.7 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.393 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.31 -38.2 73.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.62 -38.88 77.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.537 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.54 91.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 18.9 p-10 -88.74 0.28 56.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.762 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.01 20.42 68.8 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -57.54 -46.39 83.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.2 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.06 -58.04 8.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.996 0.427 . . . . 0.0 110.485 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.75 -42.53 79.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.545 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.81 -48.8 80.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.442 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.16 -41.48 98.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.49 -50.19 74.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.745 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -34.76 72.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -71.42 -51.83 21.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.176 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.42 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 40.1 m-85 -62.73 -44.61 95.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 230' ' ' ALA . 83.9 m-85 -151.31 153.09 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.513 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 49.0 p-10 -98.21 93.92 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.464 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.89 -165.59 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.444 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -122.39 108.75 13.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.683 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 239' ' ' TYR . 28.2 m -63.53 -40.06 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.428 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.1 m-85 -57.37 -43.57 83.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.71 -37.55 94.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.219 -0.796 0 CA-C-O 117.924 -1.486 . . . . 0.0 111.005 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.3 60.14 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.99 143.47 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 122.737 2.291 . . . . 0.0 112.261 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.42 -40.91 89.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.633 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -138.0 139.0 39.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.34 121.21 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.587 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.1 118.88 32.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.6 138.67 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.369 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.7 105.29 2.11 Favored Glycine 0 N--CA 1.463 0.442 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.9 m -128.75 120.52 26.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.648 -0.325 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.509 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.7 t70 -114.35 92.85 29.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.953 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.526 0 C-N-CA 122.544 2.162 . . . . 0.0 111.974 179.404 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.946 0.403 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.15 -40.84 83.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.83 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.3 -37.77 81.58 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.19 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.38 -45.05 89.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 110.163 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.19 -48.77 77.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.915 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.65 -54.69 29.88 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.15 -40.46 61.45 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.17 -41.7 81.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.971 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.8 m -53.43 -45.18 69.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.167 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.33 -46.38 83.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.279 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -60.23 -42.31 94.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 213' ' ' LEU . 97.3 mt -75.53 -16.99 15.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.41 52.96 4.46 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.706 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.8 p -146.96 171.54 15.08 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.89 142.31 27.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.038 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.14 130.92 56.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.63 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.4 m -127.29 127.1 43.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -94.03 134.89 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.4 t -129.09 127.77 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 137.89 57.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 176.07 131.04 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.5 Cg_endo -67.84 145.31 68.24 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.684 2.256 . . . . 0.0 112.562 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 58' ' ' LEU . 81.8 mt -40.41 -56.07 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.979 0.418 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.05 -26.69 1.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.008 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -20.96 18.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 55' ' ' LEU . 58.7 mt -63.77 -42.53 97.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.641 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.3 -56.84 26.99 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.821 0.701 . . . . 0.0 109.688 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.1 Cg_exo -55.84 -41.83 73.31 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.556 2.171 . . . . 0.0 111.102 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m -59.05 -44.5 91.81 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.055 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.657 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.3 tp -59.45 -43.89 93.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.185 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.45 95.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.23 10.22 2.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.496 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.21 12.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.451 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.56 -35.38 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.549 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.43 153.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.297 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.4 m-20 -93.17 -22.27 19.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.5 155.94 27.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.607 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.08 128.63 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.123 0.487 . . . . 0.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.11 107.22 8.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.701 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -159.48 178.64 9.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.618 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.4 p -65.01 -15.34 62.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.493 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.16 124.65 0.6 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.549 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.15 154.38 25.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.63 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.5 pt -105.16 148.86 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.134 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -149.16 152.18 35.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.9 -47.15 52.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.434 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.55 -40.21 71.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.707 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.4 -37.92 80.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.072 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.78 -38.84 76.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.94 -27.43 66.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.206 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.46 -51.0 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.526 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -139.01 -168.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.072 0.463 . . . . 0.0 110.49 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.31 147.74 29.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 76' ' ' ILE . 79.5 m-85 -130.01 150.11 51.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.549 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.9 t -163.36 -153.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.437 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.3 m-20 41.55 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.933 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.72 121.38 0.2 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.478 0.486 . . . . 0.0 110.503 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 58.6 mt -75.0 -68.56 0.54 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.444 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.78 167.61 26.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.6 29.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.368 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -105.05 68.24 0.81 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.713 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.58 -104.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.9 p -159.26 165.49 33.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.639 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.05 146.45 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.112 0.482 . . . . 0.0 110.432 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.95 135.99 41.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.762 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.06 164.49 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.11 148.25 25.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.01 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.19 -28.39 58.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.05 -41.66 88.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -101.63 121.41 41.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.153 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.06 109.88 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.419 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.57 129.54 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -107.16 154.11 40.64 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.35 91.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.793 2.329 . . . . 0.0 111.946 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.3 m -170.44 143.44 2.29 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.516 0.51 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.59 -33.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.35 -62.07 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.439 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -56.6 -22.48 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.826 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.2 mt -75.89 -26.03 56.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.276 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.6 47.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.454 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.79 -16.99 28.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.01 151.34 23.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.434 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.78 135.2 37.8 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.287 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.58 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.594 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 138.45 14.26 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.6 161.56 40.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.6 tp -92.52 117.51 30.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.648 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.55 157.91 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.71 50.63 52.83 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.1 p -149.9 168.75 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.783 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.451 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.8 p -73.3 -26.88 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.458 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.49 -55.31 35.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.534 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -56.98 -54.9 41.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.8 m -60.26 -51.38 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.524 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.3 t80 -61.99 -44.08 97.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.441 . . . . 0.0 110.502 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.52 -44.55 97.84 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.54 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.657 0.265 . . . . 0.0 110.651 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.5 -34.64 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.611 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.6 -50.65 17.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 111.366 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.3 12.17 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.171 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.57 -55.29 0.49 Allowed Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.35 -10.1 25.13 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.796 2.331 . . . . 0.0 111.994 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.85 -9.02 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.25 37.09 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.33 137.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.29 129.79 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.343 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.4 138.14 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.0 133.25 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.023 0.44 . . . . 0.0 109.979 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.88 127.08 42.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.31 25.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.33 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.02 7.22 29.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.19 5.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.409 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.0 tp60 -65.81 -45.77 81.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.463 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.77 -23.47 62.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.73 -36.8 85.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.94 -46.62 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.016 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.494 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.8 m-85 -64.7 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.04 -41.86 97.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.39 -43.2 91.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.998 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.4 tp -58.77 -48.2 82.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.172 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.84 -22.48 66.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.224 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.47 -18.41 25.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.55 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.64 72.38 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.82 -17.82 63.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.645 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.5 pt -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.493 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.64 -28.0 62.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.38 155.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.517 0.511 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.01 137.21 50.15 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.022 0.439 . . . . 0.0 110.074 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -86.03 103.32 14.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.7 tt0 -132.85 165.56 24.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.446 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.474 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -72.89 153.12 41.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.69 -54.68 20.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 91' ' ' TYR . 69.3 t -60.29 -48.89 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.506 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.96 89.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.41 -62.92 1.3 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.456 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.5 m -59.56 -47.49 85.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.99 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -48.93 -37.27 19.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.113 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.03 0.55 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 168' ' ' ALA . 23.8 t80 -40.72 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.771 -0.252 . . . . 0.0 111.087 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -61.44 -40.39 94.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.38 -3.35 0.42 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.632 . . . . 0.0 110.321 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.9 mt-30 -122.82 150.09 57.87 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.69 -20.92 7.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.853 2.369 . . . . 0.0 112.231 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.79 -43.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.577 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.13 -33.28 85.31 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.48 -41.14 93.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.738 0.304 . . . . 0.0 110.459 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.6 m-20 -66.12 -32.91 74.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.2 142.64 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.557 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.44 99.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.085 0.469 . . . . 0.0 110.727 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.24 167.53 28.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.647 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.91 56.45 2.74 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.67 -118.61 0.01 OUTLIER Glycine 0 CA--C 1.535 1.337 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.55 135.7 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.395 2.063 . . . . 0.0 111.996 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.3 p -125.2 -108.32 0.32 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.435 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.12 164.56 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.065 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.65 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 154.13 155.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.346 1.029 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -81.92 117.4 22.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 195' ' ' GLY . 54.1 mp0 -71.44 -18.94 62.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.81 -32.37 73.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.565 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.8 mt -60.93 -44.58 97.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.669 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.451 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.2 m-85 -114.13 9.64 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.646 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.74 -153.86 51.8 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.63 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.74 -24.93 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.789 0.328 . . . . 0.0 110.501 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.34 -124.14 1.3 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.49 156.16 44.57 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.646 0.26 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.56 30.37 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.17 137.41 33.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.534 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.32 108.38 3.28 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.44 159.12 29.68 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.293 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.657 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.42 149.79 24.76 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.803 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.2 -47.76 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.522 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.53 -25.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.791 0.329 . . . . 0.0 110.574 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.4 52.07 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.611 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -64.49 -45.11 88.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.162 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.9 -47.39 30.21 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.46 -43.72 98.14 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.506 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.2 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.798 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.91 -36.35 70.06 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.09 -77.38 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 44' ' ' ILE . 96.6 mt -28.4 -46.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.956 0.408 . . . . 0.0 110.637 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.4 -44.84 90.02 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.779 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.02 -43.56 98.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.037 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.87 92.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.199 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.34 -43.71 98.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.126 0.488 . . . . 0.0 110.144 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.53 93.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.383 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -42.71 97.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.22 -37.85 72.85 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.2 -38.88 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.44 . . . . 0.0 110.437 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.73 94.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.17 2.13 54.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.67 63.09 Favored Glycine 0 C--O 1.225 -0.451 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.441 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 83.9 m -58.07 -45.84 86.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.0 t80 -63.7 -57.73 9.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.11 -41.46 79.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.232 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.64 -48.33 81.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.459 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.21 -41.55 98.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.829 0.347 . . . . 0.0 110.294 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.76 -50.0 75.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.92 -35.43 73.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.428 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.75 -51.21 28.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.544 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.2 m-85 -61.88 -45.83 92.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.97 155.54 35.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.09 97.43 9.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.001 0.429 . . . . 0.0 110.496 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.86 -166.49 2.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.477 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.03 110.99 16.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.0 m -63.22 -40.34 88.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.417 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.0 m-85 -58.89 -42.48 89.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.274 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.94 94.12 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.957 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.47 164.59 59.93 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.07 143.63 99.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.749 2.299 . . . . 0.0 112.276 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.11 -40.24 90.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.81 142.92 36.63 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.97 129.08 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -104.1 117.12 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.337 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -111.89 138.86 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.82 104.86 2.13 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.6 m -127.98 119.3 25.21 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 122.588 -0.36 . . . . 0.0 110.91 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.9 t70 -113.63 92.46 24.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.311 -1.44 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.54 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.472 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.8 t0 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.927 0.394 . . . . 0.0 111.573 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.7 mt -68.55 -40.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.422 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.5 m-20 -61.41 -37.66 84.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.686 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.0 -43.92 86.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.13 -41.88 93.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.909 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.67 -53.3 59.92 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.589 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.92 -37.06 63.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.117 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.86 -42.29 77.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.102 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.75 -44.59 73.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.077 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.81 -47.22 81.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.162 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -59.85 -40.97 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.054 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.985 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -76.37 -17.53 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.5 52.45 4.64 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.21 170.23 16.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.898 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.37 140.59 29.32 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.964 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.5 m -117.13 131.88 56.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.583 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -128.28 127.63 43.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -93.91 135.71 34.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.58 128.82 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.31 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.83 139.4 58.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.606 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.513 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.38 131.7 0.15 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.692 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.34 145.28 65.08 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.67 2.247 . . . . 0.0 112.591 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.886 HD23 HD12 ' A' ' 58' ' ' LEU . 82.1 mt -40.27 -56.67 1.91 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.085 0.469 . . . . 0.0 111.283 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.47 -26.74 1.47 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.57 19.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.194 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.886 HD12 HD23 ' A' ' 55' ' ' LEU . 58.7 mt -63.98 -42.56 97.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.859 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.687 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.32 -57.02 25.36 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 123.933 0.771 . . . . 0.0 109.527 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.3 Cg_exo -55.46 -42.65 65.95 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.49 2.126 . . . . 0.0 110.939 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -59.19 -43.88 92.2 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.01 -44.05 91.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.109 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.72 -40.02 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.507 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.54 11.23 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.479 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.12 11.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -34.34 77.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.1 pt -124.05 153.52 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.189 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.35 -20.59 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.4 157.32 25.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.545 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.91 127.36 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.472 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.33 106.45 9.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.309 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.585 ' OG ' HD21 ' A' ' 55' ' ' LEU . 41.4 t -160.07 -178.33 6.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.575 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.3 p -64.24 -15.38 59.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.417 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.1 tp -37.96 123.76 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.557 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.44 156.84 22.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.647 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.0 pt -105.27 149.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.131 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.3 p -149.87 152.9 35.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.751 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.44 -47.5 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.9 -40.05 72.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.691 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.01 -37.82 81.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.078 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.26 -37.37 74.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.05 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.55 -27.2 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.127 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.5 -51.91 6.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.329 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.27 -168.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.118 0.485 . . . . 0.0 110.407 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.79 29.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.94 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.0 m-85 -129.93 149.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.37 -151.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.421 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.506 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.37 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -28.27 120.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.581 0.551 . . . . 0.0 110.518 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.5 mt -77.25 -69.9 0.5 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.2 p90 -149.17 166.12 29.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.589 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.88 121.67 27.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.298 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.87 69.29 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.88 -105.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.424 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.15 165.76 33.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.615 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.47 146.02 22.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.133 0.492 . . . . 0.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.08 136.11 41.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.51 111.06 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.27 165.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.73 148.45 23.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.154 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.13 -28.22 57.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.201 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.0 -41.78 88.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.12 122.22 43.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.114 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.04 110.0 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.33 129.84 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.85 154.34 41.87 Favored Pre-proline 0 N--CA 1.457 -0.096 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.641 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.24 92.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.832 2.354 . . . . 0.0 111.82 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -170.86 144.09 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.666 0.604 . . . . 0.0 110.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.3 -33.74 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.306 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.493 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.85 -62.11 2.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.74 -21.85 31.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.893 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.8 mt -76.19 -25.93 55.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.373 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.44 47.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.459 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.17 -16.25 29.5 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.5 151.56 23.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.29 135.4 38.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.231 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.04 136.49 60.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.615 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 138.62 14.32 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.1 t -130.89 161.76 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.213 0.53 . . . . 0.0 110.205 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.3 tp -92.5 117.54 30.05 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.75 157.79 1.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.76 50.29 54.52 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.46 168.78 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.835 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.453 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 77.0 p -73.1 -27.35 61.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.418 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.45 -54.87 40.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.51 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -57.16 -54.5 46.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.408 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -60.73 -51.14 70.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.446 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.02 -43.95 97.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.986 0.422 . . . . 0.0 110.476 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.68 -44.44 97.91 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.62 -14.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.6 0.238 . . . . 0.0 110.746 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.3 -34.73 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.46 -50.66 17.44 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.478 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.13 12.45 36.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.293 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.6 0.46 Allowed Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.347 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.19 -10.45 25.83 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.793 2.328 . . . . 0.0 111.951 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.51 -8.66 59.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.72 33.53 37.6 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.79 137.99 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.987 0.423 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.71 130.08 34.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.233 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.56 138.35 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.1 t -123.04 133.19 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.0 127.26 42.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.85 153.28 25.64 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.67 6.88 30.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.96 130.49 5.95 Favored Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.93 -45.67 81.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.44 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.15 -23.98 63.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.055 0.455 . . . . 0.0 110.513 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.5 t-20 -64.7 -36.53 84.59 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.551 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.93 -47.07 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.515 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.7 m-85 -63.8 -37.66 88.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.26 -42.61 98.92 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.137 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.86 -44.96 91.53 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.0 tp -58.91 -47.72 84.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.213 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -63.25 -22.47 66.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.072 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.95 -18.33 24.88 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.459 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.48 70.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -17.87 63.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.2 pt -128.24 137.45 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.449 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.8 -27.95 62.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.57 155.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.617 0.573 . . . . 0.0 110.835 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.48 50.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.957 0.408 . . . . 0.0 110.035 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.95 103.0 14.26 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.083 0.468 . . . . 0.0 110.577 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.17 165.02 25.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.441 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.463 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.34 152.4 40.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.606 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -65.99 -54.09 30.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.35 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 68.5 t -60.45 -48.94 86.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.405 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.8 87.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.787 0.327 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.15 -63.53 1.13 Allowed 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.425 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.437 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.0 m -58.77 -46.72 86.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.756 0.313 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.1 tt0 -50.04 -37.95 35.53 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.896 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.86 -65.76 0.55 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.1 t80 -40.48 -71.08 0.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.777 -0.249 . . . . 0.0 111.213 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.47 -40.06 93.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.005 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.45 -3.28 0.42 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 110.306 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 177' ' ' VAL . 61.1 mt-30 -124.37 141.81 38.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 O-C-N 121.965 -0.459 . . . . 0.0 110.858 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.71 -14.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.823 2.349 . . . . 0.0 112.379 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.0 t -63.29 -42.96 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.445 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.89 80.62 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.72 -42.13 96.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.774 0.321 . . . . 0.0 110.318 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 60.1 m-20 -65.01 -35.23 80.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.7 m-85 -156.8 143.72 18.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.11 99.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.135 0.493 . . . . 0.0 110.798 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.15 168.49 26.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.1 55.85 3.19 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.52 -116.68 0.01 OUTLIER Glycine 0 CA--C 1.538 1.498 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.14 135.63 37.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.367 2.045 . . . . 0.0 111.963 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.0 p -125.34 -108.05 0.32 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.597 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.48 165.38 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-O 118.739 -0.648 . . . . 0.0 109.966 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.54 155.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.625 1.203 . . . . 0.0 110.616 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.19 22.99 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.823 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.4 mp0 -71.93 -18.54 62.01 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.566 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.1 mt -60.98 -44.26 97.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.799 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.453 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.3 m-85 -113.79 7.88 17.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.716 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.78 -154.49 50.04 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.7 p -70.87 -25.4 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.0 110.536 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.92 -125.88 1.52 Allowed Glycine 0 CA--C 1.517 0.211 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -132.05 159.86 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.859 0.362 . . . . 0.0 110.372 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.66 -162.59 25.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.21 141.12 31.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.97 0.414 . . . . 0.0 110.611 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.27 111.73 3.95 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.6 mt -120.55 160.3 23.46 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.93 149.28 24.9 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 120.83 0.348 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.5 -48.59 65.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.763 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.49 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -71.76 51.96 0.21 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.708 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -64.37 -46.2 84.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.11 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.48 -47.08 35.48 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.096 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.24 -43.79 98.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.459 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.57 -42.85 99.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.746 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.71 -37.55 73.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.694 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.32 -77.47 0.1 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 44' ' ' ILE . 86.9 mt -28.95 -45.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.984 0.421 . . . . 0.0 110.769 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.1 m-20 -63.69 -45.47 89.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.49 -43.74 98.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.947 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.23 92.61 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.15 -43.67 98.52 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.16 0.505 . . . . 0.0 110.112 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.98 -39.36 91.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.71 -42.67 97.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.895 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.14 -38.32 73.32 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.71 -38.76 77.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 110.447 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.01 -45.48 92.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.24 0.66 55.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.54 20.06 67.5 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 84.5 m -58.09 -46.13 86.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.58 -57.15 11.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.953 0.406 . . . . 0.0 110.451 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.23 -41.42 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.149 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.458 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.01 -41.53 98.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.413 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.99 -49.67 77.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.713 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.03 -35.82 73.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.318 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.45 -50.84 33.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.536 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.0 m-85 -62.31 -45.76 91.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.534 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.47 155.44 36.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.99 98.19 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.417 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -155.16 -165.74 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.45 109.67 14.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.74 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.3 m -63.75 -40.54 89.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.581 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.3 m-85 -57.03 -43.76 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.03 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.18 164.25 54.59 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.731 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.39 99.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.662 2.241 . . . . 0.0 112.335 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.45 -40.52 89.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.0 m-20 -139.14 142.77 38.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.398 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -109.87 127.25 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.899 0.38 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.67 120.49 40.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.87 141.88 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.927 0.394 . . . . 0.0 110.376 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.66 102.36 1.58 Allowed Glycine 0 N--CA 1.463 0.483 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.9 m -125.13 119.83 29.68 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 122.693 -0.298 . . . . 0.0 111.118 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.4 t70 -112.41 94.77 28.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 C--N 1.309 -1.532 0 C-N-CA 122.459 2.106 . . . . 0.0 112.25 179.109 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.2 t0 . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.948 0.404 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.1 mt -67.26 -40.28 84.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.886 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 55.0 m-20 -61.02 -37.3 82.07 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.709 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.0 tp -65.83 -44.68 84.86 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.15 -46.5 85.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -54.3 -54.19 43.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.387 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.06 -38.15 62.23 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.953 0.406 . . . . 0.0 110.419 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.51 -42.46 74.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.608 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -54.28 -44.42 71.89 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.044 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.63 -48.04 78.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.018 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -59.35 -41.28 88.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.096 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 213' ' ' LEU . 96.8 mt -76.28 -18.21 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.571 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.11 52.35 4.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 170.28 16.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.16 141.64 28.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.06 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -117.23 131.61 56.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.682 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -127.89 127.37 43.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.454 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.24 137.81 34.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.903 0.382 . . . . 0.0 110.399 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.56 129.52 64.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.403 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -67.65 139.97 56.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.78 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.487 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.65 135.52 0.13 Allowed Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.2 Cg_endo -68.62 144.19 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.592 2.195 . . . . 0.0 112.546 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.946 HD23 HD12 ' A' ' 58' ' ' LEU . 79.5 mt -40.75 -54.1 2.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.043 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -48.67 -26.18 2.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.15 -20.78 18.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.946 HD12 HD23 ' A' ' 55' ' ' LEU . 84.4 mt -64.72 -42.47 95.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.001 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.699 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.28 -57.31 26.58 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.744 0.652 . . . . 0.0 109.616 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.0 Cg_exo -54.65 -43.26 60.71 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.658 2.239 . . . . 0.0 111.19 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.3 m -58.27 -44.74 88.55 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.691 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.87 -44.47 91.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.194 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.81 -41.06 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.492 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.08 11.31 1.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.85 12.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -33.58 75.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.529 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 pt -124.29 154.43 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -91.75 -20.81 21.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.146 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.55 159.95 22.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 58' ' ' LEU . 96.3 mt -115.82 127.54 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.067 0.46 . . . . 0.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -129.03 107.2 9.42 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.28 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.597 ' OG ' HD21 ' A' ' 55' ' ' LEU . 46.9 t -162.17 -176.95 5.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.633 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.34 -15.94 61.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.606 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.4 tp -36.89 122.63 0.83 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -82.55 155.78 24.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.627 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.663 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.29 149.17 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.296 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.3 p -150.53 152.92 34.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.812 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.21 -47.84 54.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.967 0.413 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.5 -39.83 70.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.776 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.606 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -68.41 -37.75 80.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.67 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.852 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.88 -27.58 66.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.129 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.11 -51.55 7.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.7 -167.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.36 147.04 29.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 111.044 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 76' ' ' ILE . 72.3 m-85 -130.28 150.29 51.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.1 t -165.13 -150.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.431 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.3 m-20 42.55 19.94 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.93 121.09 0.11 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.38 0.425 . . . . 0.0 110.471 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -79.28 -71.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.782 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CG ' HG21 ' A' ' 166' ' ' VAL . 35.4 p90 -148.19 165.27 31.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.624 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.32 126.05 31.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.425 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.19 67.74 0.75 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.752 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.68 -105.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.47 167.3 29.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.634 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.23 146.59 22.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.68 135.88 42.47 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.786 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.55 111.58 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.77 164.69 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.04 148.3 24.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.14 -27.88 48.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -59.29 -41.46 89.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.35 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -102.45 122.48 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.61 109.7 19.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.434 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.2 129.97 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.6 35.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.451 . . . . 0.0 110.507 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.9 Cg_endo -60.45 91.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.783 2.322 . . . . 0.0 111.9 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.1 m -169.57 141.97 2.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 123.584 0.553 . . . . 0.0 110.75 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.07 -33.42 60.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.215 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.19 -62.77 1.53 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.294 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.0 t -56.2 -21.91 25.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.138 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.12 -26.62 56.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.307 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.04 133.22 48.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.387 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -16.25 29.64 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.34 151.18 23.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.421 . . . . 0.0 110.409 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.71 134.88 38.12 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.198 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.65 136.48 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.692 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.7 138.83 14.49 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.09 161.55 40.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.145 0.497 . . . . 0.0 110.313 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.42 118.07 30.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.563 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.57 157.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.58 50.66 53.41 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.3 p -149.05 167.96 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.831 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.5 p -71.5 -29.76 65.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.2 mt-30 -58.93 -55.13 39.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.42 -55.46 33.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.38 -51.26 70.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.77 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.598 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.5 t80 -62.06 -43.91 97.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.36 97.92 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.12 -14.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.35 2.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.598 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.31 -50.7 17.75 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.38 12.61 35.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.248 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.97 -55.46 0.47 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.37 -9.98 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.78 2.32 . . . . 0.0 111.913 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -83.0 -8.74 59.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.23 33.35 36.05 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.7 137.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.009 0.433 . . . . 0.0 110.472 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -87.58 130.26 34.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.258 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.4 137.96 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.9 t -123.03 133.33 69.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.87 126.87 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -110.67 153.65 24.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.73 7.98 28.68 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.15 130.09 5.79 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.04 -45.91 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.38 -23.51 62.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.495 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.66 -36.66 84.98 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.535 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.98 -47.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.63 -38.0 89.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.22 -42.58 98.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.182 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -64.06 -45.13 90.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.037 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.529 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.7 tp -58.47 -47.95 82.38 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.206 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.56 -22.86 67.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.005 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.9 -18.76 25.54 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.548 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.01 11.17 70.51 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.61 -18.12 63.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.593 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -128.46 137.57 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 110.444 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.64 -28.72 62.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.53 155.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.24 138.62 51.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.018 0.437 . . . . 0.0 109.96 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.48 102.98 14.58 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.214 0.531 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.93 25.2 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.468 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.83 152.23 40.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 98.0 mt-10 -66.05 -53.97 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.268 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.402 HG21 ' CG ' ' A' ' 91' ' ' TYR . 70.4 t -60.08 -49.22 84.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.42 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.96 85.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.882 0.372 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.26 1.25 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.318 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.2 m -57.98 -46.39 85.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -45.61 -41.56 10.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.389 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.503 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.52 -62.06 0.47 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.721 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.655 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.69 -71.56 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.534 0.207 . . . . 0.0 111.136 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -62.16 -41.23 98.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.5 tttt -59.98 -2.17 0.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.53 0.681 . . . . 0.0 110.318 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' VAL . 52.5 mt-30 -126.45 141.93 41.49 Favored Pre-proline 0 CA--C 1.532 0.272 0 O-C-N 122.079 -0.388 . . . . 0.0 110.733 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.65 -14.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.842 2.361 . . . . 0.0 112.397 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 175' ' ' GLN . 87.6 t -62.94 -42.89 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.17 84.33 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.38 -41.1 96.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.92 -34.9 79.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.476 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.52 142.97 18.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.0 pttt -175.88 99.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.962 0.41 . . . . 0.0 110.796 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.5 m-85 -158.68 167.11 30.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.683 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.19 55.98 3.14 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 134.98 36.06 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 111.949 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -124.32 -108.35 0.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.547 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -165.42 165.07 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 CA-C-O 119.16 -0.447 . . . . 0.0 110.156 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.8 tttt 154.13 155.24 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.283 0.989 . . . . 0.0 110.669 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.15 118.51 22.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.776 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.4 mp0 -71.17 -19.07 62.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.55 -31.81 73.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.546 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.458 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.9 mt -60.88 -44.33 97.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -114.16 8.44 16.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.819 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.44 -153.58 50.76 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.663 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.1 p -71.01 -25.65 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.71 -125.97 1.53 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.5 p -132.16 160.42 36.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.504 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.54 -162.04 24.02 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.68 139.83 33.8 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.959 0.409 . . . . 0.0 110.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.65 108.75 3.47 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.0 mt -117.72 159.41 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 0.0 110.253 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.82 149.19 25.02 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 120.886 0.374 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.61 64.16 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.645 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -40.64 -22.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.81 51.55 0.28 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -64.47 -46.03 84.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.171 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.28 -47.08 37.15 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.26 -43.65 98.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.474 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.45 -43.05 99.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.823 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.77 -37.51 73.8 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.26 -77.69 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 44' ' ' ILE . 87.3 mt -28.54 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.6 m-20 -63.43 -45.57 90.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.02 -43.84 98.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.94 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.26 92.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.077 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -61.11 -43.67 98.53 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.058 0.456 . . . . 0.0 110.015 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.34 92.07 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.058 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.67 -43.52 96.45 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.2 -38.65 71.27 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.73 -38.75 76.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.024 0.44 . . . . 0.0 110.367 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.56 91.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 20.6 p-10 -88.61 -0.02 56.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.78 20.86 68.8 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.5 m -58.05 -46.38 85.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 80.4 t80 -63.26 -57.62 9.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.443 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.05 -42.43 80.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.399 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -48.66 80.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.71 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.34 -41.38 98.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.566 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.67 -50.04 75.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.63 -34.65 73.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.719 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -71.16 -51.77 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.706 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.432 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 39.4 m-85 -62.52 -44.94 95.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.67 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 230' ' ' ALA . 84.0 m-85 -151.06 153.21 34.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 49.1 p-10 -98.34 93.6 6.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.495 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.56 -165.64 2.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.511 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.447 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.36 108.8 13.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 239' ' ' TYR . 28.9 m -63.4 -40.59 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.433 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.2 m-85 -57.3 -43.49 83.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.16 94.31 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.683 0 CA-C-O 117.876 -1.513 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.73 164.37 56.03 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.78 143.75 99.44 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 122.692 2.261 . . . . 0.0 112.3 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.24 -40.0 89.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -140.1 145.54 37.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.42 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.28 130.04 66.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -105.93 117.88 35.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.448 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -113.27 140.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.44 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.2 100.45 1.46 Allowed Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.5 m -123.66 119.3 29.42 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.66 -0.318 . . . . 0.0 111.151 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 8.1 t70 -112.33 93.98 24.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.309 -1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.16 179.303 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 . . . . . 0 C--O 1.226 -0.143 0 CA-C-O 121.004 0.431 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.85 -40.13 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.892 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.03 -37.02 81.09 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.89 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.48 -44.66 82.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.177 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.8 -41.67 91.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.095 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -57.8 -53.43 58.33 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.596 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.97 -36.16 65.07 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.314 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.93 -43.18 72.17 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -55.04 -43.6 73.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.3 -48.02 77.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.019 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.49 -40.79 88.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -76.32 -18.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.46 51.75 4.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.123 0.487 . . . . 0.0 110.799 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -144.39 169.26 18.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.75 140.36 29.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.065 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -117.31 132.29 56.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.0 m -128.16 126.88 41.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.386 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.5 136.69 34.52 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.455 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.33 129.34 64.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.346 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.67 141.19 56.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.757 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.484 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 172.65 135.86 0.1 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.497 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.56 144.19 59.75 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.644 2.23 . . . . 0.0 112.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.95 HD23 HD12 ' A' ' 58' ' ' LEU . 81.0 mt -41.17 -53.64 3.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.916 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.84 -26.11 2.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.41 19.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.143 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.95 HD12 HD23 ' A' ' 55' ' ' LEU . 84.4 mt -64.84 -42.5 94.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.963 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.705 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.42 -56.97 28.54 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.772 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.705 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.1 Cg_exo -55.18 -43.04 62.8 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.562 2.175 . . . . 0.0 111.137 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -58.32 -44.42 88.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.764 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.95 -44.48 91.45 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.65 -40.92 96.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 0.0 110.431 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.77 11.38 1.38 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.92 12.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.53 -33.81 76.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -124.71 153.73 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.323 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -92.83 -20.46 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.29 158.38 24.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.674 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.566 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.41 127.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.502 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.68 106.65 9.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.301 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.593 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.6 t -161.11 -177.97 6.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.33 -15.54 60.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.646 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.13 123.09 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.558 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -82.44 155.84 24.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.704 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.655 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.03 148.73 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.232 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.45 152.81 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.781 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.66 52.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 110.567 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.37 -39.96 70.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.646 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.61 -37.57 79.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.89 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.33 -38.09 76.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.86 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.86 -27.69 66.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.02 -51.36 7.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.957 0.408 . . . . 0.0 110.69 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -139.12 -167.83 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.1 0.476 . . . . 0.0 110.457 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.64 147.06 29.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.044 0.449 . . . . 0.0 110.966 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.1 m-85 -130.05 150.21 51.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.2 t -165.08 -150.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.3 m-20 42.52 20.08 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.7 mttt -27.79 121.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.494 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 17.6 mt -79.84 -72.49 0.4 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -147.77 164.74 32.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.2 127.67 32.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.404 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -107.19 67.34 0.69 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.12 -106.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.47 167.65 28.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.58 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.413 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.4 mt -101.03 135.96 41.64 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.786 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.87 111.03 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.72 164.41 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.956 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.64 148.69 24.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.6 -28.16 53.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.13 -41.43 88.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.266 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.31 122.25 43.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 110.218 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.71 109.71 19.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.403 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.39 130.01 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.634 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.1 158.84 34.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.568 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.5 Cg_endo -60.06 90.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.819 2.346 . . . . 0.0 111.858 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -169.17 141.43 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.538 0.524 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.76 -33.14 59.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.31 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.15 -62.56 1.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.381 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.56 -21.8 29.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.062 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.1 -26.95 56.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.347 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.87 132.82 47.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.373 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -15.93 33.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.72 151.25 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 0.0 110.45 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.06 135.35 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.998 0.427 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.63 136.5 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 137.62 13.84 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.63 161.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.118 0.485 . . . . 0.0 110.31 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.2 tp -92.75 119.38 32.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.49 156.81 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.65 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.12 50.55 50.84 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.2 p -148.87 167.83 24.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 67.1 p -71.98 -28.68 63.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.458 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -59.7 -55.33 35.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.47 -55.11 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.55 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.55 -51.12 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.69 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.3 t80 -62.03 -43.9 97.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.091 0.472 . . . . 0.0 110.434 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.25 -44.38 97.77 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.03 -14.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 0.0 110.795 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.54 -34.24 2.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.692 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.36 -51.07 16.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.959 0.409 . . . . 0.0 111.539 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.24 12.69 35.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.241 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.48 0.47 Allowed Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.341 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.23 -10.09 25.27 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.781 2.32 . . . . 0.0 111.945 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.99 -8.93 59.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.46 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.55 33.36 34.92 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.58 137.44 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.913 0.387 . . . . 0.0 110.547 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.28 130.28 34.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.59 138.32 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.37 133.33 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 109.979 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.08 127.34 42.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.57 153.85 24.57 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.97 6.68 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.68 130.43 5.82 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.07 -45.92 79.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.56 -24.27 63.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.516 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -36.69 85.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.456 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.71 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.067 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -64.3 -37.87 89.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.269 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.56 -42.29 96.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.122 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -65.77 -42.35 90.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.843 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.5 tp -59.23 -48.59 81.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.185 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.2 m -62.64 -22.39 66.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.002 0.43 . . . . 0.0 110.204 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.36 -17.9 26.47 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.562 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.58 11.56 74.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.6 -17.84 63.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.5 pt -127.41 136.65 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 110.502 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.95 -28.84 62.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.201 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.13 155.12 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.792 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.22 138.27 51.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 109.978 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.15 103.21 14.58 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.23 0.538 . . . . 0.0 110.599 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.67 25.78 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.66 152.76 40.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.54 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.24 -53.97 30.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.06 -49.02 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.365 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.81 84.22 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 110.837 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.78 1.1 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 66.6 m -57.64 -46.13 84.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.7 tt0 -46.32 -42.31 14.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.338 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.1 -61.87 0.48 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.762 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.0 t80 -40.38 -71.19 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.584 0.23 . . . . 0.0 111.214 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -62.28 -40.81 97.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 174' ' ' LYS . 86.8 tttt -59.86 -2.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.579 0.704 . . . . 0.0 110.494 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 177' ' ' VAL . 58.1 mt-30 -126.5 141.78 41.09 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.832 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -43.43 -14.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.861 2.374 . . . . 0.0 112.328 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' GLN . 90.0 t -62.87 -43.03 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.589 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.86 -33.44 85.38 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.38 96.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.731 0.301 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -65.79 -34.95 79.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.503 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.8 m-85 -156.64 143.25 18.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.737 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -176.16 99.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.746 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.5 167.01 30.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.23 55.39 3.09 Favored Glycine 0 C--O 1.225 -0.413 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.11 -116.83 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.05 134.65 36.57 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.46 2.107 . . . . 0.0 111.893 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.3 p -124.03 -108.63 0.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.542 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.43 165.01 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.637 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.4 tttt 154.61 155.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.178 0.924 . . . . 0.0 110.665 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -81.27 118.92 23.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.3 -19.1 62.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.45 -31.41 72.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.494 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -60.89 -44.4 97.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.736 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.29 8.61 16.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.722 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.22 -153.81 49.97 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 76' ' ' ILE . 12.8 p -70.65 -25.72 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.99 -126.59 1.62 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.6 p -132.21 160.24 36.7 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.26 -162.93 25.27 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.06 140.22 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.419 . . . . 0.0 110.591 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.72 108.8 3.48 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.3 mt -118.22 159.72 22.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.944 0.402 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.73 148.79 25.28 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.38 64.26 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -40.57 -22.51 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.0 110.739 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.77 51.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.748 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -64.32 -46.62 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.23 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.16 -47.09 38.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 44' ' ' ILE . 63.6 tp -62.05 -43.52 98.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.53 -43.13 99.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.799 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.56 -37.65 73.47 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.696 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.29 -77.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -28.72 -45.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.846 0.355 . . . . 0.0 110.518 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 212' ' ' ALA . 87.9 m-20 -63.66 -45.81 88.45 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.02 -44.11 97.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.33 92.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.148 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.95 -43.81 98.16 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.15 91.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.087 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -64.05 -43.59 95.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.859 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.24 -38.52 71.19 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -38.98 77.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.27 -45.55 90.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.1 p-10 -88.73 -0.71 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.21 20.44 71.19 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.5 -46.22 87.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.494 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 71.0 t80 -62.35 -56.2 20.65 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.244 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.48 -40.26 78.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.059 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.32 -47.92 83.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.491 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.08 -40.77 96.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -61.11 -49.14 78.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.01 -35.74 73.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.503 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.49 -51.39 36.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.584 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 8.8 m-85 -62.01 -46.3 89.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.52 154.92 33.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.49 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.9 p-10 -98.31 96.89 8.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.45 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.63 -164.67 2.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.555 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -121.96 108.92 13.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.734 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.5 m -63.45 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.418 ' N ' HG23 ' A' ' 238' ' ' VAL . 91.3 m-85 -58.82 -42.38 89.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.288 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -62.96 -37.93 95.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.712 0 CA-C-O 117.905 -1.497 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.85 164.26 57.51 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.642 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.08 143.82 99.13 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.625 2.217 . . . . 0.0 112.309 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.09 -40.6 90.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.578 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.21 143.7 38.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.447 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.33 129.03 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.854 0.359 . . . . 0.0 110.466 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.57 117.56 34.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.372 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 141.78 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.973 0.416 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.67 106.74 2.12 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.8 m -128.94 120.06 25.44 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.634 -0.333 . . . . 0.0 111.107 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 26.9 t0 -112.41 94.67 28.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.079 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--N 1.309 -1.538 0 C-N-CA 122.463 2.109 . . . . 0.0 112.205 179.12 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 . . . . . 0 C--O 1.227 -0.126 0 CA-C-O 121.005 0.431 . . . . 0.0 111.279 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 98.1 mt -66.85 -39.98 84.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.793 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.0 -37.01 81.02 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.787 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.91 -44.84 84.02 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.33 -45.53 87.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.02 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -54.61 -54.36 42.55 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.51 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.9 -37.53 63.87 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.475 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.31 -43.11 74.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.588 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 52.0 m -54.25 -44.0 71.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.035 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -64.01 -47.93 78.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.006 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.55 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.979 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.11 -18.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.24 52.33 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.68 170.23 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.19 141.74 28.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.101 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.57 132.19 56.56 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.78 126.6 42.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.389 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.93 136.69 34.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.31 129.18 64.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.93 139.66 56.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.779 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.4 p30 175.52 135.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.52 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.1 Cg_endo -68.65 143.71 57.51 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.644 2.229 . . . . 0.0 112.461 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.893 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -40.62 -54.78 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.032 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.43 1.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.89 -20.97 18.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.893 HD12 HD23 ' A' ' 55' ' ' LEU . 54.6 mt -63.92 -42.48 97.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.791 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.706 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.88 -57.1 26.22 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.711 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -54.93 -42.94 64.2 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.615 2.21 . . . . 0.0 111.214 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.52 -44.88 89.7 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.749 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.75 -44.48 90.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.75 -41.02 96.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.484 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.06 11.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.97 12.32 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.77 -33.83 76.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.06 154.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.261 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -91.85 -20.79 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.02 160.53 21.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.637 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 58' ' ' LEU . 96.1 mt -116.1 127.76 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.052 0.453 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.2 ttp -129.12 107.42 9.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.334 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.501 ' OG ' HD21 ' A' ' 55' ' ' LEU . 38.3 t -162.72 -176.91 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -63.89 -16.22 60.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.639 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.4 tp -36.99 122.75 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.491 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.94 155.88 23.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.712 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.5 pt -105.36 149.46 8.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.347 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.7 p -150.49 152.76 34.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.775 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.02 -47.66 53.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 110.589 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.26 -39.93 70.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.807 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.639 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -38.1 75.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.81 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.75 -27.65 66.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.078 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.08 -51.1 7.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.039 0.447 . . . . 0.0 110.73 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.15 -167.57 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.135 0.493 . . . . 0.0 110.498 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.93 147.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HG22 ' A' ' 76' ' ' ILE . 74.3 m-85 -130.35 150.49 51.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -165.28 -150.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.455 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.2 m-20 42.51 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.04 120.99 0.11 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.499 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -79.95 -72.51 0.4 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.932 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -147.81 165.11 31.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.641 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.05 127.56 32.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.387 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.19 66.99 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.591 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.27 -106.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.0 p -159.23 167.44 29.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.616 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.85 146.79 23.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 0.0 110.415 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.47 135.84 42.3 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.773 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.83 110.98 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.75 164.44 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.59 148.43 24.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.06 -28.24 50.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.248 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.09 -41.35 87.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.252 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 t -102.38 122.28 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.262 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.01 109.52 19.89 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.067 0.46 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.05 129.76 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.705 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.37 159.0 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.554 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.6 Cg_endo -60.3 90.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.74 2.293 . . . . 0.0 111.884 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.3 m -169.05 141.29 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.543 0.527 . . . . 0.0 110.73 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.83 -33.52 62.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.246 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.493 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.15 -62.57 1.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -56.02 -22.0 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.12 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.46 -26.19 55.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.317 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.2 47.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.422 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.77 -15.67 30.27 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.14 150.85 24.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.429 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.55 134.82 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 110.259 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.58 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.663 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.76 137.44 13.78 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.47 161.49 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.127 0.489 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.4 tp -92.51 119.3 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.528 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.13 156.7 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.717 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.54 53.51 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -148.41 167.3 25.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.294 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 74.8 p -70.59 -31.27 68.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.468 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -58.22 -54.97 40.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.431 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -56.27 -55.74 29.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.74 -51.24 70.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.818 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.4 t80 -62.02 -44.09 97.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.78 -44.24 98.15 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.843 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.38 2.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.09 -50.98 17.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.025 0.44 . . . . 0.0 111.578 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.23 12.74 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.306 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.768 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.37 0.47 Allowed Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.432 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.25 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.747 2.298 . . . . 0.0 111.951 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -8.85 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.484 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.39 35.79 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.48 137.52 41.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.969 0.414 . . . . 0.0 110.49 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.42 130.48 34.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.343 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.22 138.57 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.45 133.61 68.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.042 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 126.77 42.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -110.14 153.9 24.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.286 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.22 6.68 28.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.13 130.2 5.83 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.97 -45.9 80.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.2 -23.78 63.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.64 -36.72 85.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.88 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.51 -37.55 87.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.67 -41.85 95.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 -42.29 89.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.572 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.7 tp -59.21 -48.53 81.25 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.134 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.5 -22.33 66.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 0.0 110.198 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.57 -17.77 26.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.603 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.87 74.4 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.86 -18.22 63.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.612 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.5 pt -126.71 135.98 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.479 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.32 -29.34 63.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.269 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.17 155.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.95 138.85 52.22 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.97 0.415 . . . . 0.0 109.924 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -86.75 102.71 14.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.216 0.531 . . . . 0.0 110.783 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 96' ' ' ARG . 51.0 tt0 -131.94 164.58 25.82 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.386 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.471 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.55 153.27 40.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.526 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.67 -54.25 25.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.237 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.6 t -59.97 -49.08 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.84 84.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.941 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.72 1.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.455 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.444 ' OG ' HD12 ' A' ' 173' ' ' LEU . 67.0 m -57.82 -46.37 84.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.32 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.6 tt0 -46.1 -41.87 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.411 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.484 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.25 -62.11 0.48 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.707 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.2 t80 -40.3 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.786 -0.244 . . . . 0.0 111.184 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -62.14 -40.71 96.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.55 -2.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.422 0.629 . . . . 0.0 110.394 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 177' ' ' VAL . 53.5 mt-30 -126.21 141.6 40.24 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.799 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.39 -14.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.792 2.328 . . . . 0.0 112.335 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 175' ' ' GLN . 91.0 t -63.04 -43.04 98.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.88 -33.46 85.49 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.06 -41.37 96.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.0 110.444 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -65.74 -34.81 79.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.465 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -156.92 143.53 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.734 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.19 99.38 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.4 m-85 -158.9 167.01 30.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.632 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.9 55.96 3.02 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.17 -116.92 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 134.76 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.502 2.135 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.2 p -124.23 -108.5 0.33 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.24 164.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.213 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.5 tttt 154.68 155.11 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 124.041 0.838 . . . . 0.0 110.706 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -81.04 118.5 22.55 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.777 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -70.5 -18.81 62.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.51 -31.61 72.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.4 mt -60.93 -44.4 97.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.702 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.07 8.33 16.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.788 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.66 -153.52 50.42 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.659 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.5 p -70.8 -25.76 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.554 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.77 -126.98 1.68 Allowed Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.8 p -132.21 160.37 36.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.418 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.98 -161.65 23.73 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.94 140.06 33.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.925 0.393 . . . . 0.0 110.611 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.73 108.71 3.48 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -117.45 159.36 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.251 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.31 148.84 25.43 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.86 -48.46 64.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.69 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -40.85 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -72.9 51.51 0.29 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.895 0.379 . . . . 0.0 110.794 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.46 -46.3 83.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.06 -47.22 38.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.026 0.441 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.14 -43.46 98.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.464 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.7 -43.02 99.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.825 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -37.44 73.52 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.48 -77.47 0.11 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.979 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -28.52 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.3 m-20 -63.5 -45.92 88.47 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.83 -43.94 97.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.929 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.1 91.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.083 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.28 91.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.051 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.73 -43.69 95.77 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.26 -38.48 71.22 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.57 -39.04 77.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.987 0.423 . . . . 0.0 110.271 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.39 91.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.649 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.3 p-10 -89.02 -0.5 57.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.87 20.75 70.81 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.48 -46.27 87.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.499 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 73.2 t80 -62.3 -56.46 18.22 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.08 -40.42 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.176 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.53 -47.89 83.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.485 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.11 -40.96 97.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.44 77.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.501 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.93 -35.74 73.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.63 -51.45 34.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.97 -45.97 91.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.6 m-85 -155.05 154.76 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.522 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.2 p-10 -97.99 96.0 7.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.439 . . . . 0.0 110.526 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.0 -164.7 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.545 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.14 108.98 13.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.4 m -63.54 -40.64 89.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.358 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.428 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.4 m-85 -58.53 -42.6 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.39 -37.67 95.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.689 0 CA-C-O 117.848 -1.529 . . . . 0.0 111.021 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 164.13 63.33 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.643 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.05 143.6 99.19 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 122.591 2.194 . . . . 0.0 112.313 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.43 -41.13 89.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.562 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -137.93 139.44 39.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.417 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.82 121.36 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.675 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.93 118.82 32.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.178 0.513 . . . . 0.0 110.154 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.56 138.69 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.96 105.75 2.15 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.2 m -129.04 120.61 26.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 122.69 -0.3 . . . . 0.0 111.018 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.6 t70 -114.42 92.9 29.77 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--N 1.308 -1.587 0 C-N-CA 122.502 2.135 . . . . 0.0 112.07 179.244 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.469 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.9 t0 . . . . . 0 C--O 1.227 -0.098 0 CA-C-O 120.97 0.414 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.01 -40.86 83.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.873 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -60.91 -37.26 81.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.829 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.88 -45.08 87.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.12 -48.54 78.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.982 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -53.0 -54.66 31.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.33 -39.88 61.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.864 0.364 . . . . 0.0 110.298 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.67 -41.94 78.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 110.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.44 -45.19 69.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.084 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.09 -46.84 82.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.042 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -60.01 -42.28 93.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.16 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.32 -17.23 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.72 53.21 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.489 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.26 171.56 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.11 142.61 27.5 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.018 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.45 131.15 56.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.24 126.94 43.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.411 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -93.73 134.66 35.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.06 127.81 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.262 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.63 137.8 57.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.776 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 176.05 131.53 0.17 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.555 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.7 Cg_endo -68.01 144.74 65.15 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.729 2.286 . . . . 0.0 112.435 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 58' ' ' LEU . 82.4 mt -40.33 -55.55 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.42 1.94 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.04 -20.94 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.249 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -63.8 -42.42 97.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.596 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.721 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.2 -56.99 25.98 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.806 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.48 -42.41 68.26 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.59 2.193 . . . . 0.0 111.179 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m -58.7 -44.89 90.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.931 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.7 tp -59.05 -44.06 91.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.35 -40.72 96.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.956 0.408 . . . . 0.0 110.452 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.04 2.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.514 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.19 12.08 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.463 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -35.5 80.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.481 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -122.34 152.89 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.264 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.2 -22.18 19.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.61 155.99 27.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.0 129.28 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.34 106.52 8.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.395 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.706 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -158.95 178.43 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.636 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -65.4 -15.35 62.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 43.9 tp -34.82 124.65 0.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.01 153.86 25.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.645 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.637 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.8 pt -104.84 148.86 8.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.297 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -149.36 152.13 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.854 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.85 -47.28 51.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.507 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.32 -39.83 70.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.735 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.94 -37.91 79.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.84 -38.95 76.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.816 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.89 -27.42 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.096 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.42 -50.84 7.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.048 0.451 . . . . 0.0 110.655 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.18 -168.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.131 0.491 . . . . 0.0 110.456 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.43 147.66 30.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.007 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.3 m-85 -129.88 149.9 51.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.563 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.7 t -163.09 -153.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.592 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 92.8 m-20 41.34 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.945 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.62 121.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.346 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.429 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.9 mt -75.09 -68.7 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.34 167.49 26.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.76 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.5 123.55 29.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.218 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.55 68.32 0.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.47 -104.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.35 165.7 32.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.741 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.34 146.35 22.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 0.0 110.443 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.9 mt -101.08 136.12 41.44 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.988 0.423 . . . . 0.0 110.81 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.8 110.41 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.2 164.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.71 148.48 23.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.988 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.6 -27.66 40.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.226 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.29 -41.83 89.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.316 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.5 122.14 43.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.94 109.35 19.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.424 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.9 129.65 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.772 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.25 159.0 33.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.523 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.46 89.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.685 2.256 . . . . 0.0 111.904 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.6 m -169.08 140.31 2.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.31 -32.38 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.0 tp10 -57.34 -62.92 1.43 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -55.39 -22.41 19.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.62 -25.8 54.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.67 132.67 46.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.95 -16.13 28.93 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.03 151.1 23.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.84 135.37 37.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.35 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.74 136.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.648 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 137.79 13.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 56.0 t -130.51 161.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.089 0.471 . . . . 0.0 110.336 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.1 tp -92.37 118.16 30.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.535 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.03 157.75 1.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.67 50.98 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.2 p -149.68 168.89 22.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.5 p -73.53 -27.25 61.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -60.45 -55.45 33.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.48 -55.1 37.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.583 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.05 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.705 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.8 t80 -62.08 -43.91 97.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.04 -44.46 97.75 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.41 -14.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.784 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.23 -34.36 2.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.55 -50.54 17.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.18 12.48 36.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.239 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.79 -55.51 0.47 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.332 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.33 25.66 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 111.952 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.76 -9.0 59.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.32 37.65 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.598 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.51 129.87 34.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.333 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 138.29 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.923 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.25 133.21 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 109.946 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.46 127.63 43.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -110.7 153.89 24.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -106.91 7.13 29.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.72 130.73 6.06 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.405 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.95 -45.92 80.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.768 0.318 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.25 62.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.7 -36.84 85.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.543 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.97 -46.79 87.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.138 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.507 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.7 m-85 -64.45 -37.65 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.348 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.86 -42.16 97.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.023 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.99 -43.38 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.96 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.578 ' HB2' HD11 ' A' ' 158' ' ' ILE . 40.8 tp -58.98 -48.15 82.6 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.79 -22.32 66.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.955 0.407 . . . . 0.0 110.164 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.78 -18.21 25.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.07 11.92 72.04 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.17 -18.24 63.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.602 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.578 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.9 pt -127.02 135.92 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.54 -28.11 62.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.43 155.71 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.49 50.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 109.947 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.94 103.14 14.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.264 0.555 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.65 165.14 25.15 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.382 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.475 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -72.79 153.05 41.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 110.634 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.4 -54.64 22.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.39 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.27 -48.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.618 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.08 89.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.862 0.363 . . . . 0.0 110.83 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.47 -63.27 1.18 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.445 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.1 m -59.28 -47.75 84.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.916 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.98 -37.44 20.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.195 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.08 -66.36 0.55 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.1 t80 -40.27 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.663 0.268 . . . . 0.0 111.194 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.35 -40.13 93.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.78 -2.84 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.443 0.64 . . . . 0.0 110.475 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.4 mt-30 -123.37 148.79 56.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.828 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.66 -19.97 3.95 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.892 2.395 . . . . 0.0 112.148 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.14 -42.55 93.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.99 -33.21 84.86 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.72 -41.26 94.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.695 0.283 . . . . 0.0 110.399 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.59 -33.93 77.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.327 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.35 142.66 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.732 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.19 99.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.754 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.17 166.76 30.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.713 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.87 56.54 2.72 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.44 -118.27 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.41 135.68 32.48 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.511 2.14 . . . . 0.0 111.918 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.7 p -125.41 -107.79 0.32 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.591 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -166.14 165.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.334 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.671 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 156.78 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 123.983 0.802 . . . . 0.0 110.665 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.84 117.24 22.58 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.5 mp0 -71.13 -18.89 62.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.85 -32.59 74.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.568 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -60.96 -44.54 97.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.71 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.4 m-85 -114.03 9.63 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.769 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.0 -154.76 52.38 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.39 -25.1 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.527 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.22 -124.32 1.32 Allowed Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.8 p -129.32 156.19 44.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.707 0.289 . . . . 0.0 110.33 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.6 -169.61 30.42 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.1 137.44 33.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.46 108.2 3.27 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.52 159.39 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.955 0.407 . . . . 0.0 110.206 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.66 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.84 149.64 24.69 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.89 -48.2 64.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.3 tp10 -38.23 -25.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.56 52.26 0.2 Allowed 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.677 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -64.56 -45.15 88.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.8 -47.3 31.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.26 -43.94 97.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.454 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.24 -42.92 99.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.724 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -36.23 70.28 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.45 -77.51 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 44' ' ' ILE . 97.0 mt -28.46 -46.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.356 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.33 -44.96 89.91 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.636 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.96 -43.66 98.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.962 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.21 93.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -43.57 98.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.28 92.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.63 -42.74 98.13 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.53 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.31 -38.42 77.05 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.86 -39.99 79.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.188 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -45.86 93.03 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.53 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.1 p30 -86.68 1.33 52.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.489 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.42 19.71 60.27 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 69.7 m -58.35 -45.63 87.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.429 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.2 t80 -63.62 -58.01 8.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.438 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.44 78.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.349 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.6 -48.53 80.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.565 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.07 -41.49 98.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.327 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.19 74.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.73 -35.16 72.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.18 -50.97 27.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.481 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.09 -45.5 93.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.2 m-85 -153.27 155.16 36.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.7 p-10 -97.26 94.86 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.504 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -152.71 -166.43 2.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.86 110.37 15.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.799 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.1 m -63.55 -40.64 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.426 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.43 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.9 m-85 -56.62 -43.83 80.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.46 94.89 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.414 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.642 0 CA-C-O 117.895 -1.503 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.88 164.27 61.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.718 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.83 143.66 99.41 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.33 -41.02 90.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.622 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.42 139.69 39.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.56 121.43 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.07 118.51 31.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.067 0.46 . . . . 0.0 110.193 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.62 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.362 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.88 105.47 2.12 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -128.77 120.37 26.26 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.676 -0.308 . . . . 0.0 110.909 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.7 t70 -114.13 92.41 26.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--N 1.309 -1.52 0 C-N-CA 122.454 2.103 . . . . 0.0 112.187 179.209 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.9 0.381 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.25 -40.06 82.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.98 -37.64 83.17 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.959 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.71 -45.25 87.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.028 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.1 -48.51 78.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.872 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -52.85 -54.81 29.11 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.353 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -51.96 -39.99 60.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.41 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.82 -41.77 78.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.752 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.3 m -53.74 -45.08 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.063 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.13 -47.03 81.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.2 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.6 -42.38 92.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.89 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.37 -17.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.62 53.02 4.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -147.03 171.2 15.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.92 142.51 27.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.35 131.22 56.83 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -127.25 126.91 43.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.39 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.4 134.73 35.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.492 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.08 127.53 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.273 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.55 137.87 57.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.74 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 175.93 131.76 0.16 Allowed Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.593 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 57' ' ' ALA . 44.2 Cg_endo -68.26 145.12 65.04 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.743 2.295 . . . . 0.0 112.382 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 81.7 mt -40.44 -55.58 2.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 111.074 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.27 -26.43 1.98 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -21.0 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.183 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 59.3 mt -63.98 -42.42 97.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.619 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -57.47 23.48 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 123.952 0.783 . . . . 0.0 109.555 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 43.4 Cg_exo -55.01 -42.39 69.62 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.628 2.219 . . . . 0.0 111.36 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.69 -44.82 90.38 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.959 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.651 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.4 tp -59.05 -44.02 91.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.255 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.55 -40.49 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.437 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.06 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.567 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.29 12.07 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.66 -35.39 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 pt -122.39 153.0 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.231 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.32 -22.16 19.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.143 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.53 155.82 27.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.656 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.11 129.03 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.15 106.67 8.5 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.329 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.707 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -159.11 178.67 9.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.43 -15.28 62.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -34.95 124.48 0.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.62 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.2 p -81.91 153.97 26.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.634 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -104.74 148.66 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.214 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.2 152.15 35.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.73 -47.43 50.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.31 -39.85 70.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.786 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -69.1 -37.71 78.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.824 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.83 -38.87 76.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.965 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.76 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.199 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.2 -50.9 7.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.716 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.07 -168.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.102 0.477 . . . . 0.0 110.481 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.3 147.73 29.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.549 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.0 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.568 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.18 -153.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.503 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.511 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.9 m-20 41.23 20.32 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.027 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.64 0.2 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.468 0.48 . . . . 0.0 110.419 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.425 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.2 mt -75.37 -68.81 0.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -178.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.9 p90 -150.47 167.6 26.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.37 123.7 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.301 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.465 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.91 68.49 0.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.729 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.71 -104.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.5 p -159.53 165.73 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.582 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.53 145.98 21.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.178 0.513 . . . . 0.0 110.443 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.84 136.27 40.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.56 111.01 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.16 165.09 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.921 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.0 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.01 -28.47 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.237 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.84 -41.98 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.266 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -101.92 121.76 42.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.212 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.87 109.92 19.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.422 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.2 mt -127.0 129.62 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.56 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -108.17 154.32 41.34 Favored Pre-proline 0 C--N 1.333 -0.124 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.648 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.33 92.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.819 2.346 . . . . 0.0 111.768 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.7 m -171.19 144.09 2.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 123.637 0.586 . . . . 0.0 110.82 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.3 -33.58 61.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.275 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 108' ' ' THR . 47.7 tp10 -58.02 -62.48 1.79 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.07 -22.33 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.08 -25.68 55.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.54 133.11 46.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.454 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.0 -17.16 28.74 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.89 151.38 23.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 110.524 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -96.27 136.23 37.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.303 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.7 136.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.667 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 139.78 14.86 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.83 161.84 40.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.327 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.4 tp -92.72 118.05 30.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.709 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.47 157.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.584 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.68 51.45 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.7 p -149.65 168.58 23.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.6 p -74.33 -25.58 59.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.497 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.01 -55.8 28.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.537 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.04 -54.29 48.42 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.498 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.21 -51.31 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.616 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.45 -43.73 98.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.057 0.456 . . . . 0.0 110.458 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.63 -44.54 97.81 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.68 -14.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 0.0 110.745 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.07 -34.77 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.565 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.37 -50.43 18.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 111.516 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.16 12.79 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.187 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.09 -55.62 0.46 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.08 -10.44 25.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.783 2.322 . . . . 0.0 111.919 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.59 -8.97 59.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.504 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.63 33.41 38.38 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.31 138.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.031 0.443 . . . . 0.0 110.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.88 129.78 35.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.2 138.9 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.58 132.05 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.999 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.9 t -98.51 130.61 45.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.81 156.58 21.76 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.06 6.89 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.642 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.76 130.75 6.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.42 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.89 -46.01 79.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 110.429 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.81 -23.25 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.451 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.71 -36.58 84.75 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.61 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.19 -47.32 84.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.054 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.519 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.83 -37.97 89.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.0 -42.13 97.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.03 -45.4 89.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.56 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.8 tp -58.06 -48.28 80.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.327 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.2 m -63.12 -22.94 67.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.018 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.53 -18.73 24.75 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.503 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.13 70.34 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.46 -18.16 63.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.593 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.6 pt -127.88 136.88 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.069 0.462 . . . . 0.0 110.434 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.74 -27.46 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.456 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.72 155.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.851 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.12 136.94 49.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.076 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.47 103.33 14.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 110.76 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.71 23.91 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.409 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.466 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.98 152.45 41.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.506 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.27 -54.55 23.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' CG ' ' A' ' 91' ' ' TYR . 74.3 t -60.28 -49.01 85.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.342 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.77 88.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 110.76 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.21 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -59.24 -47.87 83.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.978 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.13 -37.5 22.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.125 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.432 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.84 -66.23 0.56 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.662 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.9 t80 -40.69 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.561 0.219 . . . . 0.0 111.092 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -61.1 -40.25 93.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.03 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -60.53 -2.73 0.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.448 0.642 . . . . 0.0 110.386 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.0 mt-30 -122.98 147.41 51.31 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 122.099 -0.376 . . . . 0.0 110.781 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.76 -19.7 2.32 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.864 2.376 . . . . 0.0 112.306 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.55 -42.91 95.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.531 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.17 -33.26 85.32 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.41 -41.41 93.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.77 0.319 . . . . 0.0 110.479 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.3 m-20 -65.52 -33.59 76.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.1 m-85 -155.98 142.68 18.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.9 99.52 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.2 m-85 -159.24 167.46 28.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.631 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.34 56.3 2.87 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.02 -118.03 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.3 135.39 31.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.48 2.12 . . . . 0.0 112.051 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.15 -107.93 0.33 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.555 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.75 165.35 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.053 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.652 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.32 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 O-C-N 124.34 1.025 . . . . 0.0 110.607 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.15 117.67 22.48 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.76 -18.86 62.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.89 -32.38 73.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.504 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -60.79 -44.74 96.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.685 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.467 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.6 m-85 -113.97 9.66 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.722 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.22 -154.92 52.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.634 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.51 -24.74 25.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.02 -124.12 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.43 156.33 44.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 110.289 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.53 -169.53 30.26 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.37 137.26 33.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.29 108.21 3.26 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -123.46 159.31 29.31 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.278 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.651 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.9 mtm180 -86.61 149.62 24.8 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.87 -48.34 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.554 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -37.95 -25.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.826 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.45 52.25 0.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.649 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -45.69 86.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.152 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.49 -47.3 34.06 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.114 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.35 -43.74 98.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.747 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.86 -36.66 70.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.84 -77.15 0.11 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.89 HD21 HD11 ' A' ' 44' ' ' ILE . 97.5 mt -28.91 -46.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.31 -44.99 89.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.802 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.9 -43.73 98.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.36 93.81 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.18 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.32 -43.35 99.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.58 -39.08 92.57 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.73 -42.96 97.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.87 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.527 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.4 mtp -57.82 -38.21 75.16 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.02 -39.74 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.1 0.476 . . . . 0.0 110.26 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.0 92.43 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.443 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.2 p30 -86.43 1.26 51.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.69 19.57 60.73 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 70.3 m -58.28 -45.92 87.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.425 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 79.7 t80 -63.53 -57.59 9.7 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.397 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.97 -41.64 78.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.103 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.57 -48.81 79.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.505 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.62 -41.86 98.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.865 0.364 . . . . 0.0 110.566 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.78 -49.98 75.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -35.02 72.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.376 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.14 -50.93 28.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.418 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.24 -45.37 93.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.536 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.5 m-85 -154.26 155.62 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.6 97.17 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.974 0.416 . . . . 0.0 110.468 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -154.52 -166.02 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.417 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.23 110.53 15.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.9 m -63.39 -40.32 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.541 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.417 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.3 m-85 -58.54 -42.73 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.312 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.5 -37.15 94.35 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.871 -1.516 . . . . 0.0 110.917 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.48 164.26 62.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.82 99.43 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.24 -40.46 90.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.546 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.46 142.37 37.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.419 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -109.36 128.08 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.942 0.401 . . . . 0.0 110.483 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.68 117.55 34.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.348 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.58 139.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.425 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.45 105.44 2.16 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.6 m -128.11 119.33 25.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.75 -0.265 . . . . 0.0 111.077 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.4 t70 -113.53 92.58 24.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.308 -1.591 0 C-N-CA 122.484 2.123 . . . . 0.0 112.12 179.183 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.478 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.8 t0 . . . . . 0 C--O 1.227 -0.09 0 CA-C-O 120.917 0.389 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -69.33 -40.64 80.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.931 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.2 -37.34 82.64 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.744 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.37 -43.93 84.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.151 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.97 -45.14 91.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.13 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.54 -53.95 51.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.491 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.75 -37.72 59.87 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.945 0.403 . . . . 0.0 110.419 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.45 -41.9 75.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.4 m -54.16 -44.69 71.68 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.115 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.77 -47.59 80.34 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.53 -41.27 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.153 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.0 HD11 HD21 ' A' ' 213' ' ' LEU . 96.8 mt -76.27 -17.75 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.78 52.72 4.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -145.96 170.51 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.33 141.15 28.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.163 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.13 131.46 56.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.655 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -128.12 127.76 43.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.509 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.51 136.01 35.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.526 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.2 t -129.87 128.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.06 139.08 58.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.3 131.63 0.15 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.47 145.09 63.63 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.688 2.258 . . . . 0.0 112.417 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.882 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.11 -56.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.46 -26.67 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.146 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.13 -20.78 18.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.184 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.882 HD12 HD23 ' A' ' 55' ' ' LEU . 58.5 mt -63.99 -42.51 97.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.619 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.712 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.36 -56.96 25.72 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.821 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.2 Cg_exo -54.79 -43.71 56.65 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.608 2.205 . . . . 0.0 111.353 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.59 -44.71 89.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.84 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.09 -44.24 87.52 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.153 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.58 -40.34 95.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.966 0.412 . . . . 0.0 110.517 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.29 11.22 1.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.597 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.14 11.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.51 -34.28 77.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.489 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.87 153.47 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.24 -20.81 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.11 157.25 25.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.595 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.52 127.29 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.105 0.478 . . . . 0.0 110.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.478 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.45 106.3 8.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.383 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.624 ' OG ' HD21 ' A' ' 55' ' ' LEU . 48.3 t -159.9 -178.54 7.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.35 -15.49 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.7 tp -37.48 123.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 11.1 p -83.21 156.34 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.5 pt -105.13 149.41 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.317 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -150.42 152.4 34.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.754 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.04 -47.99 53.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 110.653 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.59 -39.58 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.803 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.8 -37.56 79.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.35 -37.34 75.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.24 -27.52 67.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.165 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.35 -51.54 7.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.598 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -138.46 -168.82 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 121.062 0.458 . . . . 0.0 110.468 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.72 29.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD1' HG22 ' A' ' 76' ' ' ILE . 71.0 m-85 -129.74 149.89 51.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.3 t -164.18 -151.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.5 m-20 42.77 19.32 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.815 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -28.38 120.5 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.04 -69.83 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 46.5 p90 -149.26 166.29 29.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.57 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.22 121.19 26.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.289 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.459 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.44 69.6 1.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.89 -104.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.25 165.72 32.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.5 146.22 22.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.441 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.26 136.2 41.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.786 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.403 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.75 110.71 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.63 165.11 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.854 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.46 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.031 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.99 -27.99 48.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.232 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.01 -41.74 88.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -102.35 122.35 44.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.237 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.54 109.56 19.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.43 129.88 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.81 34.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.564 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.64 89.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.773 2.316 . . . . 0.0 111.918 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -169.29 140.76 2.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.744 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.69 -32.61 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.228 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.5 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.08 -62.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.273 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.75 -22.17 22.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.925 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.73 -25.8 53.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.271 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 132.86 46.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.456 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.72 -15.56 30.56 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.53 151.39 23.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 110.45 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.21 135.58 37.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.368 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.78 136.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.52 137.72 13.88 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.44 161.71 39.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.08 0.467 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.548 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.9 tp -92.39 117.9 30.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.78 157.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.71 50.73 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.59 168.75 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.431 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 69.3 p -73.15 -27.94 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.401 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.01 -55.37 34.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -56.21 -55.34 34.38 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.06 -50.99 71.52 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.587 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 67.3 t80 -61.94 -43.98 97.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.043 0.449 . . . . 0.0 110.474 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.97 -44.44 97.8 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.41 -14.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.7 tt0 -124.96 -34.76 2.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.707 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.587 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.38 -50.51 18.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 111.471 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -99.14 12.88 34.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.184 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.1 -55.58 0.46 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.376 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.5 25.75 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.777 2.318 . . . . 0.0 111.957 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.37 -8.97 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.47 37.25 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.74 138.26 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.9 0.381 . . . . 0.0 110.527 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.79 130.18 34.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.329 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.6 138.12 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.841 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.02 133.44 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.08 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.18 127.15 42.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.725 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 153.53 25.0 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.03 7.07 29.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.654 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.17 5.84 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.93 -45.86 80.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.317 . . . . 0.0 110.431 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.58 -23.5 62.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.522 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.78 -36.45 84.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.52 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.22 -46.87 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.04 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.45 -37.44 87.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.393 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.4 p -60.92 -41.94 97.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.177 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.64 -42.93 90.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.795 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.582 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.7 tp -58.63 -48.58 80.53 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.51 -22.18 66.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.402 . . . . 0.0 110.239 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.01 -17.75 25.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.21 73.3 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.33 -17.96 63.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.899 0.38 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 153' ' ' LEU . 32.9 pt -126.92 136.14 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.63 -29.02 63.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.07 155.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.82 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.46 137.58 50.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.025 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -85.74 102.72 13.89 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.207 0.527 . . . . 0.0 110.799 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.0 164.91 25.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.393 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.49 153.12 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.21 -54.54 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.05 -49.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.549 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.08 88.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.803 0.335 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.98 -63.73 1.08 Allowed 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.538 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.442 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -58.51 -47.42 84.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.776 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -49.3 -38.17 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.14 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.6 -66.11 0.56 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.35 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.615 0.245 . . . . 0.0 111.151 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.25 -40.03 92.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.71 -2.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.446 0.641 . . . . 0.0 110.521 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 177' ' ' VAL . 60.5 mt-30 -124.44 141.6 38.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.754 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.86 -15.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.825 2.35 . . . . 0.0 112.279 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.0 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.596 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.87 80.91 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.42 96.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.302 . . . . 0.0 110.517 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -66.07 -34.47 78.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.452 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.3 m-85 -156.96 143.27 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.75 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.4 pttt -176.92 99.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.006 0.431 . . . . 0.0 110.725 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.22 167.66 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.98 55.76 3.05 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.62 -117.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.44 135.34 32.74 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.5 2.133 . . . . 0.0 112.008 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.6 p -125.38 -107.7 0.32 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.486 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.666 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.45 165.59 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.244 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.39 156.61 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.995 0.81 . . . . 0.0 110.642 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -83.16 117.85 23.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.027 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.88 -16.73 62.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.43 -32.89 74.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.543 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.7 mt -61.02 -44.51 97.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.764 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.5 7.82 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.77 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.16 -154.16 50.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.654 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.92 -25.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.862 0.363 . . . . 0.0 110.556 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.459 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.57 -126.01 1.55 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.81 159.79 37.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 110.461 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.5 -162.41 24.61 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.503 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.59 141.07 31.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.021 0.439 . . . . 0.0 110.525 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.22 111.39 3.9 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -120.44 160.58 22.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.394 . . . . 0.0 110.235 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 149.05 24.98 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.92 -49.16 63.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.93 -22.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.004 0.43 . . . . 0.0 110.82 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.06 52.13 0.24 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.764 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.52 -46.02 84.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.18 34.71 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.1 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.2 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.513 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.54 -42.86 99.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.875 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.68 -37.41 73.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.848 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.0 HD21 HD11 ' A' ' 44' ' ' ILE . 87.2 mt -28.45 -45.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.465 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.7 m-20 -63.55 -45.63 89.66 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.33 -43.72 98.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.016 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.33 92.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.184 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.2 -43.46 98.85 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.078 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.25 92.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.162 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.75 -43.15 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.862 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.1 mtp -56.49 -38.42 71.72 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -70.04 -38.82 75.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.0 110.352 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.44 92.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.29 0.91 55.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.683 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.11 20.09 66.66 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -57.82 -46.54 84.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.8 t80 -63.34 -57.5 10.15 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -41.88 78.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.309 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.26 -48.74 79.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.518 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.57 -41.66 97.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.426 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.93 -49.94 75.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.602 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -35.54 72.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.451 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.84 -50.92 30.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.2 -45.53 92.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.58 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.5 m-85 -154.05 155.41 35.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.7 p-10 -98.08 97.66 9.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.396 . . . . 0.0 110.527 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -154.63 -165.51 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.8 t0 -122.72 109.54 14.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.1 m -63.77 -40.61 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.503 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.9 m-85 -56.55 -43.97 80.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.319 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.54 93.55 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 117.909 -1.495 . . . . 0.0 110.939 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.08 164.44 58.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.683 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.97 143.48 99.35 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.723 2.282 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.25 -40.2 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.557 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.56 36.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.443 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.46 128.23 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.423 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.0 mtp180 -103.66 118.7 37.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.34 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.64 138.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.37 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.12 99.9 1.58 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.1 m -123.58 118.76 28.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.759 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.3 t70 -113.67 92.86 25.8 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.547 0 C-N-CA 122.537 2.158 . . . . 0.0 111.913 179.439 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.1 t0 . . . . . 0 C--O 1.23 0.027 0 CA-C-O 120.974 0.416 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.19 -40.59 80.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.979 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 47.8 m-20 -60.43 -37.91 82.41 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.274 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -66.21 -43.71 85.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 110.543 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.35 -44.27 92.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.171 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -56.77 -53.48 57.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.47 -37.79 63.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.051 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.21 -42.24 76.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.994 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.36 -44.37 72.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.215 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.27 -47.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.365 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.77 -40.84 89.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.126 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.002 HD11 HD21 ' A' ' 213' ' ' LEU . 97.0 mt -76.61 -17.73 14.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.83 52.36 4.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.653 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.4 170.25 16.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.831 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.26 140.64 29.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m -116.83 131.17 57.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -128.19 128.0 43.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.523 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.31 136.19 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.542 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.54 128.15 65.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.43 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.5 139.07 57.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.513 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 173.97 132.92 0.12 Allowed Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.1 Cg_endo -68.35 144.74 63.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.703 2.269 . . . . 0.0 112.574 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.94 HD23 HD12 ' A' ' 58' ' ' LEU . 76.1 mt -40.09 -55.94 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.986 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.9 -26.48 1.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.862 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.26 -20.62 19.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.918 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.94 HD12 HD23 ' A' ' 55' ' ' LEU . 84.8 mt -65.07 -42.83 93.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.699 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.68 -55.74 39.35 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.077 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.2 Cg_exo -56.12 -42.99 60.75 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.622 2.215 . . . . 0.0 111.161 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -58.98 -44.16 91.54 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.06 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.28 -44.47 88.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.13 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.78 -40.0 94.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.493 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 11.24 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.532 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.25 11.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.76 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.49 -33.86 76.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.643 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.48 153.27 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -94.58 -20.66 19.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.977 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.92 26.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 97.0 mt -116.73 128.18 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.506 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.3 ttp -128.43 106.22 8.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.411 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.624 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.6 t -158.68 -179.73 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.63 -14.62 58.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.503 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.0 tp -37.55 124.18 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.584 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.557 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.14 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.644 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.66 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.4 pt -104.93 148.96 8.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.184 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.4 p -150.63 152.62 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.679 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.08 -48.01 53.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.47 -39.98 71.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.579 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.77 -37.52 79.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -36.93 74.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.233 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.45 -27.53 67.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.292 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.23 -51.74 7.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.68 -168.55 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.4 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.71 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.599 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -164.61 -151.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.49 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.8 m-20 43.23 19.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.686 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.89 120.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.354 0.409 . . . . 0.0 110.532 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -77.34 -70.07 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.756 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.5 p90 -149.16 165.99 30.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.553 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.79 121.07 26.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.463 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.57 69.99 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.663 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -86.54 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.429 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.51 165.78 32.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.54 146.08 22.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.64 136.14 41.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.61 110.88 28.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.011 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.76 164.87 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.712 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.82 148.39 23.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.841 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.62 -27.67 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.309 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.16 -41.82 89.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.329 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.33 122.18 43.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.361 . . . . 0.0 110.254 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.34 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.394 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 129.88 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.44 159.2 33.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.6 Cg_endo -59.63 89.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.802 2.335 . . . . 0.0 112.02 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -168.93 140.91 2.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.21 -32.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.38 -62.56 1.68 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.61 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.0 t -56.07 -22.19 26.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.678 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.3 mt -76.99 -25.38 52.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.76 132.73 46.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.474 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.27 -16.03 31.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.48 151.59 23.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -96.52 135.63 38.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.393 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.04 136.66 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.639 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.36 138.8 14.43 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.7 t -131.04 161.59 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.965 0.412 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.6 tp -92.42 117.49 29.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.555 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.73 157.87 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.82 50.57 52.47 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.97 169.0 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.4 p -73.79 -26.33 60.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.497 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -60.69 -55.31 34.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.564 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.89 -54.64 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.421 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.17 -51.38 69.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.571 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.5 t80 -62.08 -43.76 98.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.416 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.8 -44.33 98.02 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.58 -14.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.615 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.32 -34.4 2.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.71 -51.03 15.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.13 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.12 12.98 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.996 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.61 -55.46 0.44 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.45 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.32 -10.39 25.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.834 2.356 . . . . 0.0 112.051 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.61 -8.73 59.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.623 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.9 33.47 37.0 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.87 138.22 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.6 129.79 34.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.421 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.9 pt -125.96 137.78 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.01 132.92 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.427 . . . . 0.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.75 43.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.617 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -110.89 153.67 25.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.373 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.8 6.95 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.19 130.68 5.97 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.01 -45.76 80.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.91 -24.08 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.69 -36.37 84.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.2 -47.13 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.3 m-85 -63.58 -37.8 88.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.364 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.22 -42.63 98.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.46 -45.42 90.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.227 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.544 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.9 tp -58.62 -48.1 82.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.256 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.0 m -63.18 -22.94 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.013 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.3 25.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.86 11.34 70.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.75 -17.84 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.8 pt -128.78 137.98 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.23 -28.02 61.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.481 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.61 155.49 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.689 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.85 50.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.153 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -85.71 103.05 14.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.58 165.11 25.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.451 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.471 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.26 151.97 41.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.7 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -65.71 -54.17 30.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 91' ' ' TYR . 68.6 t -60.04 -49.12 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.03 89.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.772 0.32 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.42 1.16 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.483 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.416 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.4 m -58.67 -47.2 85.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.95 -37.34 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.117 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.483 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.14 -65.8 0.55 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.675 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.0 t80 -40.73 -70.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.646 0.26 . . . . 0.0 110.989 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.778 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -59.47 -3.19 0.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.176 0.512 . . . . 0.0 110.377 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 177' ' ' VAL . 50.6 mt-30 -124.58 141.34 37.56 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -43.43 -14.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.844 2.362 . . . . 0.0 112.165 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.0 t -63.07 -42.8 97.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.445 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.87 -33.02 81.69 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.06 -41.35 96.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.793 0.33 . . . . 0.0 110.446 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.16 -34.46 78.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.555 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.8 m-85 -156.96 142.89 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.645 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.71 100.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.049 0.452 . . . . 0.0 110.72 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.5 m-85 -159.41 167.52 28.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.613 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.18 56.06 3.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.04 -116.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.84 135.03 35.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.436 2.091 . . . . 0.0 111.911 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.7 p -124.6 -108.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -166.39 165.17 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.662 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.66 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 O-C-N 123.951 0.782 . . . . 0.0 110.494 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.22 118.3 23.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.066 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.5 mp0 -72.13 -18.68 61.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -64.04 -31.87 73.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.636 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.7 mt -60.83 -44.57 96.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.683 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.46 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.7 m-85 -113.88 7.35 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.641 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.2 -155.32 50.37 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.66 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.19 -25.54 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.16 -125.57 1.46 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -132.07 160.12 36.87 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.412 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.23 -163.2 25.71 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -97.66 141.01 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.15 4.0 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -122.04 160.75 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.285 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 148.97 25.03 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.654 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.75 -48.83 63.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.714 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -39.88 -23.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.784 0.326 . . . . 0.0 110.544 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.0 m-20 -71.78 52.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.623 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.43 -46.27 83.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.16 34.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.42 -43.74 98.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.53 -42.84 99.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.005 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.44 -37.3 72.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.027 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.46 0.11 Allowed 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 44' ' ' ILE . 87.9 mt -28.2 -45.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.659 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.1 m-20 -63.83 -45.46 89.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.661 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.51 98.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.114 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.46 93.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.33 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.12 -43.39 98.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.241 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.36 92.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.98 -42.39 97.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.228 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.13 -38.29 73.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.9 -38.77 76.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.0 110.417 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.46 92.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.6 p-10 -88.57 0.59 56.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.1 67.95 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.7 m -57.6 -46.16 84.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.6 t80 -63.65 -57.93 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 110.53 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.56 -41.68 77.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.7 -48.53 80.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.8 -41.62 97.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.397 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.07 -49.81 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.75 -35.65 73.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -70.78 -50.98 30.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.273 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.16 -45.85 91.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.1 m-85 -153.53 155.48 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.431 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.2 p-10 -98.01 99.23 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -156.4 -165.59 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.493 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.7 t0 -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.6 m -63.76 -40.23 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.572 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.8 m-85 -56.76 -44.11 81.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.304 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.33 -36.54 93.54 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.917 -1.49 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.21 61.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.698 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.79 143.53 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 122.727 2.285 . . . . 0.0 112.308 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.404 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.39 -40.89 89.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.586 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.65 139.48 38.51 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.359 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.41 121.5 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.665 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.18 118.49 31.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.106 0.479 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.09 138.56 40.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.404 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.83 105.94 2.2 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.9 m -129.32 120.41 25.59 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 122.694 -0.298 . . . . 0.0 110.953 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.501 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.4 t70 -114.18 92.58 27.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.545 0 C-N-CA 122.454 2.103 . . . . 0.0 112.197 179.188 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.2 t0 . . . . . 0 CA--C 1.529 0.148 0 CA-C-O 120.917 0.389 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.03 -40.35 83.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.971 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.03 -37.58 83.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.909 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.74 -45.25 87.25 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -56.96 -48.63 77.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.881 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.85 -54.71 30.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.356 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -52.21 -39.94 60.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 110.412 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.73 -41.83 78.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.71 -45.29 70.4 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.074 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.93 -47.03 82.13 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.064 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.61 -42.35 92.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.89 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.41 -17.1 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.655 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.63 53.11 4.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.548 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.06 171.27 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.876 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -89.02 142.56 27.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.46 131.15 56.79 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.19 126.92 43.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.386 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -93.36 134.67 35.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.523 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.04 127.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.285 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.31 137.99 57.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.2 p30 175.89 131.34 0.16 Allowed Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.539 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.2 Cg_endo -68.23 145.22 65.52 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.677 2.251 . . . . 0.0 112.437 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.877 HD23 HD12 ' A' ' 58' ' ' LEU . 82.8 mt -40.29 -55.79 2.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -48.33 -26.25 1.94 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.9 18.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.877 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.96 -42.38 97.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.16 -57.43 23.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 123.872 0.733 . . . . 0.0 109.485 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -54.93 -42.39 69.5 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.62 2.214 . . . . 0.0 111.267 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.9 m -58.76 -44.87 90.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.873 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.656 HD21 ' HG3' ' A' ' 203' ' ' ARG . 62.4 tp -59.1 -44.01 91.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.219 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.47 -40.53 95.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.82 9.96 2.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.24 12.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.471 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.59 -35.46 80.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.29 153.19 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.58 -21.98 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.178 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.63 155.74 26.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.777 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.06 128.95 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.176 0.513 . . . . 0.0 110.441 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.0 ttp -131.06 106.47 8.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.716 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.4 t -159.1 178.53 9.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.22 -15.41 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -34.84 124.23 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.606 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.87 153.87 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.613 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.58 148.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -149.12 152.09 35.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.799 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.72 -47.28 50.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.35 -39.7 70.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -69.31 -37.57 77.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.755 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.89 -39.07 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.819 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.73 -27.63 66.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.24 -50.67 8.19 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.729 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.2 pt -139.39 -168.11 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.088 0.47 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.118 0.485 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.9 m-85 -130.0 150.0 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.554 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.05 -153.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 94.2 m-20 41.17 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.088 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.59 121.79 0.2 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.39 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.9 mt -75.6 -68.94 0.52 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.11 167.38 26.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.729 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.3 123.78 29.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.233 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.89 68.55 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.792 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.01 -104.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.45 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.53 165.7 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.41 146.04 22.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.16 0.505 . . . . 0.0 110.444 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -100.96 136.26 41.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.832 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.416 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.72 110.41 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.1 165.16 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.72 148.34 24.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.84 -27.38 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.177 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.33 -41.86 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.323 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.58 122.37 44.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.146 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.4 19.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.84 130.1 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.67 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.67 159.06 33.75 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.576 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.84 89.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.81 2.34 . . . . 0.0 111.939 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -169.27 140.68 2.39 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.523 0.514 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.8 -32.84 59.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.276 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.14 -62.74 1.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.307 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 t -55.96 -22.2 25.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -76.44 -25.9 54.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.323 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.7 133.11 46.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.388 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.89 -15.93 29.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.56 151.36 23.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.458 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.89 135.48 37.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.014 0.435 . . . . 0.0 110.336 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.54 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.51 138.59 14.33 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.87 161.65 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 121.102 0.477 . . . . 0.0 110.314 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.3 tp -92.35 117.53 30.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.682 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.64 157.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.663 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.52 53.56 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.68 168.93 22.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.775 0.321 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.3 p -73.54 -26.85 61.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.54 -55.57 31.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.53 -54.9 40.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.575 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.21 -50.88 71.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.56 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.0 t80 -62.23 -43.82 97.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.92 -44.54 97.69 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.27 -14.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.825 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.28 -34.57 2.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.598 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.4 -50.59 17.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 111.557 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -99.15 12.47 36.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.83 -55.51 0.47 Allowed Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.24 -10.27 25.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.791 2.327 . . . . 0.0 111.923 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -9.01 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.495 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.42 37.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.51 138.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.986 0.422 . . . . 0.0 110.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.48 129.75 34.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.32 138.14 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.23 133.15 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.077 0.465 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.39 127.67 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.99 153.74 25.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.245 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.09 7.42 29.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.645 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.75 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.6 tp60 -65.97 -45.91 80.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.468 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.58 -23.32 62.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.89 -36.71 85.25 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.12 -47.08 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.078 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.518 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.2 m-85 -63.61 -38.06 89.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.271 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.14 -42.27 98.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.04 -45.34 89.27 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.6 tp -58.3 -48.17 81.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -63.25 -22.77 67.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.242 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.74 24.94 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.13 11.46 69.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -18.15 63.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.94 0.4 . . . . 0.0 110.618 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.2 pt -128.29 137.36 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.397 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.89 -27.24 61.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.83 155.87 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.527 0.517 . . . . 0.0 110.838 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.05 136.83 49.8 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 109.967 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -85.2 103.05 13.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.831 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.5 tt0 -132.52 165.5 24.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.409 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.81 152.31 41.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.549 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.2 mt-10 -66.27 -54.46 24.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.33 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.1 t -60.29 -48.98 86.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.395 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.93 88.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.821 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.45 -63.1 1.22 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -59.4 -47.99 83.34 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.003 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.9 tt0 -49.06 -37.33 20.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.47 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.82 -66.32 0.56 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -71.23 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 122.745 -0.268 . . . . 0.0 111.17 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 175' ' ' GLN . 94.9 mt -61.01 -40.31 93.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -60.1 -2.79 0.47 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.538 0.685 . . . . 0.0 110.457 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.47 HE21 ' C ' ' A' ' 171' ' ' GLY . 43.0 mt-30 -123.36 148.95 56.74 Favored Pre-proline 0 N--CA 1.453 -0.306 0 O-C-N 122.011 -0.431 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.48 -20.41 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.933 2.422 . . . . 0.0 112.299 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.01 -43.24 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.588 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.59 -33.05 83.55 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.57 -41.4 94.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.733 0.302 . . . . 0.0 110.412 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.9 m-20 -65.55 -33.81 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.438 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.3 m-85 -156.19 143.0 18.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.1 pttt -177.15 99.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.093 0.473 . . . . 0.0 110.73 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.1 166.82 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.59 56.57 2.77 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -118.05 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.28 135.98 31.44 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.412 2.075 . . . . 0.0 112.015 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.47 -107.9 0.32 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.647 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.68 165.31 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.144 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.29 156.15 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.25 0.969 . . . . 0.0 110.62 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.15 117.57 22.4 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.863 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.61 -18.78 62.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.99 -32.35 73.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.518 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.4 mt -60.94 -44.62 97.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.746 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.9 m-85 -114.0 9.59 17.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.783 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.19 -154.92 52.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.53 -24.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 110.428 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 159.93 -124.16 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.3 p -129.4 156.45 44.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.712 0.292 . . . . 0.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.64 -169.42 30.22 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -94.39 137.3 33.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.922 0.391 . . . . 0.0 110.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.25 107.77 3.21 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.4 mt -123.06 159.22 28.9 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.906 0.384 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.656 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.87 149.57 24.72 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.85 -48.34 64.04 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.527 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.5 tp10 -37.98 -25.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.94 0.4 . . . . 0.0 110.842 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.47 52.2 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.622 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -64.39 -45.68 86.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.274 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.54 -47.23 34.06 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.26 -43.91 97.74 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.18 -43.0 99.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.01 -36.39 70.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.1 -77.31 0.11 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.89 HD21 HD11 ' A' ' 44' ' ' ILE . 98.3 mt -28.86 -46.08 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.958 0.408 . . . . 0.0 110.506 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.31 -44.94 90.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.782 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.5 tttm -62.08 -43.63 98.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.993 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.06 93.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.15 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.23 -43.39 98.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.994 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.26 92.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.53 -43.26 97.65 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.508 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.79 -38.32 72.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.99 -38.9 76.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 110.378 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.619 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.51 1.09 56.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.676 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.47 20.64 65.9 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.3 m -58.2 -45.97 86.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.8 t80 -63.93 -57.86 8.49 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.441 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.83 -41.83 78.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.2 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.44 -48.72 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.532 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.69 -41.88 98.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.87 0.367 . . . . 0.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.13 74.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.84 -34.9 72.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.22 -50.82 29.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.394 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.4 -45.83 91.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.552 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 66.6 m-85 -153.85 155.79 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.05 98.08 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.982 0.42 . . . . 0.0 110.412 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -155.59 -165.59 2.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.33 110.67 15.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.585 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.0 m -63.57 -40.47 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.46 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.8 m-85 -58.5 -42.55 87.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.281 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.26 -37.04 94.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.702 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 164.38 59.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.647 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.89 143.39 99.35 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.05 -40.31 90.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.82 142.81 36.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.5 mt -109.88 128.73 65.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.468 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -103.6 117.0 33.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.34 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -111.83 139.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.409 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.09 105.08 2.14 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -128.14 118.98 24.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.71 -0.289 . . . . 0.0 111.069 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.521 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.1 t70 -113.53 93.15 26.26 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.309 -1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.301 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.2 t0 . . . . . 0 C--O 1.227 -0.13 0 CA-C-O 120.931 0.396 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.88 -40.71 81.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.104 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -61.3 -37.35 82.92 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.754 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.43 -43.99 84.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.985 0.422 . . . . 0.0 110.259 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.91 -41.84 92.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.111 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -58.74 -53.61 56.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -36.73 62.61 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 110.332 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.4 -42.37 75.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.824 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.49 -44.48 72.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.116 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.97 -47.61 79.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.42 -41.03 88.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.984 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.4 -17.59 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.6 52.74 4.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.489 . . . . 0.0 110.651 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.08 17.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.885 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.36 140.84 29.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.153 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -117.31 132.01 56.69 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.632 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.43 127.73 43.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.89 135.78 34.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.64 128.44 65.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.368 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 139.41 58.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.521 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.06 131.99 0.14 Allowed Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.3 Cg_endo -68.49 145.21 63.9 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.297 . . . . 0.0 112.426 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.886 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.49 -56.66 2.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.1 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.19 -26.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.64 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.232 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.886 HD12 HD23 ' A' ' 55' ' ' LEU . 57.1 mt -63.97 -42.43 97.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.68 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.703 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.44 -56.89 26.1 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.696 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.5 Cg_exo -55.0 -43.32 60.65 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.595 2.197 . . . . 0.0 111.113 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -58.52 -44.64 89.58 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.763 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.52 -44.37 89.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.095 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.54 -40.5 95.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.11 11.08 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.13 11.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.44 -34.33 77.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.94 153.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.43 -20.35 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.128 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.55 157.64 25.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.18 127.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.523 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.42 106.79 9.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.383 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.58 ' OG ' HD21 ' A' ' 55' ' ' LEU . 41.2 t -160.28 -178.06 6.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.3 -15.52 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.391 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -37.97 123.88 1.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.62 156.82 22.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.594 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.645 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.02 149.3 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.301 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.0 p -150.3 152.28 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.735 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.94 52.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.021 0.438 . . . . 0.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.47 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.887 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.73 -37.57 79.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.912 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.34 -27.85 67.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.142 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.92 -51.98 7.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -138.19 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.1 0.476 . . . . 0.0 110.433 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.78 29.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.038 0.447 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.5 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.627 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.39 -151.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.512 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.1 m-20 43.29 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.11 119.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.6 mt -77.19 -70.07 0.49 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.9 p90 -149.35 166.33 29.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.91 122.51 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.297 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.85 68.86 0.93 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.762 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.69 -104.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.429 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.4 p -159.05 165.74 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.656 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.24 146.22 22.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.117 0.484 . . . . 0.0 110.353 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.06 135.99 41.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.7 110.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.5 m -134.29 165.03 32.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.938 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.84 148.67 23.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.3 -28.48 58.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.247 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -58.93 -41.76 88.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.281 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -101.94 122.03 43.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.75 109.86 19.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.28 129.73 70.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.579 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.5 153.97 41.81 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.672 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.3 Cg_endo -59.05 92.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -171.08 144.11 2.06 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.604 0.565 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.14 -33.55 61.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.287 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.301 -178.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.1 t -56.95 -21.99 34.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.962 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.43 -27.08 58.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.94 133.43 48.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.46 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.19 -17.34 28.7 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.31 151.76 23.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.902 0.382 . . . . 0.0 110.431 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.58 38.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.372 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.15 136.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.622 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.34 139.32 14.65 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.3 161.63 40.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.097 0.475 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.73 117.61 30.18 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.627 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.56 157.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.15 50.71 49.73 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.8 p -149.71 168.85 22.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.2 p -73.83 -25.78 60.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -61.1 -55.39 33.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.435 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.34 -53.81 53.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.77 -51.32 69.84 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.586 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.1 t80 -62.19 -43.9 97.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.85 -44.58 97.66 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.782 0.325 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.19 -34.56 2.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.667 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.39 -50.73 17.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 111.562 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.19 12.46 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.209 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.7 -55.56 0.48 Allowed Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.375 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.23 25.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.001 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.85 -8.78 59.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.44 37.02 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.31 137.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.81 129.94 35.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.8 138.56 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 63.1 t -123.92 133.65 68.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 109.935 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -95.57 127.56 41.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.55 150.62 27.22 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.251 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.96 6.05 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.13 131.37 5.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.401 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.5 tp60 -65.69 -45.7 81.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 110.415 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.85 -24.24 63.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.55 -36.52 84.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.0 -46.62 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.001 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.8 m-85 -64.37 -37.75 88.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.339 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.79 -42.12 96.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.181 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -65.58 -43.28 90.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.3 tp -58.58 -48.92 79.33 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.18 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -62.15 -22.52 65.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.382 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.91 25.62 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.544 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 12.12 73.1 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.99 -17.42 63.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.563 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.2 pt -127.39 136.48 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 110.42 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.92 -28.1 62.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.38 155.1 1.79 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.853 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.65 137.1 50.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.039 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -85.55 102.5 13.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.144 0.497 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.4 tt0 -131.6 165.0 24.62 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.377 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.44 153.11 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.47 -54.29 25.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.337 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.0 t -60.22 -49.17 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.438 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.82 87.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.13 -63.51 1.13 Allowed 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.572 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -58.78 -47.27 85.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -49.25 -38.4 26.74 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.48 -66.02 0.56 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.0 t80 -40.32 -71.04 0.09 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.608 0.242 . . . . 0.0 111.229 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.2 -40.07 92.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.959 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.65 -2.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 177' ' ' VAL . 53.8 mt-30 -124.27 141.77 38.3 Favored Pre-proline 0 C--N 1.33 -0.244 0 O-C-N 122.079 -0.388 . . . . 0.0 110.845 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -43.95 -15.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.871 2.381 . . . . 0.0 112.277 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 175' ' ' GLN . 79.4 t -62.97 -42.83 98.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.95 81.37 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.75 -41.58 95.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.726 0.298 . . . . 0.0 110.479 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.8 -34.49 78.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.578 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.6 m-85 -157.25 143.96 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.4 pttt -177.81 100.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.075 0.464 . . . . 0.0 110.782 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.9 m-85 -159.06 168.18 27.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.01 55.57 3.09 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.68 -117.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.83 135.22 35.48 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.487 2.125 . . . . 0.0 112.008 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.0 p -125.08 -108.14 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.54 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.64 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.178 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.53 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 124.17 0.919 . . . . 0.0 110.634 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.2 118.23 22.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.791 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.87 -18.57 62.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.05 73.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.464 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.4 mt -60.97 -44.36 97.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.743 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.435 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.68 7.58 17.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.697 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.99 -154.84 50.21 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.645 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.7 -25.39 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.56 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.456 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.05 -126.14 1.55 Allowed Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -131.97 159.92 37.3 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.427 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.65 -162.39 24.7 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -98.5 141.02 31.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.621 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.81 3.96 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.4 mt -120.64 160.54 23.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.307 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.95 148.98 25.1 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.18 -49.04 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.662 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -39.89 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.89 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -71.91 52.13 0.23 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.5 -46.16 84.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.18 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.46 -47.07 35.68 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.27 -43.92 97.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.459 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.55 -42.89 99.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.6 -37.36 73.1 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.64 -77.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.984 HD21 HD11 ' A' ' 44' ' ' ILE . 87.4 mt -28.72 -45.65 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.858 0.361 . . . . 0.0 110.481 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.4 m-20 -63.59 -45.64 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.6 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.77 98.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.968 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.26 -43.33 99.05 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.105 0.479 . . . . 0.0 110.071 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.41 93.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.074 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.62 -43.01 98.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.78 -38.37 72.39 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.81 -38.79 76.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.47 . . . . 0.0 110.373 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.41 92.81 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 21.0 p-10 -88.36 0.38 56.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.743 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.56 20.11 67.59 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.6 m -58.04 -46.22 85.7 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.1 t80 -63.42 -57.46 10.21 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.448 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.91 -41.78 78.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.245 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.3 -48.67 79.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.48 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.51 -41.73 97.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.39 -49.68 76.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.692 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.87 -35.26 72.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.465 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.72 -51.16 29.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.39 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.17 -45.92 91.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.581 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.0 m-85 -154.11 155.14 34.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 46.4 p-10 -97.84 101.21 12.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.476 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -157.51 -165.44 1.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.63 109.94 14.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.6 m -63.63 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.412 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.2 m-85 -58.27 -43.6 88.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.217 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.65 -36.76 93.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.418 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.657 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.983 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.12 164.47 56.69 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.82 143.34 99.36 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.624 2.216 . . . . 0.0 112.29 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.49 -40.23 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.554 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.69 36.86 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.7 128.58 66.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.5 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -104.83 118.59 36.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 110.362 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.7 138.52 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.89 99.58 1.55 Allowed Glycine 0 N--CA 1.463 0.495 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.6 m -123.41 117.68 25.74 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.696 -0.297 . . . . 0.0 111.255 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.516 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 12.8 t0 -112.85 93.04 22.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.309 -1.534 0 C-N-CA 122.424 2.083 . . . . 0.0 112.188 179.373 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.5 t0 . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.976 0.417 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.55 -41.37 82.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.119 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.71 -37.57 82.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.094 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.47 -43.96 84.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.188 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.02 -41.75 92.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.133 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.7 -53.32 59.69 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.554 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.08 -36.56 63.29 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.266 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.0 mt -69.53 -42.37 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.772 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.62 -44.02 72.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.3 tttm -64.07 -47.65 79.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -59.82 -40.81 89.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.948 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.36 -18.24 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.616 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.79 52.51 4.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 110.618 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -144.99 169.94 17.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.9 139.93 30.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.056 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -116.52 131.31 56.98 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.9 m -128.47 128.03 43.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.74 136.44 35.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.75 128.72 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.343 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.84 139.37 58.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.781 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.89 132.81 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.519 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.4 Cg_endo -68.55 144.92 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.562 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.939 HD23 HD12 ' A' ' 58' ' ' LEU . 76.9 mt -40.81 -55.81 2.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.41 -26.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.173 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.46 -20.18 19.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.939 HD12 HD23 ' A' ' 55' ' ' LEU . 86.5 mt -64.93 -42.45 94.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.959 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.52 -56.91 28.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.685 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.4 Cg_exo -55.35 -43.24 60.43 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.586 2.191 . . . . 0.0 111.035 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -58.68 -44.41 90.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.2 tp -58.53 -44.31 89.52 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -64.55 -40.36 95.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.996 0.426 . . . . 0.0 110.434 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 11.22 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.565 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.95 11.84 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.17 77.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.494 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.7 pt -124.54 153.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.281 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.284 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.95 156.88 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.755 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -117.11 128.0 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 110.534 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.477 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.38 106.51 9.05 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.399 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.608 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.2 t -159.66 -179.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.3 -15.31 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.391 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.0 tp -37.78 123.86 1.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.07 156.37 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.3 pt -104.87 148.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.9 p -150.04 152.5 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.27 -47.69 55.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.604 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.72 -39.71 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.788 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.27 -37.83 81.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.928 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.29 75.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.59 67.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.076 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.12 -51.76 7.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.6 pt -138.45 -168.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.88 146.87 29.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.87 150.0 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.641 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.2 t -164.41 -151.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.444 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.1 m-20 43.07 19.3 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.8 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mttt -28.27 120.22 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -77.26 -69.99 0.5 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.825 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 40.3 p90 -149.4 166.25 29.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.08 123.39 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.466 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.47 67.97 0.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.5 -104.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.436 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.2 p -159.58 165.99 31.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.7 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.52 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.144 0.497 . . . . 0.0 110.456 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.3 135.86 42.1 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.409 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.9 t -122.67 110.45 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.28 165.11 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.935 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.19 148.61 23.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.97 -27.84 46.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.191 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -59.1 -41.8 88.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.221 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.45 122.14 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.129 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.54 109.26 19.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.068 0.461 . . . . 0.0 110.398 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.18 129.88 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.73 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.98 159.05 34.01 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.53 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.1 Cg_endo -59.63 89.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.707 2.271 . . . . 0.0 111.943 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.6 m -169.23 140.91 2.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.546 0.529 . . . . 0.0 110.786 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.55 -32.58 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.227 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.19 -62.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.375 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.2 t -56.11 -22.18 26.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.124 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.96 -26.81 57.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.345 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.71 132.84 46.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.436 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.41 -15.92 32.43 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -87.1 151.78 22.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.71 135.89 38.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.075 0.464 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.99 136.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.738 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 138.93 14.5 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.24 161.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.068 0.461 . . . . 0.0 110.386 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.1 tp -92.71 117.95 30.54 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.51 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.58 49.15 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.7 p -149.67 168.98 22.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.94 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.44 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.3 p -74.01 -25.73 60.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.401 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.21 -55.44 32.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.468 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.09 -54.06 51.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.57 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.46 -51.01 71.31 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.702 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.25 -43.86 97.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.11 0.481 . . . . 0.0 110.44 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.21 -44.55 97.55 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.27 -14.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.801 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.38 2.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.43 -50.75 17.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 111.653 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -98.98 12.54 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.32 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.9 -55.58 0.47 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.377 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.16 -10.44 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.825 2.35 . . . . 0.0 111.959 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.61 -8.84 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.496 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.89 33.45 37.09 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.54 138.06 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.65 129.73 35.03 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.307 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.52 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.11 133.56 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.026 0.441 . . . . 0.0 109.959 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 127.97 42.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -108.29 150.45 27.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.165 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.37 5.61 34.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.68 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.44 131.87 6.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.63 -45.76 81.83 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.411 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.61 -24.43 63.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 56.9 t-20 -64.45 -36.69 85.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.79 -46.56 88.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.43 -37.6 88.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.315 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.88 -42.5 98.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.2 -43.13 92.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.884 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.0 tp -59.17 -48.37 81.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.5 m -62.69 -22.26 66.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.915 0.388 . . . . 0.0 110.026 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.89 -17.71 26.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.63 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.54 11.95 73.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.78 -17.57 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.609 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.0 pt -127.53 136.62 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.993 0.425 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.01 -28.28 62.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.36 155.27 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.802 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.61 137.44 50.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 109.95 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.66 102.95 14.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.239 0.542 . . . . 0.0 110.714 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.14 165.14 24.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.377 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.24 152.35 41.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.601 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.2 -54.13 28.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.343 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.4 -49.17 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.512 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.85 88.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 110.867 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.01 -63.49 1.14 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.589 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.9 m -58.67 -47.01 85.92 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.792 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.66 -38.05 30.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.057 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.474 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.68 -65.59 0.55 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.2 t80 -40.63 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.644 0.259 . . . . 0.0 111.394 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.4 mt -61.38 -39.87 92.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.81 -2.92 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.537 0.684 . . . . 0.0 110.499 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 177' ' ' VAL . 51.2 mt-30 -124.43 142.1 39.39 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.09 -0.382 . . . . 0.0 110.891 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -44.06 -15.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.808 2.339 . . . . 0.0 112.299 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.5 t -63.09 -43.03 98.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.632 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.62 -32.86 79.84 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.31 95.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 47.7 m-20 -65.8 -34.92 79.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.5 m-85 -157.04 143.54 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -177.22 100.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 110.728 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -159.31 167.5 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.699 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.31 55.52 3.05 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.45 -117.46 0.01 OUTLIER Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.93 135.5 36.23 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.465 2.11 . . . . 0.0 111.932 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 89.4 p -124.95 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.601 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.657 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -165.79 165.37 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.185 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.49 156.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 124.169 0.918 . . . . 0.0 110.649 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.14 118.28 22.94 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.73 -18.63 62.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.9 -32.36 73.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.57 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.452 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.6 mt -60.86 -44.25 97.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.44 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.8 m-85 -114.05 8.36 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.719 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.12 -154.7 51.04 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.651 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.71 -25.51 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.869 0.366 . . . . 0.0 110.551 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.0 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.4 p -131.97 160.06 36.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.827 0.346 . . . . 0.0 110.41 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.42 24.6 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.87 32.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.914 0.387 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.86 3.96 Favored Glycine 0 C--N 1.329 0.179 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.6 mt -121.28 160.27 24.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.94 0.4 . . . . 0.0 110.164 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.81 149.08 25.09 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.881 0.372 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.37 -48.6 65.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.669 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.94 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.015 0.436 . . . . 0.0 110.831 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.1 m-20 -71.89 52.17 0.23 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -64.42 -46.03 84.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.313 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.7 -46.94 34.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.241 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.25 -43.87 97.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.438 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.728 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.73 -37.35 73.41 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.702 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.38 0.11 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 44' ' ' ILE . 85.5 mt -28.91 -45.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.471 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.6 m-20 -63.61 -45.28 91.03 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.49 -43.79 98.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.095 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.15 -43.52 98.75 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 110.046 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.29 92.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.064 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.9 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.0 -38.32 72.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.84 -38.79 76.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 110.322 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.28 93.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.656 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.33 0.31 56.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.727 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.55 20.25 67.71 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.28 -46.15 86.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 77.2 t80 -63.44 -57.36 10.51 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.372 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.99 -41.46 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.236 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.62 -48.36 81.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.598 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.88 -41.61 98.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.402 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.62 -49.79 76.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.639 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.56 -35.35 72.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.529 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.57 -51.07 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.544 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.7 m-85 -62.28 -45.7 92.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.617 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.2 m-85 -154.3 154.82 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.0 p-10 -97.79 100.13 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.409 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -156.25 -165.39 1.9 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.58 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.6 t0 -122.5 109.89 14.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.2 m -63.39 -40.46 89.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.416 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.0 m-85 -59.06 -42.53 90.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.304 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.25 -37.08 94.3 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.659 0 CA-C-O 117.872 -1.516 . . . . 0.0 110.975 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.04 164.33 61.94 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.595 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.84 143.53 99.39 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.574 2.182 . . . . 0.0 112.32 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.41 -40.78 89.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.09 141.22 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.442 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.8 mt -109.27 127.43 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 110.567 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.28 117.71 35.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.12 0.486 . . . . 0.0 110.277 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.16 138.55 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.922 0.391 . . . . 0.0 110.537 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.59 105.25 2.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.4 m -128.3 119.52 25.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.676 -0.308 . . . . 0.0 111.242 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 10.8 t0 -113.44 92.59 23.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.308 -1.597 0 C-N-CA 122.44 2.093 . . . . 0.0 112.12 179.353 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 121.028 0.442 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.9 -41.02 84.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.845 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -60.88 -37.24 81.5 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.945 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -65.1 -45.07 86.7 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.2 -48.01 79.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.993 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.3 -54.27 38.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.352 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.75 -39.59 62.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.85 0.357 . . . . 0.0 110.308 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.0 -42.16 76.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 110.622 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.74 -44.62 70.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.128 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -63.83 -47.38 81.01 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.84 -41.68 91.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.914 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -75.56 -18.09 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.552 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.04 52.76 3.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.505 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -146.6 171.21 15.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.69 141.31 28.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.073 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.4 m -116.8 130.42 56.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.0 m -126.81 126.93 44.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -93.88 135.5 35.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.581 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.53 128.32 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.324 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.04 139.67 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.525 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.0 OUTLIER 173.93 129.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.4 Cg_endo -67.5 146.32 73.81 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.753 2.302 . . . . 0.0 112.471 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.862 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -40.45 -56.57 2.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.148 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.97 -26.82 1.91 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 111.271 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.75 -20.69 19.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.294 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.862 HD12 HD23 ' A' ' 55' ' ' LEU . 60.6 mt -64.42 -42.27 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.717 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.715 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.19 -56.76 28.13 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.7 Cg_exo -55.36 -44.06 52.52 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.628 2.219 . . . . 0.0 111.141 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.4 m -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.692 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.94 -44.24 86.82 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.6 -40.17 95.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.5 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.26 11.19 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.82 12.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.24 -34.28 77.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 178.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 pt -123.76 152.93 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.218 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.44 -20.65 20.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.302 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.38 156.51 26.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.59 HG23 HD13 ' A' ' 58' ' ' LEU . 96.8 mt -115.47 126.99 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.016 0.436 . . . . 0.0 110.475 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.31 106.04 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.309 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.681 ' OG ' HD21 ' A' ' 55' ' ' LEU . 45.6 t -159.67 -179.84 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.589 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.66 -15.48 61.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.379 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.8 tp -36.23 123.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.52 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.555 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -81.66 154.6 26.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -104.55 148.01 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -149.57 152.35 35.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.867 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.24 -47.23 55.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.48 -37.87 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.1 -38.05 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.786 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.05 -27.43 66.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.061 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.58 -50.83 7.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -139.53 -168.31 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.58 147.16 29.79 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.08 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.92 150.03 51.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.574 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.9 t -164.05 -152.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.534 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.511 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.8 m-20 41.64 19.5 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.889 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.35 121.34 0.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.392 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.433 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.6 mt -75.11 -68.66 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.893 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.45 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.8 167.72 26.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.27 28.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.264 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.86 68.26 0.91 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.785 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.84 -104.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.405 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.47 165.89 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.709 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.28 145.93 22.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.434 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.74 136.14 41.08 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 110.816 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.5 110.98 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.19 165.01 32.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.046 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.52 24.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.18 -28.31 57.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.179 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.18 -41.69 89.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -101.83 121.74 42.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.246 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.83 109.86 19.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.103 0.477 . . . . 0.0 110.503 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.04 129.79 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -108.76 154.18 41.89 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.518 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.24 92.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.758 2.305 . . . . 0.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -171.08 144.04 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.633 0.583 . . . . 0.0 110.795 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.47 -33.82 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.486 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.54 -62.7 1.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 t -56.22 -22.44 29.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.014 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.5 -26.52 58.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.246 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.39 133.44 45.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.81 -16.87 29.42 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.21 151.55 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.428 . . . . 0.0 110.491 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.31 136.15 37.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.3 t -127.59 136.99 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.78 139.9 14.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -132.1 161.71 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.044 0.449 . . . . 0.0 110.388 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.91 118.32 31.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.46 157.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.609 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.04 50.84 49.58 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -149.69 168.46 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.9 p -74.49 -25.63 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.482 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -61.0 -55.77 28.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.562 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.14 -54.11 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.588 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.28 -51.28 70.23 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.73 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.28 -43.8 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.128 0.489 . . . . 0.0 110.582 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.64 -44.48 97.89 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.63 -14.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.79 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.19 -34.64 2.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.762 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.12 -50.55 18.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.614 -178.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -99.12 12.39 36.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.287 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.49 -55.41 0.49 Allowed Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.434 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.2 -10.39 25.73 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.786 2.324 . . . . 0.0 111.993 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.63 -9.05 59.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.459 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.75 33.3 38.17 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.98 138.09 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.902 0.382 . . . . 0.0 110.627 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.92 129.8 35.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.195 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.16 138.98 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.2 t -125.59 132.1 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 109.943 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -98.43 130.59 45.05 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.998 0.427 . . . . 0.0 110.879 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -111.82 156.44 21.99 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.353 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.07 6.67 29.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.818 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.65 6.25 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.421 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.1 tp60 -65.88 -46.03 79.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.439 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.95 -23.15 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.571 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.51 -36.96 85.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 110.561 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.13 -47.08 85.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.207 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.2 m-85 -63.87 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.08 -42.28 98.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.68 -45.24 90.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.06 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.9 tp -58.87 -47.81 83.6 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.991 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -63.09 -22.93 67.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.947 0.403 . . . . 0.0 110.123 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.7 24.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.02 11.28 70.28 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.63 -18.17 63.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.627 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -127.87 136.7 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.77 -27.83 62.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.3 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.457 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.61 155.75 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.8 137.34 50.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.93 0.395 . . . . 0.0 109.955 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.92 103.19 14.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.34 0.59 . . . . 0.0 110.819 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.75 165.3 24.86 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.78 152.7 41.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.73 -54.69 20.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.279 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.45 HG21 ' CG ' ' A' ' 91' ' ' TYR . 77.0 t -60.08 -48.83 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.623 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.77 88.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.861 0.363 . . . . 0.0 110.856 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.2 -63.13 1.23 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.429 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.6 m -59.12 -47.63 84.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.851 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.4 tt0 -48.54 -38.02 19.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.17 -65.38 0.54 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.9 t80 -40.68 -71.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 111.286 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.31 -40.04 92.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -59.7 -2.91 0.41 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.451 0.643 . . . . 0.0 110.442 -179.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 173' ' ' LEU . 23.4 mt-30 -123.8 148.46 56.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.93 -20.45 2.98 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 112.195 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.74 -42.89 93.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.96 -33.24 84.88 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.44 95.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.677 0.275 . . . . 0.0 110.459 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.41 -33.62 76.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.315 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.1 m-85 -156.56 142.74 18.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.693 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.554 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.94 99.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.779 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.22 167.6 28.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.29 56.17 2.9 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -117.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.52 135.12 33.29 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.514 2.142 . . . . 0.0 111.89 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.4 p -125.08 -108.36 0.32 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.59 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.44 164.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.363 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.86 156.07 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.91 0.756 . . . . 0.0 110.657 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -82.37 117.66 22.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.937 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.97 -17.35 62.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.14 -33.05 74.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.586 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.5 mt -61.16 -44.46 97.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.697 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.6 m-85 -113.63 9.36 17.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.768 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.84 -153.51 51.43 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.66 -25.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.846 0.355 . . . . 0.0 110.5 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.13 -123.94 1.28 Allowed Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.9 p -129.36 156.27 44.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.733 0.301 . . . . 0.0 110.324 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.74 -169.44 30.34 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -95.32 138.94 32.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.71 107.26 3.2 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.664 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.1 mt -119.25 160.06 22.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.69 149.06 24.48 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.27 -48.66 65.16 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.543 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.15 -23.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -71.7 52.11 0.21 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.52 -45.23 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.16 -47.17 29.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.327 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.25 -44.17 97.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.448 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.08 -43.13 99.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.846 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.42 -37.21 72.41 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.67 -78.04 0.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.914 HD21 HD11 ' A' ' 44' ' ' ILE . 89.9 mt -28.48 -46.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.68 0.276 . . . . 0.0 110.321 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.6 m-20 -63.85 -45.01 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 178.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.78 -43.73 98.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.44 93.85 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.006 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.26 -43.61 98.6 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.994 0.426 . . . . 0.0 109.914 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.26 92.66 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.94 -42.89 97.21 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -57.05 -38.08 72.72 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.89 -38.96 76.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 110.348 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.86 94.31 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.677 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.1 p-10 -89.15 1.02 56.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.59 20.48 65.97 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.5 m -58.05 -46.33 85.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.433 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 75.1 t80 -63.64 -58.02 8.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.418 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.6 -41.76 77.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.14 -41.61 98.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.311 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.97 -50.34 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -35.33 71.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.648 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.8 -51.0 29.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.627 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 39.2 m-85 -61.95 -46.04 91.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.61 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.6 m-85 -154.35 155.79 35.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.36 99.41 10.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -156.27 -166.21 2.1 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.41 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.87 110.75 15.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.795 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.3 m -63.34 -40.41 88.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.414 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.1 m-85 -58.93 -42.9 90.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.251 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.37 -37.37 94.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.866 -1.519 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.54 164.34 58.63 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.87 99.44 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.14 -40.53 90.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.89 144.01 36.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.5 128.4 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.96 118.62 37.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.85 138.7 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.378 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.73 100.36 1.59 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -123.8 118.56 27.43 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.718 -0.283 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.518 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.8 t70 -113.32 93.15 25.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.987 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.308 -1.579 0 C-N-CA 122.468 2.112 . . . . 0.0 112.084 179.368 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 . . . . . 0 C--O 1.227 -0.103 0 CA-C-O 120.926 0.394 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.7 mt -68.81 -41.14 82.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -60.72 -37.66 82.47 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.081 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.09 -44.08 85.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.206 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.1 -44.31 91.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.093 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.51 -53.84 52.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.541 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.32 -37.44 62.28 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.57 -42.09 74.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.764 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.5 m -54.45 -44.1 72.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.102 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.15 -47.69 78.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -59.53 -41.21 89.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.069 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.006 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -76.22 -18.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.683 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.9 52.49 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.586 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -145.36 170.1 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.18 140.48 29.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.059 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -116.7 131.23 57.01 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.3 127.99 43.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.436 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -94.69 136.38 35.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.435 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.72 128.57 65.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.311 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.14 139.08 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.748 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.518 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 174.09 132.85 0.12 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.7 Cg_endo -68.42 144.75 62.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.647 2.231 . . . . 0.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.936 HD23 HD12 ' A' ' 58' ' ' LEU . 77.8 mt -40.49 -55.65 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.098 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -47.84 -26.45 1.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.34 19.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.184 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.936 HD12 HD23 ' A' ' 55' ' ' LEU . 85.1 mt -65.03 -42.33 94.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.826 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.83 -56.59 30.84 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.739 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.2 Cg_exo -55.47 -43.26 59.94 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.591 2.194 . . . . 0.0 111.108 177.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.7 m -58.83 -44.44 90.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.27 -44.36 88.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.69 -40.08 94.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 0.0 110.469 178.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.07 11.26 1.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.505 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.94 11.86 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.34 -34.19 77.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.546 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.6 pt -124.4 153.15 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.285 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.9 m-20 -93.96 -19.83 20.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.03 156.9 25.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.726 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -116.61 127.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 110.541 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.18 106.55 9.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.623 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.1 t -159.84 -179.08 7.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.639 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.29 -15.27 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.414 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.0 tp -37.56 123.77 1.01 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.533 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.16 156.38 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.627 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.652 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.2 pt -104.98 148.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.264 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.0 p -150.26 152.6 34.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.722 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.11 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.63 -39.62 71.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.708 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.7 mtt180 -68.73 -37.74 79.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -37.56 75.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.931 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.66 67.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.12 -51.73 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.617 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -138.52 -168.34 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.139 0.495 . . . . 0.0 110.416 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.03 147.04 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.558 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.4 m-85 -130.07 150.23 51.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.57 -151.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.479 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.3 m-20 42.97 19.26 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.21 120.49 0.11 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.4 mt -77.19 -70.01 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.778 -178.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.0 p90 -149.38 166.35 29.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.589 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.29 122.32 27.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.37 68.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.79 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.08 -104.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.57 165.86 31.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.624 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.68 146.7 23.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 0.0 110.473 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.6 135.68 42.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.411 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.78 110.36 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.31 164.97 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.5 -27.61 39.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.38 -41.71 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.359 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.1 t -102.38 122.0 43.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.236 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.49 109.19 19.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.411 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.469 ' C ' ' NE2' ' A' ' 106' ' ' GLN . 97.0 mt -128.37 129.61 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.612 ' NE2' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.06 159.15 33.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.555 179.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.453 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.39 89.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 111.908 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -168.88 140.35 2.53 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.511 0.507 . . . . 0.0 110.811 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.47 -32.63 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.324 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.3 tp10 -56.74 -62.85 1.45 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.443 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.64 -22.08 31.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.965 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.63 -27.26 58.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.334 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -55.08 132.96 48.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.449 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.14 -16.52 32.96 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.98 151.81 22.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 110.449 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.65 135.59 38.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.997 0.427 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -126.87 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.65 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.54 14.29 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.96 161.62 40.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.065 0.459 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.0 tp -92.71 118.33 30.95 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.56 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -52.02 157.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.1 50.64 50.43 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.7 p -149.55 168.74 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.889 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 81.8 p -73.67 -26.53 60.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.391 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.68 -55.36 34.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.99 -54.36 47.61 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.549 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.52 -51.03 71.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.2 t80 -62.21 -43.82 97.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 0.0 110.398 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.34 97.9 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.32 -14.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.44 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.703 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.37 -50.93 16.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.008 0.432 . . . . 0.0 111.545 -178.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.26 12.81 35.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.183 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.07 -55.5 0.46 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.375 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.35 -10.21 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.797 2.331 . . . . 0.0 111.993 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.76 -8.86 59.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.18 33.33 36.3 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.41 137.89 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.963 0.411 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.58 129.71 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.299 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.08 137.97 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.857 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.34 133.23 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 109.998 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.37 127.98 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.02 153.78 25.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -106.84 6.51 29.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.69 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.5 tp60 -66.18 -45.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.472 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.04 -23.74 63.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.471 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.58 -36.63 84.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.523 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.97 -46.95 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.117 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.6 m-85 -64.21 -37.69 88.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.297 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.98 -42.49 98.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.71 -43.54 93.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.038 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.7 tp -58.84 -48.34 81.69 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.38 -22.47 66.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.149 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.04 -17.81 25.64 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.577 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 12.11 73.03 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.97 -17.61 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.7 pt -127.37 136.5 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.83 -28.36 62.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.35 155.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.52 50.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.91 0.386 . . . . 0.0 110.04 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.83 102.9 14.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.149 0.499 . . . . 0.0 110.656 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.19 165.17 24.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.396 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.466 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.39 152.27 40.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.561 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.19 -54.18 28.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.9 t -60.31 -49.18 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.456 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.87 88.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.811 0.338 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.18 -63.21 1.21 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.427 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -58.69 -47.26 85.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.67 -37.58 29.16 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.057 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.426 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.81 -66.47 0.56 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.8 t80 -40.2 -71.04 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.619 0.247 . . . . 0.0 111.21 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.21 -39.94 92.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.87 -2.69 0.42 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.505 0.669 . . . . 0.0 110.477 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 177' ' ' VAL . 51.4 mt-30 -124.42 141.7 38.33 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.885 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.89 -15.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.835 2.357 . . . . 0.0 112.275 179.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.2 t -63.08 -42.75 97.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.9 80.69 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.93 -41.55 96.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.307 . . . . 0.0 110.404 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 58.9 m-20 -65.27 -35.08 79.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.745 179.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.3 m-85 -156.73 143.2 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.737 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.93 99.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 110.725 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.19 167.55 28.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.631 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.14 55.44 3.1 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.42 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.8 135.05 35.27 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.467 2.111 . . . . 0.0 111.933 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.2 p -124.66 -108.33 0.33 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.505 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.83 165.17 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.239 -179.367 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.65 155.91 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.146 0.903 . . . . 0.0 110.646 179.197 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.26 118.59 23.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.812 178.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.2 mp0 -72.05 -18.53 61.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.92 -32.1 73.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.524 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.8 mt -60.97 -44.38 97.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.767 -178.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -114.22 8.55 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.751 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.13 -154.79 51.12 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.652 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.7 p -70.72 -25.51 26.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.825 0.345 . . . . 0.0 110.508 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.13 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -132.06 160.05 37.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 110.413 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.39 24.6 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.78 32.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.89 111.62 3.91 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -120.89 160.33 23.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.226 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.71 148.93 25.23 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.612 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.06 -48.87 64.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.637 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.06 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -72.17 51.96 0.24 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -64.42 -45.92 85.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.231 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.72 -47.04 33.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.26 -43.84 97.91 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.461 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.6 -42.87 99.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.88 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.56 -37.5 73.23 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.52 -77.4 0.11 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.006 HD21 HD11 ' A' ' 44' ' ' ILE . 85.4 mt -28.85 -45.66 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.815 0.34 . . . . 0.0 110.489 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.4 m-20 -63.57 -45.33 90.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.689 178.048 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.44 -43.63 98.53 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.45 93.47 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.105 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.2 -43.42 98.91 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.063 0.459 . . . . 0.0 110.064 179.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.38 92.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.089 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.91 -42.91 97.28 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.825 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.77 -38.41 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.85 -38.83 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.46 92.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.27 0.54 56.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.59 20.09 67.63 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.4 m -58.07 -46.26 85.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.6 t80 -63.53 -57.51 9.95 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.453 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.91 -41.73 78.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -48.53 80.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -179.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.75 -41.79 98.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.469 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.2 -49.81 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.68 -35.38 72.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.426 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.64 -51.07 30.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.461 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.7 m-85 -62.19 -45.92 91.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.593 179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.6 m-85 -154.39 155.52 35.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.443 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 46.2 p-10 -98.05 101.68 13.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.497 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -158.16 -165.24 1.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.425 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -122.89 110.02 14.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.5 m -63.57 -40.2 88.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.415 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.7 m-85 -58.86 -42.96 90.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.257 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.24 -36.51 93.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.684 0 CA-C-O 117.872 -1.515 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.22 164.18 62.9 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.46 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.573 2.182 . . . . 0.0 112.279 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.51 -40.94 89.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -138.17 139.12 39.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.406 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.46 121.44 61.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.0 110.649 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.08 118.87 32.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.18 0.514 . . . . 0.0 110.176 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.56 138.44 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.516 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.47 105.71 2.2 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.0 m -129.15 120.44 25.86 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 122.707 -0.29 . . . . 0.0 111.136 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 11.3 t0 -114.26 92.95 29.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.081 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--N 1.308 -1.602 0 C-N-CA 122.396 2.064 . . . . 0.0 112.105 179.253 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.482 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.978 0.418 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -67.71 -40.97 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.875 179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -60.99 -37.21 81.69 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.766 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.9 -45.29 86.54 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.11 -48.46 78.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.017 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.18 -54.56 34.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.372 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.31 -39.95 61.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.269 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.66 -41.85 78.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.02 0.438 . . . . 0.0 110.64 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.0 m -53.47 -45.18 69.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.11 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.02 -46.93 82.27 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -60.08 -42.08 93.85 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.132 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.908 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -75.26 -17.41 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.81 53.23 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.439 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.29 171.73 14.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.3 142.86 27.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.0 m -117.71 131.37 56.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.785 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.29 126.89 43.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.39 179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -93.72 134.72 35.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.637 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.2 127.78 65.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.45 138.1 57.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.517 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.3 p30 175.73 130.9 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 57' ' ' ALA . 46.3 Cg_endo -67.74 144.95 67.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.74 2.293 . . . . 0.0 112.521 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.877 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.33 -55.62 2.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.22 -26.63 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.85 -20.95 19.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.269 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.877 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -63.87 -42.34 97.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.17 -56.95 26.44 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.772 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -55.63 -42.46 67.41 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.6 2.2 . . . . 0.0 111.178 177.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -58.71 -44.98 90.53 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.919 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.652 HD21 ' HG3' ' A' ' 203' ' ' ARG . 59.5 tp -58.86 -44.04 90.96 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.35 -40.69 96.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.88 9.91 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.24 12.21 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.43 -35.69 81.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -122.2 152.97 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.297 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.21 -22.21 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.406 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.55 156.05 27.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.85 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -114.82 128.85 71.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.117 0.484 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.482 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.21 106.74 8.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.389 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.717 ' OG ' HD21 ' A' ' 55' ' ' LEU . 38.0 t -159.55 178.66 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.93 -15.59 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.362 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.631 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.7 tp -34.99 124.28 0.57 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.889 0.376 . . . . 0.0 110.503 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.83 154.04 26.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.703 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.634 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.8 pt -104.74 148.43 9.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.335 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.1 152.06 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.856 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.97 -47.06 52.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.416 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.49 -39.85 70.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.692 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.631 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.77 -38.01 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.75 -38.94 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.45 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.094 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.57 -50.57 8.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.5 pt -139.38 -168.33 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.185 0.517 . . . . 0.0 110.466 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.42 147.79 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.47 . . . . 0.0 111.061 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.0 m-85 -130.07 150.05 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.57 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.32 -153.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.558 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.8 m-20 41.27 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.68 0.2 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.364 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.428 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 59.1 mt -75.11 -68.79 0.52 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -178.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.75 167.59 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.67 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.237 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.465 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.7 68.25 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.59 -104.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.1 165.76 33.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.17 146.26 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.453 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.8 mt -100.85 135.95 41.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.408 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.9 t -122.66 110.61 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.28 164.4 34.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.47 148.68 24.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.003 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.02 -28.56 57.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.199 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -58.93 -41.66 87.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.319 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -101.84 121.66 42.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.43 110.07 20.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.22 129.45 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.702 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -106.52 154.12 40.13 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.666 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.54 91.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.771 2.314 . . . . 0.0 111.711 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -170.64 143.39 2.17 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.589 0.556 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.84 -33.27 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.072 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.36 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -55.86 -22.2 24.08 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.094 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 mt -76.2 -25.9 55.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.229 179.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.81 133.69 47.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.407 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.22 -16.58 28.09 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.15 151.27 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.016 0.436 . . . . 0.0 110.373 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -95.53 135.17 37.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.377 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -127.15 136.72 59.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.61 138.47 14.29 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -130.77 161.68 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.071 0.462 . . . . 0.0 110.338 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.67 117.7 30.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.496 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.78 157.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.59 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.65 50.68 52.87 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.78 168.76 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 0.0 110.864 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.452 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.0 p -73.17 -27.49 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.2 -55.58 32.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.55 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -56.57 -55.03 38.94 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.63 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.15 -51.03 71.32 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.735 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.4 t80 -62.11 -43.93 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.123 0.487 . . . . 0.0 110.496 179.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.73 -44.58 97.72 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.24 -14.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.896 0.379 . . . . 0.0 110.787 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.37 -34.39 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.717 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.51 -50.62 17.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 0.0 111.617 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.96 12.17 36.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.46 -55.55 0.49 Allowed Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.37 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 55.9 Cg_endo -72.04 -10.48 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.769 2.312 . . . . 0.0 111.991 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.59 -9.29 59.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.461 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.23 37.14 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.29 137.84 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.41 129.91 34.86 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.63 138.24 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.03 133.54 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.072 0.463 . . . . 0.0 109.991 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.91 127.08 42.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.65 153.19 25.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.051 0.453 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.97 7.23 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.95 130.42 5.93 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.411 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.1 tp60 -66.06 -45.82 80.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.425 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.77 -23.4 62.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.564 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.463 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -37.13 86.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.516 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.82 -46.64 88.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.186 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.507 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.9 m-85 -64.58 -37.7 88.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.322 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.88 -42.01 97.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.058 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.24 -43.32 91.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.995 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.585 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.9 tp -58.97 -47.93 83.36 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.046 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.6 m -62.9 -22.42 66.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.44 25.13 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.66 72.28 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.75 -17.91 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.0 pt -126.9 135.78 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.45 -27.65 62.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.296 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.74 155.9 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.79 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.96 137.03 50.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -85.85 103.4 14.56 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.347 0.594 . . . . 0.0 110.851 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.7 tt0 -132.93 165.31 24.96 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.372 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.477 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -72.62 153.15 41.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 110.563 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -66.64 -54.86 18.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.361 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' CG ' ' A' ' 91' ' ' TYR . 75.6 t -60.23 -48.95 86.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.689 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.98 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.774 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.51 -63.01 1.24 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.662 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.0 m -59.55 -48.0 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.41 -37.71 17.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.426 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.07 -65.86 0.55 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.664 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.7 t80 -40.58 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 111.236 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.3 mt -61.43 -40.22 93.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 -179.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.82 -3.04 0.45 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.451 0.643 . . . . 0.0 110.521 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.9 mt-30 -122.86 149.4 56.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.08 -21.1 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.823 2.349 . . . . 0.0 112.182 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.98 -42.75 94.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.643 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.42 -33.27 85.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.4 -41.34 93.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.313 . . . . 0.0 110.464 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.4 m-20 -65.67 -33.23 75.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.299 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.37 142.64 18.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.42 99.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.21 167.22 29.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.716 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.32 56.38 2.69 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.22 -118.89 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.52 135.55 33.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.462 2.108 . . . . 0.0 111.923 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.7 p -125.43 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.566 -179.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.11 164.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 154.26 155.86 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.918 0.761 . . . . 0.0 110.641 179.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.06 117.19 22.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.857 179.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -71.2 -18.85 62.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.79 -32.43 73.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.555 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.485 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -61.05 -44.48 97.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 -178.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -114.01 9.3 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.728 179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.2 -154.3 51.74 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.634 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.38 -25.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 110.488 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.22 -124.24 1.32 Allowed Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.9 p -129.42 156.4 44.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.257 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.73 -169.43 30.31 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -94.48 137.51 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.963 0.411 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.47 108.09 3.26 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.2 mt -123.02 159.26 28.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.023 0.44 . . . . 0.0 110.114 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.652 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.9 mtm180 -86.94 149.75 24.57 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.91 -48.09 64.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.515 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -38.46 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.899 0.381 . . . . 0.0 110.733 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.69 52.11 0.21 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.642 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.57 -44.76 89.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.1 -47.33 29.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.32 -44.07 97.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.421 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.22 -43.06 99.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.16 -36.36 70.67 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.26 -77.65 0.11 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 44' ' ' ILE . 97.2 mt -28.31 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.335 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -64.22 -44.91 90.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.616 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.1 -43.69 98.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.951 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.01 -38.99 93.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.038 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.35 -43.72 98.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 109.903 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.56 93.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -43.06 97.83 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.2 mtp -57.04 -37.94 72.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.08 -39.01 75.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 110.337 178.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.69 94.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.6 p-10 -89.2 1.53 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.73 20.42 64.04 Favored Glycine 0 C--O 1.226 -0.382 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 79.7 m -58.26 -45.99 86.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.428 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.4 t80 -63.84 -58.09 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.396 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.67 -41.55 77.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.78 -48.37 81.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.2 -41.59 98.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.312 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.69 -50.35 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.597 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.34 -35.17 71.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -71.11 -50.92 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.598 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.4 m-85 -62.0 -45.56 93.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.47 155.84 35.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.42 97.94 9.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -155.49 -166.24 2.19 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.42 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.0 t0 -123.22 111.06 16.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.59 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 239' ' ' TYR . 22.4 m -63.54 -40.59 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.9 m-85 -58.61 -42.86 89.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.36 -37.19 94.45 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.628 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.955 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.4 164.38 61.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.744 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.71 143.38 99.39 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 122.655 2.237 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.4 -40.7 89.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.597 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.54 141.9 37.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -109.57 127.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -102.5 119.69 39.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.093 0.473 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -113.69 138.56 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.292 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.78 100.31 1.57 Allowed Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -123.79 119.01 28.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.673 -0.31 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 19.5 t70 -113.16 92.34 21.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.016 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 122.42 2.08 . . . . 0.0 112.13 179.288 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 . . . . . 0 C--O 1.226 -0.159 0 CA-C-O 120.97 0.414 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.0 -40.67 83.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.041 179.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -60.81 -37.56 82.41 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.88 -178.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.8 -45.0 88.08 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.14 -48.15 79.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.825 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.01 -54.49 34.54 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.323 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.58 -39.59 61.74 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.026 0.441 . . . . 0.0 110.393 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.07 -42.02 76.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.8 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.01 -44.14 70.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.041 -179.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.92 -47.56 80.06 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.973 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.56 -41.78 90.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.111 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.926 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.68 -18.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.4 m-20 60.5 52.71 4.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.188 0.518 . . . . 0.0 110.623 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.8 p -146.1 170.75 16.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.25 140.75 29.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -116.3 130.12 56.62 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.69 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.14 127.49 44.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.396 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -94.73 136.36 35.14 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.66 128.58 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 110.304 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.01 139.34 58.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.79 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.39 130.07 0.1 Allowed Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.519 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.0 Cg_endo -67.95 146.73 72.43 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.743 2.295 . . . . 0.0 112.514 -179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.909 HD23 HD12 ' A' ' 58' ' ' LEU . 81.7 mt -41.05 -55.92 2.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -48.06 -26.76 1.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.251 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.94 -20.3 19.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.252 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.909 HD12 HD23 ' A' ' 55' ' ' LEU . 86.5 mt -65.26 -42.36 93.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.694 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.35 -57.27 26.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 123.801 0.688 . . . . 0.0 109.516 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.694 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.9 Cg_exo -55.02 -43.95 54.4 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.571 2.181 . . . . 0.0 111.083 177.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -58.65 -44.55 90.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.575 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.33 -44.24 88.61 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.78 -40.24 94.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.983 0.42 . . . . 0.0 110.488 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.84 11.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.937 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.11 76.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 178.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.18 152.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.18 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -94.07 -20.23 20.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 155.87 26.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.76 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 58' ' ' LEU . 97.0 mt -116.43 127.89 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 110.443 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -128.16 105.64 8.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 110.326 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.666 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.2 t -158.66 179.24 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.19 -14.93 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.394 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 39.4 tp -35.98 124.22 0.73 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.47 154.11 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.643 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -104.51 148.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.207 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -149.8 152.63 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.818 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.28 -47.38 55.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.032 0.444 . . . . 0.0 110.548 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.44 -39.93 70.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.5 -37.83 80.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.21 -37.95 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.798 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.01 -27.73 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.094 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.13 -50.73 8.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.976 0.417 . . . . 0.0 110.774 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.67 -168.6 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.165 0.507 . . . . 0.0 110.383 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.33 147.28 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.119 0.485 . . . . 0.0 111.059 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.544 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.93 149.85 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.81 -152.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.47 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.3 m-20 41.72 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.019 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.22 121.41 0.18 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.385 0.428 . . . . 0.0 110.433 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.42 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.0 mt -75.44 -68.81 0.53 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.81 -178.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.443 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.4 p90 -150.32 167.45 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.66 123.58 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.176 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.23 68.27 0.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.775 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.16 -104.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.442 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -159.64 165.83 31.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.11 146.35 22.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.423 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.1 mt -101.38 136.04 41.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.418 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.72 111.0 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.26 165.2 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.4 23.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.64 -27.77 42.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -59.13 -41.87 89.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.249 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.6 122.18 43.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.019 0.437 . . . . 0.0 110.154 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.81 109.34 19.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.395 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.97 129.78 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.641 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.82 159.07 33.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.575 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.9 Cg_endo -59.79 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.789 2.326 . . . . 0.0 111.93 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -169.02 141.2 2.6 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.596 0.56 . . . . 0.0 110.858 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.38 -33.24 61.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.24 -62.65 1.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.333 -178.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.58 -22.11 31.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.066 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -75.53 -26.88 58.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 178.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.9 133.29 47.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 -179.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.77 -16.92 28.95 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.2 151.46 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.497 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.22 135.56 37.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.273 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.27 136.73 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.47 138.86 14.47 Favored Glycine 0 N--CA 1.462 0.383 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.92 161.68 40.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.536 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.5 tp -92.56 117.72 30.26 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.696 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.76 157.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.17 50.53 50.75 Favored Glycine 0 N--CA 1.463 0.436 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -149.6 168.79 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.457 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.1 p -73.69 -26.29 60.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.435 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.93 -55.45 32.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.431 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -56.94 -54.35 47.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.583 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.3 -51.12 70.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.641 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.8 t80 -62.31 -43.82 97.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.144 0.497 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.78 -44.41 97.92 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.3 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.835 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.65 2.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.34 -50.92 16.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.698 -178.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -99.0 12.43 36.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.72 -55.54 0.48 Allowed Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.16 25.29 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.737 2.291 . . . . 0.0 111.933 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.93 -8.85 59.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 -179.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.32 36.87 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.31 137.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.01 0.434 . . . . 0.0 110.565 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.4 129.75 34.92 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.1 pt -126.19 138.05 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.5 t -123.16 133.28 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.082 0.467 . . . . 0.0 109.899 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.36 127.59 43.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.17 153.76 25.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.265 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -107.05 7.01 29.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.67 130.28 5.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -65.74 -45.81 81.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.07 -23.91 63.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.49 -36.75 85.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.13 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.42 -38.22 90.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.13 -42.5 98.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.164 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.47 -45.95 88.45 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.4 tp -58.46 -48.14 81.74 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.161 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.32 -23.31 67.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.935 0.398 . . . . 0.0 110.066 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.89 -18.79 25.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.45 11.09 69.52 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.24 -18.31 63.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 153' ' ' LEU . 38.3 pt -128.69 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.083 0.468 . . . . 0.0 110.443 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.0 -27.35 61.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.485 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.92 155.88 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.583 0.552 . . . . 0.0 110.91 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.94 137.09 50.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.987 0.422 . . . . 0.0 109.935 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.42 103.27 14.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.238 0.542 . . . . 0.0 110.798 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.3 tt0 -132.47 165.51 24.14 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.341 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.0 152.03 41.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.565 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.33 -54.33 25.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.4 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.443 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.6 t -60.38 -48.83 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.417 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.72 88.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.3 -62.99 1.26 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.507 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.1 m -58.87 -47.38 85.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.88 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -49.16 -37.85 23.62 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.067 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.11 -65.93 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.0 t80 -40.27 -71.15 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.824 -0.221 . . . . 0.0 111.245 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.06 -40.03 92.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.948 -179.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.92 -2.28 0.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.613 0.721 . . . . 0.0 110.323 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.2 mt-30 -124.25 141.4 37.29 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.905 -0.497 . . . . 0.0 110.8 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.75 -16.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.843 2.362 . . . . 0.0 112.409 179.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 72.1 t -62.88 -43.0 98.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.619 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.85 82.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.91 -41.39 96.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.73 0.3 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.8 m-20 -65.58 -34.52 78.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.04 142.74 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.64 99.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.0 110.757 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.7 m-85 -159.07 166.82 30.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.668 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.04 56.36 2.9 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.06 -117.24 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.59 135.68 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.419 2.079 . . . . 0.0 111.984 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.9 p -124.7 -108.33 0.33 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.77 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.21 165.08 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 155.69 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 124.461 1.101 . . . . 0.0 110.69 178.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.75 118.24 22.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.87 -18.71 62.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.47 74.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.8 mt -60.92 -44.55 97.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.685 -177.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.457 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -114.24 10.05 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.758 178.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.45 51.47 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.643 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.5 p -70.85 -25.09 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.486 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 159.91 -123.97 1.29 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -129.51 156.54 43.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.76 -169.59 30.55 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -94.88 138.73 32.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.945 0.402 . . . . 0.0 110.607 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.39 107.17 3.16 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.62 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.7 mt -119.83 159.98 23.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.923 0.392 . . . . 0.0 110.143 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.76 149.11 24.39 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-O 120.833 0.349 . . . . 0.0 110.654 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.4 -48.5 65.65 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.549 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -39.76 -23.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.55 52.21 0.2 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.799 0.333 . . . . 0.0 110.661 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.33 -45.78 86.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.99 -47.12 30.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.281 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.08 -43.99 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.48 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.52 -36.98 72.27 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.94 -77.22 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.926 HD21 HD11 ' A' ' 44' ' ' ILE . 89.0 mt -29.26 -45.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -44.96 91.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.728 177.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.73 -43.79 98.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.897 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.29 93.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.05 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.18 -43.47 98.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.194 0.521 . . . . 0.0 110.032 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.33 93.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.021 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.58 -43.19 97.72 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.92 -38.28 72.65 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.95 -38.84 76.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.673 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -89.33 0.98 56.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.99 20.45 66.81 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -58.33 -45.94 87.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -63.99 -57.6 9.21 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.436 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.04 -41.44 78.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.169 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.56 -48.54 80.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.518 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.77 -41.83 98.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 110.546 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.71 -50.03 75.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.66 -35.04 71.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.409 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.83 -50.87 30.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.55 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 40.2 m-85 -62.25 -45.93 91.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.76 155.61 34.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.4 p-10 -97.35 99.05 10.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.76 -166.03 2.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.08 110.81 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.9 m -63.65 -40.44 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.415 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.6 m-85 -59.04 -42.59 90.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.305 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.2 94.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.607 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 164.25 56.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.93 143.27 99.31 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.574 2.183 . . . . 0.0 112.297 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.34 -40.71 90.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -139.13 139.95 37.79 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.0 mt -107.81 120.69 59.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 110.681 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.06 118.78 32.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.145 0.498 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -112.42 138.56 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.01 101.42 1.51 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -124.68 120.71 32.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 122.717 -0.284 . . . . 0.0 111.142 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t70 -114.07 92.73 27.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.194 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.308 -1.599 0 C-N-CA 122.417 2.078 . . . . 0.0 112.105 179.183 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.6 t0 . . . . . 0 C--O 1.227 -0.126 0 CA-C-O 120.983 0.42 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.85 -40.79 84.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.983 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -60.81 -37.38 81.77 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.891 -178.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.72 -44.49 85.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.89 -47.91 81.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.035 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.95 -54.4 39.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.347 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.35 -38.85 59.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.943 0.401 . . . . 0.0 110.311 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.29 -41.77 76.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.46 . . . . 0.0 110.556 178.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 51.0 m -53.79 -44.93 70.54 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.033 -179.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.25 -47.31 80.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.037 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.8 -42.15 92.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.201 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.945 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.32 -17.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.09 52.84 3.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.492 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.54 170.91 15.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.36 142.43 27.74 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.075 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 m -117.34 131.87 56.71 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.575 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.9 m -128.75 128.12 43.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -95.19 135.57 36.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.478 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.8 129.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.427 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.75 136.65 56.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.777 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 176.41 131.42 0.18 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.49 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.8 Cg_endo -68.28 144.81 63.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.691 2.261 . . . . 0.0 112.536 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.92 HD23 HD12 ' A' ' 58' ' ' LEU . 79.1 mt -40.29 -55.43 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.21 -26.27 1.87 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.163 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.57 -21.05 18.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.92 HD12 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -64.14 -42.44 96.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.88 179.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.716 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.68 -57.12 26.68 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 123.738 0.648 . . . . 0.0 109.67 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.716 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.14 -42.27 70.46 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.612 2.208 . . . . 0.0 111.267 177.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -45.06 90.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.944 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.6 tp -58.94 -44.08 91.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.5 -40.66 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.955 0.407 . . . . 0.0 110.456 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.86 10.38 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.84 12.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.5 -35.16 79.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.498 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -122.9 153.54 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.212 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.54 -21.53 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.285 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.3 156.72 26.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.67 129.06 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -130.55 106.7 8.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.703 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.3 t -158.96 178.69 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -65.33 -15.16 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -35.56 124.84 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.573 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.54 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -83.0 155.0 24.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.662 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.638 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.0 pt -105.04 149.2 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -149.37 152.33 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.829 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.95 -47.48 52.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.544 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.65 -39.53 71.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.88 -37.86 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -57.99 -38.62 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.868 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.81 -27.59 66.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.105 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.26 -51.22 7.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -138.5 -168.23 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 110.501 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.03 147.71 29.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 76' ' ' ILE . 75.4 m-85 -130.09 150.08 51.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.653 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.73 -152.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.498 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 97.2 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.948 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.7 mttt -29.32 121.02 0.15 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.336 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.4 mt -76.64 -69.53 0.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.842 -178.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.448 ' CG ' HG21 ' A' ' 166' ' ' VAL . 40.9 p90 -149.47 166.43 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.614 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.46 122.75 28.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.38 69.46 0.91 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.813 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.51 -104.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.393 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.17 165.77 32.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.56 145.91 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.125 0.488 . . . . 0.0 110.439 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.89 136.26 41.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.99 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.19 165.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.996 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.48 23.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.96 -28.35 56.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.04 -41.7 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.301 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.13 122.19 43.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.06 109.9 19.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.87 129.59 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.656 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -108.28 154.3 41.44 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 110.679 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.24 92.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.756 2.304 . . . . 0.0 111.649 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.02 144.02 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.669 0.606 . . . . 0.0 110.773 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.55 -33.7 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.162 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 108' ' ' THR . 47.7 tp10 -57.35 -62.63 1.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.263 -178.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.37 -21.93 27.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.037 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.0 -26.2 56.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.309 179.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.77 133.7 47.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.382 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.08 -16.78 26.36 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -85.92 151.44 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.494 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -95.86 135.39 37.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.25 136.66 60.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.658 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.5 138.53 14.3 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.9 161.66 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.2 tp -92.43 117.42 29.9 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.599 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.73 158.04 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.47 50.48 55.02 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -149.62 168.95 22.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.928 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.458 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 67.2 p -73.24 -27.58 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.13 -55.36 34.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.67 -54.82 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.695 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.37 -51.04 71.18 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.74 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.2 -43.83 97.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.44 97.81 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.43 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.0 110.778 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.23 -34.46 2.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.35 -50.56 18.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.473 . . . . 0.0 111.649 -178.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.27 12.59 35.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.83 -55.53 0.47 Allowed Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.413 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.29 -10.31 25.49 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.778 2.319 . . . . 0.0 111.934 -179.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.65 -8.88 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.14 37.63 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.28 138.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.85 130.19 34.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.0 138.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.14 133.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 109.99 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.11 127.3 42.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.83 153.7 25.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.33 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.24 7.13 29.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.41 130.47 6.03 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.03 -45.92 79.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.441 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.21 62.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.572 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.87 -36.78 85.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.536 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.03 -47.13 86.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.159 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.1 m-85 -63.74 -37.91 89.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.253 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.19 -42.4 98.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.096 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.73 -45.21 90.96 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.981 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.8 tp -58.69 -47.94 82.82 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.114 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.31 -22.96 67.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.21 -18.66 25.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.641 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.65 69.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.92 -18.13 63.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.7 pt -127.87 136.96 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.66 -27.62 62.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.457 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.8 155.89 1.74 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.817 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.92 137.12 50.19 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 109.991 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.67 103.05 14.13 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.237 0.541 . . . . 0.0 110.817 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.39 165.2 24.79 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.458 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.0 152.6 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.05 -54.37 26.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.332 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.448 HG21 ' CG ' ' A' ' 91' ' ' TYR . 70.8 t -60.24 -49.13 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.439 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.93 87.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.828 0.347 . . . . 0.0 110.759 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.37 -63.35 1.16 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.456 ' OG ' HD12 ' A' ' 173' ' ' LEU . 72.5 m -59.15 -47.88 83.67 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.927 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.01 -38.19 22.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.46 -65.73 0.56 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.676 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -70.94 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.456 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.8 mt -61.06 -39.88 91.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.192 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.65 -2.72 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.462 0.649 . . . . 0.0 110.399 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.4 mt-30 -124.14 142.21 39.26 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.5 -16.47 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.844 2.363 . . . . 0.0 112.32 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 175' ' ' GLN . 73.0 t -62.69 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.586 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.01 82.73 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.75 -41.27 95.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.733 0.302 . . . . 0.0 110.567 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -66.0 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.393 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.6 m-85 -157.07 143.65 18.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.59 100.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 110.757 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.34 167.37 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.72 56.09 2.85 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.53 -117.94 0.01 OUTLIER Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.59 135.29 33.76 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.504 2.136 . . . . 0.0 111.969 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.9 p -125.36 -107.89 0.32 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.574 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.67 165.11 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.51 156.05 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 124.024 0.828 . . . . 0.0 110.696 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.46 117.61 22.61 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.38 -18.91 62.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.72 -32.28 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.491 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.3 mt -61.0 -44.46 97.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.706 -178.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.458 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.2 m-85 -114.07 9.47 17.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.784 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.37 -155.13 52.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.638 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.9 p -70.55 -25.14 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 0.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.72 -125.17 1.41 Allowed Glycine 0 CA--C 1.518 0.272 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.6 p -131.52 159.3 38.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.63 -163.37 25.47 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.4 138.93 34.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.453 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.25 112.05 3.92 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -124.73 160.1 29.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.65 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.7 mtm180 -86.53 149.66 24.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.786 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.95 -48.4 64.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.669 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.4 tp10 -38.15 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.95 52.02 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.604 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -64.76 -44.86 88.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.401 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.16 -47.1 38.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.84 -43.49 98.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.45 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.75 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.43 -36.7 71.71 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.18 -77.31 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.945 HD21 HD11 ' A' ' 44' ' ' ILE . 96.7 mt -28.63 -46.21 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.01 -45.3 89.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.661 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.78 -43.79 98.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.955 178.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.21 93.23 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.024 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.24 -43.54 98.71 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.33 92.86 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.095 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -43.19 96.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -56.68 -38.29 72.02 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.88 76.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.98 94.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 21.4 p-10 -88.65 1.19 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.36 20.32 65.29 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.435 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 72.3 m -58.3 -45.81 87.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.9 t80 -63.89 -58.14 7.67 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.482 179.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.86 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.28 -48.63 79.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.0 -41.49 98.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.407 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.43 -50.18 74.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.62 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.89 -35.17 72.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.21 -50.95 27.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.501 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.18 -45.75 92.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.532 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -152.97 154.92 35.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.437 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.6 p-10 -97.06 95.36 7.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.987 0.422 . . . . 0.0 110.567 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.25 -166.67 2.49 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.66 110.33 15.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.5 m -63.64 -40.65 89.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.6 m-85 -56.35 -43.9 79.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -37.6 95.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.681 0 CA-C-O 117.875 -1.514 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.23 61.08 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.676 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.85 143.45 99.37 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.645 2.23 . . . . 0.0 112.299 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.32 -40.35 89.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.91 143.14 36.49 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.456 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.04 128.09 66.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 110.515 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -103.77 118.56 36.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.6 138.4 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.449 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.2 1.61 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.8 m -123.94 118.32 26.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.713 -0.287 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 24.4 t70 -113.33 92.3 22.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.309 -1.512 0 C-N-CA 122.524 2.149 . . . . 0.0 112.114 179.39 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 . . . . . 0 C--O 1.227 -0.114 0 CA-C-O 120.915 0.388 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.61 -41.01 82.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.097 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.74 -37.63 82.41 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.18 -178.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.19 -44.0 85.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.299 178.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.525 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.82 92.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.069 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.44 -53.67 54.68 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.504 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.26 -37.58 62.25 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.975 0.417 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.52 -42.03 75.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.8 m -54.54 -44.5 72.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.111 -179.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.436 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.81 -47.65 80.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.066 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -59.4 -40.96 88.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.98 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -76.56 -17.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.9 52.44 4.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.151 0.501 . . . . 0.0 110.606 -179.238 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.29 169.99 17.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.12 140.66 29.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -116.87 131.32 56.98 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.638 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.42 128.1 43.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.472 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -94.64 136.34 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.511 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.67 128.38 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.8 139.31 58.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.721 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.84 132.3 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.56 145.22 63.48 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.692 2.262 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.929 HD23 HD12 ' A' ' 58' ' ' LEU . 78.5 mt -40.48 -55.94 2.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.72 -26.55 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.117 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.35 19.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.929 HD12 HD23 ' A' ' 55' ' ' LEU . 85.3 mt -65.08 -42.56 94.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.854 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.703 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 mm -61.51 -56.64 31.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.757 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -55.44 -43.51 57.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 122.64 2.227 . . . . 0.0 111.128 177.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -44.36 90.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.848 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.28 -44.46 88.45 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.59 -40.21 95.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 110.446 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.0 11.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.538 -179.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.01 11.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.47 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 178.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.9 pt -124.48 153.28 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.361 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -94.59 -20.0 19.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.21 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.45 156.29 25.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 58' ' ' LEU . 96.9 mt -116.83 127.94 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 110.544 179.589 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.26 106.31 8.94 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.626 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.4 t -159.0 -179.57 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.569 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.56 -15.01 60.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.337 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.645 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -37.58 124.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.531 -179.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.09 156.25 23.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.667 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.655 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.7 pt -104.87 148.9 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -150.4 152.75 34.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.22 -47.93 54.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.601 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.52 -39.79 70.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.733 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.645 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.53 -37.63 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.94 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.3 -27.56 67.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.175 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.16 -51.77 7.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 110.574 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.61 -168.55 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.86 147.02 29.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.5 m-85 -129.99 149.96 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.34 -151.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.478 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.6 m-20 42.97 19.34 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.26 120.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.409 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.1 mt -77.04 -69.93 0.49 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 -178.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.44 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.4 p90 -149.3 166.26 29.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.584 -179.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 121.67 27.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.73 69.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.746 -179.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.94 -105.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.31 165.83 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.69 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.6 145.94 21.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 110.5 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.06 136.11 41.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.768 178.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 111.1 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.41 165.12 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.2 148.63 23.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.14 -28.34 57.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.98 -41.88 88.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.325 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.86 121.76 42.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 110.23 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.64 109.61 19.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.464 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.84 129.81 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.636 179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.71 154.15 41.87 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.654 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.519 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.26 92.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.824 2.349 . . . . 0.0 111.674 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.14 144.31 2.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.635 0.585 . . . . 0.0 110.787 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.26 -33.57 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.281 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.6 -62.39 1.82 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.335 -178.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.31 -22.24 29.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.936 -179.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -76.07 -26.14 56.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.84 133.35 47.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.402 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.4 -16.51 29.29 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.59 151.91 23.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.949 0.404 . . . . 0.0 110.408 -179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.38 135.64 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.307 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.04 136.61 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.662 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 139.05 14.54 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.31 161.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 110.35 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.2 tp -92.69 117.24 29.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.62 157.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.635 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.87 50.44 52.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.83 169.26 21.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.316 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.01 -25.9 60.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.9 -55.55 31.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.18 -53.94 52.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.59 -51.16 70.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.578 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.36 -43.71 98.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.384 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.01 -44.66 97.48 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.11 -14.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 0.0 110.75 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.34 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.665 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.63 -50.68 16.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.506 -178.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -99.19 12.72 35.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.17 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.24 -55.54 0.45 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.34 -10.3 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.821 2.347 . . . . 0.0 111.98 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.69 -8.7 59.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 -179.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.07 33.17 37.17 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.62 138.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.86 130.0 35.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.2 pt -126.43 138.23 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.2 t -123.18 133.16 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 109.992 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.18 127.79 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.804 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.15 153.52 25.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.74 6.55 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.699 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.6 130.43 5.98 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.05 -45.6 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.49 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.09 -23.95 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.7 -36.57 84.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.97 -47.0 86.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.126 -179.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.517 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 58.9 m-85 -63.73 -37.94 89.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.232 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.26 -42.56 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.153 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -63.72 -45.63 89.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.865 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.8 tp -58.46 -48.08 81.92 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.19 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -63.18 -22.79 67.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.91 0.386 . . . . 0.0 110.077 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.6 -18.6 24.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.55 70.01 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.83 -17.92 63.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.588 179.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.1 pt -128.53 137.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.599 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.17 -27.83 61.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.53 155.47 1.79 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.83 137.31 50.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.0 110.029 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.64 102.91 13.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.225 0.536 . . . . 0.0 110.673 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.9 tt0 -132.08 165.1 24.79 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.52 152.45 40.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.0 -54.13 29.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.25 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 91' ' ' TYR . 69.7 t -60.5 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.47 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.95 87.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.77 0.319 . . . . 0.0 110.789 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.34 1.18 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.567 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.445 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.4 m -58.67 -47.2 85.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.798 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.1 -38.25 24.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.066 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.543 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.88 -65.43 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.1 t80 -40.51 -71.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.594 0.235 . . . . 0.0 111.23 -178.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.47 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.077 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.53 -2.99 0.39 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.46 0.648 . . . . 0.0 110.448 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.543 HE21 ' C ' ' A' ' 171' ' ' GLY . 49.1 mt-30 -124.85 141.2 37.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -43.6 -14.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.858 2.372 . . . . 0.0 112.341 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.2 t -63.23 -42.91 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.553 -179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.75 -32.89 80.63 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.83 -41.6 96.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.725 0.297 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.0 m-20 -65.62 -34.92 79.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.4 m-85 -156.77 143.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.7 pttt -177.03 99.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.733 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.7 m-85 -159.24 167.98 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.37 55.86 3.14 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.13 -117.05 0.01 OUTLIER Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.66 135.04 34.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.483 2.122 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.5 p -125.11 -108.31 0.32 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.506 -179.035 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.57 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.48 155.61 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 124.077 0.861 . . . . 0.0 110.703 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.33 118.31 23.06 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.026 0.441 . . . . 0.0 109.812 179.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.94 -18.49 62.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.87 -32.24 73.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.539 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.1 mt -60.84 -44.44 96.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.725 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -113.84 8.22 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.719 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.3 -154.76 50.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.56 -25.28 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.851 0.358 . . . . 0.0 110.56 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.8 -125.75 1.5 Allowed Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.0 p -132.04 160.08 36.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.43 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.47 -162.59 24.89 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.18 140.92 31.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.615 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.11 111.9 3.97 Favored Glycine 0 CA--C 1.517 0.19 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.7 mt -121.61 160.79 23.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -87.11 148.94 25.01 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.15 -48.82 64.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.629 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -39.82 -23.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.973 0.416 . . . . 0.0 110.719 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.65 52.17 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.759 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.37 -46.29 84.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.182 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.46 -47.07 35.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.2 -43.89 97.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.45 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.56 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.856 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.51 -37.34 72.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.8 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.98 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -29.01 -45.62 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.8 m-20 -63.62 -45.48 90.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.7 98.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.945 178.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.36 92.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.152 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -61.19 -43.39 98.95 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.027 0.441 . . . . 0.0 110.063 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.26 92.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.15 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.96 97.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.886 179.283 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.78 -38.47 72.55 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -69.85 -38.81 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.374 178.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.42 92.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.661 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.9 p-10 -88.35 0.4 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.698 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.61 20.38 67.96 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.0 m -58.18 -46.17 86.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.46 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.1 t80 -63.65 -57.43 10.08 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.454 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.68 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.25 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.51 -48.6 80.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.493 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.83 -41.59 97.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.74 76.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.715 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.94 -35.45 73.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.414 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.59 -51.0 31.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.462 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.35 -45.45 93.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -153.74 155.15 35.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.16 99.47 10.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.527 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -156.41 -165.17 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.526 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.74 109.22 13.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.9 m -63.6 -40.35 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.426 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.7 m-85 -56.91 -43.7 81.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.83 93.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.708 0 CA-C-O 117.881 -1.51 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.29 164.25 62.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.587 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.91 143.53 99.37 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.564 2.176 . . . . 0.0 112.324 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.38 -41.02 90.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.081 0.467 . . . . 0.0 110.511 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.4 139.07 38.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.388 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.19 121.47 61.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.706 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.91 118.76 31.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 110.13 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -112.4 138.42 41.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 105.47 2.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -129.09 120.2 25.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.136 179.618 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.51 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 5.2 t0 -114.57 92.69 29.69 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.177 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 C--N 1.309 -1.503 0 C-N-CA 122.404 2.069 . . . . 0.0 112.135 179.462 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.7 t0 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.988 0.423 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -67.79 -40.97 84.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.847 179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -61.05 -37.21 81.81 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.824 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.99 -45.26 86.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.02 -48.32 78.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.981 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -53.23 -54.47 35.62 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.31 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.48 -39.81 61.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.872 0.367 . . . . 0.0 110.26 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.79 -42.05 77.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.053 0.454 . . . . 0.0 110.53 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.44 -44.91 69.23 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.146 -179.425 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.26 -46.94 81.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.992 179.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -60.04 -42.14 93.78 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.216 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.893 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.28 -17.46 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.429 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.85 53.2 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.424 -179.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.12 171.51 15.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -89.16 142.69 27.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.03 0.443 . . . . 0.0 109.956 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.54 131.4 56.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -127.54 127.25 43.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.401 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.86 134.68 35.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.08 127.89 66.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.38 138.0 57.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.829 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.51 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.69 130.33 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.6 Cg_endo -67.58 145.07 69.03 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.71 2.273 . . . . 0.0 112.512 -179.186 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.873 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.13 -55.76 2.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.37 -26.37 2.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.857 0.361 . . . . 0.0 111.224 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.19 -20.91 18.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.873 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.75 -42.37 97.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.643 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.721 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.21 -57.0 25.79 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.795 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.3 Cg_exo -55.39 -42.46 68.06 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.681 2.254 . . . . 0.0 111.213 177.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.1 m -58.69 -45.08 90.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.906 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 203' ' ' ARG . 62.9 tp -58.88 -44.2 91.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.148 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.26 -40.82 96.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.426 . . . . 0.0 110.424 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.79 9.87 2.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.416 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.21 12.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.991 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.456 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.36 -35.52 80.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.503 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.34 153.14 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.287 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.28 -22.18 19.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.462 -179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.62 156.14 27.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.01 129.01 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.493 . . . . 0.0 110.469 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -131.29 106.72 8.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.714 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.3 t -159.39 178.5 9.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.99 -15.52 62.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.633 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.8 tp -34.98 124.37 0.57 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.596 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.0 154.03 25.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.631 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.74 148.46 9.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.348 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.8 p -149.01 152.2 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.09 53.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.43 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.51 -39.74 70.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.671 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.633 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.8 mtt180 -68.98 -37.94 79.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.819 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -57.9 -39.03 76.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.711 -179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.79 -27.38 66.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.57 -50.77 7.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.046 0.451 . . . . 0.0 110.634 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -139.14 -168.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.1 0.476 . . . . 0.0 110.543 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 76' ' ' ILE . 80.0 m-85 -129.92 150.02 51.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.17 -153.26 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.57 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.7 m-20 41.19 20.14 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.32 0.2 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.324 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 58.5 mt -74.79 -68.51 0.54 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.931 -178.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.52 167.55 26.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.751 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.67 123.62 29.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.184 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.94 68.66 0.83 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.809 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -85.67 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.06 165.63 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.698 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.49 146.09 22.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.79 136.19 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 110.813 178.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.86 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.27 164.91 33.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.81 148.56 23.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.93 -28.42 56.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.241 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -58.76 -41.94 87.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.319 -179.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.93 121.74 42.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.016 0.436 . . . . 0.0 110.147 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -86.88 109.72 19.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -125.97 129.14 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.718 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -106.44 154.28 39.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.721 179.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.49 90.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.766 2.311 . . . . 0.0 111.628 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -170.87 143.74 2.11 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.587 0.555 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.71 -33.05 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.085 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.3 -62.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.191 -178.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -55.74 -22.14 22.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.43 -25.91 54.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.254 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.71 133.83 47.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.5 -15.56 29.28 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.94 151.52 23.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.6 135.16 37.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.357 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.16 136.59 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.57 138.45 14.27 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.3 t -130.77 161.56 40.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.082 0.468 . . . . 0.0 110.359 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.3 tp -92.41 117.45 29.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.7 158.06 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.608 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.61 50.56 53.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.4 p -149.77 168.9 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.73 0.3 . . . . 0.0 110.9 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.1 p -73.3 -27.54 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.434 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.15 -55.65 31.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.507 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.5 -54.96 39.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.698 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -60.11 -51.16 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.792 -179.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.5 t80 -62.07 -43.96 97.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.591 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.58 -44.39 98.02 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.336 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.8 tt0 -125.23 -34.28 2.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.53 -50.56 17.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.129 0.49 . . . . 0.0 111.673 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.0 12.29 36.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.252 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.66 -55.38 0.48 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.347 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 55.7 Cg_endo -72.2 -10.61 26.03 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.75 2.3 . . . . 0.0 111.965 -179.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.44 -9.17 59.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.42 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.93 33.16 37.79 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.24 138.07 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 110.628 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.67 129.84 35.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.28 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.21 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.96 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.5 t -123.0 133.35 69.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.026 0.441 . . . . 0.0 109.981 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.4 43.13 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -110.64 153.37 25.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.01 6.68 29.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.759 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.21 130.17 5.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.418 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.8 -45.87 80.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.715 0.293 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.82 -23.32 62.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.608 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.58 -37.07 86.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.11 0.481 . . . . 0.0 110.537 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.81 -46.82 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.231 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.508 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.5 m-85 -64.48 -37.72 88.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.345 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.97 -42.23 97.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.1 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.84 -43.52 92.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.122 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.583 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.0 tp -59.01 -47.76 84.03 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.023 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.85 -22.57 66.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.025 0.44 . . . . 0.0 110.12 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.63 -18.26 25.43 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.592 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.95 72.18 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.98 -18.03 63.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.606 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.6 pt -127.04 135.92 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.399 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -72.55 -27.82 62.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.313 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.52 155.99 1.88 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.838 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.15 136.71 49.58 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.68 103.48 14.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.281 0.562 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.76 165.25 24.97 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.476 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.84 153.09 41.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.34 -54.65 22.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.401 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.447 HG21 ' CG ' ' A' ' 91' ' ' TYR . 71.4 t -60.07 -49.06 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.705 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.33 -39.06 89.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.797 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.14 1.21 Allowed 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.0 m -59.5 -48.16 82.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.911 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -48.55 -37.74 18.63 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.342 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.75 -66.14 0.56 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.667 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.2 t80 -40.56 -70.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 111.218 -178.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.457 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.7 mt -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.23 -3.03 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.443 0.639 . . . . 0.0 110.499 -179.528 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 173' ' ' LEU . 55.8 mt-30 -122.71 147.09 49.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.853 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.48 -19.64 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.844 2.362 . . . . 0.0 112.228 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.87 -42.8 96.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.672 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.63 -32.97 83.35 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.044 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.57 -41.26 94.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.7 m-20 -65.83 -33.47 75.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.25 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.0 m-85 -156.79 143.04 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.675 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.8 pttt -177.94 100.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.39 167.12 29.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.696 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.07 56.72 2.66 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.43 -118.37 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.36 135.35 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.477 2.118 . . . . 0.0 111.941 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -125.36 -107.9 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.61 -179.087 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.2 p -165.59 164.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.41 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.4 tttt 153.99 156.28 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.823 0.702 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.55 116.87 22.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.02 -18.94 62.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.81 -32.52 74.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.557 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -61.04 -44.47 97.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.691 -178.08 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -113.96 9.23 17.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.743 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.18 -154.83 52.23 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.631 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.14 -25.06 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.47 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.25 -124.33 1.33 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.22 156.23 44.29 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 110.234 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.56 -169.42 30.15 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -94.52 137.48 33.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.55 108.29 3.29 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.7 mt -123.39 159.37 29.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.441 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.659 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.76 149.61 24.74 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.94 -48.04 64.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.518 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.38 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.5 m-20 -71.75 52.27 0.22 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.64 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.53 -45.54 86.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.345 -179.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.44 -47.12 35.48 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.32 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.3 -44.11 97.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.425 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.15 -36.43 70.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.19 -77.73 0.11 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.893 HD21 HD11 ' A' ' 44' ' ' ILE . 97.0 mt -28.27 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.736 0.303 . . . . 0.0 110.29 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.23 -44.83 90.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.662 178.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.99 -43.77 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.957 178.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.27 94.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.057 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -61.25 -43.71 98.44 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 109.894 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.15 92.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.67 -42.89 97.99 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.535 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -58.28 -38.33 76.8 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.0 -40.02 78.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 0.0 110.095 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.68 93.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.0 p30 -86.73 1.54 51.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.451 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.26 19.52 59.69 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 72.6 m -58.31 -45.65 87.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.49 -58.15 7.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.341 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.89 -41.33 77.86 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.46 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.53 -48.36 81.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.643 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.296 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.74 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.463 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.44 -35.39 72.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.645 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -71.14 -50.86 28.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.4 m-85 -62.27 -45.28 93.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.503 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.9 m-85 -153.3 155.06 35.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.407 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.5 p-10 -97.56 95.22 7.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.954 0.406 . . . . 0.0 110.505 179.513 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -153.16 -166.12 2.35 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.99 109.98 14.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.822 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.4 m -63.43 -40.67 89.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.39 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.2 m-85 -56.38 -43.91 79.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.49 94.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.67 0 CA-C-O 117.934 -1.481 . . . . 0.0 110.95 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.22 59.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.604 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.88 144.0 99.47 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.6 2.2 . . . . 0.0 112.235 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -65.86 -40.62 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.62 144.47 37.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.464 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -110.92 129.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -104.42 116.56 32.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.425 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.8 140.99 29.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.17 106.39 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 m -128.49 120.23 26.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.679 0.276 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.7 t70 -112.54 94.22 26.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.104 179.606 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 C--N 1.308 -1.594 0 C-N-CA 122.467 2.111 . . . . 0.0 112.19 179.334 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.8 t0 . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.041 0.448 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.8 mt -67.02 -39.99 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.741 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -60.98 -36.66 80.03 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.967 -178.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.21 -44.71 83.07 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.47 -45.08 89.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.214 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.93 -54.24 45.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.505 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.13 -37.32 64.23 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.62 -43.36 72.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 54.4 m -54.13 -44.24 71.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.165 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.9 tttm -63.91 -48.0 78.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.043 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.51 -41.11 89.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.171 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.967 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.37 -18.53 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.507 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.51 52.24 3.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.14 169.93 17.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.1 140.85 29.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.155 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.17 132.01 56.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.97 126.79 42.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.441 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.18 136.51 34.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.566 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.35 128.93 64.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.416 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.07 139.88 56.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.4 p30 175.0 135.16 0.16 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.37 143.34 57.74 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.715 2.277 . . . . 0.0 112.45 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.879 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -39.88 -54.56 2.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.119 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.84 -25.97 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.139 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.33 -20.99 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.117 -179.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.879 HD12 HD23 ' A' ' 55' ' ' LEU . 55.1 mt -64.04 -42.43 97.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.58 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -56.57 30.27 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.008 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.3 Cg_exo -55.05 -42.94 64.16 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.293 176.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.4 m -58.48 -44.94 89.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.854 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 tp -58.65 -44.54 90.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.7 -41.18 96.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.397 . . . . 0.0 110.453 178.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.03 11.08 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.29 11.95 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.61 -33.69 76.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -124.41 154.55 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.322 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -92.6 -20.79 20.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.175 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.19 159.64 23.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.582 HG23 HD13 ' A' ' 58' ' ' LEU . 96.0 mt -116.29 127.39 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 110.537 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 61.9 ttp -128.68 107.38 9.63 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.323 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.514 ' OG ' HD21 ' A' ' 55' ' ' LEU . 36.7 t -162.27 -176.79 5.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.22 -15.89 60.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.345 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.637 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.6 tp -37.51 122.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 110.502 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.03 156.21 23.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.69 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.657 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.21 149.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.0 p -150.52 152.52 34.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.787 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.08 -47.72 53.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.44 -39.78 70.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.637 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.67 -37.79 79.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.022 0.439 . . . . 0.0 110.875 179.203 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.2 -37.71 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.931 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.86 -27.41 66.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.153 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.58 -51.12 7.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 110.543 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -139.15 -168.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.49 147.29 29.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.566 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.1 m-85 -130.33 150.47 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.1 t -165.02 -150.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.474 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.0 m-20 42.74 19.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.14 120.87 0.09 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.484 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -80.0 -72.79 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.923 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -147.86 164.98 32.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.58 127.49 32.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.405 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -107.11 67.48 0.7 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.692 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.27 -106.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 32.2 p -159.45 167.85 27.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.21 146.68 23.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.055 0.455 . . . . 0.0 110.492 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -101.68 135.94 42.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.743 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 111.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.98 164.67 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 -179.165 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 148.44 24.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.31 -28.24 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.2 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -59.07 -41.35 87.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -102.38 122.31 44.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.332 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.51 109.39 19.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.062 0.458 . . . . 0.0 110.532 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.4 129.85 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.25 158.79 36.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.473 ' O ' ' OG1' ' A' ' 108' ' ' THR . 21.0 Cg_endo -60.3 91.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.736 2.29 . . . . 0.0 111.883 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.7 m -169.89 142.62 2.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.56 -33.5 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.284 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -56.73 -63.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.343 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -56.86 -21.75 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.059 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.5 -28.28 59.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -55.06 132.55 47.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.53 -16.35 35.83 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.64 151.21 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 -179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -96.38 135.58 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.287 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.44 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.708 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.83 137.81 13.97 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.4 t -131.44 161.7 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.047 0.451 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.552 ' N ' HG12 ' A' ' 119' ' ' VAL . 39.2 tp -92.99 120.55 33.41 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -52.01 155.49 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.6 50.91 45.62 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -147.85 166.1 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.662 0.267 . . . . 0.0 110.886 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 68.6 p -71.28 -30.62 66.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.3 mt-30 -58.35 -55.16 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.24 -55.43 33.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.799 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 m -60.56 -51.65 68.52 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.872 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.589 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 68.5 t80 -61.83 -44.41 96.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 110.547 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.0 -44.37 97.88 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.8 m-20 -45.44 -14.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 0.0 110.731 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.35 -34.43 2.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.589 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.8 t60 -74.04 -50.46 19.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.523 -178.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.92 12.53 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.165 -179.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.24 -55.14 0.51 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.37 -9.8 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.789 2.326 . . . . 0.0 111.988 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.12 -8.62 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.388 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.09 33.51 36.1 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.79 137.57 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.0 110.594 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.97 130.27 35.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.276 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.6 pt -128.34 139.75 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.974 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.96 132.47 70.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.133 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.3 t -97.82 129.83 44.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.763 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.1 156.93 20.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.0 6.97 27.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.25 130.56 6.08 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.24 -46.58 76.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.712 0.291 . . . . 0.0 110.413 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.02 -23.22 63.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.563 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.447 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.61 -36.54 84.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.527 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.26 -47.67 83.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.4 m-85 -63.59 -37.86 88.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.37 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.84 -42.62 98.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.44 -43.74 93.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.3 tp -59.21 -48.53 81.29 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.179 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.72 -22.85 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.962 0.411 . . . . 0.0 110.199 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.29 -18.19 26.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.3 11.03 73.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.48 -18.12 63.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.4 pt -128.37 137.31 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.38 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.409 ' O ' HG12 ' A' ' 99' ' ' VAL . 97.6 m-20 -72.88 -29.36 63.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.26 155.13 1.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.821 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.61 139.09 52.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.946 0.403 . . . . 0.0 110.029 179.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.51 103.15 14.77 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.234 0.54 . . . . 0.0 110.714 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.36 164.69 25.92 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -73.53 152.45 40.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.2 -54.11 29.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.59 -49.25 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.91 84.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.844 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.94 1.05 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.533 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.446 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.0 m -57.82 -46.51 84.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.298 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.05 -41.87 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.402 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.26 -62.26 0.48 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.623 -179.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.31 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.618 0.247 . . . . 0.0 111.083 -178.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.35 -40.71 97.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.13 -2.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.383 0.611 . . . . 0.0 110.532 -179.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.5 mt-30 -126.25 141.5 40.01 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.825 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.45 -14.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.828 2.352 . . . . 0.0 112.211 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 92.5 t -63.28 -42.91 98.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.67 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.31 84.61 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.1 -41.21 96.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.727 0.299 . . . . 0.0 110.48 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -65.8 -34.7 78.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.467 179.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.18 143.35 17.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.6 pttt -175.96 99.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.745 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.76 166.78 31.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.698 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.83 55.89 3.05 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.21 -116.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.56 134.02 32.52 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.573 2.182 . . . . 0.0 111.906 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -123.27 -109.4 0.33 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.453 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 4.4 p -164.84 164.09 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.6 tttt 154.71 154.09 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.791 0.682 . . . . 0.0 110.657 179.276 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -80.06 119.26 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.951 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.36 -19.76 62.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.18 -31.0 72.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 128' ' ' PHE . 87.9 mt -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.668 -178.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -114.46 8.18 16.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.735 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.7 -154.1 49.68 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.657 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.2 p -70.79 -25.74 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 110.606 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.1 -126.9 1.66 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.0 p -132.28 160.56 35.86 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.484 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.96 -161.74 23.87 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.8 140.45 32.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.976 0.417 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.19 3.53 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -117.86 159.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 110.248 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.9 mtm180 -86.76 148.57 25.36 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.511 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.63 -48.48 63.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.663 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -40.94 -22.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 0.0 110.734 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -73.08 51.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.739 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.41 -46.42 83.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.19 -47.12 37.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.413 HD11 HD13 ' A' ' 44' ' ' ILE . 63.4 tp -62.14 -43.7 98.26 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.59 -43.1 99.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.39 -37.59 72.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.43 -77.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.967 HD21 HD11 ' A' ' 44' ' ' ILE . 86.9 mt -28.03 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.2 m-20 -63.63 -45.76 88.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.94 -43.96 97.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.945 178.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.2 91.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.082 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.2 91.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.181 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.93 -43.44 95.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.887 179.347 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.511 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.36 -38.53 71.53 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -39.11 77.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 0.0 110.288 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.25 -45.63 90.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.653 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.3 p-10 -88.58 -0.49 57.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.71 20.49 70.27 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.9 m -58.19 -46.36 85.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.484 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -62.21 -56.68 16.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.71 -40.76 76.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.317 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -47.92 83.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.535 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.1 -40.75 96.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.251 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.62 -49.7 76.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.557 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.5 -35.74 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -69.77 -51.6 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.499 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.93 -46.27 90.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.579 179.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.67 154.64 33.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.517 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.5 p-10 -98.28 95.19 7.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.979 0.419 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -151.5 -164.13 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.12 108.49 13.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.787 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 239' ' ' TYR . 26.0 m -63.56 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.367 179.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.432 ' N ' HG23 ' A' ' 238' ' ' VAL . 89.7 m-85 -58.53 -42.51 87.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.64 95.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.669 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.28 164.39 61.59 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.86 143.52 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.539 2.159 . . . . 0.0 112.287 179.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.17 -40.33 90.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.79 142.51 36.7 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.485 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.0 mt -109.62 128.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.915 0.388 . . . . 0.0 110.489 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -103.39 116.86 33.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.128 0.49 . . . . 0.0 110.392 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.59 138.93 38.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.952 0.406 . . . . 0.0 110.575 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.02 104.4 2.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -127.57 119.24 25.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 122.759 -0.26 . . . . 0.0 111.217 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 16.4 t70 -113.63 93.21 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.155 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 C--N 1.308 -1.561 0 C-N-CA 122.502 2.134 . . . . 0.0 112.115 179.253 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.6 t0 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.98 0.419 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.68 -40.77 82.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.055 179.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 53.0 m-20 -61.16 -37.15 81.86 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.972 -178.464 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.77 -43.99 82.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.054 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.539 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.78 -41.89 92.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.293 -179.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -58.8 -53.52 57.4 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.546 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.65 -36.81 62.48 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.924 0.392 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.69 -42.37 74.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 178.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.25 -44.79 72.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.208 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -63.74 -47.79 79.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.987 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.199 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.981 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.46 -17.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.76 52.69 4.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.5 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.62 140.86 29.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.136 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.39 131.79 56.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.636 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.2 127.67 43.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -93.86 135.67 34.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.59 128.27 65.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.345 179.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.11 139.29 58.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.819 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.1 p30 174.95 132.35 0.14 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.42 144.55 61.94 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.728 2.286 . . . . 0.0 112.467 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.882 HD23 HD12 ' A' ' 58' ' ' LEU . 82.0 mt -40.01 -56.34 1.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -47.55 -26.48 1.45 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.127 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.36 -20.63 18.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.19 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.882 HD12 HD23 ' A' ' 55' ' ' LEU . 57.4 mt -63.99 -42.35 97.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.49 -56.69 27.77 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.894 -179.305 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.8 Cg_exo -54.94 -43.59 57.9 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.646 2.23 . . . . 0.0 111.249 177.02 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -58.55 -44.69 89.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.781 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.14 -44.32 87.75 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.149 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.56 -40.39 95.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.021 0.439 . . . . 0.0 110.541 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 11.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.517 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.21 12.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.44 -34.46 77.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.536 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -123.8 153.25 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.278 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.71 -20.57 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.97 157.05 25.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.739 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.603 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.02 127.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.062 0.458 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -128.64 106.69 9.12 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.583 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.0 t -159.98 -178.23 6.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.582 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.26 -15.47 60.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.0 tp -38.05 123.81 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.45 156.71 22.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.649 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.3 pt -104.88 148.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.365 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -149.92 152.32 34.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.833 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.19 -47.84 54.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.606 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.81 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.74 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.7 mtt180 -68.45 -37.8 80.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.11 74.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.875 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.45 67.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.132 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.45 -51.71 7.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.533 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.33 -168.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.81 146.73 29.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.034 0.445 . . . . 0.0 110.985 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 76' ' ' ILE . 71.7 m-85 -129.76 149.98 51.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.614 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.6 t -164.15 -151.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.516 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.5 m-20 43.11 19.18 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.801 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.92 120.12 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.0 mt -77.0 -69.99 0.49 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 166' ' ' VAL . 45.0 p90 -149.34 166.31 29.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.619 -179.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.26 121.65 27.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.438 . . . . 0.0 110.29 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.94 69.82 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.782 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.22 -104.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.465 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.29 165.87 32.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.697 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.73 145.84 21.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.503 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.27 136.05 41.75 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.77 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 110.79 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.65 164.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.94 148.42 23.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.57 -27.75 41.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.272 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -59.25 -41.74 89.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.326 -179.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.47 122.59 44.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.299 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.92 109.41 19.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.427 ' C ' ' NE2' ' A' ' 106' ' ' GLN . 97.1 mt -128.15 129.6 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.583 ' NE2' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.89 158.9 34.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.569 179.916 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.58 89.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.734 2.289 . . . . 0.0 111.913 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -169.05 140.89 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.701 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.27 -32.96 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.237 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -56.98 -62.82 1.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 -178.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -55.95 -22.04 24.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.032 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.57 -26.15 54.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.22 46.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.405 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.82 -15.6 30.88 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.98 151.86 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -179.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.48 135.51 38.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.068 0.461 . . . . 0.0 110.298 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.0 136.71 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.45 138.65 14.36 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.02 161.62 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.03 0.443 . . . . 0.0 110.367 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.2 tp -92.6 117.61 30.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.491 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.75 157.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.01 50.61 51.2 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.6 p -149.84 168.98 22.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.674 0.273 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -73.81 -26.38 60.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.446 179.401 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.66 -55.7 30.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.465 -179.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.66 -54.47 45.74 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.63 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.31 -51.25 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.675 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.05 -43.73 98.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.58 179.176 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.47 97.72 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.23 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.34 -34.15 2.74 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.47 -50.88 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.038 0.446 . . . . 0.0 111.533 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -99.07 12.61 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.99 -55.58 0.46 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.23 -10.44 25.76 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.783 2.322 . . . . 0.0 111.979 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.54 -8.88 59.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.425 -179.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.38 36.97 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.67 138.27 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.593 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.92 129.81 35.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.301 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.04 133.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 110.067 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.15 127.67 43.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -110.92 153.59 25.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.413 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.94 6.93 29.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.91 130.43 5.94 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.96 -45.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.714 0.292 . . . . 0.0 110.417 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.11 -23.72 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.453 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.72 -36.43 84.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.3 -47.12 85.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.109 -179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -63.56 -37.86 88.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.396 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.21 -42.72 99.08 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.229 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.43 -45.32 91.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 42.8 tp -58.76 -48.19 82.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.73 -22.9 66.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.947 0.403 . . . . 0.0 110.22 179.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.77 -18.22 25.31 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.622 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.71 11.24 71.34 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.43 -17.87 63.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 110.631 179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.4 pt -128.5 137.36 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.43 179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.06 -27.89 62.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.63 155.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.811 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.37 50.71 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.019 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.63 103.12 14.16 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.277 0.56 . . . . 0.0 110.761 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.35 165.06 25.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.375 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.36 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.987 0.422 . . . . 0.0 110.526 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.426 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.01 -54.28 28.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.212 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.3 t -59.78 -49.3 84.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.67 -179.295 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.83 -38.8 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.678 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.67 1.09 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.583 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -58.61 -47.62 83.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.73 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -48.75 -38.68 22.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.268 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.452 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.69 -65.65 0.55 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.678 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.7 t80 -40.23 -71.13 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.704 -0.292 . . . . 0.0 111.235 -178.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.3 mt -61.39 -39.81 92.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.79 -3.11 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.461 0.648 . . . . 0.0 110.535 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 177' ' ' VAL . 53.5 mt-30 -124.68 141.79 38.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -43.92 -14.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.797 2.331 . . . . 0.0 112.197 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.9 t -63.17 -42.78 97.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.91 81.5 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.1 -41.28 96.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.622 0.248 . . . . 0.0 110.449 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.6 m-20 -65.98 -34.61 78.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.457 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.9 m-85 -157.44 143.5 17.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.08 100.25 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.1 m-85 -159.49 167.74 27.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.654 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.57 55.65 3.15 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.59 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -179.756 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.57 135.23 33.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.518 2.146 . . . . 0.0 111.953 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.24 -108.0 0.32 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.503 -179.023 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.14 165.22 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.366 -179.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.26 155.84 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 123.758 0.661 . . . . 0.0 110.668 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.17 22.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.852 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.6 mp0 -71.87 -18.69 62.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.592 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.6 mt -60.98 -44.26 97.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.0 m-85 -113.71 7.51 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.78 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.35 -155.5 50.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.649 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.5 p -70.54 -25.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.0 110.63 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.96 -126.16 1.56 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.5 p -131.99 160.02 37.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.79 0.329 . . . . 0.0 110.483 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.46 24.87 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.17 141.16 31.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.26 111.9 3.98 Favored Glycine 0 C--N 1.329 0.185 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.6 mt -120.98 160.82 22.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -87.38 149.07 24.72 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.09 -48.93 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 -179.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -40.14 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.019 0.438 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.25 52.23 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -46.06 84.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.54 -47.06 35.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.19 -44.07 97.42 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.451 -179.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.4 -43.0 99.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.919 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.6 -37.28 72.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.792 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.981 HD21 HD11 ' A' ' 44' ' ' ILE . 86.8 mt -28.11 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 110.358 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.8 m-20 -63.53 -45.51 90.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.582 178.238 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.34 -43.62 98.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.34 93.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.057 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.19 -43.56 98.69 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.5 93.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.221 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.66 -43.08 97.79 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.841 179.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.79 -38.26 72.29 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.81 76.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.945 0.403 . . . . 0.0 110.302 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.12 93.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.659 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.73 0.41 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.682 179.499 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.57 20.24 67.74 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.461 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 89.1 m -57.83 -46.38 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.51 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.3 t80 -63.45 -58.01 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.414 179.234 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.74 76.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.565 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.53 -48.45 80.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.85 -41.41 97.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.368 179.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.09 -50.21 74.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.508 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.18 -35.77 72.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.669 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.62 -51.09 30.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.42 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.18 -45.77 91.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.57 155.0 35.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.6 p-10 -97.95 98.24 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.24 -165.43 2.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.591 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.67 109.41 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.774 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.5 m -63.86 -40.56 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.478 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.5 m-85 -56.7 -43.75 80.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.95 94.09 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.426 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.908 -1.496 . . . . 0.0 110.955 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.58 164.29 59.17 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.593 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.89 143.55 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.58 2.187 . . . . 0.0 112.295 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.23 -40.23 90.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.76 142.22 36.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.401 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.3 mt -109.41 128.68 65.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 110.511 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.41 117.02 33.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.154 0.502 . . . . 0.0 110.379 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -111.97 139.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.555 -179.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.98 105.26 2.18 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -128.12 119.1 24.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.255 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.534 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.9 t0 -113.63 93.35 27.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.121 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--N 1.308 -1.589 0 C-N-CA 122.418 2.079 . . . . 0.0 112.132 179.271 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.471 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 35.0 t0 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.48 -41.23 83.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.403 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.2 m-20 -60.89 -37.06 80.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.029 -178.468 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.81 -43.81 82.86 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.07 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.536 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.92 -41.72 92.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.124 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.89 -53.61 56.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.58 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.86 -36.56 62.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.913 0.387 . . . . 0.0 110.309 179.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.67 -42.42 74.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 178.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.5 m -54.35 -44.71 72.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.158 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -63.91 -47.74 79.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.058 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.46 -40.85 88.22 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.163 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.974 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.34 -17.97 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.536 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 60.77 52.79 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.545 -179.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.55 170.58 16.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.46 140.77 29.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.8 m -117.3 131.74 56.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.725 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.7 m -128.24 127.63 43.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.481 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.15 135.79 35.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.595 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.64 128.52 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.02 139.56 58.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.534 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 174.87 131.81 0.14 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.9 Cg_endo -68.05 144.78 65.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.745 2.297 . . . . 0.0 112.477 -179.388 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.878 HD23 HD12 ' A' ' 58' ' ' LEU . 83.3 mt -40.23 -56.0 2.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.98 -26.28 1.7 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.16 -179.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.44 -20.65 18.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.878 HD12 HD23 ' A' ' 55' ' ' LEU . 57.3 mt -63.99 -42.3 97.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.656 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.717 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.54 -56.68 27.71 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.93 -179.291 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.717 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.3 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.599 2.199 . . . . 0.0 111.12 177.232 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.86 -44.6 91.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.729 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.22 -44.36 88.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.53 -40.48 95.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.972 0.415 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.21 11.13 1.62 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.06 12.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.36 77.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.584 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.87 153.89 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.339 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.4 -20.83 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.329 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.52 157.76 25.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.783 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 HD13 ' A' ' 58' ' ' LEU . 96.2 mt -115.8 127.43 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 110.502 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.471 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.82 106.89 9.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.395 179.761 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.583 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.6 t -160.74 -177.7 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.583 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.14 -15.86 60.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.3 tp -37.98 123.52 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 110.455 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.4 156.85 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.703 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.2 pt -105.22 149.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.356 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.4 p -150.17 152.68 35.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.835 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.42 -47.48 56.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.574 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.73 -39.85 71.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.3 mtt180 -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 110.962 178.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.25 -37.18 74.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.822 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.48 -27.57 67.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.087 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.73 7.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.0 110.531 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.24 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.122 0.487 . . . . 0.0 110.452 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.94 146.6 29.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 76' ' ' ILE . 73.0 m-85 -129.72 149.97 51.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.26 -151.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.437 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.4 m-20 42.88 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.767 179.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -28.39 120.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.403 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.468 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.02 -69.88 0.5 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.888 -178.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.441 ' CG ' HG21 ' A' ' 166' ' ' VAL . 45.9 p90 -149.27 166.28 29.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.64 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.41 121.56 27.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.308 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.46 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.77 69.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 -179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.92 -104.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.22 165.62 33.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.777 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 79.0 ttt-85 -155.49 146.11 22.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.438 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.4 135.93 42.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.987 0.423 . . . . 0.0 110.818 178.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.56 110.62 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.3 165.02 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 -179.39 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.79 23.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.79 -27.95 45.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.12 -41.79 89.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -102.35 122.21 43.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.257 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.7 108.92 19.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.085 0.469 . . . . 0.0 110.425 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.07 129.92 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.59 159.18 34.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.95 0.405 . . . . 0.0 110.511 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.32 89.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.674 2.249 . . . . 0.0 111.891 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -169.2 140.82 2.45 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.459 0.474 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.09 -32.71 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.145 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.507 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.23 -62.95 1.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 t -55.74 -22.17 22.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.015 -179.154 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.4 -26.21 55.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.21 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.71 44.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.435 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.93 30.99 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -86.15 151.34 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.0 110.441 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.72 136.11 37.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.294 -179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.06 136.65 60.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.731 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 138.26 14.17 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.1 t -131.26 161.75 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.352 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.549 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.0 tp -93.05 119.63 32.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -52.04 157.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.97 50.72 50.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.1 p -149.05 167.97 24.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.715 0.293 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 81.3 p -74.06 -26.22 60.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.392 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.79 -55.47 32.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.21 -53.78 54.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.1 m -60.58 -51.34 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.1 t80 -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.131 0.491 . . . . 0.0 110.489 179.207 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.19 -44.49 97.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.276 -0.729 . . . . 0.0 111.276 -179.282 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.43 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.24 -34.1 2.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.56 -50.52 17.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.026 0.441 . . . . 0.0 111.586 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -98.94 12.5 35.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.272 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.774 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.92 -55.32 0.47 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.38 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.2 -10.71 26.18 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.778 2.319 . . . . 0.0 111.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -8.9 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.82 33.43 37.46 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.29 138.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.644 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.06 130.01 35.12 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.229 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.53 139.31 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.6 132.39 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.962 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.44 130.32 45.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.55 156.55 21.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.375 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.87 6.26 29.19 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.739 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.8 6.24 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.405 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.8 tp60 -66.13 -45.9 79.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.4 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.63 -23.31 62.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.532 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.2 t-20 -64.54 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.507 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.04 -47.16 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.26 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.7 m-85 -64.36 -37.56 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.324 179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.81 -42.17 97.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.055 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.95 -43.02 94.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.92 179.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.3 tp -59.48 -47.94 83.58 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.024 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.4 m -62.63 -22.74 66.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -17.52 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.659 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 11.82 74.38 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.72 -18.11 63.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 153' ' ' LEU . 35.3 pt -127.15 136.23 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.377 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 99' ' ' VAL . 97.6 m-20 -72.82 -28.9 62.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.302 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.484 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.11 155.55 1.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.13 138.04 51.56 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -86.25 102.93 14.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.265 0.555 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.8 tt0 -132.24 164.87 25.42 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.388 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.475 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.14 152.98 40.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.968 0.413 . . . . 0.0 110.549 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.08 -54.38 26.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.295 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.441 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.07 -49.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.709 -179.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.06 88.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.788 0.327 . . . . 0.0 110.851 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.78 1.06 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.678 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.6 m -58.64 -47.45 84.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.708 -179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.13 -38.4 25.0 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.228 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.67 -65.56 0.55 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.683 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.7 t80 -40.34 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.722 0.296 . . . . 0.0 111.312 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.8 mt -61.53 -39.61 91.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.044 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.06 -3.19 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.515 -179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 177' ' ' VAL . 61.4 mt-30 -124.28 142.28 39.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.1 -15.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.833 2.355 . . . . 0.0 112.22 179.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.3 t -62.98 -42.75 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.01 82.37 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.0 -41.29 96.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.673 0.273 . . . . 0.0 110.509 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.4 m-20 -66.02 -34.58 78.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.388 179.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -157.07 143.21 17.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.91 99.91 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.9 0.381 . . . . 0.0 110.782 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.26 166.73 30.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.729 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.45 56.01 2.91 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.29 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.8 135.51 35.33 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.478 2.119 . . . . 0.0 111.9 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.15 -107.87 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.552 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.677 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -166.5 165.39 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.351 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.677 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.21 156.42 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.748 0.655 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -82.88 117.98 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.27 -18.65 62.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.74 -32.01 73.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.581 -179.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.455 HD11 ' CG ' ' A' ' 128' ' ' PHE . 93.0 mt -61.06 -44.29 97.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.772 -178.183 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.7 7.68 17.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.763 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.89 -155.4 50.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.651 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.1 p -70.32 -25.52 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.65 -126.36 1.6 Allowed Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.355 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.66 159.64 37.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 110.47 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.61 24.96 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.32 141.18 31.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.967 0.413 . . . . 0.0 110.579 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.04 3.84 Favored Glycine 0 C--N 1.329 0.173 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.7 mt -119.71 160.52 22.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 110.202 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -87.28 149.03 24.83 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.847 0.356 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.33 -48.77 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.685 -179.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -40.63 -22.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.123 0.487 . . . . 0.0 110.682 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.08 52.18 0.24 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.769 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.45 -45.88 85.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.301 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.62 -47.14 33.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.055 0.455 . . . . 0.0 111.279 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.18 -44.08 97.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.49 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.864 179.536 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.75 -37.33 73.42 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.974 HD21 HD11 ' A' ' 44' ' ' ILE . 86.2 mt -28.39 -45.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 0.0 110.322 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.1 m-20 -63.57 -45.54 89.97 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.495 178.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.47 -43.59 98.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.25 92.86 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.045 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.002 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.51 92.95 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.179 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.54 -43.13 98.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.84 -38.27 72.42 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.89 -38.84 76.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 110.364 178.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.35 93.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 20.9 p-10 -88.34 0.44 56.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.681 179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.34 20.3 67.37 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.01 -46.36 85.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.0 t80 -63.47 -57.88 8.82 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.33 -41.72 76.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.66 -48.19 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.686 -179.539 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.15 -41.48 98.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.17 -50.11 75.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.532 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.21 -35.8 72.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.59 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.44 -50.91 33.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.2 m-85 -62.5 -45.28 93.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.521 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 72.1 m-85 -153.93 155.02 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.526 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.34 98.63 9.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.419 . . . . 0.0 110.511 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -155.59 -165.11 1.89 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.577 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.0 t0 -122.67 109.15 13.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.803 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 25.1 m -63.72 -40.53 89.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.421 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.8 m-85 -56.76 -43.71 81.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.42 -36.77 93.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.663 0 CA-C-O 117.853 -1.526 . . . . 0.0 110.976 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.03 164.31 62.27 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.651 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.86 143.46 99.37 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.47 2.114 . . . . 0.0 112.285 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.65 -40.67 88.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.605 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -138.78 141.6 38.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.363 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.02 127.69 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.4 mtp180 -101.65 117.56 35.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.157 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.378 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.6 104.71 2.13 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.1 m -127.87 119.52 25.79 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 18.2 t0 -113.23 91.89 20.62 Favored Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.069 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.87 134.06 57.43 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.466 2.111 . . . . 0.0 111.904 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.3 p -141.32 -19.65 0.78 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.805 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.4 m-85 -123.97 98.43 5.79 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.319 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.702 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.79 -61.09 0.22 Allowed Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 121.851 0.834 . . . . 0.0 110.969 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.702 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.78 -40.52 47.78 Favored 'Trans proline' 0 C--N 1.297 -2.176 0 C-N-CA 121.896 1.73 . . . . 0.0 112.22 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -78.37 -43.1 28.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.134 0.492 . . . . 0.0 110.866 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.624 ' O ' ' O ' ' A' ' 18' ' ' ALA . 97.0 mt-10 -149.28 -154.56 0.56 Allowed 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.147 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.66 177.66 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.837 0.351 . . . . 0.0 110.164 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.28 144.65 46.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.406 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -95.49 134.84 37.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.489 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -64.82 -18.9 65.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.451 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.24 -6.63 55.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.507 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.75 -7.98 55.91 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.31 158.38 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.81 0.338 . . . . 0.0 110.411 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -111.87 131.74 55.16 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.337 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.688 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.32 151.54 32.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.89 151.81 6.75 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -58.83 -42.41 89.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.872 0.368 . . . . 0.0 110.838 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.6 t0 -69.25 -28.84 66.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 0.0 111.232 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.688 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -67.66 -40.97 85.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.107 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -60.81 -37.7 82.89 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.095 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.39 -45.04 89.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.126 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.3 -47.9 80.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.143 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -53.22 -54.34 37.54 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.339 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.55 -40.25 62.35 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.102 0.477 . . . . 0.0 110.13 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.13 -42.02 80.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.945 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.2 m -54.13 -43.95 70.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.042 -179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.01 -47.12 81.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 0.0 110.225 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.8 mmt-85 -59.86 -41.79 92.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.474 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.929 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.36 -18.03 15.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.548 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.81 52.59 4.22 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.354 0.409 . . . . 0.0 110.659 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 p -146.63 171.11 15.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.1 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -88.63 141.39 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.984 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.95 130.61 56.81 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.569 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.06 127.23 44.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.277 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -94.66 135.81 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.438 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -129.54 128.92 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.939 0.4 . . . . 0.0 110.423 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.46 139.2 58.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.404 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 175.37 129.88 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.675 179.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.0 146.43 71.09 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.632 2.221 . . . . 0.0 112.402 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.876 HD23 HD12 ' A' ' 58' ' ' LEU . 83.4 mt -40.44 -56.73 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.124 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.07 -27.14 2.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.39 -20.69 19.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.048 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.876 HD12 HD23 ' A' ' 55' ' ' LEU . 60.7 mt -64.53 -42.41 95.77 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.622 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.664 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.62 -56.96 24.95 Favored Pre-proline 0 C--O 1.241 0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.667 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.664 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.6 Cg_exo -54.46 -43.52 58.04 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.435 2.09 . . . . 0.0 111.521 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.6 m -59.09 -44.32 91.92 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.777 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.5 tp -58.42 -44.14 88.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.069 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -64.6 -39.95 94.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.46 11.29 1.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.647 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.96 12.12 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.762 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.63 78.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.664 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.51 152.25 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -92.98 -20.59 20.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.23 156.18 26.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.489 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 58' ' ' LEU . 96.8 mt -115.29 127.11 72.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.451 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -128.32 105.9 8.65 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.268 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.663 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.9 t -159.33 179.87 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.625 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.78 -15.14 61.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.427 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.642 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.2 tp -36.4 123.91 0.79 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.583 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.73 154.72 25.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.778 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.82 148.35 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.2 p -149.62 152.53 35.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.738 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.37 -46.89 56.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.99 -40.17 72.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.479 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.642 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.8 mtt180 -68.09 -37.9 81.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.137 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.469 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.15 -37.83 75.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.994 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.03 -27.44 66.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.284 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.16 7.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.554 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.7 pt -139.28 -168.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.958 0.409 . . . . 0.0 110.413 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.28 146.92 29.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.83 149.81 51.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.7 t -164.09 -152.81 0.2 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.512 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.507 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.7 m-20 41.86 19.9 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.948 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.63 121.07 0.2 Allowed 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.61 0.569 . . . . 0.0 110.522 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.3 mt -75.13 -68.37 0.56 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.866 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.9 p90 -150.71 167.27 27.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.705 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.5 123.22 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.306 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.87 67.96 0.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.642 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.64 -104.89 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.38 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.9 p -159.76 166.01 31.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.635 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.35 145.99 22.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.598 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.22 135.9 41.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.49 110.98 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.483 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.0 m -134.5 164.14 34.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.732 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.17 148.33 25.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.924 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.68 -27.63 41.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.53 -41.66 90.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.273 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -102.17 122.0 43.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.802 0.334 . . . . 0.0 110.143 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.11 109.55 19.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.339 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.33 129.75 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.623 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.83 159.02 34.01 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.358 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.449 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.7 Cg_endo -59.76 89.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.74 2.293 . . . . 0.0 111.934 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -168.5 140.53 2.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.798 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -66.74 -33.05 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.185 0.516 . . . . 0.0 110.218 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.51 -62.37 1.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.612 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.19 -22.31 28.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 110.859 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -76.32 -25.89 55.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -54.56 132.69 45.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.612 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -16.57 30.25 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -85.85 151.22 23.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.749 0.309 . . . . 0.0 110.383 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.35 135.91 37.55 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.244 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.38 136.51 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.702 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.43 139.98 14.9 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.3 t -132.01 161.59 41.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 0.0 110.308 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.2 tp -92.92 119.04 31.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.488 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.9 157.3 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.35 50.79 47.99 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.4 p -149.51 168.14 24.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.855 0.36 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.26 -25.71 59.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.14 -55.16 35.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.602 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.43 -54.08 50.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.515 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.38 -51.15 70.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.542 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.594 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.3 t80 -62.23 -43.81 97.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.466 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.49 -44.53 97.88 Favored Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.82 -14.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.682 0.277 . . . . 0.0 110.761 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.42 -34.66 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.573 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.594 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.7 t60 -74.47 -50.43 18.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.435 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.37 12.53 36.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.139 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.741 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.91 -55.52 0.47 Allowed Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.416 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.6 Cg_endo -72.27 -10.32 25.54 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.727 2.285 . . . . 0.0 111.984 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.53 -9.18 59.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.536 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.26 37.88 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.32 137.94 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.825 0.345 . . . . 0.0 110.617 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.59 129.62 35.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.183 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.64 138.52 54.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.54 131.89 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 t -98.16 130.33 44.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.603 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -111.44 156.23 21.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.278 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.03 6.48 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.742 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.62 130.66 6.22 Favored Glycine 0 N--CA 1.465 0.569 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.404 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.7 tp60 -65.92 -45.87 80.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.813 0.339 . . . . 0.0 110.459 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.55 -23.61 62.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.512 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.66 -36.93 85.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.427 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.95 -46.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.316 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.511 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.3 m-85 -64.04 -37.85 88.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.31 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.02 -42.45 98.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.049 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.87 -44.45 93.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.108 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.4 tp -59.09 -47.86 83.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.147 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.05 -23.15 67.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.176 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.66 25.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.07 71.05 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.26 -18.39 63.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.704 0.288 . . . . 0.0 110.574 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.8 pt -127.7 137.64 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.09 0.471 . . . . 0.0 110.554 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -72.99 -28.35 62.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.964 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.41 155.71 1.88 Allowed 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.72 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.97 103.18 14.44 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.2 tt0 -132.96 165.27 25.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.509 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.82 152.13 41.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.658 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.412 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.13 -54.23 28.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.647 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 91' ' ' TYR . 78.1 t -60.8 -48.63 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.303 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.8 88.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 110.644 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.36 -63.28 1.18 Allowed 'General case' 0 C--O 1.215 -0.715 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.362 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.436 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.7 m -59.15 -47.18 86.25 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.92 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.446 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.55 -36.8 24.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.121 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.72 -64.99 0.52 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.7 t80 -41.34 -71.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.877 0.37 . . . . 0.0 111.009 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.73 -40.03 93.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.7 -3.34 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.223 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 173' ' ' LEU . 54.5 mt-30 -122.71 149.34 55.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.49 -20.27 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.796 2.331 . . . . 0.0 112.175 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.6 t -60.76 -42.98 94.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.495 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.65 -33.2 84.2 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.63 -41.73 95.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.837 0.351 . . . . 0.0 110.333 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.1 m-20 -65.4 -34.09 77.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.514 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.6 m-85 -155.82 142.62 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.58 99.2 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.088 0.471 . . . . 0.0 110.896 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.22 167.29 29.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.624 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.43 56.24 2.87 Favored Glycine 0 C--O 1.223 -0.583 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.05 -117.88 0.01 OUTLIER Glycine 0 CA--C 1.543 1.789 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.76 136.28 35.0 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.043 1.829 . . . . 0.0 112.036 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -125.08 -108.64 0.32 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.408 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.0 p -165.84 164.85 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 CA-C-O 118.939 -0.553 . . . . 0.0 109.807 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.19 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.373 1.046 . . . . 0.0 110.675 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -82.15 118.05 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.801 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -72.03 -18.89 61.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.986 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.48 -32.54 74.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.555 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.0 mt -60.9 -44.26 97.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.712 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.3 m-85 -114.48 9.63 16.76 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.691 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.97 -153.52 51.33 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.74 -25.47 26.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.779 0.324 . . . . 0.0 110.447 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.21 -123.92 1.28 Allowed Glycine 0 N--CA 1.46 0.245 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -129.6 156.23 44.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.69 -169.61 30.52 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -95.0 138.99 31.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.766 0.317 . . . . 0.0 110.535 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.87 107.56 3.25 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.9 mt -119.76 159.54 24.32 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.1 mtm180 -86.98 149.04 25.05 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.71 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.29 -48.07 65.55 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.712 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -40.51 -23.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.709 0.29 . . . . 0.0 110.666 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.57 52.06 0.2 Allowed 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.417 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.28 -45.74 86.73 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.87 -47.08 32.06 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.987 0.422 . . . . 0.0 111.025 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.47 -43.94 97.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.518 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.14 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.873 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.51 -36.98 72.26 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.772 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.691 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.57 -77.37 0.11 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 44' ' ' ILE . 89.7 mt -29.14 -45.49 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.247 0.342 . . . . 0.0 110.692 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -64.04 -45.07 90.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.731 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.691 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.57 -43.61 98.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.893 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.15 93.06 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.28 -43.72 98.41 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.086 0.47 . . . . 0.0 110.145 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.17 -39.21 91.9 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -42.35 98.09 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.092 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.525 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.39 -38.47 77.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.44 -39.88 81.35 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.404 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.1 92.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.522 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.525 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.8 p30 -86.33 1.04 52.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.482 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.2 19.42 61.71 Favored Glycine 0 C--O 1.225 -0.426 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 73.4 m -58.13 -45.94 86.45 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.086 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 77.3 t80 -63.5 -57.14 11.15 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.38 -41.05 79.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.01 -48.28 82.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.366 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -62.09 -41.82 98.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.293 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.8 -49.84 76.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.65 -35.56 72.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.393 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -70.59 -50.9 32.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.617 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.507 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.5 m-85 -61.97 -45.62 92.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.484 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.507 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -154.82 156.1 35.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.402 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.39 99.3 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.022 0.439 . . . . 0.0 110.409 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -156.24 -166.32 2.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.474 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.412 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.3 t0 -122.71 110.8 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.0 m -63.44 -40.25 88.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.404 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.8 m-85 -59.22 -42.54 91.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.35 94.73 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.772 0 CA-C-O 117.817 -1.546 . . . . 0.0 110.968 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.8 54.22 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -61.06 143.62 99.15 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.417 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.15 -40.49 90.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.597 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.9 143.18 36.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.407 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.1 mt -110.19 128.94 66.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.228 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.86 116.51 32.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.27 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.8 mt -111.28 138.33 40.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.351 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.43 104.44 2.11 Favored Glycine 0 N--CA 1.462 0.409 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.6 m -127.53 119.1 25.27 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.668 0.27 . . . . 0.0 110.631 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 21.5 t70 -113.55 92.55 24.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.966 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.44 134.31 60.8 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.531 2.154 . . . . 0.0 111.767 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 p -141.67 -19.53 0.75 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.766 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 20' ' ' PHE . 97.0 m-85 -124.76 98.86 5.89 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.345 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.706 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.64 -61.28 0.21 Allowed Pre-proline 0 N--CA 1.467 0.417 0 CA-C-O 121.974 0.892 . . . . 0.0 111.004 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.706 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.0 Cg_endo -50.07 -39.44 50.86 Favored 'Trans proline' 0 C--N 1.295 -2.238 0 C-N-CA 122.105 1.87 . . . . 0.0 112.07 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.3 t80 -78.82 -43.15 25.9 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.279 0.562 . . . . 0.0 110.885 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.635 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.5 mt-10 -149.34 -155.28 0.62 Allowed 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.231 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.05 177.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.781 0.324 . . . . 0.0 110.246 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.94 143.23 44.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.45 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.2 t-20 -95.91 141.84 28.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.394 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.47 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.2 p -66.15 -19.01 65.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.578 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -77.87 -6.87 55.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.439 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.69 -7.0 59.16 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.38 158.0 27.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.804 0.335 . . . . 0.0 110.406 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.8 mt -111.77 133.8 53.76 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.275 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.671 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.22 150.81 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.287 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.79 6.76 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -58.81 -42.13 88.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.741 0.305 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.7 t0 -70.17 -28.53 65.4 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.102 0.477 . . . . 0.0 111.205 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.671 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -67.76 -41.74 85.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.236 0.541 . . . . 0.0 111.282 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 48.9 m-20 -60.95 -37.48 82.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.815 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.05 -43.83 86.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.183 0.516 . . . . 0.0 110.555 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.15 -41.47 92.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.316 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -59.2 -52.89 63.73 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.535 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.21 -37.2 64.29 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.034 0.445 . . . . 0.0 109.891 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.47 -42.58 78.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.129 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.74 -44.36 73.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.125 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.07 -46.92 82.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.23 0.538 . . . . 0.0 110.399 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mmt-85 -60.28 -40.87 91.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -75.94 -17.82 15.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.705 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.74 52.16 4.51 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.706 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.19 170.12 16.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.026 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.2 140.22 29.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.008 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -116.81 131.49 56.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.524 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.04 127.5 43.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.436 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -94.06 135.52 35.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.5 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.5 128.92 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.988 0.423 . . . . 0.0 110.436 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.9 139.48 58.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.483 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.535 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.1 p30 175.68 131.43 0.16 Allowed Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.778 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.8 Cg_endo -68.08 145.41 67.11 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.613 2.209 . . . . 0.0 112.602 -179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 82.3 mt -40.37 -56.51 1.99 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -47.88 -26.66 1.77 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.855 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.1 -20.51 19.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.124 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -64.16 -42.47 96.73 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.563 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.667 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -63.17 -56.23 29.66 Favored Pre-proline 0 C--O 1.242 0.66 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.919 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.1 Cg_exo -55.29 -42.7 65.88 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.486 2.124 . . . . 0.0 111.202 177.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.7 m -58.96 -44.12 91.42 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.866 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 tp -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.191 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.36 -40.27 95.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.995 0.426 . . . . 0.0 110.51 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.4 11.1 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.631 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.35 11.68 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.755 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.18 -34.74 78.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.667 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.72 153.09 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.526 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.31 -20.87 19.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.7 156.72 25.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.493 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.6 127.02 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.5 ttp -128.4 106.66 9.15 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.247 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.595 ' OG ' HD21 ' A' ' 55' ' ' LEU . 42.3 t -160.35 -178.23 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.585 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.15 -15.32 59.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.48 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -38.27 123.58 1.16 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.614 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.34 156.88 22.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.752 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.644 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.15 149.05 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -149.83 152.45 35.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.27 -47.03 55.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.005 0.431 . . . . 0.0 110.647 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.33 -40.05 73.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.301 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -67.92 -37.92 82.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.979 0.419 . . . . 0.0 111.226 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -58.26 -37.05 74.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.149 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.56 -27.43 67.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.257 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.31 -51.73 7.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.615 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.4 -168.67 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.74 146.67 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.134 0.492 . . . . 0.0 110.73 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.79 149.88 51.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.709 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.5 t -164.4 -151.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.485 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.501 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.23 19.52 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.83 120.18 0.13 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.652 0.595 . . . . 0.0 110.509 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -77.18 -69.29 0.54 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.92 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.3 p90 -149.62 166.17 30.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.517 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.98 122.31 28.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.387 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.449 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.59 69.39 0.98 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.538 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.9 -105.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -158.85 165.63 33.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.646 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.59 145.79 21.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.85 136.13 41.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 110.92 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.833 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.453 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.37 164.93 32.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.944 0.402 . . . . 0.0 110.714 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.7 148.53 23.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.866 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.49 -28.29 59.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -59.01 -41.85 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.245 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -101.71 122.04 43.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.854 0.359 . . . . 0.0 110.121 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.16 109.7 19.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.63 129.63 71.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.636 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.01 154.25 41.25 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.553 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.464 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.65 91.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -170.74 144.35 2.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.22 -33.72 62.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.315 0.579 . . . . 0.0 110.229 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.65 -62.04 2.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.607 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -56.65 -22.05 31.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.725 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -76.47 -25.62 54.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.18 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.59 47.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.557 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -16.09 30.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.73 151.67 23.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 110.217 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.23 135.21 38.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.293 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.2 t -126.74 136.2 61.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.67 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.02 138.81 14.38 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.13 161.54 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.004 0.43 . . . . 0.0 110.239 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.538 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.53 117.69 30.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.399 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.72 1.22 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.585 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.93 50.39 52.93 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.77 168.84 22.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.456 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 71.6 p -73.29 -26.82 61.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.372 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.62 -55.03 38.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.605 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.21 -54.38 47.47 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.497 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.3 m -60.41 -51.37 69.78 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.64 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.01 -44.02 97.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.346 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.59 -44.49 97.89 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.67 -14.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.213 . . . . 0.0 110.705 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.3 tt0 -125.53 -34.53 2.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.565 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.65 -50.62 17.04 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.28 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -99.42 12.26 36.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.096 0.474 . . . . 0.0 111.133 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.69 -55.55 0.48 Allowed Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.483 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.4 -10.23 25.23 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.751 2.301 . . . . 0.0 112.039 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.38 -8.93 59.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.58 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.12 33.09 37.23 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.51 137.98 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.592 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.76 129.89 35.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.4 138.13 55.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 59.3 t -122.99 133.06 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.86 127.25 42.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.538 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -110.83 153.33 25.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.32 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.94 6.95 29.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.64 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.43 130.44 6.01 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.98 -45.72 80.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.56 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.51 -23.46 62.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.47 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.452 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.7 -36.98 86.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.496 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.85 -46.86 87.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.366 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.09 -37.85 88.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.218 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.146 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.98 -44.52 92.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.181 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 42.1 tp -59.31 -47.64 84.65 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.087 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.06 -23.0 67.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.15 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.59 -18.24 25.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.48 11.73 71.14 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.87 -18.05 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 110.602 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.6 pt -127.86 137.73 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.108 0.48 . . . . 0.0 110.527 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.21 -28.44 62.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.453 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.07 155.63 2.0 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.795 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.51 50.51 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -86.08 103.05 14.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.395 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.6 tt0 -132.6 164.68 26.12 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -72.99 152.6 41.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.392 . . . . 0.0 110.899 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.6 mt-10 -65.7 -54.04 32.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.406 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.1 t -60.75 -48.7 87.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.428 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.93 87.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.844 0.354 . . . . 0.0 110.429 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.16 -63.68 1.08 Allowed 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.351 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.446 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.8 m -58.92 -46.97 86.64 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.812 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.443 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 80.8 tt0 -49.95 -37.48 32.21 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.228 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.2 -65.39 0.54 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.658 ' N ' ' O ' ' A' ' 168' ' ' ALA . 29.7 t80 -40.74 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.831 0.348 . . . . 0.0 111.089 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.446 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.5 mt -61.88 -39.6 92.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.62 -3.96 0.57 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.276 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 177' ' ' VAL . 22.8 mt-30 -123.46 142.01 37.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -43.95 -15.21 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.82 2.347 . . . . 0.0 112.132 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.8 t -62.8 -42.96 98.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.438 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.83 -32.85 80.87 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.99 -41.55 96.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.89 0.376 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.2 m-20 -65.78 -34.63 78.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.687 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.08 143.53 18.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.635 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.2 pttt -177.16 99.57 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.117 0.484 . . . . 0.0 110.873 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.6 m-85 -159.19 168.21 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.631 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.42 55.96 3.1 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.68 -116.78 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -50.0 135.43 36.78 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.102 1.868 . . . . 0.0 111.966 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.8 p -125.25 -108.38 0.32 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.315 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.62 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.97 164.8 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 119.03 -0.51 . . . . 0.0 109.929 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 154.07 155.9 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 124.259 0.975 . . . . 0.0 110.539 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.75 117.97 23.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.808 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.67 -19.02 62.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.24 -32.06 73.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.473 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.4 mt -61.08 -43.94 98.12 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.735 -178.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.456 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.95 7.33 16.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 0.0 110.689 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.3 -155.09 50.01 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.644 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.43 -25.66 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.863 0.363 . . . . 0.0 110.593 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.449 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.05 -126.08 1.54 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -131.91 159.7 37.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.877 0.37 . . . . 0.0 110.367 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.89 25.4 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.501 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.13 141.16 31.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 110.45 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.2 112.02 3.99 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.8 mt -121.18 160.35 23.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.85 149.04 25.11 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.705 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.44 -48.2 65.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.81 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -40.9 -22.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.602 0.239 . . . . 0.0 110.587 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.86 52.09 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.431 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.31 -46.3 84.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.42 -46.93 36.89 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.89 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.5 tp -62.44 -43.93 97.65 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.359 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.24 -42.76 99.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.974 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.74 -37.37 73.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.948 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.6 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 44' ' ' ILE . 86.1 mt -29.15 -45.12 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.316 0.385 . . . . 0.0 110.843 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -64.16 -45.1 89.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.716 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.64 -43.57 98.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.945 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.15 92.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.307 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.05 -43.66 98.55 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.175 0.512 . . . . 0.0 110.312 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.27 91.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.319 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -64.07 -41.79 97.21 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.291 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.6 mtp -58.04 -38.19 75.79 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.49 -38.9 77.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.979 0.418 . . . . 0.0 110.554 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.15 93.56 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.673 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.1 p-10 -88.72 0.42 56.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.664 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.33 68.47 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -58.38 -45.85 87.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.4 t80 -63.43 -57.53 9.99 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.423 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.01 -41.06 77.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.402 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.07 -48.12 82.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.338 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.07 -41.59 98.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.333 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.84 76.34 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.679 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.6 -35.86 73.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.43 -50.91 33.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.465 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.513 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.5 -45.46 92.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.35 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.7 m-85 -153.76 155.32 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.416 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.15 98.54 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 110.458 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -155.42 -165.49 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.465 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.56 109.37 14.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.9 m -63.75 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.566 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.421 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.2 m-85 -57.18 -43.64 82.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.0 94.17 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.425 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.899 -1.5 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.5 164.43 59.96 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.689 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.07 143.69 99.11 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 122.658 2.239 . . . . 0.0 112.244 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.39 -40.83 89.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.75 139.2 38.23 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.361 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.1 121.1 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.559 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.8 118.59 31.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.108 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.5 138.23 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.305 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.57 105.39 2.14 Favored Glycine 0 N--CA 1.463 0.463 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.8 m -128.73 120.84 27.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 122.687 -0.302 . . . . 0.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.497 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.8 t70 -114.29 92.61 28.05 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.918 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.51 134.73 63.24 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.499 2.133 . . . . 0.0 111.851 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.1 p -141.92 -20.04 0.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.754 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -123.61 98.93 6.05 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.446 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.81 -61.4 0.22 Allowed Pre-proline 0 C--O 1.218 -0.602 0 CA-C-O 122.017 0.913 . . . . 0.0 111.083 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.712 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.78 -40.78 47.69 Favored 'Trans proline' 0 C--N 1.291 -2.487 0 C-N-CA 122.348 2.032 . . . . 0.0 112.197 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -77.96 -43.02 31.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.045 0.45 . . . . 0.0 110.805 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -149.64 -153.8 0.51 Allowed 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.186 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.95 177.43 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.92 0.39 . . . . 0.0 110.299 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.47 144.59 46.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.425 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.62 134.46 38.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.502 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.66 -19.04 65.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.524 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.21 -6.55 55.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.482 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.99 -8.48 55.87 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.78 158.49 26.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.882 0.373 . . . . 0.0 110.409 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -112.35 131.29 55.61 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.371 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.691 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.23 151.54 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.403 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.01 151.53 6.64 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -58.93 -41.99 88.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.698 0.285 . . . . 0.0 110.758 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 -69.53 -28.64 66.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.102 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.691 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -67.76 -40.79 84.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.939 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -60.97 -37.5 82.66 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.718 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.49 -44.94 89.4 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.117 0.484 . . . . 0.0 110.164 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.54 -48.16 80.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.901 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.26 -53.87 44.53 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.437 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.87 -40.32 63.33 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.029 0.442 . . . . 0.0 109.951 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.5 mt -67.87 -42.08 81.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.001 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.57 -45.1 69.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.169 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.31 -46.34 83.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.277 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -60.55 -42.1 95.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.194 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.895 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.36 -17.37 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.718 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.94 52.75 4.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.541 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.78 171.09 15.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.975 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.81 142.18 27.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.995 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.1 m -117.14 131.06 56.97 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.617 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.15 126.94 43.75 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.4 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -93.73 134.69 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.98 128.14 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.027 0.442 . . . . 0.0 110.344 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.14 137.79 57.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.557 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 176.53 131.68 0.18 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.75 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.2 Cg_endo -67.77 144.51 65.65 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.665 2.244 . . . . 0.0 112.732 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.89 HD23 HD12 ' A' ' 58' ' ' LEU . 81.3 mt -39.87 -55.44 1.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.96 0.41 . . . . 0.0 111.261 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.71 -26.33 2.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.962 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.08 -21.11 18.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.13 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.89 HD12 HD23 ' A' ' 55' ' ' LEU . 60.1 mt -63.7 -42.64 97.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.748 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.68 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 mm -62.22 -56.66 28.97 Favored Pre-proline 0 C--O 1.242 0.67 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.795 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.8 Cg_exo -56.09 -41.69 74.26 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.551 2.167 . . . . 0.0 110.947 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -59.08 -44.48 91.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.968 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.648 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.6 tp -59.38 -43.91 92.84 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.269 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.32 -40.58 96.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.493 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.17 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.572 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.25 11.99 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.37 -35.53 80.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.667 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.1 pt -122.43 152.78 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.0 -22.53 19.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.182 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.19 155.71 27.61 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.616 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -114.98 129.08 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 120.96 0.409 . . . . 0.0 110.384 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -131.28 106.82 8.55 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.975 0.417 . . . . 0.0 110.231 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.699 ' OG ' HD21 ' A' ' 55' ' ' LEU . 42.1 t -159.05 178.47 10.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.577 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -65.24 -15.2 62.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.513 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.24 124.5 0.61 Allowed 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.673 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.542 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.3 p -81.8 154.26 26.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.677 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.627 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.4 pt -105.0 148.65 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.4 p -149.07 152.3 35.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.738 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -46.92 53.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.004 0.431 . . . . 0.0 110.463 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.06 -39.63 72.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.537 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.81 -37.9 79.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.015 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.85 -38.48 75.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.027 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.23 -27.34 67.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.23 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.33 -51.11 7.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.4 pt -138.98 -168.21 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.986 0.422 . . . . 0.0 110.449 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.25 147.57 30.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.135 0.493 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.548 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.1 m-85 -129.86 149.92 51.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.36 -153.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.456 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.7 m-20 41.66 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.944 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.35 0.2 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.594 0.559 . . . . 0.0 110.559 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.421 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.2 mt -75.23 -68.51 0.55 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.438 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.49 167.17 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.637 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.83 123.38 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.382 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.85 68.55 0.84 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.663 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -85.83 -104.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.322 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.3 p -159.37 165.98 32.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.611 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.63 146.11 21.93 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.058 0.456 . . . . 0.0 110.47 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.95 136.23 41.13 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.816 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.37 164.71 33.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.937 0.399 . . . . 0.0 110.679 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.91 148.56 24.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.033 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.07 -27.85 47.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.187 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.04 -41.66 88.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.344 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.0 t -102.4 122.36 44.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.01 109.36 19.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.39 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.89 129.84 69.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.29 159.06 33.45 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.444 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.5 Cg_endo -60.11 89.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.777 2.318 . . . . 0.0 112.008 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -168.82 140.99 2.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.3 p -66.94 -33.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 0.0 110.225 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.22 -22.04 26.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.888 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.3 mt -76.72 -25.83 53.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.214 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.16 46.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.507 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.9 -15.85 30.05 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.54 151.32 23.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 110.308 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.02 135.55 37.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.278 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.3 136.69 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.58 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.53 138.68 14.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.2 t -130.88 161.61 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.082 0.468 . . . . 0.0 110.255 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 45.1 tp -92.38 117.57 30.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.578 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -51.87 157.57 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.694 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.16 50.61 50.23 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.6 p -149.96 168.87 22.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 110.795 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.4 p -73.7 -26.52 60.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.412 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.78 -55.15 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.598 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.02 -54.72 43.57 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.461 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.07 -51.33 70.08 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.504 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -61.8 -44.12 97.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.993 0.425 . . . . 0.0 110.489 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.59 -44.47 97.92 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.76 -14.36 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.575 0.226 . . . . 0.0 110.647 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.29 -34.62 2.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.68 -50.67 16.75 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.331 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.19 12.25 36.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.208 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.69 -55.51 0.48 Allowed Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.429 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.13 -10.28 25.68 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.802 2.334 . . . . 0.0 111.969 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.73 -8.92 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.561 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.77 33.46 37.58 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.52 137.83 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.496 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.35 129.74 34.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.254 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.6 pt -126.34 138.09 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.21 133.12 70.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 109.961 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.33 127.57 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.619 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.84 153.67 25.08 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.282 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.0 7.05 29.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.621 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.54 130.5 6.02 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.78 -45.82 81.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.54 -23.67 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.523 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.69 -36.82 85.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.525 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.19 -47.03 85.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.521 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.64 -37.98 89.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.361 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.8 p -61.06 -42.26 98.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.023 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.16 -44.58 91.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.6 tp -59.12 -47.81 83.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.097 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.7 m -63.49 -22.77 67.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.992 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.19 -18.6 25.44 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.579 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.97 11.04 70.85 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.32 -17.92 63.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 110.623 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.7 pt -128.23 137.36 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.12 0.486 . . . . 0.0 110.424 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.86 -27.43 61.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.59 155.98 1.84 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.17 136.88 49.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.9 0.381 . . . . 0.0 110.005 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -85.41 103.3 14.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.0 tt0 -133.04 165.21 25.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.494 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.46 152.12 42.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.993 0.425 . . . . 0.0 110.772 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.05 -54.53 24.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.438 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.2 -48.44 88.11 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.586 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.94 90.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.835 0.35 . . . . 0.0 110.457 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.64 -62.97 1.26 Allowed 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.436 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -59.61 -47.83 84.04 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.914 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -49.56 -36.7 24.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.179 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.456 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.39 -66.17 0.54 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.1 t80 -40.68 -70.7 0.1 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.655 0.264 . . . . 0.0 111.131 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.58 -40.12 93.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.748 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -60.69 -3.19 0.66 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.302 0.572 . . . . 0.0 110.254 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.456 HE21 ' C ' ' A' ' 171' ' ' GLY . 51.5 mt-30 -122.15 147.6 49.72 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.96 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.35 -19.12 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.844 2.362 . . . . 0.0 112.034 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.8 t -61.8 -43.21 96.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.524 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.99 -32.95 83.98 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.53 -41.09 93.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.758 0.313 . . . . 0.0 110.458 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -66.16 -32.9 74.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.53 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.0 m-85 -156.51 142.53 18.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.545 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -176.82 99.56 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.31 166.99 30.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.7 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.549 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.23 -117.71 0.01 OUTLIER Glycine 0 CA--C 1.54 1.62 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.89 136.01 35.97 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.266 1.977 . . . . 0.0 111.928 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.9 p -125.41 -108.02 0.32 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.78 165.04 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 118.932 -0.556 . . . . 0.0 110.039 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 154.04 156.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 O-C-N 124.379 1.049 . . . . 0.0 110.502 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.26 117.35 22.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.904 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.32 -18.85 62.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.66 -32.53 74.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.596 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.2 mt -61.1 -44.15 97.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.727 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.5 m-85 -114.46 9.66 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.628 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.08 -154.77 52.29 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.627 ' CG1' HD11 ' A' ' 76' ' ' ILE . 15.0 p -70.32 -25.11 26.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.38 -123.97 1.28 Allowed Glycine 0 N--CA 1.46 0.24 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.56 156.25 44.47 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.54 -169.76 30.56 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.04 137.7 32.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.548 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.65 108.32 3.3 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.3 mt -123.54 159.2 29.66 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 120.672 0.273 . . . . 0.0 110.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.648 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.8 mtm180 -86.79 149.51 24.8 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 120.712 0.292 . . . . 0.0 110.757 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.68 -47.79 63.73 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.746 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.72 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.692 0.282 . . . . 0.0 110.687 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.42 52.23 0.19 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.505 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.38 -45.77 86.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.136 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.34 -47.26 35.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.044 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.2 tp -62.52 -43.86 97.78 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.4 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.04 -42.93 99.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.79 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.0 -36.19 70.12 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.687 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.15 -77.42 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.895 HD21 HD11 ' A' ' 44' ' ' ILE . 97.2 mt -28.17 -46.35 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.971 0.415 . . . . 0.0 110.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.6 -44.71 89.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.781 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.687 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.98 -43.86 97.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.026 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.05 93.12 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.289 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.29 -43.55 98.69 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.16 0.505 . . . . 0.0 110.166 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.12 92.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.258 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.9 -41.92 97.58 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.141 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.523 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -59.1 -38.0 78.48 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -68.78 -39.84 79.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.066 0.46 . . . . 0.0 110.34 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.04 -46.07 92.21 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.519 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.3 p30 -86.26 1.09 52.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.504 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.97 19.43 61.22 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 68.3 m -58.41 -45.64 88.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.6 t80 -63.55 -58.25 7.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.936 0.398 . . . . 0.0 110.351 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.54 -41.37 76.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.486 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.96 -48.4 81.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.39 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.98 -41.59 98.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.84 -50.28 74.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.584 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.4 -35.41 71.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.478 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.03 -50.84 29.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.42 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.1 m-85 -62.2 -45.57 92.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.5 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.87 155.53 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.373 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.3 p-10 -97.56 95.93 7.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.995 0.426 . . . . 0.0 110.491 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -153.63 -166.01 2.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.92 110.4 15.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.73 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.422 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.7 m -63.69 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.584 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.422 ' N ' HG23 ' A' ' 238' ' ' VAL . 89.9 m-85 -57.8 -43.53 85.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.25 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.34 -37.47 94.9 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.728 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.23 164.61 59.69 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.745 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.09 143.69 99.03 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.734 2.289 . . . . 0.0 112.21 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.31 -40.4 89.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.74 143.2 36.88 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.37 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.6 mt -110.36 128.68 66.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.381 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.8 mtp180 -104.38 118.16 35.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.4 mt -113.04 139.2 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.308 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.03 104.69 2.19 Favored Glycine 0 N--CA 1.462 0.392 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.8 m -127.72 118.33 23.6 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 122.659 -0.318 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.2 t70 -113.38 92.59 23.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.912 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.39 134.32 60.68 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.467 2.111 . . . . 0.0 111.965 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.7 p -141.25 -19.38 0.79 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.765 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.7 m-85 -125.11 98.97 5.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.462 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.82 -61.3 0.22 Allowed Pre-proline 0 C--O 1.219 -0.55 0 CA-C-O 121.97 0.89 . . . . 0.0 111.175 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.715 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.6 Cg_endo -49.64 -39.48 46.62 Favored 'Trans proline' 0 C--N 1.291 -2.489 0 C-N-CA 122.57 2.18 . . . . 0.0 112.194 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.4 t80 -79.57 -43.29 23.28 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.911 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.617 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.19 -155.5 0.64 Allowed 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.145 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.95 177.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.947 0.403 . . . . 0.0 110.308 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.15 140.66 46.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.432 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -92.31 137.83 32.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.622 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -65.05 -19.47 66.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.47 -6.0 55.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.462 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.97 -8.31 57.63 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.74 157.01 28.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.377 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.2 mt -111.96 133.56 54.07 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.412 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.678 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.17 151.0 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.275 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.403 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.16 151.49 6.64 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -58.87 -42.16 88.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.711 0.291 . . . . 0.0 110.874 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.44 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.0 t0 -69.82 -28.11 65.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -68.55 -40.79 82.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.987 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.7 m-20 -60.65 -37.79 82.68 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.985 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.19 -43.89 85.54 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.213 0.53 . . . . 0.0 110.499 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.1 -41.73 93.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.083 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -58.83 -53.13 61.83 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.638 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.93 -37.06 63.44 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -69.01 -42.4 76.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.121 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.6 -44.62 73.22 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.229 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -64.02 -47.18 81.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.254 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -59.86 -40.72 89.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.092 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.989 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.53 -17.78 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.774 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.66 52.4 4.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.677 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.24 170.06 17.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.04 140.26 29.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.028 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.0 m -116.91 131.52 56.93 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.554 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.19 127.71 43.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.476 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -94.26 135.97 35.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.406 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.57 128.68 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.77 140.02 58.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 174.97 131.68 0.14 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.724 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.21 145.43 66.38 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.678 2.252 . . . . 0.0 112.576 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.875 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.14 -56.91 1.8 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.236 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.4 -26.75 1.41 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.986 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.29 -20.76 18.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.123 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.875 HD12 HD23 ' A' ' 55' ' ' LEU . 59.0 mt -63.97 -42.49 97.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.731 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.69 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.38 -56.64 28.59 Favored Pre-proline 0 C--O 1.24 0.586 0 O-C-N 123.698 0.624 . . . . 0.0 109.67 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.49 -42.24 70.0 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.534 2.156 . . . . 0.0 111.025 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -58.86 -44.18 90.98 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.787 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.09 -44.29 91.91 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.83 -40.52 95.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.476 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.51 10.9 1.84 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.516 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.31 11.82 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.461 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.31 -34.13 77.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.551 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.96 154.16 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.81 -20.83 20.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.99 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.82 158.88 23.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.583 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.604 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.82 127.02 73.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 CA-C-O 120.945 0.402 . . . . 0.0 110.456 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.44 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -127.5 106.05 8.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.268 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.495 ' OG ' HD21 ' A' ' 55' ' ' LEU . 36.3 t -161.07 -177.4 6.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.591 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.28 -15.05 59.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.369 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.637 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.8 tp -38.27 123.23 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.578 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.552 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.45 156.58 22.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.685 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.648 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -105.21 149.39 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.7 p -150.25 152.85 35.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.667 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.26 -47.56 55.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.025 0.44 . . . . 0.0 110.51 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.66 -39.93 71.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.63 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.637 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.41 -37.67 80.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.004 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -37.39 74.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.111 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.48 -27.53 67.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.212 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.15 -51.94 7.06 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.48 -168.29 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-O 121.04 0.448 . . . . 0.0 110.383 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.91 146.73 29.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.067 0.461 . . . . 0.0 110.832 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.544 ' CD1' HG22 ' A' ' 76' ' ' ILE . 75.4 m-85 -129.93 149.94 51.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.607 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.48 -151.67 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.413 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.505 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.74 19.26 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.99 119.92 0.11 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.483 0.489 . . . . 0.0 110.631 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.66 -70.14 0.5 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.722 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 42.8 p90 -148.91 165.72 30.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.523 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.69 121.98 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.374 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.25 68.97 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.61 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.51 -104.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.329 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.37 165.86 32.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.599 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.62 146.02 21.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -101.47 136.31 41.53 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.57 111.22 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.73 164.86 32.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.819 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.78 148.45 23.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -27.83 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.247 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.89 -41.85 88.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.305 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -102.55 122.45 44.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.146 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.85 109.36 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.28 130.07 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.593 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.03 159.01 34.19 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.483 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.454 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.96 90.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.813 2.342 . . . . 0.0 111.994 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.1 m -168.97 141.56 2.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.69 -33.33 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 110.343 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.59 -62.24 1.93 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.43 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.35 -22.0 28.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.866 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.64 -25.74 54.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.286 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.87 133.28 47.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.472 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.86 -15.79 30.15 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.49 151.33 23.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.898 0.38 . . . . 0.0 110.378 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.09 135.14 38.28 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.315 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -126.99 136.5 60.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.658 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.65 14.34 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.8 t -130.75 161.59 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.079 0.466 . . . . 0.0 110.239 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.2 tp -92.41 117.67 30.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.615 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.81 157.51 1.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.694 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.92 50.58 51.89 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.6 p -149.63 168.68 22.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.777 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 68.6 p -73.09 -27.3 61.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.445 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.3 -54.84 40.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.467 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.3 -54.38 47.4 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.378 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.62 -51.6 68.73 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.487 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.6 t80 -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.028 0.442 . . . . 0.0 110.457 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.66 -44.31 98.1 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.62 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.603 0.239 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.66 2.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.541 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.4 -50.83 16.98 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.392 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.2 12.74 35.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.16 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.11 -55.6 0.46 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.369 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.17 -10.48 25.91 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.812 2.341 . . . . 0.0 111.963 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.46 -8.73 59.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 33.53 36.97 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.77 137.88 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.984 0.421 . . . . 0.0 110.481 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.51 130.03 34.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.341 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.51 138.1 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.09 133.22 69.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.051 0.453 . . . . 0.0 110.021 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.94 127.11 42.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -110.74 153.62 25.05 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.02 6.83 29.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.635 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.12 130.34 5.88 Favored Glycine 0 N--CA 1.465 0.572 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -65.92 -45.67 81.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.484 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.84 -24.25 63.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.497 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.59 -36.38 84.04 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.526 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.14 -46.95 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.062 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.0 m-85 -63.82 -37.66 88.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.343 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.23 -42.78 99.19 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.121 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -63.95 -44.5 92.62 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.3 tp -59.0 -48.24 82.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.079 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.7 m -62.88 -22.92 67.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.09 26.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.571 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.35 11.58 71.87 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -17.82 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 153' ' ' LEU . 35.6 pt -128.31 137.77 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.113 0.483 . . . . 0.0 110.487 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.8 -28.36 62.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.991 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.59 155.7 1.8 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.819 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.82 137.53 50.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.064 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.53 103.15 14.13 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.08 0.467 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 46.9 tt0 -132.27 164.74 25.74 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.437 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.1 m-20 -73.02 152.03 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.656 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.426 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -65.91 -54.2 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.289 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.3 -48.98 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.524 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.35 -39.09 89.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.821 0.343 . . . . 0.0 110.604 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.25 -63.25 1.19 Allowed 'General case' 0 C--O 1.216 -0.682 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.437 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.5 m -58.85 -47.11 86.0 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.861 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -50.06 -37.04 31.53 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.02 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.13 -65.85 0.55 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.71 -70.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.533 0 O-C-N 122.802 -0.234 . . . . 0.0 111.096 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.65 -39.98 93.28 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.874 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.455 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.62 -3.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.627 . . . . 0.0 110.367 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 177' ' ' VAL . 58.6 mt-30 -124.21 141.62 37.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.807 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -43.87 -14.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.859 2.372 . . . . 0.0 112.319 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 175' ' ' GLN . 77.9 t -63.47 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.486 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.64 -32.75 79.59 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.01 -41.35 96.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.773 0.321 . . . . 0.0 110.388 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.4 m-20 -65.9 -34.7 78.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.756 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.3 m-85 -156.98 143.26 18.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.85 99.96 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.758 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.2 m-85 -159.28 168.01 27.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.643 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.33 55.76 3.17 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.91 -116.99 0.01 OUTLIER Glycine 0 CA--C 1.538 1.483 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.12 135.92 37.7 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.295 1.997 . . . . 0.0 112.016 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.0 p -124.97 -108.02 0.33 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.513 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.87 165.25 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.98 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.634 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.35 155.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.436 1.085 . . . . 0.0 110.476 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.09 118.31 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.911 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.3 mp0 -71.87 -18.74 62.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.036 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.76 -31.96 73.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.6 mt -60.99 -44.24 97.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.754 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.3 m-85 -113.69 7.2 17.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.724 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.53 -155.33 49.9 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.648 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.43 -25.54 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.834 0.35 . . . . 0.0 110.551 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.454 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.09 -125.84 1.5 Allowed Glycine 0 CA--C 1.519 0.285 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.3 p -132.15 160.03 37.22 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.862 0.363 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.7 25.27 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -98.17 141.41 31.12 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.937 0.399 . . . . 0.0 110.493 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.38 3.89 Favored Glycine 0 C--N 1.331 0.261 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -119.52 160.57 22.15 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.722 0.296 . . . . 0.0 110.305 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.37 149.04 24.75 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.574 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.03 -48.73 64.4 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.809 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -40.83 -22.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.828 0.347 . . . . 0.0 110.657 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.07 51.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.66 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.38 -46.1 84.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.762 0.315 . . . . 0.0 111.108 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.43 -47.14 35.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.054 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.42 -43.7 98.19 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.446 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.38 -42.94 99.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.881 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.67 -37.52 73.55 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.897 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.24 -77.57 0.1 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.989 HD21 HD11 ' A' ' 44' ' ' ILE . 86.5 mt -28.63 -45.45 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.942 0.401 . . . . 0.0 110.813 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.4 m-20 -63.76 -45.18 90.99 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.704 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.54 -43.68 98.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.963 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.2 92.34 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.205 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.16 -43.58 98.66 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.144 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.32 92.05 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.287 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.85 -42.52 97.55 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.022 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.499 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.13 -38.22 73.15 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.65 -38.83 77.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.114 0.483 . . . . 0.0 110.415 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.53 92.48 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.674 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.34 0.43 56.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.783 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.67 20.2 67.91 Favored Glycine 0 C--O 1.225 -0.424 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.8 m -57.91 -46.08 85.52 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.0 t80 -63.54 -57.6 9.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.422 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.88 -41.7 78.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.347 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -48.42 81.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.42 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.84 -41.54 97.94 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.366 . . . . 0.0 110.446 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.16 -49.78 76.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.632 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -35.86 73.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.399 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.58 -50.94 31.98 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.449 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.509 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.35 -45.23 94.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.502 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.8 m-85 -153.47 154.96 35.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.0 p-10 -98.21 96.95 8.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.01 0.433 . . . . 0.0 110.509 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -154.09 -165.11 2.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.518 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.426 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.68 109.24 14.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.5 m -63.79 -40.31 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.578 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.425 ' N ' HG23 ' A' ' 238' ' ' VAL . 83.9 m-85 -56.79 -43.63 81.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.297 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.1 -37.16 94.47 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.744 0 CA-C-O 117.907 -1.496 . . . . 0.0 110.938 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.7 164.66 53.36 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.763 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -61.0 143.83 99.43 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.654 2.236 . . . . 0.0 112.267 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.409 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.26 -40.59 90.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.608 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.42 142.73 37.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.383 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.1 mt -110.05 128.71 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.029 0.442 . . . . 0.0 110.318 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.02 117.45 34.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.311 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.0 140.57 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.278 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.24 105.39 1.96 Allowed Glycine 0 N--CA 1.462 0.428 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 77.2 m -127.76 120.8 28.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 122.722 -0.281 . . . . 0.0 110.617 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.486 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.3 t70 -112.73 93.99 26.57 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.799 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.77 135.03 65.95 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.518 2.145 . . . . 0.0 111.778 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 p -137.32 -18.39 1.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.74 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' O ' ' C ' ' A' ' 18' ' ' ALA . 84.0 m-85 -124.85 98.02 5.52 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.54 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.691 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -30.33 -60.95 0.26 Allowed Pre-proline 0 C--O 1.218 -0.591 0 CA-C-O 122.274 1.035 . . . . 0.0 111.079 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.691 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.4 Cg_endo -50.29 -41.9 49.22 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 122.323 2.015 . . . . 0.0 112.179 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.5 t80 -77.42 -42.6 35.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.176 0.512 . . . . 0.0 110.785 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.684 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.2 mt-10 -147.13 -160.21 1.13 Allowed 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.403 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.535 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 158.91 179.84 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.857 0.361 . . . . 0.0 110.16 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -133.69 141.94 47.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.42 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -90.88 137.68 32.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.509 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -65.32 -19.1 65.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.601 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -79.04 -5.17 53.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.431 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.48 -9.94 57.58 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.11 159.69 26.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 0.0 110.388 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.5 mt -114.42 134.2 55.16 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.476 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.509 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.3 p -131.93 150.56 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.197 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.75 153.83 7.35 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -60.46 -41.6 94.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.867 0.365 . . . . 0.0 110.77 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 28.7 t0 -70.52 -32.68 70.25 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.342 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.8 mt -66.75 -40.55 86.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.985 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -61.15 -36.97 81.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.723 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.98 -45.07 87.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.204 0.526 . . . . 0.0 110.426 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.27 -46.86 85.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.974 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.89 -53.82 47.25 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.516 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.21 -39.13 66.4 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.947 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.9 mt -67.98 -43.15 79.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.117 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.7 m -54.4 -43.63 71.64 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.047 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.26 -47.02 81.2 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.0 0.428 . . . . 0.0 110.328 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 mmt-85 -60.35 -41.17 93.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.018 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.904 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -75.75 -18.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.755 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.52 51.92 3.9 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.755 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.76 170.14 17.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.956 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.45 141.74 28.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.006 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.4 m -117.76 132.11 56.5 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.573 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -127.16 126.16 42.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.324 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.01 135.96 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.48 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.99 129.21 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.076 0.465 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.04 139.97 56.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.512 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 175.41 135.07 0.17 Allowed Pre-proline 0 N--CA 1.445 -0.683 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.742 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.18 143.8 60.56 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.631 2.221 . . . . 0.0 112.705 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.903 HD23 HD12 ' A' ' 58' ' ' LEU . 82.5 mt -40.48 -54.45 2.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.036 0.446 . . . . 0.0 111.152 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.92 -26.44 2.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.963 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.54 -21.01 19.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.045 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.903 HD12 HD23 ' A' ' 55' ' ' LEU . 58.2 mt -64.14 -42.77 96.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.787 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.0 -56.46 31.49 Favored Pre-proline 0 C--O 1.242 0.663 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.743 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 52.2 Cg_exo -55.64 -42.33 68.68 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.432 2.088 . . . . 0.0 111.021 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -58.84 -44.27 90.89 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.822 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -59.06 -44.36 91.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.8 -40.86 95.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.441 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.26 1.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.582 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.06 11.92 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.796 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.25 -33.93 76.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.636 178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.04 153.53 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.367 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -92.08 -21.33 20.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.14 158.52 24.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.495 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.562 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -116.0 128.02 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.395 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -129.52 107.42 9.46 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.942 0.401 . . . . 0.0 110.222 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.538 ' OG ' HD21 ' A' ' 55' ' ' LEU . 35.2 t -162.06 -178.68 6.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.591 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.26 -15.77 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.642 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -35.53 122.46 0.63 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.6 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -80.95 154.23 27.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.694 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' CG1' ' A' ' 196' ' ' VAL . 47.4 pt -105.02 148.17 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.4 p -150.14 152.86 35.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.765 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.16 -46.85 54.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.008 0.432 . . . . 0.0 110.507 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.6 -40.18 71.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.469 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.642 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.2 mtt180 -68.32 -37.99 81.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.023 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.487 ' O ' ' O ' ' A' ' 84' ' ' ILE . 87.9 mt-30 -57.88 -38.0 74.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.089 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.07 -27.81 67.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.213 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.86 -50.79 8.25 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.725 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -139.78 -166.95 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.969 0.414 . . . . 0.0 110.496 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.79 147.45 30.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.129 0.49 . . . . 0.0 110.805 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.5 m-85 -130.27 150.69 51.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.679 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.6 t -164.77 -152.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.427 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.8 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.847 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -29.95 121.72 0.17 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.664 0.603 . . . . 0.0 110.627 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.47 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 66.0 mt -78.3 -70.68 0.47 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.844 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CG ' HG21 ' A' ' 166' ' ' VAL . 51.4 p90 -148.7 165.56 31.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.54 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.354 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.448 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.68 67.74 0.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.621 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -86.87 -106.67 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.454 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.1 p -159.47 167.81 27.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.605 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.05 146.78 23.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.527 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -102.04 135.99 42.65 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.773 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.59 112.05 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.88 164.71 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.05 148.64 24.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.968 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.55 -27.96 58.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.171 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.03 -41.58 88.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -102.25 122.34 44.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.904 0.383 . . . . 0.0 110.162 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.18 109.88 19.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.25 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.13 130.04 71.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.602 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -109.3 154.29 42.25 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.17 92.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.798 2.332 . . . . 0.0 111.889 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -170.45 144.4 2.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.816 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.75 -33.88 61.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.279 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.486 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.94 -62.17 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.474 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.21 -21.85 25.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.797 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.6 mt -76.97 -25.42 52.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.265 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.08 133.21 48.66 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.429 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.63 -15.75 29.02 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.07 150.87 24.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 110.284 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.29 134.34 38.19 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.15 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.58 136.33 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.606 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.67 138.77 14.45 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.7 161.5 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.048 0.451 . . . . 0.0 110.238 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.6 tp -92.54 118.1 30.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.499 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.48 156.96 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.59 50.64 53.44 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.7 p -149.11 167.6 25.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.882 0.372 . . . . 0.0 110.814 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 67.2 p -70.92 -30.45 66.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.469 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -58.61 -54.76 43.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.509 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -56.58 -55.98 27.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.28 -51.53 69.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.654 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -61.71 -44.11 97.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.453 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.38 -44.38 98.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.56 -14.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.496 0.189 . . . . 0.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.48 -34.53 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.475 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.74 -50.64 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.335 -178.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.42 12.53 36.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.747 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.2 -55.51 0.46 Allowed Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.482 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.7 Cg_endo -72.36 -10.02 25.02 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.784 2.323 . . . . 0.0 112.036 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.86 -8.79 59.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.58 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.19 33.22 36.59 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.62 137.62 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.977 0.418 . . . . 0.0 110.487 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.23 130.16 34.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.9 pt -126.61 138.23 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.26 133.5 68.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.932 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -96.58 126.49 41.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.602 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.55 25.08 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.259 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.83 7.27 28.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.617 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.73 130.1 5.86 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.13 -45.6 80.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.8 0.333 . . . . 0.0 110.556 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.37 -23.49 62.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 110.493 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.76 -36.8 85.48 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.84 87.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.178 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.0 m-85 -64.05 -37.88 89.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.294 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.08 -42.61 98.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.157 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.67 -43.86 92.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.046 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.536 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.0 tp -59.33 -47.85 83.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.029 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -63.39 -22.95 67.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.124 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.81 -18.71 25.75 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.516 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.11 71.76 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.58 -18.1 63.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 0.0 110.629 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -128.05 137.79 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.165 0.507 . . . . 0.0 110.518 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.75 -29.46 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -174.93 155.4 2.03 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.792 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 139.15 52.16 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.876 0.369 . . . . 0.0 110.052 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.97 102.85 14.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.448 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.4 164.38 26.65 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.472 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.46 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.7 40.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -65.96 -54.33 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.317 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.403 HG21 ' CG ' ' A' ' 91' ' ' TYR . 71.1 t -60.19 -48.5 87.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.446 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.17 86.09 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.345 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.27 -63.26 1.24 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.364 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.456 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.9 m -58.22 -45.8 87.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.934 0.397 . . . . 0.0 110.445 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.43 -41.17 13.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.252 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.74 -61.93 0.47 Allowed Glycine 0 N--CA 1.466 0.647 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.649 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.5 t80 -40.79 -71.14 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 122.753 -0.263 . . . . 0.0 110.954 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.58 -40.97 98.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.96 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.1 tttt -59.83 -2.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.117 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.5 mt-30 -125.81 141.52 39.56 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.898 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -43.54 -14.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.811 2.341 . . . . 0.0 112.281 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 86.9 t -63.02 -43.21 98.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.415 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.2 84.37 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.3 -40.92 95.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.832 0.349 . . . . 0.0 110.356 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.12 -34.26 77.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.628 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.8 143.09 18.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.666 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.55 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -175.98 99.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.133 0.492 . . . . 0.0 110.852 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.55 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.3 m-85 -158.94 167.59 28.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.585 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.9 56.18 3.14 Favored Glycine 0 C--O 1.223 -0.557 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -52.1 -115.9 0.01 OUTLIER Glycine 0 CA--C 1.542 1.719 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.61 135.74 41.24 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.222 1.948 . . . . 0.0 111.86 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.9 p -124.58 -108.78 0.32 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.425 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.19 164.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 CA-C-O 118.859 -0.591 . . . . 0.0 110.002 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.3 tttt 155.13 155.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 124.439 1.087 . . . . 0.0 110.505 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -81.06 118.16 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.858 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.6 mp0 -70.93 -19.34 62.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.38 -31.79 73.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.606 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 88.0 mt -61.1 -44.05 97.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.753 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -115.04 9.26 15.94 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.673 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.39 51.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.0 p -70.7 -25.5 26.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.938 0.399 . . . . 0.0 110.54 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.448 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.0 -124.37 1.34 Allowed Glycine 0 C--N 1.33 0.226 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.0 p -130.07 157.2 43.03 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.651 0.263 . . . . 0.0 110.297 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -167.08 -168.57 29.46 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -96.09 138.35 33.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.846 0.355 . . . . 0.0 110.478 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.84 105.66 2.97 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 85' ' ' ALA . 79.0 mt -117.88 158.65 24.48 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.3 mtm180 -86.71 148.66 25.34 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.596 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.7 mttm -51.7 -47.56 63.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.92 -22.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 0.0 110.577 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.09 51.64 0.23 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.07 -46.55 83.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.8 0.333 . . . . 0.0 111.15 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.5 -47.12 35.01 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.27 -43.7 98.23 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.382 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.4 ttt-85 -62.35 -42.96 99.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.903 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.42 -37.08 72.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 109.896 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.55 -77.02 0.11 Allowed 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.904 HD21 HD11 ' A' ' 44' ' ' ILE . 88.2 mt -28.68 -45.17 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.943 0.401 . . . . 0.0 110.878 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.0 m-20 -64.24 -45.01 90.07 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.815 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.84 98.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.927 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.11 92.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.293 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.09 -43.78 98.37 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.171 0.51 . . . . 0.0 110.282 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.15 91.54 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.25 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -64.13 -42.38 96.86 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.232 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.497 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.5 mtp -57.47 -38.21 74.13 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.263 -0.644 . . . . 0.0 109.263 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.43 -39.18 78.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.08 0.467 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.617 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.4 p-10 -89.17 0.04 57.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.69 20.59 70.31 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.3 m -58.66 -45.68 88.83 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 75.2 t80 -62.22 -56.43 18.67 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.198 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.32 -40.25 77.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.234 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.7 -47.68 84.68 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.368 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.14 -40.95 97.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.875 0.369 . . . . 0.0 110.316 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.69 76.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.69 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.72 -35.92 73.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -69.17 -51.9 33.44 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.564 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 10.7 m-85 -62.38 -45.82 91.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.51 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.9 m-85 -154.14 154.61 33.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.3 p-10 -99.09 95.95 7.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.964 0.412 . . . . 0.0 110.407 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 236' ' ' PHE . 14.6 p90 -151.99 -163.77 1.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.47 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.21 108.24 13.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.687 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.425 HG23 ' N ' ' A' ' 239' ' ' TYR . 25.6 m -63.33 -40.46 89.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.596 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.425 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.1 m-85 -58.65 -41.65 86.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.285 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.16 -36.93 94.1 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.92 -1.489 . . . . 0.0 110.938 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.72 164.45 60.22 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.718 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.02 143.72 99.33 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.703 2.269 . . . . 0.0 112.226 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.29 -40.48 90.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.587 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.54 143.35 37.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.351 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.29 128.1 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.986 0.422 . . . . 0.0 110.367 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.84 118.75 37.43 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.252 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.99 138.57 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.293 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.53 100.32 1.6 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 84.8 m -123.69 118.62 27.66 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.71 -0.288 . . . . 0.0 110.854 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t0 -113.25 93.19 25.06 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.82 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.29 133.86 57.97 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.486 2.124 . . . . 0.0 111.905 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.5 p -139.69 -19.93 0.92 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.761 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.1 m-85 -124.94 99.2 6.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.424 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.86 -61.32 0.22 Allowed Pre-proline 0 C--O 1.218 -0.57 0 CA-C-O 121.982 0.896 . . . . 0.0 111.137 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.714 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.92 -39.58 49.28 Favored 'Trans proline' 0 C--N 1.292 -2.417 0 C-N-CA 122.412 2.074 . . . . 0.0 112.161 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 17' ' ' TYR . 29.4 t80 -79.04 -43.1 24.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.98 0.419 . . . . 0.0 110.93 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.63 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.7 mt-10 -149.21 -155.86 0.67 Allowed 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.187 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.44 177.7 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.909 0.385 . . . . 0.0 110.325 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.32 139.03 45.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.401 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -90.43 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.576 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.87 -19.26 65.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.11 -6.02 55.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.429 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.45 -8.71 57.0 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.68 157.61 27.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 0.0 110.435 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.4 mt -112.9 134.88 54.2 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 110.416 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.59 151.29 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.325 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.76 6.75 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -58.89 -42.09 88.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.709 0.29 . . . . 0.0 110.794 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.2 t0 -69.97 -27.97 65.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.279 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.674 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -68.7 -40.91 82.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.098 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.78 -37.87 83.36 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.038 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.2 tp -65.66 -43.93 87.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.18 0.514 . . . . 0.0 110.465 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.75 92.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.038 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.2 -53.31 58.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.529 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.75 -38.08 64.03 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 109.943 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.66 -42.23 78.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.024 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.7 m -54.47 -43.95 72.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.123 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.12 -47.05 81.49 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.291 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.9 mmt-85 -60.44 -40.93 92.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.025 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.13 -18.23 15.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.792 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.86 52.22 4.35 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.666 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -145.27 170.16 16.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.933 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -87.86 140.21 29.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.081 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -116.32 130.87 57.0 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.569 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -128.3 128.25 44.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.485 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -94.9 136.53 35.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.428 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.7 t -129.49 128.4 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.31 139.07 58.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.55 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.512 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 174.32 132.62 0.13 Allowed Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.683 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' ALA . 52.7 Cg_endo -68.11 145.03 65.62 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.599 2.199 . . . . 0.0 112.75 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.938 HD23 HD12 ' A' ' 58' ' ' LEU . 78.1 mt -40.44 -55.53 2.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.165 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.22 -26.4 1.93 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.967 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.62 19.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.022 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.938 HD12 HD23 ' A' ' 55' ' ' LEU . 85.7 mt -64.83 -42.78 94.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.909 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.678 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.65 -56.35 33.67 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.829 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.678 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 50.4 Cg_exo -55.98 -42.72 63.88 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.479 2.119 . . . . 0.0 110.967 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -59.08 -44.1 91.87 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.812 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.9 tp -58.65 -44.2 90.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.097 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.75 -40.06 94.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.433 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.15 11.32 1.54 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.503 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.02 11.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.795 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.46 -34.12 77.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.648 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.48 153.29 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.379 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -94.11 -20.25 20.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.77 156.52 25.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.545 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.593 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -116.56 127.87 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.521 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.33 106.54 9.09 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.251 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.601 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.1 t -159.19 -178.85 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.578 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.71 -15.03 60.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.442 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.1 tp -37.77 123.87 1.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.597 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.73 23.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.746 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.4 pt -105.31 148.98 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.08 152.71 35.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.756 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.25 -47.66 55.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.986 0.422 . . . . 0.0 110.61 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.14 -39.8 72.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.582 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.9 mtt180 -68.18 -37.79 81.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.3 -36.98 74.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.58 -27.58 67.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.215 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.97 -52.22 6.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.3 pt -138.09 -168.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-O 121.094 0.473 . . . . 0.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.59 146.66 29.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.085 0.469 . . . . 0.0 110.807 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.554 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.81 149.94 51.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.637 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.498 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -164.64 -151.7 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.4 m-20 43.25 19.36 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -28.3 120.11 0.12 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.552 0.533 . . . . 0.0 110.577 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -77.19 -69.86 0.5 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.794 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.415 ' CG ' HG21 ' A' ' 166' ' ' VAL . 42.9 p90 -149.39 166.18 29.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.569 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.02 122.16 27.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.389 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.468 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.38 68.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.627 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.99 -104.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.414 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.1 p -159.74 165.89 31.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.621 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.07 146.45 22.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.069 0.462 . . . . 0.0 110.465 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.476 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.2 mt -101.96 135.89 42.73 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.798 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.413 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.7 t -122.55 110.92 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.49 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.38 165.12 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.755 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.79 148.41 23.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.017 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.47 -27.43 37.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.232 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -59.5 -41.67 90.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.334 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.4 122.08 43.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.154 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.88 109.33 19.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.375 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.63 130.03 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.605 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.28 159.4 34.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.478 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.24 89.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.874 2.383 . . . . 0.0 112.006 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -168.79 140.84 2.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.98 -32.72 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.116 0.484 . . . . 0.0 110.268 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.502 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -57.81 -62.62 1.67 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.531 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.99 -22.06 24.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.888 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.58 -25.84 54.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.261 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.57 132.38 44.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.502 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 -15.93 33.92 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.55 151.46 23.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.838 0.351 . . . . 0.0 110.447 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -97.01 136.19 37.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.238 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.27 136.68 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.672 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.54 139.5 14.74 Favored Glycine 0 CA--C 1.521 0.469 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.2 t -131.64 161.74 40.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.113 0.482 . . . . 0.0 110.281 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.3 tp -92.84 119.07 31.79 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.563 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.87 157.13 1.29 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.34 50.83 47.78 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.8 p -149.49 168.12 24.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.829 0.347 . . . . 0.0 110.824 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.446 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.34 -25.54 59.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.445 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.27 -55.08 35.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.581 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -57.48 -54.06 51.1 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.874 -0.331 . . . . 0.0 110.408 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.3 -51.17 70.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.522 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.592 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.7 t80 -62.16 -43.83 97.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.0 0.429 . . . . 0.0 110.416 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.81 -44.41 97.91 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.9 -14.21 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.641 0.258 . . . . 0.0 110.642 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.25 -34.65 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.521 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.592 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.47 -50.68 17.33 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.329 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -98.94 12.82 34.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.148 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.2 -55.66 0.45 Allowed Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.428 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.2 -10.74 26.23 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.754 2.303 . . . . 0.0 112.008 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.14 -8.96 59.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.588 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.78 33.49 37.46 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.61 138.1 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.937 0.399 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.66 129.69 35.05 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.275 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.81 138.77 53.79 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.61 132.11 71.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.997 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.39 130.48 45.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.635 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -111.68 156.43 21.88 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.264 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.82 6.64 29.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.636 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.4 130.91 6.17 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.98 -45.93 79.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.32 . . . . 0.0 110.429 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.01 -23.84 63.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.456 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.455 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.67 -36.45 84.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.448 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.17 -47.28 85.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.4 m-85 -63.68 -37.67 88.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.234 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.26 -42.65 98.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.13 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.43 -45.21 91.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.002 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.54 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.7 tp -59.06 -48.24 82.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.167 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.75 -23.04 66.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.161 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -18.22 25.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.549 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.57 69.97 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.98 -18.2 63.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 110.602 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 153' ' ' LEU . 38.0 pt -128.52 137.97 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.165 0.507 . . . . 0.0 110.47 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.13 -28.41 62.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.49 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.4 155.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.826 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.5 137.89 51.07 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 120.913 0.387 . . . . 0.0 110.066 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -85.74 103.25 14.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.61 164.93 25.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.491 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.0 151.73 41.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.773 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.03 -54.23 28.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.32 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.415 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.1 t -60.29 -48.73 87.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.57 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.91 90.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.782 0.325 . . . . 0.0 110.57 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.07 -63.06 1.25 Allowed 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.452 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.441 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.7 m -58.62 -46.85 86.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.785 0.326 . . . . 0.0 110.83 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -50.23 -36.9 32.9 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.054 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.33 0.55 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 33.8 t80 -40.28 -70.98 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.765 -0.256 . . . . 0.0 111.101 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.65 -39.95 93.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -59.9 -3.23 0.5 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.274 0.559 . . . . 0.0 110.298 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 177' ' ' VAL . 55.1 mt-30 -123.91 142.23 38.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.919 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -44.02 -14.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.82 2.347 . . . . 0.0 112.227 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.1 t -63.0 -42.86 98.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.434 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.71 -32.96 80.64 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.13 -41.41 96.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.819 0.342 . . . . 0.0 110.462 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.1 m-20 -65.96 -34.82 78.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.652 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.8 m-85 -156.72 142.91 18.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.657 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.54 99.72 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.153 0.502 . . . . 0.0 110.736 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.25 167.06 29.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.628 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.81 56.03 3.02 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.3 0.01 OUTLIER Glycine 0 CA--C 1.539 1.578 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.28 135.49 38.76 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.247 1.965 . . . . 0.0 111.862 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.3 p -124.42 -108.82 0.32 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.83 165.18 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.062 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.76 155.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 O-C-N 124.324 1.015 . . . . 0.0 110.51 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -81.95 118.45 22.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.861 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -72.05 -18.73 61.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.68 -32.17 73.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.64 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 128' ' ' PHE . 93.0 mt -60.95 -44.3 97.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.446 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.9 m-85 -114.08 8.38 16.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.67 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.2 -154.55 50.79 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.654 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.68 -25.65 26.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.815 0.341 . . . . 0.0 110.59 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.468 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.27 -125.48 1.45 Allowed Glycine 0 CA--C 1.518 0.24 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.7 p -132.15 160.19 36.76 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.66 25.05 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.24 141.06 31.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.908 0.385 . . . . 0.0 110.49 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.16 111.8 3.96 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -121.2 159.95 24.82 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.682 0.277 . . . . 0.0 110.287 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -86.5 149.14 25.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.66 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.15 -48.43 64.92 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.755 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -40.4 -22.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.329 . . . . 0.0 110.631 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.14 52.02 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.592 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -64.39 -46.33 83.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.083 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.25 -47.06 37.58 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.04 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.4 -43.78 98.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.405 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.52 -42.76 99.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.897 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.81 -37.5 73.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.88 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.31 -77.42 0.11 Allowed 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.025 HD21 HD11 ' A' ' 44' ' ' ILE . 86.4 mt -28.66 -45.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 110.8 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.1 m-20 -63.9 -44.99 91.3 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.738 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.71 -43.63 98.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.966 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.61 -39.16 92.92 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.247 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -61.2 -43.49 98.79 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.156 0.503 . . . . 0.0 110.22 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.23 92.05 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.271 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.11 -42.12 97.0 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.117 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 90.9 mtp -57.52 -38.07 74.04 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.78 -38.76 76.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.053 0.454 . . . . 0.0 110.435 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.49 92.76 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.662 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.4 p-10 -88.19 0.63 55.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.765 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.76 19.85 67.75 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.7 m -57.93 -46.18 85.43 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.7 t80 -63.6 -57.61 9.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.925 0.393 . . . . 0.0 110.47 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.81 -41.73 78.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.352 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -48.21 82.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.445 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -61.96 -41.58 98.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.451 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.1 -49.84 76.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.709 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.77 -35.6 73.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.51 -50.95 32.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.498 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.1 m-85 -62.19 -45.61 92.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.48 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.7 m-85 -154.64 155.62 35.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 46.6 p-10 -97.56 101.24 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.444 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -157.88 -165.94 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.3 t0 -122.72 110.2 15.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.62 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.0 m -63.3 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.412 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.4 m-85 -59.22 -42.62 91.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -36.69 93.74 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.704 0 CA-C-O 117.88 -1.511 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.83 164.38 61.53 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.73 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.24 143.64 98.42 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.738 2.292 . . . . 0.0 112.208 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.35 -40.98 90.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.664 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -137.96 139.68 39.84 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.371 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.83 121.26 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.472 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.56 118.23 31.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.122 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.24 138.62 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.271 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.54 106.07 2.25 Favored Glycine 0 N--CA 1.463 0.458 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -129.5 120.24 25.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 122.657 -0.319 . . . . 0.0 110.76 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.522 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.5 t70 -114.05 93.02 28.31 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.852 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.74 134.39 62.44 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.491 2.127 . . . . 0.0 111.925 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -141.85 -19.7 0.74 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -124.58 99.46 6.19 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.414 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.711 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.05 -61.27 0.22 Allowed Pre-proline 0 C--O 1.217 -0.631 0 CA-C-O 122.058 0.932 . . . . 0.0 111.127 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.711 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.6 Cg_endo -49.68 -40.21 46.89 Favored 'Trans proline' 0 C--N 1.289 -2.576 0 C-N-CA 122.487 2.125 . . . . 0.0 112.165 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -78.37 -42.61 29.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.94 0.4 . . . . 0.0 110.872 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.654 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.4 mt-10 -149.63 -154.83 0.58 Allowed 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.276 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.33 177.93 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.947 0.404 . . . . 0.0 110.282 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -136.52 143.68 43.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.477 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 25' ' ' SER . 61.9 t-20 -96.58 141.28 30.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.392 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.1 p -65.99 -19.32 65.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.573 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -77.37 -7.13 55.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.452 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.09 -6.57 58.28 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.93 157.73 26.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.366 . . . . 0.0 110.425 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 82.9 mt -111.66 133.65 53.76 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.893 0.378 . . . . 0.0 110.324 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.84 151.28 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.12 151.56 6.67 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -58.71 -42.36 88.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.675 0.274 . . . . 0.0 110.843 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.444 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.3 t0 -69.35 -28.44 66.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.404 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.3 mt -68.23 -40.72 83.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.029 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -60.59 -37.84 82.67 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.893 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.3 tp -65.19 -44.14 89.38 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.224 0.535 . . . . 0.0 110.37 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.41 -47.34 84.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.907 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -54.25 -54.1 44.73 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.518 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -52.77 -39.11 61.98 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.035 0.445 . . . . 0.0 110.087 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.9 mt -68.19 -41.93 80.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.969 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -53.95 -45.08 71.18 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.061 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.17 -46.28 84.69 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.343 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -60.7 -41.93 96.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.989 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.933 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -75.62 -17.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.712 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.84 52.57 4.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.612 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -146.41 170.94 15.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.913 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.71 142.48 27.64 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.987 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.4 m -117.39 131.86 56.69 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.563 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.3 m -128.33 127.81 43.39 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.474 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -94.44 135.28 36.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.445 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.35 128.59 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.012 0.434 . . . . 0.0 110.305 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.84 137.32 57.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.565 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.522 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.3 p30 177.23 131.86 0.2 Allowed Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.695 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.19 144.74 64.03 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.664 2.243 . . . . 0.0 112.678 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.06 -56.03 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.071 0.462 . . . . 0.0 111.272 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.11 -26.35 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.007 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.35 -20.99 18.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.139 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.7 -42.47 97.98 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.759 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.691 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.39 -56.86 26.58 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 123.81 0.694 . . . . 0.0 109.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 49.2 Cg_exo -56.21 -41.36 77.47 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.499 2.133 . . . . 0.0 110.992 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.1 m -59.26 -44.27 92.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.649 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.8 tp -59.86 -43.86 94.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.114 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.43 95.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.478 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.13 2.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.43 11.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.41 -35.43 80.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.598 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.9 pt -122.79 153.27 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.318 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.4 m-20 -92.94 -21.87 19.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.131 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.28 156.42 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.628 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.05 128.26 72.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 110.397 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.444 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.1 ttp -130.44 107.0 8.91 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.011 0.434 . . . . 0.0 110.267 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.66 ' OG ' HD21 ' A' ' 55' ' ' LEU . 44.5 t -159.38 179.21 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.88 -15.18 61.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.489 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.0 tp -36.27 124.78 0.78 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.606 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.541 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -83.33 155.87 23.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.674 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.59 149.67 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -149.55 152.43 35.52 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.693 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.84 -47.46 51.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.075 0.464 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.77 -39.91 71.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.668 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.47 -37.81 80.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.043 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.95 -38.26 75.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.053 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -60.24 -27.51 67.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.221 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.26 -51.47 7.43 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.586 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.9 pt -138.21 -168.41 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.149 0 CA-C-O 121.076 0.465 . . . . 0.0 110.442 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.83 147.66 29.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.083 0.468 . . . . 0.0 110.879 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.4 m-85 -130.08 150.0 51.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.71 -152.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.412 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.504 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.4 m-20 42.41 20.09 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.6 mttt -29.17 120.77 0.14 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.66 0.6 . . . . 0.0 110.526 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 16.1 mt -76.86 -69.63 0.51 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.868 -178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.44 ' CG ' HG21 ' A' ' 166' ' ' VAL . 41.4 p90 -149.4 166.3 29.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.617 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.26 122.74 28.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.29 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.58 69.59 0.9 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.65 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.61 -104.18 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.422 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.29 166.02 32.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.596 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.9 145.75 21.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 110.414 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.89 136.2 41.13 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.41 111.11 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.1 164.99 33.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.826 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.84 23.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.039 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.28 60.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.142 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.98 -41.73 88.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.251 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.1 t -102.09 122.01 43.29 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.976 0.417 . . . . 0.0 110.079 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.11 109.93 19.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.333 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.0 129.94 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.539 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -108.93 154.23 42.0 Favored Pre-proline 0 C--N 1.334 -0.099 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.554 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.0 Cg_endo -59.36 92.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.767 2.311 . . . . 0.0 111.907 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.7 m -171.04 144.47 2.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.36 -33.73 61.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.164 0.507 . . . . 0.0 110.281 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.483 ' H ' HG22 ' A' ' 108' ' ' THR . 47.8 tp10 -58.24 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.425 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -56.34 -22.13 28.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.869 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.29 -25.8 55.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.338 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.9 45.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.475 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.67 -16.5 30.67 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.94 151.21 23.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.877 0.37 . . . . 0.0 110.382 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.91 37.72 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.41 136.61 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.63 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 139.53 14.74 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.8 t -131.83 161.74 40.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.096 0.474 . . . . 0.0 110.287 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.73 118.82 31.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.63 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -51.93 157.46 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.06 50.66 50.54 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.3 p -149.45 168.23 24.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.856 0.36 . . . . 0.0 110.791 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.433 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -74.18 -25.64 59.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.431 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -61.25 -55.1 35.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.544 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -57.64 -53.92 52.74 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -60.55 -51.36 69.76 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.46 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.601 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.1 t80 -62.08 -44.01 97.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.426 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.74 -44.42 97.93 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.526 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.94 -14.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.627 0.251 . . . . 0.0 110.675 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.19 -34.84 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.479 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.601 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.43 -50.57 17.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.435 -178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -99.04 12.56 35.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.207 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.95 -55.7 0.46 Allowed Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.4 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.5 Cg_endo -72.08 -10.6 26.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.778 2.319 . . . . 0.0 111.961 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.45 -8.76 59.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.612 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.74 33.37 38.01 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.24 137.87 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 110.532 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -87.58 129.73 35.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.233 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.6 pt -127.26 138.99 53.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.95 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.0 t -125.58 132.08 71.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.975 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 35.8 t -98.52 130.52 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -111.69 156.68 21.5 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.294 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.06 6.46 28.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.565 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.98 6.36 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.415 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.6 tp60 -66.19 -46.15 78.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 0.0 110.472 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.12 62.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.89 -36.54 84.7 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.57 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.29 -47.44 84.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.093 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.509 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.3 m-85 -63.72 -37.84 88.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.263 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.01 -42.19 97.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.081 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -64.19 -44.4 92.1 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.97 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.1 tp -58.88 -48.2 82.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.164 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.0 m -63.06 -23.01 67.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.42 -18.36 25.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.493 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.79 11.2 71.16 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.57 -18.25 63.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.659 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.553 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.8 pt -127.9 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.163 0.506 . . . . 0.0 110.456 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.86 -28.3 62.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.999 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.41 155.62 1.86 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.574 0.546 . . . . 0.0 110.873 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.43 138.0 51.21 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.993 0.425 . . . . 0.0 110.045 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.21 103.17 14.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.041 0.448 . . . . 0.0 110.569 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.25 24.98 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.04 152.55 41.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.691 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.04 -54.27 27.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.347 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.9 t -60.39 -48.66 87.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.437 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.8 88.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.783 0.325 . . . . 0.0 110.44 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.46 -63.63 1.09 Allowed 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.413 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.4 m -59.09 -47.11 86.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.749 0.309 . . . . 0.0 110.981 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -50.17 -37.6 35.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.02 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.419 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.7 -66.15 0.56 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.657 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.3 -70.69 0.1 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.734 -0.274 . . . . 0.0 111.123 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.448 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.7 mt -61.36 -39.78 91.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.93 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -60.67 -3.36 0.69 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.412 0.625 . . . . 0.0 110.354 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 177' ' ' VAL . 54.9 mt-30 -123.27 142.25 38.08 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 122.118 -0.363 . . . . 0.0 110.845 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -44.27 -16.21 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.848 2.365 . . . . 0.0 112.275 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 74.5 t -62.82 -43.04 98.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.43 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.15 -33.06 82.8 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.82 -41.25 95.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.81 0.338 . . . . 0.0 110.413 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.526 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -66.04 -34.27 77.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.509 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.4 m-85 -157.12 143.92 18.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.725 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.27 99.59 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.0 m-85 -159.09 167.14 29.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.614 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.69 56.32 2.8 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.44 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.539 1.589 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.09 135.69 37.41 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.285 1.99 . . . . 0.0 111.99 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.3 p -124.94 -108.13 0.33 Allowed 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.496 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.63 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.91 165.33 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-O 118.815 -0.612 . . . . 0.0 109.955 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.53 156.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 O-C-N 124.496 1.122 . . . . 0.0 110.468 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.07 118.04 22.72 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.917 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.1 mp0 -71.62 -18.94 62.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.576 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.3 mt -61.0 -44.19 97.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.765 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.433 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.97 8.97 17.32 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.66 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.56 -155.12 52.04 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.9 p -70.31 -25.26 26.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.862 0.363 . . . . 0.0 110.53 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.61 -125.2 1.42 Allowed Glycine 0 C--N 1.33 0.234 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.5 p -131.76 159.46 38.39 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 110.355 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.98 -162.87 24.94 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.504 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.7 139.12 34.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.945 0.402 . . . . 0.0 110.468 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.65 112.61 4.04 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.5 mt -124.76 159.5 30.81 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 120.752 0.311 . . . . 0.0 110.346 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.649 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.8 mtm180 -85.89 149.77 24.99 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.793 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.04 -48.29 64.63 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.746 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -38.57 -24.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.708 0.289 . . . . 0.0 110.715 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.53 52.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.614 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -64.48 -46.13 84.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.742 0.306 . . . . 0.0 111.136 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.0 -47.07 39.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.044 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.57 -43.4 98.91 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.466 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.425 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.6 ttt-85 -62.39 -42.82 99.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.775 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.41 -36.97 72.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.118 0.485 . . . . 0.0 109.84 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.69 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.49 -77.43 0.11 Allowed 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.933 HD21 HD11 ' A' ' 44' ' ' ILE . 98.0 mt -28.43 -45.43 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.988 0.423 . . . . 0.0 110.808 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 212' ' ' ALA . 90.0 m-20 -64.29 -45.14 89.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.78 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.69 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.89 -43.93 97.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.968 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.19 92.82 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.14 -43.62 98.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.162 0.506 . . . . 0.0 110.163 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.27 91.84 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.237 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.89 -42.45 97.48 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.0 mtp -57.47 -38.24 74.19 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.86 -38.95 76.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.1 0.476 . . . . 0.0 110.421 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.88 -44.91 93.94 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -88.95 1.3 55.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.803 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.68 19.86 65.5 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.434 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 77.0 m -58.11 -45.7 86.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.77 -57.69 9.16 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.499 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.3 -41.43 79.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.313 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.59 -48.45 80.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.483 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.13 -41.49 98.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.84 0.352 . . . . 0.0 110.448 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.48 -49.94 75.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.724 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.28 -35.37 73.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.379 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.96 -50.99 28.43 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.501 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.49 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.15 -45.27 94.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.467 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.8 m-85 -153.51 154.86 35.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.416 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.4 p-10 -96.78 95.5 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.48 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -153.12 -167.06 2.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.482 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.43 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.5 t0 -122.48 110.25 15.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.81 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 239' ' ' TYR . 22.0 m -63.52 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.574 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.418 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.6 m-85 -57.06 -43.94 82.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.238 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.75 -37.48 94.76 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.793 -1.559 . . . . 0.0 110.985 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.16 164.36 57.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.671 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -61.09 143.28 98.92 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.694 2.263 . . . . 0.0 112.14 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.63 -40.87 88.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.658 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -138.38 141.5 39.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.438 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.8 mt -109.21 127.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.331 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.84 118.8 37.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.315 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.71 141.81 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.293 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.83 107.08 2.16 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.7 m -128.81 120.83 27.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.68 0.276 . . . . 0.0 110.489 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 9.7 t70 -113.01 94.25 29.01 Favored Pre-proline 0 C--O 1.233 0.187 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.946 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.37 134.96 63.83 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.64 2.227 . . . . 0.0 111.786 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.2 p -136.7 -18.7 1.4 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.647 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' O ' ' C ' ' A' ' 18' ' ' ALA . 81.1 m-85 -125.22 97.93 5.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.422 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.696 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.63 -61.4 0.23 Allowed Pre-proline 0 C--O 1.222 -0.372 0 CA-C-O 122.0 0.905 . . . . 0.0 111.018 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.696 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.5 Cg_endo -50.13 -41.22 50.04 Favored 'Trans proline' 0 C--N 1.294 -2.336 0 C-N-CA 122.506 2.137 . . . . 0.0 112.153 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.1 t80 -78.51 -43.05 27.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.126 0.488 . . . . 0.0 110.643 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.682 ' O ' ' O ' ' A' ' 18' ' ' ALA . 94.8 mt-10 -146.73 -160.7 1.19 Allowed 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.159 -178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.4 t 157.36 -178.97 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.771 0.32 . . . . 0.0 110.299 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.73 140.94 46.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.557 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.3 t-20 -90.32 141.83 28.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.421 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.0 p -66.27 -18.79 65.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.577 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.27 -6.08 53.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.504 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.34 -9.83 57.74 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -79.65 163.02 24.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.801 0.334 . . . . 0.0 110.379 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.1 mt -117.62 137.35 52.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.494 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.495 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.1 p -133.24 151.27 33.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.318 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.49 154.05 7.42 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.63 -41.35 94.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.739 0.304 . . . . 0.0 110.686 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.8 t0 -70.5 -32.3 69.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.143 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.495 HD12 ' C ' ' A' ' 30' ' ' VAL . 96.7 mt -67.98 -39.96 82.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.869 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.2 m-20 -60.69 -37.63 82.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.982 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -65.45 -44.3 87.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.24 0.543 . . . . 0.0 110.608 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.44 -46.4 86.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.122 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.46 -53.77 49.84 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -53.41 -38.91 63.89 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.884 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.27 -42.64 79.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.054 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 48.9 m -53.68 -44.15 69.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.282 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -63.98 -46.95 82.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.04 0.448 . . . . 0.0 110.528 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.0 mmt-85 -60.46 -41.48 94.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.146 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.023 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -75.27 -18.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.805 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.51 52.25 3.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -146.87 171.05 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.802 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.45 142.14 27.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -117.59 131.82 56.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.492 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.62 127.01 43.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.401 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -95.72 137.23 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.47 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.3 129.46 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.549 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -68.43 139.06 55.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.397 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.4 p30 176.21 135.25 0.19 Allowed Pre-proline 0 N--CA 1.448 -0.572 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.804 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.5 Cg_endo -68.2 143.32 58.64 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.671 2.248 . . . . 0.0 112.63 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 80.8 mt -39.34 -55.25 1.76 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.077 0.465 . . . . 0.0 111.078 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -48.73 -26.25 2.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.752 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.03 -21.37 18.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.846 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 55.2 mt -63.95 -42.96 97.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.379 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.688 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.3 mm -62.47 -55.86 35.56 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.029 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.1 Cg_exo -55.7 -42.23 69.54 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.559 2.172 . . . . 0.0 111.257 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.4 m -58.82 -44.54 90.9 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.182 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.4 tp -58.78 -44.65 90.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.361 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.8 -40.84 95.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.531 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.36 11.39 1.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.562 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.2 11.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.646 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.0 mttt -63.5 -33.27 75.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.699 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -124.56 154.48 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.507 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -91.49 -20.89 21.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.744 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.06 160.38 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.493 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 58' ' ' LEU . 96.0 mt -116.08 127.33 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.521 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.77 107.72 9.88 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.315 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.517 ' OG ' HD21 ' A' ' 55' ' ' LEU . 35.7 t -162.42 -177.13 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.4 p -64.02 -15.68 59.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.636 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.3 122.99 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -83.09 156.34 23.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.766 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -105.53 149.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.7 p -150.87 152.85 34.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.596 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.81 -47.69 51.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.85 -39.85 72.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.35 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.636 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -69.03 -37.36 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.908 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -58.21 -37.29 74.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 110.399 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.84 67.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.352 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.71 -51.84 7.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.739 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.58 -167.7 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.509 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.37 147.14 29.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.087 0.47 . . . . 0.0 110.652 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 76' ' ' ILE . 72.4 m-85 -130.47 150.6 51.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.652 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.0 t -165.51 -151.01 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.495 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.505 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.0 m-20 43.09 20.02 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.777 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.3 mttt -27.98 120.51 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 O-C-N 123.582 0.551 . . . . 0.0 110.678 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.5 mt -79.42 -71.31 0.45 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.801 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -148.46 165.4 31.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.23 126.25 31.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.455 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.416 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.37 67.48 0.73 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -85.55 -105.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.41 167.3 29.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.574 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.2 146.77 23.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.583 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -102.01 135.99 42.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.691 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.52 111.66 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.074 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.4 m -134.9 164.29 34.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.606 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.88 24.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.825 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.67 -28.07 60.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.82 -42.07 88.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.287 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.8 t -101.97 122.04 43.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.348 . . . . 0.0 110.245 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.85 109.68 19.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.328 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.3 130.41 70.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.532 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -109.71 154.14 42.62 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.561 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.517 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.9 Cg_endo -59.53 92.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.715 2.276 . . . . 0.0 112.064 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.5 m -170.86 144.8 2.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.752 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.98 -33.98 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.333 0.587 . . . . 0.0 110.432 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.74 -62.14 2.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.676 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.8 t -56.48 -22.21 30.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.667 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.1 mt -76.9 -25.65 53.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.47 132.85 45.43 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.575 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.49 -16.5 29.8 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.79 151.22 23.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.808 0.337 . . . . 0.0 110.358 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.1 135.5 37.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.332 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.47 136.27 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.639 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.69 138.72 14.43 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.6 161.63 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.548 ' N ' HG12 ' A' ' 119' ' ' VAL . 39.5 tp -92.7 119.27 31.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -51.32 156.78 1.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.637 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.64 50.92 51.55 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.3 p -148.69 166.74 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.937 0.399 . . . . 0.0 110.727 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.1 p -71.81 -29.67 64.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.457 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.4 mt-30 -58.77 -54.78 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.588 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.59 -55.77 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.397 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.1 -51.94 67.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.523 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.9 t80 -61.64 -44.19 97.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.468 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.49 -44.48 97.95 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.74 -14.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.563 0.221 . . . . 0.0 110.605 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.76 2.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.478 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.593 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.37 -50.72 17.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.01 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -99.6 12.77 35.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.756 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.13 -55.42 0.46 Allowed Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.51 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.8 Cg_endo -72.34 -10.06 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.77 2.314 . . . . 0.0 112.093 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -82.72 -8.45 59.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.639 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.38 37.2 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.53 138.1 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.949 0.404 . . . . 0.0 110.57 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.9 130.29 34.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.394 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -127.37 138.98 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.778 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.47 132.37 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.112 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.3 t -97.81 129.47 44.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.454 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -111.3 156.35 21.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.342 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.85 7.07 27.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.577 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.27 6.08 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.08 -45.9 79.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.372 . . . . 0.0 110.578 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.09 62.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.525 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.0 t-20 -64.86 -36.53 84.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.514 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.3 -47.36 84.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.0 m-85 -63.85 -37.67 88.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.266 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.5 p -61.4 -42.53 98.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.092 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.15 -44.37 92.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.343 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.0 tp -59.01 -47.86 83.68 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.184 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.54 -22.96 67.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.995 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.13 -18.56 25.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 10.96 71.05 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.68 -18.15 63.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.704 0.288 . . . . 0.0 110.636 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.5 pt -128.18 137.81 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.13 -29.76 63.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.674 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -174.8 154.92 2.01 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.715 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.04 138.73 52.07 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.233 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -86.12 102.64 14.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.42 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.577 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.25 164.4 26.48 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.64 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.27 152.28 41.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.827 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.7 mt-10 -66.0 -54.43 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.077 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 73.2 t -59.84 -48.83 86.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.577 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.36 87.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.749 0.309 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.652 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -62.92 -62.95 1.37 Allowed 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.455 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.447 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.1 m -58.29 -45.9 87.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.953 0.406 . . . . 0.0 110.49 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -45.98 -40.78 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.401 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.434 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -112.13 -62.46 0.46 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.652 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.62 -71.59 0.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.718 0.294 . . . . 0.0 110.747 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.5 mt -62.67 -41.05 98.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.719 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.0 tttt -59.65 -3.05 0.42 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.169 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 177' ' ' VAL . 57.2 mt-30 -125.96 142.04 41.24 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.789 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.47 -15.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.803 2.335 . . . . 0.0 112.188 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 175' ' ' GLN . 89.7 t -62.5 -43.12 98.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.27 84.69 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.28 -40.72 95.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 110.511 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.517 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 49.0 m-20 -67.07 -33.6 75.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.214 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.5 m-85 -156.59 142.35 17.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.564 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.3 pttt -175.47 99.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.119 0.485 . . . . 0.0 110.712 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 93.5 m-85 -158.93 167.13 30.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.544 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 80.69 56.13 3.2 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.95 -115.95 0.01 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -50.35 135.16 39.22 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.327 2.018 . . . . 0.0 111.931 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.8 p -124.12 -108.72 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.068 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.634 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.9 164.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.038 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.634 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.7 tttt 153.85 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 124.17 0.919 . . . . 0.0 110.51 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.61 119.42 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.239 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.7 mp0 -71.72 -16.34 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.0 -32.21 73.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.683 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -61.05 -44.33 97.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -114.38 8.81 16.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.15 -153.78 51.34 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.659 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.8 p -70.93 -25.53 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.559 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.91 -126.55 1.61 Allowed Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.9 p -132.29 160.26 36.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 110.446 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.82 -161.94 24.09 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.1 mtp -98.45 140.13 33.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.829 0.347 . . . . 0.0 110.542 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.52 3.57 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 85' ' ' ALA . 83.0 mt -118.13 159.64 22.92 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.584 0.23 . . . . 0.0 110.443 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.69 148.84 25.27 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.608 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.21 -48.68 61.97 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.941 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -41.02 -22.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.497 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.3 m-20 -72.52 51.49 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.465 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.46 -46.28 83.78 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.723 0.297 . . . . 0.0 110.89 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.99 -47.2 38.84 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.763 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.387 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.28 -42.91 99.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.173 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.71 -37.46 73.56 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.205 0.526 . . . . 0.0 110.143 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.697 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.12 -77.43 0.1 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.923 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.023 HD21 HD11 ' A' ' 44' ' ' ILE . 88.7 mt -27.95 -45.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.863 0.363 . . . . 0.0 110.913 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.4 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.741 178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.697 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.1 -43.54 98.72 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.114 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.99 91.37 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.453 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.23 -43.36 99.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.412 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.23 91.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.368 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -64.22 -42.15 96.7 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.393 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -57.31 -38.2 73.66 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.62 -38.88 77.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.537 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.54 91.71 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.597 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 18.9 p-10 -88.74 0.28 56.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.762 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.01 20.42 68.8 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -57.54 -46.39 83.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.2 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 80.7 t80 -63.06 -58.04 8.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.996 0.427 . . . . 0.0 110.485 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.75 -42.53 79.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.545 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.81 -48.8 80.03 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.442 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.16 -41.48 98.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.49 -50.19 74.62 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.745 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.48 -34.76 72.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -71.42 -51.83 21.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.176 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.42 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 40.1 m-85 -62.73 -44.61 95.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.433 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.458 ' O ' ' O ' ' A' ' 230' ' ' ALA . 83.9 m-85 -151.31 153.09 34.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.513 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 49.0 p-10 -98.21 93.92 6.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.464 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.89 -165.59 2.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.444 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.452 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -122.39 108.75 13.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.683 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 239' ' ' TYR . 28.2 m -63.53 -40.06 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.632 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.428 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.1 m-85 -57.37 -43.57 83.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.71 -37.55 94.88 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.219 -0.796 0 CA-C-O 117.924 -1.486 . . . . 0.0 111.005 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.3 60.14 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.752 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.99 143.47 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 122.737 2.291 . . . . 0.0 112.261 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.42 -40.91 89.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.633 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -138.0 139.0 39.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.34 121.21 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.587 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.1 118.88 32.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.6 138.67 40.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.369 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.7 105.29 2.11 Favored Glycine 0 N--CA 1.463 0.442 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.9 m -128.75 120.52 26.56 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.648 -0.325 . . . . 0.0 110.834 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.509 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.7 t70 -114.35 92.85 29.22 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.953 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.33 134.42 60.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.544 2.162 . . . . 0.0 111.974 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.7 p -141.48 -20.31 0.76 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.716 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.6 m-85 -123.56 99.15 6.17 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.456 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.717 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.06 -61.29 0.22 Allowed Pre-proline 0 C--O 1.218 -0.559 0 CA-C-O 121.814 0.816 . . . . 0.0 111.085 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.717 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.41 -40.98 44.47 Favored 'Trans proline' 0 C--N 1.291 -2.461 0 C-N-CA 122.495 2.13 . . . . 0.0 112.211 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.3 t80 -78.13 -42.75 30.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.702 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.656 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -149.81 -154.11 0.53 Allowed 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.048 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.75 177.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.034 0.445 . . . . 0.0 110.269 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.47 144.75 46.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.442 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -95.94 134.56 38.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.9 p -64.84 -18.88 65.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.522 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.02 -6.06 53.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.499 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.29 -8.09 56.91 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.74 159.12 25.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.0 110.459 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.3 mt -112.42 131.17 55.7 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.69 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.82 151.42 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.368 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.15 151.43 6.61 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -58.67 -42.38 88.33 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.695 -0.297 . . . . 0.0 110.819 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 -69.35 -28.49 66.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.266 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.69 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -68.15 -40.84 83.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.83 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.3 -37.77 81.58 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.19 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.38 -45.05 89.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.083 0.468 . . . . 0.0 110.163 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.19 -48.77 77.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.915 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.65 -54.69 29.88 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.455 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.15 -40.46 61.45 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.7 mt -68.17 -41.7 81.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.971 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 55.8 m -53.43 -45.18 69.32 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.167 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.33 -46.38 83.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.279 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -60.23 -42.31 94.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.176 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 213' ' ' LEU . 97.3 mt -75.53 -16.99 15.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.65 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.41 52.96 4.46 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.706 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.8 p -146.96 171.54 15.08 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.89 142.31 27.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.038 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.14 130.92 56.93 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.63 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.4 m -127.29 127.1 43.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.41 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -94.03 134.89 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.466 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.4 t -129.09 127.77 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.298 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.42 137.89 57.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 176.07 131.04 0.17 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.706 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.5 Cg_endo -67.84 145.31 68.24 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.684 2.256 . . . . 0.0 112.562 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.881 HD23 HD12 ' A' ' 58' ' ' LEU . 81.8 mt -40.41 -56.07 2.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.979 0.418 . . . . 0.0 111.035 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.05 -26.69 1.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.008 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -20.96 18.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.088 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.881 HD12 HD23 ' A' ' 55' ' ' LEU . 58.7 mt -63.77 -42.53 97.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.641 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.3 -56.84 26.99 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.821 0.701 . . . . 0.0 109.688 -179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.1 Cg_exo -55.84 -41.83 73.31 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.556 2.171 . . . . 0.0 111.102 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m -59.05 -44.5 91.81 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.055 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.657 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.3 tp -59.45 -43.89 93.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.185 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.41 -40.45 95.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.455 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.23 10.22 2.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.496 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.21 12.14 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.451 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.56 -35.38 80.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.549 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.3 pt -122.43 153.03 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.297 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.4 m-20 -93.17 -22.27 19.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.093 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.5 155.94 27.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.607 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.08 128.63 72.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.123 0.487 . . . . 0.0 110.362 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.11 107.22 8.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.701 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -159.48 178.64 9.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.618 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.4 p -65.01 -15.34 62.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.493 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -35.16 124.65 0.6 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.549 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.15 154.38 25.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.628 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.63 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.5 pt -105.16 148.86 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.134 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -149.16 152.18 35.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.82 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.9 -47.15 52.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.01 0.434 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.55 -40.21 71.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.707 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.5 mtt180 -68.4 -37.92 80.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.072 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.78 -38.84 76.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.94 -27.43 66.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.206 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.46 -51.0 7.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.526 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -139.01 -168.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 CA-C-O 121.072 0.463 . . . . 0.0 110.49 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.31 147.74 29.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 76' ' ' ILE . 79.5 m-85 -130.01 150.11 51.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.549 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.9 t -163.36 -153.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.437 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.3 m-20 41.55 20.2 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.933 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.72 121.38 0.2 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 123.478 0.486 . . . . 0.0 110.503 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.431 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 58.6 mt -75.0 -68.56 0.54 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.444 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.78 167.61 26.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.665 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.6 29.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.368 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -105.05 68.24 0.81 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.713 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.58 -104.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.404 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.9 p -159.26 165.49 33.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.639 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.05 146.45 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.112 0.482 . . . . 0.0 110.432 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.95 135.99 41.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.762 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.844 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.06 164.49 34.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.11 148.25 25.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.01 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.19 -28.39 58.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.232 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -59.05 -41.66 88.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.331 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -101.63 121.41 41.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.373 . . . . 0.0 110.153 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.06 109.88 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.419 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.2 mt -126.57 129.54 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.609 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -107.16 154.11 40.64 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.662 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.35 91.37 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.793 2.329 . . . . 0.0 111.946 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.3 m -170.44 143.44 2.29 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.516 0.51 . . . . 0.0 110.851 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.9 p -67.59 -33.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.35 -62.07 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.439 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 t -56.6 -22.48 34.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.826 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.2 mt -75.89 -26.03 56.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.276 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.6 47.72 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.454 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.79 -16.99 28.7 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.01 151.34 23.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.87 0.367 . . . . 0.0 110.434 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.78 135.2 37.8 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.287 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.58 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.594 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.49 138.45 14.26 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.6 161.56 40.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.289 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.6 tp -92.52 117.51 30.02 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.648 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.55 157.91 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.71 50.63 52.83 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.1 p -149.9 168.75 22.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.82 0.343 . . . . 0.0 110.783 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.451 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.8 p -73.3 -26.88 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.458 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.49 -55.31 35.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.534 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -56.98 -54.9 41.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.904 -0.319 . . . . 0.0 110.402 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.8 m -60.26 -51.38 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.524 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.611 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.3 t80 -61.99 -44.08 97.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.025 0.441 . . . . 0.0 110.502 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.52 -44.55 97.84 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.54 -14.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.657 0.265 . . . . 0.0 110.651 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.5 -34.64 2.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.611 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.6 -50.65 17.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.831 0.348 . . . . 0.0 111.366 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.3 12.17 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.171 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.57 -55.29 0.49 Allowed Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.35 -10.1 25.13 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.796 2.331 . . . . 0.0 111.994 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.85 -9.02 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.637 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.25 37.09 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.33 137.66 40.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.29 129.79 34.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.343 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.4 138.14 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.3 t -123.0 133.25 69.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.023 0.44 . . . . 0.0 109.979 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.88 127.08 42.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -110.67 153.31 25.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.33 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -107.02 7.22 29.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.617 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.19 5.85 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.409 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.0 tp60 -65.81 -45.77 81.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.747 0.308 . . . . 0.0 110.463 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.77 -23.47 62.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.526 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.465 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.73 -36.8 85.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.523 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.94 -46.62 87.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.016 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.494 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.8 m-85 -64.7 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.04 -41.86 97.39 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.39 -43.2 91.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.998 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.4 tp -58.77 -48.2 82.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.172 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.84 -22.48 66.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.224 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.47 -18.41 25.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.55 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.64 72.38 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.82 -17.82 63.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.645 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.5 pt -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.493 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -72.64 -28.0 62.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.38 155.72 1.89 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.517 0.511 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.01 137.21 50.15 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.022 0.439 . . . . 0.0 110.074 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -86.03 103.32 14.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.127 0.489 . . . . 0.0 110.661 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.7 tt0 -132.85 165.56 24.32 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.446 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.474 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -72.89 153.12 41.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.69 -54.68 20.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.24 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 91' ' ' TYR . 69.3 t -60.29 -48.89 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.506 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.96 89.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 110.626 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.41 -62.92 1.3 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.456 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.5 m -59.56 -47.49 85.36 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.99 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -48.93 -37.27 19.45 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.113 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.27 -66.03 0.55 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 168' ' ' ALA . 23.8 t80 -40.72 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.771 -0.252 . . . . 0.0 111.087 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -61.44 -40.39 94.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.38 -3.35 0.42 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.632 . . . . 0.0 110.321 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.9 mt-30 -122.82 150.09 57.87 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.855 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.69 -20.92 7.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.853 2.369 . . . . 0.0 112.231 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.6 t -60.79 -43.08 94.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.577 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.13 -33.28 85.31 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.48 -41.14 93.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.738 0.304 . . . . 0.0 110.459 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.6 m-20 -66.12 -32.91 74.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.385 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.2 142.64 18.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.659 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.557 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.44 99.61 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.085 0.469 . . . . 0.0 110.727 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.557 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.7 m-85 -159.24 167.53 28.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.647 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.91 56.45 2.74 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.56 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.67 -118.61 0.01 OUTLIER Glycine 0 CA--C 1.535 1.337 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.55 135.7 33.49 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.395 2.063 . . . . 0.0 111.996 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.3 p -125.2 -108.32 0.32 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.435 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.65 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 5.8 p -165.12 164.56 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.065 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.65 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 154.13 155.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 O-C-N 124.346 1.029 . . . . 0.0 110.595 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -81.92 117.4 22.14 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.912 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 195' ' ' GLY . 54.1 mp0 -71.44 -18.94 62.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.81 -32.37 73.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.565 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.8 mt -60.93 -44.58 97.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.669 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.451 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.2 m-85 -114.13 9.64 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.646 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.74 -153.86 51.8 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.849 -0.901 . . . . 0.0 110.849 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.63 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.74 -24.93 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.789 0.328 . . . . 0.0 110.501 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.34 -124.14 1.3 Allowed Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.49 156.16 44.57 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.646 0.26 . . . . 0.0 110.301 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.61 -169.56 30.37 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.17 137.41 33.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 110.534 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.32 108.38 3.28 Favored Glycine 0 C--N 1.331 0.26 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.44 159.12 29.68 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.293 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.657 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.42 149.79 24.76 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.803 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.2 -47.76 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.522 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.53 -25.26 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.791 0.329 . . . . 0.0 110.574 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.4 52.07 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.611 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -64.49 -45.11 88.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.162 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.9 -47.39 30.21 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.0 tp -62.46 -43.72 98.14 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.506 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.2 -43.01 99.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.798 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.91 -36.35 70.06 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.09 -77.38 0.11 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 44' ' ' ILE . 96.6 mt -28.4 -46.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.956 0.408 . . . . 0.0 110.637 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -64.4 -44.84 90.02 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.779 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.689 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.02 -43.56 98.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.037 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.87 92.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.199 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.34 -43.71 98.41 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.126 0.488 . . . . 0.0 110.144 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.53 93.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.383 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -42.71 97.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.22 -37.85 72.85 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.2 -38.88 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.025 0.44 . . . . 0.0 110.437 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.18 -44.73 94.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.17 2.13 54.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.703 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.68 19.67 63.09 Favored Glycine 0 C--O 1.225 -0.451 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.441 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 83.9 m -58.07 -45.84 86.44 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.0 t80 -63.7 -57.73 9.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.884 0.374 . . . . 0.0 110.433 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.11 -41.46 79.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.232 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.64 -48.33 81.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.459 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.21 -41.55 98.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.829 0.347 . . . . 0.0 110.294 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.76 -50.0 75.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.92 -35.43 73.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.428 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.75 -51.21 28.63 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.544 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.2 m-85 -61.88 -45.83 92.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.598 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.0 m-85 -153.97 155.54 35.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.453 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.09 97.43 9.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.001 0.429 . . . . 0.0 110.496 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -154.86 -166.49 2.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.477 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.427 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.03 110.99 16.05 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.58 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.0 m -63.22 -40.34 88.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.417 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.0 m-85 -58.89 -42.48 89.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.274 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.94 94.12 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.957 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.47 164.59 59.93 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.764 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.07 143.63 99.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 122.749 2.299 . . . . 0.0 112.276 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.11 -40.24 90.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.81 142.92 36.63 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.0 mt -109.97 129.08 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.013 0.435 . . . . 0.0 110.337 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -104.1 117.12 33.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.337 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -111.89 138.86 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.82 104.86 2.13 Favored Glycine 0 N--CA 1.464 0.518 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.6 m -127.98 119.3 25.21 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 122.588 -0.36 . . . . 0.0 110.91 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.9 t70 -113.63 92.46 24.32 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.936 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.33 134.3 60.36 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 p -141.36 -19.31 0.78 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.783 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' O ' ' N ' ' A' ' 20' ' ' PHE . 96.5 m-85 -124.77 99.14 6.02 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.421 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.717 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.23 -61.04 0.23 Allowed Pre-proline 0 C--O 1.217 -0.656 0 CA-C-O 122.039 0.923 . . . . 0.0 111.201 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.717 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.5 Cg_endo -49.76 -39.97 47.76 Favored 'Trans proline' 0 C--N 1.288 -2.658 0 C-N-CA 122.581 2.187 . . . . 0.0 112.225 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.5 t80 -78.78 -42.69 27.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.973 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.644 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.37 -155.51 0.64 Allowed 'General case' 0 C--O 1.211 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.216 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.92 178.21 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.035 0.445 . . . . 0.0 110.312 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -136.09 143.41 44.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.471 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.2 t-20 -95.62 141.43 29.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.486 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.3 p -65.76 -19.14 65.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.551 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.14 -6.97 56.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.513 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.15 -7.32 58.54 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.18 157.85 27.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.393 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.0 mt -111.54 133.77 53.58 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.92 0.391 . . . . 0.0 110.395 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.668 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.52 151.31 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.328 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.7 151.98 6.81 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.884 -0.887 . . . . 0.0 110.884 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -58.75 -42.31 88.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 122.613 -0.345 . . . . 0.0 110.98 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.472 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.8 t0 -69.83 -28.48 65.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.668 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.7 mt -68.55 -40.69 82.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.223 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.422 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 44.5 m-20 -61.41 -37.66 84.27 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.686 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.0 -43.92 86.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.163 0.506 . . . . 0.0 110.529 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.535 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.13 -41.88 93.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.909 -178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -58.67 -53.3 59.92 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.589 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.92 -37.06 63.42 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.117 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.86 -42.29 77.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.102 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.3 m -54.75 -44.59 73.75 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.077 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.81 -47.22 81.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.162 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -59.85 -40.97 90.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.054 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.985 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -76.37 -17.53 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.836 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.5 52.45 4.64 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.21 170.23 16.66 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.898 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.37 140.59 29.32 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.964 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.5 m -117.13 131.88 56.79 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.583 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.2 m -128.28 127.63 43.15 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.404 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -93.91 135.71 34.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.58 128.82 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.31 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.83 139.4 58.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.606 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.513 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.38 131.7 0.15 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.692 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.34 145.28 65.08 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.67 2.247 . . . . 0.0 112.591 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.886 HD23 HD12 ' A' ' 58' ' ' LEU . 82.1 mt -40.27 -56.67 1.91 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.085 0.469 . . . . 0.0 111.283 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.47 -26.74 1.47 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.045 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.57 19.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.194 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.886 HD12 HD23 ' A' ' 55' ' ' LEU . 58.7 mt -63.98 -42.56 97.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.859 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.687 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.32 -57.02 25.36 Favored Pre-proline 0 C--N 1.321 -0.652 0 O-C-N 123.933 0.771 . . . . 0.0 109.527 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 51.3 Cg_exo -55.46 -42.65 65.95 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.49 2.126 . . . . 0.0 110.939 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.5 m -59.19 -43.88 92.2 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.5 tp -59.01 -44.05 91.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.109 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.72 -40.02 94.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.507 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.54 11.23 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.479 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.12 11.91 0.85 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -34.34 77.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.1 pt -124.05 153.52 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.189 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.35 -20.59 20.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.11 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.4 157.32 25.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.545 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.91 127.36 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.472 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.33 106.45 9.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.309 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.585 ' OG ' HD21 ' A' ' 55' ' ' LEU . 41.4 t -160.07 -178.33 6.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.575 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.3 p -64.24 -15.38 59.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.417 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.1 tp -37.96 123.76 1.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.557 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.44 156.84 22.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.647 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.0 pt -105.27 149.21 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.131 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.3 p -149.87 152.9 35.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.751 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.44 -47.5 56.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 0.0 110.548 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.9 -40.05 72.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.691 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.01 -37.82 81.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.078 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.26 -37.37 74.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.05 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.55 -27.2 67.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.127 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.5 -51.91 6.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.329 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.8 pt -138.27 -168.61 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 CA-C-O 121.118 0.485 . . . . 0.0 110.407 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.79 29.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.94 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.0 m-85 -129.93 149.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.609 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.37 -151.75 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.421 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.506 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.2 m-20 43.37 19.23 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -28.27 120.12 0.11 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.581 0.551 . . . . 0.0 110.518 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.5 mt -77.25 -69.9 0.5 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.2 p90 -149.17 166.12 29.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.589 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.88 121.67 27.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.298 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.87 69.29 1.04 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.88 -105.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.424 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.15 165.76 33.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.615 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.47 146.02 22.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.133 0.492 . . . . 0.0 110.443 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.08 136.11 41.46 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.51 111.06 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.27 165.11 32.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.73 148.45 23.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.154 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.13 -28.22 57.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.201 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.0 -41.78 88.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.254 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.12 122.22 43.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.042 0.448 . . . . 0.0 110.114 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.04 110.0 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.33 129.84 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.85 154.34 41.87 Favored Pre-proline 0 N--CA 1.457 -0.096 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.641 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.24 92.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.832 2.354 . . . . 0.0 111.82 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -170.86 144.09 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.666 0.604 . . . . 0.0 110.885 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.3 -33.74 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.306 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.493 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.85 -62.11 2.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.298 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.7 t -56.74 -21.85 31.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.893 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.8 mt -76.19 -25.93 55.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.373 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.82 133.44 47.61 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.459 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.17 -16.25 29.5 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.5 151.56 23.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.854 0.359 . . . . 0.0 110.394 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.29 135.4 38.18 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.231 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.04 136.49 60.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.615 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 138.62 14.32 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.1 t -130.89 161.76 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 121.213 0.53 . . . . 0.0 110.205 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.545 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.3 tp -92.5 117.54 30.05 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.75 157.79 1.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.76 50.29 54.52 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.46 168.78 22.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.835 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.453 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 77.0 p -73.1 -27.35 61.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.418 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.45 -54.87 40.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.51 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -57.16 -54.5 46.06 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.408 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.9 m -60.73 -51.14 70.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.446 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.02 -43.95 97.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.986 0.422 . . . . 0.0 110.476 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.68 -44.44 97.91 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.62 -14.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.6 0.238 . . . . 0.0 110.746 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.3 -34.73 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.46 -50.66 17.44 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.478 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.13 12.45 36.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.293 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.6 0.46 Allowed Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.347 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.19 -10.45 25.83 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.793 2.328 . . . . 0.0 111.951 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.51 -8.66 59.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.616 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.72 33.53 37.6 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.79 137.99 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.987 0.423 . . . . 0.0 110.473 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.71 130.08 34.94 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.233 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.56 138.35 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.1 t -123.04 133.19 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 109.937 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.0 127.26 42.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.693 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.85 153.28 25.64 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.67 6.88 30.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.629 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.96 130.49 5.95 Favored Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.93 -45.67 81.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.79 0.329 . . . . 0.0 110.44 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.15 -23.98 63.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.055 0.455 . . . . 0.0 110.513 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.5 t-20 -64.7 -36.53 84.59 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.551 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.93 -47.07 86.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.515 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.7 m-85 -63.8 -37.66 88.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.304 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.26 -42.61 98.92 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.137 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.86 -44.96 91.53 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.556 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.0 tp -58.91 -47.72 84.01 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.213 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -63.25 -22.47 66.89 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.072 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.95 -18.33 24.88 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.459 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.48 70.94 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.66 -17.87 63.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.358 . . . . 0.0 110.606 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.2 pt -128.24 137.45 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.222 0.534 . . . . 0.0 110.449 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.8 -27.95 62.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.991 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.57 155.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.617 0.573 . . . . 0.0 110.835 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.48 50.51 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.957 0.408 . . . . 0.0 110.035 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -85.95 103.0 14.26 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.083 0.468 . . . . 0.0 110.577 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.17 165.02 25.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.441 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.463 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.34 152.4 40.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.064 0.459 . . . . 0.0 110.606 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -65.99 -54.09 30.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.35 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 68.5 t -60.45 -48.94 86.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.405 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.16 -38.8 87.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.787 0.327 . . . . 0.0 110.587 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.15 -63.53 1.13 Allowed 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.425 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.437 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.0 m -58.77 -46.72 86.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.756 0.313 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.1 tt0 -50.04 -37.95 35.53 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.896 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.86 -65.76 0.55 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.1 t80 -40.48 -71.08 0.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.777 -0.249 . . . . 0.0 111.213 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.47 -40.06 93.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.005 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -59.45 -3.28 0.42 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 110.306 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 177' ' ' VAL . 61.1 mt-30 -124.37 141.81 38.54 Favored Pre-proline 0 CA--C 1.534 0.353 0 O-C-N 121.965 -0.459 . . . . 0.0 110.858 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.71 -14.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.823 2.349 . . . . 0.0 112.379 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.0 t -63.29 -42.96 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.445 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.89 80.62 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.72 -42.13 96.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.774 0.321 . . . . 0.0 110.318 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 60.1 m-20 -65.01 -35.23 80.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.932 0.396 . . . . 0.0 110.979 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.7 m-85 -156.8 143.72 18.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.75 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.11 99.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.135 0.493 . . . . 0.0 110.798 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.15 168.49 26.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.1 55.85 3.19 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.52 -116.68 0.01 OUTLIER Glycine 0 CA--C 1.538 1.498 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -50.14 135.63 37.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.367 2.045 . . . . 0.0 111.963 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 88.0 p -125.34 -108.05 0.32 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.597 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.48 165.38 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-O 118.739 -0.648 . . . . 0.0 109.966 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.54 155.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.625 1.203 . . . . 0.0 110.616 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.19 22.99 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.823 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.4 mp0 -71.93 -18.54 62.01 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.058 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.566 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.1 mt -60.98 -44.26 97.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.799 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.453 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.3 m-85 -113.79 7.88 17.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.716 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.78 -154.49 50.04 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.7 p -70.87 -25.4 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.0 110.536 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.92 -125.88 1.52 Allowed Glycine 0 CA--C 1.517 0.211 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -132.05 159.86 37.59 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.859 0.362 . . . . 0.0 110.372 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.66 -162.59 25.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.21 141.12 31.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.97 0.414 . . . . 0.0 110.611 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.27 111.73 3.95 Favored Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 85' ' ' ALA . 86.6 mt -120.55 160.3 23.46 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.93 149.28 24.9 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 120.83 0.348 . . . . 0.0 110.6 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.5 -48.59 65.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.763 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.49 -22.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -71.76 51.96 0.21 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.708 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -64.37 -46.2 84.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.11 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.48 -47.08 35.48 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.096 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.24 -43.79 98.03 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.459 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.426 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.57 -42.85 99.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.746 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.71 -37.55 73.71 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.694 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.32 -77.47 0.1 Allowed 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.985 HD21 HD11 ' A' ' 44' ' ' ILE . 86.9 mt -28.95 -45.24 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.984 0.421 . . . . 0.0 110.769 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.1 m-20 -63.69 -45.47 89.9 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.759 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.49 -43.74 98.33 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.947 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.23 92.61 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.149 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.15 -43.67 98.52 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.16 0.505 . . . . 0.0 110.112 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -61.98 -39.36 91.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.278 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.71 -42.67 97.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.895 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -57.14 -38.32 73.32 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.71 -38.76 77.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 110.447 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.01 -45.48 92.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.24 0.66 55.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.805 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.54 20.06 67.5 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 84.5 m -58.09 -46.13 86.01 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.58 -57.15 11.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.953 0.406 . . . . 0.0 110.451 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.23 -41.42 79.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.149 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.458 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.01 -41.53 98.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.801 0.334 . . . . 0.0 110.413 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.99 -49.67 77.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.713 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.03 -35.82 73.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.318 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.45 -50.84 33.99 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.536 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.0 m-85 -62.31 -45.76 91.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.534 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.47 155.44 36.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.99 98.19 9.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.417 . . . . 0.0 110.475 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -155.16 -165.74 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.495 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.45 109.67 14.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.74 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.3 m -63.75 -40.54 89.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.581 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.3 m-85 -57.03 -43.76 82.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.208 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.03 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.717 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.18 164.25 54.59 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.731 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.39 99.34 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 122.662 2.241 . . . . 0.0 112.335 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.45 -40.52 89.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.0 m-20 -139.14 142.77 38.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.398 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -109.87 127.25 66.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.899 0.38 . . . . 0.0 110.491 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.67 120.49 40.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.87 141.88 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-O 120.927 0.394 . . . . 0.0 110.376 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.66 102.36 1.58 Allowed Glycine 0 N--CA 1.463 0.483 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.9 m -125.13 119.83 29.68 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 122.693 -0.298 . . . . 0.0 111.118 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.4 t70 -112.41 94.77 28.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.01 134.91 61.96 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.459 2.106 . . . . 0.0 112.25 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.1 p -136.49 -19.02 1.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.731 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.7 m-85 -125.63 98.19 5.47 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.715 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.712 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -30.11 -61.21 0.25 Allowed Pre-proline 0 C--O 1.218 -0.585 0 CA-C-O 121.735 0.778 . . . . 0.0 111.064 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.712 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.4 Cg_endo -50.2 -40.21 51.7 Favored 'Trans proline' 0 C--N 1.293 -2.394 0 C-N-CA 122.4 2.067 . . . . 0.0 112.315 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.5 t80 -79.16 -43.29 24.26 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.017 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.671 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.0 mt-10 -146.29 -161.59 1.35 Allowed 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.225 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.2 t 158.13 -179.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.002 0.429 . . . . 0.0 110.25 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -133.12 141.04 47.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.4 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.28 137.44 32.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.605 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -65.24 -18.86 65.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.512 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.0 -5.11 53.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.441 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.35 -10.89 56.72 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.64 162.47 24.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.976 0.417 . . . . 0.0 110.391 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.07 137.68 52.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.943 0.402 . . . . 0.0 110.471 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.508 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.1 p -133.25 151.48 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.312 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.55 153.52 7.2 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.07 -41.38 92.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.42 . . . . 0.0 111.068 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.2 t0 -70.18 -32.5 70.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.227 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.508 HD12 ' C ' ' A' ' 30' ' ' VAL . 98.1 mt -67.26 -40.28 84.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.886 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 55.0 m-20 -61.02 -37.3 82.07 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.709 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.0 tp -65.83 -44.68 84.86 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.15 -46.5 85.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -54.3 -54.19 43.61 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.387 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.06 -38.15 62.23 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.953 0.406 . . . . 0.0 110.419 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.51 -42.46 74.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.608 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 50.7 m -54.28 -44.42 71.89 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.044 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.63 -48.04 78.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.018 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -59.35 -41.28 88.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.096 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.993 HD11 HD21 ' A' ' 213' ' ' LEU . 96.8 mt -76.28 -18.21 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.571 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.11 52.35 4.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 170.28 16.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.893 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.16 141.64 28.4 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.06 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -117.23 131.61 56.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.682 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.3 m -127.89 127.37 43.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.454 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -96.24 137.81 34.77 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.903 0.382 . . . . 0.0 110.399 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.56 129.52 64.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.403 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -67.65 139.97 56.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.78 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.487 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.65 135.52 0.13 Allowed Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.558 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.2 Cg_endo -68.62 144.19 59.42 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.592 2.195 . . . . 0.0 112.546 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.946 HD23 HD12 ' A' ' 58' ' ' LEU . 79.5 mt -40.75 -54.1 2.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.043 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -48.67 -26.18 2.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.142 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.15 -20.78 18.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.128 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.946 HD12 HD23 ' A' ' 55' ' ' LEU . 84.4 mt -64.72 -42.47 95.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.001 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.699 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.28 -57.31 26.58 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 123.744 0.652 . . . . 0.0 109.616 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.0 Cg_exo -54.65 -43.26 60.71 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.658 2.239 . . . . 0.0 111.19 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.3 m -58.27 -44.74 88.55 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.691 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.1 tp -58.87 -44.47 91.09 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.194 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.81 -41.06 96.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.492 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.08 11.31 1.51 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.85 12.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.917 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.33 -33.58 75.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.529 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 pt -124.29 154.43 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.316 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -91.75 -20.81 21.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.146 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.55 159.95 22.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.632 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 58' ' ' LEU . 96.3 mt -115.82 127.54 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.067 0.46 . . . . 0.0 110.518 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -129.03 107.2 9.42 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.28 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.597 ' OG ' HD21 ' A' ' 55' ' ' LEU . 46.9 t -162.17 -176.95 5.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.633 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.34 -15.94 61.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.345 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.606 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.4 tp -36.89 122.63 0.83 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.543 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -82.55 155.78 24.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.627 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.663 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.29 149.17 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.296 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 69.3 p -150.53 152.92 34.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.812 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.21 -47.84 54.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.967 0.413 . . . . 0.0 110.548 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.5 -39.83 70.97 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.776 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.606 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.5 mtt180 -68.41 -37.75 80.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.887 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.67 75.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.852 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.88 -27.58 66.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.129 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.11 -51.55 7.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.7 -167.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.36 147.04 29.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.085 0.469 . . . . 0.0 111.044 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 76' ' ' ILE . 72.3 m-85 -130.28 150.29 51.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.626 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.1 t -165.13 -150.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.431 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.3 m-20 42.55 19.94 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.915 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.93 121.09 0.11 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.38 0.425 . . . . 0.0 110.471 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -79.28 -71.84 0.42 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.782 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CG ' HG21 ' A' ' 166' ' ' VAL . 35.4 p90 -148.19 165.27 31.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.624 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.32 126.05 31.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.2 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.425 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -106.19 67.74 0.75 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.752 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.68 -105.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.481 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.47 167.3 29.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.634 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.23 146.59 22.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.142 0.496 . . . . 0.0 110.448 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.68 135.88 42.47 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.786 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.55 111.58 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.77 164.69 33.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.04 148.3 24.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.14 -27.88 48.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.251 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -59.29 -41.46 89.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.35 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -102.45 122.48 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.61 109.7 19.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.434 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.2 129.97 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.718 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.6 35.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.048 0.451 . . . . 0.0 110.507 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.9 Cg_endo -60.45 91.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.783 2.322 . . . . 0.0 111.9 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.1 m -169.57 141.97 2.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 123.584 0.553 . . . . 0.0 110.75 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.07 -33.42 60.93 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.215 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.19 -62.77 1.53 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.294 -178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.0 t -56.2 -21.91 25.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.138 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -76.12 -26.62 56.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.307 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -55.04 133.22 48.56 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.387 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.2 -16.25 29.64 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.34 151.18 23.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.421 . . . . 0.0 110.409 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.71 134.88 38.12 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.198 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.65 136.48 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.692 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.7 138.83 14.49 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.09 161.55 40.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 121.145 0.497 . . . . 0.0 110.313 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.42 118.07 30.57 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.563 179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.57 157.06 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.692 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.58 50.66 53.41 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.3 p -149.05 167.96 24.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.765 0.317 . . . . 0.0 110.831 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.5 p -71.5 -29.76 65.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.2 mt-30 -58.93 -55.13 39.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.42 -55.46 33.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.754 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.38 -51.26 70.24 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.77 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.598 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.5 t80 -62.06 -43.91 97.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.038 0.447 . . . . 0.0 110.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.36 97.92 Favored Glycine 0 CA--C 1.518 0.268 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.12 -14.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 110.809 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.35 2.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.598 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.31 -50.7 17.75 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.38 12.61 35.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.248 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.97 -55.46 0.47 Allowed Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.388 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.37 -9.98 24.94 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.78 2.32 . . . . 0.0 111.913 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -83.0 -8.74 59.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.23 33.35 36.05 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.7 137.81 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.009 0.433 . . . . 0.0 110.472 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -87.58 130.26 34.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.258 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.4 137.96 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.9 t -123.03 133.33 69.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.083 0.468 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -96.87 126.87 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.829 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -110.67 153.65 24.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.268 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.73 7.98 28.68 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.675 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.15 130.09 5.79 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.04 -45.91 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.741 0.305 . . . . 0.0 110.381 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.38 -23.51 62.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.495 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.66 -36.66 84.98 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.535 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.98 -47.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.13 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.63 -38.0 89.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.339 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -61.22 -42.58 98.86 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.182 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -64.06 -45.13 90.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.037 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.529 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.7 tp -58.47 -47.95 82.38 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.206 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.56 -22.86 67.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.005 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.9 -18.76 25.54 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.548 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.01 11.17 70.51 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.61 -18.12 63.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 110.593 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -128.46 137.57 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 110.444 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.64 -28.72 62.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.53 155.33 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.24 138.62 51.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.018 0.437 . . . . 0.0 109.96 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -86.48 102.98 14.58 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.214 0.531 . . . . 0.0 110.672 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.93 25.2 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.468 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.83 152.23 40.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.447 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 98.0 mt-10 -66.05 -53.97 31.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.268 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.402 HG21 ' CG ' ' A' ' 91' ' ' TYR . 70.4 t -60.08 -49.22 84.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.42 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.26 -38.96 85.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 120.882 0.372 . . . . 0.0 110.96 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.655 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.26 1.25 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.318 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.2 m -57.98 -46.39 85.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -45.61 -41.56 10.24 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.389 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.503 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.52 -62.06 0.47 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.721 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.655 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.3 t80 -40.69 -71.56 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.534 0.207 . . . . 0.0 111.136 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -62.16 -41.23 98.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 85.5 tttt -59.98 -2.17 0.38 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.53 0.681 . . . . 0.0 110.318 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' VAL . 52.5 mt-30 -126.45 141.93 41.49 Favored Pre-proline 0 CA--C 1.532 0.272 0 O-C-N 122.079 -0.388 . . . . 0.0 110.733 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -43.65 -14.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.842 2.361 . . . . 0.0 112.397 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 175' ' ' GLN . 87.6 t -62.94 -42.89 98.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.513 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.78 -33.17 84.33 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.38 -41.1 96.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.725 0.298 . . . . 0.0 110.436 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.92 -34.9 79.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.476 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -156.52 142.97 18.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.738 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.0 pttt -175.88 99.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.962 0.41 . . . . 0.0 110.796 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.5 m-85 -158.68 167.11 30.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.683 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.19 55.98 3.14 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.34 -116.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.91 134.98 36.06 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 111.949 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.2 p -124.32 -108.35 0.33 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.547 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -165.42 165.07 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.447 0 CA-C-O 119.16 -0.447 . . . . 0.0 110.156 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.8 tttt 154.13 155.24 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.283 0.989 . . . . 0.0 110.669 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.15 118.51 22.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.776 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.4 mp0 -71.17 -19.07 62.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.55 -31.81 73.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.546 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.458 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.9 mt -60.88 -44.33 97.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.764 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -114.16 8.44 16.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.819 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.44 -153.58 50.76 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.663 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.1 p -71.01 -25.65 26.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.875 0.369 . . . . 0.0 110.531 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.425 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.71 -125.97 1.53 Allowed Glycine 0 CA--C 1.519 0.287 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.5 p -132.16 160.42 36.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.851 0.358 . . . . 0.0 110.504 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.54 -162.04 24.02 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.68 139.83 33.8 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.959 0.409 . . . . 0.0 110.694 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.65 108.75 3.47 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.0 mt -117.72 159.41 23.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 0.0 110.253 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.82 149.19 25.02 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 120.886 0.374 . . . . 0.0 110.525 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.61 64.16 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.946 -0.302 . . . . 0.0 110.645 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -40.64 -22.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.031 0.443 . . . . 0.0 110.726 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.81 51.55 0.28 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.732 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -64.47 -46.03 84.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.171 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -74.28 -47.08 37.15 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.199 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.26 -43.65 98.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.474 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.45 -43.05 99.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.823 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.77 -37.51 73.8 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.26 -77.69 0.1 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.993 HD21 HD11 ' A' ' 44' ' ' ILE . 87.3 mt -28.54 -45.24 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.6 m-20 -63.43 -45.57 90.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.02 -43.84 98.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.94 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.26 92.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.077 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -61.11 -43.67 98.53 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.058 0.456 . . . . 0.0 110.015 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.34 92.07 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.058 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.522 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.67 -43.52 96.45 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.2 -38.65 71.27 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.73 -38.75 76.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.024 0.44 . . . . 0.0 110.367 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.56 91.88 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 20.6 p-10 -88.61 -0.02 56.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.716 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.78 20.86 68.8 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.5 m -58.05 -46.38 85.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 80.4 t80 -63.26 -57.62 9.84 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.443 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.05 -42.43 80.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.399 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.71 -48.66 80.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.71 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.34 -41.38 98.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.566 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.67 -50.04 75.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.735 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.63 -34.65 73.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.719 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -71.16 -51.77 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.706 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.432 ' OH ' ' OD2' ' A' ' 35' ' ' ASP . 39.4 m-85 -62.52 -44.94 95.14 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.67 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.459 ' O ' ' O ' ' A' ' 230' ' ' ALA . 84.0 m-85 -151.06 153.21 34.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.495 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 49.1 p-10 -98.34 93.6 6.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.987 0.422 . . . . 0.0 110.495 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -152.56 -165.64 2.26 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.511 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.447 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.36 108.8 13.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.711 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 239' ' ' TYR . 28.9 m -63.4 -40.59 89.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.416 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.433 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.2 m-85 -57.3 -43.49 83.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.278 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.16 94.31 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.683 0 CA-C-O 117.876 -1.513 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.73 164.37 56.03 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.704 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -60.78 143.75 99.44 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 122.692 2.261 . . . . 0.0 112.3 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.24 -40.0 89.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.549 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -140.1 145.54 37.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.42 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.28 130.04 66.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -105.93 117.88 35.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.448 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.9 mt -113.27 140.03 35.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.44 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.2 100.45 1.46 Allowed Glycine 0 N--CA 1.463 0.489 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.5 m -123.66 119.3 29.42 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 122.66 -0.318 . . . . 0.0 111.151 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 8.1 t70 -112.33 93.98 24.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.948 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.22 135.18 63.91 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.454 2.103 . . . . 0.0 112.16 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.7 p -137.22 -18.16 1.32 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.71 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.9 m-85 -124.84 97.59 5.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.711 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.716 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -30.48 -61.26 0.25 Allowed Pre-proline 0 C--O 1.218 -0.577 0 CA-C-O 121.729 0.776 . . . . 0.0 111.071 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.716 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.5 Cg_endo -49.86 -41.23 47.78 Favored 'Trans proline' 0 C--N 1.292 -2.435 0 C-N-CA 122.419 2.08 . . . . 0.0 112.357 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.2 t80 -78.31 -43.06 28.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.078 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.69 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.0 mt-10 -146.35 -161.5 1.33 Allowed 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.167 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.3 t 157.81 -179.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.03 0.443 . . . . 0.0 110.224 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.2 mttt -133.73 140.71 47.16 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.471 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -88.87 138.68 31.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.606 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -65.26 -19.15 65.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.501 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -79.81 -5.16 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.0 -10.45 57.02 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.59 158.91 27.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.991 0.424 . . . . 0.0 110.389 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.6 mt -114.21 135.38 54.11 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.536 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.508 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.1 p -131.62 150.61 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.267 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.99 152.99 7.03 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -60.23 -41.5 93.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.973 0.416 . . . . 0.0 110.851 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 -70.2 -32.75 70.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.354 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.508 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.9 mt -66.85 -40.13 85.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.892 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -61.03 -37.02 81.09 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.89 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.48 -44.66 82.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 110.177 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.8 -41.67 91.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.095 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -57.8 -53.43 58.33 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.596 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.97 -36.16 65.07 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.314 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.93 -43.18 72.17 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.777 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -55.04 -43.6 73.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.3 -48.02 77.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.019 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.49 -40.79 88.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.074 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 213' ' ' LEU . 96.5 mt -76.32 -18.69 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 61.46 51.75 4.01 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.123 0.487 . . . . 0.0 110.799 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.7 p -144.39 169.26 18.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.75 140.36 29.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.065 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -117.31 132.29 56.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.758 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.0 m -128.16 126.88 41.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.386 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.5 136.69 34.52 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.455 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -130.33 129.34 64.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.346 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.67 141.19 56.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.757 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.484 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 172.65 135.86 0.1 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.497 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.5 Cg_endo -68.56 144.19 59.75 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.644 2.23 . . . . 0.0 112.569 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.95 HD23 HD12 ' A' ' 58' ' ' LEU . 81.0 mt -41.17 -53.64 3.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.916 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.84 -26.11 2.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.41 19.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.143 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.95 HD12 HD23 ' A' ' 55' ' ' LEU . 84.4 mt -64.84 -42.5 94.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.963 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.705 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.42 -56.97 28.54 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.772 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.705 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.1 Cg_exo -55.18 -43.04 62.8 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 122.562 2.175 . . . . 0.0 111.137 177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -58.32 -44.42 88.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.764 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.7 tp -58.95 -44.48 91.45 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.65 -40.92 96.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 0.0 110.431 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.77 11.38 1.38 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.487 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.92 12.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.53 -33.81 76.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.4 pt -124.71 153.73 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.323 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.438 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -92.83 -20.46 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.196 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.29 158.38 24.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.674 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.566 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.41 127.99 73.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.081 0.467 . . . . 0.0 110.502 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.68 106.65 9.09 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.301 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.593 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.6 t -161.11 -177.97 6.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.621 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.33 -15.54 60.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.646 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.1 tp -37.13 123.09 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.921 0.391 . . . . 0.0 110.523 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.558 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -82.44 155.84 24.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.704 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.655 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.03 148.73 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.232 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.9 p -150.45 152.81 34.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.781 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.66 52.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.951 0.405 . . . . 0.0 110.567 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.37 -39.96 70.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.646 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.61 -37.57 79.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.89 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.33 -38.09 76.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.86 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.86 -27.69 66.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.02 -51.36 7.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.957 0.408 . . . . 0.0 110.69 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -139.12 -167.83 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.1 0.476 . . . . 0.0 110.457 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.64 147.06 29.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.044 0.449 . . . . 0.0 110.966 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.1 m-85 -130.05 150.21 51.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.2 t -165.08 -150.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.3 m-20 42.52 20.08 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.7 mttt -27.79 121.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.494 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 17.6 mt -79.84 -72.49 0.4 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -147.77 164.74 32.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.2 127.67 32.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.404 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -107.19 67.34 0.69 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.12 -106.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.545 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.7 p -159.47 167.65 28.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.632 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.574 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.58 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.147 0.499 . . . . 0.0 110.413 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.4 mt -101.03 135.96 41.64 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.786 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.87 111.03 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.72 164.41 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.956 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.64 148.69 24.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.6 -28.16 53.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.177 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.13 -41.43 88.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.266 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.31 122.25 43.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.985 0.422 . . . . 0.0 110.218 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.71 109.71 19.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.403 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.39 130.01 69.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.634 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.1 158.84 34.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.568 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.5 Cg_endo -60.06 90.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.819 2.346 . . . . 0.0 111.858 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -169.17 141.43 2.57 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.538 0.524 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.76 -33.14 59.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.31 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.15 -62.56 1.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.381 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.56 -21.8 29.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.062 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.1 -26.95 56.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.347 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.87 132.82 47.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.373 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.66 -15.93 33.7 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.72 151.25 23.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 0.0 110.45 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.06 135.35 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.998 0.427 . . . . 0.0 110.29 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.63 136.5 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.677 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 137.62 13.84 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.63 161.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.118 0.485 . . . . 0.0 110.31 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.2 tp -92.75 119.38 32.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.515 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.49 156.81 1.68 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.65 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.12 50.55 50.84 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.2 p -148.87 167.83 24.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.841 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 67.1 p -71.98 -28.68 63.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.458 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -59.7 -55.33 35.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.488 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.47 -55.11 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.55 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.55 -51.12 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.69 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.3 t80 -62.03 -43.9 97.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.091 0.472 . . . . 0.0 110.434 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.25 -44.38 97.77 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.03 -14.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.838 0.352 . . . . 0.0 110.795 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.54 -34.24 2.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.692 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.9 t60 -74.36 -51.07 16.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.959 0.409 . . . . 0.0 111.539 -178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -99.24 12.69 35.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.241 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.48 0.47 Allowed Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.341 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.23 -10.09 25.27 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.781 2.32 . . . . 0.0 111.945 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.99 -8.93 59.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.46 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.55 33.36 34.92 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.58 137.44 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.913 0.387 . . . . 0.0 110.547 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.28 130.28 34.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.269 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -126.59 138.32 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.37 133.33 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.043 0.449 . . . . 0.0 109.979 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.08 127.34 42.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.57 153.85 24.57 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.97 6.68 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.626 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.68 130.43 5.82 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -66.07 -45.92 79.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.747 0.308 . . . . 0.0 110.39 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.56 -24.27 63.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.516 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.464 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -36.69 85.04 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.456 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.71 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.067 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -64.3 -37.87 89.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.269 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.56 -42.29 96.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.122 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -65.77 -42.35 90.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.843 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.5 tp -59.23 -48.59 81.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.185 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.2 m -62.64 -22.39 66.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.002 0.43 . . . . 0.0 110.204 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.36 -17.9 26.47 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.562 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.58 11.56 74.34 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.6 -17.84 63.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.5 pt -127.41 136.65 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.029 0.442 . . . . 0.0 110.502 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.95 -28.84 62.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.201 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.458 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.13 155.12 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.792 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.22 138.27 51.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.954 0.407 . . . . 0.0 109.978 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -86.15 103.21 14.58 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.23 0.538 . . . . 0.0 110.599 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.13 164.67 25.78 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.465 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.66 152.76 40.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.54 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.24 -53.97 30.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.06 -49.02 85.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.365 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.81 84.22 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.769 0.319 . . . . 0.0 110.837 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.654 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.09 -63.78 1.1 Allowed 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 66.6 m -57.64 -46.13 84.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.334 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.7 tt0 -46.32 -42.31 14.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.338 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -111.1 -61.87 0.48 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.762 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.0 t80 -40.38 -71.19 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.584 0.23 . . . . 0.0 111.214 -178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.9 mt -62.28 -40.81 97.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 174' ' ' LYS . 86.8 tttt -59.86 -2.57 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.579 0.704 . . . . 0.0 110.494 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 177' ' ' VAL . 58.1 mt-30 -126.5 141.78 41.09 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.832 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -43.43 -14.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.861 2.374 . . . . 0.0 112.328 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 175' ' ' GLN . 90.0 t -62.87 -43.03 98.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.589 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.86 -33.44 85.38 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.29 -41.38 96.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.731 0.301 . . . . 0.0 110.414 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -65.79 -34.95 79.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.503 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.8 m-85 -156.64 143.25 18.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.737 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.1 pttt -176.16 99.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.003 0.43 . . . . 0.0 110.746 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.5 167.01 30.78 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.63 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.23 55.39 3.09 Favored Glycine 0 C--O 1.225 -0.413 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.548 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.11 -116.83 0.01 OUTLIER Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -50.05 134.65 36.57 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.46 2.107 . . . . 0.0 111.893 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.3 p -124.03 -108.63 0.33 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.542 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.43 165.01 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.211 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.637 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.4 tttt 154.61 155.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 124.178 0.924 . . . . 0.0 110.665 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -81.27 118.92 23.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.3 -19.1 62.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.45 -31.41 72.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.494 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -60.89 -44.4 97.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.736 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.29 8.61 16.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.722 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.22 -153.81 49.97 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 76' ' ' ILE . 12.8 p -70.65 -25.72 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.878 0.37 . . . . 0.0 110.559 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.404 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.99 -126.59 1.62 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.6 p -132.21 160.24 36.7 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.26 -162.93 25.27 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.506 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.06 140.22 32.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.981 0.419 . . . . 0.0 110.591 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.72 108.8 3.48 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.3 mt -118.22 159.72 22.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.944 0.402 . . . . 0.0 110.149 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.73 148.79 25.28 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.556 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.93 -48.38 64.26 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.619 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -40.57 -22.51 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.0 110.739 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.77 51.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.748 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -64.32 -46.62 82.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.23 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.16 -47.09 38.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 44' ' ' ILE . 63.6 tp -62.05 -43.52 98.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.45 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.53 -43.13 99.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.799 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.56 -37.65 73.47 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.696 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.29 -77.28 0.11 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -28.72 -45.02 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.846 0.355 . . . . 0.0 110.518 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 212' ' ' ALA . 87.9 m-20 -63.66 -45.81 88.45 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.664 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.02 -44.11 97.9 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.33 92.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.148 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -60.95 -43.81 98.16 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.151 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.15 91.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.087 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -64.05 -43.59 95.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.859 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.24 -38.52 71.19 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -38.98 77.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.27 -45.55 90.92 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.599 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.1 p-10 -88.73 -0.71 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.801 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 67.21 20.44 71.19 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.5 -46.22 87.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.494 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 71.0 t80 -62.35 -56.2 20.65 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.244 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -57.48 -40.26 78.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.059 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.32 -47.92 83.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.491 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.08 -40.77 96.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -61.11 -49.14 78.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.562 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.01 -35.74 73.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.503 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.49 -51.39 36.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.584 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 8.8 m-85 -62.01 -46.3 89.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.5 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.52 154.92 33.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.49 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.9 p-10 -98.31 96.89 8.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.964 0.411 . . . . 0.0 110.45 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -152.63 -164.67 2.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.555 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.8 t0 -121.96 108.92 13.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.734 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.5 m -63.45 -40.54 89.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.435 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.418 ' N ' HG23 ' A' ' 238' ' ' VAL . 91.3 m-85 -58.82 -42.38 89.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.288 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -62.96 -37.93 95.76 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.712 0 CA-C-O 117.905 -1.497 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.85 164.26 57.51 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.642 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.08 143.82 99.13 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.625 2.217 . . . . 0.0 112.309 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.09 -40.6 90.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.578 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.21 143.7 38.17 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.447 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.2 mt -110.33 129.03 66.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.854 0.359 . . . . 0.0 110.466 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.57 117.56 34.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.372 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.0 mt -114.56 141.78 29.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.973 0.416 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.67 106.74 2.12 Favored Glycine 0 N--CA 1.463 0.5 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.8 m -128.94 120.06 25.44 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.634 -0.333 . . . . 0.0 111.107 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 26.9 t0 -112.41 94.67 28.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.079 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.18 134.74 61.89 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.463 2.109 . . . . 0.0 112.205 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.1 p -136.77 -18.54 1.39 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.73 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.9 m-85 -124.66 98.06 5.56 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.817 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -30.47 -61.21 0.25 Allowed Pre-proline 0 C--O 1.218 -0.596 0 CA-C-O 121.633 0.73 . . . . 0.0 110.991 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.715 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.3 Cg_endo -49.92 -41.48 47.58 Favored 'Trans proline' 0 C--N 1.294 -2.334 0 C-N-CA 122.364 2.042 . . . . 0.0 112.328 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.3 t80 -77.99 -42.7 31.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.972 0.415 . . . . 0.0 111.011 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.704 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.2 mt-10 -146.77 -160.97 1.23 Allowed 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.131 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.3 t 157.64 -178.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.085 0.469 . . . . 0.0 110.172 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.544 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.76 140.32 45.82 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.439 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.1 t-20 -90.46 141.93 28.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.49 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.471 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.2 p -66.14 -19.02 65.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.585 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.11 -6.16 53.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.478 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.85 -9.2 58.26 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.49 162.34 25.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 110.44 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.9 mt -117.01 136.09 53.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.922 0.392 . . . . 0.0 110.544 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.505 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.0 p -132.34 151.03 34.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.343 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.49 153.47 7.18 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -60.47 -41.2 93.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.974 0.416 . . . . 0.0 110.838 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.0 t0 -70.23 -32.8 70.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.279 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.505 HD12 ' C ' ' A' ' 30' ' ' VAL . 98.1 mt -66.85 -39.98 84.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.793 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.0 -37.01 81.02 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.787 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.91 -44.84 84.02 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.33 -45.53 87.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.02 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -54.61 -54.36 42.55 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.51 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -53.9 -37.53 63.87 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.475 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.31 -43.11 74.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.588 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 52.0 m -54.25 -44.0 71.4 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.035 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.0 tttm -64.01 -47.93 78.34 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.006 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.55 -41.49 90.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.979 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.11 -18.17 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.569 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.24 52.33 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.636 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -145.68 170.23 16.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.19 141.74 28.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.101 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.57 132.19 56.56 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.8 m -127.78 126.6 42.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.389 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.93 136.69 34.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.465 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.31 129.18 64.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.373 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -67.93 139.66 56.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.779 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.4 p30 175.52 135.7 0.18 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.52 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.1 Cg_endo -68.65 143.71 57.51 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.644 2.229 . . . . 0.0 112.461 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.893 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -40.62 -54.78 2.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.032 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.43 1.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.225 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.89 -20.97 18.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.893 HD12 HD23 ' A' ' 55' ' ' LEU . 54.6 mt -63.92 -42.48 97.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.791 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.706 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.88 -57.1 26.22 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.711 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -54.93 -42.94 64.2 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.615 2.21 . . . . 0.0 111.214 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.52 -44.88 89.7 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.749 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.75 -44.48 90.58 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.75 -41.02 96.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.979 0.419 . . . . 0.0 110.484 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.06 11.19 1.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.97 12.32 0.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.922 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.77 -33.83 76.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.523 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.06 154.56 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.261 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -91.85 -20.79 21.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.175 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.02 160.53 21.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.637 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 58' ' ' LEU . 96.1 mt -116.1 127.76 73.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.052 0.453 . . . . 0.0 110.461 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.2 ttp -129.12 107.42 9.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.334 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.501 ' OG ' HD21 ' A' ' 55' ' ' LEU . 38.3 t -162.72 -176.91 5.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -63.89 -16.22 60.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.369 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.639 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.4 tp -36.99 122.75 0.84 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.491 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -82.94 155.88 23.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.712 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.659 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.5 pt -105.36 149.46 8.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.347 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 74.7 p -150.49 152.76 34.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.775 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.02 -47.66 53.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.976 0.417 . . . . 0.0 110.589 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.26 -39.93 70.37 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.807 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.639 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.6 -37.7 80.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.09 -38.1 75.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.81 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.75 -27.65 66.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.078 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.08 -51.1 7.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.039 0.447 . . . . 0.0 110.73 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.15 -167.57 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.135 0.493 . . . . 0.0 110.498 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.93 147.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.116 0.484 . . . . 0.0 110.952 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HG22 ' A' ' 76' ' ' ILE . 74.3 m-85 -130.35 150.49 51.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.649 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -165.28 -150.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.455 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.2 m-20 42.51 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.04 120.99 0.11 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.459 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.499 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.3 mt -79.95 -72.51 0.4 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.932 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -147.81 165.11 31.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.641 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.05 127.56 32.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.387 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.19 66.99 0.68 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.591 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -85.27 -106.06 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.0 p -159.23 167.44 29.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.616 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.586 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.85 146.79 23.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 0.0 110.415 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.47 135.84 42.3 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.773 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.83 110.98 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.75 164.44 33.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.001 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.59 148.43 24.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.06 -28.24 50.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.248 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.09 -41.35 87.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.252 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.6 t -102.38 122.28 43.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.262 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.01 109.52 19.89 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.067 0.46 . . . . 0.0 110.456 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.05 129.76 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.705 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.468 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.37 159.0 33.74 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.554 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.6 Cg_endo -60.3 90.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 122.74 2.293 . . . . 0.0 111.884 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.3 m -169.05 141.29 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.543 0.527 . . . . 0.0 110.73 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.83 -33.52 62.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.246 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.493 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.15 -62.57 1.66 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.279 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -56.02 -22.0 24.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.12 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.0 mt -76.46 -26.19 55.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.317 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.83 133.2 47.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.422 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.77 -15.67 30.27 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.14 150.85 24.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.97 0.414 . . . . 0.0 110.429 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.55 134.82 37.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 110.259 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.58 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.663 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.76 137.44 13.78 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -130.47 161.49 40.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.127 0.489 . . . . 0.0 110.352 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.4 tp -92.51 119.3 31.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.528 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -52.13 156.7 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.717 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.54 53.51 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -148.41 167.3 25.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.718 0.294 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 74.8 p -70.59 -31.27 68.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.468 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -58.22 -54.97 40.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.431 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -56.27 -55.74 29.57 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.726 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.74 -51.24 70.21 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.818 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.4 t80 -62.02 -44.09 97.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.071 0.462 . . . . 0.0 110.482 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.78 -44.24 98.15 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.843 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.35 -34.38 2.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.09 -50.98 17.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.025 0.44 . . . . 0.0 111.578 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -99.23 12.74 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.306 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.768 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.93 -55.37 0.47 Allowed Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.432 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.25 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.747 2.298 . . . . 0.0 111.951 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -8.85 59.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.484 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.28 33.39 35.79 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.48 137.52 41.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.969 0.414 . . . . 0.0 110.49 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.42 130.48 34.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.343 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.22 138.57 54.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.45 133.61 68.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.042 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 126.77 42.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.768 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -110.14 153.9 24.08 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.286 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -107.22 6.68 28.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.706 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.13 130.2 5.83 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.97 -45.9 80.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.399 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.2 -23.78 63.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.4 t-20 -64.64 -36.72 85.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.9 -46.88 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.149 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.5 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.51 -37.55 87.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.67 -41.85 95.9 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.078 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -66.0 -42.29 89.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.572 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.7 tp -59.21 -48.53 81.25 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.134 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.0 m -62.5 -22.33 66.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 0.0 110.198 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.57 -17.77 26.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.603 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.34 11.87 74.4 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.86 -18.22 63.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.612 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.572 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.5 pt -126.71 135.98 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.479 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.32 -29.34 63.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.269 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.17 155.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.801 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.95 138.85 52.22 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.97 0.415 . . . . 0.0 109.924 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -86.75 102.71 14.5 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.216 0.531 . . . . 0.0 110.783 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 96' ' ' ARG . 51.0 tt0 -131.94 164.58 25.82 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.386 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.471 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -73.55 153.27 40.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.526 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.8 mt-10 -66.67 -54.25 25.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.237 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 68.6 t -59.97 -49.08 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.401 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.84 84.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.941 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.72 1.12 Allowed 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.455 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.444 ' OG ' HD12 ' A' ' 173' ' ' LEU . 67.0 m -57.82 -46.37 84.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.32 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.6 tt0 -46.1 -41.87 12.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.411 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.484 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.25 -62.11 0.48 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.707 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.659 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.2 t80 -40.3 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.786 -0.244 . . . . 0.0 111.184 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -62.14 -40.71 96.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.042 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.55 -2.26 0.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.422 0.629 . . . . 0.0 110.394 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 177' ' ' VAL . 53.5 mt-30 -126.21 141.6 40.24 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.799 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.39 -14.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.792 2.328 . . . . 0.0 112.335 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 175' ' ' GLN . 91.0 t -63.04 -43.04 98.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.612 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.88 -33.46 85.49 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.06 -41.37 96.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.3 . . . . 0.0 110.444 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -65.74 -34.81 79.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.465 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -156.92 143.53 18.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.734 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.19 99.38 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.982 0.42 . . . . 0.0 110.775 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.4 m-85 -158.9 167.01 30.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.632 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.9 55.96 3.02 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.17 -116.92 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 134.76 35.25 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.502 2.135 . . . . 0.0 111.938 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.516 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.2 p -124.23 -108.5 0.33 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.647 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.24 164.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.213 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.647 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.5 tttt 154.68 155.11 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 124.041 0.838 . . . . 0.0 110.706 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -81.04 118.5 22.55 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.777 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -70.5 -18.81 62.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.06 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.51 -31.61 72.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.46 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.4 mt -60.93 -44.4 97.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.702 -178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -114.07 8.33 16.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.788 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.66 -153.52 50.42 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.659 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.5 p -70.8 -25.76 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.554 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 160.77 -126.98 1.68 Allowed Glycine 0 CA--C 1.519 0.297 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 20.8 p -132.21 160.37 36.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 110.418 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.98 -161.65 23.73 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.505 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.94 140.06 33.66 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.925 0.393 . . . . 0.0 110.611 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.73 108.71 3.48 Favored Glycine 0 C--N 1.33 0.229 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -117.45 159.36 22.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 110.251 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.31 148.84 25.43 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.55 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.86 -48.46 64.0 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.69 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -40.85 -22.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.113 0.482 . . . . 0.0 110.779 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.517 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -72.9 51.51 0.29 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.895 0.379 . . . . 0.0 110.794 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -64.46 -46.3 83.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.06 -47.22 38.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.026 0.441 . . . . 0.0 111.228 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 tp -62.14 -43.46 98.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.464 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.7 -43.02 99.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.825 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.71 -37.44 73.52 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.48 -77.47 0.11 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.979 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -28.52 -45.1 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.0 110.505 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.3 m-20 -63.5 -45.92 88.47 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.583 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.83 -43.94 97.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.929 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.1 91.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.083 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.06 -39.28 91.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.051 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.73 -43.69 95.77 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.503 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.26 -38.48 71.22 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.57 -39.04 77.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.987 0.423 . . . . 0.0 110.271 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.28 -45.39 91.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.649 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.3 p-10 -89.02 -0.5 57.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.87 20.75 70.81 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.6 m -58.48 -46.27 87.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.499 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 73.2 t80 -62.3 -56.46 18.22 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.262 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.08 -40.42 76.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.176 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.53 -47.89 83.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.485 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.11 -40.96 97.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.55 -49.44 77.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.501 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.93 -35.74 73.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.58 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -69.63 -51.45 34.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.97 -45.97 91.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 71.6 m-85 -155.05 154.76 32.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.522 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.2 p-10 -97.99 96.0 7.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.439 . . . . 0.0 110.526 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.0 -164.7 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.545 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.14 108.98 13.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.4 m -63.54 -40.64 89.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.358 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.428 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.4 m-85 -58.53 -42.6 88.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.293 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.39 -37.67 95.19 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.689 0 CA-C-O 117.848 -1.529 . . . . 0.0 111.021 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 164.13 63.33 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.643 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -61.05 143.6 99.19 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 C-N-CA 122.591 2.194 . . . . 0.0 112.313 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.43 -41.13 89.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.562 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -137.93 139.44 39.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.417 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.82 121.36 61.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.917 0.389 . . . . 0.0 110.675 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.93 118.82 32.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.178 0.513 . . . . 0.0 110.154 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.2 mt -112.56 138.69 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.492 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.96 105.75 2.15 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.2 m -129.04 120.61 26.28 Favored 'General case' 0 CA--C 1.519 -0.217 0 O-C-N 122.69 -0.3 . . . . 0.0 111.018 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 20.6 t70 -114.42 92.9 29.77 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.12 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.19 134.58 61.12 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.502 2.135 . . . . 0.0 112.07 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 p -141.84 -20.31 0.73 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.775 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.5 m-85 -123.54 99.09 6.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.614 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.12 -61.46 0.22 Allowed Pre-proline 0 C--O 1.218 -0.575 0 CA-C-O 121.433 0.635 . . . . 0.0 111.015 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.729 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.5 Cg_endo -49.35 -40.63 43.91 Favored 'Trans proline' 0 C--N 1.294 -2.306 0 C-N-CA 122.272 1.981 . . . . 0.0 112.284 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -78.21 -42.75 30.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.036 0.446 . . . . 0.0 110.942 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.9 mt-10 -149.73 -153.9 0.52 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.912 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.86 177.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.023 0.439 . . . . 0.0 110.389 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.42 144.71 46.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.452 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -95.9 134.37 38.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.637 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.76 -19.0 65.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.518 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.11 -6.17 53.86 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.448 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.41 -7.9 56.54 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.874 -0.891 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.65 159.14 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 110.442 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.5 mt -112.57 131.18 55.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.999 0.428 . . . . 0.0 110.449 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.685 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.95 151.32 32.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.401 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.02 151.27 6.52 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -58.55 -42.03 86.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.855 0.36 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.469 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.9 t0 -69.7 -28.55 65.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.157 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -68.01 -40.86 83.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.873 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -60.91 -37.26 81.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.829 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.88 -45.08 87.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.12 -48.54 78.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.982 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -53.0 -54.66 31.94 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.329 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.33 -39.88 61.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.864 0.364 . . . . 0.0 110.298 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.6 mt -68.67 -41.94 78.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.072 0.463 . . . . 0.0 110.647 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.1 m -53.44 -45.19 69.38 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.084 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.09 -46.84 82.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.042 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -60.01 -42.28 93.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.16 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.888 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.32 -17.23 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.72 53.21 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.489 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.26 171.56 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.11 142.61 27.5 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.018 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.45 131.15 56.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.741 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.24 126.94 43.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.411 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -93.73 134.66 35.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.572 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.06 127.81 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.11 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.262 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.63 137.8 57.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.776 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 176.05 131.53 0.17 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.555 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.7 Cg_endo -68.01 144.74 65.15 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.729 2.286 . . . . 0.0 112.435 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.883 HD23 HD12 ' A' ' 58' ' ' LEU . 82.4 mt -40.33 -55.55 2.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.22 -26.42 1.94 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.04 -20.94 18.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.249 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.883 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -63.8 -42.42 97.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.596 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.721 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.2 -56.99 25.98 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.806 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.48 -42.41 68.26 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.59 2.193 . . . . 0.0 111.179 177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m -58.7 -44.89 90.45 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.931 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 203' ' ' ARG . 61.7 tp -59.05 -44.06 91.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.35 -40.72 96.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.956 0.408 . . . . 0.0 110.452 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 10.04 2.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.514 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.19 12.08 1.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.463 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -35.5 80.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.481 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.6 pt -122.34 152.89 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.264 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.2 -22.18 19.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.343 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.61 155.99 27.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.0 129.28 71.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 110.406 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.469 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.8 ttp -131.34 106.52 8.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.395 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.706 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -158.95 178.43 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.636 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -65.4 -15.35 62.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.402 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 43.9 tp -34.82 124.65 0.55 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.606 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.01 153.86 25.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.645 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.637 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.8 pt -104.84 148.86 8.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.297 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.7 p -149.36 152.13 35.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.854 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.85 -47.28 51.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.507 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.32 -39.83 70.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.735 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.94 -37.91 79.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.84 -38.95 76.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.816 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.89 -27.42 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.096 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.42 -50.84 7.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.048 0.451 . . . . 0.0 110.655 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -139.18 -168.36 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-O 121.131 0.491 . . . . 0.0 110.456 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.43 147.66 30.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.094 0.473 . . . . 0.0 111.007 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.3 m-85 -129.88 149.9 51.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.563 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.7 t -163.09 -153.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.592 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 92.8 m-20 41.34 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.945 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.62 121.54 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.346 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.429 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.9 mt -75.09 -68.7 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 -178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.34 167.49 26.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.76 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.5 123.55 29.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.218 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.55 68.32 0.86 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.806 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.47 -104.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.473 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.5 p -159.35 165.7 32.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.741 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.34 146.35 22.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.119 0.485 . . . . 0.0 110.443 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.9 mt -101.08 136.12 41.44 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.988 0.423 . . . . 0.0 110.81 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.8 110.41 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.2 164.92 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.965 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.71 148.48 23.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.988 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.6 -27.66 40.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.226 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.29 -41.83 89.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.316 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.5 122.14 43.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.94 109.35 19.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.424 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.9 129.65 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.772 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.473 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.25 159.0 33.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 0.0 110.523 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.46 89.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.685 2.256 . . . . 0.0 111.904 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.6 m -169.08 140.31 2.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.776 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.31 -32.38 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.182 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.0 tp10 -57.34 -62.92 1.43 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -55.39 -22.41 19.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.015 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.62 -25.8 54.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.67 132.67 46.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.95 -16.13 28.93 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.03 151.1 23.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -95.84 135.37 37.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.35 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.74 136.5 60.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.648 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 137.79 13.94 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 56.0 t -130.51 161.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 121.089 0.471 . . . . 0.0 110.336 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.1 tp -92.37 118.16 30.64 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.535 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.03 157.75 1.23 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.581 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.67 50.98 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.2 p -149.68 168.89 22.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 110.884 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.5 p -73.53 -27.25 61.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -60.45 -55.45 33.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.48 -55.1 37.95 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.583 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.5 m -60.05 -50.98 71.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.705 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.8 t80 -62.08 -43.91 97.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.064 0.459 . . . . 0.0 110.497 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.04 -44.46 97.75 Favored Glycine 0 CA--C 1.52 0.355 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.41 -14.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 110.784 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.23 -34.36 2.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.718 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.55 -50.54 17.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.035 0.445 . . . . 0.0 111.571 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.18 12.48 36.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.239 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.77 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.79 -55.51 0.47 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.332 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.33 25.66 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.795 2.33 . . . . 0.0 111.952 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -82.76 -9.0 59.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.491 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.32 37.65 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.25 137.92 39.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.598 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.51 129.87 34.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.333 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.0 pt -126.67 138.29 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.923 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.25 133.21 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 109.946 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.46 127.63 43.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.854 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -110.7 153.89 24.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -106.91 7.13 29.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.708 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.72 130.73 6.06 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.405 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.95 -45.92 80.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.768 0.318 . . . . 0.0 110.474 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.8 -23.25 62.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.7 -36.84 85.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.543 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.97 -46.79 87.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.138 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.507 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.7 m-85 -64.45 -37.65 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.348 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.86 -42.16 97.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.023 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.99 -43.38 92.78 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.96 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.578 ' HB2' HD11 ' A' ' 158' ' ' ILE . 40.8 tp -58.98 -48.15 82.6 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.096 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.79 -22.32 66.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.955 0.407 . . . . 0.0 110.164 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.78 -18.21 25.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.07 11.92 72.04 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.17 -18.24 63.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.939 0.4 . . . . 0.0 110.602 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.578 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.9 pt -127.02 135.92 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -72.54 -28.11 62.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.43 155.71 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.856 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.49 50.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 109.947 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.94 103.14 14.38 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.264 0.555 . . . . 0.0 110.882 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.65 165.14 25.15 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.382 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.475 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -72.79 153.05 41.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 110.634 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.4 -54.64 22.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.39 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.27 -48.92 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.618 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.08 89.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.862 0.363 . . . . 0.0 110.83 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.47 -63.27 1.18 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.619 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.445 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.1 m -59.28 -47.75 84.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.916 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.98 -37.44 20.2 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.195 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.08 -66.36 0.55 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.1 t80 -40.27 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.663 0.268 . . . . 0.0 111.194 -178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.35 -40.13 93.13 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.78 -2.84 0.42 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.443 0.64 . . . . 0.0 110.475 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.4 mt-30 -123.37 148.79 56.29 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.828 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.66 -19.97 3.95 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.892 2.395 . . . . 0.0 112.148 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.14 -42.55 93.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.57 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.99 -33.21 84.86 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -60.72 -41.26 94.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.695 0.283 . . . . 0.0 110.399 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.59 -33.93 77.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.327 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.35 142.66 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.732 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.19 99.68 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.006 0.432 . . . . 0.0 110.754 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.17 166.76 30.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.713 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.87 56.54 2.72 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.566 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.44 -118.27 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.004 -0.838 . . . . 0.0 111.004 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.41 135.68 32.48 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.511 2.14 . . . . 0.0 111.918 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 94.7 p -125.41 -107.79 0.32 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.591 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -166.14 165.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.334 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.671 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 156.78 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 123.983 0.802 . . . . 0.0 110.665 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.84 117.24 22.58 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.5 mp0 -71.13 -18.89 62.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.85 -32.59 74.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.568 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -60.96 -44.54 97.17 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.71 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.4 m-85 -114.03 9.63 17.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.769 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.0 -154.76 52.38 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.39 -25.1 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.527 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.22 -124.32 1.32 Allowed Glycine 0 CA--C 1.518 0.278 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.8 p -129.32 156.19 44.41 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.707 0.289 . . . . 0.0 110.33 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.6 -169.61 30.42 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.1 137.44 33.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.936 0.398 . . . . 0.0 110.576 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.46 108.2 3.27 Favored Glycine 0 C--N 1.33 0.209 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.1 mt -123.52 159.39 29.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.955 0.407 . . . . 0.0 110.206 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.66 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.84 149.64 24.69 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.818 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.89 -48.2 64.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.529 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.3 tp10 -38.23 -25.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.92 0.39 . . . . 0.0 110.744 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.56 52.26 0.2 Allowed 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.677 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -64.56 -45.15 88.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.8 -47.3 31.46 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.4 tp -62.26 -43.94 97.67 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.454 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.24 -42.92 99.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.724 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.06 -36.23 70.28 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.698 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.45 -77.51 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 44' ' ' ILE . 97.0 mt -28.46 -46.3 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.801 0.334 . . . . 0.0 110.356 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.33 -44.96 89.91 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.636 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.96 -43.66 98.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.962 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.21 93.79 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.08 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -61.37 -43.57 98.64 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.031 0.443 . . . . 0.0 109.98 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.28 92.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.076 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.63 -42.74 98.13 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.53 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -58.31 -38.42 77.05 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -68.86 -39.99 79.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.983 0.42 . . . . 0.0 110.188 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -45.86 93.03 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.43 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.53 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.1 p30 -86.68 1.33 52.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.489 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.42 19.71 60.27 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 69.7 m -58.35 -45.63 87.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.429 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.2 t80 -63.62 -58.01 8.3 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.438 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.44 78.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.349 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.6 -48.53 80.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.565 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.07 -41.49 98.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.327 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.19 74.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.565 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.73 -35.16 72.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.572 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.18 -50.97 27.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.481 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.09 -45.5 93.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.536 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.2 m-85 -153.27 155.16 36.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.414 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.7 p-10 -97.26 94.86 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.997 0.427 . . . . 0.0 110.504 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -152.71 -166.43 2.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.553 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.86 110.37 15.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.799 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.1 m -63.55 -40.64 89.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.426 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.43 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.9 m-85 -56.62 -43.83 80.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.269 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.31 -37.46 94.89 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.414 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.642 0 CA-C-O 117.895 -1.503 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.88 164.27 61.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.718 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.83 143.66 99.41 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.719 2.279 . . . . 0.0 112.321 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.33 -41.02 90.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.622 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.42 139.69 39.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.389 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.56 121.43 61.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -94.07 118.51 31.63 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.067 0.46 . . . . 0.0 110.193 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.2 138.62 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.362 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.88 105.47 2.12 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -128.77 120.37 26.26 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 122.676 -0.308 . . . . 0.0 110.909 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.7 t70 -114.13 92.41 26.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.154 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.91 134.45 59.43 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.454 2.103 . . . . 0.0 112.187 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 p -141.79 -20.24 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.764 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.6 m-85 -123.42 99.04 6.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.464 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.09 -61.32 0.22 Allowed Pre-proline 0 C--O 1.218 -0.585 0 CA-C-O 121.737 0.779 . . . . 0.0 111.09 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.72 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.29 -40.85 43.43 Favored 'Trans proline' 0 C--N 1.29 -2.53 0 C-N-CA 122.567 2.178 . . . . 0.0 112.214 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.9 t80 -78.44 -42.72 29.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.875 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -149.78 -154.13 0.53 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.019 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 162.07 177.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.066 0.46 . . . . 0.0 110.294 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.45 144.45 46.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.448 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -95.37 134.26 38.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.587 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.73 -18.81 65.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.569 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.47 -6.53 55.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.421 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.06 -8.47 55.74 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.04 158.86 26.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.986 0.422 . . . . 0.0 110.434 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -112.46 131.31 55.63 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.936 0.398 . . . . 0.0 110.426 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.697 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.21 151.59 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.333 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.414 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.11 151.41 6.6 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -58.74 -42.14 88.13 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 122.515 -0.403 . . . . 0.0 110.979 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.5 t0 -69.24 -28.4 66.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.229 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.697 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.1 mt -68.25 -40.06 82.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.929 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -60.98 -37.64 83.17 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.959 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.71 -45.25 87.37 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.001 0.429 . . . . 0.0 110.028 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.1 -48.51 78.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.872 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -52.85 -54.81 29.11 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.353 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -51.96 -39.99 60.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.04 0.447 . . . . 0.0 110.41 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.82 -41.77 78.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.752 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.3 m -53.74 -45.08 70.41 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.063 -179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.13 -47.03 81.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.2 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.6 -42.38 92.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.89 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.37 -17.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.71 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.62 53.02 4.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.622 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -147.03 171.2 15.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.92 142.51 27.59 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.041 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.5 m -117.35 131.22 56.83 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.644 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -127.25 126.91 43.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.39 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.4 134.73 35.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.492 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.4 t -129.08 127.53 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.273 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.55 137.87 57.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.74 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.3 p30 175.93 131.76 0.16 Allowed Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.593 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 57' ' ' ALA . 44.2 Cg_endo -68.26 145.12 65.04 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.743 2.295 . . . . 0.0 112.382 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.885 HD23 HD12 ' A' ' 58' ' ' LEU . 81.7 mt -40.44 -55.58 2.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 0.0 111.074 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -48.27 -26.43 1.98 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.137 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.02 -21.0 18.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.183 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.885 HD12 HD23 ' A' ' 55' ' ' LEU . 59.3 mt -63.98 -42.42 97.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.619 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -57.47 23.48 Favored Pre-proline 0 C--N 1.321 -0.637 0 O-C-N 123.952 0.783 . . . . 0.0 109.555 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 43.4 Cg_exo -55.01 -42.39 69.62 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.628 2.219 . . . . 0.0 111.36 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.4 m -58.69 -44.82 90.38 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.959 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.651 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.4 tp -59.05 -44.02 91.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.255 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.55 -40.49 95.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.437 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 10.06 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.567 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.29 12.07 1.29 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.479 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.66 -35.39 80.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.489 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.7 pt -122.39 153.0 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.046 0.451 . . . . 0.0 110.231 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.32 -22.16 19.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.143 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.53 155.82 27.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.656 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.11 129.03 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.194 0.521 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.15 106.67 8.5 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.329 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.707 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.8 t -159.11 178.67 9.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.616 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.43 -15.28 62.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.632 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -34.95 124.48 0.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.62 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.548 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.2 p -81.91 153.97 26.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.618 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.634 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.6 pt -104.74 148.66 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.214 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.2 152.15 35.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.758 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.73 -47.43 50.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.027 0.441 . . . . 0.0 110.486 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.31 -39.85 70.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.786 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.632 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -69.1 -37.71 78.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.824 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.83 -38.87 76.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.965 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.76 66.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.199 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.2 -50.9 7.97 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.716 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.07 -168.31 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 CA-C-O 121.102 0.477 . . . . 0.0 110.481 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.3 147.73 29.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.549 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.0 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.568 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.18 -153.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.503 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.511 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.9 m-20 41.23 20.32 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.027 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.4 mttt -30.58 121.64 0.2 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.468 0.48 . . . . 0.0 110.419 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.425 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 60.2 mt -75.37 -68.81 0.52 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.808 -178.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.9 p90 -150.47 167.6 26.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.37 123.7 29.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.301 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.465 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.91 68.49 0.83 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.729 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.71 -104.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.5 p -159.53 165.73 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.582 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.53 145.98 21.95 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.178 0.513 . . . . 0.0 110.443 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -100.84 136.27 40.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.56 111.01 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.16 165.09 32.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.921 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.56 23.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.0 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.01 -28.47 57.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.237 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.84 -41.98 88.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.266 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.8 t -101.92 121.76 42.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.212 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.87 109.92 19.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.422 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.2 mt -127.0 129.62 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.56 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -108.17 154.32 41.34 Favored Pre-proline 0 C--N 1.333 -0.124 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.648 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.33 92.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.819 2.346 . . . . 0.0 111.768 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.7 m -171.19 144.09 2.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 123.637 0.586 . . . . 0.0 110.82 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.3 -33.58 61.3 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.275 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 108' ' ' THR . 47.7 tp10 -58.02 -62.48 1.79 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.291 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.07 -22.33 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.889 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.08 -25.68 55.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.54 133.11 46.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.454 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.0 -17.16 28.74 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -85.89 151.38 23.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.876 0.369 . . . . 0.0 110.524 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -96.27 136.23 37.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.303 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.4 t -127.7 136.83 59.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.667 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.68 139.78 14.86 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.83 161.84 40.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.097 0.475 . . . . 0.0 110.327 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 42.4 tp -92.72 118.05 30.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.709 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -51.47 157.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.584 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.88 50.68 51.45 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.7 p -149.65 168.58 23.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.774 0.321 . . . . 0.0 110.852 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.6 p -74.33 -25.58 59.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.497 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.01 -55.8 28.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.537 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.04 -54.29 48.42 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.498 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.21 -51.31 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.616 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.45 -43.73 98.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.057 0.456 . . . . 0.0 110.458 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.63 -44.54 97.81 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.68 -14.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 0.0 110.745 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.07 -34.77 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.565 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.37 -50.43 18.68 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.897 0.379 . . . . 0.0 111.516 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.16 12.79 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.187 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.09 -55.62 0.46 Allowed Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.347 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.08 -10.44 25.99 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.783 2.322 . . . . 0.0 111.919 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.59 -8.97 59.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.504 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.63 33.41 38.38 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.31 138.3 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 121.031 0.443 . . . . 0.0 110.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -87.88 129.78 35.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.128 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.2 138.9 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.58 132.05 71.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.999 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.9 t -98.51 130.61 45.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.81 156.58 21.76 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.265 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -107.06 6.89 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.642 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.76 130.75 6.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.42 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.89 -46.01 79.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.757 0.313 . . . . 0.0 110.429 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.81 -23.25 62.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.532 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.451 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.71 -36.58 84.75 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.61 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.19 -47.32 84.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.054 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.519 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.7 m-85 -63.83 -37.97 89.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.0 -42.13 97.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.03 -45.4 89.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.56 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.8 tp -58.06 -48.28 80.59 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.327 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.2 m -63.12 -22.94 67.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.018 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.53 -18.73 24.75 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.503 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.13 70.34 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.46 -18.16 63.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 0.0 110.593 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.6 pt -127.88 136.88 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.069 0.462 . . . . 0.0 110.434 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.74 -27.46 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.456 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.72 155.81 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.851 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.12 136.94 49.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 110.076 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -85.47 103.33 14.24 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.153 0.502 . . . . 0.0 110.76 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.77 165.71 23.91 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.409 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.466 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.98 152.45 41.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.506 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.1 mt-10 -66.27 -54.55 23.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.33 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.445 HG21 ' CG ' ' A' ' 91' ' ' TYR . 74.3 t -60.28 -49.01 85.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.342 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.49 -38.77 88.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.802 0.334 . . . . 0.0 110.76 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.662 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.21 1.19 Allowed 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.478 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -59.24 -47.87 83.75 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.978 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.458 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.8 tt0 -49.13 -37.5 22.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.125 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.432 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.84 -66.23 0.56 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.662 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.9 t80 -40.69 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.561 0.219 . . . . 0.0 111.092 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.7 mt -61.1 -40.25 93.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.03 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.0 tttt -60.53 -2.73 0.55 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.448 0.642 . . . . 0.0 110.386 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' A' ' 173' ' ' LEU . 53.0 mt-30 -122.98 147.41 51.31 Favored Pre-proline 0 CA--C 1.532 0.287 0 O-C-N 122.099 -0.376 . . . . 0.0 110.781 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.76 -19.7 2.32 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.864 2.376 . . . . 0.0 112.306 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.55 -42.91 95.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.531 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.17 -33.26 85.32 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.41 -41.41 93.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.77 0.319 . . . . 0.0 110.479 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.52 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 56.3 m-20 -65.52 -33.59 76.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.504 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.1 m-85 -155.98 142.68 18.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.711 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.551 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.2 pttt -176.9 99.52 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.041 0.448 . . . . 0.0 110.763 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.2 m-85 -159.24 167.46 28.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.631 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.34 56.3 2.87 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.02 -118.03 0.01 OUTLIER Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.3 135.39 31.67 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.48 2.12 . . . . 0.0 112.051 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.15 -107.93 0.33 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.555 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.5 p -165.75 165.35 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.478 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.053 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.652 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.32 156.01 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 O-C-N 124.34 1.025 . . . . 0.0 110.607 179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.15 117.67 22.48 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.76 -18.86 62.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.89 -32.38 73.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.504 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -60.79 -44.74 96.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.685 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.467 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.6 m-85 -113.97 9.66 17.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.722 179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.22 -154.92 52.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.634 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.51 -24.74 25.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.804 0.335 . . . . 0.0 110.495 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.02 -124.12 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.0 p -129.43 156.33 44.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.729 0.299 . . . . 0.0 110.289 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.53 -169.53 30.26 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -94.37 137.26 33.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 0.0 110.557 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.29 108.21 3.26 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.2 mt -123.46 159.31 29.31 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.278 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.651 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.9 mtm180 -86.61 149.62 24.8 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.87 -48.34 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.554 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -37.95 -25.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.907 0.384 . . . . 0.0 110.826 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.45 52.25 0.19 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.649 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -45.69 86.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.152 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.49 -47.3 34.06 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.114 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.35 -43.74 98.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.557 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.747 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -56.86 -36.66 70.31 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.693 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.84 -77.15 0.11 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.89 HD21 HD11 ' A' ' 44' ' ' ILE . 97.5 mt -28.91 -46.15 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.31 -44.99 89.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.802 178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.9 -43.73 98.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.111 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.36 93.81 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.18 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.32 -43.35 99.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.079 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.58 -39.08 92.57 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.73 -42.96 97.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.87 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.527 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.4 mtp -57.82 -38.21 75.16 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -69.02 -39.74 79.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.1 0.476 . . . . 0.0 110.26 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.0 92.43 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.443 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.2 p30 -86.43 1.26 51.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.5 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.69 19.57 60.73 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 70.3 m -58.28 -45.92 87.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.425 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 79.7 t80 -63.53 -57.59 9.7 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.397 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.97 -41.64 78.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.103 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.57 -48.81 79.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.505 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.62 -41.86 98.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.865 0.364 . . . . 0.0 110.566 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.78 -49.98 75.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.749 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.78 -35.02 72.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.376 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -71.14 -50.93 28.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.418 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.24 -45.37 93.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.536 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.5 m-85 -154.26 155.62 35.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.437 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.9 p-10 -97.6 97.17 8.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.974 0.416 . . . . 0.0 110.468 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -154.52 -166.02 2.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.417 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.23 110.53 15.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.622 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.9 m -63.39 -40.32 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.541 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.417 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.3 m-85 -58.54 -42.73 88.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.312 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.5 -37.15 94.35 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.871 -1.516 . . . . 0.0 110.917 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.48 164.26 62.02 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.667 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.94 143.82 99.43 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 122.679 2.253 . . . . 0.0 112.323 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.24 -40.46 90.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.546 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.46 142.37 37.37 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.419 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -109.36 128.08 65.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.942 0.401 . . . . 0.0 110.483 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -102.68 117.55 34.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.348 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.58 139.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.425 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.45 105.44 2.16 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.6 m -128.11 119.33 25.12 Favored 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 122.75 -0.265 . . . . 0.0 111.077 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.4 t70 -113.53 92.58 24.22 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.139 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.05 134.25 58.98 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.484 2.123 . . . . 0.0 112.12 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.0 p -141.09 -19.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.713 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.8 m-85 -124.88 98.91 5.9 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.547 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.724 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.91 -61.47 0.22 Allowed Pre-proline 0 C--O 1.22 -0.48 0 CA-C-O 121.519 0.676 . . . . 0.0 111.053 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.724 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.31 -39.69 43.53 Favored 'Trans proline' 0 C--N 1.294 -2.326 0 C-N-CA 122.484 2.123 . . . . 0.0 112.279 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.1 t80 -79.34 -42.77 24.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.906 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.9 mt-10 -149.49 -155.75 0.66 Allowed 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.03 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.41 177.52 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 0.0 110.377 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.56 140.6 46.24 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.474 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -92.23 136.96 32.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.619 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -65.07 -19.1 65.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.479 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.82 -5.82 54.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.454 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.96 -8.71 57.83 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.64 157.79 27.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.379 . . . . 0.0 110.474 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.1 mt -112.48 133.59 54.46 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 120.935 0.398 . . . . 0.0 110.451 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.666 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -132.93 150.82 33.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.353 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.04 151.22 6.5 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.39 -41.95 86.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 110.926 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.478 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.8 t0 -70.58 -27.55 64.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.322 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.666 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.8 mt -69.33 -40.64 80.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.931 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -61.2 -37.34 82.64 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.744 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.37 -43.93 84.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.151 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.97 -45.14 91.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.13 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.54 -53.95 51.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.491 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.75 -37.72 59.87 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.945 0.403 . . . . 0.0 110.419 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.45 -41.9 75.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.66 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.4 m -54.16 -44.69 71.68 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.115 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.77 -47.59 80.34 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.53 -41.27 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.153 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.0 HD11 HD21 ' A' ' 213' ' ' LEU . 96.8 mt -76.27 -17.75 15.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.78 52.72 4.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.558 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -145.96 170.51 16.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.33 141.15 28.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.163 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.13 131.46 56.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.655 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.6 m -128.12 127.76 43.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.509 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.51 136.01 35.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.526 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.2 t -129.87 128.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.428 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.06 139.08 58.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.756 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.3 131.63 0.15 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.565 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.47 145.09 63.63 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.688 2.258 . . . . 0.0 112.417 -179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.882 HD23 HD12 ' A' ' 58' ' ' LEU . 81.6 mt -40.11 -56.62 1.85 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -47.46 -26.67 1.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.146 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.13 -20.78 18.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.184 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.882 HD12 HD23 ' A' ' 55' ' ' LEU . 58.5 mt -63.99 -42.51 97.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.619 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.712 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.36 -56.96 25.72 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.821 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.712 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.2 Cg_exo -54.79 -43.71 56.65 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.608 2.205 . . . . 0.0 111.353 177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.59 -44.71 89.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.84 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.09 -44.24 87.52 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.153 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.58 -40.34 95.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.966 0.412 . . . . 0.0 110.517 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.29 11.22 1.62 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.597 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.14 11.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.871 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.51 -34.28 77.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.489 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.6 pt -123.87 153.47 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 121.011 0.434 . . . . 0.0 110.263 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.24 -20.81 20.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.119 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.11 157.25 25.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.661 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.595 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.52 127.29 73.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.105 0.478 . . . . 0.0 110.457 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.478 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.7 ttp -128.45 106.3 8.9 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.383 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.624 ' OG ' HD21 ' A' ' 55' ' ' LEU . 48.3 t -159.9 -178.54 7.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.35 -15.49 60.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.7 tp -37.48 123.72 0.99 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.503 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 11.1 p -83.21 156.34 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.571 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.5 pt -105.13 149.41 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.317 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.6 p -150.42 152.4 34.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.754 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.04 -47.99 53.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.972 0.415 . . . . 0.0 110.653 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.59 -39.58 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.803 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.4 mtt180 -68.8 -37.56 79.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.837 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.467 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.35 -37.34 75.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.24 -27.52 67.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.165 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.35 -51.54 7.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.986 0.422 . . . . 0.0 110.598 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -138.46 -168.82 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 121.062 0.458 . . . . 0.0 110.468 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.72 29.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.046 0.45 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD1' HG22 ' A' ' 76' ' ' ILE . 71.0 m-85 -129.74 149.89 51.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.603 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.3 t -164.18 -151.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.5 m-20 42.77 19.32 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.815 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -28.38 120.5 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.415 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.469 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.04 -69.83 0.5 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.748 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 46.5 p90 -149.26 166.29 29.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.57 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.22 121.19 26.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.289 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.459 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.44 69.6 1.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.738 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.89 -104.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.3 p -159.25 165.72 32.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.635 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.5 146.22 22.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.081 0.467 . . . . 0.0 110.441 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.26 136.2 41.48 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.786 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.403 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.75 110.71 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.63 165.11 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.854 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.46 23.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.031 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.99 -27.99 48.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.232 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.01 -41.74 88.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.351 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -102.35 122.35 44.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.237 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.54 109.56 19.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.467 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.43 129.88 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.654 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.73 158.81 34.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.564 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.64 89.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.773 2.316 . . . . 0.0 111.918 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.5 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -169.29 140.76 2.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.744 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.69 -32.61 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.228 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.5 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.08 -62.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.273 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.2 t -55.75 -22.17 22.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.925 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.7 mt -76.73 -25.8 53.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.271 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 132.86 46.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.456 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.72 -15.56 30.56 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.53 151.39 23.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 0.0 110.45 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.21 135.58 37.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.368 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.78 136.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.52 137.72 13.88 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.44 161.71 39.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.08 0.467 . . . . 0.0 110.339 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.548 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.9 tp -92.39 117.9 30.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.78 157.45 1.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.692 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.98 50.71 50.73 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.59 168.75 22.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 0.0 110.805 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.431 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 69.3 p -73.15 -27.94 61.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.401 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.01 -55.37 34.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.442 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -56.21 -55.34 34.38 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.566 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.06 -50.99 71.52 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.587 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 67.3 t80 -61.94 -43.98 97.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.043 0.449 . . . . 0.0 110.474 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.97 -44.44 97.8 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.41 -14.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.7 tt0 -124.96 -34.76 2.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.707 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.587 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.38 -50.51 18.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 111.471 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -99.14 12.88 34.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.184 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.1 -55.58 0.46 Allowed Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.376 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.5 25.75 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.777 2.318 . . . . 0.0 111.957 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.37 -8.97 59.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.517 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.84 33.47 37.25 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.74 138.26 38.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.9 0.381 . . . . 0.0 110.527 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.79 130.18 34.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.329 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.6 138.12 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.841 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.02 133.44 69.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.056 0.455 . . . . 0.0 110.08 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.18 127.15 42.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.725 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.56 153.53 25.0 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.355 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.03 7.07 29.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.654 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.99 130.17 5.84 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.93 -45.86 80.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.317 . . . . 0.0 110.431 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.58 -23.5 62.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.522 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.78 -36.45 84.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.52 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.22 -46.87 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.04 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.1 m-85 -64.45 -37.44 87.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.393 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.4 p -60.92 -41.94 97.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.177 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -65.64 -42.93 90.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.795 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.582 ' HB2' HD11 ' A' ' 158' ' ' ILE . 44.7 tp -58.63 -48.58 80.53 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.26 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.51 -22.18 66.08 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.945 0.402 . . . . 0.0 110.239 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.01 -17.75 25.75 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.21 73.3 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -70.33 -17.96 63.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.899 0.38 . . . . 0.0 110.572 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 153' ' ' LEU . 32.9 pt -126.92 136.14 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.473 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.63 -29.02 63.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.07 155.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.82 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.46 137.58 50.93 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.025 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -85.74 102.72 13.89 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.207 0.527 . . . . 0.0 110.799 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.581 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.1 tt0 -132.0 164.91 25.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.393 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.49 153.12 40.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.21 -54.54 23.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.249 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.05 -49.54 83.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.549 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.08 88.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.803 0.335 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.98 -63.73 1.08 Allowed 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.538 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.442 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -58.51 -47.42 84.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.776 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.0 tt0 -49.3 -38.17 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.14 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.6 -66.11 0.56 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.669 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.3 t80 -40.35 -71.01 0.09 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.615 0.245 . . . . 0.0 111.151 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.6 mt -61.25 -40.03 92.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.71 -2.89 0.41 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.446 0.641 . . . . 0.0 110.521 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 177' ' ' VAL . 60.5 mt-30 -124.44 141.6 38.09 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.754 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -43.86 -15.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.825 2.35 . . . . 0.0 112.279 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.0 t -62.91 -42.79 97.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.596 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.87 80.91 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.42 96.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.302 . . . . 0.0 110.517 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.7 m-20 -66.07 -34.47 78.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.452 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.3 m-85 -156.96 143.27 18.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.75 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.4 pttt -176.92 99.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.006 0.431 . . . . 0.0 110.725 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.8 m-85 -159.22 167.66 28.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.607 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.98 55.76 3.05 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.561 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.62 -117.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.44 135.34 32.74 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.5 2.133 . . . . 0.0 112.008 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.6 p -125.38 -107.7 0.32 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.486 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.666 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.45 165.59 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.244 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.39 156.61 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 123.995 0.81 . . . . 0.0 110.642 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -83.16 117.85 23.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.027 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.602 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.88 -16.73 62.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.43 -32.89 74.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.543 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.462 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.7 mt -61.02 -44.51 97.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.764 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.5 7.82 17.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.77 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.16 -154.16 50.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.654 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.92 -25.35 25.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.862 0.363 . . . . 0.0 110.556 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.459 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.57 -126.01 1.55 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.81 159.79 37.5 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 110.461 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.5 -162.41 24.61 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.503 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.59 141.07 31.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.021 0.439 . . . . 0.0 110.525 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.22 111.39 3.9 Favored Glycine 0 C--N 1.33 0.227 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.9 mt -120.44 160.58 22.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.926 0.394 . . . . 0.0 110.235 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 149.05 24.98 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.92 -49.16 63.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.611 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.93 -22.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.004 0.43 . . . . 0.0 110.82 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.9 m-20 -72.06 52.13 0.24 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.764 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.52 -46.02 84.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.146 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.18 34.71 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.1 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.2 -43.82 97.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.513 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.54 -42.86 99.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.875 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.68 -37.41 73.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.848 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.71 0.1 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.0 HD21 HD11 ' A' ' 44' ' ' ILE . 87.2 mt -28.45 -45.75 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.465 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.7 m-20 -63.55 -45.63 89.66 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 178.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.33 -43.72 98.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.016 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.33 92.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.184 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.2 -43.46 98.85 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.078 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.25 92.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.162 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.75 -43.15 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.862 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.1 mtp -56.49 -38.42 71.72 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -70.04 -38.82 75.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.0 110.352 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.44 92.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.29 0.91 55.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.683 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.11 20.09 66.66 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.9 m -57.82 -46.54 84.56 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.469 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.8 t80 -63.34 -57.5 10.15 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.446 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -41.88 78.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.309 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.26 -48.74 79.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.518 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.57 -41.66 97.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.426 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.93 -49.94 75.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.602 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.63 -35.54 72.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.451 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.84 -50.92 30.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.2 -45.53 92.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.58 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.5 m-85 -154.05 155.41 35.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.432 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.7 p-10 -98.08 97.66 9.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.933 0.396 . . . . 0.0 110.527 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -154.63 -165.51 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.8 t0 -122.72 109.54 14.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 24.1 m -63.77 -40.61 89.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.503 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.9 m-85 -56.55 -43.97 80.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.319 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.27 -36.54 93.55 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 117.909 -1.495 . . . . 0.0 110.939 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.08 164.44 58.99 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.683 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -60.97 143.48 99.35 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.723 2.282 . . . . 0.0 112.139 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.25 -40.2 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.557 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.56 36.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.443 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.46 128.23 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.423 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.0 mtp180 -103.66 118.7 37.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.34 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.64 138.15 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.37 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.12 99.9 1.58 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.1 m -123.58 118.76 28.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.759 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.513 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 23.3 t70 -113.67 92.86 25.8 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.959 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.09 133.92 57.58 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.537 2.158 . . . . 0.0 111.913 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 p -140.63 -19.76 0.84 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.662 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.4 m-85 -124.72 99.06 5.99 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.494 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.721 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.8 -61.67 0.21 Allowed Pre-proline 0 C--O 1.222 -0.392 0 CA-C-O 121.638 0.732 . . . . 0.0 110.914 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.721 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.9 Cg_endo -49.58 -39.34 46.09 Favored 'Trans proline' 0 C--N 1.296 -2.235 0 C-N-CA 122.523 2.149 . . . . 0.0 112.161 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.3 t80 -79.52 -43.06 23.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.972 0.415 . . . . 0.0 110.791 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.645 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.9 mt-10 -149.4 -155.41 0.63 Allowed 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.0 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.75 177.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.876 0.37 . . . . 0.0 110.402 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.5 140.01 45.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.465 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -91.71 136.47 33.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.555 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.8 p -64.91 -19.01 65.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.488 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -79.13 -5.48 54.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.486 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.91 -8.48 57.81 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.02 157.63 26.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.812 0.339 . . . . 0.0 110.469 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -112.68 134.29 54.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.481 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.676 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.44 151.0 32.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.408 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.27 151.32 6.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -58.69 -41.98 87.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.793 0.33 . . . . 0.0 110.738 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.486 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.1 t0 -70.06 -27.69 64.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.212 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -69.19 -40.59 80.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.979 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 47.8 m-20 -60.43 -37.91 82.41 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.274 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.0 tp -66.21 -43.71 85.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.11 0.481 . . . . 0.0 110.543 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.35 -44.27 92.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.171 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -56.77 -53.48 57.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.613 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.47 -37.79 63.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.051 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.21 -42.24 76.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.994 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.36 -44.37 72.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.215 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -64.27 -47.13 80.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.365 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.77 -40.84 89.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.126 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.002 HD11 HD21 ' A' ' 213' ' ' LEU . 97.0 mt -76.61 -17.73 14.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.83 52.36 4.31 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.653 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.0 p -145.4 170.25 16.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.831 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.26 140.64 29.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.205 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.1 m -116.83 131.17 57.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.576 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.2 m -128.19 128.0 43.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.523 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -94.31 136.19 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.542 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -129.54 128.15 65.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.43 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.5 139.07 57.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.531 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.513 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.7 OUTLIER 173.97 132.92 0.12 Allowed Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.1 Cg_endo -68.35 144.74 63.07 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.703 2.269 . . . . 0.0 112.574 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.94 HD23 HD12 ' A' ' 58' ' ' LEU . 76.1 mt -40.09 -55.94 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.986 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.9 -26.48 1.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.862 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.26 -20.62 19.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.918 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.94 HD12 HD23 ' A' ' 55' ' ' LEU . 84.8 mt -65.07 -42.83 93.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.566 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.699 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 mm -61.68 -55.74 39.35 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.077 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 48.2 Cg_exo -56.12 -42.99 60.75 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.622 2.215 . . . . 0.0 111.161 177.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -58.98 -44.16 91.54 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.06 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.28 -44.47 88.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.13 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.78 -40.0 94.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.493 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 11.24 1.64 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.532 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.25 11.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.76 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.49 -33.86 76.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.643 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.48 153.27 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.42 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -94.58 -20.66 19.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.977 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.95 155.92 26.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.553 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 97.0 mt -116.73 128.18 74.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.506 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.486 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.3 ttp -128.43 106.22 8.85 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.411 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.624 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.6 t -158.68 -179.73 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.579 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.63 -14.62 58.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.503 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.0 tp -37.55 124.18 1.03 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.584 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.557 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -82.94 156.14 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.644 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.66 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.4 pt -104.93 148.96 8.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.184 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.4 p -150.63 152.62 34.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.679 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.08 -48.01 53.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.47 -39.98 71.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.579 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.6 mtt180 -68.77 -37.52 79.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -36.93 74.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.233 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.45 -27.53 67.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.292 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.23 -51.74 7.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.5 pt -138.68 -168.55 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.939 0.4 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.78 146.71 29.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.79 150.02 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.599 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.3 t -164.61 -151.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.49 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.513 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.8 m-20 43.23 19.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.686 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -27.89 120.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.354 0.409 . . . . 0.0 110.532 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 15.7 mt -77.34 -70.07 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.756 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.432 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.5 p90 -149.16 165.99 30.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.553 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.79 121.07 26.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.57 69.99 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.663 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -86.54 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.429 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.51 165.78 32.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.566 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.54 146.08 22.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.8 mt -101.64 136.14 41.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.739 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 t -122.61 110.88 28.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.011 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.76 164.87 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.712 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.82 148.39 23.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.841 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.62 -27.67 41.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.309 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.16 -41.82 89.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.329 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.33 122.18 43.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.361 . . . . 0.0 110.254 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.34 19.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.394 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.56 129.88 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.576 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.44 159.2 33.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.6 Cg_endo -59.63 89.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.802 2.335 . . . . 0.0 112.02 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -168.93 140.91 2.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.5 p -67.21 -32.86 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.38 -62.56 1.68 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.61 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.0 t -56.07 -22.19 26.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.678 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 35.3 mt -76.99 -25.38 52.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.76 132.73 46.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.474 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.27 -16.03 31.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -86.48 151.59 23.38 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.826 0.346 . . . . 0.0 110.43 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -96.52 135.63 38.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.393 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.04 136.66 60.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.639 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.36 138.8 14.43 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.7 t -131.04 161.59 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.965 0.412 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.544 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.6 tp -92.42 117.49 29.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.555 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.73 157.87 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.82 50.57 52.47 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.97 169.0 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 110.834 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.4 p -73.79 -26.33 60.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.497 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -60.69 -55.31 34.72 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.564 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -56.89 -54.64 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.421 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.17 -51.38 69.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.571 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.5 t80 -62.08 -43.76 98.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.416 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.8 -44.33 98.02 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.58 -14.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.683 0.278 . . . . 0.0 110.615 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.32 -34.4 2.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.538 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.71 -51.03 15.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.13 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -99.12 12.98 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.996 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.61 -55.46 0.44 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.45 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.32 -10.39 25.55 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.834 2.356 . . . . 0.0 112.051 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.61 -8.73 59.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.623 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.9 33.47 37.0 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.87 138.22 38.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.6 129.79 34.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.421 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.9 pt -125.96 137.78 56.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.01 132.92 70.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.427 . . . . 0.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.75 43.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.617 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -110.89 153.67 25.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.373 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.8 6.95 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.629 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -132.19 130.68 5.97 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.01 -45.76 80.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.91 -24.08 63.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.525 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.69 -36.37 84.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.2 -47.13 85.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.075 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.3 m-85 -63.58 -37.8 88.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.364 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.22 -42.63 98.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.346 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.46 -45.42 90.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.227 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.544 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.9 tp -58.62 -48.1 82.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.256 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.0 m -63.18 -22.94 67.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.013 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.3 25.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.86 11.34 70.67 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.75 -17.84 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.808 0.337 . . . . 0.0 110.578 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.8 pt -128.78 137.98 55.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.23 -28.02 61.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.481 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.61 155.49 1.76 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.689 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.58 137.85 50.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.153 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -85.71 103.05 14.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.526 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.58 165.11 25.17 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.451 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.471 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.26 151.97 41.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.7 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -65.71 -54.17 30.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.432 HG21 ' CG ' ' A' ' 91' ' ' TYR . 68.6 t -60.04 -49.12 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.03 89.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.772 0.32 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.42 1.16 Allowed 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.483 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.416 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.4 m -58.67 -47.2 85.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.95 -37.34 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.117 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.483 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.14 -65.8 0.55 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.675 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.0 t80 -40.73 -70.99 0.09 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.646 0.26 . . . . 0.0 110.989 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.75 -39.9 93.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.778 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -59.47 -3.19 0.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.176 0.512 . . . . 0.0 110.377 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 177' ' ' VAL . 50.6 mt-30 -124.58 141.34 37.56 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.834 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -43.43 -14.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.844 2.362 . . . . 0.0 112.165 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.0 t -63.07 -42.8 97.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.445 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.87 -33.02 81.69 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.06 -41.35 96.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.793 0.33 . . . . 0.0 110.446 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.0 m-20 -66.16 -34.46 78.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.555 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.8 m-85 -156.96 142.89 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.645 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.71 100.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.049 0.452 . . . . 0.0 110.72 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.5 m-85 -159.41 167.52 28.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.613 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.18 56.06 3.12 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.04 -116.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.84 135.03 35.58 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.436 2.091 . . . . 0.0 111.911 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.7 p -124.6 -108.35 0.33 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.6 p -166.39 165.17 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.209 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.662 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.9 tttt 153.66 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 O-C-N 123.951 0.782 . . . . 0.0 110.494 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -82.22 118.3 23.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.066 178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.596 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.5 mp0 -72.13 -18.68 61.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -64.04 -31.87 73.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.636 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.7 mt -60.83 -44.57 96.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.683 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.46 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.7 m-85 -113.88 7.35 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.641 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.2 -155.32 50.37 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.66 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.19 -25.54 27.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.559 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.16 -125.57 1.46 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -132.07 160.12 36.87 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.412 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.23 -163.2 25.71 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -97.66 141.01 31.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.901 0.381 . . . . 0.0 110.518 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.1 112.15 4.0 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -122.04 160.75 24.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.285 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.4 mtm180 -87.07 148.97 25.03 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.654 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -51.75 -48.83 63.53 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.714 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -39.88 -23.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.784 0.326 . . . . 0.0 110.544 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.0 m-20 -71.78 52.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.623 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.43 -46.27 83.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.5 -47.16 34.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.6 tp -62.42 -43.74 98.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.449 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.53 -42.84 99.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.005 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.44 -37.3 72.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.027 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.58 -77.46 0.11 Allowed 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.002 HD21 HD11 ' A' ' 44' ' ' ILE . 87.9 mt -28.2 -45.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.659 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.1 m-20 -63.83 -45.46 89.46 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.661 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.51 98.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.114 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.46 93.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.33 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -61.12 -43.39 98.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.241 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.36 92.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.332 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.98 -42.39 97.25 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.228 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.506 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.13 -38.29 73.24 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -69.9 -38.77 76.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.994 0.426 . . . . 0.0 110.417 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.46 92.61 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.6 p-10 -88.57 0.59 56.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.74 20.1 67.95 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.7 m -57.6 -46.16 84.4 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.463 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.6 t80 -63.65 -57.93 8.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 110.53 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.56 -41.68 77.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.36 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.7 -48.53 80.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.481 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.8 -41.62 97.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.397 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.07 -49.81 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.648 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.75 -35.65 73.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -70.78 -50.98 30.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.273 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.52 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.5 m-85 -62.16 -45.85 91.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.515 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.1 m-85 -153.53 155.48 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.431 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.2 p-10 -98.01 99.23 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.483 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -156.4 -165.59 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.493 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.7 t0 -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.699 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.6 m -63.76 -40.23 88.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.572 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.8 m-85 -56.76 -44.11 81.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.304 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.33 -36.54 93.54 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.711 0 CA-C-O 117.917 -1.49 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.21 61.29 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.698 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -60.79 143.53 99.4 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 122.727 2.285 . . . . 0.0 112.308 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.39 -40.89 89.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.586 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.9 m-20 -138.65 139.48 38.51 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.359 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.6 mt -108.41 121.5 61.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.665 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.18 118.49 31.63 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.106 0.479 . . . . 0.0 110.183 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.09 138.56 40.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.404 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.83 105.94 2.2 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.9 m -129.32 120.41 25.59 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 122.694 -0.298 . . . . 0.0 110.953 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.501 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 22.4 t70 -114.18 92.58 27.43 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.185 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.97 134.36 59.2 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.454 2.103 . . . . 0.0 112.197 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 p -141.75 -20.21 0.74 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.781 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.8 m-85 -123.42 99.16 6.19 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.555 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.724 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.19 -61.37 0.22 Allowed Pre-proline 0 C--O 1.217 -0.618 0 CA-C-O 121.688 0.756 . . . . 0.0 111.099 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.724 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.9 Cg_endo -49.36 -40.64 43.98 Favored 'Trans proline' 0 C--N 1.29 -2.502 0 C-N-CA 122.449 2.1 . . . . 0.0 112.259 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.1 t80 -78.36 -42.55 30.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.795 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.658 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.1 mt-10 -150.04 -153.89 0.52 Allowed 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.049 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.96 177.83 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.023 0.44 . . . . 0.0 110.376 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.58 144.47 46.19 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.412 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -95.31 134.31 38.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.585 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.1 p -64.68 -18.92 65.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.516 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.44 -6.71 56.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.052 0.453 . . . . 0.0 110.453 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.18 -8.21 55.27 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -80.08 158.5 26.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.978 0.418 . . . . 0.0 110.426 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.13 130.93 55.73 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.956 0.408 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.692 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.12 151.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.318 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.02 151.25 6.51 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -58.5 -42.12 86.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 122.555 -0.38 . . . . 0.0 111.007 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.2 t0 -69.2 -28.59 66.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.243 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.692 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -68.03 -40.35 83.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.971 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -61.03 -37.58 83.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.909 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.74 -45.25 87.25 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -56.96 -48.63 77.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.881 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -52.85 -54.71 30.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.356 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -52.21 -39.94 60.89 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.022 0.439 . . . . 0.0 110.412 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.2 mt -68.73 -41.83 78.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.735 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.528 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.71 -45.29 70.4 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.074 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.93 -47.03 82.13 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.064 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.61 -42.35 92.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.285 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.89 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.41 -17.1 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.655 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.0 m-20 60.63 53.11 4.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.548 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.06 171.27 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.876 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -89.02 142.56 27.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.1 m -117.46 131.15 56.79 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.678 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.19 126.92 43.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.386 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -93.36 134.67 35.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.523 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.04 127.47 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.947 0.403 . . . . 0.0 110.285 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.31 137.99 57.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.2 p30 175.89 131.34 0.16 Allowed Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.539 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.464 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.2 Cg_endo -68.23 145.22 65.52 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.677 2.251 . . . . 0.0 112.437 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.877 HD23 HD12 ' A' ' 58' ' ' LEU . 82.8 mt -40.29 -55.79 2.11 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.1 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -48.33 -26.25 1.94 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.27 -20.9 18.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.877 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.96 -42.38 97.29 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.637 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.16 -57.43 23.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 123.872 0.733 . . . . 0.0 109.485 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -54.93 -42.39 69.5 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.62 2.214 . . . . 0.0 111.267 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.9 m -58.76 -44.87 90.72 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.873 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.656 HD21 ' HG3' ' A' ' 203' ' ' ARG . 62.4 tp -59.1 -44.01 91.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.219 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.47 -40.53 95.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.467 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.82 9.96 2.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.24 12.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.925 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.59 -35.46 80.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.4 pt -122.29 153.19 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.999 0.428 . . . . 0.0 110.277 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.3 m-20 -93.58 -21.98 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.178 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.63 155.74 26.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.777 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.06 128.95 72.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.176 0.513 . . . . 0.0 110.441 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.0 ttp -131.06 106.47 8.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.335 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.716 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.4 t -159.1 178.53 9.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.22 -15.41 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.4 tp -34.84 124.23 0.55 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.606 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.547 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.87 153.87 26.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.613 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.636 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.58 148.54 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -149.12 152.09 35.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.799 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.72 -47.28 50.67 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.995 0.426 . . . . 0.0 110.467 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.35 -39.7 70.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -69.31 -37.57 77.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.755 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.3 mt-30 -57.89 -39.07 76.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.819 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.73 -27.63 66.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.172 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.24 -50.67 8.19 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.971 0.415 . . . . 0.0 110.729 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.2 pt -139.39 -168.11 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 CA-C-O 121.088 0.47 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.118 0.485 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.9 m-85 -130.0 150.0 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.554 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.05 -153.44 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 94.2 m-20 41.17 20.17 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.088 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.538 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.59 121.79 0.2 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.39 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.9 mt -75.6 -68.94 0.52 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.437 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.0 p90 -150.11 167.38 26.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.729 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.3 123.78 29.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.233 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.89 68.55 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.792 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.01 -104.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.45 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.4 p -159.53 165.7 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 110.584 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.41 146.04 22.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.16 0.505 . . . . 0.0 110.444 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -100.96 136.26 41.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.832 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.416 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.72 110.41 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.477 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.1 165.16 32.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.72 148.34 24.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.075 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -54.84 -27.38 41.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.177 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.33 -41.86 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.323 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -102.58 122.37 44.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.001 0.429 . . . . 0.0 110.146 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.78 109.4 19.7 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.44 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.84 130.1 70.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.67 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.471 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.67 159.06 33.75 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.576 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.8 Cg_endo -59.84 89.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.81 2.34 . . . . 0.0 111.939 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -169.27 140.68 2.39 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.523 0.514 . . . . 0.0 110.778 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.0 p -66.8 -32.84 59.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.276 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.499 ' H ' HG22 ' A' ' 108' ' ' THR . 47.4 tp10 -57.14 -62.74 1.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.307 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 t -55.96 -22.2 25.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.991 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.4 mt -76.44 -25.9 54.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.323 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.7 133.11 46.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.388 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.89 -15.93 29.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.56 151.36 23.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.927 0.394 . . . . 0.0 110.458 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -95.89 135.48 37.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.014 0.435 . . . . 0.0 110.336 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.12 136.54 60.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.644 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.51 138.59 14.33 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.8 t -130.87 161.65 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 121.102 0.477 . . . . 0.0 110.314 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.3 tp -92.35 117.53 30.0 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.682 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.64 157.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.663 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.68 50.52 53.56 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.9 p -149.68 168.93 22.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.775 0.321 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 78.3 p -73.54 -26.85 61.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.414 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.54 -55.57 31.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.48 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -56.53 -54.9 40.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.575 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.3 m -60.21 -50.88 71.89 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.56 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.596 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.0 t80 -62.23 -43.82 97.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.92 -44.54 97.69 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.27 -14.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 110.825 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.28 -34.57 2.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.598 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.596 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.5 t60 -74.4 -50.59 17.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.967 0.413 . . . . 0.0 111.557 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -99.15 12.47 36.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.83 -55.51 0.47 Allowed Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.371 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.1 Cg_endo -72.24 -10.27 25.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.791 2.327 . . . . 0.0 111.923 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.74 -9.01 59.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.495 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.85 33.42 37.37 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.51 138.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-O 120.986 0.422 . . . . 0.0 110.51 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.48 129.75 34.95 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.9 pt -126.32 138.14 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.23 133.15 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 121.077 0.465 . . . . 0.0 109.9 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.39 127.67 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -110.99 153.74 25.13 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.245 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.09 7.42 29.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.645 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.75 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.6 tp60 -65.97 -45.91 80.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.468 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.58 -23.32 62.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.553 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.449 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.0 t-20 -64.89 -36.71 85.25 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.583 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.12 -47.08 85.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.078 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.518 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.2 m-85 -63.61 -38.06 89.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.271 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.5 p -61.14 -42.27 98.25 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.203 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -64.04 -45.34 89.27 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.55 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.6 tp -58.3 -48.17 81.33 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.3 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -63.25 -22.77 67.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.242 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.38 -18.74 24.94 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.463 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.13 11.46 69.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.76 -18.15 63.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.94 0.4 . . . . 0.0 110.618 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.2 pt -128.29 137.36 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.397 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -72.89 -27.24 61.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.477 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.83 155.87 1.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.527 0.517 . . . . 0.0 110.838 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.05 136.83 49.8 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 109.967 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -85.2 103.05 13.82 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.165 0.507 . . . . 0.0 110.831 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.5 tt0 -132.52 165.5 24.22 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.409 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.81 152.31 41.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.549 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.2 mt-10 -66.27 -54.46 24.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.33 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.437 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.1 t -60.29 -48.98 86.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.395 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.93 88.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.821 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.45 -63.1 1.22 Allowed 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.552 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -59.4 -47.99 83.34 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.003 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.9 tt0 -49.06 -37.33 20.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.15 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.47 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.82 -66.32 0.56 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -71.23 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 O-C-N 122.745 -0.268 . . . . 0.0 111.17 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 175' ' ' GLN . 94.9 mt -61.01 -40.31 93.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.5 tttt -60.1 -2.79 0.47 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.538 0.685 . . . . 0.0 110.457 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.47 HE21 ' C ' ' A' ' 171' ' ' GLY . 43.0 mt-30 -123.36 148.95 56.74 Favored Pre-proline 0 N--CA 1.453 -0.306 0 O-C-N 122.011 -0.431 . . . . 0.0 110.786 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.48 -20.41 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.933 2.422 . . . . 0.0 112.299 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.5 t -61.01 -43.24 95.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.588 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.59 -33.05 83.55 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.57 -41.4 94.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.733 0.302 . . . . 0.0 110.412 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.9 m-20 -65.55 -33.81 76.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.438 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 74.3 m-85 -156.19 143.0 18.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.771 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.1 pttt -177.15 99.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.093 0.473 . . . . 0.0 110.73 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.1 166.82 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.652 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.59 56.57 2.77 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.554 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -118.05 0.01 OUTLIER Glycine 0 CA--C 1.534 1.229 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.28 135.98 31.44 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.412 2.075 . . . . 0.0 112.015 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.47 -107.9 0.32 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.647 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.3 p -165.68 165.31 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.144 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.29 156.15 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.25 0.969 . . . . 0.0 110.62 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.15 117.57 22.4 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.863 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.61 -18.78 62.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.988 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.99 -32.35 73.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.518 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.461 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.4 mt -60.94 -44.62 97.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.746 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 45.9 m-85 -114.0 9.59 17.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.783 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.19 -154.92 52.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.53 -24.78 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 110.428 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 159.93 -124.16 1.31 Allowed Glycine 0 CA--C 1.518 0.273 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.3 p -129.4 156.45 44.05 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.712 0.292 . . . . 0.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.64 -169.42 30.22 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.4 mtp -94.39 137.3 33.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.922 0.391 . . . . 0.0 110.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.25 107.77 3.21 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.4 mt -123.06 159.22 28.9 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 120.906 0.384 . . . . 0.0 110.273 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.656 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.87 149.57 24.72 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.85 -48.34 64.04 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.527 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.5 tp10 -37.98 -25.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.94 0.4 . . . . 0.0 110.842 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.47 52.2 0.19 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.622 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -64.39 -45.68 86.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.274 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.54 -47.23 34.06 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.208 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.26 -43.91 97.74 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.18 -43.0 99.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.708 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.01 -36.39 70.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.1 -77.31 0.11 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.89 HD21 HD11 ' A' ' 44' ' ' ILE . 98.3 mt -28.86 -46.08 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.958 0.408 . . . . 0.0 110.506 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.31 -44.94 90.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.782 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.5 tttm -62.08 -43.63 98.42 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.993 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.9 -39.06 93.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.15 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.23 -43.39 98.96 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.994 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.51 -39.26 92.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.077 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.6 mt-10 -63.53 -43.26 97.65 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.508 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.3 mtp -56.79 -38.32 72.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.99 -38.9 76.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 110.378 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.619 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.5 p-10 -89.51 1.09 56.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.676 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.47 20.64 65.9 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 86.3 m -58.2 -45.97 86.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.8 t80 -63.93 -57.86 8.49 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.441 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.83 -41.83 78.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.2 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.44 -48.72 79.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.532 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -61.69 -41.88 98.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.87 0.367 . . . . 0.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.6 -50.13 74.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.752 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.84 -34.9 72.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.466 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.22 -50.82 29.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.394 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.8 m-85 -62.4 -45.83 91.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.552 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 66.6 m-85 -153.85 155.79 36.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.471 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.5 p-10 -98.05 98.08 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.982 0.42 . . . . 0.0 110.412 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -155.59 -165.59 2.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.583 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.422 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.33 110.67 15.47 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.585 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.0 m -63.57 -40.47 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.46 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 238' ' ' VAL . 90.8 m-85 -58.5 -42.55 87.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.281 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.26 -37.04 94.24 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.702 0 CA-C-O 117.85 -1.528 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 164.38 59.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.647 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.89 143.39 99.35 Favored 'Trans proline' 0 C--N 1.301 -1.958 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.05 -40.31 90.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.594 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.82 142.81 36.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.412 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.5 mt -109.88 128.73 65.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.468 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -103.6 117.0 33.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.34 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.8 mt -111.83 139.28 36.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.409 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.09 105.08 2.14 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.5 m -128.14 118.98 24.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.71 -0.289 . . . . 0.0 111.069 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.521 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 14.1 t70 -113.53 93.15 26.26 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.064 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.16 133.89 57.7 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.476 2.117 . . . . 0.0 112.09 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.2 p -140.79 -19.71 0.82 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.749 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.498 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.6 m-85 -124.87 99.27 6.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.594 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.723 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.18 -61.23 0.23 Allowed Pre-proline 0 C--O 1.218 -0.592 0 CA-C-O 121.672 0.749 . . . . 0.0 111.083 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.723 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.64 -39.5 46.62 Favored 'Trans proline' 0 C--N 1.293 -2.359 0 C-N-CA 122.449 2.1 . . . . 0.0 112.215 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.7 t80 -79.13 -42.6 25.85 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.054 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.657 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.6 mt-10 -149.38 -156.02 0.68 Allowed 'General case' 0 C--O 1.215 -0.746 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.116 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.93 178.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.067 0.46 . . . . 0.0 110.269 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -135.86 143.0 44.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.462 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.1 t-20 -95.5 141.61 28.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.528 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.0 p -65.92 -19.22 65.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.511 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.98 -6.71 55.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.424 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.77 -6.93 58.98 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -79.76 158.26 26.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 110.431 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.9 mt -111.89 134.09 53.67 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.923 0.392 . . . . 0.0 110.381 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.665 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.33 151.11 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.96 0.41 . . . . 0.0 110.31 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.76 151.65 6.66 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -58.63 -42.04 87.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.812 0.339 . . . . 0.0 110.964 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.2 t0 -70.24 -28.32 65.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.364 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.665 HD12 ' C ' ' A' ' 30' ' ' VAL . 96.7 mt -68.88 -40.71 81.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.104 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -61.3 -37.35 82.92 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.754 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.43 -43.99 84.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 120.985 0.422 . . . . 0.0 110.259 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.91 -41.84 92.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.111 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -58.74 -53.61 56.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.619 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.73 -36.73 62.61 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.977 0.418 . . . . 0.0 110.332 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.4 -42.37 75.18 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.824 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.2 m -54.49 -44.48 72.71 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.116 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.97 -47.61 79.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.029 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.42 -41.03 88.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.139 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.984 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.4 -17.59 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.649 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.6 52.74 4.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.128 0.489 . . . . 0.0 110.651 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.08 17.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.885 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -88.36 140.84 29.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.153 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.0 m -117.31 132.01 56.69 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.632 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.43 127.73 43.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.424 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -93.89 135.78 34.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.64 128.44 65.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.368 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 139.41 58.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.521 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.06 131.99 0.14 Allowed Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.553 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.3 Cg_endo -68.49 145.21 63.9 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.745 2.297 . . . . 0.0 112.426 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.886 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.49 -56.66 2.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.1 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.19 -26.57 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.284 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.3 -20.64 19.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.232 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.886 HD12 HD23 ' A' ' 55' ' ' LEU . 57.1 mt -63.97 -42.43 97.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.68 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.703 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.44 -56.89 26.1 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.696 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.5 Cg_exo -55.0 -43.32 60.65 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 122.595 2.197 . . . . 0.0 111.113 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.1 m -58.52 -44.64 89.58 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.763 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.5 tp -58.52 -44.37 89.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.095 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.54 -40.5 95.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.466 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.11 11.08 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.13 11.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.44 -34.33 77.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.94 153.44 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.198 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.43 -20.35 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.128 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.55 157.64 25.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.641 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.18 127.23 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.04 0.448 . . . . 0.0 110.523 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.42 106.79 9.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.383 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.58 ' OG ' HD21 ' A' ' 55' ' ' LEU . 41.2 t -160.28 -178.06 6.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.3 -15.52 60.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.391 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.7 tp -37.97 123.88 1.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.924 0.392 . . . . 0.0 110.551 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.554 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.62 156.82 22.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.594 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.645 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -105.02 149.3 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.301 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 76.0 p -150.3 152.28 34.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.735 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.94 52.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.021 0.438 . . . . 0.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.47 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.887 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.73 -37.57 79.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.912 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.34 -27.85 67.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.142 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -82.92 -51.98 7.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.004 0.431 . . . . 0.0 110.644 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -138.19 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.1 0.476 . . . . 0.0 110.433 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.72 146.78 29.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.038 0.447 . . . . 0.0 110.936 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.562 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.5 m-85 -129.95 150.05 51.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.627 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.39 -151.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.512 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.1 m-20 43.29 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.852 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.11 119.97 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.475 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.6 mt -77.19 -70.07 0.49 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.9 p90 -149.35 166.33 29.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.574 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.91 122.51 28.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.297 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.85 68.86 0.93 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.762 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.69 -104.87 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.429 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.4 p -159.05 165.74 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.656 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.9 ttt-85 -155.24 146.22 22.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.117 0.484 . . . . 0.0 110.353 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.483 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.06 135.99 41.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.801 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.7 110.94 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.5 m -134.29 165.03 32.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.938 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.84 148.67 23.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.3 -28.48 58.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.247 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -58.93 -41.76 88.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.281 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.4 t -101.94 122.03 43.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.75 109.86 19.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.431 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.28 129.73 70.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.579 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -108.5 153.97 41.81 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.672 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.3 Cg_endo -59.05 92.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.781 2.321 . . . . 0.0 111.727 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 6.8 m -171.08 144.11 2.06 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.604 0.565 . . . . 0.0 110.855 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.14 -33.55 61.52 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.287 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.488 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -57.3 -62.43 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.301 -178.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.1 t -56.95 -21.99 34.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.962 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.43 -27.08 58.82 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.365 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.94 133.43 48.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.46 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.19 -17.34 28.7 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.31 151.76 23.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.902 0.382 . . . . 0.0 110.431 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.49 135.58 38.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.372 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.15 136.79 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.622 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.34 139.32 14.65 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -131.3 161.63 40.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.097 0.475 . . . . 0.0 110.319 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.539 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.2 tp -92.73 117.61 30.18 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.627 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.56 157.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.694 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.15 50.71 49.73 Favored Glycine 0 N--CA 1.464 0.521 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.8 p -149.71 168.85 22.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.321 . . . . 0.0 110.893 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.2 p -73.83 -25.78 60.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.41 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -61.1 -55.39 33.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.435 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.34 -53.81 53.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.559 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.77 -51.32 69.84 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.586 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.1 t80 -62.19 -43.9 97.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.122 0.487 . . . . 0.0 110.461 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.85 -44.58 97.66 Favored Glycine 0 CA--C 1.519 0.326 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.782 0.325 . . . . 0.0 110.765 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.19 -34.56 2.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.667 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.605 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.39 -50.73 17.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 111.562 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.19 12.46 36.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.209 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.7 -55.56 0.48 Allowed Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.375 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.19 -10.23 25.53 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.773 2.315 . . . . 0.0 112.001 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.85 -8.78 59.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.509 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.91 33.44 37.02 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.31 137.96 38.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.952 0.406 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.81 129.94 35.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.28 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 pt -126.8 138.56 54.41 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 63.1 t -123.92 133.65 68.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 109.935 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.4 t -95.57 127.56 41.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.55 150.62 27.22 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.251 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.96 6.05 33.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.667 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.13 131.37 5.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.401 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.5 tp60 -65.69 -45.7 81.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 110.415 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.85 -24.24 63.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.486 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.55 -36.52 84.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.157 0.503 . . . . 0.0 110.484 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.0 -46.62 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.001 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.51 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.8 m-85 -64.37 -37.75 88.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.339 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.79 -42.12 96.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.181 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -65.58 -43.28 90.23 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.3 tp -58.58 -48.92 79.33 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.18 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -62.15 -22.52 65.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.382 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.91 25.62 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.544 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.59 12.12 73.1 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.99 -17.42 63.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.563 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.2 pt -127.39 136.48 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.102 0.477 . . . . 0.0 110.42 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.92 -28.1 62.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.145 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.38 155.1 1.79 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.853 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.65 137.1 50.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.938 0.399 . . . . 0.0 110.039 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -85.55 102.5 13.58 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.144 0.497 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.4 tt0 -131.6 165.0 24.62 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.377 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.44 153.11 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.47 -54.29 25.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.337 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.0 t -60.22 -49.17 85.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.438 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.82 87.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.773 0.32 . . . . 0.0 110.777 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.661 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.13 -63.51 1.13 Allowed 'General case' 0 C--O 1.218 -0.556 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.572 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.448 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -58.78 -47.27 85.31 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -49.25 -38.4 26.74 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.099 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.48 -66.02 0.56 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.661 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.0 t80 -40.32 -71.04 0.09 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.608 0.242 . . . . 0.0 111.229 -178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.2 -40.07 92.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.959 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.65 -2.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.507 0.67 . . . . 0.0 110.453 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 177' ' ' VAL . 53.8 mt-30 -124.27 141.77 38.3 Favored Pre-proline 0 C--N 1.33 -0.244 0 O-C-N 122.079 -0.388 . . . . 0.0 110.845 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -43.95 -15.33 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.871 2.381 . . . . 0.0 112.277 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.486 ' N ' ' O ' ' A' ' 175' ' ' GLN . 79.4 t -62.97 -42.83 98.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.95 81.37 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.75 -41.58 95.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.726 0.298 . . . . 0.0 110.479 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.9 m-20 -65.8 -34.49 78.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.578 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.6 m-85 -157.25 143.96 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.807 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.4 pttt -177.81 100.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.075 0.464 . . . . 0.0 110.782 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.9 m-85 -159.06 168.18 27.34 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.01 55.57 3.09 Favored Glycine 0 C--O 1.226 -0.39 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.555 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.68 -117.51 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.83 135.22 35.48 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.487 2.125 . . . . 0.0 112.008 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.0 p -125.08 -108.14 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.54 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.64 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.178 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.53 155.73 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 O-C-N 124.17 0.919 . . . . 0.0 110.634 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.2 118.23 22.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.791 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.87 -18.57 62.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.071 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.05 73.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.518 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.464 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.4 mt -60.97 -44.36 97.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.743 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.435 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.0 m-85 -113.68 7.58 17.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.697 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.99 -154.84 50.21 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.645 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.7 -25.39 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.857 0.36 . . . . 0.0 110.56 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.456 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.05 -126.14 1.55 Allowed Glycine 0 C--N 1.33 0.233 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.7 p -131.97 159.92 37.3 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.427 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.65 -162.39 24.7 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.8 mtp -98.5 141.02 31.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.944 0.402 . . . . 0.0 110.621 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.17 111.81 3.96 Favored Glycine 0 C--N 1.33 0.233 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.4 mt -120.64 160.54 23.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 110.307 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -86.95 148.98 25.1 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.18 -49.04 64.64 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.662 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -39.89 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.89 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -71.91 52.13 0.23 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.5 -46.16 84.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.18 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.46 -47.07 35.68 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.212 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.27 -43.92 97.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.459 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.55 -42.89 99.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.6 -37.36 73.1 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.64 -77.55 0.11 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.984 HD21 HD11 ' A' ' 44' ' ' ILE . 87.4 mt -28.72 -45.65 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.858 0.361 . . . . 0.0 110.481 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.4 m-20 -63.59 -45.64 89.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.6 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.37 -43.77 98.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.968 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.27 92.54 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.106 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.26 -43.33 99.05 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.105 0.479 . . . . 0.0 110.071 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.37 -39.41 93.09 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.074 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.62 -43.01 98.11 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.504 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.78 -38.37 72.39 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.81 -38.79 76.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.086 0.47 . . . . 0.0 110.373 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.41 92.81 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.672 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 21.0 p-10 -88.36 0.38 56.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.743 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.56 20.11 67.59 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.455 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.6 m -58.04 -46.22 85.7 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.475 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.1 t80 -63.42 -57.46 10.21 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.448 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.91 -41.78 78.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.245 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.3 -48.67 79.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.48 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.51 -41.73 97.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.548 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.39 -49.68 76.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.692 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.87 -35.26 72.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.465 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.72 -51.16 29.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.39 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.2 m-85 -62.17 -45.92 91.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.581 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.0 m-85 -154.11 155.14 34.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.47 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 46.4 p-10 -97.84 101.21 12.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.95 0.405 . . . . 0.0 110.476 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -157.51 -165.44 1.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.568 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.2 t0 -122.63 109.94 14.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.697 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.6 m -63.63 -40.41 88.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.504 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.412 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.2 m-85 -58.27 -43.6 88.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.217 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.65 -36.76 93.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.418 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.657 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.983 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.12 164.47 56.69 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.671 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.82 143.34 99.36 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.624 2.216 . . . . 0.0 112.29 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.49 -40.23 89.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.554 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.86 143.69 36.86 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.426 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.7 128.58 66.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.5 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -104.83 118.59 36.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.054 0.454 . . . . 0.0 110.362 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.7 138.52 41.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.393 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.89 99.58 1.55 Allowed Glycine 0 N--CA 1.463 0.495 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.6 m -123.41 117.68 25.74 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 122.696 -0.297 . . . . 0.0 111.255 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.516 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 12.8 t0 -112.85 93.04 22.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.18 133.84 57.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.424 2.083 . . . . 0.0 112.188 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.5 p -141.05 -19.5 0.8 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.742 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.6 m-85 -124.78 99.05 5.97 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.649 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.728 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.08 -61.33 0.22 Allowed Pre-proline 0 C--O 1.218 -0.577 0 CA-C-O 121.563 0.697 . . . . 0.0 111.125 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.728 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.73 -39.05 47.57 Favored 'Trans proline' 0 C--N 1.293 -2.384 0 C-N-CA 122.36 2.04 . . . . 0.0 112.254 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.9 t80 -79.38 -42.9 24.5 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.952 0.406 . . . . 0.0 111.132 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.8 mt-10 -149.25 -155.97 0.68 Allowed 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.114 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.24 177.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.043 0.449 . . . . 0.0 110.317 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -135.84 142.06 44.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.44 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.3 t-20 -94.81 141.71 28.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.467 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.528 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.1 p -65.88 -19.21 65.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.542 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.28 -6.96 56.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.433 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.33 -7.47 58.31 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -78.92 158.02 28.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.97 0.414 . . . . 0.0 110.403 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.4 mt -112.62 134.54 54.09 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 120.929 0.395 . . . . 0.0 110.401 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.675 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.3 p -133.42 151.2 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.361 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.83 151.64 6.67 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -58.59 -42.09 87.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.903 0.383 . . . . 0.0 111.012 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.477 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.5 t0 -70.17 -28.01 64.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.433 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.675 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -68.55 -41.37 82.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.119 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -60.71 -37.57 82.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.094 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.47 -43.96 84.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.188 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.537 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -60.02 -41.75 92.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.133 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.7 -53.32 59.69 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.554 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -54.08 -36.56 63.29 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.945 0.402 . . . . 0.0 110.266 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.0 mt -69.53 -42.37 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.772 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.62 -44.02 72.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.065 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.3 tttm -64.07 -47.65 79.28 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.986 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mmt-85 -59.82 -40.81 89.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.948 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.999 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.36 -18.24 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.616 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.79 52.51 4.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.181 0.515 . . . . 0.0 110.618 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -144.99 169.94 17.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.956 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -87.9 139.93 30.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.056 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -116.52 131.31 56.98 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.9 m -128.47 128.03 43.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.489 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.74 136.44 35.05 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.414 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -129.75 128.72 65.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.343 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.84 139.37 58.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.781 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.89 132.81 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.519 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 57' ' ' ALA . 51.4 Cg_endo -68.55 144.92 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.562 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.939 HD23 HD12 ' A' ' 58' ' ' LEU . 76.9 mt -40.81 -55.81 2.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.129 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.41 -26.65 1.39 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.173 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.46 -20.18 19.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.939 HD12 HD23 ' A' ' 55' ' ' LEU . 86.5 mt -64.93 -42.45 94.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.959 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.52 -56.91 28.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.685 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 47.4 Cg_exo -55.35 -43.24 60.43 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.586 2.191 . . . . 0.0 111.035 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.3 m -58.68 -44.41 90.23 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.688 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.2 tp -58.53 -44.31 89.52 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -64.55 -40.36 95.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.996 0.426 . . . . 0.0 110.434 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.9 11.22 1.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.565 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 55.95 11.84 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.17 77.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.494 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.7 pt -124.54 153.11 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.281 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.7 m-20 -94.37 -19.64 20.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.284 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.95 156.88 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.755 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.597 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -117.11 128.0 74.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 110.534 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.477 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.38 106.51 9.05 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.399 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.608 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.2 t -159.66 -179.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.607 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.3 -15.31 60.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.391 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.0 tp -37.78 123.86 1.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.971 0.415 . . . . 0.0 110.416 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.07 156.37 23.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.691 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.3 pt -104.87 148.87 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.238 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.9 p -150.04 152.5 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.821 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.27 -47.69 55.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.604 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.72 -39.71 71.45 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.788 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.638 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.27 -37.83 81.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.928 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.29 75.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.779 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.59 67.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.076 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.12 -51.76 7.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.019 0.438 . . . . 0.0 110.591 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.6 pt -138.45 -168.47 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.362 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.88 146.87 29.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.112 0.482 . . . . 0.0 110.998 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.561 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.3 m-85 -129.87 150.0 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.641 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.2 t -164.41 -151.57 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.444 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 98.1 m-20 43.07 19.3 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.8 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.6 mttt -28.27 120.22 0.12 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.397 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.467 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -77.26 -69.99 0.5 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.825 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 40.3 p90 -149.4 166.25 29.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.649 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.08 123.39 28.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.013 0.435 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.466 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.47 67.97 0.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.727 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.5 -104.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.436 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.2 p -159.58 165.99 31.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.7 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.573 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.06 146.52 23.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.144 0.497 . . . . 0.0 110.456 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -101.3 135.86 42.1 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 110.839 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.409 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.9 t -122.67 110.45 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.28 165.11 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.935 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.19 148.61 23.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.97 -27.84 46.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.191 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -59.1 -41.8 88.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.221 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.45 122.14 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.129 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.54 109.26 19.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.068 0.461 . . . . 0.0 110.398 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.18 129.88 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.73 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.98 159.05 34.01 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.992 0.425 . . . . 0.0 110.53 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.1 Cg_endo -59.63 89.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.707 2.271 . . . . 0.0 111.943 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.6 m -169.23 140.91 2.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 123.546 0.529 . . . . 0.0 110.786 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -66.55 -32.58 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.227 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.19 -62.72 1.56 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.375 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.2 t -56.11 -22.18 26.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.124 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.96 -26.81 57.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.345 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.71 132.84 46.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.436 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.41 -15.92 32.43 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -87.1 151.78 22.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.437 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -96.71 135.89 38.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.075 0.464 . . . . 0.0 110.298 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.99 136.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.738 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.41 138.93 14.5 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.24 161.64 40.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.068 0.461 . . . . 0.0 110.386 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.1 tp -92.71 117.95 30.54 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.51 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.98 157.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.657 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.39 50.58 49.15 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 80.7 p -149.67 168.98 22.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.94 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.44 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.3 p -74.01 -25.73 60.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.401 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.21 -55.44 32.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.468 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -57.09 -54.06 51.07 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.57 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.9 m -60.46 -51.01 71.31 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.702 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.602 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.25 -43.86 97.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.11 0.481 . . . . 0.0 110.44 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.21 -44.55 97.55 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.27 -14.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.801 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.38 2.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.602 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.1 t60 -74.43 -50.75 17.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.959 0.409 . . . . 0.0 111.653 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -98.98 12.54 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.32 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.766 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.9 -55.58 0.47 Allowed Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.377 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.16 -10.44 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.825 2.35 . . . . 0.0 111.959 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.61 -8.84 59.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.496 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.89 33.45 37.09 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.54 138.06 38.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.973 0.416 . . . . 0.0 110.598 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.65 129.73 35.03 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.307 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.52 54.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.934 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.11 133.56 68.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.026 0.441 . . . . 0.0 109.959 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 127.97 42.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -108.29 150.45 27.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.165 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -104.37 5.61 34.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.68 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -134.44 131.87 6.11 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -65.63 -45.76 81.83 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.411 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -69.61 -24.43 63.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 0.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.469 ' O ' ' OG ' ' A' ' 151' ' ' SER . 56.9 t-20 -64.45 -36.69 85.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 0.0 110.48 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.79 -46.56 88.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.133 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.5 m-85 -64.43 -37.6 88.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.315 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -60.88 -42.5 98.09 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.09 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -65.2 -43.13 92.56 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.884 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.0 tp -59.17 -48.37 81.87 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.071 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.5 m -62.69 -22.26 66.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.915 0.388 . . . . 0.0 110.026 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.89 -17.71 26.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.63 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.54 11.95 73.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -69.78 -17.57 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.609 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.0 pt -127.53 136.62 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.993 0.425 . . . . 0.0 110.479 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -73.01 -28.28 62.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.2 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.473 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.36 155.27 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.802 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.61 137.44 50.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.961 0.41 . . . . 0.0 109.95 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.66 102.95 14.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.239 0.542 . . . . 0.0 110.714 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.573 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.2 tt0 -132.14 165.14 24.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.377 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.24 152.35 41.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.028 0.442 . . . . 0.0 110.601 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.2 -54.13 28.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.343 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.8 t -60.4 -49.17 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.512 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -38.85 88.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 110.867 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.01 -63.49 1.14 Allowed 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.589 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.9 m -58.67 -47.01 85.92 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.792 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.66 -38.05 30.98 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.057 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.474 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.68 -65.59 0.55 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.2 t80 -40.63 -71.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.644 0.259 . . . . 0.0 111.394 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.4 mt -61.38 -39.87 92.27 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.81 -2.92 0.44 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.537 0.684 . . . . 0.0 110.499 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 177' ' ' VAL . 51.2 mt-30 -124.43 142.1 39.39 Favored Pre-proline 0 C--N 1.33 -0.249 0 O-C-N 122.09 -0.382 . . . . 0.0 110.891 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -44.06 -15.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.808 2.339 . . . . 0.0 112.299 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 175' ' ' GLN . 81.5 t -63.09 -43.03 98.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.632 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.62 -32.86 79.84 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.9 -41.31 95.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.73 0.3 . . . . 0.0 110.502 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 47.7 m-20 -65.8 -34.92 79.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.638 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 77.5 m-85 -157.04 143.54 18.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.9 pttt -177.22 100.15 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.982 0.42 . . . . 0.0 110.728 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -159.31 167.5 28.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.699 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.31 55.52 3.05 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.562 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.45 -117.46 0.01 OUTLIER Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.93 135.5 36.23 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.465 2.11 . . . . 0.0 111.932 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 89.4 p -124.95 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.601 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.657 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -165.79 165.37 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.185 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.49 156.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 124.169 0.918 . . . . 0.0 110.649 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.14 118.28 22.94 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.2 mp0 -71.73 -18.63 62.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.9 -32.36 73.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.57 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.452 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.6 mt -60.86 -44.25 97.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 -178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.44 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.8 m-85 -114.05 8.36 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.719 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.12 -154.7 51.04 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.651 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.71 -25.51 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.869 0.366 . . . . 0.0 110.551 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.0 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.4 p -131.97 160.06 36.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.827 0.346 . . . . 0.0 110.41 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.48 -162.42 24.6 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.87 32.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.914 0.387 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.86 3.96 Favored Glycine 0 C--N 1.329 0.179 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 84.6 mt -121.28 160.27 24.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.94 0.4 . . . . 0.0 110.164 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.81 149.08 25.09 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 120.881 0.372 . . . . 0.0 110.591 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.37 -48.6 65.48 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.669 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -39.94 -23.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.015 0.436 . . . . 0.0 110.831 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.1 m-20 -71.89 52.17 0.23 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.739 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -64.42 -46.03 84.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.313 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.7 -46.94 34.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.241 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.25 -43.87 97.84 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.438 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.51 -42.89 99.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.728 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.73 -37.35 73.41 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.702 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.38 0.11 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.999 HD21 HD11 ' A' ' 44' ' ' ILE . 85.5 mt -28.91 -45.71 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.471 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.6 m-20 -63.61 -45.28 91.03 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.49 -43.79 98.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.91 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.095 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.15 -43.52 98.75 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.06 0.457 . . . . 0.0 110.046 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.29 92.49 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.064 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.9 97.31 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -57.0 -38.32 72.91 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.84 -38.79 76.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.076 0.465 . . . . 0.0 110.322 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.28 93.31 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.656 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.33 0.31 56.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.727 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.55 20.25 67.71 Favored Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.28 -46.15 86.59 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.467 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 77.2 t80 -63.44 -57.36 10.51 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.372 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.99 -41.46 78.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.236 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.62 -48.36 81.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.598 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.88 -41.61 98.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.402 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.62 -49.79 76.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.639 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.56 -35.35 72.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.529 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.57 -51.07 30.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.544 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.51 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 35.7 m-85 -62.28 -45.7 92.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.617 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.2 m-85 -154.3 154.82 34.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.0 p-10 -97.79 100.13 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.409 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -156.25 -165.39 1.9 Allowed 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.58 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.6 t0 -122.5 109.89 14.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.645 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 239' ' ' TYR . 21.2 m -63.39 -40.46 89.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.416 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.0 m-85 -59.06 -42.53 90.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.304 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.25 -37.08 94.3 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.659 0 CA-C-O 117.872 -1.516 . . . . 0.0 110.975 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.04 164.33 61.94 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.595 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -60.84 143.53 99.39 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 122.574 2.182 . . . . 0.0 112.32 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.41 -40.78 89.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.09 141.22 38.15 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.442 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.8 mt -109.27 127.43 66.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.912 0.387 . . . . 0.0 110.567 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -101.28 117.71 35.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.12 0.486 . . . . 0.0 110.277 179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.9 mt -112.16 138.55 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.922 0.391 . . . . 0.0 110.537 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.59 105.25 2.22 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.4 m -128.3 119.52 25.28 Favored 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 122.676 -0.308 . . . . 0.0 111.242 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.525 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 10.8 t0 -113.44 92.59 23.8 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.33 134.13 59.49 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.44 2.093 . . . . 0.0 112.12 179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -141.39 -19.87 0.77 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.728 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -123.28 98.62 5.95 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.706 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.12 -61.4 0.22 Allowed Pre-proline 0 C--O 1.218 -0.564 0 CA-C-O 121.441 0.639 . . . . 0.0 111.055 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.729 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.4 Cg_endo -49.38 -40.5 44.19 Favored 'Trans proline' 0 C--N 1.295 -2.25 0 C-N-CA 122.26 1.974 . . . . 0.0 112.241 -179.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.9 t80 -78.37 -43.12 28.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.107 0.48 . . . . 0.0 111.002 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.662 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.8 mt-10 -149.23 -154.38 0.55 Allowed 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.938 -178.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.71 177.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.049 0.452 . . . . 0.0 110.407 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.43 144.76 46.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.38 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -95.81 134.44 38.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.613 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -64.61 -18.95 65.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.537 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.28 -6.36 54.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.453 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.81 -8.52 56.23 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -80.14 158.73 26.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 110.471 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.2 mt -112.45 131.76 55.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.952 0.406 . . . . 0.0 110.428 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.685 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.15 151.59 32.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.296 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.87 151.67 6.69 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.93 -41.93 88.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.856 0.36 . . . . 0.0 110.941 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.492 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.1 t0 -69.66 -28.6 66.02 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.152 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -67.9 -41.02 84.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.845 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -60.88 -37.24 81.5 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.945 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.2 tp -65.1 -45.07 86.7 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.2 -48.01 79.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.993 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -53.3 -54.27 38.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.352 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -52.75 -39.59 62.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.85 0.357 . . . . 0.0 110.308 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.0 -42.16 76.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.038 0.447 . . . . 0.0 110.622 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.74 -44.62 70.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.128 -179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.433 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.1 tttm -63.83 -47.38 81.01 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.84 -41.68 91.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.116 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.914 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -75.56 -18.09 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.552 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 61.04 52.76 3.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.505 -179.238 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 p -146.6 171.21 15.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.69 141.31 28.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.073 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.4 m -116.8 130.42 56.7 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.738 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.0 m -126.81 126.93 44.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.428 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -93.88 135.5 35.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.581 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -129.53 128.32 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.324 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.04 139.67 58.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.525 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.0 OUTLIER 173.93 129.22 0.11 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.513 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.4 Cg_endo -67.5 146.32 73.81 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.753 2.302 . . . . 0.0 112.471 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.862 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -40.45 -56.57 2.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.148 -179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.97 -26.82 1.91 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.898 0.38 . . . . 0.0 111.271 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.75 -20.69 19.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.294 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.862 HD12 HD23 ' A' ' 55' ' ' LEU . 60.6 mt -64.42 -42.27 96.14 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.717 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.715 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.19 -56.76 28.13 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.822 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.715 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.7 Cg_exo -55.36 -44.06 52.52 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.628 2.219 . . . . 0.0 111.141 177.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.4 m -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.692 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.94 -44.24 86.82 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.6 -40.17 95.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 0.0 110.5 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.26 11.19 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.82 12.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.24 -34.28 77.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.576 178.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 pt -123.76 152.93 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.218 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.44 -20.65 20.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.302 -179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.38 156.51 26.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.749 -179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.59 HG23 HD13 ' A' ' 58' ' ' LEU . 96.8 mt -115.47 126.99 73.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.016 0.436 . . . . 0.0 110.475 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.492 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -128.31 106.04 8.75 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.309 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.681 ' OG ' HD21 ' A' ' 55' ' ' LEU . 45.6 t -159.67 -179.84 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.589 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.66 -15.48 61.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.379 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.8 tp -36.23 123.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.52 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.555 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.6 p -81.66 154.6 26.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.641 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -104.55 148.01 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.375 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.1 p -149.57 152.35 35.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.867 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.24 -47.23 55.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.42 -39.97 70.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.73 -179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.48 -37.87 80.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -58.1 -38.05 75.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.786 -179.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.05 -27.43 66.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.061 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.58 -50.83 7.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.03 0.443 . . . . 0.0 110.596 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.2 pt -139.53 -168.31 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.58 147.16 29.79 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.045 0.45 . . . . 0.0 111.08 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.546 ' CD2' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.92 150.03 51.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.574 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.9 t -164.05 -152.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.051 0.453 . . . . 0.0 110.534 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.511 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.8 m-20 41.64 19.5 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.889 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.35 121.34 0.19 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.392 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.433 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 59.6 mt -75.11 -68.66 0.53 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.893 -178.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.45 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.8 167.72 26.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.09 123.27 28.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.264 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.86 68.26 0.91 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.785 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -85.84 -104.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.405 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.47 165.89 32.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.709 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.28 145.93 22.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.434 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.9 mt -100.74 136.14 41.08 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 110.816 178.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.8 t -122.5 110.98 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.19 165.01 32.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.046 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 148.52 24.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.18 -28.31 57.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.179 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.18 -41.69 89.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.307 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.8 t -101.83 121.74 42.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.246 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.83 109.86 19.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.103 0.477 . . . . 0.0 110.503 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -127.04 129.79 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.669 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -108.76 154.18 41.89 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.625 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.518 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.1 Cg_endo -59.24 92.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.758 2.305 . . . . 0.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -171.08 144.04 2.04 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.633 0.583 . . . . 0.0 110.795 179.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.47 -33.82 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.138 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.486 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.54 -62.7 1.6 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 -178.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 t -56.22 -22.44 29.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.014 -179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.5 -26.52 58.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.246 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.39 133.44 45.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 -179.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.81 -16.87 29.42 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.21 151.55 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.0 0.428 . . . . 0.0 110.491 -179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.31 136.15 37.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.024 0.44 . . . . 0.0 110.337 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.3 t -127.59 136.99 58.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.78 139.9 14.92 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -132.1 161.71 40.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.044 0.449 . . . . 0.0 110.388 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.91 118.32 31.0 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.607 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -51.46 157.61 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.609 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.04 50.84 49.58 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -149.69 168.46 23.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.45 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.9 p -74.49 -25.63 59.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.482 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -61.0 -55.77 28.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.562 -179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -57.14 -54.11 50.52 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.588 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.28 -51.28 70.23 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.73 -179.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.3 t80 -62.28 -43.8 97.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.128 0.489 . . . . 0.0 110.582 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.64 -44.48 97.89 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 -179.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.63 -14.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 0.0 110.79 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.19 -34.64 2.72 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.762 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.6 t60 -74.12 -50.55 18.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.135 0.493 . . . . 0.0 111.614 -178.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -99.12 12.39 36.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.287 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.49 -55.41 0.49 Allowed Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.434 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.3 Cg_endo -72.2 -10.39 25.73 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.786 2.324 . . . . 0.0 111.993 -179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.63 -9.05 59.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.459 -179.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.75 33.3 38.17 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.98 138.09 37.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.902 0.382 . . . . 0.0 110.627 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.92 129.8 35.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.195 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.1 pt -127.16 138.98 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.2 t -125.59 132.1 71.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 109.943 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 33.4 t -98.43 130.59 45.05 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 120.998 0.427 . . . . 0.0 110.879 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -111.82 156.44 21.99 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.353 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -107.07 6.67 29.16 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.818 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.42 130.65 6.25 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.421 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.1 tp60 -65.88 -46.03 79.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.767 0.318 . . . . 0.0 110.439 179.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.95 -23.15 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.571 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.45 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.3 t-20 -64.51 -36.96 85.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 110.561 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.13 -47.08 85.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.207 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.2 m-85 -63.87 -37.87 89.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.362 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -61.08 -42.28 98.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.166 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.68 -45.24 90.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.06 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.9 tp -58.87 -47.81 83.6 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.991 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -63.09 -22.93 67.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.947 0.403 . . . . 0.0 110.123 179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.7 24.65 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.599 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.02 11.28 70.28 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.63 -18.17 63.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.957 0.408 . . . . 0.0 110.627 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.5 pt -127.87 136.7 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.77 -27.83 62.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.3 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.457 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.61 155.75 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.8 137.34 50.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.93 0.395 . . . . 0.0 109.955 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.92 103.19 14.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.34 0.59 . . . . 0.0 110.819 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.75 165.3 24.86 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.348 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -72.78 152.7 41.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.959 0.409 . . . . 0.0 110.638 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.73 -54.69 20.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.279 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.45 HG21 ' CG ' ' A' ' 91' ' ' TYR . 77.0 t -60.08 -48.83 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.623 -179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.77 88.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.861 0.363 . . . . 0.0 110.856 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.2 -63.13 1.23 Allowed 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.65 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.429 ' OG ' HD12 ' A' ' 173' ' ' LEU . 73.6 m -59.12 -47.63 84.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.851 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.4 tt0 -48.54 -38.02 19.29 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.241 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.17 -65.38 0.54 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.9 t80 -40.68 -71.39 0.08 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 111.286 -178.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.2 mt -61.31 -40.04 92.7 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.84 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.2 tttt -59.7 -2.91 0.41 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.451 0.643 . . . . 0.0 110.442 -179.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 173' ' ' LEU . 23.4 mt-30 -123.8 148.46 56.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.854 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.93 -20.45 2.98 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.896 2.397 . . . . 0.0 112.195 178.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 74.9 t -60.74 -42.89 93.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.586 -179.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.96 -33.24 84.88 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.44 95.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.677 0.275 . . . . 0.0 110.459 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.1 m-20 -65.41 -33.62 76.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.315 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.1 m-85 -156.56 142.74 18.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.693 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.554 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.3 pttt -176.94 99.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.779 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.554 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.8 m-85 -159.22 167.6 28.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.708 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.29 56.17 2.9 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.84 -117.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.52 135.12 33.29 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.514 2.142 . . . . 0.0 111.89 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.4 p -125.08 -108.36 0.32 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.59 -179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.44 164.81 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.363 -179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.86 156.07 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.91 0.756 . . . . 0.0 110.657 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -82.37 117.66 22.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.937 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.0 mp0 -71.97 -17.35 62.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.14 -33.05 74.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.586 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.466 HD11 ' CG ' ' A' ' 128' ' ' PHE . 89.5 mt -61.16 -44.46 97.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.697 -178.006 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.45 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.6 m-85 -113.63 9.36 17.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.768 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.84 -153.51 51.43 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.4 p -70.66 -25.35 26.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.846 0.355 . . . . 0.0 110.5 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.13 -123.94 1.28 Allowed Glycine 0 CA--C 1.519 0.294 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.9 p -129.36 156.27 44.32 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.733 0.301 . . . . 0.0 110.324 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.74 -169.44 30.34 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.511 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -95.32 138.94 32.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 110.556 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.71 107.26 3.2 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.664 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.1 mt -119.25 160.06 22.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.69 149.06 24.48 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 120.855 0.359 . . . . 0.0 110.636 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.27 -48.66 65.16 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.543 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -40.15 -23.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.048 0.451 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -71.7 52.11 0.21 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.666 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.52 -45.23 88.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.388 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.16 -47.17 29.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.327 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.8 tp -62.25 -44.17 97.15 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.448 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.08 -43.13 99.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.846 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.42 -37.21 72.41 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.67 -78.04 0.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.914 HD21 HD11 ' A' ' 44' ' ' ILE . 89.9 mt -28.48 -46.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.68 0.276 . . . . 0.0 110.321 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.6 m-20 -63.85 -45.01 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.568 178.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.78 -43.73 98.27 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.44 93.85 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.006 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.26 -43.61 98.6 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.994 0.426 . . . . 0.0 109.914 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.26 92.66 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.94 -42.89 97.21 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.505 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -57.05 -38.08 72.72 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.89 -38.96 76.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.973 0.416 . . . . 0.0 110.348 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.86 94.31 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.677 -179.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.1 p-10 -89.15 1.02 56.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.619 179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.59 20.48 65.97 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.5 m -58.05 -46.33 85.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.433 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 75.1 t80 -63.64 -58.02 8.24 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.418 179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.6 -41.76 77.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.56 -48.34 81.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.596 -179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 78.7 mt -62.14 -41.61 98.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.311 179.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.97 -50.34 74.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.616 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.13 -35.33 71.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.648 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.8 -51.0 29.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.627 179.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 39.2 m-85 -61.95 -46.04 91.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.61 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.6 m-85 -154.35 155.79 35.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.411 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.1 p-10 -97.36 99.41 10.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.996 0.427 . . . . 0.0 110.415 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -156.27 -166.21 2.1 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.617 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.41 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.87 110.75 15.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.795 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.3 m -63.34 -40.41 88.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.414 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.413 ' N ' HG23 ' A' ' 238' ' ' VAL . 94.1 m-85 -58.93 -42.9 90.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.251 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.37 -37.37 94.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.664 0 CA-C-O 117.866 -1.519 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.54 164.34 58.63 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.87 99.44 Favored 'Trans proline' 0 C--N 1.301 -1.953 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.14 -40.53 90.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.564 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.89 144.01 36.97 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.5 128.4 66.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.2 mtp180 -103.96 118.62 37.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.306 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.85 138.7 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.378 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.73 100.36 1.59 Allowed Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.7 m -123.8 118.56 27.43 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 122.718 -0.283 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.518 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.8 t70 -113.32 93.15 25.22 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.987 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.16 133.8 57.29 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.468 2.112 . . . . 0.0 112.084 179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.2 p -140.18 -19.9 0.88 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.745 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.4 m-85 -124.73 99.08 5.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.601 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.04 -61.44 0.22 Allowed Pre-proline 0 C--O 1.219 -0.542 0 CA-C-O 121.626 0.727 . . . . 0.0 111.085 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.726 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.6 -39.37 46.33 Favored 'Trans proline' 0 C--N 1.294 -2.298 0 C-N-CA 122.439 2.093 . . . . 0.0 112.236 -179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.9 t80 -79.28 -42.96 24.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.928 0.394 . . . . 0.0 111.02 179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.27 -155.86 0.67 Allowed 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.01 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.72 177.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.004 0.43 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.36 139.46 45.64 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.39 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -91.01 136.79 32.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.662 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -64.83 -19.22 65.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.539 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -79.13 -5.92 55.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.512 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 -8.24 57.05 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.1 157.62 26.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.95 0.405 . . . . 0.0 110.438 179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.9 mt -112.83 134.56 54.28 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.942 0.401 . . . . 0.0 110.375 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.673 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.47 151.31 33.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.407 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.95 151.48 6.61 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.56 -42.12 87.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.925 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 -69.99 -27.92 65.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.396 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.673 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.7 mt -68.81 -41.14 82.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.017 179.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -60.72 -37.66 82.47 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.081 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 56.5 tp -66.09 -44.08 85.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.206 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.1 -44.31 91.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.093 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -56.51 -53.84 52.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.756 -0.377 . . . . 0.0 110.541 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.32 -37.44 62.28 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.921 0.391 . . . . 0.0 110.306 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.57 -42.09 74.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.764 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.5 m -54.45 -44.1 72.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.102 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.15 -47.69 78.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.08 178.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -59.53 -41.21 89.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.069 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.006 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -76.22 -18.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.683 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.9 52.49 4.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.586 -179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.2 p -145.36 170.1 17.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.18 140.48 29.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.059 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.9 m -116.7 131.23 57.01 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.654 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.3 127.99 43.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.436 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -94.69 136.38 35.07 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.435 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.72 128.57 65.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.311 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.14 139.08 58.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.748 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.518 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 174.09 132.85 0.12 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.542 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.7 Cg_endo -68.42 144.75 62.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.647 2.231 . . . . 0.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.936 HD23 HD12 ' A' ' 58' ' ' LEU . 77.8 mt -40.49 -55.65 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.098 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -47.84 -26.45 1.66 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.109 -179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.34 19.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.184 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.936 HD12 HD23 ' A' ' 55' ' ' LEU . 85.1 mt -65.03 -42.33 94.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.826 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.709 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -61.83 -56.59 30.84 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.739 -179.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.709 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.2 Cg_exo -55.47 -43.26 59.94 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.591 2.194 . . . . 0.0 111.108 177.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.7 m -58.83 -44.44 90.92 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.8 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.27 -44.36 88.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.69 -40.08 94.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 0.0 110.469 178.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.07 11.26 1.53 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.505 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.94 11.86 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.34 -34.19 77.16 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.546 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.6 pt -124.4 153.15 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.285 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.9 m-20 -93.96 -19.83 20.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.181 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.03 156.9 25.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.726 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 58' ' ' LEU . 96.7 mt -116.61 127.56 74.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.084 0.469 . . . . 0.0 110.541 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.467 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.4 ttp -128.18 106.55 9.12 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.403 179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.623 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.1 t -159.84 -179.08 7.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.639 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.29 -15.27 59.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.414 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.644 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.0 tp -37.56 123.77 1.01 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.914 0.388 . . . . 0.0 110.533 -179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.16 156.38 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.627 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.652 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.2 pt -104.98 148.99 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.264 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.0 p -150.26 152.6 34.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.722 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.11 -47.76 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.616 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.63 -39.62 71.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.708 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.644 HH12 ' CD1' ' A' ' 74' ' ' LEU . 91.7 mtt180 -68.73 -37.74 79.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.856 179.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.34 -37.56 75.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.931 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.13 -27.66 67.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.133 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.12 -51.73 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.617 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.4 pt -138.52 -168.34 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 CA-C-O 121.139 0.495 . . . . 0.0 110.416 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.03 147.04 29.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.558 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.4 m-85 -130.07 150.23 51.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.57 -151.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.479 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.3 m-20 42.97 19.26 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.21 120.49 0.11 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.49 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.461 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.4 mt -77.19 -70.01 0.49 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.778 -178.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.428 ' CG ' HG21 ' A' ' 166' ' ' VAL . 43.0 p90 -149.38 166.35 29.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.589 -179.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.29 122.32 27.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.323 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -103.37 68.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.79 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.08 -104.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.391 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 31.5 p -159.57 165.86 31.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.624 -179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.58 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -154.68 146.7 23.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 0.0 110.473 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.3 mt -101.6 135.68 42.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.762 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.411 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.78 110.36 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.31 164.97 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.845 -179.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.75 148.39 23.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.996 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.5 -27.61 39.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.252 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -59.38 -41.71 89.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.359 -179.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.1 t -102.38 122.0 43.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.236 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.49 109.19 19.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 110.411 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.469 ' C ' ' NE2' ' A' ' 106' ' ' GLN . 97.0 mt -128.37 129.61 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.666 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.612 ' NE2' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.06 159.15 33.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.555 179.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.453 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.39 89.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.699 2.266 . . . . 0.0 111.908 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.8 m -168.88 140.35 2.53 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.511 0.507 . . . . 0.0 110.811 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -66.47 -32.63 58.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.324 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.3 tp10 -56.74 -62.85 1.45 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.443 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -56.64 -22.08 31.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.965 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 mt -75.63 -27.26 58.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.334 179.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -55.08 132.96 48.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.449 -179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.14 -16.52 32.96 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.98 151.81 22.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.903 0.382 . . . . 0.0 110.449 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.65 135.59 38.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.997 0.427 . . . . 0.0 110.33 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -126.87 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.65 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.35 138.54 14.29 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.96 161.62 40.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 121.065 0.459 . . . . 0.0 110.337 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 41.0 tp -92.71 118.33 30.95 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.56 179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -52.02 157.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.663 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.1 50.64 50.43 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.7 p -149.55 168.74 22.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.739 0.304 . . . . 0.0 110.889 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 81.8 p -73.67 -26.53 60.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.391 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -60.68 -55.36 34.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.517 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.99 -54.36 47.61 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.549 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.0 m -60.52 -51.03 71.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.66 -179.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.604 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.2 t80 -62.21 -43.82 97.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 0.0 110.398 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.34 97.9 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.9 m-20 -45.32 -14.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 0.0 110.684 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.44 -34.44 2.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.703 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.604 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.37 -50.93 16.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.008 0.432 . . . . 0.0 111.545 -178.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.6 m95 -99.26 12.81 35.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.183 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.07 -55.5 0.46 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.375 179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.35 -10.21 25.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.797 2.331 . . . . 0.0 111.993 -179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.76 -8.86 59.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.18 33.33 36.3 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.41 137.89 39.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.963 0.411 . . . . 0.0 110.587 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.58 129.71 35.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.299 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.08 137.97 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.857 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.34 133.23 69.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 109.998 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.1 t -97.37 127.98 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.797 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.02 153.78 25.11 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.319 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -106.84 6.51 29.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.714 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.69 130.53 6.0 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.5 tp60 -66.18 -45.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.472 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.04 -23.74 63.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.471 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.462 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.5 t-20 -64.58 -36.63 84.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.523 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.97 -46.95 86.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.117 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.504 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.6 m-85 -64.21 -37.69 88.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.297 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.98 -42.49 98.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.023 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -64.71 -43.54 93.1 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.038 179.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.7 tp -58.84 -48.34 81.69 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.38 -22.47 66.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.149 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.04 -17.81 25.64 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.577 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 12.11 73.03 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.97 -17.61 63.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 110.621 179.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 153' ' ' LEU . 33.7 pt -127.37 136.5 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.511 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -72.83 -28.36 62.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.153 -179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.35 155.29 1.83 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.6 137.52 50.75 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.91 0.386 . . . . 0.0 110.04 179.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.83 102.9 14.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.149 0.499 . . . . 0.0 110.656 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.19 165.17 24.71 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.396 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.466 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.39 152.27 40.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.561 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.425 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.19 -54.18 28.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.428 HG21 ' CG ' ' A' ' 91' ' ' TYR . 67.9 t -60.31 -49.18 85.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.456 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.87 88.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.811 0.338 . . . . 0.0 110.825 179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.66 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.18 -63.21 1.21 Allowed 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.541 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.427 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.2 m -58.69 -47.26 85.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.924 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.4 tt0 -49.67 -37.58 29.16 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.057 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.426 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.81 -66.47 0.56 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.66 ' N ' ' O ' ' A' ' 168' ' ' ALA . 32.8 t80 -40.2 -71.04 0.09 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.619 0.247 . . . . 0.0 111.21 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.1 mt -61.21 -39.94 92.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.87 -2.69 0.42 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.505 0.669 . . . . 0.0 110.477 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 177' ' ' VAL . 51.4 mt-30 -124.42 141.7 38.33 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.885 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.89 -15.49 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.835 2.357 . . . . 0.0 112.275 179.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 175' ' ' GLN . 80.2 t -63.08 -42.75 97.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.55 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.76 -32.9 80.69 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.93 -41.55 96.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.307 . . . . 0.0 110.404 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 58.9 m-20 -65.27 -35.08 79.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.745 179.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.3 m-85 -156.73 143.2 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.737 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.542 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -176.93 99.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.412 . . . . 0.0 110.725 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.19 167.55 28.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.631 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.14 55.44 3.1 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.42 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.533 1.18 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.8 135.05 35.27 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.467 2.111 . . . . 0.0 111.933 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.2 p -124.66 -108.33 0.33 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.505 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.4 p -165.83 165.17 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.239 -179.367 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.0 tttt 153.65 155.91 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 124.146 0.903 . . . . 0.0 110.646 179.197 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.26 118.59 23.23 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.812 178.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 57.2 mp0 -72.05 -18.53 61.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -63.92 -32.1 73.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.524 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.8 mt -60.97 -44.38 97.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.767 -178.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -114.22 8.55 16.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.751 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.13 -154.79 51.12 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.652 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.7 p -70.72 -25.51 26.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.825 0.345 . . . . 0.0 110.508 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.13 -125.74 1.49 Allowed Glycine 0 CA--C 1.519 0.308 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.6 p -132.06 160.05 37.04 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.784 0.326 . . . . 0.0 110.413 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.39 24.6 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.509 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.63 140.78 32.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.621 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.89 111.62 3.91 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.2 mt -120.89 160.33 23.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.378 . . . . 0.0 110.226 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -86.71 148.93 25.23 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.612 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.06 -48.87 64.4 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.637 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -40.06 -22.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.98 0.419 . . . . 0.0 110.78 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.7 m-20 -72.17 51.96 0.24 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -64.42 -45.92 85.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.231 -179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.72 -47.04 33.54 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.26 -43.84 97.91 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.461 -179.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.6 -42.87 99.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.88 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.56 -37.5 73.23 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.52 -77.4 0.11 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.006 HD21 HD11 ' A' ' 44' ' ' ILE . 85.4 mt -28.85 -45.66 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.815 0.34 . . . . 0.0 110.489 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.4 m-20 -63.57 -45.33 90.95 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.689 178.048 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.44 -43.63 98.53 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.47 -39.45 93.47 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.105 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -61.2 -43.42 98.91 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.063 0.459 . . . . 0.0 110.064 179.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.38 92.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.089 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.91 -42.91 97.28 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.825 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.77 -38.41 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -69.85 -38.83 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.03 0.443 . . . . 0.0 110.374 178.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.46 92.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.649 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -88.27 0.54 56.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.714 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.59 20.09 67.63 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.458 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 85.4 m -58.07 -46.26 85.74 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.461 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 78.6 t80 -63.53 -57.51 9.95 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.453 179.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.91 -41.73 78.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.258 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.37 -48.53 80.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.519 -179.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.75 -41.79 98.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.469 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.2 -49.81 76.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.68 -35.38 72.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.426 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.64 -51.07 30.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.461 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.7 m-85 -62.19 -45.92 91.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.593 179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.6 m-85 -154.39 155.52 35.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.443 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 46.2 p-10 -98.05 101.68 13.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.497 179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -158.16 -165.24 1.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.511 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.425 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -122.89 110.02 14.89 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 239' ' ' TYR . 20.5 m -63.57 -40.2 88.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.434 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.415 ' N ' HG23 ' A' ' 238' ' ' VAL . 93.7 m-85 -58.86 -42.96 90.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.257 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.24 -36.51 93.52 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.408 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.684 0 CA-C-O 117.872 -1.515 . . . . 0.0 111.003 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.22 164.18 62.9 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.622 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.99 143.46 99.34 Favored 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 122.573 2.182 . . . . 0.0 112.279 179.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.51 -40.94 89.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.525 179.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -138.17 139.12 39.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.406 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.9 mt -108.46 121.44 61.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.0 110.649 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.08 118.87 32.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.18 0.514 . . . . 0.0 110.176 179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -112.56 138.44 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.516 -179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.47 105.71 2.2 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.0 m -129.15 120.44 25.86 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 122.707 -0.29 . . . . 0.0 111.136 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 11.3 t0 -114.26 92.95 29.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.081 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.22 134.33 60.04 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.396 2.064 . . . . 0.0 112.105 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.3 p -141.73 -20.19 0.74 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.743 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.6 m-85 -123.46 98.95 6.08 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.701 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.09 -61.45 0.22 Allowed Pre-proline 0 C--O 1.218 -0.553 0 CA-C-O 121.38 0.61 . . . . 0.0 110.983 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.729 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.3 Cg_endo -49.31 -40.56 43.54 Favored 'Trans proline' 0 C--N 1.296 -2.206 0 C-N-CA 122.217 1.945 . . . . 0.0 112.244 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.0 t80 -78.24 -43.1 29.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.053 0.454 . . . . 0.0 110.987 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.671 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.2 mt-10 -149.31 -153.98 0.53 Allowed 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.989 -178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.84 177.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.042 0.449 . . . . 0.0 110.415 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.51 144.62 46.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.436 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.91 134.33 39.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.669 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -64.6 -19.16 65.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.534 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -77.87 -6.23 53.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.42 -8.25 56.75 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.38 158.9 25.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.979 0.418 . . . . 0.0 110.469 179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.3 mt -112.32 131.33 55.58 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.961 0.41 . . . . 0.0 110.462 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.686 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.0 151.37 32.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.296 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.08 151.28 6.53 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -58.65 -42.04 87.47 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.808 0.337 . . . . 0.0 110.912 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.482 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 -69.68 -28.56 65.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.128 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -67.71 -40.97 84.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.875 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -60.99 -37.21 81.69 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.766 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.9 -45.29 86.54 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.11 -48.46 78.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.017 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -53.18 -54.56 34.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.372 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.31 -39.95 61.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.269 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.66 -41.85 78.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.02 0.438 . . . . 0.0 110.64 178.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.0 m -53.47 -45.18 69.48 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.11 -179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -64.02 -46.93 82.27 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -60.08 -42.08 93.85 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.132 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.908 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -75.26 -17.41 15.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.81 53.23 3.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.439 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -147.29 171.73 14.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -89.3 142.86 27.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.007 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.0 m -117.71 131.37 56.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.785 179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -127.29 126.89 43.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.39 179.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -93.72 134.72 35.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.637 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.2 127.78 65.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.302 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.45 138.1 57.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.517 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.3 p30 175.73 130.9 0.16 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.501 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 57' ' ' ALA . 46.3 Cg_endo -67.74 144.95 67.6 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.74 2.293 . . . . 0.0 112.521 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.877 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.33 -55.62 2.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.22 -26.63 2.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.85 -20.95 19.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.269 -179.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.877 HD12 HD23 ' A' ' 55' ' ' LEU . 58.1 mt -63.87 -42.34 97.53 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.17 -56.95 26.44 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.772 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.4 Cg_exo -55.63 -42.46 67.41 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.6 2.2 . . . . 0.0 111.178 177.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -58.71 -44.98 90.53 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.919 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.652 HD21 ' HG3' ' A' ' 203' ' ' ARG . 59.5 tp -58.86 -44.04 90.96 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.35 -40.69 96.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 0.0 110.48 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.88 9.91 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.463 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 57.24 12.21 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.43 -35.69 81.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.498 178.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.5 pt -122.2 152.97 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.297 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.21 -22.21 19.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.406 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.55 156.05 27.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.85 -179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -114.82 128.85 71.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.117 0.484 . . . . 0.0 110.488 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.482 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -131.21 106.74 8.52 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.389 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.717 ' OG ' HD21 ' A' ' 55' ' ' LEU . 38.0 t -159.55 178.66 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.656 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.93 -15.59 62.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.362 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.631 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.7 tp -34.99 124.28 0.57 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.889 0.376 . . . . 0.0 110.503 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.83 154.04 26.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.703 -179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.634 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.8 pt -104.74 148.43 9.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.335 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -149.1 152.06 35.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.856 179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.97 -47.06 52.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.416 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.49 -39.85 70.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.692 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.631 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.77 -38.01 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 178.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.1 mt-30 -57.75 -38.94 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.818 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.81 -27.45 66.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.094 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.57 -50.57 8.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.5 pt -139.38 -168.33 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 121.185 0.517 . . . . 0.0 110.466 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.42 147.79 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.086 0.47 . . . . 0.0 111.061 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.55 ' CD2' HG22 ' A' ' 76' ' ' ILE . 79.0 m-85 -130.07 150.05 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.57 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.32 -153.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.558 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.8 m-20 41.27 20.16 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.927 179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.68 0.2 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.364 -179.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.428 ' O ' ' OH ' ' A' ' 226' ' ' TYR . 59.1 mt -75.11 -68.79 0.52 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.948 -178.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.429 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.75 167.59 26.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.31 123.67 29.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.237 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.465 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.7 68.25 0.84 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.849 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -85.59 -104.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.397 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.1 165.76 33.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.7 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.17 146.26 22.66 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.052 0.453 . . . . 0.0 110.453 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.8 mt -100.85 135.95 41.48 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.967 0.413 . . . . 0.0 110.816 178.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.408 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.9 t -122.66 110.61 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.28 164.4 34.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.47 148.68 24.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.003 179.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.02 -28.56 57.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.199 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -58.93 -41.66 87.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.319 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.9 t -101.84 121.66 42.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -87.43 110.07 20.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.477 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.22 129.45 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.702 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -106.52 154.12 40.13 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.666 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.54 91.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.771 2.314 . . . . 0.0 111.711 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.0 m -170.64 143.39 2.17 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.589 0.556 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.84 -33.27 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.072 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.36 -62.59 1.66 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.248 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -55.86 -22.2 24.08 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.094 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 mt -76.2 -25.9 55.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.229 179.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.81 133.69 47.65 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.407 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.22 -16.58 28.09 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -86.15 151.27 23.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.016 0.436 . . . . 0.0 110.373 -179.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -95.53 135.17 37.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.377 -179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.7 t -127.15 136.72 59.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.637 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.61 138.47 14.29 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.5 t -130.77 161.68 40.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.071 0.462 . . . . 0.0 110.338 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.542 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.0 tp -92.67 117.7 30.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.496 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.78 157.96 1.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.59 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.65 50.68 52.87 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.2 p -149.78 168.76 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 0.0 110.864 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.452 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.0 p -73.17 -27.49 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.429 179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.2 -55.58 32.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.55 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -56.57 -55.03 38.94 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.63 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.6 m -60.15 -51.03 71.32 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.735 -179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 63.4 t80 -62.11 -43.93 97.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.123 0.487 . . . . 0.0 110.496 179.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.73 -44.58 97.72 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.24 -14.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.896 0.379 . . . . 0.0 110.787 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.37 -34.39 2.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.717 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.4 t60 -74.51 -50.62 17.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.148 0.499 . . . . 0.0 111.617 -178.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.96 12.17 36.71 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.46 -55.55 0.49 Allowed Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.37 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 55.9 Cg_endo -72.04 -10.48 26.1 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.769 2.312 . . . . 0.0 111.991 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.59 -9.29 59.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.461 -179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.23 37.14 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.29 137.84 39.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.608 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.41 129.91 34.86 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.354 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.63 138.24 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.5 t -123.03 133.54 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.072 0.463 . . . . 0.0 109.991 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -96.91 127.08 42.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -110.65 153.19 25.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.051 0.453 . . . . 0.0 110.348 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.97 7.23 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.794 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.95 130.42 5.93 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.411 ' OE1' HD22 ' A' ' 120' ' ' LEU . 69.1 tp60 -66.06 -45.82 80.0 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.425 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.77 -23.4 62.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.564 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.463 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.8 t-20 -64.55 -37.13 86.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.516 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.82 -46.64 88.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.186 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.507 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.9 m-85 -64.58 -37.7 88.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.322 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -60.88 -42.01 97.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.058 -179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.24 -43.32 91.78 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.995 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.585 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.9 tp -58.97 -47.93 83.36 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.046 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.6 m -62.9 -22.42 66.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.003 0.43 . . . . 0.0 110.116 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.64 -18.44 25.13 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.16 11.66 72.28 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.75 -17.91 63.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 110.631 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.0 pt -126.9 135.78 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -72.45 -27.65 62.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.296 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.74 155.9 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.79 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.96 137.03 50.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 109.927 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -85.85 103.4 14.56 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.347 0.594 . . . . 0.0 110.851 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.7 tt0 -132.93 165.31 24.96 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.372 179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.477 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.4 m-20 -72.62 153.15 41.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 110.563 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.3 mt-10 -66.64 -54.86 18.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.361 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.429 HG21 ' CG ' ' A' ' 91' ' ' TYR . 75.6 t -60.23 -48.95 86.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.689 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.98 88.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.774 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.664 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.51 -63.01 1.24 Allowed 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.662 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.452 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.0 m -59.55 -48.0 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.5 tt0 -48.41 -37.71 17.71 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.221 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.426 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -110.07 -65.86 0.55 Allowed Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.664 ' N ' ' O ' ' A' ' 168' ' ' ALA . 25.7 t80 -40.58 -70.89 0.09 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.665 0.269 . . . . 0.0 111.236 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.3 mt -61.43 -40.22 93.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.845 -179.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.4 tttt -59.82 -3.04 0.45 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.451 0.643 . . . . 0.0 110.521 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 173' ' ' LEU . 51.9 mt-30 -122.86 149.4 56.33 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.08 -21.1 6.05 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.823 2.349 . . . . 0.0 112.182 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.98 -42.75 94.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.643 -179.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -62.42 -33.27 85.77 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.4 -41.34 93.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.756 0.313 . . . . 0.0 110.464 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.4 m-20 -65.67 -33.23 75.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.299 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.4 m-85 -156.37 142.64 18.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.676 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.0 pttt -177.42 99.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.742 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.21 167.22 29.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.716 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.32 56.38 2.69 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.575 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.22 -118.89 0.01 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.52 135.55 33.27 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.462 2.108 . . . . 0.0 111.923 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.518 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.7 p -125.43 -108.25 0.32 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.566 -179.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.676 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.11 164.43 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.676 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 154.26 155.86 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 123.918 0.761 . . . . 0.0 110.641 179.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.06 117.19 22.06 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.857 179.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.1 mp0 -71.2 -18.85 62.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.79 -32.43 73.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.555 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.485 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.8 mt -61.05 -44.48 97.33 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 -178.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.452 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -114.01 9.3 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.728 179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.2 -154.3 51.74 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.634 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.8 p -70.38 -25.1 26.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 110.488 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.465 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.22 -124.24 1.32 Allowed Glycine 0 CA--C 1.519 0.311 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.37 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.9 p -129.42 156.4 44.14 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 110.257 179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.73 -169.43 30.31 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -94.48 137.51 33.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.963 0.411 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.47 108.09 3.26 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.2 mt -123.02 159.26 28.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.023 0.44 . . . . 0.0 110.114 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.652 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.9 mtm180 -86.94 149.75 24.57 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.91 -48.09 64.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.515 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.7 tp10 -38.46 -25.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.899 0.381 . . . . 0.0 110.733 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.8 m-20 -71.69 52.11 0.21 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.642 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.57 -44.76 89.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.338 -179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.1 -47.33 29.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.32 -44.07 97.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.421 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.2 ttt-85 -62.22 -43.06 99.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.16 -36.36 70.67 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.26 -77.65 0.11 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 44' ' ' ILE . 97.2 mt -28.31 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.335 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -64.22 -44.91 90.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.616 178.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -62.1 -43.69 98.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.951 178.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.01 -38.99 93.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.038 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -61.35 -43.72 98.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 109.903 179.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.56 93.74 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.1 mt-10 -63.66 -43.06 97.83 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.2 mtp -57.04 -37.94 72.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -70.08 -39.01 75.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.98 0.419 . . . . 0.0 110.337 178.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.69 94.46 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.662 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.6 p-10 -89.2 1.53 55.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.636 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 63.73 20.42 64.04 Favored Glycine 0 C--O 1.226 -0.382 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.453 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 79.7 m -58.26 -45.99 86.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.428 ' OH ' ' O ' ' A' ' 90' ' ' LEU . 78.4 t80 -63.84 -58.09 7.86 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.396 179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -56.67 -41.55 77.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.38 -179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.78 -48.37 81.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.599 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.2 -41.59 98.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.312 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.69 -50.35 74.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.597 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.34 -35.17 71.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.602 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -71.11 -50.92 28.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.598 179.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.516 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 38.4 m-85 -62.0 -45.56 93.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.596 179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.516 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.47 155.84 35.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.462 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.5 p-10 -97.42 97.94 9.53 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.982 0.42 . . . . 0.0 110.455 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -155.49 -166.24 2.19 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.524 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.42 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.0 t0 -123.22 111.06 16.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.59 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 239' ' ' TYR . 22.4 m -63.54 -40.59 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.402 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.424 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.9 m-85 -58.61 -42.86 89.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.285 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.36 -37.19 94.45 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.41 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.628 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.955 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.4 164.38 61.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.744 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.71 143.38 99.39 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 122.655 2.237 . . . . 0.0 112.326 179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.4 -40.7 89.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.597 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.1 m-20 -139.54 141.9 37.23 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.4 mt -109.57 127.24 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.7 mtp180 -102.5 119.69 39.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.093 0.473 . . . . 0.0 110.279 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -113.69 138.56 43.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.292 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.78 100.31 1.57 Allowed Glycine 0 N--CA 1.464 0.514 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -123.79 119.01 28.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 122.673 -0.31 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 19.5 t70 -113.16 92.34 21.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.016 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.86 133.66 55.59 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.42 2.08 . . . . 0.0 112.13 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -140.79 -20.11 0.82 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.774 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.1 m-85 -123.36 98.84 6.04 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.537 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.727 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.14 -61.34 0.22 Allowed Pre-proline 0 C--O 1.216 -0.685 0 CA-C-O 121.771 0.796 . . . . 0.0 111.138 179.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.727 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.54 -40.36 45.66 Favored 'Trans proline' 0 C--N 1.288 -2.606 0 C-N-CA 122.469 2.112 . . . . 0.0 112.256 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -78.39 -42.95 28.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.0 0.428 . . . . 0.0 110.91 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.7 mt-10 -149.54 -154.63 0.57 Allowed 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.116 -178.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 162.24 177.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.087 0.47 . . . . 0.0 110.237 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.5 mttt -135.41 144.05 46.31 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.388 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -95.04 134.6 37.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.632 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -64.71 -18.89 65.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.527 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.48 -6.47 55.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.368 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.93 -8.32 55.84 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.16 158.49 26.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.981 0.42 . . . . 0.0 110.476 179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.9 mt -112.44 131.91 55.32 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 120.941 0.4 . . . . 0.0 110.385 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -134.15 151.61 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.97 0.414 . . . . 0.0 110.323 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.04 151.74 6.73 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -58.85 -42.13 88.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 122.582 -0.364 . . . . 0.0 111.055 179.749 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.3 t0 -69.1 -28.39 66.45 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.353 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.2 mt -68.0 -40.67 83.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.041 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -60.81 -37.56 82.41 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.88 -178.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 43.8 tp -64.8 -45.0 88.08 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.14 -48.15 79.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.825 -178.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.01 -54.49 34.54 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.323 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -52.58 -39.59 61.74 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.026 0.441 . . . . 0.0 110.393 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt -69.07 -42.02 76.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.8 178.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 57.3 m -54.01 -44.14 70.65 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.041 -179.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -63.92 -47.56 80.06 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.973 178.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mmt-85 -59.56 -41.78 90.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.111 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.926 HD11 HD21 ' A' ' 213' ' ' LEU . 97.2 mt -75.68 -18.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.4 m-20 60.5 52.71 4.49 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.188 0.518 . . . . 0.0 110.623 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.8 p -146.1 170.75 16.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -88.25 140.75 29.16 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.068 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.1 m -116.3 130.12 56.62 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.69 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.7 m -127.14 127.49 44.67 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.396 179.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -94.73 136.36 35.14 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.413 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.66 128.58 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 120.967 0.413 . . . . 0.0 110.304 179.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.01 139.34 58.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.79 179.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.39 130.07 0.1 Allowed Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.519 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.0 Cg_endo -67.95 146.73 72.43 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.743 2.295 . . . . 0.0 112.514 -179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.909 HD23 HD12 ' A' ' 58' ' ' LEU . 81.7 mt -41.05 -55.92 2.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -48.06 -26.76 1.96 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.251 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -94.94 -20.3 19.51 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.252 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.909 HD12 HD23 ' A' ' 55' ' ' LEU . 86.5 mt -65.26 -42.36 93.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 178.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.694 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.35 -57.27 26.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 123.801 0.688 . . . . 0.0 109.516 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.694 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.9 Cg_exo -55.02 -43.95 54.4 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.571 2.181 . . . . 0.0 111.083 177.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.9 m -58.65 -44.55 90.13 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.575 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.33 -44.24 88.61 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -64.78 -40.24 94.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.983 0.42 . . . . 0.0 110.488 178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.85 11.19 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 -179.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 55.84 11.91 0.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.937 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.29 -34.11 76.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 178.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.2 pt -124.18 152.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.18 -179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -94.07 -20.23 20.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.03 155.87 26.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.76 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 58' ' ' LEU . 97.0 mt -116.43 127.89 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 110.443 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -128.16 105.64 8.51 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.992 0.425 . . . . 0.0 110.326 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.666 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.2 t -158.66 179.24 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -65.19 -14.93 61.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.394 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 39.4 tp -35.98 124.22 0.73 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.665 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -81.47 154.11 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.587 -179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.643 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.9 pt -104.51 148.26 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.207 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -149.8 152.63 35.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.818 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.28 -47.38 55.42 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.032 0.444 . . . . 0.0 110.548 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -55.44 -39.93 70.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.944 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.2 mtt180 -68.5 -37.83 80.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.475 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.21 -37.95 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.798 -179.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.01 -27.73 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.094 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.13 -50.73 8.18 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.976 0.417 . . . . 0.0 110.774 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.6 pt -139.67 -168.6 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-O 121.165 0.507 . . . . 0.0 110.383 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.33 147.28 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.119 0.485 . . . . 0.0 111.059 179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.544 ' CD1' HG22 ' A' ' 76' ' ' ILE . 76.8 m-85 -129.93 149.85 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.578 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.81 -152.65 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.47 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.512 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 99.3 m-20 41.72 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.019 179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.5 mttt -30.22 121.41 0.18 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.385 0.428 . . . . 0.0 110.433 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.42 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 60.0 mt -75.44 -68.81 0.53 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.81 -178.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.443 ' CG ' HG21 ' A' ' 166' ' ' VAL . 55.4 p90 -150.32 167.45 26.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.755 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.66 123.58 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.176 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.469 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.23 68.27 0.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.775 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -86.16 -104.97 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.442 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 30.2 p -159.64 165.83 31.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.8 ttt-85 -155.11 146.35 22.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.423 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.1 mt -101.38 136.04 41.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.418 HG22 ' NH1' ' A' ' 96' ' ' ARG . 1.8 t -122.72 111.0 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.1 m -134.26 165.2 32.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.959 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.4 23.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.64 -27.77 42.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.115 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -59.13 -41.87 89.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.249 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.7 t -102.6 122.18 43.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.019 0.437 . . . . 0.0 110.154 179.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.81 109.34 19.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.024 0.44 . . . . 0.0 110.395 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.97 129.78 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.641 179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.472 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.82 159.07 33.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.575 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' O ' ' OG1' ' A' ' 108' ' ' THR . 19.9 Cg_endo -59.79 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.789 2.326 . . . . 0.0 111.93 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -169.02 141.2 2.6 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.596 0.56 . . . . 0.0 110.858 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.38 -33.24 61.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.5 tp10 -57.24 -62.65 1.61 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.333 -178.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.5 t -56.58 -22.11 31.4 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.066 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -75.53 -26.88 58.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.41 178.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.9 133.29 47.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.417 -179.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.77 -16.92 28.95 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -86.2 151.46 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 110.497 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -96.22 135.56 37.88 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.007 0.432 . . . . 0.0 110.273 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.27 136.73 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.641 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.47 138.86 14.47 Favored Glycine 0 N--CA 1.462 0.383 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -130.92 161.68 40.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 CA-C-O 121.129 0.49 . . . . 0.0 110.261 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.536 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.5 tp -92.56 117.72 30.26 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.696 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -51.76 157.43 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.712 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.17 50.53 50.75 Favored Glycine 0 N--CA 1.463 0.436 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.3 p -149.6 168.79 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.457 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 82.1 p -73.69 -26.29 60.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.435 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.93 -55.45 32.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.431 -179.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -56.94 -54.35 47.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.583 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.3 -51.12 70.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.641 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.8 t80 -62.31 -43.82 97.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.144 0.497 . . . . 0.0 110.467 179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.78 -44.41 97.92 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.3 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.768 0.318 . . . . 0.0 110.835 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.31 -34.65 2.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.596 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.34 -50.92 16.75 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.942 0.401 . . . . 0.0 111.698 -178.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -99.0 12.43 36.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.72 -55.54 0.48 Allowed Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.356 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.29 -10.16 25.29 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.737 2.291 . . . . 0.0 111.933 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -82.93 -8.85 59.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.501 -179.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.03 33.32 36.87 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.31 137.71 40.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.01 0.434 . . . . 0.0 110.565 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -87.4 129.75 34.92 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.1 pt -126.19 138.05 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.5 t -123.16 133.28 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.082 0.467 . . . . 0.0 109.899 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.36 127.59 43.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.845 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.17 153.76 25.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.265 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -107.05 7.01 29.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.67 130.28 5.92 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -65.74 -45.81 81.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.07 -23.91 63.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 110.525 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.4 t-20 -64.49 -36.75 85.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.612 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.12 -46.97 86.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.13 -179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 59.4 m-85 -63.42 -38.22 90.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.255 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.13 -42.5 98.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.164 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.47 -45.95 88.45 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.543 ' HB2' HD11 ' A' ' 158' ' ' ILE . 45.4 tp -58.46 -48.14 81.74 Favored 'General case' 0 CA--C 1.522 -0.125 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.161 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.32 -23.31 67.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.935 0.398 . . . . 0.0 110.066 179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.89 -18.79 25.48 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.573 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.45 11.09 69.52 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.24 -18.31 63.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.582 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 153' ' ' LEU . 38.3 pt -128.69 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.083 0.468 . . . . 0.0 110.443 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.0 -27.35 61.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.225 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.485 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.92 155.88 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.583 0.552 . . . . 0.0 110.91 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.94 137.09 50.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.987 0.422 . . . . 0.0 109.935 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.42 103.27 14.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.238 0.542 . . . . 0.0 110.798 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.3 tt0 -132.47 165.51 24.14 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.341 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -73.0 152.03 41.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.0 110.565 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.4 mt-10 -66.33 -54.33 25.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.4 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.443 HG21 ' CG ' ' A' ' 91' ' ' TYR . 73.6 t -60.38 -48.83 86.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.417 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.44 -38.72 88.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.876 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.656 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.3 -62.99 1.26 Allowed 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.507 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.1 m -58.87 -47.38 85.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.88 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.0 tt0 -49.16 -37.85 23.62 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.067 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -110.11 -65.93 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.656 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.0 t80 -40.27 -71.15 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.824 -0.221 . . . . 0.0 111.245 -178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.2 mt -61.06 -40.03 92.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.948 -179.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.92 -2.28 0.55 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.613 0.721 . . . . 0.0 110.323 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.2 mt-30 -124.25 141.4 37.29 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 121.905 -0.497 . . . . 0.0 110.8 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -43.75 -16.72 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.843 2.362 . . . . 0.0 112.409 179.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.465 ' N ' ' O ' ' A' ' 175' ' ' GLN . 72.1 t -62.88 -43.0 98.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.619 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.85 82.31 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.91 -41.39 96.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.73 0.3 . . . . 0.0 110.449 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 55.8 m-20 -65.58 -34.52 78.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.479 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 73.3 m-85 -156.04 142.74 18.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.742 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.64 99.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.0 110.757 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.544 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.7 m-85 -159.07 166.82 30.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.668 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.04 56.36 2.9 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.06 -117.24 0.01 OUTLIER Glycine 0 CA--C 1.535 1.291 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.59 135.68 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.419 2.079 . . . . 0.0 111.984 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.514 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 91.9 p -124.7 -108.33 0.33 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.77 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.1 p -165.21 165.08 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-O 118.96 -0.543 . . . . 0.0 110.049 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.1 tttt 153.75 155.69 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 124.461 1.101 . . . . 0.0 110.69 178.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -81.75 118.24 22.7 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.587 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.6 mp0 -71.87 -18.71 62.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.84 -32.47 74.0 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.47 -179.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.469 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.8 mt -60.92 -44.55 97.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.685 -177.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.457 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -114.24 10.05 17.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.758 178.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 70.73 -153.45 51.47 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.643 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.5 p -70.85 -25.09 25.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.486 179.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 159.91 -123.97 1.29 Allowed Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 p -129.51 156.54 43.99 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.76 -169.59 30.55 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.512 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -94.88 138.73 32.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.945 0.402 . . . . 0.0 110.607 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.39 107.17 3.16 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.62 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 82.7 mt -119.83 159.98 23.54 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.923 0.392 . . . . 0.0 110.143 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.2 mtm180 -87.76 149.11 24.39 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-O 120.833 0.349 . . . . 0.0 110.654 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.4 -48.5 65.65 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.549 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -39.76 -23.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.026 0.441 . . . . 0.0 110.881 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.55 52.21 0.2 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.799 0.333 . . . . 0.0 110.661 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -64.33 -45.78 86.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.99 -47.12 30.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.281 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.08 -43.99 97.63 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.1 ttt-85 -62.48 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.52 -36.98 72.27 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.94 -77.22 0.11 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.926 HD21 HD11 ' A' ' 44' ' ' ILE . 89.0 mt -29.26 -45.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.892 0.377 . . . . 0.0 110.504 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -63.81 -44.96 91.73 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.728 177.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -61.73 -43.79 98.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.897 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.29 93.47 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.05 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.18 -43.47 98.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.194 0.521 . . . . 0.0 110.032 179.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.45 -39.33 93.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.021 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.2 mt-10 -63.58 -43.19 97.72 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.502 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.92 -38.28 72.65 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.95 -38.84 76.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.075 0.464 . . . . 0.0 110.308 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.54 94.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.673 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 220' ' ' MET . 21.2 p-10 -89.33 0.98 56.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.713 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.99 20.45 66.81 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.456 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 90.8 m -58.33 -45.94 87.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -63.99 -57.6 9.21 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.436 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -57.04 -41.44 78.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.169 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.56 -48.54 80.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.518 -179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.77 -41.83 98.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.837 0.351 . . . . 0.0 110.546 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.71 -50.03 75.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.66 -35.04 71.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.409 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -70.83 -50.87 30.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.55 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 40.2 m-85 -62.25 -45.93 91.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 68.7 m-85 -154.76 155.61 34.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.398 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.4 p-10 -97.35 99.05 10.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.057 0.456 . . . . 0.0 110.441 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -155.76 -166.03 2.11 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.551 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.421 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 66.1 t0 -123.08 110.81 15.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.64 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 239' ' ' TYR . 19.9 m -63.65 -40.44 89.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.473 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.415 ' N ' HG23 ' A' ' 238' ' ' VAL . 92.6 m-85 -59.04 -42.59 90.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.305 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.15 -37.2 94.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.222 -0.607 0 CA-C-O 117.811 -1.549 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.58 164.25 56.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.93 143.27 99.31 Favored 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 122.574 2.183 . . . . 0.0 112.297 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.418 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -66.34 -40.71 90.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.534 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -139.13 139.95 37.79 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.0 mt -107.81 120.69 59.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.973 0.416 . . . . 0.0 110.681 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -94.06 118.78 32.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.145 0.498 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.7 mt -112.42 138.56 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.427 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.01 101.42 1.51 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -124.68 120.71 32.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 122.717 -0.284 . . . . 0.0 111.142 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 13.1 t70 -114.07 92.73 27.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.194 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.35 134.59 61.87 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.417 2.078 . . . . 0.0 112.105 179.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.9 p -142.37 -19.78 0.7 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.771 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' O ' ' C ' ' A' ' 18' ' ' ALA . 97.3 m-85 -124.02 99.05 6.06 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.629 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.11 -61.43 0.22 Allowed Pre-proline 0 C--O 1.217 -0.614 0 CA-C-O 121.528 0.68 . . . . 0.0 111.067 179.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.729 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.53 -39.85 45.62 Favored 'Trans proline' 0 C--N 1.294 -2.303 0 C-N-CA 122.297 1.998 . . . . 0.0 112.293 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -78.88 -42.72 26.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.977 0.418 . . . . 0.0 110.992 179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.66 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.0 mt-10 -149.69 -154.61 0.56 Allowed 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.043 -178.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 162.14 177.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.041 0.448 . . . . 0.0 110.336 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.56 140.87 45.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.382 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -92.64 137.11 32.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.661 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.4 p -64.98 -19.28 65.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.564 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.75 -6.58 56.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.451 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.71 -8.73 56.58 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -78.98 156.93 28.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 110.485 179.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.5 mt -111.92 133.57 54.03 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.967 0.413 . . . . 0.0 110.385 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.698 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.3 p -134.15 151.45 32.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.37 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.417 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.19 151.15 6.49 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -58.58 -41.86 86.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.838 0.352 . . . . 0.0 110.989 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.405 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 32.6 t0 -69.58 -28.34 65.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.245 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.2 mt -67.85 -40.79 84.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.983 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -60.81 -37.38 81.77 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.891 -178.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.1 tp -65.72 -44.49 85.88 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.89 -47.91 81.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.035 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -53.95 -54.4 39.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.347 -179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.35 -38.85 59.77 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.943 0.401 . . . . 0.0 110.311 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.29 -41.77 76.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.067 0.46 . . . . 0.0 110.556 178.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 51.0 m -53.79 -44.93 70.54 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.033 -179.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -64.25 -47.31 80.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.037 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.8 -42.15 92.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.201 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.945 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.32 -17.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.575 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.09 52.84 3.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 110.492 -179.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.4 p -146.54 170.91 15.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.36 142.43 27.74 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.075 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.2 m -117.34 131.87 56.71 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.575 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.9 m -128.75 128.12 43.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -95.19 135.57 36.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.478 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.8 129.14 66.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.427 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.75 136.65 56.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.777 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 176.41 131.42 0.18 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.49 179.898 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 48.8 Cg_endo -68.28 144.81 63.77 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.691 2.261 . . . . 0.0 112.536 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.92 HD23 HD12 ' A' ' 58' ' ' LEU . 79.1 mt -40.29 -55.43 2.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -48.21 -26.27 1.87 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.163 -179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.57 -21.05 18.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.215 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.92 HD12 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -64.14 -42.44 96.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.88 179.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.716 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -61.68 -57.12 26.68 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 123.738 0.648 . . . . 0.0 109.67 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.716 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.8 Cg_exo -55.14 -42.27 70.46 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.612 2.208 . . . . 0.0 111.267 177.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -45.06 90.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.944 -179.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.65 HD21 ' HG3' ' A' ' 203' ' ' ARG . 60.6 tp -58.94 -44.08 91.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.128 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.5 -40.66 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.955 0.407 . . . . 0.0 110.456 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.86 10.38 2.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.519 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.84 12.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.5 -35.16 79.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.498 178.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.9 pt -122.9 153.54 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.212 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.1 m-20 -93.54 -21.53 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.285 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.3 156.72 26.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.774 -179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.587 HG23 HD13 ' A' ' 58' ' ' LEU . 96.6 mt -115.67 129.06 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.441 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.405 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.6 ttp -130.55 106.7 8.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.703 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.3 t -158.96 178.69 9.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -65.33 -15.16 62.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.6 tp -35.56 124.84 0.66 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.573 -179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.54 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.5 p -83.0 155.0 24.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.662 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.638 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.0 pt -105.04 149.2 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.314 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.7 p -149.37 152.33 35.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.829 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -49.95 -47.48 52.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.544 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.65 -39.53 71.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 -179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.63 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.6 mtt180 -68.88 -37.86 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.48 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -57.99 -38.62 76.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.868 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -59.81 -27.59 66.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.105 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -83.26 -51.22 7.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.647 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.48 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.0 pt -138.5 -168.23 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.16 0.505 . . . . 0.0 110.501 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.03 147.71 29.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.061 0.458 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 76' ' ' ILE . 75.4 m-85 -130.09 150.08 51.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.653 179.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.73 -152.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.498 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 97.2 m-20 41.99 20.21 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.948 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.7 mttt -29.32 121.02 0.15 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.336 -179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.4 mt -76.64 -69.53 0.51 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.842 -178.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.448 ' CG ' HG21 ' A' ' 166' ' ' VAL . 40.9 p90 -149.47 166.43 29.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.614 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.46 122.75 28.43 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.279 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.38 69.46 0.91 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.813 -179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.51 -104.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.393 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.1 p -159.17 165.77 32.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.685 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.56 145.91 21.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.125 0.488 . . . . 0.0 110.439 179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.5 mt -100.89 136.26 41.04 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.65 110.99 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.19 165.08 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.996 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.85 148.48 23.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.086 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.96 -28.35 56.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.04 -41.7 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.301 -179.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.6 t -102.13 122.19 43.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 110.237 179.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.06 109.9 19.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.398 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.87 129.59 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.656 179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -108.28 154.3 41.44 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.978 0.418 . . . . 0.0 110.679 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.515 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.24 92.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 122.756 2.304 . . . . 0.0 111.649 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.02 144.02 2.07 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.669 0.606 . . . . 0.0 110.773 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -68.55 -33.7 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.162 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 108' ' ' THR . 47.7 tp10 -57.35 -62.63 1.63 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.263 -178.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.37 -21.93 27.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.037 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.0 -26.2 56.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.309 179.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.77 133.7 47.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.382 -179.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.08 -16.78 26.36 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -85.92 151.44 23.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.939 0.4 . . . . 0.0 110.494 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -95.86 135.39 37.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -127.25 136.66 60.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.658 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.5 138.53 14.3 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.6 t -130.9 161.66 40.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 121.069 0.461 . . . . 0.0 110.333 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.54 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.2 tp -92.43 117.42 29.9 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.599 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -51.73 158.04 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.576 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.47 50.48 55.02 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -149.62 168.95 22.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.74 0.305 . . . . 0.0 110.928 -179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.458 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 67.2 p -73.24 -27.58 61.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.1 mt-30 -60.13 -55.36 34.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.442 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.67 -54.82 41.68 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.695 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.8 m -60.37 -51.04 71.18 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.74 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.6 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.8 t80 -62.2 -43.83 97.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.95 -44.44 97.81 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.319 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.43 -14.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.798 0.333 . . . . 0.0 110.778 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.6 tt0 -125.23 -34.46 2.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.709 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.6 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.35 -50.56 18.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.094 0.473 . . . . 0.0 111.649 -178.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -99.27 12.59 35.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.83 -55.53 0.47 Allowed Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.413 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.29 -10.31 25.49 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.778 2.319 . . . . 0.0 111.934 -179.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.65 -8.88 59.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.474 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.14 37.63 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.28 138.01 38.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.888 0.375 . . . . 0.0 110.572 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.85 130.19 34.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.274 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.5 pt -127.0 138.49 54.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.935 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.14 133.31 69.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 109.99 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.11 127.3 42.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -110.83 153.7 25.03 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.33 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.24 7.13 29.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.41 130.47 6.03 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.03 -45.92 79.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.441 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.59 -23.21 62.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.572 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.6 t-20 -64.87 -36.78 85.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.536 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.03 -47.13 86.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.159 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.516 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.1 m-85 -63.74 -37.91 89.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.253 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.0 p -61.19 -42.4 98.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.096 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -63.73 -45.21 90.96 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.981 179.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 158' ' ' ILE . 46.8 tp -58.69 -47.94 82.82 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.114 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.6 m -63.31 -22.96 67.2 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.21 -18.66 25.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.641 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.9 11.65 69.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.92 -18.13 63.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 0.0 110.581 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 153' ' ' LEU . 36.7 pt -127.87 136.96 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.464 179.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -72.66 -27.62 62.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.457 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.8 155.89 1.74 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.817 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.92 137.12 50.19 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 109.991 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -85.67 103.05 14.13 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.237 0.541 . . . . 0.0 110.817 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.0 tt0 -132.39 165.2 24.79 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.321 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.458 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.0 152.6 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.602 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.05 -54.37 26.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.332 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.448 HG21 ' CG ' ' A' ' 91' ' ' TYR . 70.8 t -60.24 -49.13 85.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.439 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.93 87.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.828 0.347 . . . . 0.0 110.759 179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.37 -63.35 1.16 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.627 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.456 ' OG ' HD12 ' A' ' 173' ' ' LEU . 72.5 m -59.15 -47.88 83.67 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.927 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.01 -38.19 22.65 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.19 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.46 -65.73 0.56 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.676 ' N ' ' O ' ' A' ' 168' ' ' ALA . 24.4 t80 -40.53 -70.94 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.637 0.256 . . . . 0.0 111.255 -178.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.456 HD12 ' OG ' ' A' ' 169' ' ' SER . 95.8 mt -61.06 -39.88 91.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.192 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.3 tttt -60.65 -2.72 0.57 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.462 0.649 . . . . 0.0 110.399 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 173' ' ' LEU . 58.4 mt-30 -124.14 142.21 39.26 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -44.5 -16.47 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.844 2.363 . . . . 0.0 112.32 179.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 175' ' ' GLN . 73.0 t -62.69 -43.05 98.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.586 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.22 -33.01 82.73 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.75 -41.27 95.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.733 0.302 . . . . 0.0 110.567 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -66.0 -34.28 77.74 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.393 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.6 m-85 -157.07 143.65 18.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.6 pttt -177.59 100.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.984 0.421 . . . . 0.0 110.757 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.5 m-85 -159.34 167.37 29.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.695 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.72 56.09 2.85 Favored Glycine 0 C--O 1.226 -0.363 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.558 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.53 -117.94 0.01 OUTLIER Glycine 0 CA--C 1.531 1.083 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.59 135.29 33.76 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.504 2.136 . . . . 0.0 111.969 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.9 p -125.36 -107.89 0.32 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.574 -179.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.7 p -165.67 165.11 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.51 156.05 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 124.024 0.828 . . . . 0.0 110.696 179.178 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -82.46 117.61 22.61 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.38 -18.91 62.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.09 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.72 -32.28 73.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.491 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.474 HD11 ' CG ' ' A' ' 128' ' ' PHE . 91.3 mt -61.0 -44.46 97.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.706 -178.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.458 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.2 m-85 -114.07 9.47 17.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.784 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.37 -155.13 52.25 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.638 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.9 p -70.55 -25.14 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 0.0 110.517 179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.467 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.72 -125.17 1.41 Allowed Glycine 0 CA--C 1.518 0.272 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.6 p -131.52 159.3 38.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 110.392 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -171.63 -163.37 25.47 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.51 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.3 mtp -97.4 138.93 34.1 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.453 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -89.25 112.05 3.92 Favored Glycine 0 C--N 1.33 0.219 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -124.73 160.1 29.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 110.306 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.65 ' HG3' HD21 ' A' ' 62' ' ' LEU . 89.7 mtm180 -86.53 149.66 24.8 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.786 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.95 -48.4 64.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.669 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 204' ' ' LYS . 45.4 tp10 -38.15 -25.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.6 m-20 -71.95 52.02 0.23 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.604 179.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -64.76 -44.86 88.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.401 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.16 -47.1 38.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.84 -43.49 98.65 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.45 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.75 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.43 -36.7 71.71 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.688 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.18 -77.31 0.12 Allowed 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.945 HD21 HD11 ' A' ' 44' ' ' ILE . 96.7 mt -28.63 -46.21 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -64.01 -45.3 89.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.661 178.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' A' ' 212' ' ' ALA . 66.0 tttm -61.78 -43.79 98.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.955 178.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.21 93.23 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.024 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.24 -43.54 98.71 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.33 92.86 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.095 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.84 -43.19 96.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.7 mtp -56.68 -38.29 72.02 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.628 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.88 76.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.0 110.343 178.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.98 94.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.687 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 21.4 p-10 -88.65 1.19 55.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.707 179.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 64.36 20.32 65.29 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.435 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 72.3 m -58.3 -45.81 87.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 81.9 t80 -63.89 -58.14 7.67 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.482 179.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.86 78.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.412 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.28 -48.63 79.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.56 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 79.7 mt -62.0 -41.49 98.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.407 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.43 -50.18 74.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.62 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.89 -35.17 72.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.593 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.21 -50.95 27.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.501 179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.5 m-85 -62.18 -45.75 92.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.532 179.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -152.97 154.92 35.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.437 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.6 p-10 -97.06 95.36 7.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.987 0.422 . . . . 0.0 110.567 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -153.25 -166.67 2.49 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.514 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.66 110.33 15.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.5 m -63.64 -40.65 89.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.469 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.6 m-85 -56.35 -43.9 79.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.336 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.38 -37.6 95.09 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.681 0 CA-C-O 117.875 -1.514 . . . . 0.0 110.931 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.31 164.23 61.08 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.676 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -60.85 143.45 99.37 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.645 2.23 . . . . 0.0 112.299 179.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.32 -40.35 89.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.598 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.3 m-20 -139.91 143.14 36.49 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.456 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.04 128.09 66.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 110.515 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.1 mtp180 -103.77 118.56 36.99 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.041 0.448 . . . . 0.0 110.352 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -112.6 138.4 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.449 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -106.22 100.2 1.61 Allowed Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.8 m -123.94 118.32 26.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.713 -0.287 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.523 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 24.4 t70 -113.33 92.3 22.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.98 179.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.98 133.99 57.53 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.524 2.149 . . . . 0.0 112.114 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.7 p -141.26 -19.2 0.79 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.768 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.5 m-85 -124.65 99.0 5.96 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.603 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.728 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.23 -61.36 0.23 Allowed Pre-proline 0 C--O 1.219 -0.538 0 CA-C-O 121.541 0.686 . . . . 0.0 111.058 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.728 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.49 -39.69 45.24 Favored 'Trans proline' 0 C--N 1.293 -2.378 0 C-N-CA 122.46 2.107 . . . . 0.0 112.228 -179.305 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.9 t80 -79.29 -42.84 24.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.984 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.647 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.3 mt-10 -149.58 -155.31 0.62 Allowed 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.96 -178.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.93 177.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.047 0.451 . . . . 0.0 110.355 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -134.64 140.16 45.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.403 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -91.78 137.14 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.619 179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -65.04 -19.08 65.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.507 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.51 -5.47 54.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.455 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.92 -9.32 58.18 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.45 156.81 29.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 110.424 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.8 mt -112.08 133.9 53.96 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.96 0.409 . . . . 0.0 110.452 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.676 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -133.56 151.22 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.314 -179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.96 151.53 6.63 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -58.58 -42.13 87.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.818 0.342 . . . . 0.0 110.935 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 33.9 t0 -70.01 -28.09 65.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.351 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.676 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.5 mt -68.61 -41.01 82.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.097 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -60.74 -37.63 82.41 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.18 -178.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.19 -44.0 85.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.299 178.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.525 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.18 -44.82 92.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.069 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -56.44 -53.67 54.68 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.504 -179.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.26 -37.58 62.25 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.975 0.417 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.52 -42.03 75.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.799 178.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.525 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.8 m -54.54 -44.5 72.89 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.111 -179.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.436 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.0 tttm -63.81 -47.65 80.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.066 178.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -59.4 -40.96 88.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.98 HD11 HD21 ' A' ' 213' ' ' LEU . 96.9 mt -76.56 -17.87 14.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.1 m-20 60.9 52.44 4.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.151 0.501 . . . . 0.0 110.606 -179.238 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.29 169.99 17.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -88.12 140.66 29.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.117 179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -116.87 131.32 56.98 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.638 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.8 m -128.42 128.1 43.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.472 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -94.64 136.34 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.511 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.67 128.38 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.329 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.8 139.31 58.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.721 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER 173.84 132.3 0.12 Allowed Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.53 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' ALA . 50.4 Cg_endo -68.56 145.22 63.48 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.692 2.262 . . . . 0.0 112.499 -179.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.929 HD23 HD12 ' A' ' 58' ' ' LEU . 78.5 mt -40.48 -55.94 2.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.038 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -47.72 -26.55 1.6 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.117 -179.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.32 -20.35 19.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.133 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.929 HD12 HD23 ' A' ' 55' ' ' LEU . 85.3 mt -65.08 -42.56 94.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.854 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.703 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 2.4 mm -61.51 -56.64 31.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.757 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.703 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.4 Cg_exo -55.44 -43.51 57.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 122.64 2.227 . . . . 0.0 111.128 177.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.2 m -58.8 -44.36 90.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.848 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.7 tp -58.28 -44.46 88.45 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.59 -40.21 95.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.963 0.411 . . . . 0.0 110.446 178.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.0 11.2 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.538 -179.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.01 11.86 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 179.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.1 mttt -63.47 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 178.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.9 pt -124.48 153.28 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.361 -179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -94.59 -20.0 19.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.21 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.45 156.29 25.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.712 -179.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 58' ' ' LEU . 96.9 mt -116.83 127.94 74.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.043 0.449 . . . . 0.0 110.544 179.589 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 63.2 ttp -128.26 106.31 8.94 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.39 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.626 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.4 t -159.0 -179.57 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.569 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 74' ' ' LEU . 77.9 p -64.56 -15.01 60.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.337 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.645 ' CD1' HH12 ' A' ' 80' ' ' ARG . 35.9 tp -37.58 124.24 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.89 0.376 . . . . 0.0 110.531 -179.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.09 156.25 23.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.667 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.655 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.7 pt -104.87 148.9 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.273 -179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.9 p -150.4 152.75 34.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.802 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -50.22 -47.93 54.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.601 -179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.52 -39.79 70.96 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.733 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.645 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.1 mtt180 -68.53 -37.63 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.024 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.4 -37.4 75.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.94 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.3 -27.56 67.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.175 179.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.16 -51.77 7.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 110.574 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.61 -168.55 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-O 121.053 0.454 . . . . 0.0 110.44 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.86 147.02 29.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.917 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.5 m-85 -129.99 149.96 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.8 t -164.34 -151.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.478 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.511 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.6 m-20 42.97 19.34 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.829 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -28.26 120.47 0.12 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.409 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.1 mt -77.04 -69.93 0.49 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.757 -178.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.44 ' CG ' HG21 ' A' ' 166' ' ' VAL . 44.4 p90 -149.3 166.26 29.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.584 -179.692 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 121.67 27.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.267 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.73 69.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.746 -179.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -85.94 -105.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.46 179.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.31 165.83 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.69 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.6 145.94 21.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 110.5 179.477 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.06 136.11 41.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.768 178.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 111.1 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.41 165.12 32.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.2 148.63 23.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.998 179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.14 -28.34 57.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -58.98 -41.88 88.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.325 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.86 121.76 42.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.006 0.431 . . . . 0.0 110.23 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.64 109.61 19.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.464 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.84 129.81 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.636 179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -108.71 154.15 41.87 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.654 179.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.8 Cg_endo -59.26 92.02 0.08 OUTLIER 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.824 2.349 . . . . 0.0 111.674 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.2 m -171.14 144.31 2.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.635 0.585 . . . . 0.0 110.787 179.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.26 -33.57 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.281 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 108' ' ' THR . 47.2 tp10 -57.6 -62.39 1.82 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.335 -178.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.9 t -56.31 -22.24 29.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.936 -179.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 37.3 mt -76.07 -26.14 56.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.277 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.84 133.35 47.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.402 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.4 -16.51 29.29 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.59 151.91 23.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.949 0.404 . . . . 0.0 110.408 -179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -96.38 135.64 37.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.307 -179.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.2 t -127.04 136.61 60.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.662 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.31 139.05 14.54 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.7 t -131.31 161.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.072 0.463 . . . . 0.0 110.35 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.543 ' N ' HG12 ' A' ' 119' ' ' VAL . 44.2 tp -92.69 117.24 29.78 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.579 179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -51.62 157.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.635 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.87 50.44 52.98 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.7 p -149.83 169.26 21.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.316 . . . . 0.0 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.454 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 81.5 p -74.01 -25.9 60.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.349 179.384 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.9 mt-30 -60.9 -55.55 31.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 -179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.18 -53.94 52.4 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.2 m -60.59 -51.16 70.59 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.578 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.607 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.9 t80 -62.36 -43.71 98.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.092 0.472 . . . . 0.0 110.384 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.01 -44.66 97.48 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -179.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.1 m-20 -45.11 -14.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 0.0 110.75 179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.3 -34.34 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.665 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.607 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.63 -50.68 16.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.978 0.418 . . . . 0.0 111.506 -178.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -99.19 12.72 35.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.17 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -84.24 -55.54 0.45 Allowed Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.372 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.4 Cg_endo -72.34 -10.3 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.821 2.347 . . . . 0.0 111.98 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.69 -8.7 59.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.54 -179.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.07 33.17 37.17 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.62 138.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.86 130.0 35.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.328 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.2 pt -126.43 138.23 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.2 t -123.18 133.16 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 109.992 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.8 t -97.18 127.79 43.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.804 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.15 153.52 25.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.357 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.74 6.55 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.699 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.6 130.43 5.98 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -66.05 -45.6 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 110.49 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.09 -23.95 63.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.512 -179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.3 t-20 -64.7 -36.57 84.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.445 179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.97 -47.0 86.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.126 -179.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.517 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 58.9 m-85 -63.73 -37.94 89.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.232 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 77.9 p -61.26 -42.56 98.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.153 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -63.72 -45.63 89.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.865 179.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.8 tp -58.46 -48.08 81.92 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.19 -179.74 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.8 m -63.18 -22.79 67.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.91 0.386 . . . . 0.0 110.077 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.6 -18.6 24.9 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.619 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.95 11.55 70.01 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -69.83 -17.92 63.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.401 . . . . 0.0 110.588 179.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.1 pt -128.53 137.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.497 179.599 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -73.17 -27.83 61.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.53 155.47 1.79 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.83 137.31 50.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.954 0.407 . . . . 0.0 110.029 179.22 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.64 102.91 13.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.225 0.536 . . . . 0.0 110.673 -179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.9 tt0 -132.08 165.1 24.79 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.428 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.3 m-20 -73.52 152.45 40.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.61 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.0 -54.13 29.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.25 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 91' ' ' TYR . 69.7 t -60.5 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.47 -178.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.95 87.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.77 0.319 . . . . 0.0 110.789 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.06 -63.34 1.18 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.567 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.445 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.4 m -58.67 -47.2 85.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.798 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.2 tt0 -49.1 -38.25 24.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.066 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.543 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.88 -65.43 0.55 Allowed Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.67 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.1 t80 -40.51 -71.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.594 0.235 . . . . 0.0 111.23 -178.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.464 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -61.47 -40.04 93.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 -179.077 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -59.53 -2.99 0.39 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.46 0.648 . . . . 0.0 110.448 -179.493 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.543 HE21 ' C ' ' A' ' 171' ' ' GLY . 49.1 mt-30 -124.85 141.2 37.55 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -43.6 -14.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.858 2.372 . . . . 0.0 112.341 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' GLN . 82.2 t -63.23 -42.91 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.553 -179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.75 -32.89 80.63 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.83 -41.6 96.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.725 0.297 . . . . 0.0 110.479 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 57.0 m-20 -65.62 -34.92 79.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.673 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.4 m-85 -156.77 143.42 18.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.794 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.7 pttt -177.03 99.92 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.987 0.422 . . . . 0.0 110.733 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.7 m-85 -159.24 167.98 27.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.37 55.86 3.14 Favored Glycine 0 C--O 1.226 -0.384 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.532 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.13 -117.05 0.01 OUTLIER Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.66 135.04 34.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.483 2.122 . . . . 0.0 111.965 179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.52 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 90.5 p -125.11 -108.31 0.32 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.506 -179.035 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.8 p -165.57 165.07 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.211 -179.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.48 155.61 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 124.077 0.861 . . . . 0.0 110.703 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -82.33 118.31 23.06 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.026 0.441 . . . . 0.0 109.812 179.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.9 mp0 -71.94 -18.49 62.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.87 -32.24 73.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.539 -179.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.459 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.1 mt -60.84 -44.44 96.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.725 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.454 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.4 m-85 -113.84 8.22 17.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.719 179.073 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.3 -154.76 50.89 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.655 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.6 p -70.56 -25.28 26.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.851 0.358 . . . . 0.0 110.56 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.464 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.8 -125.75 1.5 Allowed Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.0 p -132.04 160.08 36.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.43 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.47 -162.59 24.89 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.18 140.92 31.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.615 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.11 111.9 3.97 Favored Glycine 0 CA--C 1.517 0.19 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.565 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 85' ' ' ALA . 85.7 mt -121.61 160.79 23.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.273 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.6 mtm180 -87.11 148.94 25.01 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.723 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.6 mttm -52.15 -48.82 64.72 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.629 -179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -39.82 -23.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.973 0.416 . . . . 0.0 110.719 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -71.65 52.17 0.21 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.759 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.37 -46.29 84.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.182 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.46 -47.07 35.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.209 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.2 -43.89 97.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.45 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.56 -42.86 99.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.856 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -57.51 -37.34 72.83 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.8 179.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.22 0.11 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.98 HD21 HD11 ' A' ' 44' ' ' ILE . 86.3 mt -29.01 -45.62 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.784 0.326 . . . . 0.0 110.418 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.8 m-20 -63.62 -45.48 90.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 178.105 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.42 -43.7 98.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.945 178.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.36 92.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.152 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -61.19 -43.39 98.95 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.027 0.441 . . . . 0.0 110.063 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.26 92.54 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.15 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.9 -42.96 97.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.886 179.283 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.78 -38.47 72.55 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -69.85 -38.81 76.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.969 0.414 . . . . 0.0 110.374 178.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.87 -45.42 92.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.661 -179.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.9 p-10 -88.35 0.4 56.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.698 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.61 20.38 67.96 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.459 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 82.0 m -58.18 -46.17 86.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.312 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.46 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 82.1 t80 -63.65 -57.43 10.08 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.454 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.89 -41.68 78.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.25 -179.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.51 -48.6 80.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.493 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.83 -41.59 97.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.06 -49.74 76.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.715 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.94 -35.45 73.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.414 -179.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -70.59 -51.0 31.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.462 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.515 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.4 m-85 -62.35 -45.45 93.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.586 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.5 m-85 -153.74 155.15 35.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.46 179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.16 99.47 10.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.996 0.427 . . . . 0.0 110.527 179.591 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -156.41 -165.17 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.526 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.74 109.22 13.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.9 m -63.6 -40.35 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.426 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.7 m-85 -56.91 -43.7 81.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.256 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.83 93.93 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.708 0 CA-C-O 117.881 -1.51 . . . . 0.0 110.94 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.29 164.25 62.55 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.587 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -60.91 143.53 99.37 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.564 2.176 . . . . 0.0 112.324 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.406 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.4 mm-40 -66.38 -41.02 90.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.081 0.467 . . . . 0.0 110.511 179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 97.8 m-20 -138.4 139.07 38.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.388 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 81.8 mt -108.19 121.47 61.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.706 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -93.91 118.76 31.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.253 0.549 . . . . 0.0 110.13 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -112.4 138.42 41.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.41 105.47 2.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -129.09 120.2 25.51 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.677 0.275 . . . . 0.0 111.136 179.618 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.51 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 5.2 t0 -114.57 92.69 29.69 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.177 179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.96 134.73 60.89 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.404 2.069 . . . . 0.0 112.135 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.2 p -142.0 -20.2 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.745 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -123.53 99.14 6.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.697 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.733 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -29.0 -61.63 0.22 Allowed Pre-proline 0 C--O 1.218 -0.577 0 CA-C-O 121.378 0.609 . . . . 0.0 111.029 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.733 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.25 -40.62 43.06 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 C-N-CA 122.206 1.937 . . . . 0.0 112.256 -179.227 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.6 t80 -78.19 -42.9 30.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.148 0.499 . . . . 0.0 111.025 179.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' O ' ' O ' ' A' ' 18' ' ' ALA . 96.3 mt-10 -149.74 -153.68 0.51 Allowed 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.966 -178.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 161.74 177.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.078 0.466 . . . . 0.0 110.402 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.4 mttt -135.57 144.76 46.38 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.4 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -95.8 134.47 38.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.652 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -64.66 -19.02 65.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.529 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -78.23 -6.11 53.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.431 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.26 -7.76 56.77 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.67 158.77 25.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.038 0.447 . . . . 0.0 110.441 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -112.07 131.21 55.56 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.988 0.423 . . . . 0.0 110.469 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.69 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.5 p -134.15 151.4 32.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.304 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.409 ' N ' HD12 ' A' ' 34' ' ' ILE . . . 165.0 151.43 6.59 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -58.74 -41.8 87.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.909 0.385 . . . . 0.0 110.951 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.49 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 31.7 t0 -69.79 -28.47 65.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 -179.701 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.69 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -67.79 -40.97 84.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.847 179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -61.05 -37.21 81.81 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.824 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.99 -45.26 86.35 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -57.02 -48.32 78.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.981 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -53.23 -54.47 35.62 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.31 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -52.48 -39.81 61.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.872 0.367 . . . . 0.0 110.26 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.0 mt -68.79 -42.05 77.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.053 0.454 . . . . 0.0 110.53 178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.53 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 56.2 m -53.44 -44.91 69.23 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.146 -179.425 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.1 tttm -64.26 -46.94 81.51 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.992 179.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -60.04 -42.14 93.78 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.216 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.893 HD11 HD21 ' A' ' 213' ' ' LEU . 97.1 mt -75.28 -17.46 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.429 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.85 53.2 3.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.424 -179.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -147.12 171.51 15.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.95 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -89.16 142.69 27.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.03 0.443 . . . . 0.0 109.956 179.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 m -117.54 131.4 56.71 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -127.54 127.25 43.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.401 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -93.86 134.68 35.97 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.08 127.89 66.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -65.38 138.0 57.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.829 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.51 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 175.69 130.33 0.15 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.479 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 57' ' ' ALA . 45.6 Cg_endo -67.58 145.07 69.03 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.71 2.273 . . . . 0.0 112.512 -179.186 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.873 HD23 HD12 ' A' ' 58' ' ' LEU . 82.2 mt -40.13 -55.76 2.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.185 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -48.37 -26.37 2.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.857 0.361 . . . . 0.0 111.224 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.19 -20.91 18.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.241 -179.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.873 HD12 HD23 ' A' ' 55' ' ' LEU . 58.6 mt -63.75 -42.37 97.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.643 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.721 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.21 -57.0 25.79 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.795 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.721 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 44.3 Cg_exo -55.39 -42.46 68.06 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.681 2.254 . . . . 0.0 111.213 177.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.1 m -58.69 -45.08 90.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.906 -179.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 203' ' ' ARG . 62.9 tp -58.88 -44.2 91.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.148 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -64.26 -40.82 96.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.996 0.426 . . . . 0.0 110.424 178.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.79 9.87 2.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.416 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 57.21 12.13 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.991 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.3 mttt -63.36 -35.52 80.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.503 178.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -122.34 153.14 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.287 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.2 m-20 -93.28 -22.18 19.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.462 -179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.62 156.14 27.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 58' ' ' LEU . 96.5 mt -115.01 129.01 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.493 . . . . 0.0 110.469 179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.49 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.6 ttp -131.29 106.72 8.48 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.714 ' OG ' HD21 ' A' ' 55' ' ' LEU . 40.3 t -159.39 178.5 9.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.641 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.99 -15.52 62.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.374 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.633 ' CD1' HH12 ' A' ' 80' ' ' ARG . 42.8 tp -34.98 124.37 0.57 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.596 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.546 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.4 p -82.0 154.03 25.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.668 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.631 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -104.74 148.46 9.29 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.348 -179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.8 p -149.01 152.2 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.01 -47.09 53.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.43 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.51 -39.74 70.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.671 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.633 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.8 mtt180 -68.98 -37.94 79.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.819 179.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.4 mt-30 -57.9 -39.03 76.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.711 -179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -59.79 -27.38 66.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.15 179.8 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.57 -50.77 7.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.046 0.451 . . . . 0.0 110.634 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -139.14 -168.27 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 121.1 0.476 . . . . 0.0 110.543 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -107.53 147.8 30.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 111.08 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.547 ' CD2' HG22 ' A' ' 76' ' ' ILE . 80.0 m-85 -129.92 150.02 51.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.569 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.543 ' O ' ' N ' ' A' ' 89' ' ' LYS . 8.8 t -163.17 -153.26 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.57 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.514 ' OD2' ' SD ' ' A' ' 200' ' ' MET . 93.7 m-20 41.19 20.14 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.998 179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 87' ' ' THR . 99.3 mttt -30.71 121.32 0.2 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.324 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 58.5 mt -74.79 -68.51 0.54 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.931 -178.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.447 ' CG ' HG21 ' A' ' 166' ' ' VAL . 56.1 p90 -150.52 167.55 26.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.751 -179.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.67 123.62 29.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.184 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -104.94 68.66 0.83 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.809 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -85.67 -104.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.452 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.6 p -159.06 165.63 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.698 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.7 ttt-85 -155.49 146.09 22.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 0.0 110.489 179.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' O ' ' O ' ' A' ' 184' ' ' GLY . 9.7 mt -100.79 136.19 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.982 0.42 . . . . 0.0 110.813 178.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.59 110.86 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.27 164.91 33.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.81 148.56 23.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.93 -28.42 56.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.241 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -58.76 -41.94 87.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.319 -179.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.3 t -101.93 121.74 42.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.016 0.436 . . . . 0.0 110.147 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -86.88 109.72 19.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -125.97 129.14 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.718 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -106.44 154.28 39.96 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.721 179.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 108' ' ' THR . 17.7 Cg_endo -59.49 90.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.766 2.311 . . . . 0.0 111.628 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 107' ' ' PRO . 7.1 m -170.87 143.74 2.11 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.587 0.555 . . . . 0.0 110.786 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.71 -33.05 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.085 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.3 -62.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.191 -178.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.3 t -55.74 -22.14 22.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 -179.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.43 -25.91 54.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.254 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.71 133.83 47.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 -179.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.5 -15.56 29.28 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.94 151.52 23.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -95.6 135.16 37.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.357 -179.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.16 136.59 60.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.57 138.45 14.27 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.3 t -130.77 161.56 40.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.082 0.468 . . . . 0.0 110.359 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.3 tp -92.41 117.45 29.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.526 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -51.7 158.06 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.608 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.61 50.56 53.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.4 p -149.77 168.9 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.73 0.3 . . . . 0.0 110.9 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.463 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 75.1 p -73.3 -27.54 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.434 179.373 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.15 -55.65 31.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.507 -179.243 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.5 -54.96 39.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.698 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -60.11 -51.16 70.79 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.792 -179.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 64.5 t80 -62.07 -43.96 97.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.143 0.497 . . . . 0.0 110.591 179.238 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -61.58 -44.39 98.02 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.336 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.533 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.33 -14.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.8 tt0 -125.23 -34.28 2.75 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 t60 -74.53 -50.56 17.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.129 0.49 . . . . 0.0 111.673 -178.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.0 12.29 36.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.252 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.66 -55.38 0.48 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.347 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 55.7 Cg_endo -72.2 -10.61 26.03 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.75 2.3 . . . . 0.0 111.965 -179.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -82.44 -9.17 59.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.42 -179.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.93 33.16 37.79 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.24 138.07 38.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.844 0.354 . . . . 0.0 110.628 -179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.67 129.84 35.0 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.28 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.2 pt -126.52 138.21 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.96 179.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.5 t -123.0 133.35 69.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.026 0.441 . . . . 0.0 109.981 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.0 t -97.2 127.4 43.13 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -110.64 153.37 25.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.329 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -107.01 6.68 29.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.759 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.21 130.17 5.96 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.418 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.9 tp60 -65.8 -45.87 80.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.715 0.293 . . . . 0.0 110.383 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -70.82 -23.32 62.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.608 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.58 -37.07 86.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.11 0.481 . . . . 0.0 110.537 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.81 -46.82 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.231 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.508 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 61.5 m-85 -64.48 -37.72 88.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.345 179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.97 -42.23 97.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.1 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.84 -43.52 92.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.122 179.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.583 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.0 tp -59.01 -47.76 84.03 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.023 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.85 -22.57 66.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.025 0.44 . . . . 0.0 110.12 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.63 -18.26 25.43 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.592 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.01 11.95 72.18 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.98 -18.03 63.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.972 0.415 . . . . 0.0 110.606 179.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 153' ' ' LEU . 34.6 pt -127.04 135.92 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.399 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -72.55 -27.82 62.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.313 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.52 155.99 1.88 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.838 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -130.15 136.71 49.58 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -85.68 103.48 14.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.281 0.562 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.583 ' O ' ' N ' ' A' ' 96' ' ' ARG . 49.8 tt0 -132.76 165.25 24.97 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.363 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.476 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.5 m-20 -72.84 153.09 41.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.977 0.418 . . . . 0.0 110.56 179.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.34 -54.65 22.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.401 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.447 HG21 ' CG ' ' A' ' 91' ' ' TYR . 71.4 t -60.07 -49.06 85.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.705 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.33 -39.06 89.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.824 0.345 . . . . 0.0 110.797 179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.667 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.49 -63.14 1.21 Allowed 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.454 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.0 m -59.5 -48.16 82.72 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.911 -179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 82.2 tt0 -48.55 -37.74 18.63 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.342 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.75 -66.14 0.56 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.667 ' N ' ' O ' ' A' ' 168' ' ' ALA . 26.2 t80 -40.56 -70.9 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 111.218 -178.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.457 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.7 mt -61.17 -40.27 93.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.23 -3.03 0.53 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.443 0.639 . . . . 0.0 110.499 -179.528 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 173' ' ' LEU . 55.8 mt-30 -122.71 147.09 49.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.853 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.48 -19.64 2.06 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.844 2.362 . . . . 0.0 112.228 179.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.87 -42.8 96.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.672 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 181' ' ' TYR . . . -61.63 -32.97 83.35 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.044 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.57 -41.26 94.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 53.7 m-20 -65.83 -33.47 75.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.25 179.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.0 m-85 -156.79 143.04 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.675 -179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.552 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 42.8 pttt -177.94 100.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.784 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.552 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 90.9 m-85 -159.39 167.12 29.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.696 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 83.07 56.72 2.66 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.43 -118.37 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.36 135.35 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.477 2.118 . . . . 0.0 111.941 179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -125.36 -107.9 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.61 -179.087 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 6.2 p -165.59 164.89 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.41 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.4 tttt 153.99 156.28 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 123.823 0.702 . . . . 0.0 110.722 179.296 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -82.55 116.87 22.16 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.8 mp0 -71.02 -18.94 62.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.81 -32.52 74.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.557 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 128' ' ' PHE . 90.9 mt -61.04 -44.47 97.35 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.691 -178.08 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 47.1 m-85 -113.96 9.23 17.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.743 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 71.18 -154.83 52.23 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 -179.361 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.631 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.9 p -70.14 -25.06 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.892 0.377 . . . . 0.0 110.547 179.47 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.25 -124.33 1.33 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 22.6 p -129.22 156.23 44.29 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 110.234 179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -166.56 -169.42 30.15 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.514 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.5 mtp -94.52 137.48 33.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -86.55 108.29 3.29 Favored Glycine 0 C--N 1.33 0.221 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.535 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 85' ' ' ALA . 87.7 mt -123.39 159.37 29.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.441 . . . . 0.0 110.152 -179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.659 ' HG3' HD21 ' A' ' 62' ' ' LEU . 90.0 mtm180 -86.76 149.61 24.74 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.94 -48.04 64.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.518 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' LYS . 46.2 tp10 -38.38 -24.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.0 110.67 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 204' ' ' LYS . 99.5 m-20 -71.75 52.27 0.22 Allowed 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.64 179.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -64.53 -45.54 86.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.345 -179.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -74.44 -47.12 35.48 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.015 0.436 . . . . 0.0 111.32 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 58.8 tp -62.3 -44.11 97.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.425 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.435 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.5 ttt-85 -62.04 -43.06 99.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.744 179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -57.15 -36.43 70.73 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.699 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -74.19 -77.73 0.11 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.893 HD21 HD11 ' A' ' 44' ' ' ILE . 97.0 mt -28.27 -46.36 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.736 0.303 . . . . 0.0 110.29 179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -64.23 -44.83 90.66 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.662 178.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.99 -43.77 98.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.957 178.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.27 94.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.057 179.755 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -61.25 -43.71 98.44 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.965 0.412 . . . . 0.0 109.894 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.42 -39.15 92.35 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.12 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.3 mt-10 -63.67 -42.89 97.99 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.535 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.6 mtp -58.28 -38.33 76.8 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.0 -40.02 78.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.879 0.371 . . . . 0.0 110.095 178.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.68 93.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.471 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.535 ' OD1' ' O ' ' A' ' 220' ' ' MET . 16.0 p30 -86.73 1.54 51.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.451 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.26 19.52 59.69 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 223' ' ' ASP . 72.6 m -58.31 -45.65 87.63 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.426 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 81.7 t80 -63.49 -58.15 7.93 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.341 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.89 -41.33 77.86 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.46 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.53 -48.36 81.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.643 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.22 -41.43 98.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.296 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -58.74 -50.39 74.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.463 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.44 -35.39 72.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.645 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -71.14 -50.86 28.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.4 m-85 -62.27 -45.28 93.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.503 179.45 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 67.9 m-85 -153.3 155.06 35.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.407 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.5 p-10 -97.56 95.22 7.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.954 0.406 . . . . 0.0 110.505 179.513 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -153.16 -166.12 2.35 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.9 t0 -122.99 109.98 14.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.822 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.4 m -63.43 -40.67 89.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.39 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.2 m-85 -56.38 -43.91 79.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.303 -179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.29 -37.49 94.94 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.67 0 CA-C-O 117.934 -1.481 . . . . 0.0 110.95 179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.31 164.22 59.14 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.604 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.88 144.0 99.47 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.6 2.2 . . . . 0.0 112.235 179.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.2 mm-40 -65.86 -40.62 91.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.528 179.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.62 144.47 37.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.464 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.4 mt -110.92 129.96 65.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.501 -179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -104.42 116.56 32.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.425 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.8 140.99 29.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.17 106.39 2.12 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.7 m -128.49 120.23 26.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.679 0.276 . . . . 0.0 111.146 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.7 t70 -112.54 94.22 26.73 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.104 179.606 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.21 134.87 62.68 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.467 2.111 . . . . 0.0 112.19 179.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 p -136.76 -18.43 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.705 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' O ' ' C ' ' A' ' 18' ' ' ALA . 82.6 m-85 -124.78 97.73 5.41 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.799 -179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.718 ' O ' ' O ' ' A' ' 21' ' ' GLU . . . -30.46 -61.34 0.25 Allowed Pre-proline 0 C--O 1.22 -0.494 0 CA-C-O 121.373 0.606 . . . . 0.0 110.965 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.714 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 6.7 Cg_endo -49.81 -41.37 46.97 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.263 1.975 . . . . 0.0 112.281 -178.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' TYR . 26.4 t80 -78.25 -42.74 30.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.017 0.437 . . . . 0.0 111.012 179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.718 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.0 mt-10 -146.42 -161.12 1.25 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.044 -178.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 21' ' ' GLU . 1.3 t 157.59 -179.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.014 0.435 . . . . 0.0 110.345 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -133.69 140.71 47.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.356 179.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.57 138.03 31.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.59 179.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.2 p -64.86 -19.16 65.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.555 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -79.23 -4.92 52.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.473 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.59 -10.17 57.52 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -80.35 158.97 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.974 0.416 . . . . 0.0 110.46 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.42 136.18 53.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.549 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.511 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.1 p -131.82 150.8 34.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.362 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 162.9 152.92 6.99 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -60.3 -41.17 92.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.024 0.44 . . . . 0.0 110.741 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 30.8 t0 -70.56 -32.41 69.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.106 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.511 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.8 mt -67.02 -39.99 84.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.741 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -60.98 -36.66 80.03 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.967 -178.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.21 -44.71 83.07 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -58.47 -45.08 89.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.214 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -54.93 -54.24 45.25 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.505 -179.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -54.13 -37.32 64.23 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.475 179.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.62 -43.36 72.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.654 179.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 54.4 m -54.13 -44.24 71.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.165 -179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 65.9 tttm -63.91 -48.0 78.35 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.043 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.51 -41.11 89.15 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.171 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.967 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.37 -18.53 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.507 179.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 61.51 52.24 3.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.55 -179.365 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.14 169.93 17.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.851 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -88.1 140.85 29.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.155 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.17 132.01 56.75 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.692 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.1 m -127.97 126.79 42.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.441 179.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -94.18 136.51 34.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.566 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -130.35 128.93 64.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.416 179.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.07 139.88 56.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.745 179.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.4 p30 175.0 135.16 0.16 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.543 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.1 Cg_endo -68.37 143.34 57.74 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.715 2.277 . . . . 0.0 112.45 -179.176 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.879 HD23 HD12 ' A' ' 58' ' ' LEU . 83.6 mt -39.88 -54.56 2.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.119 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -48.84 -25.97 2.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.882 0.372 . . . . 0.0 111.139 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.33 -20.99 18.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.117 -179.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.879 HD12 HD23 ' A' ' 55' ' ' LEU . 55.1 mt -64.04 -42.43 97.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.58 179.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.4 mm -62.06 -56.57 30.27 Favored Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.008 -179.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.3 Cg_exo -55.05 -42.94 64.16 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 122.597 2.198 . . . . 0.0 111.293 176.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.4 m -58.48 -44.94 89.54 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.854 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 64.0 tp -58.65 -44.54 90.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.109 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.7 -41.18 96.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.935 0.397 . . . . 0.0 110.453 178.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.03 11.08 1.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.522 -179.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.29 11.95 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.61 -33.69 76.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.536 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.8 pt -124.41 154.55 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.322 -179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 95.8 m-20 -92.6 -20.79 20.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.175 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -163.19 159.64 23.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.582 HG23 HD13 ' A' ' 58' ' ' LEU . 96.0 mt -116.29 127.39 73.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.047 0.451 . . . . 0.0 110.537 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 61.9 ttp -128.68 107.38 9.63 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.323 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.514 ' OG ' HD21 ' A' ' 55' ' ' LEU . 36.7 t -162.27 -176.79 5.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.0 p -64.22 -15.89 60.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.345 179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.637 ' CD1' HH12 ' A' ' 80' ' ' ARG . 36.6 tp -37.51 122.93 0.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.954 0.407 . . . . 0.0 110.502 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.56 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.7 p -83.03 156.21 23.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.69 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.657 HD11 ' CG1' ' A' ' 196' ' ' VAL . 48.7 pt -105.21 149.29 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.383 179.973 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.0 p -150.52 152.52 34.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.787 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.08 -47.72 53.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.584 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.44 -39.78 70.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.637 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.0 mtt180 -68.67 -37.79 79.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.022 0.439 . . . . 0.0 110.875 179.203 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.481 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.5 mt-30 -58.2 -37.71 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.931 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.86 -27.41 66.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.153 179.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -83.58 -51.12 7.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 110.543 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.8 pt -139.15 -168.07 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.068 0.461 . . . . 0.0 110.468 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -106.49 147.29 29.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.566 ' CD1' HG22 ' A' ' 76' ' ' ILE . 73.1 m-85 -130.33 150.47 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 179.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 89' ' ' LYS . 10.1 t -165.02 -150.83 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.474 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.528 ' O ' ' C ' ' A' ' 89' ' ' LYS . 99.0 m-20 42.74 19.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.528 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.14 120.87 0.09 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.444 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.484 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.9 mt -80.0 -72.79 0.39 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.923 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -147.86 164.98 32.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.58 127.49 32.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.405 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -107.11 67.48 0.7 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.692 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -86.27 -106.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 32.2 p -159.45 167.85 27.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.706 -179.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.21 146.68 23.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.055 0.455 . . . . 0.0 110.492 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.7 mt -101.68 135.94 42.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.743 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.5 111.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.98 164.67 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.966 -179.165 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.53 148.44 24.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.31 -28.24 52.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.2 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -59.07 -41.35 87.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -102.38 122.31 44.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 110.332 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -87.51 109.39 19.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.062 0.458 . . . . 0.0 110.532 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.4 129.85 69.1 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.756 179.775 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.465 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -112.25 158.79 36.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.54 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' O ' ' OG1' ' A' ' 108' ' ' THR . 21.0 Cg_endo -60.3 91.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 122.736 2.29 . . . . 0.0 111.883 179.439 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.7 m -169.89 142.62 2.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.725 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.6 p -68.56 -33.5 60.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.284 179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 108' ' ' THR . 46.9 tp10 -56.73 -63.18 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.343 -178.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.4 t -56.86 -21.75 31.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.059 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.2 mt -75.5 -28.28 59.12 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -55.06 132.55 47.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.546 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.53 -16.35 35.83 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.64 151.21 23.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.995 0.426 . . . . 0.0 110.479 -179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -96.38 135.58 38.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.287 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.44 136.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.708 -179.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.83 137.81 13.97 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 120' ' ' LEU . 54.4 t -131.44 161.7 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.047 0.451 . . . . 0.0 110.392 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.552 ' N ' HG12 ' A' ' 119' ' ' VAL . 39.2 tp -92.99 120.55 33.41 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.56 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -52.01 155.49 1.83 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.6 50.91 45.62 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.8 p -147.85 166.1 28.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.662 0.267 . . . . 0.0 110.886 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 68.6 p -71.28 -30.62 66.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.3 mt-30 -58.35 -55.16 38.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -56.24 -55.43 33.3 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.799 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 m -60.56 -51.65 68.52 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.872 -179.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.589 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 68.5 t80 -61.83 -44.41 96.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.023 0.439 . . . . 0.0 110.547 179.324 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.0 -44.37 97.88 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.55 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 98.8 m-20 -45.44 -14.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 0.0 110.731 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.35 -34.43 2.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.589 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 7.8 t60 -74.04 -50.46 19.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.089 0.471 . . . . 0.0 111.523 -178.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -99.92 12.53 36.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.165 -179.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.24 -55.14 0.51 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.2 Cg_endo -72.37 -9.8 24.71 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.789 2.326 . . . . 0.0 111.988 -179.738 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.12 -8.62 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.388 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.09 33.51 36.1 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.79 137.57 40.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.0 110.594 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -87.97 130.27 35.0 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.276 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.6 pt -128.34 139.75 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.974 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.96 132.47 70.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.133 179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 36.3 t -97.82 129.83 44.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.763 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -111.1 156.93 20.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.411 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.0 6.97 27.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.25 130.56 6.08 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -66.24 -46.58 76.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.712 0.291 . . . . 0.0 110.413 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -70.02 -23.22 63.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.563 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.447 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.9 t-20 -64.61 -36.54 84.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.527 179.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.26 -47.67 83.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.121 -179.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.501 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.4 m-85 -63.59 -37.86 88.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.37 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.1 p -60.84 -42.62 98.14 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.44 -43.74 93.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.305 179.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.3 tp -59.21 -48.53 81.29 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.179 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.3 m -62.72 -22.85 66.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.962 0.411 . . . . 0.0 110.199 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.29 -18.19 26.05 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.633 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.3 11.03 73.09 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.48 -18.12 63.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.4 pt -128.37 137.31 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.38 179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.409 ' O ' HG12 ' A' ' 99' ' ' VAL . 97.6 m-20 -72.88 -29.36 63.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.26 155.13 1.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.821 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -128.61 139.09 52.45 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.946 0.403 . . . . 0.0 110.029 179.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -86.51 103.15 14.77 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.234 0.54 . . . . 0.0 110.714 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.7 tt0 -132.36 164.69 25.92 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.368 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.472 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.6 m-20 -73.53 152.45 40.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.576 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.441 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.5 mt-10 -66.2 -54.11 29.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.59 -49.25 84.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.91 84.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.844 179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.666 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -63.12 -63.94 1.05 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.533 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.446 ' OG ' HD12 ' A' ' 173' ' ' LEU . 68.0 m -57.82 -46.51 84.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.298 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 83.5 tt0 -46.05 -41.87 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.402 ' CA ' HE21 ' A' ' 175' ' ' GLN . . . -111.26 -62.26 0.48 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.623 -179.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.666 ' N ' ' O ' ' A' ' 168' ' ' ALA . 27.6 t80 -40.31 -71.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.618 0.247 . . . . 0.0 111.083 -178.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 175' ' ' GLN . 96.0 mt -62.35 -40.71 97.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 86.2 tttt -60.13 -2.52 0.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.383 0.611 . . . . 0.0 110.532 -179.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 177' ' ' VAL . 56.5 mt-30 -126.25 141.5 40.01 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.825 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -43.45 -14.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.828 2.352 . . . . 0.0 112.211 179.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 175' ' ' GLN . 92.5 t -63.28 -42.91 98.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.67 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.67 -33.31 84.61 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.1 -41.21 96.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.727 0.299 . . . . 0.0 110.48 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.525 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.5 m-20 -65.8 -34.7 78.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.467 179.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.5 m-85 -157.18 143.35 17.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 40.6 pttt -175.96 99.12 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.745 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 92.0 m-85 -158.76 166.78 31.15 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.698 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.83 55.89 3.05 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -51.21 -116.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.56 134.02 32.52 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.573 2.182 . . . . 0.0 111.906 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 95.1 p -123.27 -109.4 0.33 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.453 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 4.4 p -164.84 164.09 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.364 -179.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 86.6 tttt 154.71 154.09 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.791 0.682 . . . . 0.0 110.657 179.276 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -80.06 119.26 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.951 179.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 195' ' ' GLY . 56.7 mp0 -71.36 -19.76 62.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.053 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.18 -31.0 72.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.548 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 128' ' ' PHE . 87.9 mt -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.668 -178.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -114.46 8.18 16.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.735 179.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.7 -154.1 49.68 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.657 ' CG1' HD11 ' A' ' 76' ' ' ILE . 13.2 p -70.79 -25.74 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.854 0.359 . . . . 0.0 110.606 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.405 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 161.1 -126.9 1.66 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 21.0 p -132.28 160.56 35.86 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.484 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.96 -161.74 23.87 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.2 mtp -98.8 140.45 32.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.976 0.417 . . . . 0.0 110.54 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -88.85 109.19 3.53 Favored Glycine 0 C--N 1.33 0.211 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -179.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.3 mt -117.86 159.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.919 0.39 . . . . 0.0 110.248 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.9 mtm180 -86.76 148.57 25.36 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.511 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -51.63 -48.48 63.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.663 -179.444 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -40.94 -22.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 0.0 110.734 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.6 m-20 -73.08 51.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.739 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -64.41 -46.42 83.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.244 -179.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -74.19 -47.12 37.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.181 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.413 HD11 HD13 ' A' ' 44' ' ' ILE . 63.4 tp -62.14 -43.7 98.26 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.59 -43.1 99.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -57.39 -37.59 72.93 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.701 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.43 -77.66 0.1 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.967 HD21 HD11 ' A' ' 44' ' ' ILE . 86.9 mt -28.03 -45.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.421 179.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 212' ' ' ALA . 89.2 m-20 -63.63 -45.76 88.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 178.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.8 tttm -60.94 -43.96 97.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.945 178.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.19 -39.2 91.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.206 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.12 -43.73 98.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.082 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.0 -39.2 91.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.181 -179.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.5 mt-10 -63.93 -43.44 95.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.887 179.347 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.511 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 92.0 mtp -56.36 -38.53 71.53 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.61 -39.11 77.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 0.0 110.288 178.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.25 -45.63 90.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.653 -179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 19.3 p-10 -88.58 -0.49 57.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.754 179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 66.71 20.49 70.27 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.463 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 99.9 m -58.19 -46.36 85.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.557 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.484 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 76.2 t80 -62.21 -56.68 16.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.273 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.71 -40.76 76.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.317 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -47.92 83.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.535 -179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.1 -40.75 96.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.251 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -60.62 -49.7 76.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.557 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.5 -35.74 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -69.77 -51.6 32.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.499 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 9.0 m-85 -61.93 -46.27 90.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.579 179.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.517 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 70.4 m-85 -154.67 154.64 33.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.517 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 48.5 p-10 -98.28 95.19 7.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.979 0.419 . . . . 0.0 110.608 179.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -151.5 -164.13 1.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.582 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.441 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 42.7 t0 -122.12 108.49 13.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.787 -179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 239' ' ' TYR . 26.0 m -63.56 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.367 179.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.432 ' N ' HG23 ' A' ' 238' ' ' VAL . 89.7 m-85 -58.53 -42.51 87.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.315 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.23 -37.64 95.2 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.406 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.669 0 CA-C-O 117.885 -1.508 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.28 164.39 61.59 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -60.86 143.52 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.539 2.159 . . . . 0.0 112.287 179.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.17 -40.33 90.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.526 179.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.79 142.51 36.7 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.485 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.0 mt -109.62 128.75 65.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.915 0.388 . . . . 0.0 110.489 -179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.6 mtp180 -103.39 116.86 33.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.128 0.49 . . . . 0.0 110.392 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -111.59 138.93 38.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.952 0.406 . . . . 0.0 110.575 -179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.02 104.4 2.04 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -127.57 119.24 25.53 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 122.759 -0.26 . . . . 0.0 111.217 179.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.533 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 16.4 t70 -113.63 93.21 27.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.155 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.18 134.08 58.68 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.502 2.134 . . . . 0.0 112.115 179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.3 p -141.4 -19.67 0.77 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.745 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.7 m-85 -124.53 98.9 5.94 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.721 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.73 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.97 -61.53 0.22 Allowed Pre-proline 0 C--O 1.22 -0.495 0 CA-C-O 121.362 0.601 . . . . 0.0 110.965 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.73 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.7 Cg_endo -49.31 -39.71 43.48 Favored 'Trans proline' 0 C--N 1.296 -2.199 0 C-N-CA 122.287 1.991 . . . . 0.0 112.181 -179.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 17' ' ' TYR . 28.2 t80 -79.0 -42.61 26.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.024 0.44 . . . . 0.0 110.996 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.679 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.6 mt-10 -149.39 -155.41 0.63 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.988 -178.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.77 178.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.021 0.439 . . . . 0.0 110.402 -179.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.2 mttt -136.17 143.78 44.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.451 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.2 t-20 -96.09 141.38 29.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.558 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.525 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.2 p -66.02 -18.91 65.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.523 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.2 -6.66 55.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.414 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.78 -6.88 58.95 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -79.87 158.38 26.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.961 0.41 . . . . 0.0 110.429 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -112.01 133.93 53.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.948 0.404 . . . . 0.0 110.474 -179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.7 151.33 32.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.307 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.63 151.5 6.59 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -58.62 -41.67 86.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 34.6 t0 -70.57 -28.24 64.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.201 -179.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.663 HD12 ' C ' ' A' ' 30' ' ' VAL . 97.4 mt -68.68 -40.77 82.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.055 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 53.0 m-20 -61.16 -37.15 81.86 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.972 -178.464 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.77 -43.99 82.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.054 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.539 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.78 -41.89 92.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.293 -179.114 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -58.8 -53.52 57.4 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.546 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.65 -36.81 62.48 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.924 0.392 . . . . 0.0 110.342 179.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.69 -42.37 74.18 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 178.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.539 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 58.9 m -54.25 -44.79 72.07 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.208 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 64.9 tttm -63.74 -47.79 79.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.987 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.6 mmt-85 -59.4 -40.83 87.89 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.199 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.981 HD11 HD21 ' A' ' 213' ' ' LEU . 96.7 mt -76.46 -17.79 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.565 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.2 m-20 60.76 52.69 4.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.483 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 p -145.6 170.5 16.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -88.62 140.86 29.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.136 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 56.2 m -117.39 131.79 56.7 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.636 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.5 m -128.2 127.67 43.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -93.86 135.67 34.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.582 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.0 t -129.59 128.27 65.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.345 179.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -66.11 139.29 58.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.819 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.1 p30 174.95 132.35 0.14 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.491 179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ALA . 49.5 Cg_endo -68.42 144.55 61.94 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.728 2.286 . . . . 0.0 112.467 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.882 HD23 HD12 ' A' ' 58' ' ' LEU . 82.0 mt -40.01 -56.34 1.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -47.55 -26.48 1.45 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.127 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.36 -20.63 18.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.19 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.882 HD12 HD23 ' A' ' 55' ' ' LEU . 57.4 mt -63.99 -42.35 97.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.718 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.49 -56.69 27.77 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.894 -179.305 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.718 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 45.8 Cg_exo -54.94 -43.59 57.9 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.646 2.23 . . . . 0.0 111.249 177.02 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.1 m -58.55 -44.69 89.74 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.781 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.7 tp -58.14 -44.32 87.75 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.149 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -64.56 -40.39 95.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.021 0.439 . . . . 0.0 110.541 178.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.28 11.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.517 -179.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 56.21 12.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.877 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.44 -34.46 77.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.536 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 41.9 pt -123.8 153.25 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.278 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.71 -20.57 20.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.317 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.97 157.05 25.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.739 -179.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.603 HG23 HD13 ' A' ' 58' ' ' LEU . 96.4 mt -116.02 127.5 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.062 0.458 . . . . 0.0 110.495 179.66 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.9 ttp -128.64 106.69 9.12 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.411 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.583 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.0 t -159.98 -178.23 6.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.582 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.1 p -64.26 -15.47 60.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.628 ' CD1' HH12 ' A' ' 80' ' ' ARG . 38.0 tp -38.05 123.81 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.971 0.415 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.556 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.9 p -83.45 156.71 22.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.649 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.3 pt -104.88 148.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.365 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.2 p -149.92 152.32 34.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.833 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -50.19 -47.84 54.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.606 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.56 -39.81 71.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.74 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.628 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.7 mtt180 -68.45 -37.8 80.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.465 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.7 mt-30 -58.47 -37.11 74.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.875 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -60.43 -27.45 67.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.132 179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -83.45 -51.71 7.13 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.024 0.44 . . . . 0.0 110.533 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 81' ' ' GLN . 38.9 pt -138.33 -168.74 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 121.066 0.46 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.81 146.73 29.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.034 0.445 . . . . 0.0 110.985 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.57 ' CD1' HG22 ' A' ' 76' ' ' ILE . 71.7 m-85 -129.76 149.98 51.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.614 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.6 t -164.15 -151.68 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.516 179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.52 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.5 m-20 43.11 19.18 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.801 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.5 mttt -27.92 120.12 0.11 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' O ' ' CZ ' ' A' ' 226' ' ' TYR . 16.0 mt -77.0 -69.99 0.49 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.843 -178.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.434 ' CG ' HG21 ' A' ' 166' ' ' VAL . 45.0 p90 -149.34 166.31 29.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.619 -179.648 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.26 121.65 27.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.021 0.438 . . . . 0.0 110.29 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.462 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.94 69.82 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.782 -179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -86.22 -104.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.465 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 29.8 p -159.29 165.87 32.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.697 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' A' ' 163' ' ' GLN . 78.6 ttt-85 -155.73 145.84 21.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.026 0.441 . . . . 0.0 110.503 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 11.0 mt -101.27 136.05 41.75 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.98 0.419 . . . . 0.0 110.77 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 110.79 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.2 m -134.65 164.88 32.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.994 -179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.94 148.42 23.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.996 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.57 -27.75 41.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.272 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -59.25 -41.74 89.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.326 -179.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -102.47 122.59 44.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.009 0.433 . . . . 0.0 110.299 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -87.92 109.41 19.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.485 -179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.427 ' C ' ' NE2' ' A' ' 106' ' ' GLN . 97.1 mt -128.15 129.6 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.772 179.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.583 ' NE2' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -110.89 158.9 34.41 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.569 179.916 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.8 Cg_endo -59.58 89.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 122.734 2.289 . . . . 0.0 111.913 179.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 110' ' ' GLU . 6.9 m -169.05 140.89 2.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.701 179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.27 -32.96 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.237 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -56.98 -62.82 1.48 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 -178.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.0 t -55.95 -22.04 24.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.032 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.9 mt -76.57 -26.15 54.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.59 133.22 46.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.405 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.82 -15.6 30.88 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -86.98 151.86 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -179.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.48 135.51 38.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.068 0.461 . . . . 0.0 110.298 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.0 t -127.0 136.71 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.684 -179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.45 138.65 14.36 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.9 t -131.02 161.62 40.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.03 0.443 . . . . 0.0 110.367 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.541 ' N ' HG12 ' A' ' 119' ' ' VAL . 43.2 tp -92.6 117.61 30.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.491 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.75 157.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.686 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.01 50.61 51.2 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 179.755 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.6 p -149.84 168.98 22.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.674 0.273 . . . . 0.0 110.877 -179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' A' ' 194' ' ' PHE . 80.8 p -73.81 -26.38 60.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.446 179.401 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 129' ' ' GLY . 88.0 mt-30 -60.66 -55.7 30.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.465 -179.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -56.66 -54.47 45.74 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.63 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -60.31 -51.25 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.675 -179.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.599 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 65.4 t80 -62.05 -43.73 98.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.101 0.477 . . . . 0.0 110.58 179.176 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.07 -44.47 97.72 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.523 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.23 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.4 tt0 -125.34 -34.15 2.74 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.786 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.599 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.0 t60 -74.47 -50.88 16.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.038 0.446 . . . . 0.0 111.533 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -99.07 12.61 35.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.99 -55.58 0.46 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.386 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.23 -10.44 25.76 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.783 2.322 . . . . 0.0 111.979 -179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -82.54 -8.88 59.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.425 -179.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.97 33.38 36.97 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.0 mt -109.67 138.27 38.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.0 110.593 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -87.92 129.81 35.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.301 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.0 pt -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.04 133.15 69.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 110.067 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.9 t -97.15 127.67 43.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.789 -179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -110.92 153.59 25.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.413 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.94 6.93 29.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.747 -179.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -131.91 130.43 5.94 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -65.96 -45.83 80.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.714 0.292 . . . . 0.0 110.417 179.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.11 -23.72 63.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.526 -179.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.453 ' O ' ' OG ' ' A' ' 151' ' ' SER . 58.2 t-20 -64.72 -36.43 84.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.486 179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.3 -47.12 85.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.109 -179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 60.2 m-85 -63.56 -37.86 88.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.396 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.3 p -61.21 -42.72 99.08 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.229 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.43 -45.32 91.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.134 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.552 ' HB2' HD11 ' A' ' 158' ' ' ILE . 42.8 tp -58.76 -48.19 82.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.189 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 25.1 m -62.73 -22.9 66.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.947 0.403 . . . . 0.0 110.22 179.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.77 -18.22 25.31 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.622 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.71 11.24 71.34 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -69.43 -17.87 63.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.971 0.415 . . . . 0.0 110.631 179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 153' ' ' LEU . 37.4 pt -128.5 137.36 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.43 179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.06 -27.89 62.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.21 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.63 155.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.811 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.37 50.71 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.019 179.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -85.63 103.12 14.16 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.277 0.56 . . . . 0.0 110.761 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.591 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.0 tt0 -132.35 165.06 25.09 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.375 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.469 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.19 152.36 41.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.987 0.422 . . . . 0.0 110.526 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.426 ' CD ' ' O ' ' A' ' 241' ' ' GLY . 97.2 mt-10 -66.01 -54.28 28.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.212 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.434 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.3 t -59.78 -49.3 84.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.67 -179.295 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.83 -38.8 86.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.678 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.67 1.09 Allowed 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.583 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 173' ' ' LEU . 75.6 m -58.61 -47.62 83.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.73 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.3 tt0 -48.75 -38.68 22.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.268 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.452 ' C ' HE21 ' A' ' 175' ' ' GLN . . . -109.69 -65.65 0.55 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.678 ' N ' ' O ' ' A' ' 168' ' ' ALA . 30.7 t80 -40.23 -71.13 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.704 -0.292 . . . . 0.0 111.235 -178.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.3 mt -61.39 -39.81 92.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.6 tttt -59.79 -3.11 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.461 0.648 . . . . 0.0 110.535 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 177' ' ' VAL . 53.5 mt-30 -124.68 141.79 38.94 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -43.92 -14.72 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.797 2.331 . . . . 0.0 112.197 179.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 175' ' ' GLN . 84.9 t -63.17 -42.78 97.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.91 81.5 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.009 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.1 -41.28 96.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.622 0.248 . . . . 0.0 110.449 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.6 m-20 -65.98 -34.61 78.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.457 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 76.9 m-85 -157.44 143.5 17.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.74 -179.496 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.8 pttt -177.08 100.25 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.744 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.1 m-85 -159.49 167.74 27.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.654 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 81.57 55.65 3.15 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.59 -117.31 0.01 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -179.756 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.57 135.23 33.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.518 2.146 . . . . 0.0 111.953 179.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 92.1 p -125.24 -108.0 0.32 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.503 -179.023 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.3 p -166.14 165.22 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.366 -179.408 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.3 tttt 153.26 155.84 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 123.758 0.661 . . . . 0.0 110.668 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -82.36 118.17 22.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.852 179.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.591 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.6 mp0 -71.87 -18.69 62.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -63.86 -32.08 73.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.592 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.457 HD11 ' CG ' ' A' ' 128' ' ' PHE . 92.6 mt -60.98 -44.26 97.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.459 ' CE2' ' OG1' ' A' ' 124' ' ' THR . 46.0 m-85 -113.71 7.51 17.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.78 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 73.35 -155.5 50.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.649 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.5 p -70.54 -25.28 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.0 110.63 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.462 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.96 -126.16 1.56 Allowed Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.5 p -131.99 160.02 37.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.79 0.329 . . . . 0.0 110.483 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.7 -162.46 24.87 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.508 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 94.9 mtp -98.17 141.16 31.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.929 0.395 . . . . 0.0 110.623 -179.805 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.26 111.9 3.98 Favored Glycine 0 C--N 1.329 0.185 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.6 mt -120.98 160.82 22.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.7 mtm180 -87.38 149.07 24.72 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 120.852 0.358 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.09 -48.93 64.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.627 -179.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -40.14 -22.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.019 0.438 . . . . 0.0 110.74 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.8 m-20 -72.25 52.23 0.26 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -64.51 -46.06 84.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.246 -179.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.54 -47.06 35.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.221 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.19 -44.07 97.42 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.451 -179.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.4 -43.0 99.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.919 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -57.6 -37.28 72.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.792 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.704 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.99 0.1 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.981 HD21 HD11 ' A' ' 44' ' ' ILE . 86.8 mt -28.11 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.71 0.29 . . . . 0.0 110.358 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.8 m-20 -63.53 -45.51 90.26 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.582 178.238 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.34 -43.62 98.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.34 93.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.057 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -61.19 -43.56 98.69 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.5 93.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.221 -179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.66 -43.08 97.79 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.841 179.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.509 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.9 mtp -56.79 -38.26 72.29 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -69.99 -38.81 76.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.945 0.403 . . . . 0.0 110.302 178.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.96 -45.12 93.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.659 -179.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.509 ' OD1' ' O ' ' A' ' 220' ' ' MET . 20.7 p-10 -88.73 0.41 56.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.682 179.499 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.57 20.24 67.74 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.461 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 89.1 m -57.83 -46.38 84.84 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.51 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.464 ' CZ ' ' O ' ' A' ' 90' ' ' LEU . 83.3 t80 -63.45 -58.01 8.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.414 179.234 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.23 -41.74 76.18 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.565 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.53 -48.45 80.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.642 -179.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.85 -41.41 97.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.368 179.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.09 -50.21 74.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.508 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.18 -35.77 72.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.669 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -70.62 -51.09 30.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.42 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.514 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 36.9 m-85 -62.18 -45.77 91.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.621 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 69.1 m-85 -153.57 155.0 35.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.515 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.6 p-10 -97.95 98.24 9.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.001 0.429 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -155.24 -165.43 2.01 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.591 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.423 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 45.9 t0 -122.67 109.41 14.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.774 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 239' ' ' TYR . 23.5 m -63.86 -40.56 89.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.478 179.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 238' ' ' VAL . 84.5 m-85 -56.7 -43.75 80.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.326 -179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.32 -36.95 94.09 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.426 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.697 0 CA-C-O 117.908 -1.496 . . . . 0.0 110.955 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.58 164.29 59.17 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.593 179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.89 143.55 99.38 Favored 'Trans proline' 0 C--N 1.301 -1.943 0 C-N-CA 122.58 2.187 . . . . 0.0 112.295 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' OD1' ' A' ' 8' ' ' ASN . 99.3 mm-40 -66.23 -40.23 90.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.493 179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 7' ' ' GLN . 98.2 m-20 -139.76 142.22 36.78 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.401 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 83.3 mt -109.41 128.68 65.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 110.511 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 85.5 mtp180 -103.41 117.02 33.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.154 0.502 . . . . 0.0 110.379 179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -111.97 139.13 37.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.555 -179.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -107.98 105.26 2.18 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -128.12 119.1 24.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.255 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.534 ' HB2' ' H ' ' A' ' 53' ' ' ASN . 17.9 t0 -113.63 93.35 27.7 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.121 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.48 134.27 60.75 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.418 2.079 . . . . 0.0 112.132 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 p -141.48 -19.6 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.674 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' O ' ' C ' ' A' ' 18' ' ' ALA . 96.9 m-85 -124.52 98.9 5.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.721 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.736 ' HB3' ' CD ' ' A' ' 19' ' ' PRO . . . -28.98 -61.66 0.22 Allowed Pre-proline 0 C--O 1.219 -0.531 0 CA-C-O 121.363 0.601 . . . . 0.0 110.987 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.736 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 5.8 Cg_endo -49.4 -39.45 44.38 Favored 'Trans proline' 0 C--N 1.296 -2.222 0 C-N-CA 122.26 1.973 . . . . 0.0 112.248 -179.232 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 17' ' ' TYR . 27.7 t80 -79.06 -42.53 26.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.978 0.418 . . . . 0.0 111.174 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.678 ' O ' ' O ' ' A' ' 18' ' ' ALA . 95.8 mt-10 -149.45 -155.64 0.65 Allowed 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.032 -178.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 23' ' ' LYS . 1.2 t 160.53 178.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.092 0.472 . . . . 0.0 110.4 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' N ' ' OG ' ' A' ' 22' ' ' SER . 99.3 mttt -136.04 143.77 44.89 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.436 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 25' ' ' SER . 62.0 t-20 -96.22 141.38 29.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.452 179.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.524 ' N ' ' OD1' ' A' ' 24' ' ' ASN . 78.3 p -65.83 -19.09 65.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.573 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -78.08 -6.89 56.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.447 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.13 -7.05 58.44 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -79.73 158.51 26.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.4 mt -112.17 133.92 54.02 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.967 0.413 . . . . 0.0 110.43 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.666 ' C ' HD12 ' A' ' 34' ' ' ILE . 3.4 p -133.26 150.93 32.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.307 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 164.76 151.38 6.55 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -58.48 -41.69 85.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.905 0.383 . . . . 0.0 110.919 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.471 ' OD1' ' SD ' ' A' ' 71' ' ' MET . 35.0 t0 -70.71 -28.33 64.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.231 -179.661 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.666 HD12 ' C ' ' A' ' 30' ' ' VAL . 96.6 mt -68.48 -41.23 83.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.047 179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.403 ' OD2' ' OH ' ' A' ' 233' ' ' TYR . 54.2 m-20 -60.89 -37.06 80.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.029 -178.468 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -66.81 -43.81 82.86 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.07 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.536 ' O ' ' SG ' ' A' ' 41' ' ' CYS . . . -59.92 -41.72 92.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.333 -179.124 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -58.89 -53.61 56.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.58 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -53.86 -36.56 62.73 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.913 0.387 . . . . 0.0 110.309 179.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.1 mt -69.67 -42.42 74.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 178.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 59.5 m -54.35 -44.71 72.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.158 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 66.2 tttm -63.91 -47.74 79.35 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.058 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -59.46 -40.85 88.22 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.163 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.974 HD11 HD21 ' A' ' 213' ' ' LEU . 96.6 mt -76.34 -17.97 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.536 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 42' ' ' LYS . 98.3 m-20 60.77 52.79 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.545 -179.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.1 p -145.55 170.58 16.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.922 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -88.46 140.77 29.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.074 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 54.8 m -117.3 131.74 56.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.725 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.7 m -128.24 127.63 43.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.481 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -94.15 135.79 35.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 110.595 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.5 t -129.64 128.52 65.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.361 179.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -66.02 139.56 58.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.534 ' H ' ' HB2' ' A' ' 14' ' ' ASP . 1.2 p30 174.87 131.81 0.14 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.838 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.9 Cg_endo -68.05 144.78 65.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.745 2.297 . . . . 0.0 112.477 -179.388 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.878 HD23 HD12 ' A' ' 58' ' ' LEU . 83.3 mt -40.23 -56.0 2.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -47.98 -26.28 1.7 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.16 -179.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 54' ' ' PRO . . . -95.44 -20.65 18.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.878 HD12 HD23 ' A' ' 55' ' ' LEU . 57.3 mt -63.99 -42.3 97.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.656 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.717 ' HB ' ' HD3' ' A' ' 60' ' ' PRO . 1.5 mm -62.54 -56.68 27.71 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.93 -179.291 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.717 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 46.3 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 122.599 2.199 . . . . 0.0 111.12 177.232 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.5 m -58.86 -44.6 91.07 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.729 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 tp -58.22 -44.36 88.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -64.53 -40.48 95.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.972 0.415 . . . . 0.0 110.443 178.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.21 11.13 1.62 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.507 -179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.06 12.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' CZ ' ' A' ' 10' ' ' ARG . 97.2 mttt -63.36 -34.36 77.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.584 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.87 153.89 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.339 -179.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' HB2' ' H ' ' A' ' 10' ' ' ARG . 96.0 m-20 -93.4 -20.83 19.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.329 -179.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.52 157.76 25.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.783 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.591 HG23 HD13 ' A' ' 58' ' ' LEU . 96.2 mt -115.8 127.43 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.066 0.46 . . . . 0.0 110.502 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.471 ' SD ' ' OD1' ' A' ' 33' ' ' ASP . 62.4 ttp -128.82 106.89 9.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.395 179.761 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.583 ' OG ' HD21 ' A' ' 55' ' ' LEU . 47.6 t -160.74 -177.7 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.583 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 74' ' ' LEU . 78.2 p -64.14 -15.86 60.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.348 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.64 ' CD1' HH12 ' A' ' 80' ' ' ARG . 37.3 tp -37.98 123.52 1.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.993 0.425 . . . . 0.0 110.455 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.561 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 10.8 p -83.4 156.85 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.703 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.651 HD11 ' CG1' ' A' ' 196' ' ' VAL . 49.2 pt -105.22 149.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.356 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.4 p -150.17 152.68 35.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.835 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -50.42 -47.48 56.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.574 -179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -55.73 -39.85 71.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.602 -179.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.64 HH12 ' CD1' ' A' ' 74' ' ' LEU . 92.3 mtt180 -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.026 0.441 . . . . 0.0 110.962 178.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 84' ' ' ILE . 88.6 mt-30 -58.25 -37.18 74.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.822 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -60.48 -27.57 67.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.087 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.44 -51.73 7.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.0 110.531 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLN . 39.1 pt -138.24 -168.59 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-O 121.122 0.487 . . . . 0.0 110.452 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 202' ' ' LEU . . . -105.94 146.6 29.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 76' ' ' ILE . 73.0 m-85 -129.72 149.97 51.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 89' ' ' LYS . 9.7 t -164.26 -151.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.437 179.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 89' ' ' LYS . 98.4 m-20 42.88 19.35 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.767 179.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 88' ' ' ASP . 99.4 mttt -28.39 120.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.403 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.468 ' O ' ' CE1' ' A' ' 226' ' ' TYR . 15.9 mt -77.02 -69.88 0.5 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.888 -178.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.441 ' CG ' HG21 ' A' ' 166' ' ' VAL . 45.9 p90 -149.27 166.28 29.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.64 -179.704 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.41 121.56 27.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.065 0.46 . . . . 0.0 110.308 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.46 ' H ' ' HA2' ' A' ' 197' ' ' GLY . . . -102.77 69.52 1.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.763 -179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.92 -104.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.484 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 188' ' ' VAL . 28.7 p -159.22 165.62 33.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.777 -179.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' GLN . 79.0 ttt-85 -155.49 146.11 22.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.08 0.467 . . . . 0.0 110.438 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 184' ' ' GLY . 10.6 mt -101.4 135.93 42.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.987 0.423 . . . . 0.0 110.818 178.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 t -122.56 110.62 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.484 HG12 ' HB2' ' A' ' 160' ' ' ALA . 3.3 m -134.3 165.02 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 -179.39 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.79 23.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.79 -27.95 45.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -59.12 -41.79 89.04 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.318 -179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -102.35 122.21 43.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.02 0.438 . . . . 0.0 110.257 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -87.7 108.92 19.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.085 0.469 . . . . 0.0 110.425 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.07 129.92 69.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.751 179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.469 ' CD ' ' N ' ' A' ' 106' ' ' GLN . 0.0 OUTLIER -111.59 159.18 34.14 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.95 0.405 . . . . 0.0 110.511 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.46 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.2 Cg_endo -59.32 89.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.674 2.249 . . . . 0.0 111.891 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 110' ' ' GLU . 7.2 m -169.2 140.82 2.45 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 123.459 0.474 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 p -67.09 -32.71 59.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.145 179.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.507 ' H ' HG22 ' A' ' 108' ' ' THR . 47.1 tp10 -57.23 -62.95 1.4 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 -178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 t -55.74 -22.17 22.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.015 -179.154 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 38.3 mt -76.4 -26.21 55.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.21 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -54.4 132.71 44.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.435 -179.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.14 -15.93 30.99 Favored Glycine 0 C--N 1.331 0.285 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -86.15 151.34 23.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.0 110.441 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -96.72 136.11 37.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.294 -179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.06 136.65 60.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.731 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -105.56 138.26 14.17 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 120' ' ' LEU . 55.1 t -131.26 161.75 40.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.055 0.455 . . . . 0.0 110.352 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.549 ' N ' HG12 ' A' ' 119' ' ' VAL . 40.0 tp -93.05 119.63 32.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.548 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -52.04 157.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.58 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.97 50.72 50.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.1 p -149.05 167.97 24.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.715 0.293 . . . . 0.0 110.886 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 128' ' ' PHE . 81.3 p -74.06 -26.22 60.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.392 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 129' ' ' GLY . 87.8 mt-30 -60.79 -55.47 32.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.49 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -57.21 -53.78 54.28 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.675 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.1 m -60.58 -51.34 69.83 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.782 -179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.597 ' CZ ' ' ND1' ' A' ' 132' ' ' HIS . 66.1 t80 -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.131 0.491 . . . . 0.0 110.489 179.207 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 131' ' ' GLU . . . -62.19 -44.49 97.63 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 111.276 -0.729 . . . . 0.0 111.276 -179.282 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.532 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 99.0 m-20 -45.43 -14.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 129' ' ' GLY . 83.5 tt0 -125.24 -34.1 2.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.803 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.597 ' ND1' ' CZ ' ' A' ' 128' ' ' PHE . 8.2 t60 -74.56 -50.52 17.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.026 0.441 . . . . 0.0 111.586 -178.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -98.94 12.5 35.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.272 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.774 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . . . -83.92 -55.32 0.47 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.38 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 134' ' ' ALA . 56.0 Cg_endo -72.2 -10.71 26.18 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.778 2.319 . . . . 0.0 111.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -8.9 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.39 -179.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.82 33.43 37.46 Favored Glycine 0 CA--C 1.52 0.399 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.29 138.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.644 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -88.06 130.01 35.12 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.229 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.53 139.31 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.6 132.39 70.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.962 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -98.44 130.32 45.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -111.55 156.55 21.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.053 0.454 . . . . 0.0 110.375 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -106.87 6.26 29.19 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.739 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -130.73 130.8 6.24 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.405 ' OE1' HD22 ' A' ' 120' ' ' LEU . 68.8 tp60 -66.13 -45.9 79.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.695 0.283 . . . . 0.0 110.4 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -70.63 -23.31 62.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.532 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.457 ' O ' ' OG ' ' A' ' 151' ' ' SER . 57.2 t-20 -64.54 -36.77 85.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.507 179.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.7 mt -66.04 -47.16 85.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.26 -179.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.513 ' OH ' ' NE2' ' A' ' 163' ' ' GLN . 62.7 m-85 -64.36 -37.56 87.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.324 179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 148' ' ' ASN . 78.2 p -60.81 -42.17 97.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.055 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.95 -43.02 94.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.92 179.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.577 ' HB2' HD11 ' A' ' 158' ' ' ILE . 43.3 tp -59.48 -47.94 83.58 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.024 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.4 m -62.63 -22.74 66.64 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -90.91 -17.52 26.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.659 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.38 11.82 74.38 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -69.72 -18.11 63.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.589 179.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 153' ' ' LEU . 35.3 pt -127.15 136.23 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.377 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.4 ' O ' HG12 ' A' ' 99' ' ' VAL . 97.6 m-20 -72.82 -28.9 62.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.302 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.484 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -175.11 155.55 1.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.835 -179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -129.13 138.04 51.56 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.277 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -86.25 102.93 14.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.265 0.555 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 96' ' ' ARG . 50.8 tt0 -132.24 164.87 25.42 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.388 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.475 ' N ' ' HG2' ' A' ' 163' ' ' GLN . 98.2 m-20 -73.14 152.98 40.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.968 0.413 . . . . 0.0 110.549 179.37 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.432 ' OE1' ' O ' ' A' ' 237' ' ' ASP . 97.6 mt-10 -66.08 -54.38 26.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.295 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.441 HG21 ' CG ' ' A' ' 91' ' ' TYR . 72.6 t -60.07 -49.27 84.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.709 -179.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.06 88.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.788 0.327 . . . . 0.0 110.851 179.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 172' ' ' PHE . . . -64.08 -63.78 1.06 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.678 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.44 ' OG ' HD12 ' A' ' 173' ' ' LEU . 74.6 m -58.64 -47.45 84.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.708 -179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 174' ' ' LYS . 81.5 tt0 -49.13 -38.4 25.0 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.228 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -109.67 -65.56 0.55 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.496 -0.641 . . . . 0.0 111.496 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.683 ' N ' ' O ' ' A' ' 168' ' ' ALA . 31.7 t80 -40.34 -71.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.722 0.296 . . . . 0.0 111.312 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 175' ' ' GLN . 95.8 mt -61.53 -39.61 91.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.044 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 170' ' ' GLU . 87.7 tttt -60.06 -3.19 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.515 -179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 177' ' ' VAL . 61.4 mt-30 -124.28 142.28 39.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -44.1 -15.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.833 2.355 . . . . 0.0 112.22 179.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 175' ' ' GLN . 85.3 t -62.98 -42.75 97.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.01 82.37 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -179.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -61.0 -41.29 96.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.673 0.273 . . . . 0.0 110.509 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 181' ' ' TYR . 54.4 m-20 -66.02 -34.58 78.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.388 179.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 180' ' ' ASP . 75.9 m-85 -157.07 143.21 17.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 183' ' ' PHE . 41.5 pttt -176.91 99.91 0.05 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.9 0.381 . . . . 0.0 110.782 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.547 ' CD2' ' O ' ' A' ' 182' ' ' LYS . 91.4 m-85 -159.26 166.73 30.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.729 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 185' ' ' GLY . . . 82.45 56.01 2.91 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.567 ' O ' ' O ' ' A' ' 184' ' ' GLY . . . -50.29 -117.41 0.01 OUTLIER Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.8 135.51 35.33 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.478 2.119 . . . . 0.0 111.9 179.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 188' ' ' VAL . 93.5 p -125.15 -107.87 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.552 -179.03 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.677 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 7.0 p -166.5 165.39 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.351 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.677 ' HB2' ' O ' ' A' ' 188' ' ' VAL . 87.2 tttt 153.21 156.42 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.748 0.655 . . . . 0.0 110.625 179.358 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -82.88 117.98 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.594 ' O ' ' N ' ' A' ' 195' ' ' GLY . 55.5 mp0 -71.27 -18.65 62.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -63.74 -32.01 73.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.581 -179.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.455 HD11 ' CG ' ' A' ' 128' ' ' PHE . 93.0 mt -61.06 -44.29 97.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.772 -178.183 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.7 7.68 17.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.763 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 191' ' ' GLU . . . 72.89 -155.4 50.85 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.651 ' CG1' HD11 ' A' ' 76' ' ' ILE . 14.1 p -70.32 -25.52 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.581 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.46 ' HA2' ' H ' ' A' ' 93' ' ' ALA . . . 160.65 -126.36 1.6 Allowed Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -179.355 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 26.4 p -131.66 159.64 37.72 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.793 0.33 . . . . 0.0 110.47 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.52 -162.61 24.96 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.507 ' SD ' ' OD2' ' A' ' 88' ' ' ASP . 95.0 mtp -98.32 141.18 31.54 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.967 0.413 . . . . 0.0 110.579 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -90.13 111.04 3.84 Favored Glycine 0 C--N 1.329 0.173 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 85' ' ' ALA . 86.7 mt -119.71 160.52 22.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.992 0.425 . . . . 0.0 110.202 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 206' ' ' ASP . 88.5 mtm180 -87.28 149.03 24.83 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.847 0.356 . . . . 0.0 110.505 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 206' ' ' ASP . 68.5 mttm -52.33 -48.77 65.28 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.685 -179.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -40.63 -22.39 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.123 0.487 . . . . 0.0 110.682 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 204' ' ' LYS . 98.5 m-20 -72.08 52.18 0.24 Allowed 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.769 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -64.45 -45.88 85.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.301 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -74.62 -47.14 33.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.055 0.455 . . . . 0.0 111.279 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 60.9 tp -62.18 -44.08 97.4 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.499 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 206' ' ' ASP . 78.3 ttt-85 -62.49 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.864 179.536 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.75 -37.33 73.42 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.703 ' O ' ' N ' ' A' ' 215' ' ' LYS . . . -73.8 -77.92 0.1 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.974 HD21 HD11 ' A' ' 44' ' ' ILE . 86.2 mt -28.39 -45.7 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 0.0 110.322 179.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 212' ' ' ALA . 88.1 m-20 -63.57 -45.54 89.97 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.495 178.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 212' ' ' ALA . 65.9 tttm -61.47 -43.59 98.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.49 -39.25 92.86 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.045 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -61.14 -43.7 98.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 110.002 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -62.18 -39.51 92.95 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.179 -179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.523 ' OE2' ' NZ ' ' A' ' 215' ' ' LYS . 97.4 mt-10 -63.54 -43.13 98.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' MET . . . . . 0.507 ' O ' ' OD1' ' A' ' 223' ' ' ASP . 91.8 mtp -56.84 -38.27 72.42 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -69.89 -38.84 76.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 0.0 110.364 178.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.35 93.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.739 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 223' ' ' ASP . 20.9 p-10 -88.34 0.44 56.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.681 179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 65.34 20.3 67.37 Favored Glycine 0 CA--C 1.52 0.367 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 223' ' ' ASP . 87.1 m -58.01 -46.36 85.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 90' ' ' LEU . 82.0 t80 -63.47 -57.88 8.82 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.391 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.33 -41.72 76.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.514 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.66 -48.19 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.686 -179.539 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.15 -41.48 98.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.237 179.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 234' ' ' PHE . . . -59.17 -50.11 75.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.532 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -58.21 -35.8 72.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.59 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -70.44 -50.91 33.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.496 ' O ' ' CD1' ' A' ' 234' ' ' PHE . 37.2 m-85 -62.5 -45.28 93.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.521 179.444 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 233' ' ' TYR . 72.1 m-85 -153.93 155.02 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.526 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 235' ' ' ASP . 47.3 p-10 -98.34 98.63 9.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.979 0.419 . . . . 0.0 110.511 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -155.59 -165.11 1.89 Allowed 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.577 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 165' ' ' GLU . 46.0 t0 -122.67 109.15 13.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.803 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 239' ' ' TYR . 25.1 m -63.72 -40.53 89.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.421 179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.431 ' N ' HG23 ' A' ' 238' ' ' VAL . 85.8 m-85 -56.76 -43.71 81.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.248 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -63.42 -36.77 93.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . 0.423 ' O ' ' CD ' ' A' ' 165' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.663 0 CA-C-O 117.853 -1.526 . . . . 0.0 110.976 179.875 . . . . . . . . 1 1 . 1 stop_ save_